PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Barber, BR; Xu, JW; Perez-Losada, M; Jara, CG; Crandall, KA				Barber, Brian R.; Xu, Jiawu; Perez-Losada, Marcos; Jara, Carlos G.; Crandall, Keith A.			Conflicting Evolutionary Patterns Due to Mitochondrial Introgression and Multilocus Phylogeography of the Patagonian Freshwater Crab Aegla neuquensis	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; SOUTHERN; GENE; GLACIATIONS; INFERENCE; AEGLIDAE; MAXIMUM; ANOMURA; NUCLEAR; DNA	Background: Multiple loci and population genetic methods were employed to study the phylogeographic history of the Patagonian freshwater crab Aegla neuquensis (Aeglidae: Decopoda). This taxon occurs in two large river systems in the Patagonian Steppe, from the foothills of the Andes Mountains east to the Atlantic Ocean. Methodology/Principal Findings: A nuclear phylogeny and multilocus nested clade phylogeographic analysis detected a fragmentation event between the Negro and Chico-Chubut river systems. This event occurred approximately 137 thousand years ago. An isolation-with-migration analysis and maximum-likelihood estimates of gene flow showed asymmetrical exchange of genetic material between these two river systems exclusively in their headwaters. We used information theory to determine the best-fit demographic history between these two river systems under an isolation-with-migration model. The best-fit model suggests that the Negro and the ancestral populations have the same effective population sizes; whereas the Chico-Chubut population is smaller and shows that gene flow from the Chico-Chubut into the Negro is four times higher than in the reverse direction. Much of the Chico-Chubut system appears to have only been recently colonized while the Negro populations appear to have been in place for most of the evolutionary history of this taxon. Conclusions/Significance: Due to mitochondrial introgression, three nuclear loci provided different phylogeographic resolution than the three mitochondrial genes for an ancient fragmentation event observed in the nuclear phylogeny. However, the mitochondrial locus provided greater resolution on more recent evolutionary events. Our study, therefore, demonstrates the need to include both nuclear and mitochondrial loci for a more complete understanding of evolutionary histories and associated phylogeographic events. Our results suggest that gene flow between these systems, before and after fragmentation was through periodic paleolakes that formed in the headwaters region. Fragmentation between the Negro and Chico-Chubut systems was driven by the disappearance of these paleolakes during the Patagonian Glaciation.	[Barber, Brian R.; Xu, Jiawu; Crandall, Keith A.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Jara, Carlos G.] Univ Austral Chile, Inst Zool, Valdivia, Chile; [Crandall, Keith A.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA; [Perez-Losada, Marcos] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal	Brigham Young University; Universidad Austral de Chile; Brigham Young University; Universidade do Porto	Barber, BR (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	brbarber76@gmail.com	Crandall, Keith A./H-2789-2019; Xu, Jiawu/K-5276-2013; Perez-Losada, Marcos/I-4407-2013	Crandall, Keith A./0000-0002-0836-3389; Xu, Jiawu/0000-0002-0424-0736; Perez-Losada, Marcos/0000-0002-2585-4657	U.S. National Science Foundation (NSF) PIRE for research on Patagonian Biodiversity	U.S. National Science Foundation (NSF) PIRE for research on Patagonian Biodiversity(National Science Foundation (NSF))	This work was funded by a grant from the U.S. National Science Foundation (NSF) PIRE for research on Patagonian Biodiversity to support collaboration among the following institutions (listed alphabetically): Brigham Young University, Centro Nacional Patagonico (AR), Dalhousie University, Instituto Botanico Darwinion (AR), Universidad Austral de Chile, Universidad Nacional del Comahue, Universidad de Concepcion, and George Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Avise J, 2004, MOL MARKERS NATURAL; Avise JC, 2000, PHYLOGEOGRAPHY HIST, Vviii; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barber BR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-343; Barrowclough GF, 2009, MOL ECOL, V18, P2934, DOI 10.1111/j.1365-294X.2009.04271.x; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli Peter, 2009, V17, P42; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Carstens BC, 2009, MOL ECOL, V18, P4270, DOI 10.1111/j.1365-294X.2009.04327.x; Clapperton CM, 1993, QUATERNARY GEOLOGY G; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Edwards SV, 2000, EVOLUTION, V54, P1839; Ponce JF, 2011, BIOL J LINN SOC, V103, P363, DOI 10.1111/j.1095-8312.2011.01653.x; Fetzner JW, 2003, EVOLUTION, V57, P2101; Folguera A, 2011, BIOL J LINN SOC, V103, P250, DOI 10.1111/j.1095-8312.2011.01687.x; Garrick RC, 2008, MOL ECOL, V17, P1401, DOI 10.1111/j.1365-294X.2008.03675.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; HUNT WG, 1973, HEREDITY, V31, P11; John HM, 1991, ADAPTIVE PROTEIN EVO; Johnson JB, 2009, MOL ECOL, V18, P4137, DOI 10.1111/j.1365-294X.2009.04328.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knowles LL, 2008, EVOLUTION, V62, P2713, DOI 10.1111/j.1558-5646.2008.00481.x; Laurent E, 2006, ARLEQUIN VER 3 1 INT; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; Morrone J, 1994, J BIOGEOGR, V21, P13; Perez-Losada M, 2004, SYST BIOL, V53, P767, DOI 10.1080/10635150490522331; Perez-Losada M, 2002, BIOL CONSERV, V105, P345, DOI 10.1016/S0006-3207(01)00218-X; Perez-Losada M, 2002, J CRUSTACEAN BIOL, V22, P304, DOI 10.1651/0278-0372(2002)022[0304:PRATSO]2.0.CO;2; Perez-Losada M, 2009, CONSERV BIOL, V23, P692, DOI 10.1111/j.1523-1739.2008.01161.x; Perez-Losada M, 2011, CRUSTACEAN ISS, V19, P291; Perry WL, 2001, EVOLUTION, V55, P1153; Petit RJ, 2008, MOL ECOL, V17, P516, DOI 10.1111/j.1365-294X.2007.03589.x; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWELL JR, 1983, P NATL ACAD SCI-BIOL, V80, P492, DOI 10.1073/pnas.80.2.492; RABASSA J, 1990, QUATERNARY SCI REV, V9, P153, DOI 10.1016/0277-3791(90)90016-4; Rabassa J, 2011, BIOL J LINN SOC, V103, P316, DOI 10.1111/j.1095-8312.2011.01681.x; Rice RW, 1989, ANAL TABLES STAT TES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; Ruzzante DE, 2006, MOL ECOL, V15, P2949, DOI 10.1111/j.1365-294X.2006.03010.x; Ruzzante DE, 2011, BIOL J LINN SOC, V103, P514, DOI 10.1111/j.1095-8312.2011.01682.x; Ruzzante DE, 2011, BIOL J LINN SOC, V103, P221, DOI 10.1111/j.1095-8312.2011.01693.x; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; Singer BS, 2004, GEOL SOC AM BULL, V116, P434, DOI 10.1130/B25177.1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sugden DE, 2005, GEOGR ANN A, V87A, P273, DOI 10.1111/j.0435-3676.2005.00259.x; Tamura K, MOL BIOL EVOLUTION, V28, P2731; Templeton AR, 2004, MOL ECOL, V13, P789, DOI 10.1046/j.1365-294X.2003.02041.x; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Teske PR, 2009, MOL ECOL RESOUR, V9, P774, DOI 10.1111/j.1755-0998.2009.02534.x; Unmack PJ, 2009, BIOL J LINN SOC, V97, P876, DOI 10.1111/j.1095-8312.2009.01224.x; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Xu JW, 2009, MOL ECOL, V18, P904, DOI 10.1111/j.1365-294X.2008.04070.x; Zattara EE, 2005, J BIOGEOGR, V32, P5, DOI 10.1111/j.1365-2699.2004.01164.x; Zemlak TS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-67; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x; Zink RM, 2004, PHILOS T ROY SOC B, V359, P215, DOI 10.1098/rstb.2003.1392; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	72	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37105	10.1371/journal.pone.0037105	http://dx.doi.org/10.1371/journal.pone.0037105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685541	Green Submitted, gold, Green Published			2022-12-27	WOS:000305351700005
J	Machne, R; Murray, DB				Machne, Rainer; Murray, Douglas B.			The Yin and Yang of Yeast Transcription: Elements of a Global Feedback System between Metabolism and Chromatin	PLOS ONE			English	Article							CYCLE-REGULATED GENES; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; REMODELING COMPLEX; EUKARYOTIC GENOME; RESPIRATORY OSCILLATIONS; BIDIRECTIONAL PROMOTERS; NUCLEOSOME ORGANIZATION; ENVIRONMENTAL-CHANGES; ESCHERICHIA-COLI	When grown in continuous culture, budding yeast cells tend to synchronize their respiratory activity to form a stable oscillation that percolates throughout cellular physiology and involves the majority of the protein-coding transcriptome. Oscillations in batch culture and at single cell level support the idea that these dynamics constitute a general growth principle. The precise molecular mechanisms and biological functions of the oscillation remain elusive. Fourier analysis of transcriptome time series datasets from two different oscillation periods (0.7 h and 5 h) reveals seven distinct co-expression clusters common to both systems (34% of all yeast ORF), which consolidate into two superclusters when correlated with a compilation of 1,327 unrelated transcriptome datasets. These superclusters encode for cell growth and anabolism during the phase of high, and mitochondrial growth, catabolism and stress response during the phase of low oxygen uptake. The promoters of each cluster are characterized by different nucleotide contents, promoter nucleosome configurations, and dependence on ATP-dependent nucleosome remodeling complexes. We show that the ATP: ADP ratio oscillates, compatible with alternating metabolic activity of the two superclusters and differential feedback on their transcription via activating (RSC) and repressive (Isw2) types of promoter structure remodeling. We propose a novel feedback mechanism, where the energetic state of the cell, reflected in the ATP: ADP ratio, gates the transcription of large, but functionally coherent groups of genes via differential effects of ATP-dependent nucleosome remodeling machineries. Besides providing a mechanistic hypothesis for the delayed negative feedback that results in the oscillatory phenotype, this mechanism may underpin the continuous adaptation of growth to environmental conditions.	[Machne, Rainer] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Murray, Douglas B.] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	University of Vienna; Keio University	Machne, R (corresponding author), Univ Vienna, Inst Theoret Chem, Vienna, Austria.	raim@tbi.univie.ac.at	Machne, Rainer/AAY-2159-2020	Machne, Rainer/0000-0002-1274-5099	Vienna Science and Technology Fund (WWTF) [MA07-30]; Marie Curie Actions Network project HARVEST [238017]; SFB 618 Theoretical Biology; AMS Redergasse; Tsuruoka City; Yamagata Prefecture; Japan Science and Technology agency	Vienna Science and Technology Fund (WWTF); Marie Curie Actions Network project HARVEST; SFB 618 Theoretical Biology; AMS Redergasse; Tsuruoka City(Tsuruoka City Government); Yamagata Prefecture; Japan Science and Technology agency(Japan Science & Technology Agency (JST))	RM acknowledges support by the Vienna Science and Technology Fund (WWTF), project #MA07-30, the Marie Curie Actions Network project HARVEST, project #238017, the SFB 618 Theoretical Biology, and AMS Redergasse. DBM thanks Tsuruoka City, Yamagata Prefecture and the Japan Science and Technology agency for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Aon MA, 2007, FEBS LETT, V581, P8, DOI 10.1016/j.febslet.2006.11.068; Aon MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003624; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Calza S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-140; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; FINN R. K., 1954, BULL MATH BIOPHYS, V16, P181, DOI 10.1007/BF02478374; FINN RK, 1954, J AGR FOOD CHEM, V2, P66, DOI 10.1021/jf60022a003; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Fourel G, 2002, J BIOL CHEM, V277, P41736, DOI 10.1074/jbc.M202578200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Ha CW, 2011, NUCLEIC ACIDS RES, V39, P1336, DOI 10.1093/nar/gkq895; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim BR, 2006, CURR GENOMICS, V7, P197, DOI 10.2174/138920206777780229; KIMMICH GA, 1975, ANAL BIOCHEM, V69, P187, DOI 10.1016/0003-2697(75)90580-1; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Knight JRP, 2012, CURR OPIN ONCOL, V24, P68, DOI 10.1097/CCO.0b013e32834d813b; Kwak WJ, 2003, FEMS MICROBIOL LETT, V219, P99, DOI 10.1016/S0378-1097(02)01198-9; Ladurner AG, 2009, CELL, V138, P18, DOI 10.1016/j.cell.2009.06.025; Lai LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-627; LARSSON CM, 1979, PLANT CELL PHYSIOL, V20, P145; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lelandais G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000409; Li CM, 2006, P NATL ACAD SCI USA, V103, P16254, DOI 10.1073/pnas.0604860103; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009894; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lloyd D, 2002, FEBS LETT, V519, P41, DOI 10.1016/S0014-5793(02)02704-7; Lloyd D, 2006, NAT REV MOL CELL BIO, V7, pA1, DOI 10.1038/nrm1980-cl; Lo K, 2008, CYTOM PART A, V73A, P321, DOI 10.1002/cyto.a.20531; Lo K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-145; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; Minorsky N., 1942, J APPL MECH, V9, pA65, DOI 10.1115/1.4009185; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; MUNCH T, 1992, J BIOTECHNOL, V22, P329, DOI 10.1016/0168-1656(92)90150-8; Murray DB, 2007, BIOSYSTEMS, V90, P287, DOI 10.1016/j.biosystems.2006.09.032; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Murray DB, 2006, NAT REV MOL CELL BIO, V7, pB1, DOI 10.1038/nrm1980-c2; Murtagh F., 1985, COMPSTAT LECT, V4; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Patnaik PR, 2003, BIOTECHNOL ADV, V21, P183, DOI 10.1016/S0734-9750(03)00022-3; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Ptitsyn AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S10; SATROUTDINOV AD, 1992, FEMS MICROBIOL LETT, V98, P261, DOI 10.1016/0378-1097(92)90167-M; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Silverman SJ, 2010, P NATL ACAD SCI USA, V107, P6946, DOI 10.1073/pnas.1002422107; Sirinakis G, 2011, EMBO J; Slavov N, 2011, P NATL ACAD SCI US; Slavov N, 2011, MOL BIOL CELL, V22, P1997, DOI 10.1091/mbc.E11-02-0132; Sohn HY, 2001, YEAST, V18, P125, DOI 10.1002/1097-0061(20010130)18:2<125::AID-YEA655>3.0.CO;2-9; Sonnenschein N, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-40; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tirosh I, 2007, TRENDS GENET, V23, P318, DOI 10.1016/j.tig.2007.03.015; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Trifonov E, 2011, PHYS LIFE REV; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; TU BP, 2006, NAT REV MOL CELL BIO, V7; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; van Vugt JJFA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006345; vanWorkum M, 1996, MOL MICROBIOL, V20, P351; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Wang JQ, 2000, FEMS MICROBIOL LETT, V189, P9, DOI 10.1111/j.1574-6968.2000.tb09198.x; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; WIJKER JE, 1995, BIOPHYS CHEM, V55, P153, DOI 10.1016/0301-4622(94)00148-D; Wittmann C, 2005, BIOTECHNOL BIOENG, V89, P839, DOI 10.1002/bit.20408; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	110	27	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37906	10.1371/journal.pone.0037906	http://dx.doi.org/10.1371/journal.pone.0037906			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685547	Green Published, gold			2022-12-27	WOS:000305351700010
J	Silva, AX; Jander, G; Samaniego, H; Ramsey, JS; Figueroa, CC				Silva, Andrea X.; Jander, Georg; Samaniego, Horacio; Ramsey, John S.; Figueroa, Christian C.			Insecticide Resistance Mechanisms in the Green Peach Aphid Myzus persicae (Hemiptera: Aphididae) I: A Transcriptomic Survey	PLOS ONE			English	Article							POTATO APHID; GENE-EXPRESSION; ESTERASE GENES; INSENSITIVE ACETYLCHOLINESTERASE; PYRETHROID INSECTICIDES; DETOXIFICATION ENZYMES; KNOCKDOWN RESISTANCE; HSP70 EXPRESSION; SULZER HEMIPTERA; MOLECULAR-BASIS	Background: Insecticide resistance is one of the best examples of rapid micro-evolution found in nature. Since the development of the first synthetic insecticide in 1939, humans have invested considerable effort to stay ahead of resistance phenotypes that repeatedly develop in insects. Aphids are a group of insects that have become global pests in agriculture and frequently exhibit insecticide resistance. The green peach aphid, Myzus persicae, has developed resistance to at least seventy different synthetic compounds, and different insecticide resistance mechanisms have been reported worldwide. Methodology/Principal Findings: To further characterize this resistance, we analyzed genome-wide transcriptional responses in three genotypes of M. persicae, each exhibiting different resistance mechanisms, in response to an anticholinesterase insecticide. The sensitive genotype (exhibiting no resistance mechanism) responded to the insecticide by up-regulating 183 genes primarily ones related to energy metabolism, detoxifying enzymes, proteins of extracellular transport, peptidases and cuticular proteins. The second genotype (resistant through a kdr sodium channel mutation), up-regulated 17 genes coding for detoxifying enzymes, peptidase and cuticular proteins. Finally, a multiply resistant genotype (carrying kdr and a modified acetylcholinesterase), up-regulated only 7 genes, appears not to require induced insecticide detoxification, and instead down-regulated many genes. Conclusions/Significance: This study suggests strongly that insecticide resistance in M. persicae is more complex that has been described, with the participation of a broad array of resistance mechanisms. The sensitive genotype exhibited the highest transcriptional plasticity, accounting for the wide range of potential adaptations to insecticides that this species can evolve. In contrast, the multiply resistant genotype exhibited a low transcriptional plasticity, even for the expression of genes encoding enzymes involved in insecticide detoxification. Our results emphasize the value of microarray studies to search for regulated genes in insects, but also highlights the many ways those different genotypes can assemble resistant phenotypes depending on the environmental pressure.	[Silva, Andrea X.; Figueroa, Christian C.] Univ Austral Chile, Inst Ciencias Ambient & Evolutivas, Fac Ciencias, Valdivia, Chile; [Jander, Georg; Ramsey, John S.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Samaniego, Horacio] Univ Austral Chile, Inst Silvicultura, Fac Ciencias Forestales & Recursos Nat, Valdivia, Chile; [Samaniego, Horacio] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA	Universidad Austral de Chile; Cornell University; Boyce Thompson Institute for Plant Research; Universidad Austral de Chile; United States Department of Energy (DOE); Los Alamos National Laboratory	Silva, AX (corresponding author), Univ Austral Chile, Inst Ciencias Ambient & Evolutivas, Fac Ciencias, Valdivia, Chile.	christianfigueroa@uach.cl	Figueroa, Christian C./A-1170-2008; Jander, Georg/E-7101-2012; Samaniego, Horacio/O-8820-2015; Li, Shiguang/G-7471-2012	Figueroa, Christian C./0000-0001-9218-5564; Samaniego, Horacio/0000-0002-2485-9827; Silva, Andrea/0000-0002-4346-5524	Comision Nacional de Investigacion Cientifica y Tecnologica; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1090378]; United States Department of Agriculture [2005-35604-15446]	Comision Nacional de Investigacion Cientifica y Tecnologica; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was funded by Comision Nacional de Investigacion Cientifica y Tecnologica doctoral grant to AXS, by Fondo Nacional de Desarrollo Cientifico y Tecnologico grant No1090378 to CCF, and by the United States Department of Agriculture grant No2005-35604-15446 to GJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2006, PEST MANAG SCI, V62, P805, DOI 10.1002/ps.1225; Ahmed S, 1998, INSECT BIOCHEM MOLEC, V28, P629, DOI 10.1016/S0965-1748(98)00061-7; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anstead JA, 2004, INSECT BIOCHEM MOLEC, V34, P871, DOI 10.1016/j.ibmb.2004.06.002; Anstead JA, 2008, AGR FOREST ENTOMOL, V10, P291, DOI 10.1111/j.1461-9563.2008.00388.x; Anthony N, 1998, MOL GEN GENET, V260, P165, DOI 10.1007/s004380050882; Artigas J, 1994, INSECTOS INTERES AGR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; Blackman R.L., 2000, J ECON ENTOMOL, V2; Blackman R. L., 1994, APHID WORLDS TREES I; Bluthgen H, 2005, GENOME INFORM, V16, P106; Bluthgen N, 2005, NUCLEIC ACIDS RES, V33, P272, DOI 10.1093/nar/gki167; Brisson JA, 2010, INSECT MOL BIOL, V19, P63, DOI 10.1111/j.1365-2583.2009.00935.x; Caillaud M., 2004, PROPOSAL SEQUENCE GE; Casals B. P., 2000, Revista Fruticola, V21, P5; Casals B. P., 1999, Agro-Ciencia, V15, P55; Castaneda LE, 2011, PHYSIOL ENTOMOL, V36, P253, DOI 10.1111/j.1365-3032.2011.00793.x; Choi J, 2002, PESTIC BIOCHEM PHYS, V74, P117, DOI 10.1016/S0048-3575(02)00154-2; Chowdhuri DK, 1999, PESTIC BIOCHEM PHYS, V63, P15, DOI 10.1006/pest.1998.2390; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Criniti A, 2008, PESTIC BIOCHEM PHYS, V90, P168, DOI 10.1016/j.pestbp.2007.11.005; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; DEVONSHIRE AL, 1992, B ENTOMOL RES, V82, P459, DOI 10.1017/S0007485300042516; DEVONSHIRE AL, 1982, PESTIC BIOCHEM PHYS, V18, P235, DOI 10.1016/0048-3575(82)90110-9; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eleftherianos I, 2008, B ENTOMOL RES, V98, P183, DOI 10.1017/S0007485307005524; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Field LM, 1998, BIOCHEM J, V330, P169; Field LM, 2000, BIOCHEM J, V349, P863, DOI 10.1042/bj3490863; Field LM, 2003, BIOL J LINN SOC, V79, P107, DOI 10.1046/j.1095-8312.2003.00178.x; Field LM, 1997, BIOCHEM J, V322, P867, DOI 10.1042/bj3220867; FIELD LM, 1993, BIOCHEM J, V294, P569, DOI 10.1042/bj2940569; FIELD LM, 1988, BIOCHEM J, V251, P309, DOI 10.1042/bj2510309; Field LM, 1999, BIOCHEM J, V339, P737, DOI 10.1042/0264-6021:3390737; Figueroa CC, 2007, INSECT SCI, V14, P29, DOI 10.1111/j.1744-7917.2007.00123.x; Finney D.J, 1952, STAT METHOD BIOL ASS; Foster SP, 2011, B ENTOMOL RES, V101, P659, DOI 10.1017/S0007485310000623; Foster SP, 1997, B ENTOMOL RES, V87, P573, DOI 10.1017/S0007485300038669; Foster SP, 1996, B ENTOMOL RES, V86, P17, DOI 10.1017/S0007485300052159; Francis F, 2006, INSECT BIOCHEM MOLEC, V36, P219, DOI 10.1016/j.ibmb.2006.01.018; Fuentes-Contreras E, 2004, B ENTOMOL RES, V94, P11, DOI 10.1079/BER2003275; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Georghiou G, 1991, OCCURRENCE RESISTANC; Guedes RNC, 2006, PHYSIOL ENTOMOL, V31, P30, DOI 10.1111/j.1365-3032.2005.00479.x; Guillemaud T, 2003, B ENTOMOL RES, V93, P289, DOI 10.1079/BER2003241; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Hardstone MC, 2009, J EVOLUTION BIOL, V22, P416, DOI 10.1111/j.1420-9101.2008.01661.x; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hodgson E, 2003, J BIOCHEM MOL TOXIC, V17, P201, DOI 10.1002/jbt.10080; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jackson CJ, 2010, ANTICHOLINESTERASE PESTICIDES: METABOLISM, NEUROTOXICITY, AND EPIDEMIOLOGY, P57; Klein C., 2000, CANBERRA ACIAR MONOG, V68; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685; Lertkiatmongkol P, 2010, J VECTOR ECOL, V35, P197, DOI 10.1111/j.1948-7134.2010.00047.x; LESK AM, 2007, INTRO GENOMICS; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lopes KVG, 2010, J INSECT PHYSIOL, V56, P1050, DOI 10.1016/j.jinsphys.2010.02.020; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Martinez-Torres D, 1999, INSECT MOL BIOL, V8, P339, DOI 10.1046/j.1365-2583.1999.83121.x; MartinezTorres D, 1997, PESTIC SCI, V51, P265, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;265::AID-PS626&gt;3.0.CO;2-P; MCKENZIE JA, 1994, TRENDS ECOL EVOL, V9, P166, DOI 10.1016/0169-5347(94)90079-5; McKenzie JA, 1998, PHILOS T ROY SOC B, V353, P1729, DOI 10.1098/rstb.1998.0325; McKenzie JA, EVOLUTIONARY ECOLOGY, P347; Medina P, 2002, ARCH INSECT BIOCHEM, V51, P91, DOI 10.1002/arch.10053; MOORES GD, 1994, PESTIC BIOCHEM PHYS, V49, P114, DOI 10.1006/pest.1994.1038; Moores GD, 2000, PROC BRIGHTON CROP, V1-3, P447; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Nabeshima T, 2003, BIOCHEM BIOPH RES CO, V307, P15, DOI 10.1016/S0006-291X(03)01101-X; Nauen R, 2003, B ENTOMOL RES, V93, P47, DOI 10.1079/BER2002215; Nazir A, 2001, ARCH ENVIRON CON TOX, V41, P443, DOI 10.1007/s002440010270; Nespolo RF, 2009, EVOLUTION, V63, P2402, DOI 10.1111/j.1558-5646.2009.00706.x; Oakeshott JG, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-202; Onstad D, 2008, INSECTICIDE RESISTAN, V1; Pedra JHF, 2005, PROTEOMICS, V5, P258, DOI 10.1002/pmic.200400914; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Philippou D, 2010, PEST MANAG SCI, V66, P390, DOI 10.1002/ps.1888; POTTER C, 1952, ANN APPL BIOL, V39, P1, DOI 10.1111/j.1744-7348.1952.tb00993.x; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Saleem AM, 1994, PAK J ZOOL, V26, P327; Schoonhoven L. M., 2005, Insect-plant biology; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Silva LB, 2010, COMP BIOCHEM PHYS B, V157, P80, DOI 10.1016/j.cbpb.2010.05.008; Simon JC, 2001, P 6 INT S APH; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sogorb MA, 2010, ANTICHOLINESTERASE PESTICIDES: METABOLISM, NEUROTOXICITY, AND EPIDEMIOLOGY, P121; Somwang P, 2011, PARASITOL RES, V109, P531, DOI 10.1007/s00436-011-2280-0; Srigiriraju L, 2010, CROP PROT, V29, P197, DOI 10.1016/j.cropro.2009.11.006; *STATSOFT I, STATISTICA DAT AN SO; Stevens M., 1996, British Sugar Beet Review, V64, P34; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Valles SM, 2000, PESTIC BIOCHEM PHYS, V66, P195, DOI 10.1006/pest.1999.2462; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; Vasquez B., 1995, BOOK INSECTS RECORDS; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; WALTER CM, 1989, COMP BIOCHEM PHYS C, V94, P419, DOI 10.1016/0742-8413(89)90091-1; Wang GP, 2010, MOL BIOTECHNOL, V46, P49, DOI 10.1007/s12033-010-9274-5; Whalon ME, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P1, DOI 10.1079/9781845933531.0000; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762; Zhang J, 2008, INSECT MOL BIOL, V17, P209, DOI 10.1111/j.1365-2583.2008.00796.x; Zhu YC, 2011, J INVERTEBR PATHOL, V106, P296, DOI 10.1016/j.jip.2010.10.007	118	138	151	3	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e36366	10.1371/journal.pone.0036366	http://dx.doi.org/10.1371/journal.pone.0036366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685538	gold, Green Submitted, Green Published			2022-12-27	WOS:000305351700002
J	Li, ZL; Liu, JC; Liu, SB; Li, XQ; Yi, DH; Zhao, MG				Li, Zi-lin; Liu, Jin-cheng; Liu, Shui-bing; Li, Xiao-qiang; Yi, Ding-hua; Zhao, Ming-gao			Improvement of Vascular Function by Acute and Chronic Treatment with the GPR30 Agonist G1 in Experimental Diabetes Mellitus	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-COUPLED RECEPTOR; ENDOTHELIUM-DEPENDENT VASODILATATION; PANCREATIC-ISLETS; MICE LACKING; ESTROGEN; ACTIVATION; PHOSPHORYLATION; CELLS; 17-BETA-ESTRADIOL	The G-protein coupled estrogen receptor 30 (GPR30) is a seven-transmembrane domain receptor that mediates rapid estrogen responses in a wide variety of cell types. This receptor is highly expressed in the cardiovascular system, and exerts vasodilatory effects. The objective of the present study was to investigate the effects of GPR30 on vascular responsiveness in diabetic ovariectomized (OVX) rats and elucidate the possible mechanism involved. The roles of GPR30 were evaluated in the thoracic aorta and cultured endothelial cells. The GPR30 agonist G1 induced a dose-dependent vasodilation in the thoracic aorta of the diabetic OVX rats, which was partially attenuated by the nitric oxide synthase (NOS) inhibitor, nitro-L-arginine methylester (L-NAME) and the GPR30-selective antagonist G15. Dose-dependent vasoconstrictive responses to phenylephrine were attenuated significantly in the rings of the thoracic aorta following the acute G1 administration in the diabetic OVX rats. This effect of G1 was abolished partially by L-NAME and G15. The acute administration of G1 increased significantly the eNOS activity and the concentration of NO in the endothelial cells exposed to high glucose. G1 treatment induced an enhanced endothelium-dependent relaxation to acetylcholine (Ach) in the diabetic OVX rats. Further examination revealed that G1 induced vasodilation in the diabetic OVX rats by increasing the phosphorylation of eNOS. These findings provide preliminary evidence that GPR30 activation leads to eNOS activation, as well as vasodilation, to a certain degree and has beneficial effects on vascular function in diabetic OVX rats.	[Li, Zi-lin; Liu, Jin-cheng; Yi, Ding-hua] Fourth Mil Med Univ, Sch Pharm, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China; [Liu, Shui-bing; Li, Xiao-qiang; Zhao, Ming-gao] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Li, Zi-lin] PLA 452 Hosp, Dept Cardiothorac Surg, Chengdu, Sichuan, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Li, ZL (corresponding author), Fourth Mil Med Univ, Sch Pharm, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China.	dhyi@fmmu.edu.cn; minggao@fmmu.edu.cn	Li, Xiao-Qiang/AAA-5094-2019	Zhao, Ming-gao/0000-0002-7539-3887	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atochin DN, 2010, ENDOTHELIAL NITRIC O; Balhuizen A, 2010, MOL CELL ENDOCRINOL, V320, P16, DOI 10.1016/j.mce.2010.01.030; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Chen L, 2008, NEUROPHARMACOLOGY, V54, P1175, DOI 10.1016/j.neuropharm.2008.03.007; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Freedman JE, 1999, CIRC RES, V84, P1416; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Huang PL, 2005, CIRC RES, V96, P1129, DOI 10.1161/01.RES.0000170705.56583.45; Huang PL, 2000, SEMIN PERINATOL, V24, P87, DOI 10.1016/S0146-0005(00)80064-6; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Kumar R, 2011, ENDOCRINOLOGY, V152, P2568, DOI 10.1210/en.2010-1361; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Lindsey SH, 2011, J CARDIOVASC PHARM, V57, P598, DOI 10.1097/FJC.0b013e3182135f1c; Liu SB, 2011, CLIN EXP PHARMACOL P, V38, P577, DOI 10.1111/j.1440-1681.2011.05549.x; Meyer MR, 2012, HYPERTENSION, V59, P507, DOI 10.1161/HYPERTENSIONAHA.111.184606; Meyer MR, 2011, VASC PHARMACOL, V55, P17, DOI 10.1016/j.vph.2011.06.003; Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Natali A, 2005, EUR HEART J, V26, P464, DOI 10.1093/eurheartj/ehi113; Prossnitz ER, 2011, NAT REV ENDOCRINOL; Prossnitz ER, 2008, TRENDS PHARMACOL SCI, V29, P116, DOI 10.1016/j.tips.2008.01.001; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091; Skyrme-Jones RAP, 2000, J AM COLL CARDIOL, V35, P292, DOI 10.1016/S0735-1097(99)00547-1; Takenouchi Y, 2009, J PHARMACOL SCI, V111, P91, DOI 10.1254/jphs.09133FP; Zhong WL, 2010, DIABETES RES CLIN PR, V89, P38, DOI 10.1016/j.diabres.2010.03.013	36	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38787	10.1371/journal.pone.0038787	http://dx.doi.org/10.1371/journal.pone.0038787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679517	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900065
J	Huang, F; He, ZG				Huang, Feng; He, Zheng-Guo			Characterization of a Conserved Interaction between DNA Glycosylase and ParA in Mycobacterium smegmatis and M. tuberculosis	PLOS ONE			English	Article							BACTERIAL CHROMOSOME SEGREGATION; ESCHERICHIA-COLI; GENOME SEQUENCE; PROTEIN DNAA; PLASMID; REPAIR; IDENTIFICATION; TRANSFORMATION; PURIFICATION; REPLICATION	The chromosome partitioning proteins, ParAB, ensure accurate segregation of genetic materials into daughter cells and most bacterial species contain their homologs. However, little is known about the regulation of ParAB proteins. In this study, we found that 3-methyladenine DNA glycosylase I MsTAG(Ms5082) regulates bacterial growth and cell morphology by directly interacting with MsParA (Ms6939) and inhibiting its ATPase activity in Mycobacterium smegmatis. Using bacterial two-hybrid and pull-down techniques in combination with co-immunoprecipitation assays, we show that MsTAG physically interacts with MsParA both in vitro and in vivo. Expression of MsTAG under conditions of DNA damage induction exhibited similar inhibition of growth as the deletion of the parA gene in M. smegmatis. Further, the effect of MsTAG on mycobacterial growth was found to be independent of its DNA glycosylase activity, and to result instead from direct inhibition of the ATPase activity of MsParA. Co-expression of these two proteins could counteract the growth defect phenotypes observed in strains overexpressing MsTAG alone in response to DNA damage induction. Based on protein co-expression and fluorescent co-localization assays, MsParA and MsTAG were further found to co-localize in mycobacterial cells. In addition, the interaction between the DNA glycosylase and ParA, and the regulation of ParA by the glycosylase were conserved in M. tuberculosis and M. smegmatis. Our findings provide important new insights into the regulatory mechanism of cell growth and division in mycobacteria.	[Huang, Feng; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014		National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program	This work was supported by the National Natural Science Foundation of China (31025002 and 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (To He Z-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; BJELLAND S, 1987, NUCLEIC ACIDS RES, V15, P2787, DOI 10.1093/nar/15.7.2787; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cui T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-118; Davis MA, 1996, MOL MICROBIOL, V21, P1029, DOI 10.1046/j.1365-2958.1996.721423.x; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Gerdes K, 2004, CELL, V116, P359, DOI 10.1016/S0092-8674(04)00116-3; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hayes F, 2006, TRENDS BIOCHEM SCI, V31, P247, DOI 10.1016/j.tibs.2006.03.002; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hollis T, 2000, MUTAT RES-DNA REPAIR, V460, P201, DOI 10.1016/S0921-8777(00)00027-6; Huang F, 2010, NUCLEIC ACIDS RES, V38, P8219, DOI 10.1093/nar/gkq737; Jakimowicz D, 2002, MOL MICROBIOL, V45, P1365, DOI 10.1046/j.1365-2958.2002.03102.x; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lewis PJ, 2001, MICROBIOL-UK, V147, P519, DOI 10.1099/00221287-147-3-519; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Maloney E, 2009, TUBERCULOSIS, V89, pS65, DOI 10.1016/S1472-9792(09)70015-0; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Nisa S, 2010, J ANTIMICROB CHEMOTH, V65, P2347, DOI 10.1093/jac/dkq311; Nishizawa K, 2006, PLANT CELL REP, V25, P1355, DOI 10.1007/s00299-006-0210-x; Pan WW, 2010, J VIROL METHODS, V163, P465, DOI 10.1016/j.jviromet.2009.11.015; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scholefield G, 2012, EMBO J, V31, P1542, DOI 10.1038/emboj.2012.6; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Wang Y, 2010, J PROTEOME RES, V9, P6665, DOI 10.1021/pr100808n; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Yang MY, 2011, DNA REPAIR, V10, P595, DOI 10.1016/j.dnarep.2011.03.007; Zhang L, 2009, P NATL ACAD SCI USA, V106, P7792, DOI 10.1073/pnas.0813056106	39	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38276	10.1371/journal.pone.0038276	http://dx.doi.org/10.1371/journal.pone.0038276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675536	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341700055
J	Roth, C; Stuckrath, I; Pantel, K; Izbicki, JR; Tachezy, M; Schwarzenbach, H				Roth, Carina; Stueckrath, Isabel; Pantel, Klaus; Izbicki, Jakob R.; Tachezy, Michael; Schwarzenbach, Heidi			Low Levels of Cell-Free Circulating miR-361-3p and miR-625*as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors	PLOS ONE			English	Article							CANCER; MICRORNAS; BIOMARKERS; DIAGNOSIS; THERAPY; SERUM; BETA	The high mortality rate of lung cancer patients is mainly due to the late stage at which lung cancer is diagnosed. For effective cancer prevention programs and early diagnosis, better blood-based markers are needed. Hence, blood-based microarray profiling of microRNA (miR) expression was performed in preoperative serum of 21 non-small cell lung cancer (NSCLC) patients and 11 healthy individuals by microfluid biochips containing 1158 different miRs. Two out of the 30 most dysregulated miRs were further validated in serum of 97 NSCLC patients, 20 patients with benign lung diseases and 30 healthy individuals by TaqMan MicroRNA Assays. Microarray profiling showed that miR-361-3p and miR-625* were significantly down-regulated in serum of lung cancer patients. Their further evaluation by quantitative RT-PCR showed that the levels of miR-361-3p and miR-625* were lower in NSCLC than in benign disease (p = 0.0001) and healthy individuals (p = 0.0001, p = 0.0005, respectively). Moreover, the levels of miR-625* were significantly lower in patients with large cell lung cancer (LCLC, p = 0.014) and smoking patients (p = 0.030) than in patients with adenocarcinoma and non-smoking patients, respectively. A rise in the levels of both miRs was observed in the postoperative samples compared with the preoperative levels (p = 0.0001). Functional analyses showed that Smad2 and TGFss1 are not dysregulated by miR-361-3p and miR-625* in the lung cell line A549, respectively. Our present pilot study suggests that miR-361-3p and miR-625* might have a protective influence on the development of NSCLC, and the quantitative assessment of these miRs in blood serum might have diagnostic potential to detect NSCLC, in particular in smokers.	[Roth, Carina; Stueckrath, Isabel; Pantel, Klaus; Schwarzenbach, Heidi] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Izbicki, Jakob R.; Tachezy, Michael] Univ Med Ctr Hamburg Eppendorf, Gen Visceral & Thorac Surg Dept & Clin, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Roth, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany.	hschwarz@uke.uni-hamburg.de	Tachezy, Michael/AAD-6759-2022		Erich und Gertrud Roggenbuck-Stiftung, Hamburg	Erich und Gertrud Roggenbuck-Stiftung, Hamburg	The study was supported by the Erich und Gertrud Roggenbuck-Stiftung, Hamburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2005, J CLIN ONCOL, V23, P3175, DOI 10.1200/JCO.2005.10.462; Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bianchi F, 2011, EMBO MOL MED; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cohen EEW, 2012, CLIN LUNG CANCER, V13, P123, DOI 10.1016/j.cllc.2011.10.001; Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Feng ZJ, 2010, ONCOGENE, V29, P5416, DOI 10.1038/onc.2010.282; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Gao W, 2011, CLIN LUNG CANCER, V12, P14, DOI 10.3816/CLC.2011.n.001; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Heegaard NH, 2011, INT J CANC; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Liu X, 2011, TRANSL RES, V157, P200, DOI 10.1016/j.trsl.2011.01.001; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Planchard D, 2011, EUR J CANCER, V47, pS272, DOI 10.1016/S0959-8049(11)70173-3; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wu YY, 2011, ONCOGENE, V30, P3682, DOI 10.1038/onc.2011.85; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	34	64	72	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38248	10.1371/journal.pone.0038248	http://dx.doi.org/10.1371/journal.pone.0038248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675530	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700050
J	Wang, Q; Chen, JZ; Wang, Y; Han, X; Chen, XW				Wang, Qian; Chen, Jizheng; Wang, Yun; Han, Xiao; Chen, Xinwen			Hepatitis C Virus Induced a Novel Apoptosis-Like Death of Pancreatic Beta Cells through a Caspase 3-Dependent Pathway	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; TUMOR-NECROSIS-FACTOR; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; EXTRAHEPATIC MANIFESTATIONS; INFECTION; REPLICATION; ASSOCIATION; PREVALENCE; FAILURE	Epidemiological and experimental studies have suggested that Hepatitis C virus (HCV) infection is associated with the development of type 2 diabetes. Pancreatic beta cell failure is central to the progression of type 2 diabetes. Using virus infection system, we investigate the influence of HCV infection on the fate of the insulinoma cell line, MIN6. Our experiments demonstrate that the HCV virion itself is indispensable and has a dose- and time-dependent cytopathic effect on the cells. HCV infection inhibits cell proliferation and induces death of MIN6 cells with apoptotic characteristics, including cell surface exposure of phosphatidylserine, decreased mitochondrial membrane potential, activation of caspase 3 and poly (ADP-ribose) polymerase, and DNA fragmentation in the nucleus. However, the fact that HCV-infected cells exhibit a dilated, low-density nucleus with intact plasma and nuclear membrane indicates that a novel apoptosis-like death occurs. HCV infection also causes endoplasmic reticulum (ER) stress. Further, HCV RNA replication was detected in MIN6 cells, although the infection efficiency is very low and no progeny virus particle generates. Taken together, our data suggest that HCV infection induces death of pancreatic beta cells through an ER stress-involved, caspase 3-dependent, special pathway.	[Wang, Qian; Chen, Jizheng; Wang, Yun; Chen, Xinwen] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Wang, Qian; Han, Xiao] Nanjing Med Univ, Sch Basic Med Sci, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Nanjing Medical University	Wang, Q (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	chenxw@wh.iov.cn			National Basic Research Program of China (973 Program) [2006CB933100, 2007CB512901]; Nature Science Foundations of Jiangsu Province [BK2008441]; China Postdoctoral Science Foundation [20080430175]; Open Research Fund Program of the State Key Laboratory of Virology [2010008]; National Nature Science Foundations of China [30800044]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Nature Science Foundations of Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Open Research Fund Program of the State Key Laboratory of Virology; National Nature Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2006CB933100, 2007CB512901) (URL:http://www.973.gov.cn/AreaAppl.aspx), the Nature Science Foundations of Jiangsu Province (BK2008441)(http://www.jsnsf.gov.cn/index.aspx), the China Postdoctoral Science Foundation (20080430175)(http://www.chinapostdoctor.org.cn/V3/Program/Main.aspx) and the Open Research Fund Program of the State Key Laboratory of Virology (2010008)(http://www.virology.chinalab.gov.cn/), the National Nature Science Foundations of China (30800044) (URL:http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2004, J VIROL, V78, P491, DOI 10.1128/JVI.78.1.491-501.2004; ALLISON MED, 1994, J HEPATOL, V21, P1135, DOI 10.1016/S0168-8278(05)80631-2; Aytug S, 2003, HEPATOLOGY, V38, P1384, DOI 10.1016/j.hep.2003.09.012; BIRD GLA, 1990, ANN INTERN MED, V112, P917, DOI 10.7326/0003-4819-112-12-917; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Caronia S, 1999, HEPATOLOGY, V30, P1059, DOI 10.1002/hep.510300416; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Corbett J, 1997, DIABETOLOGIA, V40, pB27, DOI 10.1007/BF03168183; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Galossi A, 2007, J GASTROINTEST LIVER, V16, P65; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gu BH, 2003, J VIROL, V77, P5352, DOI 10.1128/JVI.77.9.5352-5359.2003; GUMBER SC, 1995, ANN INTERN MED, V123, P615, DOI 10.7326/0003-4819-123-8-199510150-00008; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Huang JF, 2007, AM J GASTROENTEROL, V102, P1237, DOI 10.1111/j.1572-0241.2007.01181.x; Jun HS, 2003, DIABETES-METAB RES, V19, P8, DOI 10.1002/dmrr.337; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Knobler H, 2003, AM J GASTROENTEROL, V98, P2751, DOI 10.1016/j.amjgastroenterol.2003.06.002; Laskus T, 1998, HEPATOLOGY, V28, P1398, DOI 10.1002/hep.510280531; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Lecube A, 2004, DIABETES CARE, V27, P1171, DOI 10.2337/diacare.27.5.1171; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Luther MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE502, DOI 10.1152/ajpendo.00424.2004; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; MARINOS G, 1995, GASTROENTEROLOGY, V108, P1453, DOI 10.1016/0016-5085(95)90694-0; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Masini M, 2005, DIABETES CARE, V28, P940, DOI 10.2337/diacare.28.4.940; Mason AL, 1999, HEPATOLOGY, V29, P328, DOI 10.1002/hep.510290235; Mehta SH, 2000, ANN INTERN MED, V133, P592, DOI 10.7326/0003-4819-133-8-200010170-00009; Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200; Negro F, 2009, WORLD J GASTROENTERO, V15, P1537, DOI 10.3748/wjg.15.1537; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ratziu V, 2005, ALIMENT PHARM THERAP, V22, P56, DOI 10.1111/j.1365-2036.2005.02598.x; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rumin S, 1999, J GEN VIROL, V80, P3007, DOI 10.1099/0022-1317-80-11-3007; SALEH MG, 1994, HEPATOLOGY, V20, P1399, DOI 10.1002/hep.1840200604; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Socha L, 2003, ANN NY ACAD SCI, V1005, P178, DOI 10.1196/annals.1288.022; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; WAN CP, 1994, J IMMUNOL METHODS, V173, P265, DOI 10.1016/0022-1759(94)90305-0; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154	55	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38522	10.1371/journal.pone.0038522	http://dx.doi.org/10.1371/journal.pone.0038522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675572	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700084
J	Kitaguchi, Y; Taraseviciene-Stewart, L; Hanaoka, M; Natarajan, R; Kraskauskas, D; Voelkel, NF				Kitaguchi, Yoshiaki; Taraseviciene-Stewart, Laimute; Hanaoka, Masayuki; Natarajan, Ramesh; Kraskauskas, Donatas; Voelkel, Norbert F.			Acrolein Induces Endoplasmic Reticulum Stress and Causes Airspace Enlargement	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; ENDOTHELIAL GROWTH-FACTOR; CIGARETTE-SMOKE; ALPHA,BETA-UNSATURATED ALDEHYDES; CELL APOPTOSIS; TOBACCO-SMOKE; LUNG-FUNCTION; EXPRESSION; EXPOSURE; PATHWAY	Background: Given the relative abundance and toxic potential of acrolein in inhaled cigarette smoke, it is surprising how little is known about the pulmonary and systemic effects of acrolein. Here we test the hypothesis whether systemic administration of acrolein could cause endoplasmic reticulum (ER) stress, and lung cell apoptosis, leading to the enlargement of the alveolar air spaces in rats. Methods: Acute and chronic effects of intraperitoneally administered acrolein were tested. Mean alveolar airspace area was measured by using light microscopy and imaging system software. TUNEL staining and immunohistochemistry (IHC) for active caspase 3 and Western blot analysis for active caspase 3, and caspase 12 were performed to detect apoptosis. The ER-stress related gene expression in the lungs was determined by Quantitative real-time PCR analysis. Acrolein-protein adducts in the lung tissue were detected by IHC. Results: Acute administration of acrolein caused a significant elevation of activated caspase 3, upregulation of VEGF expression and induced ER stress proteins in the lung tissue. The chronic administration of acrolein in rats led to emphysematous lung tissue remodeling. TUNEL staining and IHC for cleaved caspase 3 showed a large number of apoptotic septal cells in the acrolein-treated rat lungs. Chronic acrolein administration cause the endoplasmic reticulum stress response manifested by significant upregulation of ATF4, CHOP and GADd34 expression. In smokers with COPD there was a considerable accumulation of acrolein-protein adducts in the inflammatory, airway and vascular cells. Conclusions: Systemic administration of acrolein causes endoplasmic reticulum stress response, lung cell apoptosis, and chronic administration leads to the enlargement of the alveolar air spaces and emphysema in rats. The substantial accumulation of acrolein-protein adducts in the lungs of COPD patients suggest a role of acrolein in the pathogenesis of emphysema.	[Kitaguchi, Yoshiaki; Natarajan, Ramesh; Kraskauskas, Donatas; Voelkel, Norbert F.] Virginia Commonwealth Univ, Victoria Johnson Lab Obstruct Lung Dis Res, Pulm & Crit Care Med Div, Richmond, VA 23284 USA; [Kitaguchi, Yoshiaki; Hanaoka, Masayuki] Sinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano, Japan; [Taraseviciene-Stewart, Laimute] Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA	Virginia Commonwealth University; Shinshu University; University of Colorado System; University of Colorado Anschutz Medical Campus	Kitaguchi, Y (corresponding author), Virginia Commonwealth Univ, Victoria Johnson Lab Obstruct Lung Dis Res, Pulm & Crit Care Med Div, Richmond, VA 23284 USA.	Laima.Taraseviciene@ucdenver.edu		Natarajan, Ramesh/0000-0002-3431-9971; Kitaguchi, Yoshiaki/0000-0002-3922-4082	Victoria Johnson Laboratory for Obstructive Lung Research; Flight Attendant Medical Research Institute [CIA-072053]	Victoria Johnson Laboratory for Obstructive Lung Research; Flight Attendant Medical Research Institute	The Victoria Johnson Laboratory for Obstructive Lung Research (to NFV) and Flight Attendant Medical Research Institute CIA-072053 (to LTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Barnes RL, 2007, NICOTINE TOB RES, V9, P995, DOI 10.1080/14622200701488392; Bein K, 2011, MOL NUTR FOOD RES, V55, P1342, DOI 10.1002/mnfr.201100279; Berry KAZ, 2007, CHEM RES TOXICOL, V20, P1342, DOI 10.1021/tx700102n; Borchers MT, 2007, EXP MOL PATHOL, V83, P301, DOI 10.1016/j.yexmp.2007.08.020; Burcham PC, 2010, CHEM-BIOL INTERACT, V183, P416, DOI 10.1016/j.cbi.2009.12.006; Carmella SG, 2007, CHEM RES TOXICOL, V20, P986, DOI 10.1021/tx700075y; COSTA DL, 1986, AM REV RESPIR DIS, V133, P286; Deshmukh HS, 2008, AM J RESP CELL MOL, V38, P446, DOI 10.1165/rcmb.2006-0339OC; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Geraghty P, 2011, INT J CHRONIC OBSTR, V6, P309, DOI 10.2147/COPD.S19599; Ghio AJ, 2008, AM J RESP CRIT CARE, V178, P1130, DOI 10.1164/rccm.200802-334OC; Gunther M, 2008, J CELL MOL MED, V12, P2704, DOI 10.1111/j.1582-4934.2008.00255.x; Haberzettl P, 2009, TOXICOL APPL PHARM, V234, P14, DOI 10.1016/j.taap.2008.09.019; HALBOWER AC, 1994, LAB INVEST, V71, P149; Hengstermann A, 2008, FREE RADICAL BIO MED, V44, P1097, DOI 10.1016/j.freeradbiomed.2007.12.009; Ishii T, 2007, FREE RADICAL RES, V41, P1253, DOI 10.1080/10715760701678652; JERMINI C, 1976, INT ARCH OCC ENV HEA, V36, P169, DOI 10.1007/BF00378272; Jones AP, 1999, ATMOS ENVIRON, V33, P4535, DOI 10.1016/S1352-2310(99)00272-1; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Kuo WW, 2005, ENVIRON HEALTH PERSP, V113, P1349, DOI 10.1289/ehp.7479; Landau LI, 2008, PAEDIATR RESPIR REV, V9, P39, DOI 10.1016/j.prrv.2007.11.002; Li B, 2008, MOL VIS, V14, P1122; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P209, DOI 10.1002/jnr.20863; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Matsunaga T, 2004, J BIOL CHEM, V279, P28614, DOI 10.1074/jbc.M400977200; Misonou Y, 2006, NITRIC OXIDE-BIOL CH, V14, P180, DOI 10.1016/j.niox.2005.09.004; Nana-Sinkam SP, 2007, AM J RESP CRIT CARE, V175, P676, DOI 10.1164/rccm.200605-724OC; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Pawlowicz AJ, 2008, CHEM BIODIVERS, V5, P177, DOI 10.1002/cbdv.200890009; PENN A, 1994, CIRCULATION, V90, P1363, DOI 10.1161/01.CIR.90.3.1363; Petrache Irina, 2006, Proc Am Thorac Soc, V3, P510, DOI 10.1513/pats.200603-071MS; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Ramu K, 1996, TOXICOL APPL PHARM, V140, P487, DOI 10.1006/taap.1996.0245; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roy J, 2009, CHEM-BIOL INTERACT, V181, P154, DOI 10.1016/j.cbi.2009.07.001; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Sakata K, 2003, BIOCHEM BIOPH RES CO, V305, P143, DOI 10.1016/S0006-291X(03)00716-2; STEDMAN RL, 1968, CHEM REV, V68, P153, DOI 10.1021/cr60252a002; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Vasilyev N, 2005, CIRCULATION, V112, P2812, DOI 10.1161/CIRCULATIONAHA.105.542340; Visscher Daniel W, 2006, Proc Am Thorac Soc, V3, P41, DOI 10.1513/pats.200512-124JH; Volpi G, 2011, BRIT J PHARMACOL, V163, P649, DOI 10.1111/j.1476-5381.2011.01253.x; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wheat LA, 2011, ARTERIOSCL THROM VAS, V31, P1598, DOI 10.1161/ATVBAHA.111.227124; Wu CH, 2006, ARCH TOXICOL, V80, P328, DOI 10.1007/s00204-005-0050-4; Zhang SY, 2011, CHEM RES TOXICOL, V24, P119, DOI 10.1021/tx100321y	53	44	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38038	10.1371/journal.pone.0038038	http://dx.doi.org/10.1371/journal.pone.0038038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675432	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500079
J	Lefebure, T; Richards, VP; Lang, P; Pavinski-Bitar, P; Stanhope, MJ				Lefebure, Tristan; Richards, Vince P.; Lang, Ping; Pavinski-Bitar, Paulina; Stanhope, Michael J.			Gene Repertoire Evolution of Streptococcus pyogenes Inferred from Phylogenomic Analysis with Streptococcus canis and Streptococcus dysgalactiae	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; LANTIBIOTIC SALIVARICIN-A; COMPLETE GENOME SEQUENCE; POSITIVE SELECTION; M3 STRAIN; VIRULENCE; INFECTIONS; GROWTH; CLONE; IDENTIFICATION	Streptococcus pyogenes, is an important human pathogen classified within the pyogenic group of streptococci, exclusively adapted to the human host. Our goal was to employ a comparative evolutionary approach to better understand the genomic events concomitant with S. pyogenes human adaptation. As part of ascertaining these events, we sequenced the genome of one of the potential sister species, the agricultural pathogen S. canis, and combined it in a comparative genomics reconciliation analysis with two other closely related species, Streptococcus dysgalactiae and Streptococcus equi, to determine the genes that were gained and lost during S. pyogenes evolution. Genome wide phylogenetic analyses involving 15 Streptococcus species provided convincing support for a clade of S. equi, S. pyogenes, S. dysgalactiae, and S. canis and suggested that the most likely S. pyogenes sister species was S. dysgalactiae. The reconciliation analysis identified 113 genes that were gained on the lineage leading to S. pyogenes. Almost half (46%) of these gained genes were phage associated and 14 showed significant matches to experimentally verified bacteria virulence factors. Subsequent to the origin of S. pyogenes, over half of the phage associated genes were involved in 90 different LGT events, mostly involving different strains of S. pyogenes, but with a high proportion involving the horse specific pathogen S. equi subsp. equi, with the directionality almost exclusively (86%) in the S. pyogenes to S. equi direction. Streptococcus agalactiae appears to have played an important role in the evolution of S. pyogenes with a high proportion of LGTs originating from this species. Overall the analysis suggests that S. pyogenes adaptation to the human host was achieved in part by (i) the integration of new virulence factors (e. g. speB, and the sal locus) and (ii) the construction of new regulation networks (e. g. rgg, and to some extent speB).	[Lefebure, Tristan; Richards, Vince P.; Lang, Ping; Pavinski-Bitar, Paulina; Stanhope, Michael J.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Lefebure, T (corresponding author), Univ Lyon 1, Ctr Natl Rech Sci, F-69622 Villeurbanne, France.	mjs297@cornell.edu	Lefebure, Tristan/A-6489-2009; Richards, Vince/AAO-4261-2020; Richards, Vincent/AAV-1816-2021	Lefebure, Tristan/0000-0003-3923-8166; Richards, Vincent/0000-0002-9309-6595	National Institute of Allergy and Infectious Disease, U.S. National Institutes of Health [AI073368-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073368] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Disease, U.S. National Institutes of Health, under Grant No. AI073368-01A2 awarded to M.J.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ane C, 2007, MOL BIOL EVOL, V24, P412; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bejerano G, 2005, NAT METHODS, V2, P535, DOI 10.1038/nmeth0705-535; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Brandt CM, 2009, CLIN INFECT DIS, V49, P766, DOI 10.1086/605085; COLMAN G, 1993, J MED MICROBIOL, V39, P165, DOI 10.1099/00222615-39-3-165; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; DeWinter LM, 1999, CAN J VET RES, V63, P90; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Eyre DW, 2010, EUR J CLIN MICROBIOL, V29, P1459, DOI 10.1007/s10096-010-1037-5; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Galperine T, 2007, J INFECTION, V55, P23, DOI 10.1016/j.jinf.2006.12.013; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Holden MTG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000346; HUDSON RR, 1992, GENETICS, V131, P509; Jackson M, 1999, INFECT IMMUN, V67, P2867, DOI 10.1128/IAI.67.6.2867-2873.1999; Jensen A, 2012, J CLIN MICROBIOL, V50, P113, DOI 10.1128/JCM.05900-11; Jones AL, 2000, MOL MICROBIOL, V37, P1444, DOI 10.1046/j.1365-2958.2000.02099.x; Khalil S, 2011, BIOCHEMISTRY-US, V50, P533, DOI 10.1021/bi101558v; Kuusi M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-36; Lam MM, 2007, J CLIN MICROBIOL, V45, P2327, DOI 10.1128/JCM.01765-06; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Lefebure T, 2009, GENOME RES, V19, P1224, DOI 10.1101/gr.089250.108; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCormick JK, 2006, TOXINS SUPERANTIGENS, P47; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; Muller-Alouf H, 2001, TOXICON, V39, P1691, DOI 10.1016/S0041-0101(01)00156-8; Murase T, 2003, VET REC, V153, P471, DOI 10.1136/vr.153.15.471; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Panchaud A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-198; Phelps HA, 2007, INFECT IMMUN, V75, P4541, DOI 10.1128/IAI.00518-07; Richards VP, 2011, INFECT GENET EVOL, V11, P1263, DOI 10.1016/j.meegid.2011.04.019; ROLSTON KVI, 1986, ARCH INTERN MED, V146, P857, DOI 10.1001/archinte.146.5.857; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; ROSS KF, 1993, APPL ENVIRON MICROB, V59, P2014, DOI 10.1128/AEM.59.7.2014-2021.1993; Rudolph B, 2010, J BIOL CHEM, V285, P19029, DOI 10.1074/jbc.M110.103374; Ryan PA, 2007, PLOS COMPUT BIOL, V3, P1177, DOI 10.1371/journal.pcbi.0030132; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Simpson WJ, 1995, DEV BIOL STAND, V85, P639; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Starr CR, 2006, INFECT IMMUN, V74, P40, DOI 10.1128/IAI.74.1.40-48.2006; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Suzuki H, 2011, GENOME BIOL EVOL, V3, P168, DOI 10.1093/gbe/evr006; Sykes JE, 2006, JAVMA-J AM VET MED A, V228, P1723, DOI 10.2460/javma.228.11.1723; TALKINGTON DF, 1993, INFECT IMMUN, V61, P3369, DOI 10.1128/IAI.61.8.3369-3374.1993; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Thulin P, 2006, PLOS MED, V3, P371, DOI 10.1371/journal.pmed.0030053; Tikofsky LL, 2005, J DAIRY SCI, V88, P2707, DOI 10.3168/jds.S0022-0302(05)72949-0; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Webb K, 2008, MICROBIOL-SGM, V154, P3016, DOI 10.1099/mic.0.2008/018911-0; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wozniak DJ, 2003, J BACTERIOL, V185, P7297, DOI 10.1128/JB.185.24.7297-7300.2003; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	71	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37607	10.1371/journal.pone.0037607	http://dx.doi.org/10.1371/journal.pone.0037607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666370	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400035
J	Miyamoto, R; Kikuchi, Y				Miyamoto, Reiko; Kikuchi, Yoshiaki			Gender Differences of Brain Activity in the Conflicts Based on Implicit Self-Esteem	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; CEREBRAL-BLOOD-FLOW; RESPONSE CONFLICT; NEURAL BASIS; PERSONALITY; KNOWLEDGE; PREDICTS; WOMEN; ADOLESCENCE; NEUROTICISM	There are gender differences in global and domain-specific self-esteem and the incidence of some psychiatric disorders related to self-esteem, suggesting that there are gender differences in the neural basis underlying one's own self-esteem. We investigated gender differences in the brain activity while subjects (14 males and 12 females) performed an implicit self-esteem task, using fMRI. While ventromedial prefrontal cortex (vmPFC) was significantly activated in females, medial and dorsomedial PFC (dmPFC) were activated in males in the incongruent condition (self = negative) compared with the congruent condition (self = positive). Additionally, scores on the explicit self-esteem test were negatively correlated with vmPFC activity in females and positively correlated with dmPFC activity in males. Furthermore, the functional relationships among the regions found by direct gender comparisons were discussed based on the somatic-marker model. These showed that, compared to males, females more firmly store even the incongruent associations as part of their schematic self-knowledge, and such associations automatically activate the neural networks for emotional response and control, in which vmPFC plays a central role. This may explain female cognitive/behavioral traits; females have more tendency to ruminate more often than males, which sometimes results in a prolonged negative affect.	[Miyamoto, Reiko] Tokyo Metropolitan Univ, Fac Hlth Sci, Div Occupat Therapy, Tokyo 158, Japan; [Kikuchi, Yoshiaki] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Frontier Hlth Sci, Tokyo 158, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University	Miyamoto, R (corresponding author), Tokyo Metropolitan Univ, Fac Hlth Sci, Div Occupat Therapy, Tokyo 158, Japan.	ykikuchi@hs.tmu.ac.jp		Miyamoto, Reiko/0000-0002-6058-7435; Kikuichi, Yoshiaki/0000-0002-8770-139X	Ministry of Education, Science, Sports and Culture [20700433]; Grants-in-Aid for Scientific Research [22700543] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by the Ministry of Education, Science, Sports and Culture, Grants-in-Aid for Young Scientists (B), (#20700433, 2008-2009 to RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin MW, 2004, SELF IDENTITY, V3, P81, DOI 10.1080/13576500342000068; Bargh JA., 1994, HDB SOCIAL COGNITION; Baumeister RF, 1998, HDB SOCIAL PSYCHOL, P680; BEGGAN JK, 1992, J PERS SOC PSYCHOL, V62, P229, DOI 10.1037/0022-3514.62.2.229; Berman ME, 1997, CLIN PSYCHOL REV, V17, P651, DOI 10.1016/S0272-7358(97)00039-1; Bolognini M, 1996, J ADOLESCENCE, V19, P233, DOI 10.1006/jado.1996.0022; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; BUTLER LD, 1994, SEX ROLES, V30, P331, DOI 10.1007/BF01420597; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Courtney Elizabeth A, 2008, Eat Behav, V9, P408, DOI 10.1016/j.eatbeh.2008.06.001; Damasio A., 1995, NEUROSCIENTIST, V1, P19, DOI [10.1177/107385849500100104, DOI 10.1177/107385849500100104]; Deckersbach T, 2006, DEPRESS ANXIETY, V23, P133, DOI 10.1002/da.20152; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; EBMEIER KP, 1994, PERS INDIV DIFFER, V17, P587, DOI 10.1016/0191-8869(94)90131-7; Eisenberger NI, 2011, J COGNITIVE NEUROSCI, V23, P3448, DOI 10.1162/jocn_a_00027; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Franck E, 2007, BEHAV RES THER, V45, P2448, DOI 10.1016/j.brat.2007.01.008; Friederich HC, 2007, NEUROIMAGE, V37, P674, DOI 10.1016/j.neuroimage.2007.05.039; Gentile B, 2009, REV GEN PSYCHOL, V13, P34, DOI 10.1037/a0013689; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Gyurak A, 2012, SOC COGN AFFECT NEUR, V7, P322, DOI 10.1093/scan/nsr014; HAYNES NM, 1990, J SOC PSYCHOL, V130, P199, DOI 10.1080/00224545.1990.9924570; Heine SJ, 1999, PSYCHOL REV, V106, P766, DOI 10.1037/0033-295X.106.4.766; Hines M, 2010, TRENDS COGN SCI, V14, P448, DOI 10.1016/j.tics.2010.07.005; Hunter MD, 2003, NEUROIMAGE, V20, P1264, DOI 10.1016/S1053-8119(03)00374-4; Johnson DL, 1999, AM J PSYCHIAT, V156, P252; Kernis MH, 2000, PERS SOC PSYCHOL B, V26, P1297, DOI 10.1177/0146167200262010; Kim SH, 2008, NEUROREPORT, V19, P883, DOI 10.1097/WNR.0b013e328300080f; KLEIN SB, 1992, J PERS SOC PSYCHOL, V63, P739, DOI 10.1037/0022-3514.63.5.739; Klein SB, 1996, J EXP PSYCHOL GEN, V125, P250, DOI 10.1037/0096-3445.125.3.250; Kling KC, 1999, PSYCHOL BULL, V125, P470, DOI 10.1037/0033-2909.125.4.470; Koch EJ, 2002, SELF IDENTITY, V1, P271, DOI 10.1080/152988602760124883; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; LEARY MR, 1995, J SOC CLIN PSYCHOL, V14, P297, DOI 10.1521/jscp.1995.14.3.297; Lee TMC, 2002, NEUROSCI LETT, V333, P13, DOI 10.1016/S0304-3940(02)00965-5; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lieberman MD, 2004, J PERS SOC PSYCHOL, V87, P421, DOI 10.1037/0022-3514.87.4.421; Lin Y, 2005, PERS SOC PSYCHOL B, V31, P198, DOI 10.1177/0146167204271325; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; Major B., 1999, SEXISM STEREOTYPES M, P223, DOI [DOI 10.1037/10277-009, 10.1037/10277-009]; MARKUS H, 1977, J PERS SOC PSYCHOL, V35, P63, DOI 10.1037/0022-3514.35.2.63; McClure EB, 2004, BIOL PSYCHIAT, V55, P1047, DOI 10.1016/j.biopsych.2004.02.013; McGlashan R, 1988, Dimens Crit Care Nurs, V7, P28, DOI 10.1097/00003465-198801000-00005; Mezulis AH, 2004, PSYCHOL BULL, V130, P711, DOI 10.1037/0033-2909.130.5.711; Nolen-Hoeksema S, 2001, PSYCHOL WOMEN QUART, V25, P37, DOI 10.1111/1471-6402.00005; NOLENHOEKSEMA S, 1993, J ABNORM PSYCHOL, V102, P20, DOI 10.1037/0021-843X.102.1.20; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; NUTTIN JM, 1987, EUR J SOC PSYCHOL, V17, P381, DOI 10.1002/ejsp.2420170402; NUTTIN JM, 1985, EUR J SOC PSYCHOL, V15, P353, DOI 10.1002/ejsp.2420150309; O'Gorman RL, 2006, NEUROIMAGE, V31, P489, DOI 10.1016/j.neuroimage.2005.12.048; Oikawa H, 2012, NEUROIMAGE, V59, P3668, DOI 10.1016/j.neuroimage.2011.10.098; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695; Otten S, 1999, EUR J SOC PSYCHOL, V29, P1049, DOI 10.1002/(SICI)1099-0992(199912)29:8<1049::AID-EJSP985>3.0.CO;2-Q; Pahl S, 2005, EXP PSYCHOL, V52, P303, DOI 10.1027/1618-3169.52.4.303; Ponsoda V, 2008, J INDIVID DIFFER, V29, P217, DOI 10.1027/1614-0001.29.4.217; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; ROVIARO S, 1984, J BEHAV MED, V7, P61, DOI 10.1007/BF00845347; Shaywitz SE, 1999, JAMA-J AM MED ASSOC, V281, P1197, DOI 10.1001/jama.281.13.1197; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Stanley D, 2008, CURR DIR PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-8721.2008.00568.x; Stringer Suzanne J., 2003, J INSTRUCTIONAL PSYC, V30, P69; Suslow T, 2010, NEUROSCIENCE, V167, P111, DOI 10.1016/j.neuroscience.2010.01.038; THAYER RE, 1994, J PERS SOC PSYCHOL, V67, P910, DOI 10.1037/0022-3514.67.5.910; Twenge JM, 2001, PERS SOC PSYCHOL REV, V5, P321, DOI 10.1207/S15327957PSPR0504_3; Verdejo-Garcia A, 2006, CURR NEUROPHARMACOL, V4, P17, DOI 10.2174/157015906775203057; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Wang JJ, 2007, SOC COGN AFFECT NEUR, V2, P227, DOI 10.1093/scan/nsm018; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; WEISSMAN MM, 1995, SCIENCE, V269, P799, DOI 10.1126/science.7638596; Wrase J, 2003, NEUROSCI LETT, V348, P41, DOI 10.1016/S0304-3940(03)00565-2	80	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37901	10.1371/journal.pone.0037901	http://dx.doi.org/10.1371/journal.pone.0037901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666409	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400057
J	Theodoro, RC; Teixeira, MD; Felipe, MSS; Paduan, KD; Ribolla, PM; San-Blas, G; Bagagli, E				Theodoro, Raquel Cordeiro; Teixeira, Marcus de Melo; Soares Felipe, Maria Sueli; dos Santos Paduan, Karina; Ribolla, Paulo Martins; San-Blas, Gioconda; Bagagli, Eduardo			Genus Paracoccidioides: Species Recognition and Biogeographic Aspects	PLOS ONE			English	Article							ARMADILLOS DASYPUS-NOVEMCINCTUS; PHYLOGENETIC ANALYSIS; LOBOS-DISEASE; PATHOGENIC FUNGUS; ANDEAN TECTONICS; BRASILIENSIS; SPECIATION; HOST; DNA; DIFFERENTIATION	Background: Paracoccidioidomycosis is a systemic mycosis caused by Paracoccidioides brasiliensis (species S1, PS2, PS3), and Paracoccidioides lutzii. This work aimed to differentiate species within the genus Paracoccidioides, without applying multilocus sequencing, as well as to obtain knowledge of the possible speciation processes. Methodology/Principal Findings: Single nucleotide polymorphism analysis on GP43, ARF and PRP8 intein genes successfully distinguished isolates into four different species. Morphological evaluation indicated that elongated conidia were observed exclusively in P. lutzii isolates, while all other species (S1, PS2 and PS3) were indistinguishable. To evaluate the biogeographic events that led to the current geographic distribution of Paracoccidioides species and their sister species, Nested Clade and Likelihood Analysis of Geographic Range Evolution (LAGRANGE) analyses were applied. The radiation of Paracoccidioides started in northwest South America, around 11-32 million years ago, as calculated on the basis of ARF substitution rate, in the BEAST program. Vicariance was responsible for the divergence among S1, PS2 and P. lutzii and a recent dispersal generated the PS3 species, restricted to Colombia. Taking into account the ancestral areas revealed by the LAGRANGE analysis and the major geographic distribution of L. loboi in the Amazon basin, a region strongly affected by the Andes uplift and marine incursions in the Cenozoic era, we also speculate about the effect of these geological events on the vicariance between Paracoccidioides and L. loboi. Conclusions/Significance: The use of at least 3 SNPs, but not morphological criteria, as markers allows us to distinguish among the four cryptic species of the genus Paracoccidioides. The work also presents a biogeographic study speculating on how these species might have diverged in South America, thus contributing to elucidating evolutionary aspects of the genus Paracoccidioides.	[Theodoro, Raquel Cordeiro; dos Santos Paduan, Karina; Ribolla, Paulo Martins; Bagagli, Eduardo] Univ Estadual Paulista, Sao Paulo, Brazil; [Teixeira, Marcus de Melo; Soares Felipe, Maria Sueli] Univ Brasilia UNB, Brasilia, DF, Brazil; [San-Blas, Gioconda] Ctr Microbiol & Cell Biol, Venezuelan Inst Sci Res, Caracas, Venezuela	Universidade Estadual Paulista; Universidade de Brasilia; Venezuelan Institute Science Research	Theodoro, RC (corresponding author), Univ Estadual Paulista, Campus Botucatu UNESP, Sao Paulo, Brazil.	bagagli@ibb.unesp.br	Bagagli, Eduardo/C-8036-2012; Felipe, Maria Sueli/L-6260-2016; Ribolla, Paulo EM/B-9122-2012; Ribolla, Paulo/AAH-3354-2020; Theodoro, Raquel C/C-2130-2017; PADUAN, KARINA S/F-4876-2015; de Melo Teixeira, Marcus/AAP-9530-2021	Bagagli, Eduardo/0000-0002-8003-4109; Felipe, Maria Sueli/0000-0003-4347-6853; Ribolla, Paulo EM/0000-0001-8735-6090; Theodoro, Raquel C/0000-0001-5016-1046; de Melo Teixeira, Marcus/0000-0003-1763-3464	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo);  [2007/01306-5];  [2010/08839-1];  [2010/08829-6]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; ; 	The authors' funding agency is FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [http://www.fapesp.br/]. The grant numbers of the authors' projects are 2007/01306-5, 2010/08839-1 and 2010/08829-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagagli E, 1998, AM J TROP MED HYG, V58, P505, DOI 10.4269/ajtmh.1998.58.505; Bagagli E, 2003, MED MYCOL, V41, P217, DOI 10.1080/13693780310001597368; Bagagli E, 2008, MYCOPATHOLOGIA, V165, P197, DOI 10.1007/s11046-007-9050-7; Bagagli E, 2006, INFECT GENET EVOL, V6, P344, DOI 10.1016/j.meegid.2005.12.002; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batista J, 2010, MYCOSES, V53, P176, DOI 10.1111/j.1439-0507.2008.01687.x; Burns RA, 2000, J CLIN MICROBIOL, V38, P1283, DOI 10.1128/JCM.38.3.1283-1285.2000; Calcagno AM, 1998, J CLIN MICROBIOL, V36, P1733, DOI 10.1128/JCM.36.6.1733-1736.1998; Carrero LL, 2008, FUNGAL GENET BIOL, V45, P605, DOI 10.1016/j.fgb.2008.02.002; Carvalho KC, 2005, MICROBES INFECT, V7, P55, DOI 10.1016/j.micinf.2004.09.008; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Cisalpino PS, 1996, J BIOL CHEM, V271, P4553, DOI 10.1074/jbc.271.8.4553; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corredor German G., 1999, Revista Iberoamericana de Micologia, V16, P216; Corredor GG, 2005, MED MYCOL, V43, P275, DOI 10.1080/13693780412331271090; COWAN DF, 1993, J WILDLIFE DIS, V29, P488, DOI 10.7589/0090-3558-29.3.488; Coyne J.A., 2004, SPECIATION; de Aguiar MAM, 2009, NATURE, V460, P384, DOI 10.1038/nature08168; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FARIAS MR, 2005, REV INST MED TROP SP, V47, P64; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Fournier E, 2008, J EVOLUTION BIOL, V21, P122, DOI 10.1111/j.1420-9101.2007.01462.x; FRANCO M, 1987, J MED VET MYCOL, V25, P5; Hahn RC, 2003, J CLIN MICROBIOL, V41, P2849, DOI 10.1128/JCM.41.7.2849-2854.2003; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; Hebeler-Barbosa F, 2003, J CLIN MICROBIOL, V41, P5735, DOI 10.1128/JCM.41.12.5735-5737.2003; Herr RA, 2001, J CLIN MICROBIOL, V39, P309, DOI 10.1128/JCM.39.1.309-314.2001; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Kasuga T, 2002, MOL BIOL EVOL, V19, P2318, DOI 10.1093/oxfordjournals.molbev.a004056; Keely S.P., 2005, PNEUMOCYSTIS PNEUMON, V3rd ed., P39; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KWONCHUN.KJ, 1973, MYCOLOGIA, V65, P109, DOI 10.2307/3757791; Lundberg J.G., 1998, PHYLOGENY CLASSIFICA, V603, P14; Matute DR, 2006, J CLIN MICROBIOL, V44, P2153, DOI 10.1128/JCM.02540-05; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; McCullough MJ, 2000, CLIN INFECT DIS, V30, P328, DOI 10.1086/313649; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; MIGAKI G, 1971, J AM VET MED ASSOC, V159, P578; Morais FV, 2000, J CLIN MICROBIOL, V38, P3960, DOI 10.1128/JCM.38.11.3960-3966.2000; NAIFF RD, 1986, REV I MED TROP, V28, P19, DOI 10.1590/S0036-46651986000100005; Panchal M, 2007, BIOINFORMATICS, V23, P509, DOI 10.1093/bioinformatics/btl614; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Puccia R, 2008, MYCOPATHOLOGIA, V165, P275, DOI 10.1007/s11046-007-9055-2; PURTILO DT, 1975, ANAT REC, V181, P725, DOI 10.1002/ar.1091810405; Ramos-e-Silva M, 2009, ACTAS DERMO-SIFILOGR, V100, P92, DOI 10.1016/S0001-7310(09)73173-4; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ricci G, 2004, MED MYCOL, V42, P379, DOI 10.1080/1369378032000141417; Richini-Pereira VB, 2009, MEM I OSWALDO CRUZ, V104, P636, DOI 10.1590/S0074-02762009000400018; Salgado-Salazar C, 2010, CLADISTICS, V26, P613, DOI 10.1111/j.1096-0031.2010.00307.x; Sheff KW, 2010, MED MYCOL, V48, P466, DOI 10.3109/13693780903218990; Silva-Vergara ML, 2000, MED MYCOL, V38, P193, DOI 10.1080/714030937; SYMMERS WS, 1983, B SOC PATHOL EXOT, V76, P777; Taborda PR, 1999, J CLIN MICROBIOL, V37, P2031, DOI 10.1128/JCM.37.6.2031-2033.1999; Takayama A, 2010, MED MYCOL, V48, P64, DOI 10.3109/13693780902718065; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Tercarioli GR, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-92; Theodoro RC, 2008, FUNGAL GENET BIOL, V45, P1284, DOI 10.1016/j.fgb.2008.07.003; Theodoro RC, 2008, MYCOPATHOLOGIA, V165, P355, DOI 10.1007/s11046-008-9091-6; Torres I, 2010, FUNGAL GENET BIOL, V47, P373, DOI 10.1016/j.fgb.2009.11.005; ULRICH M, 1976, CLIN EXP IMMUNOL, V25, P170; Untereiner WA, 2004, MYCOLOGIA, V96, P812, DOI 10.2307/3762114; Vilela R, 2009, MYCOL RES, V113, P851, DOI 10.1016/j.mycres.2009.04.007; Vries G. A. de, 1973, Aquatic Mammals, V1, P1; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P1; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35	69	100	100	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37694	10.1371/journal.pone.0037694	http://dx.doi.org/10.1371/journal.pone.0037694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666382	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400041
J	Van Gulck, E; Bracke, L; Heyndrickx, L; Coppens, S; Atkinson, D; Merlin, C; Pasternak, A; Florence, E; Vanham, G				Van Gulck, Ellen; Bracke, Lotte; Heyndrickx, Leo; Coppens, Sandra; Atkinson, Derek; Merlin, Celine; Pasternak, Alexander; Florence, Eric; Vanham, Guido			Immune and Viral Correlates of "Secondary Viral Control" after Treatment Interruption in Chronically HIV-1 Infected Patients	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; NEUTRALIZING ANTIBODY; ELITE CONTROLLERS; PROLIFERATIVE RESPONSES; ANTIRETROVIRAL THERAPY; HIV NEUTRALIZATION; PLASMA VIREMIA; INFECTION; REPLICATION	Upon interruption of antiretroviral therapy, HIV-infected patients usually show viral load rebound to pre-treatment levels. Four patients, hereafter referred to as secondary controllers (SC), were identified who initiated therapy during chronic infection and, after stopping treatment, could control virus replication at undetectable levels for more than six months. In the present study we set out to unravel possible viral and immune parameters or mechanisms of this phenomenon by comparing secondary controllers with elite controllers and non-controllers, including patients under HAART. As candidate correlates of protection, virus growth kinetics, levels of intracellular viral markers, several aspects of HIV-specific CD4+ and CD8+ T cell function and HIV neutralizing antibodies were investigated. As expected all intracellular viral markers were lower in aviremic as compared to viremic subjects, but in addition both elite and secondary controllers had lower levels of viral unspliced RNA in PBMC as compared to patients on HAART. Ex vivo cultivation of the virus from CD4+ T cells of SC consistently failed in one patient and showed delayed kinetics in the three others. Formal in vitro replication studies of these three viruses showed low to absent growth in two cases and a virus with normal fitness in the third case. T cell responses toward HIV peptides, evaluated in IFN-gamma ELISPOT, revealed no significant differences in breadth, magnitude or avidity between SC and all other patient groups. Neither was there a difference in polyfunctionality of CD4+ or CD8+ T cells, as evaluated with intracellular cytokine staining. However, secondary and elite controllers showed higher proliferative responses to Gag and Pol peptides. SC also showed the highest level of autologous neutralizing antibodies. These data suggest that higher T cell proliferative responses and lower replication kinetics might be instrumental in secondary viral control in the absence of treatment.	[Van Gulck, Ellen; Bracke, Lotte; Heyndrickx, Leo; Coppens, Sandra; Atkinson, Derek; Merlin, Celine; Vanham, Guido] Antwerp ITMA, Inst Trop Med, Dept Biomed Sci, Virol Unit,Microbiol Grp, Antwerp, Belgium; [Pasternak, Alexander] Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, Lab Expt Virol, Amsterdam, Netherlands; [Florence, Eric] ITMA, Dept Clin Sci, HIV STD Unit, Antwerp, Belgium; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Vet & Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Amsterdam; Institute of Tropical Medicine (ITM); University of Antwerp	Van Gulck, E (corresponding author), Antwerp ITMA, Inst Trop Med, Dept Biomed Sci, Virol Unit,Microbiol Grp, Antwerp, Belgium.	evangulck@hotmail.com	Pasternak, Alexander/P-2067-2017	Pasternak, Alexander/0000-0002-4097-4251; Florence, Eric/0000-0002-7004-9120; Atkinson, Derek/0000-0001-6097-3670	Fund for Scientific Research Flanders (FWO) [G.0.370.08.N.10]; IAP (Inter-University Attraction Poles of the Belgian government) [P6/41]; EU Programme EVA Centre for AIDS Reagents, NIBSC, UK (AVIP) [LSHP-CT-2004-503487]	Fund for Scientific Research Flanders (FWO)(FWO); IAP (Inter-University Attraction Poles of the Belgian government); EU Programme EVA Centre for AIDS Reagents, NIBSC, UK (AVIP)	This work was supported by grants from the Fund for Scientific Research Flanders (FWO) (G.0.370.08.N.10) and IAP (Inter-University Attraction Poles, P6/41 of the Belgian government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Viruses (DU174, 92UG024) and TriMab were provided by the EU Programme EVA Centre for AIDS Reagents, NIBSC, UK (AVIP Contract Number LSHP-CT-2004-503487).	Addo MM, 2002, DNA CELL BIOL, V21, P671, DOI 10.1089/104454902760330219; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Anzala AO, 1998, LANCET, V351, P1632, DOI 10.1016/S0140-6736(05)77688-1; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Bedimo R, 2006, AIDS RES HUM RETROV, V22, P40, DOI 10.1089/aid.2006.22.40; Beirnaert E, 1998, J VIROL METHODS, V73, P65, DOI 10.1016/S0166-0934(98)00044-5; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Binley JM, 2000, J INFECT DIS, V181, P1249, DOI 10.1086/315379; Blankson JN, 2010, DISCOV MED, V9, P261; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; Bunce M., 1995, TISSUE ANTIGENS, V46, P355; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Gray CM, 2009, J VIROL, V83, P470, DOI 10.1128/JVI.01678-08; Guerrero MLF, 2005, CLIN INFECT DIS, V41, P390, DOI 10.1086/431487; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Heyndrickx L, 2000, J VIROL, V74, P363, DOI 10.1128/JVI.74.1.363-370.2000; Heyndrickx L, 2008, J VIROL METHODS, V148, P166, DOI 10.1016/j.jviromet.2007.11.009; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Lieberman J, 2004, AIDS, V18, P1489, DOI 10.1097/01.aids.0000131320.75396.4d; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; Pasternak AO, 2010, AIDS, V24, P1641, DOI 10.1097/QAD.0b013e32833b3171; Pasternak AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008490; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Ponsaerts P, 2002, LEUKEMIA, V16, P1324, DOI 10.1038/sj.leu.2402511; Resino S, 2003, CLIN EXP IMMUNOL, V131, P130, DOI 10.1046/j.1365-2249.2003.02034.x; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rowland-Jones S, 1997, ADV IMMUNOL, V65, P277, DOI 10.1016/S0065-2776(08)60745-2; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Scarlatti G, 1996, IMMUNOL LETT, V51, P23, DOI 10.1016/0165-2478(96)02550-3; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skiest DJ, 2004, JAIDS-J ACQ IMM DEF, V37, P1351, DOI 10.1097/00126334-200411010-00003; Steingrover R, 2008, AIDS, V22, P1583, DOI 10.1097/QAD.0b013e328305bd77; Valentine LE, 2008, J VIROL, V82, P575, DOI 10.1128/JVI.00275-07; Van Gulck E, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-6; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Yang OO, 2003, TRENDS IMMUNOL, V24, P67, DOI 10.1016/S1471-4906(02)00034-0; Zhang YJ, 1997, J INFECT DIS, V176, P1180, DOI 10.1086/514111; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	62	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37792	10.1371/journal.pone.0037792	http://dx.doi.org/10.1371/journal.pone.0037792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666392	Green Published, gold			2022-12-27	WOS:000305353400049
J	van Woudenbergh, GJ; Kuijsten, A; Drogan, D; Van Der A, DL; Romaguera, D; Ardanaz, E; Amiano, P; Barricarte, A; Beulens, JWJ; Boeing, H; Bueno-De-Mesquita, HB; Dahm, CC; Chirlaque, MD; Clavel, FC; Crowe, FL; Eomois, PP; Fagher-Azzi, G; Franks, PW; Halkjaer, J; Khaw, KT; Masala, G; Mattiello, A; Nilsson, P; Overvad, K; Quiros, JR; Rolandsson, O; Romieu, I; Sacerdote, C; Sanchez, MJ; Schulze, MB; Slimani, N; Sluijs, I; Spijkerman, AMW; Tagliabue, G; Teucher, B; Tjonneland, A; Tumino, R; Forouhi, NG; Sharp, S; Langenberg, C; Feskens, EJM; Riboli, E; Wareham, NJ				van Woudenbergh, Geertruida J.; Kuijsten, Anneleen; Drogan, Dagmar; van der A, Daphne L.; Romaguera, Dora; Ardanaz, Eva; Amiano, Pilar; Barricarte, Aurelio; Beulens, Joline W. J.; Boeing, Heiner; Bueno-de-Mesquita, H. Bas; Dahm, Christina C.; Chirlaque, M-Doleres; Clavel, Fran-coise; Crowe, Francesca L.; Eomois, Piia-Piret; Fagher-azzi, Guy; Franks, Paul W.; Halkjaer, Jytte; Khaw, Kay T.; Masala, Giovanna; Mattiello, Amalia; Nilsson, Peter; Overvad, Kim; Quiros, J. Ramon; Rolandsson, Olov; Romieu, Isabelle; Sacerdote, Carlotta; Sanchez, Maria-Jose; Schulze, Matthias B.; Slimani, Nadia; Sluijs, Ivonne; Spijkerman, Annemieke M. W.; Tagliabue, Giovanna; Teucher, Birgit; Tjonneland, Anne; Tumino, Rosario; Forouhi, Nita G.; Sharp, Stephen; Langenberg, Claudia; Feskens, Edith J. M.; Riboli, Elio; Wareham, Nicholas J.		InterAct Consortium	Tea Consumption and Incidence of Type 2 Diabetes in Europe: The EPIC-InterAct Case-Cohort Study	PLOS ONE			English	Article							BLACK TEA; GREEN TEA; OOLONG TEA; COFFEE; RISK; PLASMA; CANCER; MILK; POLYPHENOLS; ABSORPTION	Background: In previous meta-analyses, tea consumption has been associated with lower incidence of type 2 diabetes. It is unclear, however, if tea is associated inversely over the entire range of intake. Therefore, we investigated the association between tea consumption and incidence of type 2 diabetes in a European population. Methodology/Principal Findings: The EPIC-InterAct case-cohort study was conducted in 26 centers in 8 European countries and consists of a total of 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,835 individuals from a total cohort of 340,234 participants with 3.99 million person-years of follow-up. Country-specific Hazard Ratios (HR) for incidence of type 2 diabetes were obtained after adjustment for lifestyle and dietary factors using a Cox regression adapted for a case-cohort design. Subsequently, country-specific HR were combined using a random effects meta-analysis. Tea consumption was studied as categorical variable (0, >0-<1, 1-<4, >= 4 cups/day). The dose-response of the association was further explored by restricted cubic spline regression. Country specific medians of tea consumption ranged from 0 cups/day in Spain to 4 cups/day in United Kingdom. Tea consumption was associated inversely with incidence of type 2 diabetes; the HR was 0.84 [95% CI 0.71, 1.00] when participants who drank >= 4 cups of tea per day were compared with non-drinkers (p(linear) (trend) = 0.04). Incidence of type 2 diabetes already tended to be lower with tea consumption of 1-<4 cups/day (HR = 0.93 [95% CI 0.81, 1.05]). Spline regression did not suggest a non-linear association (p(non-linearity) = 0.20). Conclusions/Significance: A linear inverse association was observed between tea consumption and incidence of type 2 diabetes. People who drink at least 4 cups of tea per day may have a 16% lower risk of developing type 2 diabetes than non-tea drinkers.	[van Woudenbergh, Geertruida J.; Kuijsten, Anneleen] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Drogan, Dagmar; Boeing, Heiner; Schulze, Matthias B.] German Inst Human Nutr, Potsdam, Germany; [van der A, Daphne L.; Bueno-de-Mesquita, H. Bas; Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Romaguera, Dora; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Ardanaz, Eva; Barricarte, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Amiano, Pilar] Publ Hlth Div Gipuzkoa, San Sebastian, Spain; [Beulens, Joline W. J.; Sluijs, Ivonne] Univ Med Ctr, Utrecht, Netherlands; [Dahm, Christina C.; Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Aarhus, Denmark; [Chirlaque, M-Doleres] Murcia Reg Hlth Author, Murcia, Spain; [Clavel, Fran-coise; Fagher-azzi, Guy] INSERM, F-75654 Paris 13, France; [Crowe, Francesca L.] Univ Oxford, Oxford, England; [Eomois, Piia-Piret; Teucher, Birgit] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Franks, Paul W.] Lund Univ, Malmo, Sweden; [Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Khaw, Kay T.] Univ Cambridge, Cambridge, England; [Masala, Giovanna] Canc Res & Prevent Inst ISPO, Florence, Italy; [Mattiello, Amalia] Univ Naples Federico II, Naples, Italy; [Quiros, J. Ramon] Asturias Hlth & Hlth Care Council, Oviedo, Spain; [Rolandsson, Olov] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Romieu, Isabelle] Int Agcy Res Canc, F-69372 Lyon, France; [Sacerdote, Carlotta] Ctr Canc Prevent, Turin, Italy; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Tagliabue, Giovanna] Fdn IRCCS Ist Nazl Tumori, Canc Registry & Environm Epidemiol Unit, Milan, Italy; [Tumino, Rosario] Canc Registry & Histopathol Unit, Ragusa, Italy; [Forouhi, Nita G.; Sharp, Stephen; Langenberg, Claudia; Wareham, Nicholas J.] MRC Epidemiol Unit, Cambridge, England	Wageningen University & Research; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Netherlands National Institute for Public Health & the Environment; Imperial College London; Public Health Institute of Navarra; Utrecht University; Utrecht University Medical Center; Aarhus University; Murcia Regional Health Council; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Danish Cancer Society; University of Cambridge; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Naples Federico II; Umea University; World Health Organization; International Agency for Research on Cancer (IARC); Escuela Andaluza de Salud Publica; Fondazione IRCCS Istituto Nazionale Tumori Milan	van Woudenbergh, GJ (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.		Teucher, Birgit/J-6380-2015; Khaw, Kay-Tee/AAZ-3209-2021; Tagliabue, Giovanna/D-4194-2017; Mattiello, Amalia AM/K-5112-2016; Langenberg, Claudia/ABG-9067-2021; Feskens, Edith/ABI-1446-2020; Romaguera, Dora/ABE-7004-2020; Kuijsten, Anneleen/R-8073-2017; Masala, Giovanna/AAC-5474-2022; Sánchez, Maria-José/D-1087-2011; Schulze, Matthias B/AAH-6906-2021; Fagherazzi, Guy/P-3534-2017; Fagherazzi, Guy/ABB-2555-2020; Romaguera, Dora/AAB-2852-2020; Dahm, Christina C/G-9787-2014; Franks, Paul/AAA-3300-2020; Clavel-Chapelon, Francoise/G-6733-2014	Tagliabue, Giovanna/0000-0001-8165-5524; Mattiello, Amalia AM/0000-0003-3676-7353; Langenberg, Claudia/0000-0002-5017-7344; Feskens, Edith/0000-0001-5819-2488; Romaguera, Dora/0000-0002-5762-8558; Kuijsten, Anneleen/0000-0001-8120-7027; Masala, Giovanna/0000-0002-5758-9069; Sánchez, Maria-José/0000-0003-4817-0757; Schulze, Matthias B/0000-0002-0830-5277; Fagherazzi, Guy/0000-0001-5033-5966; Fagherazzi, Guy/0000-0001-5033-5966; Dahm, Christina C/0000-0003-0481-2893; Forouhi, Nita/0000-0002-5041-248X; tumino, rosario/0000-0003-2666-414X; Beulens, Joline/0000-0002-4181-0937; Overvad, Kim/0000-0001-6429-7921; Crowe, Francesca/0000-0003-4026-1726; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Franks, Paul/0000-0002-0520-7604; Sacerdote, Carlotta/0000-0002-8008-5096; Riboli, Elio/0000-0001-6795-6080; Tjonneland, Anne/0000-0003-4385-2097	European Union of the European Community [LSHM-CT-2006-037197]; DLvdA; AMWS; HBBdM: Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); EA and AB: Health Research Fund (FIS); Regional Government of Andalucia; Regional Government of Basque Country; Regional Government of Murcia; Regional Government of Navarra; ISCIII RETIC (Spain) [RD06/0020]; NL Agency [IGE05012]; Board of the UMC Utrecht; AM: Compagnia di San Paolo; MDC: Health Research Fund (FIS) of the Spanish Ministry of Health; Murcia Regional Government [6236]; CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; FC: Cancer Research UK; AT, JH, CCD, and KO: Danish Cancer Society; OR: Vasterbotten County Council; PWF: Swedish Research Council; Novo Nordisk; Swedish Diabetes Association; Swedish Heart-Lung Foundation; JRQ: Regional Government of the Principality of Asturias (Spain); PN and LG: Swedish Research Council; RT: AIRE-ONLUS Ragusa; AVIS-Ragusa; Sicilian Regional Government; KTK: Medical Research Council UK; Cancer Research UK; MRC [MC_UP_A100_1003] Funding Source: UKRI	European Union of the European Community; DLvdA; AMWS; HBBdM: Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Statistics Netherlands (The Netherlands)(Netherlands Government); EA and AB: Health Research Fund (FIS); Regional Government of Andalucia(Junta de Andalucia); Regional Government of Basque Country(Basque Government); Regional Government of Murcia; Regional Government of Navarra; ISCIII RETIC (Spain)(Instituto de Salud Carlos III); NL Agency; Board of the UMC Utrecht; AM: Compagnia di San Paolo(Compagnia di San Paolo); MDC: Health Research Fund (FIS) of the Spanish Ministry of Health; Murcia Regional Government(Fundacion Seneca); CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; FC: Cancer Research UK; AT, JH, CCD, and KO: Danish Cancer Society; OR: Vasterbotten County Council; PWF: Swedish Research Council; Novo Nordisk(Novo Nordisk); Swedish Diabetes Association; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); JRQ: Regional Government of the Principality of Asturias (Spain); PN and LG: Swedish Research Council; RT: AIRE-ONLUS Ragusa; AVIS-Ragusa; Sicilian Regional Government(Regione Sicilia); KTK: Medical Research Council UK; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The EPIC-InterAct project was funded by the European Union (Integrated Project LSHM-CT-2006-037197 in the Framework Program 6 of the European Community). In addition, EPIC-InterAct investigators acknowledge funding from the following agencies:-DLvdA, AMWS, and HBBdM: Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); EA and AB: Health Research Fund (FIS), Regional Governments of Andalucia, Basque Country, Murcia and Navarra, ISCIII RETIC (RD06/0020) (Spain); JWJB and IS: Verification of diabetes cases was additionally funded by NL Agency grant IGE05012 and an Incentive Grant from the Board of the UMC Utrecht; AM: Compagnia di San Paolo; MDC: Health Research Fund (FIS) of the Spanish Ministry of Health; Murcia Regional Government (No 6236), and CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; FC: Cancer Research UK; AT, JH, CCD, and KO: Danish Cancer Society; OR: Vasterbotten County Council; PWF: Swedish Research Council, Novo Nordisk, Swedish Diabetes Association, Swedish Heart-Lung Foundation; JRQ: Regional Government of the Principality of Asturias (Spain); PN and LG: Swedish Research Council; RT: AIRE-ONLUS Ragusa, AVIS-Ragusa, Sicilian Regional Government; KTK: Medical Research Council UK, Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Arts MJTJ, 2002, J AGR FOOD CHEM, V50, P1184, DOI 10.1021/jf010855a; Boggs DA, 2010, AM J CLIN NUTR, V92, P960, DOI 10.3945/ajcn.2010.29598; Carlsen MH, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-3; Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806; Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hollman PCH, 2001, FREE RADICAL RES, V34, P297, DOI 10.1080/10715760100300261; Hosoda K, 2003, DIABETES CARE, V26, P1714, DOI 10.2337/diacare.26.6.1714; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Huyen VTT, 2010, HORM METAB RES, V42, P353, DOI 10.1055/s-0030-1248298; Jing YL, 2009, J GEN INTERN MED, V24, P557, DOI 10.1007/s11606-009-0929-5; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kyle JAM, 2007, J AGR FOOD CHEM, V55, P4889, DOI 10.1021/jf070351y; Lakenbrink C, 2000, J AGR FOOD CHEM, V48, P2848, DOI 10.1021/jf9908042; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P309, DOI 10.1080/096374800426902; Leenen R, 2000, EUR J CLIN NUTR, V54, P87, DOI 10.1038/sj.ejcn.1600900; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Manikandan R, 2009, MICROSC RES TECHNIQ, V72, P723, DOI 10.1002/jemt.20721; Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505; Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966; Onland-Moret NC, 2007, J CLIN EPIDEMIOL, V60, P350, DOI 10.1016/j.jclinepi.2006.06.022; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001; Sartorelli DS, 2010, AM J CLIN NUTR, V91, P1002, DOI 10.3945/ajcn.2009.28741; Serafini M, 1996, EUR J CLIN NUTR, V50, P28; Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x; University FaAOWHOUN, 1985, WHO TECHN REP SER, V724; van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3; van het Hof KH, 1999, P SOC EXP BIOL MED, V220, P203, DOI 10.1046/j.1525-1373.1999.d01-34.x; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	33	38	38	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36910	10.1371/journal.pone.0036910	http://dx.doi.org/10.1371/journal.pone.0036910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666334	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400016
J	Yeung, TY; Seeberger, KL; Kin, T; Adesida, A; Jomha, N; Shapiro, AMJ; Korbutt, GS				Yeung, Telford Y.; Seeberger, Karen L.; Kin, Tatsuya; Adesida, Adetola; Jomha, Nadr; Shapiro, A. M. James; Korbutt, Gregory S.			Human Mesenchymal Stem Cells Protect Human Islets from Pro-Inflammatory Cytokines	PLOS ONE			English	Article							THERAPY POSITION STATEMENT; STROMAL CELLS; BONE-MARROW; INTERNATIONAL-SOCIETY; TRANSPLANTED ISLETS; EDMONTON PROTOCOL; IN-VITRO; SURVIVAL; TERM; MASS	Transplantation of human islets is an attractive alternative to daily insulin injections for patients with type 1 diabetes. However, the majority of islet recipients lose graft function within five years. Inflammation is a primary contributor to graft loss, and inhibiting pro-inflammatory cytokine activity can reverse inflammation mediated dysfunction of islet grafts. As mesenchymal stem cells (MSCs) possess numerous immunoregulatory properties, we hypothesized that MSCs could protect human islets from pro-inflammatory cytokines. Five hundred human islets were co-cultured with 0.5 or 1.0x10(6) human MSCs derived from bone marrow or pancreas for 24 hours followed by 48 hour exposure to interferon-gamma, tumor necrosis factor-alpha and interleukin 1 beta. Controls include islets cultured alone (+/- cytokines) and with human dermal fibroblasts (+/- cytokines). For all conditions, glucose stimulated insulin secretion (GSIS), total islet cellular insulin content, islet beta cell apoptosis, and potential cytoprotective factors secreted in the culture media were determined. Cytokine exposure disrupted human islet GSIS based on stimulation index and percentage insulin secretion. Conversely, culture with 1.0x10(6) bMSCs preserved GSIS from cytokine treated islets. Protective effects were not observed with fibroblasts, indicating that preservation of human islet GSIS after exposure to pro-inflammatory cytokines is MSC dependent. Islet beta cell apoptosis was observed in the presence of cytokines; however, culture of bMSCs with islets prevented beta cell apoptosis after cytokine treatment. Hepatocyte growth factor (HGF) as well as matrix metalloproteinases 2 and 9 were also identified as putative secreted cytoprotective factors; however, other secreted factors likely play a role in protection. This study, therefore, demonstrates that MSCs may be beneficial for islet engraftment by promoting cell survival and reduced inflammation.	[Yeung, Telford Y.; Seeberger, Karen L.; Kin, Tatsuya; Adesida, Adetola; Jomha, Nadr; Shapiro, A. M. James; Korbutt, Gregory S.] Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat 5 002, Dept Surg, Edmonton, AB, Canada; [Yeung, Telford Y.; Seeberger, Karen L.; Kin, Tatsuya; Shapiro, A. M. James; Korbutt, Gregory S.] Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat 5 002, Alberta Diabet Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta	Yeung, TY (corresponding author), Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat 5 002, Dept Surg, Edmonton, AB, Canada.	korbutt@ualberta.ca	Yeung, Telford/GLV-4480-2022; Adesida, Adetola B/H-3549-2011; Kin, Tatsuya/A-3776-2012	Adesida, Adetola B/0000-0003-1798-6251; Kin, Tatsuya/0000-0002-5179-6067	Juvenile Diabetes Research Foundation [4-2008-812]; Alberta Diabetes Foundation/Institute Translational Grant; Canadian Institutes for Health Research MD/PhD studentship; Alberta Innovates Health Solutions Studentship	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Alberta Diabetes Foundation/Institute Translational Grant; Canadian Institutes for Health Research MD/PhD studentship(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions Studentship	This study is supported by the Juvenile Diabetes Research Foundation (Grant # 4-2008-812) and [an Alberta Diabetes Foundation/Institute Translational Grant]. TYY is a recipient of a Canadian Institutes for Health Research MD/PhD studentship and Alberta Innovates Health Solutions Studentship. The funders had no role in study design, data collection and analysis, decision to publish or publication of manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; ALEJANDRO R, 1986, J CLIN INVEST, V78, P1339, DOI 10.1172/JCI112720; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Boumaza I, 2009, J AUTOIMMUN, V32, P33, DOI 10.1016/j.jaut.2008.10.004; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Choi SE, 2004, TRANSPL IMMUNOL, V13, P43, DOI 10.1016/j.trim.2004.04.001; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duprez IR, 2011, UPSALA J MED SCI, V116, P8, DOI 10.3109/03009734.2010.524320; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Gysemans C, 2003, DIABETOLOGIA, V46, P1115, DOI 10.1007/s00125-003-1154-0; Harb G, 2007, XENOTRANSPLANTATION, V14, P580, DOI 10.1111/j.1399-3089.2007.00427.x; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438; Itakura S, 2007, AM J TRANSPLANT, V7, P336, DOI 10.1111/j.1600-6143.2006.01643.x; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Johansson U, 2008, DIABETES, V57, P2393, DOI 10.2337/db07-0981; KAUFMAN DB, 1994, DIABETES, V43, P778, DOI 10.2337/diabetes.43.6.778; Khan WS, 2010, J ORTHOP RES, V28, P834, DOI 10.1002/jor.21043; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Luo LG, 2007, BIOCHEM BIOPH RES CO, V361, P859, DOI 10.1016/j.bbrc.2007.07.105; MANDRUPPOULSEN T, 1990, CURR TOP MICROBIOL, V164, P169; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; Park KS, 2009, TRANSPL P, V41, P3813, DOI 10.1016/j.transproceed.2009.06.193; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; RABINOVITCH A, 1993, DIABETES REV, V1, P215; Rackham CL, 2011, DIABETOLOGIA, V54, P1127, DOI 10.1007/s00125-011-2053-4; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Seeberger KL, 2006, LAB INVEST, V86, P141, DOI 10.1038/labinvest.3700377; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; Wang JF, 2011, J CELL PHYSIOL, V226, P1265, DOI 10.1002/jcp.22454	38	85	91	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38189	10.1371/journal.pone.0038189	http://dx.doi.org/10.1371/journal.pone.0038189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666480	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400098
J	Liao, GJW; Chan, KCA; Jiang, PY; Sun, H; Leung, TY; Chiu, RWK; Lo, YMD				Liao, Gary J. W.; Chan, K. C. Allen; Jiang, Peiyong; Sun, Hao; Leung, Tak Y.; Chiu, Rossa W. K.; Lo, Y. M. Dennis			Noninvasive Prenatal Diagnosis of Fetal Trisomy 21 by Allelic Ratio Analysis Using Targeted Massively Parallel Sequencing of Maternal Plasma DNA	PLOS ONE			English	Article							FORMALDEHYDE; ENRICHMENT; BLOOD; SERUM; PROPORTION; ANEUPLOIDY	Background: Plasma DNA obtained from a pregnant woman contains a mixture of maternal and fetal DNA. The fetal DNA proportion in maternal plasma is relatively consistent as determined using polymorphic genetic markers across different chromosomes in euploid pregnancies. For aneuploid pregnancies, the observed fetal DNA proportion measured using polymorphic genetic markers for the aneuploid chromosome would be perturbed. In this study, we investigated the feasibility of analyzing single nucleotide polymorphisms using targeted massively parallel sequencing to detect such perturbations in mothers carrying trisomy 21 fetuses. Methodology/Principal Findings: DNA was extracted from plasma samples collected from fourteen pregnant women carrying singleton fetuses. Hybridization-based targeted sequencing was used to enrich 2 906 single nucleotide polymorphism loci on chr7, chr13, chr18 and chr21. Plasma DNA libraries with and without target enrichment were analyzed by massively parallel sequencing. Genomic DNA samples of both the mother and fetus for each case were genotyped by single nucleotide polymorphism microarray analysis. For the targeted regions, the mean sequencing depth of the enriched samples was 225-fold higher than that of the non-enriched samples. From the targeted sequencing data, the ratio between fetus-specific and shared alleles increased by approximately 2-fold on chr21 in the paternally-derived trisomy 21 case. In comparison, the ratio is decreased by approximately 11% on chr21 in the maternally-derived trisomy 21 cases but with much overlap with the ratio of the euploid cases. Computer simulation revealed the relationship between the fetal DNA proportion, the number of informative alleles and the depth of sequencing. Conclusions/Significance: Targeted massively parallel sequencing of single nucleotide polymorphism loci in maternal plasma DNA is a potential approach for trisomy 21 detection. However, the method appears to be less robust than approaches using non-polymorphism-based counting of sequence tags in plasma.	[Liao, Gary J. W.; Chan, K. C. Allen; Jiang, Peiyong; Sun, Hao; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China; [Liao, Gary J. W.; Chan, K. C. Allen; Jiang, Peiyong; Sun, Hao; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Leung, Tak Y.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Liao, GJW (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	JIANG, Peiyong/AAZ-9898-2020; Lo, Yuk Ming Dennis/D-4468-2011; Chan, K.C. Allen/M-2930-2013; sun, hao/GRS-7732-2022; Sun, Hao/J-9964-2013; Sun, Hao/T-5576-2019	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Chan, K.C. Allen/0000-0003-1780-1691; Sun, Hao/0000-0002-5547-9501; Sun, Hao/0000-0002-5547-9501; Jiang, Peiyong/0000-0003-4523-3476	University Grants Committee of the Government of the Hong Kong Special Administration Region, China, under the Areas of Excellence Scheme [AoE/M-04/06]; Sequenom; Endowed Chair from the Li Ka Shing Foundation	University Grants Committee of the Government of the Hong Kong Special Administration Region, China, under the Areas of Excellence Scheme; Sequenom; Endowed Chair from the Li Ka Shing Foundation	The study was supported by the University Grants Committee of the Government of the Hong Kong Special Administration Region, China, under the Areas of Excellence Scheme (AoE/M-04/06) and an additional sponsored research agreement with Sequenom. YMDL was supported by an Endowed Chair from the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; Benachi A, 2005, CLIN CHEM, V51, P242; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Chinnapapagari SKR, 2005, CLIN CHEM, V51, P652, DOI 10.1373/clinchem.2004.042119; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Chiu RWK, 2011, BRIT MED J, V342, P9; Chung GTY, 2005, CLIN CHEM, V51, P655, DOI 10.1373/clinchem.2004.042168; Dhallan R, 2007, LANCET, V369, P474, DOI 10.1016/S0140-6736(07)60115-9; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851	19	43	74	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38154	10.1371/journal.pone.0038154	http://dx.doi.org/10.1371/journal.pone.0038154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666469	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349600065
J	Luzardo, OP; Henriquez-Hernandez, LA; Valeron, PF; Lara, PC; Almeida-Gonzalez, M; Losada, A; Zumbado, M; Serra-Majem, L; Alvarez-Leon, EE; Boada, LD				Luzardo, Octavio P.; Alberto Henriquez-Hernandez, Luis; Valeron, Pilar F.; Lara, Pedro C.; Almeida-Gonzalez, Maira; Losada, Antonio; Zumbado, Manuel; Serra-Majem, Lluis; Elisa Alvarez-Leon, Eva; Boada, Luis D.			The Relationship between Dioxin-Like Polychlorobiphenyls and IGF-I Serum Levels in Healthy Adults: Evidence from a Cross-Sectional Study	PLOS ONE			English	Article							GROWTH-FACTOR-I; POLYCHLORINATED-BIPHENYLS PCBS; HUDSON RIVER COMMUNITIES; BINDING PROTEIN-3; ESTROGENIC ACTIVITY; POPULATION SAMPLE; OLDER RESIDENTS; CANARY-ISLANDS; BREAST-CANCER; EXPOSURE	Objective: Insulin-like growth factor I (IGF-I) and dioxin-like polychlorobiphenyls (DL-PCBs) have been associated with the pathogenesis of several diseases like cancer, diabetes and growth disorders. Because it has been suggested that organohalogenated contaminants could influence IGF-I levels in adults, the potential relationship between DL-PCBs and IGF-I serum levels was studied in 456 healthy adults from a representative sample of the general population of the Canary Islands (Spain). Design: Free circulating serum levels of IGF-I and IGFBP-3 were measured through an ELISA methodology, while the serum levels of the 12 DL-PCBs congeners (IUPAC numbers # 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, and 189) were measured by gas chromatography/mass spectrometry (GC-MS). Results: DL-PCBs 156 and 167, Total DL-PCBs body burden (Sigma PCBs: sum over the 12 measured DL-PCBs), and Total toxic burden (in terms of toxic equivalence to dioxins: Sigma TEQs) showed a trend of inverse association with IGF-I serum levels in the whole studied population. After adjusting for potential confounders, including gender, body mass index (BMI), age, and IGF-binding protein-3 (IGFBP-3), younger (18-45 years) women with lower BMI (<27 kg/m(2)) and detectable levels of DL-PCB-156 showed significantly lower IGF-I levels than those in the same age and BMI subgroup with non-detectable levels of DL-PCB-156 (p<0.001). Similarly, Sigma PCBs and Sigma TEQs showed a tendency to an inverse association with IGF-I levels in the same group of women (p = 0.017 and p = 0.019 respectively). Conclusions: These findings suggest that DL-PCBs could be involved in the regulation of the IGF-system in a way possibly influenced by gender, age and BMI. Although these results should be interpreted with caution, such circumstances could contribute to explain the development of diseases associated to the IGF system.	[Luzardo, Octavio P.; Almeida-Gonzalez, Maira; Zumbado, Manuel; Boada, Luis D.] Univ Las Palmas Gran Canaria, Dept Clin Sci, Toxicol Unit, Las Palmas Gran Canaria, Spain; [Luzardo, Octavio P.; Alberto Henriquez-Hernandez, Luis; Valeron, Pilar F.; Lara, Pedro C.; Almeida-Gonzalez, Maira; Zumbado, Manuel; Serra-Majem, Lluis; Elisa Alvarez-Leon, Eva; Boada, Luis D.] Inst Canario Invest Canc, Las Palmas Gran Canaria, Spain; [Alberto Henriquez-Hernandez, Luis; Lara, Pedro C.] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Valeron, Pilar F.] Univ Las Palmas Gran Canaria, Dept Biochem & Mol Biol Phisiol Genet & Immunol, Las Palmas Gran Canaria, Spain; [Losada, Antonio] Hosp Univ Gran Canaria Dr Negrin, Dept Lab Tests, Las Palmas Gran Canaria, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Prevent Med & Publ Hlth Unit, Las Palmas Gran Canaria, Spain; [Elisa Alvarez-Leon, Eva] Complejo Hosp Materno Insular Gran Canari, Prevent Med Serv, Las Palmas Gran Canaria, Spain; [Alberto Henriquez-Hernandez, Luis; Lara, Pedro C.] Hosp Univ Gran Canaria Dr Negrin, Dept Radiat Oncol, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Luzardo, OP (corresponding author), Univ Las Palmas Gran Canaria, Dept Clin Sci, Toxicol Unit, Las Palmas Gran Canaria, Spain.	ldominguez@dcc.ulpgc.es	Serra-Majem, Lluis/I-6708-2019; Luzardo, Octavio P./H-3045-2019; Valeron, Pilar/AAJ-6771-2021; Dominguez-Boada, Luis/L-5577-2015; Zumbado, Manuel/B-4495-2010; Zumbado, Manuel/AAN-8373-2020; Henriquez-Hernandez, Luis Alberto/H-8981-2019	Serra-Majem, Lluis/0000-0002-9658-9061; Luzardo, Octavio P./0000-0002-4153-3028; Valeron, Pilar/0000-0001-5865-7003; Dominguez-Boada, Luis/0000-0002-0195-4565; Zumbado, Manuel/0000-0002-1534-7758; Henriquez-Hernandez, Luis Alberto/0000-0003-3237-0316; Almeida Gonzalez, Maira/0000-0003-2410-4659	Fundacion Canaria de Investigacion en Salud (FUNCIS) [21/99]; Spanish Government (Proyecto FIS, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo) [PI060601]	Fundacion Canaria de Investigacion en Salud (FUNCIS); Spanish Government (Proyecto FIS, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo)	This work was funded with the grant No. 21/99 from the Fundacion Canaria de Investigacion en Salud (FUNCIS) and a grant from the Spanish Government (Proyecto FIS, PI060601, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency EFS, 2010, EFSA J, V8, P1385; Andersson PL, 1999, ARCH ENVIRON CON TOX, V37, P145, DOI 10.1007/s002449900499; Baibas N, 2003, EUR J CANCER PREV, V12, P229, DOI 10.1097/00008469-200306000-00010; Binoux M, 1995, DIABETES METAB, V21, P330; Boada LD, 2007, GROWTH HORM IGF RES, V17, P506, DOI 10.1016/j.ghir.2007.05.004; Brabant G, 2007, PITUITARY, V10, P129, DOI 10.1007/s11102-007-0035-9; Brian JV, 2005, ENVIRON HEALTH PERSP, V113, P721, DOI 10.1289/ehp.7598; Burns JS, 2011, PEDIATRICS, V127, pE59, DOI 10.1542/peds.2009-3556; Cerna M, 2008, CHEMOSPHERE, V72, P1124, DOI 10.1016/j.chemosphere.2008.04.019; Cocchi D, 2009, TOXICOL APPL PHARM, V237, P127, DOI 10.1016/j.taap.2009.03.008; Croutch CR, 2005, TOXICOL SCI, V85, P560, DOI 10.1093/toxsci/kfi106; Crowe FL, 2011, ANN HUM BIOL, V38, P194, DOI 10.3109/03014460.2010.507221; Decastro BR, 2006, ENVIRON SCI TECHNOL, V40, P2819, DOI 10.1021/es051667u; Dickerson SM, 2011, ENDOCRINOLOGY, V152, P581, DOI 10.1210/en.2010-1103; Donato F, 2008, ENVIRON RES, V108, P380, DOI 10.1016/j.envres.2008.08.003; Dunger DB, 2003, HORM RES, V60, P131, DOI 10.1159/000074514; Everett CJ, 2007, ENVIRON RES, V103, P413, DOI 10.1016/j.envres.2006.11.002; Fitzgerald EF, 2008, ENVIRON HEALTH PERSP, V116, P209, DOI 10.1289/ehp.10432; Fitzgerald EF, 2007, ENVIRON RES, V104, P352, DOI 10.1016/j.envres.2007.01.010; Gomez JM, 2003, CLIN ENDOCRINOL, V58, P213, DOI 10.1046/j.1365-2265.2003.01698.x; Gonzalez CA, 2010, EUR J CANCER, V46, P2555, DOI 10.1016/j.ejca.2010.07.025; Hall K., 1999, Journal of Endocrinological Investigation, V22, P48; Henderson KD, 2006, CANCER EPIDEM BIOMAR, V15, P2298, DOI 10.1158/1055-9965.EPI-06-0344; Henriquez-Hernandez LA, 2011, ENVIRON RES, V111, P10, DOI 10.1016/j.envres.2010.11.005; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P862; (IARC) IAfRoC, 1987, IARC MON, V1-42, P367; Kaklamani VG, 1999, J CLIN ONCOL, V17, P813, DOI 10.1200/JCO.1999.17.3.813; Kanbur-Oksuz N, 2004, TURKISH J PEDIATR, V46, P315; Kang JH, 2008, CHEMOSPHERE, V73, P1625, DOI 10.1016/j.chemosphere.2008.07.087; KIMBROUGH RD, 1995, CRIT REV TOXICOL, V25, P133, DOI 10.3109/10408449509021611; Koppen G, 2002, CHEMOSPHERE, V48, P811, DOI 10.1016/S0045-6535(02)00111-X; LANDINWILHELMSEN K, 1994, CLIN ENDOCRINOL, V41, P351, DOI 10.1111/j.1365-2265.1994.tb02556.x; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; Lee DH, 2007, DIABETES CARE, V30, P1596, DOI 10.2337/dc07-0072; Leijs MM, 2008, CHEMOSPHERE, V73, P176, DOI 10.1016/j.chemosphere.2008.05.056; LEWITT MS, 1994, DIABETES RES CLIN PR, V23, P3, DOI 10.1016/0168-8227(94)90121-X; Longnecker MP, 2000, EPIDEMIOLOGY, V11, P44, DOI 10.1097/00001648-200001000-00010; Luzardo OP, 2012, CHEMOSPHERE; Majem LS, 2000, ARCH LATINOAM NUTR, V50, P62; Pelletier C, 2002, TOXICOL SCI, V67, P46, DOI 10.1093/toxsci/67.1.46; Philibert A, 2009, INT J ENV RES PUB HE, V6, P3179, DOI 10.3390/ijerph6123179; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; Pliskova M, 2005, ENVIRON HEALTH PERSP, V113, P1277, DOI 10.1289/ehp.7745; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rinaldi S, 2005, CANCER EPIDEM BIOMAR, V14, P48; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P276, DOI 10.1080/10937400701875923; Scarth JP, 2006, XENOBIOTICA, V36, P119, DOI 10.1080/00498250600621627; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P699, DOI 10.1530/eje.1.02131; Sherlock M, 2011, NAT REV ENDOCRINOL, V7, P291, DOI 10.1038/nrendo.2011.42; Succurro E, 2010, EUR J ENDOCRINOL, V163, P75, DOI 10.1530/EJE-10-0113; TANABE S, 1988, ENVIRON POLLUT, V50, P5, DOI 10.1016/0269-7491(88)90183-2; Tekle M, 2010, ENVIRON INT, V36, P188, DOI 10.1016/j.envint.2009.11.003; Uemura H, 2008, ENVIRON RES, V108, P63, DOI 10.1016/j.envres.2008.06.002; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; VANDENBERG M, 1994, CRIT REV TOXICOL, V24, P1; Yang FX, 2008, ENVIRON TOXICOL CHEM, V27, P220, DOI 10.1897/07-108.1; Zubero MB, 2009, CHEMOSPHERE, V76, P784, DOI 10.1016/j.chemosphere.2009.04.061; Zumbado M, 2005, SCI TOTAL ENVIRON, V339, P49, DOI 10.1016/j.scitotenv.2004.07.022; Zumbado M, 2010, GROWTH HORM IGF RES, V20, P63, DOI 10.1016/j.ghir.2009.07.003	60	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38213	10.1371/journal.pone.0038213	http://dx.doi.org/10.1371/journal.pone.0038213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666488	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600073
J	McHugh, D; O'Connor, T; Bremer, J; Aguzzi, A				McHugh, Donal; O'Connor, Tracy; Bremer, Juliane; Aguzzi, Adriano			ZyFISH: A Simple, Rapid and Reliable Zygosity Assay for Transgenic Mice	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; PRP KNOCKOUT MICE; PRION PROTEIN; QUANTITATIVE PCR; EGF RECEPTOR; LACKING; SUSCEPTIBILITY; TOXICITY; SCRAPIE; ANIMALS	Microinjection of DNA constructs into fertilized mouse oocytes typically results in random transgene integration at a single genomic locus. The resulting transgenic founders can be used to establish hemizygous transgenic mouse lines. However, practical and experimental reasons often require that such lines be bred to homozygosity. Transgene zygosity can be determined by progeny testing assays which are expensive and time-consuming, by quantitative Southern blotting which is labor-intensive, or by quantitative PCR (qPCR) which requires transgene-specific design. Here, we describe a zygosity assessment procedure based on fluorescent in situ hybridization (zyFISH). The zyFISH protocol entails the detection of transgenic loci by FISH and the concomitant assignment of homozygosity using a concise and unbiased scoring system. The method requires small volumes of blood, is scalable to at least 40 determinations per assay, and produces results entirely consistent with the progeny testing assay. This combination of reliability, simplicity and cost-effectiveness makes zyFISH a method of choice for transgenic mouse zygosity determinations.	[McHugh, Donal; O'Connor, Tracy; Bremer, Juliane; Aguzzi, Adriano] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, Zurich, Switzerland	University of Zurich; University Zurich Hospital	McHugh, D (corresponding author), Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, Schmelzbergstr, Zurich, Switzerland.	adriano.aguzzi@usz.ch	Aguzzi, Adriano/A-3351-2008; Bremer, Juliane/AAH-9487-2020	Aguzzi, Adriano/0000-0002-0344-6708	ERC Advanced Investigator award [250356]; University of Zurich; Dr. Max Husmann Foundation Zurich; Swiss National Science Foundation [3100A0-111917]; Center of Transgenesis Expertise of the National Center of Competence in Research "Neural Plasticity and Repair"; Novartis Research Foundation; European Union programs Prion Research Projects Community (PRIORITY) [222887]; Seventh Framework Programs [24098, 278611]	ERC Advanced Investigator award; University of Zurich; Dr. Max Husmann Foundation Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Center of Transgenesis Expertise of the National Center of Competence in Research "Neural Plasticity and Repair"; Novartis Research Foundation; European Union programs Prion Research Projects Community (PRIORITY); Seventh Framework Programs	Adriano Aguzzi is supported by ERC Advanced Investigator award #250356. Tracy O'Connor and Juliane Bremer are supported by funding from the University of Zurich. Donal McHugh is supported by a scholarship from the Dr. Max Husmann Foundation Zurich. This work was funded by the Swiss National Science Foundation (3100A0-111917), the Center of Transgenesis Expertise of the National Center of Competence in Research "Neural Plasticity and Repair", by an unrestricted grant of the Novartis Research Foundation to Adriano Aguzzi, and by the European Union programs Prion Research Projects Community (PRIORITY; 222887) and the Seventh Framework Programs (24098), and (278611; NeuriNox). The funders had no role in study design, data collection and analysis, decision to publish, or preparation or the manuscript.	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Buerki K, 2011, PRICE LIST RATES LAB; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Carlson GA, 1997, HUM MOL GENET, V6, P1951, DOI 10.1093/hmg/6.11.1951; Cremer Marion, 2008, V463, P205, DOI 10.1007/978-1-59745-406-3_15; DINCHUK JE, 1994, BIOTECHNIQUES, V17, P954; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P683, DOI 10.1093/nar/9.3.683; Knoll JH, 2005, CURRENT PROTOCOLS HU, P431; Kulnane LS, 2002, MAMM GENOME, V13, P223, DOI 10.1007/s00335-001-2128-5; NISHINO H, 1995, BIOTECHNIQUES, V19, P587; Paris D, 1996, TRANSGENIC RES, V5, P397, DOI 10.1007/BF01980204; Schneider MR, 2005, ANAL BIOCHEM, V344, P1, DOI 10.1016/j.ab.2005.03.035; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SWIGER RR, 1995, BIOTECHNIQUES, V18, P952; Tesson L, 2002, TRANSGENIC RES, V11, P43, DOI 10.1023/A:1013928600442; Tesson L, 2010, METHODS MOL BIOL, V597, P277, DOI 10.1007/978-1-60327-389-3_19; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; ZIMMER C, 1986, PROG BIOPHYS MOL BIO, V47, P31, DOI 10.1016/0079-6107(86)90005-2	24	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37881	10.1371/journal.pone.0037881	http://dx.doi.org/10.1371/journal.pone.0037881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666404	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305349600036
J	Yaniv, Y; Spurgeon, HA; Lyashkov, AE; Yang, DM; Ziman, BD; Maltsev, VA; Lakatta, EG				Yaniv, Yael; Spurgeon, Harold A.; Lyashkov, Alexey E.; Yang, Dongmei; Ziman, Bruce D.; Maltsev, Victor A.; Lakatta, Edward G.			Crosstalk between Mitochondrial and Sarcoplasmic Reticulum Ca2+ Cycling Modulates Cardiac Pacemaker Cell Automaticity	PLOS ONE			English	Article							SPONTANEOUS BEATING RATE; RYANODINE RECEPTOR; MYOCYTES; RABBIT; INHIBITION; CGP-37157; EXCHANGE; CHANNELS; OSCILLATIONS; CONTRACTION	Background: Mitochondria dynamically buffer cytosolic Ca2+ in cardiac ventricular cells and this affects the Ca2+ load of the sarcoplasmic reticulum (SR). In sinoatrial-node cells (SANC) the SR generates periodic local, subsarcolemmal Ca2+ releases (LCRs) that depend upon the SR load and are involved in SANC automaticity: LCRs activate an inward Na+-Ca2+ exchange current to accelerate the diastolic depolarization, prompting the ensemble of surface membrane ion channels to generate the next action potential (AP). Objective: To determine if mitochondrial Ca2+ (Ca-m(2+)), cytosolic Ca2+ (Ca-c(2+))-SR-Ca2+ crosstalk occurs in single rabbit SANC, and how this may relate to SANC normal automaticity. Results: Inhibition of mitochondrial Ca2+ influx into (Ru360) or Ca2+ efflux from (CGP-37157) decreased [Ca2+](m) to 80 +/- 8% control or increased [Ca2+](m) to 119 +/- 7% control, respectively. Concurrent with inhibition of mitochondrial Ca2+ influx or efflux, the SR Ca2+ load, and LCR size, duration, amplitude and period (imaged via confocal linescan) significantly increased or decreased, respectively. Changes in total ensemble LCR Ca2+ signal were highly correlated with the change in the SR Ca2+ load (r(2) = 0.97). Changes in the spontaneous AP cycle length (Ru360, 111 +/- 1% control; CGP-37157, 89 +/- 2% control) in response to changes in [Ca2+](m) were predicted by concurrent changes in LCR period (r(2) = 0.84). Conclusion: A change in SANC Ca-m(2+) flux translates into a change in the AP firing rate by effecting changes in Ca (2+)(c) and SR Ca2+ loading, which affects the characteristics of spontaneous SR Ca2+ release.	[Yaniv, Yael; Spurgeon, Harold A.; Lyashkov, Alexey E.; Yang, Dongmei; Ziman, Bruce D.; Maltsev, Victor A.; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Yaniv, Y (corresponding author), NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	LakattaE@mail.nih.gov	Maltsev, Victor/AAY-9460-2020; Lakatta, Edward G/AAL-1447-2020; Yaniv, Yael/B-3311-2015	Maltsev, Victor/0000-0002-3832-791X; Yaniv, Yael/0000-0002-5183-6284; Lakatta, Edward/0000-0002-4772-0035	Intramural Research Program of the National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000599] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported entirely by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Y, 2011, J CELL MOL MED, V15, P2478, DOI 10.1111/j.1582-4934.2010.01249.x; Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Chikando AC, 2011, J MOL CELL CARDIOL, V51, P627, DOI 10.1016/j.yjmcc.2011.08.003; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; Dedkova EN, 2008, CELL CALCIUM, V44, P77, DOI 10.1016/j.ceca.2007.11.002; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Dorn GW, 2010, CIRC RES, V107, P689, DOI 10.1161/CIRCRESAHA.110.225714; Gao Z, 2010, J MOL CELL CARDIOL, V49, P33, DOI 10.1016/j.yjmcc.2010.03.019; Griffiths EJ, 1997, CELL CALCIUM, V21, P321, DOI 10.1016/S0143-4160(97)90120-2; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Hashiatni H, 2010, BRIT J PHARMACOL, V161, P680, DOI 10.1111/j.1476-5381.2010.00902.x; Hernandez-SanMiguel E, 2006, CELL CALCIUM, V40, P53, DOI 10.1016/j.ceca.2006.03.009; Liu T, 2010, J MOL CELL CARDIOL, V49, P728, DOI 10.1016/j.yjmcc.2010.06.012; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Maltsev VA, 2011, AM J PHYSIOL-HEART C, V300, pH2323, DOI 10.1152/ajpheart.00110.2011; Maltsev VA, 2010, AM J PHYSIOL-HEART C, V298, pH2010, DOI 10.1152/ajpheart.00783.2009; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MIYATA H, 1991, AM J PHYSIOL, V261, pH1123, DOI 10.1152/ajpheart.1991.261.4.H1123; Neumann JT, 2011, MOL PHARMACOL, V79, P141, DOI 10.1124/mol.110.067165; O'Rourke B, 2009, J MOL CELL CARDIOL, V46, P767, DOI 10.1016/j.yjmcc.2008.12.011; Odagiri K, 2009, J MOL CELL CARDIOL, V46, P989, DOI 10.1016/j.yjmcc.2008.12.022; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; SPURGEON HA, 1990, AM J PHYSIOL, V258, pH574, DOI 10.1152/ajpheart.1990.258.2.H574; Thu LT, 2006, EUR J PHARMACOL, V552, P15, DOI 10.1016/j.ejphar.2006.09.013; Vinogradova TM, 2008, CIRC RES, V102, P761, DOI 10.1161/CIRCRESAHA.107.161679; Vinogradova TM, 2010, CIRC RES, V107, P767, DOI 10.1161/CIRCRESAHA.110.220517; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271; Yaniv Y, 2011, J MOL CELL CARDIOL, V51, P740, DOI 10.1016/j.yjmcc.2011.07.018	33	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37582	10.1371/journal.pone.0037582	http://dx.doi.org/10.1371/journal.pone.0037582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666369	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600023
J	Clouard, C; Jouhanneau, M; Meunier-Salaun, MC; Malbert, CH; Val-Laillet, D				Clouard, Caroline; Jouhanneau, Melanie; Meunier-Salauen, Marie-Christine; Malbert, Charles-Henri; Val-Laillet, David			Exposures to Conditioned Flavours with Different Hedonic Values Induce Contrasted Behavioural and Brain Responses in Pigs	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DORSOLATERAL PREFRONTAL CORTEX; PARABRACHIAL NUCLEUS LESIONS; TASTE-AVERSION; INSULAR CORTEX; HUMAN AMYGDALA; UNPLEASANT ODORS; CHORDA TYMPANI; PREFERENCE; RATS	This study investigated the behavioural and brain responses towards conditioned flavours with different hedonic values in juvenile pigs. Twelve 30-kg pigs were given four three-day conditioning sessions: they received three different flavoured meals paired with intraduodenal (i.d.) infusions of 15% glucose (F-Glu), lithium chloride (F-LiCl), or saline (control treatment, F-NaCl). One and five weeks later, the animals were subjected to three two-choice feeding tests without reinforcement to check the acquisition of a conditioned flavour preference or aversion. In between, the anaesthetised pigs were subjected to three (18)FDG PET brain imaging coupled with an olfactogustatory stimulation with the conditioned flavours. During conditioning, the pigs spent more time lying inactive, and investigated their environment less after the F-LiCl than the F-NaCl or F-Glu meals. During the two-choice tests performed one and five weeks later, the F-NaCl and F-Glu foods were significantly preferred over the F-LiCl food even in the absence of i.d. infusions. Surprisingly, the F-NaCl food was also preferred over the F-Glu food during the first test only, suggesting that, while LiCl i.d. infusions led to a strong flavour aversion, glucose infusions failed to induce flavour preference. As for brain imaging results, exposure to aversive or less preferred flavours triggered global deactivation of the prefrontal cortex, specific activation of the posterior cingulate cortex, as well as asymmetric brain responses in the basal nuclei and the temporal gyrus. In conclusion, postingestive visceral stimuli can modulate the flavour/food hedonism and further feeding choices. Exposure to flavours with different hedonic values induced metabolism differences in neural circuits known to be involved in humans in the characterization of food palatability, feeding motivation, reward expectation, and more generally in the regulation of food intake.	[Clouard, Caroline; Jouhanneau, Melanie; Malbert, Charles-Henri; Val-Laillet, David] INRA, ADNC Alimentat & Adaptat Digest Nerveuses & Compo, St Gilles, France; [Clouard, Caroline; Jouhanneau, Melanie; Meunier-Salauen, Marie-Christine] INRA, PEGASE Physiol Environm & Genet Anim & Syst Eleva, St Gilles, France; [Clouard, Caroline; Jouhanneau, Melanie; Meunier-Salauen, Marie-Christine] Agrocampus Ouest, PEGASE Physiol Environm & Genet Anim & Syst Eleva, Rennes, France	INRAE; INRAE; Institut Agro; Agrocampus Ouest	Clouard, C (corresponding author), INRA, ADNC Alimentat & Adaptat Digest Nerveuses & Compo, St Gilles, France.	david.val-laillet@rennes.inra.fr	VAL-LAILLET, David/AAH-6454-2021; Clouard, Caroline/K-1255-2014	Clouard, Caroline/0000-0002-5562-6057; Malbert, Charles-Henri/0000-0002-0665-4545	INRA (Department of Human Alimentation); INRA (Department of Animal Physiology and Livestock Systems); Brittany Region (Region Bretagne); CRITT Sante Bretagne (Centre Regional d'Innovation et de Transfert de Technologies)	INRA (Department of Human Alimentation); INRA (Department of Animal Physiology and Livestock Systems); Brittany Region (Region Bretagne)(Region Bretagne); CRITT Sante Bretagne (Centre Regional d'Innovation et de Transfert de Technologies)	This study was supported by a grant from INRA (Department of Human Alimentation; Department of Animal Physiology and Livestock Systems) and the Brittany Region (Region Bretagne), and especially by the CRITT Sante Bretagne (Centre Regional d'Innovation et de Transfert de Technologies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroff K, 2001, PHYSIOL BEHAV, V72, P691, DOI 10.1016/S0031-9384(01)00442-5; Ackroff K, 2011, PHYSIOL BEHAV, V102, P548, DOI 10.1016/j.physbeh.2011.01.004; Ackroff K, 2010, PHYSIOL BEHAV, V99, P402, DOI 10.1016/j.physbeh.2009.12.012; Ackroff K, 2009, PHYSIOL BEHAV, V97, P406, DOI 10.1016/j.physbeh.2009.03.014; Anderson AK, 2003, NEURON, V39, P581, DOI 10.1016/S0896-6273(03)00504-X; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Danilova V, 2002, J NEUROPHYSIOL, V88, P579, DOI 10.1152/jn.2002.88.2.579; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; Del Parigi A, 2002, ANN NY ACAD SCI, V967, P389; Desgranges B, 2009, EUR J NEUROSCI, V29, P1654, DOI 10.1111/j.1460-9568.2009.06711.x; Dwyer DM, 2010, PHYSIOL BEHAV, V101, P403, DOI 10.1016/j.physbeh.2010.07.004; Faurion A, 1999, NEUROSCI LETT, V277, P189, DOI 10.1016/S0304-3940(99)00881-2; Galef BG, 2003, LEARN MEMORY, P147; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; Gaultier A, 2011, EUR J NEUROSCI, V34, P1500, DOI 10.1111/j.1460-9568.2011.07848.x; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Gautier JF, 1999, AM J CLIN NUTR, V70, P806; Gilbert PE, 2003, NEUROBIOL LEARN MEM, V79, P118, DOI 10.1016/S1074-7427(02)00013-8; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hellekant G, 1997, J NEUROPHYSIOL, V77, P978, DOI 10.1152/jn.1997.77.2.978; Henkin RI, 2001, J COMPUT ASSIST TOMO, V25, P493, DOI 10.1097/00004728-200107000-00001; Kringelbach ML, 2004, NEUROIMAGE, V21, P781, DOI 10.1016/j.neuroimage.2003.09.063; Kringelbach ML, 2010, DISCOV MED, V9, P579; LAWRENCE A, 1987, ANIM BEHAV, V35, P293, DOI 10.1016/S0003-3472(87)80236-1; Le DSNT, 2006, AM J CLIN NUTR, V84, P725, DOI 10.1093/ajcn/84.4.725; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Myers KP, 2007, APPETITE, V48, P123, DOI 10.1016/j.appet.2006.07.077; Myers KP, 2006, DEV PSYCHOBIOL, V48, P380, DOI 10.1002/dev.20147; Navarro M, 2003, BRAIN RES, V990, P195, DOI 10.1016/S0006-8993(03)03530-3; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; Reilly S, 1999, BRAIN RES BULL, V48, P239, DOI 10.1016/S0361-9230(98)00173-7; Reilly S, 2000, BRAIN RES BULL, V52, P269, DOI 10.1016/S0361-9230(00)00263-X; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Reiner G, 2009, APPL ANIM BEHAV SCI, V118, P222, DOI 10.1016/j.applanim.2009.02.010; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Roman C, 2009, BRAIN RES, V1259, P68, DOI 10.1016/j.brainres.2008.12.058; Royet JP, 2004, CHEM SENSES, V29, P731, DOI 10.1093/chemse/bjh067; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Royet JP, 2000, J NEUROSCI, V20, P7752; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sclafani A, 2001, BEHAV NEUROSCI, V115, P920, DOI 10.1037//0735-7044.115.4.920; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Smeets PAM, 2006, AM J CLIN NUTR, V83, P1297, DOI 10.1093/ajcn/83.6.1297; St-Onge MP, 2005, J NUTR, V135, P1014, DOI 10.1093/jn/135.5.1014; Stafstrom-Davis CA, 2001, LEARN MEMORY, V8, P272, DOI 10.1101/lm.42101; Touzani K, 2005, EUR J NEUROSCI, V22, P1767, DOI 10.1111/j.1460-9568.2005.04360.x; Touzani K, 2002, EUR J NEUROSCI, V16, P2425, DOI 10.1046/j.1460-9568.2002.02404.x; Touzani K, 2002, BEHAV NEUROSCI, V116, P256, DOI 10.1037//0735-7044.116.2.256; Touzani K, 2001, BEHAV NEUROSCI, V115, P84, DOI 10.1037//0735-7044.115.1.84; Touzani K, 2007, EUR J NEUROSCI, V26, P1692, DOI 10.1111/j.1460-9568.2007.05798.x; Touzani K, 2010, NEUROBIOL LEARN MEM, V94, P214, DOI 10.1016/j.nlm.2010.05.009; Touzani K, 2009, NEUROBIOL LEARN MEM, V92, P464, DOI 10.1016/j.nlm.2009.06.006; Touzani K, 2009, EUR J NEUROSCI, V30, P289, DOI 10.1111/j.1460-9568.2009.06829.x; Veldhuizen MG, 2010, CHEM SENSES, V35, P121, DOI 10.1093/chemse/bjp089; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; WARWICK ZS, 1994, PHYSIOL BEHAV, V55, P501, DOI 10.1016/0031-9384(94)90107-4; Weary DM, 2009, J ANIM SCI, V87, P770, DOI 10.2527/jas.2008-1297; Weary DM, 2006, APPL ANIM BEHAV SCI, V100, P64, DOI 10.1016/j.applanim.2006.04.013; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5	71	21	21	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37968	10.1371/journal.pone.0037968	http://dx.doi.org/10.1371/journal.pone.0037968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22685528	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300149
J	Chartrain, M; Riond, JL; Stennevin, A; Vandenberghe, I; Gomes, B; Lamant, L; Meyer, N; Gairin, JE; Guilbaud, N; Annereau, JP				Chartrain, Marine; Riond, Joele; Stennevin, Aline; Vandenberghe, Isabelle; Gomes, Bruno; Lamant, Laurence; Meyer, Nicolas; Gairin, Jean Edouard; Guilbaud, Nicolas; Annereau, Jean Philippe			Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells	PLOS ONE			English	Article							MEMBRANE-TRANSPORT PROTEINS; P-GLYCOPROTEIN EXPRESSION; CANCER STEM-CELLS; MULTIDRUG-RESISTANCE; ABCB5; GENE; EPIDEMIOLOGY; ACTIVATION; FUSION	Metastatic melanoma is the most aggressive skin cancer. Recently, phenotypically distinct subpopulations of tumor cells were identified. Among them, ABCB5-expressing cells were proposed to display an enhanced tumorigenicity with stem cell-like properties. In addition, ABCB5(+) cells are thought to participate to chemoresistance through a potential efflux function of ABCB5. Nevertheless, the fate of these cells upon drugs that are used in melanoma chemotherapy remains to be clarified. Here we explored the effect of anti-melanoma treatments on the ABCB5-expressing cells. Using a melanoma xenograft model (WM266-4), we observed in vivo that ABCB5-expressing cells are enriched after a temozolomide treatment that induces a significant tumor regression. These results were further confirmed in a preliminary study conducted on clinical samples from patients that received dacarbazine. In vitro, we showed that ABCB5-expressing cells selectively survive when exposed to dacarbazine, the reference treatment of metastatic melanoma, but also to vemurafenib, a new inhibitor of the mutated kinase V600E BRAF and other various chemotherapeutic drugs. Our results show that anti-melanoma chemotherapy might participate to the chemoresistance acquisition by selecting tumor cell subpopulations expressing ABCB5. This is of particular importance in understanding the relapses observed after anti-melanoma treatments and reinforces the interest of ABCB5 and ABCB5-expressing cells as potential therapeutic targets in melanoma.	[Chartrain, Marine; Riond, Joele; Gairin, Jean Edouard] UMR 2587, CNRS Pierre Fabre, ISTMT, Toulouse, France; [Chartrain, Marine; Stennevin, Aline; Vandenberghe, Isabelle; Gomes, Bruno; Guilbaud, Nicolas; Annereau, Jean Philippe] Ctr Rech & Dev Pierre Fabre, Ctr Rech Oncol Expt, Toulouse, France; [Riond, Joele] USR 3388, CNRS Pierre Fabre, Ctr Rech & Dev Pierre Fabre, Toulouse, France; [Lamant, Laurence] INSERM, U563, CHU Purpan, Toulouse, France; [Meyer, Nicolas] Hop Larrey, Toulouse, France; [Gairin, Jean Edouard] Univ Toulouse III, Fac Pharmacie, UMR152, IRD UPS PHARMA DEV, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chartrain, M (corresponding author), UMR 2587, CNRS Pierre Fabre, ISTMT, Toulouse, France.	jelle.riond@dr14.cnrs.fr	Meyer, Nicolas/A-1174-2013; Riond, Joelle/R-6414-2016	Riond, Joelle/0000-0002-6281-2376				Abolhoda A, 1999, CLIN CANCER RES, V5, P3352; Arancia G, 1998, CYTOTECHNOLOGY, V27, P95, DOI 10.1023/A:1008040117882; Bei R, 2010, RECENT PAT ANTI-CANC, V5, P172, DOI 10.2174/157489210791760526; BERGER W, 1994, INT J CANCER, V59, P717, DOI 10.1002/ijc.2910590522; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen KG, 2006, P NATL ACAD SCI USA, V103, P9903, DOI 10.1073/pnas.0600213103; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Chen KG, 2005, PIGM CELL RES, V18, P102, DOI 10.1111/j.1600-0749.2005.00214.x; Cheung PFY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028246; Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; Elliott AM, 2009, MOL CANCER RES, V7, P79, DOI 10.1158/1541-7786.MCR-08-0235; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Fukunaga-Kalabis M, 2010, ONCOGENE; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Garbe C, 2010, EUR J CANCER, V46, P270, DOI 10.1016/j.ejca.2009.10.032; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Ichihashi N, 2001, BRIT J DERMATOL, V144, P745, DOI 10.1046/j.1365-2133.2001.04129.x; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Keshet GI, 2008, BIOCHEM BIOPH RES CO, V368, P930, DOI 10.1016/j.bbrc.2008.02.022; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Molinari A, 1998, INT J CANCER, V75, P885, DOI 10.1002/(SICI)1097-0215(19980316)75:6<885::AID-IJC11>3.0.CO;2-2; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; SCHADENDORF D, 1995, BRIT J DERMATOL, V132, P551; SCHADENDORF D, 1995, AM J PATHOL, V147, P1545; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schatton T, 2010, CANCER RES, V70, P697, DOI 10.1158/0008-5472.CAN-09-1592; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Walsh N, 2010, BRIT J CANCER, V102, P1157, DOI 10.1038/sj.bjc.6605590; Wilson BJ, 2011, CANC RES; Yang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-388; Zheng XQ, 2010, INT J ONCOL, V37, P307, DOI 10.3892/ijo_00000679	36	71	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36762	10.1371/journal.pone.0036762	http://dx.doi.org/10.1371/journal.pone.0036762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22675422	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338900004
J	Ohnishi, H; Tochio, H; Kato, Z; Kawamoto, N; Kimura, T; Kubota, K; Yamamoto, T; Funasaka, T; Nakano, H; Wong, RW; Shirakawa, M; Kondo, N				Ohnishi, Hidenori; Tochio, Hidehito; Kato, Zenichiro; Kawamoto, Norio; Kimura, Takeshi; Kubota, Kazuo; Yamamoto, Takahiro; Funasaka, Tatsuyoshi; Nakano, Hiroshi; Wong, Richard W.; Shirakawa, Masahiro; Kondo, Naomi			TRAM Is Involved in IL-18 Signaling and Functions as a Sorting Adaptor for MyD88	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; NF-KAPPA-B; TIR-DOMAIN; ENDOTOXIN TOLERANCE; INTERFERON-BETA; TRIF; TOLL-LIKE-RECEPTOR-4; MOLECULE; TLR4; TRANSDUCTION	MyD88, a Toll/interleukin-1 receptor homology (TIR) domain-containing adaptor protein, mediates signals from the Toll-like receptors (TLR) or IL-1/IL-18 receptors to downstream kinases. In MyD88-dependent TLR4 signaling, the function of MyD88 is enhanced by another TIR domain-containing adaptor, Mal/TIRAP, which brings MyD88 to the plasma membrane and promotes its interaction with the cytosolic region of TLR4. Hence, Mal is recognized as the "sorting adaptor" for MyD88. In this study, a direct interaction between MyD88-TIR and another membrane-sorting adaptor, TRAM/TICAM-2, was demonstrated in vitro. Cell-based assays including RNA interference experiments and TRAM deficient mice revealed that the interplay between MyD88 and TRAM in cells is important in mediating IL-18 signal transduction. Live cell imaging further demonstrated the co-localized accumulation of MyD88 and TRAM in the membrane regions in HEK293 cells. These findings suggest that TRAM serves as the sorting adaptor for MyD88 in IL-18 signaling, which then facilitates the signal transduction. The binding sites for TRAM are located in the TIR domain of MyD88 and actually overlap with the binding sites for Mal. MyD88, the multifunctional signaling adaptor that works together with most of the TLR members and with the IL-1/IL-18 receptors, can interact with two distinct sorting adaptors, TRAM and Mal, in a conserved manner in a distinct context.	[Ohnishi, Hidenori; Kato, Zenichiro; Kawamoto, Norio; Kimura, Takeshi; Kubota, Kazuo; Yamamoto, Takahiro; Kondo, Naomi] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan; [Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto, Japan; [Funasaka, Tatsuyoshi; Nakano, Hiroshi; Wong, Richard W.] Kanazawa Univ, Sch Nat Syst, Dept Biol, Mol & Cellular Biol Lab, Kanazawa, Ishikawa, Japan	Gifu University; Kyoto University; Kanazawa University	Ohnishi, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan.	ohnishih@gifu-u.ac.jp; tochio@moleng.kyoto-u.ac.jp	Wong, Richard W./E-9155-2011; Tochio, Hidehito/GWV-0429-2022; Kawamoto, Norio/AAN-5302-2021	Tochio, Hidehito/0000-0003-3843-3330; Kawamoto, Norio/0000-0002-3482-7781	Ministry of Education, Sports Science, Culture and Technology of Japan; Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [24650611, 24121710] Funding Source: KAKEN	Ministry of Education, Sports Science, Culture and Technology of Japan; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Sports Science, Culture and Technology of Japan and by Health and Labour Science Research Grants for Research on Intractable Disease from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bin LH, 2003, J BIOL CHEM, V278, P24526, DOI 10.1074/jbc.M303451200; Bonnert TP, 1997, FEBS LETT, V402, P81, DOI 10.1016/S0014-5793(96)01506-2; Brown V, 2006, EUR J IMMUNOL, V36, P742, DOI 10.1002/eji.200535158; Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kato Z, 2003, NAT STRUCT BIOL, V10, P966, DOI 10.1038/nsb993; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Sacre SM, 2007, J IMMUNOL, V178, P2148, DOI 10.4049/jimmunol.178.4.2148; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; Sheedy FJ, 2007, J LEUKOCYTE BIOL, V82, P196, DOI 10.1189/jlb.1206750; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	30	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38423	10.1371/journal.pone.0038423	http://dx.doi.org/10.1371/journal.pone.0038423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685567	gold, Green Submitted, Green Published			2022-12-27	WOS:000305351700030
J	Panseri, S; Cunha, C; D'Alessandro, T; Sandri, M; Russo, A; Giavaresi, G; Marcacci, M; Hung, CT; Tampieri, A				Panseri, Silvia; Cunha, Carla; D'Alessandro, Teresa; Sandri, Monica; Russo, Alessandro; Giavaresi, Gianluca; Marcacci, Maurilio; Hung, Clark T.; Tampieri, Anna			Magnetic Hydroxyapatite Bone Substitutes to Enhance Tissue Regeneration: Evaluation In Vitro Using Osteoblast-Like Cells and In Vivo in a Bone Defect	PLOS ONE			English	Article							GROWTH-FACTOR DELIVERY; GRAFT SUBSTITUTES; NANOPARTICLES; SCAFFOLDS; FORCE; DNA	In case of degenerative disease or lesion, bone tissue replacement and regeneration is an important clinical goal. In particular, nowadays, critical size defects rely on the engineering of scaffolds that are 3D structural supports, allowing cellular infiltration and subsequent integration with the native tissue. Several ceramic hydroxyapatite (HA) scaffolds with high porosity and good osteointegration have been developed in the past few decades but they have not solved completely the problems related to bone defects. In the present study we have developed a novel porous ceramic composite made of HA that incorporates magnetite at three different ratios: HA/Mgn 95/5, HA/Mgn 90/10 and HA/Mgn 50/50. The scaffolds, consolidated by sintering at high temperature in a controlled atmosphere, have been analysed in vitro using human osteoblast-like cells. Results indicate high biocompatibility, similar to a commercially available HA bone graft, with no negative effects arising from the presence of magnetite or by the use of a static magnetic field. HA/Mgn 90/10 was shown to enhance cell proliferation at the early stage. Moreover, it has been implanted in vivo in a critical size lesion of the rabbit condyle and a good level of histocompatibility was observed. Such results identify this scaffold as particularly relevant for bone tissue regeneration and open new perspectives for the application of a magnetic field in a clinical setting of bone replacement, either for magnetic scaffold fixation or magnetic drug delivery.	[Panseri, Silvia; Cunha, Carla; Russo, Alessandro; Marcacci, Maurilio] Rizzoli Orthopaed Inst, Lab Biomech & Technol Innovat, Bologna, Italy; [Panseri, Silvia; Cunha, Carla; D'Alessandro, Teresa; Sandri, Monica; Tampieri, Anna] CNR, Inst Sci & Technol Ceram, Faenza, Ravenna, Italy; [Giavaresi, Gianluca] Rizzoli Orthopaed Inst, Lab Preclin & Surg Studies, Bologna, Italy; [Giavaresi, Gianluca] Rizzoli Orthopaed Inst, Lab Biocompatibil Innovat Technol & Adv Therapies, Bologna, Italy; [Hung, Clark T.] Columbia Univ, Dept Biomed Engn, New York, NY USA	IRCCS Istituto Ortopedico Rizzoli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologia dei Materiali Ceramici (ISTEC-CNR); IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; Columbia University	Panseri, S (corresponding author), Rizzoli Orthopaed Inst, Lab Biomech & Technol Innovat, Bologna, Italy.	s.panseri@biomec.ior.it	Sandri, Monica/AAY-4322-2020; Panseri, Silvia/AAW-2856-2020; russo, alessandro ar/K-5778-2018; Giavaresi, Gianluca/J-5583-2016; Cunha, Carla/I-1884-2013	Panseri, Silvia/0000-0002-8099-7132; russo, alessandro ar/0000-0002-1580-2829; Giavaresi, Gianluca/0000-0001-7843-5969; Cunha, Carla/0000-0002-9096-5644; Sandri, Monica/0000-0001-5782-3137; Panseri, Sara/0000-0001-6970-2009; MARCACCI, MAURILIO/0000-0002-7484-1246	European Union project "MAGISTER" [NMP3-LA-2008-214685]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046568] Funding Source: NIH RePORTER	European Union project "MAGISTER"; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors strongly acknowledge the financial support from European Union project "MAGISTER" NMP3-LA-2008-214685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirfazli A, 2007, NAT NANOTECHNOL, V2, P467, DOI 10.1038/nnano.2007.234; Arruebo M, 2007, NANO TODAY, V2, P22, DOI 10.1016/S1748-0132(07)70084-1; Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017; Calori GM, 2011, INJURY, V42, pS56, DOI 10.1016/j.injury.2011.06.011; Foy SP, 2010, ACS NANO, V4, P5217, DOI 10.1021/nn101427t; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Glossop JR, 2010, J TISSUE ENG REGEN M, V4, P577, DOI 10.1002/term.293; Gould P, 2006, NANO TODAY, V1, P34, DOI 10.1016/S1748-0132(06)70115-3; Hua MY, 2010, BIOMATERIALS, V31, P7355, DOI 10.1016/j.biomaterials.2010.05.061; Jain TK, 2008, MOL PHARMACEUT, V5, P316, DOI 10.1021/mp7001285; Kanczler JM, 2010, TISSUE ENG PT A, V16, P3241, DOI [10.1089/ten.tea.2009.0638, 10.1089/ten.TEA.2009.0638]; Khaled E G, 2011, Open Orthop J, V5 Suppl 2, P289, DOI 10.2174/1874325001105010289; Khan W.S., 2012, STEM CELLS INT; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884; Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223; Lu HH, 2006, ADV BIOCHEM ENG BIOT, V102, P91, DOI 10.1007/b138509; Lu HH, 2010, ANN BIOMED ENG, V38, P2142, DOI 10.1007/s10439-010-0046-y; Nandi SK, 2010, INDIAN J MED RES, V132, P15; Ngiam M, 2011, ANN ACAD MED SINGAP, V40, P213; Panseri S., 2011, KNEE SURG SPORTS TRA; Phillips MA, 2010, NANO TODAY, V5, P143, DOI 10.1016/j.nantod.2010.03.003; Polyak B, 2008, P NATL ACAD SCI USA, V105, P698, DOI 10.1073/pnas.0708338105; Prijic S, 2010, J MEMBRANE BIOL, V236, P167, DOI 10.1007/s00232-010-9271-4; Shimizu K, 2007, J BIOMED MATER RES B, V82B, P471, DOI 10.1002/jbm.b.30752; Sun CR, 2010, ACS NANO, V4, P2402, DOI 10.1021/nn100190v; Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104; Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241; TEIXEIRA CC, 1995, CALCIFIED TISSUE INT, V56, P252, DOI 10.1007/BF00298620; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wu Y, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/1/015001; Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047	32	82	86	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38710	10.1371/journal.pone.0038710	http://dx.doi.org/10.1371/journal.pone.0038710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685602	gold, Green Published, Green Submitted			2022-12-27	WOS:000305351700065
J	Foster, BL; Nagatomo, KJ; Nociti, FH; Fong, HS; Dunn, D; Tran, AB; Wang, W; Narisawa, S; Millan, JL; Somerman, MJ				Foster, Brian L.; Nagatomo, Kanako J.; Nociti, Francisco H., Jr.; Fong, Hanson; Dunn, Daisy; Tran, Anne B.; Wang, Wei; Narisawa, Sonoko; Millan, Jose Luis; Somerman, Martha J.			Central Role of Pyrophosphate in Acellular Cementum Formation	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; DENTIN MATRIX PROTEIN-1; CELL MEMBRANE GLYCOPROTEIN-1; HUMAN PERIODONTAL-LIGAMENT; INORGANIC PYROPHOSPHATE; IN-VITRO; INFANTILE HYPOPHOSPHATASIA; HYDROXYAPATITE FORMATION; MECHANICAL-PROPERTIES; ATTACHMENT APPARATUS	Background: Inorganic pyrophosphate (PPi) is a physiologic inhibitor of hydroxyapatite mineral precipitation involved in regulating mineralized tissue development and pathologic calcification. Local levels of PPi are controlled by antagonistic functions of factors that decrease PPi and promote mineralization (tissue-nonspecific alkaline phosphatase, Alpl/TNAP), and those that increase local PPi and restrict mineralization (progressive ankylosis protein, ANK; ectonucleotide pyrophosphatase phosphodiesterase-1, NPP1). The cementum enveloping the tooth root is essential for tooth function by providing attachment to the surrounding bone via the nonmineralized periodontal ligament. At present, the developmental regulation of cementum remains poorly understood, hampering efforts for regeneration. To elucidate the role of PPi in cementum formation, we analyzed root development in knock-out ((-/-)) mice featuring PPi dysregulation. Results: Excess PPi in the Alpl(-/-) mouse inhibited cementum formation, causing root detachment consistent with premature tooth loss in the human condition hypophosphatasia, though cementoblast phenotype was unperturbed. Deficient PPi in both Ank and Enpp1(-/-) mice significantly increased cementum apposition and overall thickness more than 12-fold vs. controls, while dentin and cellular cementum were unaltered. Though PPi regulators are widely expressed, cementoblasts selectively expressed greater ANK and NPP1 along the root surface, and dramatically increased ANK or NPP1 in models of reduced PPi output, in compensatory fashion. In vitro mechanistic studies confirmed that under low PPi mineralizing conditions, cementoblasts increased Ank (5-fold) and Enpp1 (20-fold), while increasing PPi inhibited mineralization and associated increases in Ank and Enpp1 mRNA. Conclusions: Results from these studies demonstrate a novel developmental regulation of acellular cementum, wherein cementoblasts tune cementogenesis by modulating local levels of PPi, directing and regulating mineral apposition. These findings underscore developmental differences in acellular versus cellular cementum, and suggest new approaches for cementum regeneration.	[Foster, Brian L.; Nociti, Francisco H., Jr.; Tran, Anne B.; Somerman, Martha J.] Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Lab Oral Connect Tissue Biol, NIH, Bethesda, MD 20892 USA; [Nagatomo, Kanako J.; Dunn, Daisy] Univ Washington, Sch Dent, Dept Periodont, Seattle, WA 98195 USA; [Nociti, Francisco H., Jr.] Univ Estadual Campinas, Sch Dent Piracicaba, Div Periodont, Sao Paulo, Brazil; [Wang, Wei; Narisawa, Sonoko; Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Washington; University of Washington Seattle; Universidade Estadual de Campinas; Sanford Burnham Prebys Medical Discovery Institute	Foster, BL (corresponding author), Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Lab Oral Connect Tissue Biol, NIH, Bethesda, MD 20892 USA.	brian.foster@nih.gov	Nociti, Francisco/G-4907-2015; Foster, Brian/AAV-4336-2020; Foster, Brian L/H-8375-2015	Foster, Brian/0000-0003-3444-0576; Foster, Brian L/0000-0003-3444-0576; Nociti, Francisco/0000-0001-6809-8866	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH); NIH [R01DE15109, R01 AR47908, R01 DE12889]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047908, ZIAAR041196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015109] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH). Grants R01DE15109 (MJS), R01 AR47908 and R01 DE12889 (JLM) were received from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, J ORAL BIOSCI, V46, P125; Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Addison WN, 2010, BONE, V46, P1100, DOI 10.1016/j.bone.2010.01.367; ALATLIKUT I, 1994, SCAND J DENT RES, V102, P260; Beertsen W, 1999, J DENT RES, V78, P1221, DOI 10.1177/00220345990780060501; BEERTSEN W, 1985, AM J ANAT, V174, P83, DOI 10.1002/aja.1001740107; BELLOWS CG, 1992, BONE MINER, V17, P15, DOI 10.1016/0169-6009(92)90707-K; BELLOWS CG, 1991, BONE MINER, V14, P27, DOI 10.1016/0169-6009(91)90100-E; Berendsen AD, 2010, CELLS TISSUES ORGANS, V192, P116, DOI 10.1159/000289585; Berry JE, 2003, CONNECT TISSUE RES, V44, P97, DOI 10.1080/03008200390152160; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Bosshardt DD, 2005, J DENT RES, V84, P390, DOI 10.1177/154405910508400501; Bosshardt DD, 2009, PERIODONTOL 2000, V51, P208, DOI 10.1111/j.1600-0757.2009.00317.x; BRONCKERS ALJJ, 1994, J BONE MINER RES, V9, P833; BRUCKNER R. J. N. H. RICKLES, 1962, ORAL SURG ORAL MED AND ORAL PATHOL, V15, P1351, DOI 10.1016/0030-4220(62)90356-0; CHAPPLE ILC, 1993, J CLIN PERIODONTOL, V20, P615, DOI 10.1111/j.1600-051X.1993.tb00705.x; D'Errico JA, 2000, J PERIODONTOL, V71, P63, DOI 10.1902/jop.2000.71.1.63; Diekwisch TGH, 2001, INT J DEV BIOL, V45, P695; Esposito M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub3; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; FLEISCH H, 1962, NATURE, V195, P911, DOI 10.1038/195911a0; Fong H, 2009, ARCH ORAL BIOL, V54, P570, DOI 10.1016/j.archoralbio.2009.02.011; Fong H, 2009, J PERIODONTOL, V80, P1348, DOI 10.1902/jop.2009.090129; Fong H, 2009, ARCH ORAL BIOL; Foster BL, 2011, CELLS TISSUES ORGANS; Foster BL, 2007, CURR TOP DEV BIOL, V78, P47, DOI 10.1016/S0070-2153(06)78003-6; Foster Brian L., 2008, Birth Defects Research, V84, P281, DOI 10.1002/bdrc.20136; Gaengler P, 2007, DEV FUNCTION EVOLUTI, P173; Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; GROENEVELD MC, 1995, J DENT RES, V74, P1374, DOI 10.1177/00220345950740070901; Gurley KA, 2006, J BONE MINER RES, V21, P1238, DOI 10.1359/JBMR.060515; Gurley KA, 2006, AM J HUM GENET, V79, P1017, DOI 10.1086/509881; Hao JJ, 2004, BONE, V34, P921, DOI 10.1016/j.bone.2004.01.020; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Harmey D, 2006, J BONE MINER RES, V21, P1377, DOI 10.1359/JBMR.060619; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Ho SP, 2007, BIOMATERIALS, V28, P5238, DOI 10.1016/j.biomaterials.2007.08.031; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; Jayawardena CK, 2002, EUR J ORAL SCI, V110, P261, DOI 10.1034/j.1600-0447.2002.21239.x; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Johnson K, 1999, J BONE MINER RES, V14, P883, DOI 10.1359/jbmr.1999.14.6.883; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kaipatur NR, 2008, J DENT RES, V87, P839, DOI 10.1177/154405910808700907; Lillie RD, 1965, HISTOCHEMISTRY TECHN; Luan X, 2006, DEV DYN; Luan XH, 2009, EVOL DEV, V11, P247, DOI 10.1111/j.1525-142X.2009.00327.x; MacNeil R L, 1995, Connect Tissue Res, V33, P1, DOI 10.3109/03008209509016974; Marchesan JT, 2011, ARCH ORAL BIOL; McIntosh JE, 2002, MICROSC RES TECHNIQ, V59, P449, DOI 10.1002/jemt.10222; McKee MD, 1996, ANAT RECORD, V245, P293, DOI 10.1002/(SICI)1097-0185(199606)245:2<293::AID-AR13>3.0.CO;2-K; McKee MD, 2011, J DENT RES; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; Millan J.L., 2006, MAMMALIAN ALKALINE P; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Narisawa S, 1997, DEV DYNAM, V208, P432, DOI 10.1002/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1; Nociti FH, 2002, J DENT RES, V81, P817, DOI 10.1177/154405910208101204; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; Osathanon T, 2009, BIOMATERIALS, V30, P4513, DOI 10.1016/j.biomaterials.2009.05.022; Reibel A, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-6; Rios H. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P325; Rodrigues TL, 2011, J PERIODONTOL; ROSENTHAL AK, 1991, ARTHRITIS RHEUM, V34, P904, DOI 10.1002/art.1780340717; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; TENENBAUM HC, 1987, BONE MINER, V3, P13; TENENBAUM HC, 1981, J DENT RES, V60, P1586, DOI 10.1177/002203458106000308011; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; van den Bos T, 2005, J DENT RES, V84, P1021, DOI 10.1177/154405910508401110; van den Bos T, 1999, J PERIODONTAL RES, V34, P1; Whyte M.P, 2002, PRINCIPLES BONE BIOL, V2, P1569, DOI 10.1016/B978-012098652-1.50172-4; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Yang WC, 2005, J BIOL CHEM, V280, P20680, DOI 10.1074/jbc.M500104200; Ye L, 2008, J DENT RES, V87, P624, DOI 10.1177/154405910808700708	80	93	98	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38393	10.1371/journal.pone.0038393	http://dx.doi.org/10.1371/journal.pone.0038393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675556	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700069
J	Hoffmann, D; Schwarck, D; Banning, C; Brenner, M; Mariyanna, L; Krepstakies, M; Schindler, M; Millar, DP; Hauber, J				Hoffmann, Dirk; Schwarck, Doreen; Banning, Carina; Brenner, Matthias; Mariyanna, Lakshmikanth; Krepstakies, Marcel; Schindler, Michael; Millar, David P.; Hauber, Joachim			Formation of Trans-Activation Competent HIV-1 Rev:RRE Complexes Requires the Recruitment of Multiple Protein Activation Domains	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REV-RESPONSE ELEMENT; NUCLEAR EXPORT SIGNALS; VIRAL MESSENGER-RNA; GENE-EXPRESSION REQUIRES; TYPE-1 REV; TRANS-ACTIVATOR; CELLULAR COFACTOR; TARGET SEQUENCE; STRUCTURED REGION	The HIV-1 Rev trans-activator is a nucleocytoplasmic shuttle protein that is essential for virus replication. Rev directly binds to unspliced and incompletely spliced viral RNA via the cis-acting Rev Response Element (RRE) sequence. Subsequently, Rev oligomerizes cooperatively and interacts with the cellular nuclear export receptor CRM1. In addition to mediating nuclear RNA export, Rev also affects the stability, translation and packaging of Rev-bound viral transcripts. Although it is established that Rev function requires the multimeric assembly of Rev molecules on the RRE, relatively little is known about how many Rev monomers are sufficient to form a trans-activation competent Rev:RRE complex, or which specific activity of Rev is affected by its oligomerization. We here analyzed by functional studies how homooligomer formation of Rev affects the trans-activation capacity of this essential HIV-1 regulatory protein. In a gain-of-function approach, we fused various heterologous dimerization domains to an otherwise oligomerization-defective Rev mutant and were able to demonstrate that oligomerization of Rev is not required per se for the nuclear export of this viral trans-activator. In contrast, however, the formation of Rev oligomers on the RRE is a precondition to trans-activation by directly affecting the nuclear export of Rev-regulated mRNA. Moreover, experimental evidence is provided showing that at least two protein activation domains are required for the formation of trans-activation competent Rev: RRE complexes. The presented data further refine the model of Rev trans-activation by directly demonstrating that Rev oligomerization on the RRE, thereby recruiting at least two protein activation domains, is required for nuclear export of unspliced and incompletely spliced viral RNA.	[Hoffmann, Dirk; Schwarck, Doreen; Banning, Carina; Mariyanna, Lakshmikanth; Krepstakies, Marcel; Schindler, Michael; Hauber, Joachim] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Brenner, Matthias] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Millar, David P.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Heinrich Pette Institute; University of Erlangen Nuremberg; Scripps Research Institute	Hoffmann, D (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	joachim.hauber@hpi.uni-hamburg.de	Mariyanna, Lakshmikanth/ABG-4596-2021; Schindler, Michael/C-1647-2015	Mariyanna, Lakshmikanth/0000-0001-5969-1246; Schindler, Michael/0000-0001-8989-5813; Mariyanna, Lakshmikanth/0000-0001-6561-2049	Deutsche Forschungsgemeinschaft [HA2580/2-2]; Free and Hanseatic City of Hamburg; Federal Ministry of Health	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Free and Hanseatic City of Hamburg; Federal Ministry of Health	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (HA2580/2-2 to JH). The Heinrich Pette Institute is supported by the Free and Hanseatic City of Hamburg and the Federal Ministry of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; AUER M, 1994, BIOCHEMISTRY-US, V33, P2988, DOI 10.1021/bi00176a031; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; BARTEL DP, 1991, CELL, V67, P529, DOI 10.1016/0092-8674(91)90527-6; BERGER J, 1991, VIROLOGY, V183, P630, DOI 10.1016/0042-6822(91)90992-K; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Blanco FJ, 2001, J MOL BIOL, V313, P845, DOI 10.1006/jmbi.2001.5067; BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Cochrane Alan, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P287, DOI 10.2174/1568008043339677; COCHRANE AW, 1990, P NATL ACAD SCI USA, V87, P1198, DOI 10.1073/pnas.87.3.1198; COLE JL, 1993, BIOCHEMISTRY-US, V32, P11769, DOI 10.1021/bi00095a004; COOK KS, 1991, NUCLEIC ACIDS RES, V19, P1577, DOI 10.1093/nar/19.7.1577; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; DAEFLER S, 1990, P NATL ACAD SCI USA, V87, P4571, DOI 10.1073/pnas.87.12.4571; DAGOSTINO DM, 1992, MOL CELL BIOL, V12, P1375, DOI 10.1128/MCB.12.3.1375; DALY TJ, 1993, BIOCHEMISTRY-US, V32, P10497, DOI 10.1021/bi00090a028; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; DALY TJ, 1993, BIOCHEMISTRY-US, V32, P8945, DOI 10.1021/bi00085a028; Daugherty MD, 2010, P NATL ACAD SCI USA, V107, P12481, DOI 10.1073/pnas.1007022107; Dayton A I, 2000, Adv Pharmacol, V49, P199; Dayton AI, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-62; Edgcomb SP, 2008, PROTEIN SCI, V17, P420, DOI 10.1110/ps.073246608; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FISCHER U, 1994, EMBO J, V13, P4105, DOI 10.1002/j.1460-2075.1994.tb06728.x; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fries B, 2007, J BIOL CHEM, V282, P4504, DOI 10.1074/jbc.M608849200; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grewe B, 2010, J GEN VIROL, V91, P1893, DOI 10.1099/vir.0.022509-0; Groom HCT, 2009, J GEN VIROL, V90, P1303, DOI 10.1099/vir.0.011460-0; Groom HCT, 2009, J GEN VIROL, V90, P1141, DOI 10.1099/vir.0.007963-0; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; HADZOPOULOUCLADARAS M, 1989, J VIROL, V63, P1265, DOI 10.1128/JVI.63.3.1265-1274.1989; HAMMERSCHMID M, 1994, J VIROL, V68, P7329, DOI 10.1128/JVI.68.11.7329-7335.1994; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HEAPHY S, 1991, P NATL ACAD SCI USA, V88, P7366, DOI 10.1073/pnas.88.16.7366; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; HOPE TJ, 1990, P NATL ACAD SCI USA, V87, P7787, DOI 10.1073/pnas.87.19.7787; HOPE TJ, 1991, J VIROL, V65, P6001, DOI 10.1128/JVI.65.11.6001-6007.1991; HOPE TJ, 1992, J VIROL, V66, P1849, DOI 10.1128/JVI.66.4.1849-1855.1992; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jain C, 2001, MOL CELL, V7, P603, DOI 10.1016/S1097-2765(01)00207-6; KALLAND KH, 1994, MOL CELL BIOL, V14, P7436, DOI 10.1128/MCB.14.11.7436; KJEMS J, 1992, EMBO J, V11, P1119, DOI 10.1002/j.1460-2075.1992.tb05152.x; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Kjems J, 2000, Adv Pharmacol, V48, P251; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Li JL, 2002, J VIROL, V76, P8374, DOI 10.1128/JVI.76.16.8374-8382.2002; Loflin PT, 1999, METHODS, V17, P11, DOI 10.1006/meth.1998.0702; MADORE SJ, 1994, VIROLOGY, V202, P186, DOI 10.1006/viro.1994.1334; MALIM MH, 1991, J VIROL, V65, P4248, DOI 10.1128/JVI.65.8.4248-4254.1991; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; MALIM MH, 1993, MOL CELL BIOL, V13, P6180, DOI 10.1128/MCB.13.10.6180; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; Meyer BE, 1996, J VIROL, V70, P2350, DOI 10.1128/JVI.70.4.2350-2359.1996; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; OLSEN HS, 1990, GENE DEV, V4, P1357, DOI 10.1101/gad.4.8.1357; OLSEN HS, 1990, SCIENCE, V247, P845, DOI 10.1126/science.2406903; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pallesen J, 2009, FEBS J, V276, P4223, DOI 10.1111/j.1742-4658.2009.07130.x; Perales C, 2005, BBA-MOL CELL RES, V1743, P169, DOI 10.1016/j.bbamcr.2004.09.030; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Pond SJK, 2009, P NATL ACAD SCI USA, V106, P1404, DOI 10.1073/pnas.0807388106; POWELL DM, 1995, J ACQ IMMUN DEF SYND, V10, P317; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; RICHARD N, 1994, VIROLOGY, V204, P123, DOI 10.1006/viro.1994.1516; RIMSKY L, 1988, NATURE, V335, P738, DOI 10.1038/335738a0; Robertson-Anderson RM, 2011, J MOL BIOL, V410, P959, DOI 10.1016/j.jmb.2011.04.026; ROSEN CA, 1988, P NATL ACAD SCI USA, V85, P2071, DOI 10.1073/pnas.85.7.2071; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Sanchez-Velar N, 2004, GENE DEV, V18, P23, DOI 10.1101/gad.1149704; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Strebel Klaus, 2003, AIDS, V17 Suppl 4, pS25, DOI 10.1097/00002030-200317004-00003; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; Surendran R, 2004, BIOPHYS CHEM, V108, P101, DOI 10.1016/j.bpc.2003.10.013; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; Thomas SL, 1998, J VIROL, V72, P2935, DOI 10.1128/JVI.72.4.2935-2944.1998; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; TILEY LS, 1992, GENE DEV, V6, P2077, DOI 10.1101/gad.6.11.2077; VENKATESAN S, 1992, J VIROL, V66, P7469, DOI 10.1128/JVI.66.12.7469-7480.1992; VENKATESH LK, 1990, VIROLOGY, V178, P327, DOI 10.1016/0042-6822(90)90414-M; WEICHSELBRAUN I, 1992, J VIROL, V66, P2583, DOI 10.1128/JVI.66.4.2583-2587.1992; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; WINGFIELD PT, 1991, BIOCHEMISTRY-US, V30, P7527, DOI 10.1021/bi00244a023; WITHERELL GW, 1990, BIOCHEMISTRY-US, V29, P11051, DOI 10.1021/bi00502a006; ZAPP ML, 1991, P NATL ACAD SCI USA, V88, P7734, DOI 10.1073/pnas.88.17.7734; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0; Zemmel RW, 1996, J MOL BIOL, V258, P763, DOI 10.1006/jmbi.1996.0285	100	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38305	10.1371/journal.pone.0038305	http://dx.doi.org/10.1371/journal.pone.0038305			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675540	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700057
J	Kasermann, F; Boerema, DJ; Ruegsegger, M; Hofmann, A; Wymann, S; Zuercher, AW; Miescher, S				Kaesermann, Fabian; Boerema, David J.; Rueegsegger, Monika; Hofmann, Andreas; Wymann, Sandra; Zuercher, Adrian W.; Miescher, Sylvia			Analysis and Functional Consequences of Increased Fab-Sialylation of Intravenous Immunoglobulin (IVIG) after Lectin Fractionation	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIINFLAMMATORY ACTIVITY; GAMMA-GLOBULIN; AUTOIMMUNE; IMMUNODEFICIENCIES; THERAPY	It has been proposed that the anti-inflammatory effects of intravenous immunoglobulin (IVIG) might be due to the small fraction of Fc-sialylated IgG. In this study we biochemically and functionally characterized sialic acid-enriched IgG obtained by Sambucus nigra agglutinin (SNA) lectin fractionation. Two main IgG fractions isolated by elution with lactose (E1) or acidified lactose (E2) were analyzed for total IgG, F(ab')(2) and Fc-specific sialic acid content, their pattern of specific antibodies and anti-inflammatory potential in a human in vitro inflammation system based on LPS- or PHA-stimulated whole blood. HPLC and LC-MS testing revealed an increase of sialylated IgG in E1 and more substantially in the E2 fraction. Significantly, the increased amount of sialic acid residues was primarily found in the Fab region whereas only a minor increase was observed in the Fc region. This indicates preferential binding of the Fab sialic acid to SNA. ELISA analyses of a representative range of pathogen and auto-antigens indicated a skewed antibody pattern of the sialylated IVIG fractions. Finally, the E2 fraction exerted a more profound anti-inflammatory effect compared to E1 or IVIG, evidenced by reduced CD54 expression on monocytes and reduced secretion of MCP-1 (CCL2); again these effects were Fab- but not Fc-dependent. Our results show that SNA fractionation of IVIG yields a minor fraction (approx. 10%) of highly sialylated IgG, wherein the sialic acid is mainly found in the Fab region. The tested anti-inflammatory activity was associated with Fab not Fc sialylation.	[Kaesermann, Fabian; Rueegsegger, Monika; Hofmann, Andreas; Wymann, Sandra; Zuercher, Adrian W.; Miescher, Sylvia] CSL Behring AG, Res & Dev, Bern, Switzerland; [Boerema, David J.] CSL Behring LLC, Res & Dev, Kankakee, IL USA	CSL; CSL	Kasermann, F (corresponding author), CSL Behring AG, Res & Dev, Bern, Switzerland.	fabian.kaesermann@cslbehring.com		Kasermann, Fabian/0000-0002-4255-9350				Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Araujo LM, 2011, J IMMUNOL, V186, P3289, DOI 10.4049/jimmunol.1003076; Arnson Y, 2009, AUTOIMMUNITY, V42, P553, DOI 10.1080/08916930902785363; Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Baerenwaldt A, 2010, EXPERT REV CLIN IMMU, V6, P425, DOI [10.1586/eci.10.9, 10.1586/ECI.10.9]; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Basta M, 2003, NAT MED, V9, P431, DOI 10.1038/nm836; Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61; De Groot AS, 2008, BLOOD, V112, P3303, DOI 10.1182/blood-2008-02-138073; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; Guhr T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021246; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; Hartung HP, 2009, CLIN EXP IMMUNOL, V158, P23, DOI [10.1111/j.1365-2249.2009.04024.X, 10.1111/j.1365-2249.2009.04024.x]; Hartung HP, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-3002-0; IMBACH P, 1981, LANCET, V1, P1228; Imbach P, 2010, VOX SANG, V98, P385, DOI 10.1111/j.1423-0410.2009.01264.x; Jordan SC, 2009, TRANSPLANTATION, V88, P1, DOI 10.1097/TP.0b013e3181a9e89a; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Karlsson NG, 2004, RAPID COMMUN MASS SP, V18, P2282, DOI 10.1002/rcm.1626; Kaveri SV, 2011, CLIN EXP IMMUNOL, V164, P2, DOI 10.1111/j.1365-2249.2011.04387.x; Kaveri SV, 2008, NEW ENGL J MED, V359, P307, DOI 10.1056/NEJMcibr0803649; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Leontyev D, 2012, TRANSFUSION IN PRESS; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Padet L, 2011, CLIN EXP IMMUNOL, V166, P352, DOI 10.1111/j.1365-2249.2011.04476.x; Ramakrishna C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002071; Schwab I, 2012, EUR J IMMUNOL; Seite JF, 2010, BLOOD, V116, P1698, DOI 10.1182/blood-2009-12-261461; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Tackenberg B, 2010, J CLIN IMMUNOL, V30, pS65, DOI 10.1007/s10875-010-9398-1; Tha-In T, 2008, TRENDS IMMUNOL, V29, P608, DOI 10.1016/j.it.2008.08.004; Zuercher AW, 2011, PRINCIPLES IMMUNOPHA, P271	36	92	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37243	10.1371/journal.pone.0037243	http://dx.doi.org/10.1371/journal.pone.0037243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675478	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700010
J	Stafford, T; Thirkettle, M; Walton, T; Vautrelle, N; Hetherington, L; Port, M; Gurney, K; Redgrave, P				Stafford, Tom; Thirkettle, Martin; Walton, Tom; Vautrelle, Nicolas; Hetherington, Len; Port, Michael; Gurney, Kevin; Redgrave, Pete			A Novel Task for the Investigation of Action Acquisition	PLOS ONE			English	Article							RESPONSE ACQUISITION; REINFORCEMENT; VARIABILITY; IMMEDIATE; BEHAVIOR	We present a behavioural task designed for the investigation of how novel instrumental actions are discovered and learnt. The task consists of free movement with a manipulandum, during which the full range of possible movements can be explored by the participant and recorded. A subset of these movements, the 'target', is set to trigger a reinforcing signal. The task is to discover what movements of the manipulandum evoke the reinforcement signal. Targets can be defined in spatial, temporal, or kinematic terms, can be a combination of these aspects, or can represent the concatenation of actions into a larger gesture. The task allows the study of how the specific elements of behaviour which cause the reinforcing signal are identified, refined and stored by the participant. The task provides a paradigm where the exploratory motive drives learning and as such we view it as in the tradition of Thorndike [1]. Most importantly it allows for repeated measures, since when a novel action is acquired the criterion for triggering reinforcement can be changed requiring a new action to be discovered. Here, we present data using both humans and rats as subjects, showing that our task is easily scalable in difficulty, adaptable across species, and produces a rich set of behavioural measures offering new and valuable insight into the action learning process.	[Stafford, Tom; Thirkettle, Martin; Walton, Tom; Vautrelle, Nicolas; Hetherington, Len; Port, Michael; Gurney, Kevin; Redgrave, Pete] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Stafford, T (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England.	t.stafford@shef.ac.uk		Thirkettle, Martin/0000-0002-6200-3130; Stafford, Tom/0000-0002-8089-9479	European Community [ICT-IP-231722]; Wellcome Trust [091409]	European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	TS, MT, KG and PR are supported by the European Community 7th Framework Programme (FP7/2007-2013), "Challenge 2 - Cognitive Systems, Interaction, Robotics," grant agreement No. ICT-IP-231722, project "IM-CLeVeR - Intrinsically Motivated Cumulative Learning Versatile Robots." NV was supported by Wellcome Trust grant 091409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADAMS CD, 1981, Q J EXP PSYCHOL-B, V33, P109, DOI 10.1080/14640748108400816; Baldassarre G., INTRINSICAL IN PRESS; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; BRUNER JS, 1973, CHILD DEV, V44, P1; DICKINSON A, 1992, Q J EXP PSYCHOL-B, V45, P241; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; Dickinson A., 2000, EVOLUTION COGNITION, P185; Diedrichsen J, 2005, J NEUROPHYSIOL, V93, P801, DOI 10.1152/jn.00662.2004; Elsner B, 2004, PSYCHOL RES-PSYCH FO, V68, P138, DOI 10.1007/s00426-003-0151-8; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; KALNINS IV, 1973, PERCEPTION, V2, P307, DOI 10.1068/p020307; Kleiner M, 2007, PERCEPTION, V36, P14; LATTAL KA, 1990, J EXP PSYCHOL ANIM B, V16, P27, DOI 10.1037/0097-7403.16.1.27; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Neuringer A, 2010, PSYCHOL REV, V117, P972, DOI 10.1037/a0019499; Newell A., 1981, COGNITIVE SKILLS THE, P1; Paeye C, 2011, J EXP ANAL BEHAV, V95, P149, DOI 10.1901/jeab.2011.95-149; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peterson GB, 2004, J EXP ANAL BEHAV, V82, P317, DOI 10.1901/jeab.2004.82-317; Piek JP, 2002, INFANT BEHAV DEV, V25, P452, DOI 10.1016/S0163-6383(02)00145-5; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Ritter F.E., 2001, INT ENCY SOCIAL BEHA, P8602, DOI DOI 10.1016/B0-08-043076-7/01480-7; Ross C, 2002, BEHAV PROCESS, V57, P199, DOI 10.1016/S0376-6357(02)00014-1; SCHINDLER CW, 1993, B PSYCHONOMIC SOC, V31, P291; Singh SP, 1996, MACH LEARN, V22, P123, DOI 10.1007/BF00114726; Skinner B.F., 2014, CONTINGENCIES REINFO; Snycerski S, 2005, BEHAV PROCESS, V68, P1, DOI 10.1016/j.beproc.2004.08.004; Snycerski S, 2004, J EXP ANAL BEHAV, V81, P51, DOI 10.1901/jeab.2004.81-51; Staddon J., 2008, SCHOLARPEDIA, V3, P2318, DOI [10.4249/scholarpedia.2318, DOI 10.4249/SCHOLARPEDIA.2318]; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; THELEN E, 1989, DEV PSYCHOL, V25, P946, DOI 10.1037/0012-1649.25.6.946; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Woergoetter F, 2007, SCHOLARPEDIA, V3, P1448, DOI DOI 10.4249/SCH0LARPEDIA.1448; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	36	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37749	10.1371/journal.pone.0037749	http://dx.doi.org/10.1371/journal.pone.0037749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675490	Green Published, Green Accepted, gold			2022-12-27	WOS:000305341700022
J	Sestak, K; Feely, S; Fey, B; Dufour, J; Hargitt, E; Alvarez, X; Pahar, B; Gregoricus, N; Vinje, J; Farkas, T				Sestak, Karol; Feely, Stephanie; Fey, Brittney; Dufour, Jason; Hargitt, Edwin; Alvarez, Xavier; Pahar, Bapi; Gregoricus, Nicole; Vinje, Jan; Farkas, Tibor			Experimental Inoculation of Juvenile Rhesus Macaques with Primate Enteric Caliciviruses	PLOS ONE			English	Article							INFECTIOUS NONBACTERIAL GASTROENTERITIS; EPIDEMIC VIRAL GASTROENTERITIS; NORWALK VIRUS-INFECTION; IMMUNE-RESPONSES; HUMAN NOROVIRUS; NONHUMAN-PRIMATES; SECRETING CELLS; UNITED-STATES; HAWAII AGENT; IN-VITRO	Background: Tissue culture-adapted Tulane virus (TV), a GI.1 rhesus enteric calicivirus (ReCV), and a mixture of GII.2 and GII.4 human norovirus (NoV)-containing stool sample were used to intrastomacheally inoculate juvenile rhesus macaques (Macaca mulatta) in order to evaluate infection caused by these viruses. Methodology & Findings: Two of the three TV-inoculated macaques developed diarrhea, fever, virus-shedding in stools, inflammation of duodenum and 16-fold increase of TV-neutralizing (VN) serum antibodies but no vomiting or viremia. No VN-antibody responses could be detected against a GI.2 ReCV strain FT285, suggesting that TV and FT285 represent different ReCV serotypes. Both NoV-inoculated macaques remained asymptomatic but with demonstrable virus shedding in one animal. Examination of duodenum biopsies of the TV-inoculated macaques showed lymphocytic infiltration of the lamina propria and villous blunting. TV antigen-positive (TV+) cells were detected in the lamina propria. In most of the TV+ cells TV co-localized perinuclearly with calnexin - an endoplasmic reticulum protein. A few CD20+TV+ double-positive B cells were also identified in duodenum. To corroborate the authenticity of CD20+TV+ B cells, in vitro cultures of peripheral blood mononuclear cells (PBMCs) from healthy macaques were inoculated with TV. Multicolor flow cytometry confirmed the presence of TV antigen-containing B cells of predominantly CD20+HLA-DR+ phenotype. A 2-log increase of viral RNA by 6 days post inoculation (p<0.05) suggested active TV replication in cultured lymphocytes. Conclusions/Significance: Taken together, our results show that ReCVs represent an alternative cell culture and animal model to study enteric calicivirus replication, pathogenesis and immunity.	[Sestak, Karol; Feely, Stephanie; Dufour, Jason; Alvarez, Xavier; Pahar, Bapi] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Sestak, Karol; Dufour, Jason; Alvarez, Xavier; Pahar, Bapi] Tulane Univ, Sch Med, Covington, LA USA; [Fey, Brittney; Hargitt, Edwin; Farkas, Tibor] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Farkas, Tibor] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Gregoricus, Nicole; Vinje, Jan] Ctr Dis Control & Prevent, Atlanta, GA USA	Tulane University; Tulane University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Centers for Disease Control & Prevention - USA	Sestak, K (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.	ksestak@tulane.edu; tibor.farkas@cchmc.org	Pahar, Bapi/AFM-3129-2022; Vinje, Jan/ABE-6336-2020	Pahar, Bapi/0000-0003-1949-973X; Vinje, Jan/0000-0002-1530-3675; Sestak, Karol/0000-0003-3951-2719	National Institutes of Health [R21RR024871, P51RR000164, U24RR018111, P01HD013021]; Infectious Disease Scholar Fund of CCHMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164, U24RR018111, R21RR024871] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infectious Disease Scholar Fund of CCHMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health R21RR024871, P51RR000164 and U24RR018111 to KS, and P01HD013021 and the Infectious Disease Scholar Fund of CCHMC to TF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUS SG, 1973, ANN INTERN MED, V79, P18, DOI 10.7326/0003-4819-79-1-18; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Atmar RL, 2010, FOOD ENVIRON VIROL, V2, P117, DOI 10.1007/s12560-010-9038-1; Bailey D, 2010, J GEN VIROL, V91, P739, DOI 10.1099/vir.0.016279-0; Barron EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021435; Bjorck P, 1998, J IMMUNOL, V161, P5795; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Bok K, 2009, J VIROL, V83, P3647, DOI 10.1128/JVI.02028-08; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Cannon JL, 2009, J VIROL, V83, P5363, DOI 10.1128/JVI.02518-08; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; Cheetham S, 2006, J VIROL, V80, P10372, DOI 10.1128/JVI.00809-06; DOLIN R, 1975, AM J MED, V59, P761, DOI 10.1016/0002-9343(75)90461-1; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; El-Kamary SS, 2010, J INFECT DIS, V202, P1649, DOI 10.1086/657087; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Farkas T, 2010, J VIROL, V84, P8617, DOI 10.1128/JVI.00630-10; Farkas T, 2010, J GEN VIROL, V91, P734, DOI 10.1099/vir.0.015263-0; Gerondopoulos A, 2010, J GEN VIROL, V91, P1428, DOI 10.1099/vir.0.016717-0; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Jiang BM, 2004, J MED PRIMATOL, V33, P30, DOI 10.1111/j.1600-0684.2003.00051.x; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; KAPLAN JE, 1982, ANN INTERN MED, V96, P756, DOI 10.7326/0003-4819-96-6-756; L'Homme Y, 2009, VIRUS GENES, V39, P66, DOI 10.1007/s11262-009-0360-3; Lay MK, 2010, VIROLOGY, V406, P1, DOI 10.1016/j.virol.2010.07.001; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; LoBue AD, 2010, J VIROL, V84, P8530, DOI 10.1128/JVI.00727-10; Lobue AD, 2009, J VIROL, V83, P3212, DOI 10.1128/JVI.01650-08; Mazumdar K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010228; MOLICA S, 1994, HAEMATOLOGICA, V79, P452; Otto PH, 2011, J VIROL, V85, P12013, DOI 10.1128/JVI.05342-11; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Perry JW, 2010, J VIROL, V84, P6163, DOI 10.1128/JVI.00331-10; POSTIGO AA, 1991, J EXP MED, V174, P1313, DOI 10.1084/jem.174.6.1313; Ramesh G, 2005, CLIN DIAGN LAB IMMUN, V12, P192, DOI 10.1128/CDLI.12.1.192-197.2005; Rockx BHG, 2005, J MED VIROL, V75, P313, DOI 10.1002/jmv.20273; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; SCHREIBER DS, 1974, J INFECT DIS, V129, P705, DOI 10.1093/infdis/129.6.705; Sestak K, 2004, J VIROL, V78, P10258, DOI 10.1128/JVI.78.19.10258-10264.2004; Sestak K, 2003, INFECT IMMUN, V71, P4079, DOI 10.1128/IAI.71.7.4079-4086.2003; SMITH AW, 1985, J WILDLIFE DIS, V21, P426, DOI 10.7589/0090-3558-21.4.426; Souza M, 2008, J VIROL, V82, P1777, DOI 10.1128/JVI.01347-07; Subekti DS, 2002, J MED VIROL, V66, P400, DOI 10.1002/jmv.2159; Symes SJ, 2007, ARCH VIROL, V152, P1075, DOI 10.1007/s00705-007-0938-9; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Taube S, 2009, J VIROL, V83, P4092, DOI 10.1128/JVI.02245-08; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Wang YH, 2007, J MED PRIMATOL, V36, P101, DOI 10.1111/j.1600-0684.2006.00167.x; Wei C, 2008, J VIROL, V82, P11429, DOI 10.1128/JVI.00696-08; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wolf S, 2011, ARCH VIROL, V156, P1143, DOI 10.1007/s00705-011-0964-5; WYATT RG, 1978, J MED VIROL, V2, P89, DOI 10.1002/jmv.1890020203; WYATT RG, 1974, J INFECT DIS, V129, P709, DOI 10.1093/infdis/129.6.709; Yang SY, 2010, J MICROBIOL IMMUNOL, V43, P506, DOI 10.1016/S1684-1182(10)60078-3; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	58	36	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37973	10.1371/journal.pone.0037973	http://dx.doi.org/10.1371/journal.pone.0037973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666426	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400064
J	Barr, I; Hurt, A; Kelso, A; Reading, P; Ly, S; Seng, H; Buchy, P; Ung, SA; Shu, YL; Xu, CL; Xu, Z; Wang, DY; Kama, M; Singh, P; Fujisaki, S; Odagiri, T; Tashiro, M; Archkhawongs, S; Khamphaphongphanh, B; Vongphrachanh, P; Kheong, CC; Ismail, N; Burmaa, A; Darmaa, B; Nymadawa, P; Grangeon, JP; Gourinat, AC; Huang, QS; Lopez, LD; Lopez, JM; Olveda, RM; Roque, V; Jennings, L; Kang, C; Lin, C; Lin, R; Tee, WSN; Balish, A; Corwin, A; Kapella, BK; Kitsutani, P; McFarland, J; Moen, A; Xu, XY; Vu, MPH; Long, NL; Mai, LQ; Le, KHN; Nguyen, HA; Nguyen, TL; Nguyen, TN; Asgari, N; Dawainavesi, A; Denehy, EJ; Dominguez, MN; Jamsran, M; Kasai, T; Kool, J; Lewis, H; Luo, DP; Olowokure, B; Partridge, J; Pavlin, B; Samaan, G; Singh, H; Tsuyuoka, R; Vakacegu, A; Zhang, WQ				Barr, Ian; Hurt, Aeron; Kelso, Anne; Reading, Patrick; Ly, Sovann; Seng, Heng; Buchy, Philippe; Ung, Sam An; Shu, Yuelong; Xu, Cuiling; Xu, Zhen; Wang, Dayan; Kama, Mike; Singh, Prem; Fujisaki, Seiichiro; Odagiri, Takato; Tashiro, Masato; Archkhawongs, Sibounhom; Khamphaphongphanh, Bouaphanh; Vongphrachanh, Phengta; Kheong, Chong Chee; Ismail, Norizah; Burmaa, Alexanderyn; Darmaa, Badarchiin; Nymadawa, Pagbajabyn; Grangeon, Jean-Paul; Gourinat, Ann-Claire; Huang, Qiu Sue; Lopez, Liza D.; Lopez, Juan M.; Olveda, Remigio M.; Roque, Vito; Jennings, Lance; Kang, Chun; Lin, Cui; Lin, Raymond; Tee, Wen Sim Nancy; Balish, Amanda; Corwin, Andrew; Kapella, Bryan K.; Kitsutani, Paul; McFarland, Jeffrey; Moen, Ann; Xu, Xiyan; Vu Mai Phuong Hoang; Ngoc Long Long; Le Quynh Mai; Le Khanh Hang Nguyen; Hoang Anh Nguyen; Thanh Long Nguyen; Thu Ngoc Nguyen; Asgari, Nima; Dawainavesi, Akanisi; Denehy, Emma Jane; Dominguez, Maria Nerissa; Jamsran, Mendsaikhan; Kasai, Takeshi; Kool, Jacob; Lewis, Hannah; Luo, Dapeng; Olowokure, Babatunde; Partridge, Jeffrey; Pavlin, Boris; Samaan, Gina; Singh, Harpal; Tsuyuoka, Reiko; Vakacegu, Apaitia; Zhang, Wenqing		Western Pacific Region Global Infl	Epidemiological and Virological Characteristics of Influenza in the Western Pacific Region of the World Health Organization, 2006-2010	PLOS ONE			English	Article							DYNAMICS	Background: Influenza causes yearly seasonal epidemics and periodic pandemics. Global systems have been established to monitor the evolution and impact of influenza viruses, yet regional analysis of surveillance findings has been limited. This study describes epidemiological and virological characteristics of influenza during 2006-2010 in the World Health Organization's Western Pacific Region. Methodology/Principal Findings: Influenza-like illness (ILI) and influenza virus data were obtained from the 14 countries with National Influenza Centres. Data were obtained directly from countries and from FluNet, the web-based tool of the Global Influenza Surveillance and Response System. National influenza surveillance and participation in the global system increased over the five years. Peaks in ILI reporting appeared to be coincident with the proportion of influenza positive specimens. Temporal patterns of ILI activity and the proportion of influenza positive specimens were clearly observed in temperate countries: Mongolia, Japan and the Republic of Korea in the northern hemisphere, and Australia, New Zealand, Fiji and New Caledonia (France) in the southern hemisphere. Two annual peaks in activity were observed in China from 2006 through the first quarter of 2009. A temporal pattern was less evident in tropical countries, where influenza activity was observed year-round. Influenza A viruses accounted for the majority of viruses reported between 2006 and 2009, but an equal proportion of influenza A and influenza B viruses was detected in 2010. Conclusions/Significance: Despite differences in surveillance methods and intensity, commonalities in ILI and influenza virus circulation patterns were identified. Patterns suggest that influenza circulation may be dependent on a multitude of factors including seasonality and population movement. Dominant strains in Southeast Asian countries were later detected in other countries. Thus, timely reporting and regional sharing of information about influenza may serve as an early warning, and may assist countries to anticipate the potential severity and burden associated with incoming strains.	[Ung, Sam An] Natl Inst Publ Hlth, Phnom Penh, Cambodia; Dept Hlth, Hong Kong, Hong Kong, Peoples R China; [Jennings, Lance] Univ Otago, Christchurch, New Zealand; [Kang, Chun] Korea Ctr Dis Control & Prevent, Seoul, South Korea; [Lin, Cui; Lin, Raymond; Tee, Wen Sim Nancy] Minist Hlth, Singapore, Singapore; [Balish, Amanda; Corwin, Andrew; Kapella, Bryan K.; Kitsutani, Paul; McFarland, Jeffrey; Moen, Ann; Xu, Xiyan] Ctr Dis Control & Prevent, Atlanta, GA USA; [Asgari, Nima; Dawainavesi, Akanisi; Denehy, Emma Jane; Dominguez, Maria Nerissa; Jamsran, Mendsaikhan; Kasai, Takeshi; Kool, Jacob; Lewis, Hannah; Luo, Dapeng; Olowokure, Babatunde; Partridge, Jeffrey; Pavlin, Boris; Samaan, Gina; Singh, Harpal; Tsuyuoka, Reiko; Vakacegu, Apaitia; Zhang, Wenqing] WHO, Washington, DC USA	University of Otago; Korea Centers for Disease Control & Prevention (KCDC); Ministry of Health-Singapore; Centers for Disease Control & Prevention - USA; World Health Organization		partridgej@wpro.who.int	Dawainavesi, Akanisi/AAB-5972-2021; zhang, wenqing/GYA-0786-2022; Nymadawa, Pagbajab/AAE-7344-2019; Cook, Alex/B-5941-2011	Dawainavesi, Akanisi/0000-0001-5902-8145; Nymadawa, Pagbajab/0000-0002-3189-2772; BUCHY, Philippe/0000-0003-1372-3008; Asgari-Jirhandeh, Nima/0000-0002-4743-4194; Reading, Patrick/0000-0002-8860-5308; Kool, Jacob/0000-0002-9605-2918; Huang, Q. Sue/0000-0002-3923-5195; Hurt, Aeron/0000-0003-1826-4314; Kelso, Anne/0000-0002-3166-3267; Barr, Ian/0000-0002-7351-418X; Cook, Alex/0000-0002-6271-5832				Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chiu SS, 2009, CLIN INFECT DIS, V49, P1016, DOI 10.1086/605570; Hampson AW, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00100-0; Heymann D, 2010, CONTROL COMMUNICABLE; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Mardy S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-168; McCallum L, 2010, W PACIFIC SURVEILLAN, V1; Oshitani H, 2010, WEST PAC SURVEILL RE, V1, P3, DOI [10.5365/WPSAR.2010.1.1.005, 10.5365/wpsar.2010.1.1.005]; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892; World Health Organization, 2011, BIR PLAN FURTH STREN; Yang L, 2011, VACCINE, V29, P8909, DOI 10.1016/j.vaccine.2011.09.071	17	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37568	10.1371/journal.pone.0037568	http://dx.doi.org/10.1371/journal.pone.0037568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22675427	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600020
J	Ma, WH; Zhang, Z; Peng, CH; Wang, XP; Li, F; Lin, YJ				Ma, Weihua; Zhang, Zan; Peng, Chuanhua; Wang, Xiaoping; Li, Fei; Lin, Yongjun			Exploring the Midgut Transcriptome and Brush Border Membrane Vesicle Proteome of the Rice Stem Borer, Chilo suppressalis (Walker)	PLOS ONE			English	Article							THURINGIENSIS CRY1AB TOXIN; BACILLUS-THURINGIENSIS; HELICOVERPA-ARMIGERA; AMINOPEPTIDASE-N; MANDUCA-SEXTA; BINDING-PROTEINS; LARVAL MIDGUT; ALKALINE-PHOSPHATASE; HELIOTHIS-VIRESCENS; PLUTELLA-XYLOSTELLA	The rice stem borer, Chilo suppressalis (Walker) (Lepidoptera: Pyralidae), is one of the most detrimental pests affecting rice crops. The use of Bacillus thuringiensis (Bt) toxins has been explored as a means to control this pest, but the potential for C. suppressalis to develop resistance to Bt toxins makes this approach problematic. Few C. suppressalis gene sequences are known, which makes in-depth study of gene function difficult. Herein, we sequenced the midgut transcriptome of the rice stem borer. In total, 37,040 contigs were obtained, with a mean size of 497 bp. As expected, the transcripts of C. suppressalis shared high similarity with arthropod genes. Gene ontology and KEGG analysis were used to classify the gene functions in C. suppressalis. Using the midgut transcriptome data, we conducted a proteome analysis to identify proteins expressed abundantly in the brush border membrane vesicles (BBMV). Of the 100 top abundant proteins that were excised and subjected to mass spectrometry analysis, 74 share high similarity with known proteins. Among these proteins, Western blot analysis showed that Aminopeptidase N and EH domain-containing protein have the binding activities with Bt-toxin Cry1Ac. These data provide invaluable information about the gene sequences of C. suppressalis and the proteins that bind with Cry1Ac.	[Ma, Weihua; Lin, Yongjun] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Ma, Weihua; Wang, Xiaoping] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Zhang, Zan] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China; [Peng, Chuanhua] Hubei Plant Protect Stn, Wuhan, Peoples R China; [Ma, Weihua; Lin, Yongjun] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan, Peoples R China; [Zhang, Zan; Li, Fei] Minist Agr, Key Lab Monitoring & Management Plant Dis & Pests, Nanjing, Jiangsu, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Nanjing Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Ma, WH (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	lifei@njau.edu.cn; yongjunlin@mail.hzau.edu.cn	Li, Fei/B-3687-2012	Li, Fei/0000-0002-8410-5250; MA, WEIHUA/0000-0001-9521-2038	National Special Transgenic Project from the Chinese Ministry of Agriculture [2008ZX08001-001, 2009ZX08011-007B, 2011ZX08012-004]	National Special Transgenic Project from the Chinese Ministry of Agriculture	This work was surpported by the National Special Transgenic Project from the Chinese Ministry of Agriculture (grant No. 2008ZX08001-001; 2009ZX08011-007B; 2011ZX08012-004, http://www.agri.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Baxter SW, 2008, INSECT BIOCHEM MOLEC, V38, P125, DOI 10.1016/j.ibmb.2007.09.014; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Cheng XA, 2010, PEST MANAG SCI, V66, P762, DOI 10.1002/ps.1939; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Ekobu M, 2010, J ECON ENTOMOL, V103, P1493, DOI 10.1603/EC09432; Federici B.A., 2010, OPEN TOXINOL J, V3, P83, DOI [10.2174/1875414701003010083, DOI 10.2174/1875414701003010083]; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Liao CY, 2005, CURR MICROBIOL, V51, P367, DOI 10.1007/s00284-005-0051-9; Liu CX, 2010, J INSECT PHYSIOL, V56, P718, DOI 10.1016/j.jinsphys.2009.12.012; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Liu JS, 2010, J PROTEOME RES, V9, P2117, DOI 10.1021/pr900826f; Luo K, 1997, APPL ENVIRON MICROB, V63, P1024, DOI 10.1128/AEM.63.3.1024-1027.1997; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1998, BIOSCI BIOTECH BIOCH, V62, P727, DOI 10.1271/bbb.62.727; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P467, DOI 10.1016/j.ibmb.2009.05.001; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Wang GR, 2005, SCI CHINA SER C, V48, P346, DOI 10.1360/03yc0273; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yao HP, 2009, BIOSCIENCE REP, V29, P363, DOI 10.1042/BSR20080144; Yu HK, 2010, INSECT SCI, V17, P393, DOI 10.1111/j.1744-7917.2010.01333.x; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003	41	29	35	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38151	10.1371/journal.pone.0038151	http://dx.doi.org/10.1371/journal.pone.0038151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666467	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600064
J	Maher, BH; Lea, RA; Benton, M; Cox, HC; Bellis, C; Carless, M; Dyer, TD; Curran, J; Charlesworth, JC; Buring, JE; Kurth, T; Chasman, DI; Ridker, PM; Schurks, M; Blangero, J; Griffiths, LR				Maher, Bridget H.; Lea, Rod A.; Benton, Miles; Cox, Hannah C.; Bellis, Claire; Carless, Melanie; Dyer, Thomas D.; Curran, Joanne; Charlesworth, Jac C.; Buring, Julie E.; Kurth, Tobias; Chasman, Daniel I.; Ridker, Paul M.; Schuerks, Markus; Blangero, John; Griffiths, Lyn R.			An X Chromosome Association Scan of the Norfolk Island Genetic Isolate Provides Evidence for a Novel Migraine Susceptibility Locus at Xq12	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE ANALYSIS; HEPHAESTIN; EXPRESSION	Migraine is a common and debilitating neurovascular disorder with a complex envirogenomic aetiology. Numerous studies have demonstrated a preponderance of women affected with migraine and previous pedigree linkage studies in our laboratory have identified susceptibility loci on chromosome Xq24-Xq28. In this study we have used the genetic isolate of Norfolk Island to further analyse the X chromosome for migraine susceptibility loci. An association approach was employed to analyse 14,124 SNPs spanning the entire X chromosome. Genotype data from 288 individuals comprising a large core-pedigree, of which 76 were affected with migraine, were analysed. Although no SNP reached chromosome-wide significance (empirical alpha = 1 x 10(-5)) ranking by P-value revealed two primary clusters of SNPs in the top 25. A 10 SNP cluster represents a novel migraine susceptibility locus at Xq12 whilst a 11 SNP cluster represents a previously identified migraine susceptibility locus at Xq27. The strongest association at Xq12 was seen for rs599958 (OR = 1.75, P = 8.92 x 10(-4)), whilst at Xq27 the strongest association was for rs6525667 (OR = 1.53, P = 1.65 x 10(-4)). Further analysis of SNPs at these loci was performed in 5,122 migraineurs from the Women's Genome Health Study and provided additional evidence for association at the novel Xq12 locus (P<0.05). Overall, this study provides evidence for a novel migraine susceptibility locus on Xq12. The strongest effect SNP (rs102834, joint P = 1.63 x 10(-5)) is located within the 5'UTR of the HEPH gene, which is involved in iron homeostasis in the brain and may represent a novel pathway for involvement in migraine pathogenesis.	[Maher, Bridget H.; Lea, Rod A.; Benton, Miles; Cox, Hannah C.; Bellis, Claire; Griffiths, Lyn R.] Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Nathan, Qld 4111, Australia; [Bellis, Claire; Carless, Melanie; Dyer, Thomas D.; Curran, Joanne; Charlesworth, Jac C.; Blangero, John] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Charlesworth, Jac C.] Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Buring, Julie E.; Kurth, Tobias; Chasman, Daniel I.; Ridker, Paul M.; Schuerks, Markus] Harvard Univ, Sch Med, Dept Med, Div Prevent Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Kurth, Tobias; Schuerks, Markus] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Kurth, Tobias] INSERM, Unit Neuroepidemiol 708, Paris, France	Griffith University; Menzies Health Institute Queensland; Texas Biomedical Research Institute; University of Tasmania; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Duisburg Essen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Maher, BH (corresponding author), Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Nathan, Qld 4111, Australia.	l.griffths@griffth.edu.au	Belllis, Claire/GYA-5547-2022; Blangero, John/ABA-7175-2021; Kurth, Tobias/A-9243-2012; Charlesworth, Jac/J-7661-2014	Belllis, Claire/0000-0001-5073-9610; Kurth, Tobias/0000-0001-7169-2620; Charlesworth, Jac/0000-0001-6201-3518; Carless, Melanie/0000-0001-8350-2302; Benton, Miles/0000-0003-3442-965X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Lea, Rodney/0000-0002-1148-5862; Griffiths, Lyn/0000-0002-6774-5475; Curran, Joanne/0000-0002-6898-155X; Maher, Bridget/0000-0002-9735-0845	Australian National Health and Medical Research Council grant [G47268]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council grant(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by a Australian National Health and Medical Research Council grant (no. G47268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellis C, 2005, HUM HERED, V60, P211, DOI 10.1159/000090545; Bellis C, 2008, HUM GENET, V124, P543, DOI 10.1007/s00439-008-0580-y; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Cox HC, 2012, GENE, V494, P119, DOI 10.1016/j.gene.2011.11.056; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; He JQ, 2008, MOL IMMUNOL, V45, P4041, DOI 10.1016/j.molimm.2008.07.011; Hoare M., 1999, NORFOLK ISLAND REVIS, V5th ed.; Hudson DM, 2010, AM J PHYSIOL-GASTR L, V298, pG425, DOI 10.1152/ajpgi.00453.2009; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Macgregor S, 2010, EUR J HUM GENET, V18, P67, DOI 10.1038/ejhg.2009.111; Maher BH, 2012, NEUROGENETICS; McEvoy BP, 2010, HEREDITY, V105, P229, DOI 10.1038/hdy.2009.175; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mulder EJ, 2003, TWIN RES, V6, P422, DOI 10.1375/twin.6.5.422; Nyholt DR, 2000, HUM GENET, V107, P18; Nyholt DR, 1998, HUM MOL GENET, V7, P459, DOI 10.1093/hmg/7.3.459; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian ZM, 2007, J CELL BIOCHEM, V102, P1225, DOI 10.1002/jcb.21352; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stovner LJ, 2006, EUR J NEUROL, V13, P333, DOI 10.1111/j.1468-1331.2006.01184.x; Svensson DA, 2003, HEADACHE, V43, P235, DOI 10.1046/j.1526-4610.2003.03047.x; Wieser T, 2010, HEADACHE, V50, P955, DOI 10.1111/j.1526-4610.2010.01673.x	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37903	10.1371/journal.pone.0037903	http://dx.doi.org/10.1371/journal.pone.0037903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666411	gold, Green Published			2022-12-27	WOS:000305349600040
J	Asutay, E; Vastfjaill, D				Asutay, Erkin; Vastfjaill, Daniel			Perception of Loudness Is Influenced by Emotion	PLOS ONE			English	Article							FEAR; PREPAREDNESS; INTEGRATION; AMYGDALA; PHOBIAS; BINDING	Loudness perception is thought to be a modular system that is unaffected by other brain systems. We tested the hypothesis that loudness perception can be influenced by negative affect using a conditioning paradigm, where some auditory stimuli were paired with aversive experiences while others were not. We found that the same auditory stimulus was reported as being louder, more negative and fear-inducing when it was conditioned with an aversive experience, compared to when it was used as a control stimulus. This result provides support for an important role of emotion in auditory perception.	[Asutay, Erkin; Vastfjaill, Daniel] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Vastfjaill, Daniel] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden	Chalmers University of Technology; Linkoping University	Asutay, E (corresponding author), Chalmers Univ Technol, S-41296 Gothenburg, Sweden.	erkin.asutay@chalmers.se		Vastfjall, Daniel/0000-0003-2873-4500				Anderson E, 2011, J EXP SOC PSYCHOL, V47, P856, DOI 10.1016/j.jesp.2011.02.009; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Becker MW, 2009, PSYCHOL SCI, V20, P435, DOI 10.1111/j.1467-9280.2009.02303.x; Bertelson P, 2003, PSYCHOL SCI, V14, P592, DOI 10.1046/j.0956-7976.2003.psci_1470.x; Bocanegra BR, 2009, PSYCHOL SCI, V20, P707, DOI 10.1111/j.1467-9280.2009.02354.x; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Brockelmann AK, 2011, J NEUROSCI, V31, P7801, DOI 10.1523/JNEUROSCI.6236-10.2011; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Clavert GA, 2004, HDB MULTISENSORY PRO, P482; Duncan S, 2007, TRENDS COGN SCI, V11, P190, DOI 10.1016/j.tics.2007.01.007; Figner B., 2011, HDB PROCESS TRACING, P163, DOI DOI 10.4324/9780203875292-18/USING-SKIN-CONDUCTANCE-JUDGMENT-DECISION-MAKING-RESEARCH-MICHAEL-SCHULTE-MECKLENBECK-ANTON-KUEHBERGER-JOSEPH-JOHNSON-JOSEPH-JOHNSON; Fodor J. A, 1983, MODULARITY MIND; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Mineka S, 2002, BIOL PSYCHIAT, V52, P927, DOI 10.1016/S0006-3223(02)01669-4; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Rosenthal R., 1985, CONTRAST ANAL; Schmitz TW, 2009, J NEUROSCI, V29, P7199, DOI 10.1523/JNEUROSCI.5387-08.2009; Siegel EH, 2011, EMOTION, V11, P1006, DOI 10.1037/a0024590; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Wang J, 2009, J COGNITIVE NEUROSCI, V21, P2121, DOI 10.1162/jocn.2008.21147; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; WOODS TM, 2004, HDB MULTISENSORY PRO, P35; Zwicker E., 1990, PSYCHOACOUSTICS FACT, P203	33	25	25	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38660	10.1371/journal.pone.0038660	http://dx.doi.org/10.1371/journal.pone.0038660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XO	22685594	Green Published, gold			2022-12-27	WOS:000305351700057
J	Feng, JM; Sun, J; Xin, DD; Wen, JF				Feng, Jin-Mei; Sun, Jun; Xin, De-Dong; Wen, Jian-Fan			Comparative Analysis of the 5S rRNA and Its Associated Proteins Reveals Unique Primitive Rather Than Parasitic Features in Giardia lamblia	PLOS ONE			English	Article							AMINO-ACID-SEQUENCES; POLYMERASE-III; TRANSCRIPTION INITIATION; GENE PROMOTER; BRANCHING EUKARYOTE; PHYLOGENETIC PLACE; LACKING PROTOZOAN; EVOLUTION; IDENTIFICATION; GENOME	Background: 5S rRNA is a highly conserved ribosomal component. Eukaryotic 5S rRNA and its associated proteins (5S rRNA system) have become very well understood. Giardia lamblia was thought by some researchers to be the most primitive extant eukaryote while others considered it a highly evolved parasite. Previous reports have indicated that some aspects of its 5S rRNA system are simpler than that of common eukaryotes. We here explore whether this is true to its entire system, and whether this simplicity is a primitive or parasitic feature. Methodology/Principal Findings: By collecting and confirming pre-existing data and identifying new data, we obtained almost complete datasets of the system of three isolates of G. lamblia, two other parasitic excavates (Trichomonas vaginalis, Trypanosoma cruzi), and one free-living one (Naegleria gruberi). After comprehensively comparing each aspect of the system among these excavates and also with those of archaea and common eukaryotes, we found all the three Giardia isolates to harbor a same simplified 5S rRNA system, which is not only much simpler than that of common eukaryotes but also the simplest one among those of these excavates, and is surprisingly very similar to that of archaea; we also found among these excavates the system in parasitic species is not necessarily simpler than that in free-living species, conversely, the system of free-living species is even simpler in some respects than those of parasitic ones. Conclusion/Significance: The simplicity of Giardia 5S rRNA system should be considered a primitive rather than parasitically-degenerated feature. Therefore, Giardia 5S rRNA system might be a primitive system that is intermediate between that of archaea and the common eukaryotic model system, and it may reflect the evolutionary history of the eukaryotic 5S rRNA system from the archaeal form. Our results also imply G. lamblia might be a primitive eukaryote with secondary parasitically-degenerated features.	[Feng, Jin-Mei; Sun, Jun; Wen, Jian-Fan] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Feng, Jin-Mei; Sun, Jun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Xin, De-Dong] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang Normal University	Feng, JM (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	wenjf@mail.kiz.ac.cn			National Natural Science Foundation of China [30830018, 31172081]; Knowledge Innovation Program [KSCX2-EW-J-23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (30830018; 31172081) and the Knowledge Innovation Program (KSCX2-EW-J-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J, 2008, NUCLEIC ACIDS RES, V36, P5832, DOI 10.1093/nar/gkn549; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Bartlett MS, 2005, CURR OPIN MICROBIOL, V8, P677, DOI 10.1016/j.mib.2005.10.016; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; BIEKER JJ, 1985, CELL, V40, P119, DOI 10.1016/0092-8674(85)90315-0; Blombach F, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-39; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; CavalierSmith T, 1996, J MOL EVOL, V43, P551, DOI 10.1007/BF02202103; Chen XW, 2007, NUCLEIC ACIDS RES, V35, P4619, DOI 10.1093/nar/gkm474; EDLIND TD, 1987, NUCLEIC ACIDS RES, V15, P7889, DOI 10.1093/nar/15.19.7889; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GUDDAT U, 1990, CELL, V60, P619, DOI 10.1016/0092-8674(90)90665-2; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; HASHIMOTO T, 1994, MOL BIOL EVOL, V11, P65; HASHIMOTO T, 1995, MOL BIOL EVOL, V12, P782; HATAKEYAMA T, 1990, BIOCHIM BIOPHYS ACTA, V1039, P343, DOI 10.1016/0167-4838(90)90269-L; HERNANDEZRIVAS R, 1992, FEMS MICROBIOL LETT, V92, P63, DOI 10.1111/j.1574-6968.1992.tb05235.x; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; HONDA BM, 1980, CELL, V22, P119, DOI 10.1016/0092-8674(80)90160-9; Inagaki Y, 2000, MOL BIOL EVOL, V17, P882, DOI 10.1093/oxfordjournals.molbev.a026368; Jerlstrom-Hultqvist J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-543; KOCK J, 1990, MOL BIOCHEM PARASIT, V38, P295, DOI 10.1016/0166-6851(90)90033-I; KORN LJ, 1982, NATURE, V295, P101, DOI 10.1038/295101a0; Lloyd D, 2002, TRENDS MICROBIOL, V10, P122, DOI 10.1016/S0966-842X(02)02306-5; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; Peng ZH, 2004, MOL MICROBIOL, V52, P1123, DOI 10.1111/j.1365-2958.2004.04034.x; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; SORENSEN PD, 1991, NUCLEIC ACIDS RES, V19, P4147, DOI 10.1093/nar/19.15.4147; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; Szymanski M, 2002, NUCLEIC ACIDS RES, V30, P176, DOI 10.1093/nar/30.1.176; THUILLIER V, 1995, EMBO J, V14, P351, DOI 10.1002/j.1460-2075.1995.tb07009.x; Torres-Machorro AL, 2006, MOL BIOCHEM PARASIT, V145, P269, DOI 10.1016/j.molbiopara.2005.10.009; Tourova TP, 2003, MICROBIOLOGY+, V72, P389, DOI 10.1023/A:1025045919260; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; WERNER M, 1993, J BIOL CHEM, V268, P20721; Yang DC, 1999, MOL PHYLOGENET EVOL, V12, P177, DOI 10.1006/mpev.1998.0607; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432	48	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e36878	10.1371/journal.pone.0036878	http://dx.doi.org/10.1371/journal.pone.0036878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685540	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700004
J	Fountzilas, G; Dafni, U; Bobos, M; Batistatou, A; Kotoula, V; Trihia, H; Malamou-Mitsi, V; Miliaras, S; Chrisafi, S; Papadopoulos, S; Sotiropoulou, M; Filippidis, T; Gogas, H; Koletsa, T; Bafaloukos, D; Televantou, D; Kalogeras, KT; Pectasides, D; Skarlos, DV; Koutras, A; Dimopoulos, MA				Fountzilas, George; Dafni, Urania; Bobos, Mattheos; Batistatou, Anna; Kotoula, Vassiliki; Trihia, Helen; Malamou-Mitsi, Vassiliki; Miliaras, Spyros; Chrisafi, Sofia; Papadopoulos, Savvas; Sotiropoulou, Maria; Filippidis, Theodoros; Gogas, Helen; Koletsa, Triantafyllia; Bafaloukos, Dimitrios; Televantou, Despina; Kalogeras, Konstantine T.; Pectasides, Dimitrios; Skarlos, Dimosthenis V.; Koutras, Angelos; Dimopoulos, Meletios A.			Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel	PLOS ONE			English	Article							RANDOMIZED PHASE-III; DENSE SEQUENTIAL CHEMOTHERAPY; PROTEIN EXPRESSION; NEOADJUVANT CHEMOTHERAPY; TISSUE MICROARRAYS; PROGNOSTIC VALUE; DOCETAXEL; RISK; EPIRUBICIN; SURVIVAL	Background: The aim of the present study was to investigate the efficacy of adjuvant dose-dense sequential chemotherapy with epirubicin, paclitaxel, and CMF in subgroups of patients with high-risk operable breast cancer, according to tumor subtypes defined by immunohistochemistry (IHC). Materials and Methods: Formalin-fixed paraffin-embedded (FFPE) tumor tissue samples from 1,039 patients participating in two adjuvant dose-dense sequential chemotherapy phase III trials were centrally assessed in tissue micro-arrays by IHC for 6 biological markers, that is, estrogen receptor (ER), progesterone receptor (PgR), HER2, Ki67, cytokeratin 5 (CK5), and EGFR. The majority of the cases were further evaluated for HER2 amplification by FISH. Patients were classified as: luminal A (ER/PgR-positive, HER2-negative, Ki67(low)); luminal B (ER/PgR-positive, HER2-negative, Ki67(high)); luminal-HER2 (ER/PgR-positive, HER2-positive); HER2-enriched (ER-negative, PgR-negative, HER2-positive); triple-negative (TNBC) (ER-negative, PgR-negative, HER2-negative); and basal core phenotype (BCP) (TNBC, CK5-positive and/or EGFR-positive). Results: After a median follow-up time of 105.4 months the 5-year disease-free survival (DFS) and overall survival (OS) rates were 73.1% and 86.1%, respectively. Among patients with HER2-enriched tumors there was a significant benefit in both DFS and OS (log-rank test; p = 0.021 and p = 0.006, respectively) for those treated with paclitaxel. The subtype classification was found to be of both predictive and prognostic value. Setting luminal A as the referent category, the adjusted for prognostic factors HR for relapse for patients with TNBC was 1.91 (95% CI: 1.31-2.80, Wald's p = 0.001) and for death 2.53 (95% CI: 1.62-3.60, p, 0.001). Site of and time to first relapse differed according to subtype. Locoregional relapses and brain metastases were more frequent in patients with TNBC, while liver metastases were more often seen in patients with HER2-enriched tumors. Conclusions: Triple-negative phenotype is of adverse prognostic value for DFS and OS in patients treated with adjuvant dose-dense sequential chemotherapy. In the pre-trastuzumab era, the HER2-enriched subtype predicts favorable outcome following paclitaxel-containing treatment.	[Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, Papageorgiou Hosp, GR-54006 Thessaloniki, Greece; [Dafni, Urania] Univ Athens, Sch Nursing, Lab Biostat, Athens, Greece; [Bobos, Mattheos; Chrisafi, Sofia; Televantou, Despina] Aristotle Univ Thessaloniki, Mol Oncol Lab, Hellen Fdn Canc Res, Sch Med, GR-54006 Thessaloniki, Greece; [Batistatou, Anna; Malamou-Mitsi, Vassiliki] Ioannina Univ Hosp, Dept Pathol, Ioannina, Greece; [Kotoula, Vassiliki; Koletsa, Triantafyllia] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Trihia, Helen] Metaxas Canc Hosp, Dept Pathol, Piraeus, Greece; [Miliaras, Spyros] Aristotle Univ Thessaloniki, Sch Med, Dept Surg 1, Papageorgiou Hosp, GR-54006 Thessaloniki, Greece; [Papadopoulos, Savvas] Hygeia Hosp, Dept Pathol, Athens, Greece; [Sotiropoulou, Maria] Alexandra Hosp, Dept Pathol, Athens, Greece; [Filippidis, Theodoros] Micromed Histopathol Lab, Athens, Greece; [Gogas, Helen] Univ Athens, Sch Med, Dept Med 1, Laiko Gen Hosp, GR-11527 Athens, Greece; [Bafaloukos, Dimitrios] Metropolitan Hosp, Dept Med Oncol 1, Piraeus, Greece; [Kalogeras, Konstantine T.] Data Off, Hellen Cooperat Oncol Grp, Translat Res Sect, Athens, Greece; [Pectasides, Dimitrios] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece; [Skarlos, Dimosthenis V.] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Koutras, Angelos] Univ Patras, Sch Med, Univ Hosp, Div Oncol,Dept Med, GR-26110 Patras, Greece; [Dimopoulos, Meletios A.] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-11527 Athens, Greece	Aristotle University of Thessaloniki; Papageorgiou Hospital; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; University Hospital Ioannina; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Papageorgiou Hospital; Hygeia Hospital; Alexandra Hospital; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Hellenic Cooperative Oncology Group; Hippokration General Hospital; University of Patras; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens	Fountzilas, G (corresponding author), Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, Papageorgiou Hosp, GR-54006 Thessaloniki, Greece.	fountzil@auth.gr	Dimopoulos, Meletios Athanasios/AAD-4130-2019; Fountzilas, George/ABF-2139-2020; Chrisafi, Sofia/AAH-2823-2020; Dafni, Ourania/AAH-4453-2019; Bobos, Mattheos/L-5702-2019	Dafni, Ourania/0000-0003-4367-4497; Bobos, Mattheos/0000-0001-5662-9201; Dimopoulos, Meletios/0000-0001-8990-3254; `miliaras, spiros/0000-0003-4983-6821; Koletsa, Triantafyllia/0000-0002-4435-3532; Fountzilas, George/0000-0001-8045-2186	internal Hellenic Cooperative Oncology Group (HeCOG) [HE R_10/10]	internal Hellenic Cooperative Oncology Group (HeCOG)	This work has been supported by an internal Hellenic Cooperative Oncology Group (HeCOG) grant (HE R_10/10), allocated to the conduct of this work. The Hellenic Cooperative Oncology Group was therefore directly involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Bedard PL, 2010, NAT REV CLIN ONCOL, V7, P22, DOI 10.1038/nrclinonc.2009.186; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Citron ML, 2004, CANCER INVEST, V22, P555, DOI 10.1081/CNV-200027134; Coombes RC, 2011, J CLIN ONCOL, V29, P3247, DOI 10.1200/JCO.2010.32.7254; Dawood S, 2009, ANN ONCOL, V20, P621, DOI 10.1093/annonc/mdn682; Diallo-Danebrock R, 2007, CLIN CANCER RES, V13, P488, DOI 10.1158/1078-0432.CCR-06-1842; Eiermann W, 2011, J CLIN ONCOL, V29, P3877, DOI 10.1200/JCO.2010.28.5437; Ellis P, 2009, LANCET, V373, P1681, DOI 10.1016/S0140-6736(09)60740-6; Fountzilas G, 2008, ANN ONCOL, V19, P853, DOI [10.1093/annonc/mdm539, 10.1093/annonc/mdm464]; Fountzilas G, 2000, CANCER INVEST, V18, P503, DOI 10.3109/07357900009012188; Fountzilas G, 2005, ANN ONCOL, V16, P1762, DOI 10.1093/annonc/mdi366; Fountzilas G, 1997, EUR J CANCER, V33, P1893, DOI 10.1016/S0959-8049(97)00217-7; GIANNI L, 1995, J NATL CANCER I, V87, P1169, DOI 10.1093/jnci/87.15.1169; Gianni L, 2009, J CLIN ONCOL, V27, P4798, DOI 10.1200/JCO.2008.21.4791; Gogas H, 2012, BREAST CANCER RES TR, V132, P609, DOI 10.1007/s10549-011-1913-4; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hayes DF, 2007, NEW ENGL J MED, V357, P1496, DOI 10.1056/NEJMoa071167; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Iwata H, 2011, JPN J CLIN ONCOL, V41, P867, DOI 10.1093/jjco/hyr081; Jacquemier J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3051; Jacquin JP, 2012, BREAST CANCER RES TR, V134, P903, DOI 10.1007/s10549-011-1933-0; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KALLIONIEMI OP, 1991, INT J CANCER, V49, P650, DOI 10.1002/ijc.2910490504; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kosmidis PA, 2011, ANN ONCOL, V22, P827, DOI 10.1093/annonc/mdq445; Kostopoulos I, 2006, BREAST CANCER RES TR, V96, P251, DOI 10.1007/s10549-005-9062-2; Lin NU, 2007, CLIN CANCER RES, V13, P1648, DOI 10.1158/1078-0432.CCR-06-2478; Martin M, 2010, BREAST CANCER RES TR, V123, P149, DOI 10.1007/s10549-009-0663-z; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Miller KD, 2003, ANN ONCOL, V14, P1072, DOI 10.1093/annonc/mdg300; Norton L, 2001, ONCOLOGIST, V6, P30; O'Shaughnessy J, 2002, ONCOLOGIST, V7, P4; Orzano Jennifer A, 2005, Clin Breast Cancer, V6, P402, DOI 10.3816/CBC.2005.n.044; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pestalozzi BC, 2006, ANN ONCOL, V17, P935, DOI 10.1093/annonc/mdl064; Press MF, 2011, J CLIN ONCOL, V29, P859, DOI 10.1200/JCO.2009.27.5644; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Qin YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026946; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Schippinger W, 2007, AM J CLIN PATHOL, V128, P630, DOI 10.1309/51KPD70348RP6XTE; Seidman AD, 2005, CANCER CHEMOTH PHARM, V56, pS78, DOI 10.1007/s00280-005-0109-1; Sihto H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2944; Skacel M, 2002, APPL IMMUNOHISTO M M, V10, P1, DOI 10.1097/00022744-200203000-00001; Skarlos P, 2012, CANCER CHEMOTH PHARM, V69, P533, DOI 10.1007/s00280-011-1730-9; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Vallejos CS, 2010, CLIN BREAST CANCER, V10, P294, DOI 10.3816/CBC.2010.n.038; Vanden Bempt I, 2008, J CLIN ONCOL, V26, P4869, DOI 10.1200/JCO.2007.13.4296; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Zauderer M, 2009, BREAST CANCER RES TR, V117, P205, DOI 10.1007/s10549-008-0116-0	56	53	55	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37946	10.1371/journal.pone.0037946	http://dx.doi.org/10.1371/journal.pone.0037946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679488	Green Published, gold			2022-12-27	WOS:000305343900015
J	Wei, K; Gao, SL; Zhong, SC; Ma, H				Wei, Kun; Gao, Shilong; Zhong, Suchuan; Ma, Hong			Fractional Dynamics of Globally Slow Transcription and Its Impact on Deterministic Genetic Oscillation	PLOS ONE			English	Article							TIME; EQUATION; MODELS; MEMORY; END	In dynamical systems theory, a system which can be described by differential equations is called a continuous dynamical system. In studies on genetic oscillation, most deterministic models at early stage are usually built on ordinary differential equations (ODE). Therefore, gene transcription which is a vital part in genetic oscillation is presupposed to be a continuous dynamical system by default. However, recent studies argued that discontinuous transcription might be more common than continuous transcription. In this paper, by appending the inserted silent interval lying between two neighboring transcriptional events to the end of the preceding event, we established that the running time for an intact transcriptional event increases and gene transcription thus shows slow dynamics. By globally replacing the original time increment for each state increment by a larger one, we introduced fractional differential equations (FDE) to describe such globally slow transcription. The impact of fractionization on genetic oscillation was then studied in two early stage models - the Goodwin oscillator and the Rossler oscillator. By constructing a "dual memory" oscillator - the fractional delay Goodwin oscillator, we suggested that four general requirements for generating genetic oscillation should be revised to be negative feedback, sufficient nonlinearity, sufficient memory and proper balancing of timescale. The numerical study of the fractional Rossler oscillator implied that the globally slow transcription tends to lower the chance of a coupled or more complex nonlinear genetic oscillatory system behaving chaotically.	[Wei, Kun; Gao, Shilong; Zhong, Suchuan; Ma, Hong] Sichuan Univ, Coll Math, Chengdu, Sichuan, Peoples R China; [Wei, Kun] Sichuan Univ, Coll Life Sci, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Wei, K (corresponding author), Sichuan Univ, Coll Math, Chengdu, Sichuan, Peoples R China.	kunwei@ymail.com; mahong@scu.edu.cn		Zhong, Suchuan/0000-0002-2798-3700	China Postdoctoral Science Foundation	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research is funded by China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulier F, 2007, LECT NOTES COMPUT SC, V4545, P66; Brickner JH, 2010, CURR BIOL, V20, pR20, DOI 10.1016/j.cub.2009.11.013; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; Jolma IW, 2010, WIRES SYST BIOL MED, V2, P533, DOI 10.1002/wsbm.81; Jumarie G, 2009, NONLINEAR ANAL-MODEL, V14, P177, DOI 10.15388/NA.2009.14.2.14520; Jumarie G, 2007, PHYS LETT A, V363, P5, DOI 10.1016/j.physleta.2006.10.085; Jumarie G, 2006, MATH COMPUT MODEL, V44, P231, DOI 10.1016/j.mcm.2005.10.003; Khan S, 2005, PHYSICA A, V350, P183, DOI 10.1016/j.physa.2004.11.067; Kilbas AA, 2006, THEORY APPL FRACTION, P96; Kim HS, 1999, PHYSICA D, V127, P48, DOI 10.1016/S0167-2789(98)00240-1; Kugiumtzis D, 1996, PHYSICA D, V95, P13, DOI 10.1016/0167-2789(96)00054-1; LI TY, 1975, AM MATH MON, V82, P985, DOI 10.2307/2318254; MACDONALD N, 1977, J THEOR BIOL, V67, P549, DOI 10.1016/0022-5193(77)90056-X; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Metzler R, 2004, J PHYS A-MATH GEN, V37, pR161, DOI 10.1088/0305-4470/37/31/R01; Monje CA, 2010, ADV IND CONTROL, P3, DOI 10.1007/978-1-84996-335-0; Morant PE, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068104; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Oustaloup A, 2000, IEEE T CIRCUITS-I, V47, P25, DOI 10.1109/81.817385; Podlubny I., 1999, FRACTIONAL DIFFERENT; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; ROSSLER OE, 1977, B MATH BIOL, V39, P275, DOI 10.1016/S0092-8240(77)80015-3; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Sharkovsky A. N., 1964, UKR MAT ZH, V16, P61; Sokolov IM, 2002, PHYS TODAY, V55, P48, DOI 10.1063/1.1535007; Suter DM, 2011, CURR OPIN CELL BIOL, V23, P657, DOI 10.1016/j.ceb.2011.09.004; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Tenreiro Machado J., 2010, FRACT CALC APPL ANAL, V13, P447; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Xue D, 2007, ADV DES CONTROL, P1, DOI 10.1137/1.9780898718621; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	38	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38383	10.1371/journal.pone.0038383	http://dx.doi.org/10.1371/journal.pone.0038383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679500	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343900033
J	Chen, HT; Tsou, HK; Chang, CH; Tang, CH				Chen, Hsien-Te; Tsou, Hsi-Kai; Chang, Chia-Hao; Tang, Chih-Hsin			Hepatocyte Growth Factor Increases Osteopontin Expression in Human Osteoblasts through PI3K, Akt, c-Src, and AP-1 Signaling Pathway	PLOS ONE			English	Article							PARTIAL-PURIFICATION; GENE-EXPRESSION; CELLS; ACTIVATION; KINASE; SURVIVAL; BONE; DIFFERENTIATION; ASSOCIATION; FIBROBLAST	Background: Hepatocyte growth factor (HGF) has been demonstrated to stimulate osteoblast proliferation and participated bone remodeling. Osteopontin (OPN) is a secreted phosphoglycoprotein that belongs to the SIBLING family and is present during bone mineralization. However, the effects of HGF on OPN expression in human osteoblasts are large unknown. Methodology/Principal Findings: Here we found that HGF induced OPN expression in human osteoblasts dose-dependently. HGF-mediated OPN production was attenuated by c-Met inhibitor and siRNA. Pretreatment of osteoblasts with PI3K inhibitor (Ly294002), Akt inhibitor, c-Src inhibitor (PP2), or AP-1 inhibitor (curcumin) blocked the potentiating action of HGF. Stimulation of osteoblasts with HGF enhanced PI3K, Akt, and c-Src activation. In addition, incubation of cells with HGF also increased c-Jun phosphorylation, AP-1-luciferase activity, and c-Jun binding to the AP-1 element on the OPN promoter. HGF-mediated AP-1-luciferase activity and c-Jun binding to the AP-1 element was reduced by c-Met inhibitor, Ly294002, Akt inhibitor, and PP2. Conclusions/Significance: Our results suggest that the interaction between HGF and c-Met increases OPN expression in human osteoblasts via the PI3K, Akt, c-Src, c-Jun, and AP-1 signaling pathway.	[Chen, Hsien-Te] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Chen, Hsien-Te] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Chen, Hsien-Te; Tsou, Hsi-Kai] Feng Chia Univ, Dept Mat Sci & Engn, Taichung 40724, Taiwan; [Tsou, Hsi-Kai] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Tsou, Hsi-Kai] Jen Teh Jr Coll Med Nursing & Management, Ctr Gen Educ, Miaoli Cty, Taiwan; [Chang, Chia-Hao] Chang Hwa Hosp, Dept Orthoped Surg, Dept Hlth Execut Yuan, Chang Hwa Cty, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Feng Chia University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan	Chen, HT (corresponding author), China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3, NSC100-2320-B-039-032]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3; NSC100-2320-B-039-028-MY3; NSC100-2320-B-039-032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barizzone N, 2011, HUM IMMUNOL, V72, P930, DOI 10.1016/j.humimm.2011.06.009; Buitenhuis M, 2011, CURR OPIN HEMATOL, V18, P226, DOI 10.1097/MOH.0b013e32834760e5; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; D'Ippolito G, 2002, BONE, V31, P269, DOI 10.1016/S8756-3282(02)00820-7; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; Grotegut S, 2010, INT J ONCOL, V36, P1261, DOI 10.3892/ijo_00000610; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Huang HC, 2003, J BIOL CHEM, V278, P46750, DOI 10.1074/jbc.M305216200; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jiang WG, 1997, HISTOL HISTOPATHOL, V12, P537; Jin W, 2008, J BIOL CHEM, V283, P1391, DOI 10.1074/jbc.M705052200; Lane NE, 2003, ARTHRITIS RES THER, V5, P214, DOI 10.1186/ar797; LUETTEKE NC, 1985, CANCER RES, V45, P6331; Mahtouk K, 2010, BBA-REV CANCER, V1806, P208, DOI 10.1016/j.bbcan.2010.07.006; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Nakayama H, 2011, HYPERTENS RES, V34, P1141, DOI 10.1038/hr.2011.102; Qureshi HY, 2007, CELL SIGNAL, V19, P1643, DOI 10.1016/j.cellsig.2007.02.007; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sengupta S, 2003, ARTERIOSCL THROM VAS, V23, P69, DOI 10.1161/01.ATV.0000048701.86621.D0; Sharma P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-178; Taichman RS, 2001, BRIT J HAEMATOL, V112, P438, DOI 10.1046/j.1365-2141.2001.02568.x; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wang YC, 2003, ANAL BIOCHEM, V319, P206, DOI 10.1016/S0003-2697(03)00330-0; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200	32	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38378	10.1371/journal.pone.0038378	http://dx.doi.org/10.1371/journal.pone.0038378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675553	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700067
J	Chen, JW; Scaria, J; Chang, YF				Chen, Jenn-Wei; Scaria, Joy; Chang, Yung-Fu			Phenotypic and Transcriptomic Response of Auxotrophic Mycobacterium avium Subsp paratuberculosis leuD Mutant under Environmental Stress	PLOS ONE			English	Article							IMMUNE-RESPONSES; HIGH-THROUGHPUT; BIOCHEMICAL CHARACTERISTICS; RECOMBINANT ANTIGENS; ALLELIC EXCHANGE; IN-VITRO; TUBERCULOSIS; ENVELOPE; VIRULENCE; BACTERIUM	Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of severe gastroenteritis in cattle. To gain a better understanding of MAP virulence, we investigated the role of leuD gene in MAP metabolism and stress response. For this, we have constructed an auxotrophic strain of MAP by deleting the leuD gene using allelic exchange. The wildtype and mutant strains were then compared for metabolic phenotypic changes using Biolog phenotype microarrays. The responses of both strains to physiologically relevant stress conditions were assessed using DNA microarrays. Transcriptomic data was then analyzed in the context of cellular metabolic pathways and gene networks. Our results showed that deletion of leuD gene has a global effect on both MAP phenotypic and transcriptome response. At the metabolic level, the mutant strain lost the ability to utilize most of the carbon, nitrogen, sulphur, phosphorus and nutrient supplements as energy source. At the transcriptome level, more than 100 genes were differentially expressed in each of the stress condition tested. Systems level network analysis revealed that the differentially expressed genes were distributed throughout the gene network, thus explaining the global impact of leuD deletion in metabolic phenotype. Further, we find that leuD deletion impacted metabolic pathways associated with fatty acids. We verified this by experimentally estimating the total fatty acid content of both mutant and wildtype. The mutant strain had 30% less fatty acid content when compared to wildtype, thus supporting the results from transcriptional and computational analyses. Our results therefore reveal the intricate connection between the metabolism and virulence in MAP.	[Chen, Jenn-Wei; Scaria, Joy; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Chen, JW (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu		Scaria, Joy/0000-0002-5299-8074	Biotechnology Research and Development Corporation (BRDC); NYS Department of Agriculture and Markets; USDA-APHIS; National Research Initiative (NRI) of the USDA Cooperative State Research, Education and Extension Service [2008-35204-04626]; Agriculture and Food Research Initiative (AFRI) of the USDA Cooperative State Research, Education and Extension Service [2009-65119-05993]; Animal Formula Fund [NY-478455]	Biotechnology Research and Development Corporation (BRDC); NYS Department of Agriculture and Markets; USDA-APHIS(United States Department of Agriculture (USDA)); National Research Initiative (NRI) of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Agriculture and Food Research Initiative (AFRI) of the USDA Cooperative State Research, Education and Extension Service; Animal Formula Fund	This work was supported by the Biotechnology Research and Development Corporation (BRDC), a contract through a cooperative agreement between the NYS Department of Agriculture and Markets, the USDA-APHIS, the National Research Initiative (NRI) of the USDA Cooperative State Research, Education and Extension Service (2008-35204-04626), the Agriculture and Food Research Initiative (AFRI) of the USDA Cooperative State Research, Education and Extension Service (2009-65119-05993) and the Animal Formula Fund (NY-478455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr MA, 2008, CURR OPIN GASTROEN, V24, P17, DOI 10.1097/MOG.0b013e3282f1dcc4; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Borsuk S, 2007, TUBERCULOSIS, V87, P474, DOI 10.1016/j.tube.2007.07.006; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Bull TJ, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-25; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Cavaignac SM, 2000, ARCH MICROBIOL, V173, P229, DOI 10.1007/s002039900132; Chen JW, 2011, VACCINE; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; CHIODINI RJ, 1986, AM J VET RES, V47, P1442; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dosanjh NS, 2005, FEMS MICROBIOL LETT, V249, P87, DOI 10.1016/j.femsle.2005.06.004; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Grant IR, 2002, APPL ENVIRON MICROB, V68, P2428, DOI 10.1128/AEM.68.5.2428-2435.2002; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hayashi D, 2010, FEMS MICROBIOL LETT, V306, P103, DOI 10.1111/j.1574-6968.2010.01947.x; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; IZUMORI K, 1976, J BACTERIOL, V128, P587, DOI 10.1128/JB.128.2.587-591.1976; Janagama HK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-561; Janagama HK, 2009, MICROBIOL-SGM, V155, P3683, DOI 10.1099/mic.0.031948-0; Johnson DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000211; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Kathaperumal K, 2009, VACCINE, V27, P123, DOI 10.1016/j.vaccine.2008.10.019; Kathaperumal K, 2008, VACCINE, V26, P1652, DOI 10.1016/j.vaccine.2008.01.015; Khare S, 2007, VACCINE, V25, P1743, DOI 10.1016/j.vaccine.2006.11.036; Makinoshima H, 2005, NATURE, V436, P406, DOI 10.1038/nature03713; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; MILLS JA, 1994, J BACTERIOL, V176, P4803, DOI 10.1128/jb.176.16.4803-4808.1994; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Otero J, 2003, APPL ENVIRON MICROB, V69, P5039, DOI 10.1128/AEM.69.9.5039-5044.2003; Paley SM, 2002, BIOINFORMATICS, V18, P715, DOI 10.1093/bioinformatics/18.5.715; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Panas P, 2007, J APPL MICROBIOL, V103, P237, DOI 10.1111/j.1365-2672.2006.03213.x; Park KT, 2008, APPL ENVIRON MICROB, V74, P1687, DOI 10.1128/AEM.01208-07; Park SU, 2008, VACCINE, V26, P4329, DOI 10.1016/j.vaccine.2008.06.016; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rodriguez-Rojas A, 2009, J BACTERIOL, V191, P844, DOI 10.1128/JB.01081-08; Scandurra GM, 2010, INFECT IMMUN, V78, P1383, DOI 10.1128/IAI.01020-09; Shin SJ, 2005, INFECT IMMUN, V73, P5074, DOI 10.1128/IAI.73.8.5074-5085.2005; SLIJKHUIS H, 1984, J GEN MICROBIOL, V130, P2035; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wang C, 2011, J LIPIDS, V2011, DOI 10.1155/2011/676535; Webb E, 1997, J BIOL CHEM, V272, P15702, DOI 10.1074/jbc.272.25.15702; Wu CW, 2007, J BACTERIOL, V189, P7877, DOI 10.1128/JB.00780-07; YAMORI S, 1991, MICROBIOL IMMUNOL, V35, P921, DOI 10.1111/j.1348-0421.1991.tb02031.x; Zhu XC, 2008, MICROBES INFECT, V10, P1274, DOI 10.1016/j.micinf.2008.07.025	56	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37884	10.1371/journal.pone.0037884	http://dx.doi.org/10.1371/journal.pone.0037884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675497	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700026
J	Kashima, S; Suzuki, E; Okayasu, T; Louis, RJ; Eboshida, A; Subramanian, SV				Kashima, Saori; Suzuki, Etsuji; Okayasu, Toshiharu; Louis, Razafimahatratra Jean; Eboshida, Akira; Subramanian, S. V.			Association between Proximity to a Health Center and Early Childhood Mortality in Madagascar	PLOS ONE			English	Article							RURAL BURKINA-FASO; UNDER-5 MORTALITY; CARE; ACCESS; SURVIVAL; DISTANCE; SERVICES; CHILDREN; GAMBIA; IMPACT	Objective: To evaluate the association between proximity to a health center and early childhood mortality in Madagascar, and to assess the influence of household wealth, maternal educational attainment, and maternal health on the effects of distance. Methods: From birth records of subjects in the Demographic and Health Survey, we identified 12565 singleton births from January 2004 to August 2009. After excluding 220 births that lacked global positioning system information for exposure assessment, odds ratios (ORs) and their 95% confidence intervals (CIs) for neonatal mortality and infant mortality were estimated using multilevel logistic regression models, with 12345 subjects (level 1), nested within 584 village locations (level 2), and in turn nested within 22 regions (level 3). We additionally stratified the subjects by the birth order. We estimated predicted probabilities of each outcome by a three-level model including cross-level interactions between proximity to a health center and household wealth, maternal educational attainment, and maternal anemia. Results: Compared with those who lived >1.5-3.0 km from a health center, the risks for neonatal mortality and infant mortality tended to increase among those who lived further than 5.0 km from a health center; the adjusted ORs for neonatal mortality and infant mortality for those who lived >5.0-10.0 km away from a health center were 1.36 (95% CI: 0.92-2.01) and 1.42 (95% CI: 1.06-1.90), respectively. The positive associations were more pronounced among the second or later child. The distance effects were not modified by household wealth status, maternal educational attainment, or maternal health status. Conclusions: Our study suggests that distance from a health center is a risk factor for early childhood mortality (primarily, infant mortality) in Madagascar by using a large-scale nationally representative dataset. The accessibility to health care in remote areas would be a key factor to achieve better infant health.	[Kashima, Saori; Eboshida, Akira] Hiroshima Univ, Grad Sch Biomed Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Kashima, Saori; Suzuki, Etsuji] Okayama Univ, Dept Epidemiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Okayasu, Toshiharu] Japan Int Cooperat Agcy Madagascar, HIV Prevent Strengthening Project, Antananarivo, Madagascar; [Louis, Razafimahatratra Jean] Minist Hlth, Serv Stat Hlth, Antananarivo, Madagascar; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Hiroshima University; Okayama University; Harvard University; Harvard T.H. Chan School of Public Health	Kashima, S (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan.	saori_ksm@ybb.ne.jp	Suzuki, Etsuji/B-2342-2011; Kashima, Saori/B-4524-2010	Suzuki, Etsuji/0000-0002-1290-5793; Kashima, Saori/0000-0002-3401-8191; Okayasu, Toshiharu/0000-0002-4381-5125				Akello Beatrice, 2008, East Afr J Public Health, V5, P180; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Becher H, 2004, B WORLD HEALTH ORGAN, V82, P265; Chan M, 2008, LANCET, V372, P865, DOI 10.1016/S0140-6736(08)61372-0; Christian P, 2009, AM J EPIDEMIOL, V170, P1127, DOI 10.1093/aje/kwp253; Dasgupta S, 2009, INDOOR AIR, V19, P22, DOI 10.1111/j.1600-0668.2008.00558.x; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; INSTAT ICF Macro, 2010, MAD DEM HLTH SURV 20; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; Kliegman R, 2007, NELSON TXB PEDIAT, P683; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Magnani RJ, 1996, INT J EPIDEMIOL, V25, P568, DOI 10.1093/ije/25.3.568; Ministere de la sante et du planning familial, 2004, ANN STAT SECT SANT M; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P102, DOI 10.2471/BLT.10.080796; Okwaraji YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033564; Poncin X, 2009, POLITIQUES EXEMPTION; Rasbash J., 2010, MLWIN VERSION 2 22; Rothman K.J., 2008, MODERN EPIDEMIOLOGY, P128; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Rutherford ME, 2009, B WORLD HEALTH ORGAN, V87, P216, DOI 10.2471/BLT.08.052175; Rutstein SO, 2004, DHS COMP REPORTS, V6; Schellenberg JRA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-194; Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386; Sharp M, 2011, HLTH NUTR POPULATION; Siega-Riz AM, 2006, AM J OBSTET GYNECOL, V194, P512, DOI 10.1016/j.ajog.2005.08.011; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; United Nations, 2010, MILL DEV GOALS REP 2; Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562; World Health Organization (WHO), 1978, INT C PRIM HLTH CAR	30	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38370	10.1371/journal.pone.0038370	http://dx.doi.org/10.1371/journal.pone.0038370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675551	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700065
J	Oberthuer, D; Melero-Garcia, E; Dierks, K; Meyer, A; Betzel, C; Garcia-Caballero, A; Gavira, JA				Oberthuer, Dominik; Melero-Garcia, Emilio; Dierks, Karsten; Meyer, Arne; Betzel, Christian; Garcia-Caballero, Alfonso; Gavira, Jose A.			Monitoring and Scoring Counter-Diffusion Protein Crystallization Experiments in Capillaries by in situ Dynamic Light Scattering	PLOS ONE			English	Article							GLUCOSE-ISOMERASE; CRYSTAL-GROWTH; POLYHEDRAL INSTABILITY; VAPOR DIFFUSION; NUCLEATION; MICROGRAVITY; AGGREGATION; KINETICS	In this paper, we demonstrate the feasibility of using in situ Dynamic Light Scattering (DLS) to monitor counter-diffusion crystallization experiments in capillaries. Firstly, we have validated the quality of the DLS signal in thin capillaries, which is comparable to that obtained in standard quartz cuvettes. Then, we have carried out DLS measurements of a counter-diffusion crystallization experiment of glucose isomerase in capillaries of different diameters (0.1, 0.2 and 0.3 mm) in order to follow the temporal evolution of protein supersaturation. Finally, we have compared DLS data with optical recordings of the progression of the crystallization front and with a simulation model of counter-diffusion in 1D.	[Oberthuer, Dominik; Betzel, Christian] Univ Hamburg, Lab Struct Biol Infect & inflammat, Inst Biochem & Mol Biol, Hamburg, Germany; [Melero-Garcia, Emilio; Garcia-Caballero, Alfonso; Gavira, Jose A.] Univ Granada, Consejo Super Invest Cient, IACT, Lab Estudios Cristalog, Granada, Spain; [Dierks, Karsten; Meyer, Arne] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, Lubeck, Germany	University of Hamburg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; University of Lubeck	Oberthuer, D (corresponding author), Univ Hamburg, Lab Struct Biol Infect & inflammat, Inst Biochem & Mol Biol, Hamburg, Germany.	gavi@lec.csic.es	Betzel, Christian/G-8105-2018; Gavira, Jose A./C-2491-2009; Caballero, Alfonso Garcia/D-2463-2011; Oberthuer, Dominik/AAG-5059-2021	Betzel, Christian/0000-0002-3879-5019; Gavira, Jose A./0000-0002-7386-6484; Caballero, Alfonso Garcia/0000-0002-7217-0266; Oberthuer, Dominik/0000-0002-0894-9590	EU [LSHG-CT-2006-037793, 037793]; Deutsche Luft und Raumfahrtagentur, DLR [50WB1017]; "Factoria de Cristalizacion" of the Ministerio de Innovacion y Ciencia (MICINN) of Spain;  [BIO2010-16800]	EU(European Commission); Deutsche Luft und Raumfahrtagentur, DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); "Factoria de Cristalizacion" of the Ministerio de Innovacion y Ciencia (MICINN) of Spain; 	This work has been financed by the EU via the OptiCryst Project, LSHG-CT-2006-037793 (Contract No. 037793) and partially by a grant 50WB1017 of the Deutsche Luft und Raumfahrtagentur, DLR; the "Factoria de Cristalizacion" of the Ministerio de Innovacion y Ciencia (MICINN) of Spain and project BIO2010-16800 (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN ET, 1986, BIOPHYS J, V49, P47, DOI 10.1016/S0006-3495(86)83587-1; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; Brown W., 1993, DYNAMIC LIGHT SCATTE; Cardinaux F, 2011, J PHYS CHEM B, V115, P7227, DOI 10.1021/jp112180p; CARRELL HL, 1989, P NATL ACAD SCI USA, V86, P4440, DOI 10.1073/pnas.86.12.4440; CASAY GA, 1992, J CRYST GROWTH, V122, P95, DOI 10.1016/0022-0248(92)90231-7; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Curtis RA, 1998, BIOTECHNOL BIOENG, V57, P11, DOI 10.1002/(SICI)1097-0290(19980105)57:1<11::AID-BIT2>3.0.CO;2-Y; Dierks K, 2008, CRYST GROWTH DES, V8, P1628, DOI 10.1021/cg701067r; Ducruix A., 1992, CRYSTALLIZATION NUCL; FERREDAMARE AR, 1994, STRUCTURE, V2, P357, DOI 10.1016/S0969-2126(00)00037-X; FerreDAmare AR, 1997, METHOD ENZYMOL, V276, P157, DOI 10.1016/S0076-6879(97)76056-7; Forsythe EL, 2002, ACTA CRYSTALLOGR D, V58, P1601, DOI 10.1107/S0907444902014208; Garcia-Ruiz JM, 2003, METHOD ENZYMOL, V368, P130, DOI 10.1016/S0076-6879(03)68008-0; Garcia-Ruiz JM, 2003, J STRUCT BIOL, V142, P22, DOI 10.1016/S1047-8477(03)00035-2; Garcia-Ruiz JM, 2001, J CRYST GROWTH, V232, P149, DOI 10.1016/S0022-0248(01)01144-7; Garcia-Ruiz JM, 1999, J CRYST GROWTH, V196, P703, DOI 10.1016/S0022-0248(98)00851-3; GEORGALIS Y, 1995, ADV COLLOID INTERFAC, V58, P57, DOI 10.1016/0001-8686(95)00244-K; Gliko O, 2007, J PHYS CHEM B, V111, P3106, DOI 10.1021/jp068827o; Gonzalez-Ramirez LA, 2008, CRYST GROWTH DES, V8, P4324, DOI 10.1021/cg800788e; HAMPEL A, 1968, SCIENCE, V162, P1384, DOI 10.1126/science.162.3860.1384; KADIMA W, 1990, BIOPHYS J, V57, P125, DOI 10.1016/S0006-3495(90)82513-3; Kozak M, 2005, J APPL CRYSTALLOGR, V38, P555, DOI 10.1107/S0021889805010472; MALKIN A, 1994, ACTA CRYSTALLOGR D, V50, P385, DOI 10.1107/S0907444993013319; MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x; MIKOL V, 1989, FEBS LETT, V258, P63, DOI 10.1016/0014-5793(89)81616-3; Ng JD, 2003, J STRUCT BIOL, V142, P218, DOI 10.1016/S1047-8477(03)00052-2; Otalora F, 1996, J CRYST GROWTH, V169, P361, DOI 10.1016/S0022-0248(96)00394-6; Otalora F, 1997, J CRYST GROWTH, V182, P141, DOI 10.1016/S0022-0248(97)00325-4; Otalora F, 2009, PROG BIOPHYS MOL BIO, V101, P26, DOI 10.1016/j.pbiomolbio.2009.12.004; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Rosenberger F, 1996, J CRYST GROWTH, V168, P1, DOI 10.1016/0022-0248(96)00358-2; Rupp B, 2010, BIOMOLECULAR CRYSTALLOGRAPHY: PRINCIPLES, PRACTICE, AND APPLICATION TO STRUCTURAL BIOLOGY, P1; SALEMME FR, 1972, ARCH BIOCHEM BIOPHYS, V151, P533, DOI 10.1016/0003-9861(72)90530-9; Sleutel M, 2009, CRYST GROWTH DES, V9, P497, DOI 10.1021/cg800756h; Sleutel M, 2009, CRYST GROWTH DES, V9, P335, DOI 10.1021/cg800728x; Stradner A, 2004, NATURE, V432, P492, DOI 10.1038/nature03109; Streets AM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178102; Van Driessche AES, 2009, J CRYST GROWTH, V311, P3479, DOI 10.1016/j.jcrysgro.2009.04.023; Vekilov PG, 2010, CRYST GROWTH DES, V10, P5007, DOI 10.1021/cg1011633; Visuri K, 1999, BIOTECHNOL BIOENG, V64, P377, DOI 10.1002/(SICI)1097-0290(19990805)64:3<377::AID-BIT15>3.0.CO;2-C; Vivares D, 2007, CRYST GROWTH DES, V7, P1411, DOI 10.1021/cg060787q; Wessel T, 1998, P SOC PHOTO-OPT INS, V3199, P299, DOI 10.1117/12.301121; WILSON W W, 1990, Methods (Orlando), V1, P110, DOI 10.1016/S1046-2023(05)80154-9; Wilson WW, 2003, J STRUCT BIOL, V142, P56, DOI 10.1016/S1047-8477(03)00038-8; WISHAW BF, 1954, J AM CHEM SOC, V76, P2065, DOI 10.1021/ja01637a011; Yadav S, 2011, ANAL BIOCHEM, V411, P292, DOI 10.1016/j.ab.2010.12.014; Zhang J, 2003, J CHEM PHYS, V119, P10972, DOI 10.1063/1.1622380	48	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e33545	10.1371/journal.pone.0033545	http://dx.doi.org/10.1371/journal.pone.0033545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675464	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341700001
J	Liao, Y; Hu, X; Chen, J; Cai, B; Tang, JT; Ying, BW; Wang, HQ; Wang, LL				Liao, Yun; Hu, Xin; Chen, Jie; Cai, Bei; Tang, Jiangtao; Ying, Binwu; Wang, Haiqing; Wang, Lanlan			Precore Mutation of Hepatitis B Virus May Contribute to Hepatocellular Carcinoma Risk: Evidence from an Updated Meta-Analysis	PLOS ONE			English	Article							II/CORE PROMOTER/PRECORE REGIONS; PRE-S DELETION; CORE PROMOTER; GENOTYPE-C; E-ANTIGEN; ASSOCIATION; INFECTION; CARRIERS; PREVALENCE; SEQUENCES	Background: Studies focused on the correlation of mutations in the genome of Hepatitis B Virus (HBV) like Pre-S mutation, Basal Core promoter (BCP), Enhancer II (EnhII), especially Precore mutation, with the risk of hepatocellular carcinoma (HCC) have triggered stiff controversies. With an increasing number of studies in this field recently, we conducted this meta-analysis to appraise the correlations. Methods: We searched the commonly used databases both in English and Chinese till February 1st, 2012. Meta-analysis was performed in fixed/ random-effects models using STATA 10.0. Publication bias was examined through Egger's test and Begg's funnel plot. Results: In total, 85 case-control studies were included involving 16745 HBV-infected patients, of whom 5781 had HCC. Statistically significant correlations were observed in Precore mutation G1896A (OR = 1.46, 95% confidence interval [CI] = 1.15-1.85, P-OR = 0.002), G1899A (OR = 3.13, 95% CI = 2.38-4.13, P-OR<0.001) and Pre-S mutation especially Pre-S1 deletion (OR = 2.94, 95% CI = 2.22 to 3.89) and Pre-S2 deletion (OR = 3.02, 95% CI = 2.03 to 4.50). Similar correlation existed between BCP double mutation A1762T/G1764A, T1753V, C1653T and HCC. In subgroup analysis, the Asians, genotype C or HBeAg positive patients with certain above mutations may be more susceptible to HCC. Besides, the mutations like G1896A and BCP double mutation may be associated with the progression of the liver diseases. Conclusions: Precore mutation G1896A, G1899A, deletions in Pre-S region as well as the other commonly seen mutations correlated with the increased risk of HCC, especially in Asians and may predict the progression of the liver disease.	[Liao, Yun; Chen, Jie; Cai, Bei; Tang, Jiangtao; Ying, Binwu; Wang, Lanlan] Sichuan Univ, W China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China; [Hu, Xin] Sichuan Univ, W China Hosp, Dept Neurosurg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Haiqing] Sichuan Univ, W China Hosp, Liver Transplantat Ctr, Dept Liver & Vasc Surg, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Wang, LL (corresponding author), Sichuan Univ, W China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China.	wangll_wch@163.com	Ying, Binwu/AAB-5934-2022	Ying, Binwu/0000-0001-8077-3908	National Natural Science Foundation of China [NSFC-81072443, NSFC-81001325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC-81072443 and NSFC-81001325). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahramali G, 2008, WORLD J GASTROENTERO, V14, P5448, DOI 10.3748/wjg.14.5448; Bai J, 2007, CHINESE J INFECT DIS, V10, P617; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; BRUNETTO MR, 1990, J HEPATOL, V10, P258, DOI 10.1016/0168-8278(90)90062-V; CARMAN WF, 1989, LANCET, V2, P588; Chan HLY, 2009, CLIN GASTROENTEROL H, V7, P1361, DOI 10.1016/j.cgh.2009.08.004; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CH, 2008, J INFECT DIS, V198, P1634, DOI 10.1086/592990; Chen CH, 2009, INT J CANCER, V125, P621, DOI 10.1002/ijc.24416; Choi MS, 2007, J VIRAL HEPATITIS, V14, P161, DOI 10.1111/j.1365-2893.2006.00784.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Elkady A, 2008, J GASTROEN HEPATOL, V23, P474, DOI 10.1111/j.1440-1746.2008.05321.x; Guo Xia, 2007, Tumor, V27, P429; Huy TTT, 2004, J MED VIROL, V74, P228, DOI 10.1002/jmv.20175; Ito K, 2007, J GASTROENTEROL, V42, P837, DOI 10.1007/s00535-007-2100-6; Jang JW, 2007, J VIRAL HEPATITIS, V14, P169, DOI 10.1111/j.1365-2893.2006.00788.x; Jang JW, 2012, CANCER SCI, V103, P296, DOI 10.1111/j.1349-7006.2011.02170.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim JK, 2009, J MED VIROL, V81, P1002, DOI 10.1002/jmv.21501; Kusakabe A, 2011, J GASTROENTEROL, V46, P117, DOI 10.1007/s00535-010-0307-4; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Laskus T, 1998, BIOCHEM BIOPH RES CO, V244, P812, DOI 10.1006/bbrc.1998.8249; Lee MH, 2011, INTERVIROLOGY; Liu SJ, 2011, J MED VIROL, V83, P45, DOI 10.1002/jmv.21829; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lyu H, 2011, J HEPATOL, V54, pS151; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Song BC, 2005, J MED VIROL, V75, P13, DOI 10.1002/jmv.20230; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Tong MJ, 2007, LIVER INT, V27, P1356, DOI 10.1111/j.1478-3231.2007.01585.x; Truong BX, 2007, J MED VIROL, V79, P1293, DOI 10.1002/jmv.20934; Utama A, 2011, J MED VIROL, V83, P1717, DOI 10.1002/jmv.22172; Welschinger R, 2010, EUR J GASTROEN HEPAT, V22, P541, DOI 10.1097/MEG.0b013e3283344991; Yan T, 2011, J MED VIROL, V83, P996, DOI 10.1002/jmv.22067; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yeung P, 2011, J INFECT DIS, V203, P646, DOI 10.1093/infdis/jiq096; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yin JH, 2010, J GASTROENTEROL, V45, P1063, DOI 10.1007/s00535-010-0253-1; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859; Zheng JX, 2011, J VIRAL HEPATITIS, V18, pE423, DOI 10.1111/j.1365-2893.2011.01458.x; Zhu Y, 2010, CANCER EPIDEM BIOMAR, V19, P2623, DOI 10.1158/1055-9965.EPI-10-0469	46	47	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38394	10.1371/journal.pone.0038394	http://dx.doi.org/10.1371/journal.pone.0038394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675557	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900027
J	Pearse, IS; Porensky, LM; Yang, LH; Stanton, ML; Karban, R; Bhattacharyya, L; Cox, R; Dove, K; Higgins, A; Kamoroff, C; Kirk, T; Knight, C; Koch, R; Parker, C; Rollins, H; Tanner, K				Pearse, Ian S.; Porensky, Lauren M.; Yang, Louie H.; Stanton, Maureen L.; Karban, Richard; Bhattacharyya, Lisa; Cox, Rosa; Dove, Karin; Higgins, August; Kamoroff, Corrina; Kirk, Travis; Knight, Christopher; Koch, Rebecca; Parker, Corwin; Rollins, Hilary; Tanner, Kelsey			Complex Consequences of Herbivory and Interplant Cues in Three Annual Plants	PLOS ONE			English	Article							SELF/NON-SELF DISCRIMINATION; ROOT COMMUNICATION; KIN RECOGNITION; DEFENSE; VOLATILES; RESPONSES; COOPERATION	Information exchange (or signaling) between plants following herbivore damage has recently been shown to affect plant responses to herbivory in relatively simple natural systems. In a large, manipulative field study using three annual plant species (Achyrachaena mollis, Lupinus nanus, and Sinapis arvensis), we tested whether experimental damage to a neighboring conspecific affected a plant's lifetime fitness and interactions with herbivores. By manipulating relatedness between plants, we assessed whether genetic relatedness of neighboring individuals influenced the outcome of having a damaged neighbor. Additionally, in laboratory feeding assays, we assessed whether damage to a neighboring plant specifically affected palatability to a generalist herbivore and, for S. arvensis, a specialist herbivore. Our study suggested a high level of contingency in the outcomes of plant signaling. For example, in the field, damaging a neighbor resulted in greater herbivory to A. mollis, but only when the damaged neighbor was a close relative. Similarly, in laboratory trials, the palatability of S. arvensis to a generalist herbivore increased after the plant was exposed to a damaged neighbor, while palatability to a specialist herbivore decreased. Across all species, damage to a neighbor resulted in decreased lifetime fitness, but only if neighbors were closely related. These results suggest that the outcomes of plant signaling within multi-species neighborhoods may be far more context-specific than has been previously shown. In particular, our study shows that herbivore interactions and signaling between plants are contingent on the genetic relationship between neighboring plants. Many factors affect the outcomes of plant signaling, and studies that clarify these factors will be necessary in order to assess the role of plant information exchange about herbivory in natural systems.	[Pearse, Ian S.; Yang, Louie H.; Karban, Richard] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Porensky, Lauren M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Stanton, Maureen L.; Bhattacharyya, Lisa; Cox, Rosa; Dove, Karin; Higgins, August; Kamoroff, Corrina; Kirk, Travis; Knight, Christopher; Koch, Rebecca; Parker, Corwin; Rollins, Hilary; Tanner, Kelsey] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Pearse, IS (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	ispearse@ucdavis.edu	Koch, Rebecca E./AFJ-9118-2022	Koch, Rebecca E./0000-0002-9068-6231; Knight, Christopher/0000-0002-7522-4127; Yang, Louie/0000-0002-9237-5357; Mazumder, Lisa/0000-0002-1514-9882				Baldwin IT, 2002, CURR OPIN PLANT BIOL, V5, P351, DOI 10.1016/S1369-5266(02)00263-7; Broz AK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-115; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Darwin C, 1880, POWER MOVEMENT PLANT; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Fox J., 2018, R COMPANION APPL REG, VThird; Futuyma D.J., 1991, P431; Godard KA, 2008, PHYTOCHEMISTRY, V69, P1838, DOI 10.1016/j.phytochem.2008.02.011; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; Hamilton W.D., 1987, P81; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Hickman JC., 1993, JEPSON MANUAL; Holzapfel C, 2003, OECOLOGIA, V134, P72, DOI 10.1007/s00442-002-1062-x; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Karban R, 2002, ECOLOGY, V83, P1209, DOI 10.1890/0012-9658(2002)083[1209:TFCOIE]2.0.CO;2; Karban R, 2009, ECOL LETT, V12, P502, DOI 10.1111/j.1461-0248.2009.01313.x; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; MAHALL BE, 1992, ECOLOGY, V73, P2145, DOI 10.2307/1941462; Mahall BE, 1996, AM J BOT, V83, P93, DOI 10.2307/2445959; Mateo JM, 2010, ANIM BEHAV, V80, P929, DOI 10.1016/j.anbehav.2010.08.019; Murphy GP, 2009, AM J BOT, V96, P1990, DOI 10.3732/ajb.0900006; Nykanen H, 2004, OIKOS, V104, P247, DOI 10.1111/j.0030-1299.2004.12768.x; Penn DJ, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P55; Poelman EH, 2008, TRENDS PLANT SCI, V13, P534, DOI 10.1016/j.tplants.2008.08.003; R Core Development Team, 2008, R V 2 10 1; Schmitt J, 1999, AM NAT, V154, pS43, DOI 10.1086/303282; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2	33	17	17	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38105	10.1371/journal.pone.0038105	http://dx.doi.org/10.1371/journal.pone.0038105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675439	Green Published, gold			2022-12-27	WOS:000305338500088
J	Urich, E; Lazic, SE; Molnos, J; Wells, I; Freskgard, PO				Urich, Eduard; Lazic, Stanley E.; Molnos, Juliette; Wells, Isabelle; Freskgard, Per-Ola			Transcriptional Profiling of Human Brain Endothelial Cells Reveals Key Properties Crucial for Predictive In Vitro Blood-Brain Barrier Models	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LARGE T-ANTIGEN; CELLULAR-TRANSFORMATION; GENE-EXPRESSION; ELECTRICAL-RESISTANCE; LEUKOCYTE MIGRATION; ALZHEIMERS-DISEASE; NEUROVASCULAR UNIT; TIGHT JUNCTION; INTERFERON	Brain microvascular endothelial cells (BEC) constitute the blood-brain barrier (BBB) which forms a dynamic interface between the blood and the central nervous system (CNS). This highly specialized interface restricts paracellular diffusion of fluids and solutes including chemicals, toxins and drugs from entering the brain. In this study we compared the transcriptome profiles of the human immortalized brain endothelial cell line hCMEC/D3 and human primary BEC. We identified transcriptional differences in immune response genes which are directly related to the immortalization procedure of the hCMEC/D3 cells. Interestingly, astrocytic co-culturing reduced cell adhesion and migration molecules in both BECs, which possibly could be related to regulation of immune surveillance of the CNS controlled by astrocytic cells within the neurovascular unit. By matching the transcriptome data from these two cell lines with published transcriptional data from freshly isolated mouse BECs, we discovered striking differences that could explain some of the limitations of using cultured BECs to study BBB properties. Key protein classes such as tight junction proteins, transporters and cell surface receptors show differing expression profiles. For example, the claudin-5, occludin and JAM2 expression is dramatically reduced in the two human BEC lines, which likely explains their low transcellular electric resistance and paracellular leakiness. In addition, the human BEC lines express low levels of unique brain endothelial transporters such as Glut1 and Pgp. Cell surface receptors such as LRP1, RAGE and the insulin receptor that are involved in receptor-mediated transport are also expressed at very low levels. Taken together, these data illustrate that BECs lose their unique protein expression pattern outside of their native environment and display a more generic endothelial cell phenotype. A collection of key genes that seems to be highly regulated by the local surroundings of BEC within the neurovascular unit are presented and discussed.	[Urich, Eduard; Freskgard, Per-Ola] F Hoffmann La Roche Ltd, CNS Res, Basel, Switzerland; [Lazic, Stanley E.; Wells, Isabelle] F Hoffmann La Roche Ltd, Bioinformat & Exploratory Data Anal, Basel, Switzerland; [Molnos, Juliette] F Hoffmann La Roche Ltd, Translat Res Sci, Basel, Switzerland	Roche Holding; Roche Holding; Roche Holding	Urich, E (corresponding author), F Hoffmann La Roche Ltd, CNS Res, Basel, Switzerland.	per-ola.freskgard@roche.com	Lazic, Stanley/F-1160-2011; Freskgård, Per-Ola/AAY-4194-2021					Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; BASHAM TY, 1982, P NATL ACAD SCI-BIOL, V79, P3265, DOI 10.1073/pnas.79.10.3265; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; Cooper I, 2011, METHODS MOL BIOL, V762, P347, DOI 10.1007/978-1-61779-185-7_25; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Demeule M, 2008, J NEUROCHEM, V106, P1534, DOI 10.1111/j.1471-4159.2008.05492.x; DOLEI A, 1983, INFECT IMMUN, V40, P172, DOI 10.1128/IAI.40.1.172-176.1983; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Fasler-Kan E, 2010, BRAIN RES, V1354, P15, DOI 10.1016/j.brainres.2010.07.077; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Franke RM, 2010, CURR PHARM DESIGN, V16, P220, DOI 10.2174/138161210790112683; Gaillard PJ, 2000, PHARMACEUT RES, V17, P1198, DOI 10.1023/A:1026406528530; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; GREINER JW, 1984, CANCER RES, V44, P3208; Gresser I, 2007, BIOCHIMIE, V89, P723, DOI 10.1016/j.biochi.2007.03.005; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Hirase T, 1997, J CELL SCI, V110, P1603; Huang DR, 2000, IMMUNOL REV, V177, P52, DOI 10.1034/j.1600-065X.2000.17709.x; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; LAPIERRE LA, 1988, J EXP MED, V167, P794, DOI 10.1084/jem.167.3.794; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Mae M, 2011, CURR PHARM DESIGN, V17, P2750, DOI 10.2174/138161211797440113; MALE D, 1988, IMMUNOLOGY, V63, P37; Malina KCK, 2009, BRAIN RES, V1284, P12, DOI 10.1016/j.brainres.2009.05.072; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Naik P, 2012, J PHARM SCI-US, V101, P1337, DOI 10.1002/jps.23022; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Neuwelt EA, 2004, NEUROSURGERY, V54, P131, DOI 10.1227/01.NEU.0000097715.11966.8E; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Pardridge WM, 2010, COLD SPRING HARB PRO, V2010; Partanen J, 1999, CURR TOP MICROBIOL, V237, P159; Persidsky Y, 1999, J NEUROVIROL, V5, P579, DOI 10.3109/13550289909021287; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rathi AV, 2010, VIROLOGY, V406, P202, DOI 10.1016/j.virol.2010.07.018; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; RISAU W, 1990, TRENDS NEUROSCI, V13, P174, DOI 10.1016/0166-2236(90)90043-A; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Sato GH, 2010, IN VITRO CELL DEV-AN, V46, P590, DOI 10.1007/s11626-010-9315-1; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Segura I, 2009, TRENDS MOL MED, V15, P439, DOI 10.1016/j.molmed.2009.08.005; SMITH QR, 1986, J NEUROCHEM, V46, P1732; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Stanimirovic DB, 2012, J CEREBRAL BLOOD FLO; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueno M, 2010, CURR MED CHEM, V17, P1125, DOI 10.2174/092986710790827816; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401	82	131	134	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38149	10.1371/journal.pone.0038149	http://dx.doi.org/10.1371/journal.pone.0038149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675443	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500095
J	Ritie, L; Spenle, C; Lacroute, J; Bolcato-Bellemin, AL; Lefebvre, O; Bole-Feysot, C; Jost, B; Klein, A; Arnold, C; Kedinger, M; Bagnard, D; Orend, G; Simon-Assmann, P				Ritie, Lea; Spenle, Caroline; Lacroute, Joel; Bolcato-Bellemin, Anne-Laure; Lefebvre, Olivier; Bole-Feysot, Christine; Jost, Bernard; Klein, Annick; Arnold, Christiane; Kedinger, Michele; Bagnard, Dominique; Orend, Gertraud; Simon-Assmann, Patricia			Abnormal Wnt and PI3Kinase Signaling in the Malformed Intestine of lama5 Deficient Mice	PLOS ONE			English	Article							LAMININ ALPHA-5 CHAIN; BASEMENT-MEMBRANE; STEM-CELLS; HAIR MORPHOGENESIS; NUCLEAR PROTEINS; EPITHELIAL-CELLS; GENE-EXPRESSION; SELF-RENEWAL; ISOFORMS; DISEASE	Laminins are major constituents of basement membranes and are essential for tissue homeostasis. Laminin-511 is highly expressed in the intestine and its absence causes severe malformation of the intestine and embryonic lethality. To understand the mechanistic role of laminin-511 in tissue homeostasis, we used RNA profiling of embryonic intestinal tissue of lama5 knockout mice and identified a lama5 specific gene expression signature. By combining cell culture experiments with mediated knockdown approaches, we provide a mechanistic link between laminin alpha 5 gene deficiency and the physiological phenotype. We show that laminin alpha 5 plays a crucial role in both epithelial and mesenchymal cell behavior by inhibiting Wnt and activating PI3K signaling. We conclude that conflicting signals are elicited in the absence of lama5, which alter cell adhesion, migration as well as epithelial and muscle differentiation. Conversely, adhesion to laminin-511 may serve as a potent regulator of known interconnected PI3K/Akt and Wnt signaling pathways. Thus deregulated adhesion to laminin-511 may be instrumental in diseases such as human pathologies of the gut where laminin-511 is abnormally expressed as it is shown here.	[Ritie, Lea; Spenle, Caroline; Lacroute, Joel; Lefebvre, Olivier; Klein, Annick; Arnold, Christiane; Kedinger, Michele; Bagnard, Dominique; Orend, Gertraud; Simon-Assmann, Patricia] INSERM, U682, Strasbourg, France; [Ritie, Lea; Spenle, Caroline; Lacroute, Joel; Lefebvre, Olivier; Klein, Annick; Arnold, Christiane; Kedinger, Michele; Bagnard, Dominique; Orend, Gertraud; Simon-Assmann, Patricia] Univ Strasbourg, Strasbourg, France; [Bolcato-Bellemin, Anne-Laure] Polyplus Transfect, Illkirch Graffenstaden, France; [Bole-Feysot, Christine; Jost, Bernard] IGBMC, Microarray & Sequencing Platform, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ritie, L (corresponding author), Labs SVM, Schirmeck, France.	Patricia.Simon-Assmann@inserm.u-strasbg.fr	Lefebvre, Olivier/I-2388-2016; Spenle, Caroline/P-6284-2016; Bagnard, Dominique/I-6535-2013; Orend, Gertraud/E-8446-2015; Spenlé, Caroline/Z-6177-2019; Lefebvre, Olivier/S-6436-2019	Lefebvre, Olivier/0000-0001-9130-9174; Spenle, Caroline/0000-0002-6353-3109; Orend, Gertraud/0000-0003-2522-1195; Spenlé, Caroline/0000-0002-6353-3109; Lefebvre, Olivier/0000-0001-9130-9174; Bagnard, Dominique/0000-0002-5261-902X	Inserm; Association pour la Recherche sur le Cancer (ARC) [7983]; Institut National du Cancer; Hautepierre Hospital, Strasbourg; Association pour la Recherche sur le Cancer; Ligue contre le Cancer	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Hautepierre Hospital, Strasbourg; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue contre le Cancer(Ligue nationale contre le cancer)	This work has been supported by Inserm, by the Association pour la Recherche sur le Cancer (ARC # 7983: equipment to GO), the Institut National du Cancer (PSA, GO), Oncosuisse (GO), and the Hautepierre Hospital, Strasbourg (GO). LR and CS were recipients of fellowships from Association pour la Recherche sur le Cancer (LR) and the Ligue contre le Cancer (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpy F, 2005, HUM PATHOL, V36, P1055, DOI 10.1016/j.humpath.2005.07.013; Anderson EC, 2010, GASTROENTEROLOGY, V139, P718, DOI 10.1053/j.gastro.2010.07.012; BEAULIEU JF, 1994, GASTROENTEROLOGY, V106, P829, DOI 10.1016/0016-5085(94)90740-4; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Bolcato-Bellemin AL, 2003, DEV BIOL, V260, P376, DOI 10.1016/S0012-1606(03)00254-9; Bouatrouss Y, 2000, AM J PATHOL, V156, P45, DOI 10.1016/S0002-9440(10)64704-9; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Chia J, 2007, AM J PATHOL, V170, P2135, DOI 10.2353/ajpath.2007.060709; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coles EG, 2006, DEV BIOL, V289, P218, DOI 10.1016/j.ydbio.2005.10.031; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Edwards MM, 2010, J BIOL CHEM, V285, P7697, DOI 10.1074/jbc.M109.069575; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Gerhart J, 2001, J CELL BIOL, V155, P381, DOI 10.1083/jcb.200105139; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; GOULET O, 1995, J PEDIATR-US, V127, P212, DOI 10.1016/S0022-3476(95)70297-0; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Grille SJ, 2003, CANCER RES, V63, P2172; Gu J, 2002, BIOCHEM BIOPH RES CO, V296, P73, DOI 10.1016/S0006-291X(02)00831-8; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Kim BM, 2007, GASTROENTEROLOGY, V133, P529, DOI 10.1053/j.gastro.2007.04.072; Korhonen M, 2000, J HISTOCHEM CYTOCHEM, V48, P1011, DOI 10.1177/002215540004800714; Kusuma N, 2012, INT J CANCER, V130, P555, DOI 10.1002/ijc.26018; Lefebvre O, 1999, DEV BIOL, V210, P135, DOI 10.1006/dbio.1999.9270; Li J, 2003, EMBO J, V22, P2400, DOI 10.1093/emboj/cdg239; Lickert H, 2001, MECH DEVELOP, V105, P181, DOI 10.1016/S0925-4773(01)00390-2; Liu YJ, 2009, DEVELOPMENT, V136, P843, DOI 10.1242/dev.027805; Mahoney ZX, 2008, J CELL SCI, V121, P2493, DOI 10.1242/jcs.025528; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Nguyen NM, 2002, DEV BIOL, V246, P231, DOI 10.1006/dbio.2002.0658; Olsen J, 2000, BIOCHEM J, V347, P407, DOI 10.1042/0264-6021:3470407; Park YK, 2005, GENESIS, V41, P1, DOI 10.1002/gene.20088; Patey N, 1997, GASTROENTEROLOGY, V113, P833, DOI 10.1016/S0016-5085(97)70178-1; Pouliot N, 2001, EXP CELL RES, V266, P1, DOI 10.1006/excr.2001.5197; Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Simon-Assmann P, 2010, PROG MOL BIOL TRANSL, V96, P175, DOI 10.1016/S1877-1173(10)96008-0; Simon-Assmann Patricia, 2009, V522, P309, DOI 10.1007/978-1-59745-413-1_20; SIMONASSMANN P, 1994, DEV DYNAM, V201, P71, DOI 10.1002/aja.1002010108; Slavotinek AM, 2009, CLIN GENET, V75, P429, DOI 10.1111/j.1399-0004.2009.01182.x; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Teller I C, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003623; Turck N, 2005, EXP CELL RES, V303, P494, DOI 10.1016/j.yexcr.2004.10.025; Turck N, 2004, PROTEOMICS, V4, P93, DOI 10.1002/pmic.200300480; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Verzi Michael P, 2008, Organogenesis, V4, P87	54	25	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37710	10.1371/journal.pone.0037710	http://dx.doi.org/10.1371/journal.pone.0037710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666383	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400042
J	Yu, K; Zhang, T				Yu, Ke; Zhang, Tong			Metagenomic and Metatranscriptomic Analysis of Microbial Community Structure and Gene Expression of Activated Sludge	PLOS ONE			English	Article							WATER TREATMENT-PLANT; AMMONIA-OXIDIZING ARCHAEA; NITRIFICATION REACTOR; BACTERIAL COMMUNITY; QUANTIFICATION; MICROORGANISMS; DIVERSITY; PROTEINS	The present study applied both metagenomic and metatranscriptomic approaches to characterize microbial structure and gene expression of an activated sludge community from a municipal wastewater treatment plant in Hong Kong. DNA and cDNA were sequenced by Illumina Hi-seq2000 at a depth of 2.4 Gbp. Taxonomic analysis by MG-RAST showed bacteria were dominant in both DNA and cDNA datasets. The taxonomic profile obtained by BLAST against SILVA SSUref database and annotation by MEGAN showed that activated sludge was dominated by Proteobacteria, Actinobacteria, Bacteroidetes, Firmicutes and Verrucomicrobia phyla in both DNA and cDNA datasets. Global gene expression annotation based on KEGG metabolism pathway displayed slight disagreement between the DNA and cDNA datasets. Further gene expression annotation focusing on nitrogen removal revealed that denitrification-related genes sequences dominated in both DNA and cDNA datasets, while nitrifying genes were also expressed in relative high levels. Specially, ammonia monooxygenase and hydroxylamine oxidase demonstrated the high cDNA/DNA ratios in the present study, indicating strong nitrification activity. Enzyme subunits gene sequences annotation discovered that subunits of ammonia monooxygenase (amoA, amoB, amoC) and hydroxylamine oxygenase had higher expression levels compared with subunits of the other enzymes genes. Taxonomic profiles of selected enzymes (ammonia monooxygenase and hydroxylamine oxygenase) showed that ammonia-oxidizing bacteria present mainly belonged to Nitrosomonas and Nitrosospira species and no ammonia-oxidizing Archaea sequences were detected in both DNA and cDNA datasets.	[Yu, Ke; Zhang, Tong] Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Yu, K (corresponding author), Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China.	zhangt@hku.hk	Zhang, Tong/HGC-1090-2022; 張彤, Tong Zhang/C-6786-2008	Zhang, Tong/0000-0003-1148-4322	Hong Kong Research Grants Council [7198/10E]; Hong Kong UGC Special Equipment Grant [SEG HKU09]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong UGC Special Equipment Grant	The authors wish to thank the Hong Kong Research Grants Council for the financial support of this study (7198/10E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Beijing Genomics Institute (Shenzhen) for sequencing and Mr. Zhiwei Fang for his help in metadata analysis. This research is conducted using the HKU Computer Centre research computing facilities that are supported in part by the Hong Kong UGC Special Equipment Grant (SEG HKU09).	Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Geets J, 2007, APPL MICROBIOL BIOT, V75, P211, DOI 10.1007/s00253-006-0805-8; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gittel A, 2008, ENVIRON MICROBIOL, V10, P2645, DOI 10.1111/j.1462-2920.2008.01686.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Park HD, 2006, APPL ENVIRON MICROB, V72, P5643, DOI 10.1128/AEM.00402-06; Pfister CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010518; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Tavormina PL, 2011, ENV MICROBIOL REP, V3, P91, DOI 10.1111/j.1758-2229.2010.00192.x; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wilmes P, 2008, ISME J, V2, P853, DOI 10.1038/ismej.2008.38; Wittebolle L, 2008, APPL ENVIRON MICROB, V74, P286, DOI 10.1128/AEM.01006-07; Xia SQ, 2010, ENVIRON SCI TECHNOL, V44, P7391, DOI 10.1021/es101554m; Ye L, 2011, BIOTECHNOL BIOENG, V108, P2544, DOI 10.1002/bit.23211; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Zhang T, 2006, APPL MICROBIOL BIOT, V70, P281, DOI 10.1007/s00253-006-0333-6; Zhang T, 2011, ISME J; Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m	29	202	223	11	304	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38183	10.1371/journal.pone.0038183	http://dx.doi.org/10.1371/journal.pone.0038183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666477	Green Published, gold			2022-12-27	WOS:000305353400095
J	Blume, C; Felix, A; Shushakova, N; Gueler, F; Falk, CS; Haller, H; Schrader, J				Blume, Cornelia; Felix, Agnieszka; Shushakova, Nelli; Gueler, Faikah; Falk, Christine Susanne; Haller, Hermann; Schrader, Juergen			Autoimmunity in CD73/Ecto-5 '-Nucleotidase Deficient Mice Induces Renal Injury	PLOS ONE			English	Article							RECEPTOR ACTIVATION; ADENOSINE RECEPTORS; THERAPEUTIC TARGETS; ECTO-5'-NUCLEOTIDASE; INFLAMMATION; GENERATION; PROTECTS; PATHWAY; IL-18; CD73	Extracellular adenosine formed by 5'-ectonucleotidase (CD73) is involved in tubulo-glomerular feedback in the kidney but is also known to be an important immune modulator. Since CD73(-/-) mutant mice exhibit a vascular proinflammatory phenotype, we asked whether long term lack of CD73 causes inflammation related kidney pathologies. CD73(-/-) mice (13 weeks old) showed significantly increased low molecule proteinuria compared to C57BL6 wild type controls (4.8 >= 0.52 vs. 2.9 +/- 0.54 mg/24 h, p<0.03). Total proteinuria increased to 5.97 +/- 0.78 vs. 2.55 +/- 0.35 mg/24 h at 30 weeks (p<0.01) whereas creatinine clearance decreased (0.161 +/- 0.02 vs. 0.224 +/- 0.02 ml/min). We observed autoimmune inflammation in CD73(-/-) mice with glomerulitis and peritubular capillaritis, showing glomerular deposition of IgG and C3 and enhanced presence of CD11b, CD8, CD25 as well as GR-1-positive cells in the interstitium. Vascular inflammation was associated with enhanced serum levels of the cytokines IL-18 and TNF-alpha as well as VEGF and the chemokine MIP-2 (CXCL-2) in CD73(-/-) mice, whereas chemokines and cytokines in the kidney tissue were unaltered or reduced. In CD73(-/-) mice glomeruli, we found a reduced number of podocytes and endothelial fenestrations, increased capillaries per glomeruli, endotheliosis and enhanced tubular fibrosis. Our results show that adult CD73(-/-) mice exhibit spontaneous proteinuria and renal functional deterioration even without exogenous stress factors. Wehave identified an autoimmune inflammatory phenotype comprising the glomerular endothelium, leading to glomeruli inflammation and injury and to a cellular infiltrate of the renal interstitium. Thus, long term lack of CD73 reduced renal function and is associated with autoimmune inflammation.	[Blume, Cornelia; Felix, Agnieszka; Shushakova, Nelli; Gueler, Faikah; Haller, Hermann] Hannover Med Sch, Div Nephrol, Dept Med, D-3000 Hannover, Germany; [Falk, Christine Susanne] Hannover Med Sch, Inst Transplant Immunol, D-3000 Hannover, Germany; [Schrader, Juergen] Heinrich Heine Univ Duesseldorf, Inst Cardiovasc Physiol, Dusseldorf, Germany	Hannover Medical School; Hannover Medical School; Heinrich Heine University Dusseldorf	Blume, C (corresponding author), Hannover Med Sch, Div Nephrol, Dept Med, D-3000 Hannover, Germany.	Blume.cornelia@mh-hannover.de	Falk, Christine/Q-4143-2016	Falk, Christine/0000-0003-1376-7318; Blume, Cornelia/0000-0001-7487-4884	Heinrich Heine University Duesseldorf [Sonderforschungsbereich 612, B6, Z2]; Anton-Betz-Stiftung of the Rheinische Post in Duesseldorf for histomorphometrical analysis(CAB); HGF Alliance Immunotherapy;  [TRR77];  [A3]	Heinrich Heine University Duesseldorf; Anton-Betz-Stiftung of the Rheinische Post in Duesseldorf for histomorphometrical analysis(CAB); HGF Alliance Immunotherapy; ; 	This study was supported by Sonderforschungsbereich 612, subprojects B6 and Z2 of the Heinrich Heine University Duesseldorf (JS) for development and raising of the knock out mice as well as by the Anton-Betz-Stiftung of the Rheinische Post in Duesseldorf for histomorphometrical analysis(CAB) and TRR77 (project A3, CSF) and HGF Alliance Immunotherapy (CSF) and IFB (Integrated Research and Treatment Center Transplantation)(CSF) for protein bioplex assays. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Awad AS, 2008, J AM SOC NEPHROL, V19, P59, DOI 10.1681/ASN.2007030276; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Bell TD, 2010, AM J PHYSIOL-RENAL, V299, pF1158, DOI 10.1152/ajprenal.00202.2010; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; ELNAHAS AM, 1991, KIDNEY INT, V40, P29, DOI 10.1038/ki.1991.175; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Hasegawa T, 2008, CIRC RES, V103, P1410, DOI 10.1161/CIRCRESAHA.108.180059; Hashimoto S, 2006, AM J PHYSIOL-RENAL, V290, pF888, DOI 10.1152/ajprenal.00381.2005; Huang DY, 2006, AM J PHYSIOL-RENAL, V291, pF282, DOI 10.1152/ajprenal.00113.2005; Jackson EK, 2006, ANNU REV PHYSIOL, V66, P571; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; LEHIR M, 1993, AM J PHYSIOL, V264, pF377, DOI 10.1152/ajprenal.1993.264.3.F377; Linnemann C, 2009, IMMUNOLOGY, V128, pe728, DOI 10.1111/j.1365-2567.2009.03075.x; Nakav S, 2010, NEPHROL DIAL TRANSPL, V25, P931, DOI 10.1093/ndt/gfp542; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Ozuyaman B, 2006, PFLUG ARCH EUR J PHY, V452, P324, DOI 10.1007/s00424-006-0045-x; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Sitkovsky M, 2008, BRIT J PHARMACOL, V153, pS457, DOI 10.1038/bjp.2008.23; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Thompson LF, 2008, NUCLEOS NUCLEOT NUCL, V27, P755, DOI 10.1080/15257770802145678; Vallon V, 2006, PHYSIOL REV, V86, P901, DOI 10.1152/physrev.00031.2005; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; Zernecke A, 2005, CIRCULATION, V112, pU370; Zhang H, 2008, AM J PHYSIOL-RENAL, V301, P171; Zhang L, 2011, LUPUS, V20, P667, DOI 10.1177/0961203310393262; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	38	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37100	10.1371/journal.pone.0037100	http://dx.doi.org/10.1371/journal.pone.0037100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666342	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600010
J	Cameron, DR; Cohen, BS; Morrison, SA				Cameron, D. Richard; Cohen, Brian S.; Morrison, Scott A.			An Approach to Enhance the Conservation-Compatibility of Solar Energy Development	PLOS ONE			English	Article							DANGEROUS CLIMATE-CHANGE; BIODIVERSITY OFFSETS; DESERT ECOSYSTEM; UNITED-STATES; IMPACTS; TECHNOLOGIES; MITIGATION; CALIFORNIA; PROJECTS	The rapid pace of climate change poses a major threat to biodiversity. Utility-scale renewable energy development (>1 MW capacity) is a key strategy to reduce greenhouse gas emissions, but development of those facilities also can have adverse effects on biodiversity. Here, we examine the synergy between renewable energy generation goals and those for biodiversity conservation in the 13 M ha Mojave Desert of the southwestern USA. We integrated spatial data on biodiversity conservation value, solar energy potential, and land surface slope angle (a key determinant of development feasibility) and found there to be sufficient area to meet renewable energy goals without developing on lands of relatively high conservation value. Indeed, we found nearly 200,000 ha of lower conservation value land below the most restrictive slope angle (<1%); that area could meet the state of California's current 33% renewable energy goal 1.8 times over. We found over 740,000 ha below the highest slope angle (<5%) - an area that can meet California's renewable energy goal seven times over. Our analysis also suggests that the supply of high quality habitat on private land may be insufficient to mitigate impacts from future solar projects, so enhancing public land management may need to be considered among the options to offset such impacts. Using the approach presented here, planners could reduce development impacts on areas of higher conservation value, and so reduce trade-offs between converting to a green energy economy and conserving biodiversity.	[Cameron, D. Richard; Cohen, Brian S.; Morrison, Scott A.] Nature Conservancy, San Francisco, CA USA	Nature Conservancy	Cameron, DR (corresponding author), Nature Conservancy, San Francisco, CA USA.	dcameron@tnc.org			Nature Conservancy, California; Nature Conservancy	Nature Conservancy, California; Nature Conservancy	This work was supported by the Nature Conservancy, California Program (www.nature.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank The Nature Conservancy for supporting this analysis. W. Christian, J. Kiesecker, M. Kramer, B. McKenney, J. Moore, E. O'Donoghue, S. Parker, C. Pienkos, J. Randall, R. Shaw, M. Sweeney, J. Ziegler, and especially L. Crane provided helpful discussions and review of earlier versions. Two anonymous reviewers also provided insightful and helpful comments which greatly improved the paper. We also appreciate the help of Catherine Darst in supporting our use of desert tortoise model data and providing Desert Tortoise Conservation Area data.	Alvarado A, 2011, PROPOSED ME IN PRESS; Andre J, 2009, SCI NEWSLETTER; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; BLM, 2005, W MOJ PLAN HAB CONS; BLM, 2004, MOH GROUND SQUIRR CO; BLM, 2010, RIGHT WAY APPL DAT; BROWN DE, 1986, AM MIDL NAT, V116, P411, DOI 10.2307/2425750; Bunn D, 2007, CALIFORNIA WILDLIFE; Calfire, 2006, MULT LAND COV DAT FV; Clark County NV, 2000, FIN CLARK COUNT MULT; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Edenhofer O., 2011, IPCC SPECIAL REPORT; EIA US, 2009, EN CONS SECT SOURC U; Environmental Systems Research Institute (ESRI), 2009, ARCGIS V 9 3 1; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Howard J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011249; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kroeger T., 2007, EC BENEFITS PROVIDED; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Lovich JE, 1999, ENVIRON MANAGE, V24, P309, DOI 10.1007/s002679900235; Lovich JE, 2011, BIOSCIENCE, V61, P982, DOI 10.1525/bio.2011.61.12.8; Lowry JH, 2005, SW REGIONAL GAP ANAL; Mastrandrea MD, 2004, SCIENCE, V304, P571, DOI 10.1126/science.1094147; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Mehos MS, WORLD REN EN C 8 200; Miles SR, 1997, ECOLOGICAL SUBREGION; Nussear KE, 2009, MODELING HABIAT DESE; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pavlik B. M., 2008, CALIFORNIA DESERTS E; Perez R, 2002, SOL ENERGY, V73, P307, DOI 10.1016/S0038-092X(02)00122-6; Randall J.M., 2010, MOJAVE DESERT ECOREG; RETI, 2010, PHAS 2B FIN REP; RETI, 2008, PHAS 1B FIN REP; SCBD, 2008, BUS 2010 NEWSL BUS B, P3; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thorne JH, 2009, ENVIRON MANAGE, V43, P936, DOI 10.1007/s00267-008-9246-8; Tracy C.R., 2004, DESERT TORTOISE RECO; Tsoutsos T, 2005, ENERG POLICY, V33, P289, DOI 10.1016/S0301-4215(03)00241-6; USA National Geospatial-Intelligence Agency (NGA), 2000, USGS SHUTTL RAD TOP; USFWS, 2011, ASH MEAD NAT WILDL R; USFWS (U.S. Fish and Wildlife Service), 1994, DES TORT MOJ POP REC; USGS, 2010, LANDF EX VEG TYP GIS; USGS, 2010, PROT AR DAT V 1 1; Weber TC, 2010, LANDSCAPE URBAN PLAN, V96, P240, DOI 10.1016/j.landurbplan.2010.04.003; Wohlfahrt G, 2008, GLOBAL CHANGE BIOL, V14, P1475, DOI 10.1111/j.1365-2486.2008.01593.x	52	45	45	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38437	10.1371/journal.pone.0038437	http://dx.doi.org/10.1371/journal.pone.0038437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685568	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700031
J	Donker, JMW; van der Laan, L; Hendriks, YJAM; Kluytmans, JAJW				Donker, Jeroen M. W.; van der Laan, Lijckle; Hendriks, Yvonne J. A. M.; Kluytmans, Jan A. J. W.			Evaluation of Staphylococcus aureus Nasal Carriage Screening before Vascular Surgery	PLOS ONE			English	Article							SURGICAL-SITE INFECTIONS; METHICILLIN-RESISTANT; PERITONEAL-DIALYSIS; WOUND INFECTIONS; BLOOD CULTURES; MUPIROCIN; GENEXPERT; RISK	Introduction: Staphylococcus aureus is the most important pathogen in the development of surgical site infections (SSI). Patients who carry S. aureus in the nose are at increased risk for the development of SSI in cardiothoracic and orthopedic surgery. In these populations it has been shown that the risk for SSI can be substantially reduced by eradicating S. aureus carriage. For vascular surgery the relation between nasal carriage and surgical site infections has not been clearly investigated. For this reason we performed this study to analyze the relation between S. aureus nasal carriage and SSI in our vascular surgery population. Methods: A prospective cohort study was undertaken, including all patients undergoing vascular surgery between January first 2010 and December 31th 2010. Before surgery patients were screened for S. aureus nasal carriage using a PCR technique. The presence of SSI was recorded based on criteria of the CDC. Results: Screening was performed in 224. Of those, 55 (24.5%) were positive, 159 (71.0%) were negative and 10 (4.5%) were inconclusive. In the screened vascular population 4 S. aureus SSI occurred in the 55 carriers compared with 6 in 159 non-carriers (p = 0.24). A stratified analysis revealed a 10-fold increased risk in nasal carriers undergoing central reconstruction surgery (3 S. aureus SSI in 20 procedures versus 1 in 65 procedures in non-carriers, p = 0.039). Discussion: In patients undergoing central reconstruction surgery nasals carriers are at increased risk for the development of S. aureus SSI. These patients will probably benefit from perioperative treatment to eradicate nasal carriage.	[Donker, Jeroen M. W.; van der Laan, Lijckle] Amphia Hosp, Dept Surg, Breda, Netherlands; [Hendriks, Yvonne J. A. M.; Kluytmans, Jan A. J. W.] Amphia Hosp, Dept Microbiol & Infect Prevent, Breda, Netherlands; [Kluytmans, Jan A. J. W.] Vrije Univ Amsterdam Med Ctr, Dept Microbiol & Infect Prevent, Amsterdam, Netherlands	Amphia Hospital; Amphia Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Donker, JMW (corresponding author), Amphia Hosp, Dept Surg, Breda, Netherlands.	lvanderlaan@amphia.nl		van der laan, lijckle/0000-0001-5631-594X				Ammerlaan HSM, 2009, CLIN INFECT DIS, V48, P922, DOI 10.1086/597291; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Jones JC, 2007, CLIN INFECT DIS, V45, P541, DOI 10.1086/520663; Kallen AJ, 2005, INFECT CONT HOSP EP, V26, P916, DOI 10.1086/505453; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Laurent C, 2010, EUR J CLIN MICROBIOL, V29, P995, DOI 10.1007/s10096-010-0958-3; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; Nouwen J, 2006, J CLIN MICROBIOL, V44, P2233, DOI 10.1128/JCM.02083-05; Parta M, 2009, J CLIN MICROBIOL, V47, P1609, DOI 10.1128/JCM.00351-09; Spencer DH, 2011, AM J CLIN PATHOL, V136, P690, DOI 10.1309/AJCP07UGYOKBVVNC; van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2; Wassenberg MWM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014815; Wolk DM, 2009, J CLIN MICROBIOL, V47, P823, DOI 10.1128/JCM.01884-08	14	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38127	10.1371/journal.pone.0038127	http://dx.doi.org/10.1371/journal.pone.0038127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685553	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700016
J	Sawada, Y; Nishio, Y; Suzuki, K; Hirayama, K; Takeda, A; Hosokai, Y; Ishioka, T; Itoyama, Y; Takahashi, S; Fukuda, H; Mori, E				Sawada, Yoichi; Nishio, Yoshiyuki; Suzuki, Kyoko; Hirayama, Kazumi; Takeda, Atsushi; Hosokai, Yoshiyuki; Ishioka, Toshiyuki; Itoyama, Yasuto; Takahashi, Shoki; Fukuda, Hiroshi; Mori, Etsuro			Attentional Set-Shifting Deficit in Parkinson's Disease Is Associated with Prefrontal Dysfunction: An FDG-PET Study	PLOS ONE			English	Article							CEREBRAL GLUCOSE-METABOLISM; MILD COGNITIVE IMPAIRMENT; POSTERIOR PARIETAL CORTEX; L-DOPA MEDICATION; BASAL GANGLIA; DOPAMINERGIC MODULATION; VISUAL-ATTENTION; HUMAN BRAIN; TOP-DOWN; DEMENTIA	The attentional set-shifting deficit that has been observed in Parkinson's disease (PD) has long been considered neuropsychological evidence of the involvement of meso-prefrontal and prefrontal-striatal circuits in cognitive flexibility. However, recent studies have suggested that non-dopaminergic, posterior cortical pathologies may also contribute to this deficit. Although several neuroimaging studies have addressed this issue, the results of these studies were confounded by the use of tasks that required other cognitive processes in addition to set-shifting, such as rule learning and working memory. In this study, we attempted to identify the neural correlates of the attentional set-shifting deficit in PD using a compound letter task and 18F-fluoro-deoxy-glucose (FDG) positron emission tomography during rest. Shift cost, which is a measure of attentional set-shifting ability, was significantly correlated with hypometabolism in the right dorsolateral prefrontal cortex, including the putative human frontal eye field. Our results provide direct evidence that dysfunction in the dorsolateral prefrontal cortex makes a primary contribution to the attentional set-shifting deficit that has been observed in PD patients.	[Sawada, Yoichi; Nishio, Yoshiyuki; Suzuki, Kyoko; Hirayama, Kazumi; Hosokai, Yoshiyuki; Ishioka, Toshiyuki; Mori, Etsuro] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan; [Suzuki, Kyoko] Yamagata Univ, Grad Sch Med, Dept Clin Neurosci, Yamagata 990, Japan; [Hirayama, Kazumi] Yamagata Prefectural Univ Hlth Sci, Dept Occupat Therapy, Yamagata, Japan; [Takeda, Atsushi; Itoyama, Yasuto] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 980, Japan; [Fukuda, Hiroshi] Tohoku Univ, Inst Dev Aging & Canc, Dept Radiol & Nucl Med, Sendai, Miyagi 980, Japan	Tohoku University; Yamagata University; Tohoku University; Tohoku University; Tohoku University	Sawada, Y (corresponding author), Okayama Prefectural Univ, Fac Hlth & Welf Sci, Soja, Japan.	nishiou@med.tohoku.ac.jp	Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172; Suzuki, Kyoko/0000-0002-8380-1561; Ishioka, Toshiyuki/0000-0002-3987-0383; Nishio, Yoshiyuki/0000-0002-6857-1200	Ministry of Education, Culture, Sports, Science and Technology of Japan [90451591, 20020004]; Grants-in-Aid for Scientific Research [24390278] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 90451591 to Y.N.) and a Grant-in-Aid for Scientific Research on Priority Areas: System study of higher-order brain functions from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 20020004 to E.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AGID Y, 1991, LANCET, V337, P1321, DOI 10.1016/0140-6736(91)92989-F; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Asari T, 2005, NEUROIMAGE, V26, P694, DOI 10.1016/j.neuroimage.2004.12.063; Au WL, 2012, HUM BRAIN MAPP, V33, P27, DOI 10.1002/hbm.21187; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Barrett AM, 2001, NEUROLOGY, V56, P724, DOI 10.1212/WNL.56.6.724; Berding G, 2001, MOVEMENT DISORD, V16, P1014, DOI 10.1002/mds.1212; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; BOWEN FP, 1975, NEUROLOGY, V25, P701, DOI 10.1212/WNL.25.8.701; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cools R, 2001, BRAIN, V124, P2503, DOI 10.1093/brain/124.12.2503; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cools R, 2010, J COGNITIVE NEUROSCI, V22, P848, DOI 10.1162/jocn.2009.21227; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Del Dotto P, 2003, NEUROL SCI, V24, P170, DOI 10.1007/s10072-003-0114-2; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; DOWNES JJ, 1989, NEUROPSYCHOLOGIA, V27, P1329, DOI 10.1016/0028-3932(89)90128-0; Emre M, 2003, LANCET NEUROL, V2, P229, DOI 10.1016/S1474-4422(03)00351-X; FAHN S, 1987, UNIFIED PARKINSONS D, P153; Feigin A, 2001, NEUROLOGY, V57, P2083, DOI 10.1212/WNL.57.11.2083; Fera F, 2007, BRAIN RES BULL, V74, P75, DOI 10.1016/j.brainresbull.2007.05.009; FILOTEO JV, 1995, J CLIN EXP NEUROPSYC, V17, P654, DOI 10.1080/01688639508405156; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Fink GR, 1997, BRAIN, V120, P1779, DOI 10.1093/brain/120.10.1779; FLOWERS KA, 1985, J NEUROL NEUROSUR PS, V48, P517, DOI 10.1136/jnnp.48.6.517; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hayes AE, 1998, J COGNITIVE NEUROSCI, V10, P178, DOI 10.1162/089892998562645; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Hosokai Y, 2009, MOVEMENT DISORD, V24, P854, DOI 10.1002/mds.22444; Ishioka T, 2011, MOVEMENT DISORD, V26, P837, DOI 10.1002/mds.23576; Jubault T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006154; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Kehagia AA, 2009, NEUROPSYCHOLOGIA, V47, P1117, DOI 10.1016/j.neuropsychologia.2009.01.002; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marie RM, 1999, NEUROSCI LETT, V260, P77, DOI 10.1016/S0304-3940(98)00928-8; Mevorach C, 2006, NAT NEUROSCI, V9, P740, DOI 10.1038/nn1709; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Morris JC, 1997, INT PSYCHOGERIATR S, V9, P7; Navon D, 2003, ACTA PSYCHOL, V114, P273, DOI 10.1016/j.actpsy.2003.06.002; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; OWEN AM, 1993, BRAIN, V116, P1159, DOI 10.1093/brain/116.5.1159; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Pillon B., 2001, HDB NEUROPSYCHOLOGY, V6, P311; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Ravizza SM, 2002, J COGNITIVE NEUROSCI, V14, P472, DOI 10.1162/089892902317361985; Robbins TW, 2007, PHILOS T R SOC B, V362, P917, DOI 10.1098/rstb.2007.2097; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P873, DOI 10.1076/jcen.20.6.873.1111; Schendan HE, 2009, BEHAV NEUROSCI, V123, P125, DOI 10.1037/a0013734; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052	61	31	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38498	10.1371/journal.pone.0038498	http://dx.doi.org/10.1371/journal.pone.0038498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685575	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700038
J	Wang, SB; Shi, Q; Xu, Y; Xie, WL; Zhang, J; Tian, C; Guo, Y; Wang, K; Zhang, BY; Chen, C; Gao, C; Dong, XP				Wang, Shao-Bin; Shi, Qi; Xu, Yin; Xie, Wu-Ling; Zhang, Jin; Tian, Chan; Guo, Yan; Wang, Ke; Zhang, Bao-Yun; Chen, Cao; Gao, Chen; Dong, Xiao-Ping			Protein Disulfide Isomerase Regulates Endoplasmic Reticulum Stress and the Apoptotic Process during Prion Infection and PrP Mutant-Induced Cytotoxicity	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CELL-DEATH; MISFOLDED PROTEINS; NEUROTOXICITY; DYSFUNCTION; ACTIVATION; FEATURES; FAMILY	Background: Protein disulfide isomerase (PDI), is sorted to be enzymatic chaperone for reconstructing misfolded protein in endoplasmic reticulum lumen. Recently, PDI has been identified as a link between misfolded protein and neuron apoptosis. However, the potential for PDI to be involved in the pathogenesis of prion disease remains unknown. In this study, we propose that PDI may function as a pleiotropic regulator in the cytotoxicity induced by mutated prion proteins and in the pathogenesis of prion diseases. Methodology/Principal Findings: To elucidate potential alterations of PDI in prion diseases, the levels of PDI and relevant apoptotic executors in 263K infected hamsters brain tissues were evaluated with the use of Western blots. Abnormal upregulation of PDI, Grp78 and Grp58 was detected. Dynamic assays of PDI alteration identified that the upregulation of PDI started at the early stage and persistently increased till later stage. Obvious increases of PDI and Grp78 levels were also observed in cultured cells transiently expressing PrP mutants, PrP-KDEL or PrP-PG15, accompanied by significant cytotoxicities. Excessive expression of PDI partially eased ER stress and cell apoptosis caused by accumulation of PrP-KDEL, but had less effect on cytotoxicity induced by PrP-PG15. Knockdown of endogenous PDI significantly amended cytotoxicity of PrP-PG15, but had little influence on that of PrP-KDEL. A series of membrane potential assays found that apoptosis induced by misfolded PrP proteins could be regulated by PDI via mitochondrial dysfunction. Moreover, biotin-switch assays demonstrated active S-nitrosylted modifications of PDI (SNO-PDI) both in the brains of scrapie-infected rodents and in the cells with misfolded PrP proteins. Conclusion/Significance: Current data in this study highlight that PDI and its relevant executors may function as a pleiotropic regulator in the processes of different misfolded PrP proteins and at different stages during prion infection. SNO-PDI may feed as an accomplice for PDI apoptosis.	[Wang, Shao-Bin; Shi, Qi; Xu, Yin; Xie, Wu-Ling; Zhang, Jin; Tian, Chan; Guo, Yan; Wang, Ke; Zhang, Bao-Yun; Chen, Cao; Gao, Chen; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Dong, Xiao-Ping] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, SB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	dongxp238@sina.com	Xu, Yin/AAO-7503-2021; WANG, SHAO-BIN/Z-1810-2018; Dong, Xiaoping/H-4160-2015; Chen, Cao/CAF-1246-2022	WANG, SHAO-BIN/0000-0002-6699-9406; Dong, Xiaoping/0000-0002-2302-7711; Chen, Cao/0000-0002-5193-9283	Chinese National Natural Science Foundation [30800975, 81100980, 81101302, 31100117]; National Basic Research Program of China (973 Program) [2007CB310505]; China Mega-Project for Infectious Disease [2009ZX10004-101]; SKLID Development Grant [2008SKLID102, 2011SKLID211, 2011SKLID204]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Mega-Project for Infectious Disease; SKLID Development Grant	This work was supported by Chinese National Natural Science Foundation Grant (30800975, 81100980, 81101302 and 31100117), National Basic Research Program of China (973 Program) (2007CB310505), China Mega-Project for Infectious Disease (2009ZX10004-101) and SKLID Development Grant (2008SKLID102, 2011SKLID211 and 2011SKLID204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An R, 2008, SCI CHINA SER C, V51, P630, DOI 10.1007/s11427-008-0062-4; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Castilla J, 2005, FEBS LETT, V579, P6237, DOI 10.1016/j.febslet.2005.09.099; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Guo YJ, 2008, AM J MED SCI, V336, P519, DOI 10.1097/MAJ.0b013e3181643e50; Hampton RY, 2000, CURR BIOL, V10, pR518, DOI 10.1016/S0960-9822(00)00583-2; Han Lu, 2007, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V21, P208; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Liberski PP, 2008, FOLIA NEUROPATHOL, V46, P1; Martin SF, 2006, FEBS LETT, V580, P4097, DOI 10.1016/j.febslet.2006.06.054; Nunziante M, 2011, J BIOL CHEM; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Quaglio E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019339; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Shi Q, 2011, PRION, V5; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Wang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014602; Xu K, 2011, J MOL NEUROSCI, V43, P225, DOI 10.1007/s12031-010-9387-0; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6	33	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38221	10.1371/journal.pone.0038221	http://dx.doi.org/10.1371/journal.pone.0038221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685557	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700020
J	Bailey, RI; Saldamando-Benjumea, CI; Tatsuta, H; Butlin, RK				Bailey, Richard I.; Saldamando-Benjumea, Clara I.; Tatsuta, Haruki; Butlin, Roger K.			Habitat Association and Seasonality in a Mosaic and Bimodal Hybrid Zone between Chorthippus brunneus and C. jacobsi (Orthoptera: Acrididae)	PLOS ONE			English	Article							FIRE-BELLIED TOADS; BOMBINA-BOMBINA; REPRODUCTIVE ISOLATION; GRASSHOPPERS; VARIEGATA; SELECTION; PATTERNS; ORIGINS; MODEL; SONG	Understanding why some hybrid zones are bimodal and others unimodal can aid in identifying barriers to gene exchange following secondary contact. The hybrid zone between the grasshoppers Chorthippus brunneus and C. jacobsi contains a mix of allopatric parental populations and inter-mingled bimodal and unimodal sympatric populations, and provides an ideal system to examine the roles of local selection and gene flow between populations in maintaining bimodality. However, it is first necessary to confirm, over a larger spatial scale, previously identified associations between population composition and season and habitat. Here we use cline-fitting of one morphological and one song trait along two valley transects, and intervening mountains, to confirm previously identified habitat associations (mountain versus valley) and seasonal changes in population composition. As expected from previous findings of studies on a smaller spatial scale, C. jacobsi dominated mountain habitats and mixed populations dominated valleys, and C. brunneus became more prevalent in August. Controlling for habitat and incorporating into the analysis seasonal changes in cline parameters and the standard errors of parental trait values revealed wider clines than previous studies (best estimates of 6.4 to 24.5 km in our study versus 2.8 to 4.7 km in previous studies) and increased percentage of trait variance explained (52.7% and 61.5% for transects 1 and 2 respectively, versus 17.6%). Revealing such strong and consistent patterns within a complex hybrid zone will allow more focused examination of the causes of variation in bimodality in mixed populations, in particular the roles of local selection versus habitat heterogeneity and gene flow between differentiated populations.	[Bailey, Richard I.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Saldamando-Benjumea, Clara I.] Univ Nacl Colombia, Fac Ciencias, Medellin, Colombia; [Tatsuta, Haruki] Univ Ryukyus, Grad Sch Agr, Dept Ecol & Environm Sci, Nishihara, Okinawa 90301, Japan; [Butlin, Roger K.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Oslo; Universidad Nacional de Colombia; University of the Ryukyus; University of Sheffield	Bailey, RI (corresponding author), Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	r.i.bailey@bio.uio.no	Bailey, Richard/HHM-4964-2022; Butlin, Roger/F-7709-2013	Bailey, Richard/0000-0001-9870-410X; Butlin, Roger/0000-0003-4736-0954; Tatsuta, Haruki/0000-0001-8847-8874	British Council (Acciones integradas); Genetics Society; Japan Society for the Promotion of Science [12640604]; Colfuturo (Fundacion para el futuro de Colombia)	British Council (Acciones integradas); Genetics Society; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Colfuturo (Fundacion para el futuro de Colombia)	This work was funded from the grants of the British Council (Acciones integradas) and Genetics Society to Jose Bella, Roger Butlin and Clara Saldamando and from The Japan Society for the Promotion of Science grants to H. Tatsuta and H. Kishino (Grant No. 12640604). Clara Saldamando was funded by Colfuturo (Fundacion para el futuro de Colombia) during her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNTZEN JW, 1991, EVOLUTION, V45, P805, DOI 10.1111/j.1558-5646.1991.tb04352.x; Babik W, 2003, MOL ECOL, V12, P1913, DOI 10.1046/j.1365-294X.2003.01880.x; Bailey RI, 2004, J EVOLUTION BIOL, V17, P108, DOI 10.1046/j.1420-9101.2003.00648.x; Bailey RI, 2003, ECOL ENTOMOL, V28, P129, DOI 10.1046/j.1365-2311.2003.00504.x; Bailey RI, 2001, THESIS U LEEDS LEEDS; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1983, EVOLUTION, V37, P454, DOI 10.1111/j.1558-5646.1983.tb05563.x; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; Bridle JR, 2006, J EVOLUTION BIOL, V19, P1248, DOI 10.1111/j.1420-9101.2006.01080.x; Bridle JR, 2002, EVOLUTION, V56, P1184, DOI 10.1111/j.0014-3820.2002.tb01431.x; Bridle JR, 2002, ECOL ENTOMOL, V27, P499, DOI 10.1046/j.1365-2311.2002.00435.x; Bridle JR, 2001, EVOLUTION, V55, P1832, DOI 10.1111/j.0014-3820.2001.tb00832.x; Bridle JR, 1998, THESIS U LEEDS LEEDS; BUTLIN RK, 1991, PHILOS T R SOC B, V334, P297; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Harrison R.G., 1989, P111; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; HARRISON RG, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P3; HARRISON RG, 1990, OXF SURV EVOL BIOL, V7, P70; HEWITT GM, 1987, HEREDITY, V59, P457, DOI 10.1038/hdy.1987.156; HOWARD DJ, 1986, EVOLUTION, V40, P34, DOI 10.1111/j.1558-5646.1986.tb05715.x; HOWARD DJ, 1993, EVOLUTION, V47, P789, DOI 10.1111/j.1558-5646.1993.tb01234.x; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kruuk LEB, 1999, GENETICS, V153, P1959; Lunt DH, 1998, HEREDITY, V80, P633, DOI 10.1046/j.1365-2540.1998.00311.x; MacCallum CJ, 1998, EVOLUTION, V52, P227, DOI 10.1111/j.1558-5646.1998.tb05156.x; MALLET J, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P226; Ragge D.R, 1998, SONGS GRASSHOPPERS C; RAGGE DR, 1988, J NAT HIST, V22, P897, DOI 10.1080/00222938800770611; Ross CL, 2002, EVOLUTION, V56, P2296, DOI 10.1111/j.0014-3820.2002.tb00153.x; Saldamando CI, 2005, BIOL J LINN SOC, V84, P195, DOI 10.1111/j.1095-8312.2005.000424.x; Saldamando CI, 2005, J EVOLUTION BIOL, V18, P703, DOI 10.1111/j.1420-9101.2004.00838.x; SANDERSON N, 1992, EVOLUTION, V46, P595, DOI 10.1111/j.1558-5646.1992.tb02068.x; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Shuker DM, 2005, P ROY SOC B-BIOL SCI, V272, P2491, DOI 10.1098/rspb.2005.3242; SZYMURA JM, 1991, EVOLUTION, V45, P237, DOI 10.1111/j.1558-5646.1991.tb04400.x; SZYMURA JM, 1986, EVOLUTION, V40, P1141, DOI 10.1111/j.1558-5646.1986.tb05740.x; Tregenza T, 2000, EVOLUTION, V54, P1687, DOI 10.1111/j.0014-3820.2000.tb00713.x; Vines TH, 2003, EVOLUTION, V57, P1876; Voisin J.-F., 2003, ATLAS ORTHOPTERES MA	42	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37684	10.1371/journal.pone.0037684	http://dx.doi.org/10.1371/journal.pone.0037684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675485	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305341700018
J	Gronenschild, EHBM; Habets, P; Jacobs, HIL; Mengelers, R; Rozendaal, N; van Os, J; Marcelis, M				Gronenschild, Ed H. B. M.; Habets, Petra; Jacobs, Heidi I. L.; Mengelers, Ron; Rozendaal, Nico; van Os, Jim; Marcelis, Machteld			The Effects of FreeSurfer Version, Workstation Type, and Macintosh Operating System Version on Anatomical Volume and Cortical Thickness Measurements	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; GEOMETRICALLY ACCURATE; MRI; SEGMENTATION; HIPPOCAMPAL; RELIABILITY; DISEASE	FreeSurfer is a popular software package to measure cortical thickness and volume of neuroanatomical structures. However, little if any is known about measurement reliability across various data processing conditions. Using a set of 30 anatomical T1-weighted 3T MRI scans, we investigated the effects of data processing variables such as FreeSurfer version (v4.3.1, v4.5.0, and v5.0.0), workstation (Macintosh and Hewlett-Packard), and Macintosh operating system version (OSX 10.5 and OSX 10.6). Significant differences were revealed between FreeSurfer version v5.0.0 and the two earlier versions. These differences were on average 8.8 +/- 6.6% (range 1.3-64.0%) (volume) and 2.8 +/- 1.3% (1.1-7.7%) (cortical thickness). About a factor two smaller differences were detected between Macintosh and Hewlett-Packard workstations and between OSX 10.5 and OSX 10.6. The observed differences are similar in magnitude as effect sizes reported in accuracy evaluations and neurodegenerative studies. The main conclusion is that in the context of an ongoing study, users are discouraged to update to a new major release of either FreeSurfer or operating system or to switch to a different type of workstation without repeating the analysis; results thus give a quantitative support to successive recommendations stated by FreeSurfer developers over the years. Moreover, in view of the large and significant cross-version differences, it is concluded that formal assessment of the accuracy of FreeSurfer is desirable.	[Gronenschild, Ed H. B. M.; Habets, Petra; Jacobs, Heidi I. L.; Mengelers, Ron; Rozendaal, Nico; van Os, Jim; Marcelis, Machteld] Maastricht Univ, Med Ctr, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci,Dept Psychiat & Neurop, Maastricht, Netherlands; [Gronenschild, Ed H. B. M.; Habets, Petra; Jacobs, Heidi I. L.; Mengelers, Ron; Rozendaal, Nico; van Os, Jim; Marcelis, Machteld] Maastricht Univ, European Grad Sch Neurosci EURON, Maastricht, Netherlands; [Jacobs, Heidi I. L.] Res Ctr Julich, Inst Neurosci & Med 3, Cognit Neurol Sect, Julich, Germany; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; Maastricht University; Helmholtz Association; Research Center Julich; University of London; King's College London	Gronenschild, EHBM (corresponding author), Maastricht Univ, Med Ctr, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci,Dept Psychiat & Neurop, Maastricht, Netherlands.	ed.gronenschild@maastrichtuniversity.nl	Jacobs, Heidi/E-9550-2011; van Os, Jim/I-9496-2012; van Os, Jim/C-2113-2014; Habets, Petra/AAZ-1258-2021; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019	Jacobs, Heidi/0000-0001-7620-3822; van Os, Jim/0000-0002-7245-1586; Habets, Petra/0000-0001-9184-517X; van Os, Jim/0000-0002-7245-1586; Marcelis, Machteld/0000-0003-0045-9244	Geestkracht program of the Dutch Health Research Council (ZON-MW) [10-000-1002]; European Community's Seventh Framework Program (Project EU-GEI) [HEALTH-F2-2009-241909]	Geestkracht program of the Dutch Health Research Council (ZON-MW); European Community's Seventh Framework Program (Project EU-GEI)	This work was supported by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number 10-000-1002), and the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Echavarri C, 2011, BRAIN STRUCT FUNCT, V215, P265, DOI 10.1007/s00429-010-0283-8; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hammers A, 2007, NEUROIMAGE, V36, P38, DOI 10.1016/j.neuroimage.2007.02.031; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lehmann M, 2010, NEUROIMAGE, V49, P2264, DOI 10.1016/j.neuroimage.2009.10.056; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; NYLENNA M, 1991, BRIT MED J, V302, P1182, DOI 10.1136/bmj.302.6786.1182; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9	34	230	232	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38234	10.1371/journal.pone.0038234	http://dx.doi.org/10.1371/journal.pone.0038234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675527	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339900018
J	Grassmann, F; Fritsche, LG; Keilhauer, CN; Heid, IM; Weber, BHF				Grassmann, Felix; Fritsche, Lars G.; Keilhauer, Claudia N.; Heid, Iris M.; Weber, Bernhard H. F.			Modelling the Genetic Risk in Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; PREVALENCE; VARIANTS; SUSCEPTIBILITY; ASSOCIATION; MACULOPATHY; CLASSIFICATION; METAANALYSIS; RANIBIZUMAB; EXPRESSION	Late-stage age-related macular degeneration (AMD) is a common sight-threatening disease of the central retina affecting approximately 1 in 30 Caucasians. Besides age and smoking, genetic variants from several gene loci have reproducibly been associated with this condition and likely explain a large proportion of disease. Here, we developed a genetic risk score (GRS) for AMD based on 13 risk variants from eight gene loci. The model exhibited good discriminative accuracy, area-under-curve (AUC) of the receiver-operating characteristic of 0.820, which was confirmed in a cross-validation approach. Noteworthy, younger AMD patients aged below 75 had a significantly higher mean GRS (1.87, 95% CI: 1.69-2.05) than patients aged 75 and above (1.45, 95% CI: 1.36-1.54). Based on five equally sized GRS intervals, we present a risk classification with a relative AMD risk of 64.0 (95% CI: 14.11-1131.96) for individuals in the highest category (GRS 3.44-5.18, 0.5% of the general population) compared to subjects with the most common genetic background (GRS -0.05-1.70, 40.2% of general population). The highest GRS category identifies AMD patients with a sensitivity of 7.9% and a specificity of 99.9% when compared to the four lower categories. Modeling a general population around 85 years of age, 87.4% of individuals in the highest GRS category would be expected to develop AMD by that age. In contrast, only 2.2% of individuals in the two lowest GRS categories which represent almost 50% of the general population are expected to manifest AMD. Our findings underscore the large proportion of AMD cases explained by genetics particularly for younger AMD patients. The five-category risk classification could be useful for therapeutic stratification or for diagnostic testing purposes once preventive treatment is available.	[Grassmann, Felix; Fritsche, Lars G.; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, Regensburg, Germany; [Keilhauer, Claudia N.] Univ Eye Hosp Wurzburg, Wurzburg, Germany; [Heid, Iris M.] Univ Hosp Regensburg, Inst Epidemiol & Prevent Med, Regensburg, Germany; [Heid, Iris M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany	University of Regensburg; University of Wurzburg; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Grassmann, F (corresponding author), Univ Regensburg, Inst Human Genet, Regensburg, Germany.	bweb@klinik.uni-regensburg.de	Fritsche, Lars G/AAF-9387-2019	Fritsche, Lars G/0000-0002-2110-1690; Grassmann, Felix/0000-0003-1390-7528; Weber, Bernhard H.F./0000-0002-8808-7723	Deutsche Forschungsgemeinschaft [WE 1259/19-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft WE 1259/19-2. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chongsuvivatwong V., 2010, EPICALC EPIDEMIOLOGI; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Friedrich U, 2011, HUM MOL GENET, V20, P1387, DOI 10.1093/hmg/ddr020; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Fritsche LG, 2009, HUM MUTAT, V30, P1048, DOI 10.1002/humu.20957; Gibson J, 2010, BRIT J OPHTHALMOL, V94, P1382, DOI 10.1136/bjo.2010.182568; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hu B, 2006, STAT SINICA, V16, P847; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Liu QZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008250; Lumley T, 2009, RMETA METAANALYSIS R; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Miller JW, 2010, JPN J OPHTHALMOL, V54, P523, DOI 10.1007/s10384-010-0863-4; Mistry K, 2003, J AM BOARD FAM PRACT, V16, P95, DOI 10.3122/jabfm.16.2.95; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671; Schmid-Kubista KE, 2009, INVEST OPHTH VIS SCI, V50, P5070, DOI 10.1167/iovs.09-3975; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Spencer KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017784; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; [No title captured]	50	67	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37979	10.1371/journal.pone.0037979	http://dx.doi.org/10.1371/journal.pone.0037979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666427	Green Published, gold			2022-12-27	WOS:000305353400065
J	Wee, CY; Yap, PT; Denny, K; Browndyke, JN; Potter, GG; Welsh-Bohmer, KA; Wang, LH; Shen, DG				Wee, Chong-Yaw; Yap, Pew-Thian; Denny, Kevin; Browndyke, Jeffrey N.; Potter, Guy G.; Welsh-Bohmer, Kathleen A.; Wang, Lihong; Shen, Dinggang			Resting-State Multi-Spectrum Functional Connectivity Networks for Identification of MCI Patients	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; SEMANTIC MEMORY IMPAIRMENT; ALZHEIMERS-DISEASE; SMALL-WORLD; CEREBRAL-CORTEX; LOW-FREQUENCY; BRAIN; FMRI; PATTERNS	In this paper, a high-dimensional pattern classification framework, based on functional associations between brain regions during resting-state, is proposed to accurately identify MCI individuals from subjects who experience normal aging. The proposed technique employs multi-spectrum networks to characterize the complex yet subtle blood oxygenation level dependent (BOLD) signal changes caused by pathological attacks. The utilization of multi-spectrum networks in identifying MCI individuals is motivated by the inherent frequency-specific properties of BOLD spectrum. It is believed that frequency specific information extracted from different spectra may delineate the complex yet subtle variations of BOLD signals more effectively. In the proposed technique, regional mean time series of each region-of-interest (ROI) is band-pass filtered (0.025 <= f <= 0.100 Hz) before it is decomposed into five frequency sub-bands. Five connectivity networks are constructed, one from each frequency sub-band. Clustering coefficient of each ROI in relation to the other ROIs are extracted as features for classification. Classification accuracy was evaluated via leave-one-out cross-validation to ensure generalization of performance. The classification accuracy obtained by this approach is 86.5%, which is an increase of at least 18.9% from the conventional full-spectrum methods. A cross-validation estimation of the generalization performance shows an area of 0.863 under the receiver operating characteristic (ROC) curve, indicating good diagnostic power. It was also found that, based on the selected features, portions of the prefrontal cortex, orbitofrontal cortex, temporal lobe, and parietal lobe regions provided the most discriminant information for classification, in line with results reported in previous studies. Analysis on individual frequency sub-bands demonstrated that different sub-bands contribute differently to classification, providing extra evidence regarding frequency-specific distribution of BOLD signals. Our MCI classification framework, which allows accurate early detection of functional brain abnormalities, makes an important positive contribution to the treatment management of potential AD patients.	[Wee, Chong-Yaw; Yap, Pew-Thian; Shen, Dinggang] Univ N Carolina, BRIC, IDEA Lab, Chapel Hill, NC 27515 USA; [Wee, Chong-Yaw; Yap, Pew-Thian; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Denny, Kevin; Browndyke, Jeffrey N.; Wang, Lihong] Duke Univ, Med Ctr, BIAC, Durham, NC USA; [Browndyke, Jeffrey N.; Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA; [Browndyke, Jeffrey N.; Potter, Guy G.; Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Browndyke, Jeffrey N.] Duke Univ, Duke Inst Brain Sci, Durham, NC USA; [Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; Duke University; Duke University	Wee, CY (corresponding author), Univ N Carolina, BRIC, IDEA Lab, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Welsh-Bohmer, Kathleen/AAA-3178-2020; Shen, Dinggang/ABF-6812-2020; Yap, Pew-Thian/G-3292-2012; Browndyke, Jeffrey/AAE-7292-2021	Shen, Dinggang/0000-0002-7934-5698; Browndyke, Jeffrey/0000-0002-8573-7073	United States National Institutes of Health [EB006733, EB008374, EB009634, MH088520, K23-AG028982]; National Alliance for Research in Schizophrenia and Depression Young Investigator Award from The Brain and Behavior Research Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634, R01EB008374, R01EB006733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088520, K23MH087741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028982] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research in Schizophrenia and Depression Young Investigator Award from The Brain and Behavior Research Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by United States National Institutes of Health grants EB006733, EB008374, EB009634, MH088520, K23-AG028982, as well as a National Alliance for Research in Schizophrenia and Depression Young Investigator Award (LW) from The Brain and Behavior Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Bain LJ, 2008, ALZHEIMERS DEMENT, V4, P443, DOI 10.1016/j.jalz.2008.08.006; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bischkopf J, 2002, ACTA PSYCHIAT SCAND, V106, P403, DOI 10.1034/j.1600-0447.2002.01417.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Desjardins AE, 2001, NEUROIMAGE, V13, P751, DOI 10.1006/nimg.2000.0719; DUARA R, 1986, NEUROLOGY, V36, P879, DOI 10.1212/WNL.36.7.879; Eckerstrom C, 2008, J NEUROL SCI, V272, P48, DOI 10.1016/j.jns.2008.04.024; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Fan Y, 2008, BIOL PSYCHIAT, V63, P118, DOI 10.1016/j.biopsych.2007.03.015; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; Johnson SC, 2006, NEUROBIOL AGING, V27, P1604, DOI 10.1016/j.neurobiolaging.2005.09.017; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Machulda MM, 2009, J INT NEUROPSYCH SOC, V15, P372, DOI 10.1017/S1355617709090523; Machulda MM, 2003, NEUROLOGY, V61, P500, DOI 10.1212/01.WNL.0000079052.01016.78; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Pihlajamiki M, 2008, FUTUR NEUROL, V3, P409, DOI 10.2217/14796708.3.4.409; Rakotomamonjy A., 2003, Journal of Machine Learning Research, V3, P1357, DOI 10.1162/153244303322753706; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Saykin AJ, 1999, J INT NEUROPSYCH SOC, V5, P377, DOI 10.1017/S135561779955501X; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sorg C, 2009, CURR ALZHEIMER RES, V6, P541, DOI 10.2174/156720509790147106; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Thompson PM, 2007, BRIT J RADIOL, V80, pS78, DOI 10.1259/BJR/20005470; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wee CY, 2011, NEUROIMAGE, V54, P1812, DOI 10.1016/j.neuroimage.2010.10.026; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Zahn R, 2004, PSYCHIAT RES-NEUROIM, V132, P159, DOI 10.1016/j.psychresns.2004.07.006; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zhu CZ, 2005, LECT NOTES COMPUT SC, V3750, P468, DOI 10.1007/11566489_58; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	73	97	107	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37828	10.1371/journal.pone.0037828	http://dx.doi.org/10.1371/journal.pone.0037828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666397	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400051
J	Turvey, ST; Risley, CL; Barrett, LA; Hao, YJ; Ding, W				Turvey, Samuel T.; Risley, Claire L.; Barrett, Leigh A.; Hao Yujiang; Ding, Wang			River Dolphins Can Act as Population Trend Indicators in Degraded Freshwater Systems	PLOS ONE			English	Article							YANGTZE FINLESS PORPOISE; TOP PREDATORS; EXTINCTION RISK; LIFE-HISTORY; SPECIES RICHNESS; CLIMATE-CHANGE; CONSERVATION; BIODIVERSITY; CHINA; FISHERIES	Conservation attention on charismatic large vertebrates such as dolphins is often supported by the suggestion that these species represent surrogates for wider biodiversity, or act as indicators of ecosystem health. However, their capacity to act as indicators of patterns or trends in regional biodiversity has rarely been tested. An extensive new dataset of >300 last-sighting records for the Yangtze River dolphin or baiji and two formerly economically important fishes, the Yangtze paddlefish and Reeves' shad, all of which are probably now extinct in the Yangtze, was collected during an interview survey of fishing communities across the middle-lower Yangtze drainage. Untransformed last-sighting date frequency distributions for these species show similar decline curves over time, and the linear gradients of transformed last-sighting date series are not significantly different from each other, demonstrating that these species experienced correlated population declines in both timing and rate of decline. Whereas species may be expected to respond differently at the population level even in highly degraded ecosystems, highly vulnerable (e.g. migratory) species can therefore display very similar responses to extrinsic threats, even if they represent otherwise very different taxonomic, biological and ecological groupings. Monitoring the status of river dolphins or other megafauna therefore has the potential to provide wider information on the status of other threatened components of sympatric freshwater biotas, and so represents a potentially important monitoring tool for conservation management. We also show that interview surveys can provide robust quantitative data on relative population dynamics of different species.	[Turvey, Samuel T.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Risley, Claire L.] Univ Liverpool, Neston, Cheshire, England; [Barrett, Leigh A.] Freshwater Dolphin CIC, Madrid, Spain; [Hao Yujiang; Ding, Wang] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China	Zoological Society of London; University of Liverpool; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Turvey, ST (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	samuel.turvey@ioz.ac.uk			Marine Mammal Commission; Ocean Park Conservation Foundation Hong Kong; People's Trust for Endangered Species; Zoological Society of London's (ZSL's) EDGE of Existence programme; Natural Environment Research Council (NERC) Postdoctoral Fellowship; Royal Society University Research Fellowship	Marine Mammal Commission; Ocean Park Conservation Foundation Hong Kong; People's Trust for Endangered Species; Zoological Society of London's (ZSL's) EDGE of Existence programme; Natural Environment Research Council (NERC) Postdoctoral Fellowship; Royal Society University Research Fellowship(Royal Society of London)	Funding was provided by the Marine Mammal Commission, Ocean Park Conservation Foundation Hong Kong, People's Trust for Endangered Species, Zoological Society of London's (ZSL's) EDGE of Existence programme, a Natural Environment Research Council (NERC) Postdoctoral Fellowship, and a Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Bilton DT, 2006, FRESHWATER BIOL, V51, P578, DOI 10.1111/j.1365-2427.2006.01505.x; Bowen WD, 1997, MAR ECOL PROG SER, V158, P267, DOI 10.3354/meps158267; Cabeza M, 2008, J APPL ECOL, V45, P976, DOI 10.1111/j.1365-2664.2007.01364.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Caro T, 2004, ANIM CONSERV, V7, P63, DOI 10.1017/S136794300300115X; Chen DQ, 2009, ENVIRON BIOL FISH, V85, P337, DOI 10.1007/s10641-009-9517-0; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Anadon JD, 2009, CONSERV BIOL, V23, P617, DOI 10.1111/j.1523-1739.2008.01145.x; Darwall WRT, 2011, CONSERV LETT, V4, P474, DOI 10.1111/j.1755-263X.2011.00202.x; Dudgeon D, 2000, HYDROBIOLOGIA, V418, P1, DOI 10.1023/A:1003998519910; Dudgeon D, 2010, AQUAT CONSERV, V20, P127, DOI 10.1002/aqc.1098; Duncan JR, 2001, BIOL CONSERV, V102, P97, DOI 10.1016/S0006-3207(01)00077-5; Entwistle A, 2000, PRIORITIES CONSERVAT; Fang J, 2006, FRONT ECOL ENVIRON, V4, P369, DOI 10.1890/1540-9295(2006)004[0369:BCITLO]2.0.CO;2; Fu CZ, 2003, BIODIVERS CONSERV, V12, P1649, DOI 10.1023/A:1023697714517; Huang H, 1982, FRESHWATER FISHES CH, V1; Ichthyological Department of the Institute of Hydrobiology, 1976, FISH YANGTZ RIV; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Jager HI, 2008, HYDROBIOLOGIA, V602, P15, DOI 10.1007/s10750-008-9287-2; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jones JPG, 2008, J APPL ECOL, V45, P1205, DOI 10.1111/j.1365-2664.2008.01487.x; Kelkar N, 2010, CONSERV BIOL, V24, P1130, DOI 10.1111/j.1523-1739.2010.01467.x; Liao Fu-chu, 2002, Acta Hydrobiologica Sinica, V26, P623; Lindenmayer DB, 2000, CONSERV BIOL, V14, P941, DOI 10.1046/j.1523-1739.2000.98533.x; Linnell JDC, 2000, BIODIVERS CONSERV, V9, P857, DOI 10.1023/A:1008969104618; LIU CH, 1988, COPEIA, P482, DOI 10.2307/1445891; Liu Shao-ping, 2002, Acta Hydrobiologica Sinica, V26, P679; Newing H, 2011, CONDUCTING RESEARCH IN CONSERVATION: SOCIAL SCIENCE METHODS AND PRACTICE, P1; Olden JD, 2007, GLOBAL ECOL BIOGEOGR, V16, P694, DOI 10.1111/j.1466-8238.2007.00337.x; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Ping C., 1931, Contributions from the Biological Laboratory of the Science Society of China Nanking, V7, P173; Pratt Antwerp E., 1892, SNOWS TIBET CHINA; Qiu Shunlin, 1998, Freshwater Fisheries, V28, P18; QIU SL, 1989, ACTA ZOOL SINICA, V35, P300; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; Read BE, 1939, COMMON FOOD FISHES S; Reeves Randall R., 2000, Occasional Papers of the IUCN Species Survival Commission, V23, P67; Reynolds JD, 2005, CAN J FISH AQUAT SCI, V62, P854, DOI 10.1139/F05-066; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Roth T, 2008, J APPL ECOL, V45, P987, DOI 10.1111/j.1365-2664.2007.01435.x; Seddon PJ, 2008, ORYX, V42, P240, DOI 10.1017/S003060530806119X; Sergio F, 2008, J APPL ECOL, V45, P992, DOI 10.1111/j.1365-2664.2008.01484.x; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Solow AR, 2005, MATH BIOSCI, V195, P47, DOI 10.1016/j.mbs.2005.02.001; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Turvey ST, 2010, P ROY SOC B-BIOL SCI, V277, P3139, DOI 10.1098/rspb.2010.0584; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Wang H, 1997, SHAD J, V2, P4; Wei QW, 1997, ENVIRON BIOL FISH, V48, P241, DOI 10.1023/A:1007395612241; Xie P, 2003, SCIENCE, V302, P1149; Zhang X, 2003, AQUAT CONSERV, V13, P51, DOI 10.1002/aqc.547; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zheng JS, 2005, BIOCHEM GENET, V43, P307, DOI 10.1007/s10528-005-5222-7; Zhong YG, 1997, CAN J FISH AQUAT SCI, V54, P224, DOI 10.1139/cjfas-54-1-224; ZHOU K, 1977, Acta Zoologica Sinica, V23, P72; ZHOU K, 2002, ENCY MARINE MAMMALS, P58; Zhou K., 1991, BAIJI YANGTZE RIVER	60	26	26	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37902	10.1371/journal.pone.0037902	http://dx.doi.org/10.1371/journal.pone.0037902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666410	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600039
J	Ortalli, AL; Fiore, L; Di Napoli, J; Rapacioli, M; Salierno, M; Etchenique, R; Flores, V; Sanchez, V; Carri, NG; Scicolone, G				Laura Ortalli, Ana; Fiore, Luciano; Di Napoli, Jennifer; Rapacioli, Melina; Salierno, Marcelo; Etchenique, Roberto; Flores, Vladimir; Sanchez, Viviana; Gabriel Carri, Nestor; Scicolone, Gabriel			EphA3 Expressed in the Chicken Tectum Stimulates Nasal Retinal Ganglion Cell Axon Growth and Is Required for Retinotectal Topographic Map Formation	PLOS ONE			English	Article							VISUAL-SYSTEM; IN-VIVO; OPTIC TECTUM; EPHRIN-AS; MULTIPLE MECHANISMS; REPULSIVE GUIDANCE; RETROVIRAL VECTORS; NEURAL MAP; RECEPTORS; GRADIENTS	Background: Retinotopic projection onto the tectum/colliculus constitutes the most studied model of topographic mapping and Eph receptors and their ligands, the ephrins, are the best characterized molecular system involved in this process. Ephrin-As, expressed in an increasing rostro-caudal gradient in the tectum/colliculus, repel temporal retinal ganglion cell (RGC) axons from the caudal tectum and inhibit their branching posterior to their termination zones. However, there are conflicting data regarding the nature of the second force that guides nasal axons to invade and branch only in the caudal tectum/colliculus. The predominant model postulates that this second force is produced by a decreasing rostro-caudal gradient of EphA7 which repels nasal optic fibers and prevents their branching in the rostral tectum/colliculus. However, as optic fibers invade the tectum/colliculus growing throughout this gradient, this model cannot explain how the axons grow throughout this repellent molecule. Methodology/Principal Findings: By using chicken retinal cultures we showed that EphA3 ectodomain stimulates nasal RGC axon growth in a concentration dependent way. Moreover, we showed that nasal axons choose growing on EphA3-expressing cells and that EphA3 diminishes the density of interstitial filopodia in nasal RGC axons. Accordingly, in vivo EphA3 ectodomain misexpression directs nasal optic fibers toward the caudal tectum preventing their branching in the rostral tectum. Conclusions: We demonstrated in vitro and in vivo that EphA3 ectodomain (which is expressed in a decreasing rostro-caudal gradient in the tectum) is necessary for topographic mapping by stimulating the nasal axon growth toward the caudal tectum and inhibiting their branching in the rostral tectum. Furthermore, the ability of EphA3 of stimulating axon growth allows understanding how optic fibers invade the tectum growing throughout this molecular gradient. Therefore, opposing tectal gradients of repellent ephrin-As and of axon growth stimulating EphA3 complement each other to map optic fibers along the rostro-caudal tectal axis.	[Laura Ortalli, Ana; Fiore, Luciano; Di Napoli, Jennifer; Flores, Vladimir; Sanchez, Viviana; Scicolone, Gabriel] Univ Buenos Aires, Sch Med, Inst Cell Biol & Neurosci Prof E De Robertis UBA, Dev Neurobiol Lab, Buenos Aires, DF, Argentina; [Gabriel Carri, Nestor] Inst Multidisciplinary Cell Biol CONICET CIC, La Plata, Buenos Aires, Argentina; [Rapacioli, Melina; Flores, Vladimir] Favaloro Univ, Dept Bioestruct Sci, Interdisciplinary Grp Theoret Biol, Buenos Aires, DF, Argentina; [Salierno, Marcelo; Etchenique, Roberto] Univ Buenos Aires, Fac Exact & Nat Sci, Dept Inorgan Analyt & Phys Chem INQUIMAE, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Ortalli, AL (corresponding author), Univ Buenos Aires, Sch Med, Inst Cell Biol & Neurosci Prof E De Robertis UBA, Dev Neurobiol Lab, Buenos Aires, DF, Argentina.	gscicolo@retina.ar	Salierno, Marcelo/AAA-7198-2021; Salierno, Marcelo J/E-5557-2016	Salierno, Marcelo J/0000-0003-3897-3177; Fiore, Luciano/0000-0002-7661-4549	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 03135]; University of Buenos Aires [M 096, M439]; Comision de Investigaciones Cientificas de la Provincia de Buenos Aires [CIC 2010-1]; Agencia Nacional de Promocion Cientifica y Tecnologica [PME-2006-00319]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); Comision de Investigaciones Cientificas de la Provincia de Buenos Aires; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 03135), University of Buenos Aires (M 096, M439), Comision de Investigaciones Cientificas de la Provincia de Buenos Aires (CIC 2010-1 to Dr NG Carri) and Agencia Nacional de Promocion Cientifica y Tecnologica (PME-2006-00319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevins N, 2011, J NEUROSCI, V31, P10302, DOI 10.1523/JNEUROSCI.1652-11.2011; BONHOEFFER F, 1985, NATURE, V315, P408, DOI 10.1038/315409a0; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; COHEN J, 1989, DEVELOPMENT, V107, P381; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; COWAN WM, 1961, J ANAT, V95, P545; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dutting D, 1999, DEV BIOL, V216, P297, DOI 10.1006/dbio.1999.9489; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Gebhardt C, 2012, DEVELOPMENT, V139, P335, DOI 10.1242/dev.070474; Gosse NJ, 2008, NATURE, V452, P892, DOI 10.1038/nature06816; HALFTER W, 1981, NATURE, V292, P67, DOI 10.1038/292067a0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Carreres MI, 2011, J NEUROSCI, V31, P5673, DOI 10.1523/JNEUROSCI.0394-11.2011; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Kao TJ, 2011, NEURON, V71, P76, DOI 10.1016/j.neuron.2011.05.031; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Marin O, 2001, DEV BIOL, V234, P289, DOI 10.1006/dbio.2001.0268; Marler KJM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-30; Marler KJM, 2008, J NEUROSCI, V28, P12700, DOI 10.1523/JNEUROSCI.1915-08.2008; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Menzel P, 2001, DEV BIOL, V230, P74, DOI 10.1006/dbio.2000.0109; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Muhleisen TW, 2006, DEV BIOL, V297, P59, DOI 10.1016/j.ydbio.2006.04.466; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Poopalasundaram S, 2011, MOL CELL NEUROSCI, V47, P131, DOI 10.1016/j.mcn.2011.03.008; Rapacioli M, 2011, J MORPHOL, V272, P675, DOI 10.1002/jmor.10943; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Sakurai T, 2002, P NATL ACAD SCI USA, V99, P10795, DOI 10.1073/pnas.162161499; Scicolone G, 2006, J COMP NEUROL, V494, P1007, DOI 10.1002/cne.20878; Scicolone G, 1995, INT J DEV NEUROSCI, V13, P845, DOI 10.1016/0736-5748(95)00069-0; Scicolone G, 2009, BRAIN RES BULL, V79, P227, DOI 10.1016/j.brainresbull.2009.03.008; Simpson HD, 2009, CURR TOP DEV BIOL, V87, P1, DOI 10.1016/S0070-2153(09)01201-0; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Takahashi H, 2003, DEVELOPMENT, V130, P5203, DOI 10.1242/dev.00724; Takahashi H, 2009, DEV BIOL, V331, P300, DOI 10.1016/j.ydbio.2009.05.549; Tsigankov D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-155; Vearing CJ, 2005, GROWTH FACTORS, V23, P67, DOI 10.1080/08977190500055869; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yoo S, 2011, EMBO J, V30, P1593, DOI 10.1038/emboj.2011.44; Zinchuk V, 2009, PROG HISTOCHEM CYTO, V44, P125, DOI 10.1016/j.proghi.2009.03.001	61	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38566	10.1371/journal.pone.0038566	http://dx.doi.org/10.1371/journal.pone.0038566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685584	Green Submitted, gold, Green Published			2022-12-27	WOS:000305351700047
J	Silva, AX; Bacigalupe, LD; Luna-Rudloff, M; Figueroa, CC				Silva, Andrea X.; Bacigalupe, Leonardo D.; Luna-Rudloff, Manuela; Figueroa, Christian C.			Insecticide Resistance Mechanisms in the Green Peach Aphid Myzus persicae (Hemiptera: Aphididae) II: Costs and Benefits	PLOS ONE			English	Article							POTATO APHID; GENE-EXPRESSION; ESTERASE GENES; HOST-PLANT; HEAT-SHOCK; DETOXIFICATION ENZYMES; PHENOTYPIC PLASTICITY; TRANSGENIC DROSOPHILA; CYSTEINE PROTEASE; HSP70 EXPRESSION	Background: Among herbivorous insects that have exploited agro-ecosystems, the peach-potato aphid, Myzus persicae, is recognized as one of the most important agricultural pests worldwide. Uses over 400 plant species and has evolved different insecticides resistance mechanisms. As M. persicae feeds upon a huge diversity of hosts, it has been exposed to a wide variety of plant allelochemicals, which probably have promoted a wide range of detoxification systems. Methodology/Principal Findings: In this work we (i) evaluated whether insecticide resistance mutations (IRM) in M. persicae can give an advantage in terms of reproductive fitness when aphids face two hosts, pepper (Capsicum annuum) a suitable host and radish (Raphanus sativus) the unfavorable host and (ii) examined the transcriptional expression of six genes that are known to be up-regulated in response to insecticides. Our results show a significant interaction between host and IRM on the intrinsic rate of increase (r(m)). Susceptible genotypes (not carrying insensitivity mutations) had a higher r(m) on pepper, and the transcriptional levels of five genes increased on radish. The r(m) relationship was reversed on the unfavorable host; genotypes with multiple IRM exhibited higher r(m), without altering the transcriptional levels of the studied genes. Genotypes with one IRM kept a similar r(m) on both hosts, but they increased the transcriptional levels of two genes. Conclusions/Significance: Although we have studied only nine genotypes, overall our results are in agreement with the general idea that allelochemical detoxification systems could constitute a pre-adaptation for the development of insecticide resistance. Genotypes carrying IRM exhibited a higher r(m) than susceptible genotypes on radish, the more unfavorable host. Susceptible genotypes should be able to tolerate the defended host by up-regulating some metabolic genes that are also responding to insecticides. Hence, our results suggest that the trade-off among resistance mechanisms might be quite complex, with a multiplicity of costs and benefits depending on the environment.	[Silva, Andrea X.; Bacigalupe, Leonardo D.; Luna-Rudloff, Manuela; Figueroa, Christian C.] Univ Austral Chile, Inst Ciencias Ambientales & Evolutivas, Fac Ciencias, Valdivia, Chile	Universidad Austral de Chile	Silva, AX (corresponding author), Univ Austral Chile, Inst Ciencias Ambientales & Evolutivas, Fac Ciencias, Valdivia, Chile.	christianfigueroa@uach.cl	Figueroa, Christian C./A-1170-2008; Li, Shiguang/G-7471-2012	Figueroa, Christian C./0000-0001-9218-5564; Silva, Andrea/0000-0002-4346-5524	Comision Nacional de Investigacioen Cientifica y Tecnologica (CONICYT); Fondo Nacional de Desarrollo CientUfico y Tecnologico, (FONDECYT0) [1090378]; United States Department of Agriculture [2005-35604-15446]; MECESUP [AUS0805]; DID-UACh	Comision Nacional de Investigacioen Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo Nacional de Desarrollo CientUfico y Tecnologico, (FONDECYT0)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); United States Department of Agriculture(United States Department of Agriculture (USDA)); MECESUP; DID-UACh	This research was funded by Comision Nacional de Investigacioen Cientifica y Tecnologica (CONICYT) doctoral grant to AXS, by Fondo Nacional de Desarrollo CientUfico y Tecnologico, (FONDECYT0 grant No1090378 to CCF and by the United States Department of Agriculture grant No2005-35604-15446 to GJ. The authors also thank partial funding from MECESUP grant AUS0805 and DID-UACh. The authors want to thank Dr. Eduardo Fuentes-Contreras for the insecticide tolerance bioassays.	Anstead JA, 2004, INSECT BIOCHEM MOLEC, V34, P871, DOI 10.1016/j.ibmb.2004.06.002; Anstead JA, 2008, AGR FOREST ENTOMOL, V10, P291, DOI 10.1111/j.1461-9563.2008.00388.x; Anthony N, 1998, MOL GEN GENET, V260, P165, DOI 10.1007/s004380050882; Atkinson B, 1985, CHANGES EUKARYOTIC G; Azzouz H, 2005, J INSECT PHYSIOL, V51, P75, DOI 10.1016/j.jinsphys.2004.11.010; Barillari J, 2005, J AGR FOOD CHEM, V53, P9890, DOI 10.1021/jf051465h; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; BERNAYS EA, 1989, EVOL ECOL, V3, P299, DOI 10.1007/BF02285261; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bizzaro D, 2005, PESTIC BIOCHEM PHYS, V81, P51, DOI 10.1016/j.pestbp.2004.09.005; Bjorling-Poulsen M, 2008, ENV HLTH, V7; Blackman R.L., 2000, J ECON ENTOMOL, V2; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; BRATTSTEN LB, 1988, J CHEM ECOL, V14, P1919, DOI 10.1007/BF01013486; Brisson JA, 2010, INSECT MOL BIOL, V19, P63, DOI 10.1111/j.1365-2583.2009.00935.x; Cabrera-Brandt MA, 2010, CHIL J AGR RES, V70, P567, DOI 10.4067/S0718-58392010000400006; CARRIERE Y, 1994, P ROY SOC B-BIOL SCI, V258, P35, DOI 10.1098/rspb.1994.0138; Castaneda LE, 2010, J EVOLUTION BIOL, V23, P2474, DOI 10.1111/j.1420-9101.2010.02112.x; Castaneda LE, 2011, PHYSIOL ENTOMOL, V36, P253, DOI 10.1111/j.1365-3032.2011.00793.x; Castaneda LE, 2010, J INSECT PHYSIOL, V56, P1058, DOI 10.1016/j.jinsphys.2010.02.019; Chougule NP, 2005, INSECT BIOCHEM MOLEC, V35, P355, DOI 10.1016/j.ibmb.2005.01.006; Chowdhuri DK, 1999, PESTIC BIOCHEM PHYS, V63, P15, DOI 10.1006/pest.1998.2390; Costa LG, 2008, FRONT BIOSCI-LANDMRK, V13, P1240, DOI 10.2741/2758; Cristofoletti PT, 2003, J INSECT PHYSIOL, V49, P11, DOI 10.1016/S0022-1910(02)00222-6; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; Deraison C, 2004, INSECT MOL BIOL, V13, P165, DOI 10.1111/j.0962-1075.2004.00474.x; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; DEVONSHIRE AL, 1992, B ENTOMOL RES, V82, P459, DOI 10.1017/S0007485300042516; DEVONSHIRE AL, 1982, PESTIC BIOCHEM PHYS, V18, P235, DOI 10.1016/0048-3575(82)90110-9; DEVONSHIRE AL, 1986, B ENTOMOL RES, V76, P97, DOI 10.1017/S0007485300015327; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Eleftherianos I, 2008, B ENTOMOL RES, V98, P183, DOI 10.1017/S0007485307005524; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fenton B, 2010, B ENTOMOL RES, V100, P451, DOI 10.1017/S0007485309990447; Fenton B, 2010, ECOL ENTOMOL, V35, P131, DOI 10.1111/j.1365-2311.2009.01150.x; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Field LM, 1998, BIOCHEM J, V330, P169; Field LM, 2000, BIOCHEM J, V349, P863, DOI 10.1042/bj3490863; Field LM, 2003, BIOL J LINN SOC, V79, P107, DOI 10.1046/j.1095-8312.2003.00178.x; Field LM, 1997, BIOCHEM J, V322, P867, DOI 10.1042/bj3220867; FIELD LM, 1993, BIOCHEM J, V294, P569, DOI 10.1042/bj2940569; Field LM, 1999, BIOCHEM J, V339, P737, DOI 10.1042/0264-6021:3390737; Figueroa CC, 2007, INSECT SCI, V14, P29, DOI 10.1111/j.1744-7917.2007.00123.x; Foster SP, 2011, B ENTOMOL RES, V101, P659, DOI 10.1017/S0007485310000623; Foster SP, 1997, B ENTOMOL RES, V87, P573, DOI 10.1017/S0007485300038669; Foster SP, 2005, B ENTOMOL RES, V95, P37, DOI 10.1079/BER2004336; Foster SP, 2003, PEST MANAG SCI, V59, P1169, DOI 10.1002/ps.751; Foster SP, 1999, B ENTOMOL RES, V89, P133, DOI 10.1017/S0007485399000218; Foster SP, 2000, CROP PROT, V19, P873, DOI 10.1016/S0261-2194(00)00115-0; Foster SP, 1996, B ENTOMOL RES, V86, P17, DOI 10.1017/S0007485300052159; Foster SP, 2007, ANIM BEHAV, V74, P621, DOI 10.1016/j.anbehav.2006.12.018; Francis F, 2006, INSECT BIOCHEM MOLEC, V36, P219, DOI 10.1016/j.ibmb.2006.01.018; Francis F, 2005, ARCH INSECT BIOCHEM, V58, P166, DOI 10.1002/arch.20049; FUTUYMA D., 2009, EVOLUTION; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Goundoudaki S, 2003, AGR FOREST ENTOMOL, V5, P285, DOI 10.1046/j.1461-9563.2003.00190.x; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Hanlon PR, 2011, J FOOD SCI, V76, pC185, DOI 10.1111/j.1750-3841.2010.01972.x; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Karban R, 2002, ANNU REV ECOL SYST, V33, P641, DOI 10.1146/annurev.ecolsys.33.010802.150443; Krebs RA, 1997, J EXP BIOL, V200, P2007; Lee SM, 2006, CHEMOSPHERE, V65, P1074, DOI 10.1016/j.chemosphere.2006.02.042; Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685; Li XC, 2000, INSECT BIOCHEM MOLEC, V30, P75, DOI 10.1016/S0965-1748(99)00102-2; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manson JS, 2009, ECOL ENTOMOL, V34, P421, DOI 10.1111/j.1365-2311.2009.01100.x; Margaritopoulos John T., 2009, BMC Ecology, V9, P13, DOI 10.1186/1472-6785-9-13; Martinez-Torres D, 1999, INSECT MOL BIOL, V8, P339, DOI 10.1046/j.1365-2583.1999.83121.x; Marutani-Hert M, 2010, FLA ENTOMOL, V93, P519, DOI 10.1653/024.093.0408; Mello Marcia O., 2002, Braz. J. Plant Physiol., V14, P71, DOI 10.1590/S1677-04202002000200001; MOORES GD, 1994, PESTIC BIOCHEM PHYS, V49, P114, DOI 10.1006/pest.1994.1038; Moores GD, 2000, PROC BRIGHTON CROP, V1-3, P447; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Mosolov VV, 2001, APPL BIOCHEM MICRO+, V37, P115, DOI 10.1023/A:1002824527463; Nabeshima T, 2003, BIOCHEM BIOPH RES CO, V307, P15, DOI 10.1016/S0006-291X(03)01101-X; Nazir A, 2003, BBA-GEN SUBJECTS, V1621, P218, DOI 10.1016/S0304-4165(03)00060-6; Nazir A, 2001, ARCH ENVIRON CON TOX, V41, P443, DOI 10.1007/s002440010270; Nielsen SA, 2006, ENVIRON ENTOMOL, V35, P837, DOI 10.1603/0046-225X-35.4.837; Nikolakakis NN, 2003, B ENTOMOL RES, V93, P235, DOI 10.1079/BER2003230; Olivares-Donoso R, 2007, B ENTOMOL RES, V97, P61, DOI 10.1017/S0007485307004774; Onstad D, 2008, INSECTICIDE RESISTAN, V1; Peppe FB, 2003, GENET MOL BIOL, V26, P189, DOI 10.1590/S1415-47572003000200012; Philippou D, 2010, PEST MANAG SCI, V66, P390, DOI 10.1002/ps.1888; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; PINHEIRO J., 2009, NLME LINEAR NONLINEA; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Rahbe Y, 2003, PLANT SCI, V164, P441, DOI 10.1016/S0168-9452(02)00402-8; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; ROPP M, 1983, CAN J BIOCHEM CELL B, V61, P456, DOI 10.1139/o83-061; RYAN MF, 1988, J CHEM ECOL, V14, P1965, DOI 10.1007/BF01013489; Schoonhoven L. M., 2005, Insect-plant biology; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Shapiro TA, 1998, CANCER EPIDEM BIOMAR, V7, P1091; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Srigiriraju L, 2010, CROP PROT, V29, P197, DOI 10.1016/j.cropro.2009.11.006; Steinberg C.E.W., 2011, STRESS ECOLOGY ENV S; Tomlin C., 1994, PESTICIDE MANUAL WOR, V10th ed.; Tsuji A, 2008, FEBS J, V275, P5429, DOI 10.1111/j.1742-4658.2008.06674.x; Valueva TA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1305, DOI 10.1007/s10541-005-0015-5; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; Vucetic A, 2008, ARCH BIOL SCI, V60, P493, DOI 10.2298/ABS0803493V; Wang LP, 2010, CROP PROT, V29, P1280, DOI 10.1016/j.cropro.2010.07.009; WYATT IJ, 1977, J APPL ECOL, V14, P757, DOI 10.2307/2402807; Xie W, 2011, PEST MANAG SCI, V67, P87, DOI 10.1002/ps.2037; Yang XM, 2001, J ECON ENTOMOL, V94, P381, DOI 10.1603/0022-0493-94.2.381; Yoshimi T, 2009, ENVIRON TOXICOL PHAR, V28, P294, DOI 10.1016/j.etap.2009.05.008; YU SJ, 1984, COMP BIOCHEM PHYS C, V78, P145, DOI 10.1016/0742-8413(84)90062-8; Zhu-Salzman K, 2003, INSECT MOL BIOL, V12, P135, DOI 10.1046/j.1365-2583.2003.00395.x	117	28	33	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e36810	10.1371/journal.pone.0036810	http://dx.doi.org/10.1371/journal.pone.0036810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685539	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700003
J	Zhang, YC; Payne, JL				Zhang, Yichun; Payne, Jonathan L.			Size-Frequency Distributions along a Latitudinal Gradient in Middle Permian Fusulinoideans	PLOS ONE			English	Article							BODY-SIZE; THEORETICAL ECOSPACE; SPECIES RICHNESS; BERGMANNS RULE; CORAL FAUNAS; EVOLUTION; DIVERSITY; PATTERNS; GROWTH; FORAMINIFERA	Geographic gradients in body size within and among living species are commonly used to identify controls on the long-term evolution of organism size. However, the persistence of these gradients over evolutionary time remains largely unknown because ancient biogeographic variation in organism size is poorly documented. Middle Permian fusulinoidean foraminifera are ideal for investigating the temporal persistence of geographic gradients in organism size because they were diverse and abundant along a broad range of paleo-latitudes during this interval (similar to 275-260 million years ago). In this study, we determined the sizes of Middle Permian fusulinoidean fossils from three different paleo-latitudinal zones in order to examine the relationship between the size of foraminifers and regional environment. We recovered the following results: keriothecal fusulinoideans are substantially larger than nonkeriothecal fusulinoideans; fusulinoideans from the equatorial zone are typically larger than those from the north and south transitional zones; neoschwagerinid specimens within a single species are generally larger in the equatorial zone than those in both transitional zones; and the nonkeriothecal fusulinoideans Staffellidae and Schubertellidae have smaller size in the north transitional zone. Fusulinoidean foraminifers differ from most other marine taxa in exhibiting larger sizes closer to the equator, contrary to Bergmann's rule. Meridional variation in seasonality, water temperature, nutrient availability, and carbonate saturation level are all likely to have favored or enabled larger sizes in equatorial regions. Temporal variation in atmospheric oxygen concentrations have been shown to account for temporal variation in fusulinoidean size during Carboniferous and Permian time, but oxygen availability appears unlikely to explain biogeographic variation in fusulinoidean sizes, because dissolved oxygen concentrations in seawater typically increase away from the equator due to declining seawater temperatures. Consequently, our findings highlight the fact that spatial gradients in organism size are not always controlled by the same factors that govern temporal trends within the same clade.	[Zhang, Yichun] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Zhang, Yichun; Payne, Jonathan L.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Zhang, Yichun] Deakin Univ, Sch Life & Environm Sci, Melbourne, Australia	Chinese Academy of Sciences; Stanford University; Deakin University	Zhang, YC (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China.	geozyc@yahoo.com	Payne, Jonathan L/A-1240-2007; Payne, Jonathan/B-8088-2012	Payne, Jonathan L/0000-0002-9601-3310; 	National Science Foundation of China [40902006, 40921091]; State Key Laboratory of Paleontology and Stratigraphy [20102103]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Paleontology and Stratigraphy	The current research is funded by National Science Foundation of China (40902006, 40921091) and State Key Laboratory of Paleontology and Stratigraphy (20102103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegret L, 2010, GEOL SOC AM BULL, V122, P1616, DOI 10.1130/B30055.1; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Ashton KG, 2004, INTEGR COMP BIOL, V44, P403, DOI 10.1093/icb/44.6.403; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; Barnes DKA, 2001, MAR ECOL PROG SER, V210, P85, DOI 10.3354/meps210085; BLACKBURN TM, 1994, TRENDS ECOL EVOL, V9, P471, DOI 10.1016/0169-5347(94)90311-5; Blackburn TM, 2004, ECOGRAPHY, V27, P715, DOI 10.1111/j.0906-7590.2004.03999.x; Blackburn TM, 1996, OIKOS, V77, P436, DOI 10.2307/3545933; Bower JR, 2002, VELIGER, V45, P309; Bush AM, 2007, PALEOBIOLOGY, V33, P76, DOI 10.1666/06013.1; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chapelle G, 2004, OIKOS, V106, P167, DOI 10.1111/j.0030-1299.2004.12934.x; Clarke A, 2004, POLAR BIOL, V28, P62, DOI 10.1007/s00300-004-0647-8; Contreras H, 2000, REV CHIL HIST NAT, V73, P705; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; DAYTON PK, 1989, SCIENCE, V245, P1484, DOI 10.1126/science.245.4925.1484; Ebert TA, 1999, MAR ECOL PROG SER, V190, P189, DOI 10.3354/meps190189; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; FRANK PW, 1975, MAR BIOL, V31, P181, DOI 10.1007/BF00391630; Geslin E, 2011, J EXP MAR BIOL ECOL, V396, P108, DOI 10.1016/j.jembe.2010.10.011; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Groves JR, 2009, PALEOBIOLOGY, V35, P367, DOI 10.1666/0094-8373-35.3.367; HALLOCK P, 1985, PALEOBIOLOGY, V11, P195, DOI 10.1017/S0094837300011507; HALLOCK P, 1981, MAR BIOL, V62, P249, DOI 10.1007/BF00397691; Hallock P, 2000, MICROPALEONTOLOGY, V46, P95; HAWKINS BA, 1995, ECOL ENTOMOL, V20, P195, DOI 10.1111/j.1365-2311.1995.tb00446.x; HAWKINS BA, 1995, OECOLOGIA, V102, P31, DOI 10.1007/BF00333307; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; Hunt G, 2010, PALAEONTOLOGY, V53, P1255, DOI 10.1111/j.1475-4983.2010.01007.x; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Kaiho K, 1998, GEOLOGY, V26, P491, DOI 10.1130/0091-7613(1998)026<0491:GCFODS>2.3.CO;2; Kaiho K, 1999, MAR MICROPALEONTOL, V37, P53, DOI 10.1016/S0377-8398(99)00011-0; Kobayashi F., 1997, CUSHMAN FDN FORAMINI, V36, P73; Kotlyar G.V., 2003, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Geologicheskii, V78, P33; LINDSEY CC, 1966, EVOLUTION, V20, P456, DOI 10.1111/j.1558-5646.1966.tb03380.x; Linse K, 2006, DEEP-SEA RES PT II, V53, P921, DOI 10.1016/j.dsr2.2006.03.006; Lockwood R, 2005, PALEOBIOLOGY, V31, P578, DOI 10.1666/0094-8373(2005)031[0578:BSEEAT]2.0.CO;2; MACPHERSON E, 1994, ECOGRAPHY, V17, P242, DOI 10.1111/j.1600-0587.1994.tb00099.x; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; Novack-Gottshall PM, 2007, PALEOBIOLOGY, V33, P273, DOI 10.1666/06054.1; Olabarria C, 2003, MAR BIOL, V143, P723, DOI 10.1007/s00227-003-1116-6; Ozawa T., 1987, P45; Payne JL, EVOLUTION IN PRESS; Peck LS, 2010, MAR BIOL, V157, P2205, DOI 10.1007/s00227-010-1486-5; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Ross C.A., 1982, P441; Ross C.A., 1977, AMERICAN ASSOCIATION OF PETROLEUM GEOLOGISTS STUDIES IN GEOLOGY, P219; Ross C.A., 1974, Proceedings int Coral Reef Symp, V2, P327; ROSS CA, 1972, J PALEONTOL, V46, P719; Roy K, 2000, P NATL ACAD SCI USA, V97, P13150, DOI 10.1073/pnas.97.24.13150; Roy K, 2001, J BIOGEOGR, V28, P485, DOI 10.1046/j.1365-2699.2001.00561.x; Schmidt DN, 2004, SCIENCE, V303, P207, DOI 10.1126/science.1090592; Schmidt DN, 2004, PALAEOGEOGR PALAEOCL, V212, P159, DOI 10.1016/j.palaeo.2004.06.002; Shen SZ, 2009, GLOBAL PLANET CHANGE, V65, P166, DOI 10.1016/j.gloplacha.2008.10.017; Shen SZ, 2004, PALAEOGEOGR PALAEOCL, V208, P235, DOI 10.1016/j.palaeo.2004.03.009; Shi GR, 2006, J ASIAN EARTH SCI, V26, P173, DOI 10.1016/j.jseaes.2005.12.001; Shi GR, 2010, PALAEOGEOGR PALAEOCL, V298, P1, DOI 10.1016/j.palaeo.2010.07.021; SHI GR, 1995, PALAEOGEOGR PALAEOCL, V114, P241, DOI 10.1016/0031-0182(94)00079-N; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; STEELE DH, 1988, INT REV GES HYDROBIO, V73, P235, DOI 10.1002/iroh.19880730209; Thurmond HV, 2004, INTRO OCEANOGRAPHY; Ueno K, 2003, PALAEOGEOGR PALAEOCL, V193, P1, DOI 10.1016/S0031-0182(02)00708-3; Vachard D, 2004, J FORAMIN RES, V34, P232, DOI 10.2113/34.3.232; Villeger S, 2011, ECOL LETT, V14, P561, DOI 10.1111/j.1461-0248.2011.01618.x; Wang XD, 2006, J ASIAN EARTH SCI, V26, P369, DOI 10.1016/j.jseaes.2005.11.011; Wang XD, 2002, J ASIAN EARTH SCI, V20, P589, DOI 10.1016/S1367-9120(01)00064-5; Ziegler A.M., 1997, LATE GLACIAL POSTGLA, P111	68	135	141	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38603	10.1371/journal.pone.0038603	http://dx.doi.org/10.1371/journal.pone.0038603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685590	gold, Green Published, Green Submitted			2022-12-27	WOS:000305351700053
J	Klecka, J; Boukal, DS				Klecka, Jan; Boukal, David S.			Who Eats Whom in a Pool? A Comparative Study of Prey Selectivity by Predatory Aquatic Insects	PLOS ONE			English	Article							FOOD-WEB; NICHE OVERLAP; BODY-SIZE; SPATIAL AGGREGATION; COMPARATIVE ECOLOGY; LARVAE; DIET; COLEOPTERA; DYTISCIDAE; PREFERENCE	Predatory aquatic insects are a diverse group comprising top predators in small fishless water bodies. Knowledge of their diet composition is fragmentary, which hinders the understanding of mechanisms maintaining their high local diversity and of their impacts on local food web structure and dynamics. We conducted multiple-choice predation experiments using nine common species of predatory aquatic insects, including adult and larval Coleoptera, adult Heteroptera and larval Odonata, and complemented them with literature survey of similar experiments. All predators in our experiments fed selectively on the seven prey species offered, and vulnerability to predation varied strongly between the prey. The predators most often preferred dipteran larvae; previous studies further reported preferences for cladocerans. Diet overlaps between all predator pairs and predator overlaps between all prey pairs were non-zero. Modularity analysis separated all primarily nectonic predator and prey species from two groups of large and small benthic predators and their prey. These results, together with limited evidence from the literature, suggest a highly interconnected food web with several modules, in which similarly sized predators from the same microhabitat are likely to compete strongly for resources in the field (observed Pianka's diet overlap indices >0.85). Our experiments further imply that ontogenetic diet shifts are common in predatory aquatic insects, although we observed higher diet overlaps than previously reported. Hence, individuals may or may not shift between food web modules during ontogeny.	[Klecka, Jan; Boukal, David S.] Univ S Bohemia, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic; [Klecka, Jan; Boukal, David S.] Acad Sci Czech Republ, Inst Entomol, Ctr Biol, Lab Theoret Ecol,Vvi, CR-37005 Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Klecka, J (corresponding author), Univ S Bohemia, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic.	kleckj01@prf.jcu.cz	Klečka, Jan/G-7738-2011; Klecka, Jan/H-7874-2014; Boukal, David/H-4762-2014	Klecka, Jan/0000-0003-0633-3896; Boukal, David/0000-0001-8181-7458	EU Marie Curie European Reintegration Grant 'AquaMod' [PERG04-GA-2008-239543]; Grant Agency of the University of South Bohemia [GAJU 145/2010/P]; Institute of Entomology [AV0Z50070508]	EU Marie Curie European Reintegration Grant 'AquaMod'; Grant Agency of the University of South Bohemia; Institute of Entomology(Czech Academy of Sciences)	The study was supported by the EU Marie Curie European Reintegration Grant 'AquaMod' to DSB (PERG04-GA-2008-239543; URL: http://cordis.europa. eu/mariecurie-actions/erg/home.html), the Grant Agency of the University of South Bohemia (grant no. GAJU 145/2010/P; URL: http://www.jcu.cz/research/gaju) and funding by the Institute of Entomology (AV0Z50070508; URL: http://www.entu.cas.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Batzer DP, 1996, ANNU REV ENTOMOL, V41, P75, DOI 10.1146/annurev.en.41.010196.000451; BAY EC, 1974, ANNU REV ENTOMOL, V19, P441, DOI 10.1146/annurev.en.19.010174.002301; BLOIS C, 1985, FRESHWATER BIOL, V15, P505, DOI 10.1111/j.1365-2427.1985.tb00220.x; Blunck H, 1923, Z WISS ZOOL ABT A, V121, P171; Boukal David S., 2007, Klapalekiana, V43, P1; Brose U., 2005, ECOLOGY, V86, P2545, DOI [DOI 10.1890/05-0379, 10.1890/05-0379]; Chandra G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-138; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Cobbaert D, 2010, HYDROBIOLOGIA, V644, P103, DOI 10.1007/s10750-010-0100-7; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; COOPER SD, 1985, CAN J FISH AQUAT SCI, V42, P1720, DOI 10.1139/f85-216; COTHRAN ML, 1985, OIKOS, V44, P350, DOI 10.2307/3544710; Culler LE, 2009, FRESHWATER BIOL, V54, P2003, DOI 10.1111/j.1365-2427.2009.02230.x; CUMMINS KW, 1973, ANNU REV ENTOMOL, V18, P183, DOI 10.1146/annurev.en.18.010173.001151; De Roos AM, 2008, P NATL ACAD SCI USA, V105, P13930, DOI 10.1073/pnas.0803834105; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Entsminger G.L., 2001, ECOSIM NULL MODELS S; Febria CM, 2005, CAN ENTOMOL, V137, P723; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; Hamer TE, 2001, J RAPTOR RES, V35, P221; Hampton SE, 2001, HYDROBIOLOGIA, V446, P115, DOI 10.1023/A:1017543121353; HEINRICH B, 1976, ECOLOGY, V57, P874, DOI 10.2307/1941054; HENRIKSON BI, 1990, HOLARCTIC ECOL, V13, P201; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hutchinson G.E., 1993, ZOOBENTHOS, VVolume 4, P944; Ibarra-Nunez G, 2001, SOCIOBIOLOGY, V37, P723; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jennings S, 2001, J ANIM ECOL, V70, P934, DOI 10.1046/j.0021-8790.2001.00552.x; JOHANSSON A, 1992, HYDROBIOLOGIA, V248, P201, DOI 10.1007/BF00006148; JOHANSSON F, 1993, J INSECT BEHAV, V6, P253, DOI 10.1007/BF01051508; JOHANSSON F, 1991, HYDROBIOLOGIA, V209, P79, DOI 10.1007/BF00006721; JOHNSON DM, 1975, ECOLOGY, V56, P1081, DOI 10.2307/1936148; JULIANO SA, 1990, OECOLOGIA, V83, P535, DOI 10.1007/BF00317206; Kehl S, 2003, ARCH HYDROBIOL, V158, P109, DOI 10.1127/0003-9136/2003/0158-0109; Klecka J, 2011, ECOL INDIC, V11, P500, DOI 10.1016/j.ecolind.2010.07.005; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Kuhara N, 1999, OIKOS, V87, P27, DOI 10.2307/3546993; LARSON D J, 1990, Quaestiones Entomologicae, V26, P151; LAWTON JH, 1970, J ANIM ECOL, V39, P669, DOI 10.2307/2859; Leclair RJ, 1986, ENTOMOLOGICA BASILIE, V11, P669; Lim DH, 2001, BIOMETRICAL J, V43, P187, DOI 10.1002/1521-4036(200105)43:2<187::AID-BIMJ187>3.0.CO;2-Q; Luiselli L, 2008, OIKOS, V117, P321, DOI 10.1111/j.2007.0030-1299.16297.x; Lundkvist E, 2003, B ENTOMOL RES, V93, P219, DOI 10.1079/BER2003237; Luz-Agostinho KDG, 2008, HYDROBIOLOGIA, V607, P187, DOI 10.1007/s10750-008-9390-4; MANLY BFJ, 1974, BIOMETRICS, V30, P281, DOI 10.2307/2529649; MANLY BFJ, 1995, BIOMETRICS, V51, P709, DOI 10.2307/2532956; MARTIN ID, 1982, CAN J ZOOL, V60, P783, DOI 10.1139/z82-108; MCPEEK MA, 1990, ECOLOGY, V71, P83, DOI 10.2307/1940249; Murdoch JD, 2010, MAMM BIOL, V75, P36, DOI 10.1016/j.mambio.2008.12.003; MURDOCH WW, 1984, J ANIM ECOL, V53, P791, DOI 10.2307/4660; Naisbit RE, 2011, ECOLOGY, V92, P2183, DOI 10.1890/10-2234.1; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Oksanen J, 2010, R PACKAGE VERSION 1; ORR BK, 1990, ECOLOGY, V71, P68, DOI 10.2307/1940248; Pace ML, 2007, LIMNOL OCEANOGR, V52, P2177, DOI 10.4319/lo.2007.52.5.2177; PAJUNEN VI, 1983, ANN ZOOL FENN, V20, P31; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; PIANKA ER, 1976, COPEIA, P125; PIANKA ER, 1978, COPEIA, P691; Pianka ER, 1973, ANNU REV ECOL SYST, V4, P53, DOI [DOI 10.1146/ANNUREV.ES.04.110173.000413, 10.1146/annurev.es.04.110173.000413]; Pimentel CR, 2010, J FISH BIOL, V76, P2299, DOI 10.1111/j.1095-8649.2010.02586.x; R Core Development Team, 2010, R LANG ENV STAT COMP; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Riede JO, 2011, ECOL LETT, V14, P169, DOI 10.1111/j.1461-0248.2010.01568.x; Rozkosny R., 1980, KLIC VODNICH LAREV H; Rubbo MJ, 2006, J ZOOL, V269, P1, DOI 10.1111/j.1469-7998.2006.00080.x; Rudolf VHW, 2011, ECOL LETT, V14, P75, DOI 10.1111/j.1461-0248.2010.01558.x; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCOTT MA, 1983, LIMNOL OCEANOGR, V28, P352, DOI 10.4319/lo.1983.28.2.0352; Shaalan EAS, 2009, TROP BIOMED, V26, P223; Siepielski AM, 2010, ECOLOGY, V91, P3153, DOI 10.1890/10-0154.1; Spitz J, 2011, DEEP-SEA RES PT I, V58, P273, DOI 10.1016/j.dsr.2010.12.009; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Takahashi KH, 2005, OIKOS, V109, P125, DOI 10.1111/j.0030-1299.2005.13594.x; THOMPSON DJ, 1978, J ANIM ECOL, V47, P769, DOI 10.2307/3670; Turner AM, 2007, OECOLOGIA, V153, P407, DOI 10.1007/s00442-007-0736-9; Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; Velasco J, 1998, AQUAT INSECT, V20, P85, DOI 10.1076/aqin.20.2.85.4500; Walsh EJ, 2006, INVERTEBR BIOL, V125, P325, DOI 10.1111/j.1744-7410.2006.00064.x; WARREN PH, 1989, OIKOS, V55, P299, DOI 10.2307/3565588; Wathne JA, 2000, MAR ECOL PROG SER, V194, P233, DOI 10.3354/meps194233; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wertheim B, 2000, J ANIM ECOL, V69, P335, DOI 10.1046/j.1365-2656.2000.00396.x; Woodward G, 2005, ADV ECOL RES, V36, P85, DOI 10.1016/S0065-2504(05)36002-8; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x; Woodward G, 2001, J ANIM ECOL, V70, P273, DOI 10.1046/j.1365-2656.2001.00497.x; Yee DA, 2010, HYDROBIOLOGIA, V637, P33, DOI 10.1007/s10750-009-9982-7	90	77	79	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37741	10.1371/journal.pone.0037741	http://dx.doi.org/10.1371/journal.pone.0037741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679487	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900012
J	Tian, XJ; Liu, F; Zhang, XP; Li, J; Wang, W				Tian, Xiao-Jun; Liu, Feng; Zhang, Xiao-Peng; Li, Jun; Wang, Wei			A Two-Step Mechanism for Cell Fate Decision by Coordination of Nuclear and Mitochondrial p53 Activities	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; TUMOR-SUPPRESSOR; MDM2-MEDIATED UBIQUITINATION; TRANSCRIPTIONAL ACTIVATION; P53-MEDIATED APOPTOSIS; PROTECTS MICE; CYCLE ARREST; MDM2; PATHWAY; DEATH	The tumor suppressor p53 has a crucial role in the DNA damage response. Here, we proposed an integrated model of the p53 network and explored how the nuclear and mitochondrial p53 pathways are coordinated to determine cell fates after gamma-irradiation in radiosensitive tissues. Using numerical simulations, we found that depending on the extent of DNA damage, cells may survive, commit apoptosis after cell cycle arrest, or undergo apoptosis soon after irradiation. There exists a large cell-to-cell variability in outcome because of stochasticity in the generation and repair of DNA damage as well as cellular heterogeneity. At the cell population level, there occur two waves of apoptosis: a fast wave mediated by mitochondrial p53 within three hours postirradiation, and a slow wave mediated by nuclear p53 after eight hours postirradiation. Thus, we propose a two-step mechanism for cell fate decision. The first step is to decide whether DNA damage is severe enough to trigger apoptosis directly through the mitochondrial p53 pathway, while the second step is to determine whether the damage is fixed after cell cycle arrest. Such a mechanism may represent an efficient and reliable control mode, avoiding unnecessary death or greatly promoting the execution of apoptosis. It was also demonstrated that nuclear p53 can inhibit the pro-apoptotic activity of mitochondrial p53 by transactivating p21, and Mdm2 can facilitate apoptosis by promoting the mono-ubiquitination of p53. These results are either in good agreement with experimental observations or experimentally testable. Our work suggests that both the transcription-independent and -dependent p53 activities are indispensable for a reliable choice of cell fate and also provides clues to therapeutic manipulation of the p53 pathway in cancer treatment.	[Tian, Xiao-Jun] Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing, Jiangsu, Peoples R China; Nanjing Univ, Dept Phys, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Tian, XJ (corresponding author), Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing, Jiangsu, Peoples R China.	fliu@nju.edu.cn; wangwei@nju.edu.cn	Tian, Xiaojun/M-9242-2014; Liu, Feng/E-1462-2011; Zhang, Xiao-Peng/E-1973-2011; tian, xiaojun/AAW-4984-2020	Tian, Xiaojun/0000-0002-5601-2057; Zhang, Xiao-Peng/0000-0001-8170-1236; tian, xiaojun/0000-0002-5601-2057; Zhang, Xiao-Peng/0000-0002-0183-2760	National Basic Research Program of China [2007CB814806]; National Natural Science Foundation of China [11175084]; Natural Science Foundation of Jiangsu Province [BK2009008]; Program for New Century Excellent Talents in Universities [NCET-08-0269]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Basic Research Program of China (2007CB814806), the National Natural Science Foundation of China (11175084), the Natural Science Foundation of Jiangsu Province (BK2009008), the Program for New Century Excellent Talents in Universities (NCET-08-0269), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2006, INT J RADIAT BIOL, V82, P761, DOI 10.1080/09553000600949624; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Brooks CL, 2007, J BIOL CHEM, V282, P22804, DOI 10.1074/jbc.M700961200; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Deb SP, 2003, MOL CANCER RES, V1, P1009; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Janicke RU, 2007, CELL CYCLE, V6, P407; Janicke RU, 2008, CELL DEATH DIFFER, V15, P959, DOI 10.1038/cdd.2008.33; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kokontis JM, 2001, ONCOGENE, V20, P659, DOI 10.1038/sj.onc.1204139; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Pu T, 2010, BIOPHYS J, V99, P1696, DOI 10.1016/j.bpj.2010.07.042; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steele AJ, 2008, BLOOD, V112, P3827, DOI 10.1182/blood-2008-05-156380; Stewart RD, 2001, RADIAT RES, V156, P365, DOI 10.1667/0033-7587(2001)156[0365:TLKMOD]2.0.CO;2; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Vaseva AV, 2009, CELL CYCLE, V8, P1711, DOI 10.4161/cc.8.11.8596; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang TL, 2009, BIOPHYS J, V97, P415, DOI 10.1016/j.bpj.2009.04.053; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426	55	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38164	10.1371/journal.pone.0038164	http://dx.doi.org/10.1371/journal.pone.0038164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679490	gold, Green Published			2022-12-27	WOS:000305343900019
J	Wei, CH; Kao, HY; Lu, ZY				Wei, Chih-Hsuan; Kao, Hung-Yu; Lu, Zhiyong			SR4GN: A Species Recognition Software Tool for Gene Normalization	PLOS ONE			English	Article							ENTITIES	As suggested in recent studies, species recognition and disambiguation is one of the most critical and challenging steps in many downstream text-mining applications such as the gene normalization task and protein-protein interaction extraction. We report SR4GN: an open source tool for species recognition and disambiguation in biomedical text. In addition to the species detection function in existing tools, SR4GN is optimized for the Gene Normalization task. As such it is developed to link detected species with corresponding gene mentions in a document. SR4GN achieves 85.42% in accuracy and compares favorably to the other state-of-the-art techniques in benchmark experiments. Finally, SR4GN is implemented as a standalone software tool, thus making it convenient and robust for use in many text-mining applications. SR4GN can be downloaded at: http://www.ncbi.nlm.nih.gov/CBBresearch/Lu/downloads/SR4GN	[Wei, Chih-Hsuan; Lu, Zhiyong] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Wei, Chih-Hsuan; Kao, Hung-Yu] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Cheng Kung University	Wei, CH (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.	zhiyong.lu@nih.gov	Lu, Zhiyong/H-3622-2016	Lu, Zhiyong/0000-0001-9998-916X; Kao, Hung-Yu/0000-0002-8890-8544	National Institutes of Health, National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIALM000002] Funding Source: NIH RePORTER	National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research is supported by the Intramural Research Program of the National Institutes of Health, National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASU D, 1980, J AM STAT ASSOC, V75, P575, DOI 10.2307/2287648; Baumgartner WA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S9; Bontcheva K., 2004, Natural Language Engineering, V10, P349, DOI 10.1017/S1351324904003468; Carroll HD, 2010, BIOINFORMATICS, V26, P1708, DOI 10.1093/bioinformatics/btq270; Cunningham H., 2002, ACL, P168; Gerner M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-85; Hakenberg J, 2008, BIOINFORMATICS, V24, pI126, DOI 10.1093/bioinformatics/btn299; Hakenberg J, 2011, BIOINFORMATICS, V27, P2769, DOI 10.1093/bioinformatics/btr455; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Hsu CN, 2008, BIOINFORMATICS, V24, pI286, DOI 10.1093/bioinformatics/btn183; Kano Y, 2009, BIOINFORMATICS, V25, P1997, DOI 10.1093/bioinformatics/btp289; Kappeler T, 2009, TASK AUTOMATIC DETEC, P80; Krallinger M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S3; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Lu Z., 2011, BMC BIOINFORMATICS, V12; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Mu T, 2010, IMBALANCED CLASSIFIC, P851; Naderi N, 2011, BIOINFORMATICS, V27, P2721, DOI 10.1093/bioinformatics/btr452; Wang XL, 2010, BIOINFORMATICS, V26, P661, DOI 10.1093/bioinformatics/btq002; Wei C. H., 2012, P BIOCREATIVE 2012 W, P145; Wei C.-H., 2011, BMC BIOINFORMATICS, V12; Wei C-H, 2010, REPRESENTED INDICATO, V2010, P657	22	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38460	10.1371/journal.pone.0038460	http://dx.doi.org/10.1371/journal.pone.0038460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679507	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900045
J	Pitman, RT; Fong, JT; Billman, P; Puri, N				Pitman, Ryan T.; Fong, Jason T.; Billman, Penny; Puri, Neelu			Knockdown of the Fat Mass and Obesity Gene Disrupts Cellular Energy Balance in a Cell-Type Specific Manner	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FTO GENE; FOOD-INTAKE; GLUCOSE-UPTAKE; INHIBITION; VARIANT; MUSCLE; AMPK; DIFFERENTIATION; OVEREXPRESSION	Recent studies suggest that FTO variants strongly correlate with obesity and mainly influence energy intake with little effect on the basal metabolic rate. We suggest that FTO influences eating behavior by modulating intracellular energy levels and downstream signaling mechanisms which control energy intake and metabolism. Since FTO plays a particularly important role in adipocytes and in hypothalamic neurons, SH-SY5Y neuronal cells and 3T3-L1 adipocytes were used to understand how siRNA mediated knockdown of FTO expression alters cellular energy homeostasis. Cellular energy status was evaluated by measuring ATP levels using a luminescence assay and uptake of fluorescent glucose. FTO siRNA in SH-SY5Y cells mediated mRNA knockdown (-82%), increased ATP concentrations by up to 46% (P = 0.013) compared to controls, and decreased phosphorylation of AMPk and Akt in SH-SY5Y by -52% and -46% respectively as seen by immunoblotting. In contrast, FTO siRNA in 3T3-L1 cells decreased ATP concentration by -93% (p<0.0005), and increased AMPk and Akt phosphorylation by 204% and 70%, respectively suggesting that FTO mediates control of energy levels in a cell-type specific manner. Furthermore, glucose uptake was decreased in both SH-SY5Y (-51% p = 0.015) and 3T3-L1 cells (-30%, p = 0.0002). We also show that FTO knockdown decreases NPY mRNA expression in SH-SY5Y cells (-21%) through upregulation of pSTAT3 (118%). These results provide important evidence that FTO-variant linked obesity may be associated with altered metabolic functions through activation of downstream metabolic mediators including AMPk.	[Pitman, Ryan T.; Fong, Jason T.; Billman, Penny; Puri, Neelu] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford	Pitman, RT (corresponding author), Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA.	neelupur@uic.edu		Pitman, Ryan/0000-0003-4468-4347	University of Illinois at Chicago	University of Illinois at Chicago	The authors would like to acknowledge the Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago for financial support towards the open access publishing fee for this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Coll AP, 2009, MOL CELL ENDOCRINOL, V300, P147, DOI 10.1016/j.mce.2008.09.007; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gonzalez JA, 2009, J PHYSIOL-LONDON, V587, P41, DOI 10.1113/jphysiol.2008.163410; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Grunnet LG, 2009, J CLIN ENDOCR METAB, V94, P596, DOI 10.1210/jc.2008-1592; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Jing M, 2006, AM J PHYSIOL-CELL PH, V290, pC484, DOI 10.1152/ajpcell.00321.2005; Kohno D, 2011, NEUROSCI LETT, V499, P194, DOI 10.1016/j.neulet.2011.05.060; Kola B, 2008, J NEUROENDOCRINOL, V20, P942, DOI 10.1111/j.1365-2826.2008.01745.x; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Olszewski PK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-129; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Poritsanos NJ, 2010, BIOCHEM BIOPH RES CO, V400, P713, DOI 10.1016/j.bbrc.2010.08.133; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Ropelle ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003856; Russo VC, 2004, BRAIN RES, V1009, P40, DOI 10.1016/j.brainres.2004.02.042; Rutters F, 2010, PATIENT EDUC COUNS, V79, P367, DOI 10.1016/j.pec.2010.03.013; SADOWSKI HB, 1992, J BIOL CHEM, V267, P4722; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; Shah AK, 2011, ARCH BIOCHEM BIOPHYS, V509, P142, DOI 10.1016/j.abb.2011.03.005; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Tews D, 2010, HORM METAB RES, V43, P17; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wu Q, 2010, BIOCHEM BIOPH RES CO, V401, P390, DOI 10.1016/j.bbrc.2010.09.064; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	41	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38444	10.1371/journal.pone.0038444	http://dx.doi.org/10.1371/journal.pone.0038444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675562	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700074
J	Karve, TM; Preet, A; Sneed, R; Salamanca, C; Li, X; Xu, JW; Kumar, D; Rosen, EM; Saha, T				Karve, Tejaswita M.; Preet, Anju; Sneed, Rosie; Salamanca, Clara; Li, Xin; Xu, Jingwen; Kumar, Deepak; Rosen, Eliot M.; Saha, Tapas			BRCA1 Regulates Follistatin Function in Ovarian Cancer and Human Ovarian Surface Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACTIVIN-BINDING PROTEIN; TGF-BETA; BREAST-CANCER; POSTMENOPAUSAL WOMEN; TUMOR-SUPPRESSOR; II RECEPTORS; FEMALE REPRODUCTION; GENE-EXPRESSION; SERUM INHIBIN	Follistatin (FST), a folliculogenesis regulating protein, is found in relatively high concentrations in female ovarian tissues. FST acts as an antagonist to Activin, which is often elevated in human ovarian carcinoma, and thus may serve as a potential target for therapeutic intervention against ovarian cancer. The breast cancer susceptibility gene 1 (BRCA1) is a known tumor suppressor gene in human breast cancer; however its role in ovarian cancer is not well understood. We performed microarray analysis on human ovarian carcinoma cell line SKOV3 that stably overexpress wild-type BRCA1 and compared with the corresponding empty vector-transfected clones. We found that stable expression of BRCA1 not only stimulates FST secretion but also simultaneously inhibits Activin expression. To determine the physiological importance of this phenomenon, we further investigated the effect of cellular BRCA1 on the FST secretion in immortalized ovarian surface epithelial (IOSE) cells derived from either normal human ovaries or ovaries of an ovarian cancer patient carrying a mutation in BRCA1 gene. Knock-down of BRCA1 in normal IOSE cells demonstrates down-regulation of FST secretion along with the simultaneous up-regulation of Activin expression. Furthermore, knock-down of FST in IOSE cell lines as well as SKOV3 cell line showed significantly reduced cell proliferation and decreased cell migration when compared with the respective controls. Thus, these findings suggest a novel function for BRCA1 as a regulator of FST expression and function in human ovarian cells.	[Karve, Tejaswita M.; Preet, Anju; Xu, Jingwen; Rosen, Eliot M.; Saha, Tapas] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Karve, Tejaswita M.] Georgetown Univ, Sch Med, Dept Biochem & Cellular & Mol Biol, Washington, DC USA; [Sneed, Rosie; Kumar, Deepak] Univ Dist Columbia, Washington, DC USA; [Salamanca, Clara] BC Canc Res Ctr, Canadian Ovarian Tissue Bank, Vancouver, BC, Canada; [Li, Xin] Georgetown Univ, Sch Med, Dept Biostat Bioinformat & Biomath, Washington, DC USA	Georgetown University; Georgetown University; University of the District of Columbia; British Columbia Cancer Agency; Georgetown University	Karve, TM (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA.	ts283@georgetown.edu	xu, jing/GRR-8698-2022		American Cancer Society [97-152-16-2]; Fisher Center for Familial Cancer Center; Lombardi Comprehensive Cancer Center; Georgetown University; National Institutes of Health [1U56CA101429-01]; USPHS [R01-CA150646]; Susan G. Komen for the Cure [KG110580]; Living in Pink; World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10069]; NATIONAL CANCER INSTITUTE [U56CA101429, R01CA150646] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Fisher Center for Familial Cancer Center; Lombardi Comprehensive Cancer Center; Georgetown University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Living in Pink; World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Tapas Saha is thankful to American Cancer Society (IRG #97-152-16-2), Fisher Center for Familial Cancer Center, Lombardi Comprehensive Cancer Center, Georgetown University for financial support. This work was supported, in part, by National Institutes of Health Grants 1U56CA101429-01 (to Dr. Peter Shield, Deepak Kumar and Dr. Carolyn Cousin). Eliot M. Rosen has been supported, in part, by research grants from the USPHS (R01-CA150646), Susan G. Komen for the Cure (KG110580), Living in Pink, and the World Class University program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Antony ML, 2010, J CANCER RES CLIN, V136, P351, DOI 10.1007/s00432-009-0703-4; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Berchuck A, 1996, AM J OBSTET GYNECOL, V175, P738; BERCHUCK A, 1992, AM J OBSTET GYNECOL, V166, P676, DOI 10.1016/0002-9378(92)91697-9; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bloise E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-320; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Brunsvold Amy N, 2005, J Am Acad Nurse Pract, V17, P518, DOI 10.1111/j.1745-7599.2005.00091.x; Burdette JE, 2007, ENDOCR-RELAT CANCER, V14, P679, DOI 10.1677/ERC-07-0054; Calp MK, 2003, GEN COMP ENDOCR, V132, P142, DOI 10.1016/S0016-6480(03)00060-1; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen T, 2001, CANCER RES, V61, P4679; Cipriano SC, 2000, ENDOCRINOLOGY, V141, P2319, DOI 10.1210/en.141.7.2319; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Dignass AU, 2002, SCAND J GASTROENTERO, V37, P936, DOI 10.1080/003655202760230900; DiSimone N, 1996, ENDOCRINOLOGY, V137, P486, DOI 10.1210/en.137.2.486; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; ELLIOTT WM, 1993, IN VITRO CELL DEV-AN, V29A, P9; Fan SJ, 1998, ONCOGENE, V16, P3069, DOI 10.1038/sj.onc.1202116; Gao XW, 2007, FEBS LETT, V581, P5505, DOI 10.1016/j.febslet.2007.10.059; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; HEALY DL, 1993, NEW ENGL J MED, V329, P1539, DOI 10.1056/NEJM199311183292104; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Karve TM, 2012, FUNCT INTEGR GENOMIC, V12, P63, DOI 10.1007/s10142-011-0251-2; Kashimada K, 2011, ENDOCRINOLOGY, V152, P272, DOI 10.1210/en.2010-0636; Kozian DH, 1997, LAB INVEST, V76, P267; Krneta J, 2006, CANCER RES, V66, P5686, DOI 10.1158/0008-5472.CAN-05-3821; KRUK PA, 1990, LAB INVEST, V63, P132; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Li HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007091; LINDSELL CE, 1994, J REPROD FERTIL, V100, P591, DOI 10.1530/jrf.0.1000591; Mabuchi Y, 2006, ONCOL REP, V16, P373; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Menon U, 2000, BRIT J OBSTET GYNAEC, V107, P1069, DOI 10.1111/j.1471-0528.2000.tb11102.x; Metcalfe KA, 2009, BRIT J CANCER, V100, P421, DOI 10.1038/sj.bjc.6604830; Muttukrishna S, 2004, MOL CELL ENDOCRINOL, V225, P45, DOI 10.1016/j.mce.2004.02.012; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Ogino H, 2008, CLIN CANCER RES, V14, P660, DOI 10.1158/1078-0432.CCR-07-1221; Ong A, 2000, INT J CANCER, V85, P430, DOI 10.1002/(SICI)1097-0215(20000201)85:3<430::AID-IJC21>3.0.CO;2-Q; Otsuka F, 2001, BIOCHEM BIOPH RES CO, V289, P961, DOI 10.1006/bbrc.2001.6103; Razanajaona D, 2007, CANCER RES, V67, P7223, DOI 10.1158/0008-5472.CAN-07-0805; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Robertson DM, 2002, J CLIN ENDOCR METAB, V87, P816, DOI 10.1210/jc.87.2.816; Rossmanith W, 2002, MOL CARCINOGEN, V35, P1, DOI 10.1002/mc.10068; Ruspita I, 2008, J MED INVESTIG, V55, P87, DOI 10.2152/jmi.55.87; Saha T, 2006, ONCOGENE, V25, P693, DOI 10.1038/sj.onc.1209123; Saha T, 2010, J BIOL CHEM, V25; Saha T, 2009, FEBS LETT, V583, P1535, DOI 10.1016/j.febslet.2009.04.005; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sonoyama K, 2003, AM J PHYSIOL-GASTR L, V284, pG989, DOI 10.1152/ajpgi.00384.2002; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Thomas TZ, 1997, J CLIN ENDOCR METAB, V82, P3851, DOI 10.1210/jc.82.11.3851; Tinelli A, 2009, CURR GENOMICS, V10, P240, DOI 10.2174/138920209788488553; Tsigkou A, 2007, J CLIN ENDOCR METAB, V92, P2526, DOI 10.1210/jc.2007-0235; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; VALE W, 1988, RECENT PROG HORM RES, V44, P1; Vale W., 1990, HDB EXPT PHARM, P211; Wang D, 2000, CANCER RES, V60, P4507; Wang D, 2000, INT J ONCOL, V17, P1087; Welt CK, 2002, CURR OPIN OBSTET GYN, V14, P317, DOI 10.1097/00001703-200206000-00012; Welt CK, 1997, J CLIN ENDOCR METAB, V82, P3720, DOI 10.1210/jc.82.11.3720; Whittemore AS, 1997, AM J HUM GENET, V60, P496; Xu CF, 1996, SEMIN CANCER BIOL, V7, P33, DOI 10.1006/scbi.1996.0005; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; ZHOU L, 1992, BIOCHIM BIOPHYS ACTA, V1180, P130, DOI 10.1016/0925-4439(92)90061-Q	72	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37697	10.1371/journal.pone.0037697	http://dx.doi.org/10.1371/journal.pone.0037697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22685544	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339900007
J	Li, H; Song, Y; Zhang, LJ; Gu, Y; Li, FF; Pan, SY; Jiang, LN; Liu, F; Ye, J; Li, Q				Li, Hang; Song, Yue; Zhang, Li-Jun; Gu, Yu; Li, Fan-Fan; Pan, Shu-Yi; Jiang, Li-Na; Liu, Fang; Ye, Jing; Li, Qing			LSDP5 Enhances Triglyceride Storage in Hepatocytes by Influencing Lipolysis and Fatty Acid beta-Oxidation of Lipid Droplets	PLOS ONE			English	Article							CELL-DEATH; PROTEIN; ADIPOCYTES; EXPRESSION; LIVER; DIFFERENTIATION; LIPOGENESIS; DISORDERS; TISSUES; OBESITY	Lipid storage droplet protein 5 (LSDP5) is a lipid droplet-associated protein of the PAT (perilipin, adipophilin, and TIP47) family that is expressed in the liver in a peroxisome proliferator-activated receptor alpha (PPAR alpha)-dependent manner; however, its exact function has not been elucidated. We noticed that LSDP5 was localized to the surface of lipid droplets in hepatocytes. Overexpression of LSDP5 enhanced lipid accumulation in the hepatic cell line AML12 and in primary hepatocytes. Knock-down of LSDP5 significantly decreased the triglyceride content of lipid droplets, stimulated lipolysis, and modestly increased the mitochondrial content and level of fatty-acid beta-oxidation in the mitochondria. The expression of PPARa was increased in LSDP5-deficient cells and required for the increase in the level of fatty acid b-oxidation in LSDP5-deficient cells. Using serial deletions of LSDP5, we determined that the lipid droplet-targeting domain and the domain directing lipid droplet clustering overlapped and were localized to the 188 amino acid residues at the N-terminus of LSDP5. Our findings suggest that LSDP5, a novel lipid droplet protein, may contribute to triglyceride accumulation by negatively regulating lipolysis and fatty acid oxidation in hepatocytes.	[Li, Hang; Song, Yue; Gu, Yu; Li, Fan-Fan; Jiang, Li-Na; Liu, Fang; Ye, Jing; Li, Qing] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Li, Hang; Song, Yue; Gu, Yu; Li, Fan-Fan; Jiang, Li-Na; Liu, Fang; Ye, Jing; Li, Qing] Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, Xian 710032, Peoples R China; [Zhang, Li-Jun] Fourth Mil Med Univ, Tangdu Hosp, Dept Clin Lab, Xian 710032, Peoples R China; [Li, Hang; Pan, Shu-Yi] Chinese Peoples Liberat Army, Hyperbar Oxygen Ctr, Navy Gen Hosp, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Sixth Medical Center of Chinese PLA General Hospital	Li, H (corresponding author), Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Peoples R China.	yejing@fmmu.edu.cn; liqing@fmmu.edu.cn		, Yue/0000-0003-2731-3464	National Natural Science Foundation of China [30671087, 30700268, 30772261, 81000171, 81070249]; National Special Foundation for Key Drug Innovation of China [2009ZX09102-226]; Natural Science Foundation of Shaanxi Province [2007C204]; Fourth Military Medical University [2008D03];  [CBSKL2008006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Foundation for Key Drug Innovation of China; Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fourth Military Medical University; 	This work was supported by grants from the National Natural Science Foundation of China (30671087, 30700268, 30772261, 81000171 and 81070249), the National Special Foundation for Key Drug Innovation of China (2009ZX09102-226), the Natural Science Foundation of Shaanxi Province (2007C204), and the Doctoral Assistant Fund of the Fourth Military Medical University (2008D03) and CBSKL2008006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Grasselli E, 2010, INT J MOL MED, V25, P505, DOI 10.3892/ijmm_00000370; Kohjima M, 2007, INT J MOL MED, V20, P351; Li FF, 2010, FEBS J, V277, P4173, DOI 10.1111/j.1742-4658.2010.07806.x; Li H, 2010, INT J MOL MED, V26, P231, DOI 10.3892/ijmm_00000457; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Liu Fang, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P438; Liu Fang, 2009, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V25, P306; Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026; Minnaard R, 2009, J CLIN ENDOCR METAB, V94, P4077, DOI 10.1210/jc.2009-0352; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zhang LY, 2009, INT J ONCOL, V35, P25, DOI 10.3892/ijo_00000309	36	30	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e36712	10.1371/journal.pone.0036712	http://dx.doi.org/10.1371/journal.pone.0036712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675471	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900003
J	Martinelli, F; Uratsu, SL; Albrecht, U; Reagan, RL; Phu, ML; Britton, M; Buffalo, V; Fass, J; Leicht, E; Zhao, WX; Lin, DW; D'Souza, R; Davis, CE; Bowman, KD; Dandekar, AM				Martinelli, Federico; Uratsu, Sandra L.; Albrecht, Ute; Reagan, Russell L.; Phu, My L.; Britton, Monica; Buffalo, Vincent; Fass, Joseph; Leicht, Elizabeth; Zhao, Weixiang; Lin, Dawei; D'Souza, Raissa; Davis, Cristina E.; Bowman, Kim D.; Dandekar, Abhaya M.			Transcriptome Profiling of Citrus Fruit Response to Huanglongbing Disease	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER-ASIATICUS; SAO-PAULO STATE; GENE-EXPRESSION; PCR DETECTION; CROSS-TALK; PROTEIN; SUGAR; SEQUENCE; IDENTIFICATION; CARBOHYDRATE	Huanglongbing (HLB) or "citrus greening" is the most destructive citrus disease worldwide. In this work, we studied host responses of citrus to infection with Candidatus Liberibacter asiaticus (CaLas) using next-generation sequencing technologies. A deep mRNA profile was obtained from peel of healthy and HLB-affected fruit. It was followed by pathway and protein-protein network analysis and quantitative real time PCR analysis of highly regulated genes. We identified differentially regulated pathways and constructed networks that provide a deep insight into the metabolism of affected fruit. Data mining revealed that HLB enhanced transcription of genes involved in the light reactions of photosynthesis and in ATP synthesis. Activation of protein degradation and misfolding processes were observed at the transcriptomic level. Transcripts for heat shock proteins were down-regulated at all disease stages, resulting in further protein misfolding. HLB strongly affected pathways involved in source-sink communication, including sucrose and starch metabolism and hormone synthesis and signaling. Transcription of several genes involved in the synthesis and signal transduction of cytokinins and gibberellins was repressed while that of genes involved in ethylene pathways was induced. CaLas infection triggered a response via both the salicylic acid and jasmonic acid pathways and increased the transcript abundance of several members of the WRKY family of transcription factors. Findings focused on the fruit provide valuable insight to understanding the mechanisms of the HLB-induced fruit disorder and eventually developing methods based on small molecule applications to mitigate its devastating effects on fruit production.	[Martinelli, Federico; Uratsu, Sandra L.; Reagan, Russell L.; Phu, My L.; Dandekar, Abhaya M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Albrecht, Ute; Bowman, Kim D.] ARS, USDA, US Hort Res Lab, Ft Pierce, FL USA; [Leicht, Elizabeth; Zhao, Weixiang; D'Souza, Raissa; Davis, Cristina E.] Univ Calif Davis, Mech & Aerosp Engn Dept, Davis, CA 95616 USA; [Leicht, Elizabeth; D'Souza, Raissa] Univ Calif Davis, Ctr Computat Sci & Engn, Davis, CA 95616 USA; [Britton, Monica; Buffalo, Vincent; Fass, Joseph; Lin, Dawei] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Martinelli, Federico] Univ Palermo, Dipartimento Sistemi Agroambientali, Palermo, Italy	University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Palermo	Martinelli, F (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	amdandekar@ucdavis.edu	Buffalo, Vince/J-1647-2019; Davis, Cristina E/C-4437-2008; Martinelli, Federico/F-7697-2013	Buffalo, Vince/0000-0003-4510-1609; Dandekar, Abhaya/0000-0001-7925-4086	Florida Citrus Advanced Technology Program	Florida Citrus Advanced Technology Program	This work was supported by a grant received from the Florida Citrus Advanced Technology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2008, 11 INT CITR C ICC WU; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; ALMOGUERA C, 1995, PLANT PHYSIOL, V107, P765, DOI 10.1104/pp.107.3.765; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Boccara M, 2007, BIOCHIMIE, V89, P1252, DOI 10.1016/j.biochi.2007.04.011; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Duan Y, 2009, PHYTOPATHOLOGY, V99, pS157; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; Etxeberria E, 2009, PHYSIOL MOL PLANT P, V74, P76, DOI 10.1016/j.pmpp.2009.09.004; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fan J, 2010, PLANT PATHOL, V59, P1037, DOI 10.1111/j.1365-3059.2010.02328.x; Fan J, 2011, PHYSIOL PLANTARUM, V143, P235, DOI 10.1111/j.1399-3054.2011.01502.x; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gibly A, 2004, MOL PLANT MICROBE IN, V17, P1212, DOI 10.1094/MPMI.2004.17.11.1212; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Goffard N, 2007, NUCLEIC ACIDS RES, V35, pW176, DOI 10.1093/nar/gkm261; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Herbers K, 2000, MOL PLANT PATHOL, V1, P51, DOI 10.1046/j.1364-3703.2000.00007.x; Hocquellet A, 1999, MOL CELL PROBE, V13, P373, DOI 10.1006/mcpr.1999.0263; Holzmuller P, 2008, ANN NY ACAD SCI, V1149, P66, DOI 10.1196/annals.1428.061; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Kanzaki H, 2008, PLANTA, V228, P977, DOI 10.1007/s00425-008-0797-y; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Leon-Reyes A, 2009, PLANT PHYSIOL, V149, P1797, DOI 10.1104/pp.108.133926; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Lin H, 2008, MOL CELL PROBE, V22, P30, DOI 10.1016/j.mcp.2007.06.006; Lucas WJ, 1999, CURR OPIN PLANT BIOL, V2, P192, DOI 10.1016/S1369-5266(99)80035-1; Mercke P, 2004, PLANT PHYSIOL, V135, P2012, DOI 10.1104/pp.104.048116; Moreno AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031944; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; NIELSEN KK, 1994, PLANT MOL BIOL, V25, P241, DOI 10.1007/BF00023241; Panthee DR, 2007, FUNCT INTEGR GENOMIC, V7, P291, DOI 10.1007/s10142-007-0045-8; Perata P, 1997, PLANT CELL, V9, P2197, DOI 10.1105/tpc.9.12.2197; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Roitsch T, 1999, CURR OPIN PLANT BIOL, V2, P198, DOI 10.1016/S1369-5266(99)80036-3; Rosales R, 2011, J PLANT GROWTH REGUL, V30, P312, DOI 10.1007/s00344-011-9193-0; Sabehat A, 1998, PLANT PHYSIOL, V117, P651, DOI 10.1104/pp.117.2.651; SADKA A, 1994, PLANT CELL, V6, P737, DOI 10.1105/tpc.6.5.737; Sakamoto T, 2006, PLANT PHYSIOL, V142, P54, DOI 10.1104/pp.106.085811; Salzman RA, 1998, PLANT PHYSIOL, V117, P465, DOI 10.1104/pp.117.2.465; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; STITT M, 1995, ANNU REV PLANT PHYS, V46, P341, DOI 10.1146/annurev.pp.46.060195.002013; Strommer Judith, 1993, P49; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Teixeira DC, 2008, MOL CELL PROBE, V22, P139, DOI 10.1016/j.mcp.2007.12.006; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; van den Brule S, 2002, PLANTA, V216, P95, DOI 10.1007/s00425-002-0889-z; VONSCHAEWEN A, 1990, EMBO J, V9, P3033, DOI 10.1002/j.1460-2075.1990.tb07499.x; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang Z, 2006, PLANT PATHOL, V55, P630, DOI 10.1111/j.1365-3059.2006.01438.x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	67	131	145	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38039	10.1371/journal.pone.0038039	http://dx.doi.org/10.1371/journal.pone.0038039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675433	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500080
J	Tetreault, MP; Alrabaa, R; McGeehan, M; Katz, JP				Tetreault, Marie-Pier; Alrabaa, Rami; McGeehan, Megan; Katz, Jonathan P.			Kruppel-Like Factor 5 Protects against Murine Colitis and Activates JAK-STAT Signaling In Vivo	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; TRANSCRIPTION FACTOR KLF5; CANCER-CELLS; PROLIFERATION; KRUPPEL-LIKE-FACTOR-5; EXPRESSION; MICE; PROGRESSION; HOMEOSTASIS	Inflammatory bowel disease (IBD), which is characterized by chronic or recurring inflammation of the gastrointestinal tract, affects 1.4 million persons in the United States alone. KLF5, a Kruppel-like factor (KLF) family member, is expressed within the epithelia of the gastrointestinal tract and has been implicated in rapid cell proliferation, migration, and remodeling in a number of tissues. Given these functions, we hypothesized that constitutive Klf5 expression would protect against the development of colitis in vivo. To examine the role of KLF5 in vivo, we used the Villin promoter to target Klf5 to the entire horizontal axis of the small intestine and colon. Villin-Klf5 transgenic mice were born at normal Mendelian ratios and appeared grossly normal to at least 1 year of age. Surprisingly, there were no significant changes in cell proliferation or in the differentiation of any of the intestinal lineages within the duodenum, jejunum, ileum, and colon of Villin-Klf5 mice, compared to littermate controls. However, when Villin-Klf5 mice were treated with dextran sodium sulfate (DSS) to induce colitis, they developed less colonic injury and significantly reduced disease activity scores than littermate controls. The mechanism for this decreased injury may come via JAK-STAT signaling, the activation of which was increased in colonic mucosa of DSS treated Villin-Klf5 mice compared to controls. Thus, KLF5 and its downstream mediators may provide therapeutic targets and disease markers for IBD or other diseases characterized by injury and disruption of intestinal epithelia.	[Tetreault, Marie-Pier; Alrabaa, Rami; McGeehan, Megan; Katz, Jonathan P.] Univ Penn, Perelman Sch Med, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Tetreault, MP (corresponding author), Univ Penn, Perelman Sch Med, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA.	jpkatz@mail.med.upenn.edu	Tetreault, Marie-Pier/K-7950-2013		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health [R01 DK080031, DK080031-02S1]; NIDDK [P30 DK050306]; University of Pennsylvania Center for Molecular Studies in Digestive and Liver Diseases; Molecular Biology/Gene Expression Core; National Cancer Institute (NCI) of the National Institutes of Health [P01 CA098101]; NATIONAL CANCER INSTITUTE [P01CA098101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK080031] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Pennsylvania Center for Molecular Studies in Digestive and Liver Diseases; Molecular Biology/Gene Expression Core; National Cancer Institute (NCI) of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health through R01 DK080031 and DK080031-02S1 to JPK; the NIDDK through P30 DK050306, the University of Pennsylvania Center for Molecular Studies in Digestive and Liver Diseases, which includes the Molecular Pathology and Imaging Core, the Cell Culture Core, the Transgenic and Chimeric Mouse Facility, and the Molecular Biology/Gene Expression Core; and the National Cancer Institute (NCI) of the National Institutes of Health through P01 CA098101 ("Mechanisms of Esophageal Carcinogenesis"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Alonzi T, 2004, CYTOKINE, V26, P45, DOI 10.1016/j.cyto.2003.12.002; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chanchevalap S, 2004, FEBS LETT, V578, P99, DOI 10.1016/j.febslet.2004.10.079; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; COOPER HS, 1993, LAB INVEST, V69, P238; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Gibson DL, 2010, GASTROENTEROLOGY, V139, P1277, DOI 10.1053/j.gastro.2010.06.057; Goldsmith JR, 2011, AM J PATHOL, V179, P673, DOI 10.1016/j.ajpath.2011.04.032; Goldstein BG, 2007, AM J PHYSIOL-GASTR L, V292, pG1784, DOI 10.1152/ajpgi.00541.2006; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; KARAM SM, 1999, FRONT BIOSCI, V4, P286; Katz JP, 2002, GASTROENTEROL CLIN N, V31, P379, DOI 10.1016/S0889-8553(02)00006-7; Kumekawa M, 2008, BIOL PHARM BULL, V31, P1609, DOI 10.1248/bpb.31.1609; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V140, P540, DOI 10.1053/j.gastro.2010.10.061; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Neufert C, 2010, CELL CYCLE, V9, P652, DOI 10.4161/cc.9.4.10615; Ohnishi S, 2000, DEV DYNAM, V217, P421, DOI 10.1002/(SICI)1097-0177(200004)217:4<421::AID-DVDY9>3.0.CO;2-1; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tetreault MP, 2008, J CELL PHYSIOL, V214, P545, DOI 10.1002/jcp.21239; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Yang YZ, 2008, J BIOL CHEM, V283, P18812, DOI 10.1074/jbc.M801384200; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Yang YZ, 2011, CANCER RES, V71, P6475, DOI 10.1158/0008-5472.CAN-11-1702; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090	48	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38338	10.1371/journal.pone.0038338	http://dx.doi.org/10.1371/journal.pone.0038338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675454	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500134
J	Kanamarlapudi, V; Owens, SE; Lartey, J; Bernal, AL				Kanamarlapudi, Venkateswarlu; Owens, Sian E.; Lartey, Jon; Bernal, Andres Lopez			ADP-Ribosylation Factor 6 Expression and Activation Are Reduced in Myometrium in Complicated Pregnancies	PLOS ONE			English	Article							LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR; PROTEIN-COUPLED RECEPTOR; PHOSPHOLIPASE-D; SMOOTH-MUSCLE; NUCLEOTIDE EXCHANGE; MYOSIN PHOSPHATASE; RAT MYOMETRIUM; GROWTH-FACTOR; ARF6; MEMBRANE	Background: ARF6 (ADP-ribosylation factor 6) small GTP binding protein plays critical roles in actin cytoskeleton rearrangements and membrane trafficking, including internalisation of G protein coupled receptors (GPCR). ARF6 operates by cycling between GDP-bound (inactive) and GTP-bound (active) forms and is a potential regulator of GPCR-mediated uterine activity during pregnancy and labour. ARF6 contains very low intrinsic GTP binding activity and depends on GEFs (guanine nucleotide exchange factors) such as CYTH3 (cytohesin 3) to bind GTP. ARF6 and CYTH3 were originally cloned from human placenta, but there is no information on their expression in other reproductive tissues. Methods: The expression of ARF6, ARF1, and CYTH1-4 was investigated by measuring mRNA (using RT-PCR) and protein levels (using immunoblotting) in samples of myometrium obtained from non-pregnant women, and women with normal pregnancies, before or after the spontaneous onset of labour. We also analysed myometrial samples from women with spontaneous preterm labour and from women with complicated pregnancies requiring emergency preterm delivery. The GST)-effector pull down assay was used to study the presence of active ARF6 and ARF1 in all myometrial extracts. Results: ARF6, ARF1 and CYTH3 but not CYTH1, CYTH2 and CYTH4 were expressed in all samples and the levels did not change with pregnancy or labour. However, ARF6 and CYTH3 but not ARF1 levels were significantly reduced in complicated pregnancies. The alterations in the expression of ARF6 and its GEF in human myometrium indicate a potential involvement of this signalling system in modulating the response of myometrial smooth muscle in complicated pregnancies. The levels of ARF6-GTP or ARF1-GTP did not change with pregnancy or labour but ARF6-GTP levels were significantly decreased in women with severe complications of pregnancy. Conclusions: We have demonstrated a functional ARF6 system in human myometrium and a correlation between ARF6 level and activity in uterine and abnormal pregnancy.	[Kanamarlapudi, Venkateswarlu; Owens, Sian E.] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Lartey, Jon; Bernal, Andres Lopez] Univ Bristol, Sch Clin Sci, Div Obstet & Gynaecol, Bristol, Avon, England	Swansea University; University of Bristol	Kanamarlapudi, V (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	k.venkateswarlu@swansea.ac.uk; A.LopezBernal@bristol.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483; Owens, Sian-Eleri/0000-0003-1806-5235	Wellbeing of Women Research Training Fellowship; MRC [G0401232] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL2-Lartey] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/C515455/2] Funding Source: researchfish; Medical Research Council [G0401232] Funding Source: researchfish; National Institute for Health Research [CL-2012-01-501] Funding Source: researchfish	Wellbeing of Women Research Training Fellowship(Wellbeing of Women (WoW)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	JL was supported by a Wellbeing of Women Research Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal AL, 2007, SEMIN CELL DEV BIOL, V18, P340, DOI 10.1016/j.semcdb.2007.05.002; Bernal AL, 2003, BJOG-INT J OBSTET GY, V110, P39, DOI 10.1016/S1470-0328(03)00023-5; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; BREUILLER M, 1990, J CLIN ENDOCR METAB, V70, P1299, DOI 10.1210/jcem-70-5-1299; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; CREASY RK, 1991, NEW ENGL J MED, V325, P727, DOI 10.1056/NEJM199109053251009; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; HA KS, 1994, BIOCHEM J, V303, P55, DOI 10.1042/bj3030055; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hiroyama M, 2005, J CELL BIOCHEM, V95, P149, DOI 10.1002/jcb.20351; Hunzicker-Dunn M, 2002, FEBS LETT, V521, P3, DOI 10.1016/S0014-5793(02)02822-3; IKEBE M, 1987, J BIOL CHEM, V262, P9569; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jacobs S, 1999, FEBS LETT, V456, P384, DOI 10.1016/S0014-5793(99)00759-0; Kanamarlapudi V, 2012, J BIOL CHEM, VM112; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Lartey J, 2007, BIOL REPROD, V76, P971, DOI 10.1095/biolreprod.106.058982; Lartey J, 2006, BIOL REPROD, V75, P452, DOI 10.1095/biolreprod.105.049130; Lawrence J, 2005, MOL PHARMACOL, V67, P1822, DOI 10.1124/mol.105.011338; Le Stunff H, 2000, BIOCHEM J, V352, P491, DOI 10.1042/0264-6021:3520491; Lee YN, 2000, BIOCHEMISTRY-US, V39, P4863, DOI 10.1021/bi992272o; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Madziva MT, 2006, J BIOL CHEM, V281, P12178, DOI 10.1074/jbc.M601357200; Miko E, 2009, J REPROD IMMUNOL, V80, P100, DOI 10.1016/j.jri.2009.01.003; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Morrison JJ, 1997, BRIT J OBSTET GYNAEC, V104, P1341, DOI 10.1111/j.1471-0528.1997.tb11002.x; Mukherjee S, 2001, J BIOL CHEM, V276, P6524, DOI 10.1074/jbc.C000725200; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nonaka Y, 2002, TISSUE ANTIGENS, V60, P319, DOI 10.1034/j.1399-0039.2002.600406.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Strakova Z, 1997, AM J PHYSIOL-ENDOC M, V272, pE870, DOI 10.1152/ajpendo.1997.272.5.E870; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Venkateswarlu K, 2005, METHOD ENZYMOL, V404, P252, DOI 10.1016/S0076-6879(05)04024-3; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719; Venkateswarlu K, 1998, BIOCHEM J, V335, P139, DOI 10.1042/bj3350139; Venkateswarlu K, 2007, J CELL SCI, V120, P792, DOI 10.1242/jcs.03373; Yuan W, BMC RES NOTES, V3, P119; Yuan Wei, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS10, DOI 10.1186/1471-2393-7-S1-S10	46	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37954	10.1371/journal.pone.0037954	http://dx.doi.org/10.1371/journal.pone.0037954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666423	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400062
J	Rulker, T; Voss, L; Thullier, P; O' Brien, LM; Pelat, T; Perkins, SD; Langermann, C; Schirrmann, T; Dubel, S; Marschall, HJ; Hust, M; Hulseweh, B				Ruelker, Torsten; Voss, Luzie; Thullier, Philippe; O' Brien, Lyn M.; Pelat, Thibaut; Perkins, Stuart D.; Langermann, Claudia; Schirrmann, Thomas; Duebel, Stefan; Marschall, Hans-Juergen; Hust, Michael; Huelseweh, Birgit			Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo	PLOS ONE			English	Article							VENEZUELAN EQUINE ENCEPHALITIS; ENCEPHALOMYELITIS VIRUS-INFECTION; MONOCLONAL-ANTIBODY; PROTECTS MICE; GERMLINE HUMANIZATION; AIRBORNE CHALLENGE; PASSIVE PROTECTION; 24 H; VACCINE; DISEASE	Venezuelan equine encephalitis virus (VEEV) belongs to the Alphavirus genus and several species of this family are pathogenic to humans. The viruses are classified as potential agents of biological warfare and terrorism and sensitive detection as well as effective prophylaxis and antiviral therapies are required. In this work, we describe the isolation of the anti-VEEV single chain Fragment variable (scFv), ToR67-3B4, from a non-human primate (NHP) antibody gene library. We report its recloning into the bivalent scFv-Fc format and further immunological and biochemical characterisation. The scFv-Fc ToR67-3B4 recognised viable as well as formalin and beta-propionolactone (beta-Pl) inactivated virus particles and could be applied for immunoblot analysis of VEEV proteins and immuno-histochemistry of VEEV infected cells. It detected specifically the viral E1 envelope protein of VEEV but did not react with reduced viral glycoprotein preparations suggesting that recognition depends upon conformational epitopes. The recombinant antibody was able to detect multiple VEEV subtypes and displayed only marginal cross-reactivity to other Alphavirus species except for EEEV. In addition, the scFv-Fc fusion described here might be of therapeutic use since it successfully inactivated VEEV in a murine disease model. When the recombinant antibody was administered 6 hours post challenge, 80% to 100% of mice survived lethal VEEV IA/B or IE infection. Forty to sixty percent of mice survived when scFv-Fc ToR67-3B4 was applied 6 hours post challenge with VEEV subtypes II and former IIIA. In combination with E2-neutralising antibodies the NHP antibody isolated here could significantly improve passive protection as well as generic therapy of VEE.	[Ruelker, Torsten; Schirrmann, Thomas; Duebel, Stefan; Hust, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, D-38106 Braunschweig, Germany; [Voss, Luzie; Langermann, Claudia; Marschall, Hans-Juergen; Huelseweh, Birgit] ABC Schutz, WIS, Munster, Germany; [Thullier, Philippe; Pelat, Thibaut] CRSSA IRBA, La Tronche, France; [O' Brien, Lyn M.; Perkins, Stuart D.] Dept Biomed Sci, Def Sci & Technol Lab, Salisbury, Wilts, England	Braunschweig University of Technology; Defence Science & Technology Laboratory	Rulker, T (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, D-38106 Braunschweig, Germany.	birgithuelseweh@bwb.org		Dubel, Stefan/0000-0001-8811-7390; Hust, Michael/0000-0003-3418-6045; Pelat, thibaut/0000-0003-4312-1032				ALEVIZATOS AC, 1967, AM J TROP MED HYG, V16, P762, DOI 10.4269/ajtmh.1967.16.762; [Anonymous], GUID CAR US LAB AN; Bennett AM, 2000, VACCINE, V19, P337, DOI 10.1016/S0264-410X(00)00123-7; BERGE TO, 1961, J IMMUNOL, V87, P509; CASAMASSIMA AC, 1987, TERATOLOGY, V36, P287, DOI 10.1002/tera.1420360303; Charles PC, 2001, VIROLOGY, V284, P190, DOI 10.1006/viro.2001.0878; CHARLES PC, 1995, VIROLOGY, V208, P662, DOI 10.1006/viro.1995.1197; Dai X, 2008, TR2008050 DRDC SUFF; DEMUCHAMACIAS J, 1965, AM J TROP MED HYG, V14, P475, DOI 10.4269/ajtmh.1965.14.475; DIETZ WH, 1979, AM J TROP MED HYG, V28, P329, DOI 10.4269/ajtmh.1979.28.329; Duggan JM, 2001, VIRAL IMMUNOL, V14, P263, DOI 10.1089/088282401753266774; EDDY GA, 1972, INFECT IMMUN, V5, P160, DOI 10.1128/IAI.5.2.160-163.1972; Ehricht Ralf, 2009, V509, P85, DOI 10.1007/978-1-59745-372-1_6; Goodchild SA, 2011, ANTIVIR RES, V90, P1, DOI 10.1016/j.antiviral.2011.01.010; GREISERWILKE I, 1989, J GEN VIROL, V70, P743, DOI 10.1099/0022-1317-70-3-743; GREISERWILKE IM, 1991, J CLIN MICROBIOL, V29, P131, DOI 10.1128/JCM.29.1.131-137.1991; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; HENDERSON DW, 1952, J HYG-CAMBRIDGE, V50, P53, DOI 10.1017/S0022172400019422; Hu WG, 2010, VACCINE, V28, P5558, DOI 10.1016/j.vaccine.2010.06.038; Hu WG, 2004, J IMMUNOL METHODS, V289, P27, DOI 10.1016/j.jim.2004.03.007; Hu WG, 2002, HYBRIDOMA HYBRIDOM, V21, P415, DOI 10.1089/153685902321043945; Huelseweh B, 2006, PROTEOMICS, V6, P2972, DOI 10.1002/pmic.200500721; Hunt AR, 2006, J GEN VIROL, V87, P2467, DOI 10.1099/vir.0.81925-0; Hunt AR, 2011, VIROLOGY, V414, P146, DOI 10.1016/j.virol.2011.03.016; Hunt AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000739; HUST M, 2007, HDB THERAPEUTIC ANTI, P45; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; JENSEN MH, 1981, ACTA VET SCAND, V22, P85; Johnson K M, 1974, Adv Vet Sci Comp Med, V18, P79; Kirsch M, 2005, J IMMUNOL METHODS, V301, P173, DOI 10.1016/j.jim.2005.04.017; Kirsch MI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-66; Kubes V, 1939, SCIENCE, V90, P20, DOI 10.1126/science.90.2323.20; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luers AJ, 2005, COMP FUNCT GENOM, V6, P217, DOI 10.1002/cfg.478; Marschall HJ, 1995, EC1055 DEF R D GER 1; Marschall HJ, 1996, EC1178EC1179 DEF R 1; Martin SS, 2010, VACCINE, V28, P3143, DOI 10.1016/j.vaccine.2010.02.056; MATHEWS JH, 1985, J VIROL, V55, P594, DOI 10.1128/JVI.55.3.594-600.1985; May K. R., 1973, Journal of Aerosol Science, V4, P235, DOI 10.1016/0021-8502(73)90006-2; McCurdy K, 2011, VIROLOGY, V415, P20, DOI 10.1016/j.virol.2011.03.030; McKinney R. W., 1972, Venezuelan encephalitis-proceedings of the workshop-symposium on Venezuelan encephalitis virus., P369; MCKINNEY RW, 1963, AM J TROP MED HYG, V12, P597, DOI 10.4269/ajtmh.1963.12.597; Mollova S, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P3, DOI 10.1007/978-3-642-01147-4_1; Murphy KM, 2009, JANEWAYS IMMUNOLOGY; O'Brien LM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-206; Parker MD, 2010, J VIROL, V84, P12683, DOI 10.1128/JVI.01345-10; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Pelat T, 2009, MINI-REV MED CHEM, V9, P1633, DOI 10.2174/138955709791012283; Pelat T, 2009, MABS-AUSTIN, V1, P377, DOI 10.4161/mabs.1.4.8635; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Phillpotts RJ, 2006, VIRUS RES, V120, P107, DOI 10.1016/j.virusres.2006.02.003; Phillpotts RJ, 1999, VACCINE, V17, P982, DOI 10.1016/S0264-410X(98)00315-6; Phillpotts RJ, 2002, VACCINE, V20, P1497, DOI 10.1016/S0264-410X(01)00505-9; Pittman PR, 1996, VACCINE, V14, P337, DOI 10.1016/0264-410X(95)00168-Z; Powers AM, 1997, J VIROL, V71, P6697, DOI 10.1128/JVI.71.9.6697-6705.1997; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Pratt WD, 2003, VACCINE, V21, P3854, DOI 10.1016/S0264-410X(03)00328-1; RAYFIELD EJ, 1976, DIABETES, V25, P623, DOI 10.2337/diabetes.25.7.623; Reed DS, 2004, J INFECT DIS, V189, P1013, DOI 10.1086/382281; ROEHRIG JT, 1982, VIROLOGY, V118, P269, DOI 10.1016/0042-6822(82)90346-4; Roehrig JT, 1997, J CLIN MICROBIOL, V35, P1887, DOI 10.1128/JCM.35.7.1887-1890.1997; ROEHRIG JT, 1985, VIROLOGY, V142, P347, DOI 10.1016/0042-6822(85)90343-5; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Sagripanti JL, 2011, APPL ENVIRON MICROB, V77, P7289, DOI 10.1128/AEM.05553-11; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Schirrmann T, 2010, METHODS MOL BIOL, V651, P177, DOI 10.1007/978-1-60761-786-0_11; SCHMALJOHN AL, 1982, NATURE, V297, P70, DOI 10.1038/297070a0; SMITH JF, 1997, TXB MILITARY MED MED, P561; Soltes G, 2007, J BIOTECHNOL, V127, P626, DOI 10.1016/j.jbiotec.2006.08.015; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; SUDIA WD, 1975, AM J EPIDEMIOL, V101, P17, DOI 10.1093/oxfordjournals.aje.a112068; Thullier P, 2010, J MOL BIOL, V396, P1439, DOI 10.1016/j.jmb.2009.12.041; Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1; Wright AJ, 1998, ARCH VIROL, V143, P1155, DOI 10.1007/s007050050363; WUST CJ, 1987, P SOC EXP BIOL MED, V184, P56; WUST CJ, 1989, VIRUS RES, V13, P101, DOI 10.1016/0168-1702(89)90009-9	80	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37242	10.1371/journal.pone.0037242	http://dx.doi.org/10.1371/journal.pone.0037242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666347	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400023
J	Salari, N; Buchel, C; Rose, M				Salari, Neda; Buechel, Christian; Rose, Michael			Functional Dissociation of Ongoing Oscillatory Brain States	PLOS ONE			English	Article							RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; ALPHA-RHYTHM; COGNITIVE PERFORMANCE; NEURAL ACTIVITY; EEG; SYNCHRONIZATION; PRESTIMULUS; CORTEX; FLUCTUATIONS; NEUROFEEDBACK	The state of a neural assembly preceding an incoming stimulus is assumed to modulate the processing of subsequently presented stimuli. The nature of this state can differ with respect to the frequency of ongoing oscillatory activity. Oscillatory brain activity of specific frequency range such as alpha (8-12 Hz) and gamma (above 30 Hz) band oscillations are hypothesized to play a functional role in cognitive processing. Therefore, a selective modulation of this prestimulus activity could clarify the functional role of these prestimulus fluctuations. For this purpose, we adopted a novel non-invasive brain-computer-interface (BCI) strategy to selectively increase alpha or gamma band activity in the occipital cortex combined with an adaptive presentation of visual stimuli within specific brain states. During training, oscillatory brain activity was estimated online and fed back to the participants to enable a deliberate modulation of alpha or gamma band oscillations. Results revealed that volunteers selectively increased alpha and gamma frequency oscillations with a high level of specificity regarding frequency range and localization. At testing, alpha or gamma band activity was classified online and at defined levels of activity, visual objects embedded in noise were presented instantly and had to be detected by the volunteer. In experiment I, the effect of two levels of prestimulus gamma band activity on visual processing was examined. During phases of increased gamma band activity significantly more visual objects were detected. In experiment II, the effect was compared against increased levels of alpha band activity. An improvement of visual processing was only observed for enhanced gamma band activity. Both experiments demonstrate the specific functional role of prestimulus gamma band oscillations for perceptual processing. We propose that the BCI method permits the selective modulation of oscillatory activity and the direct assessment of behavioral consequences to test for functional dissociations of different oscillatory brain states.	[Salari, Neda; Buechel, Christian; Rose, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Salari, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	n.salari@uke.uni-hamburg.de			Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft and Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Adrian ED, 1934, J PHYSIOL-LONDON, V81, P440, DOI 10.1113/jphysiol.1934.sp003147; Babiloni C, 2006, CEREB CORTEX, V16, P1690, DOI 10.1093/cercor/bhj104; Becker R, 2011, J NEUROSCI, V31, P11016, DOI 10.1523/JNEUROSCI.0210-11.2011; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; BOYLAN C, 1989, INVEST OPHTH VIS SCI, V30, P2521; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Cannon R, 2007, INT J NEUROSCI, V117, P337, DOI 10.1080/00207450500514003; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Congedo M, 2004, IEEE T NEUR SYS REH, V12, P387, DOI 10.1109/TNSRE.2004.840492; de Munck JC, 2007, NEUROIMAGE, V35, P1142, DOI 10.1016/j.neuroimage.2007.01.022; Dugue L, 2011, J NEUROSCI, V31, P11889, DOI 10.1523/JNEUROSCI.1161-11.2011; Ebrahimi T, 2003, IEEE SIGNAL PROC MAG, V20, P14, DOI 10.1109/MSP.2003.1166626; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Fatourechi M, 2007, CLIN NEUROPHYSIOL, V118, P480, DOI 10.1016/j.clinph.2006.10.019; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Guderian S, 2009, P NATL ACAD SCI USA, V106, P5365, DOI 10.1073/pnas.0900289106; Hanslmayr S, 2005, APPL PSYCHOPHYS BIOF, V30, P1, DOI 10.1007/s10484-005-2169-8; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Hari R, 1997, INT J PSYCHOPHYSIOL, V26, P51, DOI 10.1016/S0167-8760(97)00755-1; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Hesselmann G, 2008, J NEUROSCI, V28, P14481, DOI 10.1523/JNEUROSCI.4398-08.2008; Jia XX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001045; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Keizer AW, 2010, NEUROIMAGE, V49, P3404, DOI 10.1016/j.neuroimage.2009.11.023; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Klimesch W, 2003, EUR J NEUROSCI, V17, P1129, DOI 10.1046/j.1460-9568.2003.02517.x; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krishnaveni V, 2006, J NEURAL ENG, V3, P338, DOI 10.1088/1741-2560/3/4/011; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Rose M, 2005, CEREB CORTEX, V15, P1290, DOI 10.1093/cercor/bhi012; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Siegel M, 2003, J NEUROSCI, V23, P4251; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Super H, 2003, J NEUROSCI, V23, P3407; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; WELFORD BP, 1962, TECHNOMETRICS, V4, P419, DOI 10.2307/1266577; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Wyart V, 2009, J NEUROSCI, V29, P8715, DOI 10.1523/JNEUROSCI.0962-09.2009; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	64	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38090	10.1371/journal.pone.0038090	http://dx.doi.org/10.1371/journal.pone.0038090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666454	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400080
J	Webb, JM; Jacobus, LM; Funk, DH; Zhou, X; Kondratieff, B; Geraci, CJ; DeWalt, RE; Baird, DJ; Richard, B; Phillips, I; Hebert, PDN				Webb, Jeffrey M.; Jacobus, Luke M.; Funk, David H.; Zhou, Xin; Kondratieff, Boris; Geraci, Christy J.; DeWalt, R. Edward; Baird, Donald J.; Richard, Barton; Phillips, Iain; Hebert, Paul D. N.			A DNA Barcode Library for North American Ephemeroptera: Progress and Prospects	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; TRICHOPTERA; PLECOPTERA; PHYLOGENY; SPECIMEN; LEVEL	DNA barcoding of aquatic macroinvertebrates holds much promise as a tool for taxonomic research and for providing the reliable identifications needed for water quality assessment programs. A prerequisite for identification using barcodes is a reliable reference library. We gathered 4165 sequences from the barcode region of the mitochondrial cytochrome c oxidase subunit I gene representing 264 nominal and 90 provisional species of mayflies (Insecta: Ephemeroptera) from Canada, Mexico, and the United States. No species shared barcode sequences and all can be identified with barcodes with the possible exception of some Caenis. Minimum interspecific distances ranged from 0.3-24.7% (mean: 12.5%), while the average intraspecific divergence was 1.97%. The latter value was inflated by the presence of very high divergences in some taxa. In fact, nearly 20% of the species included two or three haplotype clusters showing greater than 5.0% sequence divergence and some values are as high as 26.7%. Many of the species with high divergences are polyphyletic and likely represent species complexes. Indeed, many of these polyphyletic species have numerous synonyms and individuals in some barcode clusters show morphological attributes characteristic of the synonymized species. In light of our findings, it is imperative that type or topotype specimens be sequenced to correctly associate barcode clusters with morphological species concepts and to determine the status of currently synonymized species.	[Webb, Jeffrey M.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Jacobus, Luke M.] Indiana Univ Purdue Univ Columbus, Div Sci, Columbus, IN USA; [Funk, David H.] Stroud Water Res Ctr, Avondale, PA USA; [Zhou, Xin] BGI, Shenzhen, Guangdong, Peoples R China; [Kondratieff, Boris] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Geraci, Christy J.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [DeWalt, R. Edward] Univ Illinois, Prairie Res Inst, Champaign, IL 61820 USA; [Baird, Donald J.] Univ New Brunswick, Dept Biol, Canadian Rivers Inst, Environm Canada, Fredericton, NB E3B 6E1, Canada; [Richard, Barton] Florida A&M Univ, Lab Aquat Entomol, Tallahassee, FL 32307 USA; [Phillips, Iain] Saskatchewan Watershed Author, Saskatoon, SK, Canada	University of Guelph; Indiana University System; Indiana University-Purdue University Indianapolis; Beijing Genomics Institute (BGI); Colorado State University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Illinois System; University of Illinois Urbana-Champaign; Environment & Climate Change Canada; University of New Brunswick; State University System of Florida; Florida A&M University	Webb, JM (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	jmw975@yahoo.com	Zhou, Xin/AAI-9326-2021; Baird, Donald/A-5267-2009; Phillips, Iain/L-3116-2019; Hebert, Paul DN/C-4161-2013; Zhou, Xin/D-4025-2009	Zhou, Xin/0000-0002-1407-7952; Hebert, Paul DN/0000-0002-3081-6700; Zhou, Xin/0000-0002-1407-7952; Phillips, Iain/0000-0003-0955-3771	Government of Canada through Genome Canada; Ontario Genomics Institute [2008-OGI-ICI-03]; Environment Canada's Competitiveness and Environmental Sustainability Indicators (CESI) Program	Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Environment Canada's Competitiveness and Environmental Sustainability Indicators (CESI) Program	This project was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (2008-OGI-ICI-03), and Environment Canada's Competitiveness and Environmental Sustainability Indicators (CESI) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LC, 2009, J N AM BENTHOL SOC, V28, P584, DOI 10.1899/08-150.1; Baird DJ, 2011, J N AM BENTHOL SOC, V30, P125, DOI 10.1899/10-013.1; Baird DJ, 2011, J N AM BENTHOL SOC, V30, P122, DOI 10.1899/10-154.1; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Cao Y, 2011, J N AM BENTHOL SOC, V30, P680, DOI 10.1899/10-067.1; DeWaard Jeremy R., 2008, V410, P275; DeWalt RE, 2011, J N AM BENTHOL SOC, V30, P174, DOI 10.1899/10-021.1; Favret C, 2011, P ENTOMOL SOC WASH, V113, P119, DOI 10.4289/0013-8797.113.2.119; Feio MJ, 2006, CAN J FISH AQUAT SCI, V63, P367, DOI [10.1139/f05-221, 10.1139/F05-221]; Funk DH, 2008, J N AM BENTHOL SOC, V27, P647, DOI 10.1899/08-026.1; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hausmann A, 2009, ZOOTAXA, P1; Hausmann A, 2011, SPIXIANA, V34, P47; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jacobus LM, 2004, J NEW YORK ENTOMOL S, V112, P127, DOI 10.1664/0028-7199(2004)112[0127:RCTTGD]2.0.CO;2; James SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015629; LENAT DR, 1993, J N AM BENTHOL SOC, V12, P279, DOI 10.2307/1467463; Lenat DR, 2001, J N AM BENTHOL SOC, V20, P287, DOI 10.2307/1468323; Lenat DR, 1996, B N AM BENTHOLOGICAL, V13, P305, DOI DOI 10.2307/1467463; Mynott JH, 2011, INVERTEBR SYST, V25, P11, DOI 10.1071/IS10025; Ogden TH, 2009, SYST ENTOMOL, V34, P616, DOI 10.1111/j.1365-3113.2009.00488.x; Ogden TH, 2005, MOL PHYLOGENET EVOL, V37, P625, DOI 10.1016/j.ympev.2005.08.008; Pfrender ME, 2010, Q REV BIOL, V85, P319, DOI 10.1086/655118; Pilgrim EM, 2011, J N AM BENTHOL SOC, V30, P217, DOI 10.1899/10-012.1; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; Rosenberg David M., 1993, P1; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Sweeney BW, 2011, J N AM BENTHOL SOC, V30, P195, DOI 10.1899/10-016.1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Webb JM, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.6301; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zhou X, 2007, J N AM BENTHOL SOC, V26, P719, DOI 10.1899/06-089.1; Zhou X, 2011, J N AM BENTHOL SOC, V30, P131, DOI 10.1899/10-010.1; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	38	89	95	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38063	10.1371/journal.pone.0038063	http://dx.doi.org/10.1371/journal.pone.0038063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666447	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400074
J	Weis, S; Jesinghaus, M; Kovacs, P; Schleinitz, D; Schober, R; Ruffert, C; Herms, M; Wittenburg, H; Stumvoll, M; Bluher, M; Grutzmann, R; Schulz, HU; Keim, V; Mossner, J; Bugert, P; Witt, H; Drenth, JPH; Krohn, K; Rosendahl, J				Weis, Sebastian; Jesinghaus, Moritz; Kovacs, Peter; Schleinitz, Dorit; Schober, Robert; Ruffert, Claudia; Herms, Max; Wittenburg, Henning; Stumvoll, Michael; Blueher, Matthias; Gruetzmann, Robert; Schulz, Hans-Ulrich; Keim, Volker; Moessner, Joachim; Bugert, Peter; Witt, Heiko; Drenth, Joost P. H.; Krohn, Knut; Rosendahl, Jonas			Genetic Analyses of Heme Oxygenase 1 (HMOX1) in Different Forms of Pancreatitis	PLOS ONE			English	Article							CYSTIC-FIBROSIS GENE; MICROSATELLITE POLYMORPHISM; PROMOTER VARIANT; MUTATIONS; DISEASE; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; INHIBITOR; INDUCTION	Background: Heme oxygenase 1 (HMOX1) is the rate limiting enzyme in heme degradation and a key regulator of inflammatory processes. In animal models the course of pancreatitis was ameliorated by up-regulation of HMOX1 expression. Additionally, carbon monoxide released during heme breakdown inhibited proliferation of pancreatic stellate cells and might thereby prevent the development of chronic pancreatitis (CP). Transcription of HMOX1 in humans is influenced by a GT-repeat located in the promoter. As such, HMOX1 variants might be of importance in the pathogenesis of pancreatitis. Methods: The GT-repeat and SNP rs2071746 were investigated with fluorescence labelled primers and by melting curve analysis in 285 patients with acute pancreatitis, 208 patients with alcoholic CP, 207 patients with idiopathic/hereditary CP, 147 patients with alcoholic liver cirrhosis, and in 289 controls, respectively. GT-repeat analysis was extended to a total of 446 alcoholic CP patients. In addition, we performed DNA sequencing in 145 patients with alcoholic CP, 138 patients with idiopathic/hereditary CP, 147 patients with alcoholic liver cirrhosis, and 151 controls. Exon 3 screening was extended to additional patients and controls. Results: S- and L-alleles of the GT-repeat, genotypes and alleles of SNP rs2071746 and non-synonymous variants detected by sequencing were found with similar frequencies in all groups. Conclusions: Although functional data implicate a potential influence of HMOX1 variants on the pathogenesis of pancreatitis, we did not find any association. As rare non-synonymous HMOX1 variants were found in patients and controls, it is rather unlikely that they will have functional consequences essential for pancreatitis development.	[Weis, Sebastian; Jesinghaus, Moritz; Schober, Robert; Ruffert, Claudia; Herms, Max; Wittenburg, Henning; Keim, Volker; Moessner, Joachim; Rosendahl, Jonas] Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Gastroenterol & Rheumatol, Leipzig, Germany; [Kovacs, Peter; Schleinitz, Dorit; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Endocrinol, Leipzig, Germany; [Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany; [Gruetzmann, Robert] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Gen Thorac & Vasc Surg, D-01062 Dresden, Germany; [Schulz, Hans-Ulrich] Univ Magdeburg, Dept Surg, D-39106 Magdeburg, Germany; [Bugert, Peter] Univ Heidelberg, German Red Cross Blood Serv Baden Wurttemberg Hes, Med Fac Mannheim, Inst Transfus Med & Immunol, D-6800 Mannheim, Germany; [Witt, Heiko] Tech Univ Munich, Else Kroner Fresenius Zentrum Ernahrungsmed EKFZ, Dept Pediat, Munich, Germany; [Witt, Heiko] Tech Univ Munich, ZIEL, Munich, Germany; [Drenth, Joost P. H.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [Krohn, Knut] Univ Leipzig, Core Unit DNA Technol, Interdisciplinary Ctr Clin Res Leipzig, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Otto von Guericke University; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; Radboud University Nijmegen; Leipzig University	Weis, S (corresponding author), Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Gastroenterol & Rheumatol, Leipzig, Germany.	jonas.rosendahl@medizin.uni-leipzig.de	Drenth, J.P.H./H-8025-2014; Stumvoll, Michael/ABE-1121-2021; Schober, Robert/ABC-9480-2020; Drenth, Joost/V-7436-2019; Weis, Sebastian/P-9016-2014	Stumvoll, Michael/0000-0001-6225-8240; Weis, Sebastian/0000-0003-3201-2375; Kovacs, Peter/0000-0002-0290-5423	Deutsche Forschungsgemeinschaft [RO 3929/1-1, RO 3939/2-1, Wi 2036/2-2, Wi 2036/2-3]; Colora Stiftung gGmbH; Else Kroner-Fresenius-Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Colora Stiftung gGmbH; Else Kroner-Fresenius-Foundation	This work was supported by the Deutsche Forschungsgemeinschaft RO 3929/1-1 & RO 3939/2-1 (to JR) and Wi 2036/2-2 & Wi 2036/2-3 (to HW), by a grant of the Colora Stiftung gGmbH (to JR) and the Else Kroner-Fresenius-Foundation (to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; Becker T, 2007, TRANSPLANTATION, V84, P1644, DOI 10.1097/01.tp.0000290233.81395.81; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Chen P, 2010, CYTOKINE, V49, P15, DOI 10.1016/j.cyto.2009.09.013; Chen YH, 2004, EUR HEART J, V25, P39, DOI 10.1016/j.ehj.2003.10.009; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Derikx MHM, 2010, BEST PRACT RES CL GA, V24, P251, DOI 10.1016/j.bpg.2010.02.001; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Hirai H, 2003, BLOOD, V102, P1619, DOI 10.1182/blood-2002-12-3733; Kimpara T, 1997, HUM GENET, V100, P145, DOI 10.1007/s004390050480; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; MAINES MD, 1986, J BIOL CHEM, V261, P411; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; O'Reilly DA, 2008, EUR J GASTROEN HEPAT, V20, P726, DOI 10.1097/MEG.0b013e3282f5728c; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Ono K, 2004, ATHEROSCLEROSIS, V173, P315, DOI 10.1016/j.atherosclerosis.2003.11.021; Ono K, 2003, J HYPERTENS, V21, P1497, DOI 10.1097/00004872-200308000-00013; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sato H, 1997, FEBS LETT, V405, P219, DOI 10.1016/S0014-5793(97)00191-9; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; Von Dobschuetz E, 2008, PANCREAS, V36, P377, DOI 10.1097/MPA.0b013e31815ceb0e; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37981	10.1371/journal.pone.0037981	http://dx.doi.org/10.1371/journal.pone.0037981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666428	Green Published, gold			2022-12-27	WOS:000305353400066
J	Boyer, S; Brown, SDJ; Collins, RA; Cruickshank, RH; Lefort, MC; Malumbres-Olarte, J; Wratten, SD				Boyer, Stephane; Brown, Samuel D. J.; Collins, Rupert A.; Cruickshank, Robert H.; Lefort, Marie-Caroline; Malumbres-Olarte, Jagoba; Wratten, Stephen D.			Sliding Window Analyses for Optimal Selection of Mini-Barcodes, and Application to 454-Pyrosequencing for Specimen Identification from Degraded DNA	PLOS ONE			English	Article							IN-SILICO APPROACH; LAND SNAIL; MITOCHONDRIAL PSEUDOGENES; SEQUENCES; DIET; PREY; PCR; PREDATION; RDNA; PHYLOGENETICS	DNA barcoding remains a challenge when applied to diet analyses, ancient DNA studies, environmental DNA samples and, more generally, in any cases where DNA samples have not been adequately preserved. Because the size of the commonly used barcoding marker (COI) is over 600 base pairs (bp), amplification fails when the DNA molecule is degraded into smaller fragments. However, relevant information for specimen identification may not be evenly distributed along the barcoding region, and a shorter target can be sufficient for identification purposes. This study proposes a new, widely applicable, method to compare the performance of all potential 'mini-barcodes' for a given molecular marker and to objectively select the shortest and most informative one. Our method is based on a sliding window analysis implemented in the new R package SPIDER (Species IDentity and Evolution in R). This method is applicable to any taxon and any molecular marker. Here, it was tested on earthworm DNA that had been degraded through digestion by carnivorous landsnails. A 100 bp region of 16 S rDNA was selected as the shortest informative fragment (mini-barcode) required for accurate specimen identification. Corresponding primers were designed and used to amplify degraded earthworm (prey) DNA from 46 landsnail (predator) faeces using 454-pyrosequencing. This led to the detection of 18 earthworm species in the diet of the snail. We encourage molecular ecologists to use this method to objectively select the most informative region of the gene they aim to amplify from degraded DNA. The method and tools provided here, can be particularly useful (1) when dealing with degraded DNA for which only small fragments can be amplified, (2) for cases where no consensus has yet been reached on the appropriate barcode gene, or (3) to allow direct analysis of short reads derived from massively parallel sequencing without the need for bioinformatic consolidation.	[Boyer, Stephane; Cruickshank, Robert H.; Malumbres-Olarte, Jagoba] Lincoln Univ, Fac Agr & Life Sci, Dept Ecol, Lincoln, New Zealand; [Brown, Samuel D. J.; Collins, Rupert A.; Lefort, Marie-Caroline; Wratten, Stephen D.] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand	Lincoln University - New Zealand; Lincoln University - New Zealand	Boyer, S (corresponding author), Lincoln Univ, Fac Agr & Life Sci, Dept Ecol, Lincoln, New Zealand.	stephane.boyer@lincoln.ac.nz	Brown, Samuel/P-8847-2017; Wratten, Steve D/J-3467-2013; Malumbres-Olarte, Jagoba/Q-2927-2016; Boyer, Stéphane/H-8624-2013	Brown, Samuel/0000-0001-7112-421X; Wratten, Steve D/0000-0002-5168-8277; Malumbres-Olarte, Jagoba/0000-0002-6878-5719; Boyer, Stéphane/0000-0002-0750-4864; Collins, Rupert A./0000-0002-9135-1169	Solid Energy New Zealand Limited; Department of Ecology at Lincoln University; Bio-Protection Research Centre at Lincoln University; Solid Energy New Zealand Limited as part of the rehabilitation of the Stockton mine	Solid Energy New Zealand Limited; Department of Ecology at Lincoln University; Bio-Protection Research Centre at Lincoln University; Solid Energy New Zealand Limited as part of the rehabilitation of the Stockton mine	This work was supported by Solid Energy New Zealand Limited, the Department of Ecology at Lincoln University, and the Bio-Protection Research Centre at Lincoln University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This work was partly supported by Solid Energy New Zealand Limited as part of the rehabilitation of the Stockton mine. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bekaert M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn191; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; BOORE JL, 1995, GENETICS, V141, P305; Bouche M.B., 1972, LOMBRICIENS FRANCE E; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Boyer S, 2011, ZOOTAXA, P21; Boyer S, 2011, PEDOBIOLOGIA, V54, pS99, DOI 10.1016/j.pedobi.2011.09.006; Boyer S, 2011, PEDOBIOLOGIA, V54, pS153, DOI 10.1016/j.pedobi.2011.08.002; Boyer S, 2010, ZOOL MIDDLE EAST, P31; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Buckley TR, 2011, MOL PHYLOGENET EVOL, V58, P85, DOI 10.1016/j.ympev.2010.09.024; Chen W, 2009, MOL ECOL RESOUR, V9, P114, DOI 10.1111/j.1755-0998.2009.02638.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Dunshea G, 2008, B ENTOMOL RES, V98, P239, DOI 10.1017/S0007485308005993; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; France SC, 2002, HYDROBIOLOGIA, V471, P149, DOI 10.1023/A:1016517724749; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Garros C, 2008, MOL ECOL RESOUR, V8, P512, DOI 10.1111/j.1471-8286.2007.02013.x; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hoogendoorn M, 2001, MOL ECOL, V10, P2059, DOI 10.1046/j.1365-294X.2001.01316.x; Jabado OJ, 2006, NUCLEIC ACIDS RES, V34, P6605, DOI 10.1093/nar/gkl966; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; King RA, 2011, MOL ECOL RESOUR, V11, P370, DOI 10.1111/j.1755-0998.2010.02913.x; Klarica J, 2012, SOIL BIOL BIOCHEM, V45, P23, DOI 10.1016/j.soilbio.2011.09.018; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; Pop AA, 2003, PEDOBIOLOGIA, V47, P428, DOI 10.1016/S0031-4056(04)70217-6; Pop AA, 2007, EUR J SOIL BIOL, V43, pS43, DOI 10.1016/j.ejsobi.2007.08.007; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Riaz T, 2011, NUCLEIC ACIDS RES, V2011, P1; Riemann L, 2010, BIOL LETTERS, V6, P819, DOI 10.1098/rsbl.2010.0411; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stringer IAN, 2003, INVERTEBR BIOL, V122, P241; Sundquist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000484; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Van Houdt JKJ, 2010, MOL ECOL RESOUR, V10, P459, DOI 10.1111/j.1755-0998.2009.02800.x; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Walker KJ, 2008, J ROY SOC NEW ZEAL, V38, P163, DOI 10.1080/03014220809510553; Zbawicka M, 2007, GENE, V406, P191, DOI 10.1016/j.gene.2007.10.003; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	60	33	35	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38215	10.1371/journal.pone.0038215	http://dx.doi.org/10.1371/journal.pone.0038215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666489	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600074
J	Volozhantsev, NV; Oakley, BB; Morales, CA; Verevkin, VV; Bannov, VA; Krasilnikova, VM; Popova, AV; Zhilenkov, EL; Garrish, JK; Schegg, KM; Woolsey, R; Quilici, DR; Line, JE; Hiett, KL; Siragusa, GR; Svetoch, EA; Seal, BS				Volozhantsev, Nikolay V.; Oakley, Brian B.; Morales, Cesar A.; Verevkin, Vladimir V.; Bannov, Vasily A.; Krasilnikova, Valentina M.; Popova, Anastasia V.; Zhilenkov, Eugeni L.; Garrish, Johnna K.; Schegg, Kathleen M.; Woolsey, Rebekah; Quilici, David R.; Line, J. Eric; Hiett, Kelli L.; Siragusa, Gregory R.; Svetoch, Edward A.; Seal, Bruce S.			Molecular Characterization of Podoviral Bacteriophages Virulent for Clostridium perfringens and Their Comparison with Members of the Picovirinae	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; STATISTICAL-MODEL; BACILLUS-SUBTILIS; GENOMIC SEQUENCE; DNA; PROTEIN; EVOLUTION; DATABASE; POULTRY; GENES	Clostridium perfringens is a Gram-positive, spore-forming anaerobic bacterium responsible for human food-borne disease as well as non-food-borne human, animal and poultry diseases. Because bacteriophages or their gene products could be applied to control bacterial diseases in a species-specific manner, they are potential important alternatives to antibiotics. Consequently, poultry intestinal material, soil, sewage and poultry processing drainage water were screened for virulent bacteriophages that lysed C. perfringens. Two bacteriophages, designated Phi CPV4 and Phi ZP2, were isolated in the Moscow Region of the Russian Federation while another closely related virus, named Phi CP7R, was isolated in the southeastern USA. The viruses were identified as members of the order Caudovirales in the family Podoviridae with short, non-contractile tails of the C1 morphotype. The genomes of the three bacteriophages were 17.972, 18.078 and 18.397 kbp respectively; encoding twenty-six to twenty-eight ORF's with inverted terminal repeats and an average GC content of 34.6%. Structural proteins identified by mass spectrometry in the purified Phi CP7R virion included a pre-neck/appendage with putative lyase activity, major head, tail, connector/upper collar, lower collar and a structural protein with putative lysozyme-peptidase activity. All three podoviral bacteriophage genomes encoded a predicted N-acetylmuramoyl-L-alanine amidase and a putative stage V sporulation protein. Each putative amidase contained a predicted bacterial SH3 domain at the C-terminal end of the protein, presumably involved with binding the C. perfringens cell wall. The predicted DNA polymerase type B protein sequences were closely related to other members of the Podoviridae including Bacillus phage Phi 29. Whole-genome comparisons supported this relationship, but also indicated that the Russian and USA viruses may be unique members of the sub-family Picovirinae.	[Volozhantsev, Nikolay V.; Verevkin, Vladimir V.; Bannov, Vasily A.; Krasilnikova, Valentina M.; Popova, Anastasia V.; Zhilenkov, Eugeni L.; Svetoch, Edward A.] State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia; [Oakley, Brian B.; Morales, Cesar A.; Garrish, Johnna K.; Line, J. Eric; Hiett, Kelli L.; Seal, Bruce S.] USDA, Richard B Russell Agr Res Ctr, Agr Res Serv, Poultry Microbiol Safety Res Unit, Athens, GA USA; [Schegg, Kathleen M.; Woolsey, Rebekah; Quilici, David R.] Univ Nevada, Nevada Prote Ctr, Reno, NV 89557 USA; [Siragusa, Gregory R.] Danisco DuPont, Waukesha, WI USA	United States Department of Agriculture (USDA); Nevada System of Higher Education (NSHE); University of Nevada Reno	Volozhantsev, NV (corresponding author), State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia.	nikvol@obolensk.org; bruce.seal@ars.usda.gov	Oakley, Brian Oakley B/AAG-4015-2019; Volozhantsev, Nikolay V./Q-5579-2016; Popova, Anastasia V/M-4608-2014	Volozhantsev, Nikolay V./0000-0003-4667-1451; Popova, Anastasia V/0000-0003-0065-6459; Oakley, Brian/0000-0003-2098-6439	U.S. Department of Agriculture, Agricultural Research Service (CRIS) [6612-32000-060]; Russian Federation State Research Center for Applied Microbiology and Biotechnology; U.S. Department of State (DoS) via the International Science and Technology Center (ISTC); USDA Office of International Research Programs (OIRP); INBRE Program of the National Center for Research Resources [P20 RR-016464]; NIH [1S10 RR023587-01A2]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023587, P20RR016464] Funding Source: NIH RePORTER	U.S. Department of Agriculture, Agricultural Research Service (CRIS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Russian Federation State Research Center for Applied Microbiology and Biotechnology; U.S. Department of State (DoS) via the International Science and Technology Center (ISTC); USDA Office of International Research Programs (OIRP); INBRE Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support for the research was provided by the U.S. Department of Agriculture, Agricultural Research Service (CRIS project #6612-32000-060), the Russian Federation State Research Center for Applied Microbiology and Biotechnology, and the U.S. Department of State (DoS) via the International Science and Technology Center (ISTC grant #3108) administered by the ARS, USDA Office of International Research Programs (OIRP). The Nevada Proteomics Center operates under the auspices of NIH Grant #P20 RR-016464 from the INBRE Program of the National Center for Research Resources with instrumentation acquired through NIH grant #1S10 RR023587-01A2 awarded to the University of Nevada, Reno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H W, 1998, Adv Virus Res, V51, P135, DOI 10.1016/S0065-3527(08)60785-X; Ackermann Hans-W., 2009, V501, P113, DOI 10.1007/978-1-60327-164-6_12; Bren Linda, 2007, FDA Consum, V41, P20; Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Chan BK, 2012, ADV APPL MICROBIOL, V78, P1, DOI 10.1016/B978-0-12-394805-2.00001-4; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Delisle AL, 2006, APPL ENVIRON MICROB, V72, P1110, DOI 10.1128/AEM.72.2.1110-1117.2006; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Fenton Mark, 2010, Bioeng Bugs, V1, P9, DOI 10.4161/bbug.1.1.9818; Finehout EJ, 2003, ELECTROPHORESIS, V24, P3508, DOI 10.1002/elps.200305615; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Fouts DE, 2006, J BACTERIOL, V188, P3402, DOI 10.1128/JB.188.9.3402-3408.2006; GARCIA JA, 1983, VIROLOGY, V125, P18, DOI 10.1016/0042-6822(83)90060-0; GARVEY KJ, 1985, GENE, V40, P311, DOI 10.1016/0378-1119(85)90054-X; GUO PX, 1987, J MOL BIOL, V197, P219, DOI 10.1016/0022-2836(87)90120-3; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; Gyles Carlton L., 2008, Animal Health Research Reviews, V9, P149, DOI 10.1017/S1466252308001552; HAMES BD., 1981, GEL ELECTROPHORESIS, P1; HEDGES SB, 1992, MOL BIOL EVOL, V9, P366; HELMS C, 1985, DNA-J MOLEC CELL BIO, V4, P39, DOI 10.1089/dna.1985.4.39; HUDSPETH DSS, 1992, BIOCHIM BIOPHYS ACTA, V1130, P229, DOI 10.1016/0167-4781(92)90536-9; Huelsenbeck JP, 2002, SYST BIOL, V51, P32, DOI 10.1080/106351502753475862; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; LEWIS JG, 1992, J VIROL METHODS, V38, P11, DOI 10.1016/0166-0934(92)90165-A; Liepinsh E, 2003, J MOL BIOL, V327, P833, DOI 10.1016/S0022-2836(03)00185-2; Lindstrom M, 2011, FOOD MICROBIOL, V28, P192, DOI 10.1016/j.fm.2010.03.020; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Martin AC, 1996, J VIROL, V70, P3678; Matsuno K, 1999, J BACTERIOL, V181, P3392, DOI 10.1128/JB.181.11.3392-3401.1999; McClane B.A., 2001, FOOD MICROBIOLOGY FU, P351; McNair K, 2012, BIOINFORMATICS, V28, P614, DOI 10.1093/bioinformatics/bts014; MEAD DA, 1991, BIO-TECHNOL, V9, P657, DOI 10.1038/nbt0791-657; Meijer WJJ, 2001, MICROBIOL MOL BIOL R, V65, P261, DOI 10.1128/MMBR.65.2.261-287.2001; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; Morales CA, 2012, ARCH VIROL; Nariya H, 2011, APPL MICROBIOL BIOT, V90, P1973, DOI 10.1007/s00253-011-3253-z; Nelson D, 2003, J BACTERIOL, V185, P3325, DOI 10.1128/JB.185.11.3325-3332.2003; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oakley BB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-282; Perez-Arnaiz P, 2010, J MOL BIOL, V395, P223, DOI 10.1016/j.jmb.2009.10.061; Porter CJ, 2007, J MOL BIOL, V366, P540, DOI 10.1016/j.jmb.2006.11.056; RDC T, 2009, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Salas M, 2008, IUBMB LIFE, V60, P82, DOI 10.1002/iub.19; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saren AM, 2005, J MOL BIOL, V350, P427, DOI 10.1016/j.jmb.2005.04.059; Sarker MR, 1999, MOL MICROBIOL, V33, P946, DOI 10.1046/j.1365-2958.1999.01534.x; Sawires YS, 2006, ANAEROBE, V12, P23, DOI 10.1016/j.anaerobe.2005.10.002; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Seal BS, 2011, ARCH VIROL, V156, P25, DOI 10.1007/s00705-010-0812-z; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Siragusa GR, 2006, J CLIN MICROBIOL, V44, P1065, DOI 10.1128/JCM.44.3.1065-1073.2006; Smedley JG, 2004, INFECT IMMUN, V72, P6914, DOI 10.1128/IAI.72.12.6914-6923.2004; SMITH AB, 1994, BIOL J LINN SOC, V51, P279, DOI 10.1111/j.1095-8312.1994.tb00962.x; SMITH HW, 1959, J GEN MICROBIOL, V21, P622, DOI 10.1099/00221287-21-3-622; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Sozhamannan S, 2008, APPL ENVIRON MICROB, V74, P6792, DOI 10.1128/AEM.01124-08; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Van Immerseel F, 2004, AVIAN PATHOL, V33, P537, DOI 10.1080/03079450400013162; VILLANUEVA N, 1981, J VIROL, V38, P15, DOI 10.1128/JVI.38.1.15-19.1981; VLCEK C, 1986, GENE, V46, P215, DOI 10.1016/0378-1119(86)90406-3; Volozhantsev NV, 2011, VIRUS RES, V155, P433, DOI 10.1016/j.virusres.2010.11.012; Vybiral D, 2003, FEMS MICROBIOL LETT, V219, P275, DOI 10.1016/S0378-1097(03)00028-4; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Wise MG, 2005, APPL ENVIRON MICROB, V71, P3911, DOI 10.1128/AEM.71.7.3911-3916.2005; Xiang Y, 2008, P NATL ACAD SCI USA, V105, P9552, DOI 10.1073/pnas.0803787105; Xiang Y, 2006, EMBO J, V25, P5229, DOI 10.1038/sj.emboj.7601386; Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009; Young R, 2002, J MOL MICROB BIOTECH, V4, P21; Zimmer M, 2002, J BACTERIOL, V184, P4359, DOI 10.1128/JB.184.16.4359-4368.2002; Zimmer M, 2002, APPL ENVIRON MICROB, V68, P5311, DOI 10.1128/AEM.68.11.5311-5317.2002; Zou YM, 2010, COMPUT BIOL CHEM, V34, P251, DOI 10.1016/j.compbiolchem.2010.07.001	92	29	35	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38283	10.1371/journal.pone.0038283	http://dx.doi.org/10.1371/journal.pone.0038283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666499	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600076
J	Khalili, S; Liu, YN; Kornete, M; Roescher, N; Kodama, S; Peterson, A; Piccirillo, CA; Tran, SD				Khalili, Saeed; Liu, Younan; Kornete, Mara; Roescher, Nienke; Kodama, Shohta; Peterson, Alan; Piccirillo, Ciriaco A.; Tran, Simon D.			Mesenchymal Stromal Cells Improve Salivary Function and Reduce Lymphocytic Infiltrates in Mice with Sjogren's-Like Disease	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NONOBESE DIABETIC MICE; REGULATORY T-CELLS; STEM-CELLS; NOD MICE; AUTOIMMUNE-DISEASES; EPITHELIAL-CELLS; GLANDS; REVERSAL; PATHOGENESIS	Background: Non-obese diabetic (NOD) mice develop Sjogren's-like disease (SS-like) with loss of saliva flow and increased lymphocytic infiltrates in salivary glands (SGs). There are recent reports using multipotent mesenchymal stromal cells (MSCs) as a therapeutic strategy for autoimmune diseases due to their anti-inflammatory and immunomodulatory capabilities. This paper proposed a combined immuno-and cell-based therapy consisting of: A) an injection of complete Freund's adjuvant (CFA) to eradicate autoreactive T lymphocytes, and B) transplantations of MSCs to reselect lymphocytes. The objective of this was to test the effectiveness of CD45(-)/TER119(-) cells (MSCs) in re-establishing salivary function and in reducing the number of lymphocytic infiltrates (foci) in SGs. The second objective was to study if the mechanisms underlying a decrease in inflammation (focus score) was due to CFA, MSCs, or CFA+MSCs combined. Methodology/Principal Findings: Donor MSCs were isolated from bones of male transgenic eGFP mice. Eight week-old female NOD mice received one of the following treatments: insulin, CFA, MSC, or CFA+ MSC (combined therapy). Mice were followed for 14 weeks post-therapy. CD45(-)/TER119(-) cells demonstrated characteristics of MSCs as they were positive for Sca-1, CD106, CD105, CD73, CD29, CD44, negative for CD45, TER119, CD11b, had high number of CFU-F, and differentiated into osteocytes, chondrocytes and adipocytes. Both MSC and MSC+ CFA groups prevented loss of saliva flow and reduced lymphocytic infiltrations in SGs. Moreover, the influx of T and B cells decreased in all foci in MSC and MSC+CFA groups, while the frequency of Foxp3(+) (T-reg) cell was increased. MSC-therapy alone reduced inflammation (TNF-alpha, TGF-beta), but the combination of MSC+ CFA reduced inflammation and increased the regenerative potential of SGs (FGF-2, EGF). Conclusions/Significance: The combined use of MSC+ CFA was effective in both preventing saliva secretion loss and reducing lymphocytic influx in salivary glands.	[Khalili, Saeed; Liu, Younan; Tran, Simon D.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Kornete, Mara; Piccirillo, Ciriaco A.] Dept Microbiol & Immunol, Montreal, PQ, Canada; [Kornete, Mara; Piccirillo, Ciriaco A.] FOCIS Ctr Excellence, Montreal, PQ, Canada; [Roescher, Nienke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Kodama, Shohta] Fukuoka Univ, Fac Med, Dept Regenerat Med & Transplantat, Fukuoka 81401, Japan; [Peterson, Alan] McGill Univ, Fac Med, Montreal, PQ, Canada	McGill University; University of Amsterdam; Academic Medical Center Amsterdam; Fukuoka University; McGill University	Khalili, S (corresponding author), McGill Univ, Fac Dent, Montreal, PQ, Canada.	simon.tran@mcgill.ca			Canadian Institutes of Health Research (CIHR) Institute Musculoskeletal Health and Arthritis (IMHA); Canada Research Chairs (CRC); CIHR [MOP67211]; FRSQ doctoral fellowship; Grants-in-Aid for Scientific Research [22501054] Funding Source: KAKEN	Canadian Institutes of Health Research (CIHR) Institute Musculoskeletal Health and Arthritis (IMHA)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs (CRC)(Canada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ doctoral fellowship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Canadian Institutes of Health Research (CIHR) Institute Musculoskeletal Health and Arthritis (IMHA), and the Canada Research Chairs (CRC). The authors also acknowledge the financial support of CIHR grant MOP67211 (CP). MK is a recipient of a FRSQ doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayetto K, 2010, AUST DENT J, V55, P39, DOI 10.1111/j.1834-7819.2010.01197.x; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; Delaleu N, 2005, EUR J ORAL SCI, V113, P101, DOI 10.1111/j.1600-0722.2004.00183.x; Delaleu N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3313; Dieguez-Acuna F, 2007, LEUKEMIA, V21, P2192, DOI 10.1038/sj.leu.2404927; Dieguez-Acuna F, 2010, INT J BIOCHEM CELL B, V42, P1651, DOI 10.1016/j.biocel.2009.12.001; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Faustman DL, 2010, INT J BIOCHEM CELL B, V42, P1576, DOI 10.1016/j.biocel.2010.06.012; Fujisawa K, 2003, J ORAL PATHOL MED, V32, P358, DOI 10.1034/j.1600-0714.2003.t01-1-00111.x; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huntington ND, 2004, IMMUNOL LETT, V94, P167, DOI 10.1016/j.imlet.2004.05.011; Jonsson MV, 2007, CLIN REV ALLERG IMMU, V32, P215, DOI 10.1007/s12016-007-8012-7; Jonsson MV, 2006, ARTHRITIS RHEUM, V54, P2300, DOI 10.1002/art.21945; Kagami H, 2000, Adv Dent Res, V14, P99; Khalili S, 2010, INT J BIOCHEM CELL B, V42, P1893, DOI 10.1016/j.biocel.2010.08.008; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Klagsbrun M, 1989, Prog Growth Factor Res, V1, P207, DOI 10.1016/0955-2235(89)90012-4; Kodama S, 2005, CELL MOL LIFE SCI, V62, P1850, DOI 10.1007/s00018-005-5022-6; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Koski H, 2001, CLIN EXP RHEUMATOL, V19, P131; Lee BH, 2009, ARCH IMMUNOL THER EX, V57, P57, DOI 10.1007/s00005-009-0002-4; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lonyai A, 2008, HORM METAB RES, V40, P137, DOI 10.1055/s-2007-1022560; MacDonald GIA, 2011, ARTHRITIS RHEUM-US, V63, P2547, DOI 10.1002/art.30474; Madec AM, 2009, DIABETOLOGIA, V52, P1391, DOI 10.1007/s00125-009-1374-z; Nakamura H, 2007, RHEUMATOL INT, V28, P127, DOI 10.1007/s00296-007-0411-9; Nikolov NP, 2009, CURR OPIN RHEUMATOL, V21, P465, DOI 10.1097/BOR.0b013e32832eba21; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Roescher N, 2012, ORAL DIS, V18, P96, DOI 10.1111/j.1601-0825.2011.01852.x; Roescher N, 2009, ORAL DIS, V15, P519, DOI 10.1111/j.1601-0825.2009.01582.x; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Samuni Y, 2008, HUM GENE THER, V19, P279, DOI 10.1089/hum.2007.0136; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Tran SD, 2007, ANN RHEUM DIS, V66, P812, DOI 10.1136/ard.2006.064030; Tran SD, 2006, TISSUE ENG, V12, P2939, DOI 10.1089/ten.2006.12.2939; Uccelli A, 2010, CURR OPIN IMMUNOL, V22, P768, DOI 10.1016/j.coi.2010.10.012; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999	43	51	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38615	10.1371/journal.pone.0038615	http://dx.doi.org/10.1371/journal.pone.0038615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685592	Green Submitted, gold, Green Published			2022-12-27	WOS:000305351700055
J	Paratala, BS; Jacobson, BD; Kanakia, S; Francis, LD; Sitharaman, B				Paratala, Bhavna S.; Jacobson, Barry D.; Kanakia, Shruti; Deepak Francis, Leonard; Sitharaman, Balaji			Physicochemical Characterization, and Relaxometry Studies of Micro-Graphite Oxide, Graphene Nanoplatelets, and Nanoribbons	PLOS ONE			English	Article							MAGNETIC-PROPERTIES; HIGH-RELAXIVITY; TEMPERATURE FERROMAGNETISM; CARBON NANOTUBES; CONTRAST AGENTS; GADOLINIUM; T-1; GADOFULLERENES; GADONANOTUBES; COMPLEXES	The chemistry of high-performance magnetic resonance imaging contrast agents remains an active area of research. In this work, we demonstrate that the potassium permanganate-based oxidative chemical procedures used to synthesize graphite oxide or graphene nanoparticles leads to the confinement (intercalation) of trace amounts of Mn2+ ions between the graphene sheets, and that these manganese intercalated graphitic and graphene structures show disparate structural, chemical and magnetic properties, and high relaxivity (up to 2 order) and distinctly different nuclear magnetic resonance dispersion profiles compared to paramagnetic chelate compounds. The results taken together with other published reports on confinement of paramagnetic metal ions within single-walled carbon nanotubes (a rolled up graphene sheet) show that confinement (encapsulation or intercalation) of paramagnetic metal ions within graphene sheets, and not the size, shape or architecture of the graphitic carbon particles is the key determinant for increasing relaxivity, and thus, identifies nano confinement of paramagnetic ions as novel general strategy to develop paramagnetic metal-ion graphitic-carbon complexes as high relaxivity MRI contrast agents.	[Paratala, Bhavna S.; Jacobson, Barry D.; Kanakia, Shruti; Sitharaman, Balaji] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11790 USA; [Deepak Francis, Leonard] Int Iberian Nanotechnol Lab, Braga, Portugal	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; International Iberian Nanotechnology Laboratory	Paratala, BS (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11790 USA.	bsitharaman@notes.cc.sunsyb.edu	INL, Citations/K-3436-2015; Francis, Leonard/I-5718-2013	INL, Citations/0000-0002-3745-5100; Francis, Leonard/0000-0002-3833-1775; Sitharaman, Balaji/0000-0001-8391-8076; Paratala, Bhavna S/0000-0002-7695-4500	National Institutes of Health [1DP2OD007394-01]; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0521]; Wallace H Coulter Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); Wallace H Coulter Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was sponsored by National Institutes of Health (grants No. 1DP2OD007394-01), Department of Defense Breast Cancer Research Program (W81XWH-10-1-0521), and the Wallace H Coulter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime S, 2002, J BIOL INORG CHEM, V7, P58, DOI 10.1007/s007750100265; Aime S, 1998, CHEM SOC REV, V27, P19, DOI 10.1039/a827019z; Ananta JS, 2010, NAT NANOTECHNOL, V5, P815, DOI [10.1038/nnano.2010.203, 10.1038/NNANO.2010.203]; [Anonymous], SIGM ALDR 1 CERT AN; [Anonymous], 2008, INF GAD CONT CONTR A; Bie XF, 2010, SOLID STATE SCI, V12, P1364, DOI 10.1016/j.solidstatesciences.2010.05.010; BRESINSKA I, 1994, J PHYS CHEM-US, V98, P12989, DOI 10.1021/j100100a029; Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; Caravan P, 2009, CONTRAST MEDIA MOL I, V4, P89, DOI 10.1002/cmmi.267; Datta A, 2009, ACCOUNTS CHEM RES, V42, P938, DOI 10.1021/ar800250h; Du J, 2006, NANOTECHNOLOGY, V17, P4923, DOI 10.1088/0957-4484/17/19/024; Esquinazi P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024429; Fatouros PP, 2006, RADIOLOGY, V240, P756, DOI 10.1148/radiol.2403051341; Geng Y, 2009, J COLLOID INTERF SCI, V336, P592, DOI 10.1016/j.jcis.2009.04.005; Hak S, 2009, EUR J PHARM BIOPHARM, V72, P397, DOI 10.1016/j.ejpb.2008.09.017; Higginbotham AL, 2010, ACS NANO, V4, P2059, DOI 10.1021/nn100118m; Hoff L, 2001, ACOUSTIC CHARACTERIZ; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Imaging Agents, IM AG; Kato H, 2003, J AM CHEM SOC, V125, P4391, DOI 10.1021/ja027555+; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Kundaliya DC, 2004, NAT MATER, V3, P709, DOI 10.1038/nmat1221; LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Makarova TL, 2004, SEMICONDUCTORS+, V38, P615, DOI 10.1134/1.1766362; Manus LM, 2010, NANO LETT, V10, P484, DOI 10.1021/nl903264h; Mao YL, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/20/205708; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pan D, 2010, WILEY INTERDISCIPLIN; Raley JA, 2006, J ALLOY COMPD, V423, P184, DOI 10.1016/j.jallcom.2005.12.107; Rao SS, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113004; Richard C, 2008, NANO LETT, V8, P232, DOI 10.1021/nl072509z; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Schoenhalz AL, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3119640; Sitharaman B, 2005, CHEM COMMUN, P3915, DOI 10.1039/b504435a; Sitharaman B, 2007, J BIOMED NANOTECHNOL, V3, P342, DOI 10.1166/jbn.2007.043; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; SUR SK, 1995, J PHYS CHEM-US, V99, P4900, DOI 10.1021/j100014a005; SWIFT TJ, 1962, J CHEM PHYS, V37, P307, DOI 10.1063/1.1701321; Toth E, 2005, J AM CHEM SOC, V127, P799, DOI 10.1021/ja044688h; Troughton JS, 2004, INORG CHEM, V43, P6313, DOI 10.1021/ic049559g; Wang J, 2004, ADV MATER, V16, P137, DOI 10.1002/adma.200306136; Wang S, 2008, NANO LETT, V8, P4020, DOI [10.1021/nl802696f, 10.1021/nl802810g]; WHITNEY TM, 1993, SCIENCE, V261, P1316, DOI 10.1126/science.261.5126.1316; Zhou Z, 2010, THIN SOLID FILMS	46	53	53	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38185	10.1371/journal.pone.0038185	http://dx.doi.org/10.1371/journal.pone.0038185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685555	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700018
J	Paquette, SG; Banner, D; Zhao, Z; Fang, Y; Huang, SSH; Leon, AJ; Ng, DCK; Almansa, R; Martin-Loeches, I; Ramirez, P; Socias, L; Loza, A; Blanco, J; Sansonetti, P; Rello, J; Andaluz, D; Shum, B; Rubino, S; de Lejarazu, RO; Tran, D; Delogu, G; Fadda, G; Krajden, S; Rubin, BB; Bermejo-Martin, JF; Kelvin, AA; Kelvin, DJ				Paquette, Stephane G.; Banner, David; Zhao, Zhen; Fang, Yuan; Huang, Stephen S. H.; Leon, Alberto J.; Ng, Derek C. K.; Almansa, Raquel; Martin-Loeches, Ignacio; Ramirez, Paula; Socias, Lorenzo; Loza, Ana; Blanco, Jesus; Sansonetti, Paola; Rello, Jordi; Andaluz, David; Shum, Bianche; Rubino, Salvatore; Ortiz de Lejarazu, Raul; Tran, Dat; Delogu, Giovanni; Fadda, Giovanni; Krajden, Sigmund; Rubin, Barry B.; Bermejo-Martin, Jesus F.; Kelvin, Alyson A.; Kelvin, David J.			Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A Infection	PLOS ONE			English	Article							ANTIINFLAMMATORY CYTOKINE; RESPIRATORY-FAILURE; RESPONSES; IL-6; VIRUSES; DISEASE; TUBERCULOSIS; IMMUNITY; SEPSIS	Pandemic H1N1 influenza A (H1N1pdm) is currently a dominant circulating influenza strain worldwide. Severe cases of H1N1pdm infection are characterized by prolonged activation of the immune response, yet the specific role of inflammatory mediators in disease is poorly understood. The inflammatory cytokine IL-6 has been implicated in both seasonal and severe pandemic H1N1 influenza A (H1N1pdm) infection. Here, we investigated the role of IL-6 in severe H1N1pdm infection. We found IL-6 to be an important feature of the host response in both humans and mice infected with H1N1pdm. Elevated levels of IL-6 were associated with severe disease in patients hospitalized with H1N1pdm infection. Notably, serum IL-6 levels associated strongly with the requirement of critical care admission and were predictive of fatal outcome. In C57BL/6J, BALB/cJ, and B6129SF2/J mice, infection with A/Mexico/4108/2009 (H1N1pdm) consistently triggered severe disease and increased IL-6 levels in both lung and serum. Furthermore, in our lethal C57BL/6J mouse model of H1N1pdm infection, global gene expression analysis indicated a pronounced IL-6 associated inflammatory response. Subsequently, we examined disease and outcome in IL-6 deficient mice infected with H1N1pdm. No significant differences in survival, weight loss, viral load, or pathology were observed between IL-6 deficient and wild-type mice following infection. Taken together, our findings suggest IL-6 may be a potential disease severity biomarker, but may not be a suitable therapeutic target in cases of severe H1N1pdm infection due to our mouse data.	[Paquette, Stephane G.; Banner, David; Fang, Yuan; Huang, Stephen S. H.; Leon, Alberto J.; Ng, Derek C. K.; Kelvin, David J.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Expt Therapeut, Toronto, ON, Canada; [Paquette, Stephane G.; Kelvin, David J.] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON M5S 1A1, Canada; [Zhao, Zhen; Leon, Alberto J.; Kelvin, David J.] Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou, Guangdong, Peoples R China; [Fang, Yuan; Huang, Stephen S. H.; Kelvin, David J.] Univ Toronto, Dept Immunol, Fac Med, Toronto, ON, Canada; [Almansa, Raquel; Ortiz de Lejarazu, Raul; Bermejo-Martin, Jesus F.] Hosp Clin Univ, Inst Estudios Ciencias Salud Castilla & Leon, Infect & Immun Med Invest Unit, Valladolid, Spain; [Martin-Loeches, Ignacio] Sabadell Univ Hosp, Crit Care Ctr Parc Tauli, Sabadell, Spain; [Ramirez, Paula] Hosp Univ La Fe, Crit Care Dept, Soc Espanola Med Intensiva Crit & Unidades Corona, Valencia, Spain; [Socias, Lorenzo] Hosp Son Llatzer, Crit Care Dept, Soc Espanola Med Intensiva Crit & Unidades Corona, Palma De Mallorca, Spain; [Loza, Ana] Hosp N Sra de Valme, Crit Care Dept, Soc Espanola Med Intensiva Crit & Unidades Corona, Seville, Spain; [Blanco, Jesus] Hosp Univ Rio Hortega Salud Junta Castilla & Leon, Crit Care Dept, Soc Espanola Med Intensiva Crit & Unidades Corona, Valladolid, Spain; [Blanco, Jesus] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Valladolid, Spain; [Sansonetti, Paola; Delogu, Giovanni; Fadda, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy; [Rello, Jordi] Univ Autonoma Barcelona, Soc Espanola Med Intensiva Crit & Unidades Corona, Ctr Invest Biomed Red Enfermedades Resp,Area Gen, Crit Care Dept,Hosp Vall dHebron,Inst Recerca Val, E-08193 Barcelona, Spain; [Andaluz, David] Hosp Clin Univ Salud Junta Castilla & Leon, Crit Care Dept, Soc Espanola Med Intensiva Crit & Unidades Corona, Valladolid, Spain; [Shum, Bianche; Krajden, Sigmund] St Josephs Hlth Ctr, Dept Microbiol, Toronto, ON, Canada; [Rubino, Salvatore; Kelvin, David J.] Univ Sassari, Sez Microbiol Sperimentale & Clin, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Tran, Dat] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Rubin, Barry B.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Vasc Surg,Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Kelvin, Alyson A.; Kelvin, David J.] Immune Diagnost & Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Shantou University; University of Toronto; Hospital Universitari i Politecnic La Fe; Hospital Universitari Son Llatzer; Hospital del Rio Hortega; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario); University of Sassari; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Paquette, SG (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Expt Therapeut, Toronto, ON, Canada.	dkelvin@jidc.org	martin-loeches, ignacio m/Q-6645-2018; Ramírez, Paula/N-8337-2015; Rubino, Salvatore/AAC-5848-2022; Bermejo-Martin, Jesus F/J-4574-2019; Fadda, Giovanni/K-6224-2012; Almansa, Raquel/T-3414-2019; Delogu, Giovanni/I-3701-2012; Barac, Aleksandra/W-9785-2019; Matrin-Loeches, Ignacio/H-4633-2013; Rello, Jordi/P-2402-2019	martin-loeches, ignacio m/0000-0002-5834-4063; Ramírez, Paula/0000-0002-7598-3350; Bermejo-Martin, Jesus F/0000-0002-7998-6268; Delogu, Giovanni/0000-0003-0182-8267; Rello, Jordi/0000-0003-0676-6210; Almansa, Raquel/0000-0002-4144-7808	Li Ka Shing Foundation; Immune Diagnostics Research	Li Ka Shing Foundation; Immune Diagnostics Research	This work was supported by the Li Ka Shing Foundation and Immune Diagnostics & Research. Dr. Alyson A. Kelvin is the Scientific Director for Immune Diagnostics & Research and had input into experimental design and write-up of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; FERRARA JLM, 1993, CURR OPIN IMMUNOL, V5, P794, DOI 10.1016/0952-7915(93)90139-J; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gentile D, 1998, CLIN DIAGN LAB IMMUN, V5, P604, DOI 10.1128/CDLI.5.5.604-608.1998; Gilsdorf A, 2009, EUROSURVEILLANCE, V14, P19318; Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306; Health Protection Agency Health Protection Scotland National Public Health Service for Wales HPA Northern Ireland Swine Influenza Investigation Teams, 2009, EUROSURVEILLANCE, V14, P19232; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Kmietowicz Z, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4393; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kramarz P, 2009, EUROSURVEILLANCE, V14; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; Lin WC, 2010, EXP BIOL MED, V235, P57, DOI 10.1258/ebm.2009.009256; NAPOLITANO LM, 2009, MMWR-MORBID MORTAL W, V58, P749; Otte A, 2011, AM J PATHOL, V179, P230, DOI 10.1016/j.ajpath.2011.03.041; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; RYAN GB, 1977, AM J PATHOL, V86, P183; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Theoharides TC, 2002, INT ARCH ALLERGY IMM, V128, P344, DOI 10.1159/000063858; TILG H, 1994, BLOOD, V83, P113; Uyeki TM, 2009, NEW ENGL J MED, V361, P2558, DOI 10.1056/NEJMcpc0905545; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004	43	99	99	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38214	10.1371/journal.pone.0038214	http://dx.doi.org/10.1371/journal.pone.0038214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679491	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900021
J	van Beekum, O; Gao, Y; Berger, R; Koppen, A; Kalkhoven, E				van Beekum, Olivier; Gao, Yuan; Berger, Ruud; Koppen, Arjen; Kalkhoven, Eric			A Novel RNAi Lethality Rescue Screen to Identify Regulators of Adipogenesis	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; PPAR-GAMMA; TRANSCRIPTION FACTOR; ADIPOSE CONVERSION; INSULIN-RESISTANCE; MAMMALIAN-CELLS; LIPID DROPLETS; KEY REGULATOR; DIFFERENTIATION; ADIPOCYTES	Adipogenesis, the differentiation of fibroblast-like mesenchymal stem cells into mature adipocytes, is tightly regulated by a complex cascade of transcription factors, including the nuclear receptor Peroxisome proliferator activator receptor gamma (PPAR gamma). RNAi-mediated knock down libraries may present an atractive method for the identification of additional adipogenic factors. However, using in vitro adipogenesis model systems for high-throughput screening with siRNA libraries is limited since (i) differentiation is not homogeneous, but results in mixed cell populations, and (ii) the expression levels (and activity) of adipogenic regulators is highly dynamic during differentiation, indicating that the timing of RNAi-mediated knock down during differentiation may be extremely critical. Here we report a proof-of-principle for a novel RNAi screening method to identify regulators of adipogenesis that is based on lethality rescue rather than differentiation, using microRNA expression driven by a PPAR gamma responsive RNA polymerase II promoter. We validated this novel method through screening of a dedicated deubiquitinase knock down library, resulting in the identification of UCHL3 as an essential deubiquitinase in adipogenesis. This system therefore enables the identification of novel genes regulating PPAR gamma-mediated adipogenesis in a high-throughput setting.	[van Beekum, Olivier; Gao, Yuan; Berger, Ruud; Koppen, Arjen; Kalkhoven, Eric] Univ Med Ctr Utrecht, Netherlands Metabol Ctr, Dept Metab Dis, Utrecht, Netherlands; [Kalkhoven, Eric] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	van Beekum, O (corresponding author), Univ Med Ctr Utrecht, Netherlands Metabol Ctr, Dept Metab Dis, Utrecht, Netherlands.	E.Kalkhoven@umcutrecht.nl	Koppen, Arjen/GLV-6743-2022		research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)	research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)	This study was supported by the research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Fajas L, 2003, ONCOGENE, V22, P4186, DOI 10.1038/sj.onc.1206530; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gijsbers L, 2011, ANALBIOCHEM; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hegele RA, 2005, INT J OBESITY, V29, pS31, DOI 10.1038/sj.ijo.0802911; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Jeninga EH, 2007, MOL ENDOCRINOL, V21, P1049, DOI 10.1210/me.2006-0485; Koppen A, 2009, MOL CELL PROTEOMICS, V8, P2212, DOI 10.1074/mcp.M900209-MCP200; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kwon J, 2004, AM J PATHOL, V165, P1367, DOI 10.1016/S0002-9440(10)63394-9; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li FF, 2010, FEBS J, V277, P4173, DOI 10.1111/j.1742-4658.2010.07806.x; Loo LH, 2009, J CELL BIOL, V187, P375, DOI 10.1083/jcb.200904140; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Osawa Y, 2001, BIOCHEM BIOPH RES CO, V283, P627, DOI 10.1006/bbrc.2001.4841; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Park KW, 2010, J LIPID RES, V51, P2775, DOI 10.1194/jlr.M008490; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sekiguchi S, 2006, AM J PATHOL, V169, P1722, DOI 10.2353/ajpath.2006.060301; Setsuie R, 2009, FASEB J, V23, P4148, DOI 10.1096/fj.09-132217; Shigematsu S, 2001, J BIOL CHEM, V276, P15292, DOI 10.1074/jbc.M009684200; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Suzuki M, 2009, ENDOCRINOLOGY, V150, P5230, DOI 10.1210/en.2009-0332; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Villanueva CJ, 2011, CELL METAB, V13, P413, DOI 10.1016/j.cmet.2011.02.014; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	56	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37680	10.1371/journal.pone.0037680	http://dx.doi.org/10.1371/journal.pone.0037680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679485	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343900010
J	Chan, CL; Renia, L; Tan, KSW				Chan, Chuu Ling; Renia, Laurent; Tan, Kevin S. W.			A Simplified, Sensitive Phagocytic Assay for Malaria Cultures Facilitated by Flow Cytometry of Differentially-Stained Cell Populations	PLOS ONE			English	Article							FALCIPARUM-PARASITIZED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; ANEMIA; MACROPHAGES; MONOCYTES; DESTRUCTION; PROTECTION; SURFACE; MICE	Background: Phagocytosis of infected and uninfected erythrocytes is an important feature of malaria infections. Flow cytometry is a useful tool for studying phagocytic uptake of malaria-infected erythrocytes in vitro. However, current approaches are limited by the inability to discriminate between infected and uninfected erythrocytes and a failure to stain the early developmental ring stages of infected erythrocytes. The majority of infected erythrocytes in circulation are of the ring stage and these are therefore important targets to study. Methodology/Principal Findings: In vitro P. falciparum cultures comprising infected and uninfected erythrocytes were labeled and exposed to cells derived from the human monocytic THP-1 cell line. Phagocytosis was assayed by flow cytometry. Dual labeling of Plasmodium DNA and erythrocyte cytoplasm with dihydroethidium and CellTrace (TM) Violet respectively allowed, for the first time, the detection and enumeration of phagocytes with ingested erythrocytes from both early ring-and late schizont-stage P, falciparum cultures. The sensitivity of the method was tested using varying conditions including phagocyte type (monocytes versus macrophages), parasite stage (rings versus schizonts), and negative (incubation with cytochalasin D) and positive (incubation with immune sera) effectors of phagocytosis. The current assay clearly demonstrated uptake of infected and uninfected erythrocytes exposed to phagocytes; the extent of which was dependent on the conditions mentioned. Conclusions: We describe a simple, sensitive and rapid method for quantifying phagocytosis of P. falciparum-infected erythrocytes, by flow cytometry. This approach can be applied for studying parasite-phagocyte interactions under a variety of conditions. The investigation of phagocytosis of P. falciparum-infected erythrocytes can extend from looking solely at late-staged infected erythrocytes to include early-staged ones as well. It does away with the need to purify infected cells, allowing the study of effects on neighboring uninfected cells. This method may also be translated for use with different types of phagocytes.	[Chan, Chuu Ling; Renia, Laurent; Tan, Kevin S. W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol & Cellular Parasitol, Singapore 117595, Singapore; [Renia, Laurent] Singapore Immunol Network, Lab Malaria Immunobiol, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Chan, CL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol & Cellular Parasitol, Singapore 117595, Singapore.	mictank@nus.edu.sg	Tan, Kevin/C-9653-2014; Renia, Laurent/E-2117-2011	Renia, Laurent/0000-0003-0349-1557	Biomedical Research Council [08-017]; National Medical Research Council (NMRC) [EDG/1038/2011, NMRC/1310/2011]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council (NMRC)(National Medical Research Council, Singapore)	This project was generously funded by research grants from the Biomedical Research Council (SIgN 08-017) and the National Medical Research Council (NMRC EDG/1038/2011 and NMRC/1310/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Ayi K, 2005, INFECT IMMUN, V73, P2559, DOI 10.1128/IAI.73.4.2559-2563.2005; Bettiol E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-64; BUCANA CD, 1990, EXP CELL RES, V190, P69, DOI 10.1016/0014-4827(90)90145-Z; Cappadoro M, 1998, BLOOD, V92, P2527, DOI 10.1182/blood.V92.7.2527.2527_2527_2534; Dondorp AM, 1999, AM J TROP MED HYG, V60, P733, DOI 10.4269/ajtmh.1999.60.733; FADOK VA, 1992, J IMMUNOL, V148, P2207; Frevert U, 2004, TRENDS PARASITOL, V20, P417, DOI 10.1016/j.pt.2004.07.007; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; HOMMEL M, 1988, BIOL CELL, V64, P183, DOI 10.1016/0248-4900(88)90078-0; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Layez C, 2005, BLOOD, V106, P3632, DOI 10.1182/blood-2005-04-1574; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Mota MM, 1998, INFECT IMMUN, V66, P4080; Nagao T, 1996, AM J TROP MED HYG, V55, P562, DOI 10.4269/ajtmh.1996.55.562; NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430; Omi K, 2002, PARASITOL INT, V51, P361, DOI 10.1016/S1383-5769(02)00040-5; Omodeo-Sale F, 2003, BLOOD, V102, P705, DOI 10.1182/blood-2002-08-2437; Organisation WH, 1997, WEEKLY EPIDEMIOL REC, V72, P269; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; Serghides L, 2003, TRENDS PARASITOL, V19, P461, DOI 10.1016/j.pt.2003.08.006; Serghides L, 2001, J IMMUNOL, V166, P6742, DOI 10.4049/jimmunol.166.11.6742; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Taraschi T F, 1999, Novartis Found Symp, V226, P114; Taraschi TF, 1999, NOVART FDN SYMP, V226, P121; Tippett E, 2007, J IMMUNOL METHODS, V325, P42, DOI 10.1016/j.jim.2007.05.012; Urban BC, 2002, CURR OPIN IMMUNOL, V14, P458, DOI 10.1016/S0952-7915(02)00368-0; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80	41	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38523	10.1371/journal.pone.0038523	http://dx.doi.org/10.1371/journal.pone.0038523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675573	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700085
J	Fournie, G; Guitian, J; Desvaux, S; Mangtani, P; Ly, S; Cong, VC; San, S; Dung, DH; Holl, D; Pfeiffer, DU; Vong, S; Ghani, AC				Fournie, Guillaume; Guitian, Javier; Desvaux, Stephanie; Mangtani, Punam; Ly, Sowath; Vu Chi Cong; San, Sorn; Do Huu Dung; Holl, Davun; Pfeiffer, Dirk U.; Vong, Sirenda; Ghani, Azra C.			Identifying Live Bird Markets with the Potential to Act as Reservoirs of Avian Influenza A (H5N1) Virus: A Survey in Northern Viet Nam and Cambodia	PLOS ONE			English	Article							HIGHLY PATHOGENIC H5N1; POULTRY MARKETS; HONG-KONG; OUTBREAKS; EVOLUTION; IMPACT; EGYPT; KOREA; CHINA; GENE	Wet markets are common in many parts of the world and may promote the emergence, spread and maintenance of livestock pathogens, including zoonoses. A survey was conducted in order to assess the potential of Vietnamese and Cambodian live bird markets (LBMs) to sustain circulation of highly pathogenic avian influenza virus subtype H5N1 (HPAIV H5N1). Thirty Vietnamese and 8 Cambodian LBMs were visited, and structured interviews were conducted with the market managers and 561 Vietnamese and 84 Cambodian traders. Multivariate and cluster analysis were used to construct a typology of traders based on their poultry management practices. As a result of those practices and large poultry surplus (unsold poultry reoffered for sale the following day), some poultry traders were shown to promote conditions favorable for perpetuating HPAIV H5N1 in LBMs. More than 80% of these traders operated in LBMs located in the most densely populated areas, Ha Noi and Phnom Penh. The profiles of sellers operating at a given LBM could be reliably predicted using basic information about the location and type of market. Consequently, LBMs with the largest combination of risk factors for becoming virus reservoirs could be easily identified, potentially allowing control strategies to be appropriately targeted. These findings are of particular relevance to resource-scarce settings with extensively developed LBM systems, commonly found in South-East Asia.	[Fournie, Guillaume; Guitian, Javier; Pfeiffer, Dirk U.] Univ London, Dept Vet Clin Sci, Royal Vet Coll, London WC1E 7HU, England; [Desvaux, Stephanie] Ctr Cooperat Int Rech Agronom Dev, UR Anim & Gest Integree Risques, Montpellier, France; [Mangtani, Punam] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; [Ly, Sowath; Vong, Sirenda] Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia; [San, Sorn] Natl Inst Anim Sci, Hanoi, Vietnam; [San, Sorn; Holl, Davun] Minist Agr Fisheries & Forestry, Natl Inst Vet Res, Phnom Penh, Cambodia; [Do Huu Dung] Dept Anim Hlth, Hanoi, Vietnam; [Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England	University of London; University of London Royal Veterinary College; CIRAD; University of London; London School of Hygiene & Tropical Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Imperial College London	Fournie, G (corresponding author), Univ London, Dept Vet Clin Sci, Royal Vet Coll, London WC1E 7HU, England.	gfournie@rvc.ac.uk	Pfeiffer, Dirk U/C-5002-2009; Guitian, Javier/O-1185-2019; Guitian, Javier/C-3022-2009; Ghani, Azra/B-8560-2009; Guitian, Javier/O-5744-2019	Pfeiffer, Dirk U/0000-0001-7000-0530; Guitian, Javier/0000-0003-0799-0476; Guitian, Javier/0000-0003-0799-0476; Guitian, Javier/0000-0003-0799-0476; Fournie, Guillaume/0000-0002-6998-1201; Mangtani, Punam/0000-0001-7074-2999; Ghani, Azra/0000-0002-0007-4910	Bloomsbury consortium; University of London Central Research Fund; UK Medical Research Council; Medical Research Council [G0600719B] Funding Source: researchfish	Bloomsbury consortium; University of London Central Research Fund; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Guillaume Fournie thanks support from the Bloomsbury consortium and the University of London Central Research Fund. Azra C. Ghani acknowledges support from the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2010, AVIAN DIS, V54, P911, DOI 10.1637/9099-100809-RESNOTE.1; Amonsin A, 2008, EMERG INFECT DIS, V14, P1739, DOI 10.3201/eid1411.080683; Bertrand F., 2007, CS BIGS, V1, P183; Buchy P, 2009, EMERG INFECT DIS, V15, P1641, DOI 10.3201/eid1510.090115; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen JJ, 2009, VIRUS RES, V146, P19, DOI 10.1016/j.virusres.2009.08.010; Choi YK, 2005, VIROLOGY, V332, P529, DOI 10.1016/j.virol.2004.12.002; Davis CT, 2010, AVIAN DIS, V54, P307, DOI 10.1637/8801-040109-ResNote.1; Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510; Ge FF, 2009, J CLIN MICROBIOL, V47, P3294, DOI 10.1128/JCM.00355-09; General Statistics Office of Vietnam, 2010, POP POP DENS 2009 PR; General Statistics Office of Vietnam, 2010, NUMB POULTR PROV 200; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Indriani R, 2010, EMERG INFECT DIS, V16, P1889, DOI 10.3201/eid1612.100402; Kim HR, 2010, VET MICROBIOL, V141, P362, DOI 10.1016/j.vetmic.2009.09.011; Kung NY, 2003, AVIAN DIS, V47, P1037, DOI 10.1637/0005-2086-47.s3.1037; Lau EHY, 2007, EMERG INFECT DIS, V13, P1340, DOI 10.3201/eid1309.061549; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee HJ, 2010, AVIAN DIS, V54, P738, DOI 10.1637/8785-040109-ResNote.1; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Magalhaes RJS, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-10; Manly B. F. J., 2005, MULTIVARIATE STAT ME; Meleigy M, 2007, LANCET, V370, P553, DOI 10.1016/S0140-6736(07)61274-4; Minh PQ, 2009, PREV VET MED, V89, P16, DOI 10.1016/j.prevetmed.2009.01.004; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; [OIE World Organisation for Animal Health], 2011, H5N1 NOT DOM POULTR; Peyre Marisa, 2009, J Mol Genet Med, V3, P198; PP J, 2004, REV STAT APPL, V52, P93; ProMED-mail, 2008, AV INFL 122 CAMB CHI; R Development Core Team, 2010, LANG ENV STAT COMP G; Shortridge KF, 1999, VACCINE, V17, pS26, DOI 10.1016/S0264-410X(99)00102-4; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820	38	53	56	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37986	10.1371/journal.pone.0037986	http://dx.doi.org/10.1371/journal.pone.0037986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675502	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000305341700031
J	Inagaki, T; Kaneko, N; Zukin, RS; Castillo, PE; Etgen, AM				Inagaki, Tomoko; Kaneko, Naoki; Zukin, R. Suzanne; Castillo, Pablo E.; Etgen, Anne M.			Estradiol Attenuates Ischemia-Induced Death of Hippocampal Neurons and Enhances Synaptic Transmission in Aged, Long-Term Hormone-Deprived Female Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GLOBAL-ISCHEMIA; SELECTIVE VULNERABILITY; NEUROPROTECTIVE ACTIONS; POSTMENOPAUSAL WOMEN; BRAIN; STROKE; DAMAGE; PLASTICITY; THERAPY	Background: Transient global forebrain ischemia causes selective, delayed death of hippocampal CA1 pyramidal neurons, and the ovarian hormone 17 beta-estradiol (E2) reduces neuronal loss in young and middle-aged females. The neuroprotective efficacy of E2 after a prolonged period of hormone deprivation is controversial, and few studies examine this issue in aged animals given E2 treatment after induction of ischemia. Methodology/Principal Findings: The present study investigated the neuroprotective effects of E2 administered immediately after global ischemia in aged female rats (15-18 months) after 6 months of hormone deprivation. We also used electrophysiological methods to assess whether CA1 synapses in the aging hippocampus remain responsive to E2 after prolonged hormone withdrawal. Animals were ovariohysterectomized and underwent 10 min global ischemia 6 months later. A single dose of E2 (2.25 mu g) infused intraventricularly after reperfusion significantly increased cell survival, with 45% of CA1 neurons surviving vs 15% in controls. Ischemia also induced moderate loss of CA3/CA4 pyramidal cells. Bath application of 1 nM E2 onto brain slices derived from non-ischemic aged females after 6 months of hormone withdrawal significantly enhanced excitatory transmission at CA1 synapses evoked by Schaffer collateral stimulation, and normal long-term potentiation (LTP) was induced. The magnitude of LTP and of E2 enhancement of field excitatory postsynaptic potentials was indistinguishable from that recorded in slices from young rats. Conclusions/Significance: The data demonstrate that 1) acute post-ischemic infusion of E2 into the brain ventricles is neuroprotective in aged rats after 6 months of hormone deprivation; and 2) E2 enhances synaptic transmission in CA1 pyramidal neurons of aged long-term hormone deprived females. These findings provide evidence that the aging hippocampus remains responsive to E2 administered either in vivo or in vitro even after prolonged periods of hormone withdrawal.	[Inagaki, Tomoko; Kaneko, Naoki; Zukin, R. Suzanne; Castillo, Pablo E.; Etgen, Anne M.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Inagaki, T (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	Anne.Etgen@einstein.yu.edu		Castillo, Pablo/0000-0002-9834-1801	National Institutes of Health [R01 AG027702]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant R01 AG027702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2002, J NEUROSCI, V22, P3608; Adams MM, 2003, CEREB CORTEX, V13, P1271, DOI 10.1093/cercor/bhg078; Adams MM, 2001, P NATL ACAD SCI USA, V98, P8071, DOI 10.1073/pnas.141215898; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Brann D, 2012, J NEUROENDOCRINOL, V24, P34, DOI 10.1111/j.1365-2826.2011.02185.x; Carswell HVO, 2005, J STEROID BIOCHEM, V96, P89, DOI 10.1016/j.jsbmb.2005.02.016; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; De Butte-Smith M, 2009, HORM BEHAV, V55, P442, DOI 10.1016/j.yhbeh.2008.11.011; Driscoll I, 2008, NEUROBIOL AGING, V29, P1847, DOI 10.1016/j.neurobiolaging.2007.04.025; Eckel LA, 2011, PHYSIOL BEHAV, V104, P517, DOI 10.1016/j.physbeh.2011.04.014; Elzer JG, 2010, J CEREBR BLOOD F MET, V30, P935, DOI 10.1038/jcbfm.2009.258; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Etgen AM, 2011, FRONT NEUROENDOCRIN, V32, P336, DOI 10.1016/j.yfrne.2010.12.005; Farr TD, 2007, BRAIN RES, V1185, P275, DOI 10.1016/j.brainres.2007.09.009; Fester L, 2011, CELL TISSUE RES, V345, P285, DOI 10.1007/s00441-011-1221-7; Garcia-Segura LM, 2007, PSYCHONEUROENDOCRINO, V32, pS57, DOI 10.1016/j.psyneuen.2007.03.001; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Grassi S, 2011, NEUROSCIENCE, V192, P67, DOI 10.1016/j.neuroscience.2011.06.078; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Hojo Y, 2008, MOL CELL ENDOCRINOL, V290, P31, DOI 10.1016/j.mce.2008.04.017; Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; Jover-Mengual T, 2010, BRAIN RES, V1321, P1, DOI 10.1016/j.brainres.2010.01.046; Kenealy BP, 2011, ENDOCRINOLOGY, V152, P3182, DOI 10.1210/en.2011-0097; Kharlamov A, 2000, J GERONTOL A-BIOL, V55, pB135, DOI 10.1093/gerona/55.3.B135; KIRINO T, 1985, PROG BRAIN RES, V63, P39; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Kumar A, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00007; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Liu R, 2007, NEUROSCI LETT, V415, P237, DOI 10.1016/j.neulet.2007.01.074; Liu SB, 2012, J NEUROSCI, V32, P4887, DOI 10.1523/JNEUROSCI.5828-11.2012; MacLean PS, 2010, OBESITY, V18, P696, DOI 10.1038/oby.2009.307; McCullough LD, 2003, J NEUROSCI, V23, P8701; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Mukai H, 2006, NEUROSCIENCE, V138, P757, DOI 10.1016/j.neuroscience.2005.09.010; Mukai H, 2010, BBA-GEN SUBJECTS, V1800, P1030, DOI 10.1016/j.bbagen.2009.11.002; Pines A, 2002, HUM REPROD UPDATE, V8, P161, DOI 10.1093/humupd/8.2.161; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Roepke TA, 2011, FRONT BIOSCI-LANDMRK, V16, P1560, DOI 10.2741/3805; Ronnekleiv OK, 2007, SEMIN REPROD MED, V25, P165, DOI 10.1055/s-2007-973429; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rune GM, 2005, NEUROSCIENCE, V136, P833, DOI 10.1016/j.neuroscience.2005.03.056; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Saleh TM, 2005, NEUROSCIENCE, V135, P1141, DOI 10.1016/j.neuroscience.2005.06.061; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Scott E, 2012, FRONT NEUROENDOCRIN, V33, P85, DOI 10.1016/j.yfrne.2011.10.001; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Selvamani A, 2010, NEUROBIOL AGING, V31, P1618, DOI 10.1016/j.neurobiolaging.2008.08.014; Siqueira IR, 2004, BRAIN RES, V1025, P226, DOI 10.1016/j.brainres.2004.08.005; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Smith CC, 2010, P NATL ACAD SCI USA, V107, P19543, DOI 10.1073/pnas.1009307107; Strom JO, 2011, INT J MOL SCI, V12, P1533, DOI 10.3390/ijms12031533; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Toung TJ, 2004, J CEREBR BLOOD F MET, V24, P1160, DOI 10.1097/01.WCB.0000135594.13576.D2; Tu YF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-40; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Wappler EA, 2010, BEHAV BRAIN RES, V209, P42, DOI 10.1016/j.bbr.2010.01.010; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; Xu K, 2007, ADV EXP MED BIOL, V599, P199; Yang SH, 2003, ANN NY ACAD SCI, V1007, P101, DOI 10.1196/annals.1286.010; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Yi KD, 2011, BRAIN RES, V1379, P61, DOI 10.1016/j.brainres.2010.11.058; Yildirim M, 2011, BRAIN RES, V1379, P98, DOI 10.1016/j.brainres.2010.07.053; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhang M, 2011, NEUROCHEM INT, V59, P1019, DOI 10.1016/j.neuint.2011.08.023; Zhang QG, 2011, P NATL ACAD SCI USA, V108, pE617, DOI 10.1073/pnas.1104391108; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7; Zhou L, 2010, ENDOCRINOLOGY, V151, P1153, DOI 10.1210/en.2009-0254	74	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38018	10.1371/journal.pone.0038018	http://dx.doi.org/10.1371/journal.pone.0038018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675505	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341700034
J	Park, TIH; Monzo, H; Mee, EW; Bergin, PS; Teoh, HH; Montgomery, JM; Faull, RLM; Curtis, MA; Dragunow, M				Park, Thomas In-Hyeup; Monzo, Hector; Mee, Edward W.; Bergin, Peter S.; Teoh, Hoon H.; Montgomery, Johanna M.; Faull, Richard L. M.; Curtis, Maurice A.; Dragunow, Mike			Adult Human Brain Neural Progenitor Cells (NPCs) and Fibroblast-Like Cells Have Similar Properties In Vitro but Only NPCs Differentiate into Neurons	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; EMBRYONIC HUMAN CNS; STEM-CELLS; SUBVENTRICULAR ZONE; STEM/PROGENITOR CELLS; INDUCED NEUROGENESIS; CELLULAR COMPOSITION; OLFACTORY-BULB; GLIAL CULTURES; DENTATE GYRUS	The ability to culture neural progenitor cells from the adult human brain has provided an exciting opportunity to develop and test potential therapies on adult human brain cells. To achieve a reliable and reproducible adult human neural progenitor cell (AhNPC) culture system for this purpose, this study fully characterized the cellular composition of the AhNPC cultures, as well as the possible changes to this in vitro system over prolonged culture periods. We isolated cells from the neurogenic subventricular zone/hippocampus (SVZ/HP) of the adult human brain and found a heterogeneous culture population comprised of several types of post-mitotic brain cells (neurons, astrocytes, and microglia), and more importantly, two distinct mitotic cell populations; the AhNPCs, and the fibroblast-like cells (FbCs). These two populations can easily be mistaken for a single population of AhNPCs, as they both proliferate under AhNPC culture conditions, form spheres and express neural progenitor cell and early neuronal markers, all of which are characteristics of AhNPCs in vitro. However, despite these similarities under proliferating conditions, under neuronal differentiation conditions, only the AhNPCs differentiated into functional neurons and glia. Furthermore, AhNPCs showed limited proliferative capacity that resulted in their depletion from culture by 5-6 passages, while the FbCs, which appear to be from a neurovascular origin, displayed a greater proliferative capacity and dominated the long-term cultures. This gradual change in cellular composition resulted in a progressive decline in neurogenic potential without the apparent loss of self-renewal in our cultures. These results demonstrate that while AhNPCs and FbCs behave similarly under proliferative conditions, they are two different cell populations. This information is vital for the interpretation and reproducibility of AhNPC experiments and suggests an ideal time frame for conducting AhNPC-based experiments.	[Park, Thomas In-Hyeup; Dragunow, Mike] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Park, Thomas In-Hyeup; Monzo, Hector; Montgomery, Johanna M.; Faull, Richard L. M.; Curtis, Maurice A.; Dragunow, Mike] Univ Auckland, Ctr Brain Res, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Park, Thomas In-Hyeup; Monzo, Hector; Faull, Richard L. M.; Curtis, Maurice A.] Univ Auckland, Dept Anat & Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Mee, Edward W.] Auckland City Hosp, Dept Neurosurg, Auckland, New Zealand; [Bergin, Peter S.] Auckland City Hosp, Dept Neurol, Auckland, New Zealand; [Teoh, Hoon H.] Labtests, Auckland, New Zealand; [Montgomery, Johanna M.] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; Auckland City Hospital; Auckland City Hospital; University of Auckland	Park, TIH (corresponding author), Univ Auckland, Dept Pharmacol & Clin Pharmacol, Fac Med & Hlth Sci, Auckland 1, New Zealand.	m.dragunow@auckland.ac.nz		Faull, Richard/0000-0003-3385-9498; Park, Thomas In-Hyeup/0000-0002-7995-8865; Curtis, Maurice/0000-0003-4496-0233	Marsden Grant; New Zealand Tertiary Education Commission; Lynette Sullivan HD Research Fund; Health Research Council of New Zealand; Coker Charitable Trust; Hugh Green Charitable Trust Biobank; New Zealand Neurological Foundation	Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); New Zealand Tertiary Education Commission; Lynette Sullivan HD Research Fund; Health Research Council of New Zealand(Health Research Council of New Zealand); Coker Charitable Trust; Hugh Green Charitable Trust Biobank; New Zealand Neurological Foundation	This work was supported by: Marsden Grant (http://www.royalsociety.org.nz/programmes/funds/marsden); New Zealand Tertiary Education Commission Top Achievers Scholarship; Lynette Sullivan HD Research Fund; The Health Research Council of New Zealand (http://www.hrc.govt.nz); The Coker Charitable Trust; Hugh Green Charitable Trust Biobank and the New Zealand Neurological Foundation (http://www.neurological.org.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Arimura K, 2012, CURR NEUROVASC RES, V9, P1; Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691; Ayuso-Sacido A, 2008, NEUROSURGERY, V62, P223, DOI 10.1227/01.NEU.0000311081.50648.4C; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bifari F, 2009, J CELL MOL MED, V13, P3195, DOI 10.1111/j.1582-4934.2009.00706.x; BLACK RS, 1994, J NEUROCHEM, V62, P2132; BLASS JP, 1994, J NEUROL SCI, V121, P132, DOI 10.1016/0022-510X(94)90341-7; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Brewer GJ, 2001, J NEUROSCI METH, V107, P15, DOI 10.1016/S0165-0270(01)00342-9; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Coras R, 2010, BRAIN; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; D'Alessio L, 2010, SEIZURE-EUR J EPILEP, V19, P567, DOI 10.1016/j.seizure.2010.09.004; DEGIORGIO LA, 1994, J NEUROL SCI, V124, P141, DOI 10.1016/0022-510X(94)90319-0; DeGiorgio LA, 1997, INT J DEV NEUROSCI, V15, P231, DOI 10.1016/S0736-5748(96)00076-7; DeGroot CJA, 1997, J NEUROSCI RES, V49, P342, DOI 10.1002/(SICI)1097-4547(19970801)49:3<342::AID-JNR9>3.0.CO;2-C; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Emond MR, 2010, J PHYSIOL-LONDON, V588, P1929, DOI 10.1113/jphysiol.2010.187229; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Gibbons HA, 2007, J NEUROSCI METH, V166, P89, DOI 10.1016/j.jneumeth.2007.07.005; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Hattiangady B, 2010, HIPPOCAMPUS, V20, P97, DOI 10.1002/hipo.20594; Hirohata S, 2001, J LEUKOCYTE BIOL, V70, P413; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Inoue H, 2010, EXP CELL RES; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Joannides A, 2003, J HEMATOTH STEM CELL, V12, P681, DOI 10.1089/15258160360732704; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Laywell ED, 2005, J COMP NEUROL, V493, P321, DOI 10.1002/cne.20722; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; Liu YWJ, 2007, CURR PHARM BIOTECHNO, V8, P187; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Lue LF, 1996, NEUROBIOL AGING, V17, P421, DOI 10.1016/0197-4580(96)00006-1; Mamaeva D, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-99; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Moe MC, 2005, NEUROSURGERY, V56, P1182, DOI 10.1227/01.NEU.0000159881.09663.6D; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Park T.I.H., 2022, METHODS MOL BIOL, V2389, P125, DOI [10.1007/978-1-0716-1783-0_12, DOI 10.1007/978-1-0716-1783-0_12]; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richardson RM, 2006, ACTA NEUROCHIR, V148, P773, DOI 10.1007/s00701-006-0778-5; Rieske P, 2005, DIFFERENTIATION, V73, P474, DOI 10.1111/j.1432-0436.2005.00050.x; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Roy NS, 2000, J NEUROSCI RES, V59, P321, DOI 10.1002/(SICI)1097-4547(20000201)59:3<321::AID-JNR5>3.0.CO;2-9; Roy NS, 2000, NAT MED, V6, P271; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; SONTHEIMER H, 1992, J NEUROPHYSIOL, V68, P985, DOI 10.1152/jn.1992.68.4.985; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Waldvogel HJ, 2006, NAT PROTOC, V1, P2719, DOI 10.1038/nprot.2006.354; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X	83	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37742	10.1371/journal.pone.0037742	http://dx.doi.org/10.1371/journal.pone.0037742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675489	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700021
J	Patten, TM; Rennie, CJ; Robinson, PA; Gong, P				Patten, Timothy M.; Rennie, Christopher J.; Robinson, Peter A.; Gong, Pulin			Human Cortical Traveling Waves: Dynamical Properties and Correlations with Responses	PLOS ONE			English	Article							EVOKED-POTENTIALS; SYNCHRONIZATION; PATTERNS; PHASE	The spatiotemporal behavior of human EEG oscillations is investigated. Traveling waves in the alpha and theta ranges are found to be common in both prestimulus and poststimulus EEG activity. The dynamical properties of these waves, including their speeds, directions, and durations, are systematically characterized for the first time, and the results show that there are significant changes of prestimulus spontaneous waves in the presence of an external stimulus. Furthermore, the functional relevance of these waves is examined by studying how they are correlated with reaction times on a single trial basis; prestimulus alpha waves traveling in the frontal-to-occipital direction are found to be most correlated to reaction speeds. These findings suggest that propagating waves of brain oscillations might be involved in mediating long-range interactions between widely distributed parts of human cortex.	[Patten, Timothy M.; Rennie, Christopher J.; Robinson, Peter A.; Gong, Pulin] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Rennie, Christopher J.; Robinson, Peter A.] Univ Sydney, Brain Dynam Ctr, Sydney Med Sch Western, Westmead, NSW 2145, Australia; [Gong, Pulin] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Patten, TM (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	p.gong@physics.usyd.edu.au		Gong, Pulin/0000-0002-1960-3245; Robinson, Peter/0000-0002-5050-9804				Alexander DM, 2006, J NEUROSCI METH, V156, P111, DOI 10.1016/j.jneumeth.2006.02.016; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Aurlien H, 2004, CLIN NEUROPHYSIOL, V115, P665, DOI 10.1016/j.clinph.2003.10.019; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BEURLE RL, 1956, PHILOS T ROY SOC B, V240, P55, DOI 10.1098/rstb.1956.0012; Burkitt GR, 2000, CLIN NEUROPHYSIOL, V111, P246, DOI 10.1016/S1388-2457(99)00194-7; Buzsaki G., 2006, RHYTHMS BRAIN; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Farley BG, 1961, P 4 LOND S INF THEOR; Ferezou I, 2006, NEURON, V29, P33; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; Freeman WJ, 1974, MASS ACTION NERVOUS; GOLDMAN S, 1949, SCIENCE, V109, P524, DOI 10.1126/science.109.2838.524; Gong P, 2003, NEUROSCI LETT, V336, P33, DOI 10.1016/S0304-3940(02)01247-8; Gong PL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000611; Gordon E, 2005, CLIN EEG NEUROSCI, V36, P64, DOI 10.1177/155005940503600205; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Ito J, 2007, HUM BRAIN MAPP, V28, P904, DOI 10.1002/hbm.20316; Jirsa VK, 1996, PHYS REV LETT, V77, P960, DOI 10.1103/PhysRevLett.77.960; Kerr CC, 2011, CLIN NEUROPHYSIOL, V122, P134, DOI 10.1016/j.clinph.2010.05.030; Klimesch W, 2007, J NEUROPHYSIOL, V97, P1311, DOI 10.1152/jn.00876.2006; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Linkenkaer-Hansen K, 2004, J NEUROSCI, V25, P2858; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nikolaev AR, 2010, CEREB CORTEX, V20, P365, DOI 10.1093/cercor/bhp107; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Robinson PA, 2008, BIOL CYBERN, V98, P1, DOI 10.1007/s00422-007-0191-z; Robinson PA, 2004, HUM BRAIN MAPP, V23, P53, DOI 10.1002/hbm.20032; Robinson PA, 1997, PHYS REV E, V56, P826, DOI 10.1103/PhysRevE.56.826; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; van Albada SJ, 2010, CLIN NEUROPHYSIOL, V121, P21, DOI 10.1016/j.clinph.2009.09.021; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; von der Malsburg C., 2010, DYNAMIC COORDINATION; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wiener N, 1952, ARCH I CARDIOL MEX, V16, P204; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016	48	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38392	10.1371/journal.pone.0038392	http://dx.doi.org/10.1371/journal.pone.0038392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675555	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700068
J	Perego, UA; Lancioni, H; Tribaldos, M; Angerhofer, N; Ekins, JE; Olivieri, A; Woodward, SR; Pascale, JM; Cooke, R; Motta, J; Achilli, A				Perego, Ugo A.; Lancioni, Hovirag; Tribaldos, Maribel; Angerhofer, Norman; Ekins, Jayne E.; Olivieri, Anna; Woodward, Scott R.; Pascale, Juan Miguel; Cooke, Richard; Motta, Jorge; Achilli, Alessandro			Decrypting the Mitochondrial Gene Pool of Modern Panamanians	PLOS ONE			English	Article							NATIVE-AMERICAN POPULATIONS; Y-CHROMOSOME; COSTA-RICA; LATE PLEISTOCENE; MTDNA VARIATION; NORTH-AMERICA; DNA; DIVERSITY; EVOLUTIONARY; HISTORY	The Isthmus of Panama-the narrow neck of land connecting the northern and southern American landmasses-was an obligatory corridor for the Paleo-Indians as they moved into South America. Archaeological evidence suggests an unbroken link between modern natives and their Paleo-Indian ancestors in some areas of Panama, even if the surviving indigenous groups account for only 12.3% of the total population. To evaluate if modern Panamanians have retained a larger fraction of the native pre-Columbian gene pool in their maternally-inherited mitochondrial genome, DNA samples and historical records were collected from more than 1500 volunteer participants living in the nine provinces and four indigenous territories of the Republic. Due to recent gene-flow, we detected similar to 14% African mitochondrial lineages, confirming the demographic impact of the Atlantic slave trade and subsequent African immigration into Panama from Caribbean islands, and a small European (similar to 2%) component, indicating only a minor influence of colonialism on the maternal side. The majority (similar to 83%) of Panamanian mtDNAs clustered into native pan-American lineages, mostly represented by haplogroup A2 (51%). These findings reveal an overwhelming native maternal legacy in today's Panama, which is in contrast with the overall concept of personal identity shared by many Panamanians. Moreover, the A2 sub-clades A2ad and A2af (with the previously named 6 bp Huetar deletion), when analyzed at the maximum level of resolution (26 entire mitochondrial genomes), confirm the major role of the Pacific coastal path in the peopling of North, Central and South America, and testify to the antiquity of native mitochondrial genomes in Panama.	[Perego, Ugo A.; Angerhofer, Norman; Ekins, Jayne E.; Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Lancioni, Hovirag; Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Tribaldos, Maribel; Pascale, Juan Miguel; Motta, Jorge] Inst Conmemorativo Gorgas Estudios Salud, Panama City, Panama; [Angerhofer, Norman; Woodward, Scott R.] Ancestry, Provo, UT USA; [Olivieri, Anna] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Cooke, Richard] Smithsonian Trop Res Inst, Apdo, Ancon, Panama	University of Perugia; Instituto Conmemorativo Gorgas de Estudios de la Salud; University of Pavia; Smithsonian Institution; Smithsonian Tropical Research Institute	Perego, UA (corresponding author), Sorenson Mol Geneal Fdn, Salt Lake City, UT USA.	alessandro.achilli@unipg.it	OLIVIERI, ANNA/I-9235-2012; Perego, Ugo/AAG-9327-2019; Motta, Jorge Alejandro/ABI-6006-2020; Achilli, Alessandro/I-9236-2012; Lancioni, Hovirag/F-9067-2014; Tribaldos Causadias de Suarez, Maribel/L-8560-2016	OLIVIERI, ANNA/0000-0002-3941-8098; Achilli, Alessandro/0000-0001-6871-3451; Lancioni, Hovirag/0000-0001-5514-1853; Tribaldos Causadias de Suarez, Maribel/0000-0001-5212-0061	Instituto Conmemorativo Gorgas de Estudios de la Salud; Gorgas Internal Grant for Genealogy Studies; Italian Ministry of the University: FIRB-Futuro in Ricerca; Progetti Ricerca Interesse Nazionale; Sorenson Molecular Genealogy Foundation	Instituto Conmemorativo Gorgas de Estudios de la Salud; Gorgas Internal Grant for Genealogy Studies; Italian Ministry of the University: FIRB-Futuro in Ricerca; Progetti Ricerca Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Sorenson Molecular Genealogy Foundation	This research received support from the Instituto Conmemorativo Gorgas de Estudios de la Salud (to JM), Gorgas Internal Grant for Genealogy Studies (to JMP), the Italian Ministry of the University: FIRB-Futuro in Ricerca 2008 (to AA and AO), Progetti Ricerca Interesse Nazionale 2009 (to AA), and the Sorenson Molecular Genealogy Foundation (to UAP, NA and SRW). The authors are grateful to all the donors for providing biological specimens, and to everyone at the Instituto Conmemorativo Gorgas and at the Sorenson Molecular Genealogy Foundation for their work on the preliminary data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ascunce MS, 2008, HUM BIOL, V80, P287, DOI 10.3378/1534-6617-80.3.287; BARRANTES R, 1990, AM J HUM GENET, V46, P63; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bodner M, 2012, GENOME RES; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Constenla Umana A., 1991, LENGUAS AREA INTERME; Cooke R, 2005, J ARCHAEOL RES, V13, P129, DOI 10.1007/s10804-005-2486-4; Crawford MH, 1998, ORIGINS NATIVE AM EV, VXV, P308; Dalton R, 2011, NATURE, V469, P462, DOI 10.1038/469462a; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Forster P, 1996, AM J HUM GENET, V59, P935; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Harding RC, 2006, HIST PANAMA, Vxviii, P153; Kashani BH, 2012, AM J PHYS ANTHROPOL, V147, P35, DOI 10.1002/ajpa.21614; Kaufman T, 2000, AM AM PRESENT GENES, P47; KOLMAN CJ, 1995, GENETICS, V140, P275; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; O'Rourke DH, 2009, CURR BIOL, V19, pR203, DOI 10.1016/j.cub.2009.01.021; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Piperno DR, 2011, S-P B ENVIRON SCI, P185; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; Romoli Kathleen, 1987, LENGUA CUEVA; Ruiz-Narvaez EA, 2005, HUM BIOL, V77, P71, DOI 10.1353/hub.2005.0032; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006882; SANTOS M, 1994, HUM BIOL, V66, P963; SANTOS M, 1994, AM J HUM GENET, V55, P413; SANTOS M, 1994, HUM GENET, V93, P435; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, HUM MUTAT, V30, pE386; WALLACE DC, 1992, HUM BIOL, V64, P403; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; [No title captured]	57	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38337	10.1371/journal.pone.0038337	http://dx.doi.org/10.1371/journal.pone.0038337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675545	Green Published, gold			2022-12-27	WOS:000305341700060
J	Uronis, JM; Osada, T; McCall, S; Yang, XY; Mantyh, C; Morse, MA; Lyerly, HK; Clary, BM; Hsu, DS				Uronis, Joshua M.; Osada, Takuya; McCall, Shannon; Yang, Xiao Yi; Mantyh, Christopher; Morse, Michael A.; Lyerly, H. Kim; Clary, Bryan M.; Hsu, David S.			Histological and Molecular Evaluation of Patient-Derived Colorectal Cancer Explants	PLOS ONE			English	Article							HUMAN COLON-CANCER; MODELS; XENOGRAFTS; EXPRESSION; ESTABLISHMENT; CHEMOTHERAPY; BIOMARKERS; TUMORS	Mouse models have been developed to investigate colorectal cancer etiology and evaluate new anti-cancer therapies. While genetically engineered and carcinogen-induced mouse models have provided important information with regard to the mechanisms underlying the oncogenic process, tumor xenograft models remain the standard for the evaluation of new chemotherapy and targeted drug treatments for clinical use. However, it remains unclear to what extent explanted colorectal tumor tissues retain inherent pathological features over time. In this study, we have generated a panel of 27 patient-derived colorectal cancer explants (PDCCEs) by direct transplantation of human colorectal cancer tissues into NOD-SCID mice. Using this panel, we performed a comparison of histology, gene expression and mutation status between PDCCEs and the original human tissues from which they were derived. Our findings demonstrate that PDCCEs maintain key histological features, basic gene expression patterns and KRAS/BRAF mutation status through multiple passages. Altogether, these findings suggest that PDCCEs maintain similarity to the patient tumor from which they are derived and may have the potential to serve as a reliable preclinical model that can be incorporated into future strategies to optimize individual therapy for patients with colorectal cancer.	[Uronis, Joshua M.; Hsu, David S.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA; [Osada, Takuya; Yang, Xiao Yi; Mantyh, Christopher; Lyerly, H. Kim; Clary, Bryan M.] Duke Univ, Dept Surg, Durham, NC USA; [McCall, Shannon] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Morse, Michael A.; Hsu, David S.] Duke Univ, Div Med Oncol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Uronis, JM (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA.	hsu00018@dm.duke.edu	mantyh, christopher/AAJ-9140-2021; Lyerly, Herbert K/B-6528-2014; Lyerly, Herbert Kim/AAX-4925-2020	Lyerly, Herbert K/0000-0002-0063-4770; Lyerly, Herbert Kim/0000-0002-0063-4770; McCall, Shannon/0000-0003-3957-061X	American Cancer Society [119824-MRSG-10-195-01-TBG]	American Cancer Society(American Cancer Society)	This work was supported by grants from the Mentored Research Scholars Grant (119824-MRSG-10-195-01-TBG) from the American Cancer Society (www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein BA, 2011, EUR J CANCER, V47, P1343, DOI 10.1016/j.ejca.2011.03.031; Arcaroli JJ, 2010, CLIN CANCER RES, V16, P4165, DOI 10.1158/1078-0432.CCR-10-0066; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; DRUCKREY H, 1967, NATURWISSENSCHAFTEN, V54, P285, DOI 10.1007/BF00620890; Fichtner I, 2004, EUR J CANCER, V40, P298, DOI 10.1016/j.ejca.2003.10.011; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Harris LG, 2011, MOL CANCER RES, V9, P1165, DOI 10.1158/1541-7786.MCR-11-0175; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kendall SD, 2006, CELL CYCLE, V5, P1074, DOI 10.4161/cc.5.10.2734; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; Kim M, 2012, MOL CANC TH IN PRESS; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Mischek D, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/437284; Mnejja M, 2011, EUR ANN OTORHINOLARY, V128, P269, DOI 10.1016/j.anorl.2011.02.005; Papanikolaou A, 1998, CANCER LETT, V130, P29, DOI 10.1016/S0304-3835(98)00101-3; PRETLOW TG, 1993, J NATL CANCER I, V85, P394, DOI 10.1093/jnci/85.5.394; Richmond A, 2008, DIS MODEL MECH, V1, P78, DOI 10.1242/dmm.000976; Uronis JM, 2009, MAMM GENOME, V20, P261, DOI 10.1007/s00335-009-9186-5	21	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38422	10.1371/journal.pone.0038422	http://dx.doi.org/10.1371/journal.pone.0038422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675560	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700072
J	Punnoose, A; McConnell, LA; Liu, W; Mutter, AC; Koder, RL				Punnoose, Alexander; McConnell, Liza A.; Liu, Wei; Mutter, Andrew C.; Koder, Ronald L.			Fundamental Limits on Wavelength, Efficiency and Yield of the Charge Separation Triad	PLOS ONE			English	Article							ELECTRON-TRANSFER; ENERGY; PHOTOSYNTHESIS; RECOMBINATION; MOLECULES; CHEMISTRY; PROTEIN	In an attempt to optimize a high yield, high efficiency artificial photosynthetic protein we have discovered unique energy and spatial architecture limits which apply to all light-activated photosynthetic systems. We have generated an analytical solution for the time behavior of the core three cofactor charge separation element in photosynthesis, the photosynthetic cofactor triad, and explored the functional consequences of its makeup including its architecture, the reduction potentials of its components, and the absorption energy of the light absorbing primary-donor cofactor. Our primary findings are two: First, that a high efficiency, high yield triad will have an absorption frequency more than twice the reorganization energy of the first electron transfer, and second, that the relative distance of the acceptor and the donor from the primary-donor plays an important role in determining the yields, with the highest efficiency, highest yield architecture having the light absorbing cofactor closest to the acceptor. Surprisingly, despite the increased complexity found in natural solar energy conversion proteins, we find that the construction of this central triad in natural systems matches these predictions. Our analysis thus not only suggests explanations for some aspects of the makeup of natural photosynthetic systems, it also provides specific design criteria necessary to create high efficiency, high yield artificial protein-based triads.	[Punnoose, Alexander] Univ Estadual Paulista, Inst Fis Teor, BR-01405 Sao Paulo, Brazil; [Punnoose, Alexander; McConnell, Liza A.; Liu, Wei; Mutter, Andrew C.; Koder, Ronald L.] CUNY City Coll, Dept Phys, New York, NY 10031 USA	Universidade Estadual Paulista; City University of New York (CUNY) System; City College of New York (CUNY)	Punnoose, A (corresponding author), Univ Estadual Paulista, Inst Fis Teor, Rua Pamplona 145, BR-01405 Sao Paulo, Brazil.	alexander.punnoose@gmail.com; koder@sci.ccny.cuny.edu	Mutter, Andrew/AAB-6082-2020; Koder, Ronald L/A-6089-2008	Koder, Ronald/0000-0003-0868-4972	Air Force Office of Scientific Research [FA9550-10-1-0350]; NIH National Center for Research Resources [NIH 5G12 RR03060]; Center for Exploitation of Nanostructures in Sensor and Energy Systems (CENSES) under NSF [0833180]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Exploitation of Nanostructures in Sensor and Energy Systems (CENSES) under NSF; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	RLK gratefully acknowledges support by the following grants: FA9550-10-1-0350 from the Air Force Office of Scientific Research and the NIH National Center for Research Resources to CCNY (NIH 5G12 RR03060). ACM gratefully acknowledges support from the Center for Exploitation of Nanostructures in Sensor and Energy Systems (CENSES) under NSF Cooperative Agreement Award Number 0833180. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrum-Acevedo JH, 2005, INORG CHEM, V44, P6802, DOI 10.1021/ic050904r; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Braun P, 2011, PROTEINS, V79, P463, DOI 10.1002/prot.22895; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; CHO MH, 1995, J CHEM PHYS, V103, P595, DOI 10.1063/1.470094; Conlan B, 2009, BBA-BIOENERGETICS, V1787, P1112, DOI 10.1016/j.bbabio.2009.04.011; DEVAULT D, 1967, NATURE, V215, P642, DOI 10.1038/215642a0; Fry HC, 2010, J AM CHEM SOC, V132, P3997, DOI 10.1021/ja907407m; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; GUST D, 1986, J AM CHEM SOC, V108, P8028, DOI 10.1021/ja00285a025; Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Hay S, 2004, P NATL ACAD SCI USA, V101, P17675, DOI 10.1073/pnas.0406192101; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P3640, DOI 10.1073/pnas.71.9.3640; Imahori H, 2001, J AM CHEM SOC, V123, P6617, DOI 10.1021/ja004123v; Kiang NY, 2007, ASTROBIOLOGY, V7, P222, DOI 10.1089/ast.2006.0105; Koder RL, 2006, DALTON T, P3045, DOI 10.1039/b514972j; Kodis G, 2006, J AM CHEM SOC, V128, P1818, DOI 10.1021/ja055903c; Malak RA, 2004, J AM CHEM SOC, V126, P13888, DOI 10.1021/ja0401040; MARCUS RA, 1956, J CHEM PHYS, V24, P966, DOI 10.1063/1.1742723; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MARCUS RA, 1993, REV MOD PHYS, V65, P599, DOI 10.1103/RevModPhys.65.599; McConnell I, 2010, CHEM BIOL, V17, P434, DOI 10.1016/j.chembiol.2010.05.005; MEYER TJ, 1989, ACCOUNTS CHEM RES, V22, P163, DOI 10.1021/ar00161a001; Moore GF, 2008, J AM CHEM SOC, V130, P10466, DOI 10.1021/ja803015m; Moser C C, 2000, Subcell Biochem, V35, P1; Moser CC, 2005, PHOTOCH PHOTOBIO SCI, V4, P933, DOI 10.1039/b507352a; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Moser CC, 2010, BIOCH BOPHYSICA ACTA, V1797, P1537; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Myshkin E, 2002, BIOPHYS J, V82, P3305, DOI 10.1016/S0006-3495(02)75671-3; Nanda V, 2010, NAT CHEM, V2, P15, DOI [10.1038/NCHEM.473, 10.1038/nchem.473]; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; REDI M, 1980, J CHEM PHYS, V72, P6651, DOI 10.1063/1.439124; Williamson A, 2011, PHOTOSYNTH RES, V107, P71, DOI 10.1007/s11120-010-9559-3; Wohri AB, 2010, SCIENCE, V328, P630, DOI 10.1126/science.1186159; Xu Q, 2000, J PHYS CHEM B, V104, P8035, DOI 10.1021/jp000543v; Zusman LD, 1999, J CHEM PHYS, V110, P10468, DOI 10.1063/1.478976	39	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e36065	10.1371/journal.pone.0036065	http://dx.doi.org/10.1371/journal.pone.0036065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675467	Green Published, gold			2022-12-27	WOS:000305339900001
J	Aitta-Aho, T; Moykkynen, TP; Panhelainen, AE; Vekovischeva, OY; Backstrom, P; Korpi, ER				Aitta-aho, Teemu; Moykkynen, Tommi P.; Panhelainen, Anne E.; Vekovischeva, Olga Yu; Backstrom, Pia; Korpi, Esa R.			Importance of GluA1 Subunit-Containing AMPA Glutamate Receptors for Morphine State-Dependency	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; CONDITIONED PLACE PREFERENCE; LONG-TERM POTENTIATION; DOPAMINE NEURONS; DEFICIENT MICE; NMDA RECEPTOR; KNOCKOUT MICE; IN-VIVO; MEMORY; GLUR1	In state-dependency, information retrieval is most efficient when the animal is in the same state as it was during the information acquisition. State-dependency has been implicated in a variety of learning and memory processes, but its mechanisms remain to be resolved. Here, mice deficient in AMPA-type glutamate receptor GluA1 subunits were first conditioned to morphine (10 or 20 mg/kg s.c. during eight sessions over four days) using an unbiased procedure, followed by testing for conditioned place preference at morphine states that were the same as or different from the one the mice were conditioned to. In GluA1 wildtype littermate mice the same-state morphine dose produced the greatest expression of place preference, while in the knockout mice no place preference was then detected. Both wildtype and knockout mice expressed moderate morphine-induced place preference when not at the morphine state (saline treatment at the test); in this case, place preference was weaker than that in the same-state test in wildtype mice. No correlation between place preference scores and locomotor activity during testing was found. Additionally, as compared to the controls, the knockout mice showed unchanged sensitization to morphine, morphine drug discrimination and brain regional mu-opioid receptor signal transduction at the G-protein level. However, the knockout mice failed to show increased AMPA/NMDA receptor current ratios in the ventral tegmental area dopamine neurons of midbrain slices after a single injection of morphine (10 mg/kg, s.c., sliced prepared 24 h afterwards), in contrast to the wildtype mice. The results indicate impaired druginduced state-dependency in GluA1 knockout mice, correlating with impaired opioid-induced glutamate receptor neuroplasticity.	[Aitta-aho, Teemu; Moykkynen, Tommi P.; Panhelainen, Anne E.; Vekovischeva, Olga Yu; Backstrom, Pia; Korpi, Esa R.] Univ Helsinki, Inst Biomed, Helsinki, Finland	University of Helsinki	Aitta-Aho, T (corresponding author), Univ Helsinki, Inst Biomed, Helsinki, Finland.	teemu.aitta-aho@helsinki.fi		Aitta-aho, Teemu/0000-0001-9332-3340; Korpi, Esa R./0000-0003-0683-4009; Panhelainen, Anne/0000-0001-5082-4006	Finnish Foundation for Alcohol Studies; Academy of Finland; Sigrid Juselius Foundation; Finnish Graduate School of Neuroscience; Helsinki Biomedical Graduate School	Finnish Foundation for Alcohol Studies; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Graduate School of Neuroscience; Helsinki Biomedical Graduate School	The study was supported by the Finnish Foundation for Alcohol Studies (TA, TPM), the Academy of Finland (ERK), and the Sigrid Juselius Foundation (ERK). The support of the Finnish Graduate School of Neuroscience (TPM) and the Helsinki Biomedical Graduate School (AEP) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitta-aho T, 2009, PHARMACOL BIOCHEM BE, V92, P283, DOI 10.1016/j.pbb.2008.12.015; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bespalov AY, 1999, PSYCHOPHARMACOLOGY, V141, P118, DOI 10.1007/s002130050815; Bettinger JC, 2004, GENES BRAIN BEHAV, V3, P266, DOI 10.1111/j.1601-183X.2004.00080.x; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Cowen MS, 2003, NEUROPHARMACOLOGY, V45, P325, DOI 10.1016/S0028-3908(03)00174-6; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; EICH JE, 1980, MEM COGNITION, V8, P157, DOI 10.3758/BF03213419; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Heikkinen AE, 2009, NEUROPSYCHOPHARMACOL, V34, P290, DOI 10.1038/npp.2008.89; Hyytia P, 1999, N-S ARCH PHARMACOL, V360, P391, DOI 10.1007/s002109900070; Koks S, 1999, NEUROPEPTIDES, V33, P63, DOI 10.1054/npep.1999.0015; Laitinen JT, 1998, J NEUROCHEM, V71, P808; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mead AN, 2005, PSYCHOPHARMACOLOGY, V179, P164, DOI 10.1007/s00213-004-2071-8; Mead AN, 2003, J NEUROSCI, V23, P1041; Mead AN, 1999, J PHARMACOL EXP THER, V290, P9; Nikam SS, 2001, CURR MED CHEM, V8, P155, DOI 10.2174/0929867013373877; OVERTON DA, 1991, BEHAV PHARMACOL, V2, P253; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Panhelainen AE, 2011, NEUROSCIENCE, V192, P312, DOI 10.1016/j.neuroscience.2011.07.004; Patti CL, 2010, SLEEP, V33, P1669, DOI 10.1093/sleep/33.12.1669; Phillips TJ, 1996, INT REV NEUROBIOL, V39, P243, DOI 10.1016/S0074-7742(08)60669-8; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Procaccini C, 2011, EUR J NEUROSCI, V33, P161, DOI 10.1111/j.1460-9568.2010.07485.x; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sakoori K, 2005, BEHAV BRAIN RES, V160, P34, DOI 10.1016/j.bbr.2004.11.013; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shulz DE, 2000, NATURE, V403, P549, DOI 10.1038/35000586; Slot LAB, 2003, BEHAV PHARMACOL, V14, P167, DOI 10.1097/01.fbp.0000063264.43827.d0; Slot LAB, 1999, J NEUROSCI, V19, P10520; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vekovischeva OY, 2001, J NEUROSCI, V21, P4451, DOI 10.1523/JNEUROSCI.21-12-04451.2001; Vezina P, 1987, PSYCHOPHARMACOLOGY, P93; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zarrindast MR, 2006, NEUROBIOL LEARN MEM, V86, P286, DOI 10.1016/j.nlm.2006.04.002; Zarrindast MR, 2005, BEHAV BRAIN RES, V163, P100, DOI 10.1016/j.bbr.2005.04.006; Zhou RL, 2009, EUR J NEUROSCI, V30, P2318, DOI 10.1111/j.1460-9568.2009.07022.x	45	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38325	10.1371/journal.pone.0038325	http://dx.doi.org/10.1371/journal.pone.0038325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675452	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500131
J	Ma, WB; McKeller, MR; Rangel, R; Ortiz-Quintero, B; Blackburn, MR; Martinez-Valdez, H				Ma, Wenbin; McKeller, Morgan R.; Rangel, Roberto; Ortiz-Quintero, Blanca; Blackburn, Michael R.; Martinez-Valdez, Hector			Spare PRELI Gene Loci: Failsafe Chromosome Insurance?	PLOS ONE			English	Article							LEA PROTEINS; CELL-DEATH; B-CELL; MITOCHONDRIAL PROTEIN; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; MESSENGER-RNA; REAL-TIME; T-CELL; APOPTOSIS	Background: LEA (late embryogenesis abundant) proteins encode conserved N-terminal mitochondrial signal domains and C-terminal (A/TAEKAK) motif repeats, long-presumed to confer cell resistance to stress and death cues. This prompted the hypothesis that LEA proteins are central to mitochondria mechanisms that connect bioenergetics with cell responses to stress and death signaling. In support of this hypothesis, recent studies have demonstrated that mammalian LEA protein PRELI can act as a biochemical hub, which upholds mitochondria energy metabolism, while concomitantly promoting B cell resistance to stress and induced death. Hence, it is important to define in vivo the physiological relevance of PRELI expression. Methods and Findings: Given the ubiquitous PRELI expression during mouse development, embryo lethality could be anticipated. Thus, conditional gene targeting was engineered by insertion of flanking loxP (flox)/Cre recognition sites on PRELI chromosome 13 (Chr 13) locus to abort its expression in a tissue-specific manner. After obtaining mouse lines with homozygous PRELI floxed alleles (PRELIf/f), the animals were crossed with CD19-driven Cre-recombinase transgenic mice to investigate whether PRELI inactivation could affect B-lymphocyte physiology and survival. Mice with homozygous B cell-specific PRELI deletion (CD19-Cre/Chr13 PRELI-/-) bred normally and did not show any signs of morbidity. Histopathology and flow cytometry analyses revealed that cell lineage identity, morphology, and viability were indistinguishable between wild type CD19-Cre/Chr13 PRELI+/+ and CD19-Cre/Chr13 PRELI-/- deficient mice. Furthermore, B cell PRELI gene expression seemed unaffected by Chr13 PRELI gene targeting. However, identification of additional PRELI loci in mouse Chr1 and Chr5 provided an explanation for the paradox between LEA-dependent cytoprotection and the seemingly futile consequences of Chr 13 PRELI gene inactivation. Importantly, PRELI expression from spare gene loci appeared ample to surmount Chr 13 PRELI gene deficiency. Conclusions: These findings suggest that PRELI is a vital LEA B cell protein with failsafe genetics.	[Ma, Wenbin; McKeller, Morgan R.; Rangel, Roberto; Ortiz-Quintero, Blanca; Martinez-Valdez, Hector] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Blackburn, Michael R.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Ma, WB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	hmartine@mdanderson.org	Rangel, Roberto/AHE-6583-2022	Rangel, Roberto/0000-0002-9088-7957; Blackburn, Michael/0000-0002-1394-9966; ortiz, blanca/0000-0001-6298-0073; Ma, Wenbin/0000-0001-8774-7593	Leukemia and Lymphoma Society [6161-03]; National Institutes of Health (NIH) [AI056125-01, AI065796-01, T32 CA009598-15, CA-16672]; Odyssey Program; Cockrell Foundation Award for Scientific Achievement at the University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056125, R01AI065796] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Odyssey Program; Cockrell Foundation Award for Scientific Achievement at the University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The present work was supported by the grants 6161-03 from the Leukemia and Lymphoma Society and AI056125-01 and AI065796-01 from the National Institutes of Health (NIH). MRM was supported by the training grant T32 CA009598-15 from NIH. WM was supported by the Odyssey Program and the Cockrell Foundation Award for Scientific Achievement at the University of Texas MD Anderson Cancer Center. MD Anderson's Genetically Engineered Mouse and DNA Analysis Core Facilities are partially supported by NIH CA-16672 (GEMF/DAF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Albrecht U, 1997, MOL CELLULAR METHODS, P23; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Chaudhari AA, 2007, ONCOL REP, V18, P71; CURRY J, 1993, PLANT MOL BIOL, V21, P907, DOI 10.1007/BF00027121; Dee CT, 2005, DEV GENES EVOL, V215, P248, DOI 10.1007/s00427-005-0470-4; Defrance T, 2002, ADV CANCER RES, V86, P195, DOI 10.1016/S0065-230X(02)86006-7; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; ESPELUND M, 1995, PLANT CELL ENVIRON, V18, P943, DOI 10.1111/j.1365-3040.1995.tb00605.x; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; FINKELSTEIN RR, 1993, MOL GEN GENET, V238, P401, DOI 10.1007/BF00291999; Fox EJ, 2004, BIOCHEM J, V378, P817, DOI 10.1042/BJ20031504; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Goh CH, 2003, PLANT J, V36, P240, DOI 10.1046/j.1365-313X.2003.01872.x; Gottlieb E, 2006, CELL, V126, P27, DOI 10.1016/j.cell.2006.06.030; Guzman-Rojas L, 2002, IMMUNOLOGY, V107, P167, DOI 10.1046/j.1365-2567.2002.01494.x; Guzman-Rojas L, 2000, INT IMMUNOL, V12, P607, DOI 10.1093/intimm/12.5.607; Hall BM, 2011, J BIOL CHEM, V286, P39141, DOI 10.1074/jbc.M111.259853; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; Liu SS, 2010, ANN NY ACAD SCI, V1201, P84, DOI 10.1111/j.1749-6632.2010.05632.x; Ma WB, 2011, CELL RES, V21, P1564, DOI 10.1038/cr.2011.84; MARTIN D, 1991, J EXP MED, V173, P639, DOI 10.1084/jem.173.3.639; McKeller MR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.19; Mocellin S, 2003, TRENDS MOL MED, V9, P189, DOI 10.1016/S1471-4914(03)00047-9; Mukhopadhyay P, 2010, CARDIOVASC RES, V85, P773, DOI 10.1093/cvr/cvp369; Nicholls DG, 2010, ESSAYS BIOCHEM, V47, P25, DOI [10.1042/bse0470025, 10.1042/BSE0470025]; Niu S, 1996, GENE, V175, P187, DOI 10.1016/0378-1119(96)00146-1; Ogilvy S, 2003, J IMMUNOL, V171, P1792, DOI 10.4049/jimmunol.171.4.1792; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Penninger JM, 2003, NAT CELL BIOL, V5, P97, DOI 10.1038/ncb0203-97; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6; Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI [10.1042/bse0470001, 10.1042/BSE0470001]; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Singh S, 2005, J BIOMED BIOTECHNOL, P232, DOI 10.1155/JBB.2005.232; Tsubouchi A, 2009, DEVELOPMENT, V136, P3757, DOI 10.1242/dev.042135; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y	51	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37949	10.1371/journal.pone.0037949	http://dx.doi.org/10.1371/journal.pone.0037949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666421	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400060
J	Sluijter, M; Estevao, S; Hoogenboezem, T; Hartwig, NG; van Rossum, AMC; Vink, C				Sluijter, Marcel; Estevao, Silvia; Hoogenboezem, Theo; Hartwig, Nico G.; van Rossum, Annemarie M. C.; Vink, Cornelis			The RuvA Homologues from Mycoplasma genitalium and Mycoplasma pneumoniae Exhibit Unique Functional Characteristics	PLOS ONE			English	Article							HOLLIDAY-JUNCTION RESOLVASE; ESCHERICHIA-COLI RUVA; SINGLE-STRANDED-DNA; REPETITIVE CHROMOSOMAL SEQUENCES; IN-VITRO; CRYSTAL-STRUCTURE; BRANCH MIGRATION; ANTIGENIC VARIATION; HELICASE ACTIVITY; BINDING-PROTEIN	The DNA recombination and repair machineries of Mycoplasma genitalium and Mycoplasma pneumoniae differ considerably from those of gram-positive and gram-negative bacteria. Most notably, M. pneumoniae is unable to express a functional RecU Holliday junction (HJ) resolvase. In addition, the RuvB homologues from both M. pneumoniae and M. genitalium only exhibit DNA helicase activity but not HJ branch migration activity in vitro. To identify a putative role of the RuvA homologues of these mycoplasmas in DNA recombination, both proteins (RuvA(Mpn) and RuvA(Mge), respectively) were studied for their ability to bind DNA and to interact with RuvB and RecU. In spite of a high level of sequence conservation between RuvA(Mpn) and RuvA(Mge) (68.8% identity), substantial differences were found between these proteins in their activities. First, RuvA(Mge) was found to preferentially bind to HJs, whereas RuvA(Mpn) displayed similar affinities for both HJs and single-stranded DNA. Second, while RuvA(Mpn) is able to form two distinct complexes with HJs, RuvA(Mge) only produced a single HJ complex. Third, RuvA(Mge) stimulated the DNA helicase and ATPase activities of RuvB(Mge), whereas RuvA(Mpn) did not augment RuvB activity. Finally, while both RuvA(Mge) and RecU(Mge) efficiently bind to HJs, they did not compete with each other for HJ binding, but formed stable complexes with HJs over a wide protein concentration range. This interaction, however, resulted in inhibition of the HJ resolution activity of RecUMge.	[Sluijter, Marcel; Estevao, Silvia; Hoogenboezem, Theo; Hartwig, Nico G.; van Rossum, Annemarie M. C.; Vink, Cornelis] Erasmus MC Sophia Childrens Hosp, Lab Pediat Pediat Infect Dis & Immun, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Sluijter, M (corresponding author), Erasmus MC Sophia Childrens Hosp, Lab Pediat Pediat Infect Dis & Immun, Rotterdam, Netherlands.	c.vink@erasmusmc.nl	Hartwig, Nico/ABI-5467-2020; van Rossum, Annemarie/AAC-7050-2019	van Rossum, Annemarie/0000-0002-1259-477X	European Society for Pediatric Infectious Diseases; ZonMW; Erasmus MC	European Society for Pediatric Infectious Diseases; ZonMW(Netherlands Organization for Health Research and Development); Erasmus MC	AMCvR is supported by grants of the European Society for Pediatric Infectious Diseases, ZonMW, and the Erasmus MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; Ayora S, 2004, P NATL ACAD SCI USA, V101, P452, DOI 10.1073/pnas.2533829100; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Bradley AS, 2011, J BIOL CHEM, V286, P22372, DOI 10.1074/jbc.M111.233908; Canas C, 2008, NUCLEIC ACIDS RES, V36, P5242, DOI 10.1093/nar/gkn500; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; Carvalho FM, 2005, GENE, V360, P111, DOI 10.1016/j.gene.2005.06.012; Chan SN, 1997, J BIOL CHEM, V272, P14873, DOI 10.1074/jbc.272.23.14873; Estevao S, 2011, J BACTERIOL, V193, P6425, DOI 10.1128/JB.06003-11; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; Ingleston SM, 2002, EUR J BIOCHEM, V269, P1525, DOI 10.1046/j.1432-1033.2002.02805.x; Iverson-Cabral SL, 2007, MOL MICROBIOL, V66, P55, DOI 10.1111/j.1365-2958.2007.05898.x; Iverson-Cabral SL, 2006, INFECT IMMUN, V74, P3715, DOI 10.1128/IAI.00239-06; Kelly SJ, 2007, PROTEINS, V68, P961, DOI 10.1002/prot.21418; Kenri T, 1999, INFECT IMMUN, V67, P4557, DOI 10.1128/IAI.67.9.4557-4562.1999; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LLOYD RG, 1993, NUCLEIC ACIDS RES, V21, P1719, DOI 10.1093/nar/21.8.1719; Ma L, 2007, MOL MICROBIOL, V66, P220, DOI 10.1111/j.1365-2958.2007.05911.x; Maquelin K, 2009, MICROBIOL-SGM, V155, P2068, DOI 10.1099/mic.0.026724-0; McGregor N, 2005, STRUCTURE, V13, P1341, DOI 10.1016/j.str.2005.05.011; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Morimatsu K, 2002, P NATL ACAD SCI USA, V99, P11688, DOI 10.1073/pnas.142404499; MULLER B, 1993, J BIOL CHEM, V268, P17185; Nishino T, 1998, STRUCTURE, V6, P11, DOI 10.1016/S0969-2126(98)00003-3; PARSONS CA, 1992, P NATL ACAD SCI USA, V89, P5452, DOI 10.1073/pnas.89.12.5452; PETERSON SN, 1995, P NATL ACAD SCI USA, V92, P11829, DOI 10.1073/pnas.92.25.11829; PETERSON SN, 1993, J BACTERIOL, V175, P7918, DOI 10.1128/JB.175.24.7918-7930.1993; Privezentzev CV, 2005, J BIOL CHEM, V280, P3365, DOI 10.1074/jbc.M409256200; RADDING CM, 1989, BIOCHIM BIOPHYS ACTA, V1008, P131, DOI 10.1016/0167-4781(80)90001-9; Rafferty JB, 1998, J MOL BIOL, V278, P105, DOI 10.1006/jmbi.1998.1697; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; RULAND K, 1990, NUCLEIC ACIDS RES, V18, P6311, DOI 10.1093/nar/18.21.6311; SHAH R, 1994, NUCLEIC ACIDS RES, V22, P2490, DOI 10.1093/nar/22.13.2490; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; SHARPLES GJ, 1994, EMBO J, V13, P6133, DOI 10.1002/j.1460-2075.1994.tb06960.x; Sluijter M, 2011, J BACTERIOL, V193, P3941, DOI 10.1128/JB.00247-11; Sluijter M, 2010, MOL MICROBIOL, V77, P1261, DOI 10.1111/j.1365-2958.2010.07288.x; Sluijter M, 2009, INFECT IMMUN, V77, P4905, DOI 10.1128/IAI.00747-09; Sluijter M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-167; Spuesens EBM, 2011, MICROBIOL-SGM, V157, P473, DOI 10.1099/mic.0.045591-0; Spuesens EBM, 2010, J CLIN MICROBIOL, V48, P680, DOI 10.1128/JCM.02078-09; Spuesens EBM, 2009, MICROBIOL-SGM, V155, P2182, DOI 10.1099/mic.0.028506-0; SU CJ, 1988, INFECT IMMUN, V56, P3157, DOI 10.1128/IAI.56.12.3157-3161.1988; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; TSANEVA IR, 1994, J BIOL CHEM, V269, P26552; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; Vink C, 2012, FEMS MICROBIOL REV, V36, P917, DOI 10.1111/j.1574-6976.2011.00321.x; WENZEL R, 1988, NUCLEIC ACIDS RES, V16, P8337, DOI 10.1093/nar/16.17.8337; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; Whitby MC, 1998, J BIOL CHEM, V273, P35063, DOI 10.1074/jbc.273.52.35063	54	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38301	10.1371/journal.pone.0038301	http://dx.doi.org/10.1371/journal.pone.0038301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666500	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400111
J	Zhang, HG; Liu, LB; Yu, D; Kandimalla, ER; Sun, HB; Agrawal, S; Guha, C				Zhang, Huagang; Liu, Laibin; Yu, Dong; Kandimalla, Ekambar R.; Sun, Hui Bin; Agrawal, Sudhir; Guha, Chandan			An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy	PLOS ONE			English	Article							KILLER DENDRITIC CELLS; 2ND-GENERATION IMMUNOMODULATORY OLIGONUCLEOTIDES; TOLL-LIKE RECEPTOR-9; PRODUCE IFN-GAMMA; IMMUNE-RESPONSES; CPG OLIGODEOXYNUCLEOTIDES; CANCER; IMMUNOTHERAPY; RECOGNITION; MOTIF	Purpose: Recent studies have shown that a new generation of synthetic agonist of Toll-like receptor (TLR) 9 consisting a 3'-3'-attached structure and a dCp7-deaza-dG dinucultodie shows more potent immunostimulatory effects in both mouse and human than conventional CpG oligonucleotides. Radiation therapy (RT) provides a source of tumor antigens that are released from dying, irradiated, tumor cells without causing systemic immunosuppression. We, therefore, examined effect of combining RT with a designer synthetic agonist of TLR9 on anti-tumoral immunity, primary tumor growth retardation and metastases in a murine model of lung cancer. Methods: Grouped C57BL/6 and congenic B cell deficient mice (B-/-) bearing footpad 3LL tumors were treated with PBS, TLR9 agonist, control oligonucelotide, RT or the combination of RT and TLR9 agonist. Immune phenotype of splenocytes and serum IFN-gamma and IL-10 levels were analyzed by FACS and ELISA, 24 h after treatment. Tumor growth, lung metastases and survival rate were monitored and tumor specific antibodies in serum and deposition in tumor tissue were measured by ELISA and immunofluorescence. Results: TLR9 agonist expanded and activated B cells and plasmacytoid dendritic cells in wild-type mice and natural killer DCs (NKDCs) in B cell-deficient (B-/-) mice bearing ectopic Lewis lung adenocarcinoma (3LL). Combined RT with TLR9 agonist treatment inhibited 3LL tumor growth in both wild type and B-/- mice. A strong tumor-specific humoral immune response (titer: 1/3200) with deposition of mouse IgG auto-antibodies in tumor tissue were found in wildtype mice, whereas the number of tumor infiltrating NKDCs increased in B-/- mice following RT+ TLR9 agonist therapy. Furthermore, mice receiving combination therapy had fewer lung metastases and a higher survival than single treatment cohorts. Conclusions: Combination therapy with TLR9 agonist and RT induces systemic anti-tumoral humoral response, augments tumoral infiltration of NKDCs, reduces pulmonary metastases and improves survival in a murine model of 3LL cancer.	[Zhang, Huagang; Liu, Laibin; Sun, Hui Bin; Guha, Chandan] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Zhang, Huagang; Liu, Laibin; Sun, Hui Bin; Guha, Chandan] Montefiore Med Ctr, Bronx, NY 10467 USA; [Sun, Hui Bin] Albert Einstein Coll Med, Dept Orthoped, Bronx, NY 10467 USA; [Guha, Chandan] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Yu, Dong; Kandimalla, Ekambar R.; Agrawal, Sudhir] Idera Pharmaceut Inc, Cambridge, MA USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zhang, HG (corresponding author), Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA.	cguhamd@pol.net		Agrawal, Sudhir/0000-0003-4275-2510	National Institutes of Health (NIH) [R01DK064670, R01EB009040, RC2 AI087612, U19AI091175]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091175, RC2AI087612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064670] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Institutes of Health (NIH) grants R01DK064670, R01EB009040, RC2 AI087612 and U19AI091175 to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aurisicchio L, 2009, CLIN CANCER RES, V15, P1575, DOI 10.1158/1078-0432.CCR-08-2628; Cerkovnik P, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-45; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Chamoto K, 2009, CANCER SCI, V100, P934, DOI 10.1111/j.1349-7006.2009.01114.x; Chaudhry U, 2006, J AM COLL SURGEONS, V203, pS79, DOI 10.1016/j.jamcollsurg.2006.05.208; Chaudhry UI, 2006, CANCER RES, V66, P10497, DOI 10.1158/0008-5472.CAN-06-1908; Chiriva-Internati M, 2006, IN VITRO CELL DEV-AN, V42, P89; Chiron D, 2008, BLOOD, V112, P2205, DOI 10.1182/blood-2008-02-140673; Damiano V, 2007, P NATL ACAD SCI USA, V104, P12468, DOI 10.1073/pnas.0705226104; Demaria S, 2005, INT J RADIAT ONCOL, V63, P655, DOI 10.1016/j.ijrobp.2005.06.032; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Friedman EJ, 2002, CURR PHARM DESIGN, V8, P1765, DOI 10.2174/1381612023394089; Hartmann G, 2000, J IMMUNOL, V164, P1617, DOI 10.4049/jimmunol.164.3.1617; Hodge JW, 2008, ONCOLOGY-NY, V22, P1064; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Kandimalla ER, 2005, P NATL ACAD SCI USA, V102, P6925, DOI 10.1073/pnas.0501729102; Kandimalla ER, 2003, P NATL ACAD SCI USA, V100, P14303, DOI 10.1073/pnas.2335947100; Kandimalla ER, 2003, NUCLEIC ACIDS RES, V31, P2393, DOI 10.1093/nar/gkg343; Krieg AM, 2008, ONCOGENE, V27, P161, DOI 10.1038/sj.onc.1210911; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; LICHTER AS, 1995, NEW ENGL J MED, V332, P371, DOI 10.1056/NEJM199502093320607; Lugade AA, 2008, J IMMUNOL, V180, P3132, DOI 10.4049/jimmunol.180.5.3132; Mason KA, 2005, CLIN CANCER RES, V11, P361; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; Milas L, 2004, CANCER RES, V64, P5074, DOI 10.1158/0008-5472.CAN-04-0926; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pillarisetty VG, 2005, J IMMUNOL, V174, P2612, DOI 10.4049/jimmunol.174.5.2612; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Saha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029357; Stevenson FK, 2010, J CLIN ONCOL, V28, P4295, DOI 10.1200/JCO.2010.30.4212; Sutherland Robert M, 2006, Int J Radiat Oncol Biol Phys, V64, P3, DOI 10.1016/j.ijrobp.2005.08.036; Wang DQ, 2005, VACCINE, V23, P2614, DOI 10.1016/j.vaccine.2004.11.028; Wang DQ, 2004, INT J ONCOL, V24, P901; Wang H, 2006, MOL CANCER THER, V5, P1585, DOI 10.1158/1535-7163.MCT-06-0094; Yu D, 2002, NUCLEIC ACIDS RES, V30, P4460, DOI 10.1093/nar/gkf582	39	137	141	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38111	10.1371/journal.pone.0038111	http://dx.doi.org/10.1371/journal.pone.0038111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666458	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400083
J	Hammerstingl, C; Schueler, R; Bors, L; Momcilovic, D; Pabst, S; Nickenig, G; Skowasch, D				Hammerstingl, Christoph; Schueler, Robert; Bors, Lisa; Momcilovic, Diana; Pabst, Stefan; Nickenig, Georg; Skowasch, Dirk			Diagnostic Value of Echocardiography in the Diagnosis of Pulmonary Hypertension	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; DOPPLER-ECHOCARDIOGRAPHY; FREE-WALL; RECOMMENDATIONS; GUIDELINES; STRAIN	Aims: To determine the value of echocardiography including tissue Doppler imaging (TDI) and right ventricular (RV) speckle tracking analysis for the diagnosis of pulmonary hypertension (PH) and discrimination between pre- and postcapillary PH. Methods and Results: 155 consecutive patients (mean age 70.5 +/- 13.0 years, 81 [52%] male gender, BMI 27.2 +/- 6.1 kg/m(2)) with PH undergoing right heart catheterization (RHC) and transthoracic echocardiography (TTE) with TDI between January 2008 and December 2009 were retrospectively evaluated including offline speckle tracking analysis of RV contractility. After RHC 23.2% of patients (36) were diagnosed with precapillary PH. Invasive results from RHC were significantly correlated to TTE measurements (E/e, postcapillary wedge pressure [PCWP], r = 0.61, P < 0.001; mean, systolic pulmonary arterial pressure [mPAP, sPAP], r = 0.43, P < 0.001). Single echocardiographic parameters were of good predictive value for final PH-diagnosis (sPAP, area under the curve [AUC] 0.63, P = 0.025; lateral apical RV longitudinal strain [RVaSl)], AUC 0.76, P = 0.001; E/e, AUC 0.84, P < 0.001) which could be increased by combining most predictive parameters after receiver operating curves (ROC) cut off analysis (sPAP >69 mmHg, E/e <12, RVaSl >=-8.4%). TTE had a sensitivity of 33.33% and a specificity of 100% to identify patients with precapillary PH, and a negative predictive value of 84.72% to rule out precapilary PH. Conclusion: Echocardiography allows feasible and reliable estimation of PH and seems helpful to distinguish between pre- and postcapillary PH. Further prospective studies on patients with different manifestations of PH must validate the predictive value of echocardiography in this clinical setting.	[Hammerstingl, Christoph; Schueler, Robert; Bors, Lisa; Momcilovic, Diana; Pabst, Stefan; Nickenig, Georg; Skowasch, Dirk] Univ Bonn, Dept Internal Med 2, Bonn, Germany	University of Bonn	Hammerstingl, C (corresponding author), Univ Bonn, Dept Internal Med 2, Bonn, Germany.	robert.schueler@ukb.uni-bonn.de	Hammerstingl, Christoph/GQQ-3316-2022; Schueler, Robert/D-7407-2017		Actelion Pharmaceuticals Deutschland GmbH; Actelion Pharmaceuticals Germany	Actelion Pharmaceuticals Deutschland GmbH; Actelion Pharmaceuticals Germany	This study has been supported by an unrestricted grand of Actelion Pharmaceuticals Deutschland GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have received an unrestricted grant from Actelion Pharmaceuticals Germany. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahmad H, 2011, ECHOCARDIOG IN PRESS; [Anonymous], 2009, J Am Coll Cardiol, V54, pS1; Bonderman D, 2011, EUR RESPIR J, V37, P1096, DOI 10.1183/09031936.00089610; Danbrauskaite V, 2007, J AM SOC ECHOCARDIOG, V20, P1172, DOI 10.1016/j.echo.2007.02.005; Douglas PS, 2011, J AM SOC ECHOCARDIOG, V24, P229, DOI 10.1016/j.echo.2010.12.008; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Fukuda Y, 2011, J AM SOC ECHOCARDIOG, V24, P1101, DOI 10.1016/j.echo.2011.06.005; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Hadano Y, 2005, CIRC J, V69, P432, DOI 10.1253/circj.69.432; Hoeper MM, 2006, J AM COLL CARDIOL, V48, P2546, DOI 10.1016/j.jacc.2006.07.061; Lang IM, 2010, JACC-CARDIOVASC IMAG, V3, P1287, DOI 10.1016/j.jcmg.2010.09.013; Lopez-Candales A, 2009, CAN J CARDIOL, V25, pE73, DOI 10.1016/S0828-282X(09)70045-5; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Ruan QY, 2007, CHEST, V131, P395, DOI 10.1378/chest.06-1556; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]	18	28	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38519	10.1371/journal.pone.0038519	http://dx.doi.org/10.1371/journal.pone.0038519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685577	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700040
J	Li, J; Zucker, S; Pulkoski-Gross, A; Kuscu, C; Karaayvaz, M; Ju, JF; Yao, HR; Song, EW; Cao, J				Li, Jian; Zucker, Stanley; Pulkoski-Gross, Ashleigh; Kuscu, Cem; Karaayvaz, Mihriban; Ju, Jingfang; Yao, Herui; Song, Erwei; Cao, Jian			Conversion of Stationary to Invasive Tumor Initiating Cells (TICs): Role of Hypoxia in Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) Trafficking	PLOS ONE			English	Article							CANCER STEM-CELLS; IN-VITRO PROPAGATION; MATRIX-METALLOPROTEINASE; PROSPECTIVE IDENTIFICATION; MESENCHYMAL TRANSITION; E-CADHERIN; EXPRESSION; GROWTH; ACTIVATION; REGULATORS	Emerging evidence has implicated the role of tumor initiating cells (TICs) in the process of cancer metastasis. The mechanism underlying the conversion of TICs from stationary to invasive remains to be characterized. In this report, we employed less invasive breast cancer TICs, SK-3rd, that displays CD44(high)/CD24(low) with high mammosphere-forming and tumorigenic capacities, to investigate the mechanism by which stationary TICs are converted to invasive TICs. Invasive ability of SK-3rd TICs was markedly enhanced when the cells were cultured under hypoxic conditions. Given the role of membrane type 1-matrix metalloproteinase (MT1-MMP) in cancer invasion/metastasis, we explored a possible involvement of MT1-MMP in hypoxia-induced TIC invasion. Silencing of MT1-MMP by a shRNA approach resulted in diminution of hypoxia-induced cell invasion in vitro and metastasis in vivo. Under hypoxic conditions, MT1-MMP redistributed from cytoplasmic storage pools to the cell surface of TICs, which coincides with the increased cell invasion. In addition, CD44, a cancer stem-like cell marker, inversely correlated with increased cell surface MT1-MMP. Interestingly, cell surface MT1-MMP gradually disappeared when the hypoxia-treated cells were switched to normoxia, suggesting the plasticity of TICs in response to oxygen content. Furthermore, we dissected the pathways leading to upregulated MT1-MMP in cytoplasmic storage pools under normoxic conditions, by demonstrating a cascade involving Twist1-miR10b-HoxD10 leading to enhanced MT1-MMP expression in SK-3rd TICs. These observations suggest that MT1-MMP is a key molecule capable of executing conversion of stationary TICs to invasive TICs under hypoxic conditions and thereby controlling metastasis.	[Li, Jian; Pulkoski-Gross, Ashleigh; Kuscu, Cem; Cao, Jian] SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA; [Zucker, Stanley] Vet Affairs Med Ctr, Dept Res, Northport, NY USA; [Karaayvaz, Mihriban; Ju, Jingfang; Cao, Jian] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Yao, Herui; Song, Erwei] Sun Yat Sen Univ, Mem Hosp, Dept Breast Surg, Guangzhou 510275, Guangdong, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Sun Yat Sen University	Li, J (corresponding author), SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA.	s_zucker@yahoo.com; jian.cao@sunysb.edu		KUSCU, CEM/0000-0001-7154-6762; Ju, Jingfang/0000-0002-4821-7458; Karaayvaz, Mihriban/0000-0002-6264-2477	NIH/NCI [R01CA113553, R01CA166936]; Carol Baldwin Breast Cancer Foundation; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA113553, R01CA166936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518, T32GM092714] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Carol Baldwin Breast Cancer Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by NIH/NCI grants (R01CA113553 and R01CA166936) and the Carol Baldwin Breast Cancer Foundation (to J.C.); and a Merit Review grant from the Department of Veterans Affairs (to S.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; DOUGHERTY GJ, 1994, J BIOL CHEM, V269, P9074; GUO YJ, 1994, CANCER RES, V54, P1561; Han JS, 2009, INT J ONCOL, V34, P1449, DOI 10.3892/ijo_00000273; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koga F, 2007, CELL CYCLE, V6, P1393, DOI 10.4161/cc.6.11.4296; Koshikawa N, 2006, ONCOGENE, V25, P917, DOI 10.1038/sj.onc.1209128; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Martin MD, 2010, MOL CANC RES; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; Miyoshi A, 2006, INT J ONCOL, V29, P1533; Moon EJ, 2007, ANTIOXID REDOX SIGN, V9, P1237, DOI 10.1089/ars.2007.1623; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Noda K, 2005, INVEST OPHTH VIS SCI, V46, P3817, DOI 10.1167/iovs.04-1528; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Toth M, 2005, BIOCHEM J, V387, P497, DOI 10.1042/BJ20041324; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2; Zucker S, 2002, LAB INVEST, V82, P1673, DOI 10.1097/01.LAB.0000041713.74852.2A	52	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38403	10.1371/journal.pone.0038403	http://dx.doi.org/10.1371/journal.pone.0038403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679501	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900036
J	Milia, N; Congiu, A; Anagnostou, P; Montinaro, F; Capocasa, M; Sanna, E; Bisol, GD				Milia, Nicola; Congiu, Alessandra; Anagnostou, Paolo; Montinaro, Francesco; Capocasa, Marco; Sanna, Emanuele; Bisol, Giovanni Destro			Mine, Yours, Ours? Sharing Data on Human Genetic Variation	PLOS ONE			English	Article							POPULATION; EVOLUTION; DISEASE; TOOLS	The achievement of a robust, effective and responsible form of data sharing is currently regarded as a priority for biological and bio-medical research. Empirical evaluations of data sharing may be regarded as an indispensable first step in the identification of critical aspects and the development of strategies aimed at increasing availability of research data for the scientific community as a whole. Research concerning human genetic variation represents a potential forerunner in the establishment of widespread sharing of primary datasets. However, no specific analysis has been conducted to date in order to ascertain whether the sharing of primary datasets is common-practice in this research field. To this aim, we analyzed a total of 543 mitochondrial and Y chromosomal datasets reported in 508 papers indexed in the Pubmed database from 2008 to 2011. A substantial portion of datasets (21.9%) was found to have been withheld, while neither strong editorial policies nor high impact factor proved to be effective in increasing the sharing rate beyond the current figure of 80.5%. Disaggregating datasets for research fields, we could observe a substantially lower sharing in medical than evolutionary and forensic genetics, more evident for whole mtDNA sequences (15.0% vs 99.6%). The low rate of positive responses to e-mail requests sent to corresponding authors of withheld datasets (28.6%) suggests that sharing should be regarded as a prerequisite for final paper acceptance, while making authors deposit their results in open online databases which provide data quality control seems to provide the best-practice standard. Finally, we estimated that 29.8% to 32.9% of total resources are used to generate withheld datasets, implying that an important portion of research funding does not produce shared knowledge. By making the scientific community and the public aware of this important aspect, we may help popularize a more effective culture of data sharing.	[Milia, Nicola; Congiu, Alessandra; Anagnostou, Paolo; Bisol, Giovanni Destro] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Milia, Nicola; Congiu, Alessandra; Sanna, Emanuele] Univ Cagliari, Dipartimento Biol Sperimentale, Cagliari, Italy; [Anagnostou, Paolo; Montinaro, Francesco; Capocasa, Marco; Bisol, Giovanni Destro] Ist Italiano Antropol, Rome, Italy	Sapienza University Rome; University of Cagliari	Milia, N (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy.	destrobisol@uniroma1.it	Montinaro, Francesco/HDM-8551-2022; Capocasa, Marco/AAF-8315-2021	Montinaro, Francesco/0000-0002-4506-963X; Destro Bisol, Giovanni/0000-0002-4232-9715; Anagnostou, Paolo/0000-0003-0768-4612	Universita di Roma "La Sapienza"; Istituto Italiano di Antropologia; Ministero dell'Istruzione, dell'Universita e della Ricerca [200975T9EW]	Universita di Roma "La Sapienza"; Istituto Italiano di Antropologia; Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Universita di Roma "La Sapienza", Istituto Italiano di Antropologia, and the Ministero dell'Istruzione, dell'Universita e della Ricerca (Prin project 200975T9EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; [Anonymous], 1996, INT STRAT M HUM GEN, P3; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Carracedo A, 2010, FORENSIC SCI INT-GEN, V4, P145, DOI 10.1016/j.fsigen.2010.02.001; Destro-Bisol G, 2010, J ANTHROPOL SCI, V88, P93; DOE, 1993, HUMAN GENOME NEW JAN, P4; Fischer BA, 2010, SCI ENG ETHICS, V16, P783, DOI 10.1007/s11948-010-9239-x; Giffels J, 2010, SCI ENG ETHICS, V16, P801, DOI 10.1007/s11948-010-9230-6; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; King TE, 2009, TRENDS GENET, V25, P351, DOI 10.1016/j.tig.2009.06.003; Lang TD, 2011, SCIENCE, V331, P714, DOI 10.1126/science.1199349; MARSHALL E, 1990, SCIENCE, V248, P952, DOI 10.1126/science.2343306; Merton Robert K., 1972, SOCIOLOGY SCI THEORE; Mishmar D, 2010, BBA-BIOENERGETICS, V1797, P1099, DOI 10.1016/j.bbabio.2010.01.003; Murdoch CJ, 2009, GENOME MED, V1, DOI 10.1186/gm22; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Noor MAF, 2006, PLOS BIOL, V4, P1113, DOI 10.1371/journal.pbio.0040228; NORMAN C, 1985, SCIENCE, V229, P632, DOI 10.1126/science.229.4714.632; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Parson W, 2004, FORENSIC SCI INT, V139, P215, DOI 10.1016/j.forsciint.2003.11.008; Parson W, 2010, INT J LEGAL MED, V124, P505, DOI 10.1007/s00414-010-0492-y; Peltonen L, 2001, Pharmacogenomics J, V1, P5; Pennisi E, 2009, SCIENCE, V324, P1000, DOI 10.1126/science.324_1000b; Piwowar H. A., 2008, P ELPUB 2008 C EL PU; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a; Piwowar HA, 2008, PLOS MED, V5, P1315, DOI 10.1371/journal.pmed.0050183; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Tofanelli S, 2011, J ANTHROPOL SCI, V89, P201, DOI 10.4436/jass.89017; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Willuweit S, 2007, FORENSIC SCI INT-GEN, V1, P83, DOI 10.1016/j.fsigen.2007.01.017	36	30	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37552	10.1371/journal.pone.0037552	http://dx.doi.org/10.1371/journal.pone.0037552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679483	Green Published, gold			2022-12-27	WOS:000305343900008
J	Riegl, BM; Sheppard, CRC; Purkis, SJ				Riegl, Bernhard M.; Sheppard, Charles R. C.; Purkis, Sam J.			Human Impact on Atolls Leads to Coral Loss and Community Homogenisation: A Modeling Study	PLOS ONE			English	Article							ACANTHASTER-PLANCI; CLIMATE-CHANGE; REEFS; MORTALITY; RECOVERY; ECOLOGY; FUTURE; OCEAN; POPULATIONS; OUTBREAKS	We explore impacts on pristine atolls subjected to anthropogenic near-field (human habitation) and far-field (climate and environmental change) pressure. Using literature data of human impacts on reefs, we parameterize forecast models to evaluate trajectories in coral cover under impact scenarios that primarily act via recruitment and increased mortality of larger corals. From surveys across the Chagos, we investigate the regeneration dynamics of coral populations distant from human habitation after natural disturbances. Using a size-based mathematical model based on a time-series of coral community and population data from 1999-2006, we provide hind-and forecast data for coral population dynamics within lagoons and on ocean-facing reefs verified against monitoring from 1979-2009. Environmental data (currents, temperatures) were used for calibration. The coral community was simplified into growth typologies: branching and encrusting, arboresent and massive corals. Community patterns observed in the field were influenced by bleaching-related mortality, most notably in 1998. Survival had been highest in deep lagoonal settings, which suggests a refuge. Recruitment levels were higher in lagoons than on ocean-facing reefs. When adding stress by direct human pressure, climate and environmental change as increased disturbance frequency and modified recruitment and mortality levels (due to eutrophication, overfishing, pollution, heat, acidification, etc), models suggest steep declines in coral populations and loss of community diversification among habitats. We found it likely that degradation of lagoonal coral populations would impact regeneration potential of all coral populations, also on ocean-facing reefs, thus decreasing reef resilience on the entire atoll.	[Riegl, Bernhard M.; Purkis, Sam J.] Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA; [Sheppard, Charles R. C.] Univ Warwick, Dept Biol, Coventry CV4 7AL, W Midlands, England	Nova Southeastern University; University of Warwick	Riegl, BM (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA.	rieglb@nova.edu	Purkis, Sam/B-8552-2013	Riegl, Bernhard/0000-0002-6003-9324; sheppard, charles/0000-0002-2579-5124	National Oceanic and Atmospheric Administration [NA16OA1443]; OTEP	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); OTEP	BR and SP were supported by National Oceanic and Atmospheric Administration grant NA16OA1443 to NCRI. NCRI publication #146. Work by CS was supported by a grant from OTEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonius A, 1996, ATOLL RES B, V48, P1; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Burke L., 2011, REEFS RISK REVISITED; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Caswell, 2000, MATRIX POPULATION MO; Caswell W, 1998, ECOL APPL, V8, P1226, DOI 10.2307/2640975; Connell J.H., 1973, P205; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Donner Simon D., 2009, V205, P159; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fichez R, 2005, AQUAT LIVING RESOUR, V18, P125, DOI 10.1051/alr:2005015; Friedlander Alan, 2008, NOAA Technical Memorandum NOS NCCOS, V73, P263; Ginsburg RN, 1993, P C GLOB ASP COR REE, pi; Haapkyla J, 2007, VIE MILIEU, V57, P95; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Hodgson G, 1999, MAR POLLUT BULL, V38, P345, DOI 10.1016/S0025-326X(99)00002-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houk P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013913; Houk P, 2007, J OCEANOGR, V63, P149, DOI 10.1007/s10872-007-0013-x; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kittinger JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025460; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Loya Y., 1976, COELENTERATE ECOLOGY, P89; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; McManus JW, 1997, CORAL REEFS, V16, pS121, DOI 10.1007/s003380050248; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Negri AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019703; Pratchett MS, 2007, PAC SCI, V61, P113, DOI 10.1353/psc.2007.0011; Purkis SJ, 2008, CORAL REEFS, V27, P167, DOI 10.1007/s00338-007-0306-y; Riegl B, 1999, CORAL REEFS, V18, P241, DOI 10.1007/s003380050188; Riegl BM, 2009, ECOL MODEL, V220, P192, DOI 10.1016/j.ecolmodel.2008.09.022; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; SHEPPARD CRC, 1982, MAR ECOL PROG SER, V7, P83, DOI 10.3354/meps007083; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smith LD, 2005, MAR POLLUT BULL, V51, P399, DOI 10.1016/j.marpolbul.2004.11.021; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Wolanski E, 2004, J MARINE SYST, V46, P133, DOI 10.1016/j.jmarsys.2003.11.018	51	15	15	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e36921	10.1371/journal.pone.0036921	http://dx.doi.org/10.1371/journal.pone.0036921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679482	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343900005
J	Mohseni, HR; Smith, PP; Parsons, CE; Young, KS; Hyam, JA; Stein, A; Stein, JF; Green, AL; Aziz, TZ; Kringelbach, ML				Mohseni, Hamid R.; Smith, Penny P.; Parsons, Christine E.; Young, Katherine S.; Hyam, Jonathan A.; Stein, Alan; Stein, John F.; Green, Alexander L.; Aziz, Tipu Z.; Kringelbach, Morten L.			MEG Can Map Short and Long-Term Changes in Brain Activity following Deep Brain Stimulation for Chronic Pain	PLOS ONE			English	Article							ANTERIOR CINGULATE; PRINCIPLES	Deep brain stimulation (DBS) has been shown to be clinically effective for some forms of treatment-resistant chronic pain, but the precise mechanisms of action are not well understood. Here, we present an analysis of magnetoencephalography (MEG) data from a patient with whole-body chronic pain, in order to investigate changes in neural activity induced by DBS for pain relief over both short-and long-term. This patient is one of the few cases treated using DBS of the anterior cingulate cortex (ACC). We demonstrate that a novel method, null-beamforming, can be used to localise accurately brain activity despite the artefacts caused by the presence of DBS electrodes and stimulus pulses. The accuracy of our source localisation was verified by correlating the predicted DBS electrode positions with their actual positions. Using this beamforming method, we examined changes in whole-brain activity comparing pain relief achieved with deep brain stimulation (DBS ON) and compared with pain experienced with no stimulation (DBS OFF). We found significant changes in activity in pain-related regions including the pre-supplementary motor area, brainstem (periaqueductal gray) and dissociable parts of caudal and rostral ACC. In particular, when the patient reported experiencing pain, there was increased activity in different regions of ACC compared to when he experienced pain relief. We were also able to demonstrate long-term functional brain changes as a result of continuous DBS over one year, leading to specific changes in the activity in dissociable regions of caudal and rostral ACC. These results broaden our understanding of the underlying mechanisms of DBS in the human brain.	[Mohseni, Hamid R.; Parsons, Christine E.; Young, Katherine S.; Stein, Alan; Kringelbach, Morten L.] Univ Oxford, Univ Dept Psychiat, Oxford, England; [Mohseni, Hamid R.; Smith, Penny P.] Univ Oxford, Inst Biomed Engn, Sch Engn Sci, Oxford, England; [Mohseni, Hamid R.; Parsons, Christine E.; Young, Katherine S.; Hyam, Jonathan A.; Kringelbach, Morten L.] Aarhus Univ, CFIN, Aarhus, Denmark; [Mohseni, Hamid R.; Stein, John F.; Green, Alexander L.; Aziz, Tipu Z.; Kringelbach, Morten L.] John Radcliffe Hosp, Dept Neurosurg, Oxford OX3 9DU, England; [Mohseni, Hamid R.; Parsons, Christine E.; Young, Katherine S.; Kringelbach, Morten L.] Univ Oxford, Dept Psychiat, Oxford Ctr Human Brain Act OHBA, Oxford, England	University of Oxford; University of Oxford; Aarhus University; University of Oxford; University of Oxford	Mohseni, HR (corresponding author), Univ Oxford, Univ Dept Psychiat, Oxford, England.	Morten.Kringelbach@psych.ox.ac.uk	Kringelbach, Morten L/AAF-5508-2020; Parsons, Christine/G-9286-2016; Young, Katherine/O-9198-2017; Kringelbach, Morten/AAW-5847-2021; Parsons, Christine/V-3571-2019	Parsons, Christine/0000-0003-2856-6308; Young, Katherine/0000-0002-1378-6415; Kringelbach, Morten/0000-0002-3908-6898; Parsons, Christine/0000-0003-2856-6308; Stein, Alan/0000-0001-8207-2822	Wellcome Trust; Engineering and Physical Sciences Research Council UK (EPSRC) [WT 088877/Z/09/Z]; TrygFonden Charitable Foundation; Medical Research Council; Norman Collisson Foundation; Charles Wolfson Charitable Trust	Wellcome Trust(Wellcome Trust); Engineering and Physical Sciences Research Council UK (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); TrygFonden Charitable Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Norman Collisson Foundation; Charles Wolfson Charitable Trust	This work is funded by The Wellcome Trust and Engineering and Physical Sciences Research Council UK (EPSRC) under grant number WT 088877/Z/09/Z. MLK is funded by the TrygFonden Charitable Foundation and TZA is funded by the Medical Research Council, the Norman Collisson Foundation and the Charles Wolfson Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dalal SS, 2006, IEEE T BIO-MED ENG, V53, P1357, DOI 10.1109/TBME.2006.873752; Davis KD, 2000, J NEUROSURG, V92, P64, DOI 10.3171/jns.2000.92.1.0064; Deniau JM, 2010, EUR J NEUROSCI, V32, P1080, DOI 10.1111/j.1460-9568.2010.07413.x; Hansen P.C., 2010, MEG INTRO METHODS; Haykin S., 2002, ADAPTIVE FILTER THEO; Henson RN, 2009, NEUROIMAGE, V47, P581, DOI 10.1016/j.neuroimage.2009.04.063; Hirschmann J, 2011, NEUROIMAGE, V55, P1159, DOI 10.1016/j.neuroimage.2010.11.063; KESELMAN HJ, 1980, PSYCHOPHYSIOLOGY, V17, P499, DOI 10.1111/j.1469-8986.1980.tb00190.x; Kringelbach ML, 2009, J PAIN MANAGEMENT, V2, P301; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Kringelbach ML, 2007, NEUROREPORT, V18, P223, DOI 10.1097/WNR.0b013e328010dc3d; Kringelbach ML, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00008; Kringelbach ML, 2010, EUR J NEUROSCI, V32, P1070, DOI 10.1111/j.1460-9568.2010.07419.x; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Litvak V, 2010, NEUROIMAGE, V50, P1578, DOI 10.1016/j.neuroimage.2009.12.115; Makela JP., 2007, INT C SERIES, V1300, P345, DOI DOI 10.1016/J.ICS.2007.02.003; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; Mohseni HR, 2012, IEEE T BIOM IN PRESS; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Popescu M, 2008, IEEE T BIO-MED ENG, V55, P1092, DOI 10.1109/TBME.2007.906504; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Ray NJ, 2009, J CLIN NEUROSCI, V16, P32, DOI 10.1016/j.jocn.2008.03.004; Ray Nj, 2007, Biomed Imaging Interv J, V3, pe25, DOI 10.2349/biij.3.1.e25; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Volkmann J, 2002, MOVEMENT DISORD, V17, pS181, DOI 10.1002/mds.10162; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	30	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37993	10.1371/journal.pone.0037993	http://dx.doi.org/10.1371/journal.pone.0037993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675503	gold, Green Published			2022-12-27	WOS:000305341700032
J	Takahashi, M; Elbarbary, RA; Abe, M; Sato, M; Yoshida, T; Yamada, Y; Tamura, M; Nashimoto, M				Takahashi, Masayuki; Elbarbary, Reyad A.; Abe, Mayumi; Sato, Mari; Yoshida, Tetsuo; Yamada, Yoji; Tamura, Masato; Nashimoto, Masayuki			Elimination of Specific miRNAs by Naked 14-nt sgRNAs	PLOS ONE			English	Article							3' PROCESSING ENDORIBONUCLEASE; RNA CLEAVAGE; MULTIPLE-MYELOMA; GENE-EXPRESSION; TRNASE Z(L); MICRORNAS; NUCLEOTIDES; DISCOVERY; HEPTAMERS; DIRECTION	tRNase Z(L)-utilizing efficacious gene silencing (TRUE gene silencing) is a newly developed technology to suppress mammalian gene expression. TRUE gene silencing works on the basis of a unique enzymatic property of mammalian tRNase Z(L), which is that it can recognize a pre-tRNA-like or micro-pre-tRNA-like complex formed between target RNA and artificial small guide RNA (sgRNA) and can cleave any target RNA at any desired site. There are four types of sgRNA, 5'-half-tRNA, RNA heptamer, hook RNA, and similar to 14-nt linear RNA. Here we show that a 14-nt linear-type sgRNA against human miR-16 can guide tRNase Z(L) cleavage of miR-16 in vitro and can downregulate the miR-16 level in HEK293 cells. We also demonstrate that the 14-nt sgRNA can be efficiently taken up without any transfection reagents by living cells and can exist stably in there for at least 24 hours. The naked 14-nt sgRNA significantly reduced the miR-16 level in HEK293 and HL60 cells. Three other naked 14-nt sgRNAs against miR-142-3p, miR-206, and miR-19a/b are also shown to downregulate the respective miRNA levels in various mammalian cell lines. Our observations suggest that in general we can eliminate a specific cellular miRNA at least by similar to 50% by using a naked 14-nt sgRNA on the basis of TRUE gene silencing.	[Takahashi, Masayuki; Elbarbary, Reyad A.; Abe, Mayumi; Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan; [Sato, Mari; Tamura, Masato] Hokkaido Univ, Grad Sch Dent Med, Dept Biochem & Mol Biol, Sapporo, Hokkaido, Japan; [Yoshida, Tetsuo; Yamada, Yoji] Kyowa Hakko Kirin Co Ltd, Biol Res Labs, Machida, Tokyo, Japan	Niigata University; Hokkaido University; Kyowa Kirin Ltd	Takahashi, M (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	mnashimoto@nupals.ac.jp	tamura, masato/B-7304-2009	tamura, masato/0000-0003-3700-5203; Rzq, kareem/0000-0003-3784-9430	Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency	Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency	This work was supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Elbarbary RA, 2009, FEBS LETT, V583, P3241, DOI 10.1016/j.febslet.2009.09.015; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Elbarbary RA, 2009, BIOCHEM BIOPH RES CO, V379, P924, DOI 10.1016/j.bbrc.2008.12.173; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; GALLAGHER R, 1979, BLOOD, V54, P713; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Habu Y, 2005, NUCLEIC ACIDS RES, V33, P235, DOI 10.1093/nar/gki164; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; MATSUOKA Y, 1967, P SOC EXP BIOL MED, V125, P1246; Nakashima A, 2007, GENE THER, V14, P78, DOI 10.1038/sj.gt.3302841; NASHIMOTO M, 1995, NUCLEIC ACIDS RES, V23, P3642, DOI 10.1093/nar/23.18.3642; Nashimoto M, 1999, J MOL BIOL, V287, P727, DOI 10.1006/jmbi.1999.2639; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; Nashimoto M, 1997, NUCLEIC ACIDS RES, V25, P1148, DOI 10.1093/nar/25.6.1148; Nashimoto M, 1998, NUCLEIC ACIDS RES, V26, P2565, DOI 10.1093/nar/26.11.2565; NASHIMOTO M, 1996, RNA, V2, P2523; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Sano T, 2011, BIOCHEM BIOPH RES CO, V416, P427, DOI 10.1016/j.bbrc.2011.11.091; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Takaku H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh092; Takaku H, 2004, NUCLEIC ACIDS RES, V32, P4429, DOI 10.1093/nar/gkh774; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tamura M, 2003, NUCLEIC ACIDS RES, V31, P4354, DOI 10.1093/nar/gkg641; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	30	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38496	10.1371/journal.pone.0038496	http://dx.doi.org/10.1371/journal.pone.0038496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675569	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700081
J	Villar, S; Ortiz-Cuaran, S; Abedi-Ardekani, B; Gouas, D; da Costa, AN; Plymoth, A; Khuhaprema, T; Kalalak, A; Sangrajrang, S; Friesen, MD; Groopman, JD; Hainaut, P				Villar, Stephanie; Ortiz-Cuaran, Sandra; Abedi-Ardekani, Behnoush; Gouas, Doriane; da Costa, Andre Nogueira; Plymoth, Amelie; Khuhaprema, Thiravud; Kalalak, Anant; Sangrajrang, Suleeporn; Friesen, Marlin D.; Groopman, John D.; Hainaut, Pierre			Aflatoxin-Induced TP53 R249S Mutation in HepatoCellular Carcinoma in Thailand: Association with Tumors Developing in the Absence of Liver Cirrhosis	PLOS ONE			English	Article							P53 MUTATIONS; PLASMA; DNA; INFECTION; CANCER; B-1	Primary Liver Cancer (PLC) is the leading cause of death by cancer among males in Thailand and the 3rd among females. Most cases are hepatocellular carcinoma (HCC) but cholangiocarcinomas represent between 4 and 80% of liver cancers depending upon geographic area. Most HCC are associated with chronic infection by Hepatitis B Virus while a G -> T mutation at codon 249 of the TP53 gene, R249S, specific for exposure to aflatoxin, is detected in tumors for up to 30% of cases. We have used Short Oligonucleotide Mass Analysis (SOMA) to quantify free circulating R249S-mutated DNA in plasma using blood specimens collected in a hospital case: control study. Plasma R249S-mutated DNA was detectable at low concentrations (>= 67 copies/mL) in 53 to 64% of patients with primary liver cancer or chronic liver disease and in 19% of controls. 44% of patients with HCC and no evidence of cirrhosis had plasma concentrations of R249S-mutated DNA >= 150 copies/mL, compared to 21% in patients with both HCC and cirrhosis, 22% in patients with cholangiocarcinoma, 12% in patients with non-cancer chronic liver disease and 3% of subjects in the reference group. Thus, plasma concentrations of R249S-mutated DNA >= 150 copies/mL tended to be more common in patients with HCC developing without pre-existing cirrhosis (p = 0.027). Overall, these results support the preferential occurrence of R249S-mutated DNA in HCC developing in the absence of cirrhosis in a context of HBV chronic infection.	[Villar, Stephanie; Ortiz-Cuaran, Sandra; Abedi-Ardekani, Behnoush; Gouas, Doriane; da Costa, Andre Nogueira; Hainaut, Pierre] Int Agcy Res Canc, F-69372 Lyon, France; [Plymoth, Amelie] Karolinska Inst, Stockholm, Sweden; [Khuhaprema, Thiravud; Kalalak, Anant; Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok, Thailand; [Friesen, Marlin D.; Groopman, John D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hainaut, Pierre] Int Prevent Res Inst, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); Karolinska Institutet; National Cancer Institute - Thailand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Villar, S (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	pierre.hainaut@i-pri.org	Hainaut, Pierre/B-6018-2012; Abedi-Ardekani, Behnoush/O-7829-2016; /X-4205-2019; Friesen, Marlin D/D-7328-2012	Hainaut, Pierre/0000-0002-1303-1610; Abedi-Ardekani, Behnoush/0000-0002-0980-0587; /0000-0003-4690-2133; Ortiz-Cuaran, Sandra/0000-0003-1152-5681	IARC; Ligue Contre le Cancer, Departement du Rhone, France	IARC; Ligue Contre le Cancer, Departement du Rhone, France	This work was supported by funds from IARC and from Ligue Contre le Cancer, Departement du Rhone, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GLOBOCAN 2008 CANC I; [Anonymous], 2008, WORLD CANC REP; Besaratinia A, 2009, GASTROENTEROLOGY, V137, P1127, DOI 10.1053/j.gastro.2009.06.002; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; Galy O, 2011, HEPAT RES TREAT; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Gouas D, 2009, CANCER LETT, V286, P29, DOI 10.1016/j.canlet.2009.02.057; Groopman John D., 2005, Cancer Biomarkers, V1, P5; International Agency for Research on Cancer, 2009, REV HUM CARC B; International Agency for Research on Cancer, 2002, SOM TRAD HERB MED SO; Kirk GD, 2000, JNCI-J NATL CANCER I, V92, P148, DOI 10.1093/jnci/92.2.148; Kuang SY, 2005, CANCER EPIDEM BIOMAR, V14, P380, DOI 10.1158/1055-9965.EPI-04-0380; Lipigorngoson S, 2003, FOOD ADDIT CONTAM A, V20, P838, DOI 10.1080/0265203031000156060; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Lleonart ME, 2005, CANCER EPIDEM BIOMAR, V14, P2956, DOI 10.1158/1055-9965.EPI-05-0612; Poovorawan Y, 2011, J VIRAL HEPATITIS, V18, P369, DOI 10.1111/j.1365-2893.2010.01312.x; Poovorawan Y, 2000, VACCINE, V19, P943, DOI 10.1016/S0264-410X(00)00216-4; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; SRIVATANAKUL P, 1991, INT J CANCER, V48, P329, DOI 10.1002/ijc.2910480303; Srivatanakul Petcharin, 2004, Asian Pac J Cancer Prev, V5, P118; Strosnider H, 2006, ENVIRON HEALTH PERSP, V114, P1898, DOI 10.1289/ehp.9302; Umoh NJ, 2011, LIVER INT, V31, P215, DOI 10.1111/j.1478-3231.2010.02418.x; Villar S, 2011, ENV HLTH PERSPECT; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264	24	32	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37707	10.1371/journal.pone.0037707	http://dx.doi.org/10.1371/journal.pone.0037707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675488	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341700020
J	Driskell, EA; Pickens, JA; Humberd-Smith, J; Gordy, JT; Bradley, KC; Steinhauer, DA; Berghaus, RD; Stallknecht, DE; Howerth, EW; Tompkins, SM				Driskell, Elizabeth A.; Pickens, Jennifer A.; Humberd-Smith, Jennifer; Gordy, James T.; Bradley, Konrad C.; Steinhauer, David A.; Berghaus, Roy D.; Stallknecht, David E.; Howerth, Elizabeth W.; Tompkins, Stephen Mark			Low Pathogenic Avian Influenza Isolates from Wild Birds Replicate and Transmit via Contact in Ferrets without Prior Adaptation	PLOS ONE			English	Article							POLYMERASE SUBUNIT PB2; SINGLE AMINO-ACID; A VIRUSES; RECEPTOR SPECIFICITY; HONG-KONG; HEMAGGLUTININ RESIDUES; GENETIC COMPATIBILITY; RESPIRATORY-TRACT; HUMAN INFECTION; ANIMAL-MODELS	Direct transmission of avian influenza viruses to mammals has become an increasingly investigated topic during the past decade; however, isolates that have been primarily investigated are typically ones originating from human or poultry outbreaks. Currently there is minimal comparative information on the behavior of the innumerable viruses that exist in the natural wild bird host. We have previously demonstrated the capacity of numerous North American avian influenza viruses isolated from wild birds to infect and induce lesions in the respiratory tract of mice. In this study, two isolates from shorebirds that were previously examined in mice (H1N9 and H6N1 subtypes) are further examined through experimental inoculations in the ferret with analysis of viral shedding, histopathology, and antigen localization via immunohistochemistry to elucidate pathogenicity and transmission of these viruses. Using sequence analysis and glycan binding analysis, we show that these avian viruses have the typical avian influenza binding pattern, with affinity for cell glycoproteins/glycolipids having terminal sialic acid (SA) residues with alpha 2,3 linkage [Neu5Ac(alpha 2,3)Gal]. Despite the lack of alpha 2,6 linked SA binding, these AIVs productively infected both the upper and lower respiratory tract of ferrets, resulting in nasal viral shedding and pulmonary lesions with minimal morbidity. Moreover, we show that one of the viruses is able to transmit to ferrets via direct contact, despite its binding affinity for alpha 2,3 linked SA residues. These results demonstrate that avian influenza viruses, which are endemic in aquatic birds, can potentially infect humans and other mammals without adaptation. Finally this work highlights the need for additional study of the wild bird subset of influenza viruses in regard to surveillance, transmission, and potential for reassortment, as they have zoonotic potential.	[Driskell, Elizabeth A.; Howerth, Elizabeth W.] Univ Georgia, Dept Pathol, Athens, GA 30602 USA; [Pickens, Jennifer A.; Humberd-Smith, Jennifer; Gordy, James T.; Tompkins, Stephen Mark] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Bradley, Konrad C.; Steinhauer, David A.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Berghaus, Roy D.; Stallknecht, David E.] Univ Georgia, Dept Populat Hlth, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Emory University; University System of Georgia; University of Georgia	Driskell, EA (corresponding author), Univ Georgia, Dept Pathol, Athens, GA 30602 USA.	smt@uga.edu	Gordy, James/AAV-4024-2020; Berghaus, Roy/GPX-7566-2022; Tompkins, Stephen/A-3317-2008	Berghaus, Roy/0000-0002-8813-3056; Tompkins, Stephen/0000-0002-1523-5588; Gordy, James/0000-0003-2588-0756; Bradley, Konrad/0000-0001-8761-6219	Centers for Disease Control (CDC) [5U19Cl00040102]; National Institutes of Health [HHSN266200700006C]	Centers for Disease Control (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Centers for Disease Control (CDC) grant 5U19Cl00040102 and National Institutes of Health contract HHSN266200700006C. The CDC provided CDC approval of animal protocols for this study and reviewed this manuscript prior to submission for publication. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Belser JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002569; Belser JA, 2011, J VIROL, V85, P1563, DOI 10.1128/JVI.02231-10; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Bradley KC, 2011, VIROLOGY, V413, P169, DOI 10.1016/j.virol.2011.01.027; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Claas ECJ, 1998, VACCINE, V16, P977, DOI 10.1016/S0264-410X(98)00005-X; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Driskell EA, 2010, VIROLOGY, V399, P280, DOI 10.1016/j.virol.2010.01.005; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Gillim-Ross L, 2008, J VIROL, V82, P10854, DOI 10.1128/JVI.01206-08; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kemink S A G, 2004, Ned Tijdschr Geneeskd, V148, P2190; Klopfleisch R, 2007, VET PATHOL, V44, P261, DOI 10.1354/vp.44-3-261; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; McBrayer A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-149; Medeiros R, 2001, VIROLOGY, V289, P74, DOI 10.1006/viro.2001.1121; Nam JH, 2011, J VIROL, V85, P13271, DOI 10.1128/JVI.05038-11; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; O'Donnell CD, 2011, MICROBES INFECT, V13, P502, DOI 10.1016/j.micinf.2011.01.014; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; Oh J., 2008, EMERG INFECT DIS, V14, P741, DOI [10.3201/eid1405.071471, DOI 10.3201/eid1405.071471]; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith JH, 2011, J VIROL, V85, P7572, DOI 10.1128/JVI.00512-11; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; SUZUKI Y, 1985, J BIOL CHEM, V260, P1362; SWEET C, 1985, ARCH VIROL, V85, P305, DOI 10.1007/BF01314239; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tripp RA, 2009, CURR TOP MICROBIOL, V333, P397, DOI 10.1007/978-3-540-92165-3_19; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Uyeki TM, 2002, EMERG INFECT DIS, V8, P154, DOI 10.3201/eid0802.010148; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	66	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38067	10.1371/journal.pone.0038067	http://dx.doi.org/10.1371/journal.pone.0038067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675507	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900011
J	Louapre, P; Bittebiere, AK; Clement, B; Pierre, JS; Mony, C				Louapre, Philipe; Bittebiere, Anne-Kristel; Clement, Bernard; Pierre, Jean-Sebastien; Mony, Cendrine			How Past and Present Influence the Foraging of Clonal Plants?	PLOS ONE			English	Article							DIVISION-OF-LABOR; ENVIRONMENTAL HETEROGENEITY; MORPHOLOGICAL PLASTICITY; LIGHT QUALITY; GROWTH; INTEGRATION; AVAILABILITY; EVOLUTION; RESPONSES; BEHAVIOR	Clonal plants spreading horizontally and forming a network structure of ramets exhibit complex growth patterns to maximize resource uptake from the environment. They respond to spatial heterogeneity by changing their internode length or branching frequency. Ramets definitively root in the soil but stay interconnected for a varying period of time thus allowing an exchange of spatial and temporal information. We quantified the foraging response of clonal plants depending on the local soil quality sampled by the rooting ramet (i.e. the present information) and the resource variability sampled by the older ramets (i.e. the past information). We demonstrated that two related species, Potentilla reptans and P. anserina, responded similarly to the local quality of their environment by decreasing their internode length in response to nutrient-rich soil. Only P. reptans responded to resource variability by decreasing its internode length. In both species, the experience acquired by older ramets influenced the plastic response of new rooted ramets: the internode length between ramets depended not only on the soil quality locally sampled but also on the soil quality previously sampled by older ramets. We quantified the effect of the information perceived at different time and space on the foraging behavior of clonal plants by showing a non-linear response of the ramet rooting in the soil of a given quality. These data suggest that the decision to grow a stolon or to root a ramet at a given distance from the older ramet results from the integration of the past and present information about the richness and the variability of the environment.	[Louapre, Philipe; Bittebiere, Anne-Kristel; Clement, Bernard; Pierre, Jean-Sebastien; Mony, Cendrine] Univ Rennes 1, UMR CNRS ECOBIO 6553, UMS OSUR 3343, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite Rennes 2; Universite de Rennes	Louapre, P (corresponding author), Univ Rennes 1, UMR CNRS ECOBIO 6553, UMS OSUR 3343, Rennes, France.	philippe.louapre@mail-univscience.com			Agence Nationale de la Recherche [ANR-08-SYSC-012]; CNRS [UMR 6553 EcoBio]; University of Rennes 1 [UMR 6553 EcoBio]	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1	This research was funded as a part of the program from the Agence Nationale de la Recherche for CM (ANR-08-SYSC-012). PL was supported by UMR 6553 EcoBio allocated by CNRS and University of Rennes 1. There were no additional external funding sources for this study. The funders did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; Alpi A, 2007, TRENDS PLANT SCI, V12, P135, DOI 10.1016/j.tplants.2007.03.002; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; CAIN ML, 1994, ECOLOGY, V75, P933, DOI 10.2307/1939417; Garzon PC, 2011, ADAPT BEHAV, V19, P155, DOI 10.1177/1059712311409446; CHAZDON RL, 1988, AM J BOT, V75, P1459, DOI 10.2307/2444696; D'Hertefeldt T, 1999, J ECOL, V87, P258, DOI 10.1046/j.1365-2745.1999.00345.x; D'Hertefeldt T, 1998, OIKOS, V81, P229, DOI 10.2307/3547044; DEKROON H, 1994, FOLIA GEOBOT PHYTOTX, V29, P123, DOI 10.1007/BF02803790; DONG M, 1993, NEW PHYTOL, V124, P291, DOI 10.1111/j.1469-8137.1993.tb03819.x; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1; ERIKSSON O, 1988, J ECOL, V76, P522, DOI 10.2307/2260610; ERIKSSON O, 1986, VEGETATIO, V67, P17; Fischer M, 2001, EVOL ECOL, V15, P565, DOI 10.1023/A:1016013721469; Gardner SN, 1999, ECOLOGY, V80, P1202, DOI 10.1890/0012-9658(1999)080[1202:MIISCO]2.0.CO;2; GROSS KL, 1995, J ECOL, V83, P357, DOI 10.2307/2261590; HARTNETT DC, 1985, J ECOL, V73, P415, DOI 10.2307/2260484; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hill MO, 1997, J VEG SCI, V8, P579, DOI 10.2307/3237210; Huber H, 1996, FUNCT ECOL, V10, P401, DOI 10.2307/2390290; Huber H, 1999, PLANT ECOL, V141, P107, DOI 10.1023/A:1009861521047; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; JACKSON RB, 1993, J ECOL, V81, P683, DOI 10.2307/2261666; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; MACDONALD SE, 1993, J ECOL, V81, P769, DOI 10.2307/2261674; McNamara JM, 2006, OIKOS, V112, P243, DOI 10.1111/j.0030-1299.2006.14228.x; McNickle GG, 2009, TRENDS ECOL EVOL, V24, P419, DOI 10.1016/j.tree.2009.03.004; McNickle GG, 2009, P NATL ACAD SCI USA, V106, P4747, DOI 10.1073/pnas.0807971106; Nilsson J, 2008, EVOL ECOL, V22, P437, DOI 10.1007/s10682-007-9199-z; NOBLE JC, 1983, J ECOL, V71, P865, DOI 10.2307/2259598; Oborny B, 2004, COMPLEXITY, V9, P22, DOI 10.1002/cplx.20012; PRICE EAC, 1992, J ECOL, V80, P25, DOI 10.2307/2261060; Sachs T, 2001, EVOL ECOL, V15, P485, DOI 10.1023/A:1016053402813; SLADE AJ, 1987, J ECOL, V75, P95, DOI 10.2307/2260538; SLADE AJ, 1987, J ECOL, V75, P639, DOI 10.2307/2260196; Stuefer JF, 1998, OECOLOGIA, V117, P1, DOI 10.1007/s004420050624; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; Stuefer JF, 2002, J EVOLUTION BIOL, V15, P880, DOI 10.1046/j.1420-9101.2002.00435.x; Sutherland W. J., 1990, Living in a patchy environment., P45; SUTHERLAND WJ, 1988, OIKOS, V52, P239, DOI 10.2307/3565196; SVENSSON BM, 1994, FOLIA GEOBOT PHYTOTX, V29, P159, DOI 10.1007/BF02803792; Trewavas A, 2005, NATURWISSENSCHAFTEN, V92, P401, DOI 10.1007/s00114-005-0014-9; Trewavas A, 2005, TRENDS PLANT SCI, V10, P413, DOI 10.1016/j.tplants.2005.07.005; TURKINGTON R, 1991, OECOLOGIA, V86, P183, DOI 10.1007/BF00317530; Van Kleunen M, 2000, J EVOLUTION BIOL, V13, P237; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Van Kleunen M, 2003, J EVOLUTION BIOL, V16, P474, DOI 10.1046/j.1420-9101.2003.00532.x; Wijesinghe DK, 1997, J ECOL, V85, P17, DOI 10.2307/2960624; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	53	30	31	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38288	10.1371/journal.pone.0038288	http://dx.doi.org/10.1371/journal.pone.0038288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675539	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900022
J	Murtagh, MJ; Watson, DLB; Jenkings, KN; Lie, MLS; Mackintosh, JE; Ford, GA; Thomson, RG				Murtagh, Madeleine J.; Watson, Duika L. Burges; Jenkings, K. Neil; Lie, Mabel L. S.; Mackintosh, Joan E.; Ford, Gary A.; Thomson, Richard G.			Situationally-Sensitive Knowledge Translation and Relational Decision Making in Hyperacute Stroke: A Qualitative Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; THROMBOLYSIS; ENCOUNTER; AUTONOMY; CONSENT; SUPPORT; TRIAL	Stroke is a leading cause of disability. Early treatment of acute ischaemic stroke with rtPA reduces the risk of longer term dependency but carries an increased risk of causing immediate bleeding complications. To understand the challenges of knowledge translation and decision making about treatment with rtPA in hyperacute stroke and hence to inform development of appropriate decision support we interviewed patients, their family and health professionals. The emergency setting and the symptomatic effects of hyper-acute stroke shaped the form, content and manner of knowledge translation to support decision making. Decision making about rtPA in hyperacute stroke presented three conundrums for patients, family and clinicians. 1) How to allow time for reflection in a severely time-limited setting. 2) How to facilitate knowledge translation regarding important treatment risks and benefits when patient and family capacity is blunted by the effects and shock of stroke. 3) How to ensure patient and family views are taken into account when the situation produces reliance on the expertise of clinicians. Strategies adopted to meet these conundrums were fourfold: face to face communication; shaping decisions; incremental provision of information; and communication tailored to the individual patient. Relational forms of interaction were understood to engender trust and allay anxiety. Shaping decisions with patients was understood as an expression of confidence by clinicians that helped alleviate anxiety and offered hope and reassurance to patients and their family experiencing the shock of the stroke event. Neutral presentations of information and treatment options promoted uncertainty and contributed to anxiety. 'Drip feeding' information created moments for reflection: clinicians literally made time. Tailoring information to the particular patient and family situation allowed clinicians to account for social and emotional contexts. The principal responses to the challenges of decision making about rtPA in hyperacute stroke were relational decision support and situationally-sensitive knowledge translation.	[Murtagh, Madeleine J.; Watson, Duika L. Burges; Jenkings, K. Neil; Lie, Mabel L. S.; Mackintosh, Joan E.; Thomson, Richard G.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Murtagh, Madeleine J.] Univ Leicester, Coll Med Biol Sci & Psychol, Dept Hlth Sci, Leicester, Leics, England; [Watson, Duika L. Burges] Univ Durham, Wolfson Res Inst, Ctr Translat Res, Stockton, CA USA; [Ford, Gary A.] Newcastle Univ, Fac Med Sci, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ford, Gary A.] Newcastle upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Lie, Mabel L. S.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; University of Leicester; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Murtagh, MJ (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	mm399@le.ac.uk	Ford, Gary/AAY-6405-2020; Burges Watson, Duika/C-4899-2009	Ford, Gary/0000-0001-8719-4968; Burges Watson, Duika/0000-0002-5791-9670	National Institute for Health Research (NIHR) [RP-PG-0606-1241]; National Institute for Health Research [RP-PG-0606-1241] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (RP-PG-0606-1241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams K., 1998, WILLIAM MARY LAW REV, V40, P805; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Ciccone A, 2003, LANCET NEUROL, V2, P375, DOI 10.1016/S1474-4422(03)00412-5; Coulter A., 2009, IMPLEMENTING SHARED; Cruikshank B, 1999, WILL EMPOWER DEMOCRA; Davies M, 2008, HEALTH CARE ANAL, V16, P315, DOI 10.1007/s10728-007-0075-3; Dodds S, 2000, RELATIONAL AUTONOMY; Entwistle VA, 2010, J GEN INTERN MED, P1; Farnworth A, 2008, PATIENT EDUC COUNS, V71, P116, DOI 10.1016/j.pec.2007.11.020; Forsyth R, 2011, QUALITATIVE HLTH RES; Gobo G, 2004, QUALITATIVE RES PRAC; GRECO M, 1993, ECON SOC, V22, P357, DOI 10.1080/03085149300000024; GROFMAN B, 1985, THEOR DECIS, V19, P31, DOI 10.1007/BF00134353; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Lang ES, 2007, ACAD EMERG MED, V14, P919, DOI 10.1197/j.aem.2007.07.002; Legare F, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-2; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lown BA, 2009, HEALTH EXPECT, V12, P160, DOI 10.1111/j.1369-7625.2008.00525.x; Murtagh MJ, 2003, SOC SCI MED, V56, P1643, DOI 10.1016/S0277-9536(02)00172-7; Murtagh MJ, 2011, HUM GENET, P1; National Audit Office, 2005, RED BRAIN DAM FAST A; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; Potter J., 1996, REPRESENTING REALITY; Rapley T, 2006, SOC SCI MED, V62, P2267, DOI 10.1016/j.socscimed.2005.10.011; Rosenbaum JR, 2004, STROKE, V35, pE353, DOI 10.1161/01.STR.0000136555.28503.55; Ruiz-Moral R, 2010, HEALTH EXPECT, V13, P33, DOI 10.1111/j.1369-7625.2009.00578.x; Say R, 2006, PATIENT EDUC COUNS, V60, P102, DOI 10.1016/j.pec.2005.02.003; Silverman D., 2009, DOING QUALITATIVE RE; Stake R.E., 2005, SAGE HDB QUALITATIVE, V3rd, P119; Stoljar Natalie, 2000, RELATIONAL AUTONOMY, P98; Straus SE, 2009, KNOWLEDGE TRANSLATIO; Watson DB, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-5	34	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37066	10.1371/journal.pone.0037066	http://dx.doi.org/10.1371/journal.pone.0037066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UI	22675477	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305339900005
J	Busse, S; von Grumbkow, P; Hummel, S; Shah, DN; Shah, RDT; Li, JK; Zhang, XP; Yoshizawa, K; Wedmann, S; Hornschemeyer, T				Buesse, Sebastian; von Grumbkow, Philipp; Hummel, Susanne; Shah, Deep Narayan; Shah, Ram Devi Tachamo; Li, Jingke; Zhang, Xueping; Yoshizawa, Kazunori; Wedmann, Sonja; Hoernschemeyer, Thomas			Phylogeographic Analysis Elucidates the Influence of the Ice Ages on the Disjunct Distribution of Relict Dragonflies in Asia	PLOS ONE			English	Article							EPIOPHLEBIA-LAIDLAWI TILLYARD; PHYLOGENETIC ANALYSIS; DNA-SEQUENCES; ODONATA; INFERENCE; ALIGNMENT; MRBAYES; 28S	Unusual biogeographic patterns of closely related groups reflect events in the past, and molecular analyses can help to elucidate these events. While ample research on the origin of disjunct distributions of different organism groups in the Western Paleartic has been conducted, such studies are rare for Eastern Palearctic organisms. In this paper we present a phylogeographic analysis of the disjunct distribution pattern of the extant species of the strongly cool-adapted Epiophlebia dragonflies from Asia. We investigated sequences of the usually more conserved 18 S rDNA and 28 S rDNA genes and the more variable sequences of ITS1, ITS2 and CO2 of all three currently recognised Epiophlebia species and of a sample of other odonatan species. In all genes investigated the degrees of similarity between species of Epiophlebia are very high and resemble those otherwise found between different populations of the same species in Odonata. This indicates that substantial gene transfer between these populations occurred in the comparatively recent past. Our analyses imply a wide distribution of the ancestor of extant Epiophlebia in Southeast Asia during the last ice age, when suitable habitats were more common. During the following warming phase, its range contracted, resulting in the current disjunct distribution. Given the strong sensitivity of these species to climatic parameters, the current trend to increasing global temperatures will further reduce acceptable habitats and seriously threaten the existences of these last representatives of an ancient group of Odonata.	[Buesse, Sebastian; Hoernschemeyer, Thomas] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Morphol Systemat & Evolutionary Biol, Gottingen, Germany; [von Grumbkow, Philipp; Hummel, Susanne] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Hist Anthropol & Human Ecol, Gottingen, Germany; [Shah, Deep Narayan] Senckenberg Res Inst, Dept River Ecol & Conservat, Gelnhausen, Germany; [Shah, Deep Narayan] Nat Hist Museums, Gelnhausen, Germany; [Shah, Ram Devi Tachamo] Hindu Kush Himalayan Benthol Soc, Kathmandu, Nepal; [Zhang, Xueping] Harbin Normal Univ, Coll Heilongjiang Prov, Key Lab Remote Sensing Monitoring Geog Environm, Harbin, Peoples R China; [Yoshizawa, Kazunori] Hokkaido Univ Sapporo, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Wedmann, Sonja] Senckenberg Res Inst, Messel, Germany; [Wedmann, Sonja] Nat Hist Museums, Res Stn Messel Pit, Messel, Germany	University of Gottingen; University of Gottingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Harbin Normal University; Hokkaido University; Senckenberg Gesellschaft fur Naturforschung (SGN)	Busse, S (corresponding author), Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Morphol Systemat & Evolutionary Biol, Gottingen, Germany.	thoerns@gwdg.de	Yoshizawa, Kazunori/A-4268-2012; Hörnschemeyer, Thomas/AAU-9813-2020; Tachamo, Ram Devi/AAA-8590-2019; Yoshizawa, Kazunori/Q-9390-2019	Hörnschemeyer, Thomas/0000-0002-4924-5389; Tachamo, Ram Devi/0000-0002-1061-2903; Yoshizawa, Kazunori/0000-0001-6170-4296; Wedmann, Sonja/0000-0002-9778-4125	DFG (Deutsche Forschungsgemeinschaft) [HO2306/6-1]; DFG Heisenberg grant [HO2306/7-1]; National Science Foundation of China [41071033]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DFG Heisenberg grant(German Research Foundation (DFG)); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was partly financed through the DFG (Deutsche Forschungsgemeinschaft) grant HO2306/6-1. TH was directly supported through the DFG Heisenberg grant HO2306/7-1. JL and XZ were supported by a grant from the National Science Foundation of China (No. 41071033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina A, 1954, MORPHOLOGICAL STUDY; Asahina A, 1963, TOMBO, V6, P18; ASAHINA SYOZIRO, 1961, INTERNATL REV GESAMTEN HYDROBIOL, V46, P441, DOI 10.1002/iroh.19610460310; Bernard R, 2011, J ZOOL SYST EVOL RES, V49, P292, DOI 10.1111/j.1439-0469.2011.00630.x; Brockhaus T, 2009, ODONATOLOGICA, V38, P203; Bybee SM, 2008, CLADISTICS, V24, P477, DOI 10.1111/j.1096-0031.2007.00191.x; Carle Frank Louis, 2008, Arthropod Systematics & Phylogeny, V66, P37; Carpenter FM, 1992, TREATISE INVERTEBR R, V4, P59; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Davies A, 1992, FLYING KIMMINSIA, V3, P10; Dumont HJ, 2010, SYST ENTOMOL, V35, P6, DOI 10.1111/j.1365-3113.2009.00489.x; Fleck G, 2008, J ZOOL SYST EVOL RES, V46, P310, DOI 10.1111/j.1439-0469.2008.00474.x; Fleck G, 2003, ANN SOC ENTOMOL FR, V39, P55, DOI 10.1080/00379271.2003.10697363; Freeland JR, 2003, ECOL ENTOMOL, V28, P413, DOI 10.1046/j.1365-2311.2003.00521.x; Friedrich M, 1997, MOL BIOL EVOL, V14, P644, DOI 10.1093/oxfordjournals.molbev.a025804; FURUKAWA HARUO, 1934, ANNOT ZOOL JAPONENSES, V14, P451; Grimaldi David, 2005, pi; Habel JC, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P1, DOI 10.1007/978-3-540-92160-8; Hasegawa E, 2006, ENTOMOL SCI, V9, P55, DOI 10.1111/j.1479-8298.2006.00154.x; Hastings D. A., 1999, GLOBAL LAND ONE KILO; Ho SYW, 2011, SYST BIOL, V60, P366, DOI 10.1093/sysbio/syq099; Hovmoller R, 2002, CLADISTICS, V18, P313, DOI 10.1111/j.1096-0031.2002.tb00153.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hummel S, 2003, ANCIENT DNA TYPING M; Ikeda H, 1998, B U MUSEUM U TOKYO; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; Li JK, 2012, SYST ENTOMOL, V37, P408, DOI 10.1111/j.1365-3113.2011.00610.x; Li ZX, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045404; Lohmann H, 1996, ENTOMOL ZEITSCHR, V106, P209; Lomolino MV, 2006, BIOGEOGRAPHY; Millien-Parra V, 1999, J BIOGEOGR, V26, P959, DOI 10.1046/j.1365-2699.1999.00346.x; Nel A., 1993, NUMERO HORS SERIE, V3, P1; Nesemann H, 2011, ODONATOLOGICA, V40, P191; Nylander JAA., 2004, BIOINFORMATICS; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Rehn AC, 2003, SYST ENTOMOL, V28, P181, DOI 10.1046/j.1365-3113.2003.00210.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Segota T, 1973, EISZEITALTER GEGENWA, V23, P107; Selys Longchamps E.D., 1889, COMPTES RENDUS SOC E, V3, P153; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tabaru N., 1984, Tombo (Tokyo), V27, P27; Tamariz J, 2006, J FORENSIC SCI, V51, P790, DOI 10.1111/j.1556-4029.2006.00172.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tillyard R. J., 1921, Records of the Indian Museum, V22, P93; TUSHINGHAM AM, 1993, QUATERNARY RES, V39, P125, DOI 10.1006/qres.1993.1015; Xylander WER, 2003, LEHRB SPEZIELLE, P167	48	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38132	10.1371/journal.pone.0038132	http://dx.doi.org/10.1371/journal.pone.0038132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666462	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400087
J	Zuo, NM; Fang, JL; Lv, XY; Zhou, Y; Hong, Y; Li, T; Tong, HB; Wang, XL; Wang, WD; Jiang, TZ				Zuo, Nianming; Fang, Jiliang; Lv, Xueyu; Zhou, Yuan; Hong, Yang; Li, Tao; Tong, Haibing; Wang, Xiaoling; Wang, Weidong; Jiang, Tianzi			White Matter Abnormalities in Major Depression: A Tract-Based Spatial Statistics and Rumination Study	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; DIFFUSION-TENSOR; ELECTROCONVULSIVE-THERAPY; FUNCTIONAL NEUROANATOMY; BIPOLAR DISORDER; RTMS TREATMENT; CIRCUITS; ADULTS; BRAIN	Increasing evidence indicates that major depressive disorder (MDD) is usually accompanied by altered white matter in the prefrontal cortex, the parietal lobe and the limbic system. As a behavioral abnormity of MDD, rumination has been believed to be a substantial indicator of the mental state of the depressive state. So far, however, no report that we are aware of has evaluated the relationship between white matter alterations and the ruminative state. In this study, we first explored the altered white matter using a tract-based spatial statistics (TBSS) method based on diffusion tensor imaging of 19 healthy and 16 depressive subjects. We then investigated correlations between the altered white matter microstructure in the identified altered regions and the severity of ruminations measured by the ruminative response scale. Our results demonstrated altered white matter microstructure in circuits connecting the prefrontal lobe, the parietal lobe and the limbic system (p<0.005, uncorrected), findings which support previous research. More importantly, the result also indicated that a greater alteration in the white matter is associated with a more ruminative state (p<0.05, Bonferroni corrected). The detected abnormalities in the white matter should be interpreted cautiously because of the small sample size in this study. This finding supports the psychometric significance of white matter deficits in MDD.	[Zuo, Nianming; Jiang, Tianzi] Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, LIAMA Ctr Computat Med, Beijing, Peoples R China; [Fang, Jiliang; Hong, Yang; Tong, Haibing; Wang, Xiaoling] China Acad Chinese Med Sci, Guang An Men Hosp, Dept Radiol, Lab Funct Brain Imaging, Beijing, Peoples R China; [Lv, Xueyu; Li, Tao; Wang, Weidong] China Acad Chinese Med Sci, Guang An Men Hosp, Dept Psychol, Beijing, Peoples R China; [Zhou, Yuan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuroinformat, Minist Educ, Chengdu 610054, Peoples R China; [Jiang, Tianzi] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Chinese Academy of Sciences; Institute of Automation, CAS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Electronic Science & Technology of China; University of Queensland	Zuo, NM (corresponding author), Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, LIAMA Ctr Computat Med, Beijing, Peoples R China.	prof_wwd@126.com; jiangtz@nlpr.ia.ac.cn	Zhou, Yuan/AAI-6570-2021; Zhou, Yuan/N-5569-2017; Fang, Jiliang/AAE-5400-2020; Jiang, Tianzi/I-4256-2012	Zhou, Yuan/0000-0001-6378-1711; Zhou, Yuan/0000-0001-6378-1711; Jiang, Tianzi/0000-0001-9531-291X	Natural Science Foundation of China [81000634, 30772845, 30870668, 60831004]; National Institutes of Health/National Center for Complementary and Alternative Medicine, USA [F05 AT003022-01-04]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F05AT003022] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health/National Center for Complementary and Alternative Medicine, USA; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was partially supported by the Natural Science Foundation of China, Grant Nos. 81000634, 30772845, 30870668, 60831004, and National Institutes of Health/National Center for Complementary and Alternative Medicine (F05 AT003022-01-04), USA. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Bagby RM, 2004, COGNITIVE THER RES, V28, P527, DOI 10.1023/B:COTR.0000045562.17228.29; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bech P, 2002, ACTA PSYCHIAT SCAND, V106, P252, DOI 10.1034/j.1600-0447.2002.01404.x; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Blumberg HP, 2006, BIOL PSYCHIAT, V59, P611, DOI 10.1016/j.biopsych.2005.08.031; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Brunoni AR, 2010, ARQ NEURO-PSIQUIAT, V68, P433, DOI 10.1590/S0004-282X2010000300021; Cardoso EF, 2008, INT J NEUROPSYCHOPH, V11, P173, DOI 10.1017/S1461145707007961; Chan S, 2009, ARCH SUICIDE RES, V13, P123, DOI 10.1080/13811110902835015; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; Colloby SJ, 2011, J AFFECT DISORDERS, V135, P216, DOI 10.1016/j.jad.2011.07.025; Cullen KR, 2010, J AM ACAD CHILD PSY, V49, P173, DOI 10.1016/j.jaac.2009.11.005; Dalby RB, 2010, PSYCHIAT RES-NEUROIM, V184, P38, DOI 10.1016/j.pscychresns.2010.06.008; Dannlowski U, 2009, INT J NEUROPSYCHOPH, V12, P11, DOI 10.1017/S1461145708008973; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Farrow TFD, 2005, BIOL PSYCHIAT, V58, P713, DOI 10.1016/j.biopsych.2005.04.033; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Haber SN, 2000, J NEUROSCI, V20, P2369; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; Hooley JM, 2009, PSYCHIAT RES-NEUROIM, V171, P106, DOI 10.1016/j.pscychresns.2008.04.001; Huang H, 2011, NEUROPSYCHOPHARMACOL, V36, P684, DOI 10.1038/npp.2010.199; Jhanwar Venu Gopal, 2011, Indian J Psychol Med, V33, P92, DOI 10.4103/0253-7176.85406; Joormann J., 2005, COGNITIVE LIMITATION, P275, DOI [DOI 10.1017/CB09780511720413.012, 10.1017/CBO9780511720413.012]; Kieseppa T, 2010, J AFFECT DISORDERS, V120, P240, DOI 10.1016/j.jad.2009.04.023; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Kubicki M, 2003, BIOL PSYCHIAT, V54, P1171, DOI 10.1016/S0006-3223(03)00419-0; Ladouceur CD, 2012, DEV COGN NEUROS-NETH, V2, P36, DOI 10.1016/j.dcn.2011.06.002; Li LJ, 2007, BRAIN RES, V1168, P124, DOI 10.1016/j.brainres.2007.06.094; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Marchand WR, 2012, PROG NEURO-PSYCHOPH, V36, P290, DOI 10.1016/j.pnpbp.2011.10.016; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; McLaughlin KA, 2011, BEHAV RES THER, V49, P186, DOI 10.1016/j.brat.2010.12.006; Miranda R, 2007, BEHAV RES THER, V45, P3088, DOI 10.1016/j.brat.2007.07.015; Nobuhara K, 2004, NEUROPSYCHOBIOLOGY, V50, P48, DOI 10.1159/000077941; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; Nofzinger EA, 2004, ARCH GEN PSYCHIAT, V61, P695, DOI 10.1001/archpsyc.61.7.695; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Oudega ML, 2011, J CLIN PSYCHIAT, V72, P104, DOI 10.4088/JCP.08m04989blu; Peng HJ, 2012, J AFFECT DISORDERS, V136, P249, DOI 10.1016/j.jad.2011.12.006; Purves D, 2004, NEUROSCIENCE, P773; Reetz K, 2008, BIOL PSYCHIAT, V64, P241, DOI 10.1016/j.biopsych.2007.12.010; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schneider B, 2011, PROG NEUROBIOL, V95, P703, DOI 10.1016/j.pneurobio.2011.08.001; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Shimony JS, 2009, BIOL PSYCHIAT, V66, P245, DOI 10.1016/j.biopsych.2009.02.032; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Taylor Warren D, 2007, Neuropsychiatr Dis Treat, V3, P669; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Thompson RJ, 2010, BEHAV RES THER, V48, P459, DOI 10.1016/j.brat.2010.01.007; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Versace A, 2008, ARCH GEN PSYCHIAT, V65, P1041, DOI 10.1001/archpsyc.65.9.1041; Wall CA, 2011, J CLIN PSYCHIAT, V72, P1263, DOI 10.4088/JCP.11m07003; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wu F, 2011, PSYCHIAT RES-NEUROIM, V191, P80, DOI 10.1016/j.pscychresns.2010.09.002; [杨娟 YANG Juan], 2009, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V17, P27; Zhu XL, 2011, BRAIN RES, V1369, P223, DOI 10.1016/j.brainres.2010.10.104; Zou K, 2008, J PSYCHIATR NEUROSCI, V33, P525	72	53	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37561	10.1371/journal.pone.0037561	http://dx.doi.org/10.1371/journal.pone.0037561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666366	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400033
J	Brink, DL; Gilbert, M; Xie, XJ; Petley-Ragan, L; Auld, VJ				Brink, Deidre L.; Gilbert, Mary; Xie, Xiaojun; Petley-Ragan, Lindsay; Auld, Vanessa J.			Glial Processes at the Drosophila Larval Neuromuscular Junction Match Synaptic Growth	PLOS ONE			English	Article							BLOOD-NERVE BARRIER; SEPTATE JUNCTION; PERIPHERAL GLIA; IN-VIVO; ELECTRICAL-ACTIVITY; FASCICLIN-II; SYSTEM; CELLS; PLASTICITY; AXONS	Glia are integral participants in synaptic physiology, remodeling and maturation from blowflies to humans, yet how glial structure is coordinated with synaptic growth is unknown. To investigate the dynamics of glial development at the Drosophila larval neuromuscular junction (NMJ), we developed a live imaging system to establish the relationship between glia, neuronal boutons, and the muscle subsynaptic reticulum. Using this system we observed processes from two classes of peripheral glia present at the NMJ. Processes from the subperineurial glia formed a blood-nerve barrier around the axon proximal to the first bouton. Processes from the perineurial glial extended beyond the end of the blood-nerve barrier into the NMJ where they contacted synapses and extended across non-synaptic muscle. Growth of the glial processes was coordinated with NMJ growth and synaptic activity. Increasing synaptic size through elevated temperature or the highwire mutation increased the extent of glial processes at the NMJ and conversely blocking synaptic activity and size decreased the presence and size of glial processes. We found that elevated temperature was required during embryogenesis in order to increase glial expansion at the nmj. Therefore, in our live imaging system, glial processes at the NMJ are likely indirectly regulated by synaptic changes to ensure the coordinated growth of all components of the tripartite larval NMJ.	[Brink, Deidre L.; Gilbert, Mary; Xie, Xiaojun; Petley-Ragan, Lindsay; Auld, Vanessa J.] Univ British Columbia, Inst Life Sci, Dept Zool Cell & Dev Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Brink, DL (corresponding author), Univ British Columbia, Inst Life Sci, Dept Zool Cell & Dev Biol, Vancouver, BC V5Z 1M9, Canada.	auld@zoology.ubc.ca		Petley-Ragan, Lindsay/0000-0001-5316-7267; Auld, Vanessa/0000-0003-3976-9186	Canadian Institute of Health Research [MOP-82862]; Natural Sciences and Engineering Research Council [RGPIN 227814-06]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funded by Canadian Institute of Health Research (MOP-82862) and Natural Sciences and Engineering Research Council RGPIN 227814-06 http://www.nserc-crsng.gc.ca/Index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brink Dee, 2009, J Vis Exp, DOI 10.3791/1154; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Danjo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017131; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Georgiou J, 1999, J NEUROSCI, V19, P3836; GORCZYCA MG, 1991, J NEUROBIOL, V22, P391, DOI 10.1002/neu.480220407; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hartenstein V, 2011, GLIA, V59, P1237, DOI 10.1002/glia.21162; Huang YM, 2002, J NEUROSCI, V22, P1698, DOI 10.1523/JNEUROSCI.22-05-01698.2002; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Keller LC, 2011, NEURON, V72, P760, DOI 10.1016/j.neuron.2011.09.031; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; Lavery W, 2007, J NEUROSCI, V27, P279, DOI 10.1523/JNEUROSCI.3370-06.2007; Lnenicka GA, 2003, J NEUROBIOL, V54, P337, DOI 10.1002/neu.10133; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Macleod GT, 2004, J NEUROSCI, V24, P2496, DOI 10.1523/JNEUROSCI.5372-03.2004; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024; Rival T, 2006, J NEUROBIOL, V66, P1061, DOI 10.1002/neu.20270; ROBITAILLE R, 1995, J NEUROSCI, V15, P7121; Rochon D, 2001, J NEUROSCI, V21, P3819, DOI 10.1523/JNEUROSCI.21-11-03819.2001; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Schulte J, 2003, J CELL BIOL, V161, P991, DOI 10.1083/jcb.200303192; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Shieh BH, 1997, P NATL ACAD SCI USA, V94, P12682, DOI 10.1073/pnas.94.23.12682; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; SOKOLOWSKI MB, 1984, ANIM BEHAV, V32, P645, DOI 10.1016/S0003-3472(84)80139-6; SONNENFELD MJ, 1995, J COMP NEUROL, V359, P644, DOI 10.1002/cne.903590410; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Todd KJ, 2007, EUR J NEUROSCI, V25, P1287, DOI 10.1111/j.1460-9568.2007.05385.x; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Xie XJ, 2011, DEVELOPMENT, V138, P3813, DOI 10.1242/dev.064816; Yager J, 2001, P NATL ACAD SCI USA, V98, P10445, DOI 10.1073/pnas.191107698; Zhong Y, 2004, J NEUROSCI, V24, P1439, DOI 10.1523/JNEUROSCI.0740-02.2004; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	62	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37876	10.1371/journal.pone.0037876	http://dx.doi.org/10.1371/journal.pone.0037876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666403	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600035
J	Marta-Almeida, M; Reboreda, R; Rocha, C; Dubert, J; Nolasco, R; Cordeiro, N; Luna, T; Rocha, A; Silva, JDLE; Queiroga, H; Peliz, A; Ruiz-Villarreal, M				Marta-Almeida, Martinho; Reboreda, Rosa; Rocha, Carlos; Dubert, Jesus; Nolasco, Rita; Cordeiro, Nuno; Luna, Tiago; Rocha, Alfredo; Lencart e Silva, Joao D.; Queiroga, Henrique; Peliz, Alvaro; Ruiz-Villarreal, Manuel			Towards Operational Modeling and Forecasting of the Iberian Shelves Ecosystem	PLOS ONE			English	Article							CONTINENTAL-SHELF; NORTHWEST IBERIA; OCEAN MODEL; CRAB LARVAE; SYSTEM; COASTAL; CLIMATOLOGY; DISPERSAL; BOUNDARY; DYNAMICS	There is a growing interest on physical and biogeochemical oceanic hindcasts and forecasts from a wide range of users and businesses. In this contribution we present an operational biogeochemical forecast system for the Portuguese and Galician oceanographic regions, where atmospheric, hydrodynamic and biogeochemical variables are integrated. The ocean model ROMS, with a horizontal resolution of 3 km, is forced by the atmospheric model WRF and includes a Nutrients-Phytoplankton-Zooplankton-Detritus biogeochemical module (NPZD). In addition to oceanographic variables, the system predicts the concentration of nitrate, phytoplankton, zooplankton and detritus (mmol N m(-3)). Model results are compared against radar currents and remote sensed SST and chlorophyll. Quantitative skill assessment during a summer upwelling period shows that our modelling system adequately represents the surface circulation over the shelf including the observed spatial variability and trends of temperature and chlorophyll concentration. Additionally, the skill assessment also shows some deficiencies like the overestimation of upwelling circulation and consequently, of the duration and intensity of the phytoplankton blooms. These and other departures from the observations are discussed, their origins identified and future improvements suggested. The forecast system is the first of its kind in the region and provides free online distribution of model input and output, as well as comparisons of model results with satellite imagery for qualitative operational assessment of model skill.	[Marta-Almeida, Martinho; Reboreda, Rosa; Rocha, Carlos; Dubert, Jesus; Nolasco, Rita; Cordeiro, Nuno; Rocha, Alfredo; Lencart e Silva, Joao D.] Univ Aveiro, CESAM Dep Fis, P-3800 Aveiro, Portugal; [Luna, Tiago] Univ Aveiro, Inst Ambiente & Desenvolvimento, P-3800 Aveiro, Portugal; [Queiroga, Henrique] Univ Aveiro, CESAM Dep Biol, P-3800 Aveiro, Portugal; [Peliz, Alvaro] Univ Lisbon, Ctr Oceanog, P-1699 Lisbon, Portugal; [Ruiz-Villarreal, Manuel] Ctr Oceanog A Coruna, Inst Espanol Oceanog, Galicia, Spain	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Lisboa; Spanish Institute of Oceanography	Marta-Almeida, M (corresponding author), Univ Aveiro, CESAM Dep Fis, P-3800 Aveiro, Portugal.	mma@ua.pt	Reboreda, Rosa/AAT-5876-2021; Marta-Almeida, Martinho/C-1715-2008; Rocha, Alfredo/E-1201-2011; Dubert, Jesus/B-7517-2008; Nolasco, Rita TS/D-1809-2019; Queiroga, Henrique/C-5134-2008; Ruiz-Villarreal, Manuel/F-3389-2010; Lencart e Silva, João D./B-3513-2011; Ramírez, Sergio/J-8073-2014; Dubert, Jesus/B-2803-2009; Peliz, Alvaro/C-8154-2009; Cordeiro, Nuno/D-5185-2019	Marta-Almeida, Martinho/0000-0001-8214-3096; Rocha, Alfredo/0000-0003-4940-6522; Queiroga, Henrique/0000-0002-2338-0013; Ruiz-Villarreal, Manuel/0000-0003-0169-0958; Lencart e Silva, João D./0000-0001-8237-6981; Dubert, Jesus/0000-0002-3338-6777; Peliz, Alvaro/0000-0003-1649-5151; Cordeiro, Nuno/0000-0001-8239-4020; nolasco, maria rita/0000-0003-1942-8800	project RAIA; Programa Operativo de Cooperacion Transfronteriza Espasimilar toa-Portugal, POCTEP [0313-RAIA-1-E]; FCT [SFRH/BD/33388/2008]	project RAIA; Programa Operativo de Cooperacion Transfronteriza Espasimilar toa-Portugal, POCTEP; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors CR and NC are supported by project RAIA funded by Programa Operativo de Cooperacion Transfronteriza Espa similar to a-Portugal, POCTEP 2007-2013 (0313-RAIA-1-E). R.Reboreda is supported by the FCT grant SFRH/BD/33388/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JI, 2007, J MARINE SYST, V68, P381, DOI 10.1016/j.jmarsys.2007.01.005; Barth A, 2008, CONT SHELF RES, V28, P561, DOI 10.1016/j.csr.2007.11.004; Berx B, 2011, OCEANOGRAPHY, V24, P166, DOI 10.5670/oceanog.2011.14; Borja A, 2005, CONT SHELF RES, V25, P1768, DOI 10.1016/j.csr.2005.05.004; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Brachet G, 2004, SPACE POLICY, V20, P7, DOI 10.1016/j.spacepol.2003.11.002; Capet XJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020123; Cornillon P, 2009, OCEANOGRAPHY, V22, P116, DOI 10.5670/oceanog.2009.43; da Silva A.M., 1994, ATLAS SURFACE MARINE, V6; Dufois F, 2012, OCEAN MODEL, V47, P113, DOI 10.1016/j.ocemod.2012.01.007; FASHAM MJR, 1990, J MAR RES, V48, P591, DOI 10.1357/002224090784984678; Ferreira APGF, 2007, SENSIBILIDADE PARAME; Ferreira J.G., 2003, TRANSITIONAL COASTAL; Garcia H. E., 2006, WORLD OCEAN ATLAS 20; Geider RJ, 1997, MAR ECOL PROG SER, V148, P187, DOI 10.3354/meps148187; Gruber N, 2006, DEEP-SEA RES PT I, V53, P1483, DOI 10.1016/j.dsr.2006.06.005; Haidvogel DB, 2008, J COMPUT PHYS, V227, P3595, DOI 10.1016/j.jcp.2007.06.016; Jolliff JK, 2009, J MARINE SYST, V76, P64, DOI 10.1016/j.jmarsys.2008.05.014; Kone V, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002427; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Lazzari P, 2010, OCEAN SCI, V6, P25, DOI 10.5194/os-6-25-2010; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Levitus S., 1994, WORLD OCEAN ATLAS 19, V3; Marta-Almeida M, 2006, MAR ECOL PROG SER, V307, P1, DOI 10.3354/meps307001; Marta-Almeida M, 2011, J OPER OCEANOGR, V4, P3, DOI 10.1080/1755876X.2011.11020123; Marta-Almeida M, 2008, CAN J FISH AQUAT SCI, V65, P2253, DOI 10.1139/F08-138; Marta-Almeida M, 2011, ENVIRON MODELL SOFTW, V26, P680, DOI 10.1016/j.envsoft.2010.11.015; National Oceanic and Atmospheric Administration, 2003, GFS ATM MOD; Neumann T, 2000, J MARINE SYST, V25, P405, DOI 10.1016/S0924-7963(00)00030-0; Otero P, 2008, J MARINE SYST, V72, P238, DOI 10.1016/j.jmarsys.2007.05.016; Otero P, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004740; Otero P, 2009, ICES J MAR SCI, V66, P1853, DOI 10.1093/icesjms/fsp156; Otero P., 2011, OCEANS 2011, DOI [10.1109/Oceans-Spain.2011.6003564, DOI 10.1109/OCEANS-SPAIN.2011.6003564]; Otero P, 2010, SCI MAR, V74, P247, DOI 10.3989/scimar.2010.74n2247; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Peliz A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004159; Peliz A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004771; Penven P, 2006, OCEAN MODEL, V12, P157, DOI 10.1016/j.ocemod.2005.05.002; Pinardi N., 2002, OCEAN FORECASTING CO; Ruiz-Villarreal M, 2006, EUROPEAN OPERATIONAL, P342; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Siddorn JR, 2007, J MARINE SYST, V65, P417, DOI 10.1016/j.jmarsys.2006.01.018; Signell RP, 2008, J MARINE SYST, V69, P154, DOI 10.1016/j.jmarsys.2007.02.013; Silva PA, 2007, J COASTAL RES, V29, P1622; Skamarock W.C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Sotillo MG, 2008, MAR POLLUT BULL, V56, P686, DOI 10.1016/j.marpolbul.2007.12.021; Teruzzi A, 2011, MERCATOR OCEAN NEWSL, V40; WOOSTER WS, 1976, J MAR RES, V34, P131; Zhang X, 2012, J OPER OCEANOGR, V5, P19, DOI 10.1080/1755876X.2012.11020129	49	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37343	10.1371/journal.pone.0037343	http://dx.doi.org/10.1371/journal.pone.0037343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666349	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600013
J	Rasila, TS; Vihinen, M; Paulin, L; Haapa-Paananen, S; Savilahti, H				Rasila, Tiina S.; Vihinen, Mauno; Paulin, Lars; Haapa-Paananen, Saija; Savilahti, Harri			Flexibility in MuA Transposase Family Protein Structures: Functional Mapping with Scanning Mutagenesis and Sequence Alignment of Protein Homologues	PLOS ONE			English	Article							IN-VITRO TRANSPOSITION; DNA-BINDING DOMAIN; PHAGE-MU; BACTERIOPHAGE-MU; STRAND TRANSFER; MOLECULAR-BIOLOGY; RIBONUCLEASE-H; STRATEGY; EFFICIENT; RECOMBINATION	MuA transposase protein is a member of the retroviral integrase superfamily (RISF). It catalyzes DNA cleavage and joining reactions via an initial assembly and subsequent structural transitions of a protein-DNA complex, known as the Mu transpososome, ultimately attaching transposon DNA to non-specific target DNA. The transpososome functions as a molecular DNA-modifying machine and has been used in a wide variety of molecular biology and genetics/genomics applications. To analyze structure-function relationships in MuA action, a comprehensive pentapeptide insertion mutagenesis was carried out for the protein. A total of 233 unique insertion variants were generated, and their activity was analyzed using a quantitative in vivo DNA transposition assay. The results were then correlated with the known MuA structures, and the data were evaluated with regard to the protein domain function and transpososome development. To complement the analysis with an evolutionary component, a protein sequence alignment was produced for 44 members of MuA family transposases. Altogether, the results pinpointed those regions, in which insertions can be tolerated, and those where insertions are harmful. Most insertions within the subdomains I gamma, II alpha, II beta, and III alpha completely destroyed the transposase function, yet insertions into certain loop/linker regions of these subdomains increased the protein activity. Subdomains I alpha and III beta were largely insertion-tolerant. The comprehensive structure-function data set will be useful for designing MuA transposase variants with improved properties for biotechnology/genomics applications, and is informative with regard to the function of RISF proteins in general.	[Rasila, Tiina S.; Paulin, Lars; Haapa-Paananen, Saija; Savilahti, Harri] Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland; [Vihinen, Mauno] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Vihinen, Mauno] BioMediTech, Tampere, Finland; [Vihinen, Mauno] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Savilahti, Harri] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland	University of Helsinki; Tampere University; Lund University; University of Turku	Rasila, TS (corresponding author), Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland.	harri.savilahti@utu.fi	Vihinen, Mauno/A-8452-2012	Vihinen, Mauno/0000-0002-9614-7976; Savilahti, Harri/0000-0002-6246-2572	Academy of Finland; Finnish National Technology Agency (TEKES); Biocenter Finland; Medical Reseach Fund of Tampere University Hospital; Sigrid Juselius Foundation; Finnish Cultural Foundation; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Finnish National Technology Agency (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES)); Biocenter Finland; Medical Reseach Fund of Tampere University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Emil Aaltonen Foundation	This study has been funded by the Academy of Finland, Finnish National Technology Agency (TEKES), Biocenter Finland, Medical Reseach Fund of Tampere University Hospital, Sigrid Juselius Foundation, Finnish Cultural Foundation, and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhverdyan VZ, 2011, APPL MICROBIOL BIOT, V91, P857, DOI 10.1007/s00253-011-3416-y; Aldaz H, 1996, CELL, V85, P257, DOI 10.1016/S0092-8674(00)81102-2; BAKER TA, 1992, GENE DEV, V6, P2221, DOI 10.1101/gad.6.11.2221; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; BAKER TA, 1994, P NATL ACAD SCI USA, V91, P6654, DOI 10.1073/pnas.91.14.6654; BAKER TA, 1991, CELL, V65, P1003, DOI 10.1016/0092-8674(91)90552-A; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boeke JD, 2002, MOBILE DNA, P24; Brady T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr140; Chaconas George, 2002, P384; Choi W, 2010, P NATL ACAD SCI USA, V107, P10014, DOI 10.1073/pnas.0912615107; CLUBB RT, 1994, STRUCTURE, V2, P1041, DOI 10.1016/S0969-2126(94)00107-3; Clubb RT, 1997, J MOL BIOL, V273, P19, DOI 10.1006/jmbi.1997.1312; Craig NL, 2002, MOBILE DNA 2; CRAIGIE R, 1987, CELL, V51, P493, DOI 10.1016/0092-8674(87)90645-3; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Goldhaber-Gordon I, 2002, J BIOL CHEM, V277, P7703, DOI 10.1074/jbc.M110342200; Goldhaber-Gordon I, 2002, J BIOL CHEM, V277, P7694, DOI 10.1074/jbc.M110341200; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Gronholm M, 2006, ONCOGENE, V25, P4389, DOI 10.1038/sj.onc.1209475; Haapa S, 1999, NUCLEIC ACIDS RES, V27, P2777, DOI 10.1093/nar/27.13.2777; Haapa S, 1999, GENOME RES, V9, P308; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; HARSHEY RM, 1986, J GENET, V65, P159, DOI 10.1007/BF02931149; Hayes F, 2003, ANNU REV GENET, V37, P3, DOI 10.1146/annurev.genet.37.110801.142807; HOWE MM, 1975, SCIENCE, V190, P624, DOI 10.1126/science.1103291; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim YC, 2009, J MOL MICROB BIOTECH, V17, P30, DOI 10.1159/000178019; Krementsova E, 1998, J BIOL CHEM, V273, P31358, DOI 10.1074/jbc.273.47.31358; Krupovic M, 2006, J VIROL, V80, P9270, DOI 10.1128/JVI.00536-06; Lamberg A, 2002, APPL ENVIRON MICROB, V68, P705, DOI 10.1128/AEM.68.2.705-712.2002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; LEUNG PC, 1989, NATURE, V338, P656, DOI 10.1038/338656a0; LEUNG PC, 1991, J MOL BIOL, V219, P189, DOI 10.1016/0022-2836(91)90561-J; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; MIZUUCHI K, 1983, CELL, V35, P785, DOI 10.1016/0092-8674(83)90111-3; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; MIZUUCHI M, 1989, CELL, V58, P399, DOI 10.1016/0092-8674(89)90854-4; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; NAKAYAMA C, 1987, P NATL ACAD SCI USA, V84, P1809, DOI 10.1073/pnas.84.7.1809; Nesmelova IV, 2010, ADV DRUG DELIVER REV, V62, P1187, DOI 10.1016/j.addr.2010.06.006; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Orsini L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm070; Paatero AO, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn801; Pajunen M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm563; Pajunen MI, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-24; Pajunen MI, 2005, MICROBIOL-SGM, V151, P1209, DOI 10.1099/mic.0.27807-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petyuk V, 2004, J BIOL CHEM, V279, P37040, DOI 10.1074/jbc.M406042200; Poussu E, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni102; Poussu E, 2004, PROTEINS, V54, P681, DOI 10.1002/prot.10467; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Rice P, 1996, CURR OPIN STRUC BIOL, V6, P76, DOI 10.1016/S0959-440X(96)80098-4; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Saariaho AH, 2005, VIROLOGY, V331, P6, DOI 10.1016/j.virol.2004.09.041; Saarlaho AH, 2006, NUCLEIC ACIDS RES, V34, P3139, DOI 10.1093/nar/gkl405; Sambrook J., 2001, MOL CLONING LAB MANU; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; Schumacher S, 1997, EMBO J, V16, P7532, DOI 10.1093/emboj/16.24.7532; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; Tanaka Y, 2001, EMBO J, V20, P6612, DOI 10.1093/emboj/20.23.6612; Vilen H, 2003, J VIROL, V77, P123, DOI 10.1128/JVI.77.1.123-134.2003; von Nandelstadh P, 2005, EXP CELL RES, V310, P131, DOI 10.1016/j.yexcr.2005.06.027; Weber M, 2010, MOL BIOL CELL, V21, P1362, DOI 10.1091/mbc.E09-07-0546; WU ZG, 1995, EMBO J, V14, P3835, DOI 10.1002/j.1460-2075.1995.tb00053.x; WU ZG, 1992, J BIOL CHEM, V267, P9552; Yang JY, 1996, CELL, V85, P447, DOI 10.1016/S0092-8674(00)81122-8; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Yuan JF, 2005, GENE DEV, V19, P840, DOI 10.1101/gad.1291405; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	84	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37922	10.1371/journal.pone.0037922	http://dx.doi.org/10.1371/journal.pone.0037922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666413	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600042
J	Zhang, Y; Wang, MY; He, J; Wang, JC; Yang, YJ; Jin, L; Chen, ZY; Ma, XJ; Sun, MH; Xia, KQ; Hong, XN; Wei, QY; Zhou, XY				Zhang, Yan; Wang, Meng-Yun; He, Jing; Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li; Chen, Zhi-Yu; Ma, Xue-Jun; Sun, Meng-Hong; Xia, Kai-Qin; Hong, Xiao-Nan; Wei, Qing-Yi; Zhou, Xiao-Yan			Tumor Necrosis Factor-alpha Induced Protein 8 Polymorphism and Risk of Non-Hodgkin's Lymphoma in a Chinese Population: A Case-Control Study	PLOS ONE			English	Article							COMMON GENETIC-VARIANTS; DEATH EFFECTOR DOMAIN; BODY-MASS INDEX; FACTOR TNF; SCC-S2; SUSCEPTIBILITY; IDENTIFICATION; INFLAMMATION; FREQUENCIES; METASTASIS	Background: Non-Hodgkin's lymphoma (NHL) has been reported to be associated with autoimmune and pro-inflammatory response, and genetic polymorphisms of candidate genes involved in autoimmune and pro-inflammatory response may influence the susceptibility to NHL. To evaluate the role of such genetic variations in risk of NHL, we conducted a case-control study of 514 NHL patients and 557 cancer-free controls in a Chinese population. Method: We used the Taqman assay to genotype six potentially functional single nucleotide polymorphisms (SNPs) in six previously reported inflammation and immune-related genes (TNF rs1799964T>C, LTA rs1800683G>A, IL-10 rs1800872T>G, LEP rs2167270G>A, LEPR rs1327118C>G, TNFAIP8 rs1045241C>T). Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (95% CI). Results: We observed a significantly increased risk of NHL associated with the TNFAIP8 rs1045241C>T polymorphism (adjusted OR = 3.03; 95% CI = 1.68-5.45 for TT vs. CC and adjusted OR = 2.03; 95% CI = 1.53-2.69 for CT/TT vs. CC). The risk associated with the T allele was more evident in subgroups of 40-60 year-old, non-smokers or light-smokers (less than 25 pack-years), and subjects with normal weight or overweight. Risk for both B and T cell non-Hodgkin's lymphoma was elevated for CT/TT genotypes (adjusted OR = 1.95, 95% CI = 1.41-2.70 for B cell NHL and adjusted OR = 2.22, 95% CI = 1.49-3.30 for T cell NHL), particularly for DLBCL (adjusted OR = 2.01, 95% CI = 1.41-2.85) and FL (adjusted OR = 2.53, 95% CI = 1.17-5.45). These risks were not observed for variant genotypes of other five SNPs compared with their common homozygous genotypes. Conclusions: The polymorphism of TNFAIP8 rs1045241C>T may contribute to NHL susceptibility in a Chinese population. Further large-scale and well-designed studies are needed to confirm these results.	[Zhang, Yan; Chen, Zhi-Yu; Hong, Xiao-Nan] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Zhang, Yan; Wang, Meng-Yun; He, Jing; Chen, Zhi-Yu; Ma, Xue-Jun; Sun, Meng-Hong; Xia, Kai-Qin; Hong, Xiao-Nan; Zhou, Xiao-Yan] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Wang, Meng-Yun; He, Jing; Xia, Kai-Qin; Wei, Qing-Yi; Zhou, Xiao-Yan] Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China; [Ma, Xue-Jun] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Sun, Meng-Hong; Xia, Kai-Qin; Zhou, Xiao-Yan] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Wei, Qing-Yi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Zhang, Y (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China.	xnhong@126.com; xyzhou100@yahoo.com	Zhang, Yong/H-1774-2012; Zhang, Yiming/HGB-7344-2022; Jin, Li/C-1468-2009; Zhang, Yufeng/GZL-1973-2022; Wang, Jiucun/J-8744-2012; He, Jing/M-5774-2015; Jin, Li/M-5063-2019	Zhang, Yong/0000-0002-5831-637X; Jin, Li/0000-0002-4546-2415; Wang, Jiucun/0000-0003-2765-0620; He, Jing/0000-0002-1954-2892; 	National Natural Science Foundation of China [30870985, 30973391]; Ministry of Health [201002007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health	This study was supported by the funding from National Natural Science Foundation of China (30870985, 30973391) and the Ministry of Health (201002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V50, P265; Chen Y, 2010, BLOOD, V117, P585; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; Dong QZ, 2010, CANCER SCI, V101, P1562, DOI 10.1111/j.1349-7006.2010.01557.x; Fernberg P, 2010, CANCER CAUSE CONTROL, V21, P759, DOI 10.1007/s10552-010-9504-y; Freundt EC, 2008, CELL, V133, P401, DOI 10.1016/j.cell.2008.04.017; Hadisaputri YE, 2011, ANN SURG ONCOLOGY; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Kumar D, 2000, J BIOL CHEM, V275, P2973, DOI 10.1074/jbc.275.4.2973; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Lan Q, 2011, BRIT J HAEMATOL, V153, P341, DOI 10.1111/j.1365-2141.2010.08424.x; Larsson SC, 2007, INT J CANCER, V121, P1564, DOI 10.1002/ijc.22762; Li AN, 2010, MOL GENET GENOMICS, V284, P185, DOI 10.1007/s00438-010-0558-z; Li X, 2011, ANN ONCOL, V22, P141; Liang XY, 2009, BRIT J HAEMATOL, V146, P418, DOI 10.1111/j.1365-2141.2009.07790.x; Lou Y, 2011, MOL IMMUNOLOGY; Patel S, 1997, ORAL ONCOL, V33, P197, DOI 10.1016/S0964-1955(96)00065-6; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Skibola CF, 2010, AM J EPIDEMIOL, V171, P267, DOI 10.1093/aje/kwp383; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Wang SS, 2007, CANCER RES, V67, P5042, DOI 10.1158/0008-5472.CAN-06-4752; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Willett EV, 2005, BRIT J CANCER, V93, P811, DOI 10.1038/sj.bjc.6602762; Xi WJ, 2011, MOL IMMUNOL, V48, P1203, DOI 10.1016/j.molimm.2011.03.002; Xiao H, 2011, ANN HEMATOL, V90, P725, DOI 10.1007/s00277-010-1079-x; You ZB, 2001, J BIOL CHEM, V276, P26398, DOI 10.1074/jbc.M102464200; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhang SY, 2010, BBA-MOL BASIS DIS, V1802, P1078, DOI 10.1016/j.bbadis.2010.08.003; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	36	42	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37846	10.1371/journal.pone.0037846	http://dx.doi.org/10.1371/journal.pone.0037846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666399	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600033
J	Mrak, LN; Zielinska, AK; Beenken, KE; Mrak, IN; Atwood, DN; Griffin, LM; Lee, CY; Smeltzer, MS				Mrak, Lara N.; Zielinska, Agnieszka K.; Beenken, Karen E.; Mrak, Ian N.; Atwood, Danielle N.; Griffin, Linda M.; Lee, Chia Y.; Smeltzer, Mark S.			saeRS and sarA Act Synergistically to Repress Protease Production and Promote Biofilm Formation in Staphylococcus aureus	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; EXTRACELLULAR PROTEASES; MUTANTS; PHENOTYPE; AGR; OSTEOMYELITIS; INFECTION; SYSTEM; IMPACT	Mutation of the staphylococcal accessory regulator (sarA) limits biofilm formation in diverse strains of Staphylococcus aureus, but there are exceptions. One of these is the commonly studied strain Newman. This strain has two defects of potential relevance, the first being mutations that preclude anchoring of the fibronectin-binding proteins FnbA and FnbB to the cell wall, and the second being a point mutation in saeS that results in constitutive activation of the saePQRS regulatory system. We repaired these defects to determine whether either plays a role in biofilm formation and, if so, whether this could account for the reduced impact of sarA in Newman. Restoration of surface-anchored FnbA enhanced biofilm formation, but mutation of sarA in this fnbA-positive strain increased rather than decreased biofilm formation. Mutation of sarA in an saeS-repaired derivative of Newman (P18L) or a Newman saeRS mutant (Delta saeRS) resulted in a biofilm-deficient phenotype like that observed in clinical isolates, even in the absence of surface-anchored FnbA. These phenotypes were correlated with increased production of extracellular proteases and decreased accumulation of FnbA and/or Spa in the P18L and Delta saeRS sarA mutants by comparison to the Newman sarA mutant. The reduced accumulation of Spa was reversed by mutation of the gene encoding aureolysin, while the reduced accumulation of FnbA was reversed by mutation of the sspABC operon. These results demonstrate that saeRS and sarA act synergistically to repress the production of extracellular proteases that would otherwise limit accumulation of critical proteins that contribute to biofilm formation, with constitutive activation of saeRS limiting protease production, even in a sarA mutant, to a degree that can be correlated with increased enhanced capacity to form a biofilm. Although it remains unclear whether these effects are mediated directly or indirectly, studies done with an sspA:: lux reporter suggest they are mediated at a transcriptional level.	[Mrak, Lara N.; Zielinska, Agnieszka K.; Beenken, Karen E.; Mrak, Ian N.; Atwood, Danielle N.; Griffin, Linda M.; Lee, Chia Y.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Mrak, LN (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	smeltzermarks@uams.edu	Smeltzer, Mark/M-2009-2018	Smeltzer, Mark/0000-0002-0878-0692	NIAID [RO1-AI074935]; Clinical and Translational Sciences Award [RR0298884]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074935, R01AI067857] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Clinical and Translational Sciences Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID grant RO1-AI074935 to MSS. Support was also obtained from resources provided through the Clinical and Translational Sciences Award (RR0298884) to the University of Arkansas for Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Beenken KE, 2012, INFECT IMMUN; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Blevins JS, 1999, MOL MICROBIOL, V33, P317, DOI 10.1046/j.1365-2958.1999.01475.x; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Casillas-Ituarte NN, 2012, J BIOL CHEM, V287, P6693, DOI 10.1074/jbc.M111.285692; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Cierny G, 2011, PLAST RECONSTR SURG, V127, p190S, DOI 10.1097/PRS.0b013e3182025070; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Lou Q, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-146; Luong TT, 2011, J BACTERIOL, V193, P686, DOI 10.1128/JB.00987-10; Mainiero M, 2010, J BACTERIOL, V192, P613, DOI 10.1128/JB.01242-09; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Nagarajan V, 2009, FEMS MICROBIOL LETT, V295, P204, DOI 10.1111/j.1574-6968.2009.01595.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Schafer D, 2009, J BACTERIOL, V191, P7306, DOI 10.1128/JB.00630-09; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P4096, DOI 10.1128/AAC.00484-09; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P2475, DOI 10.1128/AAC.01432-08; Yarwood JA, 2007, J BACTERIOL, V189, P7961, DOI 10.1128/JB.00789-07; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	35	61	63	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38453	10.1371/journal.pone.0038453	http://dx.doi.org/10.1371/journal.pone.0038453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685571	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700034
J	Tian, LC; Lei, B; Shao, J; Wei, L; Kijlstra, A; Yang, PZ				Tian, Lichun; Lei, Bo; Shao, Ju; Wei, Lin; Kijlstra, Aize; Yang, Peizeng			AAV2-Mediated Combined Subretinal Delivery of IFN-alpha and IL-4 Reduces the Severity of Experimental Autoimmune Uveoretinitis	PLOS ONE			English	Article							REGULATORY T-CELLS; ADENOASSOCIATED VIRUS; GENE-TRANSFER; THERAPY; UVEITIS; RECEPTOR; CYTOKINES; PREVENTS; EFFICACY; SAFETY	We previously showed that adeno-associated virus 2 (AAV2) mediated subretinal delivery of human interferon-alpha (IFN-alpha) could effectively inhibit experimental autoimmune uveoretinitis (EAU). In this study we investigated whether subretinal injection of both AVV2. IFN-alpha and AAV2. IL-4 had a stronger inhibition on EAU activity. B10RIII mice were subretinally injected with AAV2. IFN-alpha alone (1.5x10(7) vg), AAV2. IL-4 alone (3.55x10(7) vg), and AAV2. IFN-alpha combined with AAV2. IL-4. PBS, AAV2 vector encoding green fluorescent protein (AAV2. GFP) (5x10(7) vg) was subretinally injected as a control. IFN-alpha and IL-4 were effectively expressed in the eyes from three weeks to three months following subretinal injection of AAV2 vectors either alone or following combined administration and significantly attenuated EAU activity clinically and histopathologically. AAV2. IL-4 showed a better therapeutic effect as compared to AAV2. IFN-alpha. The combination of AAV2. IL-4 and AAV2. IFN-alpha was not significantly different as compared to AAV2. IL-4 alone. There was no difference concerning DTH (delayed-type hypersensitivity) reaction, lymphocyte proliferation and IL-17 production among the investigated treatment groups, suggesting that local retinal gene delivery did not affect the systemic immune response.	[Tian, Lichun; Lei, Bo; Shao, Ju; Wei, Lin; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Tian, Lichun; Lei, Bo; Shao, Ju; Wei, Lin; Yang, Peizeng] Chongqing Eye Inst, Chongqing, Peoples R China; [Tian, Lichun] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Eye Res Inst Maastricht, Dept Ophthalmol, Maastricht, Netherlands	Chongqing Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013	Lei, Bo/0000-0002-5497-0905	Key Project of Medical Science and Technology of Chongqing; Key Project of Health Bureau of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Natural Science Foundation Major International (Regional) Joint Research Project [30910103912]; National Natural Science Foundation Project [30973242]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; PAR-EU Scholars Program	Key Project of Medical Science and Technology of Chongqing; Key Project of Health Bureau of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Natural Science Foundation Major International (Regional) Joint Research Project; National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; PAR-EU Scholars Program	This study was supported by the funds of Key Project of Medical Science and Technology of Chongqing, Key Project of Health Bureau of Chongqing, Chongqing Key Laboratory of Ophthalmology (CSTC,2008CA5003), Natural Science Foundation Major International (Regional) Joint Research Project (30910103912), National Natural Science Foundation Project (30973242), Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality and PAR-EU Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Broderick CA, 2005, MOL THER, V12, P369, DOI 10.1016/j.ymthe.2005.03.018; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Butti E, 2008, GENE THER, V15, P504, DOI 10.1038/gt.2008.10; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Cottard V, 2000, GENE THER, V7, P1930, DOI 10.1038/sj.gt.3301324; Dick AD, 1997, BRIT J OPHTHALMOL, V81, P1107, DOI 10.1136/bjo.81.12.1107; Forrester John V, 2007, Chem Immunol Allergy, V92, P228, DOI 10.1159/000099274; Goldstein H, 1980, ADV OPHTHALMOL, V40, P1; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Gueudry J, 2008, AM J OPHTHALMOL, V146, P837, DOI 10.1016/j.ajo.2008.08.038; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Kosar A, 1999, RHEUMATOL INT, V19, P11, DOI 10.1007/s002960050091; Kotter I, 1998, BRIT J OPHTHALMOL, V82, P488, DOI 10.1136/bjo.82.5.488; Lei B, 2009, MOL VIS, V15, P1374; Mackensen F, 2011, OPHTHALMOLOGE, V108, P213, DOI 10.1007/s00347-010-2260-2; Mackensen F, 2009, CLIN OPHTHALMOL, V3, P559; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Rehman KK, 2008, MOL THER, V16, P1409, DOI 10.1038/mt.2008.116; Skapenko A, 2005, J IMMUNOL, V175, P6107, DOI 10.4049/jimmunol.175.9.6107; Smith JR, 2005, HUM GENE THER, V16, P1037, DOI 10.1089/hum.2005.16.1037; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; Tian LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019542; Trittibach P, 2008, GENE THER, V15, P1478, DOI 10.1038/gt.2008.109; WACKER WB, 1965, NATURE, V206, P253, DOI 10.1038/206253a0; Wang W, 2008, CLIN CANCER RES, V14, P8314, DOI 10.1158/1078-0432.CCR-08-0705; Yang DSF, 2008, BRIT J HOSP MED, V69, P575, DOI 10.12968/hmed.2008.69.10.31317	32	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37995	10.1371/journal.pone.0037995	http://dx.doi.org/10.1371/journal.pone.0037995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685550	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700013
J	Meng, XF; D'Arcy, C				Meng, Xiangfei; D'Arcy, Carl			Education and Dementia in the Context of the Cognitive Reserve Hypothesis: A Systematic Review with Meta-Analyses and Qualitative Analyses	PLOS ONE			English	Review							ALZHEIMERS-DISEASE; BRAIN RESERVE; RISK; PREVALENCE; HEALTH; BIAS; PUBLICATION; POPULATION; PREVENTION; MEMANTINE	Background: Cognitive reserve (CR) or brain reserve capacity explains why individuals with higher IQ, education, or occupational attainment have lower risks of developing dementia, Alzheimer's disease (AD) or vascular dementia (VaD). The CR hypothesis postulates that CR reduces the prevalence and incidence of AD or VaD. It also hypothesizes that among those who have greater initial cognitive reserve (in contrast to those with less reserve) greater brain pathology occurs before the clinical symptoms of disease becomes manifest. Thus clinical disease onset triggers a faster decline in cognition and function, and increased mortality among those with initial greater cognitive reserve. Disease progression follows distinctly separate pathological and clinical paths. With education as a proxy we use meta-analyses and qualitative analyses to review the evidence for the CR hypothesis. Methodology/Principal Findings: We searched PubMed, PsycoINFO, EMBASE, HealthStar, and Scopus databases from January 1980 to June 2011 for observational studies with clear criteria for dementia, AD or VaD and education. One hundred and thirty-three articles with a variety of study designs met the inclusion criteria. Prevalence and incidence studies with odds ratios (ORs), relative risks or original data were included in the meta-analyses. Other studies were reviewed qualitatively. The studies covered 437,477 subjects. Prevalence and incidence studies with pooled ORs of 2.61 (95% CI 2.21-3.07) and 1.88 (95% CI 1.51-2.34) respectively, showed low education increased the risk of dementia. Heterogeneity and sensitivity tests confirmed the evidence. Generally, study characteristics had no effect on conclusions. Qualitative analyses also showed the protective effects of higher education on developing dementia and with clinical disease onset hastening a decline in cognition and function, and greater brain pathology. Conclusion/Significance: This systematic review and meta-analyses covering a wide range of observational studies and diverse settings provides robust support for the CR hypothesis. The CR hypothesis suggests several avenues for dementia prevention.	[Meng, Xiangfei; D'Arcy, Carl] Univ Saskatchewan, Dept Psychiat, Saskatoon, SK S7N 0W0, Canada; [Meng, Xiangfei] Univ Saskatchewan, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada; [D'Arcy, Carl] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Meng, XF (corresponding author), Univ Saskatchewan, Dept Psychiat, Saskatoon, SK S7N 0W0, Canada.	xim443@mail.usask.ca	Meng, Xiangfei/I-6715-2019		University of Saskatchewan; Canadian Institute Health Research-Public Health; Agricultural Rural Ecosystem and Saskatchewan Health Research Foundation	University of Saskatchewan; Canadian Institute Health Research-Public Health(Canadian Institutes of Health Research (CIHR)); Agricultural Rural Ecosystem and Saskatchewan Health Research Foundation	XM was awarded a scholarship under the Chinese State Scholarship Fund for a study year abroad at the University of Saskatchewan. The systematic review was started during that period and was followed up later during a post-doctoral scholarships from Canadian Institute Health Research-Public Health and the Agricultural Rural Ecosystem and Saskatchewan Health Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert SM, 1999, AM J PUBLIC HEALTH, V89, P95, DOI 10.2105/AJPH.89.1.95; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Andel R, 2005, J GERONTOL B-PSYCHOL, V60, pP251, DOI 10.1093/geronb/60.5.P251; BICKEL H, 1994, PSYCHOL MED, V24, P179, DOI 10.1017/S0033291700026945; Black N, 1996, BRIT MED J, V312, P1215; Caamano-Isorna F, 2006, NEUROEPIDEMIOLOGY, V26, P226, DOI 10.1159/000093378; Canadian Study of Health and Aging Working Group, 2001, NEUROLOGY, V55, P66; Del Ser T, 1999, BRAIN, V122, P2309, DOI 10.1093/brain/122.12.2309; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2001, SYSTEMATIC REV HLTH; Fratiglioni L, 2007, J ALZHEIMERS DIS, V12, P11; Helmer C, 1999, NEUROLOGY, V53, P1953, DOI 10.1212/WNL.53.9.1953; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4; Manly JJ, 2005, J GERIATR PSYCH NEUR, V18, P213, DOI 10.1177/0891988705281868; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McVeigh C, 2006, CLIN INTERV AGING, V1, P229, DOI 10.2147/ciia.2006.1.3.229; Menken M, 2000, ARCH NEUROL-CHICAGO, V57, P418, DOI 10.1001/archneur.57.3.418; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; MOLSA PK, 1982, ACTA NEUROL SCAND, V65, P541; Mortimer JA, 2005, J GERIATR PSYCH NEUR, V18, P218, DOI 10.1177/0891988705281869; Paradise M, 2009, INT PSYCHOGERIATR, V21, P25, DOI 10.1017/S1041610208008053; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Reisberg B., 2003, NEW ENGL J MED, V348, P1333, DOI [10.1056/NEJMoa013128, DOI 10.1056/NEJMOA013128]; Ritchie K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3885; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Sharp ES, 2011, ALZ DIS ASSOC DIS, V25, P289, DOI 10.1097/WAD.0b013e318211c83c; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Turner RS, 2006, SEMIN NEUROL, V26, P499, DOI 10.1055/s-2006-951622; Tyas SL, 2001, INT J EPIDEMIOL, V30, P590, DOI 10.1093/ije/30.3.590; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Wells G.A., NEWCASTLE OTTAWA SCA; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; World Health Organization, 1992, ICD 10 CLASSIFICATIO, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P	42	380	389	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38268	10.1371/journal.pone.0038268	http://dx.doi.org/10.1371/journal.pone.0038268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675535	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700054
J	Nadler, C; Koby, S; Peleg, A; Johnson, AC; Suddala, KC; Sathiyamoorthy, K; Smith, BE; Saper, MA; Rosenshine, I				Nadler, Chen; Koby, Simi; Peleg, Adi; Johnson, Austin C.; Suddala, Krishna C.; Sathiyamoorthy, Karthik; Smith, Bennett E.; Saper, Mark A.; Rosenshine, Ilan			Cycling of Etk and Etp Phosphorylation States Is Involved in Formation of Group 4 Capsule by Escherichia coli	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GRAM-NEGATIVE BACTERIA; POLYSACCHARIDE EXPORT; KINASE WZC; EXOPOLYSACCHARIDE; IDENTIFICATION; MECHANISM; REVEALS	Capsules frequently play a key role in bacterial interactions with their environment. Escherichia coli capsules were categorized as groups 1 through 4, each produced by a distinct mechanism. Etk and Etp are members of protein families required for the production of group 1 and group 4 capsules. These members function as a protein tyrosine kinase and protein tyrosine phosphatase, respectively. We show that Etp dephosphorylates Etk in vivo, and mutations rendering Etk or Etp catalytically inactive result in loss of group 4 capsule production, supporting the notion that cyclic phosphorylation and dephosphorylation of Etk is required for capsule formation. Notably, Etp also becomes tyrosine phosphorylated in vivo and catalyzes rapid auto-dephosphorylation. Further analysis identified Tyr121 as the phosphorylated residue of Etp. Etp containing Phe, Glu or Ala in place of Tyr121 retained phosphatase activity and catalyzed dephosphorylation of Etp and Etk. Although EtpY121E and EtpY121A still supported capsule formation, EtpY121F failed to do so. These results suggest that cycles of phosphorylation and dephosphorylation of Etp, as well as Etk, are involved in the formation of group 4 capsule, providing an additional regulatory layer to the complex control of capsule production.	[Nadler, Chen; Koby, Simi; Peleg, Adi; Rosenshine, Ilan] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Johnson, Austin C.; Suddala, Krishna C.; Sathiyamoorthy, Karthik] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA; [Smith, Bennett E.; Saper, Mark A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Hebrew University of Jerusalem; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nadler, C (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel.	saper@umich.edu; ilanr@ekmd.huji.ac.il	Sathiyamoorthy, Karthik/K-6190-2015; Suddala, Krishna Chaitanya/I-2545-2019	Sathiyamoorthy, Karthik/0000-0002-5736-8709; Suddala, Krishna Chaitanya/0000-0003-1597-2622	United States-Israel Binational Science Foundation; Abisch-Frenkel Foundation; Israel Academy of Science and Humanities; National Institute of Allergy and Infectious Disease, National Institutes of Health [R21AI088543]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088543] Funding Source: NIH RePORTER	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Abisch-Frenkel Foundation; Israel Academy of Science and Humanities; National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the United States-Israel Binational Science Foundation (to I. R. and M. A. S.), the Abisch-Frenkel Foundation (to C.N. and I. R.), and the Israel Academy of Science and Humanities (I. R.). Partial support was provided by grant R21AI088543 (M. A. S.) from the National Institute of Allergy and Infectious Disease, National Institutes of Health. I. R. is the Etta Rosensohn Professor of Bacteriology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Blobel J, 2009, FEBS J, V276, P4346, DOI 10.1111/j.1742-4658.2009.07139.x; Bucciantini M, 1999, FEBS LETT, V456, P73, DOI 10.1016/S0014-5793(99)00828-5; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Araujo C, 2010, RES MICROBIOL, V161, P595, DOI 10.1016/j.resmic.2010.05.014; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lescop E, 2006, J BIOL CHEM, V281, P19570, DOI 10.1074/jbc.M601263200; LEVINE MM, 1978, LANCET, V1, P1119; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Peleg A, 2005, J BACTERIOL, V187, P5259, DOI 10.1128/JB.187.15.5259-5266.2005; Rigacci S, 1996, J BIOL CHEM, V271, P1278, DOI 10.1074/jbc.271.3.1278; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000; Schwarzer D, 2006, J AM CHEM SOC, V128, P4192, DOI 10.1021/ja0585174; Shifrin Y, 2008, J BACTERIOL, V190, P5063, DOI 10.1128/JB.00440-08; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200	24	69	70	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37984	10.1371/journal.pone.0037984	http://dx.doi.org/10.1371/journal.pone.0037984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675501	Green Published, gold			2022-12-27	WOS:000305341700030
J	Tome, HVV; Martins, GF; Lima, MAP; Campos, LAO; Guedes, RNC				Tome, Hudson Vaner V.; Martins, Gustavo F.; Lima, Maria Augusta P.; Campos, Lucio Antonio O.; Guedes, Raul Narciso C.			Imidacloprid-Induced Impairment of Mushroom Bodies and Behavior of the Native Stingless Bee Melipona quadrifasciata anthidioides	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; NEONICOTINOID INSECTICIDES; LEARNING PERFORMANCES; RISK-ASSESSMENT; COLONY LOSSES; PESTICIDES; HYMENOPTERA; TOXICITY; BRAIN; POLLINATION	Declines in pollinator colonies represent a worldwide concern. The widespread use of agricultural pesticides is recognized as a potential cause of these declines. Previous studies have examined the effects of neonicotinoid insecticides such as imidacloprid on pollinator colonies, but these investigations have mainly focused on adult honey bees. Native stingless bees (Hymenoptera: Apidae: Meliponinae) are key pollinators in neotropical areas and are threatened with extinction due to deforestation and pesticide use. Few studies have directly investigated the effects of pesticides on these pollinators. Furthermore, the existing impact studies did not address the issue of larval ingestion of contaminated pollen and nectar, which could potentially have dire consequences for the colony. Here, we assessed the effects of imidacloprid ingestion by stingless bee larvae on their survival, development, neuromorphology and adult walking behavior. Increasing doses of imidacloprid were added to the diet provided to individual worker larvae of the stingless bee Melipona quadrifasciata anthidioides throughout their development. Survival rates above 50% were only observed at insecticide doses lower than 0.0056 mu g active ingredient (a.i.)/bee. No sublethal effect on body mass or developmental time was observed in the surviving insects, but the pesticide treatment negatively affected the development of mushroom bodies in the brain and impaired the walking behavior of newly emerged adult workers. Therefore, stingless bee larvae are particularly susceptible to imidacloprid, as it caused both high mortality and sublethal effects that impaired brain development and compromised mobility at the young adult stage. These findings demonstrate the lethal effects of imidacloprid on native stingless bees and provide evidence of novel serious sublethal effects that may compromise colony survival. The ecological and economic importance of neotropical stingless bees as pollinators, their susceptibility to insecticides and the vulnerability of their larvae to insecticide exposure emphasize the importance of studying these species.	[Tome, Hudson Vaner V.; Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Martins, Gustavo F.; Campos, Lucio Antonio O.] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Lima, Maria Augusta P.] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Tome, HVV (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	guedes@ufv.br	Lima, Maria Augusta P./F-9038-2012; Tomé, Hudson V.V./E-6957-2014; Serrano, Jose/A-2854-2009; Martins, Gustavo Ferreira/AAL-7744-2020; Guedes, Raul Narciso Carvalho/L-3924-2013; Martins, Gustavo F/L-9107-2015	Serrano, Jose/0000-0002-1565-5216; Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Martins, Gustavo F/0000-0003-0614-8551; Pereira Lima, Maria Augusta/0000-0002-7044-7671	Minas Gerais State Foundation for Research Aid; National Council of Scientific and Technological Development (CNPq - PQ); CAPES Foundation [AUX PE - PROEX 191/2009]	Minas Gerais State Foundation for Research Aid; National Council of Scientific and Technological Development (CNPq - PQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by awards from the Minas Gerais State Foundation for Research Aid, the National Council of Scientific and Technological Development (CNPq - PQ) and the CAPES Foundation (AUX PE - PROEX 191/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; [Anonymous], SAS STAT US GUID V8; Antonini Y., 2006, Braz. J. Biol., V66, P463, DOI 10.1590/S1519-69842006000300012; Armengaud C, 2000, BRAIN RES, V859, P390, DOI 10.1016/S0006-8993(00)02016-3; ATKINS EL, 1986, J APICULT RES, V25, P242, DOI 10.1080/00218839.1986.11100725; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; BAI DL, 1991, PESTIC SCI, V33, P197, DOI 10.1002/ps.2780330208; dos Santos SAB, 2009, GENET MOL RES, V8, P751; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Brittain CA, 2010, BASIC APPL ECOL, V11, P106, DOI 10.1016/j.baae.2009.11.007; Brodsgaard HF, 2003, APIDOLOGIE, V34, P139, DOI 10.1051/apido:2003003; Buckingham SD, 1997, J EXP BIOL, V200, P2685; Casida JE, 2004, J PESTIC SCI, V29, P81, DOI 10.1584/jpestics.29.81; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cra-Api, 2009, REL SULL SVOLT PRIM; Croft B. A., 1990, ARTHROPOD BIOL CONTR; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; DERUIJTER A, 1987, APIDOLOGIE, V18, P356; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Fahrbach SE, 1995, LEARN MEMORY, V2, P199, DOI 10.1101/lm.2.5.199; Farris SM, 1999, J COMP NEUROL, V414, P97, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;97::AID-CNE8&gt;3.0.CO;2-Q; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Freitas BM, 2009, APIDOLOGIE, V40, P332, DOI 10.1051/apido/2009012; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Goldberg B, 1999, J PHYSL, V514, P759; Guez D, 2001, NEUROBIOL LEARN MEM, V76, P183, DOI 10.1006/nlme.2000.3995; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Koch H, 1997, APIDOLOGIE, V28, P439, DOI 10.1051/apido:19970610; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; MACIEIRA OJD, 1989, J APICULT RES, V28, P3, DOI 10.1080/00218839.1989.11100813; Malone LA, 2002, APIDOLOGIE, V33, P447, DOI 10.1051/apido:2002030; Malun D, 2002, J NEUROBIOL, V50, P31, DOI 10.1002/neu.10015; Medrzycki Piotr, 2003, Bulletin of Insectology, V56, P59; MENZEL R, 1993, APIDOLOGIE, V24, P157, DOI 10.1051/apido:19930301; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Ministerio da Agricultura Pecuaria e Abastecimento, 2011, AGROFIT SIST AGR FIT; Mizunami Makoto, 1993, P199; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Moo-Valle H, 2004, APIDOLOGIE, V35, P587, DOI 10.1051/apido:2004054; Moraes Simone S., 2000, Anais da Sociedade Entomologica do Brasil, V29, P31, DOI 10.1590/S0301-80592000000100004; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; [NRC] National Research Council, 2006, STAT POLL N AM; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Valdovinos-Nunez GR, 2009, J ECON ENTOMOL, V102, P1737, DOI 10.1603/029.102.0502; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Reetz JE, 2011, APIDOLOGIE, V42, P596, DOI 10.1007/s13592-011-0049-1; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sigg D, 1997, J NEUROSCI, V17, P7148; Siqueira MAL, 2008, THESIS U FEDERAL VIC; Slaa EJ, 2006, APIDOLOGIE, V37, P293, DOI 10.1051/apido:2006022; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tasei JN, 2002, HONEY BEES: ESTIMATING THE ENVIRONMENTAL IMPACT OF CHEMICALS, P101, DOI 10.1201/9780203218655.ch7; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Villa S, 2000, ECOTOXICOLOGY, V9, P287, DOI 10.1023/A:1026522112328; Waldschmidt AM, 1995, THESIS U FEDERAL VIC; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	84	87	89	4	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38406	10.1371/journal.pone.0038406	http://dx.doi.org/10.1371/journal.pone.0038406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675559	Green Published, gold			2022-12-27	WOS:000305341700071
J	Wali, RK; Kunte, DP; De La Cruz, M; Tiwari, AK; Brasky, J; Weber, CR; Gibson, TP; Patel, A; Savkovic, SD; Brockstein, BE; Roy, HK				Wali, Ramesh K.; Kunte, Dhananjay P.; De La Cruz, Mart; Tiwari, Ashish K.; Brasky, Jeffrey; Weber, Christopher R.; Gibson, Tina P.; Patel, Amir; Savkovic, Suzana D.; Brockstein, Bruce E.; Roy, Hemant K.			Topical Polyethylene Glycol as a Novel Chemopreventive Agent for Oral Cancer via Targeting of Epidermal Growth Factor Response	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FACTOR RECEPTOR EXPRESSION; TRANS-RETINOIC ACID; COLON CARCINOGENESIS; MOLECULAR-BIOLOGY; HIGH-RISK; PHASE-II; HEAD; TRIAL; INHIBITION	Head and neck squamous cell carcinoma (HNSCC) is a major cause of morbidity and mortality underscoring the need for safe and effective chemopreventive strategies. Targeting epidermal growth factor receptor (EGFR) is attractive in that it is an early critical event in HNSCC pathogenesis. However, current agents lack efficacy or have unacceptable toxicity. Several groups have demonstrated that the over-the-counter medication, polyethylene glycol (PEG) has remarkable chemopreventive efficacy against colon carcinogenesis. Importantly, we reported that this effect is mediated through EGFR internalization/degradation. In the current study, we investigated the chemopreventive efficacy of this agent against HNSCC, using both the well validated animal model 4-NQO (4-nitroquinoline 1-oxide) rat model and cell culture with the human HNSCC cell line SCC-25. We demonstrated that daily topical application of 10% PEG-8000 in the oral cavity (tongue and cavity wall) post 4NQO initiation resulted in a significant reduction in tumor burden (both, tumor size and tumors/tumor bearing rat) without any evidence of toxicity. Immunohistochemical studies depicted decreased proliferation (number of Ki67-positive cells) and reduced expression of EGFR and its downstream effectors cyclin D1 in the tongue mucosa of 4NQO-rats treated with PEG. We showed that EGFR was also markedly downregulated in SCC-25 cells by PEG-8000 with a concomitant induction of G1-S phase cell-cycle arrest, which was potentially mediated through upregulated p21(cip1/waf1). In conclusion, we demonstrate, for the first time, that PEG has promising efficacy and safety as a chemopreventive efficacy against oral carcinogenesis.	[Wali, Ramesh K.; Kunte, Dhananjay P.; De La Cruz, Mart; Tiwari, Ashish K.; Brasky, Jeffrey; Gibson, Tina P.; Patel, Amir; Savkovic, Suzana D.; Brockstein, Bruce E.; Roy, Hemant K.] NorthShore Univ Healthsyst, Dept Med, Evanston, IL USA; [Weber, Christopher R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	NorthShore University Health System; University of Chicago	Wali, RK (corresponding author), NorthShore Univ Healthsyst, Dept Med, Evanston, IL USA.	rwali@northshore.org	Roy, Hemant/AAC-9096-2020	Weber, Christopher/0000-0002-2117-3184	National Institute of Health [U01CA111257, R21CA141112, 1R21CA156944-01, RO3CA139528, RO1CA156186]; NATIONAL CANCER INSTITUTE [R21CA141112, R01CA156186, R21CA156944, U01CA111257, R03CA139528] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institute of Health U01CA111257, R21CA141112, 1R21CA156944-01, RO3CA139528, RO1CA156186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE; Benchekroun MT, 2010, CANCER PREV RES, V3, P800, DOI 10.1158/1940-6207.CAPR-09-0163; Chang SS, 2008, J SURG ONCOL, V97, P640, DOI 10.1002/jso.21023; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Choi Y, 2003, INT J CANCER, V107, P145, DOI 10.1002/ijc.11354; Corpet DE, 2003, CANCER EPIDEM BIOMAR, V12, P391; Corpet DE, 1999, CARCINOGENESIS, V20, P915, DOI 10.1093/carcin/20.5.915; Corpet DE, 2000, CANCER RES, V60, P3160; Dannenberg AJ, 2001, ANN NY ACAD SCI, V952, P109, DOI 10.1111/j.1749-6632.2001.tb02731.x; Dorval E, 2006, GASTROEN CLIN BIOL, V30, P1196, DOI 10.1016/S0399-8320(06)73511-4; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Gu XB, 2008, CLIN CANCER RES, V14, P1840, DOI 10.1158/1078-0432.CCR-07-1811; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; Lee JJ, 2000, CLIN CANCER RES, V6, P1702; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Long NK, 2007, ONCOL REP, V17, P879; Mallery SR, 2008, CANCER RES, V68, P4945, DOI 10.1158/0008-5472.CAN-08-0568; Mulshine JL, 2004, CLIN CANCER RES, V10, P1565, DOI 10.1158/1078-0432.CCR-1020-3; Napier SS, 2008, J ORAL PATHOL MED, V37, P1, DOI 10.1111/j.1600-0714.2007.00579.x; Papaclimitrakopoulou VA, 2008, CLIN CANCER RES, V14, P2095, DOI 10.1158/1078-0432.CCR-07-4024; Papadimitrakopoulou VA, 2009, J CLIN ONCOL, V27, P599, DOI 10.1200/JCO.2008.17.1850; Park K, 2005, J CONTROL RELEASE, V104, P167, DOI 10.1016/j.jconrel.2005.01.013; Parnaud G, 2001, INT J CANCER, V92, P63, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1158>3.3.CO;2-#; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Putti TC, 2002, HISTOPATHOLOGY, V41, P144, DOI 10.1046/j.1365-2559.2002.01436.x; Roesch-Ely M, 2010, J PATHOL, V221, P462, DOI 10.1002/path.2726; Rosin MP, 2010, CANCER PREV RES, V3, P797, DOI 10.1158/1940-6207.CAPR-10-0114; Roy HK, 2006, MOL CANCER THER, V5, P2060, DOI 10.1158/1535-7163.MCT-06-0054; Roy HK, 2011, INT J ONCOL, V38, P529, DOI 10.3892/ijo.2010.875; Roy HK, 2004, CANCER LETT, V215, P35, DOI 10.1016/j.canlet.2004.05.012; SHIN DM, 1994, CANCER RES, V54, P3153; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tanaka T, 2011, PATHOLOG RES INT; Tang XH, 2004, CLIN CANCER RES, V10, P301, DOI 10.1158/1078-0432.CCR-0999-3; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tsao AS, 2009, CANCER PREV RES, V2, P931, DOI 10.1158/1940-6207.CAPR-09-0121; Wali RK, 2008, MOL CANCER THER, V7, P3103, DOI 10.1158/1535-7163.MCT-08-0434	41	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38047	10.1371/journal.pone.0038047	http://dx.doi.org/10.1371/journal.pone.0038047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675506	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700035
J	Czernik, C; Rhode, S; Metze, B; Schmalisch, G; Buhrer, C				Czernik, Christoph; Rhode, Stefanie; Metze, Boris; Schmalisch, Gerd; Buehrer, Christoph			Persistently Elevated Right Ventricular Index of Myocardial Performance in Preterm Infants with Incipient Bronchopulmonary Dysplasia	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; CONGENITAL HEART-DISEASE; DOPPLER ASSESSMENT; NORMAL-CHILDREN; TEI-INDEX; ECHOCARDIOGRAPHY; CIRCULATION; PRESSURE; DAMAGE	Objectives: Elevated pulmonary vascular resistance occurs during the first days after birth in all newborn infants and persists in infants at risk for bronchopulmonary dysplasia (BPD). It is difficult to measure in a non-invasive fashion. We assessed the usefulness of the right ventricular index of myocardial performance (RIMP) to estimate pulmonary vascular resistance in very low birth weight infants. Study Design: Prospective echocardiography on day of life (DOL) 2, 7, 14, and 28 in 121 preterm infants (median [quartiles] gestational age 28 [26-29] weeks, birth weight 998 [743-1225] g) of whom 36 developed BPD (oxygen supplementation at 36 postmenstrual weeks). Results: RIMP derived by conventional pulsed Doppler technique was unrelated to heart rate or mean blood pressure. RIMP on DOL 2 was similar in infants who subsequently did (0.39 [0.33-0.55]) and did not develop BPD (0.39 [0.28-0.51], p = 0.467). RIMP declined steadily in non-BPD infants but not in BPD infants (DOL 7: 0.31[0.22-0.39] vs. 0.35[0.29-0.48], p = 0.014; DOL 14: 0.23[0.17-0.30] vs. 0.35[0.25-0.43], p<0.001; DOL 28: 0.21[0.15-0.28] vs. 0.31 [0.21-0.35], p = 0.015). Conclusions: In preterm infants, a decline in RIMP after birth was not observed in those with incipient BPD. The pattern of RIMP measured in preterm infants is commensurate with that of pulmonary vascular resistance.	[Czernik, Christoph; Rhode, Stefanie; Metze, Boris; Schmalisch, Gerd; Buehrer, Christoph] Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Czernik, C (corresponding author), Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany.	christoph.czernik@charite.de		Metze, Boris/0000-0001-8864-1969				Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Blanchard DG, 2009, JACC-CARDIOVASC IMAG, V2, P143, DOI 10.1016/j.jcmg.2008.10.012; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Eidem BW, 1998, J AM SOC ECHOCARDIOG, V11, P849, DOI 10.1016/S0894-7317(98)70004-5; Eto GY, 1999, J AM SOC ECHOCARDIOG, V12, P1058, DOI 10.1016/S0894-7317(99)70102-1; Filbrun AG, 2011, PEDIATR PULM, V46, P369, DOI 10.1002/ppul.21378; Gao YS, 2010, PHYSIOL REV, V90, P1291, DOI 10.1152/physrev.00032.2009; HARADA K, 1995, AM J CARDIOL, V76, P634, DOI 10.1016/S0002-9149(99)80175-1; HISLOP AA, 1990, PEDIATR PULM, V9, P152, DOI 10.1002/ppul.1950090306; Horton KD, 2009, J AM SOC ECHOCARDIOG, V22, P776, DOI 10.1016/j.echo.2009.04.027; Huez S, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-9; Ishii M, 2000, PEDIATR CARDIOL, V21, P416, DOI 10.1007/s002460010100; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kozak-Barany A, 2001, J PEDIATR-US, V139, P539, DOI 10.1067/mpd.2001.118199; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Melek M, 2006, ECHOCARDIOGR-J CARD, V23, P120, DOI 10.1111/j.1540-8175.2006.00180.x; Mourani PM, 2004, AM J RESP CRIT CARE, V170, P1006, DOI 10.1164/rccm.200310-1483oc; Murase M, 2000, PEDIATR CARDIOL, V21, P452, DOI 10.1007/s002460010107; Murase M, 2009, PEDIATR CARDIOL, V30, P928, DOI 10.1007/s00246-009-9464-8; Sahni Rakesh, 2005, J Perinatol, V25, P41, DOI 10.1038/sj.jp.7211210; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Su BH, 1997, ARCH DIS CHILD-FETAL, V77, pF23, DOI 10.1136/fn.77.1.F23; Sugiura T, 2003, PEDIATR RES, V53, P927, DOI 10.1203/01.PDR.0000061540.81669.2A; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Tsutsumi T, 1999, PEDIATR INT, V41, P722, DOI 10.1046/j.1442-200x.1999.01155.x; Vonk MC, 2007, EUR J ECHOCARDIOGR, V8, P317, DOI 10.1016/j.euje.2006.06.002; Yates AR, 2008, J PEDIATR-US, V152, P766, DOI 10.1016/j.jpeds.2007.11.039; Yeo TC, 1998, AM J CARDIOL, V81, P1157, DOI 10.1016/S0002-9149(98)00140-4	32	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38352	10.1371/journal.pone.0038352	http://dx.doi.org/10.1371/journal.pone.0038352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675548	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339900025
J	Shanmugam, NKN; Ellenbogen, S; Trebicka, E; Wang, LJ; Mukhopadhyay, S; Lacy-Hulbert, A; Gallini, CA; Garrett, WS; Cherayil, BJ				Shanmugam, Nanda Kumar N.; Ellenbogen, Shiri; Trebicka, Estela; Wang, Lijian; Mukhopadhyay, Subhankar; Lacy-Hulbert, Adam; Gallini, Carey Ann; Garrett, Wendy S.; Cherayil, Bobby J.			Tumor Necrosis Factor alpha Inhibits Expression of the Iron Regulating Hormone Hepcidin in Murine Models of Innate Colitis	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS PROTEIN; ULCERATIVE-COLITIS; IN-VIVO; INFLAMMATION; HFE; DISEASE; GROWTH; STAT3; MACROPHAGES; HOMEOSTASIS	Background: Abnormal expression of the liver peptide hormone hepcidin, a key regulator of iron homeostasis, contributes to the pathogenesis of anemia in conditions such as inflammatory bowel disease (IBD). Since little is known about the mechanisms that control hepcidin expression during states of intestinal inflammation, we sought to shed light on this issue using mouse models. Methodology/Principal Findings: Hepcidin expression was evaluated in two types of intestinal inflammation caused by innate immune activation-dextran sulfate sodium (DSS)-induced colitis in wild-type mice and the spontaneous colitis occurring in T-bet/Rag2-deficient (TRUC) mice. The role of tumor necrosis factor (TNF) alpha was investigated by in vivo neutralization, and by treatment of a hepatocyte cell line, as well as mice, with the recombinant cytokine. Expression and activation of Smad1, a positive regulator of hepcidin transcription, were assessed during colitis and following administration or neutralization of TNF alpha. Hepcidin expression progressively decreased with time during DSS colitis, correlating with changes in systemic iron distribution. TNF alpha inhibited hepcidin expression in cultured hepatocytes and non-colitic mice, while TNF alpha neutralization during DSS colitis increased it. Similar results were obtained in TRUC mice. These effects involved a TNF alpha-dependent decrease in Smad1 protein but not mRNA. Conclusions/Significance: TNF alpha inhibits hepcidin expression in two distinct types of innate colitis, with down-regulation of Smad1 protein playing an important role in this process. This inhibitory effect of TNF alpha may be superseded by other factors in the context of T cell-mediated colitis given that in the latter form of intestinal inflammation hepcidin is usually upregulated.	[Shanmugam, Nanda Kumar N.; Ellenbogen, Shiri; Trebicka, Estela; Wang, Lijian; Cherayil, Bobby J.] Massachusetts Gen Hosp, Mucosal Immunol Lab, Boston, MA 02114 USA; [Mukhopadhyay, Subhankar; Lacy-Hulbert, Adam] Massachusetts Gen Hosp, Dept Pediat, Dev Immunol Lab, Boston, MA 02114 USA; [Mukhopadhyay, Subhankar] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Lacy-Hulbert, Adam; Garrett, Wendy S.; Cherayil, Bobby J.] Harvard Univ, Sch Med, Boston, MA USA; [Gallini, Carey Ann; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Gallini, Carey Ann; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Oxford; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health	Shanmugam, NKN (corresponding author), Massachusetts Gen Hosp, Mucosal Immunol Lab, Boston, MA 02114 USA.	cherayil@helix.mgh.harvard.edu		Navalpur Shanmugam, Nanda Kumar/0000-0003-2916-8563; Lacy-Hulbert, Adam/0000-0003-2162-0156; Mukhopadhyay, Subhankar/0000-0002-7110-6473; Garrett, Wendy/0000-0002-5092-0150	National Institutes of Health [R56AI089700, R01AI089700, RO1CA154426, K08AI078942]; Wellcome Trust Flexible Travel Award Fellowship; NATIONAL CANCER INSTITUTE [R01CA154426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089700, K08AI078942, R01AI089700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Flexible Travel Award Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by grants from the National Institutes of Health to BJC (R56AI089700, R01AI089700) and to WSG (RO1CA154426, K08AI078942). SM was supported by a Wellcome Trust Flexible Travel Award Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arnold J, 2009, EUR J GASTROEN HEPAT, V21, P335, DOI 10.1097/MEG.0b013e32830e2885; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bitzer M, 2000, GENE DEV, V14, P187; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Constante M, 2007, AM J PATHOL, V170, P497, DOI 10.2353/ajpath.2007.060437; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Hiasa Y, 2006, J VIROL METHODS, V132, P195, DOI 10.1016/j.jviromet.2005.10.014; Koening CL, 2009, BLOOD, V114, P1913, DOI 10.1182/blood-2009-03-209577; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lee PL, 2009, ANNU REV PATHOL-MECH, V4, P489, DOI 10.1146/annurev.pathol.4.110807.092205; Leso V, 2010, EUR J GASTROEN HEPAT, V22, P779, DOI 10.1097/MEG.0b013e328331b654; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Olakanmi O, 2007, J LEUKOCYTE BIOL, V81, P195, DOI 10.1189/jlb.0606405; Oustamanolakis P, 2011, EUR J GASTROEN HEPAT, V23, P262, DOI 10.1097/MEG.0b013e328343b885; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Schumann K, 2010, J TRACE ELEM MED BIO, V24, P58, DOI 10.1016/j.jtemb.2009.10.002; Semrin G, 2006, INFLAMM BOWEL DIS, V12, P1101, DOI 10.1097/01.mib.0000235097.86360.04; Stein J, 2010, NAT REV GASTRO HEPAT, V7, P599, DOI 10.1038/nrgastro.2010.151; Wang HZ, 2011, J IMMUNOL, V187, P6410, DOI 10.4049/jimmunol.1101436; Wang LJ, 2012, INFLAMM BOWEL DIS, V18, P112, DOI 10.1002/ibd.21675; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	41	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38136	10.1371/journal.pone.0038136	http://dx.doi.org/10.1371/journal.pone.0038136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675442	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500091
J	Ijiri, T; Ashihara, T; Umetani, N; Igarashi, T; Haraguchi, R; Yokota, H; Nakazawa, K				Ijiri, Takashi; Ashihara, Takashi; Umetani, Nobuyuki; Igarashi, Takeo; Haraguchi, Ryo; Yokota, Hideo; Nakazawa, Kazuo			A Kinematic Approach for Efficient and Robust Simulation of the Cardiac Beating Motion	PLOS ONE			English	Article							FIBER ORIENTATION	Computer simulation techniques for cardiac beating motions potentially have many applications and a broad audience. However, most existing methods require enormous computational costs and often show unstable behavior for extreme parameter sets, which interrupts smooth simulation study and make it difficult to apply them to interactive applications. To address this issue, we present an efficient and robust framework for simulating the cardiac beating motion. The global cardiac motion is generated by the accumulation of local myocardial fiber contractions. We compute such local-to-global deformations using a kinematic approach; we divide a heart mesh model into overlapping local regions, contract them independently according to fiber orientation, and compute a global shape that satisfies contracted shapes of all local regions as much as possible. A comparison between our method and a physics-based method showed that our method can generate motion very close to that of a physics-based simulation. Our kinematic method has high controllability; the simulated ventricle-wall-contraction speed can be easily adjusted to that of a real heart by controlling local contraction timing. We demonstrate that our method achieves a highly realistic beating motion of a whole heart in real time on a consumer-level computer. Our method provides an important step to bridge a gap between cardiac simulations and interactive applications.	[Ijiri, Takashi; Yokota, Hideo] RIKEN, Biores Infrastruct Construct Team, Wako, Saitama, Japan; [Ashihara, Takashi] Shiga Univ Med Sci, Heart Rhythm Ctr, Dept Cardiovasc & Resp Med, Otsu, Shiga 52021, Japan; [Umetani, Nobuyuki; Igarashi, Takeo] Univ Tokyo, Dept Comp Sci, Tokyo, Japan; [Haraguchi, Ryo; Nakazawa, Kazuo] Natl Cerebral & Cardiovasc Ctr, Res Inst, Lab Biomed Sci & Informat Management, Suita, Osaka, Japan	RIKEN; Shiga University of Medical Science; University of Tokyo; National Cerebral & Cardiovascular Center - Japan	Ijiri, T (corresponding author), RIKEN, Biores Infrastruct Construct Team, Wako, Saitama, Japan.	takashi.ijiri@riken.jp	Haraguchi, Ryo/AAS-6426-2021		JSPS;  [22700115];  [21790717];  [21500420];  [22136011]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; 	This work was supported in part by Grant-in-Aid for Young Scientists (B) (22700115; 21790717), Grant-in-Aid for Scientific Research (C) (21500420), Grant-in-Aid for Scientific Research on Innovative Areas (22136011), and JSPS Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2004, P ANN INT IEEE EMBS, V26, P3658; Ashihara T, 1999, J ELECTROCARDIOL, V32, P129, DOI 10.1016/S0022-0736(99)90062-6; Buckberg G D, 2001, Semin Thorac Cardiovasc Surg, V13, P402; DEMER LL, 1983, J PHYSIOL-LONDON, V339, P615, DOI 10.1113/jphysiol.1983.sp014738; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Herman Irving P, 2007, BIOL MED PHYS BIOMED; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Ho SY, 2009, CLIN ANAT, V22, P52, DOI 10.1002/ca.20634; Hunter PJ, 2003, ANNU REV BIOMED ENG, V5, P147, DOI 10.1146/annurev.bioeng.5.040202.121537; Ijiri T, 2009, COMPUT GRAPH FORUM, V28, P1821, DOI 10.1111/j.1467-8659.2009.01559.x; Liao SH, 2011, COMPUT ANIMAT VIRT W, V22, P269, DOI 10.1002/cav.393; Lin DHS, 1998, J BIOMECH ENG-T ASME, V120, P504, DOI 10.1115/1.2798021; Liu F, 2001, JSME INT J C-MECH SY, V44, P125; Matsuoka S, 2003, JPN J PHYSIOL, V53, P105, DOI 10.2170/jjphysiol.53.105; Muller M, 2005, ACM T GRAPHIC, V24, P471, DOI 10.1145/1073204.1073216; NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365, DOI 10.1152/ajpheart.1991.260.4.H1365; OHAYON J, 1988, BIOPHYS J, V54, P1077, DOI 10.1016/S0006-3495(88)83044-3; Rivers AR, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239533; Rungjiratananon W, 2010, COMPUT GRAPH FORUM, V29, P2438, DOI [10.1111/j.1467-8659.2010.01755.x, 10.1111/J.1467-8659.2010.01755.x]; Ruprecht D, 1998, MATH VISUALIZATION, P61; Si H, 2006, PROCEEDINGS OF THE 15TH INTERNATIONAL MESHING ROUNDTABLE, P509, DOI 10.1007/978-3-540-34958-7_29; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Takamatsu K, 2009, ACM SIGGRAPH ASIA 20; Takayama K, 2008, J PHYSIOL SCI, V58, P487, DOI 10.2170/physiolsci.RP008108; Teran J., 2003, ACM SIGGRAPH/Eurographics Symposium on Computer Animation, P68; TRAILL TA, 1978, BRIT HEART J, V40, P162; Watanabe H, 2002, JSME INT J C-MECH SY, V45, P1003, DOI 10.1299/jsmec.45.1003; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zhukov L, 2003, IEEE VISUALIZATION 2003, PROCEEDINGS, P597, DOI 10.1109/VISUAL.2003.1250425	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36706	10.1371/journal.pone.0036706	http://dx.doi.org/10.1371/journal.pone.0036706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666327	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400013
J	Norenzayan, A; Gervais, WM; Trzesniewski, KH				Norenzayan, Ara; Gervais, Will M.; Trzesniewski, Kali H.			Mentalizing Deficits Constrain Belief in a Personal God	PLOS ONE			English	Article							ASPERGER-SYNDROME; FUNCTIONING AUTISM; EMPATHY QUOTIENT; RELIGION; MIND; FOUNDATIONS; THINKING; ADULTS; BRAIN	Religious believers intuitively conceptualize deities as intentional agents with mental states who anticipate and respond to human beliefs, desires and concerns. It follows that mentalizing deficits, associated with the autistic spectrum and also commonly found in men more than in women, may undermine this intuitive support and reduce belief in a personal God. Autistic adolescents expressed less belief in God than did matched neuro-typical controls (Study 1). In a Canadian student sample (Study 2), and two American national samples that controlled for demographic characteristics and other correlates of autism and religiosity (Study 3 and 4), the autism spectrum predicted reduced belief in God, and mentalizing mediated this relationship. Systemizing (Studies 2 and 3) and two personality dimensions related to religious belief, Conscientiousness and Agreeableness (Study 3), failed as mediators. Mentalizing also explained the robust and well-known, but theoretically debated, gender gap in religious belief wherein men show reduced religious belief (Studies 2-4).	[Norenzayan, Ara; Gervais, Will M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Trzesniewski, Kali H.] Univ Calif Davis, Dept Human Dev & Family Studies, Davis, CA 95616 USA	University of British Columbia; University of California System; University of California Davis	Norenzayan, A (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	ara@psych.ubc.ca	Trzesniewski, Kali H/D-3912-2009	Trzesniewski, Kali H/0000-0001-8165-3107	SSHRC (Social Sciences and Humanities Research Council) grants [410-2010-0297, 410-2009-1449]; APA (American Psychological Association) Division 36 research seed grant	SSHRC (Social Sciences and Humanities Research Council) grants; APA (American Psychological Association) Division 36 research seed grant	The authors acknowledge support by SSHRC (Social Sciences and Humanities Research Council) grants to Norenzayan (410-2010-0297) and Trzesniewski (410-2009-1449), and an APA (American Psychological Association) Division 36 research seed grant to Gervais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atran S, 2004, BEHAV BRAIN SCI, V27, P713, DOI 10.1017/S0140525X04000172; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barrett J.L., 2004, WHY WOULD ANYONE BEL; Barrett JL, 1996, COGNITIVE PSYCHOL, V31, P219, DOI 10.1006/cogp.1996.0017; Barrett JL, 2000, TRENDS COGN SCI, V4, P29, DOI 10.1016/S1364-6613(99)01419-9; Bering Jesse, 2011, BELIEF INSTINCT PSYC; Bering JM, 2002, REV GEN PSYCHOL, V6, P3, DOI 10.1037//1089-2680.6.1.3; Bloom P, 2007, DEVELOPMENTAL SCI, V10, P147, DOI 10.1111/j.1467-7687.2007.00577.x; Boyer P, 2008, NATURE, V455, P1038, DOI 10.1038/4551038a; Boyer Pascal, 2001, RELIG EXPLAINED EVOL; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Crespi B, 2008, BEHAV BRAIN SCI, V31, P284, DOI 10.1017/S0140525X08004457; Epley N, 2009, P NATL ACAD SCI USA, V106, P21533, DOI 10.1073/pnas.0908374106; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Gervais WM, 2012, J EXP SOC PSYCHOL, V48, P298, DOI 10.1016/j.jesp.2011.09.006; Gervais WM, 2011, RELIGION, V41, P389, DOI 10.1080/0048721X.2011.604510; Gray K, 2011, P NATL ACAD SCI USA, V108, P477, DOI 10.1073/pnas.1015493108; Guthrie Stewart, 1993, FACES CLOUDS NEW THE; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; HOGE DR, 1972, J SCI STUD RELIG, V11, P369; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Lane JD, 2010, CHILD DEV, V81, P1475, DOI 10.1111/j.1467-8624.2010.01486.x; McCauley Robert N., 2011, WHY RELIG IS NATURAL; McCullough ME, 2005, J PERS SOC PSYCHOL, V89, P78, DOI 10.1037/0022-3514.89.1.78; McKay R, 2011, P ROY SOC B-BIOL SCI, V278, P1858, DOI 10.1098/rspb.2010.2125; Mitchell JP, 2009, PHILOS T R SOC B, V364, P1309, DOI 10.1098/rstb.2008.0318; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Norris Pippa, 2004, SACRED SECULAR RELIG; Paloutzian RF, 1991, MANUAL SPIRITUAL WEL; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Roth LM, 2007, AM SOCIOL REV, V72, P205, DOI 10.1177/000312240707200204; Saroglou V, 2010, PERS SOC PSYCHOL REV, V14, P108, DOI 10.1177/1088868309352322; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Stark R, 2002, J SCI STUD RELIG, V41, P495, DOI 10.1111/1468-5906.00133; Taylor M, 1997, CHILD DEV, V68, P436, DOI 10.1111/j.1467-8624.1997.tb01950.x; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; Walter T, 1998, BRIT J SOCIOL, V49, P640, DOI 10.2307/591293; Waytz A, 2010, TRENDS COGN SCI, V14, P383, DOI 10.1016/j.tics.2010.05.006	42	155	156	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36880	10.1371/journal.pone.0036880	http://dx.doi.org/10.1371/journal.pone.0036880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959YF	22666332	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400015
J	Poon, R; Hong, HL; Wei, X; Pan, J; Alman, BA				Poon, Raymond; Hong, Helen; Wei, Xin; Pan, James; Alman, Benjamin A.			A High Throughput Screen Identifies Nefopam as Targeting Cell Proliferation in beta-Catenin Driven Neoplastic and Reactive Fibroproliferative Disorders	PLOS ONE			English	Article							FIBROMATOSIS DESMOID TUMOR; DEPENDENT TRANSCRIPTIONAL ACTIVATION; HYPERPLASTIC CUTANEOUS WOUNDS; AGGRESSIVE FIBROMATOSIS; PULMONARY-FIBROSIS; SIGNALING PATHWAY; MOUSE MODEL; IN-VITRO; DISEASE; EXPRESSION	Fibroproliferative disorders include neoplastic and reactive processes (e. g. desmoid tumor and hypertrophic scars). They are characterized by activation of beta-catenin signaling, and effective pharmacologic approaches are lacking. Here we undertook a high throughput screen using human desmoid tumor cell cultures to identify agents that would inhibit cell viability in tumor cells but not normal fibroblasts. Agents were then tested in additional cell cultures for an effect on cell proliferation, apoptosis, and beta-catenin protein level. Ultimately they were tested in Apc1638N mice, which develop desmoid tumors, as well as in wild type mice subjected to full thickness skin wounds. The screen identified Neofopam, as an agent that inhibited cell numbers to 42% of baseline in cell cultures from beta-catenin driven fibroproliferative disorders. Nefopam decreased cell proliferation and beta-catenin protein level to 50% of baseline in these same cell cultures. The half maximal effective concentration in-vitro was 0.5 uM and there was a plateau in the effect after 48 hours of treatment. Nefopam caused a 45% decline in tumor number, 33% decline in tumor volume, and a 40% decline in scar size when tested in mice. There was also a 50% decline in beta-catenin level in-vivo. Nefopam targets beta-catenin protein level in mesenchymal cells in-vitro and in-vivo, and may be an effective therapy for neoplastic and reactive processes driven by beta-catenin mediated signaling.	[Poon, Raymond; Hong, Helen; Alman, Benjamin A.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Wei, Xin] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Pan, James] Univ Toronto, Donnelly Ctr Cellular & Mol Res, Toronto, ON, Canada; [Pan, James] Univ Toronto, Banting & Best Inst Med Res, Toronto, ON, Canada; [Alman, Benjamin A.] Univ Toronto, Dept Surg, Div Orthopaed, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Poon, R (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	benjamin.alman@sickkids.ca			Canadian Institutes of Health Research (CIHR) [RFN 15136]; Canadian Cancer Society Research Institute; Desmoid Tumor Research Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Desmoid Tumor Research Foundation	This work was funded by grants from the Canadian Institutes of Health Research (CIHR) RFN 15136, the Canadian Cancer Society Research Institute, and the Desmoid Tumor Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alman BA, 1997, AM J PATHOL, V151, P329; ALMAN BA, 1992, J PEDIATR ORTHOPED, V12, P1; Aymard G, 2002, J PHARMACEUT BIOMED, V30, P1013, DOI 10.1016/S0731-7085(02)00443-0; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Bock O, 2006, ARCH DERMATOL RES, V297, P433, DOI 10.1007/s00403-006-0651-7; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; CASE MT, 1975, TOXICOL APPL PHARM, V33, P46, DOI 10.1016/0041-008X(75)90242-2; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Cheon S, 2005, LAB INVEST, V85, P416, DOI 10.1038/labinvest.3700237; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; CLARK RAF, 1993, DERMATOL CLIN, V11, P647, DOI 10.1016/S0733-8635(18)30218-3; Couture J, 2000, CLIN GENET, V57, P205, DOI 10.1034/j.1399-0004.2000.570306.x; ESPOSITO E, 1986, EUR J PHARMACOL, V128, P157, DOI 10.1016/0014-2999(86)90762-4; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Girard P, 2004, EUR J PHARMACOL, V503, P63, DOI 10.1016/j.ejphar.2004.09.030; HEEL RC, 1980, DRUGS, V19, P249, DOI 10.2165/00003495-198019040-00001; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Henriksson E, 2006, IN VITRO CELL DEV-AN, V42, P320; Hwang I, 2009, ARCH PHARM RES, V32, P1653, DOI 10.1007/s12272-009-2200-3; Juarez-Rojop IE, 2006, PAIN, V122, P118, DOI 10.1016/j.pain.2006.01.018; Kim TH, 2011, TOHOKU J EXP MED, V223, P45, DOI 10.1620/tjem.223.45; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Li C, 1998, AM J PATHOL, V153, P709, DOI 10.1016/S0002-9440(10)65614-3; MARAZZITI D, 1991, DRUG EXP CLIN RES, V17, P259; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; PILLANS PI, 1995, NEW ZEAL MED J, V108, P382; Poon R, 2001, ONCOGENE, V20, P451, DOI 10.1038/sj.onc.1204107; Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101; Silkstone D, 2008, NAT CLIN PRACT RHEUM, V4, P413, DOI 10.1038/ncprheum0838; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smits R, 1998, GASTROENTEROLOGY, V114, P275, DOI 10.1016/S0016-5085(98)70478-0; Tejpar S, 1999, ONCOGENE, V18, P6615, DOI 10.1038/sj.onc.1203041; Tejpar S, 2001, BRIT J CANCER, V85, P98, DOI 10.1054/bjoc.2001.1857; TISCHLER AS, 1986, J ENDOCRINOL, V110, P309, DOI 10.1677/joe.0.1100309; TOBIN WE, 1972, J CLIN PHARMACOL N D, V12, P230; Varallo VM, 2003, ONCOGENE, V22, P3680, DOI 10.1038/sj.onc.1206415; Verleye M, 2004, BRAIN RES, V1013, P249, DOI 10.1016/j.brainres.2004.04.035; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; WANG RIH, 1979, J CLIN PHARMACOL, V19, P395, DOI 10.1002/j.1552-4604.1979.tb02498.x; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9; Yang JC, 1998, J CLIN ONCOL, V16, P197, DOI 10.1200/JCO.1998.16.1.197; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11	51	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37940	10.1371/journal.pone.0037940	http://dx.doi.org/10.1371/journal.pone.0037940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666417	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400059
J	Brannelly, LA; Chatfield, MWH; Richards-Zawacki, CL				Brannelly, Laura A.; Chatfield, Matthew W. H.; Richards-Zawacki, Corinne L.			Field and Laboratory Studies of the Susceptibility of the Green Treefrog (Hyla cinerea) to Batrachochytrium dendrobatidis Infection	PLOS ONE			English	Article							AMPHIBIAN DECLINES; EMERGING DISEASE; WATER-LOSS; CHYTRIDIOMYCOSIS; MORTALITY; TEMPERATURE; RESISTANCE; IMMUNITY; ECOLOGY; FROGS	Amphibians worldwide are experiencing devastating declines, some of which are due to the amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd). Populations in the southeastern United States, however, have not been noticeably affected by the pathogen. The green treefrog (Hyla cinerea) is abundant and widespread in the southeastern United States, but has not been documented to harbor Bd infection. This study examined the susceptibility of H. cinerea to two strains of Bd in the lab and the prevalence of infection in wild populations of this species in southeastern Louisiana. Although we were able to infect H. cinerea with Bd in the lab, we did not observe any clinical signs of chytridiomycosis. Furthermore, infection by Bd does not appear to negatively affect body condition or growth rate of post-metamorphic individuals. We found no evidence of infection in surveys of wild H. cinerea. Our results suggest that H. cinerea is not susceptible to chytridiomycosis post-metamorphosis and probably is not an important carrier of the fungal pathogen Bd in the southeastern United States, although susceptibility at the larval stage remains unknown.	[Brannelly, Laura A.; Chatfield, Matthew W. H.; Richards-Zawacki, Corinne L.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA	Tulane University	Brannelly, LA (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	lbrannel@tulane.edu	Brannelly, Laura A/V-2589-2019; Richards-Zawacki, Corinne/F-2731-2011	Brannelly, Laura A/0000-0003-2975-9494; Richards-Zawacki, Corinne/0000-0002-4212-041X				Ackleh AS, 2010, ECOL MODEL, V221, P281, DOI 10.1016/j.ecolmodel.2009.10.012; Beasley VR, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P75; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brannelly LA, CLIN TRIALS IN PRESS; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Chatfield MWH, 2011, DIS AQUAT ORGAN, V94, P235, DOI 10.3354/dao02337; Conlon JM, 2011, CELL TISSUE RES, V343, P201, DOI 10.1007/s00441-010-1014-4; FREED AN, 1980, PHYSIOL ZOOL, V53, P433, DOI 10.1086/physzool.53.4.30157881; Gagliardo R., 2008, International Zoo Yearbook, V42, P125, DOI 10.1111/j.1748-1090.2008.00043.x; Gahl MK, 2011, CONSERV BIOL, P1; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Lannoo MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022211; Lehtinen RM, 2006, COPEIA, P159, DOI 10.1643/0045-8511(2006)6[159:TEDOBC]2.0.CO;2; McCallum ML, 2007, HERPETOLOGICA, V63, P269, DOI 10.1655/0018-0831(2007)63[269:PTBIAR]2.0.CO;2; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Richter SC, 2009, COPEIA, P799, DOI 10.1643/CH-09-070; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, pE117; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Timpe Elizabeth K., 2008, Herpetological Review, V39, P447; Voyles J, 2009, PHD THESIS J COOK U; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; WYGODA M, 1988, HERPETOLOGICA, V44, P251; WYGODA ML, 1991, HERPETOLOGICA, V47, P328; WYGODA ML, 1993, HERPETOLOGICA, V49, P365; Zacharow M, 2003, SOUTHEAST NAT, V2, P575, DOI 10.1656/1528-7092(2003)002[0575:UGPPTM]2.0.CO;2	36	21	23	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38473	10.1371/journal.pone.0038473	http://dx.doi.org/10.1371/journal.pone.0038473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685572	gold, Green Published, Green Submitted			2022-12-27	WOS:000305351700035
J	Sun, J; Xia, WB; He, SL; Zhao, Z; Nie, M; Li, M; Jiang, Y; Xing, XP; Wang, O; Meng, XW; Zhou, XY				Sun, Jing; Xia, Weibo; He, Shuli; Zhao, Zhen; Nie, Min; Li, Mei; Jiang, Yan; Xing, Xiaoping; Wang, Ou; Meng, Xunwu; Zhou, Xueying			Novel and Recurrent Mutations of WISP3 in Two Chinese Families with Progressive Pseudorheumatoid Dysplasia	PLOS ONE			English	Article							MEMBER WISP3; CCN FAMILY; IDENTIFICATION; ARTHROPATHY; PROTEINS; GENE	Background: The WNT1-inducible signaling pathway protein 3 (WISP3), which belongs to the CCN (cysteine-rich protein 61, connective tissue growth factor, nephroblastoma overexpressed) family, is a secreted cysteine-rich matricellular protein that is involved in chondrogenesis, osteogenesis and tumorigenesis. WISP3 gene mutations are associated with progressive pseudorheumatoid dysplasia (PPD, OMIM208230), an autosomal recessive genetic disease that is characterized by the swelling of multiple joints and disproportionate dwarfism. Methodology/Principal Findings: Four PPD patients from two unrelated Chinese families were recruited for this study. The clinical diagnosis was confirmed by medical history, physical examinations, laboratory results and radiological abnormalities. WISP3 mutations were detected by direct DNA sequence analysis. In total, four different mutations were identified, which consisted of two missense mutations, one deletion and one insertion that spanned exons 3, 5 and 6 of the WISP3 gene. One of the missense mutations (c.342T>G/p.C114W) and a seven-base pair frameshift deletion (c.716_722del/p.E239fs*16) were novel. The other missense mutation (c.1000T>C/p.S334P) and the insertion mutation (c.866_867insA/p.Q289fs*31) had previously been identified in Chinese patients. All four cases had a compound heterozygous status, and their parents were heterozygous carriers of these mutations. Conclusions/Significance: The results of our study expand the spectrum of WISP3 mutations that are associated with PPD and further elucidate the function of WISP3.	[Sun, Jing; Xia, Weibo; He, Shuli; Zhao, Zhen; Nie, Min; Li, Mei; Jiang, Yan; Xing, Xiaoping; Wang, Ou; Meng, Xunwu; Zhou, Xueying] Chinese Acad Med Sci, Dept Endocrinol, Peking Union Med Coll Hosp, Key Lab Endocrinol,Minist Hlth, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Sun, J (corresponding author), Chinese Acad Med Sci, Dept Endocrinol, Peking Union Med Coll Hosp, Key Lab Endocrinol,Minist Hlth, Beijing, Peoples R China.	xiaweibo@medmail.com.cn			National Science Foundation of China [81070687, 81170805]; National Science and Technology Pillar Program [2006BAI02B03]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2008ZX09312-016]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Pillar Program; National Science and Technology Major Projects for "Major New Drugs Innovation and Development"	This work was supported by the National Science Foundation of China (no. 81070687 and 81170805 for Weibo Xia); National Science and Technology Pillar Program (2006BAI02B03 for Weibo Xia); and National Science and Technology Major Projects for "Major New Drugs Innovation and Development" (grant 2008ZX09312-016 for Weibo Xia). The data collection, analysis, and manuscript preparation were supported by these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Delague V, 2005, AM J MED GENET A, V138A, P118, DOI 10.1002/ajmg.a.30906; Ehl S, 2004, RHEUMATOL INT, V24, P53, DOI 10.1007/s00296-003-0341-0; Fischer J, 1998, HUM GENET, V103, P60, DOI 10.1007/s004390050784; [高惠英 Gao Huiying], 2010, [中华风湿病学杂志, Chinese Journal of Rheumatology], V14, P553; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hurvitz JR, 1999, NAT GENET, V23, P94, DOI 10.1038/12699; Liao E Y, 2004, Hum Genet, V115, P174; Nakamura Y, 2007, J CLIN INVEST, V117, P3075, DOI 10.1172/JCI32001; Peng Yi-qun, 2004, Zhonghua Yi Xue Za Zhi, V84, P1796; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Temiz F, 2011, J PEDIATR ENDOCR MET, V24, P105, DOI 10.1515/JPEM.2011.117; WYNNEDAVIES R, 1982, J BONE JOINT SURG BR, V64, P442, DOI 10.1302/0301-620X.64B4.6807993; Ye Jun, 2010, Zhonghua Er Ke Za Zhi, V48, P194; Yue H, 2009, BONE, V44, P547, DOI 10.1016/j.bone.2008.11.005	14	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38643	10.1371/journal.pone.0038643	http://dx.doi.org/10.1371/journal.pone.0038643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685593	gold, Green Submitted, Green Published			2022-12-27	WOS:000305351700056
J	Oberthuer, A; Donmez, F; Oberhauser, F; Hahn, M; Hoppenz, M; Hoehn, T; Roth, B; Laudes, M				Oberthuer, Andre; Doenmez, Fatma; Oberhaeuser, Frank; Hahn, Moritz; Hoppenz, Marc; Hoehn, Thomas; Roth, Bernhard; Laudes, Matthias			Hypoadiponectinemia in Extremely Low Gestational Age Newborns with Severe Hyperglycemia - A Matched-Paired Analysis	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; ADIPONECTIN LEVELS; RISK-FACTOR; HUMAN-MILK; TERM	Background: Hyperglycemia is commonly observed in extremely low gestational age newborns (ELGANs) and is associated with both increased morbidity and mortality. The objective of this study was to examine the relationship between neonatal hyperglycemia and adiponectin levels in ELGANs. Methodology/Principal Findings: Ten preterm infants between 22+6/7 and 27+3/7 weeks' gestation with neonatal hyperglycemia (defined as pre-feeding blood glucose levels above 200mg/dl on two consecutive measurements with a maximum parenteral glucose infusion of 4mg/kg*min(-1)) formed the case cohort of this study. To every single patient of this case cohort a patient with normal fasting (=pre-feeding) blood glucose levels was matched in terms of gestational age and gender. Adiponectin ELISAs were performed both at onset of hyperglycemia and at term-equivalent age. In the case cohort 9/10 patients had to be treated with insulin for 1-26 days (range 0.01-0.4 IU/kg*h(-1)). Compared to matched-paired controls, significant hypoadiponectinemia was observed at onset of hyperglycemia in these affected patients (6.9 mu g/ml versus 15.1 mu g/ml, p = 0.009). At term equivalent age, normoglycemia without any insulin treatment was found in both groups. Moreover, adiponectin levels at that time were no longer significantly different (12.3 mu g/ml versus 20.0 mu g/ml; p = 0.051) possibly indicating a mechanistic relevance of this adipokine in regulating insulin sensitivity in ELGANs. Conclusions/Significance: Decreased circulating adiponectin levels are correlated with hyperglycemia in ELGANs and may contribute to the pathogenesis of impaired glucose homeostasis in these infants. These findings suggest that adiponectin might be a potential future drug target for the potentially save treatment of hyperglycemia in pre-term infants.	[Oberthuer, Andre; Roth, Bernhard] Univ Cologne, Childrens Hosp, Neonatal & Pediat Intens Care Unit, D-50931 Cologne, Germany; [Doenmez, Fatma; Hoppenz, Marc] City Cologne, Childrens Hosp, Neonatal & Pediat Intens Care Unit, Cologne, Germany; [Oberhaeuser, Frank] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Hahn, Moritz] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Hoehn, Thomas] Univ Dusseldorf, Dept Gen Pediat, Dusseldorf, Germany; [Laudes, Matthias] Univ Hosp Schleswig Holstein, Dept Gen Internal Med, Kiel, Germany	University of Cologne; University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf; University of Kiel; Schleswig Holstein University Hospital	Oberthuer, A (corresponding author), Univ Cologne, Childrens Hosp, Neonatal & Pediat Intens Care Unit, D-50931 Cologne, Germany.	andre.oberthuer@uk-koeln.de	Laudes, Matthias/C-8885-2011					Beardsall K, 2008, NEW ENGL J MED, V359, P1873, DOI 10.1056/NEJMoa0803725; Cianfarani S, 2004, J CLIN ENDOCR METAB, V89, P1346, DOI 10.1210/jc.2003-031704; Hays SP, 2006, PEDIATRICS, V118, P1811, DOI 10.1542/peds.2006-0628; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Kajantie E, 2004, J CLIN ENDOCR METAB, V89, P4031, DOI 10.1210/jc.2004-0018; Kajantie E, 2010, DIABETES CARE, V33, P2623, DOI 10.2337/dc10-0912; Kao LS, 2006, J PERINATOL, V26, P730, DOI 10.1038/sj.jp.7211593; Martin LJ, 2006, AM J CLIN NUTR, V83, P1106, DOI 10.1093/ajcn/83.5.1106; Newburg DS, 2010, J PEDIATR-US, V156, pS41, DOI 10.1016/j.jpeds.2009.11.020; Saito M, 2011, NEONATOLOGY, V100, P93, DOI 10.1159/000322654; Siahanidou T, 2007, ARCH DIS CHILD-FETAL, V92, P286, DOI 10.1136/adc.2006.106112; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Voigt M, 1996, GEBURTSH FRAUENHEILK, V56, P550, DOI 10.1055/s-2007-1023283	13	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38481	10.1371/journal.pone.0038481	http://dx.doi.org/10.1371/journal.pone.0038481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679509	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900047
J	Teixeira, S; Serrao, EA; Arnaud-Haond, S				Teixeira, Sara; Serrao, Ester A.; Arnaud-Haond, Sophie			Panmixia in a Fragmented and Unstable Environment: The Hydrothermal Shrimp Rimicaris exoculata Disperses Extensively along the Mid-Atlantic Ridge	PLOS ONE			English	Article							DEEP-SEA VENT; LARVAL DISPERSAL; POPULATION BOTTLENECKS; MICROSATELLITE MARKERS; MUSSELS BIVALVIA; EASTERN PACIFIC; GENE FLOW; CONNECTIVITY; BRESILIIDAE; DECAPODA	Dispersal plays a fundamental role in the evolution and persistence of species, and especially for species inhabiting extreme, ephemeral and highly fragmented habitats as hydrothermal vents. The Mid-Atlantic Ridge endemic shrimp species Rimicaris exoculata was studied using microsatellite markers to infer connectivity along the 7100-Km range encompassing the sampled sites. Astonishingly, no genetic differentiation was found between individuals from the different geographic origins, supporting a scenario of widespread large-scale dispersal despite the habitat distance and fragmentation. We hypothesize that delayed metamorphosis associated to temperature differences or even active directed migration dependent on physical and/or chemical stimuli could explain these results and warrant further studies on adaptation and dispersal mechanisms.	[Teixeira, Sara; Arnaud-Haond, Sophie] IFREMER, Ctr Brest, DEEP, Brest, France; [Teixeira, Sara; Serrao, Ester A.] Univ Algarve, CIMAR, Ctr Marine Sci, Faro, Portugal	Ifremer; Universidade do Algarve	Teixeira, S (corresponding author), IFREMER, Ctr Brest, DEEP, Brest, France.	steixeira@ualg.pt	Arnaud-Haond, Sophie/B-2479-2008; Teixeira, Sara/M-3424-2013; Serrao, Ester A/C-6686-2012	Arnaud-Haond, Sophie/0000-0001-5814-8452; Teixeira, Sara/0000-0003-0419-2348; Serrao, Ester A/0000-0003-1316-658X	Census of Marine Life project; DeepOases project; ANR (l'Agence Nationale de la Recherche, France); EU; FCT (Fundacao para a Ciencia e a Tecnologia, Portugal)	Census of Marine Life project; DeepOases project; ANR (l'Agence Nationale de la Recherche, France)(French National Research Agency (ANR)); EU(European Commission); FCT (Fundacao para a Ciencia e a Tecnologia, Portugal)(Portuguese Foundation for Science and Technology)	This research was supported by Census of Marine Life project and DeepOases project funded by ANR (l'Agence Nationale de la Recherche, France), the EU FP7 Hermione project, and a postdoctoral fellowship (to ST) from FCT (Fundacao para a Ciencia e a Tecnologia, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DK, 2011, SCIENCE, V332, P580, DOI 10.1126/science.1201066; Allen CE, 2001, MAR ECOL-P S Z N I, V22, P241, DOI 10.1046/j.1439-0485.2001.01755.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Audzijonyte A, 2010, EVOLUTION, V64, P2369, DOI 10.1111/j.1558-5646.2010.00987.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Beerli P, 1999, GENETICS, V152, P763; Beerli Peter, 2009, V17, P42; Belkhir K., 2004, GENETIX 4 05 LOGICIE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRKY CW, 1983, GENETICS, V103, P513; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Copley JTP, 1997, MAR BIOL, V129, P723, DOI 10.1007/s002270050215; Cornuet JM, 1996, GENETICS, V144, P2001; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Creasey S, 1996, MAR BIOL, V125, P473; Daguin C, 2005, MOL ECOL NOTES, V5, P780, DOI 10.1111/j.1471-8286.2005.01061.x; Dixon DR, 1998, CAH BIOL MAR, V39, P383; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faure B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006485; Fusaro AJ, 2008, MOL ECOL RESOUR, V8, P132, DOI 10.1111/j.1471-8286.2007.01897.x; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Herring PJ, 1998, CAH BIOL MAR, V39, P387; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Jollivet D, 1999, EVOLUTION, V53, P1128, DOI 10.1111/j.1558-5646.1999.tb04527.x; Jollivet D, 2000, J MAR BIOL ASSOC UK, V80, P55, DOI 10.1017/S0025315499001563; Khripounoff A, 2008, DEEP-SEA RES PT I, V55, P532, DOI 10.1016/j.dsr.2008.01.001; Kingsford MJ, 2002, B MAR SCI, V70, P309; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; LUTZ RA, 1979, AM ZOOL, V19, P927; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; MARUYAMA T, 1984, GENETICS, V108, P745; Moalic Y, 2012, SYST BIOL, V61, P127, DOI 10.1093/sysbio/syr088; Mullineaux LS, 2010, P NATL ACAD SCI USA, V107, P7829, DOI 10.1073/pnas.0913187107; Nielsen R, 1997, GENETICS, V146, P711; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Plouviez S, 2009, MOL ECOL, V18, P3903, DOI 10.1111/j.1365-294X.2009.04325.x; Pond D, 1997, MAR ECOL PROG SER, V146, P289, DOI 10.3354/meps146289; Pond DW, 1997, MAR ECOL PROG SER, V156, P167, DOI 10.3354/meps156167; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pradillon F, 2001, NATURE, V413, P698, DOI 10.1038/35099674; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RENNINGER GH, 1995, BIOL BULL, V189, P69, DOI 10.2307/1542456; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Shank TM, 1998, MOL MAR BIOL BIOTECH, V7, P88; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Teixeira S, 2011, CONS GENET RES, V4, P84; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; Thurnherr AM, 2008, J MAR RES, V66, P347, DOI 10.1357/002224008786176034; Tyler PA, 2003, HYDROBIOLOGIA, V503, P9, DOI 10.1023/B:HYDR.0000008492.53394.6b; Tyler PA, 2000, J MAR BIOL ASSOC UK, V80, P739, DOI 10.1017/S0025315400002605; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VANDOVER CL, 1989, NATURE, V337, P458, DOI 10.1038/337458a0; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Waser PM, 2011, MOL ECOL, V20, P1277, DOI 10.1111/j.1365-294X.2011.05002.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zelnio KA, 2010, CONSERV GENET RESOUR, V2, P223, DOI 10.1007/s12686-010-9243-0	70	50	52	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38521	10.1371/journal.pone.0038521	http://dx.doi.org/10.1371/journal.pone.0038521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679511	Green Published, gold			2022-12-27	WOS:000305343900054
J	Bista, M; Smithson, D; Pecak, A; Salinas, G; Pustelny, K; Min, J; Pirog, A; Finch, K; Zdzalik, M; Waddell, B; Wladyka, B; Kedracka-Krok, S; Dyer, MA; Dubin, G; Guy, RK				Bista, Michal; Smithson, David; Pecak, Aleksandra; Salinas, Gabriella; Pustelny, Katarzyna; Min, Jaeki; Pirog, Artur; Finch, Kristin; Zdzalik, Michal; Waddell, Brett; Wladyka, Benedykt; Kedracka-Krok, Sylwia; Dyer, Michael A.; Dubin, Grzegorz; Guy, R. Kiplin			On the Mechanism of Action of SJ-172550 in Inhibiting the Interaction of MDM4 and p53	PLOS ONE			English	Article							MOLECULE; RECEPTOR; LIGANDS; PATHWAY	SJ-172550 (1) was previously discovered in a biochemical high throughput screen for inhibitors of the interaction of MDMX and p53 and characterized as a reversible inhibitor (J. Biol. Chem. 2010; 285:10786). Further study of the biochemical mode of action of 1 has shown that it acts through a complicated mechanism in which the compound forms a covalent but reversible complex with MDMX and locks MDMX into a conformation that is unable to bind p53. The relative stability of this complex is influenced by many factors including the reducing potential of the media, the presence of aggregates, and other factors that influence the conformational stability of the protein. This complex mechanism of action hinders the further development of compound 1 as a selective MDMX inhibitor.	[Bista, Michal] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Bista, Michal; Pecak, Aleksandra; Pustelny, Katarzyna; Wladyka, Benedykt] Jagiellonian Univ, Dept Analyt Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Smithson, David; Salinas, Gabriella; Min, Jaeki; Finch, Kristin; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Pirog, Artur; Kedracka-Krok, Sylwia] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland; [Finch, Kristin; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Zdzalik, Michal; Dubin, Grzegorz] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland; [Waddell, Brett] St Jude Childrens Res Hosp, Hartwell Ctr Biotechnol, Memphis, TN 38105 USA; [Kedracka-Krok, Sylwia; Dubin, Grzegorz] Malopolska Ctr Biotechnol, Krakow, Poland; [Dyer, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD USA	Max Planck Society; Jagiellonian University; St Jude Children's Research Hospital; Jagiellonian University; St Jude Children's Research Hospital; Jagiellonian University; St Jude Children's Research Hospital; Jagiellonian University; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute	Bista, M (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	kip.guy@stjude.org	Dubin, Grzegorz/J-8168-2014; Władyka, Benedykt/T-7039-2019; Guy, Rodney/J-7107-2013; Dyer, Michael/N-8134-2018	Dubin, Grzegorz/0000-0002-5535-5760; Władyka, Benedykt/0000-0002-9075-3529; Guy, Rodney/0000-0002-9638-2060; Pustelny, Katarzyna/0000-0001-8430-8608; Min, Jaeki/0000-0002-0083-3198; Bista, Michal/0000-0002-0411-2275; Bista, Michal/0000-0001-9237-1199; Pirog, Artur/0000-0001-5049-043X	Polish National Centre for Research and Development [77/L-1/09]; Polish Ministry of Science and Higher Education [2023/B/P01/2010/39, K/PBW/000676]; European Union [POIG.02.01.00-12-064/08, POIG.02.01.00-12-167/08]; American Lebanese Syrian Associated Charities (ALSAC); St Jude Children's Research Hospital	Polish National Centre for Research and Development; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St Jude Children's Research Hospital	This work was supported by grants 77/L-1/09 from the Polish National Centre for Research and Development (to G.D.); 2023/B/P01/2010/39 (K/PBW/000676) from the Polish Ministry of Science and Higher Education (to S.K.-K.); the European Union structural funds (grants POIG.02.01.00-12-064/08 and POIG.02.01.00-12-167/08); and the American Lebanese Syrian Associated Charities (ALSAC) and St Jude Children's Research Hospital. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LA, 2005, J BIOL CHEM, V280, P43048, DOI 10.1074/jbc.M506693200; Artz JD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-478; Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Bose P, 2009, EXPERT OPIN INV DRUG, V18, P1735, DOI 10.1517/13543780903305428; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v; Hwang JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200436; Hwang JY, 2009, J MED CHEM, V52, P3892, DOI 10.1021/jm9002704; Hwang JY, 2012, J MED CHEM; Kuhn DJ, 2011, CURR CANCER DRUG TAR, V11, P285; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Ocana A, 2009, CANCER TREAT REV, V35, P685, DOI 10.1016/j.ctrv.2009.08.001; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; Reed D, 2010, J BIOL CHEM, V285, P10786, DOI 10.1074/jbc.M109.056747; Senisterra G, 2011, ASSAY DRUG DEV TECHN; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wallentin L, 2009, EUR HEART J, V30, P1964, DOI 10.1093/eurheartj/ehp296; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527	24	43	46	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37518	10.1371/journal.pone.0037518	http://dx.doi.org/10.1371/journal.pone.0037518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675482	gold, Green Published			2022-12-27	WOS:000305341700015
J	Bartpho, T; Wongsurawat, T; Wongratanacheewin, S; Talaat, AM; Karoonuthaisiri, N; Sermswan, RW				Bartpho, Thanatchaporn; Wongsurawat, Thidathip; Wongratanacheewin, Surasakdi; Talaat, Adel M.; Karoonuthaisiri, Nitsara; Sermswan, Rasana W.			Genomic Islands as a Marker to Differentiate between Clinical and Environmental Burkholderia pseudomallei	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; PLASTICITY; MELIOIDOSIS; NORMALIZATION; VIRULENCE; IDENTIFICATION; EPIDEMIOLOGY; STREPTOMYCES; EVOLUTION	Burkholderia pseudomallei, as a saprophytic bacterium that can cause a severe sepsis disease named melioidosis, has preserved several extra genes in its genome for survival. The sequenced genome of the organism showed high diversity contributed mainly from genomic islands (GIs). Comparative genome hybridization (CGH) of 3 clinical and 2 environmental isolates, using whole genome microarrays based on B. pseudomallei K96243 genes, revealed a difference in the presence of genomic islands between clinical and environmental isolates. The largest GI, GI8, of B. pseudomallei was observed as a 2 sub-GI named GIs8.1 and 8.2 with distinguishable %GC content and unequal presence in the genome. GIs8.1, 8.2 and 15 were found to be more common in clinical isolates. A new GI, GI16c, was detected on chromosome 2. Presences of GIs8.1, 8.2, 15 and 16c were evaluated in 70 environmental and 64 clinical isolates using PCR assays. A combination of GIs8.1 and 16c (positivity of either GI) was detected in 70% of clinical isolates and 11.4% of environmental isolates (P<0.001). Using BALB/c mice model, no significant difference of time to mortality was observed between K96243 isolate and three isolates without GIs under evaluation (P>0.05). Some virulence genes located in the absent GIs and the difference of GIs seems to contribute less to bacterial virulence. The PCR detection of 2 GIs could be used as a cost effective and rapid tool to detect potentially virulent isolates that were contaminated in soil.	[Bartpho, Thanatchaporn; Wongratanacheewin, Surasakdi] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Bartpho, Thanatchaporn; Wongratanacheewin, Surasakdi; Sermswan, Rasana W.] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Wongsurawat, Thidathip; Karoonuthaisiri, Nitsara] Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Talaat, Adel M.] Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI USA; [Sermswan, Rasana W.] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Wisconsin System; University of Wisconsin Madison; Khon Kaen University	Bartpho, T (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	rasana@kku.ac.th	Simawaranon Bartpho, Theeraya/GYI-9839-2022; Wongsurawat, Thidathip/K-5590-2019	Simawaranon Bartpho, Theeraya/0000-0001-9803-3588; 	Thailand Research Fund [RMU4980044]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0116/2548]	Thailand Research Fund(Thailand Research Fund (TRF)); Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	Funding was provided by Thailand Research Fund RMU4980044, Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Center of Excellence in Specific Health Problems in Greater Mekong Sub-region cluster (SHeP-GMS), Khon Kaen University, and the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0116/2548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Bengtsson H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-177; Bengtsson H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-100; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Dobrindt U, 2003, J BACTERIOL, V185, P1831, DOI 10.1128/JB.185.6.1831-1840.2003; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Jayapal KP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-229; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Korbsrisate S, 2007, MICROBIOL-SGM, V153, P1907, DOI 10.1099/mic.0.2006/003004-0; Loprasert S, 2003, ARCH MICROBIOL, V180, P498, DOI 10.1007/s00203-003-0621-9; Loprasert S, 2002, GENE, V296, P161, DOI 10.1016/S0378-1119(02)00854-5; Madigan M.T., 2006, BROCK BIOL MICROORGA; Moore RA, 2004, INFECT IMMUN, V72, P4172, DOI 10.1128/IAI.72.7.4172-4187.2004; Ong C, 2004, GENOME RES, V14, P2295, DOI 10.1101/gr.1608904; Palasatien Supapong, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS5, DOI 10.1016/S0035-9203(08)70003-8; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI 10.1128/jb.186.15.5040-5051.2004; Samosornsuk N, 1999, AM J TROP MED HYG, V61, P735, DOI 10.4269/ajtmh.1999.61.735; Sarkar-Tyson M, 2007, J MED MICROBIOL, V56, P1005, DOI 10.1099/jmm.0.47043-0; Sarmiento-Rubiano LA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-504; Sermswan RW, 2001, ACTA TROP, V80, P237, DOI 10.1016/S0001-706X(01)00176-0; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; Song Y, 2005, J BACTERIOL, V187, P785, DOI 10.1128/JB.187.2.785-790.2005; Subsin B, 2003, J BACTERIOL, V185, P7008, DOI 10.1128/JB.185.23.7008-7014.2003; Tan P, 2002, TRENDS MICROBIOL, V10, P484, DOI 10.1016/S0966-842X(02)02465-4; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; Ulett GC, 2001, MICROBES INFECT, V3, P621, DOI 10.1016/S1286-4579(01)01417-4; Vanaporn M, 2008, FEMS MICROBIOL LETT, V284, P191, DOI 10.1111/j.1574-6968.2008.01216.x; Vellasamy KM, 2009, MICROB PATHOGENESIS, V47, P111, DOI 10.1016/j.micpath.2009.06.003; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Weaver D, 2004, MOL MICROBIOL, V51, P1535, DOI 10.1111/j.1365-2958.2003.03920.x; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Woo PCY, 2002, DIAGN MICR INFEC DIS, V44, P143, DOI 10.1016/S0732-8893(02)00439-X; Woods DE, 2002, TRENDS MICROBIOL, V10, P483, DOI 10.1016/S0966-842X(02)02464-2; Wu CW, 2006, J BACTERIOL, V188, P711, DOI 10.1128/JB.188.2.711-723.2006; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	47	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37762	10.1371/journal.pone.0037762	http://dx.doi.org/10.1371/journal.pone.0037762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675491	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900008
J	Clement, JAJ; Magalon, H; Glais, I; Jacquot, E; Andrivon, D				Clement, Julie A. J.; Magalon, Helene; Glais, Isabelle; Jacquot, Emmanuel; Andrivon, Didier			To Be or Not to Be Solitary: Phytophthora infestans' Dilemma for Optimizing its Reproductive Fitness in Multiple Infections	PLOS ONE			English	Article							WITHIN-HOST COMPETITION; INTRASPECIFIC COMPETITION; LATE BLIGHT; VIRULENCE; EVOLUTION; PARASITE; DYNAMICS; EPIDEMIOLOGY; ALLOCATION; SELECTION	The success of parasitic life lies in an optimal exploitation of the host to satisfy key functions directly involved in reproductive fitness. Resource availability generally decreases over time with host mortality, but also during multiple infections, where different strains of parasite share host resources. During multiple infections, the number of parasite strains and their genetic relatedness are known to influence their reproductive rates. Using infections of the potato plant Solanum tuberosum with the parasite Phytophthora infestans, we set up an experimental design to separate dose effects (double-vs. single-site infections) from genetic relatedness (different vs. identical genotypes) on the reproductive fitness of competing parasite genotypes. We showed the existence of two basic response patterns - increase or decrease in reproductive fitness in multiple infections-depending on the parasite genotype. In all cases, the intensity of the response of any genotype depended on the genotype of the competing strain. This diversity of responses to multiple infections is probably maintained by the fluctuating frequencies of multiple infections in nature, arising from variations in disease pressure over the course of an epidemic and between successive epidemics. It allows a rapid response of parasitic populations to changing environments, which are particularly intense in agricultural systems.	[Clement, Julie A. J.; Magalon, Helene; Glais, Isabelle; Jacquot, Emmanuel; Andrivon, Didier] Univ Rennes 1, Agrocampus Ouest, Inst Natl Rech Agron, Inst Genet Environm & Plant Protect, Le Rheu, France	INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes	Clement, JAJ (corresponding author), Univ Perpignan Via Domitia, Ctr Natl Rech Sci, Lab Ecol & Evolut Interact, Perpignan, France.	jajclement@gmail.com	Clement, Julie/P-5978-2017; Magalon, Helene/ABH-1252-2020; Jacquot, Emmanuel/AAH-4367-2021	Magalon, Helene/0000-0002-7061-955X; Clement, Julie A.J./0000-0002-3243-9718	INRA; BBSRC; BIOExploit (EU) [FOOD-CT-2005-513959]; EMERFUNDIS (Agence Nationale de la Recherche) [07-BDIV-003]	INRA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BIOExploit (EU); EMERFUNDIS (Agence Nationale de la Recherche)(French National Research Agency (ANR))	This research was part of the projects 'Invasion and persistence of plant pathogens' funded by INRA and BBSRC, EMERFUNDIS (Agence Nationale de la Recherche grant 07-BDIV-003) and BIOExploit (EU integrated project FOOD-CT-2005-513959). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andanson A, 2010, THESIS U NANCY 1 H P; ANDRIVON D, 1995, PHYTOPATHOLOGY, V85, P1053; Balmer O, 2009, ECOLOGY, V90, P3367, DOI 10.1890/08-2291.1; Bashey F, 2011, OIKOS, V120, P1539, DOI 10.1111/j.1600-0706.2011.19304.x; Bell AS, 2006, EVOLUTION, V60, P1358, DOI 10.1111/j.0014-3820.2006.tb01215.x; Ben-Ami F, 2008, EVOLUTION, V62, P1700, DOI 10.1111/j.1558-5646.2008.00391.x; Bonsall MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012440; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; BULL JJ, 1991, EVOLUTION, V45, P875, DOI [10.1111/j.1558-5646.1991.tb04356.x, 10.2307/2409695]; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Chamberlain M, 1997, ADV BOT RES, V24, P71; Choisy M, 2010, AM NAT, V175, pE105, DOI 10.1086/651587; Clement JAJ, 2010, J EVOLUTIONARY BIOL; Clement JAJ, 2011, REPROD STRATEGY HETE; Crawley M.J., 2007, R BOOK; Davies CM, 2002, PARASITOLOGY, V124, P31, DOI 10.1017/S0031182001008873; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; GALLEGLY ME, 1958, PHYTOPATHOLOGY, V48, P274; Gower CM, 2005, EVOLUTION, V59, P544, DOI 10.1111/j.0014-3820.2005.tb01014.x; Hood ME, 2003, AM NAT, V162, P122, DOI 10.1086/375539; Koskella B, 2006, AM NAT, V168, P121, DOI 10.1086/505770; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Lopez-Villavicencio M, 2011, EVOLUTION, V65, P1357, DOI 10.1111/j.1558-5646.2010.01207.x; Lord CC, 1999, PHILOS T R SOC B, V354, P799, DOI 10.1098/rstb.1999.0432; MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138; Maziero JMN, 2009, PLANT DIS, V93, P459, DOI 10.1094/PDIS-93-5-0459; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Mideo N, 2009, TRENDS PARASITOL, V25, P261, DOI 10.1016/j.pt.2009.03.001; Pariaud B, 2009, PLANT PATHOL, V58, P409, DOI 10.1111/j.1365-3059.2009.02039.x; PERRIN N, 1993, ANNU REV ECOL SYST, V24, P379, DOI 10.1146/annurev.es.24.110193.002115; R Development Core Team, 2005, R LANG ENV STAT COMP; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Robertson NF, 1991, PHYTOPHTHORA INFESTA, V10, P1; Roff Derek A., 1992; Staves PA, 2010, EVOLUTION, V64, P2643, DOI 10.1111/j.1558-5646.2010.00999.x; Stearns S.C., 1992, pi; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; Vizoso DB, 2005, OECOLOGIA, V143, P157, DOI 10.1007/s00442-004-1771-4; Wargo AR, 2007, P ROY SOC B-BIOL SCI, V274, P2629, DOI 10.1098/rspb.2007.0873	43	14	14	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37838	10.1371/journal.pone.0037838	http://dx.doi.org/10.1371/journal.pone.0037838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675493	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339900009
J	Cicek, MS; Cunningham, JM; Fridley, BL; Serie, DJ; Bamlet, WR; Diergaarde, B; Haile, RW; Le Marchand, L; Krontiris, TG; Younghusband, HB; Gallinger, S; Newcomb, PA; Hopper, JL; Jenkins, MA; Casey, G; Schumacher, F; Chen, Z; DeRycke, MS; Templeton, AS; Winship, I; Green, RC; Green, JS; Macrae, FA; Parry, S; Young, GP; Young, JP; Buchanan, D; Thomas, DC; Bishop, DT; Lindor, NM; Thibodeau, SN; Potter, JD; Goode, EL				Cicek, Mine S.; Cunningham, Julie M.; Fridley, Brooke L.; Serie, Daniel J.; Bamlet, William R.; Diergaarde, Brenda; Haile, Robert W.; Le Marchand, Loic; Krontiris, Theodore G.; Younghusband, H. Banfield; Gallinger, Steven; Newcomb, Polly A.; Hopper, John L.; Jenkins, Mark A.; Casey, Graham; Schumacher, Fredrick; Chen, Zhu; DeRycke, Melissa S.; Templeton, Allyson S.; Winship, Ingrid; Green, Roger C.; Green, Jane S.; Macrae, Finlay A.; Parry, Susan; Young, Graeme P.; Young, Joanne P.; Buchanan, Daniel; Thomas, Duncan C.; Bishop, D. Timothy; Lindor, Noralane M.; Thibodeau, Stephen N.; Potter, John D.; Goode, Ellen L.		Colon CFR	Colorectal Cancer Linkage on Chromosomes 4q21, 8q13, 12q24, and 15q22	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DEFECTIVE MISMATCH REPAIR; FAMILIAL COLON-CANCER; SUSCEPTIBILITY LOCI; MICROSATELLITE INSTABILITY; LYNCH-SYNDROME; GENES; SCAN; HEREDITARY; RISK	A substantial proportion of familial colorectal cancer (CRC) is not a consequence of known susceptibility loci, such as mismatch repair (MMR) genes, supporting the existence of additional loci. To identify novel CRC loci, we conducted a genome-wide linkage scan in 356 white families with no evidence of defective MMR (i.e., no loss of tumor expression of MMR proteins, no microsatellite instability (MSI)-high tumors, or no evidence of linkage to MMR genes). Families were ascertained via the Colon Cancer Family Registry multi-site NCI-supported consortium (Colon CFR), the City of Hope Comprehensive Cancer Center, and Memorial University of Newfoundland. A total of 1,612 individuals (average 5.0 per family including 2.2 affected) were genotyped using genome-wide single nucleotide polymorphism linkage arrays; parametric and non-parametric linkage analysis used MERLIN in a priori-defined family groups. Five lod scores greater than 3.0 were observed assuming heterogeneity. The greatest were among families with mean age of diagnosis less than 50 years at 4q21.1 (dominant HLOD = 4.51, alpha = 0.84, 145.40 cM, rs10518142) and among all families at 12q24.32 (dominant HLOD = 3.60, alpha = 0.48, 285.15 cM, rs952093). Among families with four or more affected individuals and among clinic-based families, a common peak was observed at 15q22.31 (101.40 cM, rs1477798; dominant HLOD = 3.07, alpha = 0.29; dominant HLOD = 3.03, alpha = 0.32, respectively). Analysis of families with only two affected individuals yielded a peak at 8q13.2 (recessive HLOD = 3.02, alpha = 0.51, 132.52 cM, rs1319036). These previously unreported linkage peaks demonstrate the continued utility of family-based data in complex traits and suggest that new CRC risk alleles remain to be elucidated.	[Cicek, Mine S.; Cunningham, Julie M.; Fridley, Brooke L.; Serie, Daniel J.; Bamlet, William R.; DeRycke, Melissa S.; Lindor, Noralane M.; Thibodeau, Stephen N.; Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Lab Med & Pathol & Med Genet, Coll Med, Rochester, MN 55905 USA; [Diergaarde, Brenda] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Haile, Robert W.; Casey, Graham; Schumacher, Fredrick; Chen, Zhu; Thomas, Duncan C.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Krontiris, Theodore G.] Beckman Res Inst City Hope, Dept Mol Med, Duarte, CA USA; [Younghusband, H. Banfield; Green, Roger C.; Green, Jane S.] Mem Univ Newfoundland, Fac Med, St John, NF, Canada; [Gallinger, Steven] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Newcomb, Polly A.; Templeton, Allyson S.; Potter, John D.] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Hopper, John L.; Jenkins, Mark A.; Winship, Ingrid] Univ Melbourne, Dept Publ Hlth, Melbourne, Vic 3010, Australia; [Hopper, John L.; Jenkins, Mark A.; Winship, Ingrid] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Macrae, Finlay A.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia; [Parry, Susan] Auckland City Hosp, New Zealand Familial GI Canc Registry, Auckland, New Zealand; [Young, Graeme P.] Flinders Univ S Australia, Flinders Ctr Canc Prevent & Control, Adelaide, SA 5001, Australia; [Young, Joanne P.; Buchanan, Daniel] Queensland Inst Med Res, Familial Canc Lab, Brisbane, Qld 4006, Australia; [Bishop, D. Timothy] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Parry, Susan] Middlemore Hosp, Dept Gastroenterol, Auckland 6, New Zealand	Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; City of Hope; Beckman Research Institute of City of Hope; Memorial University Newfoundland; University of Toronto; Fred Hutchinson Cancer Center; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Auckland City Hospital; Flinders University South Australia; QIMR Berghofer Medical Research Institute; University of Leeds; Massey University	Cicek, MS (corresponding author), Mayo Clin, Dept Hlth Sci Res, Lab Med & Pathol & Med Genet, Coll Med, Rochester, MN 55905 USA.	egoode@mayo.edu	Gallinger, Steven/E-4575-2013; Winship, Ingrid M/D-7204-2016; Jenkins, Mark/P-7803-2015; Young, Joanne P/H-7774-2014; Fridley, Brooke L/D-8315-2015; Schumacher, Fredrick/R-6043-2019	Jenkins, Mark/0000-0002-8964-6160; Fridley, Brooke L/0000-0001-7739-7956; Schumacher, Fredrick/0000-0002-3073-7463; Bishop, Tim/0000-0002-8752-8785; Diergaarde, Brenda/0000-0002-3578-6547; Buchanan, Daniel/0000-0003-2225-6675; Winship, Ingrid/0000-0001-8535-6003; Young, Graeme/0000-0001-9458-8383; Young, Joanne/0000-0002-1514-1522; Potter, John/0000-0001-5439-1500; Bamlet, William/0000-0003-2903-1284	Colon Cancer Family Registry and PIs [R01-CA104667]; NATIONAL CANCER INSTITUTE [U24CA074783, U01CA078296, U24CA074799, P30CA015704, U24CA074800, U01CA097735, U01CA074800, U01CA074783, U24CA074806, R25CA092049, U01CA074794, U24CA074794, U24CA097735, U01CA074806, U01CA074799, R01CA104667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019876] Funding Source: NIH RePORTER; Cancer Research UK [10589] Funding Source: researchfish	Colon Cancer Family Registry and PIs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Research UK(Cancer Research UK)	This work was supported by R01-CA104667 through cooperative agreements with the members of the Colon Cancer Family Registry and PIs. Collaborating centers include the Australian Colorectal Cancer Family Registry (UO1 CA097735), the USC Familial Colorectal Neoplasia Collaborative Group (UO1 CA074799), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (UO1 CA074800), Ontario Registry for Studies of Familial Colorectal Cancer (UO1 CA074783), Seattle Colorectal Cancer Family Registry (UO1 CA074794), University of Hawaii Colorectal Cancer Family Registry (UO1 CA074806), and University of California Irvine Informatics Center (UO1 CA078296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Boland CR, 1998, CANCER RES, V58, P5248; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Daley D, 2008, AM J HUM GENET, V82, P723, DOI 10.1016/j.ajhg.2008.01.007; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Djureinovic T, 2006, GUT, V55, P362, DOI 10.1136/gut.2005.075333; Easton DF, 2003, PROSTATE, V57, P261, DOI 10.1002/pros.10300; Elston RC, 1996, GENET EPIDEMIOL, V13, P535, DOI 10.1002/(SICI)1098-2272(1996)13:6<535::AID-GEPI2>3.3.CO;2-R; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; Goode EL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S82; Gray-McGuire C, 2010, CANCER RES, V70, P5409, DOI 10.1158/0008-5472.CAN-10-0188; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Hemminki K, 2001, BRIT J CANCER, V84, P388, DOI 10.1054/bjoc.2000.1585; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Jenkins MA, 2002, INT J CANCER, V102, P166, DOI 10.1002/ijc.10670; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Kemp ZE, 2006, CANCER RES, V66, P5003, DOI 10.1158/0008-5472.CAN-05-4074; Kemp Z, 2006, HUM MOL GENET, V15, P2903, DOI 10.1093/hmg/ddl231; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Lu L, 2011, PROSTATE; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Middeldorp A, 2010, GENE CHROMOSOME CANC, V49, P539, DOI 10.1002/gcc.20763; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; Neklason DW, 2008, CANCER RES, V68, P8993, DOI 10.1158/0008-5472.CAN-08-1376; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Nomoto H, 2003, J BIOCHEM, V134, P231, DOI 10.1093/jb/mvg135; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ott J., 1999, ANAL HUMAN GENETIC L; Perea J, 2010, WORLD J GASTROENTERO, V16, P3697, DOI 10.3748/wjg.v16.i29.3697; Peters U, 2011, HUMAN GENETICS; Picelli S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-87; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; RISCH N, 1990, AM J HUM GENET, V46, P229; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Siegel R., 2011, CA CANC J CLIN; Skoglund J, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.033928; Stuckless S, 2007, FAM CANCER, V6, P1, DOI 10.1007/s10689-006-0014-8; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Verbeke H, 2011, CYTOKINE GROWTH F R, V22, P345, DOI 10.1016/j.cytogfr.2011.09.002; WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201; Wiesner GL, 2003, P NATL ACAD SCI USA, V100, P12961, DOI 10.1073/pnas.2132286100; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	58	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38175	10.1371/journal.pone.0038175	http://dx.doi.org/10.1371/journal.pone.0038175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675446	Green Published, Green Accepted, gold			2022-12-27	WOS:000305338500103
J	Armeanu-Ebinger, S; Wenz, J; Seitz, G; Leuschner, I; Handgretinger, R; Mau-Holzmann, UA; Bonin, M; Sipos, B; Fuchs, J; Warmann, SW				Armeanu-Ebinger, Sorin; Wenz, Julia; Seitz, Guido; Leuschner, Ivo; Handgretinger, Rupert; Mau-Holzmann, Ulrike A.; Bonin, Michael; Sipos, Bence; Fuchs, Joerg; Warmann, Steven W.			Characterisation of the Cell Line HC-AFW1 Derived from a Pediatric Hepatocellular Carcinoma	PLOS ONE			English	Article							BETA-CATENIN GENE; HUMAN HEPATOBLASTOMA; LIVER-TUMORS; CHILDHOOD; EXPRESSION; CANCER; HETEROZYGOSITY; ESTABLISHMENT; PATHWAYS; CHILDREN	Current treatment of paediatric hepatocellular carcinoma (HCC) is often inefficient due to advanced disease at diagnosis and resistance to common drugs. The aim of this study was to generate a cell line derived from a paediatric HCC in order to expand research in this field. We established the HC-AFW1 cell line from a liver neoplasm of a 4-year-old boy through culturing of primary tumor specimens. The cell line has been stable for over one year of culturing and has a doubling time of 40 h. The tumour cells have an epithelial histology and express HCC-associated proteins such as Alpha-fetoprotein (AFP), Glypican 3, E-cadherin, CD10, CD326, HepPar1 and Vimentin. Forty-nine amino acids in exon 3 of beta-Catenin that involve the phosphorylation sites of GSK3 were absent and beta-Catenin is detectable in the cell nuclei. Cytogenetic analysis revealed large anomalies in the chromosomal map. Several alterations of gene copy numbers were detected by genome-wide SNP array. Among the different drugs tested, cisplatin and irinotecan showed effective inhibition of tumour cell growth in a proliferation assay at concentrations below 5 mu g/ml. Subcutaneous xenotransplantation of HC-AFW1 cells into NOD/SCID mice resulted in fast growing dedifferentiated tumours with high levels of serum AFP. Histological analyses of the primary tumour and xenografts included national and international expert pathological review. Consensus reading characterised the primary tumour and the HC-AFW1-derived tumours as HCC. HC-AFW1 is the first cell line derived from a paediatric HCC without a background of viral hepatitis or cirrhosis and represents a valuable tool for investigating the biology of and therapeutic strategies for childhood HCC.	[Armeanu-Ebinger, Sorin; Wenz, Julia; Seitz, Guido; Fuchs, Joerg; Warmann, Steven W.] Univ Childrens Hosp Tubingen, Dept Pediat Surg & Pediat Urol, Tubingen, Germany; [Leuschner, Ivo] Univ Hosp Schleswig Holstein, Dept Pediat Pathol, Kiel, Germany; [Handgretinger, Rupert] Univ Childrens Hosp, Dept Pediat Oncol Hematol, Tubingen, Germany; [Mau-Holzmann, Ulrike A.; Bonin, Michael] Univ Tubingen, Dept Med Genet, Tubingen, Germany; [Sipos, Bence] Univ Tubingen, Dept Pathol, Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Kiel; Schleswig Holstein University Hospital; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Armeanu-Ebinger, S (corresponding author), Univ Childrens Hosp Tubingen, Dept Pediat Surg & Pediat Urol, Tubingen, Germany.	armeanu@uni-tuebingen.de	Seitz, Guido/G-2742-2015; Seitz, Guido/AAH-5460-2019	Seitz, Prof. Dr. Guido/0000-0001-9280-1451	Department of Pediatric Surgery, University Children's Hospital Tubingen	Department of Pediatric Surgery, University Children's Hospital Tubingen	This work was suported by the Department of Pediatric Surgery, University Children's Hospital Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Adesina AM, 2009, HUM PATHOL, V40, P843, DOI 10.1016/j.humpath.2008.10.022; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179; Brummendorf TH, 2001, ANN NY ACAD SCI, V938, P293; Chen TTL, 2009, PEDIATR BLOOD CANCER, V53, P1040, DOI 10.1002/pbc.22187; Crawley JJ, 2002, GENOME BIOL, V3; Czauderna P, 2002, MED PEDIATR ONCOL, V39, P519, DOI 10.1002/mpo.10178; Czauderna P, 2002, J CLIN ONCOL, V20, P2798, DOI 10.1200/JCO.2002.06.102; DOI I, 1976, GANN, V67, P1; Eicher C, 2011, INT J ONCOL, V38, P447, DOI 10.3892/ijo.2010.860; Fuchs J, 1996, J PEDIATR SURG, V31, P1241, DOI 10.1016/S0022-3468(96)90242-0; Gupta AA, 2011, PEDIATR BLOOD CANCER, V56, P1013, DOI 10.1002/pbc.22893; Kim H, 2000, LIVER, V20, P173, DOI 10.1034/j.1600-0676.2000.020002173.x; Koch A, 1999, CANCER RES, V59, P269; Konnikova L, 2005, CANCER RES, V65, P6516, DOI 10.1158/0008-5472.CAN-05-0924; Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4; Legoix P, 1999, ONCOGENE, V18, P4044, DOI 10.1038/sj.onc.1202800; Lopez-Terrada D, 2009, HUM PATHOL, V40, P1512, DOI 10.1016/j.humpath.2009.07.003; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Miyoshi Y, 1998, CANCER RES, V58, P2524; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; PARK JG, 1995, INT J CANCER, V62, P276, DOI 10.1002/ijc.2910620308; Pietsch T, 1996, LAB INVEST, V74, P809; Prokurat A, 2002, MED PEDIATR ONCOL, V39, P510, DOI 10.1002/mpo.10177; Scheil S, 2003, INT J CANCER, V105, P347, DOI 10.1002/ijc.11082; Schmidt A, 2011, TOXICOLOGY, V281, P7, DOI 10.1016/j.tox.2011.01.006; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Van Nhieu JT, 1999, AM J PATHOL, V155, P703, DOI 10.1016/S0002-9440(10)65168-1; Wang LL, 2010, AM J SURG PATHOL, V34, P287, DOI 10.1097/PAS.0b013e3181ce5f1e; Warmann SW, 2008, J SURG RES, V144, P43, DOI 10.1016/j.jss.2007.03.054; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yu CW, 2006, BIOORG MED CHEM LETT, V16, P1686, DOI 10.1016/j.bmcl.2005.12.019; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	33	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38223	10.1371/journal.pone.0038223	http://dx.doi.org/10.1371/journal.pone.0038223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666492	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400105
J	Bouchard, C; Blair, SN; Church, TS; Earnest, CP; Hagberg, JM; Hakkinen, K; Jenkins, NT; Karavirta, L; Kraus, WE; Leon, AS; Rao, DC; Sarzynski, MA; Skinner, JS; Slentz, CA; Rankinen, T				Bouchard, Claude; Blair, Steven N.; Church, Timothy S.; Earnest, Conrad P.; Hagberg, James M.; Hakkinen, Keijo; Jenkins, Nathan T.; Karavirta, Laura; Kraus, William E.; Leon, Arthur S.; Rao, D. C.; Sarzynski, Mark A.; Skinner, James S.; Slentz, Cris A.; Rankinen, Tuomo			Adverse Metabolic Response to Regular Exercise: Is It a Rare or Common Occurrence?	PLOS ONE			English	Article							RISK REDUCTION INTERVENTION; SUDDEN CARDIAC DEATH; HERITAGE FAMILY; SUBMAXIMAL EXERCISE; PHYSICAL-ACTIVITY; DEFINED EXERCISE; REPRODUCIBILITY; DESIGN; HERITABILITY; AGGREGATION	Background: Individuals differ in the response to regular exercise. Whether there are people who experience adverse changes in cardiovascular and diabetes risk factors has never been addressed. Methodology/Principal Findings: An adverse response is defined as an exercise-induced change that worsens a risk factor beyond measurement error and expected day-to-day variation. Sixty subjects were measured three times over a period of three weeks, and variation in resting systolic blood pressure (SBP) and in fasting plasma HDL-cholesterol (HDL-C), triglycerides (TG), and insulin (FI) was quantified. The technical error (TE) defined as the within-subject standard deviation derived from these measurements was computed. An adverse response for a given risk factor was defined as a change that was at least two TEs away from no change but in an adverse direction. Thus an adverse response was recorded if an increase reached 10 mm Hg or more for SBP, 0.42 mmol/L or more for TG, or 24 pmol/L or more for FI or if a decrease reached 0.12 mmol/L or more for HDL-C. Completers from six exercise studies were used in the present analysis: Whites (N = 473) and Blacks (N = 250) from the HERITAGE Family Study; Whites and Blacks from DREW (N = 326), from INFLAME (N = 70), and from STRRIDE (N = 303); and Whites from a University of Maryland cohort (N = 160) and from a University of Jyvaskyla study (N = 105), for a total of 1,687 men and women. Using the above definitions, 126 subjects (8.4%) had an adverse change in FI. Numbers of adverse responders reached 12.2% for SBP, 10.4% for TG, and 13.3% for HDL-C. About 7% of participants experienced adverse responses in two or more risk factors. Conclusions/Significance: Adverse responses to regular exercise in cardiovascular and diabetes risk factors occur. Identifying the predictors of such unwarranted responses and how to prevent them will provide the foundation for personalized exercise prescription.	[Bouchard, Claude; Sarzynski, Mark A.; Rankinen, Tuomo] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA 70808 USA; [Blair, Steven N.] Univ S Carolina, Dept Exercise Sci & Epidemiol Biostat, Columbia, SC 29208 USA; [Church, Timothy S.; Earnest, Conrad P.] Pennington Biomed Res Ctr, Prevent Med Lab, Baton Rouge, LA USA; [Hagberg, James M.; Jenkins, Nathan T.] Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA; [Hakkinen, Keijo; Karavirta, Laura] Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland; [Kraus, William E.; Slentz, Cris A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Leon, Arthur S.] Univ Minnesota, Sch Kinesiol, Minneapolis, MN USA; [Rao, D. C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Skinner, James S.] Indiana Univ, Bloomington, IN USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University System of Maryland; University of Maryland College Park; University of Jyvaskyla; Duke University; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); Indiana University System; Indiana University Bloomington	Bouchard, C (corresponding author), Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA 70808 USA.	claude.bouchard@pbrc.edu	Bouchard, Claude/A-7637-2009; Rankinen, Tuomo/N-1984-2017; Earnest, Conrad P./M-6849-2017; Bouchard, Claude/AAE-2035-2019; Sarzynski, Mark/A-9798-2014	Bouchard, Claude/0000-0002-0048-491X; Earnest, Conrad P./0000-0002-6546-1268; Karavirta, Laura/0000-0003-1372-2304; Kraus, William E/0000-0003-1930-9684	National Institutes of Health (NIH) [HL-45670, HL-47323, HL-47317, HL-47327, HL-47321, HL-66262, HL-57354, AG-17474, AG-15389, T32 AG00068, T32 AR048523]; John W. Barton, Sr. Chair in Genetics and Nutrition; John S. McIlhenny Chair in Health Wisdom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045670, R01HL057354, R01HL047321, R01HL047317, R01HL047327, R01HL047323, R01HL066262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR048523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015389, R01AG017474] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John W. Barton, Sr. Chair in Genetics and Nutrition; John S. McIlhenny Chair in Health Wisdom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Studies used for this report were supported by multiple grants from the National Institutes of Health (NIH): HL-45670, HL-47323, HL-47317, HL-47327, HL-47321, HL-66262, HL-57354, AG-17474, and AG-15389. C. Bouchard is partially supported by the John W. Barton, Sr. Chair in Genetics and Nutrition. T. Church is partially supported by the John S. McIlhenny Chair in Health Wisdom. N.T. Jenkins was supported by NIH T32 AG00068 and NIH T32 AR048523. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2005, DIABETOLOGIA, V48, P1142, DOI 10.1007/s00125-005-1769-4; Bateman LA, 2011, AM J CARDIOL, V108, P838, DOI 10.1016/j.amjcard.2011.04.037; BOUCHARD C, 1995, MED SCI SPORT EXER, V27, P721; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Boule NG, 2005, DIABETES CARE, V28, P108, DOI 10.2337/diacare.28.1.108; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Despres JP, 1999, CLIN BIOCHEM, V32, P157, DOI 10.1016/S0009-9120(98)00106-4; Gagnon J, 1996, ANN EPIDEMIOL, V6, P520, DOI 10.1016/S1047-2797(96)00068-3; Hong YL, 2000, MED SCI SPORT EXER, V32, P1438, DOI 10.1097/00005768-200008000-00012; Karavirta L, 2011, MED SCI SPORT EXER, V43, P484, DOI 10.1249/MSS.0b013e3181f1bf0d; Katzmarzyk Peter T., 2000, Ethnicity and Disease, V10, P138; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Kraus WE, 2001, MED SCI SPORT EXER, V33, P1774, DOI 10.1097/00005768-200110000-00025; Leon AS, 2002, INT J SPORTS MED, V23, P1, DOI 10.1055/s-2002-19270; Malina R.M., 1973, DHEW PUBLICATION, P73; Morss GM, 2004, MED SCI SPORT EXER, V36, P336, DOI 10.1249/01.MSS.0000113738.06267.E5; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rankinen T, 2002, MED SCI SPORT EXER, V34, P1219, DOI 10.1097/00005768-200208000-00001; Rankinen T, 2012, J APPL PHYSIOL, V112, P892, DOI 10.1152/japplphysiol.01287.2011; Rice T, 2002, MED SCI SPORT EXER, V34, P972, DOI 10.1097/00005768-200206000-00011; Rice T, 2002, CIRCULATION, V105, P1904, DOI 10.1161/01.CIR.0000014969.85364.9F; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; Skinner JS, 1999, MED SCI SPORT EXER, V31, P1623, DOI 10.1097/00005768-199911000-00020; Thompson AM, 2008, CONTEMP CLIN TRIALS, V29, P418, DOI 10.1016/j.cct.2007.09.009; THOMPSON PD, 1984, NEW ENGL J MED, V311, P914, DOI 10.1056/NEJM198410043111410; THOMPSON PD, 1993, MED SCI SPORT EXER, V25, P981; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; U.S.A Department of Health and Human Services, 2008, 2008 ACT GUID AM; Wilmore JH, 1998, MED SCI SPORT EXER, V30, P259, DOI 10.1097/00005768-199802000-00014; Wilmore JH, 1997, INT J OBESITY, V21, P297, DOI 10.1038/sj.ijo.0800404; Wilund KR, 2002, METABOLISM, V51, P1053, DOI 10.1053/meta.2002.33356	33	257	262	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37887	10.1371/journal.pone.0037887	http://dx.doi.org/10.1371/journal.pone.0037887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666405	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400055
J	Koenecke, C; Prinz, I; Bubke, A; Schreder, A; Lee, CW; Pabst, O; Forster, R				Koenecke, Christian; Prinz, Immo; Bubke, Anja; Schreder, Alina; Lee, Chun-Wei; Pabst, Oliver; Foerster, Reinhold			Shift of Graft-Versus-Host-Disease Target Organ Tropism by Dietary Vitamin A	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; BONE-MARROW-TRANSPLANTATION; ALLOREACTIVE T-CELLS; IN-VIVO; CHEMOKINE TECK; RECEPTOR CCR9; MECHANISMS; EXPRESSION; INTEGRIN; TREG	Gut-homing of donor T cells is causative for the development of intestinal GvHD in recipients of allogeneic hematopoietic stem cell transplantation (HSCT). Expression of the gut-specific homing receptors integrin-alpha 4 beta 7 and chemokine receptor CCR9 on T cells is imprinted in gut-associated lymphoid tissues (GALT) under the influence of the vitamin A metabolite retinoic acid. Here we addressed the role of vitamin A deficiency in HSCT-recipients for donor T cell migration in the course of experimental GvHD. Vitamin A-deficient (VAD) mice were prepared by feeding them a vitamin A-depleted diet. Experiments were performed in a C57BL/6 into BALB/c model of acute GvHD. We found that expression of integrin-alpha 4 beta 7 and CCR9 in GALT was reduced in VAD recipients after HSCT. Competitive in vivo homing assays showed that allogeneic T cells primed in VAD mice did not home as efficiently to the intestine as T cells primed in mice fed with standard diet (STD). The course of GvHD was ameliorated in VAD HSCT-recipients and, consequently, their survival was prolonged compared to recipients receiving STD. However, VAD-recipients were not protected and died of clinical GvHD. We found reduced numbers of donor T cells in the intestine but increased cell counts and tissue damage in other organs of VAD-recipients. Furthermore, we observed high IFN-gamma(+)CD4(+) and low FoxP3(+)CD4(+) frequencies of total donor CD4(+) T cells in VAD as compared to STD recipients. Taken together, these results indicate that dietary vitamin A deficiency in HSCT-recipients changed target organ tropism in GvHD but also resulted in fatal inflammation after HSCT.	[Koenecke, Christian; Prinz, Immo; Bubke, Anja; Schreder, Alina; Lee, Chun-Wei; Pabst, Oliver; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany	Hannover Medical School	Koenecke, C (corresponding author), Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany.	koenecke.christian@mh-hannover.de	Förster, Reinhold/D-6770-2011; Prinz, Immo/A-3026-2010; Pabst, Oliver/H-5014-2016; Koenecke, Christian/C-3138-2009	Prinz, Immo/0000-0002-8789-9578; Pabst, Oliver/0000-0002-5533-883X; Koenecke, Christian/0000-0001-7025-1735; Forster, Reinhold/0000-0001-6190-7923	Deutsche Forschungsgemeinschaft [KO 3582/3-1]; Deutsche Krebshilfe [109451];  [SFB738-B5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); 	This work was supported by grants from Deutsche Forschungsgemeinschaft KO 3582/3-1 (CK) URL: www.dfg.de, Deutsche Krebshilfe Nr. 109451 (CK) URL: www.krebshilfe.de, and SFB738-B5 (RF) URL: www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Beilhack A, 2008, BLOOD, V111, P2919, DOI 10.1182/blood-2007-09-112789; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hammerschmidt SI, 2011, J CLIN INVEST, V178, P7211, DOI [10.1172/JCI44262DS1, DOI 10.1172/JCI44262DS1]; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Harrison EH, 2005, ANNU REV NUTR, V25, P87, DOI 10.1146/annurev.nutr.25.050304.092614; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Ichiba T, 2003, BLOOD, V102, P763, DOI 10.1182/blood-2002-09-2748; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kang SG, 2009, GASTROENTEROLOGY, V137, P1391, DOI 10.1053/j.gastro.2009.06.063; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Koenecke C, 2009, EUR J IMMUNOL, V39, P372, DOI 10.1002/eji.200838741; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Menning A, 2010, EUR J IMMUNOL, V40, P2539, DOI 10.1002/eji.200939938; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Petrovic A, 2004, BLOOD, V103, P1542, DOI 10.1182/blood-2003-03-0957; Reddy P, 2008, BIOL BLOOD MARROW TR, V14, P129, DOI 10.1016/j.bbmt.2007.10.021; Sackstein R, 2006, BIOL BLOOD MARROW TR, V12, P2, DOI 10.1016/j.bbmt.2005.09.015; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Seth S, 2011, P NATL ACAD SCI USA, V108, pE32, DOI 10.1073/pnas.1017969108; Seth S, 2011, J IMMUNOL, V186, P3364, DOI 10.4049/jimmunol.1002598; Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669; Tallman MS, 2005, NEW STRATEGIES TREAT, P143, DOI [10.1182/asheducation-2005.1.143, DOI 10.1182/ASHEDUCATION-2005.1.143]; Terwey TH, 2005, BLOOD, V106, P3322, DOI 10.1182/blood-2005-05-1860; Waldman E, 2006, BLOOD, V107, P1703, DOI 10.1182/blood-2005-08-3445; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; YASMINEH WG, 1989, TRANSPLANTATION, V48, P809, DOI 10.1097/00007890-198911000-00017; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598	34	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38252	10.1371/journal.pone.0038252	http://dx.doi.org/10.1371/journal.pone.0038252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666498	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400110
J	Zhou, P; Liu, L; Tong, HC; Dong, XZ				Zhou, Peng; Liu, Lei; Tong, Huichun; Dong, Xiuzhu			Role of Operon aao(So)-mutT in Antioxidant Defense in Streptococcus oligofermentans	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; OXIDATIVE STRESS; LACTOCOCCUS-LACTIS; SP-NOV.; AMINOACETONE; SUPEROXIDE; OXIDASE; MUTANS; ACID; H2O2	Previously, we have found that an insertional inactivation of aao(So), a gene encoding L-amino acid oxidase (LAAO), causes marked repression of the growth of Streptococcus oligofermentans. Here, we found that aao(So) and mutT, a homolog of pyrophosphohydrolase gene of Escherichia coli, constituted an operon. Deletion of either gene did not impair the growth of S. oligofermentans, but double deletion of both aao(So) and mutT was lethal. Quantitative PCR showed that the transcript abundance of mutT was reduced for 13-fold in the aao(So) insertional mutant, indicating that gene polarity derived from the inactivation of aao(So) attenuated the expression of mutT. Enzymatic assays were conducted to determine the biochemical functions of LAAO and MutT of S. oligofermentans. The results indicated that LAAO functioned as an aminoacetone oxidase [47.75 nmol H2O2 (min.mg protein)(-1)]; and MutT showed the pyrophosphohydrolase activity, which removed mutagens such as 8-oxo-dGTP. Like paraquat, aao(So) mutations increased the expression of SOD, and addition of aminoacetone (final concentration, 5 mM) decreased the mutant's growth by 11%, indicating that the aao(So) mutants are under ROS stress. HPLC did reveal elevated levels of cytoplasmic aminoacetone in both the deletion and insertional gene mutants of aao(So). Electron spin resonance spectroscopy showed increased hydroxyl radicals in both types of aao(So) mutant. This demonstrated that inactivation of aao(So) caused the elevation of the prooxidant aminoacetone, resulting the cellular ROS stress. Our study indicates that the presence of both LAAO and MutT can prevent endogenous metabolites-generated ROS and mutagens. In this way, we were able to determine the role of the aao(So)-mutT operon in antioxidant defense in S. oligofermentans.	[Zhou, Peng; Liu, Lei; Tong, Huichun; Dong, Xiuzhu] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Zhou, P (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	Tonghuichun@im.ac.cn; dongxz@im.ac.cn	zhou, peng/S-9353-2019	Zhou, Peng/0000-0002-0221-5967; Zhou, Peng/0000-0001-8619-1124	China National Science Foundation [30870042]	China National Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the China National Science Foundation under grant 30870042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2006, INFECT IMMUN, V74, P1631, DOI 10.1128/IAI.74.3.1631-1642.2006; Barre O, 2007, J BACTERIOL, V189, P5947, DOI 10.1128/JB.00576-07; Bashir Q, 2009, J BIOCHEM, V146, P95, DOI 10.1093/jb/mvp051; Bialkowski K, 1998, NUCLEIC ACIDS RES, V26, P3194, DOI 10.1093/nar/26.13.3194; Buffoni F, 2000, MOL GENET METAB, V71, P559, DOI 10.1006/mgme.2000.3098; CLAPP PA, 1994, FREE RADICAL RES, V21, P147, DOI 10.3109/10715769409056566; Deng YL, 1999, ANAL BIOCHEM, V270, P97, DOI 10.1006/abio.1999.4058; Dong XZ, 2000, INT J SYST EVOL MICR, V50, P119, DOI 10.1099/00207713-50-1-119; Dutra F, 2001, CHEM RES TOXICOL, V14, P1323, DOI 10.1021/tx015526r; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Hiraku Y, 1999, ARCH BIOCHEM BIOPHYS, V365, P62, DOI 10.1006/abbi.1999.1161; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Kalam MA, 2006, NUCLEIC ACIDS RES, V34, P2305, DOI 10.1093/nar/gkl099; Kazachkov M, 2005, J CHROMATOGR B, V824, P116, DOI 10.1016/j.jchromb.2005.07.006; Liu L, 2012, APPL ENV MI IN PRESS; Magnani D, 2008, J BACTERIOL, V190, P536, DOI 10.1128/JB.01481-07; Mao SY, 2009, ANAL BIOCHEM, V384, P20, DOI 10.1016/j.ab.2008.09.029; MARCUS JP, 1993, BIOCHIM BIOPHYS ACTA, V1164, P299, DOI 10.1016/0167-4838(93)90262-P; Marriott HM, 2006, INT J BIOCHEM CELL B, V38, P1848, DOI 10.1016/j.biocel.2006.06.001; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Nakabeppu Y, 2010, MUTAT RES-GEN TOX EN, V703, P51, DOI 10.1016/j.mrgentox.2010.06.006; Nie Z, 2006, MAGN RESON CHEM, V44, P38, DOI 10.1002/mrc.1730; Pericone CD, 2002, J BACTERIOL, V184, P4392, DOI 10.1128/JB.184.16.4392-4399.2002; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; Rodriguez R, 2005, P NATL ACAD SCI USA, V102, P3175, DOI 10.1073/pnas.0500367102; Sartori A, 2008, CHEM RES TOXICOL, V21, P1841, DOI 10.1021/tx8001753; Scardovi V, 1986, BERGEYS MANUAL SYSTE; Scorei R, 2005, BIOL TRACE ELEM RES, V107, P127, DOI 10.1385/BTER:107:2:127; Seki M, 2004, J BACTERIOL, V186, P2046, DOI 10.1128/JB.186.7.2046-2051.2004; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Soonsanga S, 2008, MOL MICROBIOL, V68, P978, DOI 10.1111/j.1365-2958.2008.06200.x; Spolarics Z, 1997, AM J PHYSIOL-GASTR L, V273, pG1304, DOI 10.1152/ajpgi.1997.273.6.G1304; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Tong HC, 2003, INT J SYST EVOL MICR, V53, P1101, DOI 10.1099/ijs.0.02493-0; Tong HC, 2008, J BACTERIOL, V190, P4716, DOI 10.1128/JB.00363-08; Tong HC, 2007, MOL MICROBIOL, V63, P872, DOI 10.1111/j.1365-2958.2006.05546.x; Tong HC, 2006, FEMS MICROBIOL LETT, V264, P213, DOI 10.1111/j.1574-6968.2006.00453.x; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000; Zhu Baoli, 2009, Weishengwu Xuebao, V49, P1341	41	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38133	10.1371/journal.pone.0038133	http://dx.doi.org/10.1371/journal.pone.0038133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666463	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400088
J	Calabrese, F; Guidotti, G; Molteni, R; Racagni, G; Mancini, M; Riva, MA				Calabrese, Francesca; Guidotti, Gianluigi; Molteni, Raffaella; Racagni, Giorgio; Mancini, Michele; Riva, Marco Andrea			Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment	PLOS ONE			English	Article							D-ASPARTATE ANTAGONIST; SYNAPTIC PLASTICITY; TYROSINE PHOSPHORYLATION; GLUTAMATERGIC SYSTEM; NR2B SUBUNIT; DEPRESSION; ALTERS; ANTIDEPRESSANTS; TRAFFICKING; RELEASE	It is now well established that the glutamatergic system contributes to the pathophysiology of depression. Exposure to stress, a major precipitating factor for depression, enhances glutamate release that can contribute to structural abnormalities observed in the brain of depressed subjects. On the other hand, it has been demonstrated that NMDA antagonists, like ketamine, exert an antidepressant effect at preclinical and clinical levels. On these bases, the purpose of our study was to investigate whether chronic mild stress is associated with specific alterations of the NMDA receptor complex, in adult rats, and to establish whether concomitant antidepressant treatment could normalize such deficits. We found that chronic stress increases the expression of the obligatory GluN1 subunit, as well as of the accessory subunits GluN2A and GluN2B at transcriptional and translational levels, particularly in the ventral hippocampus. Concomitant treatment with the antidepressant duloxetine was able to normalize the increase of glutamatergic receptor subunit expression, and correct the changes in receptor phosphorylation produced by stress exposure. Our data suggest that prolonged stress, a condition that has etiologic relevance for depression, may enhance glutamate activity through post-synaptic mechanisms, by regulating NMDA receptors, and that antidepressants may in part normalize such changes. Our results provide support to the notion that antidepressants may exert their activity in the long-term also via modulation of the glutamatergic synapse.	[Calabrese, Francesca; Guidotti, Gianluigi; Molteni, Raffaella; Racagni, Giorgio; Riva, Marco Andrea] Univ Milan, Dept Pharmacol & Biomol Sci, Ctr Neuropharmacol, Milan, Italy; [Mancini, Michele] Eli Lilly Italia SpA, Dept Med, Sesto Fiorentino, Italy; [Racagni, Giorgio; Riva, Marco Andrea] Univ Milan, Ctr Excellence Neurodegenerat Dis, Milan, Italy	University of Milan; Eli Lilly; University of Milan	Calabrese, F (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Ctr Neuropharmacol, Milan, Italy.	M.Riva@unimi.it	Calabrese, Francesca/K-8899-2016; Racagni, Giorgio A./B-5826-2011; Riva, Marco Andrea/N-7418-2017; Molteni, Raffaella/Q-5011-2017	Riva, Marco Andrea/0000-0002-1699-5060; Calabrese, Francesca/0000-0001-7946-2424; Molteni, Raffaella/0000-0002-5481-7572	Ministry of Health [Ricerca Finalizzata RF 2007 conv/42]; Regione Lombardia	Ministry of Health; Regione Lombardia(Regione Lombardia)	This publication was made possible by grants to M. A. Riva from the Ministry of Health (Ricerca Finalizzata RF 2007 conv/42), from Regione Lombardia (Accordo Quadro 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bobula B, 2003, NEUROSCIENCE, V120, P765, DOI 10.1016/S0306-4522(03)00380-4; Bobula B, 2008, PHARMACOL REP, V60, P865; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Bymaster FP, 2005, CURR PHARM DESIGN, V11, P1475, DOI 10.2174/1381612053764805; Calabrese F, 2011, PHARMACOL THERAPEUT, V132, P39, DOI 10.1016/j.pharmthera.2011.05.007; Christian KM, 2011, NEUROSCIENCE, V174, P26, DOI 10.1016/j.neuroscience.2010.11.033; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Du J, 2004, J NEUROSCI, V24, P6578, DOI 10.1523/JNEUROSCI.1258-04.2004; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fontella FU, 2004, NEUROCHEM RES, V29, P1703, DOI 10.1023/B:NERE.0000035805.46592.6c; Fumagalli F, 2010, INT J NEUROPSYCHOPH, V13, P1255, DOI 10.1017/S1461145710000544; Fumagalli F, 2009, J NEUROCHEM, V109, P1733, DOI 10.1111/j.1471-4159.2009.06088.x; Garcia LSB, 2009, PROG NEURO-PSYCHOPH, V33, P450, DOI 10.1016/j.pnpbp.2009.01.004; Krugers HJ, 2010, NAT REV NEUROSCI, V11, P675, DOI 10.1038/nrn2913; Kuzmiski JB, 2010, NAT NEUROSCI, V13, P1257, DOI 10.1038/nn.2629; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; McEwen BS, 2002, EUR PSYCHIAT, V17, p318S; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Musazzi L, 2011, NEUROCHEM INT, V59, P138, DOI 10.1016/j.neuint.2011.05.002; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; NOWAK G, 1993, J PHARMACOL EXP THER, V265, P1380; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Rosenzweig-Lipson S, 2007, PHARMACOL THERAPEUT, V113, P134, DOI 10.1016/j.pharmthera.2006.07.002; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Sessoms-Sikes S, 2005, MOL CELL NEUROSCI, V29, P139, DOI 10.1016/j.mcn.2005.01.006; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Taniguchi S, 2009, EMBO J, V28, P3717, DOI 10.1038/emboj.2009.300; Tata DA, 2008, SYNAPSE, V62, P325, DOI 10.1002/syn.20497; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Uher R, 2008, MOL PSYCHIATR, V13, P1070, DOI 10.1038/mp.2008.92; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	42	77	79	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37916	10.1371/journal.pone.0037916	http://dx.doi.org/10.1371/journal.pone.0037916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666412	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600041
J	Huang, M; Volgushev, M; Wolf, F				Huang, Min; Volgushev, Maxim; Wolf, Fred			A Small Fraction of Strongly Cooperative Sodium Channels Boosts Neuronal Encoding of High Frequencies	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; DYNAMICAL RESPONSE PROPERTIES; PYRAMIDAL NEURONS; NEOCORTICAL NEURONS; NEUROBLASTOMA-CELLS; RYANODINE RECEPTORS; CORTICAL-NEURONS; POPULATION; AXON; BACKPROPAGATION	Generation of action potentials (APs) is a crucial step in neuronal information processing. Existing biophysical models for AP generation almost universally assume that individual voltage-gated sodium channels operate statistically independently, and their avalanche-like opening that underlies AP generation is coordinated only through the transmembrane potential. However, biological ion channels of various types can exhibit strongly cooperative gating when clustered. Cooperative gating of sodium channels has been suggested to explain rapid onset dynamics and large threshold variability of APs in cortical neurons. It remains however unknown whether these characteristic properties of cortical APs can be reproduced if only a fraction of channels express cooperativity, and whether the presence of cooperative channels has an impact on encoding properties of neuronal populations. To address these questions we have constructed a conductance-based neuron model in which we continuously varied the size of a fraction p of sodium channels expressing cooperativity and the strength of coupling between cooperative channels l. We show that starting at a critical value of the coupling strength lambda*, the activation curve of sodium channels develops a discontinuity at which opening of all coupled channels becomes an all-or-none event, leading to very rapid AP onsets. Models with a small fraction, 5-15%, of strongly cooperative channels generate APs with the most rapid onset dynamics. In this regime APs are triggered by simultaneous opening of the cooperative channel fraction and exhibit a pronounced biphasic waveform often observed in cortical neurons. We further show that presence of a small fraction of cooperative Na+ channels significantly improves the ability of neuronal populations to phase-lock their firing to high frequency input fluctuation. We conclude that presence of a small fraction of strongly coupled sodium channels can explain characteristic features of cortical APs and has a functional impact of enhancing the spike encoding of rapidly varying signals.	[Huang, Min; Wolf, Fred] GAUSS, Max Planck Inst Dynam & Self Org, Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Huang, Min; Wolf, Fred] GAUSS, Fac Phys, Gottingen, Germany; [Huang, Min] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Volgushev, Maxim] Univ Connecticut, Dept Psychol, Storrs, CT USA	Max Planck Society; Beijing Normal University; University of Connecticut	Huang, M (corresponding author), GAUSS, Max Planck Inst Dynam & Self Org, Bernstein Ctr Computat Neurosci, Gottingen, Germany.	maxim.volgushev@uconn.edu; fred-wl@nld.ds.mpg.de	Wolf, Fred/D-5771-2011; Volgushev, Maxim/AAO-6793-2020	Wolf, Fred/0000-0002-7068-3762; Volgushev, Maxim/0000-0002-8080-1136	Federal Ministry of Education and Research, Germany [01GQ1005B, 01GQ07113, 01GQ07112]; German-Israeli Foundation for Scientific Research and Development [I-906-17.1/2006]; German Research Foundation [SFB889]; Volkswagenstiftung Stiftung [ZN2632]; Max Planck Society; University of Connecticut; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087631] Funding Source: NIH RePORTER	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); German Research Foundation(German Research Foundation (DFG)); Volkswagenstiftung Stiftung; Max Planck Society(Max Planck Society); University of Connecticut; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the Federal Ministry of Education and Research, Germany (www.bmbf.de, http://www.bmbf.de, grants #01GQ1005B, #01GQ07113, #01GQ07112) and German-Israeli Foundation for Scientific Research and Development (www.gif.org.il, http://www.gif.org.il, grant #I-906-17.1/2006) to MV, FW; German Research Foundation (www.dfg.de, http://www.dfg.de, SFB889), Volkswagenstiftung Stiftung (http://www.volkswagenstiftung.de, #ZN2632) and the Max Planck Society (www.mpg.de, http://www.mpg.de) to FW; and start-up funds from the University of Connecticut to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH RW, 1987, J NEUROSCI, V7, P418; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Badel L, 2008, BIOL CYBERN, V99, P361, DOI 10.1007/s00422-008-0259-4; Baranauskas G, 2010, NEUROSCIENCE, V167, P1070, DOI 10.1016/j.neuroscience.2010.02.072; Baranauskas G, 2006, J NEUROSCI, V26, P671, DOI 10.1523/JNEUROSCI.2283-05.2006; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Boucsein C, 2009, J NEUROSCI, V29, P1006, DOI 10.1523/JNEUROSCI.3424-08.2009; Bray D, 2004, ANNU REV BIOPH BIOM, V33, P53, DOI 10.1146/annurev.biophys.33.110502.132703; Brunel N, 2001, PHYS REV LETT, V86, P2186, DOI 10.1103/PhysRevLett.86.2186; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; ECCLES JC, 1958, J PHYSIOL-LONDON, V143, P11, DOI 10.1113/jphysiol.1958.sp006041; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; IWASA K, 1986, BIOPHYS J, V50, P531, DOI 10.1016/S0006-3495(86)83491-9; Keleshian AM, 2000, BIOPHYS J, V78, P1, DOI 10.1016/S0006-3495(00)76568-4; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P767, DOI 10.1085/jgp.59.6.767; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Kondgen H, 2008, CEREB CORTEX, V18, P2086, DOI 10.1093/cercor/bhm235; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Mathews PJ, 2010, NAT NEUROSCI, V13, P601, DOI 10.1038/nn.2530; Molina ML, 2006, J BIOL CHEM, V281, P18837, DOI 10.1074/jbc.M600342200; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Naundorf B, 2007, NATURE, V445, pE2, DOI 10.1038/nature05534; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Platkiewicz J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000850; POST JA, 1985, BIOCHIM BIOPHYS ACTA, V845, P119, DOI 10.1016/0167-4889(85)90062-X; Schindler H, 1984, Prog Clin Biol Res, V164, P291; Silberberg G, 2004, J NEUROPHYSIOL, V91, P704, DOI 10.1152/jn.00415.2003; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Tchumatchenko T, 2011, J NEUROSCI, V31, P12171, DOI 10.1523/JNEUROSCI.2182-11.2011; UNDROVINAS AI, 1992, CIRC RES, V71, P1231, DOI 10.1161/01.RES.71.5.1231; Wang XJ, 1996, J NEUROSCI, V16, P6402; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	45	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37629	10.1371/journal.pone.0037629	http://dx.doi.org/10.1371/journal.pone.0037629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666374	Green Published, gold			2022-12-27	WOS:000305349600025
J	Fredriksson, K; Fielhaber, JA; Lam, JK; Yao, XL; Meyer, KS; Keeran, KJ; Zywicke, GJ; Qu, X; Yu, ZX; Moss, J; Kristof, AS; Levine, SJ				Fredriksson, Karin; Fielhaber, Jill A.; Lam, Jonathan K.; Yao, Xianglan; Meyer, Katharine S.; Keeran, Karen J.; Zywicke, Gayle J.; Qu, Xuan; Yu, Zu-Xi; Moss, Joel; Kristof, Arnold S.; Levine, Stewart J.			Paradoxical Effects of Rapamycin on Experimental House Dust Mite-Induced Asthma	PLOS ONE			English	Article							MAMMALIAN TARGET; ALLERGIC INFLAMMATION; AIRWAY INFLAMMATION; IN-VITRO; MTOR; SIROLIMUS; PHOSPHORYLATION; EOSINOPHILS; SUPPRESSOR; THERAPY	The mammalian target of rapamycin (mTOR) modulates immune responses and cellular proliferation. The objective of this study was to assess whether inhibition of mTOR with rapamycin modifies disease severity in two experimental murine models of house dust mite (HDM)-induced asthma. In an induction model, rapamycin was administered to BALB/c mice coincident with nasal HDM challenges for 3 weeks. In a treatment model, nasal HDM challenges were performed for 6 weeks and rapamycin treatment was administered during weeks 4 through 6. In the induction model, rapamycin significantly attenuated airway inflammation, airway hyperreactivity (AHR) and goblet cell hyperplasia. In contrast, treatment of established HDM-induced asthma with rapamycin exacerbated AHR and airway inflammation, whereas goblet cell hyperplasia was not modified. Phosphorylation of the S6 ribosomal protein, which is downstream of mTORC1, was increased after 3 weeks, but not 6 weeks of HDM-challenge. Rapamycin reduced S6 phosphorylation in HDM-challenged mice in both the induction and treatment models. Thus, the paradoxical effects of rapamycin on asthma severity paralleled the activation of mTOR signaling. Lastly, mediastinal lymph node re-stimulation experiments showed that treatment of rapamycin-naive T cells with ex vivo rapamycin decreased antigen-specific Th2 cytokine production, whereas prior exposure to in vivo rapamycin rendered T cells refractory to the suppressive effects of ex vivo rapamycin. We conclude that rapamycin had paradoxical effects on the pathogenesis of experimental HDM-induced asthma. Thus, consistent with the context-dependent effects of rapamycin on inflammation, the timing of mTOR inhibition may be an important determinant of efficacy and toxicity in HDM-induced asthma.	[Fredriksson, Karin; Lam, Jonathan K.; Yao, Xianglan; Meyer, Katharine S.; Moss, Joel; Levine, Stewart J.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Keeran, Karen J.; Zywicke, Gayle J.] NHLBI, Lab Anim Med & Surg, NIH, Bethesda, MD 20892 USA; [Qu, Xuan; Yu, Zu-Xi] NHLBI, Pathol Core Facil, NIH, Bethesda, MD 20892 USA; [Fielhaber, Jill A.; Kristof, Arnold S.] McGill Univ, Dept Med, Ctr Hlth, Crit Care Div, Montreal, PQ, Canada; [Fielhaber, Jill A.; Kristof, Arnold S.] McGill Univ, Dept Med, Ctr Hlth, Div Resp, Montreal, PQ, Canada; [Fielhaber, Jill A.; Kristof, Arnold S.] McGill Univ, Meakins Christie Labs, Dept Med, Ctr Hlth, Montreal, PQ, Canada	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); McGill University; McGill University; McGill University	Fredriksson, K (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	levines@nhlbi.nih.gov			Division of Intramural Research of the National Heart, Lung, and Blood Institute of the National Institutes of Health; LAM Foundation; Tuberous Sclerosis Alliance; Canadian Institutes of Health; National Institutes of Health [R01 CA125436]; National Institutes of Health (NIH) [60/528,340]; NATIONAL CANCER INSTITUTE [R01CA125436] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002541, ZIAHL006056, ZIGHL006020, ZICHL005904] Funding Source: NIH RePORTER	Division of Intramural Research of the National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); LAM Foundation; Tuberous Sclerosis Alliance; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Division of Intramural Research of the National Heart, Lung, and Blood Institute of the National Institutes of Health. ASK has received research support from the LAM Foundation, the Tuberous Sclerosis Alliance, the Canadian Institutes of Health, and the National Institutes of Health (R01 CA125436). ASK also has received funding through a National Institutes of Health Intramural Research Program Contract. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.; JM has received royalties from a patent (United States Provisional Patent Application No. 60/528,340 filed 09 Dec 2003) licensed from the National Institutes of Health (NIH) that is related to the topic of this manuscript. ASK has received research support from the LAM Foundation, the Canadian Institutes of Health, and the NIH (R01 CA125436). ASK also has received funding through a NIH Intramural Research Program Contract. ASK has a patent on a topic related to this manuscript (United States Provisional Patent Application No. 60/528,340 filed 09 Dec 2003). SJL has two patents that are unrelated to the topic of this manuscript (United States Patent 7,135,303, Filed February 28, 2001 and United States Patent 7,655,752 B2, Filed March 24, 2006). These competing interests do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the PLoS One guide for authors.	Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; De Alba J, 2010, EUR RESPIR J, V35, P1377, DOI 10.1183/09031936.00022908; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dittrich E, 2004, TRANSPL INT, V17, P215, DOI 10.1007/s00147-004-0700-0; Eynott PR, 2003, IMMUNOLOGY, V109, P461, DOI 10.1046/j.1365-2567.2003.01672.x; Fielhaber JA, 2009, J BIOL CHEM, V284, P24341, DOI 10.1074/jbc.M109.033530; Fujitani Y, 2003, AM J RESP CRIT CARE, V167, P193, DOI 10.1164/rccm.200205-455OC; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hackstein H, 2002, BLOOD, V100, P1084, DOI 10.1182/blood.V100.3.1084; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; Halayko AJ, 2004, AM J RESP CELL MOL, V31, P266, DOI 10.1165/rcmb.2003-0272OC; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; Ho IC, 2009, IMMUNITY, V30, P759, DOI 10.1016/j.immuni.2009.06.002; HOM JT, 1993, CLIN IMMUNOL IMMUNOP, V68, P293, DOI 10.1006/clin.1993.1130; Huang TJ, 2002, EUR J PHARMACOL, V437, P187, DOI 10.1016/S0014-2999(02)01295-5; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Korfhagen TR, 2009, AM J RESP CELL MOL, V41, P562, DOI 10.1165/rcmb.2008-0377OC; Kristof AS, 2010, LYMPHAT RES BIOL, V8, P33, DOI 10.1089/lrb.2009.0019; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Morelon E, 2000, NEW ENGL J MED, V343, P225, DOI 10.1056/NEJM200007203430317; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091; Thaunat O, 2005, TRANSPLANTATION, V80, P1212, DOI 10.1097/01.tp.0000179106.07382.6a; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; Walters EH, 2008, CURR OPIN ALLERGY CL, V8, P39, DOI 10.1097/ACI.0b013e3282f42696; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; Ying S, 1999, J IMMUNOL, V163, P3976; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zhou LM, 2005, AM J RESP CELL MOL, V33, P195, DOI 10.1165/rcmb.2004-0411OC	43	23	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e33984	10.1371/journal.pone.0033984	http://dx.doi.org/10.1371/journal.pone.0033984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22685525	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300002
J	Brown, J; Clasen, T				Brown, Joe; Clasen, Thomas			High Adherence Is Necessary to Realize Health Gains from Water Quality Interventions	PLOS ONE			English	Article							DRINKING-WATER; DEVELOPING-COUNTRIES; DIARRHEA; IMPACT; SANITATION; HOME	Background: Safe drinking water is critical for health. Household water treatment (HWT) has been recommended for improving access to potable water where existing sources are unsafe. Reports of low adherence to HWT may limit the usefulness of this approach, however. Methods and Findings: We constructed a quantitative microbial risk model to predict gains in health attributable to water quality interventions based on a range of assumptions about pre-treatment water quality; treatment effectiveness in reducing bacteria, viruses, and protozoan parasites; adherence to treatment interventions; volume of water consumed per person per day; and other variables. According to mean estimates, greater than 500 DALYs may be averted per 100,000 person-years with increased access to safe water, assuming moderately poor pre-treatment water quality that is a source of risk and high treatment adherence (>90% of water consumed is treated). A decline in adherence from 100% to 90% reduces predicted health gains by up to 96%, with sharpest declines when pre-treatment water quality is of higher risk. Conclusions: Results suggest that high adherence is essential in order to realize potential health gains from HWT.	[Brown, Joe; Clasen, Thomas] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Brown, J (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England.	joe.brown@lshtm.ac.uk			Unilever, Ltd.; Hindustan Unilever, Ltd.	Unilever, Ltd.; Hindustan Unilever, Ltd.	This research was supported in part by Unilever, Ltd., whose subsidiary, Hindustan Unilever, Ltd., (www.hul.co.in) manufactures and sells water treatment products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This study was supported in part by a grant to the London School of Hygiene & Tropical Medicine by Unilever, Ltd., which produces and sells point-of-use water treatment products including the Pureit (R) water filter. Unilever had no role in the design of the study, analysis of the data, or preparation and submission of the manuscript for publication. As an employee of LSHTM and otherwise, TC and JB provide research and consulting services to UN organizations, government agencies, NGOs and private companies that promote water, sanitation and hygiene interventions including point-of-use water treatment products. These include, without limitation, the World Health Organization, UNICEF, the United States Agency for International Development, the Department for International Development, Medentech, Unilever and Vestergaard-Frandsen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2009, DIARRH WHY CHILDR AR; [Anonymous], SAFE WATER ALL HARNE; [Anonymous], 2002, MANAGING WATER HOME; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Blakely T, 2005, B WORLD HEALTH ORGAN, V83, P118; Boisson S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012613; Brown J., 2007, USE CERAMIC WATER FI, Vvol. 1; Brown J, 2008, AM J TROP MED HYG, V79, P394, DOI 10.4269/ajtmh.2008.79.394; CHRISTIAN RR, 1983, APPL ENVIRON MICROB, V45, P603, DOI 10.1128/AEM.45.2.603-609.1983; Clasen T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub2; Clasen TF, 2008, ENVIRON SCI TECHNOL, V42, P4255, DOI 10.1021/es7024802; Colindres RE, 2007, J WATER HEALTH, V5, P367, DOI 10.2166/wh.2007.032; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Haas CN, 1996, WATER RES, V30, P1036, DOI 10.1016/0043-1354(95)00228-6; Havelaar A., 2003, QUANTIFYING PUBLIC H; Hunter PR, 2009, SCI TOTAL ENVIRON, V407, P2621, DOI 10.1016/j.scitotenv.2009.01.018; Luby S, 2001, Int J Infect Dis, V5, P144, DOI 10.1016/S1201-9712(01)90089-X; Mausezahl D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000125; MINTZ ED, 1995, JAMA-J AM MED ASSOC, V273, P948, DOI 10.1001/jama.273.12.948; Mong Y, 2001, AM J PUBLIC HEALTH, V91, P1577, DOI 10.2105/AJPH.91.10.1577; NSF (National Sanitation Foundation now NSF-International), 2003, NSF P231 MICR WAT PU; Onda K, 2012, INT J ENV RES PUB HE, V9, P880, DOI 10.3390/ijerph9030880; Rosa G, 2010, AM J TROP MED HYG, V82, P289, DOI 10.4269/ajtmh.2010.09-0382; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; US Environmental Protection Agency, 1987, GUID STAND PROT TEST; Waddington H., 2009, WATER SANITATION HYG; WHO, 2011, GUID DRINK WAT QUAL; WHO, 2011, EV HOUS WAT TREATM O; WHO UNICEF, 2012, PROGR SAN DRINK WAT; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2007, COMB WAT DIS HOUS LE; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	35	55	55	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36735	10.1371/journal.pone.0036735	http://dx.doi.org/10.1371/journal.pone.0036735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22685574	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305335000052
J	Ekeowa-Anderson, AL; Purdie, KJ; Gibbon, K; Byrne, CR; Arbeit, JM; Harwood, CA; O'Shaughnessy, RFL				Ekeowa-Anderson, Arucha L.; Purdie, Karin J.; Gibbon, Karen; Byrne, Carolyn R.; Arbeit, Jeffrey M.; Harwood, Catherine A.; O'Shaughnessy, Ryan F. L.			AKT1 Loss Correlates with Episomal HPV16 in Vulval Intraepithelial Neoplasia	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; NONMELANOMA SKIN-CANCER; VIRAL INTEGRATION; LESIONS; INFECTION; PCR; IDENTIFICATION; INDIVIDUALS; CARCINOMA; INCREASE	Anogenital malignancy has a significant association with high-risk mucosal alpha-human papillomaviruses (alpha-PV), particularly HPV 16 and 18 whereas extragenital SCC has been linked to the presence of cutaneous beta and gamma-HPV types. Vulval skin may be colonised by both mucosal and cutaneous (beta-, mu-, nu-and gamma-) PV types, but there are few systematic studies investigating their presence and their relative contributions to vulval malignancy. Dysregulation of AKT, a serine/threonine kinase, plays a significant role in several cancers. Mucosal HPV types can increase AKT phosphorylation and activity whereas cutaneous HPV types down-regulate AKT1 expression, probably to weaken the cornified envelope to promote viral release. We assessed the presence of mucosal and cutaneous HPV in vulval malignancy and its relationship to AKT1 expression in order to establish the corresponding HPV and AKT1 profile of normal vulval skin, vulval intraepithelial neoplasia (VIN) and vulval squamous cell carcinoma (vSCC). We show that HPV16 is the principle HPV type present in VIN, there were few detectable beta types present and AKT1 loss was not associated with the presence of these cutaneous HPV. We show that HPV16 early gene expression reduced AKT1 expression in transgenic mouse epidermis. AKT1 loss in our VIN cohort correlated with presence of high copy number, episomal HPV16. Maintained AKT1 expression correlated with low copy number, an increased frequency of integration and increased HPV16E7 expression, a finding we replicated in another untyped cohort of vSCC. Since expression of E7 reflects tumour progression, these findings suggest that AKT1 loss associated with episomal HPV16 may have positive prognostic implications in vulval malignancy.	[Ekeowa-Anderson, Arucha L.; Purdie, Karin J.; Gibbon, Karen; Byrne, Carolyn R.; Harwood, Catherine A.; O'Shaughnessy, Ryan F. L.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Cutaneous Res, London, England; [Ekeowa-Anderson, Arucha L.; Gibbon, Karen] Whipps Cross Univ Hosp, Dept Dermatol, London, England; [O'Shaughnessy, Ryan F. L.] UCL, Inst Child Hlth, Dept Immunobiol, London, England; [O'Shaughnessy, Ryan F. L.] UCL, Inst Child Hlth, Dept Dermatol, London, England; [Arbeit, Jeffrey M.] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Washington University (WUSTL)	Ekeowa-Anderson, AL (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Cutaneous Res, London, England.	r.oshaughnessy@ich.ucl.ac.uk	Arbeit, Jeffrey/K-6920-2019	Harwood, Catherine/0000-0002-1375-0965; O'Shaughnessy, Ryan/0000-0002-3701-0267	Wellcome Trust; Barts and the London Charitable Foundation; Cancer Research UK; British Skin Foundation; Cancer Research UK [13044] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [W0907] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Barts and the London Charitable Foundation; Cancer Research UK(Cancer Research UK); British Skin Foundation; Cancer Research UK(Cancer Research UK); Great Ormond Street Hospital Childrens Charity	ROS is funded by the Wellcome Trust and Barts and the London Charitable Foundation, CB is funded by Cancer Research UK, KJP and CAH are funded by Cancer Research UK, the British Skin Foundation and Barts and the London Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Arron ST, 2011, J INVEST DERMATOL, V131, P1745, DOI 10.1038/jid.2011.91; Davy C, 2009, VIROLOGY, V394, P266, DOI 10.1016/j.virol.2009.08.035; De Koning M, 2005, METH MOLEC MED, V119, P115; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Feltkamp MCW, 2008, J CLIN VIROL, V43, P353, DOI 10.1016/j.jcv.2008.09.009; Flores R, 2006, INT J CANCER, V118, P1187, DOI 10.1002/ijc.21477; Ganguly N, 2009, J BIOSCIENCES, V34, P113, DOI 10.1007/s12038-009-0013-7; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; Harwood CA, 1999, J CLIN MICROBIOL, V37, P3545, DOI 10.1128/JCM.37.11.3545-3555.1999; Harwood CA, 2002, CURR OPIN INFECT DIS, V15, P101, DOI 10.1097/00001432-200204000-00002; Jones RW, 2001, EUR J GYNAECOL ONCOL, V22, P393; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Menges CW, 2006, CANCER RES, V66, P5555, DOI 10.1158/0008-5472.CAN-06-0499; Middleton K, 2003, J VIROL, V77, P10186, DOI 10.1128/JVI.77.19.10186-10201.2003; O'Shaughnessy RFL, 2007, CANCER RES, V67, P8207, DOI 10.1158/0008-5472.CAN-07-0755; O'Shaughnessy RFL, 2007, J BIOL CHEM, V282, P17297, DOI 10.1074/jbc.M610386200; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Potocnik M, 2006, J MED VIROL, V78, P1673, DOI 10.1002/jmv.20753; Raj K, 2004, J VIROL, V78, P7199, DOI 10.1128/JVI.78.13.7199-7207.2004; Schaper ID, 2005, CANCER RES, V65, P1394, DOI 10.1158/0008-5472.CAN-04-3263; Scurry J, 1999, INT J GYNECOL CANCER, V9, P187; Shtilbans V, 2008, ANN DIAGN PATHOL, V12, P153, DOI 10.1016/j.anndiagpath.2007.12.001; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Theelen W, 2010, AM J PATHOL, V177, P2022, DOI 10.2353/ajpath.2010.090901; van de Nieuwenhof HP, 2008, CRIT REV ONCOL HEMAT, V68, P131, DOI 10.1016/j.critrevonc.2008.02.012; Weissenborn SJ, 2003, J CLIN MICROBIOL, V41, P2763, DOI 10.1128/JCM.41.6.2763-2767.2003; Winder DM, 2007, J PATHOL, V213, P27, DOI 10.1002/path.2206	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38608	10.1371/journal.pone.0038608	http://dx.doi.org/10.1371/journal.pone.0038608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685591	Green Submitted, gold, Green Published			2022-12-27	WOS:000305351700054
J	Gould, WA; Heine, SJ				Gould, Wren A.; Heine, Steven J.			Implicit Essentialism: Genetic Concepts Are Implicitly Associated with Fate Concepts	PLOS ONE			English	Article							SOCIAL CATEGORIES; NOVELTY SEEKING; ATTITUDES; COGNITION; BELIEFS; WILL; RESPONSIBILITY; METAANALYSIS; STEREOTYPES; ACTIVATION	Genetic essentialism is the tendency for people to think in more essentialist ways upon encountering genetic concepts. The current studies assessed whether genetic essentialist biases would also be evident at the automatic level. In two studies, using different versions of the Implicit Association Test [1], we found that participants were faster to categorize when genes and fate were linked, compared to when these two concepts were kept separate and opposing. In addition to the wealth of past findings of genetic essentialism with explicit and deliberative measures, these biases appear to be also evident with implicit measures	[Gould, Wren A.; Heine, Steven J.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Gould, WA (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	heine@psych.ubc.ca			Social Science and Humanities Research Council of Canada [410-2011-0409]	Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was funded by the Social Science and Humanities Research Council of Canada, Grant 410-2011-0409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkes HR, 2004, PSYCHOL INQ, V15, P257, DOI 10.1207/s15327965pli1504_01; Atran S, 1998, BEHAV BRAIN SCI, V21, P547, DOI 10.1017/S0140525X98001277; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x; Bluemke M, 2008, EUR J SOC PSYCHOL, V38, P977, DOI 10.1002/ejsp.487; Brescoll V, 2004, PSYCHOL SCI, V15, P515, DOI 10.1111/j.0956-7976.2004.00712.x; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cvencek D, 2011, CHILD DEV, V82, P766, DOI 10.1111/j.1467-8624.2010.01529.x; Dar-Nimrod I, 2006, SCIENCE, V314, P435, DOI 10.1126/science.1131100; Dar-Nimrod I, 2011, AGGRESSIVE BEHAV, V37, P440, DOI 10.1002/ab.20401; Dar-Nimrod I, 2011, PSYCHOL BULL, V137, P800, DOI 10.1037/a0021860; Day L, 2010, DISCOVERY NEWS; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; Feltz A, 2009, MIND LANG, V24, P1, DOI 10.1111/j.1468-0017.2008.01351.x; Gil-White FJ, 2001, CURR ANTHROPOL, V42, P515, DOI 10.1086/321802; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2001, Z EXP PSYCHOL, V48, P85, DOI 10.1026//0949-3946.48.2.85; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363; Johnson W, 2010, CURR DIR PSYCHOL SCI, V19, P177, DOI 10.1177/0963721410370136; Keller J, 2005, J PERS SOC PSYCHOL, V88, P686, DOI 10.1037/0022-3514.88.4.686; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Kluger J, TIME; MEDIN D, 1989, SIMILARITY AND ANALOGICAL REASONING, P179, DOI 10.1017/CBO9780511529863.009; Monterosso J, 2005, ETHICS BEHAV, V15, P139, DOI 10.1207/s15327019eb1502_4; Nichols S, 2007, NOUS, V41, P663, DOI 10.1111/j.1468-0068.2007.00666.x; Nosek BA, 2002, J PERS SOC PSYCHOL, V83, P44, DOI 10.1037//0022-3514.83.1.44; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Paulhus DL, 2011, J PERS ASSESS, V93, P96, DOI 10.1080/00223891.2010.528483; Rangel U, 2011, J PERS SOC PSYCHOL, V100, P1056, DOI 10.1037/a0022401; Rehder B, 2005, COGNITIVE PSYCHOL, V50, P264, DOI 10.1016/j.cogpsych.2004.09.002; Rips J L, 1989, SIMILARITY ANALOGICA, P21, DOI [10.1017/CBO9780511529863.004, DOI 10.1017/CBO9780511529863.004]; Schinka JA, 2002, AM J MED GENET, V114, P643, DOI 10.1002/ajmg.10649; Shostak S, 2009, SOC PSYCHOL QUART, V72, P77, DOI 10.1177/019027250907200107; Taylor MG, 2009, CHILD DEV, V80, P461, DOI 10.1111/j.1467-8624.2009.01272.x; Voland E, 2000, EUR PSYCHOL, V5, P196, DOI 10.1027//1016-9040.5.3.196	37	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38176	10.1371/journal.pone.0038176	http://dx.doi.org/10.1371/journal.pone.0038176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XO	22685554	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700017
J	Leen, EN; Baeza, G; Curry, S				Leen, Eoin N.; Baeza, Gabriela; Curry, Stephen			Structure of a Murine Norovirus NS6 Protease-Product Complex Revealed by Adventitious Crystallisation	PLOS ONE			English	Article							VIRUS 3C PROTEASE; RAY CRYSTALLOGRAPHIC STRUCTURE; DISEASE VIRUS; CRYSTAL-STRUCTURE; CLEAVAGE SITES; NONSTRUCTURAL POLYPROTEIN; 3C-LIKE PROTEASE; BINDING SITE; ACTIVE-SITE; FOOT	Murine noroviruses have emerged as a valuable tool for investigating the molecular basis of infection and pathogenesis of the closely related human noroviruses, which are the major cause of non-bacterial gastroenteritis. The replication of noroviruses relies on the proteolytic processing of a large polyprotein precursor into six non-structural proteins (NS1-2, NS3, NS4, NS5, NS6(pro), NS7(pol)) by the virally-encoded NS6 protease. We report here the crystal structure of MNV NS6(pro), which has been determined to a resolution of 1.6 angstrom. Adventitiously, the crystal contacts are mediated in part by the binding of the C-terminus of NS6(pro) within the peptide-binding cleft of a neighbouring molecule. This insertion occurs for both molecules in the asymmetric unit of the crystal in a manner that is consistent with physiologically-relevant binding, thereby providing two independent views of a protease-peptide complex. Since the NS6(pro) C-terminus is formed in vivo by NS6 pro processing, these crystal contacts replicate the protease-product complex that is formed immediately following cleavage of the peptide bond at the NS6-NS7 junction. The observed mode of binding of the C-terminal product peptide yields new insights into the structural basis of NS6(pro) specificity.	[Leen, Eoin N.; Baeza, Gabriela; Curry, Stephen] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Leen, EN (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England.	s.curry@imperial.ac.uk		Curry, Stephen/0000-0002-0552-8870; Leen, Eoin/0000-0002-1845-5949	Wellcome trust United Kingdom [GR083248]; Biotechnology and Biological Sciences Research Council [BB/J001708/1]; BBSRC [BB/J001708/1] Funding Source: UKRI	Wellcome trust United Kingdom(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Wellcome trust United Kingdom (Ref. GR083248) and the Biotechnology and Biological Sciences Research Council Ref BB/J001708/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Birtley JR, 2005, J BIOL CHEM, V280, P11520, DOI 10.1074/jbc.M413254200; Blakeney SJ, 2003, VIROLOGY, V308, P216, DOI 10.1016/S0042-6822(03)00004-7; Chaudhry Y, 2007, J GEN VIROL, V88, P2091, DOI 10.1099/vir.0.82940-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curry S, 2007, INT J BIOCHEM CELL B, V39, P1, DOI 10.1016/j.biocel.2006.07.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Ettayebi K, 2003, J VIROL, V77, P11790, DOI 10.1128/JVI.77.21.11790-11797.2003; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Hardy ME, 2002, VIRUS RES, V89, P29, DOI 10.1016/S0168-1702(02)00114-4; Hussey RJ, 2010, BIOCHEMISTRY; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kahan SM, 2011, VIROLOGY, V421, P202, DOI 10.1016/j.virol.2011.09.030; Liu BL, 1996, J VIROL, V70, P2605, DOI 10.1128/JVI.70.4.2605-2610.1996; Liu BL, 1999, J GEN VIROL, V80, P291, DOI 10.1099/0022-1317-80-2-291; Lu GW, 2011, J VIROL, V85, P10319, DOI 10.1128/JVI.00787-11; Matthews DA, 1999, P NATL ACAD SCI USA, V96, P11000, DOI 10.1073/pnas.96.20.11000; MATTHEWS DA, 1994, CELL, V77, P761, DOI 10.1016/0092-8674(94)90059-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; Nakamura K, 2005, J VIROL, V79, P13685, DOI 10.1128/JVI.79.21.13685-13693.2005; Ng KKS, 2004, J BIOL CHEM, V279, P16638, DOI 10.1074/jbc.M400584200; Nunn CM, 2005, J MOL BIOL, V350, P145, DOI 10.1016/j.jmb.2005.04.013; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SCHAFFER FL, 1980, J GEN VIROL, V47, P215, DOI 10.1099/0022-1317-47-1-215; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sharp TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013130; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Sosnovtsev SV, 2010, CALICIVIRUSES: MOLECULAR AND CELLULAR VIROLOGY, P65; Sweeney TR, 2007, J VIROL, V81, P115, DOI 10.1128/JVI.01587-06; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; WIRBLICH C, 1995, J VIROL, V69, P7159, DOI 10.1128/JVI.69.11.7159-7168.1995; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Yin J, 2005, J MOL BIOL, V354, P854, DOI 10.1016/j.jmb.2005.09.074; Yunus MA, 2010, J VIROL METHODS, V169, P112, DOI 10.1016/j.jviromet.2010.07.006; Zeitler CE, 2006, J VIROL, V80, P5050, DOI 10.1128/JVI.80.10.5050-5058.2006; Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200; Zunszain PA, 2010, J MOL BIOL, V395, P375, DOI 10.1016/j.jmb.2009.10.048	45	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38723	10.1371/journal.pone.0038723	http://dx.doi.org/10.1371/journal.pone.0038723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685603	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700066
J	Nabuurs, RJA; Rutgers, KS; Welling, MM; Metaxas, A; de Backer, ME; Rotman, M; Bacskai, BJ; van Buchem, MA; van der Maarel, SM; van der Weerd, L				Nabuurs, Rob J. A.; Rutgers, Kim S.; Welling, Mick M.; Metaxas, Athanasios; de Backer, Maaike E.; Rotman, Maarten; Bacskai, Brian J.; van Buchem, Mark A.; van der Maarel, Silvere M.; van der Weerd, Louise			In Vivo Detection of Amyloid-beta Deposits Using Heavy Chain Antibody Fragments in a Transgenic Mouse Model for Alzheimer's Disease	PLOS ONE			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; SINGLE-DOMAIN ANTIBODIES; PLAQUES; BRAIN; MICE; ANGIOPATHY; IMMUNOTHERAPY; PREVENTION; NANOBODIES; PEPTIDES	This study investigated the in vivo properties of two heavy chain antibody fragments (VHH), ni3A and pa2H, to differentially detect vascular or parenchymal amyloid-beta deposits characteristic for Alzheimer's disease and cerebral amyloid angiopathy. Blood clearance and biodistribution including brain uptake were assessed by bolus injection of radiolabeled VHH in APP/PS1 mice or wildtype littermates. In addition, in vivo specificity for A beta was examined in more detail with fluorescently labeled VHH by circumventing the blood-brain barrier via direct application or intracarotid co-injection with mannitol. All VHH showed rapid renal clearance (10-20 min). Twenty-four hours post-injection Tc-99m-pa2H resulted in a small yet significant higher cerebral uptake in the APP/PS1 animals. No difference in brain uptake were observed for Tc-99m-ni3A or DTPA(In-111)-pa2H, which lacked additional peptide tags to investigate further clinical applicability. In vivo specificity for A beta was confirmed for both fluorescently labeled VHH, where pa2H remained readily detectable for 24 hours or more after injection. Furthermore, both VHH showed affinity for parenchymal and vascular deposits, this in contrast to human tissue, where ni3A specifically targeted only vascular A beta. Despite a brain uptake that is as yet too low for in vivo imaging, this study provides evidence that VHH detect A beta deposits in vivo, with high selectivity and favorable in vivo characteristics, making them promising tools for further development as diagnostic agents for the distinctive detection of different A beta deposits.	[Nabuurs, Rob J. A.; Welling, Mick M.; de Backer, Maaike E.; van Buchem, Mark A.; van der Weerd, Louise] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Rutgers, Kim S.; Rotman, Maarten; van der Maarel, Silvere M.; van der Weerd, Louise] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Metaxas, Athanasios] Free Univ Amsterdam, Med Ctr, Radionuclide Ctr, Amsterdam, Netherlands; [Bacskai, Brian J.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Bacskai, Brian J.] Harvard Univ, Sch Med, Charlestown, MA USA; [van der Weerd, Louise] Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Harvard University; Massachusetts General Hospital; Harvard University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nabuurs, RJA (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands.	R.J.A.Nabuurs@LUMC.nl	Bacskai, Brian/AAE-9583-2021; van Buchem, Mark/AAC-9843-2022; Welling, Mick/A-4582-2012; Rotman, Maarten/Q-2349-2019; van der Maarel, Silvere/X-3631-2018; van der Weerd, Louise/B-5421-2014; Metaxas, Athanasios/G-8198-2011	van Buchem, Mark/0000-0003-1881-1998; Welling, Mick/0000-0002-2249-5601; Rotman, Maarten/0000-0002-4987-7298; van der Maarel, Silvere/0000-0001-8103-711X; Metaxas, Athanasios/0000-0002-8747-7068; van der Weerd, Louise/0000-0002-5997-2125	Center for Translational Molecular Medicine, LeARN; Innovatiegericht OnderzoeksProgramma (IOP)Genomics [IGE05005]; Center for Medical Systems Biology, CMSB2; Netherlands Organisation for Scientific Research (NWO) Athena [700.58.801]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER	Center for Translational Molecular Medicine, LeARN; Innovatiegericht OnderzoeksProgramma (IOP)Genomics; Center for Medical Systems Biology, CMSB2; Netherlands Organisation for Scientific Research (NWO) Athena; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Research was supported by: (1) the Center for Translational Molecular Medicine, LeARN, http://www.ctmm.nl; (2) Innovatiegericht OnderzoeksProgramma (IOP)Genomics, IGE05005, http://www.agentschapnl.nl/nl/programmas-regelingen/iop-genomics; (3) the Center for Medical Systems Biology, CMSB2, http://www.cmsb.nl; and (4) The Netherlands Organisation for Scientific Research (NWO) Athena, 700.58.801, http://www.nwo.nl/nwohome.nsf/pages/NWOA_6ZXCX3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Behr TM, 1998, EUR J NUCL MED, V25, P201, DOI 10.1007/s002590050216; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; Chartier A, 2009, HUM MOL GENET, V18, P1849, DOI 10.1093/hmg/ddp101; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gainkam LOT, 2008, J NUCL MED, V49, P788, DOI 10.2967/jnumed.107.048538; Greenberg SM, 2003, NAT MED, V9, P389, DOI 10.1038/nm847; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Huang L, 2010, EXPERT REV MOL DIAGN, V10, P777, DOI 10.1586/ERM.10.62; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jicha GA, 2009, EXPERT OPIN BIOL TH, V9, P481, DOI [10.1517/14712590902828285 , 10.1517/14712590902828285]; Johnson KA, 2007, ANN NEUROL, V62, P229, DOI 10.1002/ana.21164; Klunk WE, 2005, J NEUROSCI, V25, P10598, DOI 10.1523/JNEUROSCI.2990-05.2005; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Leskovjan AC, 2009, NEUROIMAGE, V47, P1215, DOI 10.1016/j.neuroimage.2009.05.063; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Natte R, 2001, ANN NEUROL, V50, P765, DOI 10.1002/ana.10040; Richardson James A, 2002, ILAR J, V43, P89; Robbins EM, 2006, J NEUROSCI, V26, P365, DOI 10.1523/JNEUROSCI.3854-05.2006; Rutgers KS, 2011, NEUROSCIENCE, V190, P37, DOI 10.1016/j.neuroscience.2011.05.076; Rutgers KS, 2011, NEUROBIOL AGING, V32, P1774, DOI 10.1016/j.neurobiolaging.2009.11.012; Skoch J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1846075; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; van Groen T, 2006, NEUROBIOL DIS, V23, P653, DOI 10.1016/j.nbd.2006.05.010; Verheesen P, 2006, HUM MOL GENET, V15, P105, DOI 10.1093/hmg/ddi432; Wadghiri Youssef Zaim, 2004, V299, P365; Weller RO, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt6; Welling MM, 2005, J LABELLED COMPD RAD, V48, P683, DOI 10.1002/jlcr.961; Welling MM, 2000, EUR J NUCL MED, V27, P292, DOI 10.1007/s002590050036	41	31	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38284	10.1371/journal.pone.0038284	http://dx.doi.org/10.1371/journal.pone.0038284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675537	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700056
J	Roy, A; Bauer, SM; Lawrence, BP				Roy, Anirban; Bauer, Stephen M.; Lawrence, B. Paige			Developmental Exposure to Bisphenol A Modulates Innate but Not Adaptive Immune Responses to Influenza A Virus Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; T-CELL RESPONSES; IN-VITRO; PERINATAL EXPOSURE; INTERFERON-GAMMA; DENDRITIC CELLS; TOBACCO-SMOKE; HUMAN HEALTH; CD8(+); ACTIVATION	Bisphenol A (BPA) is used in numerous products, such as plastic bottles and food containers, from which it frequently leaches out and is consumed by humans. There is a growing public concern that BPA exposure may pose a significant threat to human health. Moreover, due to the widespread and constant nature of BPA exposure, not only adults but fetuses and neonates are also exposed to BPA. There is mounting evidence that developmental exposures to chemicals from our environment, including BPA, contribute to diseases late in life; yet, studies of how early life exposures specifically alter the immune system are limited. Herein we report an examination of how maternal exposure to a low, environmentally relevant dose of BPA affects the immune response to infection with influenza A virus. We exposed female mice during pregnancy and through lactation to the oral reference dose for BPA listed by the US Environmental Protection Agency, and comprehensively examined immune parameters directly linked to disease outcomes in adult offspring following infection with influenza A virus. We found that developmental exposure to BPA did not compromise disease-specific adaptive immunity against virus infection, or reduce the host's ability to clear the virus from the infected lung. However, maternal exposure to BPA transiently reduced the extent of infection-associated pulmonary inflammation and anti-viral gene expression in lung tissue. From these observations, we conclude that maternal exposure to BPA slightly modulates innate immunity in adult offspring, but does not impair the anti-viral adaptive immune response, which is critical for virus clearance and survival following influenza virus infection.	[Roy, Anirban; Bauer, Stephen M.; Lawrence, B. Paige] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14627 USA	University of Rochester	Roy, A (corresponding author), Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14627 USA.	Paige_lawrence@urmc.rochester.edu			National Institutes of Health (NIH) [RC2-ES018750, R01-ES017250, R01-HL097141, T32-ES07026, T32-HL066988, P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097141, T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, R01ES017250, RC2ES018750, T32ES007026] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the following National Institutes of Health (NIH) grants: RC2-ES018750, R01-ES017250, R01-HL097141, T32-ES07026, T32-HL066988, and P30-ES01247. The funders had no role in data collection, analysis, decision to publish or preparation of this manuscript. In conjunction with other scientists examining potential health effects of early life BPA exposure, the National Institute of Environmental Health Science (NIEHS) coordinated meetings of grantees, who jointly agreed upon exposure dose ranges, time frame, and proper environmental controls to minimize BPA exposure from animal housing and feed.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Ayyanan A, 2011, MOL ENDOCRINOL, V25, P1915, DOI 10.1210/me.2011-1129; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Betts RJ, 2012, J VIROL, V86, P2817, DOI 10.1128/JVI.05685-11; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Dietert RR, 2009, CHEM RES TOXICOL, V22, P17, DOI 10.1021/tx800198m; Fernandez MA, 2008, J IMMUNOL, V180, P1556, DOI 10.4049/jimmunol.180.3.1556; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Gallo D, 2008, MENOPAUSE, V15, P718, DOI 10.1097/gme.0b013e318167b92a; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Glasser R, 2009, J ALLERGY CLIN IMMUN, V123, P1117, DOI 10.1016/j.jaci.2009.01.043; Golub MS, 2010, BIRTH DEFECTS RES B, V89, P441, DOI 10.1002/bdrb.20275; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2136, DOI 10.1271/bbb.70004; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Guo HC, 2010, CELL MOL IMMUNOL, V7, P227, DOI 10.1038/cmi.2010.14; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Heilmann C, 2006, PLOS MED, V3, P1352, DOI 10.1371/journal.pmed.0030311; Heilmann C, 2010, ENVIRON HEALTH PERSP, V118, P1434, DOI 10.1289/ehp.1001975; Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487; Integrated Risk Information System United States Environmental Protection Agency (EPA), BISPH A CASRN 80 05; Jin GB, 2010, TOXICOL SCI, V116, P514, DOI 10.1093/toxsci/kfq153; Karupiah G, 1998, J EXP MED, V188, P1541, DOI 10.1084/jem.188.8.1541; Kim JY, 2003, CANCER LETT, V196, P69, DOI 10.1016/S0304-3835(03)00219-2; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lawrence BP, 2007, VIRAL IMMUNOL, V20, P231, DOI 10.1089/vim.2007.0013; Lawrence BP, 2006, J IMMUNOL, V177, P5819, DOI 10.4049/jimmunol.177.9.5819; Lawrence BP, 2004, TOXICOL SCI, V79, P304, DOI 10.1093/toxsci/kfh094; Lawrence BP, 2000, J TOXICOL ENV HEAL A, V61, P39, DOI 10.1080/00984100050116771; Lee MH, 2003, IMMUNOLOGY, V109, P76, DOI 10.1046/j.1365-2567.2003.01631.x; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Midoro-Horiuti T, 2010, ENVIRON HEALTH PERSP, V118, P273, DOI 10.1289/ehp.0901259; Mielke H, 2009, TOXICOL LETT, V190, P32, DOI 10.1016/j.toxlet.2009.06.861; Miller TE, 1998, TOXICOL SCI, V42, P129, DOI 10.1093/toxsci/42.2.129; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Mortaz E, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-47; *NIH, 2008, NIH PUBL; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA479, DOI 10.1016/j.autrev.2011.11.022; Ohshima Y, 2007, PEDIATR RES, V62, P60, DOI 10.1203/PDR.0b013e3180674dae; Padmanabhan V, 2008, J PERINATOL, V28, P258, DOI 10.1038/sj.jp.7211913; Penn AL, 2007, ENVIRON HEALTH PERSP, V115, P548, DOI 10.1289/ehp.9780; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; Raherison C, 2007, RESP MED, V101, P107, DOI 10.1016/j.rmed.2006.04.010; Rangel-Moreno J, 2008, J IMMUNOL, V180, P454, DOI 10.4049/jimmunol.180.1.454; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Roy A, 2007, J VIROL, V81, P1110, DOI 10.1128/JVI.01964-06; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryan LK, 2000, PHOTOCHEM PHOTOBIOL, V72, P497, DOI 10.1562/0031-8655(2000)072<0497:ETUREM>2.0.CO;2; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Sawai C, 2003, ENVIRON HEALTH PERSP, V111, P1883, DOI 10.1289/ehp.6359; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Sharkhuu T, 2011, J IMMUNOTOXICOL, V8, P183, DOI 10.3109/1547691X.2011.568978; Sharkhuu T, 2010, TOXICOL LETT, V196, P12, DOI 10.1016/j.toxlet.2010.03.017; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Sugita-Konishi Y, 2003, TOXICOL LETT, V136, P217, DOI 10.1016/S0378-4274(02)00388-0; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Takahashi O, 2000, ENVIRON HEALTH PERSP, V108, P931, DOI 10.2307/3435050; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Teske S, 2005, AM J PHYSIOL-LUNG C, V289, pL111, DOI 10.1152/ajplung.00318.2004; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vandenberg LN, 2008, REPROD TOXICOL, V26, P210, DOI 10.1016/j.reprotox.2008.09.015; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Winans B, 2011, REPROD TOXICOL, V31, P327, DOI 10.1016/j.reprotox.2010.09.004; Wolstenholme JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025448; Yan HM, 2008, ENVIRON HEALTH PERSP, V116, P514, DOI 10.1289/ehp.10829; Yin DQ, 2007, J ENVIRON SCI, V19, P232, DOI 10.1016/S1001-0742(07)60038-2; Yoshino S, 2004, IMMUNOLOGY, V112, P489, DOI 10.1111/j.1365-2567.2004.01900.x	76	31	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38448	10.1371/journal.pone.0038448	http://dx.doi.org/10.1371/journal.pone.0038448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675563	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700075
J	Saul, MC; Gessay, GM; Gammie, SC				Saul, Michael C.; Gessay, Griffin M.; Gammie, Stephen C.			A New Mouse Model for Mania Shares Genetic Correlates with Human Bipolar Disorder	PLOS ONE			English	Article							GENOME-WIDE SCAN; REAL-TIME PCR; SINGLE-NUCLEOTIDE POLYMORPHISMS; CONVERGENT FUNCTIONAL GENOMICS; WHEEL-RUNNING BEHAVIOR; ANIMAL-MODEL; LINKAGE SCAN; GLN460ARG POLYMORPHISM; SUSCEPTIBILITY LOCUS; SUGGESTIVE LINKAGE	Bipolar disorder (BPD) is a debilitating heritable psychiatric disorder. Contemporary rodent models for the manic pole of BPD have primarily utilized either single locus transgenics or treatment with psychostimulants. Our lab recently characterized a mouse strain termed Madison (MSN) that naturally displays a manic phenotype, exhibiting elevated locomotor activity, increased sexual behavior, and higher forced swimming relative to control strains. Lithium chloride and olanzapine treatments attenuate this phenotype. In this study, we replicated our locomotor activity experiment, showing that MSN mice display generationally-stable mania relative to their outbred ancestral strain, hsd:ICR (ICR). We then performed a gene expression microarray experiment to compare hippocampus of MSN and ICR mice. We found dysregulation of multiple transcripts whose human orthologs are associated with BPD and other psychiatric disorders including schizophrenia and ADHD, including: Epor, Smarca4, Cmklr1, Cat, Tac1, Npsr1, Fhit, and P2rx7. RT-qPCR confirmed dysregulation for all of seven transcripts tested. Using a novel genome enrichment algorithm, we found enrichment in genome regions homologous to human loci implicated in BPD in replicated linkage studies including homologs of human cytobands 1p36, 3p14, 3q29, 6p21-22, 12q24, 16q24, and 17q25. Using a functional network analysis, we found dysregulation of a gene system related to chromatin packaging, a result convergent with recent human findings on BPD. Our findings suggest that MSN mice represent a polygenic model for the manic pole of BPD showing much of the genetic systems complexity of the corresponding human disorder. Further, the high degree of convergence between our findings and the human literature on BPD brings up novel questions about evolution by analogy in mammalian genomes.	[Saul, Michael C.; Gessay, Griffin M.; Gammie, Stephen C.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Gammie, Stephen C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Saul, MC (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	csaul@wisc.edu	Saul, Michael C./N-9303-2019	Saul, Michael C./0000-0002-4916-8619	University of Wisconsin-Madison Vilas Associate's Award; National Institutes of Health [MH0856427]	University of Wisconsin-Madison Vilas Associate's Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported primarily by a University of Wisconsin-Madison Vilas Associate's Award to SCG. Additional funding was provided by a National Institutes of Health R01 to SCG (MH0856427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Jamra R, 2007, AM J HUM GENET, V81, P974, DOI 10.1086/521690; Andreazza AC, 2007, J PSYCHIATR RES, V41, P523, DOI 10.1016/j.jpsychires.2006.07.013; Angst J, 2003, EUR NEUROPSYCHOPHARM, V13, pS43, DOI 10.1016/S0924-977X(03)00077-4; Badenhop R, 2002, MOL PSYCHIATR, V7, P851, DOI 10.1038/sj.mp.4001114; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Baum AE, 2008, MOL PSYCHIATR, V13, P466, DOI 10.1038/mp.2008.16; BERGGREN U, 1981, J NEURAL TRANSM, V50, P157, DOI 10.1007/BF01249137; BERRETTINI WH, 1985, BIOL PSYCHIAT, V20, P965, DOI 10.1016/0006-3223(85)90193-3; Bertolino A, 2003, BIOL PSYCHIAT, V53, P906, DOI 10.1016/S0006-3223(02)01911-X; Bondy B, 2003, BIOL PSYCHIAT, V53, P538, DOI 10.1016/S0006-3223(02)01544-5; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; BOWMAN MB, 1982, NEUROSCI BIOBEHAV R, V6, P321, DOI 10.1016/0149-7634(82)90044-6; Braw Y, 2006, PSYCHONEUROENDOCRINO, V31, P1105, DOI 10.1016/j.psyneuen.2006.07.003; Bronikowski AM, 2004, EVOLUTION, V58, P2079, DOI 10.1111/j.0014-3820.2004.tb00491.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buttenchon HN, 2010, PSYCHIAT GENET, V20, P93, DOI 10.1097/YPG.0b013e32833a2066; Cheng R, 2006, MOL PSYCHIATR, V11, P252, DOI 10.1038/sj.mp.4001778; Crow TJ, 2007, AM J PSYCHIAT, V164, P13, DOI 10.1176/appi.ajp.164.1.13; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; Detera-Wadleigh SD, 2011, PHARMACOPSYCHIATRY, V44, pS35, DOI 10.1055/s-0031-1275275; Detera-Wadleigh SD, 1999, AM J MED GENET, V88, P255, DOI 10.1002/(SICI)1096-8628(19990618)88:3<255::AID-AJMG8>3.0.CO;2-V; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Doyle AE, 2010, J AM ACAD CHILD PSY, V49, P378, DOI 10.1016/j.jaac.2010.01.008; Edgar PF, 2000, MOL PSYCHIATR, V5, P85, DOI 10.1038/sj.mp.4000580; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Einat H, 2006, J PSYCHOPHARMACOL, V20, P714, DOI 10.1177/0269881106060241; Etain B, 2006, MOL PSYCHIATR, V11, P685, DOI 10.1038/sj.mp.4001815; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; Ewald H, 2005, AM J MED GENET B, V133B, P25, DOI 10.1002/ajmg.b.30106; Ewald H, 1998, PSYCHIATR GENET, V8, P131, DOI 10.1097/00041444-199800830-00002; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Fatemi SH, 2000, MOL PSYCHIATR, V5, P571, DOI 10.1038/sj.mp.4000794; Flaisher-Grinberg S, 2010, J PSYCHOPHARMACOL, V24, P437, DOI 10.1177/0269881108097905; Flaisher-Grinberg Shlomit, 2010, Front Psychiatry, V1, P10, DOI 10.3389/fpsyt.2010.00010; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde; Frey BN, 2007, PROG NEURO-PSYCHOPH, V31, P283, DOI 10.1016/j.pnpbp.2006.06.011; Fullerton JM, 2010, BIOL PSYCHIAT, V67, P478, DOI 10.1016/j.biopsych.2009.10.022; FURUKAWA T, 1975, PSYCHOPHARMACOLOGIA, V42, P243, DOI 10.1007/BF00421263; Gammie SC, 2003, HORM BEHAV, V44, P209, DOI 10.1016/S0018-506X(03)00140-5; Gammie SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001974; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gershon ES, 2011, AM J PSYCHIAT, V168, P253, DOI 10.1176/appi.ajp.2010.10091340; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Hannah-Poquette C, 2011, BEHAV BRAIN RES, V223, P222, DOI 10.1016/j.bbr.2011.04.047; Harrison-Read PE, 2009, J PSYCHOPHARMACOL, V23, P334, DOI 10.1177/0269881108089840; Hasegawa S, 2006, NEUROCHEM INT, V48, P358, DOI 10.1016/j.neuint.2005.11.012; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kandaswamy R, 2012, AM J MED GENET B, V159B, P201, DOI 10.1002/ajmg.b.32014; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Le-Niculescu H, 2007, NEUROSCI BIOBEHAV R, V31, P897, DOI 10.1016/j.neubiorev.2007.05.008; Lien YJ, 2010, AM J MED GENET B, V153B, P1, DOI 10.1002/ajmg.b.30948; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Lyons-Warren A, 2005, MOL PSYCHIATR, V10, P807, DOI 10.1038/sj.mp.4001703; MAES M, 1992, J AFFECT DISORDERS, V24, P183, DOI 10.1016/0165-0327(92)90066-F; Mahon PB, 2011, AM J MED GENET B, V156B, P370, DOI 10.1002/ajmg.b.31172; Marcheco-Teruel B, 2006, AM J MED GENET B, V141B, P833, DOI 10.1002/ajmg.b.30314; McCarthy MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032091; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; McQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Miskowiak KW, 2012, PSYCHOPHARMACOLOGY, V219, P687, DOI 10.1007/s00213-011-2511-1; Miskowiak KW, 2009, PSYCHOPHARMACOLOGY, V207, P133, DOI 10.1007/s00213-009-1641-1; Nagy G, 2008, PROG NEURO-PSYCHOPH, V32, P1884, DOI 10.1016/j.pnpbp.2008.08.021; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; OVERSTREET DH, 1995, PSYCHOPHARMACOLOGY, V121, P27, DOI 10.1007/BF02245589; Pato CN, 2004, AM J MED GENET B, V127B, P30, DOI 10.1002/ajmg.b.30001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; REGLAND B, 1994, J NEURAL TRANSM-GEN, V98, P143, DOI 10.1007/BF01277017; Reinscheid RK, 2005, FEBS J, V272, P5689, DOI 10.1111/j.1742-4658.2005.04982.x; Reinscheid RK, 2005, MOL INTERV, V5, P42, DOI 10.1124/mi5.1.8; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1243, DOI 10.1037/0735-7044.117.6.1243; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; Romanos M, 2008, MOL PSYCHIATR, V13, P522, DOI 10.1038/mp.2008.12; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Rudan I, 2010, PSYCHIAT DANUB, V22, P190; Schosser A, 2004, J PSYCHIATR RES, V38, P357, DOI 10.1016/j.jpsychires.2003.11.004; Schulze TG, 2004, BIOL PSYCHIAT, V56, P18, DOI 10.1016/j.biopsych.2004.04.004; Schumacher J, 2005, AM J HUM GENET, V77, P1102, DOI 10.1086/498619; Scotti MAL, 2011, PHYSIOL BEHAV, V103, P376, DOI 10.1016/j.physbeh.2011.03.005; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Serretti A, 2008, MOL PSYCHIATR, V13, P742, DOI 10.1038/mp.2008.29; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; Tomas C, 2006, PSYCHIAT GENET, V16, P145; Virit O, 2008, KLIN PSIKOFARMAKOL B, V18, P282; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wegener G, 2010, INT J NEUROPSYCHOPH, V13, P461, DOI 10.1017/S1461145709990241; Won H, 2011, NAT MED, V17, P566, DOI 10.1038/nm.2330; Zandi PP, 2007, MOL PSYCHIATR, V12, P630, DOI 10.1038/sj.mp.4002027; Zubenko GS, 2003, AM J MED GENET B, V123B, P1, DOI 10.1002/ajmg.b.20073	104	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38128	10.1371/journal.pone.0038128	http://dx.doi.org/10.1371/journal.pone.0038128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675514	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700040
J	Fu, GY; Hu, CS; Wang, QD; Quinn, PC; Lee, K				Fu, Genyue; Hu, Chao S.; Wang, Qiandong; Quinn, Paul C.; Lee, Kang			Adults Scan Own- and Other-Race Faces Differently	PLOS ONE			English	Article							NEOCLASSICAL FACIAL CANONS; CATEGORIZATION; RECOGNITION; CHINESE; INFANCY; MEMORY	It is well established that individuals show an other-race effect (ORE) in face recognition: they recognize own-race faces better than other-race faces. The present study tested the hypothesis that individuals would also scan own-and other-race faces differently. We asked Chinese participants to remember Chinese and Caucasian faces and we tested their memory of the faces over five testing blocks. The participants' eye movements were recorded with the use of an eye tracker. The data were analyzed with an Area of Interest approach using the key AOIs of a face (eyes, nose, and mouth). Also, we used the iMap toolbox to analyze the raw data of participants' fixation on each pixel of the entire face. Results from both types of analyses strongly supported the hypothesis. When viewing target Chinese or Caucasian faces, Chinese participants spent a significantly greater proportion of fixation time on the eyes of other-race Caucasian faces than the eyes of own-race Chinese faces. In contrast, they spent a significantly greater proportion of fixation time on the nose and mouth of Chinese faces than the nose and mouth of Caucasian faces. This pattern of differential fixation, for own-and other-race eyes and nose in particular, was consistent even as participants became increasingly familiar with the target faces of both races. The results could not be explained by the perceptual salience of the Chinese nose or Caucasian eyes because these features were not differentially salient across the races. Our results are discussed in terms of the facial morphological differences between Chinese and Caucasian faces and the enculturation of mutual gaze norms in East Asian cultures.	[Fu, Genyue; Hu, Chao S.; Wang, Qiandong] Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China; [Quinn, Paul C.] Univ Delaware, Dept Psychol, Newark, DE USA; [Lee, Kang] Univ Toronto, Dr Eric Jackman Inst Child Study, Toronto, ON, Canada; [Lee, Kang] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	Zhejiang Normal University; University of Delaware; University of Toronto; University of California System; University of California San Diego	Fu, GY (corresponding author), Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China.	kang.lee@utoronto.ca	Hu, Chao S./I-2666-2019	Hu, Chao S./0000-0003-3315-9651	Natural Sciences and Engineering Research Council of Canada; National Institutes of Health (NIH) [R01HD046526]; National Science Foundation of China [30528027, 31028010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The present study was supported by a grant from the Natural Sciences and Engineering Research Council of Canada, the National Institutes of Health (NIH) (R01HD046526), and the National Science Foundation of China (30528027 and 31028010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzures G, 2010, DEVELOPMENTAL SCI, V13, P553, DOI 10.1111/j.1467-7687.2009.00900.x; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Caharel S, 2011, INT J PSYCHOPHYSIOL, V79, P266, DOI 10.1016/j.ijpsycho.2010.10.018; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Farkas LG, 2000, AESTHET PLAST SURG, V24, P179, DOI 10.1007/s002660010029; Feingold GA, 1914, J AM INST CRIM LAW C, V5, P39, DOI 10.2307/1133283; Ferguson KT, 2009, INFANCY, V14, P263, DOI 10.1080/15250000902839369; Frank MC, 2009, COGNITION, V110, P160, DOI 10.1016/j.cognition.2008.11.010; Ge LZ, 2009, PERCEPTION, V38, P1199, DOI 10.1068/p6136; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; Goodman GS, 2007, J EXP CHILD PSYCHOL, V98, P233, DOI 10.1016/j.jecp.2007.08.004; Hajnis Karle, 1994, P201; Hannula DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00166; Hayden A, 2009, PSYCHON B REV, V16, P270, DOI 10.3758/PBR.16.2.270; Hugenberg K, 2010, PSYCHOL REV, V117, P1168, DOI 10.1037/a0020463; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kelly DJ, 2011, DEVELOPMENTAL SCI, V14, P1176, DOI 10.1111/j.1467-7687.2011.01067.x; Kelly DJ, 2009, J EXP CHILD PSYCHOL, V104, P105, DOI 10.1016/j.jecp.2009.01.006; Kinzler KD, 2009, SOC COGNITION, V27, P623, DOI 10.1521/soco.2009.27.4.623; Kisilevsky BS, 1998, DEV PSYCHOL, V34, P629, DOI 10.1037/0012-1649.34.4.629; Le TT, 2002, AESTHET PLAST SURG, V26, P64, DOI 10.1007/s00266-001-0033-7; Lee K., 2012, OXF HDB FACE PERCEPT, V8, P1, DOI [10.1093/oxfordhb/9780199559053.001.0001, DOI 10.1093/OXFORDHB/9780199559053.013.0039, 10.1093/oxfordhb/9780199559053.013.0039]; Liu SY, 2011, J EXP CHILD PSYCHOL, V108, P180, DOI 10.1016/j.jecp.2010.06.008; McCarthy A, 2006, J CROSS CULT PSYCHOL, V37, P717, DOI 10.1177/0022022106292079; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Natu V, 2011, NEUROIMAGE, V54, P2547, DOI 10.1016/j.neuroimage.2010.10.006; Sangrigoli S, 2004, DEVELOPMENTAL SCI, V7, P74, DOI 10.1111/j.1467-7687.2004.00324.x; Shutts K, 2007, PSYCHOL SCI, V18, P763, DOI 10.1111/j.1467-9280.2007.01975.x; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Wheeler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018621; Yuki M, 2007, J EXP SOC PSYCHOL, V43, P303, DOI 10.1016/j.jesp.2006.02.004	34	57	58	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37688	10.1371/journal.pone.0037688	http://dx.doi.org/10.1371/journal.pone.0037688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UI	22675486	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339900006
J	Gray, EE; Friend, S; Suzuki, K; Phan, TG; Cyster, JG				Gray, Elizabeth E.; Friend, Sherree; Suzuki, Kazuhiro; Tri Giang Phan; Cyster, Jason G.			Subcapsular Sinus Macrophage Fragmentation and CD169(+) Bleb Acquisition by Closely Associated IL-17-Committed Innate-Like Lymphocytes	PLOS ONE			English	Article							LYMPH-NODES; B-CELL; DENDRITIC CELLS; T-CELLS; IMMUNE-COMPLEXES; MARGINAL ZONE; RECEPTOR; ANTIGEN; EXPRESSION; INFECTION	Subcapsular sinus macrophages (SSMs) in lymph nodes are rapidly exposed to antigens arriving in afferent lymph and have a role in their capture and display to B cells. In tissue sections SSMs exhibit long cellular processes and express high amounts of CD169. Here, we show that many of the cells present in lymph node cell suspensions that stain for CD169 are not macrophages but lymphocytes that have acquired SSM-derived membrane blebs. The CD169 bleb(+) lymphocytes are enriched for IL-17 committed IL-7R alpha(hi)CCR6(+) T cells and NK cells. In addition, the CD169 staining detected on small numbers of CD11c(hi) dendritic cells is frequently associated with membrane blebs. Counter intuitively the CD169 bleb(+) lymphocytes are mostly CD4 and CD8 negative whereas many SSMs express CD4. In situ, many IL-7R alpha(hi) cells are present at the subcapsular sinus and interfollicular regions and migrate in close association with CD169(+) macrophages. These findings suggest SSMs undergo fragmentation during tissue preparation and release blebs that are acquired by closely associated cells. They also suggest an intimate crosstalk between SSMs and IL-17 committed innate-like lymphocytes that may help provide early protection of the lymph node against lymph-borne invaders.	[Gray, Elizabeth E.; Suzuki, Kazuhiro; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Gray, Elizabeth E.; Suzuki, Kazuhiro; Cyster, Jason G.] UCSF, Dept Microbiol & Immunol, San Francisco, CA USA; [Friend, Sherree] Amnis Corp, Seattle, WA USA; [Tri Giang Phan] Garvan Inst Med Res, Sydney, NSW, Australia; [Tri Giang Phan] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Garvan Institute of Medical Research; University of New South Wales Sydney	Gray, EE (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Phan, Tri Giang/G-3937-2012	Phan, Tri Giang/0000-0002-4909-2984; Suzuki, Kazuhiro/0000-0002-9081-538X	National Institutes of Health [AI45073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI45073. JGC is an Investigator of the Howard Hughes Medical Institute. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Asano K, 2010, IMMUNITY; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; CROCKER PR, 1995, J CLIN INVEST, V95, P635, DOI 10.1172/JCI117708; CROCKER PR, 1987, J EXP MED, V166, P613, DOI 10.1084/jem.166.2.613; CROCKER PR, 1989, J EXP MED, V169, P1333, DOI 10.1084/jem.169.4.1333; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; FOSSUM S, 1983, ANAT EMBRYOL, V167, P229, DOI 10.1007/BF00298513; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; NOSSAL GJV, 1965, IMMUNOLOGY, V9, P349; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; STEER HW, 1987, J ANAT, V152, P23; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; WOOD GS, 1983, J IMMUNOL, V131, P212; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	55	64	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38258	10.1371/journal.pone.0038258	http://dx.doi.org/10.1371/journal.pone.0038258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675532	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339900020
J	Valdez-Moreno, M; Quintal-Lizama, C; Gomez-Lozano, R; Garcia-Rivas, MD				Valdez-Moreno, Martha; Quintal-Lizama, Carolina; Gomez-Lozano, Ricardo; del Carmen Garcia-Rivas, Maria			Monitoring an Alien Invasion: DNA Barcoding and the Identification of Lionfish and Their Prey on Coral Reefs of the Mexican Caribbean	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; CRUSTACEA DECAPODA CARIDEA; PTEROIS-VOLITANS; RED LIONFISH; SCORPAENIDAE; DENDROCHIRUS; PREDATION; RATES	Background: In the Mexican Caribbean, the exotic lionfish Pterois volitans has become a species of great concern because of their predatory habits and rapid expansion onto the Mesoamerican coral reef, the second largest continuous reef system in the world. This is the first report of DNA identification of stomach contents of lionfish using the barcode of life reference database (BOLD). Methodology/Principal Findings: We confirm with barcoding that only Pterois volitans is apparently present in the Mexican Caribbean. We analyzed the stomach contents of 157 specimens of P. volitans from various locations in the region. Based on DNA matches in the Barcode of Life Database (BOLD) and GenBank, we identified fishes from five orders, 14 families, 22 genera and 34 species in the stomach contents. The families with the most species represented were Gobiidae and Apogonidae. Some prey taxa are commercially important species. Seven species were new records for the Mexican Caribbean: Apogon mosavi, Coryphopterus venezuelae, C. thrix, C. tortugae, Lythrypnus minimus, Starksia langi and S. ocellata. DNA matches, as well as the presence of intact lionfish in the stomach contents, indicate some degree of cannibalism, a behavior confirmed in this species by the first time. We obtained 45 distinct crustacean prey sequences, from which only 20 taxa could be identified from the BOLD and GenBank databases. The matches were primarily to Decapoda but only a single taxon could be identified to the species level, Euphausia americana. Conclusions/Significance: This technique proved to be an efficient and useful method, especially since prey species could be identified from partially-digested remains. The primary limitation is the lack of comprehensive coverage of potential prey species in the region in the BOLD and GenBank databases, especially among invertebrates.	[Valdez-Moreno, Martha; Quintal-Lizama, Carolina] El Colegio Frontera Sur, Unidad Chetumal, Quintana Roo, Mexico; [Gomez-Lozano, Ricardo; del Carmen Garcia-Rivas, Maria] Comis Nacl Areas Nat Protegidas, Quintana Roo, Mexico	El Colegio de la Frontera Sur (ECOSUR)	Valdez-Moreno, M (corresponding author), El Colegio Frontera Sur, Unidad Chetumal, Quintana Roo, Mexico.	mvaldez@ecosur.mx			Comision Nacional Para el Conocimiento y Uso de la Biodiversidad (CONABIO) [HE009]; Consejo Nacional de Ciencia y Tecnologia (CONACYT thru Mexican Barcode of Life, MEXBOL); Genome Canada through the Biodiversity Institute of Ontario	Comision Nacional Para el Conocimiento y Uso de la Biodiversidad (CONABIO); Consejo Nacional de Ciencia y Tecnologia (CONACYT thru Mexican Barcode of Life, MEXBOL); Genome Canada through the Biodiversity Institute of Ontario(Genome Canada)	Genome Canada through the Biodiversity Institute of Ontario supported sequencing. Comision Nacional Para el Conocimiento y Uso de la Biodiversidad (CONABIO HE009) and Consejo Nacional de Ciencia y Tecnologia (CONACYT thru Mexican Barcode of Life, MEXBOL) funded this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Perera A, 2010, AQUAT INVASIONS, V5, pS9, DOI 10.3391/ai.2010.5.S1.003; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Baldwin CC, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.79.1045; Barbour AB, 2010, MAR ECOL PROG SER, V401, P291, DOI 10.3354/meps08373; Budarf AC, 2011, J FISH BIOL, V79, P112, DOI 10.1111/j.1095-8649.2011.02999.x; Carreon-Martinez L, 2011, J FISH BIOL, V78, P1170, DOI 10.1111/j.1095-8649.2011.02925.x; Castellanos I, 2002, REV BIOL TROP, V50, P77; Castellanos Osorio Ivan A., 1998, Caribbean Marine Studies, V6, P1; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; deWaard JR, 2009, BIODIVERS CONSERV, V18, P3825, DOI 10.1007/s10531-009-9682-7; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Arias-Gonzalez JE, 2011, ENVIRON RES, V111, P917, DOI 10.1016/j.envres.2011.07.008; Fishelson L, 1997, ENVIRON BIOL FISH, V50, P391, DOI 10.1023/A:1007331304122; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Freshwater D. Wilson, 2009, Journal of the North Carolina Academy of Science, V125, P39; FROESE R., 2012, FISHBASE; Garcia-Madrigal M., 2002, UNIV CIENC, V36, P140; GREENFIELD D W, 1979, Fieldiana Zoology, V73, P9; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hamner RM, 2007, J FISH BIOL, V71, P214, DOI 10.1111/j.1095-8649.2007.01575.x; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochzius M, 2003, MOL PHYLOGENET EVOL, V28, P396, DOI 10.1016/S1055-7903(02)00444-X; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lavett SC, 2003, ATOLL RES B, V497, P1; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; MARKHAM J C, 1990, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V61, P405; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Roman-Contreras R, 2010, HIDROBIOLOGICA, V20, P222; Roman-Contreras R, 2010, REV MEX BIODIVERS, V81, P43; Roman-Contreras R, 2009, HIDROBIOLOGICA, V19, P119; Ruiz-Carus R, 2006, BIOL CONSERV, V128, P384, DOI 10.1016/j.biocon.2005.10.012; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmitter-Soto Juan Jacobo, 2000, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V71, P143; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Valdez-Moreno M, 2010, MAR FRESHWATER RES, V61, P665, DOI 10.1071/MF09222; Vasquez-Yeomans L, 2011, BIOL INVASIONS, V13, P2635, DOI 10.1007/s10530-011-9968-z; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whitfield PE, 2007, BIOL INVASIONS, V9, P53, DOI 10.1007/s10530-006-9005-9; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289; Wilson JJ, 2011, BMC ECOLOGY, P11; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	46	100	108	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e36636	10.1371/journal.pone.0036636	http://dx.doi.org/10.1371/journal.pone.0036636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675470	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339900002
J	Wang, INE; Wang, X; Ge, XH; Anderson, J; Ho, M; Ashley, E; Liu, JW; Butte, MJ; Yazawa, M; Dolmetsch, RE; Quertermous, T; Yang, PC				Wang, I-Ning E.; Wang, Xiang; Ge, Xiaohu; Anderson, Joshua; Ho, Michael; Ashley, Euan; Liu, Jianwei; Butte, Manish J.; Yazawa, Masayuki; Dolmetsch, Ricardo E.; Quertermous, Thomas; Yang, Phillip C.			Apelin Enhances Directed Cardiac Differentiation of Mouse and Human Embryonic Stem Cells	PLOS ONE			English	Article							RECEPTOR APJ; HEART; MYOCARDIUM; LIGAND; CONTRACTILITY; ACTIVATION; MECHANISMS; DISEASE; PROMISE; GENE	Apelin is a peptide ligand for an orphan G-protein coupled receptor (APJ receptor) and serves as a critical gradient for migration of mesodermal cells fated to contribute to the myocardial lineage. The present study was designed to establish a robust cardiac differentiation protocol, specifically, to evaluate the effect of apelin on directed differentiation of mouse and human embryonic stem cells (mESCs and hESCs) into cardiac lineage. Different concentrations of apelin (50, 100, 500 nM) were evaluated to determine its differentiation potential. The optimized dose of apelin was then combined with mesodermal differentiation factors, including BMP-4, activin-A, and bFGF, in a developmentally specific temporal sequence to examine the synergistic effects on cardiac differentiation. Cellular, molecular, and physiologic characteristics of the apelin-induced contractile embryoid bodies (EBs) were analyzed. It was found that 100 nM apelin resulted in highest percentage of contractile EB for mESCs while 500 nM had the highest effects on hESCs. Functionally, the contractile frequency of mESCs-derived EBs (mEBs) responded appropriately to increasing concentration of isoprenaline and diltiazem. Positive phenotype of cardiac specific markers was confirmed in the apelin-treated groups. The protocol, consisting of apelin and mesodermal differentiation factors, induced contractility in significantly higher percentage of hESC-derived EBs (hEBs), up-regulated cardiac-specific genes and cell surface markers, and increased the contractile force. In conclusion, we have demonstrated that the treatment of apelin enhanced cardiac differentiation of mouse and human ESCs and exhibited synergistic effects with mesodermal differentiation factors.	[Wang, I-Ning E.; Wang, Xiang; Ge, Xiaohu; Anderson, Joshua; Ho, Michael; Ashley, Euan; Quertermous, Thomas; Yang, Phillip C.] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Liu, Jianwei; Butte, Manish J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Yazawa, Masayuki; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wang, INE (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	iewang@stanford.edu	Butte, Manish/AAM-8604-2020; Butte, Manish/T-8860-2019	Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595; Quertermous, Thomas/0000-0002-7645-9067	National Institute of Health [1R01HL097516-01]; Katherine McCormick Postdoctoral Fellowship for Women in Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077676, R01HL097516] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Katherine McCormick Postdoctoral Fellowship for Women in Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research is supported by National Institute of Health (1R01HL097516-01, PI: PYang), and Katherine McCormick Postdoctoral Fellowship for Women in Medicine (IEWang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir G, 2008, ANN THORAC SURG, V86, P1311, DOI 10.1016/j.athoracsur.2008.06.058; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Barnes G, 2010, HEART, V96, P1011, DOI 10.1136/hrt.2009.191122; Beaglehole R, 2004, LANCET, V363, P2084, DOI 10.1016/S0140-6736(04)16461-1; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; D'Aniello C, 2009, CIRC RES, V105, P231, DOI 10.1161/CIRCRESAHA.109.201186; Dai TY, 2006, EUR J PHARMACOL, V553, P222, DOI 10.1016/j.ejphar.2006.09.034; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hendry SL, 2008, J THORAC CARDIOV SUR, V136, P1028, DOI 10.1016/j.jtcvs.2007.12.053; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Inui M, 2006, DEV BIOL, V298, P188, DOI 10.1016/j.ydbio.2006.06.028; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Segev H, 2005, DEV GROWTH DIFFER, V47, P295; Suzuki Y, 2007, MAGN RESON MED, V57, P1173, DOI 10.1002/mrm.21219; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tempel D, 2010, SCI SESS 2010 AM HEA; Thygesen K, 2007, EUR HEART J, V28, P2525; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wang C, 2008, AM J PHYSIOL-HEART C, V294, pH2540, DOI 10.1152/ajpheart.00046.2008; Wang Xiang, 2008, J Vis Exp, DOI 10.3791/825; Weir RAP, 2006, AM J CARDIOL, V97, p13F, DOI 10.1016/j.amjcard.2006.03.005; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011; Zhang FX, 2008, BIODRUGS, V22, P361, DOI 10.2165/0063030-200822060-00003; Zhu Wei-Zhong, 2009, Transplant Rev (Orlando), V23, P53, DOI 10.1016/j.trre.2008.05.005	42	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38328	10.1371/journal.pone.0038328	http://dx.doi.org/10.1371/journal.pone.0038328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675543	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900024
J	Gosselin-Badaroudine, P; Keller, DI; Huang, H; Pouliot, V; Chatelier, A; Osswald, S; Brink, M; Chahine, M				Gosselin-Badaroudine, Pascal; Keller, Dagmar I.; Huang, Hai; Pouliot, Valerie; Chatelier, Aurelien; Osswald, Stefan; Brink, Marijke; Chahine, Mohamed			A Proton Leak Current through the Cardiac Sodium Channel Is Linked to Mixed Arrhythmia and the Dilated Cardiomyopathy Phenotype	PLOS ONE			English	Article							SICK SINUS SYNDROME; LONG-QT SYNDROME; SCN5A MUTATION; CONDUCTION DISORDER; MOLECULAR-MECHANISM; BRUGADA-SYNDROME; XENOPUS OOCYTES; GENETIC-BASIS; GATING PORE; HEART	Cardiac Na+ channels encoded by the SCN5A gene are essential for initiating heart beats and maintaining a regular heart rhythm. Mutations in these channels have recently been associated with atrial fibrillation, ventricular arrhythmias, conduction disorders, and dilated cardiomyopathy (DCM). We investigated a young male patient with a mixed phenotype composed of documented conduction disorder, atrial flutter, and ventricular tachycardia associated with DCM. Further family screening revealed DCM in the patient's mother and sister and in three of the mother's sisters. Because of the complex clinical phenotypes, we screened SCN5A and identified a novel mutation, R219H, which is located on a highly conserved region on the fourth helix of the voltage sensor domain of Na(v)1.5. Three family members with DCM carried the R219H mutation. The wild-type (WT) and mutant Na+ channels were expressed in a heterologous expression system, and intracellular pH (pHi) was measured using a pH-sensitive electrode. The biophysical characterization of the mutant channel revealed an unexpected selective proton leak with no effect on its biophysical properties. The H+ leak through the mutated Nav1.5 channel was not related to the Na+ permeation pathway but occurred through an alternative pore, most probably a proton wire on the voltage sensor domain. We propose that acidification of cardiac myocytes and/or downstream events may cause the DCM phenotype and other electrical problems in affected family members. The identification of this clinically significant H+ leak may lead to the development of more targeted treatments.	[Gosselin-Badaroudine, Pascal; Huang, Hai; Pouliot, Valerie; Chatelier, Aurelien; Chahine, Mohamed] Univ Laval, Robert Giffard Res Ctr, Quebec City, PQ, Canada; [Keller, Dagmar I.] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland; [Keller, Dagmar I.; Osswald, Stefan] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; [Keller, Dagmar I.; Brink, Marijke] Univ Basel Hosp, Cardiobiol Res Labs, CH-4031 Basel, Switzerland; [Chahine, Mohamed] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada	Laval University; University of Zurich; University Zurich Hospital; University of Basel; University of Basel; Laval University	Gosselin-Badaroudine, P (corresponding author), Univ Laval, Robert Giffard Res Ctr, Quebec City, PQ, Canada.	mohamed.chahine@phc.ulaval.ca	Chatelier, Aurelien/P-5056-2016; Osswald, Stefan/A-6904-2018	Osswald, Stefan/0000-0002-9240-6731; Brink, Marijke/0000-0002-1790-0190; chatelier, aurelien/0000-0002-7441-1182	Heart and Stroke Foundation of Quebec; Canadian Institutes of Health Research [MT-13181]; Stiftung fur Kardiovaskulare Forschung; University Hospital Basel, Switzerland	Heart and Stroke Foundation of Quebec; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stiftung fur Kardiovaskulare Forschung; University Hospital Basel, Switzerland	This work was supported by grants from the Heart and Stroke Foundation of Quebec and Canadian Institutes of Health Research Grant MT-13181. D. I. Keller was supported by a grant from Stiftung fur Kardiovaskulare Forschung, University Hospital Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2006, PACE, V29, P1130, DOI 10.1111/j.1540-8159.2006.00507.x; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Chahine M, 1998, BIOPHYS J, V75, P236, DOI 10.1016/S0006-3495(98)77510-1; Chahine M, 2005, J MOL CELL CARDIOL, V38, P571, DOI 10.1016/j.yjmcc.2005.01.003; CHAHINE M, 1992, J MOL CELL CARDIOL, V24, P1231, DOI 10.1016/0022-2828(92)93090-7; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Cheng JD, 2010, CTS-CLIN TRANSL SCI, V3, P287, DOI 10.1111/j.1752-8062.2010.00249.x; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; Ge JB, 2008, CIRC-ARRHYTHMIA ELEC, V1, P83, DOI 10.1161/CIRCEP.107.750752; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Groenewegen WA, 2003, CIRC RES, V92, P14, DOI 10.1161/01.RES.0000050585.07097.D7; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; KEELING PJ, 1995, BRIT HEART J, V73, P417; KOHMOTO O, 1990, CIRC RES, V66, P622, DOI 10.1161/01.RES.66.3.622; Li QJ, 2009, BIOCHEM BIOPH RES CO, V380, P132, DOI 10.1016/j.bbrc.2009.01.052; Makita N, 2006, CIRCULATION, V114, P505; McNair WP, 2011, J AM COLL CARDIOL, V57, P2160, DOI 10.1016/j.jacc.2010.09.084; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Nguyen TP, 2008, CIRC RES, V102, P364, DOI 10.1161/CIRCRESAHA.107.164673; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; PIWNICAWORMS D, 1985, J GEN PHYSIOL, V85, P43, DOI 10.1085/jgp.85.1.43; Pomes R, 2002, BIOPHYS J, V82, P2304, DOI 10.1016/S0006-3495(02)75576-8; Schonberger J, 2001, AM J HUM GENET, V69, P249, DOI 10.1086/321978; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shi RM, 2008, EUROPACE, V10, P1329, DOI 10.1093/europace/eun202; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Struyk AF, 2007, J GEN PHYSIOL, V130, P11, DOI 10.1085/jgp.200709755; Surber R, 2008, CARDIOVASC RES, V77, P740, DOI 10.1093/cvr/cvm096; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; Tan BH, 2007, CARDIOVASC RES, V76, P409, DOI 10.1016/j.cardiores.2007.08.006; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	46	73	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38331	10.1371/journal.pone.0038331	http://dx.doi.org/10.1371/journal.pone.0038331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675453	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500132
J	Jewkes, R; Nduna, M; Shai, NJ; Dunkle, K				Jewkes, Rachel; Nduna, Mzikazi; Shai, Nwabisa Jama; Dunkle, Kristin			Prospective Study of Rape Perpetration by Young South African Men: Incidence & Risk Factors	PLOS ONE			English	Article							RURAL EASTERN-CAPE; SEXUAL ASSAULT PERPETRATION; STEPPING STONES; TRANSACTIONAL SEX; PARTNER VIOLENCE; HIV; BEHAVIOR; WOMEN; PREVALENCE; PREDICTORS	Background: There has been very little prospective research on rape perpetration among men. This paper describes the incidence and risk factors for new rape and attempted rape events among young South African men in an HIV prevention trial. Methods: We followed 1,147 men aged 15-26 years who enrolled into a cluster randomised controlled trial to evaluate the HIV prevention behavioural intervention Stepping Stones. Incidence rate ratios for factors associated with incident rape were derived from Poisson models. Results: The young men reported 217 incident rapes (completed or attempted) of a girl or woman over 1,914 person years of follow up, yielding a rape incidence of 11.2 per 100 person years. Overall 24.9% of men had previously raped at baseline, and 18.9% did so during the follow up. Among the latter, 61.3% raped for the first time, and 38.7% re-offended. Multivariable Poisson modelling showed a higher incidence of rape perpetration among men who had ever used drugs (IRR 1.86 95% CI 1.39, 2.49), had eight or more lifetime partners (IRR 1.48 95% CI 1.09, 2.01), had been physically violent toward a female partner (IRR 1.50 95% CI 1.11, 2.03) and had disclosed rape perpetration at baseline (IRR 1.45 95% CI 1.07, 1.97). A lower incidence was found among those with greater resistance to peer pressure (IRR 0.85 95% CI 0.74, 0.97). Conclusions: The findings highlight the importance of male gender socialisation and addressing delinquent youth subcultures in rape prevention. Prevention requires change in hegemonic masculinity, with its emphasis on gender hierarchy, exaggerated performance of heterosexuality and control of women. Interventions are needed to address male socialisation with delinquent peers, by reducing exposure to childhood trauma and strengthening opportunities for gainful employment (in work or recreation).	[Jewkes, Rachel; Shai, Nwabisa Jama] MRC, Gender & Hlth Res Unit, Pretoria, South Africa; [Jewkes, Rachel; Shai, Nwabisa Jama] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Nduna, Mzikazi] Univ Witwatersrand, Dept Psychol, Johannesburg, South Africa; [Dunkle, Kristin] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of Witwatersrand; University of Witwatersrand; Emory University; Rollins School Public Health	Jewkes, R (corresponding author), MRC, Gender & Hlth Res Unit, Pretoria, South Africa.	rjewkes@mrc.ac.za	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Jewkes, Rachel/0000-0002-4330-6267; Shai, Nwabisa/0000-0003-4171-9129	National Institute of Mental Health [MH 64882-01, MH 64882-04S1A1, 1R03MH085599]; South African Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064882, R03MH085599] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by National Institute of Mental Health grant no. MH 64882-01, MH 64882-04S1A1, 1R03MH085599 and the South African Medical Research Council. KD's participation was also partially facilitated by the Center for AIDS Research at Emory University (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey A, 2006, AGGRESSIVE BEHAV, V32, P54, DOI 10.1002/ab.20107; Abbey A, 2004, J CONSULT CLIN PSYCH, V72, P747, DOI 10.1037/0022-006X.72.5.747; Abrahams N, 2004, B WORLD HEALTH ORGAN, V82, P330; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bijleveld C.C., 2007, EUR J CRIMINOL, V4, P5, DOI [DOI 10.1177/1477370807071728, 10.1177/1477370807071728]; Bourgois P, 1996, BRIT J CRIMINOL, V36, P412; Casey EA, 2009, J INTERPERS VIOLENCE, V24, P1129, DOI 10.1177/0886260508322198; Dean K, 1997, J PERSONALITY SOCIAL, P72; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Dworkin Andrea., 1987, INTERCOURSE; Fals-Stewart W, 2003, ADDICT BEHAV, V28, P1555, DOI 10.1016/j.addbeh.2003.08.035; Fonagy P., 2003, PSYCHOANALYTIC THEOR; Garcia-Moreno C, 2005, WHO MULT STUD WOM HL; Gavey Nicola, 2005, JUST SEX CULTURAL SC; Greenland S, 1998, MODERN EPIDEMIOLOGY; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; JEWKES R, 2002, SOC SCI MED, V55, P153; Jewkes R, 2011, PLOS ONE, V6; Jewkes R, 2002, STEPPING STONES SEXU; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2010, HEALTH EDUC RES, V25, P1074, DOI 10.1093/her/cyq062; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Knight RA, 2003, ANN NY ACAD SCI, V989, P72, DOI 10.1111/j.1749-6632.2003.tb07294.x; Machisa M, 2011, WAR HOME; MALAMUTH NM, 1995, J PERS SOC PSYCHOL, V69, P353, DOI 10.1037/0022-3514.69.2.353; MALAMUTH NM, 1991, J CONSULT CLIN PSYCH, V59, P670, DOI 10.1037/0022-006X.59.5.670; Morris RE, 2002, ARCH PEDIAT ADOL MED, V156, P831, DOI 10.1001/archpedi.156.8.831; Parks GA, 2006, SEX ABUSE-J RES TR, V18, P319, DOI 10.1007/s11194-006-9028-x; Seto MC, 2010, PSYCHOL BULL, V136, P526, DOI 10.1037/a0019700; Simbayi LC, 2006, AM J HEALTH BEHAV, V30, P158, DOI 10.5993/AJHB.30.2.5; Swartout KM, 2010, J INTERPERS VIOLENCE, V25, P1716, DOI 10.1177/0886260509354586; Whisnant R, 2007, GLOBAL FEMINIST ETHI; White JW, 2004, CRIM JUSTICE BEHAV, V31, P182, DOI 10.1177/0093854803261342; Wood K, 2003, ETHNOGRAPHY SEXUAL H; Wood K., 2001, CHANGING MEN SO AFRI, P317; World Health Organization/London School of Hygiene and Tropical Medicine, 2010, PREV INT PARTN SEX V	39	28	29	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38210	10.1371/journal.pone.0038210	http://dx.doi.org/10.1371/journal.pone.0038210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22675449	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500111
J	Bai, YH; Shi, Q; Wen, DH; Li, ZX; Jefferson, WA; Feng, CP; Tang, XY				Bai, Yaohui; Shi, Qing; Wen, Donghui; Li, Zongxun; Jefferson, William A.; Feng, Chuanping; Tang, Xiaoyan			Bacterial Communities in the Sediments of Dianchi Lake, a Partitioned Eutrophic Waterbody in China	PLOS ONE			English	Article							ORGANIC-CARBON; ARCHAEAL ASSEMBLAGES; SPATIAL-DISTRIBUTION; SEASONAL-CHANGES; DIVERSITY; TAIHU; PHOSPHORUS; SEQUENCES; ABUNDANCE; SIZE	Bacteria play an important role in the decomposition and cycling of a variety of compounds in freshwater aquatic environments, particularly nutrient-rich eutrophic lakes. A unique Chinese eutrophic lake - Dianchi - was selected for study because it has two separate and distinct basins, Caohai with higher organic carbon levels and Waihai with lower organic carbon levels. Sediment bacterial communities were studied in the two basins using samples collected in each season from June 2010 to March 2011. Barcoded pyrosequencing based on the 16 S rRNA gene found that certain common phyla, Proteobacteria, Bacteroidetes, Firmicutes and Chloroflexi, were dominant in the sediments from both basins. However, from the class to genus level, the dominant bacterial groups found in the sediments were distinct between the two basins. Correlation analysis revealed that, among the environmental parameters examined, total organic carbon (TOC) accounted for the greatest proportion of variability in bacterial community. Interestingly, study results suggest that increasing allochthonous organic carbon could enhance bacterial diversity and biomass in the sediment. In addition, analysis of function genes (amoA and nosZ) demonstrated that ammonia-oxidizing bacteria (AOB) were dominant in sediments, with 99% belonging to Nitrosomonas. Denitrifying bacteria were comparatively diverse and were associated with some cultivatable bacteria.	[Bai, Yaohui; Jefferson, William A.] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, Beijing, Peoples R China; [Bai, Yaohui; Wen, Donghui; Tang, Xiaoyan] Peking Univ, Coll Environm Sci & Engn, Key Lab Water & Sediment Sci, Minist Educ, Beijing 100871, Peoples R China; [Shi, Qing; Feng, Chuanping] China Univ Geosci, Sch Water Resource & Environm Sci, Beijing, Peoples R China; [Li, Zongxun] Kunming Inst Environm Sci, Kunming, Yunnan Province, Peoples R China; [Jefferson, William A.] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Peking University; China University of Geosciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, YH (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, POB 934, Beijing, Peoples R China.	yhbai@rcees.ac.cn		Feng, Chuanping/0000-0002-9700-4416	General Project [51008003]; National Natural Science Foundation of China; Postdoctoral Science Foundation of China [201104016]	General Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This study was supported by a General Project (No. 51008003) granted by the National Natural Science Foundation of China and a special financial grant (201104016) from the Postdoctoral Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1988, HYDROBIOLOGIA, V159, P159; Ansari AA, EUTROPHICATION CAUSE; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chen GY, 2009, RES MICROBIOL, V160, P173, DOI 10.1016/j.resmic.2009.01.003; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Dang HY, 2010, APPL ENVIRON MICROB, V76, P4691, DOI 10.1128/AEM.02563-09; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dillon JG, 2009, HYDROBIOLOGIA, V632, P49, DOI 10.1007/s10750-009-9827-4; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Gao L, 2005, ENVIRON GEOL, V48, P835, DOI 10.1007/s00254-005-0005-3; GAUDETTE HE, 1974, J SEDIMENT PETROL, V44, P249; Gong ZJ, 2009, LIMNOLOGY, V10, P247, DOI 10.1007/s10201-009-0282-8; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Gudasz C, 2012, LIMNOL OCEANOGR, V57, P163, DOI 10.4319/lo.2012.57.1.0163; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hempel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-58; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hong PY, 2010, APPL ENVIRON MICROB, V76, P5631, DOI 10.1128/AEM.00281-10; Hu J, 2009, ENVIRON GEOL, V58, P833, DOI 10.1007/s00254-008-1559-7; Hubert CRJ, 2012, ENVIRON MICROBIOL, V14, P387, DOI 10.1111/j.1462-2920.2011.02521.x; Jansson M, 2007, TRENDS ECOL EVOL, V22, P316, DOI 10.1016/j.tree.2007.02.015; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li RY, 2007, PEDOSPHERE, V17, P265, DOI 10.1016/S1002-0160(07)60033-2; Liu YM, 2006, ENVIRON TOXICOL, V21, P289, DOI 10.1002/tox.20182; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Luo J, 2004, FUNGAL DIVERS, V16, P93; [吕明姬 Lv Mingji], 2011, [环境科学学报, Acta Scientiae Circumstantiae], V31, P299; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Moss JA, 2006, APPL ENVIRON MICROB, V72, P5679, DOI 10.1128/AEM.02773-05; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nealson KH, 1997, ANNU REV EARTH PL SC, V25, P403, DOI 10.1146/annurev.earth.25.1.403; Niu Y, 2011, WATER RES, V45, P4169, DOI 10.1016/j.watres.2011.05.022; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Scala DJ, 1999, APPL ENVIRON MICROB, V65, P1681; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; Shade A, 2007, LIMNOL OCEANOGR, V52, P487, DOI 10.4319/lo.2007.52.2.0487; Shao KQ, 2011, CAN J MICROBIOL, V57, P263, DOI [10.1139/W11-003, 10.1139/w11-003]; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; State Environmental Protection Administration of China, 1989, MON AN METH WAT WAST; Steven B, 2011, AQUAT MICROB ECOL, V64, P41, DOI 10.3354/ame01507; Su Tao, 2011, ENV SCI SURVEY, V30, P33, DOI DOI 10.3969/j.issn.1673-9655.2011.05.010; Tamaki H, 2005, APPL ENVIRON MICROB, V71, P2162, DOI 10.1128/AEM.71.4.2162-2169.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang XM, 2009, MICROB ECOL, V58, P307, DOI 10.1007/s00248-008-9482-8; TRANVIK LJ, 1988, MICROBIAL ECOL, V16, P311, DOI 10.1007/BF02011702; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wen DH, 2012, ANN MICROBIOL, V62, P715, DOI 10.1007/s13213-011-0311-9; Wu X, 2007, FEMS MICROBIOL ECOL, V61, P85, DOI 10.1111/j.1574-6941.2007.00326.x; Wu YC, 2010, ENV MICROBIOL REP, V2, P569, DOI 10.1111/j.1758-2229.2010.00146.x; Xiong YQ, 2010, J PALEOLIMNOL, V44, P217, DOI 10.1007/s10933-009-9398-4; Ye WJ, 2009, FEMS MICROBIOL ECOL, V70, P263, DOI 10.1111/j.1574-6941.2009.00761.x; Zeng J, 2008, CAN J MICROBIOL, V54, P1053, DOI 10.1139/W08-098; Zhou C, 2011, GEOMICROBIOL J, V28, P660, DOI 10.1080/01490451.2010.511438	65	126	143	6	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37796	10.1371/journal.pone.0037796	http://dx.doi.org/10.1371/journal.pone.0037796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666393	gold, Green Submitted, Green Published			2022-12-27	WOS:000305353400050
J	Lai, SL; Cheah, SC; Wong, PF; Noor, SM; Mustafa, MR				Lai, Siew-Li; Cheah, Shiau-Chuen; Wong, Pooi-Fong; Noor, Suzita Mohd; Mustafa, Mohd Rais			In Vitro and In Vivo Anti-Angiogenic Activities of Panduratin A	PLOS ONE			English	Article							KAEMPFERIA-PANDURATA; TUMOR ANGIOGENESIS; ENDOTHELIAL-CELLS; CANCER; INHIBITOR; INDUCTION; APOPTOSIS; MIGRATION; METALLOPROTEINASES; ACTIVATION	Background: Targeting angiogenesis has emerged as an attractive and promising strategy in anti-cancer therapeutic development. The present study investigates the anti-angiogenic potential of Panduratin A (PA), a natural chalcone isolated from Boesenbergia rotunda by using both in vitro and in vivo assays. Methodology/Principal Findings: PA exerted selective cytotoxicity on human umbilical vein endothelial cells (HUVECs) with IC50 value of 6.91 +/- 0.85 mu M when compared to human normal fibroblast and normal liver epithelial cells. Assessment of the growth kinetics by cell impedance-based Real-Time Cell Analyzer showed that PA induced both cytotoxic and cytostatic effects on HUVECs, depending on the concentration used. Results also showed that PA suppressed VEGF-induced survival and proliferation of HUVECs. Furthermore, endothelial cell migration, invasion, and morphogenesis or tube formation demonstrated significant time-and dose-dependent inhibition by PA. PA also suppressed matrix metalloproteinase-2 (MMP-2) secretion and attenuated its activation to intermediate and active MMP-2. In addition, PA suppressed F-actin stress fiber formation to prevent migration of the endothelial cells. More importantly, anti-angiogenic potential of PA was also evidenced in two in vivo models. PA inhibited neo-vessels formation in murine Matrigel plugs, and angiogenesis in zebrafish embryos. Conclusions/Significance: Taken together, our study demonstrated the distinctive anti-angiogenic properties of PA, both in vitro and in vivo. This report thus reveals another biological activity of PA in addition to its reported anti-inflammatory and anti-cancer activities, suggestive of PA's potential for development as an anti-angiogenic agent for cancer therapy.	[Lai, Siew-Li; Cheah, Shiau-Chuen; Wong, Pooi-Fong; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 50603, Malaysia; [Noor, Suzita Mohd] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Lai, SL (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 50603, Malaysia.	rais@um.edu.my	Mustafa, Mohamed R/B-1647-2009; Cheah, Shiau-Chuen/H-7564-2013; NOOR, SUZITA M/B-9883-2010; WONG, POOI-FONG PF/B-5234-2010	Mustafa, Mohamed R/0000-0002-7864-5189; Cheah, Shiau-Chuen/0000-0002-9247-7265; NOOR, SUZITA M/0000-0001-5344-8165; WONG, POOI-FONG PF/0000-0002-6705-2521	Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG) [E000002-20001]; Fundamental Research Grant Scheme (FRGS) [FP039/2010A]	Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG); Fundamental Research Grant Scheme (FRGS)	This work was funded by Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG) E000002-20001 (URL: http://hir.um.edu.my/) and partially supported by Fundamental Research Grant Scheme (FRGS) FP039/2010A (URL: http://jpt.mohe.gov.my/menupenyelidik.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; Cheah SC, 2011, MOLECULES, V16, P2583, DOI 10.3390/molecules16032583; Childs S, 2002, DEVELOPMENT, V129, P973; COOMBER BL, 1990, ARTERIOSCLEROSIS, V10, P215, DOI 10.1161/01.ATV.10.2.215; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Foda HD, 2001, DRUG DISCOV TODAY, V6, P478, DOI 10.1016/S1359-6446(01)01752-4; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fong TAT, 1999, CANCER RES, V59, P99; Ghosh RN, 2007, METH MOL B, V356, P63; Goodwin AM, 2007, MICROVASC RES, V74, P172, DOI 10.1016/j.mvr.2007.05.006; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Imai K, 1996, CANCER RES, V56, P2707; Jeong SJ, 2011, PHYTOTHER RES, V25, P1, DOI 10.1002/ptr.3224; Kargozaran H, 2007, CLIN EXP METASTAS, V24, P495, DOI 10.1007/s10585-007-9086-6; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kidd KR, 2003, BRIT J PHARMACOL, V140, P585, DOI 10.1038/sj.bjp.0705496; Kok T. W., 2005, Angiogenesis, V8, P3, DOI 10.1007/s10456-005-2892-z; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P1376, DOI 10.1167/iovs.05-1223; Malinda KM, 2003, METH MOLEC MED, V78, P329; Mojzis J, 2008, PHARMACOL RES, V57, P259, DOI 10.1016/j.phrs.2008.02.005; Moldovan L, 2006, CARDIOVASC RES, V71, P236, DOI 10.1016/j.cardiores.2006.05.003; MOORE GL, 1981, BIOCHEM MED METAB B, V26, P167, DOI 10.1016/0006-2944(81)90043-0; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; Pang XF, 2009, CANCER RES, V69, P518, DOI 10.1158/0008-5472.CAN-08-2531; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Rodriguez Luis G., 2004, V294, P23; Rukayadi Y, 2009, ANTIMICROB AGENTS CH, V53, P4529, DOI 10.1128/AAC.00624-09; Samant RS, 2011, ONCOTARGET, V2, P122; Shindo K, 2006, BIOSCI BIOTECH BIOCH, V70, P2281, DOI 10.1271/bbb.60086; Sohn JH, 2005, BIOL PHARM BULL, V28, P1083, DOI 10.1248/bpb.28.1083; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Vucenik I, 2004, CARCINOGENESIS, V25, P2115, DOI 10.1093/carcin/bgh232; Xiao H, 2006, EJC SUPPL, V4, P195, DOI 10.1016/S1359-6349(06)70651-6; Yun JM, 2003, PLANTA MED, V69, P1102, DOI 10.1055/s-2003-45190; Yun JM, 2006, CARCINOGENESIS, V27, P1454, DOI 10.1093/carcin/bgi348; Zoellner H, 1996, J CELL SCI, V109, P2571	40	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38103	10.1371/journal.pone.0038103	http://dx.doi.org/10.1371/journal.pone.0038103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666456	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305353400081
J	Liang, Y; Zhang, LL; Gao, J; Hu, D; Ai, Y				Liang, Yi; Zhang, Lingli; Gao, Ju; Hu, Die; Ai, Yuan			Rituximab for Children with Immune Thrombocytopenia: A Systematic Review	PLOS ONE			English	Review							MONOCLONAL-ANTIBODY RITUXIMAB; B-CELL DEPLETION; AUTOIMMUNE CYTOPENIAS; ANTI-CD20 RITUXIMAB; SERUM SICKNESS; PURPURA ITP; CHILDHOOD; THERAPY; ADULTS; METAANALYSIS	Background: Rituximab has been widely used off-label as a second line treatment for children with immune thrombocytopenia (ITP). However, its role in the management of pediatric ITP requires clarification. To understand and interpret the available evidence, we conducted a systematic review to assess the efficacy and safety of rituximab for children with ITP. Methodology/Principal Findings: We searched MEDLINE, EMBASE, Cochrane Library, CBM, CNKI, abstract databases of American Society of Hematology, American Society of Clinical Oncology and Pediatric Academic Society. Clinical studies published in full text or abstract only in any language that met predefined inclusion criteria were eligible. Efficacy analysis was restricted to studies enrolling 5 or more patients. Safety was evaluated from all studies that reported data of toxicity. 14 studies (323 patients) were included for efficacy assessment in children with primary ITP. The pooled complete response (platelet count >= 100 x 10(9)/L) and response (platelet count >= 30 x 10(9)/L) rate after rituximab treatment were 39% (95% CI, 30% to 49%) and 68% (95% CI, 58% to 77%), respectively, with median response duration of 12.8 month. 4 studies (29 patients) were included for efficacy assessment in children with secondary ITP. 11 (64.7%) of 17 patients associated with Evans syndrome achieved response. All 6 patients with systemic lupus erythematosus associated ITP and all 6 patients with autoimmune lymphoproliferative syndrome associated ITP achieved response. 91 patients experienced 108 adverse events associated with rituximab, among that, 91 (84.3%) were mild to moderate, and no death was reported. Conclusions/Significance: Randomized controlled studies on effect of rituximab for children with ITP are urgently needed, although a series of uncontrolled studies found that rituximab resulted in a good platelet count response both in children with primary and children secondary ITP. Most adverse events associated with rituximab were mild to moderate, and no death was reported.	[Liang, Yi; Zhang, Lingli; Hu, Die] Sichuan Univ, W China Univ Hosp 2, Dept Pharm, Chengdu 610064, Peoples R China; [Liang, Yi; Hu, Die] Sichuan Univ, W China Sch Pharm, Chengdu 610064, Peoples R China; [Gao, Ju; Ai, Yuan] Sichuan Univ, W China Univ Hosp 2, Dept Pediat Hematol & Oncol, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Liang, Y (corresponding author), Sichuan Univ, W China Univ Hosp 2, Dept Pharm, Chengdu 610064, Peoples R China.	zhlingli@sina.com						Adeli MMG, 2009, PEDIATR HEMAT ONCOL, V26, P566, DOI 10.3109/08880010903271697; [Anonymous], NAT CANC I COMM TERM; Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Bader-Meunier B, 2007, HAEMATOLOGICA, V92, P1691, DOI 10.3324/haematol.11540; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bengtson KL, 2003, J PEDIATR-US, V143, P670, DOI 10.1067/S0022-3476(03)00446-3; Bennett CM, 2006, BLOOD, V107, P2639, DOI 10.1182/blood-2005-08-3518; Bisogno G, 2007, EUR J PEDIATR, V166, P85, DOI 10.1007/s00431-006-0222-0; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Citak EC, 2011, J TROP PEDIATRICS, V57, P71, DOI 10.1093/tropej/fmq033; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Cooper Nichola, 2010, Curr Rheumatol Rep, V12, P94, DOI 10.1007/s11926-010-0090-5; Cooper N, 2009, BRIT J HAEMATOL, V146, P120, DOI 10.1111/j.1365-2141.2009.07715.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; Dogan M, 2009, INDIAN J PEDIATR, V76, P1141, DOI 10.1007/s12098-009-0230-y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eupropean Medicine Agency website, SUMM EUR PUBL ASS RE; Gentner Jennifer, 2008, Pediatric Asthma Allergy & Immunology, V21, P99, DOI 10.1089/pai.2008.0003; Golay J, 2000, BLOOD, V95, P3900; Goto S, 2009, INT J HEMATOL, V89, P305, DOI 10.1007/s12185-009-0269-6; Grace RF, 2011, PEDIAT BLOOD CA 0614; Kim JJ, 2007, BRIT J HAEMATOL, V138, P94, DOI 10.1111/j.1365-2141.2007.06616.x; Kim JY, 2009, BLOOD, V114, P4461; Kuhne T, 2003, J PEDIATR-US, V143, P605, DOI 10.1067/S0022-3476(03)00535-3; Kumar S, 2009, PEDIATRICS, V123, pE159, DOI 10.1542/peds.2008-2361; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lorenzana AN, 2002, THERAPEUTIC EFFECT R, P1043; National Institute of Clinical Excellence (NICE), QUAL ASS CAS SER; Parodi E, 2009, BRIT J HAEMATOL, V144, P552, DOI 10.1111/j.1365-2141.2008.07487.x; Pescovitz MD, 2006, AM J TRANSPLANT, V6, P859, DOI 10.1111/j.1600-6143.2006.01288.x; Pospisilova D, 2010, ANN HEMATOL S1, V89, pS105; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Pusiol A, 2004, EUR J PEDIATR, V163, P305, DOI 10.1007/s00431-004-1417-x; Quartier P, 2003, CLIN INFECT DIS, V36, pE47, DOI 10.1086/345746; Rafailidis PI, 2007, CANCER, V109, P2182, DOI 10.1002/cncr.22666; Rao A, 2008, PEDIATR BLOOD CANCER, V50, P822, DOI 10.1002/pbc.21264; Rao VK, 2009, PEDIATR BLOOD CANCER, V52, P847, DOI 10.1002/pbc.21965; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Romanos-Sirakis E, 2011, J ALLERGY CLIN IMMUN, V127, pAB198, DOI 10.1016/j.jaci.2010.12.789; Sampaio I, 2010, HAEMATOL-HEMATOL J, V95, P750; Sharma A, 2005, BLOOD, V106, p82B; Taube T, 2005, HAEMATOLOGICA, V90, P281; Terrell DR, 2010, AM J HEMATOL, V85, P174, DOI 10.1002/ajh.21616; Wang HM, 2011, J THROMB HAEMOST, V9, P330; Wang J, 2005, J PEDIATR-US, V146, P217, DOI 10.1016/j.jpeds.2004.09.004; Xu S, 2011, J CHINA PEDIAT BLOOD, V16, P129; Yadav SP, 2006, BLOOD, V108, p50B, DOI 10.1182/blood.V108.11.3892.3892; Yang J, 2011, CHINESE J OBSTET GYN, V7, P474	49	51	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36698	10.1371/journal.pone.0036698	http://dx.doi.org/10.1371/journal.pone.0036698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666325	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400011
J	Ruzicka, F; Jech, R; Novakova, L; Urgosik, D; Vymazal, J; Ruzicka, E				Ruzicka, Filip; Jech, Robert; Novakova, Lucie; Urgosik, Dusan; Vymazal, Josef; Ruzicka, Evzen			Weight Gain Is Associated with Medial Contact Site of Subthalamic Stimulation in Parkinson's Disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; BODY-WEIGHT; BASAL GANGLIA; NUCLEUS STIMULATION; ENERGY-INTAKE; FOOD-INTAKE; REWARD; LOCALIZATION; MECHANISMS; ELECTRODES	The aim of our study was to assess changes in body-weight in relation to active electrode contact position in the subthalamic nucleus. Regular body weight measurements were done in 20 patients with advanced Parkinson's disease within a period of 18 months after implantation. T1-weighted (1.5T) magnetic resonance images were used to determine electrode position in the subthalamic nucleus and the Unified Parkinson's disease rating scale (UPDRS-III) was used for motor assessment. The distance of the contacts from the wall of the third ventricle in the mediolateral direction inversely correlated with weight gain (r = -0.55, p<0.01) and with neurostimulation-related motor condition expressed as the contralateral hemi-body UPDRS-III (r = -0.42, p<0.01). Patients with at least one contact within 9.3 mm of the wall experienced significantly greater weight gain (9.4+/-(SD) 4.4 kg, N = 11) than those with both contacts located laterally (3.9+/-2.7 kg, N = 9) (p<0.001). The position of the active contact is critical not only for motor outcome but is also associated with weight gain, suggesting a regional effect of subthalamic stimulation on adjacent structures involved in the central regulation of energy balance, food intake or reward.	[Ruzicka, Filip; Jech, Robert; Novakova, Lucie; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Ruzicka, Filip; Jech, Robert; Novakova, Lucie; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Ruzicka, Filip; Jech, Robert; Novakova, Lucie; Ruzicka, Evzen] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic; [Urgosik, Dusan] Na Homolce Hosp, Dept Stereotact & Radiat Neurosurg, Prague, Czech Republic; [Vymazal, Josef] Na Homolce Hosp, Dept Radiol, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; General University Hospital Prague; Na Homolce Hospital; Na Homolce Hospital	Ruzicka, F (corresponding author), Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic.	jech@cesnet.cz	Urgošík, Dušan/AAA-9551-2021; Jech, Robert/HHY-7342-2022; Růžička, Evžen/F-9299-2017	Jech, Robert/0000-0002-9732-8947; Růžička, Evžen/0000-0002-4893-9661; Ruzicka, Filip/0000-0003-2743-2703	Czech Science Foundation [309/09/1145]; Czech Ministry of Health [IGA NT12282-5/2011]; Czech Ministry of Education [MSM 0021620849, PRVOUK-P26/LF1/4]; Medtronic Czechia	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Health(Ministry of Health, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Medtronic Czechia(Medtronic)	This work was supported by the Czech Science Foundation: grant project 309/09/1145, Czech Ministry of Health: IGA NT12282-5/2011 and by the Czech Ministry of Education: research project MSM 0021620849 and PRVOUK-P26/LF1/4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R. Jech, D. Urgosik and Evzen Ruzicka received consulting fees from Medtronic Czechia. R. Jech received a travel grant from Medtronic Czechia to attend the XVIII World Congress of Parkinson's disease and Related Disorders in 2009. The authors declare no other potential conflicts of interest with respect to the authorship and/or publication of this article. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bachmann CG, 2006, MOVEMENT DISORD, V21, P1824, DOI 10.1002/mds.21068; Bannier S, 2009, J NEUROL NEUROSUR PS, V80, P484, DOI 10.1136/jnnp.2008.158576; Barichella M, 2003, MOVEMENT DISORD, V18, P1337, DOI 10.1002/mds.10543; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Daniluk S, 2010, ACTA NEUROCHIR, V152, P201, DOI 10.1007/s00701-009-0514-z; Davis C, 2007, APPETITE, V48, P12, DOI 10.1016/j.appet.2006.05.016; Delikanaki-Skaribas E, 2009, MOVEMENT DISORD, V24, P667, DOI 10.1002/mds.22372; Gironell A, 2002, NEUROLOGIA, V17, P310; Godinho F, 2006, J NEUROL, V253, P1347, DOI 10.1007/s00415-006-0222-z; GROENEWEGEN HJ, 1993, NEUROSCIENCE, V57, P113, DOI 10.1016/0306-4522(93)90115-V; GROENEWEGEN HJ, 1990, J COMP NEUROL, V294, P607, DOI 10.1002/cne.902940408; Haegelen C, 2009, MED HYPOTHESES, V72, P421, DOI 10.1016/j.mehy.2008.07.065; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; Hamel W, 2003, J NEUROL NEUROSUR PS, V74, P1036, DOI 10.1136/jnnp.74.8.1036; Herzog J, 2004, MOVEMENT DISORD, V19, P1050, DOI 10.1002/mds.20056; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Holmberg B, 2005, MOVEMENT DISORD, V20, P976, DOI 10.1002/mds.20492; Jakes RW, 2004, INT J EPIDEMIOL, V33, P1382, DOI 10.1093/ije/dyh181; Jech R, 2001, MOVEMENT DISORD, V16, P1126, DOI 10.1002/mds.1217; Jech R, 2006, CLIN NEUROPHYSIOL, V117, P1017, DOI 10.1016/j.clinph.2006.01.009; Johnson MD, 2008, NEUROTHERAPEUTICS, V5, P294, DOI 10.1016/j.nurt.2008.01.010; Lardeux S, 2009, J NEUROPHYSIOL, V102, P2526, DOI 10.1152/jn.91009.2008; Lee EM, 2011, BRAIN BEHAV, V1, P12, DOI 10.1002/brb3.9; Ludwig J, 2007, J NEUROL NEUROSUR PS, V78, P742, DOI 10.1136/jnnp.2006.103739; Machado A, 2006, MOVEMENT DISORD, V21, pS247, DOI 10.1002/mds.20959; Macia F, 2004, MOVEMENT DISORD, V19, P206, DOI 10.1002/mds.10630; Maks CB, 2009, J NEUROL NEUROSUR PS, V80, P659, DOI 10.1136/jnnp.2007.126219; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P589, DOI 10.1016/j.clinph.2003.10.033; Montaurier C, 2007, BRAIN, V130, P1808, DOI 10.1093/brain/awm113; Morel A, 2007, ATLAS HUMAN THALAMUS; Mueller K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018544; Novakova L, 2007, NEUROENDOCRINOL LETT, V28, P21; Novakova L, 2011, NEUROENDOCRINOL LETT, V32, P437; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Perlemoine C, 2005, BRIT J NUTR, V93, P191, DOI 10.1079/BJN20041297; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; Priori A, 2001, NEUROL SCI, V22, P85, DOI 10.1007/s100720170059; Richter EO, 2004, J NEUROSURG, V100, P541, DOI 10.3171/jns.2004.100.3.0541; Rieu I, 2011, J NEUROL SCI, V310, P267, DOI 10.1016/j.jns.2011.06.055; Rouaud T, 2010, P NATL ACAD SCI USA, V107, P1196, DOI 10.1073/pnas.0908189107; Saint-Cyr JA, 2002, J NEUROSURG, V97, P1152, DOI 10.3171/jns.2002.97.5.1152; Sauleau P, 2009, MOVEMENT DISORD, V24, P2149, DOI 10.1002/mds.22765; SCHOELLER DA, 1990, NUTR REV, V48, P373, DOI 10.1111/j.1753-4887.1990.tb02882.x; Serranova T, 2011, MOVEMENT DISORD, V26, P2260, DOI 10.1002/mds.23880; Shon YM, 2010, NEUROSCI LETT, V475, P136, DOI 10.1016/j.neulet.2010.03.060; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Turner MS, 2001, J NEUROSCI, V21, P2820, DOI 10.1523/JNEUROSCI.21-08-02820.2001; Walker HC, 2009, PARKINSONISM RELAT D, V15, P709, DOI 10.1016/j.parkreldis.2009.01.009; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Winter C, 2008, EXP BRAIN RES, V185, P497, DOI 10.1007/s00221-007-1171-1; Wise RA, 2005, J COMP NEUROL, V493, P115, DOI 10.1002/cne.20689; Yelnik J, 2003, J NEUROSURG, V99, P89, DOI 10.3171/jns.2003.99.1.0089; Zhu XL, 2002, ACTA NEUROCHIR, V144, P959, DOI 10.1007/s00701-002-0982-x	58	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38020	10.1371/journal.pone.0038020	http://dx.doi.org/10.1371/journal.pone.0038020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666437	Green Submitted, gold, Green Published			2022-12-27	WOS:000305353400069
J	Elmabsout, AA; Kumawat, A; Saenz-Mendez, P; Krivospitskaya, O; Savenstrand, H; Olofsson, PS; Eriksson, LA; Strid, A; Valen, G; Torma, H; Sirsjo, A				Elmabsout, Ali Ateia; Kumawat, Ashok; Saenz-Mendez, Patricia; Krivospitskaya, Olesya; Savenstrand, Helena; Olofsson, Peder S.; Eriksson, Leif A.; Strid, Ake; Valen, Guro; Torma, Hans; Sirsjo, Allan			Cloning and Functional Studies of a Splice Variant of CYP26B1 Expressed in Vascular Cells	PLOS ONE			English	Article							TRANS-RETINOIC ACID; SMOOTH-MUSCLE-CELLS; HUMAN CYTOCHROME-P450; METABOLIZING ENZYME; IDENTIFICATION; RESISTANCE; LIVER; P450S	Background: All-trans retinoic acid (atRA) plays an essential role in the regulation of gene expression, cell growth and differentiation and is also important for normal cardiovascular development but may in turn be involved in cardiovascular diseases, i.e. atherosclerosis and restenosis. The cellular atRA levels are under strict control involving several cytochromes P450 isoforms (CYPs). CYP26 may be the most important regulator of atRA catabolism in vascular cells. The present study describes the molecular cloning, characterization and function of atRA-induced expression of a spliced variant of the CYP26B1 gene. Methodology/Principal Findings: The coding region of the spliced CYP26B1 lacking exon 2 was amplified from cDNA synthesized from atRA-treated human aortic smooth muscle cells and sequenced. Both the spliced variant and full length CYP26B1 was found to be expressed in cultured human endothelial and smooth muscle cells, and in normal and atherosclerotic vessel. atRA induced both variants of CYP26B1 in cultured vascular cells. Furthermore, the levels of spliced mRNA transcript were 4.5 times higher in the atherosclerotic lesion compared to normal arteries and the expression in the lesions was increased 20-fold upon atRA treatment. The spliced CYP26B1 still has the capability to degrade atRA, but at an initial rate one-third that of the corresponding full length enzyme. Transfection of COS-1 and THP-1 cells with the CYP26B1 spliced variant indicated either an increase or a decrease in the catabolism of atRA, probably depending on the expression of other atRA catabolizing enzymes in the cells. Conclusions/Significance: Vascular cells express the spliced variant of CYP26B1 lacking exon 2 and it is also increased in atherosclerotic lesions. The spliced variant displays a slower and reduced degradation of atRA as compared to the full-length enzyme. Further studies are needed, however, to clarify the substrate specificity and role of the CYP26B1 splice variant in health and disease.	[Elmabsout, Ali Ateia; Kumawat, Ashok; Krivospitskaya, Olesya; Sirsjo, Allan] Univ Orebro, Sch Hlth Sci, Dept Clin Med, Orebro, Sweden; [Saenz-Mendez, Patricia] UdelaR, Computat Chem & Biol Grp, Fac Quim, Montevideo, Uruguay; [Savenstrand, Helena; Strid, Ake] Univ Orebro, Orebro Life Sci Ctr, Dept Sci & Technol, Orebro, Sweden; [Olofsson, Peder S.] Karolinska Inst, Dept Med, Ctr Mol Med, Stockholm, Sweden; [Olofsson, Peder S.] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA; [Eriksson, Leif A.] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Valen, Guro] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway; [Valen, Guro] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Torma, Hans] Uppsala Univ, Dept Med Sci Dermatol & Venereol, Uppsala, Sweden	Orebro University; Universidad de la Republica, Uruguay; Orebro University; Karolinska Institutet; Northwell Health; University of Gothenburg; University of Oslo; University of Oslo; Uppsala University	Elmabsout, AA (corresponding author), Univ Orebro, Sch Hlth Sci, Dept Clin Med, Orebro, Sweden.	allan.sirsjo@.oru.se	Strid, Åke/J-9068-2019; Saenz-Méndez, Patricia/G-3678-2011; Törmä, Hans/F-8152-2011; Eriksson, Leif A/D-1226-2012	Strid, Åke/0000-0003-3315-8835; Saenz-Méndez, Patricia/0000-0002-6711-4972; Törmä, Hans/0000-0002-3617-8551; Eriksson, Leif A/0000-0001-5654-3109; Kumawat, Ashok Kumar/0000-0002-2244-9816	Swedish Science Research Council (VR); Orebro University	Swedish Science Research Council (VR)(Swedish Research Council); Orebro University	The Swedish Science Research Council (VR) and Orebro University financially supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Chen H, 2000, DRUG METAB DISPOS, V28, P315; Colbert Melissa C, 2002, Cardiovasc Toxicol, V2, P25, DOI 10.1385/CT:2:1:25; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Gallagher RE, 2002, LEUKEMIA, V16, P1940, DOI 10.1038/sj.leu.2402719; Kizaki M, 1996, BLOOD, V87, P725, DOI 10.1182/blood.V87.2.725.bloodjournal872725; Krivospitskaya O, 2012, MOL MED IN PRESS; Lorie EP, 2009, BRIT J DERMATOL, V160, P26, DOI 10.1111/j.1365-2133.2008.08895.x; Lorie EP, 2009, BBA-MOL CELL BIOL L, V1791, P220, DOI 10.1016/j.bbalip.2008.12.004; Maden M, 2001, INT REV CYTOL, V209, P1; Marill J, 2000, MOL PHARMACOL, V58, P1341, DOI 10.1124/mol.58.6.1341; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Ocaya P, 2007, ARTERIOSCL THROM VAS, V27, P1542, DOI 10.1161/ATVBAHA.106.138602; Ocaya PA, 2011, J VASC RES, V48, P23, DOI 10.1159/000317397; Olofsson PS, 2009, J MOL MED-JMM, V87, P337, DOI 10.1007/s00109-008-0412-5; Osanai M, 2005, MOL PHARMACOL, V67, P1808, DOI 10.1124/mol.104.005769; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Rhee EJ, 2012, BBA-MOL CELL BIOL L, V1821, P230, DOI 10.1016/j.bbalip.2011.07.001; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Streb Jeffrey W., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P31, DOI 10.2174/1568006033337393; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Wagsater D, 2006, J VASC RES, V43, P377, DOI 10.1159/000094258; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Yamamoto Y, 2000, FASEB J, V14, P2119, DOI 10.1096/fj.00-0061com; Zolfaghari R, 2007, AM J PHYSIOL-GASTR L, V292, pG1029, DOI 10.1152/ajpgi.00494.2006	28	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e36839	10.1371/journal.pone.0036839	http://dx.doi.org/10.1371/journal.pone.0036839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666329	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600006
J	Ingrassia, R; Lanzillotta, A; Sarnico, I; Benarese, M; Blasi, F; Borgese, L; Bilo, F; Depero, L; Chiarugi, A; Spano, PF; Pizzi, M				Ingrassia, Rosaria; Lanzillotta, Annamaria; Sarnico, Ilenia; Benarese, Marina; Blasi, Francesco; Borgese, Laura; Bilo, Fabjola; Depero, Laura; Chiarugi, Alberto; Spano, Pier Franco; Pizzi, Marina			1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-kappa B/RelA Acetylation at Lys310	PLOS ONE			English	Article							DIVALENT METAL TRANSPORTER-1; PARKINSONS-DISEASE; IRON CHELATORS; SUBSTANTIA-NIGRA; B ACTIVATION; BELGRADE RAT; ISOFORMS; LOCALIZATION; DEFEROXAMINE; NEUROPROTECTION	The molecular mechanisms responsible for increasing iron and neurodegeneration in brain ischemia are an interesting area of research which could open new therapeutic approaches. Previous evidence has shown that activation of nuclear factor kappa B (NF-kappa B) through RelA acetylation on Lys310 is the prerequisite for p50/RelA-mediated apoptosis in cellular and animal models of brain ischemia. We hypothesized that the increase of iron through a NF-kappa B-regulated 1B isoform of the divalent metal transporter-1 (1B/DMT1) might contribute to post-ischemic neuronal damage. Both in mice subjected to transient middle cerebral artery occlusion (MCAO) and in neuronally differentiated SK-N-SH cells exposed to oxygen-glucose-deprivation (OGD), 1A/DMT1 was only barely expressed while the 1B/DMT1 without iron-response-element (-IRE) protein and mRNA were early up-regulated. Either OGD or over-expression of 1B/(-)IRE DMT1 isoform significantly increased iron uptake, as detected by total reflection X-ray fluorescence, and iron-dependent cell death. Iron chelation by deferoxamine treatment or (2) IRE DMT1 RNA silencing displayed significant neuroprotection against OGD which concomitantly decreased intracellular iron levels. We found evidence that 1B/(-)IRE DMT1 was a target gene for RelA activation and acetylation on Lys310 residue during ischemia. Chromatin immunoprecipitation analysis of the 1B/DMT1 promoter showed there was increased interaction with RelA and acetylation of H3 histone during OGD exposure of cortical neurons. Over-expression of wild-type RelA increased 1B/DMT1 promoter-luciferase activity, the (2) IRE DMT1 protein, as well as neuronal death. Expression of the acetylation-resistant RelA-K310R construct, which carried a mutation from lysine 310 to arginine, but not the acetyl-mimic mutant RelA-K310Q, down-regulated the 1B/DMT1 promoter, consequently offering neuroprotection. Our data showed that 1B/(-)IRE DMT1 expression and intracellular iron influx are early downstream responses to NF-kappa B/RelA activation and acetylation during brain ischemia and contribute to the pathogenesis of stroke-induced neuronal damage.	[Ingrassia, Rosaria] Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Lanzillotta, Annamaria; Sarnico, Ilenia; Benarese, Marina; Spano, Pier Franco; Pizzi, Marina] Univ Brescia, Sch Med, Div Pharmacol, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Blasi, Francesco; Chiarugi, Alberto] Univ Florence, Dept Pharmacol, Florence, Italy; [Borgese, Laura; Bilo, Fabjola; Depero, Laura] Univ Brescia, Sch Engn, Chem Technol Lab, Brescia, Italy; [Spano, Pier Franco; Pizzi, Marina] IRCCS S Camillo Hosp, Venice, Italy; [Lanzillotta, Annamaria; Sarnico, Ilenia; Benarese, Marina; Spano, Pier Franco; Pizzi, Marina] Univ Brescia, Sch Med, Natl Inst Neurosci Italy, Brescia, Italy	University of Brescia; University of Brescia; University of Florence; University of Brescia; IRCCS Ospedale San Camillo; University of Brescia	Ingrassia, R (corresponding author), Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Brescia, Italy.	ingrassi@med.unibs.it	Spano, Pier Franco A/E-7621-2010; Borgese, Laura/ABF-9537-2021; Ingrassia, Rosaria/AAC-3140-2021; Blasi, Francesco/G-1055-2015; Pizzi, Marina/K-2064-2016; SPANO, PIERFRANCO/J-9944-2016; Depero, Laura Eleonora/A-3176-2009	Borgese, Laura/0000-0003-3486-2656; Blasi, Francesco/0000-0002-6616-8418; Bilo, Fabjola/0000-0001-7362-3258; Pizzi, Marina/0000-0002-4857-5204; SPANO, PIERFRANCO/0000-0002-9906-0964; Depero, Laura Eleonora/0000-0001-7818-3212	Progetti di Ricerca di Interesse Nazionale-PRIN [PROT. 20089BARSR_003]; Network Enabled Drug Design Project- NEDD, Regione Lombardia, Italy [CUP H81J09002660007]	Progetti di Ricerca di Interesse Nazionale-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Network Enabled Drug Design Project- NEDD, Regione Lombardia, Italy	The study was partially supported by Progetti di Ricerca di Interesse Nazionale-PRIN 2008 (Grant number: PROT. 20089BARSR_003) and by Network Enabled Drug Design Project- NEDD (CUP H81J09002660007), Regione Lombardia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSHACHAR D, 1991, J NEUROCHEM, V56, P1441, DOI 10.1111/j.1471-4159.1991.tb11444.x; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs; Burdo JR, 1999, NEUROSCIENCE, V93, P1189, DOI 10.1016/S0306-4522(99)00207-9; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chew KCM, 2011, J BIOL CHEM, V286, P33380, DOI 10.1074/jbc.M111.268409; Connor JR, 2009, BBA-GEN SUBJECTS, V1790, DOI 10.1016/j.bbagen.2009.05.004; CRENON I, 1993, ONCOGENE, V8, P867; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Du F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004593; Faraco G, 2010, STROKE, V41, P181, DOI 10.1161/STROKEAHA.109.567826; Faucheux BA, 1997, BRAIN RES, V749, P170, DOI 10.1016/S0006-8993(96)01412-6; Garrick MD, 2006, BIOCHEM J, V398, P539, DOI 10.1042/BJ20051987; Gassen M, 1997, PHARMACOL TOXICOL, V80, P159, DOI 10.1111/j.1600-0773.1997.tb00390.x; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haile DJ, 1999, AM J MED SCI, V318, P230, DOI 10.1097/00000441-199910000-00003; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Hidalgo C, 2007, ANTIOXID REDOX SIGN, V9, P245, DOI 10.1089/ars.2007.9.245; HILL JM, 1985, P NATL ACAD SCI USA, V82, P4553, DOI 10.1073/pnas.82.13.4553; Hirsch EC, 2009, PARKINSONISM RELAT D, V15, pS209, DOI 10.1016/S1353-8020(09)70816-8; Huang E, 2004, NEUROSCIENCE, V128, P487, DOI 10.1016/j.neuroscience.2004.06.055; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Inta I, 2006, J NEUROSCI, V26, P12896, DOI 10.1523/JNEUROSCI.3670-06.2006; Jang SI, 2006, EUR J PHARMACOL, V542, P1, DOI 10.1016/j.ejphar.2006.04.044; Jiang H, 2006, NEUROCHEM INT, V49, P605, DOI 10.1016/j.neuint.2006.04.015; Kuo HC, 2004, J NEUROSCI RES, V76, P497, DOI 10.1002/jnr.20112; Kupershmidt L, 2011, NEUROSCIENCE, V189, P345, DOI 10.1016/j.neuroscience.2011.03.040; Lanzillotta A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.76; Lee JY, 2010, J CEREBR BLOOD F MET, V30, P1793, DOI 10.1038/jcbfm.2010.137; Lis A, 2005, BIOCHEM PHARMACOL, V69, P1647, DOI 10.1016/j.bcp.2005.03.023; Lis A, 2004, MOL BRAIN RES, V122, P62, DOI 10.1016/j.molbrainres.2003.11.023; Mandel S, 2007, PROG NEUROBIOL, V82, P348, DOI 10.1016/j.pneurobio.2007.06.001; Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Okauchi M, 2010, STROKE, V41, P375, DOI 10.1161/STROKEAHA.109.569830; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Paradkar PN, 2006, J NEUROCHEM, V96, P1768, DOI 10.1111/j.1471-4159.2006.03702.x; Paramar PN, 2006, BIOCHEM J, V394, P173, DOI 10.1042/BJ20051296; Pizzi M, 2002, EUR J NEUROSCI, V16, P2342, DOI 10.1046/j.1460-9568.2002.02403.x; Pizzi M, 2006, EUR J PHARMACOL, V545, P22, DOI 10.1016/j.ejphar.2006.06.027; Qian ZM, 2011, J CELL PHYSIOL, V226, P1596, DOI 10.1002/jcp.22485; Roth JA, 2000, J NEUROSCI, V20, P7595; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Sarnico I, 2009, J NEUROCHEM, V108, P475, DOI 10.1111/j.1471-4159.2008.05783.x; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Siddiq A, 2009, J NEUROSCI, V29, P8828, DOI 10.1523/JNEUROSCI.1779-09.2009; Snyder AM, 2009, BBA-GEN SUBJECTS, V1790, P606, DOI 10.1016/j.bbagen.2008.08.005; Tabuchi M, 2002, MOL BIOL CELL, V13, P4371, DOI 10.1091/mbc.E02-03-0165; Tacchini L, 2002, HEPATOLOGY, V36, P103, DOI 10.1053/jhep.2002.33997; VIDAL S, 1995, MAMM GENOME, V6, P224, DOI 10.1007/BF00352405; Wang D, 2010, IUBMB LIFE, V62, P629, DOI 10.1002/iub.363; Wang XS, 2003, NEUROSCIENCE, V120, P21, DOI 10.1016/S0306-4522(03)00293-8; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Xu HM, 2010, J CELL BIOCHEM, V111, P1537, DOI 10.1002/jcb.22885; Xu HM, 2010, NEUROPHARMACOLOGY, V58, P488, DOI 10.1016/j.neuropharm.2009.09.002; Yang L, 2011, CELL PHYSIOL BIOCHEM, V27, P23, DOI 10.1159/000325202; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Youdim MBH, 2004, ANN NY ACAD SCI, V1012, P306, DOI 10.1196/annals.1306.025; Youdim MBH, 1999, ANN NY ACAD SCI, V890, P7, DOI 10.1111/j.1749-6632.1999.tb07977.x; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang SZ, 2009, NEUROBIOL AGING, V30, P1466, DOI 10.1016/j.neurobiolaging.2007.11.025; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230; Zhu L, 2008, J CELL MOL MED, V12, P569, DOI 10.1111/j.1582-4934.2007.00145.x	63	33	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38019	10.1371/journal.pone.0038019	http://dx.doi.org/10.1371/journal.pone.0038019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666436	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600054
J	Schmidt, J; Riechers, A; Stoll, R; Amann, T; Fink, F; Spruss, T; Gronwald, W; Konig, B; Hellerbrand, C; Bosserhoff, AK				Schmidt, Jennifer; Riechers, Alexander; Stoll, Raphael; Amann, Thomas; Fink, Florian; Spruss, Thilo; Gronwald, Wolfram; Koenig, Burkhard; Hellerbrand, Claus; Bosserhoff, Anja Katrin			Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition	PLOS ONE			English	Article							MALIGNANT-MELANOMA; CELLS; EXPRESSION; MIGRATION; TRANSITION; SECRETION; INVASION; SPECTRA; FAMILY	Melanoma is the most aggressive form of skin cancer, with fast progression and early dissemination mediated by the melanoma inhibitory activity (MIA) protein. Here, we discovered that dimerization of MIA is required for functional activity through mutagenesis of MIA which showed the correlation between dimerization and functional activity. We subsequently identified the dodecapeptide AR71, which prevents MIA dimerization and thereby acts as a MIA inhibitor. Two-dimensional nuclear magnetic resonance (NMR) spectroscopy demonstrated the binding of AR71 to the MIA dimerization domain, in agreement with in vitro and in vivo data revealing reduced cell migration, reduced formation of metastases and increased immune response after AR71 treatment. We believe AR71 is a lead structure for MIA inhibitors. More generally, inhibiting MIA dimerization is a novel therapeutic concept in melanoma therapy.	[Schmidt, Jennifer; Bosserhoff, Anja Katrin] Univ Regensburg, Inst Pathol, Regensburg, Germany; [Riechers, Alexander; Koenig, Burkhard] Univ Regensburg, Inst Organ Chem, D-8400 Regensburg, Germany; [Stoll, Raphael] Ruhr Univ Bochum, Biomol NMR, Fac Chem & Biochem, Bochum, Germany; [Amann, Thomas; Hellerbrand, Claus] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany; [Fink, Florian; Gronwald, Wolfram] Univ Regensburg, Inst Funct Gen, Regensburg, Germany; [Spruss, Thilo] Univ Regensburg, Inst Pharm, D-8400 Regensburg, Germany	University of Regensburg; University of Regensburg; Ruhr University Bochum; University of Regensburg; University of Regensburg; University of Regensburg	Schmidt, J (corresponding author), Univ Regensburg, Inst Pathol, Regensburg, Germany.	anja.bosserhoff@klinik.uni-regensburg.de	Bosserhoff, Anja/GNH-4801-2022; Koenig, Burkhard/O-8172-2019; Koenig, Burkhard/A-1362-2009; Koenig, Burkhard/GRX-2026-2022	Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850; Bosserhoff, Anja/0000-0001-8147-394X	German Research Foundation; German Cancer Aid (Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung; FCI; Proteincenter (NRW Center of Excellence); RUBiospek	German Research Foundation(German Research Foundation (DFG)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); FCI(Fonds der Chemischen Industrie); Proteincenter (NRW Center of Excellence); RUBiospek	This work was supported by the German Research Foundation and the German Cancer Aid (Deutsche Krebshilfe) to AKB. Furthermore, RS gratefully recognizes generous support from the Bundesministerium fur Bildung und Forschung, FCI, Proteincenter (NRW Center of Excellence), and RUBiospek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; BLESCH A, 1994, CANCER RES, V54, P5695; Bosserhoff AK, 1996, J BIOL CHEM, V271, P490, DOI 10.1074/jbc.271.1.490; Bosserhoff AK, 2003, LAB INVEST, V83, P1583, DOI 10.1097/01.LAB.0000097191.12477.5D; Bosserhoff AK, 2002, HISTOL HISTOPATHOL, V17, P289, DOI 10.14670/HH-17.289; Bosserhoff AK, 2001, MELANOMA RES, V11, P417, DOI 10.1097/00008390-200108000-00013; Carrascal MT, 2003, CANCER RES, V63, P491; DAVIS DG, 1985, J AM CHEM SOC, V107, P7197, DOI 10.1021/ja00310a085; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Guba M, 2000, BRIT J CANCER, V83, P1216, DOI 10.1054/bjoc.2000.1424; Jachimczak P, 2005, INT J CANCER, V113, P88, DOI 10.1002/ijc.20549; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; Lougheed JC, 2001, P NATL ACAD SCI USA, V98, P5515, DOI 10.1073/pnas.091601698; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Moser M, 2002, MOL CELL BIOL, V22, P1438, DOI 10.1128/MCB.22.5.1438-1445.2002; Riechers A, 2009, BIOTECHNIQUES, V47, P837, DOI 10.2144/000113223; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Schmidt J, 2009, INT J CANCER, V125, P1587, DOI 10.1002/ijc.24508; Schwarten M, 2007, BIOMOL NMR ASSIGM, V1, P105, DOI 10.1007/s12104-007-9030-3; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Stahlecker J, 2000, ANTICANCER RES, V20, P5041; Stoll R, 2008, CURR PROTEIN PEPT SC, V9, P221, DOI 10.2174/138920308784534014; Stoll R, 2001, EMBO J, V20, P340, DOI 10.1093/emboj/20.3.340; Stoll R, 2006, BIOL CHEM, V387, P1601, DOI 10.1515/BC.2006.199; Tatzel J, 2005, PIGM CELL RES, V18, P92, DOI 10.1111/j.1600-0749.2005.00212.x; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616	29	15	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37941	10.1371/journal.pone.0037941	http://dx.doi.org/10.1371/journal.pone.0037941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666418	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600045
J	Wu, YC; Wang, XJ; Yu, L; Chan, FKL; Cheng, ASL; Yu, J; Sung, JJY; Wu, WKK; Cho, CH				Wu, Ya C.; Wang, Xiao J.; Yu, Le; Chan, Francis K. L.; Cheng, Alfred S. L.; Yu, Jun; Sung, Joseph J. Y.; Wu, William K. K.; Cho, Chi H.			Hydrogen Sulfide Lowers Proliferation and Induces Protective Autophagy in Colon Epithelial Cells	PLOS ONE			English	Article							ULCERATIVE-COLITIS; IN-VITRO; CANCER; PROTEIN; HUMANS	Hydrogen sulfide (H2S) is a gaseous bacterial metabolite that reaches high levels in the large intestine. In the present study, the effect of H2S on the proliferation of normal and cancerous colon epithelial cells was investigated. An immortalized colon epithelial cell line (YAMC) and a panel of colon cancer cell lines (HT-29, SW1116, HCT116) were exposed to H2S at concentrations similar to those found in the human colon. H2S inhibited normal and cancerous colon epithelial cell proliferation as measured by MTT assay. The anti-mitogenic effect of H2S was accompanied by G(1)-phase cell cycle arrest and the induction of the cyclin-dependent kinase inhibitor p21(Cip). Moreover, exposure to H2S led to features characteristic of autophagy, including increased formation of LC3B(+) autophagic vacuoles and acidic vesicular organelles as determined by immunofluorescence and acridine orange staining, respectively. Abolition of autophagy by RNA interference targeting Vps34 or Atg7 enhanced the anti-proliferative effect of H2S. Further mechanistic investigation revealed that H2S stimulated the phosphorylation of AMP-activated protein kinase (AMPK) and inhibited the phosphorylation of mammalian target of rapamycin (mTOR) and S6 kinase. Inhibition of AMPK significantly reversed H2S-induced autophagy and inhibition of cell proliferation. Collectively, we demonstrate that H2S inhibits colon epithelial cell proliferation and induces protective autophagy via the AMPK pathway.	[Wu, Ya C.; Yu, Le; Cho, Chi H.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Wang, Xiao J.; Chan, Francis K. L.; Cheng, Alfred S. L.; Yu, Jun; Sung, Joseph J. Y.; Wu, William K. K.] Chinese Univ Hong Kong, Inst Digest Dis, LKS Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Wang, Xiao J.; Chan, Francis K. L.; Cheng, Alfred S. L.; Yu, Jun; Sung, Joseph J. Y.; Wu, William K. K.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wu, YC (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	wukakei@cuhk.edu.hk	Cheng, Alfred SL/C-3327-2014; Wu, William K.K./A-3277-2009; Cho, Chi Hin/C-6543-2014; Chan, Francis K. L./F-4851-2010; Sung, Joseph J. Y./R-3203-2018; wu, william/HII-5817-2022; Yu, Jun/D-8569-2015	Cheng, Alfred SL/0000-0003-2345-6951; Wu, William K.K./0000-0002-5662-5240; Cho, Chi Hin/0000-0002-7658-3260; Chan, Francis K. L./0000-0001-7388-2436; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Jun/0000-0001-5008-2153				Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; FLORIN T, 1991, GUT, V32, P766, DOI 10.1136/gut.32.7.766; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Kawabata A, 2007, PAIN, V132, P74, DOI 10.1016/j.pain.2007.01.026; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Levine J, 1998, AM J GASTROENTEROL, V93, P83, DOI 10.1111/j.1572-0241.1998.083_c.x; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; Magee EA, 2000, AM J CLIN NUTR, V72, P1488; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Picton R, 2007, DIGEST DIS SCI, V52, P373, DOI 10.1007/s10620-006-9529-y; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Schicho R, 2006, GASTROENTEROLOGY, V131, P1542, DOI 10.1053/j.gastro.2006.08.035; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Tripatara P, 2008, LAB INVEST, V88, P1038, DOI 10.1038/labinvest.2008.73; Turk HF, 2011, INT J CANCER, V128, P63, DOI 10.1002/ijc.25323; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Wu WKK, 2012, ONCOGENE, V31, P939, DOI 10.1038/onc.2011.295	24	82	88	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37572	10.1371/journal.pone.0037572	http://dx.doi.org/10.1371/journal.pone.0037572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22679478	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600021
J	Ciesielski, F; Davis, B; Rittig, M; Bonev, BB; O'Shea, P				Ciesielski, Filip; Davis, Benjamin; Rittig, Michael; Bonev, Boyan B.; O'Shea, Paul			Receptor-Independent Interaction of Bacterial Lipopolysaccharide with Lipid and Lymphocyte Membranes; the Role of Cholesterol	PLOS ONE			English	Article							LATERAL DIFFUSION; LPS; BINDING; RAFTS; MICRODOMAINS; RECOGNITION; INSERTION; PHASES; MODEL; TLR4	Lipopolysaccharide (LPS) is a major constituent of bacterial outer membranes where it makes up the bulk of the outer leaflet and plays a key role as determinant of bacterial interactions with the host. Membrane-free LPS is known to activate T-lymphocytes through interactions with Toll-like receptor 4 via multiprotein complexes. In the present study, we investigate the role of cholesterol and membrane heterogeneities as facilitators of receptor-independent LPS binding and insertion, which underpin bacterial interactions with the host in symbiosis, pathogenesis and cell invasion. We use fluorescence spectroscopy to investigate the interactions of membrane-free LPS from intestinal Gram-negative organisms with cholesterol-containing model membranes and with T-lymphocytes. LPS preparations from Klebsiella pneumoniae and Salmonella enterica were found to bind preferentially to mixed lipid membranes by comparison to pure PC bilayers. The same was observed for LPS from the symbiote Escherichia coli but with an order of magnitude higher dissociation constant. Insertion of LPS into model membranes confirmed the preference for sphimgomyelin/cholesterol-containing systems. LPS insertion into Jurkat T-lymphocyte membranes reveals that they have a significantly greater LPS-binding capacity by comparison to methyl-b-cyclodextrin cholesterol-depleted lymphocyte membranes, albeit at slightly lower binding rates.	[Ciesielski, Filip; Rittig, Michael; Bonev, Boyan B.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England; [Davis, Benjamin; O'Shea, Paul] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Ciesielski, F (corresponding author), Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England.	Boyan.Bonev@nottingham.ac.uk; Paul.OShea@nottingham.ac.uk		Bonev, Boyan/0000-0001-7156-2412; O'Shea, paul/0000-0001-9313-8313; Davis, Benjamin/0000-0001-6121-1635	United Kingdom Medical Research Council through a Doctoral Training Award; Institute of Infection and Immunity, Nottingham	United Kingdom Medical Research Council through a Doctoral Training Award; Institute of Infection and Immunity, Nottingham	The authors (BBB and MR) would like to acknowledge the financial contribution of the United Kingdom Medical Research Council in supporting FC through a Doctoral Training Award, and the Institute of Infection and Immunity, Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam JM, 2011, CHEM PHYS LIPIDS, V164, P166, DOI 10.1016/j.chemphyslip.2010.12.008; ALMEIDA PFF, 1992, BIOCHEMISTRY-US, V31, P6739, DOI 10.1021/bi00144a013; Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Davis BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013522; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Duggan J, 2008, EUR BIOPHYS J BIOPHY, V37, P1279, DOI 10.1007/s00249-008-0349-1; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Filippov A, 2004, BIOPHYS J, V86, P891, DOI 10.1016/S0006-3495(04)74164-8; Filippov A, 2003, BIOPHYS J, V84, P3079, DOI 10.1016/S0006-3495(03)70033-2; Golding C, 1996, BIOCHEMISTRY-US, V35, P10931, DOI 10.1021/bi960905i; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MAYER LD, 1986, CHEM PHYS LIPIDS, V40, P333, DOI 10.1016/0009-3084(86)90077-0; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Richardson G, 2007, BIOPHYS J, V92, P4145, DOI 10.1529/biophysj.106.090233; Rouquette-Jazdanian AK, 2006, CELL SIGNAL, V18, P105, DOI 10.1016/j.cellsig.2005.03.024; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Triantafilou M, 2002, J CELL SCI, V115, P2603; WALL J, 1995, MOL MEMBR BIOL, V12, P183, DOI 10.3109/09687689509027506; WALL J, 1995, J CELL SCI, V108, P2673; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	34	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38677	10.1371/journal.pone.0038677	http://dx.doi.org/10.1371/journal.pone.0038677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685597	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700060
J	Le Page, C; Marineau, A; Bonza, PK; Rahimi, K; Cyr, L; Labouba, I; Madore, J; Delvoye, N; Mes-Masson, AM; Provencher, DM; Cailhier, JF				Le Page, Cecile; Marineau, Alexandre; Bonza, Patrick K.; Rahimi, Kurosh; Cyr, Louis; Labouba, Ingrid; Madore, Jason; Delvoye, Nathalie; Mes-Masson, Anne-Marie; Provencher, Diane M.; Cailhier, Jean-Francois			BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GYNECOLOGIC-ONCOLOGY-GROUP; POOR-PROGNOSIS; MAMMARY-GLAND; MESSENGER-RNA; GENE FAMILY; B7 FAMILY; BUTYROPHILIN; MACROPHAGES; ACTIVATION	BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC). Here, we evaluated the prognostic value of BT3.2 at the protein level in specimen from 199 HG-EOC patients. As the only known role of butyrophilin proteins is in immune regulation, we evaluated the association between BT3.2 expression and intratumoral infiltration of immune cells by immunohistochemistry with specific antibodies against BT3.2, CD3, CD4, CD8, CD20, CD68 and CD206. Epithelial BT3.2 expression was significantly associated with longer overall survival and lower risk of disease progression (HR = 0.651, p = 0.006 and HR = 0.642, p = 0.002, respectively) and significantly associated with a higher density of infiltrating T cells, particularly CD4+ cells (0.272, p < 0.001). We also observed a strong association between the relative density of CD206+ cells, as evaluated by the ratio of intratumoral CD206+/CD68+ expression, and risk of disease progression (HR = 1.355 p = 0.044, respectively). In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206+/CD68+ expression is associated with high risk of disease progression. While the role of BT3.2 is still unknown, our result suggest that BT3.2 expression by epithelial cells may modulates the intratumoral infiltration of immune cells.	[Le Page, Cecile; Marineau, Alexandre; Bonza, Patrick K.; Cyr, Louis; Labouba, Ingrid; Madore, Jason; Delvoye, Nathalie; Mes-Masson, Anne-Marie; Provencher, Diane M.; Cailhier, Jean-Francois] CRCHUM, Montreal, PQ, Canada; [Le Page, Cecile; Marineau, Alexandre; Bonza, Patrick K.; Cyr, Louis; Labouba, Ingrid; Madore, Jason; Delvoye, Nathalie; Mes-Masson, Anne-Marie; Provencher, Diane M.; Cailhier, Jean-Francois] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Rahimi, Kurosh] CHUM, Dept Pathol, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie; Cailhier, Jean-Francois] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Provencher, Diane M.] CHUM, Div Gynecol Oncol, Montreal, PQ, Canada; [Cailhier, Jean-Francois] CHUM, Div Nephrol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Le Page, C (corresponding author), CRCHUM, Montreal, PQ, Canada.	jf.cailhier@umontreal.ca	Le Page, Cecile/B-3215-2010	Le Page, Cecile/0000-0002-8020-1544; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Marineau, Alexandre/0000-0003-0163-8391; Madore, Jason/0000-0002-3499-474X	Cancer Research Society; Fondation Carole Epstein; Fonds de Recherche en Sante du Quebec	Cancer Research Society; Fondation Carole Epstein; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Cancer Research Society and Fondation Carole Epstein. Dr. Cailhier holds a clinicien-chercheur scholarship from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler-Dorner L, 2012, TRENDS IMMUNOL, V33, P34, DOI 10.1016/j.it.2011.09.007; Al-Attar A, 2010, PATHOL ONCOL RES, V16, P361, DOI 10.1007/s12253-009-9230-5; Allavena P, 2011, EXP CELL RES, V317, P664, DOI 10.1016/j.yexcr.2010.11.013; Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Banghart LR, 1998, J BIOL CHEM, V273, P4171, DOI 10.1074/jbc.273.7.4171; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; Bas A, 2011, P NATL ACAD SCI USA, V108, P4376, DOI 10.1073/pnas.1010647108; Bosmuller H, 2011, VIRCHOWS ARCH, V459, P183, DOI 10.1007/s00428-011-1110-1; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Compte E, 2004, EUR J IMMUNOL, V34, P2089, DOI 10.1002/eji.200425227; Cubillos-Ruiz JR, 2011, CELL CYCLE, V10, P368, DOI 10.4161/cc.10.3.14565; Fung-Kee-Fung M, 2007, Curr Oncol, V14, P195; Gavalas NG, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/791603; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Le Page C, 2008, CANCER EPIDEM BIOMAR, V17, P913, DOI 10.1158/1055-9965.EPI-07-0692; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Ling V, 2003, GENOMICS, V82, P365, DOI 10.1016/S0888-7543(03)00126-5; LINSLEY PS, 1994, PROTEIN SCI, V3, P1341, DOI 10.1002/pro.5560030820; Loos M, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/683875; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Messal N, 2011, EUR J IMMUNOL, V41, P3443, DOI 10.1002/eji.201141404; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Nguyen T, 2006, J IMMUNOL, V176, P7354, DOI 10.4049/jimmunol.176.12.7354; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Rustin GJS, 2011, INT J GYNECOL CANCER, V21, P419, DOI 10.1097/IGC.0b013e3182070f17; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shah CA, 2008, GYNECOL ONCOL, V109, P215, DOI 10.1016/j.ygyno.2008.01.010; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smith IA, 2010, J IMMUNOL, V184, P3514, DOI 10.4049/jimmunol.0900416; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Stumpf M, 2009, BRIT J CANCER, V101, P1513, DOI 10.1038/sj.bjc.6605274; Sun X, 2003, GENE THER, V10, P1728, DOI 10.1038/sj.gt.3302070; TaziAhnini R, 1997, IMMUNOGENETICS, V47, P55, DOI 10.1007/s002510050326; Tetu B, 2008, MODERN PATHOL, V21, P1002, DOI 10.1038/modpathol.2008.80; Torroella-Kouri M, 2009, CANCER RES, V69, P4800, DOI 10.1158/0008-5472.CAN-08-3427; Wakabayashi Mark T, 2008, J Natl Compr Canc Netw, V6, P803; Wakabayashi MT, 2008, J NATL COMPR CANC NE, V6, P811; Winter WE, 2008, J CLIN ONCOL, V26, P83, DOI 10.1200/JCO.2007.13.1953; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Yamashiro H, 2010, J LEUKOCYTE BIOL, V88, P757, DOI 10.1189/jlb.0309156; Yamazaki T, 2010, J IMMUNOL, V185, P5907, DOI 10.4049/jimmunol.1000835; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zietarska M, 2010, HISTOPATHOLOGY, V57, P323, DOI 10.1111/j.1365-2559.2010.03602.x	50	69	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38541	10.1371/journal.pone.0038541	http://dx.doi.org/10.1371/journal.pone.0038541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685580	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700043
J	de Kleijn, S; Kox, M; Sama, IE; Pillay, J; van Diepen, A; Huijnen, MA; van der Hoeven, JG; Ferwerda, G; Hermans, PWM; Pickkers, P				de Kleijn, Stan; Kox, Matthijs; Sama, Iziah Edwin; Pillay, Janesh; van Diepen, Angela; Huijnen, Martijn A.; van der Hoeven, Johannes G.; Ferwerda, Gerben; Hermans, Peter W. M.; Pickkers, Peter			Transcriptome Kinetics of Circulating Neutrophils during Human Experimental Endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; EXPRESSION; APOPTOSIS; SEPSIS; HETEROGENEITY; INHIBITION; CYTOSCAPE; CELLS	Polymorphonuclear cells (neutrophils) play an important role in the systemic inflammatory response syndrome and the development of sepsis. These cells are essential for the defense against microorganisms, but may also cause tissue damage. Therefore, neutrophil numbers and activity are considered to be tightly regulated. Previous studies have investigated gene transcription during experimental endotoxemia in whole blood and peripheral blood mononuclear cells. However, the gene transcription response of the circulating pool of neutrophils to systemic inflammatory stimulation in vivo is currently unclear. We examined neutrophil gene transcription kinetics in healthy human subjects (n = 4) administered a single dose of endotoxin (LPS, 2 ng/kg iv). In addition, freshly isolated neutrophils were stimulated ex vivo with LPS, TNF alpha, G-CSF and GM-CSF to identify stimulus-specific gene transcription responses. Whole transcriptome microarray analysis of circulating neutrophils at 2, 4 and 6 hours after LPS infusion revealed activation of inflammatory networks which are involved in signaling of TNF alpha and IL-1 alpha and IL-1 beta. The transcriptome profile of inflammatory activated neutrophils in vivo reflects extended survival and regulation of inflammatory responses. These changes in neutrophil transcriptome suggest a combination of early activation of circulating neutrophils by TNF alpha and G-CSF and a mobilization of young neutrophils from the bone marrow.	[de Kleijn, Stan; van Diepen, Angela; Ferwerda, Gerben; Hermans, Peter W. M.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Sama, Iziah Edwin; Huijnen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Pillay, Janesh] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [van Diepen, Angela] Leiden Univ, Med Ctr, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Kleijn, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands.	J.Ferwerda@cukz.umcn.nl	Ferwerda, J.G./L-4305-2015; Hermans, Peter W.M./H-8042-2014; Kox, Matthijs/L-4454-2015; van der Hoeven, J.G./H-8048-2014; Huijnen, M.A./H-8051-2014; Pickkers, P./H-8080-2014	Pickkers, P./0000-0002-1104-4303; Pillay, Janesh/0000-0001-8037-6638; Sama, Iziah/0000-0002-9056-7152	ZonMW, The Netherlands [85100003]; VIRGO consortium, an Innovative Cluster; Dutch Government, The Netherlands [BSIK 03012]	ZonMW, The Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government); VIRGO consortium, an Innovative Cluster; Dutch Government, The Netherlands(Netherlands Government)	SdK is supported by ZonMW, The Netherlands, Grant No. 85100003. IES was supported by the VIRGO consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK 03012), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida K, 2005, J ATHEROSCLER THROMB, V12, P53, DOI 10.5551/jat.12.53; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cowland JB, 1999, J LEUKOCYTE BIOL, V66, P989, DOI 10.1002/jlb.66.6.989; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hsu LC, 2011, NAT IMMUNOL, V12, P144, DOI 10.1038/ni.1976; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Keel M, 1997, BLOOD, V90, P3356, DOI 10.1182/blood.V90.9.3356; Kox M, 2011, CRIT CARE MED; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lowry SF, 2005, SHOCK, V24, P94, DOI 10.1097/01.shk.0000191340.23907.a1; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Passamonti F, 2004, BRIT J HAEMATOL, V126, P650, DOI 10.1111/j.1365-2141.2004.05098.x; Paunel-Gorgulu A, 2011, CRIT CARE, V15, DOI 10.1186/cc9965; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Pillay J, 2010, J LEUKOCYTE BIOL, V88, P211, DOI 10.1189/jlb.1209793; Sama IE, 2010, BIOINFORMATICS, V26, P2737, DOI 10.1093/bioinformatics/btq474; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006; Tang BMP, 2007, AM J RESP CRIT CARE, V176, P676, DOI 10.1164/rccm.200612-1819OC; Theilgaard-Monch K, 2006, BLOOD, V108, P353, DOI 10.1182/blood-2005-09-3890; van der Meer W, 2007, J ENDOTOXIN RES, V13, P94, DOI 10.1177/0968051907079101; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; van Raam BJ, 2008, BLOOD, V112, P2046, DOI 10.1182/blood-2008-04-149575; Wong HR, 2010, PEDIATR CRIT CARE ME, V11, P349, DOI 10.1097/PCC.0b013e3181c519b4; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6; Zhang P, 2005, SHOCK, V23, P344, DOI 10.1097/01.shk.0000158960.93832.de	34	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38255	10.1371/journal.pone.0038255	http://dx.doi.org/10.1371/journal.pone.0038255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679495	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343900025
J	Inoue, K; Shimozono, S; Yoshida, H; Kurata, H				Inoue, Kentaro; Shimozono, Shinichi; Yoshida, Hideaki; Kurata, Hiroyuki			Application of Approximate Pattern Matching in Two Dimensional Spaces to Grid Layout for Biochemical Network Maps	PLOS ONE			English	Article							BIOLOGICAL NETWORKS; GRAPH LAYOUT; ANALYSIS TOOL; VISUALIZATION; ALGORITHM; CYTOSCAPE; CADLIVE; ENVIRONMENT; NOTATION; SYSTEM	Background: For visualizing large-scale biochemical network maps, it is important to calculate the coordinates of molecular nodes quickly and to enhance the understanding or traceability of them. The grid layout is effective in drawing compact, orderly, balanced network maps with node label spaces, but existing grid layout algorithms often require a high computational cost because they have to consider complicated positional constraints through the entire optimization process. Results: We propose a hybrid grid layout algorithm that consists of a non-grid, fast layout (preprocessor) algorithm and an approximate pattern matching algorithm that distributes the resultant preprocessed nodes on square grid points. To demonstrate the feasibility of the hybrid layout algorithm, it is characterized in terms of the calculation time, numbers of edge-edge and node-edge crossings, relative edge lengths, and F-measures. The proposed algorithm achieves outstanding performances compared with other existing grid layouts. Conclusions: Use of an approximate pattern matching algorithm quickly redistributes the laid-out nodes by fast, non-grid algorithms on the square grid points, while preserving the topological relationships among the nodes. The proposed algorithm is a novel use of the pattern matching, thereby providing a breakthrough for grid layout. This application program can be freely downloaded from http//www.cadlive.jp/hybridlayout/hybridlayout.html.	[Inoue, Kentaro; Kurata, Hiroyuki] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan; [Shimozono, Shinichi; Yoshida, Hideaki] Kyushu Inst Technol, Dept Artificial Intelligence, Iizuka, Fukuoka, Japan; [Kurata, Hiroyuki] Kyushu Inst Technol, Biomed Informat R&D Ctr, Iizuka, Fukuoka, Japan	Kyushu Institute of Technology; Kyushu Institute of Technology; Kyushu Institute of Technology	Inoue, K (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan.	kurata@bio.kyutech.ac.jp	Inoue, Kentaro/P-4920-2016	Inoue, Kentaro/0000-0002-7447-5856	Japan Society for the Promotion of Science [22300101]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23134506]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research (B) (22300101) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/) and Grant-in-Aid for Scientific Research on Innovative Areas (23134506) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T., 1999, Combinatorial Pattern Matching. 10th Annual Symposium, CPM 99. Proceedings (Lecture Notes in Computer Science Vol.1645), P212; Archambault D, 2007, IEEE T VIS COMPUT GR, V13, P305, DOI 10.1109/TVCG.2007.46; Baitaluk M, 2006, NUCLEIC ACIDS RES, V34, pW466, DOI 10.1093/nar/gkl308; Balasundaram B, 2008, WILEY SERIES BIOINFO, P65; Barsky A, 2008, IEEE T VIS COMPUT GR, V14, P1253, DOI 10.1109/TVCG.2008.117; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Bartel G, 2011, LECT NOTES COMPUT SC, V6502, P80, DOI 10.1007/978-3-642-18469-7_8; Becker MY, 2001, BIOINFORMATICS, V17, P461, DOI 10.1093/bioinformatics/17.5.461; Bourqui R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-29; Brandes U, 2009, LECT NOTES COMPUT SC, V5417, P218, DOI 10.1007/978-3-642-00219-9_21; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Deckard A, 2006, BIOINFORMATICS, V22, P2966, DOI 10.1093/bioinformatics/btl520; Demir E, 2002, BIOINFORMATICS, V18, P996, DOI 10.1093/bioinformatics/18.7.996; Dobkin D. P., 1997, Graph Drawing. 5th International Symposium, GD '97. Proceedings, P262, DOI 10.1007/3-540-63938-1_68; Dogrusoz U, 2006, BIOINFORMATICS, V22, P374, DOI 10.1093/bioinformatics/bti776; Dogrusoz U, 2004, LECT NOTES COMPUT SC, V3383, P442; Doi Atsushi, 2003, Appl Bioinformatics, V2, P185; Dwyer T, 2006, LECT NOTES COMPUT SC, V3843, P153; Dwyer T, 2008, LECT NOTES COMPUT SC, V4875, P219; Dwyer T, 2006, IEEE T VIS COMPUT GR, V12, P821, DOI 10.1109/TVCG.2006.156; EADES P, 1993, INFORM PROCESS LETT, V47, P319, DOI 10.1016/0020-0190(93)90079-O; Eades P., 1984, C NUMERANTIUM, V42, P149; Enright AJ, 2001, BIOINFORMATICS, V17, P853, DOI 10.1093/bioinformatics/17.9.853; Finkel R. A., 1974, Acta Informatica, V4, P1, DOI 10.1007/BF00288933; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Gajer P., 2002, Journal of Graph Algorithms and Applications, V6, DOI 10.7155/jgaa.00052; Gansner ER, 2004, LECT NOTES COMPUT SC, V3383, P239; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Goesmann A, 2002, BIOINFORMATICS, V18, P124, DOI 10.1093/bioinformatics/18.1.124; Gursoy A, 2000, LECT NOTES COMPUT SC, V1900, P234; Hachul S, 2006, LECT NOTES COMPUT SC, V3843, P235; Hachul S, 2004, LECT NOTES COMPUT SC, V3383, P285; He S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-31; Hoffmann F., 1998, Proceedings of the Fourteenth Annual Symposium on Computational Geometry, P231, DOI 10.1145/276884.276911; Holford M, 2005, BIOINFORMATICS, V21, P1596, DOI 10.1093/bioinformatics/bti153; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Inostroza-Ponta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014468; Inoue K, 2011, BIOCHEM ENG J, V54, P200, DOI 10.1016/j.bej.2011.02.022; Iragne F, 2005, BIOINFORMATICS, V21, P272, DOI 10.1093/bioinformatics/bth494; Ju BH, 2003, BIOINFORMATICS, V19, P317, DOI 10.1093/bioinformatics/19.2.317; Ju BH, 2003, BIOINFORMATICS, V19, pi177, DOI 10.1093/bioinformatics/btg1022; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Karp PD., 1994, 3 INT C BIOINF GEN R, P225; Kojima K, 2008, BIOINFORMATICS, V24, P1433, DOI 10.1093/bioinformatics/btn196; Kojima K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-76; Kojima K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-335; Koren Y, 2003, LECT NOTES COMPUT SC, V2697, P496; Kurata H, 2005, GENOME RES, V15, P590, DOI 10.1101/gr.3463705; Kurata H, 2003, NUCLEIC ACIDS RES, V31, P4071, DOI 10.1093/nar/gkg461; Kurata H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm769; Li WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002541; Li WJ, 2005, BIOINFORMATICS, V21, P2036, DOI 10.1093/bioinformatics/bti290; Lu ZP, 2009, LECT NOTES COMPUT SC, V5482, P1; Makinen V, 2001, EIGHTH SYMPOSIUM ON STRING PROCESSING AND INFORMATION RETRIEVAL, PROCEEDINGS, P153, DOI 10.1109/SPIRE.2001.989751; Mei J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/043025; Meyer B, 1998, LECT NOTES COMPUT SC, V1547, P246; Nagasaki Masao, 2003, Appl Bioinformatics, V2, P181; Salamonsen W, 1999, Pac Symp Biocomput, P392; Schacherer F, 2001, BIOINFORMATICS, V17, P1053, DOI 10.1093/bioinformatics/17.11.1053; Schreiber F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-375; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401; SUGIYAMA K, 1981, IEEE T SYST MAN CYB, V11, P109, DOI 10.1109/TSMC.1981.4308636; Vismara L, 2000, SOFTWARE PRACT EXPER, V30, P1235, DOI 10.1002/1097-024X(200009)30:11<1235::AID-SPE339>3.0.CO;2-B; von Landesberger T, 2011, COMPUT GRAPH FORUM, V30, P1719, DOI 10.1111/j.1467-8659.2011.01898.x; Wegner K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-212; Wybrow M, 2006, LECT NOTES COMPUT SC, V3843, P446; Yamada T, 2003, P 20 INT C MACH LEAR	73	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37739	10.1371/journal.pone.0037739	http://dx.doi.org/10.1371/journal.pone.0037739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679486	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900011
J	Mihara, M; Hara, H; Araki, J; Kikuchi, K; Narushima, M; Yamamoto, T; Iida, T; Yoshimatsu, H; Murai, N; Mitsui, K; Okitsu, T; Koshima, I				Mihara, Makoto; Hara, Hisako; Araki, Jun; Kikuchi, Kazuki; Narushima, Mitsunaga; Yamamoto, Takumi; Iida, Takuya; Yoshimatsu, Hidehiko; Murai, Noriyuki; Mitsui, Kito; Okitsu, Taro; Koshima, Isao			Indocyanine Green (ICG) Lymphography Is Superior to Lymphoscintigraphy for Diagnostic Imaging of Early Lymphedema of the Upper Limbs	PLOS ONE			English	Article							LOWER-EXTREMITY LYMPHEDEMA; QUALITY-OF-LIFE; BREAST-CANCER; DYE	Background: Secondary lymphedema causes swelling in limbs due to lymph retention following lymph node dissection in cancer therapy. Initiation of treatment soon after appearance of edema is very important, but there is no method for early diagnosis of lymphedema. In this study, we compared the utility of four diagnostic imaging methods: magnetic resonance imaging (MRI), computed tomography (CT), lymphoscintigraphy, and Indocyanine Green (ICG) lymphography. Patients and Methods: Between April 2010 and November 2011, we examined 21 female patients (42 arms) with unilateral mild upper limb lymphedema using the four methods. The mean age of the patients was 60.4 years old (35-81 years old). Biopsies of skin and collecting lymphatic vessels were performed in 7 patients who underwent lymphaticovenous anastomosis. Results: The specificity was 1 for all four methods. The sensitivity was 1 in ICG lymphography and MRI, 0.62 in lymphoscintigraphy, and 0.33 in CT. These results show that MRI and ICG lymphography are superior to lymphoscintigraphy or CT for diagnosis of lymphedema. In some cases, biopsy findings suggested abnormalities in skin and lymphatic vessels for which lymphoscintigraphy showed no abnormal findings. ICG lymphography showed a dermal backflow pattern in these cases. Conclusions: Our findings suggest the importance of dual diagnosis by examination of the lymphatic system using ICG lymphography and evaluation of edema in subcutaneous fat tissue using MRI.	[Mihara, Makoto; Hara, Hisako; Araki, Jun; Kikuchi, Kazuki; Narushima, Mitsunaga; Yamamoto, Takumi; Iida, Takuya; Yoshimatsu, Hidehiko; Koshima, Isao] Univ Tokyo, Dept Plast Surg & Reconstruct Surg, Tokyo, Japan; [Murai, Noriyuki; Mitsui, Kito] Saiseikai Kawaguchi Hosp, Dept Vasc Surg, Saitama, Japan; [Okitsu, Taro] Keio Univ, Dept Rehabil Med, Tokyo, Japan	University of Tokyo; Keio University	Mihara, M (corresponding author), Univ Tokyo, Dept Plast Surg & Reconstruct Surg, Tokyo, Japan.	mihara@keiseigeka.name	Yamamoto, Takumi/Y-7658-2019; Yoshimatsu, Hidehiko/AAA-8955-2020		Japanese funding program for next generation world-leading research [LS039]	Japanese funding program for next generation world-leading research	The study was supported by a grant from the Japanese funding program for next generation world-leading research (project number: LS039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; [Anonymous], 2009, LYMPHOLOGY, V42, P51; Beveridge N, 2010, CLIN NUCL MED, V35, P579, DOI 10.1097/RLU.0b013e3181e4dc3c; Chang L, 2011, CLIN NUCL MED, V36, pE11, DOI 10.1097/RLU.0b013e31820aa35a; Das IJ, 2011, RADIOTHER ONCOL, V100, P293, DOI 10.1016/j.radonc.2010.09.016; DUEWELL S, 1992, RADIOLOGY, V184, P227, DOI 10.1148/radiology.184.1.1609085; Finnane A, 2011, EXPERT REV PHARM OUT, V11, P287, DOI [10.1586/ERP.11.30, 10.1586/erp.11.30]; Jensen MR, 2010, CLIN PHYSIOL FUNCT I, V30, P389, DOI 10.1111/j.1475-097X.2010.00969.x; Kim DS, 2010, ARCH PHYS MED REHAB, V91, P1844, DOI 10.1016/j.apmr.2010.09.008; Maegawa J, 2010, MICROSURG, V30, P437, DOI 10.1002/micr.20772; Marotel M, 1998, LYMPHOLOGY, V31, P180; Nesvold IL, 2010, ACTA ONCOL, V49, P347, DOI 10.3109/02841860903302905; Ogata F, 2007, ANN PLAS SURG, V59, P180, DOI 10.1097/01.sap.0000253341.70866.54; Ogata F, 2007, ANN PLAS SURG, V58, P652, DOI 10.1097/01.sap.0000250896.42800.a2; Ogunbiyi SO, 2009, BRIT J SURG, V96, P1274, DOI 10.1002/bjs.6716; Partsch Hugo, 2003, Lymphat Res Biol, V1, P71, DOI 10.1089/15396850360495727; Ridner SH, 2011, SUPPORT CARE CANCER, V19, P631, DOI 10.1007/s00520-010-0870-5; Rockson SG, 2010, ANN NY ACAD SCI, V1207, pE2, DOI 10.1111/j.1749-6632.2010.05804.x; Sadeghi R, 2010, HELL J NUCL MED, V13, P6; Tomczak H, 2005, NUCL MED REV, V8, P37; Yamamoto T, 2011, ANN PLAS SURG, V67, P637, DOI 10.1097/SAP.0b013e318208fd75; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P1541, DOI 10.1016/j.bjps.2011.05.025; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df	26	155	160	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38182	10.1371/journal.pone.0038182	http://dx.doi.org/10.1371/journal.pone.0038182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675520	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700043
J	Schettino, A; Loeys, T; Bossi, M; Pourtois, G				Schettino, Antonio; Loeys, Tom; Bossi, Manuela; Pourtois, Gilles			Valence-Specific Modulation in the Accumulation of Perceptual Evidence Prior to Visual Scene Recognition	PLOS ONE			English	Article							TOP-DOWN FACILITATION; SPATIAL-FREQUENCY; PROACTIVE BRAIN; NEGATIVITY BIAS; FEARFUL FACES; MERE EXPOSURE; TIME-COURSE; EMOTION; ATTENTION; MODEL	Visual scene recognition is a dynamic process through which incoming sensory information is iteratively compared with predictions regarding the most likely identity of the input stimulus. In this study, we used a novel progressive unfolding task to characterize the accumulation of perceptual evidence prior to scene recognition, and its potential modulation by the emotional valence of these scenes. Our results show that emotional (pleasant and unpleasant) scenes led to slower accumulation of evidence compared to neutral scenes. In addition, when controlling for the potential contribution of non-emotional factors (i.e., familiarity and complexity of the pictures), our results confirm a reliable shift in the accumulation of evidence for pleasant relative to neutral and unpleasant scenes, suggesting a valence-specific effect. These findings indicate that proactive iterations between sensory processing and top-down predictions during scene recognition are reliably influenced by the rapidly extracted (positive) emotional valence of the visual stimuli. We interpret these findings in accordance with the notion of a genuine positivity offset during emotional scene recognition.	[Schettino, Antonio; Pourtois, Gilles] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Loeys, Tom] Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium; [Bossi, Manuela] Univ Pavia, Dept Psychol, I-27100 Pavia, Italy	Ghent University; Ghent University; University of Pavia	Schettino, A (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	gilles.pourtois@ugent.be	Schettino, Antonio/H-8675-2016	Schettino, Antonio/0000-0001-8065-6082; Pourtois, Gilles/0000-0002-5109-2801; Loeys, Tom/0000-0003-4551-5502	European Research Council [200758]; Ghent University (BOF) [05Z01708]	European Research Council(European Research Council (ERC)European Commission); Ghent University (BOF)(Ghent University)	This work is supported by grants from the European Research Council (starting grant #200758) and Ghent University (BOF grant #05Z01708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Alink A, 2010, J NEUROSCI, V30, P2960, DOI 10.1523/JNEUROSCI.3730-10.2010; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Blair MR, 2009, J EXP PSYCHOL LEARN, V35, P1196, DOI 10.1037/a0016272; Bocanegra BR, 2009, PSYCHOL SCI, V20, P707, DOI 10.1111/j.1467-9280.2009.02354.x; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; BRADLEY MM, 1993, BEHAV NEUROSCI, V107, P970, DOI 10.1037/0735-7044.107.6.970; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Cacioppo J T, 1997, Pers Soc Psychol Rev, V1, P3, DOI 10.1207/s15327957pspr0101_2; Cacioppo JT, 1999, J PERS SOC PSYCHOL, V76, P839, DOI 10.1037/0022-3514.76.5.839; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Cacioppo JT, 1999, PSYCHOPHYSIOLOGY, V36, pS4; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carretie L, 2007, NEUROPSYCHOLOGIA, V45, P1187, DOI 10.1016/j.neuropsychologia.2006.10.013; Conklin LR, 2009, J BEHAV THER EXP PSY, V40, P120, DOI 10.1016/j.jbtep.2008.07.001; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; Delplanque S, 2007, J NEUROSCI METH, V165, P144, DOI 10.1016/j.jneumeth.2007.05.030; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Driver J, 1996, COGNITIVE PSYCHOL, V31, P248, DOI 10.1006/cogp.1996.0018; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Enns JT, 2008, TRENDS COGN SCI, V12, P327, DOI 10.1016/j.tics.2008.06.001; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Goffaux V, 2011, CEREB CORTEX, V21, P467, DOI 10.1093/cercor/bhq112; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grossberg S, 2009, PHILOS T R SOC B, V364, P1223, DOI 10.1098/rstb.2008.0307; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; Ito T, 1998, PERS SOC PSYCHOL B, V24, P855, DOI 10.1177/0146167298248006; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Kim S, 2011, MEM COGNITION, V39, P649, DOI 10.3758/s13421-010-0050-3; Kveraga K, 2007, BRAIN COGNITION, V65, P145, DOI 10.1016/j.bandc.2007.06.007; Lang P.J., 2008, A8 U FLOR; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Libkuman TM, 2007, BEHAV RES METHODS, V39, P326, DOI 10.3758/BF03193164; Lochmann T, 2011, CURR OPIN NEUROBIOL, V21, P774, DOI 10.1016/j.conb.2011.05.018; Marr D., 1982, VISION COMPUTATIONAL; Mendes WB, 2007, J PERS SOC PSYCHOL, V92, P698, DOI 10.1037/0022-3514.92.4.698; Monahan JL, 2000, PSYCHOL SCI, V11, P462, DOI 10.1111/1467-9280.00289; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Norris CJ, 2010, BIOL PSYCHOL, V84, P422, DOI 10.1016/j.biopsycho.2010.03.011; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Palmer S., 1999, VISION SCI PHOTONS P; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Philiastides MG, 2011, CURR BIOL, V21, P980, DOI 10.1016/j.cub.2011.04.034; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Rahnev D, 2011, J NEUROSCI, V31, P10741, DOI 10.1523/JNEUROSCI.1478-11.2011; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Schettino A, 2011, NEUROIMAGE, V55, P1227, DOI 10.1016/j.neuroimage.2011.01.009; Schupp H, 2006, J PSYCHOPHYSIOL, V20, P115; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 2006, NEUROREPORT, V17, P365, DOI 10.1097/01.wnr.0000203355.88061.c6; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Shook NJ, 2007, J BEHAV THER EXP PSY, V38, P144, DOI 10.1016/j.jbtep.2006.10.005; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Spratling MW, 2008, VISION RES, V48, P1391, DOI 10.1016/j.visres.2008.03.009; Spruyt A, 2007, EXP PSYCHOL, V54, P44, DOI 10.1027/1618-3169.54.1.44; Spruyt A, 2009, J MEM LANG, V61, P37, DOI 10.1016/j.jml.2009.03.004; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Treisman AM, 1998, CURR OPIN NEUROBIOL, V8, P218, DOI 10.1016/S0959-4388(98)80143-8; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Wiens S, 2011, BIOL PSYCHOL, V86, P83, DOI 10.1016/j.biopsycho.2010.11.001; Winkielman P, 2003, PSYCHOLOGY OF EVALUATION, P189; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Winston JS, 2003, CURR BIOL, V13, P1824, DOI 10.1016/j.cub.2003.09.038; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zajonc RB, 2001, CURR DIR PSYCHOL SCI, V10, P224, DOI 10.1111/1467-8721.00154	98	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38064	10.1371/journal.pone.0038064	http://dx.doi.org/10.1371/journal.pone.0038064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22675437	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500085
J	Bombari, D; Mora, B; Schaefer, SC; Mast, FW; Lehr, HA				Bombari, Dario; Mora, Braulio; Schaefer, Stephan C.; Mast, Fred W.; Lehr, Hans-Anton			What Was I Thinking? Eye-Tracking Experiments Underscore the Bias that Architecture Exerts on Nuclear Grading in Prostate Cancer	PLOS ONE			English	Article							ERROR; MEDICINE; SEE	We previously reported that nuclear grade assignment of prostate carcinomas is subject to a cognitive bias induced by the tumor architecture. Here, we asked whether this bias is mediated by the non-conscious selection of nuclei that "match the expectation" induced by the inadvertent glance at the tumor architecture. 20 pathologists were asked to grade nuclei in high power fields of 20 prostate carcinomas displayed on a computer screen. Unknown to the pathologists, each carcinoma was shown twice, once before a background of a low grade, tubule-rich carcinoma and once before the background of a high grade, solid carcinoma. Eye tracking allowed to identify which nuclei the pathologists fixated during the 8 second projection period. For all 20 pathologists, nuclear grade assignment was significantly biased by tumor architecture. Pathologists tended to fixate on bigger, darker, and more irregular nuclei when those were projected before kigh grade, solid carcinomas than before low grade, tubule-rich carcinomas (and vice versa). However, the morphometric differences of the selected nuclei accounted for only 11% of the architecture-induced bias, suggesting that it can only to a small part be explained by the unconscious fixation on nuclei that "match the expectation". In conclusion, selection of "matching nuclei" represents an unconscious effort to vindicate the gravitation of nuclear grades towards the tumor architecture.	[Bombari, Dario; Mast, Fred W.] Univ Bern, Inst Psychol, Bern, Switzerland; [Mora, Braulio; Schaefer, Stephan C.; Lehr, Hans-Anton] CHU Vaudois, Univ Inst Pathol, Lausanne, Switzerland	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bombari, D (corresponding author), Univ Bern, Inst Psychol, Bern, Switzerland.	hansanton.lehr@yahoo.de	Mast, Fred/B-5058-2013	Mast, Fred/0000-0002-0665-4457	Swiss National Science Foundation [32000-120417]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by a grant from the Swiss National Science Foundation (No32000-120417 "cognition bias in cancer grading"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan TA, 2000, NEW ENGL J MED, V342, P1123, DOI 10.1056/NEJM200004133421510; Charlin BD, 2000, ACAD MED, V75, P182, DOI 10.1097/00001888-200002000-00020; CHIMOWITZ MI, 1990, ANN NEUROL, V28, P78, DOI 10.1002/ana.410280114; Croskerry P, 2000, ACAD EMERG MED, V7, P1223, DOI 10.1111/j.1553-2712.2000.tb00467.x; Day L, 2010, AM J CRIT CARE, V19, P296, DOI 10.4037/ajcc2010839; Elston EW, 1993, HISTOPATHOLOGY, V19, P403; Fandel TM, 2008, J PATHOL, V216, P193, DOI 10.1002/path.2395; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Graber M, 2002, ACAD MED, V77, P981, DOI 10.1097/00001888-200210000-00009; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Hamilton PW, 2009, J PATHOL, V218, P285, DOI 10.1002/path.2527; Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453; Krupinski EA, 2006, HUM PATHOL, V37, P1543, DOI 10.1016/j.humpath.2006.08.024; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Lehner PE, 2008, IEEE T SYST MAN CY A, V38, P584, DOI 10.1109/TSMCA.2008.918634; McLendon RE, 2006, ARCH PATHOL LAB MED, V130, P613; Meissner CA, 2002, LAW HUMAN BEHAV, V26, P469, DOI 10.1023/A:1020278620751; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pines JM, 2006, ACAD EMERG MED, V13, P90, DOI 10.1197/j.aem.2005.07.028; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Regehr G, 1996, ACAD MED, V71, P988, DOI 10.1097/00001888-199609000-00015; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; Tolkott MA, 1989, IEEE T SYST MAN CYB, V189, P606; Tversky A, 1974, HEURISTIC BIASES SCI, V186, P1124; Vickrey BG, 2010, ANN NEUROL, V67, P425, DOI 10.1002/ana.21907; Wiegmann DA, 2010, CHEST, V137, P250, DOI 10.1378/chest.09-1176	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38023	10.1371/journal.pone.0038023	http://dx.doi.org/10.1371/journal.pone.0038023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666438	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400070
J	Kroener, S; Mulholland, PJ; New, NN; Gass, JT; Becker, HC; Chandler, JL				Kroener, Sven; Mulholland, Patrick J.; New, Natasha N.; Gass, Justin T.; Becker, Howard C.; Chandler, L. Judson			Chronic Alcohol Exposure Alters Behavioral and Synaptic Plasticity of the Rodent Prefrontal Cortex	PLOS ONE			English	Article							CHRONIC ETHANOL EXPOSURE; NMDA RECEPTOR SUBUNIT; D-ASPARTATE RECEPTORS; LONG-TERM POTENTIATION; CALCIUM SPIKES; MESSENGER-RNA; UP-REGULATION; WITHDRAWAL; EXPRESSION; DRINKING	In the present study, we used a mouse model of chronic intermittent ethanol (CIE) exposure to examine how CIE alters the plasticity of the medial prefrontal cortex (mPFC). In acute slices obtained either immediately or 1-week after the last episode of alcohol exposure, voltage-clamp recording of excitatory post-synaptic currents (EPSCs) in mPFC layer V pyramidal neurons revealed that CIE exposure resulted in an increase in the NMDA/AMPA current ratio. This increase appeared to result from a selective increase in the NMDA component of the EPSC. Consistent with this, Western blot analysis of the postsynaptic density fraction showed that while there was no change in expression of the AMPA GluR1 subunit, NMDA NR1 and NRB subunits were significantly increased in CIE exposed mice when examined immediately after the last episode of alcohol exposure. Unexpectedly, this increase in NR1 and NR2B was no longer observed after 1-week of withdrawal in spite of a persistent increase in synaptic NMDA currents. Analysis of spines on the basal dendrites of layer V neurons revealed that while the total density of spines was not altered, there was a selective increase in the density of mushroom-type spines following CIE exposure. Examination of NMDA-receptor mediated spike-timing-dependent plasticity (STDP) showed that CIE exposure was associated with altered expression of long-term potentiation (LTP). Lastly, behavioral studies using an attentional set-shifting task that depends upon the mPFC for optimal performance revealed deficits in cognitive flexibility in CIE exposed mice when tested up to 1-week after the last episode of alcohol exposure. Taken together, these observations are consistent with those in human alcoholics showing protracted deficits in executive function, and suggest these deficits may be associated with alterations in synaptic plasticity in the mPFC.	[Kroener, Sven] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Mulholland, Patrick J.; New, Natasha N.; Gass, Justin T.; Becker, Howard C.; Chandler, L. Judson] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Becker, Howard C.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA	University of Texas System; University of Texas Dallas; Medical University of South Carolina; Medical University of South Carolina	Kroener, S (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	kroener@utdallas.edu	Mulholland, Patrick J/L-9353-2017; Chandler, Lawrence/N-8569-2017; Kroener, Sven/F-4561-2012	Chandler, Lawrence/0000-0002-1468-7320; Kroener, Sven/0000-0003-1728-8111	National Institutes of Health [AA017527, AA010983, AA019967, AA010761, AA007474, AA017922, AA013641, AA019362]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institutes of Health (Grants AA017527, AA010983, AA019967, AA010761, AA007474, AA017922, AA013641, and AA019362; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 1998, CURR OPIN NEUROBIOL, V8, P234, DOI 10.1016/S0959-4388(98)80145-1; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BECKER HC, 1993, ALCOHOL CLIN EXP RES, V17, P94, DOI 10.1111/j.1530-0277.1993.tb00731.x; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bonci A, 1999, J NEUROSCI, V19, P3723; Boulougouris V, 2007, BEHAV BRAIN RES, V179, P219, DOI 10.1016/j.bbr.2007.02.005; Carlson VCC, 2011, NEUROPSYCHOPHARMACOL, V36, P2513, DOI 10.1038/npp.2011.140; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; Carpenter-Hyland EP, 2006, EUR J NEUROSCI, V24, P3496, DOI 10.1111/j.1460-9568.2006.05247.x; Chandler LJ, 2003, PHARMACOL THERAPEUT, V99, P311, DOI 10.1016/S0163-7258(03)00096-2; Clapp P, 2010, J PHARMACOL EXP THER, V332, P720, DOI 10.1124/jpet.109.158741; Dalton GL, 2011, PSYCHOPHARMACOLOGY, V216, P525, DOI 10.1007/s00213-011-2246-z; Dias R, 1997, J NEUROSCI, V17, P9285; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Floresco SB, 2006, NEUROPSYCHOPHARMACOL, V31, P297, DOI 10.1038/sj.npp.1300825; Floresco SB, 2008, BEHAV BRAIN RES, V190, P85, DOI 10.1016/j.bbr.2008.02.008; Floresco SB, 2006, PSYCHOPHARMACOLOGY, V188, P567, DOI 10.1007/s00213-006-0404-5; Follesa P, 1996, J BIOL CHEM, V271, P13297, DOI 10.1074/jbc.271.23.13297; Fujii S, 2008, BRAIN RES, V1211, P13, DOI 10.1016/j.brainres.2008.02.052; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Ghods-Sharifi S, 2008, NEUROBIOL LEARN MEM, V89, P567, DOI 10.1016/j.nlm.2007.10.007; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Griffin WC, 2009, PSYCHOPHARMACOLOGY, V201, P569, DOI 10.1007/s00213-008-1324-3; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Hardy PA, 1999, BRAIN RES, V819, P33, DOI 10.1016/S0006-8993(98)01340-7; Hendricson AW, 2007, J PHARMACOL EXP THER, V321, P60, DOI 10.1124/jpet.106.111419; Hendricson AW, 2004, J NEUROPHYSIOL, V91, P2568, DOI 10.1152/jn.00997.2003; Jeanes ZM, 2011, J PHARMACOL EXP THER, V336, P155, DOI 10.1124/jpet.110.171009; Kalev-Zylinska ML, 2007, J NEUROSCI, V27, P10456, DOI 10.1523/JNEUROSCI.2789-07.2007; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kalluri HSG, 1998, MOL BRAIN RES, V58, P221, DOI 10.1016/S0169-328X(98)00112-0; Kampa BM, 2006, J NEUROSCI, V26, P7424, DOI 10.1523/JNEUROSCI.3062-05.2006; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kash TL, 2009, NEUROPSYCHOPHARMACOL, V34, P2420, DOI 10.1038/npp.2009.69; Krystal JH, 2011, NEUROPSYCHOPHARMACOL, V36, P701, DOI 10.1038/npp.2010.203; Kumari M, 2000, PROG DRUG RES, V54, P152; Lebron K, 2004, LEARN MEMORY, V11, P544, DOI 10.1101/lm.78604; Lopez MF, 2011, ALCOHOL CLIN EXP RES, V35, P953, DOI 10.1111/j.1530-0277.2010.01426.x; Lopez MF, 2005, PSYCHOPHARMACOLOGY, V181, P688, DOI 10.1007/s00213-005-0026-3; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; Mulholland PJ, 2011, BIOL PSYCHIAT, V69, P625, DOI 10.1016/j.biopsych.2010.09.025; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; Narita M, 2000, EUR J PHARMACOL, V401, P191, DOI 10.1016/S0014-2999(00)00428-3; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Pandey SC, 2008, J NEUROSCI, V28, P2589, DOI 10.1523/JNEUROSCI.4752-07.2008; Qiang M, 2007, MOL PHARMACOL, V72, P95, DOI 10.1124/mol.106.033043; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Roberto M, 2004, J NEUROSCI, V24, P1594, DOI 10.1523/JNEUROSCI.5077-03.2004; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Sanderson JL, 2009, NEUROPHARMACOLOGY, V56, P541, DOI 10.1016/j.neuropharm.2008.10.012; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Snell LD, 1996, MOL BRAIN RES, V40, P71; Stramiello M, 2010, SYNAPSE, V64, P644, DOI 10.1002/syn.20764; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tu Y, 2007, J NEUROSCI, V27, P4765, DOI 10.1523/JNEUROSCI.5378-06.2007; Veatch LM, 2002, BRAIN RES, V946, P272, DOI 10.1016/S0006-8993(02)02895-0; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; Weitlauf C, 2008, ALCOHOL CLIN EXP RES, V32, P690, DOI 10.1111/j.1530-0277.2008.00625.x; Xia JX, 2006, ALCOHOL CLIN EXP RES, V30, P819, DOI 10.1111/j.1530-0277.2006.00095.x; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zhou FC, 2007, BRAIN RES, V1134, P148, DOI 10.1016/j.brainres.2006.11.046	65	148	148	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37541	10.1371/journal.pone.0037541	http://dx.doi.org/10.1371/journal.pone.0037541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666364	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400031
J	Long, Y; Li, LC; Li, Q; He, XZ; Cui, ZB				Long, Yong; Li, Linchun; Li, Qing; He, Xiaozhen; Cui, Zongbin			Transcriptomic Characterization of Temperature Stress Responses in Larval Zebrafish	PLOS ONE			English	Article							NUCLEAR HORMONE-RECEPTORS; GENE-EXPRESSION; HEAT-STRESS; GILLICHTHYS-MIRABILIS; THERMAL-ACCLIMATION; COLD; FISH; MICROARRAY; HYPOTHALAMUS; ADAPTATION	Temperature influences nearly all biochemical, physiological and life history activities of fish, but the molecular mechanisms underlying the temperature acclimation remains largely unknown. Previous studies have identified many temperature-regulated genes in adult tissues; however, the transcriptional responses of fish larvae to temperature stress are not well understood. In this study, we characterized the transcriptional responses in larval zebrafish exposed to cold or heat stress using microarray analysis. In comparison with genes expressed in the control at 28 degrees C, a total of 2680 genes were found to be affected in 96 hpf larvae exposed to cold (16 degrees C) or heat (34 degrees C) for 2 and 48 h and most of these genes were expressed in a temperature-specific and temporally regulated manner. Bioinformatic analysis identified multiple temperature-regulated biological processes and pathways. Biological processes overrepresented among the earliest genes induced by temperature stress include regulation of transcription, nucleosome assembly, chromatin organization and protein folding. However, processes such as RNA processing, cellular metal ion homeostasis and protein transport and were enriched in genes up-regulated under cold exposure for 48 h. Pathways such as mTOR signalling, p53 signalling and circadian rhythm were enriched among cold-induced genes, while adipocytokine signalling, protein export and arginine and praline metabolism were enriched among heat-induced genes. Although most of these biological processes and pathways were specifically regulated by cold or heat, common responses to both cold and heat stresses were also found. Thus, these findings provide new interesting clues for elucidation of mechanisms underlying the temperature acclimation in fish.	[Long, Yong; Li, Qing; He, Xiaozhen; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Li, Linchun] Xiamen Ocean Vocat Coll, Dept Biotechnol, Xiamen, Fujian, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Long, Y (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zbcui@ihb.ac.cn			National Natural Science Foundation of China [31101892]; National High-tech RD (863) Program [2007AA10Z164]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech RD (863) Program(National High Technology Research and Development Program of China)	This work was funded by grants from the National Natural Science Foundation of China (#31101892 to Y. Long) and the National High-tech R&D (863) Program (#2007AA10Z164 to Z. Cui). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bachtell RK, 2003, BRAIN RES, V960, P157, DOI 10.1016/S0006-8993(02)03807-6; Beitinger TL, 2000, ENVIRON BIOL FISH, V58, P237, DOI 10.1023/A:1007676325825; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Buckley BA, 2006, J EXP BIOL, V209, P2660, DOI 10.1242/jeb.02292; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Cheng YS, 2011, LIPIDS, V46, P95, DOI 10.1007/s11745-010-3494-0; Chou MY, 2008, J EXP BIOL, V211, P3077, DOI 10.1242/jeb.019950; Cortemeglia C, 2005, T AM FISH SOC, V134, P1431, DOI 10.1577/T04-197.1; Cossins AR, 2005, NAT REV GENET, V6, P324, DOI 10.1038/nrg1590; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DEVRIES AL, 1971, SCIENCE, V172, P1152, DOI 10.1126/science.172.3988.1152; diIorio PJ, 1996, CELL STRESS CHAPERON, V1, P139; Donaldson MR, 2008, J FISH BIOL, V73, P1491, DOI 10.1111/j.1095-8649.2008.02061.x; Driedzic WR, 1996, J EXP ZOOL, V275, P186, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<186::AID-JEZ10>3.3.CO;2-T; FADER SC, 1994, J THERM BIOL, V19, P335, DOI 10.1016/0306-4565(94)90070-1; Fang H, 2009, MOL CELL TOXICOL, V5, P40; GERLACH GF, 1990, AM J PHYSIOL, V259, pR237, DOI 10.1152/ajpregu.1990.259.2.R237; GOLDSPINK G, 1995, J THERM BIOL, V20, P167, DOI 10.1016/0306-4565(94)00045-K; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; HOCHACHKA PW, 1970, J BIOL CHEM, V245, P6567; Johnston IA, 1996, ANIMALS TEMPERATURE, Vxvi, P419; JOHNSTON PV, 1964, COMP BIOCHEM PHYSIOL, V11, P303, DOI 10.1016/0010-406X(64)90111-2; JOYCE MP, 1992, NEUROSCIENCE, V49, P163, DOI 10.1016/0306-4522(92)90084-F; Ju Z, 2002, MOL GENET GENOMICS, V268, P87, DOI 10.1007/s00438-002-0727-9; Kassahn KS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-358; Kassahn KS, 2007, MOL ECOL, V16, P1749, DOI 10.1111/j.1365-294X.2006.03178.x; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Logan CA, 2011, AM J PHYSIOL-REG I, V300, pR1373, DOI 10.1152/ajpregu.00689.2010; Long Y, 2011, COMP BIOCHEM PHYS C, V153, P381, DOI 10.1016/j.cbpc.2011.01.002; McKitrick DJ, 2000, BRAIN RES BULL, V53, P307, DOI 10.1016/S0361-9230(00)00346-4; Mukhi S, 2007, TOXICOL SCI, V96, P246, DOI 10.1093/toxsci/kfm001; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Pan J, 2008, BIOPHYS J, V94, P117, DOI 10.1529/biophysj.107.115691; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Plaisier SB, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq636; Podrabsky JE, 2004, J EXP BIOL, V207, P2237, DOI 10.1242/jeb.01016; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schaefer J, 2006, J FISH BIOL, V69, P722, DOI 10.1111/j.1095-8649.2006.01145.x; Schilling TF, 1996, DEVELOPMENT, V123, P329; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIMON SA, 1995, BIOPHYS J, V69, P1473, DOI 10.1016/S0006-3495(95)80017-2; SOMERO GN, 1971, AM ZOOL, V11, P157; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; St-Pierre J, 1998, J EXP BIOL, V201, P2961; TEMPLETON M, 1961, J HISTOCHEM CYTOCHEM, V9, P670, DOI 10.1177/9.6.670; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; THORNHILL JA, 1994, CAN J PHYSIOL PHARM, V72, P89, DOI 10.1139/y94-014; Trezise AEO, 2005, CURR BIOL, V15, pR794, DOI 10.1016/j.cub.2005.09.025; UEDA MJ, 1976, J CELL BIOL, V71, P670, DOI 10.1083/jcb.71.2.670; Vergauwen L, 2010, COMP BIOCHEM PHYS A, V157, P149, DOI 10.1016/j.cbpa.2010.06.160; Vornanen M, 2005, AM J PHYSIOL-REG I, V289, pR1177, DOI 10.1152/ajpregu.00157.2005; Weidenhammer EM, 1996, NUCLEIC ACIDS RES, V24, P1164, DOI 10.1093/nar/24.6.1164; Xu Joshua, 2010, Hum Genomics, V4, P428; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	63	121	134	10	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37209	10.1371/journal.pone.0037209	http://dx.doi.org/10.1371/journal.pone.0037209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666345	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400021
J	Shiffman, D; Trompet, S; Louie, JZ; Rowland, CM; Catanese, JJ; Iakoubova, OA; Kirchgessner, TG; Westendorp, RGJ; de Craen, AJM; Slagboom, PE; Buckley, BM; Stott, DJ; Sattar, N; Devlin, JJ; Packard, CJ; Ford, I; Sacks, FM; Jukema, JW				Shiffman, Dov; Trompet, Stella; Louie, Judy Z.; Rowland, Charles M.; Catanese, Joseph J.; Iakoubova, Olga A.; Kirchgessner, Todd G.; Westendorp, Rudi G. J.; de Craen, Anton J. M.; Slagboom, P. Eline; Buckley, Brendan M.; Stott, David J.; Sattar, Naveed; Devlin, James J.; Packard, Christopher J.; Ford, Ian; Sacks, Frank M.; Jukema, J. Wouter			Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; STATIN THERAPY; TRP719ARG POLYMORPHISM; MYOCARDIAL-INFARCTION; WHOLE-GENOME; GENOTYPE; EFFICACY; RISK	Statin therapy reduces the risk of coronary heart disease (CHD), however, the person-to-person variability in response to statin therapy is not well understood. We have investigated the effect of genetic variation on the reduction of CHD events by pravastatin. First, we conducted a genome-wide association study of 682 CHD cases from the Cholesterol and Recurrent Events (CARE) trial and 383 CHD cases from the West of Scotland Coronary Prevention Study (WOSCOPS), two randomized, placebo-controlled studies of pravastatin. In a combined case-only analysis, 79 single nucleotide polymorphisms (SNPs) were associated with differential CHD event reduction by pravastatin according to genotype (P < 0.0001), and these SNPs were analyzed in a second stage that included cases as well as non-cases from CARE and WOSCOPS and patients from the PROspective Study of Pravastatin in the Elderly at Risk/PHArmacogenomic study of Statins in the Elderly at risk for cardiovascular disease (PROSPER/PHASE), a randomized placebo controlled study of pravastatin in the elderly. We found that one of these SNPs (rs13279522) was associated with differential CHD event reduction by pravastatin therapy in all 3 studies: P = 0.002 in CARE, P = 0.01 in WOSCOPS, P = 0.002 in PROSPER/PHASE. In a combined analysis of CARE, WOSCOPS, and PROSPER/PHASE, the hazard ratio for CHD when comparing pravastatin with placebo decreased by a factor of 0.63 (95% CI: 0.52 to 0.75) for each extra copy of the minor allele (P = 4.8x10(-7)). This SNP is located in DnaJ homolog subfamily C member 5B (DNAJC5B) and merits investigation in additional randomized studies of pravastatin and other statins.	[Shiffman, Dov; Louie, Judy Z.; Rowland, Charles M.; Catanese, Joseph J.; Iakoubova, Olga A.; Devlin, James J.] Celera Inc, Alameda, CA 94502 USA; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Trompet, Stella; Westendorp, Rudi G. J.; de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Kirchgessner, Todd G.] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ USA; [Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Buckley, Brendan M.] Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [Stott, David J.; Packard, Christopher J.] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Sattar, Naveed] Univ Glasgow, British Heart Fdn, Fac Med, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Sacks, Frank M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Bristol-Myers Squibb; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University College Cork; University of Glasgow; University of Glasgow; University of Glasgow; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Shiffman, D (corresponding author), Celera Inc, Alameda, CA 94502 USA.	dov.shiffman@celera.com	Jukema, J. Wouter/ABD-6503-2021; Ford, Ian/ABE-6145-2020; Slagboom, P. Eline/R-4790-2016	Jukema, J. Wouter/0000-0002-3246-8359; Slagboom, P. Eline/0000-0002-2875-4723	European Union's Seventh Framework Programme [HEALTH-F2-2009-223004]	European Union's Seventh Framework Programme	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement nu HEALTH-F2-2009-223004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Davis BR, 2004, STAT MED, V23, P2413, DOI 10.1002/sim.1831; Evans GJO, 2003, TRAFFIC, V4, P653, DOI 10.1034/j.1600-0854.2003.00127.x; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Ference BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028834; Gorleku OA, 2010, BIOCHEMISTRY-US, V49, P5308, DOI 10.1021/bi100550h; Hopewell JC, 2011, J AM COLL CARDIOL, V57, P2000, DOI 10.1016/j.jacc.2011.02.015; Iakoubova OA, 2008, J AM COLL CARDIOL, V51, P449, DOI 10.1016/j.jacc.2007.10.017; Iakoubova OA, 2008, J AM COLL CARDIOL, V51, P435, DOI 10.1016/j.jacc.2007.05.057; Iakoubova OA, 2010, EUR J CARDIOV PREV R, V17, P455, DOI 10.1097/HJR.0b013e328336a0dd; Johnson JN, 2010, BIOCHEM CELL BIOL, V88, P157, DOI [10.1139/O09-124, 10.1139/o09-124]; Krauss RM, 2008, CIRCULATION, V117, P1537, DOI 10.1161/CIRCULATIONAHA.107.708388; Maitland-van der Zee Anke-Hilse, 2005, Curr Atheroscler Rep, V7, P204; Mangravite LM, 2006, PHARMACOGENOMICS J, V6, P360, DOI 10.1038/sj.tpj.6500384; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ridker PM, 2011, CIRC-CARDIOVASC GENE, V4, P312, DOI 10.1161/CIRCGENETICS.110.959353; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Shiffman D, 2010, AM J CARDIOL, V105, P1300, DOI 10.1016/j.amjcard.2009.12.049; Thompson JF, 2005, PHARMACOGENOMICS J, V5, P352, DOI 10.1038/sj.tpj.6500328; Thompson JF, 2009, CIRC-CARDIOVASC GENE, V2, P173, DOI 10.1161/CIRCGENETICS.108.818062; Voora D, 2009, CURR CARDIOVASC RISK, V3, P434, DOI 10.1007/s12170-009-0064-1; Voora D, 2008, CIRC-CARDIOVASC GENE, V1, P100, DOI 10.1161/CIRCGENETICS.108.795013; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004	29	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38240	10.1371/journal.pone.0038240	http://dx.doi.org/10.1371/journal.pone.0038240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666496	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400109
J	Toukam, DK; Tenbusch, M; Stang, A; Temchura, V; Bonsmann, MSG; Grewe, B; Koch, S; Meyerhans, A; Nchinda, G; Kaptue, L; Uberla, K				Toukam, Donatien Kamdem; Tenbusch, Matthias; Stang, Alexander; Temchura, Vladimir; Bonsmann, Michael Storcksdieck genannt; Grewe, Bastian; Koch, Stefanie; Meyerhans, Andreas; Nchinda, Godwin; Kaptue, Lazare; Ueberla, Klaus			Targeting Antibody Responses to the Membrane Proximal External Region of the Envelope Glycoprotein of Human Immunodeficiency Virus	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; HIV-1 GP41; ECTODOMAIN REGION; TYPE-1; EPITOPE; 4E10; 2F5; NEUTRALIZATION; PROTEIN; CONFORMATION	Although human immunodeficiency type 1 (HIV-1) infection induces strong antibody responses to the viral envelope glycoprotein (Env) only a few of these antibodies possess the capacity to neutralize a broad range of strains. The induction of such antibodies represents an important goal in the development of a preventive vaccine against the infection. Among the broadly neutralizing monoclonal antibodies discovered so far, three (2F5, Z13 and 4E10) target the short and hidden membrane proximal external region (MPER) of the gp41 transmembrane protein. Antibody responses to MPER are rarely observed in HIV-infected individuals or after immunization with Env immunogens. To initiate antibody responses to MPER in its membrane-embedded native conformation, we generated expression plasmids encoding the membrane-anchored ectodomain of gp41 with N-terminal deletions of various sizes. Following transfection of these plasmids, the MPER domains are displayed on the cell surface and incorporated into HIV virus like particles (VLP). Transfected cells displaying MPER mutants bound as efficiently to both 2F5 and 4E10 as cells transfected with a plasmid encoding full-length Env. Mice immunized with VLPs containing the MPER mutants produced MPER-specific antibodies, the levels of which could be increased by the trimerization of the displayed proteins as well as by a DNA prime-VLP boost immunization strategy. Although 2F5 competed for binding to MPER with antibodies in sera of some of the immunized mice, neutralizing activity could not be detected. Whether this is due to inefficient binding of the induced antibodies to MPER in the context of wild type Env or whether the overall MPER-specific antibody response induced by the MPER display mutants is too low to reveal neutralizing activity, remains to be determined.	[Toukam, Donatien Kamdem; Tenbusch, Matthias; Stang, Alexander; Temchura, Vladimir; Bonsmann, Michael Storcksdieck genannt; Grewe, Bastian; Ueberla, Klaus] Ruhr Univ Bochum, Dept Mol & Med Virol, Bochum, Germany; [Koch, Stefanie] Fraunhofer Inst Biomed Engn, Sulzbach, Germany; [Meyerhans, Andreas] Univ Pompeu Fabra, ICREA Infect Biol Lab, Dept Expt & Hlth Sci, Barcelona, Spain; [Nchinda, Godwin] Chantal Biya Int Reference Ctr Res HIV AIDS Preve, Immunol Lab, Yaounde, Cameroon; [Kaptue, Lazare] Univ Montagnes, Inst Super Sci Sante, Bangante, Cameroon	Ruhr University Bochum; Fraunhofer Gesellschaft; ICREA; Pompeu Fabra University	Toukam, DK (corresponding author), Ruhr Univ Bochum, Dept Mol & Med Virol, Univ Str 150, Bochum, Germany.	Klaus.ueberla@rub.de	Meyerhans, Andreas/D-3382-2014; Meyerhans, Andreas/S-2559-2019	Meyerhans, Andreas/0000-0003-0620-5317; Meyerhans, Andreas/0000-0003-0620-5317	European Commission FP6 program (DEC-VAC) [LSHP-CT-2005-018685]; EUROPRISE network of excellence; German Research Foundation [TRR60/1]; Bill & Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery - CAVD - Grant) [OPP38580_01]; ICREA Funding Source: Custom	European Commission FP6 program (DEC-VAC); EUROPRISE network of excellence; German Research Foundation(German Research Foundation (DFG)); Bill & Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery - CAVD - Grant); ICREA(ICREA)	This work was supported by grants from the European Commission FP6 program (DEC-VAC, LSHP-CT-2005-018685; EUROPRISE network of excellence), the German Research Foundation (TRR60/1) and the Bill & Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery - CAVD - Grant # OPP38580_01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2009, PNAS, P2; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Binley JM, 1996, AIDS RES HUM RETROV, V12, P911, DOI 10.1089/aid.1996.12.911; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CLOSA MONTERO C., 2005, CURRENT PROTOCOLS IM, P17; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Harbury B, 1994, NATURE, V371, P80; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Leapman RD, 2002, ANALYSIS, V76, P7863, DOI [10.1128/JVI.76.15.7863, DOI 10.1128/JVI.76.15.7863]; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Park SH, 2008, J IMMUNOL METHODS, V331, P27, DOI 10.1016/j.jim.2007.10.012; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Quinnan GV, 1999, AIDS RES HUM RETROV, V15, P561, DOI 10.1089/088922299311088; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tenbusch M, 2010, VACCINE, V28, P3273, DOI 10.1016/j.vaccine.2010.02.090; Wagner R, 2000, HUM GENE THER, V11, P2403, DOI 10.1089/104303400750038507; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	32	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38068	10.1371/journal.pone.0038068	http://dx.doi.org/10.1371/journal.pone.0038068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666448	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400075
J	Welzel, F; Kaehler, C; Isau, M; Hallen, L; Lehrach, H; Krobitsch, S				Welzel, Franziska; Kaehler, Christian; Isau, Melanie; Hallen, Linda; Lehrach, Hans; Krobitsch, Sylvia			FOX-2 Dependent Splicing of Ataxin-2 Transcript Is Affected by Ataxin-1 Overexpression	PLOS ONE			English	Article							RNA-BINDING PROTEINS; SPINOCEREBELLAR ATAXIA; POLYGLUTAMINE EXPANSION; STRESS GRANULES; GENE-EXPRESSION; CELL-TYPE; DISEASE; TYPE-1; SCA1; IDENTIFICATION	Alternative splicing is a fundamental posttranscriptional mechanism for controlling gene expression, and splicing defects have been linked to various human disorders. The splicing factor FOX-2 is part of a main protein interaction hub in a network related to human inherited ataxias, however, its impact remains to be elucidated. Here, we focused on the reported interaction between FOX-2 and ataxin-1, the disease-causing protein in spinocerebellar ataxia type 1. In this line, we further evaluated this interaction by yeast-2-hybrid analyses and co-immunoprecipitation experiments in mammalian cells. Interestingly, we discovered that FOX-2 localization and splicing activity is affected in the presence of nuclear ataxin-1 inclusions. Moreover, we observed that FOX-2 directly interacts with ataxin-2, a protein modulating spinocerebellar ataxia type 1 pathogenesis. Finally, we provide evidence that splicing of pre-mRNA of ataxin-2 depends on FOX-2 activity, since reduction of FOX-2 levels led to increased skipping of exon 18 in ataxin-2 transcripts. Most striking, we observed that ataxin-1 overexpression has an effect on this splicing event as well. Thus, our results demonstrate that FOX-2 is involved in splicing of ataxin-2 transcripts and that this splicing event is altered by overexpression of ataxin-1.	[Welzel, Franziska; Kaehler, Christian; Hallen, Linda; Krobitsch, Sylvia] Max Planck Inst Mol Genet, Otto Warburg Lab, D-14195 Berlin, Germany; [Isau, Melanie; Lehrach, Hans] Max Planck Inst Mol Genet, Dept Vertebrate Gen, D-14195 Berlin, Germany; [Welzel, Franziska; Kaehler, Christian; Isau, Melanie] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany	Max Planck Society; Max Planck Society; Free University of Berlin	Welzel, F (corresponding author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany.	krobitsc@molgen.mpg.de	Kaehler, Christian/A-2912-2015		Max Planck Society; Ataxia UK [PSMOGE 727]	Max Planck Society(Max Planck Society); Ataxia UK	This work was supported by the Max Planck Society and Ataxia UK (PSMOGE 727; www.ataxia.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affaitati A, 2001, GENE, V267, P89, DOI 10.1016/S0378-1119(01)00402-4; Al-Ramahi I, 2007, PLOS GENET, V3, P2551, DOI 10.1371/journal.pgen.0030234; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Bettencourt C, 2010, NEUROGENETICS, V11, P193, DOI 10.1007/s10048-009-0216-y; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Branco J, 2008, HUM MOL GENET, V17, P376, DOI 10.1093/hmg/ddm315; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; Delestienne N, 2010, FEBS J, V277, P2496, DOI 10.1111/j.1742-4658.2010.07664.x; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Einum DD, 2003, ARCH NEUROL-CHICAGO, V60, P97, DOI 10.1001/archneur.60.1.97; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Goto J, 1997, NEUROSCI RES, V28, P373, DOI 10.1016/S0168-0102(97)00056-4; Gottschalk A, 1998, RNA, V4, P374; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hallen L, 2011, HUM MOL GENET, V20, P104, DOI 10.1093/hmg/ddq436; Hamshere ML, 2009, BRIT J PSYCHIAT, V195, P23, DOI 10.1192/bjp.bp.108.061424; Harris GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013695; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Jiang W, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-72; Kang S, 2009, MOL CELLS, V27, P621, DOI 10.1007/s10059-009-0095-y; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim SJ, 2003, BIOCHEM BIOPH RES CO, V307, P660, DOI 10.1016/S0006-291X(03)01241-5; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Lale S, 2011, FETAL PEDIAT PATHOL; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Li CX, 2006, CANCER RES, V66, P1990, DOI 10.1158/0008-5472.CAN-05-2593; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Matilla-Duenas A, 2008, CEREBELLUM, V7, P106, DOI 10.1007/s12311-008-0009-0; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Neuwald AF, 1998, J MOL MED, V76, P3, DOI 10.1007/s109-1998-8098-0; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Papin C, 2008, FEBS J, V275, P490, DOI 10.1111/j.1742-4658.2007.06216.x; Ralser M, 2005, HUM MOL GENET, V14, P2893, DOI 10.1093/hmg/ddi321; Ralser M, 2005, J MOL BIOL, V346, P203, DOI 10.1016/j.jmb.2004.11.024; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; Rich T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001014; Sahba S, 1998, GENOMICS, V47, P359, DOI 10.1006/geno.1997.5131; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Truant R, 2006, CAN J NEUROL SCI, V33, P278, DOI 10.1017/S031716710000514X; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsunemi T, 2008, NEUROSCI LETT, V447, P78, DOI 10.1016/j.neulet.2008.09.065; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	66	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37985	10.1371/journal.pone.0037985	http://dx.doi.org/10.1371/journal.pone.0037985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666429	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400067
J	Dieppois, G; Ducret, V; Caille, O; Perron, K				Dieppois, Guennaelle; Ducret, Verena; Caille, Olivier; Perron, Karl			The Transcriptional Regulator CzcR Modulates Antibiotic Resistance and Quorum Sensing in Pseudomonas aeruginosa	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; BASIC-AMINO-ACIDS; OUTER-MEMBRANE; GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; VIRULENCE FACTORS; ESCHERICHIA-COLI; CYSTIC-FIBROSIS; POLYMYXIN-B; SYSTEMS	The opportunistic pathogen Pseudomonas aeruginosa responds to zinc, cadmium and cobalt by way of the CzcRS two-component system. In presence of these metals the regulatory protein CzcR induces the expression of the CzcCBA efflux pump, expelling and thereby inducing resistance to Zn, Cd and Co. Importantly, CzcR co-regulates carbapenem antibiotic resistance by repressing the expression of the OprD porin, the route of entry for these antibiotics. This unexpected co-regulation led us to address the role of CzcR in other cellular processes unrelated to the metal response. We found that CzcR affected the expression of numerous genes directly involved in the virulence of P. aeruginosa even in the absence of the inducible metals. Notably the full expression of quorum sensing 3-oxo-C12-HSL and C4-HSL autoinducer molecules is impaired in the absence of CzcR. In agreement with this, the virulence of the czcRS deletion mutant is affected in a C. elegans animal killing assay. Additionally, chromosome immunoprecipitation experiments allowed us to localize CzcR on the promoter of several regulated genes, suggesting a direct control of target genes such as oprD, phzA1 and lasI. All together our data identify CzcR as a novel regulator involved in the control of several key genes for P. aeruginosa virulence processes.	[Dieppois, Guennaelle; Ducret, Verena; Caille, Olivier; Perron, Karl] Univ Geneva, Microbiol Unit, Dept Bot & Plant Biol, Geneva, Switzerland	University of Geneva	Dieppois, G (corresponding author), EPFL SV GHI UPLEM, Lausanne, Switzerland.	karl.perron@unige.ch	Perron, Karl/AAC-3128-2022	Perron, Karl/0000-0002-3259-4638	Swiss National Science Fondation [31003A_124931]; Novartis foundation; Ernst et Lucie Schmidheiny foundation	Swiss National Science Fondation(Swiss National Science Foundation (SNSF)); Novartis foundation(Novartis); Ernst et Lucie Schmidheiny foundation	This work was supported by funding from the Swiss National Science Fondation (Grant 31003A_124931 to KP), the Novartis foundation and the Ernst et Lucie Schmidheiny foundation (to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; Alteri CJ, 2011, MOL MICROBIOL; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; BRENNER S, 1974, GENETICS, V77, P71; Brocker M, 2011, J BACTERIOL, V193, P1237, DOI 10.1128/JB.01032-10; Caille O, 2007, J BACTERIOL, V189, P4561, DOI 10.1128/JB.00095-07; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Conejo MC, 2003, ANTIMICROB AGENTS CH, V47, P2313, DOI 10.1128/AAC.47.7.2313-2315.2003; De Kievit T, 1999, J BACTERIOL, V181, P2175, DOI 10.1128/JB.181.7.2175-2184.1999; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gales AC, 2006, CLIN MICROBIOL INFEC, V12, P315, DOI 10.1111/j.1469-0691.2005.01351.x; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gooderham WJ, 2009, MICROBIOL-SGM, V155, P699, DOI 10.1099/mic.0.024554-0; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Gray RD, 2010, CHEST, V137, P635, DOI 10.1378/chest.09-1047; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; GUAN CD, 1983, J BACTERIOL, V156, P710, DOI 10.1128/JB.156.2.710-717.1983; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Martinez-Martinez L, 1999, ANTIMICROB AGENTS CH, V43, P397, DOI 10.1128/AAC.43.2.397; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; Miller J.H., 1972, EXPT MOL GENETICS; Moss JE, 2000, CELL MICROBIOL, V2, P443, DOI 10.1046/j.1462-5822.2000.00065.x; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Peix A, 2009, INFECT GENET EVOL, V9, P1132, DOI 10.1016/j.meegid.2009.08.001; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; Perron K, 2004, J BIOL CHEM, V279, P8761, DOI 10.1074/jbc.M312080200; Perry J, 2011, MOL BIOSYST, V7, P1388, DOI 10.1039/c0mb00329h; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; Rampioni G, 2007, MOL MICROBIOL, V66, P1557, DOI 10.1111/j.1365-2958.2007.06029.x; REITZER LJ, 1983, P NATL ACAD SCI-BIOL, V80, P5554, DOI 10.1073/pnas.80.18.5554; Rodrigue A, 2000, TRENDS MICROBIOL, V8, P498, DOI 10.1016/S0966-842X(00)01833-3; Rosenfeld M, 2003, CURR OPIN PULM MED, V9, P492, DOI 10.1097/00063198-200311000-00008; Sambrook J., MOL CLONING LAB MANU; SCARLATO V, 1990, P NATL ACAD SCI USA, V87, P6753, DOI 10.1073/pnas.87.17.6753; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; SEED PC, 1995, J BACTERIOL, V177, P654, DOI 10.1128/jb.177.3.654-659.1995; SIEGMUND I, 1991, BIOTECHNOL TECH, V5, P265, DOI 10.1007/BF02438660; Silflow CD, 2001, J CELL BIOL, V153, P63, DOI 10.1083/jcb.153.1.63; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; TRIAS J, 1990, J BIOL CHEM, V265, P15680; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; Van Delden C, 1998, INFECT IMMUN, V66, P4499; Van Delden C, 2001, J BACTERIOL, V183, P5376, DOI 10.1128/JB.183.18.5376-5384.2001; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Verhamme DT, 2002, MICROBIOL-SGM, V148, P69, DOI 10.1099/00221287-148-1-69; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Zakikhany K, 2010, MOL MICROBIOL, V77, P771, DOI 10.1111/j.1365-2958.2010.07247.x	68	74	78	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38148	10.1371/journal.pone.0038148	http://dx.doi.org/10.1371/journal.pone.0038148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666466	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600063
J	Liu, YQ; Hu, XY; Lu, T; Cheng, YN; Young, CYF; Yuan, HQ; Lou, HX				Liu, Yong-Qing; Hu, Xiao-Yan; Lu, Tao; Cheng, Yan-Na; Young, Charles Y. F.; Yuan, Hui-Qing; Lou, Hong-Xiang			Retigeric Acid B Exhibits Antitumor Activity through Suppression of Nuclear Factor-kappa B Signaling in Prostate Cancer Cells in Vitro and in Vivo	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; URSOLIC ACID; ACETYL-11-KETO-BETA-BOSWELLIC ACID; P65 PHOSPHORYLATION; ANDROGEN RECEPTOR; DOWN-REGULATION; ALPHA KINASE; INHIBITION; ACTIVATION; APOPTOSIS	Previously, we reported that retigeric acid B (RB), a natural pentacyclic triterpenic acid isolated from lichen, inhibited cell growth and induced apoptosis in androgen-independent prostate cancer (PCa) cells. However, the mechanism of action of RB remains unclear. In this study, we found that using PC3 and DU145 cells as models, RB inhibited phosphorylation levels of I kappa B alpha and p65 subunit of NF-kappa B in a time- and dosage-dependent manner. Detailed study revealed that RB blocked the nuclear translocation of p65 and its DNA binding activity, which correlated with suppression of NF-kappa B-regulated proteins including Bcl-2, Bcl-x(L), cyclin D1 and survivin. NF-kappa B reporter assay suggested that RB was able to inhibit both constitutive activated-NF-kappa B and LPS (lipopolysaccharide)-induced activation of NF-kappa B. Overexpression of RelA/p65 rescued RB-induced cell death, while knockdown of RelA/p65 significantly promoted RB-mediated inhibitory effect on cell proliferation, suggesting the crucial involvement of NF-kappa B pathway in this event. We further analyzed antitumor activity of RB in in vivo study. In C57BL/6 mice carrying RM-1 homografts, RB inhibited tumor growth and triggered apoptosis mainly through suppressing NF-kappa B activity in tumor tissues. Additionally, DNA microarray data revealed global changes in the gene expression associated with cell proliferation, apoptosis, invasion and metastasis in response to RB treatment. Therefore, our findings suggested that RB exerted its anti-tumor effect by targeting the NF-kappa B pathway in PCa cells, and this could be a general mechanism for the anti-tumor effect of RB in other types of cancers as well.	[Liu, Yong-Qing; Hu, Xiao-Yan; Yuan, Hui-Qing] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250100, Peoples R China; [Liu, Yong-Qing; Lou, Hong-Xiang] Shandong Univ, Sch Pharmaceut Sci, Dept Nat Product Chem, Jinan 250100, Peoples R China; [Lu, Tao] Indiana Univ, Dept Biochem & Mol Biol, Dept Pharmacol & Toxicol, Sch Med, Indianapolis, IN 46202 USA; [Cheng, Yan-Na] Shandong Univ, Sch Pharmaceut Sci, Dept Pharmacol, Jinan 250100, Peoples R China; [Young, Charles Y. F.] Mayo Clin, Mayo Clin Coll Med, Dept Urol, Rochester, MN USA	Shandong University; Shandong University; Indiana University System; Indiana University-Purdue University Indianapolis; Shandong University; Mayo Clinic	Liu, YQ (corresponding author), Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250100, Peoples R China.	lyuanhq@sdu.edu.cn; louhongxiang@sdu.edu.cn			National Natural Science Foundation of China [30973551, 30925038]; Shandong Scientific Technology Program [2008GG10002042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Scientific Technology Program	This work was supported by the National Natural Science Foundation of China (30973551, 30925038), and Shandong Scientific Technology Program (2008GG10002042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catz SD, 2003, APOPTOSIS, V8, P29, DOI 10.1023/A:1021692801278; Chintharlapalli S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-371; Gasparian AV, 2002, J CELL SCI, V115, P141; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Huang CY, 2011, TOXICOL IN VITRO, V25, P1274, DOI 10.1016/j.tiv.2011.04.014; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim DK, 2009, CANCER RES, V69, P923, DOI 10.1158/0008-5472.CAN-08-2115; Kunnumakkara AB, 2009, MOL CANCER RES, V7, P118, DOI 10.1158/1541-7786.MCR-08-0154; Lessard L, 2003, BJU INT, V91, P417, DOI 10.1046/j.1464-410X.2003.04104.x; Liu H, 2010, CHEM-BIOL INTERACT, V188, P598, DOI 10.1016/j.cbi.2010.07.024; Mauro C, 2009, METHODS MOL BIOL, V512, P169, DOI 10.1007/978-1-60327-530-9_10; Park B, 2011, INT J CANCER, V129, P23, DOI 10.1002/ijc.25966; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Shanmugam MK, 2011, INT J CANCER, V129, P1552, DOI 10.1002/ijc.26120; Shishodia S, 2003, CANCER RES, V63, P4375; Sriprasad S, 2009, SURG ONCOL, V18, P185, DOI 10.1016/j.suronc.2009.07.001; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Syrovets T, 2005, J BIOL CHEM, V280, P6170, DOI 10.1074/jbc.M409477200; Takada Y, 2003, J IMMUNOL, V171, P3278, DOI 10.4049/jimmunol.171.6.3278; Takada Y, 2006, J IMMUNOL, V176, P3127, DOI 10.4049/jimmunol.176.5.3127; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; Viji V, 2010, BRIT J PHARMACOL, V162, P1291; Yuan HQ, 2005, CARCINOGENESIS, V26, P793, DOI 10.1093/carcin/bgi021; Yuan HQ, 2008, BIOCHEM PHARMACOL, V75, P2112, DOI 10.1016/j.bcp.2008.03.005; Yuan Huiqing, 2010, Mol Cell Biochem, V339, P253, DOI 10.1007/s11010-010-0388-7; Zhang AL, 2006, CANCER LETT, V233, P185, DOI 10.1016/j.canlet.2005.03.051	29	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38000	10.1371/journal.pone.0038000	http://dx.doi.org/10.1371/journal.pone.0038000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666431	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349600050
J	Steinberg, G				Steinberg, Gero			Cytoplasmic Fungal Lipases Release Fungicides from Ultra-Deformable Vesicular Drug Carriers	PLOS ONE			English	Article							TDT 067 TERBINAFINE; ENDOPLASMIC-RETICULUM; CELL-WALL; PATHOGENIC DEVELOPMENT; USTILAGO-MAYDIS; ENDOCYTOSIS; TRANSFERSOMES; ACTIN; DYNAMICS; MOTILITY	The Transfersome (R) is a lipid vesicle that contains membrane softeners, such as Tween 80, to make it ultra-deformable. This feature makes the Transfersome (R) an efficient carrier for delivery of therapeutic drugs across the skin barrier. It was reported that TDT 067 (a topical formulation of 15 mg/ml terbinafine in Transfersome (R) vesicles) has a much more potent antifungal activity in vitro compared with conventional terbinafine, which is a water-insoluble fungicide. Here we use ultra-structural studies and live imaging in a model fungus to describe the underlying mode of action. We show that terbinafine causes local collapse of the fungal endoplasmic reticulum, which was more efficient when terbinafine was delivered in Transfersome (R) vesicles (TFVs). When applied in liquid culture, fluorescently labeled TFVs rapidly entered the fungal cells (T-1/2 similar to 2 min). Entry was F-actin-and ATP-independent, indicating that it is a passive process. Ultra-structural studies showed that passage through the cell wall involves significant deformation of the vesicles, and depends on a high concentration of the surfactant Tween 80 in their membrane. Surprisingly, the TFVs collapsed into lipid droplets after entry into the cell and the terbinafine was released from their interior. With time, the lipid bodies were metabolized in an ATP-dependent fashion, suggesting that cytosolic lipases attack and degrade intruding TFVs. Indeed, the specific monoacylglycerol lipase inhibitor URB602 prevented Transfersome (R) degradation and neutralized the cytotoxic effect of Transfersome (R)-delivered terbinafine. These data suggest that (a) Transfersomes deliver the lipophilic fungicide Terbinafine to the fungal cell wall, (b) the membrane softener Tween 80 allows the passage of the Transfersomes into the fungal cell, and (c) fungal lipases digest the invading Transfersome (R) vesicles thereby releasing their cytotoxic content. As this mode of action of Transfersomes is independent of the drug cargo, these results demonstrate the potential of Transfersomes in the treatment of all fungal diseases.	Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	University of Exeter	Steinberg, G (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	G.Steinberg@exeter.ac.uk			Celtic Pharma Development Services Bermuda Ltd., New York, USA; Celtic Pharma	Celtic Pharma Development Services Bermuda Ltd., New York, USA; Celtic Pharma	This work was supported by Celtic Pharma Development Services Bermuda Ltd., New York, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by Celtic Pharma. This did not influence the outcome or judgment of the data. This does not alter the author's adherence to all the PLoS ONE policies on sharing data and materials.	Adamikova L, 2004, MOL BIOL CELL, V15, P1969, DOI 10.1091/mbc.E03-09-0675; Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Aguilar PS, 2010, P NATL ACAD SCI USA, V107, P4170, DOI 10.1073/pnas.0914094107; Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Benson Heather A E, 2006, Expert Opin Drug Deliv, V3, P727, DOI 10.1517/17425247.3.6.727; Berepiki A, 2011, NAT REV MICROBIOL, V9, P876, DOI 10.1038/nrmicro2666; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; BORGSTROM B, 1988, BIOCHIM BIOPHYS ACTA, V962, P308, DOI 10.1016/0005-2760(88)90260-3; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; Casadevall A, 2009, TRENDS MICROBIOL, V17, P158, DOI 10.1016/j.tim.2008.12.005; Cevc G, 1998, BBA-BIOMEMBRANES, V1368, P201, DOI 10.1016/S0005-2736(97)00177-6; Cevc G, 2004, ADV DRUG DELIVER REV, V56, P675, DOI 10.1016/j.addr.2003.10.028; Cevc G, 2001, BBA-BIOMEMBRANES, V1514, P191, DOI 10.1016/S0005-2736(01)00369-8; CEVC G, 1995, J CONTROL RELEASE, V36, P3, DOI 10.1016/0168-3659(95)00056-E; Cevc G, 2010, J CONTROL RELEASE, V141, P277, DOI 10.1016/j.jconrel.2009.10.016; Copland MJ, 2005, IMMUNOL CELL BIOL, V83, P97, DOI 10.1111/j.1440-1711.2005.01315.x; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Foster KW, 2004, J AM ACAD DERMATOL, V50, P748, DOI 10.1016/S0190-9622(03)02117-0; Fuchs U, 2005, MOL BIOL CELL, V16, P2746, DOI 10.1091/mbc.E05-03-0176; Fuchs U, 2006, PLANT CELL, V18, P2066, DOI 10.1105/tpc.105.039388; Ganendren R, 2004, ANTIMICROB AGENTS CH, V48, P1561, DOI 10.1128/AAC.48.5.1561-1569.2004; Ghannoum M, 2012, ANTIMICROBI IN PRESS; Ghannoum M, 2011, J CLIN MICROBIOL, V49, P1716, DOI 10.1128/JCM.00083-11; Ghannoum M, 2011, J AM ACAD DERMATOL, V64, pAB93; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gupta PN, 2005, J PHARM PHARMACOL, V57, P295, DOI 10.1211/0022357055515; Haneke E, 1999, J EUR ACAD DERMATOL, V12, pS2, DOI 10.1016/S0926-9959(99)00052-5; HAY RJ, 1993, J AM ACAD DERMATOL, V29, pS50, DOI 10.1016/S0190-9622(08)81838-5; HIROSE S, 1974, J BIOCHEM-TOKYO, V76, P213, DOI 10.1093/oxfordjournals.jbchem.a130549; Hofer C, 2004, CYTOKINE, V25, P141, DOI 10.1016/j.cyto.2003.10.010; Inoue T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002037; Jacobson ES, 2005, MED MYCOL, V43, P327, DOI 10.1080/13693780412331271081; Jain S, 2003, DRUG DEV IND PHARM, V29, P1013, DOI 10.1081/DDC-120025458; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Katz HI, 1999, BRIT J DERMATOL, V141, P26; King AR, 2007, CHEM BIOL, V14, P1357, DOI 10.1016/j.chembiol.2007.10.017; Kulkarni PR, 2011, INT J PHARM SCI RES, V2, P735, DOI 10.13040/IJPSR.0975-8232.2(4).735-41; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; LYTLE CD, 1995, APPL ENVIRON MICROB, V61, P643, DOI 10.1128/AEM.61.2.643-649.1995; Mahlert M, 2009, J CELL SCI, V122, P2402, DOI 10.1242/jcs.039354; Pereira RD, 1996, APPL BIOCHEM BIOTECH, V59, P135, DOI 10.1007/BF02787815; PETRANYI G, 1984, SCIENCE, V224, P1239, DOI 10.1126/science.6547247; PLANAS ME, 1992, ANESTH ANALG, V75, P615; Plou FJ, 1998, BIOTECHNOL TECH, V12, P183, DOI 10.1023/A:1008809105270; Read ND, 2003, FUNGAL GENET BIOL, V39, P199, DOI 10.1016/S1087-1845(03)00045-8; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roberts DT, 1997, DERMATOLOGY, V194, P37, DOI 10.1159/000246183; ROBERTS DT, 1994, J AM ACAD DERMATOL, V31, pS78, DOI 10.1016/S0190-9622(08)81274-1; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; RYDER NS, 1992, BRIT J DERMATOL, V126, P2, DOI 10.1111/j.1365-2133.1992.tb00001.x; RYDER NS, 1985, ANTIMICROB AGENTS CH, V27, P252, DOI 10.1128/AAC.27.2.252; Schuster M, 2012, EMBO J, V31, P214, DOI 10.1038/emboj.2011.361; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Shaw BD, 2011, FUNGAL BIOL-UK, V115, P541, DOI 10.1016/j.funbio.2011.02.010; SHINITZKY M, 1976, BIOCHIM BIOPHYS ACTA, V433, P133, DOI 10.1016/0005-2736(76)90183-8; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Steinberg G, 1998, J CELL SCI, V111, P2235; Steinberg Gero, 2011, Fungal Biology Reviews, V25, P14, DOI 10.1016/j.fbr.2011.01.008; Straube A, 2001, EMBO J, V20, P5091, DOI 10.1093/emboj/20.18.5091; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Treichel H, 2010, FOOD BIOPROCESS TECH, V3, P182, DOI 10.1007/s11947-009-0202-2; Tsai B, 2007, ANNU REV CELL DEV BI, V23, P23, DOI 10.1146/annurev.cellbio.23.090506.123454; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Voigt CA, 2005, PLANT J, V42, P364, DOI 10.1111/j.1365-313X.2005.02377.x; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; Zhang Y.Q., 2010, VIRULENCE, V1, P1	81	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38181	10.1371/journal.pone.0038181	http://dx.doi.org/10.1371/journal.pone.0038181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666476	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349600069
J	Wang, YJ; Wang, YT; Jung, TP				Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping			Translation of EEG Spatial Filters from Resting to Motor Imagery Using Independent Component Analysis	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; SINGLE-TRIAL EEG; SYNCHRONIZATION; CLASSIFICATION; ALGORITHMS; DYNAMICS	Electroencephalogram (EEG)-based brain-computer interfaces (BCIs) often use spatial filters to improve signal-to-noise ratio of task-related EEG activities. To obtain robust spatial filters, large amounts of labeled data, which are often expensive and labor-intensive to obtain, need to be collected in a training procedure before online BCI control. Several studies have recently developed zero-training methods using a session-to-session scenario in order to alleviate this problem. To our knowledge, a state-to-state translation, which applies spatial filters derived from one state to another, has never been reported. This study proposes a state-to-state, zero-training method to construct spatial filters for extracting EEG changes induced by motor imagery. Independent component analysis (ICA) was separately applied to the multi-channel EEG in the resting and the motor imagery states to obtain motor-related spatial filters. The resultant spatial filters were then applied to single-trial EEG to differentiate left- and right-hand imagery movements. On a motor imagery dataset collected from nine subjects, comparable classification accuracies were obtained by using ICA-based spatial filters derived from the two states (motor imagery: 87.0%, resting: 85.9%), which were both significantly higher than the accuracy achieved by using monopolar scalp EEG data (80.4%). The proposed method considerably increases the practicality of BCI systems in real-world environments because it is less sensitive to electrode misalignment across different sessions or days and does not require annotated pilot data to derive spatial filters.	[Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, San Diego, CA 92103 USA; [Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Wang, YJ (corresponding author), Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, San Diego, CA 92103 USA.	yijun@sccn.ucsd.edu	Wang, Yijun/GXW-1763-2022; Wang, Yijun/F-3547-2012		Abraxis Bioscience Inc.; US Army Research Laboratory [W911NF-10-2-0022]; Army Research Office [W911NF-09-1-0510]; Office of Naval Research [N00014-08-1215]; DARPA [USDI D11PC20183]	Abraxis Bioscience Inc.; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Army Research Office; Office of Naval Research(Office of Naval Research); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by a gift fund from Abraxis Bioscience Inc. Research was also sponsored in part by the US Army Research Laboratory (W911NF-10-2-0022), Army Research Office (W911NF-09-1-0510), Office of Naval Research (N00014-08-1215), and DARPA (USDI D11PC20183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Congedo M, 2010, INT J PSYCHOPHYSIOL, V78, P89, DOI 10.1016/j.ijpsycho.2010.06.003; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duda R.O., 2000, PATTERN CLASSIFICATI; Gouy-Pailler C, 2010, IEEE T BIO-MED ENG, V57, P469, DOI 10.1109/TBME.2009.2032162; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Huang RS, 2008, NEUROIMAGE, V39, P1896, DOI 10.1016/j.neuroimage.2007.10.036; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; James CJ, 2005, PHYSIOL MEAS, V26, pR15, DOI 10.1088/0967-3334/26/1/R02; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lou B, 2008, J NEURAL ENG, V5, P342, DOI 10.1088/1741-2560/5/3/007; M³ller K-R., 2004, BIOMED TECH, V49, P11, DOI [DOI 10.13109/9783666351419.11, 10.13109/9783666351419.11]; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Naeem M, 2006, J NEURAL ENG, V3, P208, DOI 10.1088/1741-2560/3/3/003; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V103, P642, DOI 10.1016/S0013-4694(97)00080-1; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vidaurre C, 2007, IEEE T BIO-MED ENG, V54, P550, DOI 10.1109/TBME.2006.888836; Vigario R, 2000, IEEE T BIO-MED ENG, V47, P589, DOI 10.1109/10.841330; Wang YJ, 2007, P ANN INT IEEE EMBS, P5059, DOI 10.1109/IEMBS.2007.4353477; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YJ, 2009, LECT NOTES ARTIF INT, V5638, P437, DOI 10.1007/978-3-642-02812-0_52; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699; Zhang Dan, 2007, Comput Intell Neurosci, P39714, DOI 10.1155/2007/39714	36	40	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37665	10.1371/journal.pone.0037665	http://dx.doi.org/10.1371/journal.pone.0037665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666377	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600026
J	Wu, XM; Li, YQ; Wan, XL; Kayira, TM; Cao, RJ; Ju, XD; Zhu, XJ; Zhao, G				Wu, Xinmin; Li, Yunqian; Wan, Xilin; Kayira, Tabitha Mlowoka; Cao, Rangjuan; Ju, Xingda; Zhu, Xiaojuan; Zhao, Gang			Down-Regulation of Neogenin Accelerated Glioma Progression through Promoter Methylation and Its Overexpression in SHG-44 Induced Apoptosis	PLOS ONE			English	Article							DCC GENE-PRODUCT; REPULSIVE GUIDANCE; DEPENDENCE RECEPTORS; NEURONAL DIFFERENTIATION; NETRIN-1 RECEPTOR; MULTIPLE ROLES; CELL-DEATH; EXPRESSION; CANCER; SURVIVAL	Background: Dependence receptors have been proved to act as tumor suppressors in tumorigenesis. Neogenin, a DCC homologue, well known for its fundamental role in axon guidance and cellular differentiation, is also a dependence receptor functioning to control apoptosis. However, loss of neogenin has been reported in several kinds of cancers, but its role in glioma remains to be further investigated. Methodology/Principal Findings: Western blot analysis showed that neogenin level was lower in glioma tissues than in their matching surrounding non-neoplastic tissues (n = 13, p<0.01). By immunohistochemical analysis of 69 primary and 16 paired initial and recurrent glioma sections, we found that the loss of neogenin did not only correlate negatively with glioma malignancy (n = 69, p<0.01), but also glioma recurrence (n = 16, p<0.05). Kaplan-Meier plot and Cox proportional hazards modelling showed that over-expressive neogenin could prolong the tumor latency (n = 69, p<0.001, 1187.6 +/- 162.6 days versus 687.4 +/- 254.2 days) and restrain high-grade glioma development (n = 69, p<0.01, HR: 0.264, 95% CI: 0.102 to 0.687). By Methylation specific polymerase chain reaction (MSP), we reported that neogenin promoter was methylated in 31.0% (9/29) gliomas, but absent in 3 kinds of glioma cell lines. Interestingly, the prevalence of methylation in high-grade gliomas was higher than low-grade gliomas and non-neoplastic brain tissues (n = 33, p, 0.05) and overall methylation rate increased as glioma malignancy advanced. Furthermore, when cells were over-expressed by neogenin, the apoptotic rate in SHG-44 was increased to 39.7% compared with 8.1% in the blank control (p<0.01) and 9.3% in the negative control (p<0.01). Conclusions/Significance: These observations recapitulated the proposed role of neogenin as a tumor suppressor in gliomas and we suggest its down-regulation owing to promoter methylation is a selective advantage for glioma genesis, progression and recurrence. Furthermore, the induction of apoptosis in SHG-44 cells after overexpression of neogenin, indicated that neogenin could be a novel target for glioma therapy.	[Wu, Xinmin; Wan, Xilin; Kayira, Tabitha Mlowoka; Cao, Rangjuan; Ju, Xingda; Zhu, Xiaojuan] NE Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China; [Wu, Xinmin; Li, Yunqian; Zhao, Gang] Jilin Univ, First Hosp, Dept Neurosurg, Changchun 130023, Peoples R China	Northeast Normal University - China; Jilin University	Wu, XM (corresponding author), NE Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China.	zhuxj720@nenu.edu.cn; zhaogang20052000@yahoo.com.cn		Zhu, Xiao-Juan/0000-0001-8386-8064	Program for New Century Excellent Talents in University [NCET-07-0173, 111496019]; National Natural Science Foundation of China [30670689, 30871302, 31171042]; National Natural Science Foundation of Jilin Province, China [200805130]; Scientific Research Foundation from Northeast Normal University [09ZDQD04, 10JCXK002]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jilin Province, China; Scientific Research Foundation from Northeast Normal University	This work was supported by the Program for New Century Excellent Talents in University (NCET-07-0173; 111496019), the National Natural Science Foundation of China (30670689; 30871302; 31171042), the National Natural Science Foundation of Jilin Province, China (200805130), and the Scientific Research Foundation from Northeast Normal University (09ZDQD04, 10JCXK002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2005, CELL DEATH DIFFER, V12, P1057, DOI 10.1038/sj.cdd.4401601; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Bernet A, 2007, GASTROENTEROLOGY, V133, P1840, DOI 10.1053/j.gastro.2007.08.009; Berrar D, 2005, J COMPUT BIOL, V12, P534, DOI 10.1089/cmb.2005.12.534; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Cole SJ, 2007, INT J BIOCHEM CELL B, V39, P1569, DOI 10.1016/j.biocel.2006.11.009; Connelly L, 2011, ONCOGENE, V30, P1402, DOI 10.1038/onc.2010.521; Delloye-Bourgeois C, 2009, J EXP MED, V206, P833, DOI 10.1084/jem.20082299; Eveno C, 2011, AM J PATHOL, V178, P1861, DOI 10.1016/j.ajpath.2010.12.019; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Fitzgerald DP, 2007, GENE EXPR PATTERNS, V7, P784, DOI 10.1016/j.modgep.2007.05.004; Fujita Y, 2008, CELL DEATH DIFFER, V15, P1593, DOI 10.1038/cdd.2008.92; Grady WM, 2007, GASTROENTEROLOGY, V133, P2045, DOI 10.1053/j.gastro.2007.10.034; Graf D, 2007, ARCH BIOCHEM BIOPHYS, V462, P162, DOI 10.1016/j.abb.2007.03.029; Hanninen MM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-36; HEDRICK L, 1994, GENE DEV, V8, P1174, DOI 10.1101/gad.8.10.1174; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hibi K, 2010, ANTICANCER RES, V30, P107; Hibi K, 2009, WORLD J SURG, V33, P1053, DOI 10.1007/s00268-008-9909-x; Jarjour AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025408; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Lee HK, 2008, KOREAN J PHYSIOL PHA, V12, P225, DOI 10.4196/kjpp.2008.12.5.225; Lee JE, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-85-154; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005; Lin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018608; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 2005, BRIT J CANCER, V93, P1, DOI 10.1038/sj.bjc.6602656; Mehlen P, 2004, CELL MOL LIFE SCI, V61, P1854, DOI 10.1007/s00018-004-3467-7; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Mehlen P, 2010, CURR OPIN ONCOL, V22, P46, DOI 10.1097/CCO.0b013e328333dcd1; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Nakatani K, 1998, J NEURO-ONCOL, V40, P237, DOI 10.1023/A:1006114328134; Nighat PK, 2011, J CANC RES EXPT ONCO, V3; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Papanastasiou AD, 2011, ONCOTARGET, V2, P363; Paradisi A, 2009, P NATL ACAD SCI USA, V106, P17146, DOI 10.1073/pnas.0901767106; Paunu N, 2002, INT J CANCER, V97, P819, DOI 10.1002/ijc.10107; ReyesMugica M, 1997, CANCER RES, V57, P382; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Shibata D, 1996, NEW ENGL J MED, V335, P1727, DOI 10.1056/NEJM199612053352303; Shin GJ, 2008, J MOL HISTOL, V39, P105, DOI 10.1007/s10735-007-9138-x; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Tran T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026858; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Yamashita T, 2007, CURR OPIN NEUROBIOL, V17, P29, DOI 10.1016/j.conb.2006.12.001; Yang F, 2011, J STRUCT BIOL, V174, P239, DOI 10.1016/j.jsb.2010.10.005	57	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38074	10.1371/journal.pone.0038074	http://dx.doi.org/10.1371/journal.pone.0038074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666451	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600061
J	Zhang, BY; Green, JV; Murthy, SK; Radisic, M				Zhang, Boyang; Green, James V.; Murthy, Shashi K.; Radisic, Milica			Label-Free Enrichment of Functional Cardiomyocytes Using Microfluidic Deterministic Lateral Flow Displacement	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ENGINEERED HEART-TISSUE; ELECTRICAL-STIMULATION; CARDIAC MYOCYTES; TRANSPLANTATION; SURVIVAL; SIZE; PHENOTYPE; IMPROVES; SYSTEMS	Progress in cardiac cell replacement therapies and tissue engineering critically depends on our ability to isolate functional cardiomyocytes (CMs) from heterogeneous cell mixtures. Label-free enrichment of cardiomyocytes is desirable for future clinical application of cell based products. Taking advantage of the physical properties of CMs, a microfluidic system was designed to separate CMs from neonatal rat heart tissue digest based on size using the principles of deterministic lateral displacement (DLD). For the first time, we demonstrate enrichment of functional CMs up to 91 +/- 2.4% directly from the digested heart tissue without any pre-treatment or labeling. Enriched cardiomyocytes remained viable after sorting and formed contractile cardiac patches in 3-dimensional culture. The broad significance of this work lies in demonstrating functional cell enrichment from the primary tissue digest leading directly to the creation of the engineered tissue.	[Zhang, Boyang; Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Green, James V.; Murthy, Shashi K.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Zhang, Boyang; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; Northeastern University; University of Toronto	Zhang, BY (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	smurthy@coe.neu.edu; m.radisic@utoronto.ca			National Institutes of Health [R01-EB009327]; Natural Sciences and Engineering Research Council Discovery Accelerator Supplement [RGPAS 396125-10]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council Discovery Accelerator Supplement; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by National Institutes of Health RO1 (R01-EB009327) and Natural Sciences and Engineering Research Council Discovery Accelerator Supplement (RGPAS 396125-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AC N, 1980, CYTOBIOS, V20; Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001; Au HTH, 2009, LAB CHIP, V9, P564, DOI 10.1039/b810034a; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Brown MA, 2008, BIOTECHNOL PROGR, V24, P907, DOI 10.1002/btpr.11; Cooper R, 2007, LAB CHIP; Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372; Dengler J, 2010, BIOTECHNOL BIOENG; Dengler J, 2007, FUTUR CARDIOL, V3, P425, DOI 10.2217/14796678.3.4.425; Dubois NC, 2011, NAT BIOTECHNOL; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Green JV, 2009, ANAL CHEM, V81, P9178, DOI 10.1021/ac9018395; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567; Huwer H, 2003, CELL TRANSPLANT, V12, P757, DOI 10.3727/000000003108747361; Inglis DW, 2008, J IMMUNOL METHODS, V329, P151, DOI 10.1016/j.jim.2007.10.004; Inglis DW, 2006, LAB CHIP, V6, P655, DOI 10.1039/b515371a; Iyer RK, 2009, J TISSUE ENG REGEN M, V3, P196, DOI 10.1002/term.153; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Langer R, 2007, TISSUE ENG, V13, P1, DOI 10.1089/ten.2006.0219; Li RK, 1996, ANN THORAC SURG, V62, P654; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Murthy SK, 2006, BIOMED MICRODEVICES, V8, P231, DOI 10.1007/s10544-006-8169-5; Naito H, 2006, CIRCULATION, V114, pI72, DOI 10.1161/CIRCULATIONAHA.105.001560; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Perin EC, 2011, PHASE 2 DOSE ESCALAT; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; RADISIC M, 2007, J BIOMED MAT RES A; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	44	31	32	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37619	10.1371/journal.pone.0037619	http://dx.doi.org/10.1371/journal.pone.0037619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666372	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600024
J	Azad, MB; Lissitsyn, Y; Miller, GE; Becker, AB; HayGlass, KT; Kozyrskyj, AL				Azad, Meghan B.; Lissitsyn, Yuri; Miller, Gregory E.; Becker, Allan B.; HayGlass, Kent T.; Kozyrskyj, Anita L.			Influence of Socioeconomic Status Trajectories on Innate Immune Responsiveness in Children	PLOS ONE			English	Article							C-REACTIVE PROTEIN; EARLY-LIFE ORIGINS; CIRCULATING INTERLEUKIN-6; INFLAMMATORY MARKERS; CHILDHOOD ASTHMA; STRESS; RISK; DISEASE; OBESITY; HEALTH	Objectives: Lower socioeconomic status (SES) is consistently associated with poor health, yet little is known about the biological mechanisms underlying this inequality. In children, we examined the impact of early-life SES trajectories on the intensity of global innate immune activation, recognizing that excessive activation can be a precursor to inflammation and chronic disease. Methods: Stimulated interleukin-6 production, a measure of immune responsiveness, was analyzed ex vivo for 267 Canadian schoolchildren from a 1995 birth cohort in Manitoba, Canada. Childhood SES trajectories were determined from parent-reported housing data using a longitudinal latent-class modeling technique. Multivariate regression was conducted with adjustment for potential confounders. Results: SES was inversely associated with innate immune responsiveness (p = 0.003), with persistently low-SES children exhibiting responses more than twice as intense as their high-SES counterparts. Despite initially lower SES, responses from children experiencing increasing SES trajectories throughout childhood were indistinguishable from high-SES children. Low-SES effects were strongest among overweight children (p<0.01). Independent of SES trajectories, immune responsiveness was increased in First Nations children (p<0.05) and urban children with atopic asthma (p<0.01). Conclusions: These results implicate differential immune activation in the association between SES and clinical outcomes, and broadly imply that SES interventions during childhood could limit or reverse the damaging biological effects of exposure to poverty during the preschool years.	[Azad, Meghan B.; Kozyrskyj, Anita L.] Univ Alberta, Dept Pediat, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Lissitsyn, Yuri; Becker, Allan B.; HayGlass, Kent T.] Univ Manitoba, Dept Immunol, Winnipeg, MB R3T 2N2, Canada; [Miller, Gregory E.] Univ British Columbia, Dept Physiol, Vancouver, BC, Canada; [Becker, Allan B.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada	University of Alberta; University of Manitoba; University of British Columbia; University of Manitoba	Azad, MB (corresponding author), Univ Alberta, Dept Pediat, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.	kozyrsky@ualberta.ca	Azad, Meghan/H-7226-2019	Azad, Meghan/0000-0002-5942-4444; HayGlass, Kent/0000-0002-4621-7737	Canadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; Killam Trusts; Women and Children's Health Research Institute/Stollery Children's Hospital Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Killam Trusts; Women and Children's Health Research Institute/Stollery Children's Hospital Foundation	This study was funded by the Canadian Institutes of Health Research (CIHR-www.cihr.ca). MA is supported by CIHR, Alberta Innovates Health Solutions (www.aihealthsolutions.ca), and the Killam Trusts (www.killamtrusts.ca) YL is an associate member of the CIHR National Training Program in Allergy and Asthma. KTH holds a Canada Research Chair in Immunology (http://www.chairs-chaires.gc.ca/). ALK holds a Research Chair supported by the Women and Children's Health Research Institute/Stollery Children's Hospital Foundation (wchri.srv.ualberta.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilyo G, 2011, J PERINATOL, V31, P30, DOI 10.1038/jp.2010.53; Arad I, 2010, ISR MED ASSOC J, V12, P419; Atlanta: Centers for Disease Control and Prevention, 2000, CDC GROWTH CHARTS US, P314; Autenrieth C, 2009, MED SCI SPORT EXER, V41, P1706, DOI 10.1249/MSS.0b013e3181a15512; Barnabe C, 2008, J RHEUMATOL, V35, P1145; Bruce SG, 2010, CHRONIC DIS CAN, V31, P27; Carroll JE, 2011, BRAIN BEHAV IMMUN, V25, P1468, DOI 10.1016/j.bbi.2011.05.016; Chen E, 2009, THORAX, V64, P38, DOI 10.1136/thx.2007.095091; Chen E, 2003, PSYCHOSOM MED, V65, P984, DOI 10.1097/01.PSY.0000097340.54195.3C; Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Chen Y, 2010, J ASTHMA, V47, P263, DOI 10.3109/02770900903427011; Choi Bernard C K, 2005, Prev Chronic Dis, V2, pA16; Cohen S, 2004, PSYCHOSOM MED, V66, P553, DOI 10.1097/01.psy.0000126200.05189.d3; de Pablo Raul, 2011, J Intensive Care Med, V26, P125, DOI 10.1177/0885066610384465; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Fitzpatrick AM, 2010, J ALLERGY CLIN IMMUN, V125, P851, DOI 10.1016/j.jaci.2010.01.048; Gimeno D, 2007, EUR J EPIDEMIOL, V22, P675, DOI 10.1007/s10654-007-9171-9; Gold DR, 2009, J ALLERGY CLIN IMMUN, V124, P1078, DOI 10.1016/j.jaci.2009.08.021; Guzman C, 2010, OPEN NEUROENDOCRINOL, V3, P152; Haddy N, 2005, EUR J HUM GENET, V13, P109, DOI 10.1038/sj.ejhg.5201294; Herberth G, 2007, J PSYCHOSOM RES, V63, P451, DOI 10.1016/j.jpsychores.2007.06.012; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Howe LD, 2010, INT J OBESITY, V34, P1149, DOI 10.1038/ijo.2010.52; Huttunen K, 2010, J ENVIRON MONITOR, V12, P1368, DOI 10.1039/c002579h; Johnson RC, 2011, AM J PUBLIC HEALTH, V101, P2317, DOI 10.2105/AJPH.2011.300252; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Keavney B, 2006, INT J EPIDEMIOL, V35, P935, DOI 10.1093/ije/dyl114; Keavney B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d144; Kozyrskyj AL, 2011, J DEV ORIG HLTH DIS, V2, P72, DOI 10.1017/S2040174410000723; Kozyrskyj AL, 2009, ALLERGY, V64, P1185, DOI 10.1111/j.1398-9995.2009.02033.x; Kozyrskyj AL, 2010, AM J PUBLIC HEALTH, V100, P540, DOI 10.2105/AJPH.2008.150771; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Larcombe L, 2005, GENES IMMUN, V6, P140, DOI 10.1038/sj.gene.6364157; Lissitsyn Y, 2007, CAN J PHYSIOL PHARM, V85, P739, DOI 10.1139/Y07-064; Loucks EB, 2010, SOC SCI MED, V71, P187, DOI 10.1016/j.socscimed.2010.03.012; Manfredi B, 1998, BRAIN BEHAV IMMUN, V12, P201, DOI 10.1006/brbi.1998.0525; Marin TJ, 2008, PSYCHOSOM MED, V70, P152, DOI 10.1097/PSY.0b013e3181647d16; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Noakes PS, 2003, ALLERGY, V58, P1053, DOI 10.1034/j.1398-9995.2003.00290.x; Petersen KL, 2008, PSYCHOSOM MED, V70, P646, DOI 10.1097/PSY.0b013e31817b8ee4; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Pollitt RA, 2007, EUR J EPIDEMIOL, V22, P55, DOI 10.1007/s10654-006-9082-1; Radon K, 2007, PEDIATRICS, V120, P354, DOI 10.1542/peds.2006-3624; Raison CL, 2010, ARCH GEN PSYCHIAT, V67, P1211, DOI 10.1001/archgenpsychiatry.2010.161; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Saxton KB, 2011, BRAIN BEHAV IMMUN; Scheede-Bergdahl C, 2011, CLIN NUTR; Scott NM, 2009, J IMMUNOL, V182, P1411, DOI 10.4049/jimmunol.182.3.1411; Scrivo R, 2010, AUTOIMMUN REV; Sears B, 2011, J OBES, V2011, DOI 10.1155/2011/431985; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Townsend MS, 2006, J AM DIET ASSOC, V106, P34, DOI 10.1016/j.jada.2005.11.008; Whiteley W, 2011, STROKE; Williams MJA, 2006, J EPIDEMIOL COMMUN H, V60, P146, DOI 10.1136/jech.2005.039222; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wong GWK, 2008, PEDIATR PULM, V43, P107, DOI 10.1002/ppul.20755; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Wright RJ, 2010, AM J RESP CRIT CARE, V182, P25, DOI 10.1164/rccm.200904-0637OC; YOKOYAMA A, 1995, AM J RESP CRIT CARE, V151, P1354, DOI 10.1164/ajrccm.151.5.7735584; Young TK, 2000, CAN MED ASSOC J, V163, P561	62	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38669	10.1371/journal.pone.0038669	http://dx.doi.org/10.1371/journal.pone.0038669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XO	22685596	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700059
J	Lima, L; Ortiz, PA; da Silva, FM; Alves, JMP; Serrano, MG; Cortez, AP; Alfieri, SC; Buck, GA; Teixeira, MMG				Lima, Luciana; Ortiz, Paola A.; da Silva, Flavia Maia; Alves, Joao Marcelo P.; Serrano, Myrna G.; Cortez, Alane P.; Alfieri, Silvia C.; Buck, Gregory A.; Teixeira, Marta M. G.			Repertoire, Genealogy and Genomic Organization of Cruzipain and Homologous Genes in Trypanosoma cruzi, T. cruzi-Like and Other Trypanosome Species	PLOS ONE			English	Article							MAJOR CYSTEINE PROTEINASE; PHYLOGENETIC ANALYSIS; PROTEASE INHIBITORS; CELL RESPONSES; CHAGAS-DISEASE; CYTOCHROME-B; INVASION; SEQUENCE; DIONISII; IDENTIFICATION	Trypanosoma cruzi, the agent of Chagas disease, is a complex of genetically diverse isolates highly phylogenetically related to T. cruzi-like species, Trypanosoma cruzi marinkellei and Trypanosoma dionisii, all sharing morphology of blood and culture forms and development within cells. However, they differ in hosts, vectors and pathogenicity: T. cruzi is a human pathogen infective to virtually all mammals whilst the other two species are non-pathogenic and bat restricted. Previous studies suggest that variations in expression levels and genetic diversity of cruzipain, the major isoform of cathepsin L-like (CATL) enzymes of T. cruzi, correlate with levels of cellular invasion, differentiation, virulence and pathogenicity of distinct strains. In this study, we compared 80 sequences of genes encoding cruzipain from 25 T. cruzi isolates representative of all discrete typing units (DTUs TcI-TcVI) and the new genotype Tcbat and 10 sequences of homologous genes from other species. The catalytic domain repertoires diverged according to DTUs and trypanosome species. Relatively homogeneous sequences are found within and among isolates of the same DTU except TcV and TcVI, which displayed sequences unique or identical to those of TcII and TcIII, supporting their origin from the hybridization between these two DTUs. In network genealogies, sequences from T. cruzi clustered tightly together and closer to T. c. marinkellei than to T. dionisii and largely differed from homologues of T. rangeli and T. b. brucei. Here, analysis of isolates representative of the overall biological and genetic diversity of T. cruzi and closest T. cruzi-like species evidenced DTU- and species-specific polymorphisms corroborating phylogenetic relationships inferred with other genes. Comparison of both phylogenetically close and distant trypanosomes is valuable to understand host-parasite interactions, virulence and pathogenicity. Our findings corroborate cruzipain as valuable target for drugs, vaccine, diagnostic and genotyping approaches.	[Lima, Luciana; Ortiz, Paola A.; da Silva, Flavia Maia; Alves, Joao Marcelo P.; Cortez, Alane P.; Alfieri, Silvia C.; Teixeira, Marta M. G.] Univ Sao Paulo, ICB, Dept Parasitol, Sao Paulo, Brazil; [Alves, Joao Marcelo P.; Serrano, Myrna G.; Buck, Gregory A.] Virginia Commonwealth Univ, Coll Med, Dept Microbiol & Immunol, Richmond, VA USA; [Cortez, Alane P.] Univ Fed Goias, Fac Farm, Goiania, Go, Brazil	Universidade de Sao Paulo; Virginia Commonwealth University; Universidade Federal de Goias	Lima, L (corresponding author), Univ Sao Paulo, ICB, Dept Parasitol, Sao Paulo, Brazil.	mmgteix@icb.usp.br	Alfieri, Silvia/G-2132-2012; Alves, Joao M.P./G-8927-2011; Teixeira, Marta M G/B-1115-2009	Alfieri, Silvia/0000-0001-9574-2151; Alves, Joao M.P./0000-0001-5914-2087; Ortiz Vargas, Paola Andrea/0000-0002-3450-3429	Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); NSF (USA); CNPq-PROTAX (Programa Nacional de Taxonomia do CNPq); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil)	Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSF (USA)(National Science Foundation (NSF)); CNPq-PROTAX (Programa Nacional de Taxonomia do CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by grants from Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) to MMGT and from the NSF (USA) Grant: Assembling the Tree of Life: Phylum Euglenozoa (GAB, PI). PAO is doctorate fellow sponsored by CNPq-PROTAX (Programa Nacional de Taxonomia do CNPq). LL, APC and FMS are postdoctoral fellows sponsored by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez VE, 2012, BBA-PROTEINS PROTEOM, V1824, P195, DOI 10.1016/j.bbapap.2011.05.011; Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; ARNHOLDT ACV, 1993, J IMMUNOL, V151, P3171; Atayde VD, 2004, INT J PARASITOL, V34, P851, DOI 10.1016/j.ijpara.2004.03.003; Atkinson HJ, 2009, TRENDS PARASITOL, V25, P573, DOI 10.1016/j.pt.2009.09.006; Baker J.R., 1985, Parasitology Today, V1, P111, DOI 10.1016/0169-4758(85)90006-7; BAKER JR, 1978, J GEN MICROBIOL, V104, P79, DOI 10.1099/00221287-104-1-79; Barnabe C, 2003, INFECT GENET EVOL, V2, P201, DOI 10.1016/S1567-1348(02)00130-2; BONALDO MC, 1991, PARASITOL RES, V77, P567, DOI 10.1007/BF00931014; Branquinha MH, 1999, MOL BIOCHEM PARASIT, V102, P179, DOI 10.1016/S0166-6851(99)00107-3; BRANQUINHA MH, 1994, BRAZ J MED BIOL RES, V27, P495; Caffrey CR, 2009, MOL BIOCHEM PARASIT, V167, P12, DOI 10.1016/j.molbiopara.2009.04.009; CAMPETELLA O, 1992, MOL BIOCHEM PARASIT, V50, P225, DOI 10.1016/0166-6851(92)90219-A; Cavazzana M, 2010, INT J PARASITOL, V40, P345, DOI 10.1016/j.ijpara.2009.08.015; Cazorla SI, 2008, VACCINE, V26, P1999, DOI 10.1016/j.vaccine.2008.02.011; Cazorla SI, 2010, J INFECT DIS, V202, P136, DOI 10.1086/652872; Cazorla SI, 2009, EXPERT REV VACCINES, V8, P921, DOI [10.1586/erv.09.45, 10.1586/ERV.09.45]; Cazzulo JJ, 1997, BIOL CHEM, V378, P1; Cazzulo JJ, 2001, CURR PHARM DESIGN, V7, P1143, DOI 10.2174/1381612013397528; Cerqueira GC, 2008, MOL BIOCHEM PARASIT, V157, P65, DOI 10.1016/j.molbiopara.2007.10.002; Claser C, 2007, MICROBES INFECT, V9, P1011, DOI 10.1016/j.micinf.2007.04.006; Cortez AP, 2009, MOL CELL PROBE, V23, P44, DOI 10.1016/j.mcp.2008.11.003; Da Silva FM, 2007, MOL ECOL, V16, P3361, DOI 10.1111/j.1365-294X.2007.03371.x; da Silva FM, 2009, ACTA TROP, V109, P199, DOI 10.1016/j.actatropica.2008.11.005; Oliveira MPD, 2009, ACTA TROP, V110, P65, DOI 10.1016/j.actatropica.2009.01.008; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; Doyle PS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002139; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Fampa P, 2010, VECTOR-BORNE ZOONOT, V10, P839, DOI 10.1089/vbz.2009.0223; Fampa P, 2010, PARASITOL RES, V107, P443, DOI 10.1007/s00436-010-1888-9; Ferreira RC, 2012, INFECT GENET EVOL, V12, P1064, DOI 10.1016/j.meegid.2012.03.010; Flores-Lopez CA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001272; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; Freitas LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025914; Garcia HA, 2011, INT J PARASITOL, V41, P1385, DOI 10.1016/j.ijpara.2011.09.001; GLAUERT AM, 1982, J CELL SCI, V56, P371; Gomes SAO, 2009, PARASITOL RES, V105, P743, DOI 10.1007/s00436-009-1446-5; Hamilton PB, 2011, INFECT GENET EVOL, V11, P44, DOI 10.1016/j.meegid.2010.10.012; Hamilton PB, 2012, TRENDS PARASITOL, V28, P136, DOI 10.1016/j.pt.2012.01.006; Haolla FA, 2009, VACCINE, V27, P5644, DOI 10.1016/j.vaccine.2009.07.013; HARTH G, 1993, MOL BIOCHEM PARASIT, V58, P17, DOI 10.1016/0166-6851(93)90086-D; Higo H, 2007, PARASITOL RES, V100, P1023, DOI 10.1007/s00436-006-0376-8; Hoare C.A., 1972, P1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-54; Kikuchi SA, 2010, EXP PARASITOL, V126, P540, DOI 10.1016/j.exppara.2010.06.005; Lima APCA, 2001, MOL BIOCHEM PARASIT, V114, P41, DOI 10.1016/S0166-6851(01)00236-5; LIMA APCD, 1994, MOL BIOCHEM PARASIT, V67, P333, DOI 10.1016/0166-6851(94)00144-8; Lima L, 2012, PROTIST IN PRESS; Maeda FY, 2012, ACTA TROP, V121, P141, DOI 10.1016/j.actatropica.2011.10.017; Marcili A, 2009, PARASITOLOGY, V136, P641, DOI 10.1017/S0031182009005861; Marcili A, 2009, INFECT GENET EVOL, V9, P1265, DOI 10.1016/j.meegid.2009.07.003; Marcili A, 2009, INT J PARASITOL, V39, P615, DOI 10.1016/j.ijpara.2008.09.015; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; MARTINEZ J, 1991, INFECT IMMUN, V59, P4275, DOI 10.1128/IAI.59.11.4275-4277.1991; MARTINEZ J, 1995, FEMS MICROBIOL LETT, V129, P135, DOI 10.1016/0378-1097(95)00147-W; McKerrow JH, 2009, MEM I OSWALDO CRUZ, V104, P263, DOI 10.1590/S0074-02762009000900034; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; MEIRELLES MNL, 1992, MOL BIOCHEM PARASIT, V52, P175, DOI 10.1016/0166-6851(92)90050-T; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; Molyneux D.H., 1991, P195; Monteiro AC, 2007, PLOS PATHOG, V3, P1730, DOI 10.1371/journal.ppat.0030185; Ortiz PA, 2009, ACTA TROP, V112, P249, DOI 10.1016/j.actatropica.2009.07.036; PETRY K, 1987, J NEUROIMMUNOL, V16, P237, DOI 10.1016/0165-5728(87)90078-6; Pillay D, 2010, PROTEIN EXPRES PURIF, V74, P264, DOI 10.1016/j.pep.2010.06.021; Rodrigues AC, 2010, PARASITOL INT, V59, P318, DOI 10.1016/j.parint.2010.03.002; Rozas N, 2008, PARASITOLOGY, V135, P1157, DOI 10.1017/S0031182008004794; Ruszczyk A, 2008, FISH SHELLFISH IMMUN, V24, P205, DOI 10.1016/j.fsi.2007.10.015; Santos CC, 2005, J CELL SCI, V118, P901, DOI 10.1242/jcs.01677; SCHARFSTEIN J, 1986, J IMMUNOL, V137, P1336; SCHARFSTEIN J, 1983, J IMMUNOL, V131, P972; Scharfstein Julio, 2008, V47, P140; Schnapp AR, 2002, MICROBES INFECT, V4, P805, DOI 10.1016/S1286-4579(02)01600-3; Telleria J, 2010, P NATL ACAD SCI USA, V107, P20411, DOI 10.1073/pnas.1015496107; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	82	26	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38385	10.1371/journal.pone.0038385	http://dx.doi.org/10.1371/journal.pone.0038385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685565	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700028
J	Vaitaitis, GM; Wagner, DH				Vaitaitis, Gisela M.; Wagner, David H., Jr.			Galectin-9 Controls CD40 Signaling through a Tim-3 Independent Mechanism and Redirects the Cytokine Profile of Pathogenic T Cells in Autoimmunity	PLOS ONE			English	Article							N-GLYCOSYLATION; LIGAND; ACTIVATION; EXPRESSION; PROMOTES; INFLAMMATION; REPERTOIRE; POPULATION; RESPONSES; IMMUNITY	While it has long been understood that CD40 plays a critical role in the etiology of autoimmunity, glycobiology is emerging as an important contributor. CD40 signaling is also gaining further interest in transplantation and cancer therapies. Work on CD40 signaling has focused on signaling outcomes and blocking of its ligand, CD154, while little is known about the actual receptor itself and its control. We demonstrated that CD40 is in fact several receptors occurring as constellations of differentially glycosylated forms of the protein that can sometimes form hybrid receptors with other proteins. An enticing area of autoimmunity is differential glycosylation of immune molecules leading to altered signaling. Galectins interact with carbohydrates on proteins to effect such signaling alterations. Studying autoimmune prone NOD and non-autoimmune BALB/c mice, here we reveal that in-vivo CD40 signals alter the glycosylation status of non-autoimmune derived CD4 T cells to resemble that of autoimmune derived CD4 T cells. Galectin-9 interacts with CD40 and, at higher concentrations, prevents CD40 induced proliferative responses of CD4(lo)CD40(+) effector T cells and induces cell death through a Tim-3 independent mechanism. Interestingly, galectin-9, at lower concentrations, alters the surface expression of CD3, CD4, and TCR, regulating access to those molecules and thereby redirects the inflammatory cytokine phenotype and CD3 induced proliferation of autoimmune CD4(lo)CD40(+) T cells. Understanding the dynamics of the CD40 receptor(s) and the impact of glycosylation status in immunity will gain insight into how to maintain useful CD40 signals while shutting down detrimental ones.	[Vaitaitis, Gisela M.; Wagner, David H., Jr.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Vaitaitis, Gisela M.; Wagner, David H., Jr.] Univ Colorado Denver, Webb Waring Ctr, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Vaitaitis, GM (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO USA.	david.wagner@ucdenver.edu		Vaitaitis, Gisela/0000-0001-6413-8322	American Diabetes Association [1-08-CD-19]; National Institute of Diabetes, Digestive and Kidney Diseases [5 R01 DK075013]; Amercian Recovery and Reinvestment Act [3 R01 DK075013-03S2]; Kleberg Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075013] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Amercian Recovery and Reinvestment Act; Kleberg Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the American Diabetes Association (award number 1-08-CD-19; www.diabetes.org), the National Institute of Diabetes, Digestive and Kidney Diseases (award number 5 R01 DK075013; www.niddk.nih.gov), the Amercian Recovery and Reinvestment Act (award number 3 R01 DK075013-03S2; www.recovery.gov), and the Kleberg Foundation awarded to DHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RL, 2008, J AUTOIMMUN, V31, P385, DOI 10.1016/j.jaut.2008.09.001; Balasa B, 1997, J IMMUNOL, V159, P4620; Barr T, 2006, VACCINE S2, V24, pS2; Carlring J, 2004, VACCINE, V22, P3323, DOI 10.1016/j.vaccine.2004.02.043; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Hatzifoti C, 2007, IMMUNOLOGY, V122, P98, DOI 10.1111/j.1365-2567.2007.02617.x; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; HOXIE JA, 1986, J IMMUNOL, V137, P1194; Klyosov AA, 2008, GALECTINS; Law CL, 2009, ADV EXP MED BIOL, V647, P8, DOI 10.1007/978-0-387-89520-8_2; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Loskog ASI, 2009, SEMIN IMMUNOL, V21, P301, DOI 10.1016/j.smim.2009.07.001; Margolles-Clark E, 2009, J MOL MED, V87, P1133, DOI 10.1007/s00109-009-0519-3; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Munroe ME, 2007, J IMMUNOL, V178, P671, DOI 10.4049/jimmunol.178.2.671; Nanji SA, 2006, DIABETES, V55, P27, DOI 10.2337/diabetes.55.01.06.db04-1154; Niwa H, 2009, CLIN IMMUNOL, V132, P184, DOI 10.1016/j.clim.2009.04.012; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Su EW, 2011, GLYCOBIOLOGY, V21, P1258, DOI 10.1093/glycob/cwq214; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; Vaitaitis GM, 2010, MOL IMMUNOL, V47, P2303, DOI 10.1016/j.molimm.2010.05.288; Vaitaitis GM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002076; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vonderheide RH, 2007, CLIN CANCER RES, V13, P1083, DOI 10.1158/1078-0432.CCR-06-1893; Wagner DH, 2009, DIABETOLOGIA, V52, P997, DOI 10.1007/s00125-009-1357-0; Wagner DH, 2007, CLIN IMMUNOL, V123, P1, DOI 10.1016/j.clim.2006.08.006; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Wagner DH, 1999, INT J MOL MED, V4, P231; Waid DM, 2008, J LEUKOCYTE BIOL, V84, P431, DOI 10.1189/jlb.1207857; Waid DM, 2007, CLIN IMMUNOL, V124, P138, DOI 10.1016/j.clim.2007.05.003; Waid DM, 2004, EUR J IMMUNOL, V34, P1488, DOI 10.1002/eji.200324703; Wang JF, 2009, J IMMUNOL, V182, P4036, DOI 10.4049/jimmunol.0802981; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	43	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38708	10.1371/journal.pone.0038708	http://dx.doi.org/10.1371/journal.pone.0038708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685601	Green Submitted, gold, Green Published			2022-12-27	WOS:000305351700064
J	Bruce, T; Meirelles, PM; Garcia, G; Paranhos, R; Rezende, CE; de Moura, RL; Filho, RF; Coni, EOC; Vasconcelos, AT; Amado, G; Hatay, M; Schmieder, R; Edwards, R; Dinsdale, E; Thompson, FL				Bruce, Thiago; Meirelles, Pedro M.; Garcia, Gizele; Paranhos, Rodolfo; Rezende, Carlos E.; de Moura, Rodrigo L.; Filho, Ronaldo-Francini; Coni, Ericka O. C.; Vasconcelos, Ana Tereza; Amado Filho, Gilberto; Hatay, Mark; Schmieder, Robert; Edwards, Robert; Dinsdale, Elizabeth; Thompson, Fabiano L.			Abrolhos Bank Reef Health Evaluated by Means of Water Quality, Microbial Diversity, Benthic Cover, and Fish Biomass Data	PLOS ONE			English	Article							CORAL-REEFS; NUTRIENT ENRICHMENT; ORGANIC-MATTER; MARINE RESERVE; PHASE-SHIFTS; HERBIVORY; BACTERIOPLANKTON; PROCHLOROCOCCUS; EUTROPHICATION; COMMUNITIES	The health of the coral reefs of the Abrolhos Bank (southwestern Atlantic) was characterized with a holistic approach using measurements of four ecosystem components: (i) inorganic and organic nutrient concentrations, [1] fish biomass, [1] macroalgal and coral cover and (iv) microbial community composition and abundance. The possible benefits of protection from fishing were particularly evaluated by comparing sites with varying levels of protection. Two reefs within the well-enforced no-take area of the National Marine Park of Abrolhos (Parcel dos Abrolhos and California) were compared with two unprotected coastal reefs (Sebastiao Gomes and Pedra de Leste) and one legally protected but poorly enforced coastal reef (the "paper park" of Timbebas Reef). The fish biomass was lower and the fleshy macroalgal cover was higher in the unprotected reefs compared with the protected areas. The unprotected and protected reefs had similar seawater chemistry. Lower vibrio CFU counts were observed in the fully protected area of California Reef. Metagenome analysis showed that the unprotected reefs had a higher abundance of archaeal and viral sequences and more bacterial pathogens, while the protected reefs had a higher abundance of genes related to photosynthesis. Similar to other reef systems in the world, there was evidence that reductions in the biomass of herbivorous fishes and the consequent increase in macroalgal cover in the Abrolhos Bank may be affecting microbial diversity and abundance. Through the integration of different types of ecological data, the present study showed that protection from fishing may lead to greater reef health. The data presented herein suggest that protected coral reefs have higher microbial diversity, with the most degraded reef (Sebastiao Gomes) showing a marked reduction in microbial species richness. It is concluded that ecological conditions in unprotected reefs may promote the growth and rapid evolution of opportunistic microbial pathogens.	[Bruce, Thiago; Meirelles, Pedro M.; Garcia, Gizele; Paranhos, Rodolfo; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Dept Marine Biol, Rio De Janeiro, Brazil; [Rezende, Carlos E.] Univ Estadual Norte Fluminense, Biosci & Biotechnol Ctr, Rio De Janeiro, Brazil; [de Moura, Rodrigo L.] Univ Estadual Santa Cruz, Dept Ecol, Ilheus, BA, Brazil; [Filho, Ronaldo-Francini; Coni, Ericka O. C.] Univ Fed Paraiba UFPB, Appl Sci & Educ Ctr, Joao Pessoa, Paraiba, Brazil; [Vasconcelos, Ana Tereza] Lab Nacl Comp Cient, Petropolis, Rio De Janeiro, Brazil; [Amado Filho, Gilberto] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Hatay, Mark; Dinsdale, Elizabeth] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Schmieder, Robert; Edwards, Robert] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Edwards, Robert] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	Universidade Federal do Rio de Janeiro; Universidade Estadual do Norte Fluminense; Universidade Estadual de Santa Cruz; Universidade Federal da Paraiba; Laboratorio Nacional de Computacao Cientifica (LNCC); Jardim Botanico do Rio de Janeiro; California State University System; San Diego State University; California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory	Bruce, T (corresponding author), Univ Fed Rio de Janeiro, Dept Marine Biol, Rio De Janeiro, Brazil.	fabiano.thompson@biologia.ufrj.br	Meirelles, Pedro/AAL-4542-2020; Francini-Filho, Ronaldo/I-5708-2012; Meirelles, Pedro/GRY-0806-2022; Tmcocean, Inct/J-8735-2013; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Rodrigues, Thiago/J-6363-2013; Edwards, Robert/Q-1691-2019; Meirelles, Pedro/AAK-5942-2021; de Moura, Rodrigo Leao/AAL-5781-2020; de Rezende, Carlos E/I-1893-2015; FILHO, GILBERTO M AMADO/I-1324-2012; Vasconcelos, Ana Tereza R/I-1011-2012; Paranhos, Rodolfo/F-1927-2011	Francini-Filho, Ronaldo/0000-0002-7678-6797; Edwards, Robert/0000-0001-8383-8949; Meirelles, Pedro/0000-0002-1306-0331; de Moura, Rodrigo Leao/0000-0002-5597-6196; Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Thompson, Fabiano/0000-0002-7562-1683; de Rezende, Carlos/0000-0003-2804-8930; dinsdale, elizabeth/0000-0002-2177-203X	CNPq (Equivalent of NSF in Brazil); CAPES (Equivalent of NSF in Brazil); FAPERJ (Equivalent of NSF in Rio de Janeiro); USA Embassy; NSF; International Foundation of Science (IFS)	CNPq (Equivalent of NSF in Brazil); CAPES (Equivalent of NSF in Brazil); FAPERJ (Equivalent of NSF in Rio de Janeiro); USA Embassy; NSF(National Science Foundation (NSF)); International Foundation of Science (IFS)(International Foundation for Science)	Funding was provided by CNPq (Equivalent of NSF in Brazil); CAPES (Equivalent of NSF in Brazil); FAPERJ (Equivalent of NSF in Rio de Janeiro); USA Embassy; NSF; and International Foundation of Science (IFS). All are government agencies, not commercial sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Andrade L, 2007, BRAZ J MICROBIOL, V38, P330, DOI 10.1590/S1517-83822007000200028; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Barash Y, 2005, BACTERIAL STRAIN BA; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Bell PRF, 2007, AMBIO, V36, P416, DOI 10.1579/0044-7447(2007)36[416:ROESFT]2.0.CO;2; BELL PRF, 1992, WATER RES, V26, P553, DOI 10.1016/0043-1354(92)90228-V; Bourne DG, 2011, ISME J, V5, P559, DOI 10.1038/ismej.2010.143; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Cherrier J, 1996, MAR ECOL PROG SER, V139, P267, DOI 10.3354/meps139267; Costa OS, 2006, J MARINE SYST, V60, P63, DOI 10.1016/j.jmarsys.2005.11.006; Costa OS, 2000, HYDROBIOLOGIA, V440, P307, DOI 10.1023/A:1004104118208; Costa OS, 2008, J S AM EARTH SCI, V25, P257, DOI 10.1016/j.jsames.2007.10.002; de Castro AP, 2010, MICROB ECOL, V59, P658, DOI 10.1007/s00248-010-9646-1; De Moura RL, 2009, COAST MANAGE, V37, P617, DOI 10.1080/08920750903194165; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; DUCKLOW HW, 1992, ADV MICROB ECOL, V12, P113; Dutra GF, 2010, BRASIL ATLANTICO PAI, P200; Edgar GJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P730, DOI 10.1111/j.1466-8238.2010.00642.x; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Francini-Filho RB, 2008, FISH RES, V93, P346, DOI 10.1016/j.fishres.2008.06.011; Francini-Filho RB, 2010, FORAGING ACTIVITY RO; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Francini RB, 2008, AQUAT CONSERV, V18, P1166, DOI 10.1002/aqc.966; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hutchings P, 2001, MAR POLLUT BULL, V42, P81, DOI 10.1016/S0025-326X(00)00182-X; Ivars-Martinez E, 2008, MOL ECOL, V17, P4092, DOI 10.1111/j.1365-294X.2008.03883.x; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Koroleff F., 1976, METHODS SEAWATER ANA, P117; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V298, P275, DOI 10.1016/S0022-0981(03)00363-0; Leao ZMAN, 2003, LATIN AMERICAN CORAL REEFS, P9, DOI 10.1016/B978-044451388-5/50003-5; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lewis JB, 1997, MAR POLLUT BULL, V34, P622, DOI 10.1016/S0025-326X(96)00184-1; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minte-Vera CV, 2008, MAR ECOL PROG SER, V367, P283, DOI 10.3354/meps07511; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Moura RL, 2007, AREAS PROTEGIDAS, P168; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Ovalle ARC, 1999, GEO-MAR LETT, V19, P179, DOI 10.1007/s003670050107; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Rezende CE, 2010, ESTUAR COAST SHELF S, V87, P479, DOI 10.1016/j.ecss.2010.02.008; Rezende CE, 2006, CARACTERISTICAS HIDR; Rohwer F., 2010, CORAL REEFS MICROBIA; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Sandin SA, 2011, OECOLOGIA, P1; Schloss PD, 2005, INTRO DOTUR COMPUTER, P1501; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIEBURTH J M, 1969, Journal of Experimental Marine Biology and Ecology, V3, P290, DOI 10.1016/0022-0981(69)90052-5; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singer E, 2011, APPL ENVIRON MICROB, V77, P2763, DOI 10.1128/AEM.01866-10; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; SMITH SV, 1981, PAC SCI, V35, P279; Sondergaard M, 2000, LIMNOL OCEANOGR, V45, P1097, DOI 10.4319/lo.2000.45.5.1097; Sotka EE, 2009, CORAL REEFS, V28, P555, DOI 10.1007/s00338-009-0529-1; SUMMERHAYES CP, 1976, J SEDIMENT PETROL, V46, P819; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Wagner D, 2008, B MAR SCI, V83, P553; Zar JH, 1999, BIOSTATISTICAL ANAL	84	105	105	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e36687	10.1371/journal.pone.0036687	http://dx.doi.org/10.1371/journal.pone.0036687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679480	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900001
J	McArthur, MA; Sztein, MB				McArthur, Monica A.; Sztein, Marcelo B.			Heterogeneity of Multifunctional IL-17A Producing S. Typhi-Specific CD8+T Cells in Volunteers following Ty21a Typhoid Immunization	PLOS ONE			English	Article							CD8(+) T-CELLS; ATTENUATED VACCINE STRAINS; DRUG-RESISTANCE; TH17 CELLS; RESPONSES; IMMUNITY; VIRUS; EFFECTOR; SUBSET; INTERLEUKIN-17	Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, continues to cause significant morbidity and mortality world-wide. CD8+ T cells are an important component of the cell mediated immune (CMI) response against S. Typhi. Recently, interleukin (IL)-17A has been shown to contribute to mucosal immunity and protection against intracellular pathogens. To investigate multifunctional IL-17A responses against S. Typhi antigens in T memory subsets, we developed multiparametric flow cytometry methods to detect up to 6 cytokines/chemokines (IL-10, IL-17A, IL-2, interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and macrophage inflammatory protein-1 beta (MIP-1 beta)) simultaneously. Five volunteers were immunized with a 4 dose regimen of live-attenuated S. Typhi vaccine (Ty21a), peripheral blood mononuclear cells (PBMC) were isolated before and at 11 time points after immunization, and CMI responses were evaluated. Of the 5 immunized volunteers studied, 3 produced detectable CD8+ T cell responses following stimulation with S. Typhi-infected autologous B lymphoblastoid cell lines (B-LCL). Additionally, 2 volunteers had detectable levels of intracellular cytokines in response to stimulation with S. Typhi-infected HLA-E restricted cells. Although the kinetics of the responses differed among volunteers, all of the responses were bi- or tri-phasic and included multifunctional CD8+ T cells. Virtually all of the IL-17A detected was derived from multifunctional CD8+ T cells. The presence of these multifunctional IL-17A+ CD8+ T cells was confirmed using an unsupervised analysis program, flow cytometry clustering without K (FLOCK). This is the first report of IL-17A production in response to S. Typhi in humans, indicating the presence of a Tc17 response which may be important in protection. The presence of IL-17A in multifunctional cells co-producing Tc1 cytokines (IL-2, IFN-gamma and TNF-Phi) may also indicate that the distinction between Tc17 and Tc1 responses in humans is not as clearly delineated as suggested by in vitro experiments and animal models.	[McArthur, Monica A.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [McArthur, Monica A.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	McArthur, MA (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	msztein@medicine.umaryland.edu	McArthur, Monica/AAD-9682-2019		National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) [R01 AI036525, U19 AI082655]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082655, R01AI036525] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) federal research grants R01 AI036525 and U19 AI082655 (CCHI) to MBS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Atkins BL, 1998, JAMA-J AM MED ASSOC, V279, P579, DOI 10.1001/jama.279.8.579; Bhutta ZA, 1996, ARCH DIS CHILD, V75, P214, DOI 10.1136/adc.75.3.214; Bhutta ZA, 2009, JAMA-J AM MED ASSOC, V302, P898, DOI 10.1001/jama.2009.1259; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Harish BN, 2011, INDIAN J MED MICROBI, V29, P223, DOI 10.4103/0255-0857.83904; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Lee N, 1998, J IMMUNOL, V160, P4951; LEVINE MM, 1989, PEDIATR INFECT DIS J, V8, P374, DOI 10.1097/00006454-198906000-00010; Lynch MF, 2009, JAMA-J AM MED ASSOC, V302, P859, DOI 10.1001/jama.2009.1229; Marques JM, 2011, IMMUNOBIOLOGY; Mirza SH, 1996, J MED MICROBIOL, V44, P317, DOI 10.1099/00222615-44-5-317; Nigam P, 2011, J IMMUNOL, V186, P745, DOI 10.4049/jimmunol.1002807; Qian Y, 2010, CYTOM PART B-CLIN CY, V78B, pS69, DOI 10.1002/cyto.b.20554; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Salerno-Goncalves R, 2002, J IMMUNOL, V169, P2196, DOI 10.4049/jimmunol.169.4.2196; Salerno-Goncalves R, 2005, INFECT IMMUN, V73, P3521, DOI 10.1128/IAI.73.6.3521-3530.2005; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Salerno-Goncalves R, 2003, J IMMUNOL, V170, P2734, DOI 10.4049/jimmunol.170.5.2734; Salerno-Goncalves R, 2010, CLIN VACCINE IMMUNOL, V17, P1305, DOI 10.1128/CVI.00234-10; Salerno-Goncalves R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005879; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Sellge G, 2010, J IMMUNOL, V184, P2076, DOI 10.4049/jimmunol.0900978; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Sztein MB, 2007, CLIN INFECT DIS, V45, pS15, DOI 10.1086/518140; SZTEIN MB, 1994, J INFECT DIS, V170, P1508, DOI 10.1093/infdis/170.6.1508; SZTEIN MB, 1995, J IMMUNOL, V155, P3987; Wahid R, 2008, MUCOSAL IMMUNOL, V1, P389, DOI 10.1038/mi.2008.30; Wahid R, 2007, VACCINE, V25, P1416, DOI 10.1016/j.vaccine.2006.10.040; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818	41	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38408	10.1371/journal.pone.0038408	http://dx.doi.org/10.1371/journal.pone.0038408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679502	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343900037
J	Voorham, J; Haaijer-Ruskamp, FM; Wolffenbuttel, BHR; de Zeeuw, D; Stolk, RP; Denig, P				Voorham, Jaco; Haaijer-Ruskamp, Flora M.; Wolffenbuttel, Bruce H. R.; de Zeeuw, Dick; Stolk, Ronald P.; Denig, Petra			Differential Effects of Comorbidity on Antihypertensive and Glucose-Regulating Treatment in Diabetes Mellitus - A Cohort Study	PLOS ONE			English	Article							QUALITY-OF-CARE; TREATMENT INTENSIFICATION; TREATMENT DECISIONS; CLINICAL INERTIA; BLOOD-PRESSURE; HYPERTENSION; MANAGEMENT; THERAPY; IMPACT; BURDEN	Background: Comorbidity is often mentioned as interfering with "optimal" treatment decisions in diabetes care. It is suggested that diabetes-related comorbidity will increase adequate treatment, whereas diabetes-unrelated comorbidity may decrease this process of care. We hypothesized that these effects differ according to expected priority of the conditions. Methods: We evaluated the relationship between comorbidity and treatment intensification in a study of 11,248 type 2 diabetes patients using the GIANTT (Groningen Initiative to Analyse type 2 diabetes Treatment) database. We formed a cohort of patients with a systolic blood pressure >= 140 mmHg (6,820 hypertensive diabetics), and a cohort of patients with an HbA1c >= 7% (3,589 hyperglycemic diabetics) in 2007. We differentiated comorbidity by diabetes-related or unrelated conditions and by priority. High priority conditions include conditions that are life-interfering, incident or requiring new medication treatment. We performed Cox regression analyses to assess association with treatment intensification, defined as dose increase, start, or addition of drugs. Results: In both the hypertensive and hyperglycemic cohort, only patients with incident diabetes-related comorbidity had a higher chance of treatment intensification (HR 4.48, 2.33-8.62 (p<0.001) for hypertensives; HR 2.37, 1.09-5.17 (p = 0.030) for hyperglycemics). Intensification of hypertension treatment was less likely when a new glucose-regulating drug was prescribed (HR 0.24, 0.06-0.97 (p = 0.046)). None of the prevalent or unrelated comorbidity was significantly associated with treatment intensification. Conclusions: Diabetes-related comorbidity induced better risk factor treatment only for incident cases, implying that appropriate care is provided more often when complications occur. Diabetes-unrelated comorbidity did not affect hypertension or hyperglycemia management, even when it was incident or life-interfering. Thus, the observed "undertreatment" in diabetes care cannot be explained by constraints caused by such comorbidity.	[Voorham, Jaco; Haaijer-Ruskamp, Flora M.; de Zeeuw, Dick; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Dept Clin Pharmacol, Groningen, Netherlands; [Voorham, Jaco; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Dept Epidemiol, Groningen, Netherlands; [Voorham, Jaco; Haaijer-Ruskamp, Flora M.; de Zeeuw, Dick; Stolk, Ronald P.; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Hlth Res, Groningen, Netherlands; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Fac Med Sci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Voorham, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Dept Clin Pharmacol, Groningen, Netherlands.	j.voorham@umcg.nl	Stolk, Ronald P/B-2341-2013; Wolffenbuttel, Bruce/A-8419-2011; Denig, Petra/L-9865-2014; de Zeeuw, Dick/E-9080-2014	Stolk, Ronald P/0000-0002-0518-1205; Wolffenbuttel, Bruce/0000-0001-9262-6921; Denig, Petra/0000-0002-7929-4739; de Zeeuw, Dick/0000-0003-3434-7777; Voorham, Jaco/0000-0001-9002-1865	Graduate School for Health Research, University of Groningen, The Netherlands	Graduate School for Health Research, University of Groningen, The Netherlands(Netherlands Government)	Funding for this research was obtained from the Graduate School for Health Research, University of Groningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolen SD, 2008, J GEN INTERN MED, V23, P543, DOI 10.1007/s11606-008-0507-2; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Caughey GE, 2010, DIABETES RES CLIN PR, V87, P385, DOI 10.1016/j.diabres.2009.10.019; Cayea D, 2007, DRUG AGING, V24, P851, DOI 10.2165/00002512-200724100-00005; Chaudhry SI, 2005, J AM GERIATR SOC, V53, P1214, DOI 10.1111/j.1532-5415.2005.53370.x; Conwell LJ, 2008, POPUL HEALTH MANAG, V11, P217, DOI 10.1089/pop.2007.0017; Grant RW, 2002, AM J MED, V112, P603, DOI 10.1016/S0002-9343(02)01103-8; Halanych JH, 2007, DIABETES CARE, V30, P2999, DOI 10.2337/dc06-1836; Hicks PC, 2006, DIABETES CARE, V29, P2580, DOI 10.2337/dc06-1124; Kerr EA, 2008, ANN INTERN MED, V148, P717, DOI 10.7326/0003-4819-148-10-200805200-00004; Kerr EA, 2007, J GEN INTERN MED, V22, P1635, DOI 10.1007/s11606-007-0313-2; Krein SL, 2009, J GEN INTERN MED, V24, P911, DOI 10.1007/s11606-009-1020-y; Lagu T, 2008, J GEN INTERN MED, V23, P1208, DOI 10.1007/s11606-008-0647-4; Lamberts H., 1987, ICPC INT CLASSIFICAT; Parchman ML, 2007, ANN FAM MED, V5, P196, DOI 10.1370/afm.679; Parchman ML, 2006, ANN FAM MED, V4, P40, DOI 10.1370/afm.422; Parnes BL, 2004, DIABETES CARE, V27, P13, DOI 10.2337/diacare.27.1.13; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Rodondi N, 2006, ANN INTERN MED, V144, P475, DOI 10.7326/0003-4819-144-7-200604040-00006; Safford MM, 2007, J GEN INTERN MED, V22, P1648, DOI 10.1007/s11606-007-0433-8; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Sidorenkov G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024278; Turchin A, 2008, CIRCULATION, V117, P623, DOI 10.1161/CIRCULATIONAHA.107.733949; Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002; Vitry AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014024; Voorham J, 2010, QUAL SAF HEALTH CARE, V19, P411, DOI 10.1136/qshc.2008.030106; Voorham J, 2008, DIABETES CARE, V31, P501, DOI 10.2337/dc07-1043; Voorham J, 2007, J AM MED INFORM ASSN, V14, P349, DOI 10.1197/jamia.M2128; Voorham J, 2010, PHARMACOEPIDEM DR S, V19, P1078, DOI 10.1002/pds.2023; Wang PS, 2005, HYPERTENSION, V46, P273, DOI 10.1161/01.HYP.0000172753.96583.e1; WHO Collaborating Centre for Drug Statistics Methodology, 2010, GUID ATC CLASS DDD A; Woodard LD, 2011, MED CARE, V49, P605, DOI 10.1097/MLR.0b013e31820f0ed0	32	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38707	10.1371/journal.pone.0038707	http://dx.doi.org/10.1371/journal.pone.0038707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679516	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900064
J	Cencini, M; Pigolotti, S; Munoz, MA				Cencini, Massimo; Pigolotti, Simone; Munoz, Miguel A.			What Ecological Factors Shape Species-Area Curves in Neutral Models?	PLOS ONE			English	Article							SPATIAL MODELS; SPECIATION; PATTERNS; BIOGEOGRAPHY	Understanding factors that shape biodiversity and species coexistence across scales is of utmost importance in ecology, both theoretically and for conservation policies. Species-area relationships (SARs), measuring how the number of observed species increases upon enlarging the sampled area, constitute a convenient tool for quantifying the spatial structure of biodiversity. While general features of species-area curves are quite universal across ecosystems, some quantitative aspects can change significantly. Several attempts have been made to link these variations to ecological forces. Within the framework of spatially explicit neutral models, here we scrutinize the effect of varying the local population size (i.e. the number of individuals per site) and the level of habitat saturation (allowing for empty sites). We conclude that species-area curves become shallower when the local population size increases, while habitat saturation, unless strongly violated, plays a marginal role. Our findings provide a plausible explanation of why SARs for microorganisms are flatter than those for larger organisms.	[Cencini, Massimo] CNR, Ist Sistemi Complessi, Rome, Italy; [Pigolotti, Simone] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain; [Munoz, Miguel A.] Univ Granada, Inst Carlos I Fsica Teor & Computac, Fac Ciencias, Granada, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Universitat Politecnica de Catalunya; University of Granada	Cencini, M (corresponding author), CNR, Ist Sistemi Complessi, Rome, Italy.	mamunoz@onsager.ugr.es	Munoz, Miguel A/J-9627-2012; Cencini, Massimo/C-1191-2008; Pigolotti, Simone/AAU-2395-2021; MUÑOZ, MIGUEL A/M-4099-2015	Munoz, Miguel A/0000-0002-0529-6221; Cencini, Massimo/0000-0001-7073-5000; Pigolotti, Simone/0000-0002-6157-6906; MUÑOZ, MIGUEL A/0000-0003-0152-9080	Spanish MICINN [FIS2009-08451]; Junta de Andalucia, Proyecto de Excelencia [P09-FQM4682]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia, Proyecto de Excelencia(Junta de Andalucia)	This work was supported by Spanish MICINN project FIS2009-08451 and Junta de Andalucia, Proyecto de Excelencia P09-FQM4682. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bramson M, 1996, ANN PROBAB, V24, P1727; Brose U, 2004, NATURE, V428, P167, DOI 10.1038/nature02297; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Durrett R, 1996, J THEOR BIOL, V179, P119, DOI 10.1006/jtbi.1996.0053; Durrett R, 2008, PROBAB APPL SER, P1, DOI 10.1007/978-0-387-78168-6_1; Etienne RS, 2007, J THEOR BIOL, V248, P522, DOI 10.1016/j.jtbi.2007.06.010; Etienne RS, 2007, OIKOS, V116, P241, DOI [10.1111/j.2007.0030-1299.15438.x, 10.1111/j.0030-1299.2007.15438.x]; Etienne RS, 2011, THEOR ECOL-NETH, V4, P87, DOI 10.1007/s12080-010-0076-y; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fenchel T, 2003, SCIENCE, V301, P925, DOI 10.1126/science.1089242; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gillespie J. H., 2004, POPULATION GENETICS; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; HOLLEY RA, 1975, ANN PROBAB, V3, P643, DOI 10.1214/aop/1176996306; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hubbell Stephen P., 2001, V32, pi; Kimura M., 1953, ANNU REP NAT I GENET, V3, P62; Kopp M, 2010, BIOESSAYS, V32, P564, DOI 10.1002/bies.201000023; Lomolino MV, 2001, PROG PHYS GEOG, V25, P1; Marro J., 1999, NONEQUILIBRIUM PHASE, DOI 10.1017/CBO9780511524288; MARTINS ML, 1991, PHYS REV LETT, V66, P2045, DOI 10.1103/PhysRevLett.66.2045; O'Dwyer JP, 2010, ECOL LETT, V13, P87, DOI 10.1111/j.1461-0248.2009.01404.x; Pigolotti S, 2009, J THEOR BIOL, V260, P83, DOI 10.1016/j.jtbi.2009.05.023; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosindell J, 2008, ECOL INFORM, V3, P259, DOI 10.1016/j.ecoinf.2008.05.001; Rosindell J, 2007, ECOL LETT, V10, P586, DOI 10.1111/j.1461-0248.2007.01050.x; Rosindell J, 2010, ECOL LETT, V13, P716, DOI 10.1111/j.1461-0248.2010.01463.x; Rosindell J, 2009, ECOLOGY, V90, P1743, DOI 10.1890/08-0661.1; Schoener T.W., 1976, P 16 INT ORNITHOLOGI, V1, P629, DOI DOI 10.1111/J.1474-919X.1905.TB07792.X; Tilman D., 1982, Monographs in Population Biology, pi; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Vanpeteghem D, 2010, J MATH BIOL, V61, P323, DOI 10.1007/s00285-009-0303-6; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Warren PB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051922; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woodcock S, 2006, ECOL LETT, V9, P805, DOI 10.1111/j.1461-0248.2006.00929.x; Zillio T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098101	47	17	17	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38232	10.1371/journal.pone.0038232	http://dx.doi.org/10.1371/journal.pone.0038232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675526	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700048
J	Denoyer, A; Godefroy, D; Celerier, I; Frugier, J; Degardin, J; Harrison, JK; Brignole-Baudouin, F; Picaud, S; Baleux, F; Sahel, JA; Rostene, W; Baudouin, C				Denoyer, Alexandre; Godefroy, David; Celerier, Isabelle; Frugier, Julie; Degardin, Julie; Harrison, Jeffrey K.; Brignole-Baudouin, Francoise; Picaud, Serge; Baleux, Francoise; Sahel, Jose A.; Rostene, William; Baudouin, Christophe			CXCR3 Antagonism of SDF-1(5-67) Restores Trabecular Function and Prevents Retinal Neurodegeneration in a Rat Model of Ocular Hypertension	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CENTRAL-NERVOUS-SYSTEM; MESHWORK CELLS; AQUEOUS-HUMOR; CHEMOKINE RECEPTOR; IN-VITRO; EXTRACELLULAR-MATRIX; T-LYMPHOCYTES; SDF-1; EXPRESSION	Glaucoma, the most common cause of irreversible blindness, is a neuropathy commonly initiated by pathological ocular hypertension due to unknown mechanisms of trabecular meshwork degeneration. Current antiglaucoma therapy does not target the causal trabecular pathology, which may explain why treatment failure is often observed. Here we show that the chemokine CXCL12, its truncated form SDF-1(5-67), and the receptors CXCR4 and CXCR3 are expressed in human glaucomatous trabecular tissue and a human trabecular cell line. SDF-1(5-67) is produced under the control of matrix metallo-proteinases, TNF-alpha, and TGF-beta 2, factors known to be involved in glaucoma. CXCL12 protects in vitro trabecular cells from apoptotic death via CXCR4 whereas SDF-1(5-67) induces apoptosis through CXCR3 and caspase activation. Ocular administration of SDF-1(5-67) in the rat increases intraocular pressure. In contrast, administration of a selective CXCR3 antagonist in a rat model of ocular hypertension decreases intraocular pressure, prevents retinal neurodegeneration, and preserves visual function. The protective effect of CXCR3 antagonism is related to restoration of the trabecular function. These data demonstrate that proteolytic cleavage of CXCL12 is involved in trabecular pathophysiology, and that local administration of a selective CXCR3 antagonist may be a beneficial therapeutic strategy for treating ocular hypertension and subsequent retinal degeneration.	[Denoyer, Alexandre; Godefroy, David; Frugier, Julie; Degardin, Julie; Brignole-Baudouin, Francoise; Picaud, Serge; Sahel, Jose A.; Rostene, William; Baudouin, Christophe] Univ Paris 06, UPMC, Inst Vis, UMRS968, Paris, France; [Denoyer, Alexandre; Godefroy, David; Frugier, Julie; Degardin, Julie; Brignole-Baudouin, Francoise; Picaud, Serge; Sahel, Jose A.; Rostene, William; Baudouin, Christophe] INSERM, U968, Paris, France; [Denoyer, Alexandre; Godefroy, David; Frugier, Julie; Degardin, Julie; Brignole-Baudouin, Francoise; Picaud, Serge; Sahel, Jose A.; Rostene, William; Baudouin, Christophe] CNRS, U7210, Paris, France; [Denoyer, Alexandre; Sahel, Jose A.; Baudouin, Christophe] Quinze Vingts Natl Ophthalmol Hosp, Paris, France; [Celerier, Isabelle] INSERM, Ctr Rech Cordeliers, Team 1, U872, Paris, France; [Harrison, Jeffrey K.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Brignole-Baudouin, Francoise] Univ Paris 05, Fac Biol & Pharmacol Sci, Dept Toxicol, Paris, France; [Baleux, Francoise] Inst Pasteur, CNRS 2128, Unite Chim Biomol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; State University System of Florida; University of Florida; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Denoyer, A (corresponding author), Univ Paris 06, UPMC, Inst Vis, UMRS968, Paris, France.	alexandre.denoyer@gmail.com	Sahel, Jose-Alain/F-3172-2017; DENOYER, Alexandre/AAS-6605-2021; Rostene, William/F-2754-2017; Picaud, Serge/H-4012-2014	Sahel, Jose-Alain/0000-0002-4831-1153; Picaud, Serge/0000-0002-0548-5145; Baudouin, Christophe/0000-0003-1743-6698; BRIGNOLE-BAUDOUIN, FRANCOISE/0000-0002-2006-5384; ROSTENE, WILLIAM/0000-0003-0409-5361; Godefroy, David/0000-0003-4706-2711; DENOYER, Alexandre/0000-0003-4730-0425	INSERM; UPMC; NIH [AI058256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058256] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by INSERM grants for AD, DG, JD, WR and CB, by a UPMC grant for IC and JF, and by an NIH grant for JKH (AI058256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Baleriola J, 2008, MOL VIS, V14, P1513; Barbieri F, 2006, ANN NY ACAD SCI, V1090, P332, DOI 10.1196/annals.1378.037; Bhutto IA, 2006, BRIT J OPHTHALMOL, V90, P906, DOI 10.1136/bjo.2006.090357; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Bourcier T, 2003, MOL VIS, V9, P96; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cedrone C, 2008, PROG BRAIN RES, V173, P3, DOI 10.1016/S0079-6123(08)01101-1; Crane IJ, 2000, J IMMUNOL, V165, P4372, DOI 10.4049/jimmunol.165.8.4372; Curnow SJ, 2004, J IMMUNOL, V172, P7154, DOI 10.4049/jimmunol.172.11.7154; Danias J, 2006, EXP EYE RES, V82, P219, DOI 10.1016/j.exer.2005.06.013; Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P642; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; GRIERSON I, 1987, EYE, V1, P204, DOI 10.1038/eye.1987.38; Hamard P, 2003, GRAEF ARCH CLIN EXP, V241, P1037, DOI 10.1007/s00417-003-0777-7; Hamard P, 2002, BRIT J OPHTHALMOL, V86, P1046, DOI 10.1136/bjo.86.9.1046; Heise CE, 2005, J PHARMACOL EXP THER, V313, P1263, DOI 10.1124/jpet.105.083683; HERNANDEZ MR, 1987, INVEST OPHTH VIS SCI, V28, P1655; JONES RF, 1966, EXP EYE RES, V5, P208, DOI 10.1016/S0014-4835(66)80009-X; Jopling LA, 2007, BRIT J PHARMACOL, V152, P1260, DOI 10.1038/sj.bjp.0707519; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Liu C, 2011, CARCINOGENESIS, V32, P129, DOI 10.1093/carcin/bgq224; Lu Z, 2008, EXP EYE RES, V86, P271, DOI 10.1016/j.exer.2007.10.018; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; MEDINA J, 2004, 29 NAT MED CHEM S; Morrison JC, 2011, EXP EYE RES, V93, P156, DOI 10.1016/j.exer.2010.08.005; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nissirios N, 2008, INVEST OPHTH VIS SCI, V49, P2478, DOI 10.1167/iovs.07-0965; PANG IH, 1994, CURR EYE RES, V13, P51, DOI 10.3109/02713689409042398; Pujol F, 2005, J CELL SCI, V118, P1071, DOI 10.1242/jcs.01694; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROHEN JW, 1993, EXP EYE RES, V56, P683, DOI 10.1006/exer.1993.1085; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Sawada H, 2010, INVEST OPHTH VIS SCI, V51, P903, DOI 10.1167/iovs.09-4247; SHERWOOD ME, 1988, EXP EYE RES, V46, P881, DOI 10.1016/S0014-4835(88)80040-X; Shifera AS, 2010, EXP EYE RES, V91, P42, DOI 10.1016/j.exer.2010.04.001; SOMMER A, 1989, AM J OPHTHALMOL, V107, P186, DOI 10.1016/0002-9394(89)90221-3; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Thomas BB, 2004, J NEUROSCI METH, V138, P7, DOI 10.1016/j.jneumeth.2004.03.007; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; Van Wanrooij EJA, 2008, ARTERIOSCL THROM VAS, V28, P251, DOI 10.1161/ATVBAHA.107.147827; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; Verzijl D, 2008, J PHARMACOL EXP THER, V325, P544, DOI 10.1124/jpet.107.134783; YABLONSKI ME, 1978, EXP EYE RES, V27, P135, DOI 10.1016/0014-4835(78)90083-0; Yu SY, 2006, EXP EYE RES, V83, P758, DOI 10.1016/j.exer.2006.03.014; Zhang H, 2011, J NEUROSCI, V9, P143; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127; Zhang YY, 2009, EXP EYE RES, V89, P748, DOI 10.1016/j.exer.2009.06.015; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819	62	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37873	10.1371/journal.pone.0037873	http://dx.doi.org/10.1371/journal.pone.0037873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675496	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700025
J	Klingseisen, L; Ehrenschwender, M; Heigl, U; Wajant, H; Hehlgans, T; Schutze, S; Schneider-Brachert, W				Klingseisen, Laura; Ehrenschwender, Martin; Heigl, Ulrike; Wajant, Harald; Hehlgans, Thomas; Schuetze, Stefan; Schneider-Brachert, Wulf			E3-14.7K Is Recruited to TNF-Receptor 1 and Blocks TNF Cytolysis Independent from Interaction with Optineurin	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; E3 14.7-KILODALTON PROTEIN; MYOSIN-VI; APOPTOSIS; CELLS; COMPARTMENTALIZATION; INHIBITOR; BINDING; 14.7K	Escape from the host immune system is essential for intracellular pathogens. The adenoviral protein E3-14.7K (14.7K) is known as a general inhibitor of tumor necrosis factor (TNF)-induced apoptosis. It efficiently blocks TNF-receptor 1 (TNFR1) internalization but the underlying molecular mechanism still remains elusive. Direct interaction of 14.7K and/or associated proteins with the TNFR1 complex has been discussed although to date not proven. In our study, we provide for the first time evidence for recruitment of 14.7K and the 14.7K interacting protein optineurin to TNFR1. Various functions have been implicated for optineurin such as regulation of receptor endocytosis, vesicle trafficking, regulation of the nuclear factor kappa B (NF-kappa B) pathway and antiviral signaling. We therefore hypothesized that binding of optineurin to 14.7K and recruitment of both proteins to the TNFR1 complex is essential for protection against TNF-induced cytotoxic effects. To precisely dissect the individual role of 14.7K and optineurin, we generated and characterized a 14.7K mutant that does not confer TNF-resistance but is still able to interact with optineurin. In H1299 and KB cells expressing 14.7K wild-type protein, neither decrease in cell viability nor cleavage of caspases was observed upon stimulation with TNF. In sharp contrast, cells expressing the non-protective mutant of 14.7K displayed reduced viability and cleavage of initiator and effector caspases upon TNF treatment, indicating ongoing apoptotic cell death. Knockdown of optineurin in 14.7K expressing cells did not alter the protective effect as measured by cell viability and caspase activation. Taken together, we conclude that optineurin despite its substantial role in vesicular trafficking, endocytosis of cell surface receptors and recruitment to the TNFR1 complex is dispensable for the 14.7K-mediated protection against TNF-induced apoptosis.	[Klingseisen, Laura; Ehrenschwender, Martin; Heigl, Ulrike; Schneider-Brachert, Wulf] Univ Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany; [Wajant, Harald] Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, Wurzburg, Germany; [Hehlgans, Thomas] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Schuetze, Stefan] Univ Kiel, Inst Immunol, Kiel, Germany	University of Regensburg; University of Wurzburg; University of Regensburg; University of Kiel	Klingseisen, L (corresponding author), Univ Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany.	wulf.schneider@klinik.uni-regensburg.de	Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949; Ehrenschwender, Martin/0000-0003-4681-8628	Deutsche Forschungsgemeinschaft (DFG) [HE3116/8, PDFG-SFB 877, SCHN697/3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Supported by grants of the Deutsche Forschungsgemeinschaft (DFG) HE3116/8 to TH, PDFG-SFB 877 project B1 to SS, and SCHN697/3 to WSB. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond LM, 2011, MOL BIOL CELL, V22, P54, DOI 10.1091/mbc.E10-06-0553; Burgert HG, 2000, VIRUS GENES, V21, P13, DOI 10.1023/A:1008135928310; GOODING LR, 1990, J IMMUNOL, V145, P3080; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HORTON TM, 1991, J VIROL, V65, P2629, DOI 10.1128/JVI.65.5.2629-2639.1991; Horwitz MS, 2004, J GENE MED, V6, pS172, DOI 10.1002/jgm.495; Kim HJ, 2002, PROTEIN SCI, V11, P1117, DOI 10.1110/ps.4180102; Li HY, 2011, MOL VIS, V17, P3314; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MOSSELMANS R, 1988, J IMMUNOL, V141, P3096; Mrowka R, 2008, FEBS J, V275, P3178, DOI 10.1111/j.1742-4658.2008.06471.x; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; RANHEIM TS, 1993, J VIROL, V67, P2159, DOI 10.1128/JVI.67.4.2159-2167.1993; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Swarup G, 2010, J BIOSCIENCES, V35, P501, DOI 10.1007/s12038-010-0056-9; WONG GHW, 1992, J IMMUNOL, V149, P3350; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041; ZILLI D, 1992, BIOCHEM BIOPH RES CO, V188, P177, DOI 10.1016/0006-291X(92)92366-6	24	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38348	10.1371/journal.pone.0038348	http://dx.doi.org/10.1371/journal.pone.0038348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675546	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700061
J	Godefroit, P; Bolotsky, YL; Lauters, P				Godefroit, Pascal; Bolotsky, Yuri L.; Lauters, Pascaline			A New Saurolophine Dinosaur from the Latest Cretaceous of Far Eastern Russia	PLOS ONE			English	Article							LAMBEOSAURINE DINOSAUR; HADROSAURIDAE; ORIGIN	Background: Four main dinosaur sites have been investigated in latest Cretaceous deposits from the Amur/Heilongjiang Region: Jiayin and Wulaga in China (Yuliangze Formation), Blagoveschensk and Kundur in Russia (Udurchukan Formation). More than 90% of the bones discovered in these localities belong to hollow-crested lambeosaurine saurolophids, but flat-headed saurolophines are also represented: Kerberosaurus manakini at Blagoveschensk and Wulagasaurus dongi at Wulaga. Methodology/Principal Findings: Herein we describe a new saurolophine dinosaur, Kundurosaurus nagornyi gen. et sp. nov., from the Udurchukan Formation (Maastrichtian) of Kundur, represented by disarticulated cranial and postcranial material. This new taxon is diagnosed by four autapomorphies. Conclusions/Significance: A phylogenetic analysis of saurolophines indicates that Kundurosaurus nagornyi is nested within a rather robust clade including Edmontosaurus spp., Saurolophus spp., and Prosaurolophus maximus, possibly as a sister-taxon for Kerberosaurus manakini also from the Udurchukan Formation of Far Eastern Russia. The high diversity and mosaic distribution of Maastrichtian hadrosaurid faunas in the Amur-Heilongjiang region are the result of a complex palaeogeographical history and imply that many independent hadrosaurid lineages dispersed without any problem between western America and eastern Asia at the end of the Cretaceous.	[Godefroit, Pascal; Lauters, Pascaline] Inst Royal Sci Nat Belgique, Dept Palaeontol, B-1040 Brussels, Belgium; [Bolotsky, Yuri L.] Russian Acad Sci, Inst Geol & Nat Management, Far Eastern Branch, Blagoveshchensk, Russia; [Lauters, Pascaline] Univ Libre Bruxelles, Sect Anthropol, Brussels, Belgium	Institute of Geology & Nature Management FEB RAS; Russian Academy of Sciences; Universite Libre de Bruxelles	Godefroit, P (corresponding author), Inst Royal Sci Nat Belgique, Dept Palaeontol, B-1040 Brussels, Belgium.	Pascal.Godefroit@naturalsciences.be	Lauters, Pascaline/AAJ-8493-2020		Federal Scientific Policy of the Belgian state (S&T bilateral cooperation program) [BL/36/C22 - R12]; Russian Foundation of Basic Research [07-05-00168]; Far Eastern Branch of Russian Academy of Sciences [06-III-A-06-477]; Fonds pour la Formation la Recherche dans l'Industrie et dans l'Agriculture (FRIA)	Federal Scientific Policy of the Belgian state (S&T bilateral cooperation program); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Far Eastern Branch of Russian Academy of Sciences(Russian Academy of Sciences); Fonds pour la Formation la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	Excavation, preparation, and study of the specimen were supported by grants from the Federal Scientific Policy of the Belgian state (S&T bilateral cooperation program BL/36/C22 - R12), from the Russian Foundation of Basic Research (07-05-00168), and from the Far Eastern Branch of Russian Academy of Sciences (06-III-A-06-477). The excavations at Kundur were also supported, from a logistic point of view, by the gold-mining company Pakrovskiy Rudnik. PL's research was supported by a grant from the Fonds pour la Formation la Recherche dans l'Industrie et dans l'Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifanov VR, 2002, CRETACEOUS CONTINENT, P25; Averianov A. O., 2002, CRETACEOUS CONTINENT, P27; Bell PR, 2011, ACTA PALAEONTOL POL, V56, P703, DOI 10.4202/app.2010.0061; Bolotsky YL, 2004, J VERTEBR PALEONTOL, V24, P351, DOI 10.1671/1110; Brett-Surman M.K., 1989, REVISION HADROSAURID, P1; Brown B, 1914, B AM MUS NAT HIST, V33, P559; Brown B, 1913, B AM MUS NAT HIST, V32, P395; Danilov I. G., 2002, Russian Journal of Herpetology, V9, P155; Fiorillo AR, 2008, GEOL SOC AM SPEC PAP, V442, P313, DOI 10.1130/2008.442(15); Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit P, 2000, CR ACAD SCI II A, V330, P875, DOI 10.1016/S1251-8050(00)00214-7; Godefroit P, 2003, C R PALEVOL, V2, P143, DOI 10.1016/S1631-0683(03)00017-4; Godefroit Pascal, 2001, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V71, P119; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Godefroit P, 2012, ACTA PALAEONTOL POL, V57, P527, DOI 10.4202/app.2011.0051; Godefroit P, 2009, NATURWISSENSCHAFTEN, V96, P495, DOI 10.1007/s00114-008-0499-0; Goloboff PA, TNT TREE ANAL USING; Hopson J.A., 1979, P39; HOPSON J A, 1975, Paleobiology, V1, P21; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; LAMBE LM, 1920, MEMOIRS CANADIAN GEO, V120, P1; Langston W., 1960, Fieldiana Geology Memoir, V3, P313; Lauters P, 2008, PALAIOS, V23, P153, DOI 10.2110/palo.2006.p06-031r; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Markevich V.S., 2001, FLORA DINOZAVRY GRAN, P79; MARYANSKA T, 1979, LETHAIA, V12, P265, DOI 10.1111/j.1502-3931.1979.tb01006.x; Nichols DJ, 2008, PLANTS AND THE K-T BOUNDARY, P1, DOI 10.1017/CBO9780511535536; Nichols DJ, 2004, MESOZOIC SYSTEMS ROC, P503; NICHOLS DJ, 1993, GEOLOGICAL ASS CANAD, V39, P539; Nixon K.C., 2002, WINCLADA VER 1 00 08; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Parks W.A., 1919, T ROY SOC CAN SECT 3, V13, P51; Pinna G., 1979, MEM SOC ITAL SCI NAT, V22, P33; Prieto-Marquez A, 2005, J VERTEBR PALEONTOL, V25, P144, DOI 10.1671/0272-4634(2005)025[0144:NIOTCO]2.0.CO;2; Prieto-Marquez A., 2010, ZOOLOGICAL J LINNEAN, V159, P135; Prieto-Marquez Albert, 2007, P91; Riabinin A.N., 1930, MEMOIRES SOC PALEONT, V2, P1; Rozhdestvensky AK, 1966, PALEONTOL ZH, V1966, P103; Rozhdestvensky AK, 1968, UPPER PALEOZOIC MESO, P97; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Tumanova TA, 2004, PALEONTOL J+, V38, P73; Van Itterbeeck J, 2005, GEOL MAG, V142, P735, DOI 10.1017/S0016756805001226; Wagner J.R., 2001, THESIS TEXAS TECH U; Wu W, 2010, GLOBAL GEOLOGY, V29, P1	47	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36849	10.1371/journal.pone.0036849	http://dx.doi.org/10.1371/journal.pone.0036849			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666331	gold, Green Published			2022-12-27	WOS:000305353400014
J	Lim, YM; Hayashi, S; Tsuda, L				Lim, Young-Mi; Hayashi, Shigeo; Tsuda, Leo			Ebi/AP-1 Suppresses Pro-Apoptotic Genes Expression and Permits Long-Term Survival of Drosophila Sensory Neurons	PLOS ONE			English	Article							OXIDATIVE STRESS; HEARING-LOSS; CELL-DEATH; TRANSCRIPTION FACTOR; COREPRESSOR COMPLEX; DEGENERATION; ACTIVATION; REPRESSION; ANGIOGENESIS; CHECKPOINT	Sensory organs are constantly exposed to physical and chemical stresses that collectively threaten the survival of sensory neurons. Failure to protect stressed neurons leads to age-related loss of neurons and sensory dysfunction in organs in which the supply of new sensory neurons is limited, such as the human auditory system. Transducin beta-like protein 1 (TBL1) is a candidate gene for ocular albinism with late-onset sensorineural deafness, a form of X-linked age-related hearing loss. TBL1 encodes an evolutionarily conserved F-box-like and WD40 repeats-containing subunit of the nuclear receptor co-repressor/silencing mediator for retinoid and thyroid hormone receptor and other transcriptional co-repressor complexes. Here we report that a Drosophila homologue of TBL1, Ebi, is required for maintenance of photoreceptor neurons. Loss of ebi function caused late-onset neuronal apoptosis in the retina and increased sensitivity to oxidative stress. Ebi formed a complex with activator protein 1 (AP-1) and was required for repression of Drosophila pro-apoptotic and anti-apoptotic genes expression. These results suggest that Ebi/AP-1 suppresses basal transcription levels of apoptotic genes and thereby protects sensory neurons from degeneration.	[Lim, Young-Mi; Tsuda, Leo] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan; [Hayashi, Shigeo] RIKEN, Ctr Dev Biol, Lab Morphogenet Signaling, Chuo Ku, Kobe, Hyogo, Japan; [Hayashi, Shigeo] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan	National Center for Geriatrics & Gerontology; RIKEN; Kobe University	Lim, YM (corresponding author), Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan.	ltsuda@ncgg.go.jp	Hayashi, Shigeo/J-9628-2019; Hayashi, Shigeo/N-5128-2015	Hayashi, Shigeo/0000-0001-7785-1290; Hayashi, Shigeo/0000-0001-7785-1290	Ministry of Education and Scientific Research for Priority Areas in Japan	Ministry of Education and Scientific Research for Priority Areas in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been funded by a Grant-in-Aid from the Ministry of Education and Scientific Research for Priority Areas in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Bassi MT, 1999, AM J HUM GENET, V64, P1604, DOI 10.1086/302408; Cerna D, 2005, J MOL BIOL, V351, P923, DOI 10.1016/j.jmb.2005.06.025; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Guenther MG, 2000, GENE DEV, V14, P1048; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hilfiker-Kleiner D, 2005, CIRCULATION, V112, P1470, DOI 10.1161/CIRCULATIONAHA.104.518472; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lambert C, 2003, APOPTOSIS, V8, P551, DOI 10.1023/A:1026113222478; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ogita K, 2000, NEUROREPORT, V11, P859, DOI 10.1097/00001756-200003200-00040; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; PERKINS KK, 1988, EMBO J, V7, P4265, DOI 10.1002/j.1460-2075.1988.tb03324.x; Riva C, 2007, EXP GERONTOL, V42, P327, DOI 10.1016/j.exger.2006.10.014; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Suganuma T, 2010, CELL, V142, P726, DOI 10.1016/j.cell.2010.07.045; Tanaka-Matakatsu M, 2009, DEV BIOL, V326, P347, DOI 10.1016/j.ydbio.2008.11.035; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; Tsuda L, 2006, EMBO J, V25, P3191, DOI 10.1038/sj.emboj.7601179; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Xiang L, 2011, AGING-US, V3, P1098, DOI 10.18632/aging.100396; Zhu DH, 2009, J BIOL CHEM, V284, P9529, DOI 10.1074/jbc.M809393200; Zine A, 2004, CNS NEUROL DISORD-DR, V3, P325, DOI 10.2174/1568007043337166	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37028	10.1371/journal.pone.0037028	http://dx.doi.org/10.1371/journal.pone.0037028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666340	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400020
J	Sterner, KN; Weckle, A; Chugani, HT; Tarca, AL; Sherwood, CC; Hof, PR; Kuzawa, CW; Boddy, AM; Abbas, A; Raaum, RL; Gregoire, L; Lipovich, L; Grossman, LI; Uddin, M; Goodman, M; Wildman, DE				Sterner, Kirstin N.; Weckle, Amy; Chugani, Harry T.; Tarca, Adi L.; Sherwood, Chet C.; Hof, Patrick R.; Kuzawa, Christopher W.; Boddy, Amy M.; Abbas, Asad; Raaum, Ryan L.; Gregoire, Lucie; Lipovich, Leonard; Grossman, Lawrence I.; Uddin, Monica; Goodman, Morris; Wildman, Derek E.			Dynamic Gene Expression in the Human Cerebral Cortex Distinguishes Children from Adults	PLOS ONE			English	Article							POSITRON EMISSION TOMOGRAPHY; MHC CLASS-I; HUMAN-BRAIN; NEURONAL PLASTICITY; PREFRONTAL CORTEX; CNS DEVELOPMENT; HUMAN GROWTH; PROBE LEVEL; HLA-E; EVOLUTION	In comparison with other primate species, humans have an extended juvenile period during which the brain is more plastic. In the current study we sought to examine gene expression in the cerebral cortex during development in the context of this adaptive plasticity. We introduce an approach designed to discriminate genes with variable as opposed to uniform patterns of gene expression and found that greater inter-individual variance is observed among children than among adults. For the 337 transcripts that show this pattern, we found a significant overrepresentation of genes annotated to the immune system process (pFDR congruent to 0). Moreover, genes known to be important in neuronal function, such as brain-derived neurotrophic factor (BDNF), are included among the genes more variably expressed in childhood. We propose that the developmental period of heightened childhood neuronal plasticity is characterized by more dynamic patterns of gene expression in the cerebral cortex compared to adulthood when the brain is less plastic. That an overabundance of these genes are annotated to the immune system suggests that the functions of these genes can be thought of not only in the context of antigen processing and presentation, but also in the context of nervous system development.	[Sterner, Kirstin N.; Weckle, Amy; Boddy, Amy M.; Abbas, Asad; Gregoire, Lucie; Lipovich, Leonard; Grossman, Lawrence I.; Uddin, Monica; Goodman, Morris; Wildman, Derek E.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [Chugani, Harry T.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Chugani, Harry T.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Sherwood, Chet C.] George Washington Univ, Dept Anthropol, Washington, DC USA; [Hof, Patrick R.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA; [Hof, Patrick R.] Mt Sinai Sch Med, Friedman Brian Inst, New York, NY USA; [Kuzawa, Christopher W.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Raaum, Ryan L.] CUNY Herbert H Lehman Coll, Dept Anthropol, Bronx, NY 10468 USA; [Raaum, Ryan L.] CUNY, Grad Ctr, Bronx, NY USA; [Goodman, Morris] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Wildman, Derek E.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; George Washington University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Northwestern University; City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System; Wayne State University; Wayne State University	Sterner, KN (corresponding author), Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA.	dwildman@genetics.wayne.edu	Raaum, Ryan L/B-4609-2008; Lipovich, Leonard/B-2355-2019	Raaum, Ryan L/0000-0003-4723-5475; Lipovich, Leonard/0000-0002-0531-3570; Sterner, Kirstin/0000-0001-8429-4533; Wildman, Derek/0000-0002-6374-5136	National Science Foundation [BCS0827546, BCS0827531]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation [grant numbers BCS0827546 and BCS0827531]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman J.M., 1999, EVOLVING BRAINS; [Anonymous], 2010, R LANG ENV STAT COMP; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Berlucchi G, 2009, EXP BRAIN RES, V192, P307, DOI 10.1007/s00221-008-1611-6; BLALOCK JE, 1984, J IMMUNOL, V132, P1067; BLALOCK JE, 1994, IMMUNOL TODAY, V15, P504, DOI 10.1016/0167-5699(94)90205-4; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonilla FA, 2010, J ALLERGY CLIN IMMUN, V125, pS33, DOI 10.1016/j.jaci.2009.09.017; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Fourgeaud L, 2010, P NATL ACAD SCI USA, V107, P22278, DOI 10.1073/pnas.0914064107; Galvan A, 2010, HUM BRAIN MAPP, V31, P879, DOI 10.1002/hbm.21029; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Glantz LA, 2007, NEUROSCIENCE, V149, P582, DOI 10.1016/j.neuroscience.2007.06.036; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Harris LW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-28; Haynes L, 2005, CURR OPIN IMMUNOL, V17, P476, DOI 10.1016/j.coi.2005.07.003; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACOBS B, 1995, CEREB CORTEX, V5, P222, DOI 10.1093/cercor/5.3.222; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; King A, 2000, EUR J IMMUNOL, V30, P1623, DOI 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kioussis D, 2009, IMMUNITY, V31, P705, DOI 10.1016/j.immuni.2009.09.009; Kren L, 2011, NEUROPATHOLOGY, V31, P129, DOI 10.1111/j.1440-1789.2010.01149.x; Leigh SR, 2001, EVOL ANTHROPOL, V10, P223, DOI 10.1002/evan.20002; Leigh SR, 1998, AM J PHYS ANTHROPOL, V107, P331; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; McAllister AK, 2009, NEURON, V64, P9, DOI 10.1016/j.neuron.2009.09.038; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Ribic A, 2010, CELL MOL NEUROBIOL, V30, P827, DOI 10.1007/s10571-010-9510-3; Rolleke U, 2006, J NEUROIMMUNOL, V176, P39, DOI 10.1016/j.jneuroim.2006.04.015; Sherwood CC, 2008, J ANAT, V212, P426, DOI 10.1111/j.1469-7580.2008.00868.x; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Sperling A, 1998, ENCY IMMUNOLOGY, P13; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; TOMASELLO M., 2001, CULTURAL ORIGINS HUM; Vitkovic L, 2000, MOL PSYCHIATR, V5, P604, DOI 10.1038/sj.mp.4000813; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015	54	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37714	10.1371/journal.pone.0037714	http://dx.doi.org/10.1371/journal.pone.0037714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666384	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400043
J	McCartney-Melstad, E; Waller, T; Micucci, PA; Barros, M; Draque, J; Amato, G; Mendez, M				McCartney-Melstad, Evan; Waller, Tomas; Micucci, Patricio A.; Barros, Mariano; Draque, Juan; Amato, George; Mendez, Martin			Population Structure and Gene Flow of the Yellow Anaconda (Eunectes notaeus) in Northern Argentina	PLOS ONE			English	Article							MALE-BIASED DISPERSAL; MITOCHONDRIAL-DNA; UNSAMPLED POPULATIONS; MIGRATION RATES; BOA-CONSTRICTOR; F-STATISTICS; SNAKE; DIFFERENTIATION; REGRESSION; SOFTWARE	Yellow anacondas (Eunectes notaeus) are large, semiaquatic boid snakes found in wetland systems in South America. These snakes are commercially harvested under a sustainable management plan in Argentina, so information regarding population structuring can be helpful for determination of management units. We evaluated genetic structure and migration using partial sequences from the mitochondrial control region and mitochondrial genes cyt-b and ND4 for 183 samples collected within northern Argentina. A group of landscape features and environmental variables including several treatments of temperature and precipitation were explored as potential drivers of observed genetic patterns. We found significant population structure between most putative population comparisons and bidirectional but asymmetric migration in several cases. The configuration of rivers and wetlands was found to be significantly associated with yellow anaconda population structure (IBD), and important for gene flow, although genetic distances were not significantly correlated with the environmental variables used here. More in-depth analyses of environmental data may be needed to fully understand the importance of environmental conditions on population structure and migration. These analyses indicate that our putative populations are demographically distinct and should be treated as such in Argentina's management plan for the harvesting of yellow anacondas.	[McCartney-Melstad, Evan] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [McCartney-Melstad, Evan; Amato, George] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Waller, Tomas; Micucci, Patricio A.; Barros, Mariano; Draque, Juan] Fdn Biodiversidad Argentina, Buenos Aires, DF, Argentina; [Mendez, Martin] Wildlife Conservat Soc, Bronx, NY USA	Columbia University; American Museum of Natural History (AMNH); Wildlife Conservation Society	McCartney-Melstad, E (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	mmendez@wcs.org	McCartney-Melstad, Evan/G-4860-2014	McCartney-Melstad, Evan/0000-0002-1803-1126	Office veterinaire federal of Switzerland; Yellow Anaconda Management Program; Alfred P. Sloan Foundation	Office veterinaire federal of Switzerland; Yellow Anaconda Management Program; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	The Office veterinaire federal of Switzerland and the Yellow Anaconda Management Program funded field work. The Alfred P. Sloan Foundation funded laboratory work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bates PD, 2000, J HYDROL, V236, P54, DOI 10.1016/S0022-1694(00)00278-X; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; BONETTO A A, 1989, Regulated Rivers Research and Management, V4, P333, DOI 10.1002/rrr.3450040402; Burkart R., 1999, ECOREGIONES ARGENTIN, P42; Cardozo G, 2008, BIOL CONSERV, V141, P3050, DOI 10.1016/j.biocon.2008.08.026; Cardozo Gabriela, 2007, P328; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; CRIST EP, 1984, IEEE T GEOSCI REMOTE, V22, P256, DOI 10.1109/TGRS.1984.350619; da Paz AR, 2011, HYDROL PROCESS, V25, P1498, DOI 10.1002/hyp.7926; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Douglas DA, 2006, ZOOL SCR, V35, P545, DOI 10.1111/j.1463-6409.2006.00257.x; Dubey S, 2008, MOL ECOL, V17, P3506, DOI 10.1111/j.1365-294X.2008.03859.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Goudet J, 1996, GENETICS, V144, P1933; Hellborg L, 2005, MOL ECOL, V14, P2025, DOI 10.1111/j.1365-294X.2005.02559.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Howes BJ, 2009, CONSERV GENET, V10, P407, DOI 10.1007/s10592-008-9607-0; Johnson BL, 1999, CONSERV ECOL, V3; Keogh JS, 2007, BIOL LETTERS, V3, P33, DOI 10.1098/rsbl.2006.0570; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Manier MK, 2005, MOL ECOL, V14, P3965, DOI 10.1111/j.1365-294X.2005.02734.x; MANTEL N, 1967, CANCER RES, V27, P209; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meister B, 2010, BIOL J LINN SOC, V101, P51, DOI 10.1111/j.1095-8312.2010.01474.x; Mendez M, 2007, BIOL BOAS PYTHONS, P405; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Micucci P. A., 2007, IGUANA, V14, P161; Micucci PA, 2006, MANEJO FAUNA SILVEST, P77; Morello J, 1971, SERIES FITOGEOGRAFIC, V11, P113; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Narum S., 2006, CONSERV GENET, V7, P811, DOI [10.1007/s10592-006-9189-7, DOI 10.1007/S10592-006-9189-7]; Nei M., 1987, MOL EVOLUTIONARY GEN; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poissant J, 2005, MOL ECOL, V14, P1321, DOI 10.1111/j.1365-294X.2005.02500.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Prosser MR, 1999, MOL ECOL, V8, P329, DOI 10.1046/j.1365-294X.1999.00530.x; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Rivas Jesus A., 2007, P312; Rivas Jesus A., 2007, P128; Rivera PC, 2006, AUSTRAL ECOL, V31, P948, DOI 10.1111/j.1442-9993.2006.01661.x; Rosel PE, 1996, MAR BIOL, V125, P11, DOI 10.1007/BF00350756; Rousset F, 1997, GENETICS, V145, P1219; Sanchez-Fernandez D, 2011, BIOL J LINN SOC, V103, P891, DOI 10.1111/j.1095-8312.2011.01668.x; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VOGLER AP, 1994, CONSERV BIOL, V8, P354, DOI 10.1046/j.1523-1739.1994.08020354.x; Waller Tomas, 2007, P340; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1943, GENETICS, V28, P114	67	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37473	10.1371/journal.pone.0037473	http://dx.doi.org/10.1371/journal.pone.0037473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22675425	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338900026
J	Meisner, S; Lehur, PA; Moran, B; Martins, L; Jemec, GBE				Meisner, Soren; Lehur, Paul-Antoine; Moran, Brendan; Martins, Lina; Jemec, Gregor Borut Ernst			Peristomal Skin Complications Are Common, Expensive, and Difficult to Manage: A Population Based Cost Modeling Study	PLOS ONE			English	Article							STOMA-RELATED COMPLICATIONS; OSTOMY PATIENTS; COLOSTOMY; LIFE	Background: Peristomal skin complications (PSCs) are the most common post-operative complications following creation of a stoma. Living with a stoma is a challenge, not only for the patient and their carers, but also for society as a whole. Due to methodological problems of PSC assessment, the associated health-economic burden of medium to longterm complications has been poorly described. Aim: The aim of the present study was to create a model to estimate treatment costs of PSCs using the standardized assessment Ostomy Skin Tool as a reference. The resultant model was applied to a real-life global data set of stoma patients (n = 3017) to determine the prevalence and financial burden of PSCs. Methods: Eleven experienced stoma care nurses were interviewed to get a global understanding of a treatment algorithm that formed the basis of the cost analysis. The estimated costs were based on a seven week treatment period. PSC costs were estimated for five underlying diagnostic categories and three levels of severity. The estimated treatment costs of severe cases of PSCs were increased 2-5 fold for the different diagnostic categories of PSCs compared with mild cases. French unit costs were applied to the global data set. Results: The estimated total average cost for a seven week treatment period (including appliances and accessories) was 263 is an element of for those with PSCs (n = 1742) compared to 215 is an element of for those without PSCs (n = 1172). A co-variance analysis showed that leakage level had a significant impact on PSC cost from 'rarely/never' to 'always/often' p < 0.00001 and from 'rarely/never' to 'sometimes' p = 0.0115. Conclusion: PSCs are common and troublesome and the consequences are substantial, both for the patient and from a health economic viewpoint. PSCs should be diagnosed and treated at an early stage to prevent long term, debilitating and expensive complications.	[Meisner, Soren] Bispebjerg Hosp, Stoma Care Clin, Copenhagen, Denmark; [Lehur, Paul-Antoine] Univ Hosp Nantes, Inst Digest Dis, Nantes, France; [Moran, Brendan] N Hampshire Hosp, Pelican Canc Fdn, Basingstoke, Hants, England; [Martins, Lina] London Hlth Sci Ctr, London, ON, Canada; [Jemec, Gregor Borut Ernst] Univ Copenhagen, Roskilde Hosp, Fac Hlth Sci, Dept Dermatol, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; Nantes Universite; CHU de Nantes; London Health Sciences Centre; University of Copenhagen	Meisner, S (corresponding author), Bispebjerg Hosp, Stoma Care Clin, Copenhagen, Denmark.	smei0001@bbh.regionh.dk	Jemec, Gregor/H-6702-2019	Jemec, Gregor/0000-0002-0712-2540	Coloplast A/S	Coloplast A/S	Coloplast A/S supported the work of this study by providing funding for external consultancy for unit cost collection, data analysis and preparation of the manuscript. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2011, GASTROENTEROL NURS, V9, P4; Colwell J C, 2001, J Wound Ostomy Continence Nurs, V28, P6, DOI 10.1067/mjw.2001.112082; Davis J.S., 2011, GASTROINTESTINAL NUR, V9, P14, DOI [10.12968/gasn.2011.9.Sup2.14, DOI 10.12968/gasn.2011.9.Sup2.14]; HELLMAN J, 1990, INT J DERMATOL, V29, P129, DOI 10.1111/j.1365-4362.1990.tb04085.x; Holm EA, 2004, PEDIATR DERMATOL, V21, P623, DOI 10.1111/j.0736-8046.2004.21601.x; Jemec GB, 2011, BRIT J DERMATOL, V164, P330, DOI 10.1111/j.1365-2133.2010.10093.x; Jemec GBE, 2008, BRIT J DERMATOL, V159, P1211, DOI 10.1111/j.1365-2133.2008.08839.x; LONDONOSCHIMMER EE, 1994, DIS COLON RECTUM, V37, P916, DOI 10.1007/BF02052598; Martins L., 2011, GASTROINTEST NURS, V9, P9; Martins L, 2010, BR J NURS, V19, P932; Martins L, 2008, WORLD COUNCIL ENTERO, P28; Martins Lina, 2010, Br J Nurs, V19, P932; Nybaek H, 2010, J EUR ACAD DERMATOL, V24, P249, DOI 10.1111/j.1468-3083.2010.03566.x; Nybaek H, 2009, ACTA DERM-VENEREOL, V89, P64, DOI 10.2340/00015555-0536; Persson E, 2010, COLORECTAL DIS, V12, P971, DOI 10.1111/j.1463-1318.2009.01941.x; Pittman J, 2008, J WOUND OSTOMY CONT, V35, P493, DOI 10.1097/01.WON.0000335961.68113.cb; Porrett T, 2013, GASTROINTESTINAL NUR, V9, P19, DOI [10.12968/gasn.2011.9.Sup2.19, DOI 10.12968/GASN.2011.9.SUP2.19]; Price P, 2004, BR J NURS, V1, P10; Prieto L, 2005, HLTH QUALITY LIFE OU, P3; Robertson I, 2005, COLORECTAL DIS, V7, P279, DOI 10.1111/j.1463-1318.2005.00785.x; Shabbir J, 2010, COLORECTAL DIS, V12, P958, DOI 10.1111/j.1463-1318.2009.02006.x; Wille-Jorgensen P, 2010, COLORECTAL DIS, V12, P957, DOI 10.1111/j.1463-1318.2010.02376.x	22	47	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37813	10.1371/journal.pone.0037813	http://dx.doi.org/10.1371/journal.pone.0037813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22679479	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900047
J	Serrano-Sanchez, JA; Lera-Navarro, A; Dorado-Garcia, C; Gonzalez-Henriquez, JJ; Sanchis-Moysi, J				Antonio Serrano-Sanchez, Jose; Lera-Navarro, Angela; Dorado-Garcia, Cecilia; Jose Gonzalez-Henriquez, Juan; Sanchis-Moysi, Joaquin			Contribution of Individual and Environmental Factors to Physical Activity Level among Spanish Adults	PLOS ONE			English	Article							NATIONALLY REPRESENTATIVE SAMPLE; SOCIAL-COGNITIVE DETERMINANTS; LEISURE-TIME; OUTCOME EXPECTATIONS; PUBLIC-HEALTH; ACTIVITY RECOMMENDATIONS; ACTIVITY QUESTIONNAIRE; PERCEIVED ENVIRONMENT; EXERCISE FACILITIES; BUILT ENVIRONMENT	Background: Lack of physical activity (PA) is a major risk for chronic disease and obesity. The main aims of the present study were to identify individual and environmental factors independently associated with PA and examine the relative contribution of these factors to PA level in Spanish adults. Methodology/Principal Findings: A population-based cross-sectional sample of 3,000 adults (18-75 years old) from Gran Canaria (Spain) was selected using a multistage stratified random sampling method. The participants were interviewed at home using a validated questionnaire to assess PA as well as individual and environmental factors. The data were analyzed using bivariate and multivariate logistic regression. One demographic variable (education), two cognitive (self-efficacy and perceived barriers), and one social environmental (organized format) were independently associated with PA in both genders. Odds ratios ranged between 1.76-2.07 in men and 1.35-2.50 in women (both p<0.05). Individual and environmental factors explained about one-third of the variance in PA level. Conclusions/Significance: Self-efficacy and perceived barriers were the most significant factors to meet an adequate level of PA. The risk of insufficient PA was twofold greater in men with primary or lesser studies and who are employed. In women, living in rural environments increased the risk of insufficient PA. The promotion of organized PA may be an efficient way to increase the level of PA in the general population. Improvement in the access to sport facilities and places for PA is a prerequisite that may be insufficient and should be combined with strategies to improve self-efficacy and overcome perceived barriers in adulthood.	[Antonio Serrano-Sanchez, Jose; Dorado-Garcia, Cecilia; Sanchis-Moysi, Joaquin] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Lera-Navarro, Angela] Univ A Coruna, Dept Phys Educ, La Coruna, Spain; [Jose Gonzalez-Henriquez, Juan] Univ Las Palmas Gran Canaria, Dept Math, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidade da Coruna; Universidad de Las Palmas de Gran Canaria	Serrano-Sanchez, JA (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Campus Univ Tafira S-N, Las Palmas Gran Canaria, Spain.	jserrano@def.ulpgc.es	González-Henríquez, Juan José jjgh/K-8808-2014; Serrano-Sanchez, Jose A/L-3691-2014; Henríquez, Juan José González/AAZ-7810-2020; Dorado García, Cecilia/ABC-2792-2021; SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Dorado Garcia, Cecilia/B-4586-2010	González-Henríquez, Juan José jjgh/0000-0002-0622-5580; Serrano-Sanchez, Jose A/0000-0002-4868-8751; Henríquez, Juan José González/0000-0002-0622-5580; SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Dorado Garcia, Cecilia/0000-0001-6616-6810	Government of Gran Canaria [35/03/22034]	Government of Gran Canaria	This study was supported by the Government of Gran Canaria (contract no 35/03/22034). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Anderson ES, 2006, HEALTH PSYCHOL, V25, P510, DOI 10.1037/0278-6133.25.4.510; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Badland H, 2006, HEALTH PLACE, V12, P538, DOI 10.1016/j.healthplace.2005.08.007; Ball K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-33; Ball K, 2006, J SCI MED SPORT, V9, P367, DOI 10.1016/j.jsams.2006.06.010; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bauman A, 1999, AUST NZ J PUBL HEAL, V23, P322, DOI 10.1111/j.1467-842X.1999.tb01265.x; Bergman P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-367; Bergman P, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-8; Blanchard CM, 2005, INT J OBESITY, V29, P720, DOI 10.1038/sj.ijo.0802927; Booth ML, 2000, PREV MED, V31, P15, DOI 10.1006/pmed.2000.0661; Brownson RC, 2004, AM J PUBLIC HEALTH, V94, P473, DOI 10.2105/AJPH.94.3.473; Brownson RC, 2001, AM J PUBLIC HEALTH, V91, P1995, DOI 10.2105/AJPH.91.12.1995; Castro CM, 1999, PSYCHOL HEALTH, V14, P277, DOI 10.1080/08870449908407328; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Cleland V, 2010, SOC SCI MED, V70, P2011, DOI 10.1016/j.socscimed.2010.02.028; Cleland VJ, 2010, HEALTH EDUC RES, V25, P268, DOI 10.1093/her/cyn054; De Bourdeaudhuij I, 2005, PUBLIC HEALTH NUTR, V8, P886, DOI 10.1079/PHN2005735; De Bourdeaudhuij I, 2002, PREV MED, V34, P279, DOI 10.1006/pmed.2001.0979; Deforche B, 2010, PREV MED, V50, pS24, DOI 10.1016/j.ypmed.2009.08.017; Deforche B, 2000, J SPORT MED PHYS FIT, V40, P362; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21; Ding D, 2012, HEALTH PLACE, V18, P100, DOI 10.1016/j.healthplace.2011.08.021; Duncan M, 2005, PREV MED, V40, P363, DOI 10.1016/j.ypmed.2004.06.017; Duncan Mitch J, 2005, Int J Behav Nutr Phys Act, V2, P11, DOI 10.1186/1479-5868-2-11; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Eyler AA, 1999, SOC SCI MED, V49, P781, DOI 10.1016/S0277-9536(99)00137-9; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Giles-Corti B, 2002, SOC SCI MED, V54, P1793, DOI 10.1016/S0277-9536(01)00150-2; Giles-Corti B, 2006, J SCI MED SPORT, V9, P357, DOI 10.1016/j.jsams.2006.06.021; Godin G, 1994, ADV EXERCISE ADHEREN, P113; Handy S, 2006, J AM PLANN ASSOC, V72, P55, DOI 10.1080/01944360608976724; Handy SL, 1997, ENVIRON PLANN A, V29, P1175, DOI 10.1068/a291175; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HOSMER DW, 2000, WILEY PS TX, P1; Humpel N, 2004, AM J HEALTH PROMOT, V18, P239, DOI 10.4278/0890-1171-18.3.239; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; King AC, 2000, HEALTH PSYCHOL, V19, P354, DOI 10.1037//0278-6133.19.4.354; Leslie E, 1999, PREV MED, V28, P20, DOI 10.1006/pmed.1998.0375; Lim K, 2005, PREV MED, V40, P33, DOI 10.1016/j.ypmed.2004.04.046; Margetts BM, 1999, PUBLIC HEALTH NUTR, V2, P97, DOI 10.1017/S1368980099000142; Marquez DX, 2006, J BEHAV MED, V29, P281, DOI 10.1007/s10865-006-9055-6; Martinez-Gonzalez MA, 2001, MED SCI SPORT EXER, V33, P1142, DOI 10.1097/00005768-200107000-00011; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; MCAULEY E, 1992, J BEHAV MED, V15, P65, DOI 10.1007/BF00848378; McAuley E, 2010, ARCH PHYS MED REHAB, V91, P100, DOI 10.1016/j.apmr.2009.09.011; McCormack GR, 2009, J PHYS ACT HEALTH, V6, P657, DOI 10.1123/jpah.6.5.657; McNeill LH, 2006, ANN BEHAV MED, V31, P36, DOI 10.1207/s15324796abm3101_7; Menard S, 2000, AM STAT, V54, P17, DOI 10.2307/2685605; Merrill RM, 2004, PERCEPT MOTOR SKILL, V99, P1277, DOI 10.2466/PMS.99.7.1277-1289; Meseguer CM, 2011, REV ESP CARDIOL, V64, P21, DOI [10.1016/j.recesp.2010.07.007, 10.1016/j.rec.2010.06.010]; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Molina-Garcia J, 2010, PREV MED, V51, P136, DOI 10.1016/j.ypmed.2010.05.009; Pan SY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-21; Panter J, 2008, PREV MED, V46, P303, DOI 10.1016/j.ypmed.2007.11.005; Pascual C, 2009, HEALTH PLACE, V15, P553, DOI 10.1016/j.healthplace.2008.08.007; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Prodaniuk Tricia R, 2004, Int J Behav Nutr Phys Act, V1, P7, DOI 10.1186/1479-5868-1-7; Reed JA, 2005, J AM COLL HEALTH, V53, P285, DOI 10.3200/JACH.53.6.285-290; Resnick B, 2000, J GERONTOL B-PSYCHOL, V55, pS352, DOI 10.1093/geronb/55.6.S352; Ronda G, 2001, HEALTH PROMOT INT, V16, P305, DOI 10.1093/heapro/16.4.305; Rovniak LS, 2002, ANN BEHAV MED, V24, P149, DOI 10.1207/S15324796ABM2402_12; Rutten A, 2001, J EPIDEMIOL COMMUN H, V55, P139, DOI 10.1136/jech.55.2.139; SALLIS J F, 1988, Health Education Research, V3, P283, DOI 10.1093/her/3.3.283; Sallis J.F., 1997, HLTH BEHAV HLTH ED T, P403; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; SALLIS JF, 1989, PREV MED, V18, P20, DOI 10.1016/0091-7435(89)90051-0; SALLIS JF, 1990, PUBLIC HEALTH REP, V105, P179; Sallis JF., 1999, PHYS ACTIVITY BEHAV, Vvol. 3; Santos R, 2008, PREV MED, V47, P83, DOI 10.1016/j.ypmed.2008.02.027; Serrano-Sanchez JA, 2006, P 4 C SPAN SOC SPORT, P179; Shibata A, 2009, J PHYS ACT HEALTH, V6, P24, DOI 10.1123/jpah.6.1.24; Shibata A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-60; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Taymoori P, 2010, HEALTH EDUC RES, V25, P257, DOI 10.1093/her/cyn051; Troped PJ, 2001, PREV MED, V32, P191, DOI 10.1006/pmed.2000.0788; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Watts P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-128; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; Wilcox S, 2000, J EPIDEMIOL COMMUN H, V54, P667, DOI 10.1136/jech.54.9.667; World Health Organization, 2004, GLOB STRAT DIET PHYS; Zunft HJF, 1999, PUBLIC HEALTH NUTR, V2, P153, DOI 10.1017/S1368980099000208	84	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38693	10.1371/journal.pone.0038693	http://dx.doi.org/10.1371/journal.pone.0038693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959XO	22685598	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700061
J	Fan, JY; Zhang, YS; Chuang-Smith, ON; Frank, KL; Guenther, BD; Kern, M; Schlievert, PM; Herzberg, MC				Fan, Jingyuan; Zhang, Yongshu; Chuang-Smith, Olivia N.; Frank, Kristi L.; Guenther, Brian D.; Kern, Marissa; Schlievert, Patrick M.; Herzberg, Mark C.			Ecto-5 '-Nucleotidase: A Candidate Virulence Factor in Streptococcus sanguinis Experimental Endocarditis	PLOS ONE			English	Article							ADENOSINE RECEPTOR AGONISTS; GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; PLATELET-AGGREGATION; INFECTIVE ENDOCARDITIS; LEISHMANIA-AMAZONENSIS; VIRIDANS STREPTOCOCCI; ENDOTHELIAL-CELLS; HUMAN MONOCYTES; INHIBITS IL-12	Streptococcus sanguinis is the most common cause of infective endocarditis (IE). Since the molecular basis of virulence of this oral commensal bacterium remains unclear, we searched the genome of S. sanguinis for previously unidentified virulence factors. We identified a cell surface ecto-5'-nucleotidase (Nt5e), as a candidate virulence factor. By colorimetric phosphate assay, we showed that S. sanguinis Nt5e can hydrolyze extracellular adenosine triphosphate to generate adenosine. Moreover, a nt5e deletion mutant showed significantly shorter lag time (P<0.05) to onset of platelet aggregation than the wild-type strain, without affecting platelet-bacterial adhesion in vitro (P=0.98). In the absence of nt5e, S. sanguinis caused IE (4 d) in a rabbit model with significantly decreased mass of vegetations (P<0.01) and recovered bacterial loads (log(10)CFU, P=0.01), suggesting that Nt5e contributes to the virulence of S. sanguinis in vivo. As a virulence factor, Nt5e may function by (i) hydrolyzing ATP, a pro-inflammatory molecule, and generating adenosine, an immunosuppressive molecule to inhibit phagocytic monocytes/macrophages associated with valvular vegetations. (ii) Nt5e-mediated inhibition of platelet aggregation could also delay presentation of platelet microbicidal proteins to infecting bacteria on heart valves. Both plausible Nt5e-dependent mechanisms would promote survival of infecting S. sanguinis. In conclusion, we now show for the first time that streptococcal Nt5e modulates S. sanguinis-induced platelet aggregation and may contribute to the virulence of streptococci in experimental IE.	[Fan, Jingyuan; Zhang, Yongshu; Guenther, Brian D.; Kern, Marissa; Herzberg, Mark C.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Chuang-Smith, Olivia N.; Frank, Kristi L.; Schlievert, Patrick M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Herzberg, Mark C.] Minneapolis Vet Affairs Med Ctr, Mucosal & Vaccine Res Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Fan, JY (corresponding author), Univ Rochester, Eastman Inst Oral Hlth, Div Periodontol, Rochester, NY 14627 USA.	mcherzb@umn.edu		Schlievert, Patrick/0000-0001-8314-9369	National Institutes of Health/National Institute of Dental and Craniofacial Research [R01DE08590, AI074283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008590] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grants R01DE08590 (MCH) and AI074283 (PMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berredo-Pinho M, 2001, ARCH BIOCHEM BIOPHYS, V391, P16, DOI 10.1006/abbi.2001.2384; Cossart P, 2000, P NATL ACAD SCI USA, V97, P5013, DOI 10.1073/pnas.97.10.5013; CRISTALLI G, 1994, J MED CHEM, V37, P1720, DOI 10.1021/jm00037a024; Davies JR, 2009, MICROBIOL-SGM, V155, P1977, DOI 10.1099/mic.0.027854-0; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; ERICKSON PR, 1990, J BIOL CHEM, V265, P14080; GAREN A, 1960, BIOCHIM BIOPHYS ACTA, V38, P470, DOI 10.1016/0006-3002(60)91282-8; GOULD K, 1975, J CLIN INVEST, V56, P1364, DOI 10.1172/JCI108216; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; HERZBERG MC, 1983, INFECT IMMUN, V40, P120, DOI 10.1128/IAI.40.1.120-125.1983; HERZBERG MC, 1983, INFECT IMMUN, V39, P1457, DOI 10.1128/IAI.39.3.1457-1469.1983; HERZBERG MC, 1990, INFECT IMMUN, V58, P515, DOI 10.1128/IAI.58.2.515-522.1990; HERZBERG MC, 1992, INFECT IMMUN, V60, P4809, DOI 10.1128/IAI.60.11.4809-4818.1992; HERZBERG MC, 1993, CRIT REV ORAL BIOL M, V4, P435, DOI 10.1177/10454411930040032501; Imai M, 2000, BIOCHEM BIOPH RES CO, V270, P272, DOI 10.1006/bbrc.2000.2410; Iyu D, 2011, ARTERIOSCL THROM VAS, V31, P416, DOI 10.1161/ATVBAHA.110.219501; Kawashima Y, 2000, BLOOD, V96, P2157; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Ki MR, 2011, J MICROBIOL BIOTECHN, V21, P483, DOI 10.4014/jmb.1101.01017; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; LeMoine O, 1996, J IMMUNOL, V156, P4408; Link AA, 2000, J IMMUNOL, V164, P436, DOI 10.4049/jimmunol.164.1.436; MACFARLANE GD, 1994, ORAL MICROBIOL IMMUN, V9, P180, DOI 10.1111/j.1399-302X.1994.tb00056.x; MACRINA FL, 1983, GENE, V25, P145; Meyer MW, 1998, INFECT IMMUN, V66, P5906, DOI 10.1128/IAI.66.12.5906-5914.1998; MEYER MW, 1995, THROMB HAEMOSTASIS, V73, P680; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Nobbs AH, 2007, J BACTERIOL, V189, P3106, DOI 10.1128/JB.01535-06; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Pinheiro CM, 2006, EXP PARASITOL, V114, P16, DOI 10.1016/j.exppara.2006.02.007; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; SOBERAY AH, 1987, THROMB HAEMOSTASIS, V57, P222; Thammavongsa V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-56; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; Veltrop MHAM, 2000, INFECT IMMUN, V68, P4818, DOI 10.1128/IAI.68.8.4818-4821.2000; Weiss WJ, 2004, J ANTIMICROB CHEMOTH, V53, P480, DOI 10.1093/jac/dkh078; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yeaman MR, 1999, DRUG RESIST UPDATE, V2, P116, DOI 10.1054/drup.1999.0069; Yeaman MR, 1997, INFECT IMMUN, V65, P1023, DOI 10.1128/IAI.65.3.1023-1031.1997; YEAMAN MR, 1994, INFECT IMMUN, V62, P3416, DOI 10.1128/IAI.62.8.3416-3423.1994; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120; Yeaman MR, 1997, CLIN INFECT DIS, V25, P969; Yokota M, 2001, MICROBIOL IMMUNOL, V45, P699, DOI 10.1111/j.1348-0421.2001.tb01304.x; Zhang YS, 2004, INFECT IMMUN, V72, P3489, DOI 10.1128/IAI.72.6.3489-3494.2004; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	52	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38059	10.1371/journal.pone.0038059	http://dx.doi.org/10.1371/journal.pone.0038059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685551	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700014
J	Khan, AA; Rodriguez, A; Sebert, S; Kaakinen, M; Cauchi, S; Froguel, P; Hartikainen, AL; Pouta, A; Jarvelin, MR				Khan, Anokhi Ali; Rodriguez, Alina; Sebert, Sylvain; Kaakinen, Marika; Cauchi, Stephane; Froguel, Philippe; Hartikainen, Anna-Liisa; Pouta, Anneli; Jarvelin, Marjo-Riitta			The Interplay of Variants Near LEKR and CCNL1 and Social Stress in Relation to Birth Size	PLOS ONE			English	Article							PERINATAL OUTCOMES; WEIGHT; GROWTH	Background: We previously identified via a genome wide association study variants near LEKR and CCNL1 and in the ADCY5 genes lead to lower birthweight. Here, we study the impact of these variants and social stress during pregnancy, defined as social adversity and neighborhood disparity, on infant birth size. We aimed to determine whether the addition of genetic variance magnified the observed associations. Methodology/Principal Findings: We analyzed data from the Northern Finland Birth Cohort 1986 (n = 5369). Social adversity was defined by young maternal age (<20 years), low maternal education (<11 years), and/or single marital status. Neighborhood social disparity was assessed by discrepancy between neighborhoods relative to personal socio-economic status. These variables are indicative of social and socioeconomic stress, but also of biological risk. The adjusted multiple regression analysis showed smaller birth size in both infants of mothers who experienced social adversity (birthweight by -40.4 g, 95% CI -61.4, -19.5; birth length -0.14 cm, 95% CI -0.23, -0.05; head circumference -0.09 cm 95% CI -0.15, -0.02) and neighborhood disparity (birthweight -28.8 g, 95% CI -47.7, -10.0; birth length -0.12 cm, 95% CI -0.20, -0.05). The birthweight-lowering risk allele (SNP rs900400 near LEKR and CCNL1) magnified this association in an additive manner. However, likely due to sample size restriction, this association was not significant for the SNP rs9883204 in ADCY5. Birth size difference due to social stress was greater in the presence of birthweight-lowering alleles. Conclusions/Significance: Social adversity, neighborhood disparity, and genetic variants have independent associations with infant birth size in the mutually adjusted analyses. If the newborn carried a risk allele rs900400 near LEKR/CCNL1, the impact of stress on birth size was stronger. These observations give support to the hypothesis that individuals with genetic or other biological risk are more vulnerable to environmental influences. Our study indicates the need for further research to understand the mechanisms by which genes impact individual vulnerability to environmental insults.	[Khan, Anokhi Ali; Rodriguez, Alina; Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Ctr Environm & Hlth, Hlth Protect Agcy, Med Res Council,Dept Epidemiol & Biostat, London, England; [Rodriguez, Alina] Kings Coll London, Social Genet Dev Psychiat Ctr, Med Res Council, London, England; [Rodriguez, Alina] Mid Sweden Univ, Dept Social Sci Psychol, Ostersund, Sweden; [Sebert, Sylvain; Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Cauchi, Stephane; Froguel, Philippe] Univ Lille 2, Inst Pasteur, Inst Biol Lille, Ctr Natl Rech Sci,Unites Mixte Rech 8199, F-59800 Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland	Health Protection Agency; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; Mid-Sweden University; University of Oulu; University of Oulu; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; University of Oulu; Finland National Institute for Health & Welfare	Khan, AA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Environm & Hlth, Hlth Protect Agcy, Med Res Council,Dept Epidemiol & Biostat, London, England.	m.jarvelin@imperial.ac.uk	Fazli, Ghazal/AAE-8320-2022; Rodriguez, Alina/B-3541-2015; FROGUEL, Philippe/O-6799-2017	Rodriguez, Alina/0000-0003-1209-8802; FROGUEL, Philippe/0000-0003-2972-0784; Kaakinen, Marika/0000-0002-9228-0462; Sebert, Sylvain/0000-0001-6681-6983; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Ali Khan, Anokhi/0000-0003-3671-4550	Academy of Finland (Center of Excellence in Complex Disease Genetics and SALVE) [104781, 120315, 129269, 1114194]; University Hospital Oulu, Biocenter; University of Oulu, Finland [75617]; European Commission (EURO-BLCS, Framework 5 award) [QLG1-CT-2000-01643]; Medical Research Council, UK [G0500539, G0600705]; Biocentrum Helsinki; VINNMER [P32925-1]; FAS; French Government (Agence Nationale de la Recherche); French Region of Nord Pas De Calais; Programme Hospitalier de Recherche Clinique (French Ministry of Health); Association Francaise des Diabetiques; Programme National de Recherche sur le Diabete; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Divisional Grant Imperial College London [G24038];  [HEALTH-F4-2007-201413]; MRC [G0600705] Funding Source: UKRI	Academy of Finland (Center of Excellence in Complex Disease Genetics and SALVE); University Hospital Oulu, Biocenter; University of Oulu, Finland; European Commission (EURO-BLCS, Framework 5 award); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biocentrum Helsinki; VINNMER; FAS; French Government (Agence Nationale de la Recherche)(French National Research Agency (ANR)); French Region of Nord Pas De Calais(Region Hauts-de-France); Programme Hospitalier de Recherche Clinique (French Ministry of Health); Association Francaise des Diabetiques; Programme National de Recherche sur le Diabete; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Divisional Grant Imperial College London; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support was received from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE). ENGAGE project and grant agreement HEALTH-F4-2007-201413. The DNA extractions, sample quality controls, biobank up-keeping and aliquotting was performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. Dr Rodriguez received support partly from VINNMER (P32925-1) and FAS. Part of this work was conducted while Dr Rodriguez was at Uppsala University, Sweden. This work was in part supported by the French Government (Agence Nationale de la Recherche), the French Region of Nord Pas De Calais (Contrat de Projets Etat-Region), Programme Hospitalier de Recherche Clinique (French Ministry of Health), and the following charities: Association Francaise des Diabetiques, Programme National de Recherche sur le Diabete, Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques. Ali Khan was funded via Divisional Grant Imperial College London [G24038]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajafari F, 2002, AM J OBSTET GYNECOL, V186, P843, DOI 10.1067/mob.2002.121624; Andersson EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027096; Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; Auger N, 2008, J EPIDEMIOL COMMUN H, V62, P402, DOI 10.1136/jech.2007.064535; Avison WR, 1997, CAN MED ASSOC J, V156, P661; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Belkacemi L, 2010, BIOL REPROD, V83, P325, DOI 10.1095/biolreprod.110.084517; Bernstein IM, 2005, OBSTET GYNECOL, V106, P986, DOI 10.1097/01.AOG.0000182580.78402.d2; Bird ST, 2000, FAM PLANN PERSPECT, V32, P281, DOI 10.2307/2648196; Bosma H, 2001, AM J EPIDEMIOL, V153, P363, DOI 10.1093/aje/153.4.363; Briggs MM, 2007, J OBSTET GYNAECOL CA, V29, P546, DOI 10.1016/S1701-2163(16)32506-3; Cairney J, 2003, SOC PSYCH PSYCH EPID, V38, P442, DOI 10.1007/s00127-003-0661-0; Chadio SE, 2007, J ENDOCRINOL, V192, P495, DOI 10.1677/JOE-06-0172; Chandola T, 2006, J R STAT SOC A STAT, V169, P337, DOI 10.1111/j.1467-985X.2006.00411.x; Chandra PC, 2002, INT J GYNECOL OBSTET, V79, P117, DOI 10.1016/S0020-7292(02)00240-0; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9; COTTERRELL M, 1972, J NEUROCHEM, V19, P2151, DOI 10.1111/j.1471-4159.1972.tb05124.x; de Vienne CM, 2009, EUR J OBSTET GYN R B, V147, P151, DOI 10.1016/j.ejogrb.2009.08.006; Dunlop S A, 1997, J Matern Fetal Med, V6, P309; Engel SM, 2005, PAEDIATR PERINAT EP, V19, P334, DOI 10.1111/j.1365-3016.2005.00676.x; Englert RC, 2008, BIOL PSYCHOL, V77, P32, DOI 10.1016/j.biopsycho.2007.08.011; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Fairley L, 2006, J EPIDEMIOL COMMUN H, V60, P31, DOI 10.1136/jech.2005.038380; Fiocco AJ, 2007, PSYCHONEUROENDOCRINO, V32, P1158, DOI 10.1016/j.psyneuen.2007.08.008; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Glover V, 2009, PSYCHONEUROENDOCRINO, V34, P430, DOI 10.1016/j.psyneuen.2008.10.005; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gudmundsson S, 1997, ACTA OBSTET GYN SCAN, V76, P318, DOI 10.1111/j.1600-0412.1997.tb07985.x; Haldre K, 2007, EUR J OBSTET GYN R B, V131, P45, DOI 10.1016/j.ejogrb.2006.05.002; Halileh S, 2008, MATERN CHILD HLTH J, V12, P606, DOI 10.1007/s10995-007-0226-z; Hansen AM, 2009, BASIC CLIN PHARMACOL, V105, P73, DOI 10.1111/j.1742-7843.2009.00444.x; Harville EW, 2008, ULTRASOUND OBST GYN, V32, P23, DOI 10.1002/uog.5344; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Holt V, 2003, PAEDIAT PERINATAL S, VS1, P31; Huang WL, 1999, OBSTET GYNECOL, V94, P213, DOI 10.1016/S0029-7844(99)00265-3; JARVELIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P310, DOI 10.1111/j.1471-0528.1993.tb12971.x; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Kongnyuy EJ, 2008, MATERN CHILD HLTH J, V12, P149, DOI 10.1007/s10995-007-0235-y; Koubovec D, 2005, Curr Psychiatry Rep, V7, P274, DOI 10.1007/s11920-005-0081-9; KOUTA-database (koulun tilastoaineisto), 1993, KOUTA DAT; Law CM, 1996, J HYPERTENS, V14, P935; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; LOU HC, 1994, DEV MED CHILD NEUROL, V36, P826; Luo ZC, 2004, OBSTET GYNECOLOGY, V6; Martyn CN, 1996, LANCET, V348, P1264, DOI 10.1016/S0140-6736(96)04257-2; Miech R, 2007, ANN EPIDEMIOL, V17, P289, DOI 10.1016/j.annepidem.2006.07.015; Mollborn S, 2009, J HEALTH SOC BEHAV, V50, P310, DOI 10.1177/002214650905000305; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Mortensen LH, 2008, J EPIDEMIOL COMMUN H, V62, P325, DOI 10.1136/jech.2007.061473; Moss TJM, 2005, AM J OBSTET GYNECOL, V192, P146, DOI 10.1016/j.ajog.2004.06.065; Nobile CGA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-192; Obel C, 2005, PSYCHONEUROENDOCRINO, V30, P647, DOI 10.1016/j.psyneuen.2004.11.006; Pearl M, 2001, AM J PUBLIC HEALTH, V91, P1808, DOI 10.2105/AJPH.91.11.1808; Peterson J, 2006, EARLY HUM DEV, V82, P325, DOI 10.1016/j.earlhumdev.2005.09.014; Raatikainen K, 2005, BJOG-INT J OBSTET GY, V112, P1411, DOI 10.1111/j.1471-0528.2005.00667.x; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x; Rodriguez A, 2009, J CHILD PSYCHOL PSYC, V50, P1073, DOI 10.1111/j.1469-7610.2009.02071.x; Salzman BE, 2006, PRIMARY CARE, V33, P1, DOI 10.1016/j.pop.2005.11.014; Sawchuk LA, 1997, J ADOLESCENT HEALTH, V21, P259, DOI 10.1016/S1054-139X(97)00114-6; Scheepens A, 2003, J PHYSIOL-LONDON, V552, P163, DOI 10.1113/jphysiol.2003.043414; Sellstrom E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-267; SHOHAMYAKUBOVICH I, 1988, INT J EPIDEMIOL, V17, P370, DOI 10.1093/ije/17.2.370; STROBINO DM, 1995, AM J EPIDEMIOL, V142, P504, DOI 10.1093/oxfordjournals.aje.a117668; Sundquist J, 2011, ARCH DIS CHILD, V96, P380, DOI 10.1136/adc.2009.180042; Tapia-Rombo CA, 2001, ARCH MED RES, V32, P304, DOI 10.1016/S0188-4409(01)00281-8; Torres-Arreola LP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-20; Vaarasmaki M, 2009, AM J EPIDEMIOL, V169, P1209, DOI 10.1093/aje/kwp020; Vik T, 1996, ARCH DIS CHILD, V1, p33F	73	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38216	10.1371/journal.pone.0038216	http://dx.doi.org/10.1371/journal.pone.0038216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685556	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305351700019
J	Love, KR; Politano, TJ; Panagiotou, V; Jiang, B; Stadheim, TA; Love, JC				Love, Kerry Routenberg; Politano, Timothy J.; Panagiotou, Vasiliki; Jiang, Bo; Stadheim, Terrance A.; Love, J. Christopher			Systematic Single-Cell Analysis of Pichia pastoris Reveals Secretory Capacity Limits Productivity	PLOS ONE			English	Article							PROTEIN EXPRESSION; GENE DOSAGE; SELECTION; SEQUENCE; NOISE	Biopharmaceuticals represent the fastest growing sector of the global pharmaceutical industry. Cost-efficient production of these biologic drugs requires a robust host organism for generating high titers of protein during fermentation. Understanding key cellular processes that limit protein production and secretion is, therefore, essential for rational strain engineering. Here, with single-cell resolution, we systematically analysed the productivity of a series of Pichia pastoris strains that produce different proteins both constitutively and inducibly. We characterized each strain by qPCR, RT-qPCR, microengraving, and imaging cytometry. We then developed a simple mathematical model describing the flux of folded protein through the ER. This combination of single-cell measurements and computational modelling shows that protein trafficking through the secretory machinery is often the rate-limiting step in single-cell production, and strategies to enhance the overall capacity of protein secretion within hosts for the production of heterologous proteins may improve productivity.	[Love, Kerry Routenberg; Politano, Timothy J.; Panagiotou, Vasiliki; Love, J. Christopher] MIT, Koch Inst Integrat Canc Res, Dept Chem Engn, Cambridge, MA USA; [Jiang, Bo; Stadheim, Terrance A.] GlycoFi, Lebanon, NH USA	Massachusetts Institute of Technology (MIT)	Love, KR (corresponding author), MIT, Koch Inst Integrat Canc Res, Dept Chem Engn, Cambridge, MA USA.	clove@mit.edu			Merck Co.; Merck	Merck Co.(Merck & Company); Merck(Merck & Company)	This study was funded by Merck & Co. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This study was funded by Merck. BJ and TAS are paid employees of GlycoFi, a wholly-owned subsidiary of Merck & Co. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abad S, 2010, BIOTECHNOL J, V5, P413, DOI 10.1002/biot.200900233; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barnard GC, 2010, J IND MICROBIOL BIOT, V37, P961, DOI 10.1007/s10295-010-0746-1; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Claeyssens S, 2003, AM J PHYSIOL-GASTR L, V285, pG840, DOI 10.1152/ajpgi.00060.2003; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dragosits M, 2009, J PROTEOME RES, V8, P1380, DOI 10.1021/pr8007623; Farid SS, 2007, J CHROMATOGR B, V848, P8, DOI 10.1016/j.jchromb.2006.07.037; Gasser B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-179; Gasser B, 2007, APPL ENVIRON MICROB, V73, P6499, DOI 10.1128/AEM.01196-07; Gasser B, 2006, BIOTECHNOL BIOENG, V94, P353, DOI 10.1002/bit.20851; Goodman M, 2009, NAT REV DRUG DISCOV, V8, P837, DOI 10.1038/nrd3040; Graf A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-390; Guerfal M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-49; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Harding HP, 1999, NATURE, V398, P90, DOI 10.1038/18057; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hohenblum H, 2004, BIOTECHNOL BIOENG, V85, P367, DOI 10.1002/bit.10904; Inan M, 2006, BIOTECHNOL BIOENG, V93, P771, DOI 10.1002/bit.20762; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Klabunde J, 2007, FEMS YEAST RES, V7, P1168, DOI 10.1111/j.1567-1364.2007.00271.x; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; Lorsch JR, 1999, EMBO J, V18, P6705, DOI 10.1093/emboj/18.23.6705; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Love KR, 2010, BIOTECHNOL BIOENG, V106, P319, DOI 10.1002/bit.22688; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mattanovich D., 2009, MICROBIAL CELL FACTO, V8; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Molinari A, 2005, CURR TOP MICROBIOL, V300, P1; Ogunniyi AO, 2009, NAT PROTOC, V4, P767, DOI 10.1038/nprot.2009.40; Papanikou E, 2009, FEBS LETT, V583, P3746, DOI 10.1016/j.febslet.2009.10.072; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Pilbrough W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008432; Pomerening JR, 2008, CURR OPIN BIOTECH, V19, P381, DOI 10.1016/j.copbio.2008.06.009; Potgieter TI, 2009, J BIOTECHNOL, V139, P318, DOI 10.1016/j.jbiotec.2008.12.015; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Resina D, 2007, MICROBIAL CELL FACTO, P6; Sheridan C, 2010, NAT BIOTECHNOL, V28, P307, DOI 10.1038/nbt0410-307; Stadlmayr G, 2010, BIOTECHNOL BIOENG, V105, P543, DOI 10.1002/bit.22573; Sumi A, 1999, BIOSEPARATION, V8, P195, DOI 10.1023/A:1008081314112; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vinci F, 2004, J BIOL CHEM, V279, P15059, DOI 10.1074/jbc.M311480200; Xuan YJ, 2009, FEMS YEAST RES, V9, P1271, DOI 10.1111/j.1567-1364.2009.00571.x	51	51	52	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37915	10.1371/journal.pone.0037915	http://dx.doi.org/10.1371/journal.pone.0037915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685548	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700011
J	Wu, Y; Lu, WL; Lin, W; Leng, G; Feng, JF				Wu, Yu; Lu, Wenlian; Lin, Wei; Leng, Gareth; Feng, Jianfeng			Bifurcations of Emergent Bursting in a Neuronal Network	PLOS ONE			English	Article							NEURAL OSCILLATIONS; SPIKING NEURONS; THETA RHYTHM; SYNCHRONIZATION; INHIBITION; MECHANISM; DYNAMICS; METASTABILITY; ASSEMBLIES; CHAINS	Complex neuronal networks are an important tool to help explain paradoxical phenomena observed in biological recordings. Here we present a general approach to mathematically tackle a complex neuronal network so that we can fully understand the underlying mechanisms. Using a previously developed network model of the milk-ejection reflex in oxytocin cells, we show how we can reduce a complex model with many variables and complex network topologies to a tractable model with two variables, while retaining all key qualitative features of the original model. The approach enables us to uncover how emergent synchronous bursting can arise from a neuronal network which embodies known biological features. Surprisingly, the bursting mechanisms are similar to those found in other systems reported in the literature, and illustrate a generic way to exhibit emergent and multiple time scale oscillations at the membrane potential level and the firing rate level.	[Wu, Yu; Lu, Wenlian; Lin, Wei; Feng, Jianfeng] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Wu, Yu; Lu, Wenlian; Lin, Wei; Feng, Jianfeng] Fudan Univ, Sch Math Sci, Shanghai 200433, Peoples R China; [Lu, Wenlian; Lin, Wei] Fudan Univ, Key Lab Math Nonlinear Sci, Shanghai 200433, Peoples R China; [Lu, Wenlian; Lin, Wei] Minist Educ China, Shanghai, Peoples R China; [Leng, Gareth] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Wu, Yu; Lu, Wenlian; Feng, Jianfeng] Univ Warwick, Ctr Comp Sci, Coventry CV4 7AL, W Midlands, England; [Wu, Yu; Lu, Wenlian; Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	Fudan University; Fudan University; Fudan University; Ministry of Education, China; University of Edinburgh; University of Warwick; University of Warwick	Wu, Y (corresponding author), Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China.	jffeng@fudan.edu.cn	Lin, Wei/C-9640-2011; Leng, Gareth/C-6688-2011	Lin, Wei/0000-0002-1863-4306; Leng, Gareth/0000-0002-2388-8466; feng, jianfeng/0000-0002-9328-5732	China Scholarship Council (CSC); European Commission [FP7-PEOPLE-2011-IIF-302421]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [200921]; Shanghai Rising-Star Program [11QA1400400]; Shanghai Guidance of Science and Technology (SGST) [09DZ2272900]; NSF of China [10971035]; Talent Programs [10SG02, NCET-11-0109, 11QH1400200]; Wellcome Trust; Royal Society; EU; UK EPSRC; National Centre for Mathematics and Interdisciplinary Sciences (NCMIS) in the Chinese Academy of Sciences	China Scholarship Council (CSC)(China Scholarship Council); European Commission(European CommissionEuropean Commission Joint Research Centre); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Shanghai Rising-Star Program; Shanghai Guidance of Science and Technology (SGST); NSF of China(National Natural Science Foundation of China (NSFC)); Talent Programs; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); EU(European Commission); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for Mathematics and Interdisciplinary Sciences (NCMIS) in the Chinese Academy of Sciences	YW was supported by the China Scholarship Council (CSC). WLL (Wenlian Lu) was jointly supported by the Marie Curie International Incoming Fellowship from the European Commission (FP7-PEOPLE-2011-IIF-302421), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 200921), the Shanghai Rising-Star Program (No. 11QA1400400), and the Shanghai Guidance of Science and Technology (SGST) (No. 09DZ2272900). WL (Wei Lin) was supported by the NSF of China (No. 10971035) and the Talent Programs (Nos. 10SG02, NCET-11-0109 and 11QH1400200). GL was supported by the Wellcome Trust. JF is a Royal Society Wolfson Research Merit Award holder, partially supported by a EU Grant BION, a UK EPSRC grant and National Centre for Mathematics and Interdisciplinary Sciences (NCMIS) in the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund N, 2007, NONLINEARITY, V20, P2551, DOI 10.1088/0951-7715/20/11/006; BERTRAM R, 1995, B MATH BIOL, V57, P413, DOI 10.1007/BF02460633; BERTRAM R, 1994, BIOL CYBERN, V70, P359, DOI 10.1007/BF00200333; Bertram R, 2008, B MATH BIOL, V70, P1979, DOI 10.1007/s11538-008-9335-0; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Buzsaki G., 2006, RHYTHMS BRAIN; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Dodla R, 2006, J NEUROPHYSIOL, V95, P2664, DOI 10.1152/jn.00752.2005; Ermentrout B, 2003, NEURAL COMPUT, V15, P2483, DOI 10.1162/089976603322385054; ERMENTROUT GB, 1984, SIAM J APPL MATH, V44, P80, DOI 10.1137/0144007; Ermentrout GB, 2002, PHYSIOL BEHAV, V77, P629, DOI 10.1016/S0031-9384(02)00898-3; Feng J, 2010, FRONTIERS COMPUTATIO; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kendrick KM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-55; Kuznetsov, 2013, ELEMENTS APPL BIFURC; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Medvedev GS, 2001, SIAM J APPL MATH, V61, P1762, DOI 10.1137/S0036139900368807; Niebur E, 2002, CURR OPIN NEUROBIOL, V12, P190, DOI 10.1016/S0959-4388(02)00310-0; Olypher AV, 2010, J COMPUT NEUROSCI, V28, P361, DOI 10.1007/s10827-010-0213-z; Rossoni E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000123; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Shilnikov A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048101; Skinner F K, 1994, J Comput Neurosci, V1, P69, DOI 10.1007/BF00962719; Smerieri A, 2010, J NEUROSCI, V30, P14173, DOI 10.1523/JNEUROSCI.0945-10.2010; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tabak J, 2010, J NEUROPHYSIOL, V103, P2208, DOI 10.1152/jn.00857.2009; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks M, COMMUNICATION; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vladimirski BB, 2008, J COMPUT NEUROSCI, V25, P39, DOI 10.1007/s10827-007-0064-4; Wang XJ, 1996, J NEUROSCI, V16, P6402; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097; Zhang X, PLOS ONE IN PRESS	40	47	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38402	10.1371/journal.pone.0038402	http://dx.doi.org/10.1371/journal.pone.0038402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685566	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700029
J	Burrell, K; Hill, RP; Zadeh, G				Burrell, Kelly; Hill, Richard P.; Zadeh, Gelareh			High-Resolution In-Vivo Analysis of Normal Brain Response to Cranial Irradiation	PLOS ONE			English	Article							RADIATION-INDUCED APOPTOSIS; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL PROGENITOR CELLS; BLOOD PARTITION-COEFFICIENT; MARROW STROMAL CELLS; UMBILICAL-CORD BLOOD; ADULT BONE-MARROW; STEM-CELLS; SPINAL-CORD; INTRACEREBRAL TRANSPLANTATION	Radiation therapy (RT) is a widely accepted treatment strategy for many central nervous system (CNS) pathologies. However, despite recognized therapeutic success, significant negative consequences are associated with cranial irradiation (CR), which manifests months to years post-RT. The pathophysiology and molecular alterations that culminate in the long-term detrimental effects of CR are poorly understood, though it is thought that endothelial injury plays a pivotal role in triggering cranial injury. We therefore explored the contribution of bone marrow derived cells (BMDCs) in their capacity to repair and contribute to neo-vascularization following CR. Using high-resolution in vivo optical imaging we have studied, at single-cell resolution, the spatio-temporal response of BMDCs in normal brain following CR. We demonstrate that BMDCs are recruited specifically to the site of CR, in a radiation dose and temporal-spatial manner. We establish that BMDCs do not form endothelial cells but rather they differentiate predominantly into inflammatory cells and microglia. Most notably we provide evidence that more than 50% of the microglia in the irradiated region of the brain are not resident microglia but recruited from the bone marrow following CR. These results have invaluable therapeutic implications as BMDCs may be a primary therapeutic target to block acute and long-term inflammatory response following CR. Identifying the critical steps involved in the sustained recruitment and differentiation of BMDCs into microglia at the site of CR can provide new insights into the mechanisms of injury following CR offering potential therapeutic strategies to counteract the long-term adverse effects of CR.	[Burrell, Kelly] SickKids Res Inst, Brain Tumor Res Ctr, Toronto, ON, Canada; [Hill, Richard P.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Hill, Richard P.] Univ Hlth Network, Campbell Family Inst Canc Res, Toronto, ON, Canada; [Hill, Richard P.; Zadeh, Gelareh] Univ Toronto, Toronto, ON, Canada; [Zadeh, Gelareh] Toronto Western Hosp, Univ Hlth Network, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Burrell, K (corresponding author), SickKids Res Inst, Brain Tumor Res Ctr, Toronto, ON, Canada.	Gelareh.zadeh@uhn.on.ca		Hill, Richard Peter/0000-0001-5331-8045	Canadian Institute of Health Research; Sickkids funding group b.r.a.i.n.child	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Sickkids funding group b.r.a.i.n.child	Funding for this work was provided by Canadian Institute of Health Research funding body and the Sickkids funding group b.r.a.i.n.child. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2005, MOL THER, V12, P994, DOI 10.1016/j.ymthe.2005.07.693; Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Ahn GO, 2009, ANGIOGENESIS, V12, P159, DOI 10.1007/s10456-009-9135-7; Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; [Anonymous], 2010, NAT MED, V16, P1380; Asahara T, 1999, CIRCULATION; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Brush J, 2007, SEMIN RADIAT ONCOL, V17, P121, DOI 10.1016/j.semradonc.2006.11.008; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Davoust N, 2008, TRENDS IMMUNOL, V29, P227, DOI 10.1016/j.it.2008.01.010; De Palma M, 2006, BBA-REV CANCER, V1766, P159, DOI 10.1016/j.bbcan.2006.06.003; Duda DG, 2006, BLOOD, V107, P2774, DOI 10.1182/blood-2005-08-3210; Elkabes S, 1996, J NEUROSCI, V16, P2508; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Gaber MW, 2003, INT J RADIAT BIOL, V79, P359, DOI 10.1080/0955300031000114738; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gaspar LE, 2010, J NEURO-ONCOL, V96, P17, DOI 10.1007/s11060-009-0060-9; Gondi V, 2010, CURR OPIN NEUROL, V23, P556, DOI 10.1097/WCO.0b013e32833f8cb5; HaimovitzFriedman A, 1997, STEM CELLS, V15, P43; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Hong JH, 1999, INT J RADIAT BIOL, V75, P1421, DOI 10.1080/095530099139287; Hong JH, 2003, INT J RADIAT BIOL, V79, P159, DOI 10.1080/0955300031000076894; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Le Bourhis X, 2010, BREAST CANCER RES TR, V120, P17, DOI 10.1007/s10549-009-0686-5; Leithner C, 2010, J CEREBR BLOOD F MET, V30, P1821, DOI 10.1038/jcbfm.2010.160; Li YQ, 2003, CANCER RES, V63, P5950; Li YQ, 1996, CANCER RES, V56, P5417; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; LJUBIMOVA NV, 1991, BRIT J RADIOL, V64, P934, DOI 10.1259/0007-1285-64-766-934; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; MYERS R, 1986, BRIT J CANCER, V53, P221; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pena LA, 2000, CANCER RES, V60, P321; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rivest Serge, 2011, Expert Rev Neurother, V11, P783, DOI 10.1586/ern.11.64; Rotolo JA, 2009, BLOOD, V114, P3693, DOI 10.1182/blood-2008-11-191148; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Siegal T, 1996, INT J RADIAT ONCOL, V36, P649, DOI 10.1016/S0360-3016(96)00357-4; Simard AR, 2006, MOL PSYCHIATR, V11, P327, DOI 10.1038/sj.mp.4001809; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sun YP, 2004, MAGN RESON MED, V51, P893, DOI 10.1002/mrm.20029; Truman JP, 2010, PLOS ONE, V5, DOI [10.1371/annotation/6e222ad5-b175-4a00-9d04-4d120568a897, 10.1371/journal.pone.0012310]; VANDERKOGEL AJ, 1986, BRIT J CANCER, V53, P207; Zhang HR, 2009, J NEURO-ONCOL, V93, P165, DOI 10.1007/s11060-008-9757-4; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	65	42	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38366	10.1371/journal.pone.0038366	http://dx.doi.org/10.1371/journal.pone.0038366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675549	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700063
J	Musel, B; Chauvin, A; Guyader, N; Chokron, S; Peyrin, C				Musel, Benoit; Chauvin, Alan; Guyader, Nathalie; Chokron, Sylvie; Peyrin, Carole			Is Coarse-to-Fine Strategy Sensitive to Normal Aging?	PLOS ONE			English	Article							SPATIAL-FREQUENCY CHANNELS; AGE-RELATED MACULOPATHY; DEVELOPMENTAL-CHANGES; GLOBAL PRECEDENCE; HOME-ENVIRONMENT; SCENE; INFORMATION; PERCEPTION; CATEGORIZATION; CELLS	Theories on visual perception agree that visual recognition begins with global analysis and ends with detailed analysis. Different results from neurophysiological, computational, and behavioral studies all indicate that the totality of visual information is not immediately conveyed, but that information analysis follows a predominantly coarse-to-fine processing sequence (low spatial frequencies are extracted first, followed by high spatial frequencies). We tested whether such processing continues to occur in normally aging subjects. Young and aged participants performed a categorization task (indoor vs. outdoor scenes), using dynamic natural scene stimuli, in which they resorted to either a coarse-to-fine (CtF) sequence or a reverse fine-to-coarse sequence (FtC). The results show that young participants categorized CtF sequences more quickly than FtC sequences. However, sequence processing interacts with semantic category only for aged participants. The present data support the notion that CtF categorization is effective even in aged participants, but is constrained by the spatial features of the scenes, thus highlighting new perspectives in visual models.	[Musel, Benoit; Chauvin, Alan; Peyrin, Carole] Univ Pierre Mendes France, CNRS, UMR 5105, Lab Psychol & Neurocognit, Grenoble, France; [Guyader, Nathalie] CNRS, UMR 5216, GIPSA Lab, Grenoble, France; [Chokron, Sylvie] Fdn Ophtalmol Rothschild, Unite Fonct Vis & Cognit, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Musel, B (corresponding author), Univ Pierre Mendes France, CNRS, UMR 5105, Lab Psychol & Neurocognit, Grenoble, France.	benoit.musel@upmf-grenoble.fr	Chauvin, Alan/D-2731-2012; Chauvin, Alan/AAJ-8531-2020	Chauvin, Alan/0000-0002-6498-2766; Chauvin, Alan/0000-0002-6498-2766; Peyrin, Carole/0000-0001-7792-092X	Region Rhone-Alpes	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by Region Rhone-Alpes. We thank Catherine Dal Molin for the English revision of the manuscript.	BADCOCK JC, 1990, PERCEPTION, V19, P617, DOI 10.1068/p190617; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bruyer R, 2000, EXP AGING RES, V26, P285, DOI 10.1080/036107300750015705; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Connell BR, 1997, ARCH PHYS MED REHAB, V78, P179, DOI 10.1016/S0003-9993(97)90261-6; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; DINEEN JT, 1980, DEV PSYCHOBIOL, V13, P123, DOI 10.1002/dev.420130204; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; GINSBURG AP, 1986, HDB PERCEPTION HUMAN, V2, P1; GORKANI MM, 1994, INT C PATT RECOG, P459, DOI 10.1109/ICPR.1994.576325; Gosselin F, 2002, TRENDS COGN SCI, V6, P70, DOI 10.1016/S1364-6613(00)01838-6; Guerin-Dugue A, 2000, PATTERN RECOGN LETT, V21, P1135, DOI 10.1016/S0167-8655(00)00074-X; Guyader N, 2004, CR BIOL, V327, P313, DOI 10.1016/j.crvi.2004.02.006; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; Herault J., 1997, 5th European Symposium on Artificial Neural Networks ESANN '97. Proceedings, P91; Hughes HC, 1996, J COGNITIVE NEUROSCI, V8, P197, DOI 10.1162/jocn.1996.8.3.197; KENNEDY H, 1985, J NEUROSCI, V5, P2815; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; LAMB MR, 1993, PERCEPT PSYCHOPHYS, V54, P773, DOI 10.3758/BF03211802; Lord SR, 2006, AGE AGEING, V35, P55, DOI 10.1093/ageing/afl088; Lux S, 2008, CORTEX, V44, P21, DOI 10.1016/j.cortex.2005.08.001; Mayer, 1999, BERLIN AGING STUDY A, P384; Mermillod Martial, 2005, Brain Cogn, V57, P151, DOI 10.1016/j.bandc.2004.08.035; Musel B, 2011, VISUAL NEUROSCI, V28, P529, DOI 10.1017/S0952523811000435; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Oken BS, 1999, J GERIATR PSYCH NEUR, V12, P76, DOI 10.1177/089198879901200207; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; PARKER DM, 1992, PERCEPTION, V21, P147, DOI 10.1068/p210147; Parker DM, 1996, J EXP PSYCHOL HUMAN, V22, P1448, DOI 10.1037/0096-1523.22.6.1448; Parker DM, 1999, CURR PSYCHOL, V18, P118, DOI 10.1007/s12144-999-1021-3; Parker DM, 1997, PERCEPTION, V26, P1169, DOI 10.1068/p261169; Peyrin C, 2005, NEUROIMAGE, V28, P464, DOI 10.1016/j.neuroimage.2005.06.006; Peyrin C, 2010, J COGNITIVE NEUROSCI, V22, P2768, DOI 10.1162/jocn.2010.21424; POGGIO GF, 1972, INVEST OPHTH VISUAL, V11, P368; Poirel N, 2008, DEV PSYCHOL, V44, P245, DOI 10.1037/0012-1649.44.1.245; Poirel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020879; Renforth P., 2004, AUSTR OCCUPATIONAL T, V67, P488; Renninger LW, 2004, VISION RES, V44, P2301, DOI 10.1016/j.visres.2004.04.006; Roux F, 2001, BRAIN COGNITION, V46, P383, DOI 10.1006/brcg.2001.1296; Rubenstein LZ, 1999, J AM GERIATR SOC, V47, P111, DOI 10.1111/j.1532-5415.1999.tb01911.x; Schyns PG, 1997, PERCEPTION, V26, P1027, DOI 10.1068/p261027; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Shams L, 2002, VISION RES, V42, P2547, DOI 10.1016/S0042-6989(02)00202-X; SHULMAN GL, 1986, PERCEPTION, V15, P259, DOI 10.1068/p150259; Stark S, 2001, DISABIL SOC, V16, P37, DOI 10.1080/713662037; Staudinger MR, 2011, CORTEX, V47, P854, DOI 10.1016/j.cortex.2010.08.001; TOOTELL RB, 1981, SCIENCE, V214, P813, DOI 10.1126/science.7292014; Van Essen David C., 1995, P383; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057	55	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38493	10.1371/journal.pone.0038493	http://dx.doi.org/10.1371/journal.pone.0038493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675568	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700080
J	Ping, LY; Mavridou, DAI; Emberly, E; Westermann, M; Ferguson, SJ				Ping, Liyan; Mavridou, Despoina A. I.; Emberly, Eldon; Westermann, Martin; Ferguson, Stuart J.			Vital Dye Reaction and Granule Localization in Periplasm of Escherichia coli	PLOS ONE			English	Article							5-CYANO-2,3-DITOLYL TETRAZOLIUM CHLORIDE; GREEN FLUORESCENT PROTEIN; SUBCELLULAR-LOCALIZATION; ELECTRON-TRANSPORT; CELLULAR REDUCTION; CRYSTAL-STRUCTURE; CELLS; BACTERIA; SYSTEM; MTT	Background: Tetrazolium salts are widely used in biology as indicators of metabolic activity - hence termed vital dyes - but their reduction site is still debated despite decades of intensive research. The prototype, 2,3,5-triphenyl tetrazolium chloride, which was first synthesized a century ago, often generates a single formazan granule at the old pole of Escherichia coli cells after reduction. So far, no explanation for their pole localization has been proposed. Method/Principal Findings: Here we provide evidence that the granules form in the periplasm of bacterial cells. A source of reducing power is deduced to be thiol groups destined to become disulfides, since deletion of dsbA, coding for thiol-oxidase, enhances the formation of reduced formazan. However, pervasive reduction did not result in a random distribution of formazan aggregates. In filamentous cells, large granules appear at regular intervals of about four normal cell-lengths, consistent with a diffusion-to-capture model. Computer simulations of a minimal biophysical model showed that the pole localization of granules is a spontaneous process, i.e. small granules in a normal size bacterium have lower energy at the poles. This biased their diffusion to the poles. They kept growing there and eventually became fixed. Conclusions: We observed that formazan granules formed in the periplasm after reduction of tetrazolium, which calls for re-evaluation of previous studies using cell-free systems that liberate inaccessible intracellular reductant and potentially generate artifacts. The localization of formazan granules in E. coli cells can now be understood. In living bacteria, the seeds formed at or migrated to the new pole would become visible only when that new pole already became an old pole, because of the relatively slow growth rate of granules relative to cell division.	[Ping, Liyan] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany; [Mavridou, Despoina A. I.; Ferguson, Stuart J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Emberly, Eldon] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Westermann, Martin] Univ Jena, Ctr Electron Microscopy, Univ Hosp, Jena, Germany	Max Planck Society; University of Oxford; Simon Fraser University; Friedrich Schiller University of Jena	Ping, LY (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany.	lping@ice.mpg.de; eemberly@sfu.ca; stuart.ferguson@bioch.ox.ac.uk	Mavridou, Despoina/ABG-5940-2020; Karamati, Rezaei/C-3197-2009	Mavridou, Despoina/0000-0002-7449-1151; Karamati, Rezaei/0000-0002-6052-9753	NSERC; Canadian Institute for Advanced Research (CIFAR); Wellcome Trust [092532]; Max-Planck Society	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Wellcome Trust(Wellcome TrustEuropean Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by NSERC and the Canadian Institute for Advanced Research (CIFAR), the Wellcome Trust (grant number 092532) and the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1988, MOL REPROD DEV; BARNES EM, 1956, J GEN MICROBIOL, V14, P57, DOI 10.1099/00221287-14-1-57; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 1995, P NATL ACAD SCI USA, V92, P477, DOI 10.1073/pnas.92.2.477; Bernas T, 2000, ARCH BIOCHEM BIOPHYS, V380, P108, DOI 10.1006/abbi.2000.1907; Bernas T, 1999, BBA-MOL CELL RES, V1451, P73, DOI 10.1016/S0167-4889(99)00071-3; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; CURRIER HB, 1954, SCIENCE, V119, P817, DOI 10.1126/science.119.3101.817; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; GRAHAM LL, 1991, TRENDS BIOCHEM SCI, V16, P328, DOI 10.1016/0968-0004(91)90135-I; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Johno H, 2010, APPL BIOCHEM BIOTECH, V162, P1529, DOI 10.1007/s12010-010-8934-z; KAPRELYANTS AS, 1993, APPL ENVIRON MICROB, V59, P3187, DOI 10.1128/AEM.59.10.3187-3196.1993; LEDERBERG J, 1948, J BACTERIOL, V56, P695, DOI 10.1128/JB.56.5.695-695.1948; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; MADDOCK JR, 1993, J BACTERIOL, V175, P7125, DOI 10.1128/JB.175.22.7125-7129.1993; Maki N, 2000, J BACTERIOL, V182, P4337, DOI 10.1128/JB.182.15.4337-4342.2000; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; PERIANIN A, 1984, CLIN EXP IMMUNOL, V57, P244; Ping LY, 2008, MOL MICROBIOL, V69, P1427, DOI 10.1111/j.1365-2958.2008.06372.x; Ping LY, 2010, J MOL BIOL, V397, P906, DOI 10.1016/j.jmb.2010.02.008; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; Prisco U, 2005, J R SOC INTERFACE, V2, P169, DOI 10.1098/rsif.2005.0032; Ramamurthi KS, 2009, P NATL ACAD SCI US; ROBERTS LW, 1951, SCIENCE, V113, P692, DOI 10.1126/science.113.2946.692; ROBERTS LW, 1955, STAIN TECHNOL, V30, P291, DOI 10.3109/10520295509114481; Saberi S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000986; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Santini CL, 2001, J BIOL CHEM, V276, P8159, DOI 10.1074/jbc.C000833200; SCHAULE G, 1993, APPL ENVIRON MICROB, V59, P3850, DOI 10.1128/AEM.59.11.3850-3857.1993; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Smith JJ, 1997, J MICROBIOL METH, V29, P161, DOI 10.1016/S0167-7012(97)00036-5; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Tachon S, 2009, MICROBIOL-SGM, V155, P2941, DOI 10.1099/mic.0.029678-0; THRONEBERRY GO, 1953, SCIENCE, V117, P13, DOI 10.1126/science.117.3027.13-a; Ullrich S, 1996, APPL ENVIRON MICROB, V62, P4587, DOI 10.1128/AEM.62.12.4587-4593.1996; Wang H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.218101; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412	51	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38427	10.1371/journal.pone.0038427	http://dx.doi.org/10.1371/journal.pone.0038427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675561	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700073
J	Wildsmith, KR; Basak, JM; Patterson, BW; Pyatkivskyy, Y; Kim, J; Yarasheski, KE; Wang, JX; Mawuenyega, KG; Jiang, H; Parsadanian, M; Yoon, H; Kasten, T; Sigurdson, WC; Xiong, CJ; Goate, A; Holtzman, DM; Bateman, RJ				Wildsmith, Kristin R.; Basak, Jacob M.; Patterson, Bruce W.; Pyatkivskyy, Yuriy; Kim, Jungsu; Yarasheski, Kevin E.; Wang, Jennifer X.; Mawuenyega, Kwasi G.; Jiang, Hong; Parsadanian, Maia; Yoon, Hyejin; Kasten, Tom; Sigurdson, Wendy C.; Xiong, Chengjie; Goate, Alison; Holtzman, David M.; Bateman, Randall J.			In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; E APOE POLYMORPHISM; BETA-AMYLOID LEVELS; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; E GENOTYPE; TARGETED REPLACEMENT; CLEARANCE RATES; TRANSGENIC MICE; E METABOLISM	Apolipoprotein E (ApoE) is the strongest genetic risk factor for Alzheimer's disease and has been implicated in the risk for other neurological disorders. The three common ApoE isoforms (ApoE2, E3, and E4) each differ by a single amino acid, with ApoE4 increasing and ApoE2 decreasing the risk of Alzheimer's disease (AD). Both the isoform and amount of ApoE in the brain modulate AD pathology by altering the extent of amyloid beta (Ab) peptide deposition. Therefore, quantifying ApoE isoform production and clearance rates may advance our understanding of the role of ApoE in health and disease. To measure the kinetics of ApoE in the central nervous system (CNS), we applied in vivo stable isotope labeling to quantify the fractional turnover rates of ApoE isoforms in 18 cognitively-normal adults and in ApoE3 and ApoE4 targeted-replacement mice. No isoform-specific differences in CNS ApoE3 and ApoE4 turnover rates were observed when measured in human CSF or mouse brain. However, CNS and peripheral ApoE isoform turnover rates differed substantially, which is consistent with previous reports and suggests that the pathways responsible for ApoE metabolism are different in the CNS and the periphery. We also demonstrate a slower turnover rate for CSF ApoE than that for amyloid beta, another molecule critically important in AD pathogenesis.	[Wildsmith, Kristin R.; Basak, Jacob M.; Pyatkivskyy, Yuriy; Kim, Jungsu; Mawuenyega, Kwasi G.; Jiang, Hong; Parsadanian, Maia; Yoon, Hyejin; Kasten, Tom; Sigurdson, Wendy C.; Goate, Alison; Holtzman, David M.; Bateman, Randall J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Patterson, Bruce W.; Yarasheski, Kevin E.; Wang, Jennifer X.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Xiong, Chengjie] Washington Univ, Sch Med, Dept Biostat, St Louis, MO USA; [Goate, Alison] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Goate, Alison] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Goate, Alison; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Goate, Alison; Holtzman, David M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wildsmith, KR (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	batemanr@neuro.wustl.edu	Yarasheski, Kevin E/A-3025-2008; Yoon, Hyejin/AAI-8641-2021; Yarasheski, Kevin/AAC-7450-2021; Kim, Jungsu/F-2457-2012	Yarasheski, Kevin/0000-0001-5436-2451; Kim, Jungsu/0000-0002-6931-8581; Bateman, Randall/0000-0002-7729-1702; Goate, Alison/0000-0002-0576-2472; Patterson, Bruce W/0000-0001-9261-0233	Alzheimer's Disease Research (American Health Assistance Foundation) [A2008-345]; Hope Center for Neurological Disorders at Washington University; NIA [K23 AG030946, AG13956]; NINDS [RO1-NS065667]; NIH [UL1 RR024992, TL1 RR024995, KL2 RR 024994]; Washington University Biomedical Mass Spectrometry Research Facility [P30NS069329, P30-RR000954, DK020579]; Washington University ADRC Genetics Core [P50-AG05681]; Washington University Nutrition Obesity Research Center [DK056341]; Eli Lilly; Pfizer; Astra-Zeneca; Astrazeneca; Merck; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992, KL2RR024994, TL1RR024995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P60DK020579, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065667, P30NS069329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG030946, P50AG005681, R01AG013956, R37AG013956] Funding Source: NIH RePORTER	Alzheimer's Disease Research (American Health Assistance Foundation); Hope Center for Neurological Disorders at Washington University; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Biomedical Mass Spectrometry Research Facility; Washington University ADRC Genetics Core; Washington University Nutrition Obesity Research Center; Eli Lilly(Eli Lilly); Pfizer(Pfizer); Astra-Zeneca(AstraZeneca); Astrazeneca(AstraZeneca); Merck(Merck & Company); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Alzheimer's Disease Research (a program of the American Health Assistance Foundation) Grant A2008-345 (KRW and RJB) and a postdoctoral fellowship (JK); the Hope Center for Neurological Disorders at Washington University (RJB); NIA K23 AG030946 (RJB), AG13956 (DMH), NINDS RO1-NS065667 (RJB), and NIH-supported UL1 RR024992, TL1 RR024995 and KL2 RR 024994 (ICTS CRU), P30NS069329 (JK) Washington University Biomedical Mass Spectrometry Research Facility (P30-RR000954, DK020579), Washington University ADRC Genetics Core (P50-AG05681), and Washington University Nutrition Obesity Research Center (DK056341) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DMH co-founded C2N Diagnostics, and is on the scientific advisory board of C2N Diagnostics, and Pfizer, and receives grants that did not support this work from Eli Lilly, Pfizer, and Astra-Zeneca. RJB co-founded C2N Diagnostics and is on the scientific advisory board of C2N Diagnostics and receives grants that did not support this work from Astrazeneca, and Merck. BWP provides consultation services for tracer turnover kinetics for C2N Diagnostics. KRW now works for Genentech, which did not provide any funding for this study, and did not have any involvement or influence in data production, data analysis, decision to publish, or manuscript preparation. None of the above stated competing interests alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Bateman RJ, 2007, J AM SOC MASS SPECTR, V18, P997, DOI 10.1016/j.jasms.2007.02.009; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Beffert U, 1999, BRAIN RES, V843, P87, DOI 10.1016/S0006-8993(99)01894-6; Bekris LM, 2008, J ALZHEIMERS DIS, V13, P255; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Burt TD, 2008, P NATL ACAD SCI USA, V105, P8718, DOI 10.1073/pnas.0803526105; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dinkel RE, 2006, NUTR METAB CARDIOVAS, V16, P215, DOI 10.1016/j.numecd.2005.06.004; Elbert DL, 2011, NAT MED, V17, P1179, DOI 10.1038/nm.2496; Elias N, 2000, ARTERIOSCL THROM VAS, V20, P1309, DOI 10.1161/01.ATV.20.5.1309; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fishman RA., 1992, CEREBROSPINAL FLUID; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Fukumoto H, 2003, EXP NEUROL, V183, P249, DOI 10.1016/S0014-4886(03)00088-8; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; GREGG RE, 1981, SCIENCE, V211, P584, DOI 10.1126/science.7455696; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; GREGG RE, 1984, J LIPID RES, V25, P1167; Harr SD, 1996, J NEUROCHEM, V66, P2429; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Ikewaki K, 2002, J LAB CLIN MED, V140, P369, DOI 10.1067/mlc.2002.129066; Khachaturian AS, 2004, ARCH GEN PSYCHIAT, V61, P518, DOI 10.1001/archpsyc.61.5.518; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Korwek KM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-21; KRUL ES, 1988, J LIPID RES, V29, P1309; LEHTIMAKI T, 1995, HUM GENET, V95, P39; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Millar JS, 1998, METABOLISM, V47, P922, DOI 10.1016/S0026-0495(98)90345-6; Mooijaart SP, 2006, PLOS MED, V3, P874, DOI 10.1371/journal.pmed.0030176; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Ramakrishnan R, 2006, J LIPID RES, V47, P2738, DOI 10.1194/jlr.M600302-JLR200; Ramaswamy G, 2005, J NEUROSCI, V25, P10658, DOI 10.1523/JNEUROSCI.1922-05.2005; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; SMIT M, 1988, HUM GENET, V80, P287, DOI 10.1007/BF01790099; Sullivan PM, 2004, NEUROSCIENCE, V124, P725, DOI 10.1016/j.neuroscience.2003.10.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; TALBOT C, 1994, LANCET, V343, P1432, DOI 10.1016/S0140-6736(94)92557-7; Wahrle SE, 2003, EXP NEUROL, V183, P4, DOI 10.1016/S0014-4886(03)00185-7; Wahrle SE, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-7; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; Wildsmith KR, 2009, ANAL BIOCHEM, V395, P116, DOI 10.1016/j.ab.2009.07.049; Wolfe RR., 2005, ISOTOPE TRACERS META, V2; Wood SJ, 1996, BIOCHEMISTRY-US, V35, P12623, DOI 10.1021/bi961074j; Xu PT, 1996, NEUROBIOL DIS, V3, P229, DOI 10.1006/nbdi.1996.0023; Yamauchi K, 1999, CLIN CHEM, V45, P497; YARASHESKI KE, 1992, BIOL MASS SPECTROM, V21, P486, DOI 10.1002/bms.1200211004; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	55	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38013	10.1371/journal.pone.0038013	http://dx.doi.org/10.1371/journal.pone.0038013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675504	Green Published, gold			2022-12-27	WOS:000305341700033
J	Yang, K; Chen, HN; Chen, XZ; Lu, QC; Pan, L; Liu, J; Dai, B; Zhang, B; Chen, ZX; Chen, JP; Hu, JK				Yang, Kun; Chen, Hai-Ning; Chen, Xin-Zu; Lu, Qing-Chun; Pan, Lin; Liu, Jie; Dai, Bin; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Hu, Jian-Kun			Transthoracic Resection versus Non-Transthoracic Resection for Gastroesophageal Junction Cancer: A Meta-Analysis	PLOS ONE			English	Article							TOTAL GASTRECTOMY METAANALYSIS; LIMITED TRANSHIATAL RESECTION; GASTRIC CARDIA; EN-BLOC; THORACOABDOMINAL APPROACH; ESOPHAGEAL RESECTION; SURGICAL THERAPY; DISTAL ESOPHAGUS; ADENOCARCINOMA; CARCINOMA	Background: The aim of this meta-analysis is to evaluate the impact of transthoracic resection on long-term survival of patients with GEJ cancer and to compare the postoperative morbidity and mortality of patients undergoing transthoracic resection with those of patients who were not undergoing transthoracic resection. Method: Searches of electronic databases identifying studies from Medline, Cochrane Library trials register, and WHO Trial Registration etc were performed. Outcome measures were survival, postoperative morbidity and mortality, and operation related events. Results: Twelve studies (including 5 RCTs and 7 non-RCTs) comprising 1105 patients were included in this meta-analysis, with 591 patients assigned treatment with transthoracic resection. Transthoracic resection did not increase the 5-y overall survival rate for RCTs and non-RCTs (HR = 1.01, 95% CI 0.80- 1.29 and HR = 0.89, 95% CI 0.70- 1.14, respectively). Stratified by the Siewert classification, our result showed no obvious differences were observed between the group with transthoracic resection and group without transthoracic resection (P>0.05). The postoperative morbidity (RR = 0.69, 95% CI 0.48- 1.00 and OR = 0.55, 95% CI 0.25- 1.22) and mortality (RD = -0.03, 95% CI -0.06- 0.00 and RD = 0.00, 95% CI -0.05- 0.05) of RCTs and non-RCTs did not suggest any significant differences between the two groups. Hospital stay was long with thransthoracic resection (WMD = -5.80, 95% CI -10.38- -1.23) but did not seem to differ in number of harvested lymph nodes, operation time, blood loss, numbers of patients needing transfusion, and reoperation rate. The results of sensitivity analyses were similar to the primary analyses. Conclusions: There were no significant differences of survival rate and postoperative morbidity and mortality between transthoracic resection group and non-transthoracic resection group. Both surgical approaches are acceptable, and that one offers no clear advantage over the other. However, the results should be interpreted cautiously since the qualities of included studies were suboptimal.	[Yang, Kun; Chen, Xin-Zu; Liu, Jie; Dai, Bin; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Hu, Jian-Kun] Sichuan Univ, W China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Chen, Hai-Ning; Lu, Qing-Chun; Pan, Lin] Sichuan Univ, W China Sch Med, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Yang, K (corresponding author), Sichuan Univ, W China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	zhangbo7310@126.com	Yang, Kun/A-4293-2010; Lu, Qingchun/K-8250-2019; Chen, Xin-Zu/K-2988-2019; Chen, Xin-Zu/C-2515-2009; Chen, Xin-Zu/G-6579-2014	Chen, Xin-Zu/0000-0002-7619-6244; Hu, Jiankun/0000-0003-0230-1432	Scientific and Technological Department of Sichuan Province, People's Republic of China [2008SZ0168]; National Natural Science Foundation of China [81071777]	Scientific and Technological Department of Sichuan Province, People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by Projects (2008SZ0168) in the Science & Technology Pillar Program, Scientific and Technological Department of Sichuan Province, People's Republic of China (http://www.scst.gov.cn/info/) and a grant from National Natural Science Foundation of China (No.81071777). (http://www.nsfc.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athoracsur.2003.07.002; Barbour AP, 2007, ANN SURG, V246, P1, DOI 10.1097/01.sla.0000255563.65157.d2; Biere SSAY, 2011, DIGEST SURG, V28, P29, DOI 10.1159/000322014; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Boshier PR, 2011, ANN SURG, V254, P894, DOI 10.1097/SLA.0b013e3182263781; Chang AC, 2008, ANN THORAC SURG, V85, P424, DOI 10.1016/j.athoracsur.2007.10.007; Chou SH, 2009, HEPATO-GASTROENTEROL, V56, P707; Chu KM, 1997, AM J SURG, V174, P320, DOI 10.1016/S0002-9610(97)00105-0; Colvin H, 2011, INTERACT CARDIOV TH, V12, P265, DOI 10.1510/icvts.2010.252148; Dixon E, 2005, ANN SURG, V241, P450, DOI 10.1097/01.sla.0000154258.30305.df; Dresner SM, 2001, SURGERY, V129, P103, DOI 10.1067/msy.2001.110024; ELLIS FH, 1989, MAYO CLIN PROC, V64, P945, DOI 10.1016/S0025-6196(12)61222-1; Falk J, 2007, ACTA ONCOL, V46, P1070, DOI 10.1080/02841860701403046; Gertler R, 2009, AM J GASTROENTEROL, V104, P2838, DOI 10.1038/ajg.2009.456; GOLDFADEN D, 1986, J THORAC CARDIOV SUR, V91, P242; GOLDMINC M, 1993, BRIT J SURG, V80, P367, DOI 10.1002/bjs.1800800335; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Hulscher JBF, 2001, ANN THORAC SURG, V72, P306, DOI 10.1016/S0003-4975(00)02570-4; HUSEMANN B, 1989, BRIT J SURG, V76, P136, DOI 10.1002/bjs.1800760210; Jacobi CA, 1997, EUR J CARDIO-THORAC, V11, P32, DOI 10.1016/S1010-7940(96)01106-2; Johansson J, 2004, ARCH SURG-CHICAGO, V139, P627, DOI 10.1001/archsurg.139.6.627; Khan K.S., 2001, 4 CRD NHS CTR REV DI; Kodama I, 1998, INT SURG, V83, P205; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MOON MR, 1992, ARCH SURG-CHICAGO, V127, P951; *NORD COCHR CTR CO, 2008, REV MAN REVMAN COMP; OKAMURA T, 1989, AM SURGEON, V55, P248; Omloo JMT, 2007, ANN SURG, V246, P992, DOI 10.1097/SLA.0b013e31815c4037; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pedrazzani C, 2007, J THORAC CARDIOV SUR, V134, P378, DOI 10.1016/j.jtcvs.2007.03.034; POWELL J, 1990, BRIT J CANCER, V62, P440, DOI 10.1038/bjc.1990.314; Rizzetto C, 2008, J THORAC CARDIOV SUR, V135, P1228, DOI 10.1016/j.jtcvs.2007.10.082; Sasako M, 2010, AM SOC CLIN ONC 2010; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Siewert JR, 2000, ANN SURG, V232, P353; Siewert JR, 1998, BRIT J SURG, V85, P1457; Stark SP, 1996, AM J SURG, V172, P478, DOI 10.1016/S0002-9610(96)00224-3; Wong J, 2006, LANCET ONCOL, V7, P613, DOI 10.1016/S1470-2045(06)70770-7; Yang K, 2010, AM J GASTROENTEROL, V105, P1208, DOI 10.1038/ajg.2010.42; Yekebas EF, 2006, J SURG ONCOL, V93, P541, DOI 10.1002/jso.20544; Zheng Bin, 2010, Chin J Cancer, V29, P747	44	12	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37698	10.1371/journal.pone.0037698	http://dx.doi.org/10.1371/journal.pone.0037698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675487	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700019
J	Safdar, H; Cheung, KL; Vos, HL; Gonzalez, FJ; Reitsma, PH; Inoue, Y; van Vlijmen, BJM				Safdar, Huma; Cheung, Ka Lei; Vos, Hans L.; Gonzalez, Frank J.; Reitsma, Pieter H.; Inoue, Yusuke; van Vlijmen, Bart J. M.			Modulation of Mouse Coagulation Gene Transcription following Acute In Vivo Delivery of Synthetic Small Interfering RNAs Targeting HNF4 alpha and C/EBP alpha	PLOS ONE			English	Article							NUCLEAR FACTOR 4-ALPHA; ESTROGEN-RECEPTOR-ALPHA; BINDING-PROTEIN-ALPHA; LIPID HOMEOSTASIS; LIVER-FUNCTION; KNOCKOUT MICE; HEMOPHILIA-B; EXPRESSION; PROMOTER; DISRUPTION	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) and CCAAT/enhancer-binding protein alpha (C/EBP alpha) are important for the transcriptional control of coagulation factors. To determine in vivo the direct role of HNF4 alpha and C/EBP alpha in control of genes encoding coagulation factors, a synthetic small interfering (si) RNA approach was used that enabled strong reduction of mouse hepatic HNF4 alpha and C/EBP alpha under conditions that minimized target-related secondary effects. For both HNF4 alpha and C/EBP alpha, intravenous injection of specific synthetic siRNAs (siHNF4 alpha and siC/EBP alpha) resulted in more than 75% reduction in their liver transcript and protein levels 2 days post-injection. For siHNF4 alpha, this coincided with marked and significantly reduced transcript levels of the coagulation genes Hrg, Proz, Serpina5, F11, F12, F13b, Serpinf2, F5, and F9 (in order of magnitude of effect) as compared to levels in control siRNA injected animals. Significant decreases in HNF4 alpha target gene mRNA levels were also observed at 5 days post-siRNA injection, despite a limited level of HNF4 alpha knockdown at this time point. Compared to HNF4 alpha, C/EBP alpha knockdown had a modest impact on genes encoding coagulation factors. A strong reduction in C/EBP alpha transcript and protein levels resulted in significantly affected transcript levels of the control genes Pck1 and Fasn and a modest downregulation for coagulation genes Fba, Fbg and F5. F5 and F11 were the sole coagulation genes that were significantly affected upon prolonged (5 day) C/EBP alpha knockdown. We conclude that in the mouse, HNF4 alpha has a direct and essential regulatory role for multiple hepatic coagulation genes, while a role for C/EBP alpha is more restricted. In addition, this study demonstrates that synthetic siRNA provides a simple and fast means for determining liver transcription factor involvement in vivo.	[Safdar, Huma; Cheung, Ka Lei; Vos, Hans L.; Reitsma, Pieter H.; van Vlijmen, Bart J. M.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Gonzalez, Frank J.] NCI, Lab Metab, Bethesda, MD 20892 USA; [Inoue, Yusuke] Gunma Univ Kiryu, Grad Sch Engn, Dept Chem & Chem Biol, Gunma, Japan	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gunma University	Safdar, H (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	h.safdar@lumc.nl	Inoue, Yusuke/O-6207-2018	Inoue, Yusuke/0000-0002-9710-7482; Safdar, Huma/0000-0002-0716-3895	Dutch Organization for Scientific Research (NWO-TOP) [40-00812-98-07-045]	Dutch Organization for Scientific Research (NWO-TOP)	This project is financially supported by the Dutch Organization for Scientific Research (NWO-TOP Grant #40-00812-98-07-045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbini AA, 1997, BLOOD, V89, P176, DOI 10.1182/blood.V89.1.176.176_176_182; Begbie M, 2000, THROMB HAEMOSTASIS, V84, P216; Ceelie H, 2003, J THROMB HAEMOST, V1, P1688, DOI 10.1046/j.1538-7836.2003.00393.x; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x; CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0; Davies N, 1997, BRIT J HAEMATOL, V99, P578, DOI 10.1046/j.1365-2141.1997.4603263.x; Farsetti A, 1998, ENDOCRINOLOGY, V139, P4581, DOI 10.1210/en.139.11.4581; FernandezRachubinski FA, 1996, J BIOL CHEM, V271, P29502, DOI 10.1074/jbc.271.46.29502; FIGUEIREDO MS, 1995, J BIOL CHEM, V270, P11828, DOI 10.1074/jbc.270.20.11828; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Hall AJ, 2006, BRIT J HAEMATOL, V135, P538, DOI 10.1111/j.1365-2141.2006.06327.x; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; MIAO CH, 1992, J BIOL CHEM, V267, P7395; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Nagai N, 2008, THROMB RES, V122, P549, DOI 10.1016/j.thromres.2007.12.017; Qiao LP, 2006, ENDOCRINOLOGY, V147, P3060, DOI 10.1210/en.2005-1507; REIJNEN MJ, 1992, P NATL ACAD SCI USA, V89, P6300, DOI 10.1073/pnas.89.14.6300; Safdar H, 2010, J THROMB HAEMOST, V8, P2839, DOI 10.1111/j.1538-7836.2010.04080.x; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Sugawara H, 2007, J THROMB HAEMOST, V5, P2250, DOI 10.1111/j.1538-7836.2007.02738.x; Tarumi T, 2002, J BIOL CHEM, V277, P18510, DOI 10.1074/jbc.M201886200; van Rossenberg SMW, 2003, BIOCONJUGATE CHEM, V14, P1077, DOI 10.1021/bc0340417; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	35	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38104	10.1371/journal.pone.0038104	http://dx.doi.org/10.1371/journal.pone.0038104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675511	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900013
J	Lau, EHY; Cheng, CKY; Ip, DKM; Cowling, BJ				Lau, Eric H. Y.; Cheng, Calvin K. Y.; Ip, Dennis K. M.; Cowling, Benjamin J.			Situational Awareness of Influenza Activity Based on Multiple Streams of Surveillance Data Using Multivariate Dynamic Linear Model	PLOS ONE			English	Article								Background: Multiple sources of influenza surveillance data are becoming more available; however integration of these data streams for situational awareness of influenza activity is less explored. Methods and Results: We applied multivariate time-series methods to sentinel outpatient and school absenteeism surveillance data in Hong Kong during 2004-2009. School absenteeism data and outpatient surveillance data experienced interruptions due to school holidays and changes in public health guidelines during the pandemic, including school closures and the establishment of special designated flu clinics, which in turn provided 'drop-in' fever counts surveillance data. A multivariate dynamic linear model was used to monitor influenza activity throughout epidemics based on all available data. The inferred level followed influenza activity closely at different times, while the inferred trend was less competent with low influenza activity. Correlations between inferred level and trend from the multivariate model and reference influenza activity, measured by the product of weekly laboratory influenza detection rates and weekly general practitioner influenza-like illness consultation rates, were calculated and compared with those from univariate models. Over the whole study period, there was a significantly higher correlation (rho = 0.82, p <= 0.02) for the inferred trend based on the multivariate model compared to other univariate models, while the inferred trend from the multivariate model performed as well as the best univariate model in the pre-pandemic and the pandemic period. The inferred trend and level from the multivariate model was able to match, if not outperform, the best univariate model albeit with missing data plus drop-in and drop-out of different surveillance data streams. An overall influenza index combining level and trend was constructed to demonstrate another potential use of the method. Conclusions: Our results demonstrate the potential use of multiple streams of influenza surveillance data to promote situational awareness about the level and trend of seasonal and pandemic influenza activity.	[Lau, Eric H. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lau, EHY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	ehylau@hku.hk	Cowling, Benjamin John/C-4263-2009; Lau, Eric/AAJ-6588-2021; Ip, Dennis Kai Ming/C-4283-2009	Cowling, Benjamin John/0000-0002-6297-7154; Lau, Eric/0000-0002-6688-9637; Ip, Dennis Kai Ming/0000-0003-3592-8709	Research Fund for the Control of Infectious Diseases of the Food and Health Bureau of the Hong Kong Special Administrative Region Government [11101092]; Area of Excellence Scheme of the University Grants Committee [AoE/M-12/06]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Fund for the Control of Infectious Diseases of the Food and Health Bureau of the Hong Kong Special Administrative Region Government; Area of Excellence Scheme of the University Grants Committee; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was in part funded by the Research Fund for the Control of Infectious Diseases of the Food and Health Bureau of the Hong Kong Special Administrative Region Government (grant no. 11101092), the Area of Excellence Scheme of the University Grants Committee (grant no. AoE/M-12/06), and the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant number U54 GM088558). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707; Buckeridge DL, 2008, J AM MED INFORM ASSN, V15, P760, DOI 10.1197/jamia.M2799; Centers for Disease Control and Prevention, 2011, FLU ACT SURV; Cheng CKY, 2012, EMERG INFECT DIS, V18, P885, DOI 10.3201/eid1805.111796; Cowling BJ, 2008, EMERG INFECT DIS, V14, P1660, DOI 10.3201/eid1410.080646; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; International Society for Disease Surveillance, 2011, DISTR; Lau EHY, 2008, EMERG INFECT DIS, V14, P1154, DOI 10.3201/eid1407.080060; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Mnatsakanyan ZR, 2009, J AM MED INFORM ASSN, V16, P855, DOI 10.1197/jamia.M2647; Paul M, 2011, STAT MED, V30, P1118, DOI 10.1002/sim.4177; Schmidt WP, 2010, EUROSURVEILLANCE, V15, P4; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Vergu E, 2006, EMERG INFECT DIS, V12, P416, DOI 10.3201/eid1203.050573; West M., 2006, BAYESIAN FORECASTING; WHO, 2011, MAN LAB DIAGN VIR SU; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216	18	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38346	10.1371/journal.pone.0038346	http://dx.doi.org/10.1371/journal.pone.0038346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675456	Green Published, gold			2022-12-27	WOS:000305338500137
J	Agarwal, SK; Jothi, R				Agarwal, Sunita K.; Jothi, Raja			Genome-Wide Characterization of Menin-Dependent H3K4me3 Reveals a Specific Role for Menin in the Regulation of Genes Implicated in MEN1-Like Tumors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ENDOCRINE-NEOPLASIA TYPE-1; HISTONE METHYLTRANSFERASE COMPLEX; PANCREATIC NEUROENDOCRINE TUMORS; SUPPRESSOR MENIN; EXPRESSED GENES; IN-VITRO; DIFFERENTIATION; MICE; LEUKEMIA	Inactivating mutations in the MEN1 gene predisposing to the multiple endocrine neoplasia type 1 (MEN1) syndrome can also cause sporadic pancreatic endocrine tumors. MEN1 encodes menin, a subunit of MLL1/MLL2-containing histone methyltransferase complexes that trimethylate histone H3 at lysine 4 (H3K4me3). The importance of menin-dependent H3K4me3 in normal and transformed pancreatic endocrine cells is unclear. To study the role of menin-dependent H3K4me3, we performed in vitro differentiation of wild-type as well as menin-null mouse embryonic stem cells (mESCs) into pancreatic islet-like endocrine cells (PILECs). Gene expression analysis and genome-wide H3K4me3 ChIP-Seq profiling in wild-type and menin-null mESCs and PILECs revealed menin-dependent H3K4me3 at the imprinted Dlk1-Meg3 locus in mESCs, and all four Hox loci in differentiated PILECs. Specific and significant loss of H3K4me3 and gene expression was observed for genes within the imprinted Dlk1-Meg3 locus in menin-null mESCs and the Hox loci in menin-null PILECs. Given that the reduced expression of genes within the DLK1-MEG3 locus and the HOX loci is associated with MEN1-like sporadic tumors, our data suggests a possible role for menin-dependent H3K4me3 at these genes in the initiation and progression of sporadic pancreatic endocrine tumors. Furthermore, our investigation also demonstrates that menin-null mESCs can be differentiated in vitro into islet-like endocrine cells, underscoring the utility of menin-null mESC-derived specialized cell types for genome-wide high-throughput studies.	[Agarwal, Sunita K.] NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; [Jothi, Raja] Natl Inst Environm Hlth Sci, Syst Biol Sect, Biostat Branch, NIH, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Agarwal, SK (corresponding author), NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA.	SunitaA@mail.nih.gov; jothi@mail.nih.gov	Agarwal, Sunita K/D-1428-2016; Jothi, Raja/G-3780-2015	Agarwal, Sunita K/0000-0002-7557-3191; Jothi, Raja/0000-0002-4833-1090	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [1ZIADK075035-03]; National Institute of Environmental Health Sciences [1ZIAES102625-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102625] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (SKA; Project number: 1ZIADK075035-03), and the National Institute of Environmental Health Sciences (RJ; Project number: 1ZIAES102625-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2009, HORM RES, V71, P131, DOI 10.1159/000192450; Balasubramanian D, 2009, ADV EXP MED BIOL, V668, P105; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Benetatos L, 2011, INT J CANCER, V129, P773, DOI 10.1002/ijc.26052; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bingham EL, 2009, STEM CELLS DEV, V18, P1071, DOI 10.1089/scd.2008.0337; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Cheunsuchon P, 2011, AM J PATHOL, V179, P2120, DOI 10.1016/j.ajpath.2011.07.002; Dani C, 1997, J CELL SCI, V110, P1279; Fontaniere S, 2008, J ENDOCRINOL, V199, P287, DOI 10.1677/JOE-08-0289; Gordon FE, 2010, ENDOCRINOLOGY, V151, P2443, DOI 10.1210/en.2009-1151; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jensen RT, 2006, J GASTROINTEST SURG, V10, P324, DOI 10.1016/j.gassur.2005.08.022; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muntean AG, 2011, ANN REV PATHOLOGY; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Naujok O, 2011, MOL THER, V19, P1759, DOI 10.1038/mt.2011.165; Novotny E, 2009, MECH DEVELOP, V126, P517, DOI 10.1016/j.mod.2009.04.001; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shen HCJ, 2010, ENDOCRINOLOGY, V151, P4024, DOI 10.1210/en.2009-1251; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; Shen HCJ, 2008, ENDOCR-RELAT CANCER, V15, P267, DOI 10.1677/ERC-07-0191; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Velculescu VE, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003001; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang HL, 2011, MOL MED REP, V4, P301, DOI 10.3892/mmr.2011.409; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	36	36	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37952	10.1371/journal.pone.0037952	http://dx.doi.org/10.1371/journal.pone.0037952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666422	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400061
J	Larsen, FW; Turner, WR; Brooks, TM				Larsen, Frank W.; Turner, Will R.; Brooks, Thomas M.			Conserving Critical Sites for Biodiversity Provides Disproportionate Benefits to People	PLOS ONE			English	Article							ECOSYSTEM SERVICES; CONSERVATION PRIORITIES; ECONOMIC-BENEFITS; DIVERSITY; POVERTY; WORLDS; AREAS; CARBON; COSTS; LAND	Protecting natural habitats in priority areas is essential to halt the loss of biodiversity. Yet whether these benefits for biodiversity also yield benefits for human well-being remains controversial. Here we assess the potential human well-being benefits of safeguarding a global network of sites identified as top priorities for the conservation of threatened species. Conserving these sites would yield benefits - in terms of a) climate change mitigation through avoidance of CO2 emissions from deforestation; b) freshwater services to downstream human populations; c) retention of option value; and d) benefits to maintenance of human cultural diversity - significantly exceeding those anticipated from randomly selected sites within the same countries and ecoregions. Results suggest that safeguarding sites important for biodiversity conservation provides substantial benefits to human well-being.	[Larsen, Frank W.; Turner, Will R.] Conservat Int, Sci & Knowledge Div, Arlington, VA 22202 USA; [Larsen, Frank W.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Brooks, Thomas M.] NatureServe, Arlington, VA USA; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas, Australia; [Brooks, Thomas M.] Univ Philippines, World Agroforestry Ctr, Los Banos, Laguna, Philippines	Conservation International; University of Copenhagen; Nature Conservancy; University of Tasmania; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University	Larsen, FW (corresponding author), Conservat Int, Sci & Knowledge Div, Arlington, VA 22202 USA.	frankwugtlarsen@gmail.com	Larsen, Frank/C-5172-2009	Brooks, Thomas/0000-0001-8159-3116	Danish Council for Research (FNU); Gordon and Betty Moore Foundation; John D. and Catherine T. MacArthur Foundation	Danish Council for Research (FNU)(Danish Natural Science Research Council); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); John D. and Catherine T. MacArthur Foundation	FWL acknowledges a grant from the Danish Council for Research (FNU). All authors are grateful for funding from the Gordon and Betty Moore Foundation, and for partial support by an award from the John D. and Catherine T. MacArthur Foundation to NatureServe addressing "Dashboard assessments: proof-of-concept and baselines." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Alcamo J, 2003, HYDROLOG SCI J, V48, P317, DOI 10.1623/hysj.48.3.317.45290; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2009, GROSS DOM PROD 2008; Armsworth PR, 2007, CONSERV BIOL, V21, P1383, DOI 10.1111/j.1523-1739.2007.00821.x; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Balmford A., 2008, EC BIODIVERSITY ECOS; *BIRDLIFE INT, 2008, STAT WORLDS BIRDS; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Bruijnzeel LA, 2004, AGR ECOSYST ENVIRON, V104, P185, DOI 10.1016/j.agee.2004.01.015; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Campbell A, 2008, CARBON EMISSIONS FOR; CBD, 2010, DEC X 2 STRAT PLAN B; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P206; Chivian E, 2008, SUSTAINING LIFE HUMA; da Fonseca GAB, 2007, PLOS BIOL, V5, P1645, DOI 10.1371/journal.pbio.0050216; Dudley N., 2003, RUNNING PURE IMPORTA; EC-JRC (EUROPEAN COMMISSION JOINT RESEARCH CENTRE), 2006, GLOB LAND COV 2000 D; Egoh B, 2009, BIOL CONSERV, V142, P553, DOI 10.1016/j.biocon.2008.11.009; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Hastings D. A., 1999, GLOBAL LAND ONE KILO; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN, 2014, IUCN RED LIST THREAT; Iverson JB, EMYSYSTEM WORLD TURT; Langhammer P.F., 2007, IDENTIFICATION GAP A; Larsen FW, 2011, CONSERV LETT, V4, P355, DOI 10.1111/j.1755-263X.2011.00183.x; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Luck GW, 2009, CONSERV LETT, V2, P179, DOI 10.1111/j.1755-263X.2009.00064.x; MAFFI L, 2001, NEW DIRECTIONS ANTHR, P24; Manne LL, 2003, EVOL ECOL RES, V5, P517; McKinsey & Company, 2009, PATHW LOW CARB EC VE; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; Moore JL, 2002, P ROY SOC B-BIOL SCI, V269, P1645, DOI 10.1098/rspb.2002.2075; Mulligan M, 2005, FID FRP PROJECT ZF02; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; Naidoo R, 2007, BIOL CONSERV, V140, P40, DOI 10.1016/j.biocon.2007.07.025; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; *OAK RIDG NAT LAB, 2006, LANDSCAN GLOB POP DA; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paolillo J. C., 2006, EVALUATING LANGUAGE; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Roe D, 2008, ORYX, V42, P491, DOI 10.1017/S0030605308002032; Ruesch A, 2008, NEW GLOBAL BIOMASS C; Scharlemann JPW, 2010, ORYX, V44, P352, DOI 10.1017/S0030605310000542; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; STRASSBURG B, 2009, GLOBAL ENVIRON CHANG, V19, P265, DOI [DOI 10.1016/j.gloenvcha.2008.11.004, DOI 10.1016/J.GLOENVCHA.2008.11.004]; Stuart S. N., 2008, THREATENED AMPHIBIAN; Sutherland WJ, 2003, NATURE, V423, P276, DOI 10.1038/nature01607; TEEB, 2010, EC EC BIOD MAINSTR E; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; Turner WR, 2007, BIOSCIENCE, V57, P868, DOI 10.1641/B571009; Turner WR, 2012, BIOSCIENCE, V62, P85, DOI 10.1525/bio.2012.62.1.13; U.S.Geological Survey, 2000, HYDRO1K EL DER DAT; UNEP-WCMC, 2008, WORLD DAT PROT AR WD; UNFCCC, 2010, CANC AGR; United Nations Development Programme (UNDP), 2008, HUM DEV IND STAT UPD; United Nations Food and Agricultural Organization, 2005, GLOB FOR RES ASS 200; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671	66	28	28	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36971	10.1371/journal.pone.0036971	http://dx.doi.org/10.1371/journal.pone.0036971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666337	Green Published, gold			2022-12-27	WOS:000305353400019
J	Yamashita, Y; Tani, J				Yamashita, Yuichi; Tani, Jun			Spontaneous Prediction Error Generation in Schizophrenia	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; SYNAPTIC PLASTICITY; MODELS; DEFICITS; DISCONNECTION; DYSCONNECTION; CONNECTIVITY; PSYCHOSIS; MOVEMENT; BEHAVIOR	Goal-directed human behavior is enabled by hierarchically-organized neural systems that process executive commands associated with higher brain areas in response to sensory and motor signals from lower brain areas. Psychiatric diseases and psychotic conditions are postulated to involve disturbances in these hierarchical network interactions, but the mechanism for how aberrant disease signals are generated in networks, and a systems-level framework linking disease signals to specific psychiatric symptoms remains undetermined. In this study, we show that neural networks containing schizophrenia-like deficits can spontaneously generate uncompensated error signals with properties that explain psychiatric disease symptoms, including fictive perception, altered sense of self, and unpredictable behavior. To distinguish dysfunction at the behavioral versus network level, we monitored the interactive behavior of a humanoid robot driven by the network. Mild perturbations in network connectivity resulted in the spontaneous appearance of uncompensated prediction errors and altered interactions within the network without external changes in behavior, correlating to the fictive sensations and agency experienced by episodic disease patients. In contrast, more severe deficits resulted in unstable network dynamics resulting in overt changes in behavior similar to those observed in chronic disease patients. These findings demonstrate that prediction error disequilibrium may represent an intrinsic property of schizophrenic brain networks reporting the severity and variability of disease symptoms. Moreover, these results support a systems-level model for psychiatric disease that features the spontaneous generation of maladaptive signals in hierarchical neural networks.	[Yamashita, Yuichi; Tani, Jun] RIKEN Brain Sci Inst, Lab Behav & Dynam Cognit, Wako, Saitama, Japan	RIKEN	Yamashita, Y (corresponding author), JST, ERATO, Okanoya Emot Informat Project, Wako, Saitama, Japan.	tani1216jp@gmail.com	Tani, Jun/AAI-8287-2020; Tani, Jun/H-3681-2012		KAKENHI [23700279]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (#23700279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banyai M, 2011, NEUROIMAGE, V58, P870, DOI 10.1016/j.neuroimage.2011.06.046; Bassett DS, 2011, TRENDS COGN SCI, V15, P200, DOI 10.1016/j.tics.2011.03.006; Becerril KE, 2011, NEUROIMAGE, V54, P1495, DOI 10.1016/j.neuroimage.2010.09.046; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Cocchi L, 2012, HUM BRAIN MAPP, V33, P1089, DOI 10.1002/hbm.21270; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2011, NEUROPSYCHOPHARMACOL, V36, P294, DOI 10.1038/npp.2010.163; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Fetz EE, 2002, HDB BRAIN THEORY NEU; Fourneret P, 2001, NEUROREPORT, V12, P1203, DOI 10.1097/00001756-200105080-00030; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 2005, BEHAV BRAIN SCI, V28, P764, DOI 10.1017/S0140525X05290131; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Gallagher S, 2004, PSYCHOPATHOLOGY, V37, P8, DOI 10.1159/000077014; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Jeannerod M, 2009, EXP BRAIN RES, V192, P527, DOI 10.1007/s00221-008-1533-3; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; Kanai R, 2004, VISION RES, V44, P2605, DOI 10.1016/j.visres.2003.10.028; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kerns JG, 2005, AM J PSYCHIAT, V162, P1833, DOI 10.1176/appi.ajp.162.10.1833; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Mazaheri A, 2010, BIOL PSYCHIAT, V67, P617, DOI 10.1016/j.biopsych.2009.11.022; Quintana J, 2003, BIOL PSYCHIAT, V53, P12, DOI 10.1016/S0006-3223(02)01435-X; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Schneider K, 1991, KLINISCHE PSYCHOPATH; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Tani J, 2003, NEURAL NETWORKS, V16, P11, DOI 10.1016/S0893-6080(02)00214-9; Tani J, 2008, NEURAL NETWORKS, V21, P584, DOI 10.1016/j.neunet.2008.03.008; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Vercammen A, 2010, BIOL PSYCHIAT, V67, P912, DOI 10.1016/j.biopsych.2009.11.017; Williams LE, 2010, SCHIZOPHR RES, V121, P101, DOI 10.1016/j.schres.2009.10.021; Yamashita Y, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00018; Yamashita Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000220; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353	47	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37843	10.1371/journal.pone.0037843	http://dx.doi.org/10.1371/journal.pone.0037843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666398	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400052
J	Bonfiglio, S; Ginja, C; De Gaetano, A; Achilli, A; Olivieri, A; Colli, L; Tesfaye, K; Agha, SH; Gama, LT; Cattonaro, F; Penedo, MCT; Ajmone-Marsan, P; Torroni, A; Ferretti, L				Bonfiglio, Silvia; Ginja, Catarina; De Gaetano, Anna; Achilli, Alessandro; Olivieri, Anna; Colli, Licia; Tesfaye, Kassahun; Agha, Saif Hassan; Gama, Luis T.; Cattonaro, Federica; Penedo, M. Cecilia T.; Ajmone-Marsan, Paolo; Torroni, Antonio; Ferretti, Luca			Origin and Spread of Bos taurus: New Clues from Mitochondrial Genomes Belonging to Haplogroup T1	PLOS ONE			English	Article							CREOLE CATTLE; GENETIC DIVERSITY; AFRICAN; SEQUENCE; MTDNA; DNA; MATRILINEAGES	Background: Most genetic studies on modern cattle have established a common origin for all taurine breeds in the Near East, during the Neolithic transition about 10 thousand years (ka) ago. Yet, the possibility of independent and/or secondary domestication events is still debated and is fostered by the finding of rare mitochondrial DNA (mtDNA) haplogroups like P, Q and R. Haplogroup T1, because of its geographic distribution, has been the subject of several investigations pointing to a possible independent domestication event in Africa and suggesting a genetic contribution of African cattle to the formation of Iberian and Creole cattle. Whole mitochondrial genome sequence analysis, with its proven effectiveness in improving the resolution of phylogeographic studies, is the most appropriate tool to investigate the origin and structure of haplogroup T1. Methodology: A survey of >2200 bovine mtDNA control regions representing 28 breeds (15 European, 10 African, 3 American) identified 281 subjects belonging to haplogroup T1. Fifty-four were selected for whole mtDNA genome sequencing, and combined with ten T1 complete sequences from previous studies into the most detailed T1 phylogenetic tree available to date. Conclusions: Phylogenetic analysis of the 64 T1 mitochondrial complete genomes revealed six distinct sub-haplogroups (T1a-T1f). Our data support the overall scenario of a Near Eastern origin of the T1 sub-haplogroups from as much as eight founding T1 haplotypes. However, the possibility that one sub-haplogroup (T1d) arose in North Africa, in domesticated stocks, shortly after their arrival from the Near East, can not be ruled out. Finally, the previously identified "African-derived American" (AA) haplotype turned out to be a sub-clade of T1c (T1c1a1). This haplotype was found here for the first time in Africa (Egypt), indicating that it probably originated in North Africa, reached the Iberian Peninsula and sailed to America, with the first European settlers.	[Bonfiglio, Silvia; De Gaetano, Anna; Olivieri, Anna; Torroni, Antonio; Ferretti, Luca] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Ginja, Catarina] Univ Lisbon, Inst Nacl Recursos Biol, Mol Biol Grp, INIA, P-1699 Lisbon, Portugal; [Ginja, Catarina] Univ Lisbon, Environm Biol Ctr, Fac Sci, P-1699 Lisbon, Portugal; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Colli, Licia; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Ctr Ric Biodivers & DNA Ant BioDNA, Piacenza, Italy; [Colli, Licia; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Ist Zootecn, Piacenza, Italy; [Tesfaye, Kassahun] Univ Addis Ababa, Fac Life Sci, Microbial Cellular & Mol Biol Program Unit, Addis Ababa, Ethiopia; [Agha, Saif Hassan] Ain Shams Univ, Fac Agr, Dept Anim Prod, Cairo, Egypt; [Gama, Luis T.] Univ Tecn Lisboa, Fac Med Vet, Lisbon, Portugal; [Cattonaro, Federica] Appl Genom Inst IGA, Udine, Italy; [Penedo, M. Cecilia T.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA	University of Pavia; Universidade de Lisboa; Universidade de Lisboa; University of Perugia; Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Addis Ababa University; Egyptian Knowledge Bank (EKB); Ain Shams University; Universidade de Lisboa; University of California System; University of California Davis	Bonfiglio, S (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	luca.ferretti@unipv.it	De Gaetano, Anna/GWC-1521-2022; Ferretti, Luca/D-2337-2013; Gama, Luis T/N-4172-2018; Achilli, Alessandro/I-9236-2012; Bonfiglio, Silvia/AAC-1988-2019; Colli, Licia/AAC-2985-2021; OLIVIERI, ANNA/I-9235-2012; Torroni, Antonio/E-1557-2011; AJMONE MARSAN, Paolo/M-2466-2018	Gama, Luis T/0000-0003-3894-3488; Achilli, Alessandro/0000-0001-6871-3451; OLIVIERI, ANNA/0000-0002-3941-8098; Torroni, Antonio/0000-0002-4163-4478; Ginja, Catarina/0000-0003-2278-7089; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Agha, Saif/0000-0003-3373-146X; Bonfiglio, Silvia/0000-0002-4422-1580; Ferretti, Luca/0000-0001-5044-8442	Italian Ministry of Education, University and Research: Progetti FIRB-Futuro in Ricerca; Fondazione Alma Mater Ticinensis	Italian Ministry of Education, University and Research: Progetti FIRB-Futuro in Ricerca; Fondazione Alma Mater Ticinensis	This research received support from the Italian Ministry of Education, University and Research: Progetti FIRB-Futuro in Ricerca 2008 (to AA and AO) and Fondazione Alma Mater Ticinensis (to AT and LF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bonfiglio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015760; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Caramelli D., 2006, HUM EVOL, V21, P107; Carvajal-Carmona LG, 2003, GENETICS, V165, P1457; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Cortes O, 2008, ANIM GENET, V39, P649, DOI 10.1111/j.1365-2052.2008.01782.x; Cymbron T, 1999, P ROY SOC B-BIOL SCI, V266, P597, DOI 10.1098/rspb.1999.0678; Dadi H, 2009, ANIM GENET, V40, P556, DOI 10.1111/j.1365-2052.2009.01866.x; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Douglas KC, 2011, MITOCHONDRION, V11, P166, DOI 10.1016/j.mito.2010.09.005; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Ginja C, 2010, ANIM GENET, V41, P128, DOI 10.1111/j.1365-2052.2009.01976.x; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Lari M, 2011, BMC EVOL BIOL, V11, P32; Liron JP, 2006, ANIM GENET, V37, P379, DOI 10.1111/j.1365-2052.2006.01452.x; Mannen H, 2004, MOL PHYLOGENET EVOL, V32, P539, DOI 10.1016/j.ympev.2004.01.010; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Miretti MM, 2004, J HERED, V95, P450, DOI 10.1093/jhered/esh070; Miretti MM, 2002, J HERED, V93, P323, DOI 10.1093/jhered/93.5.323; Mirol PM, 2003, HEREDITY, V91, P248, DOI 10.1038/sj.hdy.6800312; Perez-Pardal L, 2010, HEREDITY, V105, P511, DOI 10.1038/hdy.2010.30; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088	28	56	57	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38601	10.1371/journal.pone.0038601	http://dx.doi.org/10.1371/journal.pone.0038601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685589	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700052
J	Hemming, K; Chilton, PJ; Lilford, RJ; Avery, A; Sheikh, A				Hemming, Karla; Chilton, Peter J.; Lilford, Richard J.; Avery, Anthony; Sheikh, Aziz			Bayesian Cohort and Cross-Sectional Analyses of the PINCER Trial: A Pharmacist-Led Intervention to Reduce Medication Errors in Primary Care	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; DRUG-RELATED MORBIDITY; MEDICINES MANAGEMENT; PRIOR DISTRIBUTIONS; PUBLIC-POLICY; BASE-LINE; STATISTICS; METAANALYSIS; INFORMATION; INDICATORS	Background: Medication errors are an important source of potentially preventable morbidity and mortality. The PINCER study, a cluster randomised controlled trial, is one of the world's first experimental studies aiming to reduce the risk of such medication related potential for harm in general practice. Bayesian analyses can improve the clinical interpretability of trial findings. Methods: Experts were asked to complete a questionnaire to elicit opinions of the likely effectiveness of the intervention for the key outcomes of interest - three important primary care medication errors. These were averaged to generate collective prior distributions, which were then combined with trial data to generate Bayesian posterior distributions. The trial data were analysed in two ways: firstly replicating the trial reported cohort analysis acknowledging pairing of observations, but excluding non-paired observations; and secondly as cross-sectional data, with no exclusions, but without acknowledgement of the pairing. Frequentist and Bayesian analyses were compared. Findings: Bayesian evaluations suggest that the intervention is able to reduce the likelihood of one of the medication errors by about 50 (estimated to be between 20% and 70%). However, for the other two main outcomes considered, the evidence that the intervention is able to reduce the likelihood of prescription errors is less conclusive. Conclusions: Clinicians are interested in what trial results mean to them, as opposed to what trial results suggest for future experiments. This analysis suggests that the PINCER intervention is strongly effective in reducing the likelihood of one of the important errors; not necessarily effective in reducing the other errors. Depending on the clinical importance of the respective errors, careful consideration should be given before implementation, and refinement targeted at the other errors may be something to consider.	[Hemming, Karla; Chilton, Peter J.; Lilford, Richard J.] Univ Birmingham, Sch Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Avery, Anthony] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, eHealth Res Grp, Edinburgh, Midlothian, Scotland	University of Birmingham; University of Nottingham; University of Edinburgh	Hemming, K (corresponding author), Univ Birmingham, Sch Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England.	k.hemming@bham.ac.uk	Sheikh, Aziz/D-2818-2009; Hemming, karla/AAB-3391-2021	Sheikh, Aziz/0000-0001-7022-3056; Hemming, karla/0000-0002-2226-6550; Lilford, Richard/0000-0002-0634-984X; Avery, Anthony/0000-0001-7591-4438; Chilton, Peter/0000-0001-8809-9735	National Institute of Health Research; Engineering and Physical Sciences Research Council of the United Kingdom [GR/S29874/01]; Patient Safety Research Portfolio; Edinburgh MRC Methodology Trial Hub; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; Medical Research Council [G0800808] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10008] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Patient Safety Research Portfolio; Edinburgh MRC Methodology Trial Hub(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	K. Hemming and R. J. Lilford were funded in part by a National Institute of Health Research grant for Collaborations for Leadership in Applied Health Research and Care (CLAHRC), for the duration of this work. R. J. Lilford was also funded in part by the Engineering and Physical Sciences Research Council of the United Kingdom through the MATCH programme (grant GR/S29874/01). The views expressed in this publication are not necessarily those of the NIHR or the Department of Health. A. Sheikh and A. Avery were funded in part by Patient Safety Research Portfolio and Edinburgh MRC Methodology Trial Hub. The funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamina M, 2009, CANCER-AM CANCER SOC, V115, P5371, DOI 10.1002/cncr.24628; Avery AJ, 2002, BRIT J GEN PRACT, V52, pS17; Avery AJ, 2010, PINCER TRIAL CLUSTER; Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; Avery AJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-28; Baudouin V, 2012, PEDIATR NEPHROL, V27, P389, DOI 10.1007/s00467-011-2006-7; Braunholtz D, 1997, BRIT MED J, V314, P1202, DOI 10.1136/bmj.314.7088.1202a; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Goodman SN, 2005, CLIN TRIALS, V2, P305, DOI 10.1191/1740774505cn102oa; Hammersley VS, 2006, J CLIN PHARM THER, V31, P223, DOI 10.1111/j.1365-2710.2006.00723.x; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johnson SR, 2010, J CLIN EPIDEMIOL, V63, P355, DOI 10.1016/j.jclinepi.2009.06.003; Kalil AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002291; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; Lilford RJ, 2003, PUBLIC MONEY MANAGE, V23, P203, DOI 10.1111/1467-9302.00369; Lilford RJ, 1996, BRIT MED J, V313, P603; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Ma JH, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-37; Miksad RA, 2009, J CLIN ONCOL, V27, P2245, DOI 10.1200/JCO.2008.16.2586; Morris CJ, 2004, QUAL SAF HEALTH CARE, V13, P181, DOI 10.1136/qshc.2003.008334; Nixon RM, 2003, STAT MED, V22, P2673, DOI 10.1002/sim.1483; O'Hagan A, 2002, STAT METHODS MED RES, V11, P469, DOI 10.1191/0962280202sm305ra; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; Presanis AM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5408; Proschan MA, 1996, STAT MED, V15, P1059, DOI 10.1002/(SICI)1097-0258(19960530)15:10<1059::AID-SIM219>3.0.CO;2-2; Royal S, 2006, QUAL SAF HEALTH CARE, V15, P23, DOI 10.1136/qshc.2004.012153; Spiegelhalter D J, 2000, Health Technol Assess, V4, P1; Spiegelhalter DJ, 2004, STAT SCI, V19, P156, DOI 10.1214/088342304000000080; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Turner RM, 2009, J R STAT SOC A STAT, V172, P21, DOI 10.1111/j.1467-985X.2008.00547.x; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123	31	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38306	10.1371/journal.pone.0038306	http://dx.doi.org/10.1371/journal.pone.0038306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685559	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700022
J	Krintel, SB; Essioux, L; Wool, A; Johansen, JS; Schreiber, E; Zekharya, T; Akiva, P; Ostergaard, M; Hetland, ML				Krintel, Sophine B.; Essioux, Laurent; Wool, Assaf; Johansen, Julia S.; Schreiber, Ehud; Zekharya, Tomer; Akiva, Pinchas; Ostergaard, Mikkel; Hetland, Merete L.			CD6 and Syntaxin Binding Protein 6 Variants and Response to Tumor Necrosis Factor Alpha Inhibitors in Danish Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							ANTI-TNF TREATMENT; GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; DIFFERENTIAL RESPONSE; CANDIDATE GENES; THERAPY; METHOTREXATE; ADALIMUMAB; INFLIXIMAB; RECEPTOR	Background: TNF alpha inhibitor therapy has greatly improved the treatment of patients with rheumatoid arthritis, however at least 30% do not respond. We aimed to investigate insertions and deletions (INDELS) associated with response to TNF alpha inhibitors in patients with rheumatoid arthritis (RA). Methodology and Principal Findings: In the DANBIO Registry we identified 237 TNF alpha inhibitor naive patients with RA (81% women; median age 56 years; disease duration 6 years) who initiated treatment with infliximab (n = 160), adalimumab (n = 56) or etanercept (n = 21) between 1999 and 2008 according to national treatment guidelines. Clinical response was assessed at week 26 using EULAR response criteria. Based on literature, we selected 213 INDELS potentially related to RA and treatment response using the GeneVa (R) (Compugen) in silico database of 350,000 genetic variations in the human genome. Genomic segments were amplified by polymerase chain reaction (PCR), and genotyped by Sanger sequencing or fragment analysis. We tested the association between genotypes and EULAR good response versus no response, and EULAR good response versus moderate/no response using Fisher's exact test. At baseline the median DAS28 was 5.1. At week 26, 68 (29%) patients were EULAR good responders, while 81 (34%) and 88 (37%) patients were moderate and non-responders, respectively. A 19 base pair insertion within the CD6 gene was associated with EULAR good response vs. no response (OR = 4.43, 95% CI: 1.99-10.09, p = 7.211 x 10(-5)) and with EULAR good response vs. moderate/no response (OR = 4.54, 95% CI: 2.29-8.99, p = 3.336 x 10(-6)). A microsatellite within the syntaxin binding protein 6 (STXBP6) was associated with EULAR good response vs. no response (OR = 4.01, 95% CI: 1.92-8.49, p = 5.067 x 10(-5)). Conclusion: Genetic variations within CD6 and STXBP6 may influence response to TNF alpha inhibitors in patients with RA.	[Krintel, Sophine B.; Ostergaard, Mikkel; Hetland, Merete L.] Copenhagen Univ Hosp Glostrup, DANBIO Registry, Copenhagen, Denmark; [Krintel, Sophine B.; Ostergaard, Mikkel; Hetland, Merete L.] Copenhagen Univ Hosp Glostrup, Dept Rheumatol, Copenhagen, Denmark; [Essioux, Laurent] Hoffmann La Roche Ag, CH-4002 Basel, Switzerland; [Wool, Assaf; Schreiber, Ehud; Zekharya, Tomer; Akiva, Pinchas] Compugen Ltd, Tel Aviv, Israel; [Johansen, Julia S.] Univ Copenhagen, Copenhagen Univ Hosp Herlev, Dept Med, Copenhagen, Denmark; [Johansen, Julia S.] Univ Copenhagen, Copenhagen Univ Hosp Herlev, Dept Oncol, Copenhagen, Denmark; [Johansen, Julia S.; Ostergaard, Mikkel; Hetland, Merete L.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Roche Holding; University of Copenhagen; University of Copenhagen; University of Copenhagen	Krintel, SB (corresponding author), Copenhagen Univ Hosp Glostrup, DANBIO Registry, Copenhagen, Denmark.	krintel@sophine.dk	Hetland, Merete L/AAE-5297-2019	Hetland, Merete L/0000-0003-4229-6818	Danish Rheumatism Association; Research Council at Herlev Hospital, Denmark; Hoffmann-La Roche; Abbott; Amgen; Bristol-Myers Squibb; Centocor; Genmab; Glaxo-Smith-Kline; Mundipharma; Novo; Pfizer; Roche; Schering-Plough; UCB; Wyeth; Centocor/Janssen; MSD/Schering-Plough; Pfizer/Wyeth; Research Council at Herlev Hospital, Copenhagen, Denmark	Danish Rheumatism Association; Research Council at Herlev Hospital, Denmark; Hoffmann-La Roche(Hoffmann-La Roche); Abbott(Abbott Laboratories); Amgen(Amgen); Bristol-Myers Squibb(Bristol-Myers Squibb); Centocor; Genmab(Genmab); Glaxo-Smith-Kline(GlaxoSmithKline); Mundipharma; Novo; Pfizer(Pfizer); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); UCB(UCB Pharma SA); Wyeth(Wyeth); Centocor/Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD/Schering-Plough(Merck & CompanySchering Plough Corporation); Pfizer/Wyeth(WyethPfizer); Research Council at Herlev Hospital, Copenhagen, Denmark	This study was supported by grants from The Danish Rheumatism Association, The Research Council at Herlev Hospital, Denmark, and Hoffmann-La Roche. Data analysis was performed in collaboration with employees of Compugen and Roche. The funders had no influence on data collection and decisions to publish. The study design and data analysis were conducted in collaboration between all co-authors.; The authors have read the journal's policy and have the following conflicts: MO has received consulting fees, speaking fees and/or research grants from Abbott, Amgen, Bristol-Myers Squibb, Centocor, Genmab, Glaxo-Smith-Kline, Mundipharma, Novo, Pfizer, Roche, Schering-Plough, UCB and Wyeth. MLH has received consulting fees, speaking fees and/or research grants from Abbott, Bristol-Myers Squibb, Centocor/Janssen, Glaxo-Smith-Kline, MSD/Schering-Plough, Pfizer/Wyeth, Roche, UCB. AW, ES, TZ, and PA are full time employees at Compugen. LE is a full time employee at Roche. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; The expert technical assistance of Teresa Rozenfeld, Department of Rheumatology, Copenhagen University Hospitals at Hvidovre and Glostrup, Copenhagen, Denmark is gratefully acknowledged. Henrik Skjodt, Inge Juul Sorensen, Uffe Moller Dohn, Lene Surland Knudsen, Michael Sejer Hansen, Soren Jacobsen, and Gina Kollerup are acknowledged for recruiting patients at the Copenhagen University Hospitals at Hvidovre, Herlev, Rigshospitalet, Bispebjerg and Gentofte, Copenhagen, Denmark. We also thank the patients who participated in this study. The study was supported by grants from The Danish Rheumatism Association, The Research Council at Herlev Hospital, Copenhagen, Denmark, and Hoffmann-La Roche.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bowes JD, 2009, PHARMACOGENET GENOM, V19, P319, DOI 10.1097/FPC.0b013e328328d51f; Canete JD, 2009, ANN RHEUM DIS, V68, P1547, DOI 10.1136/ard.2008.096982; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cole SM, 2008, AM J MED GENET B, V147B, P86, DOI 10.1002/ajmg.b.30564; Coulthard LR, 2011, ANN RHEUM DIS, V70, P98, DOI 10.1136/ard.2010.133249; Criswell LA, 2004, ARTHRITIS RHEUM-US, V50, P2750, DOI 10.1002/art.20469; Cuchacovich M, 2006, SCAND J RHEUMATOL, V35, P435, DOI 10.1080/03009740600904284; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; Dohn UM, 2009, ANN RHEUM DIS, V68, P1585, DOI 10.1136/ard.2008.097048; Emery P, 2011, ANN RHEUM DIS, V70, P2063, DOI 10.1136/ard.2010.148015; Grant SFA, 2007, EXPERT REV MOL DIAGN, V7, P371, DOI 10.1586/14737159.7.4.371; Hammaker D, 2012, ARTHRITIS RHEUM-US, V64, P678, DOI 10.1002/art.33359; Hansen NT, 2009, CLIN PHARMACOL THER, V86, P183, DOI 10.1038/clpt.2009.42; Hetland ML, 2011, RHEUMATOLOGY, V50, P69, DOI 10.1093/rheumatology/keq309; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Ibanez A, 2006, J IMMUNOL, V177, P1152, DOI 10.4049/jimmunol.177.2.1152; Ku CS, 2010, J HUM GENET, V55, P403, DOI 10.1038/jhg.2010.55; Landewe RBM, 2003, ARTHRITIS RHEUM, V48, P1, DOI 10.1002/art.10732; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1903; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Liu CY, 2008, MOL MED, V14, P575, DOI 10.2119/2008-00056.Liu; Maxwell JR, 2008, HUM MOL GENET, V17, P3532, DOI 10.1093/hmg/ddn245; Mugnier B, 2003, ARTHRITIS RHEUM, V48, P1849, DOI 10.1002/art.11168; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; Nair P, 2010, CLIN EXP IMMUNOL, V162, P116, DOI 10.1111/j.1365-2249.2010.04235.x; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Padyukov L, 2003, ANN RHEUM DIS, V62, P526, DOI 10.1136/ard.62.6.526; Plant D, 2011, ARTHRITIS RHEUM-US, V63, P645, DOI 10.1002/art.30130; Plenge RM, 2008, CURR OPIN RHEUMATOL, V20, P145, DOI 10.1097/BOR.0b013e3282f5135b; Potter C, 2010, ANN RHEUM DIS, V69, P1315, DOI 10.1136/ard.2009.117309; Potter C, 2010, PHARMACOGENET GENOM, V20, P338, DOI 10.1097/FPC.0b013e32833878d7; Prajapati R, 2011, PHARMACOGENOMICS, V12, P1571, DOI [10.2217/PGS.11.114, 10.2217/pgs.11.114]; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rantalaiho V, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3060; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Scales SJ, 2002, J BIOL CHEM, V277, P28271, DOI 10.1074/jbc.M204929200; Soto L, 2011, CLIN RHEUMATOL, V30, P391, DOI 10.1007/s10067-011-1679-4; Suarez-Gestal M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2990; Tan RJL, 2010, ANN RHEUM DIS, V69, P1029, DOI 10.1136/ard.2009.118406; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Toonen EJM, 2008, ANN RHEUM DIS, V67, P1174, DOI 10.1136/ard.2008.088138; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697	46	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38539	10.1371/journal.pone.0038539	http://dx.doi.org/10.1371/journal.pone.0038539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685579	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700042
J	Zug, R; Hammerstein, P				Zug, Roman; Hammerstein, Peter			Still a Host of Hosts for Wolbachia: Analysis of Recent Data Suggests That 40% of Terrestrial Arthropod Species Are Infected	PLOS ONE			English	Article							DIVERSITY; POPULATIONS; COLEOPTERA; PHYLOGENY; DIPTERA	Wolbachia are intracellular bacteria that manipulate the reproduction of their arthropod hosts in remarkable ways. They are predominantly transmitted vertically from mother to offspring but also occasionally horizontally between species. In doing so, they infect a huge range of arthropod species worldwide. Recently, a statistical analysis estimated the infection frequency of Wolbachia among arthropod hosts to be 66%. At the same time, the authors of this analysis highlighted some weaknesses of the underlying data and concluded that in order to improve the estimate, a larger number of individuals per species should be assayed and species be chosen more randomly. Here we apply the statistical approach to a more appropriate data set from a recent survey that tested both a broad range of species and a sufficient number of individuals per species. Indeed, we find a substantially different infection frequency: We now estimate the proportion of Wolbachia-infected species to be around 40% which is lower than the previous estimate but still points to a surprisingly high number of arthropods harboring the bacteria. Notwithstanding this difference, we confirm the previous result that, within a given species, typically most or only a few individuals are infected. Moreover, we extend our analysis to include several reproductive parasites other than Wolbachia that were also screened for in the aforementioned empirical survey. For these symbionts we find a large variation in estimated infection frequencies and corroborate the finding that Wolbachia are the most abundant endosymbionts among arthropod species.	[Zug, Roman; Hammerstein, Peter] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany	Humboldt University of Berlin	Zug, R (corresponding author), Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany.	roman.zug@biologie.hu-berlin.de	Zug, Roman/ADE-3784-2022	Zug, Roman/0000-0002-9506-5362	Deutsche Forschungsgemeinschaft [SFB 618]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp), SFB 618: "Theoretical Biology: Robustness, Modularity and Evolutionary Design of Living Systems." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthofer W, 2009, ENVIRON MICROBIOL, V11, P1923, DOI 10.1111/j.1462-2920.2009.01914.x; Arthofer W, 2009, MOL ECOL, V18, P3816, DOI 10.1111/j.1365-294X.2009.04321.x; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hughes GL, 2011, APPL ENVIRON MICROB, V77, P2165, DOI 10.1128/AEM.02878-10; Kondo NI, 2011, ZOOL SCI, V28, P501, DOI 10.2108/zsj.28.501; Simoes PM, 2011, MOL ECOL RESOUR, V11, P567, DOI 10.1111/j.1755-0998.2010.02955.x; Sun X, 2007, ENVIRON ENTOMOL, V36, P1283, DOI 10.1603/0046-225X(2007)36[1283:DAPOWI]2.0.CO;2; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wiwatanaratanabutr I, 2009, ZOOL SCI, V26, P171, DOI 10.2108/zsj.26.171; Yun Y, 2011, NEOTROP ENTOMOL, V40, P164, DOI 10.1590/S1519-566X2011000200002	17	579	609	6	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38544	10.1371/journal.pone.0038544	http://dx.doi.org/10.1371/journal.pone.0038544			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685581	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700044
J	Langlois-Klassen, D; Kunimoto, D; Saunders, LD; Chui, L; Boffa, J; Menzies, D; Long, R				Langlois-Klassen, Deanne; Kunimoto, Dennis; Saunders, L. Duncan; Chui, Linda; Boffa, Jody; Menzies, Dick; Long, Richard			A Population-Based Cohort Study of Mycobacterium tuberculosis Beijing Strains: An Emerging Public Health Threat in an Immigrant-Receiving Country?	PLOS ONE			English	Article							DRUG-RESISTANCE; MULTIDRUG-RESISTANCE; TREATMENT FAILURE; FAMILY GENOTYPES; FOREIGN-BORN; ASSOCIATION; VIETNAM; LINEAGE; EPIDEMIOLOGY; SUBLINEAGES	Introduction: Mycobacterium tuberculosis Beijing strains are frequently associated with tuberculosis outbreaks and drug resistance. However, contradictory evidence and limited study generalizability make it difficult to foresee if the emergence of Beijing strains in high-income immigrant-receiving countries poses an increased public health threat. The purpose of this study was to determine if Beijing strains are associated with high risk disease presentations relative to other strains within Canada. Methods: This was a retrospective population-based study of culture-confirmed active TB cases in a major immigrant-receiving province of Canada in 1991 through 2007. Of 1,852 eligible cases, 1,826 (99%) were successfully genotyped. Demographic, clinical, and mycobacteriologic surveillance data were combined with molecular diagnostic data. The main outcome measures were site of disease, lung cavitation, sputum smear positivity, bacillary load, and first-line antituberculosis drug resistance. Results: A total of 350 (19%) patients had Beijing strains; 298 (85%) of these were born in the Western Pacific. Compared to non-Beijing strains, Beijing strains were significantly more likely to be associated with polyresistance (aOR 1.8; 95% CI 1.0-3.3; p = 0.046) and multidrug-resistance (aOR 3.4; 1.0-11.3; p = 0.049). Conversely, Beijing strains were no more likely than non-Beijing strains to be associated with respiratory disease (aOR 1.3; 1.0-1.8; p = 0.053), high bacillary load (aOR 1.2; 0.6-2.7), lung cavitation (aOR 1.0; 0.7-1.5), immediately life-threatening forms of tuberculosis (aOR 0.8; 0.5-1.6), and monoresistance (aOR 0.9; 0.6-1.3). In subgroup analyses, Beijing strains only had a significant association with multidrug-resistant tuberculosis (aOR 6.1; 1.2-30.4), and an association of borderline significance with polyresistant tuberculosis (aOR 1.8; 1.0-3.5; p = 0.062), among individuals born in the Western Pacific. Conclusion: Other than an increased risk of polyresistant or multidrug-resistant tuberculosis, Beijing strains appear to pose no more of a public health threat than non-Beijing strains within a high-income immigrant-receiving country.	[Langlois-Klassen, Deanne; Saunders, L. Duncan; Long, Richard] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Langlois-Klassen, Deanne; Boffa, Jody; Long, Richard] Univ Alberta, TB Program Evaluat & Res Unit, Edmonton, AB, Canada; [Kunimoto, Dennis; Long, Richard] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Chui, Linda] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Chui, Linda] Prov Lab Publ Hlth, Edmonton, AB, Canada; [Menzies, Dick] McGill Univ, Ctr Hlth, Div Resp, Montreal, PQ, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; McGill University	Langlois-Klassen, D (corresponding author), Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada.	deanne.langlois-klassen@ualberta.ca		Langlois-Klassen, Deanne/0000-0002-4095-4234; Boffa, Jody/0000-0002-8183-6461; Kunimoto, Dennis/0000-0002-7691-5448	Canadian Institutes of Health Research (CIHR); Health Canada, First Nations and Inuit Health Branch (FNIHB); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship - Doctoral Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Health Canada, First Nations and Inuit Health Branch (FNIHB); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship - Doctoral Award(Canadian Institutes of Health Research (CIHR))	This investigation was supported by grants from the Canadian Institutes of Health Research (CIHR) and Health Canada, First Nations and Inuit Health Branch (FNIHB). D. Langlois-Klassen was also supported by the CIHR Frederick Banting and Charles Best Canada Graduate Scholarship - Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2006, CLIN EXP IMMUNOL, V145, P389, DOI 10.1111/j.1365-2249.2006.03162.x; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Borgdorff MW, 2003, EMERG INFECT DIS, V9, P1310; Borydorff MW, 2004, TUBERCULOSIS, V84, P337, DOI 10.1016/j.tube.2003.10.002; Brown T, 2010, EMERG INFECT DIS, V16, P272, DOI 10.3201/eid1602.091032; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Burman WJ, 2009, EMERG INFECT DIS, V15, P1061, DOI 10.3201/eid1507.081253; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Buu TN, 2010, CLIN INFECT DIS, V51, P879, DOI 10.1086/656410; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Citizenship and Immigration Canada, 2009, ANN REP PARL IMM; Citizenship and Immigration Canada. Canada, 2009, FACTS FIG 2008 IMM O; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Glynn JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012259; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Jensen M, 2012, INT J TUBERC LUNG D, V16, P43, DOI 10.5588/ijtld.11.0374; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Jou RW, 2005, J CLIN MICROBIOL, V43, P95, DOI 10.1128/JCM.43.1.95-100.2005; Kang HY, 2010, J MED MICROBIOL, V59, P1191, DOI 10.1099/jmm.0.022103-0; Kato-Maeda M, 2010, INT J TUBERC LUNG D, V14, P538; Kong Y, 2007, J CLIN MICROBIOL, V45, P409, DOI 10.1128/JCM.01459-06; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Kubica T, 2004, INT J TUBERC LUNG D, V8, P1107; Kunimoto D, 2004, INT J TUBERC LUNG D, V8, P1213; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; Langlois-Klassen D, 2011, EUR RESPIR J, V38, P895, DOI 10.1183/09031936.00196610; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Li GL, 2010, BIOMED ENVIRON SCI, V23, P188, DOI 10.1016/S0895-3988(10)60051-7; Lillebaek T, 2003, EMERG INFECT DIS, V9, P1553, DOI 10.3201/eid0912.030276; Long R, 2001, AM J EPIDEMIOL, V153, P903, DOI 10.1093/aje/153.9.903; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Martinez-Gamboa A, 2008, ARCH MED RES, V39, P809, DOI 10.1016/j.arcmed.2008.08.006; Mokrousov I, 2006, ANTIMICROB AGENTS CH, V50, P2820, DOI 10.1128/AAC.00324-06; Nahid P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010753; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Pepperell CS, 2011, P NATL ACAD SCI USA, V108, P6526, DOI 10.1073/pnas.1016708108; Public Health Agency of Canada, 2007, CAN TUB STAND; Qian LS, 1999, J CLIN MICROBIOL, V37, P471, DOI 10.1128/JCM.37.2.471-474.1999; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Statistics Canada, 2006, CUM PROF 2006 PROV T; Sun YJ, 2006, EPIDEMIOL INFECT, V134, P329, DOI 10.1017/S095026880500525X; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; van Crevel R, 2001, EMERG INFECT DIS, V7, P880; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; World Health Organization Regional Office for the Western Pacific, 2011, WHO W PAC REG COUNTR	62	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38431	10.1371/journal.pone.0038431	http://dx.doi.org/10.1371/journal.pone.0038431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679504	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343900041
J	Martin-Rufian, M; Tosina, M; Campos-Sandoval, JA; Manzanares, E; Lobo, C; Segura, JA; Alonso, FJ; Mates, JM; Marquez, J				Martin-Rufian, Mercedes; Tosina, Marta; Campos-Sandoval, Jose A.; Manzanares, Elisa; Lobo, Carolina; Segura, J. A.; Alonso, Francisco J.; Mates, Jose M.; Marquez, Javier			Mammalian Glutaminase Gls2 Gene Encodes Two Functional Alternative Transcripts by a Surrogate Promoter Usage Mechanism	PLOS ONE			English	Article							RAT HEPATIC GLUTAMINASE; MOLECULAR-CLONING; START SITES; EXPRESSION; METABOLISM; PROTEIN; IDENTIFICATION; LOCALIZATION; METHYLOME; SEQUENCE	Background: Glutaminase is expressed in most mammalian tissues and cancer cells, but the regulation of its expression is poorly understood. An essential step to accomplish this goal is the characterization of its species- and cell-specific isoenzyme pattern of expression. Our aim was to identify and characterize transcript variants of the mammalian glutaminase Gls2 gene. Methodology/Principal Findings: We demonstrate for the first time simultaneous expression of two transcript variants from the Gls2 gene in human, rat and mouse. A combination of RT-PCR, primer-extension analysis, bioinformatics, real-time PCR, in vitro transcription and translation and immunoblot analysis was applied to investigate GLS2 transcripts in mammalian tissues. Short (LGA) and long (GAB) transcript forms were isolated in brain and liver tissue of human, rat and mouse. The short LGA transcript arises by a combination of two mechanisms of transcriptional modulation: alternative transcription initiation and alternative promoter. The LGA variant contains both the transcription start site (TSS) and the alternative promoter in the first intron of the Gls2 gene. The full human LGA transcript has two in-frame ATGs in the first exon, which are missing in orthologous rat and mouse transcripts. In vitro transcription and translation of human LGA yielded two polypeptides of the predicted size, but only the canonical full-length protein displayed catalytic activity. Relative abundance of GAB and LGA transcripts showed marked variations depending on species and tissues analyzed. Conclusions/Significance: This is the first report demonstrating expression of alternative transcripts of the mammalian Gls2 gene. Transcriptional mechanisms giving rise to GLS2 variants and isolation of novel GLS2 transcripts in human, rat and mouse are presented. Results were also confirmed at the protein level, where catalytic activity was demonstrated for the human LGA protein. Relative abundance of GAB and LGA transcripts was species-and tissue-specific providing evidence of a differential regulation of GLS2 transcripts in mammals.	[Martin-Rufian, Mercedes; Tosina, Marta; Campos-Sandoval, Jose A.; Manzanares, Elisa; Lobo, Carolina; Segura, J. A.; Alonso, Francisco J.; Mates, Jose M.; Marquez, Javier] Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, Lab Quim Prot, E-29071 Malaga, Spain	Universidad de Malaga	Martin-Rufian, M (corresponding author), Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, Lab Quim Prot, E-29071 Malaga, Spain.	marquez@uma.es	Matés, José M./L-1350-2014; Campos-Sandoval, José/I-7375-2018; marquez, javier/K-3289-2012	Matés, José M./0000-0001-9795-1993; Campos-Sandoval, José/0000-0002-2457-9884; marquez, javier/0000-0003-3317-3963; Tosina Garcia, Marta/0000-0001-5057-2291; Alonso Carrion, Francisco Jose/0000-0002-9431-163X	Ministry of Science and Innovation of Spain [SAF2010-17573]; regional Andalusian government (Junta de Andalucia) [CVI-6656]; RTA RETICS (Universitat de les Illes Balears and Red Tematica de Investigacion Cooperativa en Salud network from the Spanish Health Institute Carlos III) [RD06/1012]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); regional Andalusian government (Junta de Andalucia)(Junta de Andalucia); RTA RETICS (Universitat de les Illes Balears and Red Tematica de Investigacion Cooperativa en Salud network from the Spanish Health Institute Carlos III)	This work was supported by Grant SAF2010-17573 from the Ministry of Science and Innovation of Spain, Excellence Grant CVI-6656 from the regional Andalusian government (Junta de Andalucia), and Grant RD06/1012 of the RTA RETICS (Universitat de les Illes Balears and Red Tematica de Investigacion Cooperativa en Salud network from the Spanish Health Institute Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aledo JC, 2000, MAMM GENOME, V11, P1107, DOI 10.1007/s003350010190; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campos JA, 2003, BBA-PROTEINS PROTEOM, V1648, P17, DOI 10.1016/S1570-9639(03)00026-8; Campos-Sandoval JA, 2007, INT J BIOCHEM CELL B, V39, P765, DOI 10.1016/j.biocel.2006.12.002; Castell L, 2004, J BIOL CHEM, V279, P13305, DOI 10.1074/jbc.M309520200; ChungBok MI, 1997, BIOCHEM J, V324, P193, DOI 10.1042/bj3240193; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; de la Rosa V, 2009, NEUROCHEM INT, V55, P76, DOI 10.1016/j.neuint.2009.02.021; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gomez-Fabre PM, 2000, BIOCHEM J, V345, P365, DOI 10.1042/0264-6021:3450365; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jacox E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012274; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Marquez J, 2006, NEUROCHEM INT, V48, P465, DOI 10.1016/j.neuint.2005.10.015; Marquez Javier, 2010, Biomol Concepts, V1, P3, DOI 10.1515/bmc.2010.006; Mates JM, 2002, INT J BIOCHEM CELL B, V34, P439, DOI 10.1016/S1357-2725(01)00143-1; Olalla L, 2002, J BIOL CHEM, V277, P38939, DOI 10.1074/jbc.C200373200; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Perez-Gomez C, 2005, BIOCHEM J, V386, P535, DOI 10.1042/BJ20040996; Perez-Gomez C, 2003, BIOCHEM J, V370, P771, DOI 10.1042/BJ20021445; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Porter LD, 2002, PHYSIOL GENOMICS, V9, P157, DOI 10.1152/physiolgenomics.00017.2002; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SMITH EM, 1990, J BIOL CHEM, V265, P10631; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Turner A, 2003, BIOCHEM J, V370, P403, DOI 10.1042/BJ20021360; Vousden KH, 2010, P NATL ACAD SCI USA, V107, P7117, DOI 10.1073/pnas.1002656107; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yamashita R, 2005, GENE, V350, P129, DOI 10.1016/j.gene.2005.01.012; YOUNG RA, 1981, CELL, V23, P451, DOI 10.1016/0092-8674(81)90140-9	44	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38380	10.1371/journal.pone.0038380	http://dx.doi.org/10.1371/journal.pone.0038380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679499	Green Published, gold			2022-12-27	WOS:000305343900032
J	Atak, ZK; De Keersmaecker, K; Gianfelici, V; Geerdens, E; Vandepoel, R; Pauwels, D; Porcu, M; Lahortiga, I; Brys, V; Dirks, WG; Quentmeier, H; Cloos, J; Cuppens, H; Uyttebroeck, A; Vandenberghe, P; Cools, J; Aerts, S				Atak, Zeynep Kalender; De Keersmaecker, Kim; Gianfelici, Valentina; Geerdens, Ellen; Vandepoel, Roel; Pauwels, Daphnie; Porcu, Michael; Lahortiga, Idoya; Brys, Vanessa; Dirks, Willy G.; Quentmeier, Hilmar; Cloos, Jacqueline; Cuppens, Harry; Uyttebroeck, Anne; Vandenberghe, Peter; Cools, Jan; Aerts, Stein			High Accuracy Mutation Detection in Leukemia on a Selected Panel of Cancer Genes	PLOS ONE			English	Article							ACTIVATING MUTATIONS; JAK3; TET2; EXPRESSION; DISCOVERY; FREQUENCY; ALIGNMENT; NOTCH1; PTEN	With the advent of whole-genome and whole-exome sequencing, high-quality catalogs of recurrently mutated cancer genes are becoming available for many cancer types. Increasing access to sequencing technology, including bench-top sequencers, provide the opportunity to re-sequence a limited set of cancer genes across a patient cohort with limited processing time. Here, we re-sequenced a set of cancer genes in T-cell acute lymphoblastic leukemia (T-ALL) using Nimblegen sequence capture coupled with Roche/454 technology. First, we investigated how a maximal sensitivity and specificity of mutation detection can be achieved through a benchmark study. We tested nine combinations of different mapping and variant-calling methods, varied the variant calling parameters, and compared the predicted mutations with a large independent validation set obtained by capillary re-sequencing. We found that the combination of two mapping algorithms, namely BWA-SW and SSAHA2, coupled with the variant calling algorithm Atlas-SNP2 yields the highest sensitivity (95%) and the highest specificity (93%). Next, we applied this analysis pipeline to identify mutations in a set of 58 cancer genes, in a panel of 18 T-ALL cell lines and 15 T-ALL patient samples. We confirmed mutations in known T-ALL drivers, including PHF6, NF1, FBXW7, NOTCH1, KRAS, NRAS, PIK3CA, and PTEN. Interestingly, we also found mutations in several cancer genes that had not been linked to T-ALL before, including JAK3. Finally, we re-sequenced a small set of 39 candidate genes and identified recurrent mutations in TET1, SPRY3 and SPRY4. In conclusion, we established an optimized analysis pipeline for Roche/454 data that can be applied to accurately detect gene mutations in cancer, which led to the identification of several new candidate T-ALL driver mutations.	[Atak, Zeynep Kalender; De Keersmaecker, Kim; Gianfelici, Valentina; Geerdens, Ellen; Vandepoel, Roel; Pauwels, Daphnie; Porcu, Michael; Lahortiga, Idoya; Vandenberghe, Peter; Cools, Jan; Aerts, Stein] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [De Keersmaecker, Kim; Gianfelici, Valentina; Geerdens, Ellen; Vandepoel, Roel; Pauwels, Daphnie; Porcu, Michael; Lahortiga, Idoya; Cools, Jan] VIB, Ctr Biol Dis, Louvain, Belgium; [Brys, Vanessa; Cuppens, Harry] Univ Hosp Leuven, Louvain, Belgium; [Dirks, Willy G.; Quentmeier, Hilmar] Deutsch Sammlung Mikroorganismen & Zellkulturen G, Braunschweig, Germany; [Cloos, Jacqueline] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Atak, ZK (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	jan.cools@cme.vib-kuleuven.be; stein.aerts@med.kuleuven.be	Atak, Zeynep Kalender/AAW-1560-2020; Aerts, Stein/A-1100-2009; Gianfelici, Valentina/AAA-8632-2020; De Keersmaecker, Kim/W-9702-2018	Atak, Zeynep Kalender/0000-0003-4761-8169; Aerts, Stein/0000-0002-8006-0315; De Keersmaecker, Kim/0000-0002-7420-9531; Dirks, Wilhelm/0000-0001-9781-0998; Gianfelici, Valentina/0000-0003-3326-091X; Cools, Jan/0000-0001-6626-5843; Cloos, Jacqueline/0000-0001-9150-8026; Vandenberghe, Peter/0000-0003-4719-1935; Porcu, Michael/0000-0002-9369-5547	Belgian federal government (Cancer Plan - Translational Research); K. U. Leuven [GOA/11/010, PF/10/016 SymBioSys]; Foundation Against Cancer [2010-154]; FWO-Vlaanderen [G.0287.07]; European Research Council (ERC); FWO-Vlaanderen; Agentschap voor Innovatie door Wetenschap en Technologie	Belgian federal government (Cancer Plan - Translational Research); K. U. Leuven(KU Leuven); Foundation Against Cancer; FWO-Vlaanderen(FWO); European Research Council (ERC)(European Research Council (ERC)European Commission); FWO-Vlaanderen(FWO); Agentschap voor Innovatie door Wetenschap en Technologie	This work was supported by the Belgian federal government (Cancer Plan - Translational Research), the K. U. Leuven (grant GOA/11/010 to J. Cools and PV; grant PF/10/016 SymBioSys to J. Cools and SA), the Foundation Against Cancer (grant 2010-154 to SA), the FWO-Vlaanderen (G.0287.07, J. Cools), and the European Research Council (ERC-starting grant to J. Cools). KDK is a postdoctoral researcher funded by the FWO-Vlaanderen, PV is a Senior Clinical Investigator supported by FWO-Vlaanderen, DP and MP are funded by Agentschap voor Innovatie door Wetenschap en Technologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Cornejo MG, 2009, BLOOD, V113, P2746, DOI 10.1182/blood-2008-06-164368; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280; Elliott NE, 2011, BLOOD, V118, P3911, DOI 10.1182/blood-2010-12-319467; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Heesch S, 2010, HAEMATOL-HEMATOL J, V95, P942, DOI 10.3324/haematol.2009.016386; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krieger D, 2010, HAEMATOL-HEMATOL J, V95, P158, DOI 10.3324/haematol.2009.007526; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malinge S, 2008, BLOOD, V112, P4220, DOI 10.1182/blood-2008-01-136366; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; Vainchenker W, 2008, SEMIN CELL DEV BIOL, V19, P385, DOI 10.1016/j.semcdb.2008.07.002; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117	38	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38463	10.1371/journal.pone.0038463	http://dx.doi.org/10.1371/journal.pone.0038463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675565	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700077
J	Flowe, HD				Flowe, Heather D.			Do Characteristics of Faces That Convey Trustworthiness and Dominance Underlie Perceptions of Criminality?	PLOS ONE			English	Article							FACIAL STEREOTYPES; EXPRESSIONS	Background: This study tested whether the 2D face evaluation model proposed by Oosterhof and Todorov can parsimoniously account for why some faces are perceived as more criminal-looking than others. The 2D model proposes that trust and dominance are spontaneously evaluated from features of faces. These evaluations have adaptive significance from an evolutionary standpoint because they indicate whether someone should be approached or avoided. Method: Participants rated the emotional state, personality traits, and criminal appearance of faces shown in photographs. The photographs were of males and females taken under naturalistic conditions (i.e., police mugshots) and highly controlled conditions. In the controlled photographs, the emotion display of the actor was systematically varied (happy expression, emotionally neutral expression, or angry expression). Results: Both male and female faces rated high in criminal appearance were perceived as less trustworthy and more dominant in police mugshots as well as in photographs taken under highly controlled conditions. Additionally, emotionally neutral faces were deemed as less trustworthy if they were perceived as angry, and more dominant if they were morphologically mature. Systematically varying emotion displays also affected criminality ratings, with angry faces perceived as the most criminal, followed by neutral faces and then happy faces. Conclusion: The 2D model parsimoniously accounts for criminality perceptions. This study extends past research by demonstrating that morphological features that signal high dominance and low trustworthiness can also signal high criminality. Spontaneous evaluations regarding criminal propensity may have adaptive value in that they may help us to avoid someone who is physically threatening. On the other hand, such evaluations could inappropriately influence decision making in criminal identification lineups. Hence, additional research is needed to discover whether and how people can avoid making evaluations regarding criminality from a person's facial appearance.	Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England	University of Leicester	Flowe, HD (corresponding author), Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England.	hf49@le.ac.uk		Flowe, Heather/0000-0001-5343-5313				BERRY DS, 1985, J PERS SOC PSYCHOL, V48, P312, DOI 10.1037/0022-3514.48.2.312; Bull R., 1988, SOCIAL PSYCHOL FACIA; Caspers H.M., 2009, N AM J PSYCHOL, V11, P323; Flowe HD, 2011, APPL COGNITIVE PSYCH, V25, P265, DOI 10.1002/acp.1673; GOLDSTEIN AG, 1984, B PSYCHONOMIC SOC, V22, P549; Hess U, 2005, COGNITION EMOTION, V19, P515, DOI 10.1080/02699930441000364; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; MacLin M.K., 2006, N AM J PSYCHOL, V8, P197; MacLin O. H., 2004, N AM J PSYCHOL, V6, P145; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; Montepare JM, 1998, ADV EXP SOC PSYCHOL, V30, P93, DOI 10.1016/S0065-2601(08)60383-4; Neth D, 2009, J VISION, V9, DOI 10.1167/9.1.5; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; SHOEMAKER DJ, 1973, SOC FORCES, V51, P427, DOI 10.2307/2576687; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Ward C, 2012, APPL COGNITIVE PSYCH, V26, P482, DOI 10.1002/acp.2823; Wilcock R., 2008, WITNESS IDENTIFICATI; YARMEY AD, 1993, APPL COGNITIVE PSYCH, V7, P419, DOI 10.1002/acp.2350070505; Zebrowitz L., 2004, J CULTURAL EVOLUTION, V2, P93, DOI DOI 10.1556/JCEP.2.2004.1-2.6; ZEBROWITZ LA, 1991, LAW HUMAN BEHAV, V15, P603, DOI 10.1007/BF01065855; ZEBROWITZ LA, 1999, READING FACES WINDOW	22	31	31	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37253	10.1371/journal.pone.0037253	http://dx.doi.org/10.1371/journal.pone.0037253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675479	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700011
J	Germain, M; Saut, N; Oudot-Mellakh, T; Letenneur, L; Dupuy, AM; Bertrand, M; Alessi, MC; Lambert, JC; Zelenika, D; Emmerich, J; Tiret, L; Cambien, F; Lathrop, M; Amouyel, P; Morange, PE; Tregouet, DA				Germain, Marine; Saut, Noemie; Oudot-Mellakh, Tiphaine; Letenneur, Luc; Dupuy, Anne-Marie; Bertrand, Marion; Alessi, Marie-Christine; Lambert, Jean-Charles; Zelenika, Diana; Emmerich, Joseph; Tiret, Laurence; Cambien, Francois; Lathrop, Mark; Amouyel, Philippe; Morange, Pierre-Emmanuel; Tregouet, David-Alexandre			Caution in Interpreting Results from Imputation Analysis When Linkage Disequilibrium Extends over a Large Distance: A Case Study on Venous Thrombosi	PLOS ONE			English	Article							BLOOD-LOSS; ASSOCIATION; GENE	By applying an imputation strategy based on the 1000 Genomes project to two genome-wide association studies (GWAS), we detected a susceptibility locus for venous thrombosis on chromosome 11p11.2 that was missed by previous GWAS analyses that had been conducted on the same datasets. A comprehensive linkage disequilibrium and haplotype analysis of the whole locus where twelve SNPs exhibited association p-values lower than 2.23 10(-11) and the use of independent case-control samples demonstrated that the culprit variant was a rare variant located similar to 1 Mb away from the original hits, not tagged by current genome-wide genotyping arrays and even not well imputed in the original GWAS samples. This variant was in fact the rs1799963, also known as the FII G20210A prothrombin mutation. This work may be of major interest not only for its scientific impact but also for its methodological findings.	[Germain, Marine; Oudot-Mellakh, Tiphaine; Tiret, Laurence; Cambien, Francois; Tregouet, David-Alexandre] Univ Paris 06, INSERM, UMR S 937, ICAN Inst, Paris, France; [Saut, Noemie; Alessi, Marie-Christine; Morange, Pierre-Emmanuel] Univ Mediterranee, INSERM, UMR S 1062, Marseille, France; [Letenneur, Luc] Univ Victor Segalen, INSERM, UMR S 897, Bordeaux, France; [Dupuy, Anne-Marie] Hop La Colombiere, INSERM, UMR S 888, Montpellier, France; [Bertrand, Marion] Univ Paris 06, INSERM, UMR S 708, Paris, France; [Lambert, Jean-Charles; Amouyel, Philippe] Univ Lille Nord France, Inst Pasteur Lille, INSERM, UMR S 744, Lille, France; [Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, Inst Genom, Commissariat Energie Atom, Evry, France; [Emmerich, Joseph] Univ Paris 05, Hop Europeen Georges Pompidou, INSERM, UMR S 765, Paris, France; [Amouyel, Philippe] Ctr Hosp Reg Univ Lille, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille	Germain, M (corresponding author), Univ Paris 06, INSERM, UMR S 937, ICAN Inst, Paris, France.	pierre.morange@ap-hm.fr; david.tregouet@upmc.fr	LETENNEUR, Luc/T-4424-2019; Trégouët, David-Alexandre/P-9210-2019; Cambien, Francois/AAP-9751-2020; ALESSI, Marie-christine/AAK-3582-2020; Tregouet, David-Alexandre/E-3961-2016; Lambert, jean-charles/A-9553-2014; Morange, Pierre/T-9070-2019; lambert, jean-charles/F-8787-2013	LETENNEUR, Luc/0000-0002-3274-937X; Trégouët, David-Alexandre/0000-0001-9084-7800; ALESSI, Marie-christine/0000-0003-3927-5792; Lambert, jean-charles/0000-0003-0829-7817; Morange, Pierre/0000-0002-9065-722X; lambert, jean-charles/0000-0003-0829-7817; Germain, Marine/0000-0002-8489-8916; Amouyel, Philippe/0000-0001-9088-234X; dupuy, anne marie/0000-0001-6538-3944	Agence Nationale pour la Recherche [ANR-07-MRAR-021]; Program Hospitalier de recherche Clinique (PHRC2009 RENOVA-TV); Fondation pour la Recherche Medicale; Program Hospitalier de Recherche Clinique; Program Hospitalier de recherche Clinique [20002]; Fondation de France; Leducq Foundation; Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale; Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon; Ministry of Research-Inserm Programme 'Cohorts and collection of biological material	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Program Hospitalier de recherche Clinique (PHRC2009 RENOVA-TV); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Program Hospitalier de Recherche Clinique; Program Hospitalier de recherche Clinique; Fondation de France(Fondation de France); Leducq Foundation(Leducq Foundation); Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale; Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon(Region Occitanie); Ministry of Research-Inserm Programme 'Cohorts and collection of biological material	MG was supported by grants funded by the Agence Nationale pour la Recherche (Project ANR-07-MRAR-021) and the Program Hospitalier de recherche Clinique (PHRC2009 RENOVA-TV). TOM was supported by a grant from the Fondation pour la Recherche Medicale. The MARTHA project was supported by a grant from the Program Hospitalier de Recherche Clinique and the FARIVE study by grants from the Fondation pour la Recherche Medicale, the Program Hospitalier de recherche Clinique (PHRC 20002; PHRC2009 RENOVA-TV), the Fondation de France, and the Leducq Foundation. The 3C Study is conducted under a partnership agreement between Inserm, the Victor Segalen -Bordeaux II University and Sanofi-Synthelabo. The Fondation pour la Recherche Medicale funded the preparation and first phase of the study. The 3C-Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale, the Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante, the Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon and, the Fondation de France, the Ministry of Research-Inserm Programme 'Cohorts and collection of biological material'. The Lille Genopole received an unconditional grant from Eisai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Day-Williams AG, 2011, AM J HUM GENET, V89, P446, DOI 10.1016/j.ajhg.2011.08.001; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Han S, 2011, HUM MOL GENET; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lindqvist PG, 1998, THROMB HAEMOSTASIS, V79, P69; Lindqvist PG, 2001, THROMB HAEMOSTASIS, V86, P1122; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MANTEL N, 1959, J NATL CANCER I, V22, P719; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	20	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38538	10.1371/journal.pone.0038538	http://dx.doi.org/10.1371/journal.pone.0038538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675575	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700087
J	Linden, DEJ; Habes, I; Johnston, SJ; Linden, S; Tatineni, R; Subramanian, L; Sorger, B; Healy, D; Goebel, R				Linden, David E. J.; Habes, Isabelle; Johnston, Stephen J.; Linden, Stefanie; Tatineni, Ranjit; Subramanian, Leena; Sorger, Bettina; Healy, David; Goebel, Rainer			Real-Time Self-Regulation of Emotion Networks in Patients with Depression	PLOS ONE			English	Article							THOUGHT CONTROL; INDIVIDUAL-DIFFERENCES; CORTICAL ACTIVITY; BRAIN; VALIDATION; ACTIVATION; THERAPY; QUESTIONNAIRE; RESPONSES; REWARD	Many patients show no or incomplete responses to current pharmacological or psychological therapies for depression. Here we explored the feasibility of a new brain self-regulation technique that integrates psychological and neurobiological approaches through neurofeedback with functional magnetic resonance imaging (fMRI). In a proof-of-concept study, eight patients with depression learned to upregulate brain areas involved in the generation of positive emotions (such as the ventrolateral prefrontal cortex (VLPFC) and insula) during four neurofeedback sessions. Their clinical symptoms, as assessed with the 17-item Hamilton Rating Scale for Depression (HDRS), improved significantly. A control group that underwent a training procedure with the same cognitive strategies but without neurofeedback did not improve clinically. Randomised blinded clinical trials are now needed to exclude possible placebo effects and to determine whether fMRI-based neurofeedback might become a useful adjunct to current therapies for depression.	[Linden, David E. J.; Habes, Isabelle; Subramanian, Leena; Healy, David] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Sch Med, Cardiff, S Glam, Wales; [Linden, David E. J.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Linden, David E. J.; Habes, Isabelle; Sorger, Bettina; Goebel, Rainer] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Johnston, Stephen J.] Brunel Univ, Sch Social Sci, Uxbridge UB8 3PH, Middx, England; [Linden, Stefanie] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Tatineni, Ranjit; Healy, David] Betsi Cadwaladr Univ Hlth Board, Mental Hlth Serv, Bangor, Gwynedd, Wales	Cardiff University; Bangor University; Maastricht University; Brunel University; University of London; King's College London	Linden, DEJ (corresponding author), Cardiff Univ, Inst Psychol Med & Clin Neurosci, Sch Med, Cardiff, S Glam, Wales.	LindenD@cardiff.ac.uk	Linden, David/S-9948-2019; Linden, David E J/C-7355-2013	Linden, David/0000-0002-5638-9292; Linden, David E J/0000-0002-5638-9292; Sorger, Bettina/0000-0003-1393-3144; Johnston, Stephen/0000-0001-9360-8856; Goebel, Rainer/0000-0003-1780-2467	Wales Institute of Cognitive Neuroscience; Welsh Assembly Government; Medical Research Council [G1100629/1]; MRC [G1100629] Funding Source: UKRI; Medical Research Council [G0801418B, G1100629] Funding Source: researchfish	Wales Institute of Cognitive Neuroscience; Welsh Assembly Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wales Institute of Cognitive Neuroscience with funds from the Welsh Assembly Government and by the Medical Research Council (grant reference G1100629/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Caria A, 2010, BIOL PSYCHIAT, V68, P425, DOI 10.1016/j.biopsych.2010.04.020; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Erk S, 2010, J NEUROSCI, V30, P15726, DOI 10.1523/JNEUROSCI.1856-10.2010; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; Heller AS, 2009, P NATL ACAD SCI USA, V106, P22445, DOI 10.1073/pnas.0910651106; Heubeck BG, 1998, PERS INDIV DIFFER, V25, P785, DOI 10.1016/S0191-8869(98)00124-X; Jarrett RB, 2001, ARCH GEN PSYCHIAT, V58, P381, DOI 10.1001/archpsyc.58.4.381; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Johnston S, 2011, COGN AFFECT BEHAV NE, V11, P44, DOI 10.3758/s13415-010-0010-1; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lang P. J., 1999, INT AFFECTIVE PICTUR; Linden DEJ, 2006, MOL PSYCHIATR, V11, P528, DOI 10.1038/sj.mp.4001816; Luciano JV, 2005, PERS INDIV DIFFER, V38, P997, DOI 10.1016/j.paid.2004.06.020; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McNair D.M., 1971, MANUAL PROFILES MOOD; Merkl A, 2009, EXP NEUROL, V219, P20, DOI 10.1016/j.expneurol.2009.04.027; Nyenhuis DL, 1999, J CLIN PSYCHOL, V55, P79, DOI 10.1002/(SICI)1097-4679(199901)55:1<79::AID-JCLP8>3.0.CO;2-7; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Ruhc HG, 2011, J CLIN PSYCHIAT 0809; Ruiz S, 2011, HUM BRAIN M IN PRESS; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; SELMI PM, 1990, AM J PSYCHIAT, V147, P51; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weiskopf N, 2004, J PHYSIOL-PARIS, V98, P357, DOI 10.1016/j.jphysparis.2005.09.019; WELLS A, 1994, BEHAV RES THER, V32, P871, DOI 10.1016/0005-7967(94)90168-6; Williams AD, 2010, J PSYCHOPATHOL BEHAV, V32, P397, DOI 10.1007/s10862-009-9171-z; Yoo SS, 2006, NEUROREPORT, V17, P1273, DOI 10.1097/01.wnr.0000227996.53540.22; Zotev V, 2010, PLOS ONE, V6, P1	44	245	247	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38115	10.1371/journal.pone.0038115	http://dx.doi.org/10.1371/journal.pone.0038115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675513	Green Accepted, Green Published, gold			2022-12-27	WOS:000305341700039
J	McCormick, A; Jacobsen, ID; Broniszewska, M; Beck, J; Heesemann, J; Ebel, F				McCormick, Allison; Jacobsen, Ilse D.; Broniszewska, Marzena; Beck, Julia; Heesemann, Juergen; Ebel, Frank			The Two-Component Sensor Kinase TcsC and Its Role in Stress Resistance of the Human-Pathogenic Mold Aspergillus fumigatus	PLOS ONE			English	Article							NIKA HISTIDINE KINASE; SIGNAL-TRANSDUCTION; RESPONSE REGULATORS; SYSTEM; INVOLVEMENT; ADAPTATION; PROTEINS; NIDULANS; GENES; SAKA	Two-component signaling systems are widespread in bacteria, but also found in fungi. In this study, we have characterized TcsC, the only Group III two-component sensor kinase of Aspergillus fumigatus. TcsC is required for growth under hyperosmotic stress, but dispensable for normal growth, sporulation and conidial viability. A characteristic feature of the Delta tcsC mutant is its resistance to certain fungicides, like fludioxonil. Both hyperosmotic stress and treatment with fludioxonil result in a TcsC-dependent phosphorylation of SakA, the final MAP kinase in the high osmolarity glycerol (HOG) pathway, confirming a role for TcsC in this signaling pathway. In wild type cells fludioxonil induces a TcsC-dependent swelling and a complete, but reversible block of growth and cytokinesis. Several types of stress, such as hypoxia, exposure to farnesol or elevated concentrations of certain divalent cations, trigger a differentiation in A. fumigatus toward a "fluffy" growth phenotype resulting in white, dome-shaped colonies. The Delta tcsC mutant is clearly more susceptible to these morphogenetic changes suggesting that TcsC normally antagonizes this process. Although TcsC plays a role in the adaptation of A. fumigatus to hypoxia, it seems to be dispensable for virulence.	[McCormick, Allison; Broniszewska, Marzena; Beck, Julia; Heesemann, Juergen; Ebel, Frank] Univ Munich, Max von Pettenkofer Inst, Munich, Germany; [Jacobsen, Ilse D.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Heesemann, Juergen] Univ Munich, Ctr Integrated Prot Sci Munich, Fac Med, Munich, Germany	University of Munich; Hans Knoll Institute (HKI); University of Munich	McCormick, A (corresponding author), Univ Munich, Max von Pettenkofer Inst, Munich, Germany.	ebel@mvp.uni-meunchen.de	Ebel, Frank/AAF-2303-2022; Ebel, Frank/AFH-1488-2022; Jacobsen, Ilse/B-3155-2011	Ebel, Frank/0000-0002-1027-1440; Ebel, Frank/0000-0002-1027-1440; Jacobsen, Ilse/0000-0002-6033-9984; Seeger, Allison/0000-0002-5332-3722	LMUexcellent program [ZUK22]; Wilhelm-Sander-Foundation [2007.102.2]; Center of Integrated Protein Science (Munich) [Forschungssaule B]	LMUexcellent program; Wilhelm-Sander-Foundation; Center of Integrated Protein Science (Munich)	This work was supported by the LMUexcellent program (grant number: ZUK22; www.unimuenchen.de/excellent/), a grant of the Wilhelm-Sander-Foundation to F. E. (grant number: 2007.102.2; www.sanst.de/) and a grant of the Center of Integrated Protein Science (Munich) to J.H. (grant: Forschungssaule B; www.cipsm.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Ben-Ami R, 2010, VIRULENCE, V1, P164, DOI 10.4161/viru.1.3.11750; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Dichtl K, 2010, MOL MICROBIOL, V76, P1191, DOI 10.1111/j.1365-2958.2010.07170.x; Du C, 2006, MED MYCOL, V44, P211, DOI 10.1080/13693780500338886; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P844, DOI 10.1271/bbb.70051; Hagiwara D, 2009, BIOSCI BIOTECH BIOCH, V73, P1566, DOI 10.1271/bbb.90063; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; Hill TW., 2001, FUNGAL GENET NEWSL, V48, P20, DOI [DOI 10.4148/1941-4765.1173, 10.4148/1941-4765.1173]; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10; Kojima K, 2004, MOL MICROBIOL, V53, P1785, DOI 10.1111/j.1365-2958.2004.04244.x; Kotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015729; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Li DM, 2010, CURR OPIN MICROBIOL, V13, P424, DOI 10.1016/j.mib.2010.04.007; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; Meena N, 2010, J BIOL CHEM, V285, P12121, DOI 10.1074/jbc.M109.075721; Miskei M, 2009, FUNGAL GENET BIOL, V46, pS105, DOI 10.1016/j.fgb.2008.07.013; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; Pott GB, 2000, FUNGAL GENET BIOL, V31, P55, DOI 10.1006/fgbi.2000.1225; Santos J L, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.98.re1; Shimizu K, 2001, GENETICS, V157, P591; TAMAME M, 1983, MOL CELL BIOL, V3, P2287, DOI 10.1128/MCB.3.12.2287; Vargas-Perez I, 2007, EUKARYOT CELL, V6, P1570, DOI 10.1128/EC.00085-07; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yu JH, 1996, EMBO J, V15, P5184, DOI 10.1002/j.1460-2075.1996.tb00903.x	30	36	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38262	10.1371/journal.pone.0038262	http://dx.doi.org/10.1371/journal.pone.0038262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675534	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700053
J	Pena, J; Harris, E				Pena, Jose; Harris, Eva			Early Dengue Virus Protein Synthesis Induces Extensive Rearrangement of the Endoplasmic Reticulum Independent of the UPR and SREBP-2 Pathway	PLOS ONE			English	Article							STEROL REGULATORY ELEMENT; HEPATITIS-C VIRUS; FATTY-ACID SYNTHESIS; LIPID DROPLET; VIRAL REPLICATION; BINDING-PROTEIN; ER STRESS; MEMBRANE-ALTERATIONS; RNA REPLICATION; INFECTED CELLS	The rearrangement of intracellular membranes has been long reported to be a common feature in diseased cells. In this study, we used dengue virus (DENV) to study the role of the unfolded protein response (UPR) and sterol-regulatory-element-binding-protein-2 (SREBP-2) pathway in the rearrangement and expansion of the endoplasmic reticulum (ER) early after infection. Using laser scanning confocal and differential interference contrast microscopy, we demonstrate that rearrangement and expansion of the ER occurs early after DENV-2 infection. Through the use of mouse embryonic fibroblast cells deficient in XBP1 and ATF6, we show that ER rearrangement early after DENV infection is independent of the UPR. We then demonstrate that enlargement of the ER is independent of the SREBP-2 activation and upregulation of 3-hydroxy-3-methylglutaryl-Coenzyme-A reductase, the rate-limiting enzyme in the cholesterol biosynthesis pathway. We further show that this ER rearrangement is not inhibited by the treatment of DENV-infected cells with the cholesterol-inhibiting drug lovastatin. Using the transcription inhibitor actinomycin D and the translation elongation inhibitor cycloheximide, we show that de novo viral protein synthesis but not host transcription is necessary for expansion and rearrangement of the ER. Lastly, we demonstrate that viral infection induces the reabsorption of lipid droplets into the ER. Together, these results demonstrate that modulation of intracellular membrane architecture of the cell early after DENV-2 infection is driven by viral protein expression and does not require the induction of the UPR and SREBP-2 pathways. This work paves the way for further study of virally-induced membrane rearrangements and formation of cubic membranes.	[Pena, Jose; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Pena, Jose; Harris, Eva] Univ Calif Berkeley, Grad Grp Microbiol, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pena, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	jpena360@yahoo.com; eharris@berkeley.edu			National Institutes of Health [AI052324]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI052324 to EH and an National Institutes of Health supplemental grant to JP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almsherqi ZA, 2009, INT REV CEL MOL BIO, V274, P275, DOI 10.1016/S1937-6448(08)02006-6; Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; Chua JJE, 2004, VIRUS RES, V102, P151, DOI 10.1016/j.virusres.2004.01.025; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Deng Y, 2010, TRENDS CELL BIOL, V20, P371, DOI 10.1016/j.tcb.2010.04.001; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001; Fujimoto T., 2011, COLD SPRING HARB PER, V3; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gouttenoire J, J VIROL, V84, P12529; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Higashi Y, 2003, J BIOL CHEM, V278, P21450, DOI 10.1074/jbc.M301376200; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Quiroga AD, 2011, TRENDS ENDOCRIN MET, V22, P218, DOI 10.1016/j.tem.2011.03.003; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Roingeard P, 2011, BIOL CELL, V103, P223, DOI 10.1042/BC20100119; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sandig G, 1999, DRUG METAB REV, V31, P393, DOI 10.1081/DMR-100101926; SARNOW P, 1989, P NATL ACAD SCI USA, V86, P5795, DOI 10.1073/pnas.86.15.5795; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Yamamoto A, 1996, J CELL SCI, V109, P1727; Yang Q, 1997, NUCLEIC ACIDS RES, V25, P2800, DOI 10.1093/nar/25.14.2800; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973	69	52	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38202	10.1371/journal.pone.0038202	http://dx.doi.org/10.1371/journal.pone.0038202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675522	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341700045
J	Wu, K; Dong, DD; Fang, H; Levillain, F; Jin, W; Mei, J; Gicquel, B; Du, YZ; Wang, KK; Gao, Q; Neyrolles, O; Zhang, J				Wu, Kang; Dong, Dandan; Fang, Hai; Levillain, Florence; Jin, Wen; Mei, Jian; Gicquel, Brigitte; Du, Yanzhi; Wang, Kankan; Gao, Qian; Neyrolles, Olivier; Zhang, Ji			An Interferon-Related Signature in the Transcriptional Core Response of Human Macrophages to Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; IFN-GAMMA; EXPRESSION; BIOINFORMATICS; VISUALIZATION; ACTIVATION; PROGRAMS; DRIVEN; SPREAD; FAMILY	The W-Beijing family of Mycobacterium tuberculosis (Mtb) strains is known for its high-prevalence and -virulence, as well as for its genetic diversity, as recently reported by our laboratories and others. However, little is known about how the immune system responds to these strains. To explore this issue, here we used reverse engineering and genome-wide expression profiling of human macrophage-like THP-1 cells infected by different Mtb strains of the W-Beijing family, as well as by the reference laboratory strain H37Rv. Detailed data mining revealed that host cell transcriptome responses to H37Rv and to different strains of the W-Beijing family are similar and overwhelmingly induced during Mtb infections, collectively typifying a robust gene expression signature ("THP1r2Mtb-induced signature"). Analysis of the putative transcription factor binding sites in promoter regions of genes in this signature identified several key regulators, namely STATs, IRF-1, IRF-7, and Oct-1, commonly involved in interferon-related immune responses. The THP1r2Mtb-induced signature appeared to be highly relevant to the interferon-inducible signature recently reported in active pulmonary tuberculosis patients, as revealed by cross-signature and cross-module comparisons. Further analysis of the publicly available transcriptome data from human patients showed that the signature appears to be relevant to active pulmonary tuberculosis patients and their clinical therapy, and be tuberculosis specific. Thus, our results provide an additional layer of information at the transcriptome level on mechanisms involved in host macrophage response to Mtb, which may also implicate the robustness of the cellular defense system that can effectively fight against genetic heterogeneity in this pathogen.	[Wu, Kang; Fang, Hai; Jin, Wen; Wang, Kankan; Zhang, Ji] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Wu, Kang; Fang, Hai; Jin, Wen; Wang, Kankan; Zhang, Ji] Shanghai Jiao Tong Univ, Sino French Res Ctr Life Sci & Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Wu, Kang; Fang, Hai; Du, Yanzhi; Zhang, Ji] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci,Sch Med, Shanghai 200030, Peoples R China; [Dong, Dandan; Gao, Qian] Fudan Univ, Key Lab Med Mol Virol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Levillain, Florence; Neyrolles, Olivier] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Levillain, Florence; Neyrolles, Olivier] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Mei, Jian] Shanghai Municipal CDC, Dept TB Control, Shanghai, Peoples R China; [Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wu, K (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	olivier.neyrolles@ipbs.fr; jizhang@sibs.ac.cn	Neyrolles, Olivier/AAG-3692-2019	Neyrolles, Olivier/0000-0003-0047-5885; Wu, Kang/0000-0002-9024-795X	European Community [200973, LSHP-CT-2006-037919]; National Natural Science Foundation Grants of China [90919059, 30730033, 31171257, 30971623, 81170503]; Chinese Academy of Sciences [KSCX1-YW-22-01, KSCX2-EW-Q-1-08]; Ministry of Science and Technology of China [2009CB825607]; Shanghai Commission of Science and Technology [09410706500]; Centre de la Recherche Scientifique (CNRS); Institut Pasteur; CNRS-ATIP	European Community(European Commission); National Natural Science Foundation Grants of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Centre de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); CNRS-ATIP(Centre National de la Recherche Scientifique (CNRS))	This work was supported in part by the European Community (FP7 project TB-VIR, grant no. 200973, and FP6 project TB-ADAPT, grant no. LSHP-CT-2006-037919). Also, this work was supported in part by National Natural Science Foundation Grants of China (90919059, 30730033, 31171257, 30971623, and 81170503), Chinese Academy of Sciences (KSCX1-YW-22-01, and KSCX2-EW-Q-1-08), Ministry of Science and Technology of China (2009CB825607), and the Shanghai Commission of Science and Technology (09410706500), the Centre de la Recherche Scientifique (CNRS) and the Institut Pasteur. ON is a fellow of a CNRS-ATIP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameixa C, 2001, INFECT IMMUN, V69, P2470, DOI 10.1128/IAI.69.4.2470-2476.2001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2002, GENOME BIOL, V3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang H, 2011, OMICS, V15, P483, DOI 10.1089/omi.2010.0066; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005158; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Kipnis A, 2003, IMMUNOLOGY, V109, P547, DOI 10.1046/j.1365-2567.2003.01680.x; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Lyadova IV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010469; Mesplede T, 2005, MOL CELL BIOL, V25, P8717, DOI 10.1128/MCB.25.19.8717-8731.2005; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Olmos S, 2010, J IMMUNOL, V184, P895, DOI 10.4049/jimmunol.0901230; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Remoli ME, 2002, J IMMUNOL, V169, P366, DOI 10.4049/jimmunol.169.1.366; Saito K, 2006, J IMMUNOL, V176, P2496, DOI 10.4049/jimmunol.176.4.2496; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schnappinger D, 2006, MICROBES INFECT, V8, P1132, DOI 10.1016/j.micinf.2005.10.027; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594; Xiao L, 2003, FEBS LETT, V538, P117, DOI 10.1016/S0014-5793(03)00156-X	53	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38367	10.1371/journal.pone.0038367	http://dx.doi.org/10.1371/journal.pone.0038367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675550	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700064
J	Caroselli, E; Zaccanti, F; Mattioli, G; Falini, G; Levy, O; Dubinsky, Z; Goffredo, S				Caroselli, Erik; Zaccanti, Francesco; Mattioli, Guido; Falini, Giuseppe; Levy, Oren; Dubinsky, Zvy; Goffredo, Stefano			Growth and Demography of the Solitary Scleractinian Coral Leptopsammia pruvoti along a Sea Surface Temperature Gradient in the Mediterranean Sea	PLOS ONE			English	Article							BALANOPHYLLIA-EUROPAEA SCLERACTINIA; MASS-MORTALITY; POPULATION-DYNAMICS; SEXUAL REPRODUCTION; COLONY SIZE; DENSITY; DENDROPHYLLIIDAE; CALCIFICATION; RECRUITMENT; STRATEGIES	The demographic traits of the solitary azooxanthellate scleractinian Leptopsammia pruvoti were determined in six populations on a sea surface temperature (SST) gradient along the western Italian coasts. This is the first investigation of the growth and demography characteristics of an azooxanthellate scleractinian along a natural SST gradient. Growth rate was homogeneous across all populations, which spanned 7 degrees of latitude. Population age structures differed between populations, but none of the considered demographic parameters correlated with SST, indicating possible effects of local environmental conditions. Compared to another Mediterranean solitary scleractinian, Balanophyllia europaea, zooxanthellate and whose growth, demography and calcification have been studied in the same sites, L. pruvoti seems more tolerant to temperature increase. The higher tolerance of L. pruvoti, relative to B. europaea, may rely on the absence of symbionts, and thus the lack of an inhibition of host physiological processes by the heat-stressed zooxanthellae. However, the comparison between the two species must be taken cautiously, due to the likely temperature differences between the two sampling depths. Increasing research effort on determining the effects of temperature on the poorly studied azooxanthellate scleractinians may shed light on the possible species assemblage shifts that are likely to occur during the current century as a consequence of global climatic change.	[Caroselli, Erik; Zaccanti, Francesco; Goffredo, Stefano] Alma Mater Studiorum Univ Bologna, Dept Evolutionary & Expt Biol, Marine Sci Grp, Bologna, Italy; [Mattioli, Guido] Hosp Porretta Terme, Operat Unit Radiol & Diagnost Images, Porretta Terme, Italy; [Falini, Giuseppe] Univ Bologna, Dept Chem, Bologna, Italy; [Levy, Oren; Dubinsky, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	University of Bologna; University of Bologna; Bar Ilan University	Caroselli, E (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Evolutionary & Expt Biol, Marine Sci Grp, Bologna, Italy.	stefano.goffredo@marinesciencegroup.org	Caroselli, Erik/GXW-2445-2022	goffredo, stefano/0000-0002-5022-9503; CAROSELLI, ERIK/0000-0001-6434-5663	European Research Council under the European Union's Seventh Framework Programme [249930]; Associazione dei Tour Operator Italiani (ASTOI); Marine and Freshwater Science Group Association; Ministry of Education, University and Research (MIUR)	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Associazione dei Tour Operator Italiani (ASTOI); Marine and Freshwater Science Group Association; Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no [249930 - CoralWarm: Corals and global warming: the Mediterranean versus the Red Sea]. This research was financed by the Associazione dei Tour Operator Italiani (ASTOI), the Marine and Freshwater Science Group Association, and the Ministry of Education, University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, SCI MAR, V69, P347, DOI 10.3989/scimar.2005.69n3347; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Bablet J. P., 1985, P 5 INT COR REEF S, V4, P361; Bak RPM, 1998, MAR ECOL PROG SER, V162, P301, DOI 10.3354/meps162301; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; BARNES DJ, 1988, J EXP MAR BIOL ECOL, V121, P37, DOI 10.1016/0022-0981(88)90022-6; Bastidas C, 2004, HYDROBIOLOGIA, V530, P433, DOI 10.1007/s10750-004-2663-7; BEVERTON R. J. H., 1956, RAPPORTS PROCES VERB, V140, P67; BOSSCHER H, 1993, CORAL REEFS, V12, P97, DOI 10.1007/BF00302109; Brahmi C, 2010, CORAL REEFS, V29, P175, DOI 10.1007/s00338-009-0557-x; Buddemeier R.W., 1976, Oceanography and Marine Biology an Annual Review, V14, P183; Caroselli E, 2011, ZOOLOGY, V114, P255, DOI 10.1016/j.zool.2011.04.003; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Chadwick-Furman NE, 2000, J EXP MAR BIOL ECOL, V249, P199, DOI 10.1016/S0022-0981(00)00204-5; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Connell J.H., 1973, P205; Cordes EE, 2001, MAR BIOL, V138, P491, DOI 10.1007/s002270000470; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Elahi R, 2007, J EXP MAR BIOL ECOL, V349, P183, DOI 10.1016/j.jembe.2007.05.007; FABENS AJ, 1965, GROWTH, V29, P265; FORD E., 1933, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V19, P305; FOSTER AB, 1988, CORAL REEFS, V7, P37, DOI 10.1007/BF00301980; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gass SE, 2006, MAR POLLUT BULL, V52, P549, DOI 10.1016/j.marpolbul.2005.10.002; Gerrodette T, 1979, THESIS U CALIFORNIA; Goffredo S, 2008, CORAL REEFS, V27, P623, DOI 10.1007/s00338-008-0362-y; Goffredo S, 2008, CORAL REEFS, V27, P751, DOI 10.1007/s00338-008-0391-6; Goffredo S, 2006, MAR BIOL, V148, P923, DOI 10.1007/s00227-005-0137-8; Goffredo S, 2005, MAR BIOL, V147, P485, DOI 10.1007/s00227-005-1567-z; Goffredo S, 2004, CORAL REEFS, V23, P433, DOI 10.1007/s00338-004-0395-9; Goffredo S, 2003, MAR BIOL, V142, P411, DOI 10.1007/s00227-002-0980-9; Goffredo S, 2002, MAR ECOL PROG SER, V229, P83, DOI 10.3354/meps229083; Goffredo S, 2007, MAR BIOL, V152, P351, DOI 10.1007/s00227-007-0695-z; Goffredo S, 2006, J EXP MAR BIOL ECOL, V336, P221, DOI 10.1016/j.jembe.2006.05.012; Goffredo S, 2011, MAR BIOL RES, V7, P272, DOI 10.1080/17451000.2010.492222; Goffredo S, 2010, MAR BIOL, V157, P2603, DOI 10.1007/s00227-010-1522-5; Goffredo S, 2009, ISR J ECOL EVOL, V55, P99, DOI 10.1560/IJEE.55.2.99; Goffredo S, 2009, LIMNOL OCEANOGR, V54, P930, DOI 10.4319/lo.2009.54.3.0930; GRIGG RW, 1974, ECOLOGY, V55, P387, DOI 10.2307/1935226; GRIGG RW, 1975, AM NAT, V109, P647, DOI 10.1086/283035; GRIGG RW, 1984, PSZNI MAR ECOL, V5, P57, DOI 10.1111/j.1439-0485.1984.tb00307.x; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Hamel JF, 2010, CORAL REEFS, V29, P521, DOI 10.1007/s00338-010-0590-9; Harper J. L., 1977, Population biology of plants.; Helmle KP., 2000, PROC 9 INT CORAL REE, V1, P365; Hoegh-Guldberg O, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P391, DOI 10.1007/978-94-007-0114-4_22; Hughes RN, 1989, FUNCTIONAL BIOL CLON; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; JOHNSON KG, 1992, J EXP MAR BIOL ECOL, V164, P171, DOI 10.1016/0022-0981(92)90173-8; KAIN JM, 1989, BRIT PHYCOL J, V24, P203, DOI 10.1080/00071618900650221; Knittweis L, 2009, CORAL REEFS, V28, P793, DOI 10.1007/s00338-009-0513-9; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; LASKER HR, 1981, BIOL BULL, V160, P292, DOI 10.2307/1540889; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Barros Monica Moraes Lins de, 2006, Braz. j. oceanogr., V54, P213, DOI 10.1590/S1679-87592006000300005; LOGAN A, 1991, B MAR SCI, V49, P847; LOYA Y, 1976, NATURE, V259, P478, DOI 10.1038/259478a0; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Metalpa RR, 2000, CORAL REEFS, V19, P24, DOI 10.1007/s003380050221; Mundet L, 2001, TOURISM MANAGE, V22, P501, DOI 10.1016/S0261-5177(01)00016-4; Nozawa Y, 2008, MAR ECOL PROG SER, V358, P151, DOI 10.3354/meps07342; Pauly D., 1984, FISH POPULATION DYNA; Peirano A, 1999, MAR ECOL PROG SER, V185, P195, DOI 10.3354/meps185195; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; QUEGUINER J, 1978, OCEAN MANAGE, V3, P179, DOI 10.1016/0302-184X(78)90003-3; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Rinkevich B, 1995, RESTOR ECOL, V3, P241, DOI 10.1111/j.1526-100X.1995.tb00091.x; Rogers A, 2011, INT EARTH SYST EXP W; ROSS MA, 1984, PSZNI MAR ECOL, V5, P75; Sakai K, 1998, BIOL BULL, V195, P319, DOI 10.2307/1543143; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sparre P, 1989, MANUAL FAO FISHERIES, V1, P1; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Tsimplis MN, 2006, DEV EARTH ENV SCI, V4, P227; Tsounis G, 2007, ECOSYSTEMS, V10, P975, DOI 10.1007/s10021-007-9072-5; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; WALFORD LA, 1946, BIOL BULL, V90, P141, DOI 10.2307/1538217; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wetherall J.A., 1987, ICLARM Conference Proceedings, P53; Yamashiro H, 1998, J EXP MAR BIOL ECOL, V225, P253, DOI 10.1016/S0022-0981(97)00229-3; Zibrowius H, 1980, MEMOIRES I OCEANOGRA, V11, P1	85	30	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e37848	10.1371/journal.pone.0037848	http://dx.doi.org/10.1371/journal.pone.0037848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675495	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339900010
J	Huang, WW; He, TT; Chai, CS; Yang, Y; Zheng, YH; Zhou, P; Qiao, XX; Zhang, B; Liu, ZZ; Wang, JR; Shi, CH; Lei, LP; Gao, K; Li, HW; Zhong, S; Yao, LB; Huang, ME; Lei, M				Huang, Weiwei; He, Tiantian; Chai, Chengsen; Yang, Yuan; Zheng, Yahong; Zhou, Pei; Qiao, Xiaoxia; Zhang, Bin; Liu, Zengzhen; Wang, Junru; Shi, Changhong; Lei, Liping; Gao, Kun; Li, Hewei; Zhong, Sue; Yao, Libo; Huang, Meng-Er; Lei, Ming			Triptolide Inhibits the Proliferation of Prostate Cancer Cells and Down-Regulates SUMO-Specific Protease 1 Expression	PLOS ONE			English	Article							ANDROGEN RECEPTOR; C-JUN; DEPENDENT TRANSCRIPTION; MOLECULAR-BIOLOGY; BREAST-CANCER; CROSS-TALK; KAPPA-B; PATHWAY; GROWTH; APOPTOSIS	Recently, traditional Chinese medicine and medicinal herbs have attracted more attentions worldwide for its anti-tumor efficacy. Celastrol and Triptolide, two active components extracted from the Chinese herb Tripterygium wilfordii Hook F (known as Lei Gong Teng or Thunder of God Vine), have shown anti-tumor effects. Celastrol was identified as a natural 26 s proteasome inhibitor which promotes cell apoptosis and inhibits tumor growth. The effect and mechanism of Triptolide on prostate cancer (PCa) is not well studied. Here we demonstrated that Triptolide, more potent than Celastrol, inhibited cell growth and induced cell death in LNCaP and PC-3 cell lines. Triptolide also significantly inhibited the xenografted PC-3 tumor growth in nude mice. Moreover, Triptolide induced PCa cell apoptosis through caspases activation and PARP cleavage. Unbalance between SUMOylation and deSUMOylation was reported to play an important role in PCa progression. SUMO-specific protease 1 (SENP1) was thought to be a potential marker and therapeutical target of PCa. Importantly, we observed that Triptolide down-regulated SENP1 expression in both mRNA and protein levels in dose-dependent and time-dependent manners, resulting in an enhanced cellular SUMOylation in PCa cells. Meanwhile, Triptolide decreased AR and c-Jun expression at similar manners, and suppressed AR and c-Jun transcription activity. Furthermore, knockdown or ectopic SENP1, c-Jun and AR expression in PCa cells inhibited the Triptolide anti-PCa effects. Taken together, our data suggest that Triptolide is a natural compound with potential therapeutic value for PCa. Its anti-tumor activity may be attributed to mechanisms involving down-regulation of SENP1 that restores SUMOylation and deSUMOyaltion balance and negative regulation of AR and c-Jun expression that inhibits the AR and c-Jun mediated transcription in PCa.	[Huang, Weiwei; He, Tiantian; Chai, Chengsen; Yang, Yuan; Zheng, Yahong; Zhou, Pei; Qiao, Xiaoxia; Zhang, Bin; Liu, Zengzhen; Wang, Junru; Lei, Ming] NW A&F Univ, Coll Life Sci, Key Lab Agr Mol Biol, Yangling, Shaanxi Provinc, Peoples R China; [He, Tiantian; Huang, Meng-Er] Univ Paris 11, Ctr Natl Rech Sci, Inst Curie, UMR3348, Orsay, France; [Shi, Changhong; Yao, Libo] Fourth Mil Med Univ, State Key Lab Tumor Biol, Xian 710032, Shaanxi Provinc, Peoples R China; [Lei, Liping; Zhong, Sue] Xian San Yao Biopharmaceut Corp, Xian, Shaanxi Provinc, Peoples R China; [Gao, Kun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Gansu Province, Peoples R China; [Li, Hewei] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China	Northwest A&F University - China; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Air Force Military Medical University; Lanzhou University; Beijing University of Chinese Medicine	Huang, WW (corresponding author), NW A&F Univ, Coll Life Sci, Key Lab Agr Mol Biol, Yangling, Shaanxi Provinc, Peoples R China.	leiming70@hotmail.com	wang, junru/E-8981-2015; zhong, sue/GRY-4030-2022; haung, weiwei/M-8866-2019; Wang, Junru/GPF-3569-2022	wang, junru/0000-0003-1967-5967; 	National Forestry Public Welfare Industry Research Project [201204603]; Program for New Century Excellent Talents in University [NCET-08-0467]; 100 Talents Program of Shaanxi Province of China	National Forestry Public Welfare Industry Research Project; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 100 Talents Program of Shaanxi Province of China	This study was funded by National Forestry Public Welfare Industry Research Project (201204603), Program for New Century Excellent Talents in University (NCET-08-0467) and 100 Talents Program of Shaanxi Province of China to Ming Lei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Annereau JP, 2006, P AM ASS CANC RES, V47, P1366; Antonoff MB, 2009, SURGERY, V146, P282, DOI 10.1016/j.surg.2009.04.023; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Cai CM, 2007, MOL CANCER RES, V5, P725, DOI 10.1158/1541-7786.MCR-06-0430; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; Dai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014153; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Ghobrial IM, 2010, J CLIN ONCOL, V28, P1422, DOI 10.1200/JCO.2009.25.3237; Gottlicher M, 1998, J MOL MED-JMM, V76, P480, DOI 10.1007/s001090050242; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hobisch A, 1996, PROSTATE, V28, P129; Jang SY, 2011, CANCER LETT, V300, P57, DOI 10.1016/j.canlet.2010.09.006; Kaikkonen S, 2009, MOL ENDOCRINOL, V23, P292, DOI 10.1210/me.2008-0219; Karamouzis MV, 2008, BREAST CANCER RES TR, V107, P195, DOI 10.1007/s10549-007-9552-5; Kim KI, 2006, MOL CELLS, V22, P247; Kiviharju TM, 2002, CLIN CANCER RES, V8, P2666; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li W, 2011, PLANTA MED, V77, P27, DOI 10.1055/s-0030-1250076; Liu J, 2009, PHYTOMEDICINE, V16, P1006, DOI 10.1016/j.phymed.2009.03.021; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; McCallum C, 2007, IMMUNOBIOLOGY, V212, P549, DOI 10.1016/j.imbio.2007.02.002; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mohler JL, 1996, CLIN CANCER RES, V2, P889; Pan JX, 2010, CANCER LETT, V292, P149, DOI 10.1016/j.canlet.2009.11.018; Petrie K, 2008, NAT CELL BIOL, V10, P507, DOI 10.1038/ncb0508-507; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Richardson Paul G, 2003, Cancer Control, V10, P361; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Shamon LA, 1997, CANCER LETT, V112, P113, DOI 10.1016/S0304-3835(96)04554-5; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Tan BJ, 2011, ONCOL REP, V26, P1315, DOI 10.3892/or.2011.1406; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wan CK, 2006, CANCER LETT, V241, P31, DOI 10.1016/j.canlet.2005.10.001; Xianxi WX, 2006, J MOL MED, V84, P405, DOI 10.1007/s00109-005-0022-4; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023993; Wang ZP, 2009, EXP MOL MED, V41, P717, DOI 10.3858/emm.2009.41.10.078; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Xu Y, 2010, J BIOL CHEM, V285, P36682, DOI 10.1074/jbc.M110.164236; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang SM, 2003, MOL CANCER THER, V2, P65; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhu WB, 2009, MOL PHARMACOL, V75, P812, DOI 10.1124/mol.108.052605	60	35	43	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37693	10.1371/journal.pone.0037693	http://dx.doi.org/10.1371/journal.pone.0037693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666381	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400040
J	Hummelshoj, T; Ma, YJ; Munthe-Fog, L; Bjarnsholt, T; Moser, C; Skjoedt, MO; Romani, L; Fujita, T; Endo, Y; Garred, P				Hummelshoj, Tina; Ma, Ying Jie; Munthe-Fog, Lea; Bjarnsholt, Thomas; Moser, Claus; Skjoedt, Mikkel-Ole; Romani, Luigina; Fujita, Teizo; Endo, Yuichi; Garred, Peter			The Interaction Pattern of Murine Serum Ficolin-A with Microorganisms	PLOS ONE			English	Article							INNATE IMMUNE RECOGNITION; MANNAN-BINDING LECTIN; H-FICOLIN; HAKATA ANTIGEN; PATHWAY; INFECTIONS; BACTERIA; MOUSE; ACID	The ficolins are soluble pattern recognition molecules in the lectin pathway of complement, but the spectrum and mode of interaction with pathogens are largely unknown. In this study, we investigated the binding properties of the murine serum ficolin-A towards a panel of different clinical relevant microorganisms (N = 45) and compared the binding profile with human serum ficolin-2 and ficolin-3. Ficolin-A was able to bind Gram-positive bacteria strains including E. faecalis, L. monocytogenes and some S. aureus strains, but not to the investigated S. agalactiae (Group B streptococcus) strains. Regarding Gram-negative bacteria ficolin-A was able to bind to some E. coli and P. aeruginosa strains, but not to the investigated Salmonella strains. Of particular interest ficolin-A bound strongly to the pathogenic E. coli, O157:H7 and O149 strains, but it did not bind to the non-pathogenic E. coli, ATCC 25922 strain. Additionally, ficolin-A was able to bind purified LPS from these pathogenic strains. Furthermore, ficolin-A bound to a clinical isolate of the fungus A. fumigatus. In general ficolin-2 showed similar selective binding spectrum towards pathogenic microorganisms as observed for ficolin-A indicating specific pathophysiological roles of these molecules in host defence. In contrast, ficolin-3 did not bind to any of the investigated microorganisms and the anti-microbial role of ficolin-3 still remains elusive.	[Hummelshoj, Tina; Ma, Ying Jie; Munthe-Fog, Lea; Skjoedt, Mikkel-Ole; Garred, Peter] Rigshosp, Dept Clin Immunol, Mol Med Lab, DK-2100 Copenhagen, Denmark; [Bjarnsholt, Thomas; Moser, Claus] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Bjarnsholt, Thomas] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Fujita, Teizo; Endo, Yuichi] Fukushima Med Univ, Sch Med, Dept Immunol, Fukushima, Japan	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Perugia; Fukushima Medical University	Hummelshoj, T (corresponding author), Rigshosp, Dept Clin Immunol, Mol Med Lab, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk	Romani, Luigina/O-9987-2018; Jie, Ying/AAJ-4697-2021; Moser, Claus Ernst/N-5951-2017; Bjarnsholt, Thomas/ABD-6178-2021; Moser, Claus Ernst/GPK-5546-2022	Jie, Ying/0000-0003-4003-2579; Moser, Claus Ernst/0000-0002-7664-8570; Moser, Claus Ernst/0000-0002-7664-8570; Garred, Peter/0000-0002-2876-8586; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Munthe-Fog, Lea/0000-0003-1345-176X; Romani, Luigina/0000-0002-1356-525X; Bjarnsholt, Thomas/0000-0002-8003-7414	Carlsberg Foundation; Novo Nordisk Research Foundation; Lundbeck Foundation; Research Foundation of the Capital Region of Denmark; Danish Agency for Science, Technology and Innovation; Grants-in-Aid for Scientific Research [22570144] Funding Source: KAKEN	Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Research Foundation of the Capital Region of Denmark; Danish Agency for Science, Technology and Innovation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from The Carlsberg Foundation, The Novo Nordisk Research Foundation, The Lundbeck Foundation, The Research Foundation of the Capital Region of Denmark and The Danish Agency for Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIOLE VT, 1993, CLIN INFECT DIS, V17, pS481, DOI 10.1093/clinids/17.Supplement_2.S481; Aoyagi Y, 2008, INFECT IMMUN, V76, P179, DOI 10.1128/IAI.00837-07; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Heidema J, 2011, BMJ-BRIT MED J, V342, DOI [10.1136/bmj.d3884, DOI 10.1136/BMJ.D3884]; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Kjaer TR, 2011, J LEUKOCYTE BIOL, V90, P425, DOI 10.1189/jlb.0411201; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Liu Y, 2005, MOL IMMUNOL, V42, P1265, DOI 10.1016/j.molimm.2004.11.019; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Nahid AM, 2006, DEV COMP IMMUNOL, V30, P335, DOI 10.1016/j.dci.2005.04.002; Ohashi T, 1998, ARCH BIOCHEM BIOPHYS, V360, P223, DOI 10.1006/abbi.1998.0957; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740, DOI 10.1128/AEM.60.2.740-745.1994; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Swierzko A, 2012, GLYCOBIOLOGY, V22, P267, DOI 10.1093/glycob/cwr119; Tsujimura M, 2002, CLIN CHIM ACTA, V325, P139, DOI 10.1016/S0009-8981(02)00274-7; Wachsmuth I. Kaye, 1991, Acta Paediatrica Japonica, V33, P603; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Yang LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019647	40	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38196	10.1371/journal.pone.0038196	http://dx.doi.org/10.1371/journal.pone.0038196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666482	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400099
J	Yu, H; Chen, JX; Xu, X; Li, Y; Zhao, HH; Fang, YP; Li, XX; Zhou, W; Wang, W; Wang, YH				Yu, Hua; Chen, Jianxin; Xu, Xue; Li, Yan; Zhao, Huihui; Fang, Yupeng; Li, Xiuxiu; Zhou, Wei; Wang, Wei; Wang, Yonghua			A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data	PLOS ONE			English	Article							DIVERSITY-ORIENTED SYNTHESIS; SUPPORT VECTOR MACHINE; SIMPLEX-VIRUS TYPE-1; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; PROTEIN INTERACTIONS; INTERACTION NETWORKS; INHIBITORY-ACTIVITY; THYMIDINE KINASE; GENE-EXPRESSION; RANDOM FOREST	In silico prediction of drug-target interactions from heterogeneous biological data can advance our system-level search for drug molecules and therapeutic targets, which efforts have not yet reached full fruition. In this work, we report a systematic approach that efficiently integrates the chemical, genomic, and pharmacological information for drug targeting and discovery on a large scale, based on two powerful methods of Random Forest (RF) and Support Vector Machine (SVM). The performance of the derived models was evaluated and verified with internally five-fold cross-validation and four external independent validations. The optimal models show impressive performance of prediction for drug-target interactions, with a concordance of 82.83%, a sensitivity of 81.33%, and a specificity of 93.62%, respectively. The consistence of the performances of the RF and SVM models demonstrates the reliability and robustness of the obtained models. In addition, the validated models were employed to systematically predict known/unknown drugs and targets involving the enzymes, ion channels, GPCRs, and nuclear receptors, which can be further mapped to functional ontologies such as target-disease associations and target-target interaction networks. This approach is expected to help fill the existing gap between chemical genomics and network pharmacology and thus accelerate the drug discovery processes.	[Yu, Hua; Xu, Xue; Fang, Yupeng; Li, Xiuxiu; Zhou, Wei; Wang, Yonghua] NW A&F Univ, Coll Life Sci, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China; [Chen, Jianxin; Zhao, Huihui; Wang, Wei] Beijing Univ Chinese Med, Beijing, Peoples R China; [Li, Yan] Dalian Univ Technol, Dept Chem Engn & Mat Sci, Dalian, Peoples R China; [Wang, Yonghua] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Wang, Yonghua] NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Beijing University of Chinese Medicine; Dalian University of Technology; Northwest A&F University - China; Northwest A&F University - China	Yu, H (corresponding author), NW A&F Univ, Coll Life Sci, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China.	wangwei@bucm.edu.cn; yh_wang@nwsuaf.edu.cn	Li, Yuan/GXV-1310-2022; , Paulin/U-9063-2019; Chen, Jianxin/G-5881-2015; Li, Yang/GWM-7879-2022; li, yong/HDN-3885-2022	, Paulin/0000-0001-6045-3712; Chen, Jianxin/0000-0003-4067-5638; 	National Natural Science Foundation of China [31170796]; Youth Fund of Northwest A F University; National Basic Research Program of China (973 Program) [2011CB505106]; National Department Public Benefit Research Foundation [200807007]; International Science and Technology Cooperation of China [2008DFA30610]; National Science Foundation of China [30902020, 81173463, 81102730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Fund of Northwest A F University; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Department Public Benefit Research Foundation; International Science and Technology Cooperation of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Natural Science Foundation of China (Grant No. 31170796) and also the Youth Fund of Northwest A & F University. This work was partially supported by the National Basic Research Program of China (973 Program) under grant No. 2011CB505106, the National Department Public Benefit Research Foundation (200807007), the International Science and Technology Cooperation of China (2008DFA30610), and the National Science Foundation of China (30902020, 81173463 and 81102730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2007, NEOPLASIA, V9, P222, DOI 10.1593/neo.06673; Balakin KV, 2002, J CHEM INF COMP SCI, V42, P1332, DOI 10.1021/ci025538y; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Ballesteros J, 2001, Curr Opin Drug Discov Devel, V4, P561; Biezonski DK, 2010, J NEUROCHEM, V112, P951, DOI 10.1111/j.1471-4159.2009.06515.x; Bock JR, 2005, J CHEM INF MODEL, V45, P1402, DOI 10.1021/ci050006d; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRIDGES CC, 1966, PSYCHOL REP, V18, P851, DOI 10.2466/pr0.1966.18.3.851; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; Buryanovskyy L, 2004, BIOCHEMISTRY-US, V43, P11417, DOI 10.1021/bi049162o; Byvatov E, 2003, J CHEM INF COMP SCI, V43, P1882, DOI 10.1021/ci0341161; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Datta S, 2003, BIOINFORMATICS, V19, P459, DOI 10.1093/bioinformatics/btg025; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Donnelly LE, 2004, AM J PHYSIOL-LUNG C, V287, pL774, DOI 10.1152/ajplung.00110.2004; Doucet JP, 2007, CURR COMPUT-AID DRUG, V3, P263, DOI 10.2174/157340907782799372; Erhan D, 2006, J CHEM INF MODEL, V46, P626, DOI 10.1021/ci050367t; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Frimurer TM, 2005, BIOORG MED CHEM LETT, V15, P3707, DOI 10.1016/j.bmcl.2005.05.102; Haggarty SJ, 2003, CHEM BIOL, V10, P383, DOI 10.1016/S1074-5521(03)00095-4; Han LY, 2004, NUCLEIC ACIDS RES, V32, P6437, DOI 10.1093/nar/gkh984; Hansen JP, 2002, J PHARMACOL EXP THER, V300, P1093, DOI 10.1124/jpet.300.3.1093; Hao M, 2011, INT J MOL SCI, V12, P1259, DOI 10.3390/ijms12021259; Hao M, 2010, INT J MOL SCI, V11, P3413, DOI 10.3390/ijms11093413; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; Jacoby E, 2003, DRUG NEWS PERSPECT, V16, P93, DOI 10.1358/dnp.2003.16.2.829326; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; KAUFMAN HE, 1985, OPHTHALMOLOGY, V92, P533; KLABUNDE T, 2006, LIGAND DESIGN G PROT, P115; Krejsa CM, 2003, CURR OPIN DRUG DISC, V6, P470; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Li Y, 2009, QSAR COMB SCI, V28, P396, DOI 10.1002/qsar.200810100; Li YY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002139; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; LYON RA, 1986, PSYCHOPHARMACOLOGY, V88, P525; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Mithoefer MC, 2011, J PSYCHOPHARMACOL, V25, P439, DOI 10.1177/0269881110378371; Nagamine M, 2000, J CLIN MICROBIOL, V38, P2750, DOI 10.1128/JCM.38.7.2750-2752.2000; Nagamine N, 2007, BIOINFORMATICS, V23, P2004, DOI 10.1093/bioinformatics/btm266; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Satoh T, 2004, INT J RADIAT ONCOL, V59, P562, DOI 10.1016/j.ijrobp.2004.01.020; Schmitt BM, 2004, CHEMBIOCHEM, V5, P1384, DOI 10.1002/cbic.200400126; Selken J, 2007, PHARMACOL BIOCHEM BE, V86, P622, DOI 10.1016/j.pbb.2007.02.006; Shankaran H, 1999, EUR J PHARMACOL, V385, P103, DOI 10.1016/S0014-2999(99)00728-1; Sprague JE, 2003, J PHARMACOL EXP THER, V305, P159, DOI 10.1124/jpet.102.044982; Sun XL, 2008, MOL DIVERS, V12, P157, DOI 10.1007/s11030-008-9092-x; Suzuki M, 2006, ANTIVIR RES, V72, P157, DOI 10.1016/j.antiviral.2006.05.001; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; VANE JR, 1998, INFLAMM RES, V2, P78, DOI DOI 10.1007/S000110050284; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Waterbury LD, 2006, CURR MED RES OPIN, V22, P1133, DOI 10.1185/030079906X112471; Wild K, 1997, PROTEIN SCI, V6, P2097; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xia Z, 2009, LECT NOTES OPER RES, V11, P123; Yabuuchi H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.5; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Yamanishi Y, 2011, J CHEM INF MODEL, V51, P1183, DOI 10.1021/ci100476q; Zhao CY, 2006, TOXICOLOGY, V217, P105, DOI 10.1016/j.tox.2005.08.019; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141	73	270	286	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37608	10.1371/journal.pone.0037608	http://dx.doi.org/10.1371/journal.pone.0037608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666371	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400036
J	Gutierrez-Ibanez, C; Iwaniuk, AN; Lisney, TJ; Faunes, M; Marin, GJ; Wylie, DR				Gutierrez-Ibanez, Cristian; Iwaniuk, Andrew N.; Lisney, Thomas J.; Faunes, Macarena; Marin, Gonzalo J.; Wylie, Douglas R.			Functional Implications of Species Differences in the Size and Morphology of the Isthmo Optic Nucleus (ION) in Birds	PLOS ONE			English	Article							CENTRIFUGAL VISUAL-SYSTEM; LOWER-FIELD MYOPIA; PHYLOGENETIC COMPARATIVE METHODS; SOMATIC SENSORY REPRESENTATION; LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; PIGEONS COLUMBA-LIVIA; AVIAN RETINA; LAMINAR ORGANIZATION; MOLECULAR PHYLOGENY	In birds, there is a retinofugal projection from the brain to the retina originating from the isthmo optic nucleus (ION) in the midbrain. Despite a large number of anatomical, physiological and histochemical studies, the function of this retinofugal system remains unclear. Several functions have been proposed including: gaze stabilization, pecking behavior, dark adaptation, shifting attention, and detection of aerial predators. This nucleus varies in size and organization among some species, but the relative size and morphology of the ION has not been systematically studied. Here, we present a comparison of the relative size and morphology of the ION in 81 species of birds, representing 17 different orders. Our results show that several orders of birds, besides those previously reported, have a large, well-organized ION, including: hummingbirds, woodpeckers, coots and allies, and kingfishers. At the other end of the spectrum, parrots, herons, waterfowl, owls and diurnal raptors have relatively small ION volumes. ION also appears to be absent or unrecognizable is several taxa, including one of the basal avian groups, the tinamous, which suggests that the ION may have evolved only in the more modern group of birds, Neognathae. Finally, we demonstrate that evolutionary changes in the relative size and the cytoarchitectonic organization of ION have occurred largely independent of phylogeny. The large relative size of the ION in orders with very different lifestyles and feeding behaviors suggest there is no clear association with pecking behavior or predator detection. Instead, our results suggest that the ION is more complex and enlarged in birds that have eyes that are emmetropic in some parts of the visual field and myopic in others. We therefore posit that the ION is involved in switching attention between two parts of the retina i.e. from an emmetropic to a myopic part of the retina.	[Gutierrez-Ibanez, Cristian; Wylie, Douglas R.] Univ Alberta, Univ Ctr Neurosci, Edmonton, AB, Canada; [Iwaniuk, Andrew N.] Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Faunes, Macarena; Marin, Gonzalo J.] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Lisney, Thomas J.; Wylie, Douglas R.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Marin, Gonzalo J.] Univ Finis Terrae, Fac Med, Santiago, Chile	University of Alberta; University of Lethbridge; Universidad de Chile; University of Alberta; Universidad Finis Terrae	Gutierrez-Ibanez, C (corresponding author), Univ Alberta, Univ Ctr Neurosci, Edmonton, AB, Canada.	cagutier@ualberta.ca	Lisney, Thomas/AAA-3288-2021; Iwaniuk, Andrew/H-7255-2019	Lisney, Thomas/0000-0001-5149-3720; Iwaniuk, Andrew/0000-0001-9273-3655; Gutierrez-Ibanez, Cristian/0000-0002-0468-8223	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to ANI and DRW (http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumann T, 2001, WILDLIFE RES, V28, P379, DOI 10.1071/WR99092; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Brown DM, 1999, AUK, V116, P141, DOI 10.2307/4089461; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cajal SR, 1888, REV TRIM HISTOL NORM, V2, P1; CATSICAS S, 1987, NATURE, V326, P186, DOI 10.1038/326186a0; CHMIELEWSKI CE, 1988, ANAT HISTOL EMBRYOL, V17, P319, DOI 10.1111/j.1439-0264.1988.tb00570.x; CLARKE PGH, 1976, Q J EXP PHYSIOL CMS, V61, P351, DOI 10.1113/expphysiol.1976.sp002366; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; Craigie EH, 1930, J COMP NEUROL, V49, P223, DOI 10.1002/cne.900490202; CROSSLAND WJ, 1978, BRAIN RES, V145, P239, DOI 10.1016/0006-8993(78)90860-0; Davis KE, 2008, THESIS U GLASGOW UK; DEACON TW, 1990, INT J PRIMATOL, V11, P193, DOI 10.1007/BF02192869; Demery ZP, 2011, P ROY SOC B-BIOL SCI, V278, P3687, DOI 10.1098/rspb.2011.0374; DESROCHERS BA, 1986, CAN J ZOOL, V64, P1400, DOI 10.1139/z86-208; Dogiel A.S., 1895, ANAT ENTWICKLUNGSGES, V44, P622, DOI [10.1007/BF02934032, DOI 10.1007/BF02934032]; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Driskell AC, 2004, MOL PHYLOGENET EVOL, V31, P943, DOI 10.1016/j.ympev.2003.10.017; Duncan RP, 2007, ECOLOGY, V88, P324, DOI 10.1890/0012-9658(2007)88[324:TTMTOE]2.0.CO;2; EBINGER P, 1987, J HIRNFORSCH, V28, P291; EBINGER P, 1995, J BRAIN RES, V36, P219; EBINGER P, 1995, BRAIN BEHAV EVOLUT, V45, P286, DOI 10.1159/000113557; EDDLEMAN WR, 1985, WILSON BULL, V97, P463; FERGUSON JL, 1978, BRAIN BEHAV EVOLUT, V15, P294, DOI 10.1159/000123784; FEYERABEND B, 1994, NEUROSCI LETT, V182, P66, DOI 10.1016/0304-3940(94)90207-0; Finger TE, 1975, ACTA PHYSL SCAND S, V638, P59; FITZKE FW, 1985, J PHYSIOL-LONDON, V369, P33, DOI 10.1113/jphysiol.1985.sp015886; Galifret Y, 1971, Vision Res, VSuppl 3, P185; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gass C.L., 1981, P159; GUNDERSEN HJG, 1981, J MICROSC-OXFORD, V121, P65, DOI 10.1111/j.1365-2818.1981.tb01199.x; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HAHMANN U, 1992, VISUAL NEUROSCI, V9, P225, DOI 10.1017/S0952523800010634; HAYES BP, 1983, EXP BRAIN RES, V49, P189; Higgins PJ, 2002, HDB AUSTR NZ ANTARCT, V5; Hirschberger W, 1971, THESIS GOETHE U FRAN; HODOS W, 1990, VISION RES, V30, P653, DOI 10.1016/0042-6989(90)90091-X; HOLDEN AL, 1968, J PHYSIOL-LONDON, V197, P199, DOI 10.1113/jphysiol.1968.sp008555; HOLDEN AL, 1972, J PHYSIOL-LONDON, V223, P419, DOI 10.1113/jphysiol.1972.sp009856; Holyoak DT., 2001, NIGHTJARS THEIR ALLI; Howard CV, 2005, UNBIASED STEREOLOGY; HOWARD V, 1985, J MICROSC-OXFORD, V138, P203, DOI 10.1111/j.1365-2818.1985.tb02613.x; Ives AR, 2007, SYST BIOL, V56, P252, DOI 10.1080/10635150701313830; Iwaniuk A., 2004, INT J COMP PSYCHOL, V17, P17; Iwaniuk AN, 2007, J COMP NEUROL, V500, P211, DOI 10.1002/cne.21098; JAKSIC FM, 1985, ORNIS SCAND, V16, P165, DOI 10.2307/3676627; Janke A, 2001, P ROY SOC B-BIOL SCI, V268, P623, DOI 10.1098/rspb.2000.1402; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; KAAS JH, 1978, J COMP NEUROL, V182, P517, DOI 10.1002/cne.901820308; Kahn DM, 2002, J COMP NEUROL, V447, P114, DOI 10.1002/cne.10206; Karten H.J., 1967, STEREOTAXIC ATLAS BR; Kimball RT, 2008, J AVIAN BIOL, V39, P438, DOI 10.1111/j.2008.0908-8857.04270.x; KNIPLING RR, 1978, PHYSIOL BEHAV, V21, P813, DOI 10.1016/0031-9384(78)90022-7; Kolmer W, 1924, PFLUEGERS ARCH GESAM, V2, P266; KRUGER L, 1969, AM J ANAT, V125, P247, DOI 10.1002/aja.1001250302; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; LINDSEY GD, 1994, J FIELD ORNITHOL, V65, P76; Lindstrom SH, 2009, VISUAL NEUROSCI, V26, P215, DOI 10.1017/S0952523809090063; Lindstrom SH, 2010, VISUAL NEUROSCI, V27, P103, DOI 10.1017/S0952523810000155; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Maddison WP, 2019, MESQUITE MODULAR SYS; MARIN G, 1990, EXP BRAIN RES, V82, P263; MARTIN GR, 1986, J COMP PHYSIOL A, V159, P545, DOI 10.1007/BF00604174; MARTIN GR, 1994, J COMP PHYSIOL A, V174, P787; MARTIN GR, 1994, BRAIN BEHAV EVOLUT, V44, P74, DOI 10.1159/000113571; Martin Graham R., 1993, P5; McConkey KR, 2004, EMU, V104, P369, DOI 10.1071/MU03060; Medina M, 2004, J COMP NEUROL, V468, P65, DOI 10.1002/cne.10959; MICELI D, 1995, VISUAL NEUROSCI, V12, P425, DOI 10.1017/S0952523800008336; Miceli D, 1999, BEHAV BRAIN RES, V98, P203, DOI 10.1016/S0166-4328(98)00085-0; Miceli D, 1997, VISUAL NEUROSCI, V14, P213, DOI 10.1017/S0952523800011354; Midford PE, 2008, PDAP MESQUITE TRANSL; MILES FA, 1972, BRAIN RES, V48, P93, DOI 10.1016/0006-8993(72)90172-2; MILES FA, 1972, BRAIN RES, V48, P115, DOI 10.1016/0006-8993(72)90173-4; Moore JM, 2011, P NATL ACAD SCI USA, V108, P16440, DOI 10.1073/pnas.1102077108; MORITA Y, 1985, J COMP NEUROL, V238, P187, DOI 10.1002/cne.902380206; MURPHY CJ, 1995, VISION RES, V35, P1153, DOI 10.1016/0042-6989(94)00240-M; NICKLA DL, 1994, VISUAL NEUROSCI, V11, P401, DOI 10.1017/S0952523800001747; OLEARY DDM, 1982, J COMP NEUROL, V212, P399, DOI 10.1002/cne.902120407; PEARLMAN AL, 1976, J COMP NEUROL, V166, P123, DOI 10.1002/cne.901660109; Pereira SL, 2007, SYST BIOL, V56, P656, DOI 10.1080/10635150701549672; PUBOLS BH, 1972, BRAIN BEHAV EVOLUT, V5, P342; PUBOLS BH, 1965, J NEUROPHYSIOL, V28, P312, DOI 10.1152/jn.1965.28.2.312; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; Ramon y Cajal S., 1889, ANAT ANZEIGER, V4, P111; Reperant J, 2007, BRAIN RES REV, V53, P161, DOI 10.1016/j.brainresrev.2006.08.004; Reperant J, 2006, BRAIN RES REV, V52, P1, DOI 10.1016/j.brainresrev.2005.11.008; REPERANT J, 1989, INT REV CYTOL, V118, P115, DOI 10.1016/S0074-7696(08)60874-8; ROGERS LJ, 1972, BRAIN RES, V48, P147, DOI 10.1016/0006-8993(72)90175-8; SANDERSON KJ, 1974, J COMP NEUROL, V153, P239, DOI 10.1002/cne.901530303; SCHAEFFEL F, 1994, J OPT SOC AM A, V11, P487, DOI 10.1364/JOSAA.11.000487; Scheaffer R.L., 1996, ELEMENTARY SURVEY SA; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; SHORTESS GK, 1975, BRAIN RES, V88, P525, DOI 10.1016/0006-8993(75)90665-4; SHORTESS GK, 1977, PHYSIOL BEHAV, V18, P409, DOI 10.1016/0031-9384(77)90252-9; SHOWERS MJC, 1968, J COMP NEUROL, V132, P589, DOI 10.1002/cne.901320407; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; SOHAL GS, 1975, EXP NEUROL, V46, P521, DOI 10.1016/0014-4886(75)90123-5; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; TATE J, 1973, AUK, V90, P840, DOI 10.2307/4084364; UCHIYAMA H, 1989, VISUAL NEUROSCI, V3, P183, DOI 10.1017/S0952523800009950; Uchiyama H, 2005, VISUAL NEUROSCI, V22, P881, DOI 10.1017/S0952523805226160; Uchiyama H, 1998, VISUAL NEUROSCI, V15, P417; Uchiyama H, 1996, VISUAL NEUROSCI, V13, P1119, DOI 10.1017/S0952523800007768; Uchiyama H, 1999, NEUROCOMPUTING, V26-7, P565, DOI 10.1016/S0925-2312(99)00035-1; Uchiyama H, 2004, J COMP NEUROL, V476, P146, DOI 10.1002/cne.20225; UCHIYAMA H, 1994, VISION RES, V34, P2189, DOI 10.1016/0042-6989(94)90101-5; Verhaart W. J. C., 1971, J Hirnforsch, V13, P39; WARD R, 1991, NATO ADV SCI I A-LIF, V222, P61; WEIDNER C, 1989, Biological Structures and Morphogenesis, V2, P89; WEIDNER C, 1987, BRAIN RES, V436, P153, DOI 10.1016/0006-8993(87)91568-X; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WESTCOTT DA, 1988, AUST J ZOOL, V36, P335, DOI 10.1071/ZO9880335; Wink M, 2008, OWLS WORLD, P42; Wink Michael, 2004, P517; Witmer MC, 1996, AUK, V113, P414, DOI 10.2307/4088908; WOLFOBERHOLLENZER F, 1987, NEUROSCI LETT, V73, P16, DOI 10.1016/0304-3940(87)90023-1; WOODSON W, 1995, J COMP NEUROL, V362, P489, DOI 10.1002/cne.903620405; WOODSON W, 1991, J COMP NEUROL, V305, P470, DOI 10.1002/cne.903050310; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160	130	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37816	10.1371/journal.pone.0037816	http://dx.doi.org/10.1371/journal.pone.0037816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666395	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600031
J	Mitchell, JE; Chetty, S; Govender, P; Pillay, M; Jaggernath, M; Kasmar, A; Ndung'u, T; Klenerman, P; Walker, BD; Kasprowicz, VO				Mitchell, Jessica E.; Chetty, Shivan; Govender, Pamla; Pillay, Mona; Jaggernath, Manjeetha; Kasmar, Anne; Ndung'u, Thumbi; Klenerman, Paul; Walker, Bruce D.; Kasprowicz, Victoria O.			Prospective Monitoring Reveals Dynamic Levels of T Cell Immunity to Mycobacterium Tuberculosis in HIV Infected Individuals	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; WITHIN-SUBJECT VARIABILITY; ELISPOT TEST; SKIN-TEST; DIAGNOSIS; RESPONSES; ENUMERATION; SENSITIVITY; PREVALENCE; EXPOSURE	Monitoring of latent Mycobacterium tuberculosis infection may prevent disease. We tested an ESAT-6 and CFP-10-specific IFN-gamma Elispot assay (RD1-Elispot) on 163 HIV-infected individuals living in a TB-endemic setting. An RD1-Elispot was performed every 3 months for a period of 3-21 months. 62% of RD1-Elispot negative individuals were positive by cultured Elispot. Fluctuations in T cell response were observed with rates of change ranging from -150 to +153 spot-forming cells (SFC)/200,000 PBMC in a 3-month period. To validate these responses we used an RD1-specific real time quantitative PCR assay for monokine-induced by IFN-gamma (MIG) and IFN-gamma inducible protein-10 (IP10) (MIG: r = 0.6527, p = 0.0114; IP-10: r = 0.6967, p = 0.0056; IP-10+MIG: r = 0.7055, p = 0.0048). During follow-up 30 individuals were placed on ARVs and 4 progressed to active TB. Fluctuations in SFC did not correlate with CD4 count, viral load, treatment initiation, or progression to active TB. The RD1-Elispot appears to have limited value in this setting.	[Mitchell, Jessica E.; Ndung'u, Thumbi; Walker, Bruce D.; Kasprowicz, Victoria O.] MIT, Ragon Inst MGH, Boston, MA USA; [Kasmar, Anne] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA USA; [Kasprowicz, Victoria O.] Kwazulu Natal Res Inst TB & HIV K RITH, Nelson R Mandela Sch Med, Durban, South Africa; [Mitchell, Jessica E.; Chetty, Shivan; Govender, Pamla; Pillay, Mona; Jaggernath, Manjeetha; Ndung'u, Thumbi; Walker, Bruce D.; Kasprowicz, Victoria O.] Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Klenerman, Paul] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Klenerman, Paul] Univ Oxford, James Martin Sch 21st Century, Nuffield Dept Med, Oxford, England	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kwazulu Natal; University of Kwazulu Natal; University of Oxford; University of Oxford	Mitchell, JE (corresponding author), MIT, Ragon Inst MGH, Boston, MA USA.	vkasprowicz@partners.org		Ndung'u, Thumbi/0000-0003-2962-3992; klenerman, paul/0000-0003-4307-9161	Howard Hughes Medical Institute; Medical Research Council of South Africa; KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); National Institutes of Health; National Institute for Health Research [NF-SI-0510-10204] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089858, P30AI060354] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council of South Africa(South African Medical Research Council); KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to funders: The Howard Hughes Medical Institute, the Medical Research Council of South Africa, The KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Clark SA, 2007, CLIN EXP IMMUNOL, V150, P238, DOI 10.1111/j.1365-2249.2007.03477.x; Connell TG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-138; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Kasprowicz V, 2006, J VIROL, V80, P11209, DOI 10.1128/JVI.01173-06; Kasprowicz VO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020606; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kipfer B, 2008, SWISS MED WKLY, V138, P267, DOI 2008/17/smw-12051; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Leyten EMS, 2006, J CLIN MICROBIOL, V44, P1197, DOI 10.1128/JCM.44.3.1197-1201.2006; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Richeldi L, 2007, PEDIATRICS, V119, pE1, DOI 10.1542/peds.2006-1057; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Shafer RW, 1996, CLIN INFECT DIS, V22, P683, DOI 10.1093/clinids/22.4.683; Smith SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007972; Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15; Tuuminen T, 2010, CLIN VACCINE IMMUNOL, V17, P596, DOI 10.1128/CVI.00320-09; van Brummelen SE, 2010, CLIN VACCINE IMMUNOL, V17, P937, DOI 10.1128/CVI.00005-10; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; WHO, 2010, POL STAT PREV THER T; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; Zellweger JP, 2005, INT J TUBERC LUNG D, V9, P1242; Zwerling A, 2011, THORAX	49	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37920	10.1371/journal.pone.0037920	http://dx.doi.org/10.1371/journal.pone.0037920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685549	gold, Green Published, Green Submitted			2022-12-27	WOS:000305351700012
J	Seguin, A; Forstmeier, W				Seguin, Aurelie; Forstmeier, Wolfgang			No Band Color Effects on Male Courtship Rate or Body Mass in the Zebra Finch: Four Experiments and a Meta-Analysis	PLOS ONE			English	Article							MALE ATTRACTIVENESS; BEHAVIORAL ECOLOGY; SEXUAL SELECTION; MATE CHOICE; PREFERENCES; INVESTMENT; FEEDBACK	Replication of experiments is essential for distinguishing real effects from type 1 errors and idiosyncrasies. One of the most replicated experiments in behavioral ecology is the presumed manipulation of male attractiveness in zebra finches by adding red or green color bands. Red-banded males were found to have higher fitness than green-banded males, and most empirical evidence suggests that this effect is mediated by female mating preferences rather than by male-male competition. A recent study, however, reported that color bands affected male courtship rate and body mass independently of female behavior. If this effect was real, some earlier findings of female preferences and maternal effects on offspring traits could potentially be reinterpreted as being mediated indirectly via effects on male behavior. This new perspective seems appealing also in light of a growing interest in bi-directional feedback mechanisms between endocrinology and ornamentation. However, here we report four independent failures to replicate this effect of color bands on courtship rate and body mass. Combining this new experimental data with all the published evidence in a meta-analysis shows that color bands seem to affect neither male courtship rate (average effect size d = 0.02) nor male body mass (d = -0.07). The present case is a reminder that replication of experiments lies at the heart of distinguishing between real effects and false positive findings.	[Seguin, Aurelie; Forstmeier, Wolfgang] Max Planck Inst Ornithol, Seewiesen, Germany	Max Planck Society	Seguin, A (corresponding author), Max Planck Inst Ornithol, Seewiesen, Germany.	forstmeier@orn.mpg.de			Max Planck Society (MPS)	Max Planck Society (MPS)(Max Planck Society)	The study was supported only by the Max Planck Society (MPS), but not by any external funding sources. The funder (MPS) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolund E, 2009, P R SOC B, V276, P707, DOI 10.1098/rspb.2008.1251; BURLEY N, 1981, SCIENCE, V211, P721, DOI 10.1126/science.211.4483.721; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; BURLEY N, 1988, ANIM BEHAV, V36, P1235, DOI 10.1016/S0003-3472(88)80085-X; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; BURLEY NT, 1994, ANIM BEHAV, V48, P1031, DOI 10.1006/anbe.1994.1336; Burley NT, 1996, BEHAV ECOL, V7, P218, DOI 10.1093/beheco/7.2.218; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; Cuthill IC, 1997, P ROY SOC B-BIOL SCI, V264, P1093, DOI 10.1098/rspb.1997.0151; Fawcett TW, 2009, BEHAV ECOL, V20, P68, DOI 10.1093/beheco/arn116; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Forstmeier W, 2004, ANIM BEHAV, V68, P1005, DOI 10.1016/j.anbehav.2004.02.003; Forstmeier W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000952; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gleeson DJ, 2006, AUST J ZOOL, V54, P375, DOI 10.1071/ZO06001; Gorman HE, 2005, J AVIAN BIOL, V36, P413; Griffith SC, 2010, EMU, V110, P251, DOI 10.1071/MU10006; HOUTMAN AM, 1992, P ROY SOC B-BIOL SCI, V249, P3, DOI 10.1098/rspb.1992.0075; Hunt S, 1997, ANIM BEHAV, V54, P1383, DOI 10.1006/anbe.1997.0540; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jennions MD, 1998, ANIM BEHAV, V55, P61, DOI 10.1006/anbe.1997.0579; Kelly CD, 2006, Q REV BIOL, V81, P221, DOI 10.1086/506236; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Owens IPF, 2006, TRENDS ECOL EVOL, V21, P356, DOI 10.1016/j.tree.2006.03.014; Palmer AR, 2000, ANNU REV ECOL SYST, V31, P441, DOI 10.1146/annurev.ecolsys.31.1.441; Pariser EC, 2010, BEHAV ECOL, V21, P264, DOI 10.1093/beheco/arp185; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Pearson FD, 1999, ANIM BEHAV, V57, P173, DOI 10.1006/anbe.1998.0924; RATCLIFFE LM, 1987, CAN J ZOOL, V65, P333, DOI 10.1139/z87-052; Royle NJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P2015, DOI 10.1007/s00265-010-1013-1; Rubenstein DR, 2008, TRENDS ECOL EVOL, V23, P655, DOI 10.1016/j.tree.2008.07.010; Rutstein AN, 2004, ANIM BEHAV, V68, P1087, DOI 10.1016/j.anbehav.2004.02.011; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Schuett W, 2010, J ETHOL, V28, P273, DOI 10.1007/s10164-009-0181-9; SHUSTER SM, 2003, MG BEH ECOL, pR7; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; ZANN R, 1994, AUK, V111, P131; Zann RA., 1996, ZEBRA FINCH SYNTHESI	42	18	18	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37785	10.1371/journal.pone.0037785	http://dx.doi.org/10.1371/journal.pone.0037785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685545	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700008
J	Caputi, A; Fuchs, EC; Allen, K; Le Magueresse, C; Monyer, H				Caputi, Antonio; Fuchs, Elke C.; Allen, Kevin; Le Magueresse, Corentin; Monyer, Hannah			Selective Reduction of AMPA Currents onto Hippocampal Interneurons Impairs Network Oscillatory Activity	PLOS ONE			English	Article							PHASE-PRECESSION; PATH-INTEGRATION; PYRAMIDAL CELLS; PLACE CELLS; THETA OSCILLATIONS; NEURONAL-ACTIVITY; SPATIAL WORKING; GAP-JUNCTIONS; GRID CELLS; MEMORY	Reduction of excitatory currents onto GABAergic interneurons in the forebrain results in impaired spatial working memory and altered oscillatory network patterns in the hippocampus. Whether this phenotype is caused by an alteration in hippocampal interneurons is not known because most studies employed genetic manipulations affecting several brain regions. Here we performed viral injections in genetically modified mice to ablate the GluA4 subunit of the AMPA receptor in the hippocampus (GluA4(HC-/-) mice), thereby selectively reducing AMPA receptor-mediated currents onto a subgroup of hippocampal interneurons expressing GluA4. This regionally selective manipulation led to a strong spatial working memory deficit while leaving reference memory unaffected. Ripples (125-250 Hz) in the CA1 region of GluA4(HC-/-) mice had larger amplitude, slower frequency and reduced rate of occurrence. These changes were associated with an increased firing rate of pyramidal cells during ripples. The spatial selectivity of hippocampal pyramidal cells was comparable to that of controls in many respects when assessed during open field exploration and zigzag maze running. However, GluA4 ablation caused altered modulation of firing rate by theta oscillations in both interneurons and pyramidal cells. Moreover, the correlation between the theta firing phase of pyramidal cells and position was weaker in GluA4(HC-/-) mice. These results establish the involvement of AMPA receptor-mediated currents onto hippocampal interneurons for ripples and theta oscillations, and highlight potential cellular and network alterations that could account for the altered working memory performance.	[Caputi, Antonio] Heidelberg Univ, Fac Med, Dept Clin Neurobiol, Heidelberg, Germany; German Canc Res Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Caputi, A (corresponding author), Heidelberg Univ, Fac Med, Dept Clin Neurobiol, Heidelberg, Germany.	h.monyer@dkfz-heidelberg.de		Allen, Kevin/0000-0001-5319-3721; Monyer, Hannah/0000-0002-9332-5749; Le Magueresse, Corentin/0000-0001-8418-4991	European Commission; European Research Council	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission)	KA held a Humboldt Research Fellowship for Postdoctoral Studies (http://www.humboldt-foundation.de). HM was supported by the Seventh Framework Programme of the European Commission (SPACEBRAIN; http://cordis.europa.eu/fp7/home_en.html) and a European Research Council Advanced Grant (GABACellsAndMemory; http://erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2011, J NEUROSCI, V31, P6542, DOI 10.1523/JNEUROSCI.6512-10.2011; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cacucci F, 2008, P NATL ACAD SCI USA, V105, P7863, DOI 10.1073/pnas.0802908105; Castro L, 2012, J COMPUT NEUROSCI; Catania MV, 1998, EUR J NEUROSCI, V10, P3479, DOI 10.1046/j.1460-9568.1998.00356.x; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Cutsuridis V, 2012, HIPPOCAMPUS, V22, P1597, DOI 10.1002/hipo.21002; de Almeida L, 2012, HIPPOCAMPUS, V22, P200, DOI 10.1002/hipo.20882; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Deacon RMJ, 2002, BEHAV BRAIN RES, V133, P57, DOI 10.1016/S0166-4328(01)00451-X; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; Fisher N., 1995, STAT ANAL CIRCULAR D; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Racz A, 2009, J NEUROSCI, V29, P2563, DOI 10.1523/JNEUROSCI.5036-08.2009; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Schmitt WB, 2003, J NEUROSCI, V23, P3953; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Taxidis J, 2012, HIPPOCAMPUS, V22, P995, DOI 10.1002/hipo.20930; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Traub RD, 2000, J NEUROSCI, V20, P2086; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YLINEN A, 1995, J NEUROSCI, V15, P30	62	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37318	10.1371/journal.pone.0037318	http://dx.doi.org/10.1371/journal.pone.0037318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675480	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700012
J	Prescott, J; Thompson, DJ; Kraft, P; Chanock, SJ; Audley, T; Brown, J; Leyland, J; Folkerd, E; Doody, D; Hankinson, SE; Hunter, DJ; Jacobs, KB; Dowsett, M; Cox, DG; Easton, DF; De Vivo, I				Prescott, Jennifer; Thompson, Deborah J.; Kraft, Peter; Chanock, Stephen J.; Audley, Tina; Brown, Judith; Leyland, Jean; Folkerd, Elizabeth; Doody, Deborah; Hankinson, Susan E.; Hunter, David J.; Jacobs, Kevin B.; Dowsett, Mitch; Cox, David G.; Easton, Douglas F.; De Vivo, Immaculata			Genome-Wide Association Study of Circulating Estradiol, Testosterone, and Sex Hormone-Binding Globulin in Postmenopausal Women	PLOS ONE			English	Article							BREAST-CANCER RISK; COMMON GENETIC-VARIATION; STEROID-HORMONE; COLLABORATIVE REANALYSIS; INDIVIDUAL DATA; SHBG GENE; ESTROGEN; METAANALYSIS; COHORT; REPRODUCIBILITY	Genome-wide association studies (GWAS) have successfully identified common genetic variants that contribute to breast cancer risk. Discovering additional variants has become difficult, as power to detect variants of weaker effect with present sample sizes is limited. An alternative approach is to look for variants associated with quantitative traits that in turn affect disease risk. As exposure to high circulating estradiol and testosterone, and low sex hormone-binding globulin (SHBG) levels is implicated in breast cancer etiology, we conducted GWAS analyses of plasma estradiol, testosterone, and SHBG to identify new susceptibility alleles. Cancer Genetic Markers of Susceptibility (CGEMS) data from the Nurses' Health Study (NHS), and Sisters in Breast Cancer Screening data were used to carry out primary meta-analyses among similar to 1600 postmenopausal women who were not taking postmenopausal hormones at blood draw. We observed a genome-wide significant association between SHBG levels and rs727428 (joint beta = -0.126; joint P = 2.09 x 10(-16)), downstream of the SHBG gene. No genome-wide significant associations were observed with estradiol or testosterone levels. Among variants that were suggestively associated with estradiol (P<10(-5)), several were located at the CYP19A1 gene locus. Overall results were similar in secondary meta-analyses that included similar to 900 NHS current postmenopausal hormone users. No variant associated with estradiol, testosterone, or SHBG at P<10(-5) was associated with postmenopausal breast cancer risk among CGEMS participants. Our results suggest that the small magnitude of difference in hormone levels associated with common genetic variants is likely insufficient to detectably contribute to breast cancer risk.	[Prescott, Jennifer; Hankinson, Susan E.; Hunter, David J.; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Prescott, Jennifer; Hankinson, Susan E.; Hunter, David J.; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA USA; [Prescott, Jennifer; Kraft, Peter; Hankinson, Susan E.; Hunter, David J.; Cox, David G.; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Thompson, Deborah J.; Audley, Tina; Brown, Judith; Leyland, Jean; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Chanock, Stephen J.; Jacobs, Kevin B.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Folkerd, Elizabeth; Doody, Deborah; Dowsett, Mitch] Royal Marsden Hosp, Acad Dept Biochem, London SW3 6JJ, England; [Hankinson, Susan E.] Univ Massachusetts, Div Biostat & Epidemiol, Amherst, MA 01003 USA; [Cox, David G.] Ctr Leon Berard, CNRS UMR5286, INSERM U1052, Canc Res Ctr Lyon, F-69373 Lyon, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Royal Marsden NHS Foundation Trust; University of Massachusetts System; University of Massachusetts Amherst; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Prescott, J (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	david.cox@lyon.unicancer.fr	Cox, David/ABA-7454-2020; Cox, David G/A-2023-2009	Cox, David G/0000-0002-2152-9259; Cox, David/0000-0003-2047-4687; De Vivo, Immaculata/0000-0002-7185-7402; Jacobs, Kevin/0000-0002-4657-6473	National Institutes of Health (NIH) [CA87969, CA49449, CA128034, T32 CA 09001]; Cancer Research UK [C1287/A10118, C1287/8459]; la Ligue Contre le Cancer, Comite du Savoie; Cancer Research UK [10118, 11022] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA049449, ZIACP010201, U01CA049449, R03CA128034, P01CA087969, T32CA009001] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); la Ligue Contre le Cancer, Comite du Savoie; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The NHS was supported by the National Institutes of Health (NIH; http://grants.nih.gov/grants/oer.htm) [CA87969, CA49449, CA128034]. JP was supported by NIH training grant T32 CA 09001. SIBS was supported by programme grant C1287/A10118 and project grants from Cancer Research UK (http://science.cancerresearchuk.org/) [grant numbers C1287/8459]. DFE is a Principal Research Fellow of Cancer Research UK. DGC receives support from la Ligue Contre le Cancer, Comite du Savoie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Beckmann L, 2011, J CLIN ENDOCR METAB, V96, pE360, DOI 10.1210/jc.2010-0912; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Canzian F, 2010, HUM MOL GENET, V19, P3873, DOI 10.1093/hmg/ddq291; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; Coviello AD, 2011, J CLIN ENDOCR METAB, V96, pE1491, DOI 10.1210/jc.2011-0050; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; DOWSETT M, 1987, CANCER RES, V47, P1957; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Haiman CA, 2005, J CLIN ENDOCR METAB, V90, P2198, DOI 10.1210/jc.2004-1417; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Hankinson Susan E, 2005, Breast Dis, V24, P3; HARADA N, 1992, AM J HUM GENET, V51, P666; HUNTER DJ, 2007, NAT GENET; Kaaks R, 2005, ENDOCR-RELAT CANCER, V12, P1071, DOI 10.1677/erc.1.01038; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liao DJ, 2002, J STEROID BIOCHEM, V80, P175, DOI 10.1016/S0960-0760(01)00185-6; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LONNING PE, 1989, J STEROID BIOCHEM, V34, P551, DOI 10.1016/0022-4731(89)90143-X; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Mitamura R, 2000, J CLIN ENDOCR METAB, V85, P1074, DOI 10.1210/jc.85.3.1074; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reeves GK, 2009, BRIT J CANCER, V100, P538, DOI 10.1038/sj.bjc.6604853; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Shah NR, 2005, MENOPAUSE, V12, P668, DOI 10.1097/01.gme.0000184221.63459.e1; Stone J, 2009, J CLIN ENDOCR METAB, V94, P4793, DOI 10.1210/jc.2009-0713; Thompson D, 2004, J MAMMARY GLAND BIOL, V9, P221, DOI 10.1023/B:JOMG.0000048770.90334.3b; Thompson DJ, 2008, CANCER EPIDEM BIOMAR, V17, P3490, DOI 10.1158/1055-9965.EPI-08-0734; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zeleniuch-Jacquotte A, 2004, BRIT J CANCER, V90, P153, DOI 10.1038/sj.bjc.6601517	49	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37815	10.1371/journal.pone.0037815	http://dx.doi.org/10.1371/journal.pone.0037815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675492	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700023
J	Pinheiro, A; Nunes, MJ; Milagre, I; Rodrigues, E; Silva, MJ; de Almeida, IT; Rivera, I				Pinheiro, Ana; Nunes, Maria Joao; Milagre, Ines; Rodrigues, Elsa; Silva, Maria Joao; de Almeida, Isabel Tavares; Rivera, Isabel			Demethylation of the Coding Region Triggers the Activation of the Human Testis-Specific PDHA2 Gene in Somatic Tissues	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; OPEN READING FRAME; DNA METHYLATION; CPG DINUCLEOTIDES; E1-ALPHA SUBUNIT; INTRONLESS GENE; EXPRESSION; PROMOTER; TRANSCRIPTION; BINDING	Human PDHA2 is a testis-specific gene that codes for the E-1 alpha subunit of Pyruvate Dehydrogenase Complex (PDC), a crucial enzyme system in cell energy metabolism. Since activation of the PDHA2 gene in somatic cells could be a new therapeutic approach for PDC deficiency, we aimed to identify the regulatory mechanisms underlying the human PDHA2 gene expression. Functional deletion studies revealed that the -122 to -6 promoter region is indispensable for basal expression of this TATA-less promoter, and suggested a role of an epigenetic program in the control of PDHA2 gene expression. Indeed, treatment of SH-SY5Y cells with the hypomethylating agent 5-Aza-2'-deoxycytidine (DAC) promoted the reactivation of the PDHA2 gene, by inducing the recruitment of the RNA polymerase II to the proximal promoter region and the consequent increase in PDHA2 mRNA levels. Bisulfite sequencing analysis revealed that DAC treatment induced a significant demethylation of the CpG island II (nucleotides + 197 to +460) in PDHA2 coding region, while the promoter region remained highly methylated. Taken together with our previous results that show an in vivo correlation between PDHA2 expression and the demethylation of the CpG island II in testis germ cells, the present results show that internal methylation of the PDHA2 gene plays a part in its repression in somatic cells. In conclusion, our data support the novel finding that methylation of the PDHA2 coding region can inhibit gene transcription. This represents a key mechanism for absence of PDHA2 expression in somatic cells and a target for PDC therapy.	[Pinheiro, Ana; Nunes, Maria Joao; Milagre, Ines; Rodrigues, Elsa; Silva, Maria Joao; de Almeida, Isabel Tavares; Rivera, Isabel] Res Inst Med & Pharmaceut Sci iMed UL, Lisbon, Portugal; [Rodrigues, Elsa; Silva, Maria Joao; de Almeida, Isabel Tavares; Rivera, Isabel] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Pinheiro, A (corresponding author), Res Inst Med & Pharmaceut Sci iMed UL, Lisbon, Portugal.	iarivera@ff.ul.pt	iMed.ULisboa, CellFun/A-4244-2014; Nunes, Maria João/F-6766-2015; de Almeida, Isabel Tavares/F-8319-2014; Milagre, Ines/AAC-4409-2021; Rivera, Isabel/AAS-3204-2021; Rodrigues, Elsa/J-3100-2012; Rivera, Isabel/A-5863-2014; Silva, Maria João/F-7225-2015; iMed.ULisboa, MetGen/B-5293-2014; Nunes, Maria João/AAB-5062-2022	Nunes, Maria João/0000-0002-4922-633X; Rivera, Isabel/0000-0001-6892-729X; Rodrigues, Elsa/0000-0003-1669-365X; Rivera, Isabel/0000-0001-6892-729X; Silva, Maria João/0000-0002-2185-7762; Nunes, Maria João/0000-0002-4922-633X; Milagre, Ines/0000-0003-4753-5523; Tavares de Almeida, Isabel/0000-0002-4024-8305	Fundacao para a Ciencia e a Tecnologia (FCT), Lisboa, Portugal [SFRH/BD/31264/2006]	Fundacao para a Ciencia e a Tecnologia (FCT), Lisboa, Portugal(Portuguese Foundation for Science and Technology)	This study was supported by the PhD grant SFRH/BD/31264/2006, from the Fundacao para a Ciencia e a Tecnologia (FCT), Lisboa, Portugal, awarded to Ana Pinheiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BROWN GK, 1989, ANN NY ACAD SCI, V573, P360, DOI 10.1111/j.1749-6632.1989.tb15011.x; BROWN RM, 1989, GENOMICS, V4, P174, DOI 10.1016/0888-7543(89)90297-8; Choi JK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r89; CHOI YC, 1991, J BIOL CHEM, V266, P20504; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; Datta U, 1999, BBA-GENE STRUCT EXPR, V1447, P236, DOI 10.1016/S0167-4781(99)00158-X; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; De Smet C, 1999, MOL CELL BIOL, V19, P7327; del Mazo J, 1994, CHROMOSOME RES, V2, P147, DOI 10.1007/BF01553493; FITZGERALD J, 1993, GENOMICS, V18, P636, DOI 10.1016/S0888-7543(05)80366-0; Fitzgerald J, 1996, MOL BIOL EVOL, V13, P1023, DOI 10.1093/oxfordjournals.molbev.a025652; GRAESSMANN A, 1994, MOL CELL BIOL, V14, P2004, DOI 10.1128/MCB.14.3.2004; Hisano M, 2003, NUCLEIC ACIDS RES, V31, P4797, DOI 10.1093/nar/gkg670; Hohn T, 1996, P NATL ACAD SCI USA, V93, P8334, DOI 10.1073/pnas.93.16.8334; IANNELLO RC, 1992, BIOL REPROD, V47, P48, DOI 10.1095/biolreprod47.1.48; Iannello RC, 2000, J BIOL CHEM, V275, P19603, DOI 10.1074/jbc.M001867200; IANNELLO RC, 1994, REPROD FERT DEVELOP, V6, P599, DOI 10.1071/RD9940599; Iannello RC, 1995, REPROD FERT DEVELOP, V7, P705, DOI 10.1071/RD9950705; Iannello RC, 1997, MOL CELL BIOL, V17, P612, DOI 10.1128/MCB.17.2.612; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; Kroft TL, 2001, BIOL REPROD, V65, P1522, DOI 10.1095/biolreprod65.5.1522; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Milagre I, 2008, J NEUROCHEM, V106, P835, DOI 10.1111/j.1471-4159.2008.05442.x; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; Pinheiro A, 2012, UNIQUE CASE FA UNPUB; Pinheiro A, 2010, MOL GENET METAB, V99, P425, DOI 10.1016/j.ymgme.2009.11.002; Robinson BH, 1996, J INHERIT METAB DIS, V19, P452, DOI 10.1007/BF01799106; ROCAMORA N, 1989, FEBS LETT, V247, P415, DOI 10.1016/0014-5793(89)81382-1; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110; Zhu SK, 2005, CIRCULATION, V112, P1353, DOI 10.1161/CIRCULATIONAHA.104.519025	36	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38076	10.1371/journal.pone.0038076	http://dx.doi.org/10.1371/journal.pone.0038076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675509	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339900012
J	Guo, WB; Tao, J; Yang, C; Song, CJ; Geng, WT; Li, Q; Wang, YY; Kong, MM; Wang, SF				Guo, Wenbin; Tao, Jian; Yang, Chao; Song, Cunjiang; Geng, Weitao; Li, Qiang; Wang, Yuanyuan; Kong, Meimei; Wang, Shufang			Introduction of Environmentally Degradable Parameters to Evaluate the Biodegradability of Biodegradable Polymers	PLOS ONE			English	Article							SOIL; PHB	Environmentally Degradable Parameter (K-Ed) is of importance in the describing of biodegradability of environmentally biodegradable polymers (BDPs). In this study, a concept K-Ed was introduced. A test procedure of using the ISO 14852 method and detecting the evolved carbon dioxide as an analytical parameter was developed, and the calculated K-Ed was used as an indicator for the ultimate biodegradability of materials. Starch and polyethylene used as reference materials were defined as the K-Ed values of 100 and 0, respectively. Natural soil samples were inoculated into bioreactors, followed by determining the rates of biodegradation of the reference materials and 15 commercial BDPs over a 2-week test period. Finally, a formula was deduced to calculate the value of K-Ed for each material. The K-Ed values of the tested materials have a positive correlation to their biodegradation rates in the simulated soil environment, and they indicated the relative biodegradation rate of each material among all the tested materials. Therefore, the K-Ed was shown to be a reliable indicator for quantitatively evaluating the potential biodegradability of BDPs in the natural environment.	[Guo, Wenbin; Tao, Jian; Song, Cunjiang; Geng, Weitao; Li, Qiang; Wang, Yuanyuan] Nankai Univ, Coll Life Sci, Minist Educ, Dept Microbiol,Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Yang, Chao; Kong, Meimei; Wang, Shufang] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Guo, WB (corresponding author), Nankai Univ, Coll Life Sci, Minist Educ, Dept Microbiol,Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China.	songcj@nankai.edu.cn; wangshufang@nankai.edu.cn	Lv, Yuanjie/AER-0767-2022	Guo, Wenbin/0000-0001-7197-6260	National Key Basic Research Program of China ("973" Program) [2012CB725204]; National High Technology Research and Development Program of China ("863" Program) [2012AA021505]; Natural Science Foundation of China [31070039, 51073081]; Project of Tianjin, China [1JCYBJC09500]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021505] Funding Source: NIH RePORTER	National Key Basic Research Program of China ("973" Program)(National Basic Research Program of China); National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Tianjin, China; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors gratefully acknowledge the financial support from National Key Basic Research Program of China ("973" Program) 2012CB725204, National High Technology Research and Development Program of China ("863" Program) 2012AA021505, Natural Science Foundation of China grant nos. 31070039, 51073081 and 51073081, Project of Tianjin, China 1JCYBJC09500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai YP, 2009, MATER DESIGN, V30, P892, DOI 10.1016/j.matdes.2008.05.047; [Anonymous], 1999, 14851 ISO; [Anonymous], 1999, 14852 ISO; [Anonymous], 1997, 846 ISO; Colby R.H., 2003, POLYM PHYS; Ding Q, 2003, CARBOHYD POLYM, V51, P333, DOI 10.1016/S0144-8617(02)00190-X; Doi Y, 2002, NAT MATER, V1, P207, DOI 10.1038/nmat783; Goel R, 2008, INT BIODETER BIODEGR, V61, P167, DOI 10.1016/j.ibiod.2007.07.001; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; Guo WB, 2010, POLYM TEST, V29, P832, DOI 10.1016/j.polymertesting.2010.07.004; Ishikuri S, 1992, NEW COMPILATION SOIL; *ISO, 1999, 14855 ISO; Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025; Mizuno W, 2003, KOBUNSHI RONBUNSHU, V60, P622, DOI 10.1295/koron.60.622; Montgomery R, 2004, BIORESOURCE TECHNOL, V91, P1, DOI 10.1016/S0960-8524(03)00154-8; Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002; Nikolic MS, 2001, POLYM DEGRAD STABIL, V74, P263, DOI 10.1016/S0141-3910(01)00156-2; OTAKE Y, 1995, J APPL POLYM SCI, V56, P1789, DOI 10.1002/app.1995.070561309; Rodrigues G, 2008, CARBOHYD POLYM, V73, P74, DOI 10.1016/j.carbpol.2007.11.010; Rosa DD, 2004, J POLYM ENVIRON, V12, P239; Ryan SM, 2006, APPL ENVIRON MICROB, V72, P5289, DOI 10.1128/AEM.00257-06; Shafiee S, 2009, ENERG POLICY, V37, P181, DOI 10.1016/j.enpol.2008.08.016; Song JH, 2009, PHILOS T R SOC B, V364, P2127, DOI 10.1098/rstb.2008.0289; Tokiwa Y, 2004, BIOTECHNOL LETT, V26, P771, DOI 10.1023/B:BILE.0000025927.31028.e3; Verlinden RAJ, 2007, J APPL MICROBIOL, V102, P1437, DOI 10.1111/j.1365-2672.2007.03335.x; Zhao Q, 2008, POLYM DEGRAD STABIL, V93, P1571, DOI 10.1016/j.polymdegradstab.2008.05.002	26	23	24	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38341	10.1371/journal.pone.0038341	http://dx.doi.org/10.1371/journal.pone.0038341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675455	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500135
J	Ingles-Esteve, J; Morales, M; Dalmases, A; Garcia-Carbonell, R; Jene-Sanz, A; Lopez-Bigas, N; Iglesias, M; Ruiz-Herguido, C; Rovira, A; Rojo, F; Albanell, J; Gomis, RR; Bigas, A; Espinosa, L				Ingles-Esteve, Julia; Morales, Monica; Dalmases, Alba; Garcia-Carbonell, Ricard; Jene-Sanz, Alba; Lopez-Bigas, Nuria; Iglesias, Mar; Ruiz-Herguido, Cristina; Rovira, Ana; Rojo, Federico; Albanell, Joan; Gomis, Roger R.; Bigas, Anna; Espinosa, Lluis			Inhibition of Specific NF-kappa B Activity Contributes to the Tumor Suppressor Function of 14-3-3 sigma in Breast Cancer	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CELL-PROLIFERATION; BONE METASTASIS; NUCLEAR EXPORT; IKK-ALPHA; ACTIVATION; INFLAMMATION; APOPTOSIS; PROGRESSION; CARCINOMA	14-3-3 sigma is frequently lost in human breast cancers by genetic deletion or promoter methylation. We have now investigated the involvement of 14-3-3 sigma in the termination of NF-kappa B signal in mammary cells and its putative role in cancer relapse and metastasis. Our results show that 14-3-3 sigma regulates nuclear export of p65-NF-kappa B following chronic TNF alpha stimulation. Restoration of 14-3-3 sigma in breast cancer cells reduces migration capacity and metastatic abilities in vivo. By microarray analysis, we have identified a genetic signature that responds to TNF alpha in a 14-3-3 sigma-dependent manner and significantly associates with different breast and other types of cancer. By interrogating public databases, we have found that overexpression of this signature correlates with poor relapse-free survival in breast cancer patients. Finally, screening of 96 human breast tumors showed that NF-kappa B activation strictly correlates with the absence of 14-3-3 sigma and it is significantly associated with worse prognosis in the multivariate analysis. Our findings identify a genetic signature that is important for breast cancer prognosis and for future personalized treatments based on NF-kappa B targeting.	[Ingles-Esteve, Julia; Dalmases, Alba; Garcia-Carbonell, Ricard; Ruiz-Herguido, Cristina; Rovira, Ana; Rojo, Federico; Albanell, Joan; Bigas, Anna; Espinosa, Lluis] Hosp Mar Res Inst, IMIM, Canc Res Program, Barcelona, Spain; [Morales, Monica; Gomis, Roger R.] IRB, Barcelona, Spain; [Dalmases, Alba; Rovira, Ana; Albanell, Joan] Hosp Mar, Med Oncol Serv, Barcelona, Spain; [Garcia-Carbonell, Ricard; Iglesias, Mar] Hosp Mar, Dept Pathol, Barcelona, Spain; [Jene-Sanz, Alba; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain; [Lopez-Bigas, Nuria] ICREA, Barcelona, Spain; [Rojo, Federico] IIS Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; ICREA; Fundacion Jimenez Diaz	Ingles-Esteve, J (corresponding author), Hosp Mar Res Inst, IMIM, Canc Res Program, Barcelona, Spain.	abigas@imim.es; lespinosa@imim.es	Lopez-Bigas, Nuria/F-6193-2011; Gasull, Martina/J-4076-2019; Morales-Ballús, Mònica/AAE-3086-2021; Gomis, Roger R/E-9788-2016; Ruiz, Cristina/AGV-9518-2022; Albanell, Joan/R-9470-2019; Rojo, Federico/S-6551-2016; Espinosa, Lluis/ABA-4564-2020; Bigas, Anna/A-7457-2014; Rovira, Ana/ABH-5661-2020	Lopez-Bigas, Nuria/0000-0003-4925-8988; Morales-Ballús, Mònica/0000-0002-9478-6280; Gomis, Roger R/0000-0001-6473-2858; Ruiz, Cristina/0000-0002-5133-3564; Espinosa, Lluis/0000-0002-2897-4099; Bigas, Anna/0000-0003-4801-6899; Rovira, Ana/0000-0003-1301-2599; Jene-Sanz, Alba/0000-0003-3665-8333; Rojo, Federico/0000-0001-9989-0290	ISCIII/FEDER-Subdireccion General de Evaluacion y Fomento de la Investigacion [PI07/0778, PI10/01128, PS09/1296, PS09/01285]; AGAUR [2009SGR23, 2009SGR321]; Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio 2010, Programa Consolider and Instituto de Salud Carlos III (ISCIII)/FEDER [RD06/0020/0098, RD06/0020/0109]; BBVA foundation and Asociacion Espanola Contra el Cancer; Spanish Ministry of Science and Technology [SAF2009-06954]; Science and Education Spanish Ministry (MEC) FPI predoctoral fellowship [BES-2008-001850]; ICREA Funding Source: Custom	ISCIII/FEDER-Subdireccion General de Evaluacion y Fomento de la Investigacion(Instituto de Salud Carlos III); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio 2010, Programa Consolider and Instituto de Salud Carlos III (ISCIII)/FEDER(Instituto de Salud Carlos III); BBVA foundation and Asociacion Espanola Contra el Cancer(BBVA Foundation); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Science and Education Spanish Ministry (MEC) FPI predoctoral fellowship(National Health and Medical Research Council (NHMRC) of Australia); ICREA(ICREA)	This work was funded by ISCIII/FEDER-Subdireccion General de Evaluacion y Fomento de la Investigacion (PI07/0778, PI10/01128, PS09/1296 and PS09/01285), AGAUR (2009SGR23 and 2009SGR321) and Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio 2010, Programa Consolider and Instituto de Salud Carlos III (ISCIII)/FEDER (RD06/0020/0098 and RD06/0020/0109). Financial support was provided to RRG by BBVA foundation and Asociacion Espanola Contra el Cancer. NLB acknowledges funding from the Spanish Ministry of Science and Technology (SAF2009-06954). AJ-S was funded by Science and Education Spanish Ministry (MEC) FPI predoctoral fellowship (BES-2008-001850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera C, 2006, J CELL SCI, V119, P3695, DOI 10.1242/jcs.03086; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Bengtsson H., 2008, 745 U CAL DEP STAT; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chan SYY, 2010, ONCOL REP, V24, P949, DOI 10.3892/or_00000941; Che XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-306; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Gundem G, 2012, GENOME MED, V4, DOI 10.1186/gm327; Gundem G, 2010, NAT METHODS, V7, P92, DOI 10.1038/nmeth0210-92; Hodgson JG, 2005, CANCER RES, V65, P9695, DOI 10.1158/0008-5472.CAN-05-0755; Holland PM, 2010, CANCER BIOL THER, V9, P539, DOI 10.4161/cbt.9.7.11266; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lodygin D, 2005, CELL RES, V15, P237, DOI 10.1038/sj.cr.7290292; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Nicolini A, 2009, MED RES REV, V29, P436, DOI 10.1002/med.20143; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; R Development Core Team, 2010, LANG ENV STAT COMP; Rivas MA, 2010, BREAST CANCER RES TR, V122, P111, DOI 10.1007/s10549-009-0546-3; Sangaletti S, 2010, CANCER RES, V70, P7764, DOI 10.1158/0008-5472.CAN-10-0471; Schaefer J., 2010, CORPCOR EFFICIENT ES; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Su CH, 2010, CANC RES; Sung B, 2010, INT J CANC; Tan W, 2011, NATURE; Therneau T, 2009, SURVIVAL SURVIVAL AN, P235; Tobinick EL, 2003, CLIN THER, V25, P2279, DOI 10.1016/S0149-2918(03)80219-9; Venkatraman M, 2005, MOL CARCINOGEN, V44, P51, DOI 10.1002/mc.20116; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Zhang GJ, 1999, ANTICANCER RES, V19, P1427; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790; Zurita M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-217	60	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38347	10.1371/journal.pone.0038347	http://dx.doi.org/10.1371/journal.pone.0038347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675457	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500138
J	Kim, Y; Vaughan, K; Greenbaum, J; Peters, B; Law, M; Sette, A				Kim, Yohan; Vaughan, Kerrie; Greenbaum, Jason; Peters, Bjoern; Law, Mansun; Sette, Alessandro			A Meta-Analysis of the Existing Knowledge of Immunoreactivity against Hepatitis C Virus (HCV)	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; IMMUNE EPITOPE DATA; INFLUENZA-A VIRUS; NS2 PROTEIN; NEUTRALIZING ANTIBODIES; ANTIGENIC DETERMINANTS; ENVELOPE GLYCOPROTEINS; VIRAL REPLICATION; ATOMIC MOBILITY; CORE PROTEIN	Approximately 3% of the world population is infected by HCV, which represents a major global health challenge. Almost 400 different scientific reports present immunological data related to T cell and antibody epitopes derived from HCV literature. Analysis of all HCV-related epitope hosted in the Immune Epitope Database (IEDB), a repository of freely accessible immune epitope data, revealed more than 1500 and 1900 distinct T cell and antibody epitopes, respectively. The inventory of all data revealed specific trends in terms of the host and the HCV genotypes from which sequences were derived. Upon further analysis we found that this large number of epitopes reflects overlapping structures, and homologous sequences derived from different HCV isolates. To access and visualize this information we developed a novel strategy that assembles large sets of epitope data, maps them onto reference genomes and displays the frequency of positive responses. Compilation of the HCV immune reactivity from hundreds of different studies, revealed a complex and thorough picture of HCV immune epitope data to date. The results pinpoint areas of more intense reactivity or research activities at the level of antibody, CD4 and CD8 responses for each of the individual HCV proteins. In general, the areas targeted by the different effector immune functions were distinct and antibody reactivity was positively correlated with hydrophilicity, while T cell reactivity correlated with hydrophobicity. At the sequence level, epitopes frequently recognized by both T cell and B cell correlated with low variability, and our analysis thus highlighted areas of potential interest for practical applications. The human reactivity was further analyzed to pinpoint differential patterns of reactivity associated with acute versus chronic infection, to reveal the apparent impact of glycosylation on T cell, but not antibody responses, and to highlight a paucity of studies involved antibody epitopes associated with virus neutralization.	[Kim, Yohan; Vaughan, Kerrie; Greenbaum, Jason; Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Immune Epitope Database IEDB, La Jolla, CA USA; [Law, Mansun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Scripps Research Institute	Kim, Y (corresponding author), La Jolla Inst Allergy & Immunol, Immune Epitope Database IEDB, La Jolla, CA USA.	kvaughan@liai.org	Sette, Alessandro/AFO-8916-2022	Law, Mansun/0000-0002-8934-9756	National Institutes of Health National Institute of Allergy and Infectious Diseases [HHSN26620040006C]	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The La Jolla Institute of Allergy and Immunology is supported by the National Institutes of Health National Institute of Allergy and Infectious Diseases, contract number HHSN26620040006C, under the Immune Epitope Database and Analysis Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus AGN, 2011, FUTURE MICROBIOL, V6, P279, DOI [10.2217/fmb.11.9, 10.2217/FMB.11.9]; Bansal A, 2005, AIDS, V19, P241; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; Beld M, 1999, HEPATOLOGY, V29, P1288, DOI 10.1002/hep.510290442; Berkhoff EGM, 2007, J GEN VIROL, V88, P530, DOI 10.1099/vir.0.82120-0; Blythe Martin J, 2007, Immunome Res, V3, P10, DOI 10.1186/1745-7580-3-10; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Chang KM, 1997, J CLIN INVEST, V100, P2376, DOI 10.1172/JCI119778; Diepolder HM, 1997, J VIROL, V71, P6011, DOI 10.1128/JVI.71.8.6011-6019.1997; Edwards VC, 2012, J GEN VIROL, V93, P1, DOI 10.1099/vir.0.035956-0; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Elazar M, 2004, J VIROL, V78, P11393, DOI 10.1128/JVI.78.20.11393-11400.2004; Franck N, 2005, J VIROL, V79, P2700, DOI 10.1128/JVI.79.5.2700-2708.2005; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Gretton SN, 2005, J GEN VIROL, V86, P1415, DOI 10.1099/vir.0.80768-0; HARADA S, 1991, J VIROL, V65, P3015, DOI 10.1128/JVI.65.6.3015-3021.1991; HIJIKATA M, 1991, BIOCHEM BIOPH RES CO, V175, P220, DOI 10.1016/S0006-291X(05)81223-9; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; Moutaftsi M, 2010, FUTURE MICROBIOL, V5, P221, DOI [10.2217/fmb.09.110, 10.2217/FMB.09.110]; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Rahman F, 2004, HEPATOLOGY, V40, P87, DOI 10.1002/hep.20253; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; SANTOLINI E, 1995, J VIROL, V69, P7461, DOI 10.1128/JVI.69.12.7461-7471.1995; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; TAINER JA, 1985, ANNU REV IMMUNOL, V3, P501, DOI 10.1146/annurev.iy.03.040185.002441; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; TANJI Y, 1995, J VIROL, V69, P1575, DOI 10.1128/JVI.69.3.1575-1581.1995; Troesch M, 2006, VIROLOGY, V352, P357, DOI 10.1016/j.virol.2006.05.015; VALLARI DS, 1992, J CLIN MICROBIOL, V30, P552, DOI 10.1128/JCM.30.3.552-556.1992; Vaughan K, 2009, PARASITE IMMUNOL, V31, P78, DOI 10.1111/j.1365-3024.2008.01077.x; Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006; Vita R, 2008, CYTOM PART A, V73A, P1066, DOI 10.1002/cyto.a.20585; Wang Y, 2011, VIRUSES-BASEL, V3, P2127, DOI 10.3390/v3112127; WEINER AJ, 1991, VIROLOGY, V180, P842, DOI 10.1016/0042-6822(91)90104-J; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; Yamaga AK, 2002, J BIOL CHEM, V277, P33228, DOI 10.1074/jbc.M202304200; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zarebski LM, 2008, EXPERT REV VACCINES, V7, P55, DOI 10.1586/14760584.7.1.55	44	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38028	10.1371/journal.pone.0038028	http://dx.doi.org/10.1371/journal.pone.0038028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675428	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500075
J	Wang, F; Ye, P; Luo, LM; Xu, RY; Bai, YY; Wu, HM				Wang, Fan; Ye, Ping; Luo, Leiming; Xu, Ruyi; Bai, Yongyi; Wu, Hongmei			Association of Glomerular Filtration Rate with High-Sensitivity Cardiac Troponin T in a Community-Based Population Study in Beijing	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; STAGE RENAL-DISEASE; CARDIOVASCULAR-DISEASE; UNIVERSAL DEFINITION; RISK; ADULTS; INSUFFICIENCY; PREVALENCE; MORTALITY	Background: Reduced renal function is an independent risk factor for cardiovascular disease mortality, and persistently elevated cardiac troponin T (cTnT) is frequently observed in patients with end-stage renal disease. In the general population the relationship between renal function and cTnT levels may not be clear because of the low sensitivity of the assay. In this study, we investigated the level of cTnT using a highly sensitive assay (hs-cTnT) and evaluated the association of estimated glomerular filtration rate (eGFR) with detectable hs-cTnT levels in a community-based population. Methods: The serum hs-cTnT levels were measured in 1365 community dwelling population aged >= 45 years in Beijing, China. eGFR was determined by the Chinese modifying modification of diet in renal disease (C-MDRD) equation. Results: With the highly sensitive assay, cTnT levels were detectable (>= 3pg/mL) in 744 subjects (54.5%). The result showed that eGFR was associated with Log hs-cTnT (r = 20.14, P<0.001). After adjustment for the high predicted Framingham Coronary Heart Disease (CHD) risk (10-year risk >20%) and other prognostic indicators, moderate to severe reduced eGFR was independently associated with detectable hs-cTnT, whereas normal to mildly reduced eGFR was not independently associated with detectable hs-cTnT. In addition, after adjustment for other risk factors, the high predicted Framingham CHD risk was associated with detectable hs-cTnT in the subjects with different quartile levels of eGFR. Conclusion: The levels of hs-cTnT are detectable in a community-based Chinese population and low eGFR is associated with detectable hs-cTnT. Moreover, eGFR and high predicted Framingham CHD risk are associated with detectable hs-cTnT in subjects with moderate-to-severe reduced renal function.	[Wang, Fan; Ye, Ping; Luo, Leiming; Xu, Ruyi; Bai, Yongyi; Wu, Hongmei] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Wang, F (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	3393d@sina.com	Luo, Leiming/AAD-5533-2019		Capital Medical Development Fund of Beijing [2009-2038]; National Basic Research Program of China [2012CB517503]	Capital Medical Development Fund of Beijing; National Basic Research Program of China(National Basic Research Program of China)	This study was supported by a grant from the Capital Medical Development Fund of Beijing (2009-2038) and the National Basic Research Program of China (2012CB517503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas NA, 2005, CLIN CHEM, V51, P2059, DOI 10.1373/clinchem.2005.055665; Alpert JS, 2008, NAT CLIN PRACT CARD, V5, P678, DOI 10.1038/ncpcardio1329; Antman EM, 2002, NEW ENGL J MED, V346, P2079, DOI 10.1056/NEJMe020049; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Berl T, 2006, CLIN J AM SOC NEPHRO, V1, P8, DOI 10.2215/CJN.00730805; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Cardiovascular Disease in Dialysis Patients Work Group, 2005, AM J KIDNEY DIS S, V45, pS7; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Conway B, 2005, NEPHROL DIAL TRANSPL, V20, P2759, DOI 10.1093/ndt/gfi125; deFilippi CR, 2010, J AM COLL CARDIOL, V55, P441, DOI 10.1016/j.jacc.2009.07.069; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Diris JHC, 2004, CIRCULATION, V109, P23, DOI 10.1161/01.CIR.0000109483.45211.8F; Everett BM, 2011, CIRCULATION, V123, P2811, DOI 10.1161/CIRCULATIONAHA.110.009928; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; Gabr AEM, 2004, SAUDI MED J, V25, P1015; Hu J, 2009, PUBLIC HEALTH NURS, V26, P500, DOI 10.1111/j.1525-1446.2009.00810.x; Inrig JK, 2008, NEPHROL DIAL TRANSPL, V23, P934, DOI 10.1093/ndt/gfm689; Kanbay M, 2009, BLOOD PURIFICAT, V27, P220, DOI 10.1159/000197562; Kehl DW, 2011, CLIN RES CARDIOL, V100, P359, DOI 10.1007/s00392-010-0255-2; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Nakayama M, 2010, CLIN EXP NEPHROL, V14, P333, DOI 10.1007/s10157-010-0295-y; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Otsuka T, 2010, AM HEART J, V159, P972, DOI 10.1016/j.ahj.2010.02.036; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Shankar A, 2008, NEPHROL DIAL TRANSPL, V23, P1910, DOI 10.1093/ndt/gfm878; Sharma R, 2006, HEART, V92, P804, DOI 10.1136/hrt.2005.069666; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Tsutamoto T, 2009, EUR J HEART FAIL, V11, P653, DOI 10.1093/eurjhf/hfp072; Turakhia MP, 2009, EUR HEART J, V30, P2478, DOI 10.1093/eurheartj/ehp270; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Xu R, 2011, INT J CARDIOL, V149, P253, DOI 10.1016/j.ijcard.2011.02.032; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang LX, 2007, NEPHROL DIAL TRANSPL, V22, P1093, DOI 10.1093/ndt/gfl763	38	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38218	10.1371/journal.pone.0038218	http://dx.doi.org/10.1371/journal.pone.0038218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675450	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500112
J	Davis, FM; Peters, AA; Grice, DM; Cabot, PJ; Parat, MO; Roberts-Thomson, SJ; Monteith, GR				Davis, Felicity M.; Peters, Amelia A.; Grice, Desma M.; Cabot, Peter J.; Parat, Marie-Odile; Roberts-Thomson, Sarah J.; Monteith, Gregory R.			Non-Stimulated, Agonist-Stimulated and Store-Operated Ca2+ Influx in MDA-MB-468 Breast Cancer Cells and the Effect of EGF-Induced EMT on Calcium Entry	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOPLASMIC-RETICULUM; SMOOTH-MUSCLE; TRPC CHANNELS; ION CHANNELS; I-CRAC; STIM1; ACTIVATION; ORAI1; LOCALIZATION	In addition to their well-defined roles in replenishing depleted endoplasmic reticulum (ER) Ca2+ reserves, molecular components of the store-operated Ca2+ entry pathway regulate breast cancer metastasis. A process implicated in cancer metastasis that describes the conversion to a more invasive phenotype is epithelial-mesenchymal transition (EMT). In this study we show that EGF-induced EMT in MDA-MB-468 breast cancer cells is associated with a reduction in agonist-stimulated and store-operated Ca2+ influx, and that MDA-MB-468 cells prior to EMT induction have a high level of non-stimulated Ca2+ influx. The potential roles for specific Ca2+ channels in these pathways were assessed by siRNA-mediated silencing of ORAI1 and transient receptor potential canonical type 1 (TRPC1) channels in MDA-MB-468 breast cancer cells. Non-stimulated, agonist-stimulated and store-operated Ca2+ influx were significantly inhibited with ORAI1 silencing. TRPC1 knockdown attenuated non-stimulated Ca2+ influx in a manner dependent on Ca2+ influx via ORAI1. TRPC1 silencing was also associated with reduced ERK1/2 phosphorylation and changes in the rate of Ca2+ release from the ER associated with the inhibition of the sarco/endoplasmic reticulum Ca2+-ATPase (time to peak [Ca2+](CYT) = 188.7 +/- 34.6 s (TRPC1 siRNA) versus 124.0 +/- 9.5 s (non-targeting siRNA); P<0.05). These studies indicate that EMT in MDA-MB-468 breast cancer cells is associated with a pronounced remodeling of Ca2+ influx, which may be due to altered ORAI1 and/or TRPC1 channel function. Our findings also suggest that TRPC1 channels in MDA-MB-468 cells contribute to ORAI1-mediated Ca2+ influx in non-stimulated cells.	[Davis, Felicity M.; Peters, Amelia A.; Grice, Desma M.; Cabot, Peter J.; Parat, Marie-Odile; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Queensland	Davis, FM (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	gregm@uq.edu.au	Parat, Marie-Odile/G-4410-2010; Roberts-Thomson, Sarah J/B-4282-2011; Monteith, Gregory/B-1626-2008; Peters, Amelia/AAP-3886-2021; Cabot, Peter John/B-2424-2013; Grice, Desma M/A-7730-2011; Roberts-Thomson, Sarah/W-5676-2019; Davis, Felicity M/P-1387-2016; Peters, Amelia A/E-4254-2010	Parat, Marie-Odile/0000-0003-4895-7381; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Monteith, Gregory/0000-0002-4345-530X; Peters, Amelia/0000-0002-0700-7817; Cabot, Peter John/0000-0003-1778-3753; Roberts-Thomson, Sarah/0000-0001-8202-5786; Davis, Felicity M/0000-0001-9112-118X; 	National Health and Medical Research Council (NHMRC) [569645, 1022263, 511262]; Australian Postgraduate Award	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	This research was partially supported by National Health and Medical Research Council (NHMRC) project grants (569645 & 1022263). FD was funded by an NHMRC Biomedical Postgraduate Scholarship (511262); www.nhmrc.gov.au. DG was supported by an Australian Postgraduate Award; http://www.innovation.gov.au. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Berbey C, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.N109.073221; Berbey C, 2009, J BIOL CHEM, V284, P36387, DOI 10.1074/jbc.M109.073221; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Davis FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023464; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Graham SJL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206946; Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Hu JJ, 2011, BIOCHEM BIOPH RES CO, V411, P786, DOI 10.1016/j.bbrc.2011.07.025; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582; Lee JM, 2011, AM J PHYSIOL-CELL PH, V301, pC969, DOI 10.1152/ajpcell.00136.2011; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; Scrimgeour N, 2009, J PHYSIOL-LONDON, V587, P2903, DOI 10.1113/jphysiol.2009.170662; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Tajeddine N, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.L109.073221; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yu PC, 2010, CIRC RES, V106, P1221, DOI 10.1161/CIRCRESAHA.109.207670; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	54	79	79	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36923	10.1371/journal.pone.0036923	http://dx.doi.org/10.1371/journal.pone.0036923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666335	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400017
J	Demidenko, NV; Penin, AA				Demidenko, Natalia V.; Penin, Aleksey A.			Comparative Analysis of Gene Expression Level by Quantitative Real-Time PCR Has Limited Application in Objects with Different Morphology	PLOS ONE			English	Article							STEM-CELL MAINTENANCE; RT-PCR; RELATIVE QUANTIFICATION; FLOWER DEVELOPMENT; TARGET GENES; ARABIDOPSIS; NORMALIZATION; WUSCHEL; MERISTEMS; INTEGRITY	qRT-PCR is a generally acknowledged method for gene expression analysis due to its precision and reproducibility. However, it is well known that the accuracy of qRT-PCR data varies greatly depending on the experimental design and data analysis. Recently, a set of guidelines has been proposed that aims to improve the reliability of qRT-PCR. However, there are additional factors that have not been taken into consideration in these guidelines that can seriously affect the data obtained using this method. In this study, we report the influence that object morphology can have on qRT-PCR data. We have used a number of Arabidopsis thaliana mutants with altered floral morphology as models for this study. These mutants have been well characterised (including in terms of gene expression levels and patterns) by other techniques. This allows us to compare the results from the qRT-PCR with the results inferred from other methods. We demonstrate that the comparison of gene expression levels in objects that differ greatly in their morphology can lead to erroneous results.	[Demidenko, Natalia V.; Penin, Aleksey A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Genet, Moscow, Russia; [Demidenko, Natalia V.; Penin, Aleksey A.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Evolutionary Genom Lab, Moscow, Russia; [Penin, Aleksey A.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Demidenko, NV (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Genet, Moscow, Russia.	demidenkonatalia@gmail.com	Penin, Aleksey/A-5477-2011; Demidenko, Natalia/J-3202-2012	Penin, Aleksey/0000-0002-9057-3974	Russian Foundation for Basic Research [12-04-1599a]; Ministry of Education and Science of Russian Federation [GK-16.512.11.2153]; President's program for support of scientific schools [376.2012.4]; Innovative Project Grants for Young Scientists [UMNIK-13151-9]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); President's program for support of scientific schools; Innovative Project Grants for Young Scientists	The study is supported by the Russian Foundation for Basic Research (project no. 12-04-1599a), the Ministry of Education and Science of Russian Federation (GK-16.512.11.2153) and President's program for support of scientific schools (project no. 376.2012.4) and Innovative Project Grants for Young Scientists (UMNIK-13151-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chervoneva I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-253; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Laux T, 1996, DEVELOPMENT, V122, P87; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Liu XG, 2011, PLANT CELL, V23, P3654, DOI 10.1105/tpc.111.091538; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	21	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38161	10.1371/journal.pone.0038161	http://dx.doi.org/10.1371/journal.pone.0038161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666472	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400093
J	Ismail, Y; Mahendran, V; Octavia, S; Day, AS; Riordan, SM; Grimm, MC; Lan, RT; Lemberg, D; Tran, TAT; Zhang, L				Ismail, Yazan; Mahendran, Vikneswari; Octavia, Sophie; Day, Andrew S.; Riordan, Stephen M.; Grimm, Michael C.; Lan, Ruiting; Lemberg, Daniel; Tran, Thi Anh Tuyet; Zhang, Li			Investigation of the Enteric Pathogenic Potential of Oral Campylobacter concisus Strains Isolated from Patients with Inflammatory Bowel Disease	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; CROHNS-DISEASE; II SECRETION; EPITHELIAL-CELLS; S-LAYER; IDENTIFICATION; CLASSIFICATION; HELICOBACTER; ATTACHMENT; ARCOBACTER	Background: Campylobacter concisus, a bacterium colonizing the human oral cavity, has been shown to be associated with inflammatory bowel disease (IBD). This study investigated if patients with IBD are colonized with specific oral C. concisus strains that have potential to cause enteric diseases. Methodology: Seventy oral and enteric C. concisus isolates obtained from eight patients with IBD and six controls were examined for housekeeping genes by multilocus sequence typing (MLST), Caco2 cell invasion by gentamicin-protection-assay, protein analysis by mass spectrometry and SDS-PAGE, and morphology by scanning electron microscopy. The whole genome sequenced C. concisus strain 13826 which was isolated from an individual with bloody diarrhea was included in MLST analysis. Principal Findings: MLST analysis showed that 87.5% of individuals whose C. concisus belonged to Cluster I had inflammatory enteric diseases (six IBD and one with bloody diarrhea), which was significantly higher than that in the remaining individuals (28.6%) (P < 0.05). Enteric invasive C. concisus (EICC) oral strain was detected in 50% of patients with IBD and none of the controls. All EICC strains were in Cluster 1. The C. concisus strain colonizing intestinal tissues of patient No. 1 was closely related to the oral C. concisus strain from patient No. 6 and had gene recombination with the patient's own oral C. concisus. The oral and intestinal C. concisus strains of patient No. 3 were the same strain. Some individuals were colonized with multiple oral C. concisus strains that have undergone natural recombination. Conclusions: This study provides the first evidence that patients with IBD are colonized with specific oral C. concisus strains, with some being EICC strains. C. concisus colonizing intestinal tissues of patients with IBD at least in some instances results from an endogenous colonization of the patient's oral C. concisus and that C. concisus strains undergo natural recombination.	[Ismail, Yazan; Mahendran, Vikneswari; Octavia, Sophie; Lan, Ruiting; Tran, Thi Anh Tuyet; Zhang, Li] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Day, Andrew S.; Lemberg, Daniel] Sydney Childrens Hosp, Dept Gastroenterol, Sydney, NSW, Australia; [Day, Andrew S.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Day, Andrew S.] Univ Otago, Dept Paediat, Christchurch, New Zealand; [Riordan, Stephen M.] Prince Wales Hosp, Gastrointestinal & Liver Unit, Sydney, NSW, Australia; [Grimm, Michael C.] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia; [Riordan, Stephen M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of Otago; University of New South Wales Sydney; University of New South Wales Sydney	Ismail, Y (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	L.Zhang@unsw.edu.au		Grimm, Michael/0000-0001-9426-3917; Lan, Ruiting/0000-0001-9834-5258; Octavia, Sophie/0000-0001-8506-9127; Lemberg, Daniel/0000-0002-8583-0956; Zhang, Li/0000-0001-7506-8278; Ismail, Yazan/0000-0002-7020-3642	Broad Medical Research Program of the Broad Foundation [IBD0273-R]; Faculty of Science, University of New South Wales [FRG2011]; Al-Balaq' Applied University, Jordan	Broad Medical Research Program of the Broad Foundation; Faculty of Science, University of New South Wales; Al-Balaq' Applied University, Jordan	This work was supported by the Broad Medical Research Program of the Broad Foundation (Grant no: IBD0273-R) and a research grant awarded to Dr Li Zhang from the Faculty of Science, University of New South Wales (FRG2011). Yazan Ismail is supported by a PhD scholarship from Al-Balaq' Applied University, Jordan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; BASTYNS K, 1995, MOL CELL PROBE, V9, P247, DOI 10.1016/S0890-8508(95)90114-0; BLASER MJ, 1994, MOL MICROBIOL, V14, P453, DOI 10.1111/j.1365-2958.1994.tb02180.x; Chaban B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-73; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; CUMMINGS JH, 1983, LANCET, V1, P1206; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Engberg J, 2005, CLIN MICROBIOL INFEC, V11, P288, DOI 10.1111/j.1469-0691.2005.01111.x; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; GARCIA MM, 1995, J BACTERIOL, V177, P1976, DOI 10.1128/jb.177.8.1976-1980.1995; HALE TL, 1979, INFECT IMMUN, V24, P879, DOI 10.1128/IAI.24.3.879-886.1979; Istivan TS, 2004, J MED MICROBIOL, V53, P483, DOI 10.1099/jmm.0.45554-0; Iwobi A, 2003, INFECT IMMUN, V71, P1872, DOI 10.1128/IAI.71.4.1872-1879.2003; Kaakoush NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029045; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Karlyshev AV, 2004, MICROBIOL-SGM, V150, P1957, DOI 10.1099/mic.0.26721-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson CL, 2008, CAMPYLOBACTER; Lastovica AJ, 2006, CLIN MICROBIOL NEWSL, V28, P7; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; LEVITT MD, 1969, NEW ENGL J MED, V281, P122, DOI 10.1056/NEJM196907172810303; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Lynch OA, 2011, INT J FOOD MICROBIOL, V150, P171, DOI 10.1016/j.ijfoodmicro.2011.07.037; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Matsheka MI, 2001, J CLIN MICROBIOL, V39, P3684, DOI 10.1128/JCM.39.10.3684-3689.2001; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Misawa N, 2000, INFECT IMMUN, V68, P6168, DOI 10.1128/IAI.68.11.6168-6175.2000; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021490; Nielsen HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023858; Petersen RF, 2007, J APPL MICROBIOL, V103, P2601, DOI 10.1111/j.1365-2672.2007.03515.x; REEVES PR, 1994, COMPUT APPL BIOSCI, V10, P281; Russel M, 1998, J MOL BIOL, V279, P485, DOI 10.1006/jmbi.1998.1791; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Suerbaum S, 2001, J BACTERIOL, V183, P2553, DOI 10.1128/JB.183.8.2553-2559.2001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; Thompson Stuart A, 2002, Ann Periodontol, V7, P43, DOI 10.1902/annals.2002.7.1.43; VANDAMME P, 1989, J CLIN MICROBIOL, V27, P1775, DOI 10.1128/JCM.27.8.1775-1781.1989; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	52	54	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38217	10.1371/journal.pone.0038217	http://dx.doi.org/10.1371/journal.pone.0038217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666490	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400103
J	Li, PN; Li, H; Wu, ML; Wang, SY; Kong, QY; Zhang, Z; Sun, Y; Liu, J; Lv, DC				Li, Pei-Nan; Li, Hong; Wu, Mo-Li; Wang, Shou-Yu; Kong, Qing-You; Zhang, Zhen; Sun, Yuan; Liu, Jia; Lv, De-Cheng			A Cost-Effective Transparency-Based Digital Imaging for Efficient and Accurate Wound Area Measurement	PLOS ONE			English	Article							TRACINGS; PLANIMETRY	Wound measurement is an objective and direct way to trace the course of wound healing and to evaluate therapeutic efficacy. Nevertheless, the accuracy and efficiency of the current measurement methods need to be improved. Taking the advantages of reliability of transparency tracing and the accuracy of computer-aided digital imaging, a transparency-based digital imaging approach is established, by which data from 340 wound tracing were collected from 6 experimental groups (8 rats/group) at 8 experimental time points (Day 1, 3, 5, 7, 10, 12, 14 and 16) and orderly archived onto a transparency model sheet. This sheet was scanned and its image was saved in JPG form. Since a set of standard area units from 1 mm(2) to 1 cm(2) was integrated into the sheet, the tracing areas in JPG image were measured directly, using the "Magnetic lasso tool" in Adobe Photoshop program. The pixel values/PVs of individual outlined regions were obtained and recorded in an average speed of 27 second/region. All PV data were saved in an excel form and their corresponding areas were calculated simultaneously by the formula of Y (PV of the outlined region)/X (PV of standard area unit) x Z (area of standard unit). It took a researcher less than 3 hours to finish area calculation of 340 regions. In contrast, over 3 hours were expended by three skillful researchers to accomplish the above work with traditional transparency-based method. Moreover, unlike the results obtained traditionally, little variation was found among the data calculated by different persons and the standard area units in different sizes and shapes. Given its accurate, reproductive and efficient properties, this transparency-based digital imaging approach would be of significant values in basic wound healing research and clinical practice.	[Li, Pei-Nan; Wang, Shou-Yu; Zhang, Zhen; Lv, De-Cheng] Dalian Med Univ, Clin Coll 1, Dept Orthoped Surg, Dalian, Peoples R China; [Li, Hong; Wu, Mo-Li; Kong, Qing-You; Sun, Yuan; Liu, Jia] Dalian Med Univ, Coll Med Sci, Dept Cell Biol, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University	Li, PN (corresponding author), Dalian Med Univ, Clin Coll 1, Dept Orthoped Surg, Dalian, Peoples R China.	lvdecheng55@126.com			National Natural Science Foundation of China [30971038, 81071971]; Liaoning Education Department for the Creative Research Team [2007-7-26, 2008T028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Education Department for the Creative Research Team	This work was supported by the grants from National Natural Science Foundation of China (No. 30971038 and No. 81071971) and from Liaoning Education Department for the Creative Research Team (2007-7-26 and 2008T028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahanger AA, 2011, N-S ARCH PHARMACOL, V384, P93, DOI 10.1007/s00210-011-0653-7; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOHANNON RW, 1983, PHYS THER, V63, P1622, DOI 10.1093/ptj/63.10.1622; Bowling FL, 2009, DIABETIC MED, V26, P93, DOI 10.1111/j.1464-5491.2008.02611.x; Chang Angela Christine, 2011, Eplasty, V11, pe18; Dorsett-Martin WA, 2004, WOUND REPAIR REGEN, V12, P591, DOI 10.1111/j.1067-1927.2004.12601.x; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gethin G, 2006, J CLIN NURS, V15, P422, DOI 10.1111/j.1365-2702.2006.01364.x; Gethin G, 2006, WOUNDS UK, V2, P1; Grey JE, 2006, BRIT MED J, V332, P285, DOI 10.1136/bmj.332.7536.285; GRIFFIN JW, 1993, PHYS THER, V73, P117, DOI 10.1093/ptj/73.2.117; Lagan KM, 2000, ARCH PHYS MED REHAB, V81, P1110, DOI 10.1053/apmr.2000.6281; Langemo Diane, 2008, Adv Skin Wound Care, V21, P42, DOI 10.1097/01.ASW.0000284967.69863.2f; Oduncu Hakan, 2004, Int J Low Extrem Wounds, V3, P151; Paul DR, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-26; Rajbhandari SM, 1999, DIABETIC MED, V16, P339, DOI 10.1046/j.1464-5491.1999.00053.x; Shaw J, 2007, DIABETES CARE, V30, P2641, DOI 10.2337/dc07-0122; Shrivastava R, 2011, DIABETES RES CLIN PR, V92, P92, DOI 10.1016/j.diabres.2010.12.021; St-Supery Veronique, 2011, Ann Plast Surg, V67, P193, DOI 10.1097/SAP.0b013e3181f3e0e8; Vitalo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005523; Wendelken ME, 2011, WOUNDS, V23, P267	21	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38069	10.1371/journal.pone.0038069	http://dx.doi.org/10.1371/journal.pone.0038069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666449	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400076
J	Liu, XF; Bera, TK; Kahue, C; Escobar, T; Fei, ZL; Raciti, GA; Pastan, I				Liu, Xiu-Fen; Bera, Tapan K.; Kahue, Charissa; Escobar, Thelma; Fei, Zhaoliang; Raciti, Gregory A.; Pastan, Ira			ANKRD26 and Its Interacting Partners TRIO, GPS2, HMMR and DIPA Regulate Adipogenesis in 3T3-L1 Cells	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; TYROSINE PHOSPHATASE; ANKYRIN REPEAT; SUBUNIT GPS2; PROTEIN; KINASE; RHAMM; OBESITY; GENE; FIBROBLASTS	Partial inactivation of the Ankyrin repeat domain 26 (Ankrd26) gene causes obesity and diabetes in mice and increases spontaneous and induced adipogenesis in mouse embryonic fibroblasts. However, it is not yet known how the Ankrd26 protein carries out its biological functions. We identified by yeast two-hybrid and immunoprecipitation assays the triple functional domain protein (TRIO), the G protein pathway suppressor 2 (GPS2), the delta-interacting protein A (DIPA) and the hyaluronan-mediated motility receptor (HMMR) as ANKRD26 interacting partners. Adipogenesis of 3T3-L1 cells was increased by selective down-regulation of Ankrd26, Trio, Gps2, Hmmr and Dipa. Furthermore, GPS2 and DIPA, which are normally located in the nucleus, were translocated to the cytoplasm, when the C-terminus of ANKRD26 was introduced into these cells. These findings provide biochemical evidence that ANKRD26, TRIO, GPS2 and HMMR are novel and important regulators of adipogenisis and identify new targets for the modulation of adipogenesis.	[Liu, Xiu-Fen; Bera, Tapan K.; Kahue, Charissa; Escobar, Thelma; Fei, Zhaoliang; Raciti, Gregory A.; Pastan, Ira] NCI, Mol Biol Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liu, XF (corresponding author), NCI, Mol Biol Lab, Canc Res Ctr, NIH, Bldg 37, Bethesda, MD 20892 USA.	pastani@mail.nih.gov	pastan, ira/P-9319-2019; fei, zhaoliang/ADK-2083-2022	pastan, ira/0000-0002-9223-0270; fei, zhaoliang/0000-0002-5400-8126; Escobar, Thelma/0000-0001-5352-3903; RACITI, GREGORYALEXANDER/0000-0003-2742-5634	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010298] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Bera TK, 2008, P NATL ACAD SCI USA, V105, P270, DOI 10.1073/pnas.0710978105; Bezy O, 2005, J BIOL CHEM, V280, P11432, DOI 10.1074/jbc.M411741200; Brazas R, 1996, SCIENCE, V274, P90, DOI 10.1126/science.274.5284.90; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Fei ZL, 2011, J BIOL CHEM, V286, P27761, DOI 10.1074/jbc.M111.248435; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Hahn Y, 2006, GENE, V366, P238, DOI 10.1016/j.gene.2005.07.045; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jefcoate Colin R., 2008, V456, P173, DOI 10.1007/978-1-59745-245-8_13; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Kim WK, 2009, J CELL SCI, V122, P4160, DOI 10.1242/jcs.053009; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; Maxwell CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001199; Medley QG, 2003, J BIOL CHEM, V278, P13265, DOI 10.1074/jbc.M300277200; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Raciti GA, 2011, DIABETOLOGIA, V54, P2911, DOI 10.1007/s00125-011-2263-9; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Tolg C, 2010, J BIOL CHEM, V285, P26461, DOI 10.1074/jbc.M110.121491; TURLEY EA, 1991, J CELL BIOL, V112, P1041, DOI 10.1083/jcb.112.5.1041; Walder K, 2003, CURR PHARM DESIGN, V9, P1357, DOI 10.2174/1381612033454739; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	32	24	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38130	10.1371/journal.pone.0038130	http://dx.doi.org/10.1371/journal.pone.0038130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666460	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400085
J	Yao, Z; Namkung, W; Ko, EA; Park, J; Tradtrantip, L; Verkman, AS				Yao, Zhen; Namkung, Wan; Ko, Eun A.; Park, Jinhong; Tradtrantip, Lukmanee; Verkman, A. S.			Fractionation of a Herbal Antidiarrheal Medicine Reveals Eugenol as an Inhibitor of Ca2+-Activated Cl- Channel TMEM16A	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; CHLORIDE SECRETION; MOLECULAR-BASIS; ESSENTIAL OIL; NEURONS; PHARMACOKINETICS; EXPRESSION; CURRENTS; PROTEIN; INJURY	The Ca2+-activated Cl- channel TMEM16A is involved in epithelial fluid secretion, smooth muscle contraction and neurosensory signaling. We identified a Thai herbal antidiarrheal formulation that inhibited TMEM16A Cl- conductance. C18-reversed-phase HPLC fractionation of the herbal formulation revealed >98% of TMEM16A inhibition activity in one out of approximately 20 distinct peaks. The purified, active compound was identified as eugenol (4-allyl-2-methoxyphenol), the major component of clove oil. Eugenol fully inhibited TMEM16A Cl- conductance with single-site IC50 similar to 150 mu M. Eugenol inhibition of TMEM16A in interstitial cells of Cajal produced strong inhibition of intestinal contraction in mouse ileal segments. TMEM16A Cl- channel inhibition adds to the list of eugenol molecular targets and may account for some of its biological activities.	[Yao, Zhen; Namkung, Wan; Ko, Eun A.; Tradtrantip, Lukmanee; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Yao, Zhen; Namkung, Wan; Ko, Eun A.; Tradtrantip, Lukmanee; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Namkung, Wan; Park, Jinhong] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Inchon, South Korea	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yonsei University	Yao, Z (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu			National Institutes of Health [DK72517, HL73856, DK35124, DK86125, EB00415, EY13574]; Cystic Fibrosis Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124, P30DK072517, RC1DK086125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK72517, HL73856, DK35124, DK86125, EB00415, and EY13574 and Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqareer A, 2006, J DENT, V34, P747, DOI 10.1016/j.jdent.2006.01.009; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; BARTELS HA, 1947, AM J ORTHOD ORAL SUR, V33, P458; Baskaran Y, 2010, TOXICOLOGY, V268, P204, DOI 10.1016/j.tox.2009.12.018; Canani RB, 2003, GASTROENTEROLOGY, V124, P368, DOI 10.1053/gast.2003.50056; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; Damiani CEN, 2004, J CARDIOVASC PHARM, V44, P688, DOI 10.1097/00005344-200412000-00011; Deans S. G., 1995, Flavour and Fragrance Journal, V10, P323, DOI 10.1002/ffj.2730100507; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; FISCHER IU, 1990, J CHROMATOGR-BIOMED, V525, P369, DOI 10.1016/S0378-4347(00)83413-1; Guenette SA, 2006, J VET PHARMACOL THER, V29, P265, DOI 10.1111/j.1365-2885.2006.00740.x; Guenette SA, 2007, EUR J PHARMACOL, V562, P60, DOI 10.1016/j.ejphar.2007.01.044; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Kaur G, 2010, MOL CARCINOGEN, V49, P290, DOI 10.1002/mc.20601; Lee MH, 2005, J DENT RES, V84, P848, DOI 10.1177/154405910508400913; Li HY, 2007, J DENT RES, V86, P898, DOI 10.1177/154405910708600918; Lima FC, 2011, FUND CLIN PHARMACOL, V25, P690, DOI 10.1111/j.1472-8206.2010.00892.x; Lionnet L, 2010, PHYTOTHER RES, V24, P1645, DOI 10.1002/ptr.3174; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Magalhaes CB, 2010, J APPL PHYSIOL, V108, P845, DOI 10.1152/japplphysiol.00560.2009; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Pal D, 2010, J DERMATOL SCI, V59, P31, DOI 10.1016/j.jdermsci.2010.04.013; Park CK, 2009, PAIN, V144, P84, DOI 10.1016/j.pain.2009.03.016; Said MM, 2011, FUND CLIN PHARMACOL, V25, P708, DOI 10.1111/j.1472-8206.2010.00900.x; Takahashi A, 2000, J MED MICROBIOL, V49, P801, DOI 10.1099/0022-1317-49-9-801; THOMPSON D, 1989, MOL PHARMACOL, V36, P809; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Yeon KY, 2011, PAIN, V152, P2108, DOI 10.1016/j.pain.2011.05.018	33	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38030	10.1371/journal.pone.0038030	http://dx.doi.org/10.1371/journal.pone.0038030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666439	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400071
J	Alves, L; Azevedo, A; Silva, S; Barros, H				Alves, Luis; Azevedo, Ana; Silva, Susana; Barros, Henrique			Socioeconomic Inequalities in the Prevalence of Nine Established Cardiovascular Risk Factors in a Southern European Population	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; MULTILEVEL ANALYSIS; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; HEALTH; POSITION; DISEASE; ASSOCIATION; DETERMINANTS	The evaluation of the gender-specific prevalence of cardiovascular risk factors across socioeconomic position (SEP) categories may unravel mechanisms involved in the development of coronary heart disease. Using a sample of 1704 community dwellers of a Portuguese urban center aged 40 years or older, assessed in 1999-2003, we quantified the age-standardized prevalence of nine established cardiovascular risk factors (diabetes mellitus, hypertension, hypercholesterolemia, smoking, sedentariness, abdominal obesity, poor diet, excessive alcohol intake and depression) across SEP and gender categories. Data on individual education and occupation were collected by questionnaire and used to characterize SEP. The prevalence of seven out of nine well-established risk factors was higher in men. Among women, the prevalence of most of the studied risk factors was higher in lower SEP groups. The main exception was smoking, which increased with education and occupation levels. Among men, socioeconomic gradients were less clear, but lower SEP was associated with a higher prevalence of diabetes, excessive alcohol intake and depression in a graded mode. The historical cultural beliefs and practices captured throughout the lifecourse frame the wide socioeconomic gradients discernible in our study conducted in an unequal European developed population. While men were more exposed to most risk factors, the clearer associations between SEP and risk factors among women support that their adoption of particular healthy behaviors is more dependent on material and symbolic conditions. To fully address the issue of health inequalities, interventions within the health systems should be complemented with population-based policies specifically designed to reduce socioeconomic gradients.	[Alves, Luis; Azevedo, Ana; Silva, Susana; Barros, Henrique] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal; [Alves, Luis; Azevedo, Ana; Silva, Susana; Barros, Henrique] Univ Porto ISPUP, Inst Publ Hlth, Oporto, Portugal; Santo Andre de Canidelo Hlth Family Unit, Vila Nova De Gaia, Portugal	Universidade do Porto; Universidade do Porto	Alves, L (corresponding author), Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lalves@med.up.pt	Silva, Susana/AAV-5517-2020; Alves, Luís Andrés Amorim/C-1618-2018; Azevedo, Ana/AAA-2287-2020; Barros, Henrique/A-5488-2008; Barros, Henrique/Q-8609-2019; Silva, Susana/E-5828-2012	Silva, Susana/0000-0002-1335-8648; Alves, Luís Andrés Amorim/0000-0001-5855-2754; Azevedo, Ana/0000-0002-7368-9609; Barros, Henrique/0000-0003-4699-6571; Silva, Susana/0000-0002-1335-8648	Fundacao para a Ciencia e a Tecnologia (Foundation for Science and Technology) [POCI/SAU-ESP/61160/2004]	Fundacao para a Ciencia e a Tecnologia (Foundation for Science and Technology)	Funded by Fundacao para a Ciencia e a Tecnologia (Foundation for Science and Technology) (POCI/SAU-ESP/61160/2004) http://www.fct.mctes.pt/projectos/pub/2004/painel_result/vglobal_projecto.asp?idProjecto=61160&idElemConcurso=34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Annandale E, 2000, GENDER INEQUALITIES, Vix, P214; [Anonymous], 1997, GUID CONTR MON TOB E; Barreto A., 2003, SOCIAL CHANGE PORTUG; Bartley M, 2004, HLTH INEQUALITY INTR, Vviii, P208; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berkman L, 2000, SOCIAL EPIDEMIOLOGY, Vxxii, P391; Bloomfield K, 2006, ALCOHOL ALCOHOLISM, V41, pI26, DOI 10.1093/alcalc/agl073; Bourdieu P., 1979, DISTINCTION CRITIQUE; BUCOLO G, 1973, CLIN CHEM, V19, P476; Camoes M, 2010, ANN HUM BIOL, V37, P186, DOI 10.3109/03014460903341836; CARVALHO M, 2011, PERSISTENCIA DESIGUA; Chichlowska KL, 2008, PSYCHOSOM MED, V70, P986, DOI 10.1097/PSY.0b013e318183a491; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Courtenay W. H., 2002, International Journal of Men's Health, V1, P281, DOI 10.3149/jmh.0103.281; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; CRIQUI MH, 1980, PREV MED, V9, P525, DOI 10.1016/0091-7435(80)90047-X; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Davey Smith G, 2003, HLTH INEQUALITIES LI, Vlix, P548; Den Hond E, 2003, BLOOD PRESS MONIT, V8, P37, DOI 10.1097/00126097-200302000-00008; Dolan E, 2004, BLOOD PRESS MONIT, V9, P307, DOI 10.1097/00126097-200412000-00007; Fernandez E, 2001, PREV MED, V32, P218, DOI 10.1006/pmed.2000.0794; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fraga Sílvia, 2005, Arq Med, V19, P207; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gallo WT, 2006, OCCUP ENVIRON MED, V63, P683, DOI 10.1136/oem.2006.026823; Guerreiro M, 1995, REV PORTUGUESA NEURO, V1, P9; Hart C, 1997, SOC SCI MED, V45, P893, DOI 10.1016/S0277-9536(96)00431-5; Instituto do Emprego e Formacao Profissional, 1994, NAT CLASS OCC; JIN RL, 1995, CAN MED ASSOC J, V153, P529; Kimmel MS, 2006, MANHOOD AM CULTURAL, Vxi, P322; Krauss RM, 2000, CIRCULATION, V102, P2284; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lopes C, 2000, THESIS U PORTO PORTO, P79; Lopes C, 2007, J AM DIET ASSOC, V107, P276, DOI 10.1016/j.jada.2006.11.008; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Loucks EB, 2007, ANN EPIDEMIOL, V17, P782, DOI 10.1016/j.annepidem.2007.05.003; Machado A, 2009, CONSUMO TABACO POPUL, V4, P5; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Marmot MG, 2006, SOCIAL DETERMINANTS, Vx, P366; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Myint PK, 2006, GERONTOLOGY, V52, P51, DOI 10.1159/000089826; National Research Council (U.S.). Subcommittee on the Tenth Edition of the RDAs. National Institutes of Health (U.S.) National Research Council (U.S.). Committee on Dietary Allowances, 1989, REC DIET ALL, Vx, P284; Oakes JM, 2006, METHODS SOCIAL EPIDE, Vxxv, P478; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Pleck JH, 1981, MYTH MASCULINITY, Vix, P229; Ramos E, 2004, ANN EPIDEMIOL, V14, P437, DOI 10.1016/j.annepidem.2003.09.013; Regidor E, 2006, J EPIDEMIOL COMMUN H, V60, P74, DOI 10.1136/jech.2005.038331; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Santos AC, 2003, PUBLIC HEALTH, V117, P430, DOI 10.1016/S0033-3506(03)00139-2; SCHMAND B, 1995, J NEUROL NEUROSUR PS, V59, P170, DOI 10.1136/jnnp.59.2.170; Seale C, 2008, SOCIOLOGY, V42, P453, DOI 10.1177/0038038508088835; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Thurston RC, 2005, AM J EPIDEMIOL, V162, P57, DOI 10.1093/aje/kwi159; Viinamaki H, 2004, NORD J PSYCHIAT, V58, P49, DOI 10.1080/08039480310000798; WARNICK GR, 1978, J LIPID RES, V19, P65; Wilkinson RG, 2010, SPIRIT LEVEL WHY GRE, Vxv, P330; Williams J.E., 1990, MEASURING SEX STEREO, VVol. 6; WILSON MG, 1991, AM J PREV MED, V7, P280, DOI 10.1016/S0749-3797(18)30900-0; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Wolin KY, 2008, J PHYS ACT HEALTH, V5, P229, DOI 10.1123/jpah.5.2.229; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	66	30	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37158	10.1371/journal.pone.0037158	http://dx.doi.org/10.1371/journal.pone.0037158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22666343	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349600011
J	Clegg, HV; Itahana, Y; Itahana, K; Ramalingam, S; Zhang, YP				Clegg, Hilary V.; Itahana, Yoko; Itahana, Koji; Ramalingam, Sundhar; Zhang, Yanping			Mdm2 RING Mutation Enhances p53 Transcriptional Activity and p53-p300 Interaction	PLOS ONE			English	Article							UBIQUITIN LIGASE; FINGER DOMAIN; IN-VITRO; MECHANISTIC INSIGHTS; ONCOPROTEIN MDM2; DNA-DAMAGE; ACETYLATION; ACTIVATION; DEGRADATION; PROTEIN	The p53 transcription factor and tumor suppressor is regulated primarily by the E3 ubiquitin ligase Mdm2, which ubiquitinates p53 to target it for proteasomal degradation. Aside from its ubiquitin ligase function, Mdm2 has been believed to be capable of suppressing p53's transcriptional activity by binding with and masking the transactivation domain of p53. The ability of Mdm2 to restrain p53 activity by binding alone, without ubiquitination, was challenged by a 2007 study using a knockin mouse harboring a single cysteine-to-alanine point mutation (C462A) in Mdm2's RING domain. Mouse embryonic fibroblasts with this mutation, which abrogates Mdm2's E3 ubiquitin ligase activity without affecting its ability to bind with p53, were unable to suppress p53 activity. In this study, we utilized the Mdm2(C462A) mouse model to characterize in further detail the role of Mdm2's RING domain in the control of p53. Here, we show in vivo that the Mdm2(C462A) protein not only fails to suppress p53, but compared to the complete absence of Mdm2, Mdm2(C462A) actually enhances p53 transcriptional activity toward p53 target genes p21/CDKN1A, MDM2, BAX, NOXA, and 14-3-3s. In addition, we found that Mdm2(C462A) facilitates the interaction between p53 and the acetyltransferase CBP/p300, and it fails to heterodimerize with its homolog and sister regulator of p53, Mdmx, suggesting that a fully intact RING domain is required for Mdm2's inhibition of the p300-p53 interaction and for its interaction with Mdmx. These findings help us to better understand the complex regulation of the Mdm2-p53 pathway and have important implications for chemotherapeutic agents targeting Mdm2, as they suggest that inhibition of Mdm2's E3 ubiquitin ligase activity may be sufficient for increasing p53 activity in vivo, without the need to block Mdm2-p53 binding.	[Clegg, Hilary V.; Itahana, Yoko; Itahana, Koji; Ramalingam, Sundhar; Zhang, Yanping] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Clegg, Hilary V.; Itahana, Yoko; Itahana, Koji; Ramalingam, Sundhar; Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Itahana, Yoko; Itahana, Koji] Duke NUS Grad Med Sch Singapore, Canc & Stem Cell Biol Program, Singapore, Singapore	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National University of Singapore	Clegg, HV (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.	ypzhang@med.unc.edu	Itahana, Koji/J-5505-2013	Itahana, Koji/0000-0002-7241-2894	National Institutes of Health; American Cancer Society [2R01-CA100302, 1R01-CA127770, 1RC2CA148487-01]; NATIONAL CANCER INSTITUTE [RC2CA148487, R01CA167637, R01CA127770, R01CA100302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health and the American Cancer Society (2R01-CA100302, 1R01-CA127770, and 1RC2CA148487-01, to Y.Z.). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Liu L, 1999, MOL CELL BIOL, V19, P1202; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Sabbatini P, 2002, DNA CELL BIOL, V21, P519, DOI 10.1089/104454902320219077; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	26	10	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38212	10.1371/journal.pone.0038212	http://dx.doi.org/10.1371/journal.pone.0038212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666487	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600072
J	Ahmad, E; Rabbani, G; Zaidi, N; Ahmad, B; Khan, RH				Ahmad, Ejaz; Rabbani, Gulam; Zaidi, Nida; Ahmad, Basir; Khan, Rizwan Hasan			Pollutant-Induced Modulation in Conformation and beta-Lactamase Activity of Human Serum Albumin	PLOS ONE			English	Article							CIRCULAR-DICHROISM; LIGAND-BINDING; SECONDARY STRUCTURE; PROTEIN; SITE	Structural changes in human serum albumin (HSA) induced by the pollutants 1-naphthol, 2-naphthol and 8-quinolinol were analyzed by circular dichroism, fluorescence spectroscopy and dynamic light scattering. The alteration in protein conformational stability was determined by helical content induction (from 55 to 75%) upon protein-pollutant interactions. Domain plasticity is responsible for the temperature-mediated unfolding of HSA. These findings were compared to HSA-hydrolase activity. We found that though HSA is a monomeric protein, it shows heterotropic allostericity for beta-lactamase activity in the presence of pollutants, which act as K- and V-type non-essential activators. Pollutants cause conformational changes and catalytic modifications of the protein (increase in beta-lactamase activity from 100 to 200%). HSA-pollutant interactions mediate other protein-ligand interactions, such as HSA-nitrocefin. Therefore, this protein can exist in different conformations with different catalytic properties depending on activator binding. This is the first report to demonstrate the catalytic allostericity of HSA through a mechanistic approach. We also show a correlation with non-microbial drug resistance as HSA is capable of self-hydrolysis of beta-lactam drugs, which is further potentiated by pollutants due to conformational changes in HSA.	[Ahmad, Ejaz; Rabbani, Gulam; Zaidi, Nida; Ahmad, Basir; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Ahmad, E (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Khan, Rizwan/GXZ-5789-2022; Rabbani, Gulam/AAE-5629-2022; Ahmad, Ejaz/L-1506-2013; Ahmad, Basir/O-9344-2017; Khan, Rizwan Hasan/F-8276-2014	Rabbani, Gulam/0000-0002-5293-8231; Ahmad, Ejaz/0000-0002-5713-6713; Ahmad, Basir/0000-0002-0120-5097; Khan, Rizwan Hasan/0000-0002-9965-8982; Zaidi, Dr Nida/0000-0003-2579-2190	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance to E. Ahmad, G. Rabbani and N. Zaidi in the form of a Senior Research Fellowship was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India. R.H. Khan is an Associate Professor in A.M.U., Aligarh. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Ahmad E, 2010, BIOCHIMIE, V92, P885, DOI 10.1016/j.biochi.2010.03.023; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BROWN JR, 1976, FED PROC, V35, P2141; CARTER DC, 1994, EUR J BIOCHEM, V226, P1049, DOI 10.1111/j.1432-1033.1994.01049.x; Chadborn N, 1999, BIOPHYS J, V76, P2198, DOI 10.1016/S0006-3495(99)77375-3; CHEN RF, 1984, ANAL LETT PT B, V17, P857, DOI 10.1080/0003271811681085; CREAMER TP, 1992, P NATL ACAD SCI USA, V89, P5937, DOI 10.1073/pnas.89.13.5937; CREAMER TP, 1994, PROTEINS, V19, P85, DOI 10.1002/prot.340190202; DUMAS C, 1983, FEBS LETT, V153, P128, DOI 10.1016/0014-5793(83)80132-X; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Flora K, 1998, BIOPHYS J, V75, P1084, DOI 10.1016/S0006-3495(98)77598-8; HAYBALL PJ, 1992, BIOCHEM PHARMACOL, V44, P291, DOI 10.1016/0006-2952(92)90012-8; Kamal JKA, 2004, P NATL ACAD SCI USA, V101, P13411, DOI 10.1073/pnas.0405724101; Khrapunov S, 2002, BIOCHEMISTRY-US, V41, P9559, DOI 10.1021/bi0255773; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Liu MF, 2000, J BACTERIOL, V182, P6509, DOI 10.1128/JB.182.22.6509-6513.2000; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; MANNING MC, 1991, BIOPOLYMERS, V31, P569, DOI 10.1002/bip.360310511; Musah RA, 2002, J MOL BIOL, V315, P845, DOI 10.1006/jmbi.2001.5287; Myers JK, 1998, PROTEIN SCI, V7, P383; Narazaki R, 1997, BBA-PROTEIN STRUCT M, V1338, P275, DOI 10.1016/S0167-4838(96)00221-X; NERLI B, 1994, BIOCHEM MOL BIOL INT, V32, P789; NEWCOMER ME, 1981, J BIOL CHEM, V256, P3218; Oncley JL, 2003, BIOPHYS CHEM, V100, P151, DOI 10.1016/S0301-4622(02)00276-4; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2003, P NATL ACAD SCI USA, V100, P6440, DOI 10.1073/pnas.1137188100; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Pico GA, 1997, INT J BIOL MACROMOL, V20, P63, DOI 10.1016/S0141-8130(96)01153-1; Rezaei-Tavirani M, 2006, J BIOCHEM MOL BIOL, V39, P530, DOI 10.5483/BMBRep.2006.39.5.530; Salvi A, 1997, DRUG METAB DISPOS, V25, P395; Sardar PS, 2008, J PHYS CHEM B, V112, P3451, DOI 10.1021/jp074598+; Sinha SS, 2008, J PHYS CHEM B, V112, P4884, DOI 10.1021/jp709809b; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Thumser AEA, 1998, J LIPID RES, V39, P1033; Toniolo C, 1996, J AM CHEM SOC, V118, P2744, DOI 10.1021/ja9537383; Weljie AM, 2003, PROTEIN SCI, V12, P228, DOI 10.1110/ps.0226203; Yoder G, 1997, J AM CHEM SOC, V119, P10278, DOI 10.1021/ja971392l	43	68	68	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38372	10.1371/journal.pone.0038372	http://dx.doi.org/10.1371/journal.pone.0038372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685563	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700026
J	Jelfs, B; Banaji, M; Tachtsidis, I; Cooper, CE; Elwell, CE				Jelfs, Beth; Banaji, Murad; Tachtsidis, Ilias; Cooper, Chris E.; Elwell, Clare E.			Modelling Noninvasively Measured Cerebral Signals during a Hypoxemia Challenge: Steps towards Individualised Modelling	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; OXIDASE REDOX STATE; ADULT BRAIN; OXIDATIVE-PHOSPHORYLATION; NORMOBARIC HYPEROXIA; MATHEMATICAL-MODEL; PRESSURE CHANGES; BLOOD-FLOW; OXYGENATION; HEMODYNAMICS	Noninvasive approaches to measuring cerebral circulation and metabolism are crucial to furthering our understanding of brain function. These approaches also have considerable potential for clinical use "at the bedside". However, a highly nontrivial task and precondition if such methods are to be used routinely is the robust physiological interpretation of the data. In this paper, we explore the ability of a previously developed model of brain circulation and metabolism to explain and predict quantitatively the responses of physiological signals. The five signals all noninvasively-measured during hypoxemia in healthy volunteers include four signals measured using near-infrared spectroscopy along with middle cerebral artery blood flow measured using transcranial Doppler flowmetry. We show that optimising the model using partial data from an individual can increase its predictive power thus aiding the interpretation of NIRS signals in individuals. At the same time such optimisation can also help refine model parametrisation and provide confidence intervals on model parameters. Discrepancies between model and data which persist despite model optimisation are used to flag up important questions concerning the underlying physiology, and the reliability and physiological meaning of the signals.	[Jelfs, Beth; Tachtsidis, Ilias; Elwell, Clare E.] UCL, Dept Med Phys & Bioengn, London, England; [Banaji, Murad] Univ Portsmouth, Dept Math, Portsmouth, Hants, England; [Cooper, Chris E.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	University of London; University College London; University of Portsmouth; University of Essex	Jelfs, B (corresponding author), UCL, Dept Med Phys & Bioengn, London, England.	bjelfs@medphys.ucl.ac.uk	Tachtsidis, Ilias/N-2747-2018; Cooper, Chris/AAK-9729-2020; Jelfs, Beth/AAO-1191-2020	Tachtsidis, Ilias/0000-0002-8125-0313; Cooper, Chris/0000-0003-0381-3990; Jelfs, Beth/0000-0002-6844-7154; Elwell, Clare/0000-0002-7281-7234; Banaji, Murad/0000-0002-4983-0377	Department of Health's National Institute for Health Research Centres; Engineering and Physical Sciences Research Council [EP/D060982/1]; Medical Research Council (MRC) [G0701458]; Wellcome Trust [WT/089914/A/09/Z]; EPSRC [EP/D060982/1] Funding Source: UKRI; MRC [G0701458] Funding Source: UKRI; Medical Research Council [G0701458] Funding Source: researchfish	Department of Health's National Institute for Health Research Centres(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The initial study was undertaken at University College London Hospitals and partially funded by the Department of Health's National Institute for Health Research Centres funding scheme. Subsequent research in this paper was funded in part by the Engineering and Physical Sciences Research Council grant EP/D060982/1, Medical Research Council (MRC) grant G0701458 and Wellcome Trust grant WT/089914/A/09/Z. No additional external funding received for this study and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rawi PG, 2006, STROKE, V37, P2720, DOI 10.1161/01.STR.0000244807.99073.ae; Banaj M, 2006, J THEOR BIOL, V243, P501, DOI 10.1016/j.jtbi.2006.07.006; Banaji M, 2005, MATH BIOSCI, V194, P125, DOI 10.1016/j.mbs.2004.10.005; Banaji M, PLOS COMPUT BIOL, V4; Banaji M, 2006, STUD MULTIDISCIP, V3, P247; Banaji M, 2010, ADV EXP MED BIOL, V662, P285, DOI 10.1007/978-1-4419-1241-1_41; Banaji M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000212; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; COOPER CE, 1994, BIOCHEM SOC T, V22, P974, DOI 10.1042/bst0220974; Cooper CE, 1998, BIOCHEM J, V332, P627, DOI 10.1042/bj3320627; Duong TQ, 2007, BRAIN RES, V1135, P186, DOI 10.1016/j.brainres.2006.11.097; Edmonds Harvey L Jr, 2004, Semin Cardiothorac Vasc Anesth, V8, P147; Edvinsson L., 2002, CEREBRAL BLOOD FLOW, V2nd ed; ELWELL CE, 1994, J APPL PHYSIOL, V77, P2753, DOI 10.1152/jappl.1994.77.6.2753; Heekeren HR, 1999, J CEREBR BLOOD F MET, V19, P592, DOI 10.1097/00004647-199906000-00002; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; Hunt K, 2006, PHYSIOL MEAS, V27, P777, DOI 10.1088/0967-3334/27/9/002; Kakihana Y, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940583; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; McLeod AD, 2003, ANESTH ANALG, V97, P851, DOI 10.1213/01.ANE.0000072541.57132.BA; MCPHERSON RW, 1987, AM J PHYSIOL, V253, pH890, DOI 10.1152/ajpheart.1987.253.4.H890; Moroz T, 2012, ADV EXP MED BIOL, V737, P293, DOI 10.1007/978-1-4614-1566-4_43; Nagdyman N, 2008, PEDIATR ANESTH, V18, P160, DOI 10.1111/j.1460-9592.2007.02365.x; Nollert G, 2000, THORAC CARDIOV SURG, V48, P247, DOI 10.1055/s-2000-6895; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; OLDENDORF WH, 1965, CIRC RES, V17, P532, DOI 10.1161/01.RES.17.6.532; Press W. H., 1992, ART SCI COMPUTING; SAKAI F, 1985, J CEREBR BLOOD F MET, V5, P207, DOI 10.1038/jcbfm.1985.27; Smith M, 2011, PHILOS T R SOC A, V369, P4452, DOI 10.1098/rsta.2011.0242; Springett RJ, 2003, ADV EXP MED BIOL, V530, P555; Suzuki S, 1999, P SOC PHOTO-OPT INS, V3597, P582, DOI 10.1117/12.356862; Tachtsidis I, 2007, PHYSIOL MEAS, V28, P199, DOI 10.1088/0967-3334/28/2/008; Tachtsidis I, 2009, ADV EXP MED BIOL, V645, P315, DOI 10.1007/978-0-387-85998-9_47; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tisdall MM, 2008, ADV EXP MED BIOL, V614, P217, DOI 10.1007/978-0-387-74911-2_25; Tisdall MM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718541; Tisdall MM, 2009, ANESTH ANALG, V109, P906, DOI 10.1213/ane.0b013e3181aedcdc; Ursino M, 1998, AM J PHYSIOL-HEART C, V274, pH1715, DOI 10.1152/ajpheart.1998.274.5.H1715; Ursino M, 2000, AM J PHYSIOL-HEART C, V279, pH2439, DOI 10.1152/ajpheart.2000.279.5.H2439; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Wong FY, 2008, PEDIATRICS, V121, pE604, DOI 10.1542/peds.2007-1487	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38297	10.1371/journal.pone.0038297	http://dx.doi.org/10.1371/journal.pone.0038297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679497	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305343900028
J	Dinu, LP; Ionescu, R				Dinu, Liviu P.; Ionescu, Radu			An Efficient Rank Based Approach for Closest String and Closest Substring	PLOS ONE			English	Article							AGGREGATION	This paper aims to present a new genetic approach that uses rank distance for solving two known NP-hard problems, and to compare rank distance with other distance measures for strings. The two NP-hard problems we are trying to solve are closest string and closest substring. For each problem we build a genetic algorithm and we describe the genetic operations involved. Both genetic algorithms use a fitness function based on rank distance. We compare our algorithms with other genetic algorithms that use different distance measures, such as Hamming distance or Levenshtein distance, on real DNA sequences. Our experiments show that the genetic algorithms based on rank distance have the best results.	[Dinu, Liviu P.; Ionescu, Radu] Univ Bucharest, Fac Math & Comp Sci, Bucharest, Romania	University of Bucharest	Dinu, LP (corresponding author), Univ Bucharest, Fac Math & Comp Sci, Bucharest, Romania.	ldinu@fmi.unibuc.ro	Ionescu, Radu Tudor/H-1914-2016; Dinu, Liviu P/AAQ-5547-2020; Ionescu, Radu/AAF-6493-2020	Ionescu, Radu/0000-0002-9301-1950	University of Bucharest	University of Bucharest	This research was conducted without any funds. The authors supported this work from their salary as researchers at the University of Bucharest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banzhaf W., 1998, GENETIC PROGRAMMING; Ben-Dor A, 1997, LECT NOTES COMPUT SC, V1264, P247; Chimani M., 2011, P M ALG ENG EXP, P13; de la Higuera C, 2000, THEOR COMPUT SCI, V230, P39, DOI 10.1016/S0304-3975(97)00240-5; Deng X, 2003, SIAM J COMPUT, V32, P1073, DOI 10.1137/S0097539701397825; DIACONIS P, 1977, J ROY STAT SOC B MET, V39, P262, DOI 10.1111/j.2517-6161.1977.tb01624.x; Dinu A, 2005, LECT NOTES COMPUT SC, V3406, P785; Dinu Liviu P., 2012, Combinatorial Pattern Matching. Proceedings 23rd Annual Symposium, CPM 2012, P413, DOI 10.1007/978-3-642-31265-6_33; Dinu LP, 2006, FUND INFORM, V73, P361; Dinu LP, 2006, THEOR COMPUT SCI, V359, P455, DOI 10.1016/j.tcs.2006.05.024; Dinu LP, 2003, FUND INFORM, V55, P39; Dinu LP, 2011, P 13 S SYMB NUM ALG, P207; Dinu LP, 2008, P LREC; Frances M, 1997, THEOR COMPUT SYST, V30, P113; Fraser A., 1970, COMPUTER MODELS GENE; FRASER A. S., 1957, AUSTRALIAN JOUR BIOL SCI, V10, P484; Gramm J., 2002, CURRENTS COMPUTATION, P74; HOLMQUIST R, 1988, MOL BIOL EVOL, V5, P201; KARPOVSKY M, 1981, IEEE T INFORM THEORY, V27, P462, DOI 10.1109/TIT.1981.1056379; Koonin EV, 1999, BIOINFORMATICS, V15, P265, DOI 10.1093/bioinformatics/15.4.265; Lanctot JK, 2003, INFORM COMPUT, V185, P41, DOI 10.1016/S0890-5401(03)00057-9; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Li M, 2002, J COMPUT SYST SCI, V65, p[111, 473]; Liew AWC, 2005, PATTERN RECOGN, V38, P2055, DOI 10.1016/j.patcog.2005.02.019; Liu X, 2005, LECT NOTES ARTIF INT, V3584, P591; Nicolas F, 2003, LECT NOTES COMPUT SC, V2676, P315; Nicolas F, 2005, J DISCRET ALGORITHMS, V3, P390, DOI 10.1016/j.jda.2004.08.015; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Popov VY, 2007, THEOR COMPUT SCI, V385, P115, DOI 10.1016/j.tcs.2007.05.029; Roman S, 1992, GRADUATE TEXTS MATH; Schmitt LM, 2001, THEOR COMPUT SCI, V259, P1, DOI 10.1016/S0304-3975(00)00406-0; States D J, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P211; Wang L, 2005, J BIOINF COMPUT BIOL, V3, P1038; Wooley JC, 1999, J COMPUT BIOL, V6, P459, DOI 10.1089/106652799318391	34	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37576	10.1371/journal.pone.0037576	http://dx.doi.org/10.1371/journal.pone.0037576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675483	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700016
J	Liu, B; Faller, LL; Klitgord, N; Mazumdar, V; Ghodsi, M; Sommer, DD; Gibbons, TR; Treangen, TJ; Chang, YC; Li, S; Stine, OC; Hasturk, H; Kasif, S; Segre, D; Pop, M; Amar, S				Liu, Bo; Faller, Lina L.; Klitgord, Niels; Mazumdar, Varun; Ghodsi, Mohammad; Sommer, Daniel D.; Gibbons, Theodore R.; Treangen, Todd J.; Chang, Yi-Chien; Li, Shan; Stine, O. Colin; Hasturk, Hatice; Kasif, Simon; Segre, Daniel; Pop, Mihai; Amar, Salomon			Deep Sequencing of the Oral Microbiome Reveals Signatures of Periodontal Disease	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE PROFILE; PORPHYROMONAS-GINGIVALIS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BACTERIAL DIVERSITY; GENETIC-ANALYSIS; FATTY-ACIDS; GENOME; PATHOGENS; IDENTIFICATION; PREVALENCE	The oral microbiome, the complex ecosystem of microbes inhabiting the human mouth, harbors several thousands of bacterial types. The proliferation of pathogenic bacteria within the mouth gives rise to periodontitis, an inflammatory disease known to also constitute a risk factor for cardiovascular disease. While much is known about individual species associated with pathogenesis, the system-level mechanisms underlying the transition from health to disease are still poorly understood. Through the sequencing of the 16S rRNA gene and of whole community DNA we provide a glimpse at the global genetic, metabolic, and ecological changes associated with periodontitis in 15 subgingival plaque samples, four from each of two periodontitis patients, and the remaining samples from three healthy individuals. We also demonstrate the power of whole-metagenome sequencing approaches in characterizing the genomes of key players in the oral microbiome, including an unculturable TM7 organism. We reveal the disease microbiome to be enriched in virulence factors, and adapted to a parasitic lifestyle that takes advantage of the disrupted host homeostasis. Furthermore, diseased samples share a common structure that was not found in completely healthy samples, suggesting that the disease state may occupy a narrow region within the space of possible configurations of the oral microbiome. Our pilot study demonstrates the power of high-throughput sequencing as a tool for understanding the role of the oral microbiome in periodontal disease. Despite a modest level of sequencing (similar to 2 lanes Illumina 76 bp PE) and high human DNA contamination ( up to similar to 90%) we were able to partially reconstruct several oral microbes and to preliminarily characterize some systems-level differences between the healthy and diseased oral microbiomes.	[Liu, Bo; Ghodsi, Mohammad; Sommer, Daniel D.; Gibbons, Theodore R.; Treangen, Todd J.; Pop, Mihai] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Liu, Bo; Ghodsi, Mohammad; Pop, Mihai] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Faller, Lina L.; Klitgord, Niels; Mazumdar, Varun; Chang, Yi-Chien; Kasif, Simon; Segre, Daniel; Amar, Salomon] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Gibbons, Theodore R.; Pop, Mihai] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [Li, Shan; Stine, O. Colin] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Kasif, Simon; Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Hasturk, Hatice] Forysth Inst, Dept Periodontol, Cambridge, MA USA; [Kasif, Simon] Harvard Massachusetts Inst Technol, Childrens Informat Program, Div Hlth Sci & Technol, Boston, MA USA; [Treangen, Todd J.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Amar, Salomon] Boston Univ, Ctr Antiinflammatory Therapeut, Goldman Sch Dent Med, Boston, MA 02215 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Boston University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; Boston University; Boston University; Harvard University; Johns Hopkins University; Boston University	Liu, B (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	dsegre@bu.edu; mpop@umiacs.umd.edu; samar@bu.edu	Pop, Mihai/A-7987-2013; Segre, Daniel/A-1993-2009	Pop, Mihai/0000-0001-9617-5304; Segre, Daniel/0000-0003-4859-1914; Amar, Salomon/0000-0002-0017-5930	National Institutes of Health (NIH)-National Institute of Dental and Craniofacial Research [R01DE015345, R01DE014079]; NIH [R01-HG-04885, RC2-GM-092602-01]; National Science Foundation [IIS-0812111]; Bill and Melinda Gates Foundation; National Institute of General Medical Sciences [1RC2GM092602-01];  [PRJNA78025]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092602] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data Availability: The data described in this paper have been submitted to NCBI under project ID: PRJNA78025.; SA and HA were supported by National Institutes of Health (NIH)-National Institute of Dental and Craniofacial Research grants R01DE015345, and R01DE014079. MP, DDS, TJT, BL and TG were supported in part by the NIH grant R01-HG-04885, the National Science Foundation grant IIS-0812111 to MP, and by the Bill and Melinda Gates Foundation (PI Jim Nataro) subcontract to MP. DS, LF, VM and NK were partially supported by NIH grant RC2-GM-092602-01. The work of YC, SK, DS, LF and VM at Boston University was also supported in part by GO grant from National Institute of General Medical Sciences (1RC2GM092602-01 to COMBREX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Ali J, 2011, AUTOIMMUNITY REV; Barnes VM, 2009, J DENT RES, V88, P851, DOI 10.1177/0022034509341967; Bascones-Martinez A, 2011, MED ORAL PATOLOGIA O; Belda-Ferre P, 2011, ISME J, P1; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Campan P, 1997, J CLIN PERIODONTOL, V24, P907, DOI 10.1111/j.1600-051X.1997.tb01210.x; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chen YS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-294; Cicek Y, 2005, PROSTAG LEUKOTR ESS, V72, P147, DOI 10.1016/j.plefa.2004.10.013; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Conly Jm, 2005, Can J Infect Dis Med Microbiol, V16, P159; Cvitkovitch DG, 2003, J CLIN INVEST, V112, P1626, DOI 10.1172/JCI200320430; Darby I, 2001, PERIODONTOL 2000, V26, P33, DOI 10.1034/j.1600-0757.2001.2260103.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; DELISLE AL, 1978, INFECT IMMUN, V20, P303, DOI 10.1128/IAI.20.1.303-306.1978; Diaz-Torres ML, 2006, FEMS MICROBIOL LETT, V258, P257, DOI 10.1111/j.1574-6968.2006.00221.x; Edwards JS, 2002, ENVIRON MICROBIOL, V4, P133, DOI 10.1046/j.1462-2920.2002.00282.x; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; Frias J, 2001, INFECT IMMUN, V69, P3431, DOI 10.1128/IAI.69.5.3431-3434.2001; Ghodsi M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-271; Glass EM, 2010, COLD SPRING HARBOR P; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Jenkinson HF, 2011, ENVIRON MICROBIOL, V13, P3077, DOI 10.1111/j.1462-2920.2011.02573.x; Johnson PLF, 2006, GENOME RES, V16, P1320, DOI 10.1101/gr.5431206; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keijser B, 2008, J DENT RES, P87; Kesavalu L, 2007, ORAL MICROBIOL IMMUN, V22, P232, DOI 10.1111/j.1399-302X.2007.00346.x; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren S, 2011, BIOINFORMATICS; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li Yingrui, 2010, Human Genomics, V4, P271; Lipsitch M, 2001, TRENDS MICROBIOL, V9, P438, DOI 10.1016/S0966-842X(01)02130-8; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Liu Bo, 2011, BMC Proc, V5 Suppl 2, pS9, DOI 10.1186/1753-6561-5-S2-S9; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Maeda K, 2004, MICROBES INFECT, V6, P1163, DOI 10.1016/j.micinf.2004.06.005; Maeda K, 2004, INFECT IMMUN, V72, P1341, DOI 10.1128/IAI.72.3.1341-1348.2004; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08; Mineoka T, 2008, J PERIODONTOL, V79, P670, DOI [10.1902/jop.2008.070398, 10.1902/jop.2008.070398 ]; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Panina EM, 2003, FEMS MICROBIOL LETT, V222, P211, DOI 10.1016/S0378-1097(03)00303-3; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; PHILLIPS GJ, 1987, NUCLEIC ACIDS RES, V15, P2627, DOI 10.1093/nar/15.6.2627; Pike R, 2002, J ANTIMICROB CHEMOTH, V49, P777, DOI 10.1093/jac/dkf019; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roberts RJ, NUCL ACIDS RES, V39, pD11; Rodrigues RMJ, 2004, J CLIN PERIODONTOL, V31, P420, DOI 10.1111/j.1600-051X.2004.00493.x; Rosenstein ED, 2003, PROSTAG LEUKOTR ESS, V68, P213, DOI 10.1016/S0952-3278(02)00272-7; Siqueira JF, 2006, ORAL SURG ORAL MED O, V102, P259, DOI 10.1016/j.tripleo.2005.09.021; SLOTS J, 1979, J CLIN PERIODONTOL, V6, P351, DOI 10.1111/j.1600-051X.1979.tb01935.x; Socransky S, 1998, MICROBIAL COMPLEXES, P134; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stefanopoulos PK, 2004, ORAL SURG ORAL MED O, V98, P398, DOI 10.1016/j.tripleo.2004.01.016; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Teles R, 2011, ORAL DIS; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van Winkelhoff A J, 1999, Ned Tijdschr Tandheelkd, V106, P290; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	87	255	268	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37919	10.1371/journal.pone.0037919	http://dx.doi.org/10.1371/journal.pone.0037919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675498	gold, Green Published			2022-12-27	WOS:000305341700027
J	Munar, E; Nadal, M; Rossello, J; Flexas, A; Moratti, S; Maestu, F; Marty, G; Cela-Conde, CJ				Munar, Enric; Nadal, Marcos; Rossello, Jaume; Flexas, Albert; Moratti, Stephan; Maestu, Fernando; Marty, Gisele; Cela-Conde, Camilo J.			Lateral Orbitofrontal Cortex Involvement in Initial Negative Aesthetic Impression Formation	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL INDEXES; PROCESSING SYMMETRY; EVALUATIVE JUDGMENT; ACTIVATION; REPRESENTATIONS; PREFERENCE; CONTEXT; REWARD; MEG	It is well established that aesthetic appreciation is related with activity in several different brain regions. The identification of the neural correlates of beauty or liking ratings has been the focus of most prior studies. Not much attention has been directed towards the fact that humans are surrounded by objects that lead them to experience aesthetic indifference or leave them with a negative aesthetic impression. Here we explore the neural substrate of such experiences. Given the neuroimaging techniques that have been used, little is known about the temporal features of such brain activity. By means of magnetoencephalography we registered the moment at which brain activity differed while participants viewed images they considered to be beautiful or not. Results show that the first differential activity appears between 300 and 400 ms after stimulus onset. During this period activity in right lateral orbitofrontal cortex (lOFC) was greater while participants rated visual stimuli as not beautiful than when they rated them as beautiful. We argue that this activity is associated with an initial negative aesthetic impression formation, driven by the relative hedonic value of stimuli regarded as not beautiful. Additionally, our results contribute to the understanding of the nature of the functional roles of the lOFC.	[Munar, Enric; Nadal, Marcos; Rossello, Jaume; Flexas, Albert; Marty, Gisele; Cela-Conde, Camilo J.] Univ Balearic Isl, Human Evolut & Cognit Grp IFISC CSIC, Palma De Mallorca, Spain; [Moratti, Stephan; Maestu, Fernando] Univ Complutense, Ctr Biomed Technol, Cognit & Computat Neurosci Lab, E-28040 Madrid, Spain; [Moratti, Stephan; Maestu, Fernando] Politecn Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Complutense University of Madrid; Universidad Politecnica de Madrid	Munar, E (corresponding author), Univ Balearic Isl, Human Evolut & Cognit Grp IFISC CSIC, Palma De Mallorca, Spain.	enric.munar@uib.cat	Cela-Conde, Camilo J/J-7806-2015; Munar, Enric/AAK-4175-2021; Flexas, Albert/U-6228-2017; Rosselló, Jaume/AAA-6333-2020; maestu, fernando/M-7480-2019; Nadal, Marcos/A-5817-2009; Moratti, Stephan/A-5605-2019; Munar, Enric/C-7397-2011; Maestu, Fernando/E-3213-2012	Munar, Enric/0000-0001-7330-8389; Flexas, Albert/0000-0002-0104-7113; Rosselló, Jaume/0000-0003-4010-7868; maestu, fernando/0000-0002-3195-0071; Nadal, Marcos/0000-0002-9341-4688; Moratti, Stephan/0000-0003-0824-8759; Maestu, Fernando/0000-0002-3195-0071; /0000-0001-8350-7728	Ministerio de Economia y Competitividad (Spanish Government) [SEJ2007-64374/PSIC, FFI2010-20759]	Ministerio de Economia y Competitividad (Spanish Government)	This work was supported by two grants of the Ministerio de Economia y Competitividad (http://www.mineco.gob.es/) (Spanish Government): SEJ2007-64374/PSIC and FFI2010-20759. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray S, 2010, J NEUROPHYSIOL, V103, P2506, DOI 10.1152/jn.01030.2009; Cela-Conde CJ, 2009, P NATL ACAD SCI USA, V106, P3847, DOI 10.1073/pnas.0900304106; Cela-Conde CJ, 2004, P NATL ACAD SCI USA, V101, P6321, DOI 10.1073/pnas.0401427101; CHEVRIER J, 1980, PERCEPT MOTOR SKILL, V50, P839, DOI 10.2466/pms.1980.50.3.839; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Cupchik GC, 2009, BRAIN COGNITION, V70, P84, DOI 10.1016/j.bandc.2009.01.003; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 2010, CEREB CORTEX, V20, P198, DOI 10.1093/cercor/bhp092; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; FRITH CD, 1974, J GEN PSYCHOL, V91, P163; Grabenhorst F, 2009, NEUROIMAGE, V48, P258, DOI 10.1016/j.neuroimage.2009.06.045; Hauk O, 2002, J NEUROSCI METH, V113, P111, DOI 10.1016/S0165-0270(01)00484-8; Hofel L, 2007, J PSYCHOPHYSIOL, V21, P9, DOI 10.1027/0269-8803.21.1.9; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Jacobsen T, 2003, COGN AFFECT BEHAV NE, V3, P289, DOI 10.3758/CABN.3.4.289; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Kirk U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003754; Kirk U, 2009, NEUROIMAGE, V44, P1125, DOI 10.1016/j.neuroimage.2008.10.009; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Liang XY, 2010, SOC NEUROSCI-UK, V5, P320, DOI 10.1080/17470911003619916; Locher P, 2008, SPATIAL VISION, V21, P55, DOI 10.1163/156856808782713762; LOOFT WR, 1971, J GEN PSYCHOL, V85, P307, DOI 10.1080/00221309.1971.9920680; Maestu F, 2002, NEUROIMAGE, V17, P1579, DOI 10.1006/nimg.2002.1235; Mangin J.-F., 1995, Journal of Mathematical Imaging and Vision, V5, P297, DOI 10.1007/BF01250286; Munar E, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00185; Nadal M, 2008, SPATIAL VISION, V21, P379, DOI 10.1163/156856808784532653; Nadal M, 2011, BRAIN COGNITION, V76, P172, DOI 10.1016/j.bandc.2011.01.009; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, J NEUROSCI, V23, P7931; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Windmann S, 2006, J COGNITIVE NEUROSCI, V18, P1198, DOI 10.1162/jocn.2006.18.7.1198; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	35	18	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38152	10.1371/journal.pone.0038152	http://dx.doi.org/10.1371/journal.pone.0038152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675517	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305341700042
J	Schnupf, P; Sansonetti, PJ				Schnupf, Pamela; Sansonetti, Philippe J.			Quantitative RT-PCR profiling of the Rabbit Immune Response: Assessment of Acute Shigella flexneri Infection	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES INFECTION; HOST-DEFENSE; PROTECTIVE IMMUNITY; BACTERIAL PATHOGENS; GENE-EXPRESSION; MODEL; INNATE; CELLS; INFLAMMATION; SYSTEM	Quantitative reverse transcription PCR analysis is an important tool to monitor changes in gene expression in animal models. The rabbit is a widely accepted and commonly used animal model in the study of human diseases and infections by viral, fungal, bacterial and protozoan pathogens. Only a limited number of rabbit genes have, however, been analyzed by this method as the rabbit genome sequence remains unfinished. Recently, increasing coverage of the genome has permitted the prediction of a growing number of genes that are relevant in the context of the immune response. We hereby report the design of twenty-four quantitative PCR primer pairs covering common cytokines, chemoattractants, antimicrobials and enzymes for a rapid, sensitive and quantitative analysis of the rabbit immune response. Importantly, all primer pairs were designed to be used under identical experimental conditions, thereby enabling the simultaneous analysis of all genes in a high-throughput format. This tool was used to analyze the rabbit innate immune response to infection with the human gastrointestinal pathogen Shigella flexneri. Beyond the known inflammatory mediators, we identified IL-22, IL-17A and IL-17F as highly upregulated cytokines and as first responders to infection during the innate phase of the host immune response. This set of qPCR primers also provides a convenient tool for monitoring the rabbit immune response during infection with other pathogens and other inflammatory conditions.	[Schnupf, Pamela; Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Schnupf, Pamela; Sansonetti, Philippe J.] Inst Pasteur, INSERM U786, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Schnupf, P (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.	psanson@pasteur.fr	Schnupf, Pamela/G-6040-2017	Schnupf, Pamela/0000-0003-4292-1257	European Molecular Biology Organization; Marie Curie Intra-European fellowship; European Research Council	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie Intra-European fellowship(European Commission); European Research Council(European Research Council (ERC)European Commission)	This work was funded by a European Molecular Biology Organization long term fellowship and a Marie Curie Intra-European fellowship to PS, and a European Research Council advanced grant (HOMEOPITH) to PJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Chakrabarti A, 1997, J MED VET MYCOL, V35, P295; Chandra J, 2011, VIRULENCE, V2, P466, DOI 10.4161/viru.2.5.16341; Christensen Neil D., 2005, Antiviral Chemistry & Chemotherapy, V16, P355; CONNER ME, 1988, J VIROL, V62, P1625, DOI 10.1128/JVI.62.5.1625-1633.1988; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; FOLEY DM, 1995, J CLIN INVEST, V96, P965, DOI 10.1172/JCI118144; Fong IW, 1997, J CLIN MICROBIOL, V35, P48, DOI 10.1128/JCM.35.1.48-52.1997; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Godornes C, 2007, CYTOKINE, V38, P1, DOI 10.1016/j.cyto.2007.04.002; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hamada S, 2008, IMMUNOLOGY, V125, P170, DOI 10.1111/j.1365-2567.2008.02841.x; Hanes DE, 2001, INFECT IMMUN, V69, P6523, DOI 10.1128/IAI.69.10.6523-6526.2001; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Islam D, 1997, INFECT IMMUN, V65, P739, DOI 10.1128/IAI.65.2.739-749.1997; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kang SJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/394730; KATAKURA S, 1990, APMIS, V98, P313, DOI 10.1111/j.1699-0463.1990.tb01038.x; Kreuter KA, 2008, COMPARATIVE MED, V58, P287; Le Negrate G, 2011, CELLULAR MICROBIOLOG; LOPEZREVILLA R, 1992, PARASITOL RES, V78, P260, DOI 10.1007/BF00931737; Manabe YC, 2008, TUBERCULOSIS, V88, P187, DOI 10.1016/j.tube.2007.10.006; Milhorn D, 2010, ANN NY ACAD SCI, V1194, P72, DOI 10.1111/j.1749-6632.2010.05491.x; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Pavan-Langston D, 1990, Trans Am Ophthalmol Soc, V88, P727; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; Phinikaridou A, 2009, J LIPID RES, V50, P787, DOI 10.1194/jlr.M800460-JLR200; Raqib R, 2000, INFECT IMMUN, V68, P3620, DOI 10.1128/IAI.68.6.3620-3629.2000; Raqib R, 1996, ANN NY ACAD SCI, V797, P299, DOI 10.1111/j.1749-6632.1996.tb52985.x; Raqib R, 2002, INFECT IMMUN, V70, P3199, DOI 10.1128/IAI.70.6.3199-3207.2002; RAQIB R, 1995, INFECT IMMUN, V63, P289, DOI 10.1128/IAI.63.1.289-296.1995; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Sellge G, 2010, J IMMUNOL, V184, P2076, DOI 10.4049/jimmunol.0900978; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; SPIRA WM, 1981, INFECT IMMUN, V32, P739, DOI 10.1128/IAI.32.2.739-747.1981; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; TENDLER M, 1991, J PARASITOL, V77, P138, DOI 10.2307/3282571; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Woodruff-Pak DS, 2007, J ALZHEIMERS DIS, V11, P371; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	51	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36446	10.1371/journal.pone.0036446	http://dx.doi.org/10.1371/journal.pone.0036446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675469	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700005
J	Sun, Q; Shi, L; Prescott, J; Chiuve, SE; Hu, FB; De Vivo, I; Stampfer, MJ; Franks, PW; Manson, JE; Rexrode, KM				Sun, Qi; Shi, Ling; Prescott, Jennifer; Chiuve, Stephanie E.; Hu, Frank B.; De Vivo, Immaculata; Stampfer, Meir J.; Franks, Paul W.; Manson, Joann E.; Rexrode, Kathryn M.			Healthy Lifestyle and Leukocyte Telomere Length in US Women	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; BREAST-CANCER; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; PRIMARY PREVENTION; DIABETES-MELLITUS; HUMAN FIBROBLASTS; RISK-FACTORS	Context: Whether a healthy lifestyle may be associated with longer telomere length is largely unknown. Objectives: To examine healthy lifestyle practices, which are primary prevention measures against major age-related chronic diseases, in relation to leukocyte telomere length. Design and Setting: Cross-sectional analysis in the Nurses' Health Study (NHS). Participants: The population consisted of 5,862 women who participated in multiple prospective case-control studies within the NHS cohort. Z scores of leukocyte telomere length were derived within each case-control study. Based on prior work, we defined low-risk or healthy categories for five major modifiable factors assessed in 1988 or 1990: non-current smoking, maintaining a healthy body weight (body mass index in 18.5-24.9 kg/m(2)), engaging in regular moderate or vigorous physical activities (>= 150 minutes/week), drinking alcohol in moderation (1 drink/week to,2 drinks/day), and eating a healthy diet (Alternate Healthy Eating Index score in top 50%). We calculated difference (%) of the z scores contrasting low-risk groups with reference groups to evaluate the association of interest. Results: Although none of the individual low-risk factors was significantly associated with larger leukocyte telomere length z scores, we observed a significant, positive relationship between the number of low-risk factors and the z scores. In comparison with women who had zero low-risk factors (1.9% of the total population) and were, therefore, considered the least healthy group, the leukocyte telomere length z scores were 16.4%, 22.1%, 28.7%, 22.6%, and 31.2% (P for trend = 0.015) higher for women who had 1 to 5 low-risk factors, respectively. Conclusions: Adherence to a healthy lifestyle, defined by major modifiable risk factors, was associated with longer telomere length in leukocytes.	[Sun, Qi; Chiuve, Stephanie E.; Hu, Frank B.; Stampfer, Meir J.; Franks, Paul W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sun, Qi; Prescott, Jennifer; Hu, Frank B.; De Vivo, Immaculata; Stampfer, Meir J.; Manson, Joann E.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Sun, Qi; Prescott, Jennifer; Chiuve, Stephanie E.; Hu, Frank B.; De Vivo, Immaculata; Stampfer, Meir J.; Manson, Joann E.; Rexrode, Kathryn M.] Harvard Univ, Sch Med, Boston, MA USA; [Shi, Ling] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Prescott, Jennifer; Hu, Frank B.; De Vivo, Immaculata; Stampfer, Meir J.; Manson, Joann E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Prescott, Jennifer; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Franks, Paul W.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Chiuve, Stephanie E.; Manson, Joann E.; Rexrode, Kathryn M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Lund University; Harvard University; Brigham & Women's Hospital	Sun, Q (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	qisun@hsph.harvard.edu	Franks, Paul/AAA-3300-2020; Hu, Frank/C-1919-2013; Rexrode, Kathryn M/I-1177-2018	De Vivo, Immaculata/0000-0002-7185-7402; Chiuve, Stephanie/0000-0002-3524-8917; Rexrode, Kathryn/0000-0003-3387-8429; Franks, Paul/0000-0002-0520-7604	National Institutes of Health [CA87969, CA82838, CA4449, HL34594, HL088521]; National Heart, Lung, and Blood Institute [K99HL098459]; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA082838] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL088521, K99HL098459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by research grants CA87969, CA82838, CA4449, HL34594, and HL088521 from the National Institutes of Health. Dr. Sun was supported by a career development award K99HL098459 from the National Heart, Lung, and Blood Institute. Dr. Hu is a recipient of an American Heart Association Established Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2010, SEER CANC STAT REV 1; Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Aviv A, 2009, AM J CLIN NUTR, V89, P1721, DOI 10.3945/ajcn.2009.27807; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Devore EE, 2011, NEUROSCI LETT, V492, P15, DOI 10.1016/j.neulet.2011.01.041; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HANKINSON SE, 1995, CANCER CAUSE CONTROL, V6, P217, DOI 10.1007/BF00051793; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Liang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023462; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Mychaleckyj JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-91; National Diabetes Foundation, 2011, NAT DIAB FACT SHEET; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donnell CJ, 2008, ARTERIOSCL THROM VAS, V28, P1165, DOI 10.1161/ATVBAHA.107.154849; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Sun Q, 2007, CIRCULATION, V115, P1858, DOI 10.1161/CIRCULATIONAHA.106.679985; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; von Zglinicki T, 2003, NAT BIOTECHNOL, V21, P229, DOI 10.1038/nbt0303-229b; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1992, JAMA-J AM MED ASSOC, V268, P2037, DOI 10.1001/jama.268.15.2037; Wilson WRW, 2008, EUR HEART J, V29, P2689, DOI 10.1093/eurheartj/ehn386; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	65	67	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38374	10.1371/journal.pone.0038374	http://dx.doi.org/10.1371/journal.pone.0038374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675460	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500141
J	Van Laar, TA; Lin, YH; Miller, CL; Karna, SLR; Chambers, JP; Seshu, J				Van Laar, Tricia A.; Lin, Ying-Han; Miller, Christine L.; Karna, S. L. Rajasekhar; Chambers, James P.; Seshu, J.			Effect of Levels of Acetate on the Mevalonate Pathway of Borrelia burgdorferi	PLOS ONE			English	Article							HMG-COA REDUCTASE; LYME-DISEASE SPIROCHETE; COENZYME-A REDUCTASE; OUTER-SURFACE PROTEIN; GENE-EXPRESSION; MURINE MODEL; CHOLESTERYL GALACTOSIDE; ISOPRENOID BIOSYNTHESIS; STAPHYLOCOCCUS-AUREUS; RESPONSE REGULATOR	Borrelia burgdorferi, the agent of Lyme disease, is a spirochetal pathogen with limited metabolic capabilities that survives under highly disparate host-specific conditions. However, the borrelial genome encodes several proteins of the mevalonate pathway (MP) that utilizes acetyl-CoA as a substrate leading to intermediate metabolites critical for biogenesis of peptidoglycan and post-translational modifications of proteins. In this study, we analyzed the MP and contributions of acetate in modulation of adaptive responses in B. burgdorferi. Reverse-transcription PCR revealed that components of the MP are transcribed as individual open reading frames. Immunoblot analysis using monospecific sera confirmed synthesis of members of the MP in B. burgdorferi. The rate-limiting step of the MP is mediated by HMG-CoA reductase (HMGR) via conversion of HMG-CoA to mevalonate. Recombinant borrelial HMGR exhibited a K-m value of 132 mu M with a V-max of 1.94 mu mol NADPH oxidized minute(-1) (mg protein)(-1) and was inhibited by statins. Total protein lysates from two different infectious, clonal isolates of B. burgdorferi grown under conditions that mimicked fed-ticks (pH 6.8/37 degrees C) exhibited increased levels of HMGR while other members of the MP were elevated under unfed-tick (pH 7.6/23 degrees C) conditions. Increased extra-cellular acetate gave rise to elevated levels of MP proteins along with RpoS, CsrA(Bb) and their respective regulons responsible for mediating vertebrate host-specific adaptation. Both lactone and acid forms of two different statins inhibited growth of B. burgdorferi strain B31, while overexpression of HMGR was able to partially overcome that inhibition. In summary, these studies on MP and contributions of acetate to host-specific adaptation have helped identify potential metabolic targets that can be manipulated to reduce the incidence of Lyme disease.	[Van Laar, Tricia A.] S Texas Ctr Emerging Infect Dis, San Antonio, TX USA; Ctr Excellence Infect Genom, Dept Biol, San Antonio, TX USA; Univ Texas San Antonio, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA)	Van Laar, TA (corresponding author), S Texas Ctr Emerging Infect Dis, San Antonio, TX USA.	j.seshu@utsa.edu	Karna, Sai Lakshmi Rajasekhar/AAG-6587-2019; Van Laar, Tricia/H-8177-2019	Karna, Sai Lakshmi Rajasekhar/0000-0002-1876-7117; Van Laar, Tricia/0000-0002-4654-8501	Public Health Service from the National Institute of Allergy and Infectious Diseases [SC1-AI-078559]; Army Research Office of the Department of Defense [W911NF-11-1-0136]; South Texas Center for Emerging Infectious Diseases; Center of Excellence in Infection Genomics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI078559] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Army Research Office of the Department of Defense; South Texas Center for Emerging Infectious Diseases; Center of Excellence in Infection Genomics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partly supported by Public Health Service grant SC1-AI-078559 from the National Institute of Allergy and Infectious Diseases, the Army Research Office of the Department of Defense under Contract No. W911NF-11-1-0136, predoctoral fellowships from the South Texas Center for Emerging Infectious Diseases (to TAV and SLRK) and predoctoral fellowships from the Center of Excellence in Infection Genomics (to TAV and CLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; BARBOUR AG, 1989, REV INFECT DIS, V11, pS1470; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Ben-Menachem G, 2003, P NATL ACAD SCI USA, V100, P7913, DOI 10.1073/pnas.1232451100; Bischoff KM, 1996, J BACTERIOL, V178, P19, DOI 10.1128/jb.178.1.19-23.1996; BISCHOFF KM, 1992, BIOCHEM MED METAB B, V48, P149, DOI 10.1016/0885-4505(92)90060-C; Bochar DA, 1999, MOL GENET METAB, V66, P122, DOI 10.1006/mgme.1998.2786; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Bratton RL, 2008, MAYO CLIN PROC, V83, P566, DOI 10.4065/83.5.566; Brissette CA, 2009, MICROBIOL-SGM, V155, P863, DOI 10.1099/mic.0.024604-0; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Dandache P, 2008, INFECT DIS CLIN N AM, V22, P235, DOI 10.1016/j.idc.2007.12.012; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; ENDO A, 1992, J LIPID RES, V33, P1569; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Ghosh PM, 1997, BBA-MOL CELL RES, V1359, P13, DOI 10.1016/S0167-4889(97)00091-8; Gilbert MA, 2007, MOL MICROBIOL, V63, P1259, DOI 10.1111/j.1365-2958.2007.05593.x; Gilmore RD, 2001, MICROBES INFECT, V3, P799, DOI 10.1016/S1286-4579(01)01435-6; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Hedl M, 2004, PROTEIN SCI, V13, P1693, DOI 10.1110/ps.03597504; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; LaRocca TJ, 2010, CELL HOST MICROBE, V8, P331, DOI 10.1016/j.chom.2010.09.001; Li C, 2011, INFECT IMMUN, V79, P1270; Liang KH, 2003, KIDNEY INT, V64, P192, DOI 10.1046/j.1523-1755.2003.00041.x; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Maruskova M, 2008, INFECT IMMUN, V76, P5274, DOI 10.1128/IAI.00803-08; Maruskova M, 2008, INFECT IMMUN, V76, P391, DOI 10.1128/IAI.01118-07; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; Nardelli DT, 2009, FUTURE MICROBIOL, V4, P457, DOI 10.2217/FMB.09.17; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Pitzer JE, 2011, INFECT IMMUN, V79, P1815, DOI 10.1128/IAI.00075-11; Raju BVS, 2011, INFECT IMMUN, V79, P3407, DOI 10.1128/IAI.05234-11; Ramamoorthy R, 2001, INFECT IMMUN, V69, P2739, DOI 10.1128/IAI.69.4.2739-2742.2001; Robinzon S, 2009, J VIROL, V83, P5495, DOI 10.1128/JVI.01880-08; Rogers EA, 2009, MOL MICROBIOL, V71, P1551, DOI 10.1111/j.1365-2958.2009.06621.x; Samuels D S, 1995, Methods Mol Biol, V47, P253; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sanjuan E, 2009, INFECT IMMUN, V77, P5149, DOI 10.1128/IAI.00673-09; Schroder NWJ, 2003, J BIOL CHEM, V278, P33645, DOI 10.1074/jbc.M305799200; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seemanapalli SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015830; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Seshu J, 2004, MOL MICROBIOL, V54, P1352, DOI 10.1111/j.1365-2958.2004.04352.x; Seshu J, 2004, INFECT IMMUN, V72, P1580, DOI 10.1128/IAI.72.3.1580-1586.2004; Smythe CDW, 1998, J INVEST DERMATOL, V111, P139, DOI 10.1046/j.1523-1747.1998.00246.x; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Stubs G, 2009, J BIOL CHEM, V284, P13326, DOI 10.1074/jbc.M809575200; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Takahashi S, 1999, J BACTERIOL, V181, P1256, DOI 10.1128/JB.181.4.1256-1263.1999; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Theivagt AE, 2006, BIOCHEMISTRY-US, V45, P14397, DOI 10.1021/bi0614636; Tilly K, 2009, INFECT IMMUN, V77, P2672, DOI 10.1128/IAI.01193-08; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Voynova NE, 2004, J BACTERIOL, V186, P61, DOI 10.1128/JB.186.1.61-67.2004; Wanke M, 2001, ACTA BIOCHIM POL, V48, P663; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Wilding EI, 2000, J BACTERIOL, V182, P5147, DOI 10.1128/JB.182.18.5147-5152.2000; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100	74	35	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38171	10.1371/journal.pone.0038171	http://dx.doi.org/10.1371/journal.pone.0038171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675445	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338500100
J	Capsoni, S; Marinelli, S; Ceci, M; Vignone, D; Amato, G; Malerba, F; Paoletti, F; Meli, G; Viegi, A; Pavone, F; Cattaneo, A				Capsoni, Simona; Marinelli, Sara; Ceci, Marcello; Vignone, Domenico; Amato, Gianluca; Malerba, Francesca; Paoletti, Francesca; Meli, Giovanni; Viegi, Alessandro; Pavone, Flaminia; Cattaneo, Antonino			Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FACTOR GENE-THERAPY; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; TRANSGENIC MICE; CRYSTAL-STRUCTURE; SENSORY NEURONS; NGF; TRKA; RECEPTOR	Nerve Growth Factor (NGF) is being considered as a therapeutic candidate for Alzheimer's disease (AD) treatment but the clinical application is hindered by its potent pro-nociceptive activity. Thus, to reduce systemic exposure that would induce pain, in recent clinical studies NGF was administered through an invasive intracerebral gene-therapy approach. Our group demonstrated the feasibility of a non-invasive intranasal delivery of NGF in a mouse model of neurodegeneration. NGF therapeutic window could be further increased if its nociceptive effects could be avoided altogether. In this study we exploit forms of NGF, mutated at residue R100, inspired by the human genetic disease HSAN V (Hereditary Sensory Autonomic Neuropathy Type V), which would allow increasing the dose of NGF without triggering pain. We show that "painless" hNGF displays full neurotrophic and anti-amyloidogenic activities in neuronal cultures, and a reduced nociceptive activity in vivo. When administered intranasally to APPxPS1 mice (n = 8), hNGFP61S/R100E prevents the progress of neurodegeneration and of behavioral deficits. These results demonstrate the in vivo neuroprotective and anti-amyloidogenic properties of hNGFR100 mutants and provide a rational basis for the development of "painless" hNGF variants as a new generation of therapeutics for neurodegenerative diseases.	[Capsoni, Simona; Ceci, Marcello; Vignone, Domenico; Amato, Gianluca; Malerba, Francesca; Paoletti, Francesca; Meli, Giovanni; Cattaneo, Antonino] European Brain Res Inst, Rome, Italy; [Capsoni, Simona; Malerba, Francesca; Viegi, Alessandro; Cattaneo, Antonino] Scuola Normale Super Pisa, Pisa, Italy; [Marinelli, Sara; Pavone, Flaminia] CNR, Inst Neurosci, Rome, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR)	Capsoni, S (corresponding author), European Brain Res Inst, Rome, Italy.	antonino.cattaneo@sns.it	Cattaneo, Antonino/K-4471-2016; Marinelli, Sara/L-7738-2019; Cattaneo, Antonino/AAA-7252-2019	Cattaneo, Antonino/0000-0002-6975-8923; Marinelli, Sara/0000-0001-5393-4796; Pavone, Flaminia/0000-0001-5189-2748; Capsoni, Simona/0000-0003-2670-8237; Ceci, Marcello/0000-0002-5066-1590; Meli, Giovanni/0000-0002-4633-364X	Ministero Universita' e Ricerca [RBAP10L8TY]; Italian Institute of Technology (EBRI/IIT project)	Ministero Universita' e Ricerca(Ministry of Education, Universities and Research (MIUR)); Italian Institute of Technology (EBRI/IIT project)	The work was supported by: Ministero Universita' e Ricerca (Project RBAP10L8TY) and Italian Institute of Technology (EBRI/IIT project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulkassim T, 2011, MOL PHARMACOL, V80, P498, DOI 10.1124/mol.111.071332; Aguado F, 1998, ACTA NEUROPATHOL, V96, P495, DOI 10.1007/s004010050924; Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bruno MA, 2009, J NEUROPATH EXP NEUR, V68, P857, DOI 10.1097/NEN.0b013e3181aed9e6; Capsoni S, 2002, MOL CELL NEUROSCI, V21, P15, DOI 10.1006/mcne.2002.1163; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Capsoni S, 2002, P NATL ACAD SCI USA, V99, P12432, DOI 10.1073/pnas.192442999; Capsoni S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017321; Capsoni S, 2010, P NATL ACAD SCI USA, V107, P12299, DOI 10.1073/pnas.1007181107; Capsoni S, 2009, J ALZHEIMERS DIS, V16, P371, DOI 10.3233/JAD-2009-0953; CATTANEO A, 1988, J NEUROCHEM, V50, P1003, DOI 10.1111/j.1471-4159.1988.tb10565.x; Cattaneo A, 2008, J ALZHEIMERS DIS, V15, P255; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; CHEVALIER S, 1994, BLOOD, V83, P1479; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Connor B, 1996, MOL BRAIN RES, V42, P1, DOI 10.1016/S0169-328X(96)00040-X; Covaceuszach S, 2010, BIOCHEM BIOPH RES CO, V391, P824, DOI 10.1016/j.bbrc.2009.11.146; Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158, DOI 10.2174/156720509787602870; Culmsee C, 2002, NEUROSCIENCE, V115, P1089, DOI 10.1016/S0306-4522(02)00539-0; de Andrade DC, 2008, EUR J NEUROL, V15, P712, DOI 10.1111/j.1468-1331.2008.02172.x; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Delcroix JD, 2004, PROG BRAIN RES, V146, P3, DOI 10.1016/S0079-6123(03)46001-69; Doya H, 2005, BIOCHEM BIOPH RES CO, V335, P132, DOI 10.1016/j.bbrc.2005.07.055; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; Frey WH, 1997, DRUG DELIV, V4, P87, DOI 10.3109/10717549709051878; Giacobini E, 2007, J ALZHEIMERS DIS, V12, P37; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Heese K, 1998, J NEUROCHEM, V70, P699; Heikkinen T, 2004, EXP NEUROL, V187, P105, DOI 10.1016/j.expneurol.2004.01.015; HOLLAND DR, 1994, J MOL BIOL, V239, P385, DOI 10.1006/jmbi.1994.1380; Houeland G, 2010, J NEUROSCI, V30, P13089, DOI 10.1523/JNEUROSCI.0457-10.2010; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; JUNIER MP, 1994, MOL BRAIN RES, V24, P247, DOI 10.1016/0169-328X(94)90138-4; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Ma QL, 2007, J NEUROCHEM, V103, P1594, DOI 10.1111/j.1471-4159.2007.04869.x; Mahapatra S, 2009, J BIOL CHEM, V284, P33600, DOI 10.1074/jbc.M109.058420; Malerba F, 2011, EXPERT OPIN DRUG DEL, V8, P1277, DOI 10.1517/17425247.2011.588204; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; Mazzitelli S, 2011, J NEUROSCI, V31, P16969, DOI 10.1523/JNEUROSCI.4491-11.2011; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MCMAHON SB, 1995, NAT MED, V1, P774, DOI 10.1038/nm0895-774; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Meli G, 2009, J MOL BIOL, V387, P584, DOI 10.1016/j.jmb.2009.01.061; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Nizzari M, 2007, J BIOL CHEM, V282, P13833, DOI 10.1074/jbc.M610146200; Oderfeld-Nowak B, 2003, NEUROSCIENCE, V120, P31, DOI 10.1016/S0306-4522(03)00289-6; PETTY BG, 1994, ANN NEUROL, V36, P244, DOI 10.1002/ana.410360221; PODUSLO JF, 1994, P NATL ACAD SCI USA, V91, P5705, DOI 10.1073/pnas.91.12.5705; POLUHA W, 1995, ONCOGENE, V10, P185; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ruberti F, 2000, J NEUROSCI, V20, P2589; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; SONNENFELD KH, 1982, J NEUROSCI RES, V8, P375, DOI 10.1002/jnr.490080226; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Tuszynski MH, 2007, ALZ DIS ASSOC DIS, V21, P179, DOI 10.1097/WAD.0b013e318068d6d2; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; Wegiel J, 2000, ACTA NEUROPATHOL, V100, P356, DOI 10.1007/s004010000199; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wilson SG, 2003, J PHARMACOL EXP THER, V304, P547, DOI 10.1124/jpet.102.041889; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Young KF, 2009, NEUROCHEM INT, V55, P796, DOI 10.1016/j.neuint.2009.08.002	74	57	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37555	10.1371/journal.pone.0037555	http://dx.doi.org/10.1371/journal.pone.0037555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666365	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400032
J	Laukkanen, L; Leimu, R; Muola, A; Lilley, M; Salminen, JP; Mutikainen, P				Laukkanen, Liisa; Leimu, Roosa; Muola, Anne; Lilley, Marianna; Salminen, Juha-Pekka; Mutikainen, Pia			Plant Chemistry and Local Adaptation of a Specialized Folivore	PLOS ONE			English	Article							POPULATION-SIZE; MATING SYSTEM; HOST PLANTS; HERBIVORE; SELECTION; COEVOLUTION; HISTORY; FITNESS; METAANALYSIS; SPECIFICITY	Local adaptation is central for creating and maintaining spatial variation in plant-herbivore interactions. Short-lived insect herbivores feeding on long-lived plants are likely to adapt to their local host plants, because of their short generation time, poor dispersal, and geographically varying selection due to variation in plant defences. In a reciprocal feeding trial, we investigated the impact of geographic variation in plant secondary chemistry of a long-lived plant, Vincetoxicum hirundinaria, on among-population variation in local adaptation of a specialist leaf-feeding herbivore, Abrostola asclepiadis. The occurrence and degree of local adaptation varied among populations. This variation correlated with qualitative and quantitative differences in plant chemistry among the plant populations. These findings provide insights into the mechanisms driving variation in local adaptation in this specialized plant-herbivore interaction.	[Laukkanen, Liisa; Muola, Anne; Lilley, Marianna] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Leimu, Roosa] Univ Oxford, Dept Plant Sci, Oxford, England; [Salminen, Juha-Pekka] Univ Turku, Dept Chem, Turku, Finland; [Mutikainen, Pia] ETH Zentrum, ETH Zurich, Inst Integrat Biol, Zurich, Switzerland	University of Turku; University of Oxford; University of Turku; ETH Zurich	Laukkanen, L (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	liisa.laukkanen@utu.fi	Salminen, Juha-Pekka/N-3313-2017	Salminen, Juha-Pekka/0000-0002-2912-7094; Muola, Anne/0000-0003-1828-6425	Academy of Finland [8109859]	Academy of Finland(Academy of Finland)	This study was financially supported by the grant 8109859 of the Academy of Finland (http://www.aka.fi) for RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Barnett V., 1994, OUTLIERS STAT DATA; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Berenbaum MR, 2006, ECOLOGY, V87, P3070, DOI 10.1890/0012-9658(2006)87[3070:PWAHPA]2.0.CO;2; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; BOWERS MD, 1988, J CHEM ECOL, V14, P319, DOI 10.1007/BF01022549; BOWERS MD, 1983, J CHEM ECOL, V9, P475, DOI 10.1007/BF00990220; Del Campo ML, 2003, ECOL ENTOMOL, V28, P405, DOI 10.1046/j.1365-2311.2003.00524.x; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Etile E, 2008, OIKOS, V117, P135, DOI 10.1111/j.2007.0030-1299.16114.x; Evenden ML, 2006, ANN ENTOMOL SOC AM, V99, P837, DOI 10.1603/0013-8746(2006)99[837:BSAADI]2.0.CO;2; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Forare Jonas, 1995, Entomologisk Tidskrift, V116, P179; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gandon S, 1998, TRENDS ECOL EVOL, V13, P214, DOI 10.1016/S0169-5347(98)01358-5; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; HANKS LM, 1994, ECOLOGY, V75, P2301, DOI 10.2307/1940885; HAUKIOJA E, 1985, ECOL ENTOMOL, V10, P267, DOI 10.1111/j.1365-2311.1985.tb00723.x; Hereford J, 2008, NEW PHYTOL, V178, P888, DOI 10.1111/j.1469-8137.2008.02405.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Karl I, 2010, POPUL ECOL, V52, P307, DOI 10.1007/s10144-009-0191-z; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Laine AL, 2009, J EXP BOT, V60, P2957, DOI 10.1093/jxb/erp168; Leimu R, 2004, ANN BOT-LONDON, V93, P107, DOI 10.1093/aob/mch012; Leimu R, 2006, BASIC APPL ECOL, V7, P224, DOI 10.1016/j.baae.2005.09.002; Leimu R, 2005, ACTA OECOL, V28, P325, DOI 10.1016/j.actao.2005.06.004; Leimu R, 2005, CONSERV BIOL, V19, P349, DOI 10.1111/j.1523-1739.2005.00480.x; Leimu R, 2002, OIKOS, V98, P229, DOI 10.1034/j.1600-0706.2002.980205.x; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Mitchell-Olds T, 2001, TRENDS ECOL EVOL, V16, P693, DOI 10.1016/S0169-5347(01)02291-1; MOPPER S, 1995, EVOLUTION, V49, P810, DOI [10.2307/2410404, 10.1111/j.1558-5646.1995.tb02317.x]; Muola A, 2010, J EVOLUTION BIOL, V23, P2185, DOI 10.1111/j.1420-9101.2010.02077.x; Muola A, 2010, ECOLOGY, V91, P2650, DOI 10.1890/09-0589.1; Ortegon-Campos I, 2009, J EVOLUTION BIOL, V22, P2288, DOI 10.1111/j.1420-9101.2009.01847.x; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Rhoades DF, 1979, HERBIVORES THEIR INT, P1; Schoonhoven L.M., 1998, INSECT PLANT BIOL PH; Spitzer B, 2006, EVOLUTION, V60, P1859, DOI 10.1111/j.0014-3820.2006.tb00529.x; Staerk D, 2000, J NAT PROD, V63, P1584, DOI 10.1021/np0003443; Strauss SY, 1997, OECOLOGIA, V110, P77, DOI 10.1007/s004420050135; Tack AJM, 2010, ECOLOGY, V91, P2253, DOI 10.1890/09-0080.1; Tammaru T, 2002, OECOLOGIA, V133, P430, DOI 10.1007/s00442-002-1057-7; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Van Zandt PA, 2004, OIKOS, V104, P401, DOI 10.1111/j.0030-1299.2004.12964.x; Van Zandt PA, 1998, AM NAT, V152, P595, DOI 10.1086/286192; von Numers M, 1998, GLOBAL ECOL BIOGEOGR, V7, P421, DOI 10.2307/2997713; Zangerl AR, 2008, P NATL ACAD SCI USA, V105, P4547, DOI 10.1073/pnas.0710280105	53	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38225	10.1371/journal.pone.0038225	http://dx.doi.org/10.1371/journal.pone.0038225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666493	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400106
J	Cerina, F; De Leo, V; Barthelemy, M; Chessa, A				Cerina, Federica; De Leo, Vincenzo; Barthelemy, Marc; Chessa, Alessandro			Spatial Correlations in Attribute Communities	PLOS ONE			English	Article							NETWORK	Community detection is an important tool for exploring and classifying the properties of large complex networks and should be of great help for spatial networks. Indeed, in addition to their location, nodes in spatial networks can have attributes such as the language for individuals, or any other socio-economical feature that we would like to identify in communities. We discuss in this paper a crucial aspect which was not considered in previous studies which is the possible existence of correlations between space and attributes. Introducing a simple toy model in which both space and node attributes are considered, we discuss the effect of space-attribute correlations on the results of various community detection methods proposed for spatial networks in this paper and in previous studies. When space is irrelevant, our model is equivalent to the stochastic block model which has been shown to display a detectability-non detectability transition. In the regime where space dominates the link formation process, most methods can fail to recover the communities, an effect which is particularly marked when space-attributes correlations are strong. In this latter case, community detection methods which remove the spatial component of the network can miss a large part of the community structure and can lead to incorrect results.	[Cerina, Federica; Chessa, Alessandro] Univ Cagliari, Dept Phys, Cagliari, Italy; [Cerina, Federica; De Leo, Vincenzo; Chessa, Alessandro] Complex Syst Computat Lab, Linkalab, Cagliari, Italy; [De Leo, Vincenzo] CRS4 Bioinformat, Pula, Italy; [Barthelemy, Marc] CEA, CNRS, URA 2306, Inst Phys Theor IPhT, F-91198 Gif Sur Yvette, France; [Chessa, Alessandro] Univ Roma La Sapienza, Dept Phys, UOS, Inst Complex Syst,CNR, I-00185 Rome, Italy	University of Cagliari; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome	Cerina, F (corresponding author), Univ Cagliari, Dept Phys, Cagliari, Italy.	alessandro.chessa@dsf.unica.it			operating program of Regione Sardegna (European Social Fund) [L.R.7/2007]	operating program of Regione Sardegna (European Social Fund)	The author Vincenzo De Leo had support for his research from the operating program of Regione Sardegna (European Social Fund 2007-2013), L.R.7/2007, "Promotion of scientic research and technological innovation in Sardinia." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrat A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/05/P05003; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Calabrese F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020814; Campello RJGB, 2007, PATTERN RECOGN LETT, V28, P833, DOI 10.1016/j.patrec.2006.11.010; Chavez M, 2010, COMPLEX NETWORKS NEW; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Daraganova G, 2011, SOCIAL NETWORKS; De Montis A, 2011, ARXIV11032467V119; Decelle A, 2011, PHYS REV LETT, V107, P4; Denceud L, 2006, STUD CLASS DATA ANAL, P21; Erlander S, 1990, GRAVITY MODEL TRANSP, Vix; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Grady D, 2011, ARXIV11041200V1; Gregory S, 2011, PHYSICA A, V391; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Hu D, 2011, ARXIV11065793; Hu D, 2011, P IEEE GLOBECOM 11 H, P1; Jain A. K., ALGORITHMS CLUSTERIN; Kaluza Pablo, 2010, J R Soc Interface, V7, P1093, DOI 10.1098/rsif.2009.0495; Karrer B, 2007, PHYS REV E, V77, P10; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239	29	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37507	10.1371/journal.pone.0037507	http://dx.doi.org/10.1371/journal.pone.0037507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666361	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600017
J	Lostal, W; Bartoli, M; Roudaut, C; Bourg, N; Krahn, M; Pryadkina, M; Borel, P; Suel, L; Roche, JA; Stockholm, D; Bloch, RJ; Levy, N; Bashir, R; Richard, I				Lostal, William; Bartoli, Marc; Roudaut, Carinne; Bourg, Nathalie; Krahn, Martin; Pryadkina, Marina; Borel, Perrine; Suel, Laurence; Roche, Joseph A.; Stockholm, Daniel; Bloch, Robert J.; Levy, Nicolas; Bashir, Rumaisa; Richard, Isabelle			Lack of Correlation between Outcomes of Membrane Repair Assay and Correction of Dystrophic Changes in Experimental Therapeutic Strategy in Dysferlinopathy	PLOS ONE			English	Article							NULL SKELETAL-MUSCLE; MYOBLAST FUSION; T-TUBULE; RECOVERY; PROTEIN; GENE; DEFICIENCY; MYOFERLIN; INTERACTS; GROWTH	Mutations in the dysferlin gene are the cause of Limb-girdle Muscular Dystrophy type 2B and Miyoshi Myopathy. The dysferlin protein has been implicated in sarcolemmal resealing, leading to the idea that the pathophysiology of dysferlin deficiencies is due to a deficit in membrane repair. Here, we show using two different approaches that fullfiling membrane repair as asseyed by laser wounding assay is not sufficient for alleviating the dysferlin deficient pathology. First, we generated a transgenic mouse overexpressing myoferlin to test the hypothesis that myoferlin, which is homologous to dysferlin, can compensate for the absence of dysferlin. The myoferlin overexpressors show no skeletal muscle abnormalities, and crossing them with a dysferlin-deficient model rescues the membrane fusion defect present in dysferlin-deficient mice in vitro. However, myoferlin overexpression does not correct muscle histology in vivo. Second, we report that AAV-mediated transfer of a minidysferlin, previously shown to correct the membrane repair deficit in vitro, also fails to improve muscle histology. Furthermore, neither myoferlin nor the minidysferlin prevented myofiber degeneration following eccentric exercise. Our data suggest that the pathogenicity of dysferlin deficiency is not solely related to impairment in sarcolemmal repair and highlight the care needed in selecting assays to assess potential therapies for dysferlinopathies.	[Lostal, William; Roudaut, Carinne; Bourg, Nathalie; Pryadkina, Marina; Borel, Perrine; Suel, Laurence; Stockholm, Daniel; Richard, Isabelle] Genethon, CNRS, UMR8587, Evry, France; [Bartoli, Marc; Krahn, Martin; Levy, Nicolas] Univ Mediterranee, Hop Enfants Timone, AP HM, Dept Med Genet, Marseille, France; [Bartoli, Marc; Krahn, Martin; Levy, Nicolas] Univ Mediterranee, Inserm, UMR S 910, Fac Med Timone, Marseille, France; [Roche, Joseph A.; Bloch, Robert J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Bashir, Rumaisa] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 1TA, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University System of Maryland; University of Maryland Baltimore; Durham University	Lostal, W (corresponding author), Genethon, CNRS, UMR8587, Evry, France.	richard@genethon.fr	Richard, isabelle/J-8298-2013; Stockholm, Daniel/J-7912-2013; Bartoli, Marc/O-8893-2016; LEVY, Nicolas/J-1632-2014; Bartoli, Marc/Q-5979-2017; Lostal, William/Q-1079-2018	Bartoli, Marc/0000-0003-3339-9858; LEVY, Nicolas/0000-0001-5171-6365; Bartoli, Marc/0000-0003-3339-9858; Roche, Joseph/0000-0002-9497-6850; Lostal, William/0000-0003-1014-1950	AFM; jain Foundation; Jain Foundation Inc.	AFM(Association Francaise contre les Myopathies); jain Foundation; Jain Foundation Inc.	This work was supported by grants from the AFM (www.AFM-telethon.fr) and the jain Foundation (www.jain-foundation.org). WL was the recipient of the Jain Foundation Inc. fellowship. The funders had no role in study design, data collection and analysis or decision to publish. Regarding the preparation of the manuscript, one person of the foundation served as reader for english editing.	Aartsma-Rus A, 2010, EUR J HUM GENET, V18, P889, DOI 10.1038/ejhg.2010.4; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Cacciottolo M, 2011, J BIOL CHEM; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013854; Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522; Demonbreun AR, 2010, FASEB J; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Glover LE, 2010, ANN NEUROL, V67, P384, DOI 10.1002/ana.21926; Han R, 2010, J CLIN INVEST, V120, P4366, DOI 10.1172/JCI42390; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Humphrey GW, 2012, EXP CELL RES, V318, P127, DOI 10.1016/j.yexcr.2011.10.004; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Klinge L, 2010, MUSCLE NERVE, V41, P166, DOI 10.1002/mus.21166; Krahn M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000951; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Lovering RM, 2007, ARCH PHYS MED REHAB, V88, P617, DOI 10.1016/j.apmr.2007.02.010; Matsuda C, 1999, NEUROLOGY, V53, P1119, DOI 10.1212/WNL.53.5.1119; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Millay DP, 2009, AM J PATHOL, V175, P1817, DOI 10.2353/ajpath.2009.090107; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Posey AD, 2011, CURR TOP DEV BIOL, V96, P203, DOI 10.1016/B978-0-12-385940-2.00008-5; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Roche JA, 2008, NEUROREPORT, V19, P1579, DOI 10.1097/WNR.0b013e328311ca35; Roche JA, 2010, AM J PHYSIOL-CELL PH, V298, pC298, DOI 10.1152/ajpcell.00122.2009; Selcen D, 2001, NEUROLOGY, V56, P1472, DOI 10.1212/WNL.56.11.1472; Wein N, 2010, NEUROMUSCULAR DISORD, V20, P57, DOI 10.1016/j.nmd.2009.08.004; Wenzel K, 2005, J IMMUNOL, V175, P6219, DOI 10.4049/jimmunol.175.9.6219	40	47	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38036	10.1371/journal.pone.0038036	http://dx.doi.org/10.1371/journal.pone.0038036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666441	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000305349600057
J	Sama, DM; Abdul, HM; Furman, JL; Artiushin, IA; Szymkowski, DE; Scheff, SW; Norris, CM				Sama, Diana M.; Abdul, Hafiz Mohmmad; Furman, Jennifer L.; Artiushin, Irina A.; Szymkowski, David E.; Scheff, Stephen W.; Norris, Christopher M.			Inhibition of Soluble Tumor Necrosis Factor Ameliorates Synaptic Alterations and Ca2+ Dysregulation in Aged Rats	PLOS ONE			English	Article							LONG-TERM DEPRESSION; NF-KAPPA-B; SUBUNIT MESSENGER-RNA; CALCIUM-CHANNEL ACTIVITY; CYTOKINE UP-REGULATION; FACTOR-ALPHA; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; TNF-ALPHA; AREA CA1	The role of tumor necrosis factor alpha (TNF) in neural function has been investigated extensively in several neurodegenerative conditions, but rarely in brain aging, where cognitive and physiologic changes are milder and more variable. Here, we show that protein levels for TNF receptor 1 (TNFR1) are significantly elevated in the hippocampus relative to TNF receptor 2 (TNFR2) in aged (22 months) but not young adult (6 months) Fischer 344 rats. To determine if altered TNF/TNFR1 interactions contribute to key brain aging biomarkers, aged rats received chronic (4-6 week) intracranial infusions of XPro1595: a soluble dominant negative TNF that preferentially inhibits TNFR1 signaling. Aged rats treated with XPro1595 showed improved Morris Water Maze performance, reduced microglial activation, reduced susceptibility to hippocampal long-term depression, increased protein levels for the GluR1 type glutamate receptor, and lower L-type voltage sensitive Ca2+ channel (VSCC) activity in hippocampal CA1 neurons. The results suggest that diverse functional changes associated with brain aging may arise, in part, from selective alterations in TNF signaling.	[Sama, Diana M.] Univ Kentucky, Grad Ctr Gerontol, Lexington, KY 40536 USA; [Abdul, Hafiz Mohmmad; Artiushin, Irina A.; Scheff, Stephen W.; Norris, Christopher M.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Szymkowski, David E.] Xencor Inc, Monrovia, CA USA	University of Kentucky; University of Kentucky	Sama, DM (corresponding author), Univ Kentucky, Grad Ctr Gerontol, Lexington, KY 40536 USA.	cnorr2@uky.edu		Szymkowski, David/0000-0002-8934-7902	National Institutes of Health [AG027297, AG024190, AG000242]; KSCHIRT award; NATIONAL INSTITUTE ON AGING [T32AG000242, R01AG027297, K01AG024190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KSCHIRT award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants: AG027297, AG024190, AG000242, and a KSCHIRT award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albensi BC, 2000, SYNAPSE, V35, P151; Aloe L, 1999, CYTOKINE, V11, P45, DOI 10.1006/cyto.1998.0397; BARNES CA, 1992, HIPPOCAMPUS, V2, P457, DOI 10.1002/hipo.450020413; Barnum CJ, 2011, EXP NEUROL, V229, P198, DOI 10.1016/j.expneurol.2011.02.016; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Billard JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009843; Blalock EM, 2001, EPILEPSY RES, V43, P211, DOI 10.1016/S0920-1211(00)00199-6; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brewer LD, 2009, J NEUROSCI, V29, P6058, DOI 10.1523/JNEUROSCI.5253-08.2009; Campbell LW, 1996, J NEUROSCI, V16, P6286; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Chen KC, 2000, P NATL ACAD SCI USA, V97, P4357, DOI 10.1073/pnas.070056097; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; DISTERHOFT JF, 1994, ANN NY ACAD SCI, V747, P382; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Foster TC, 1997, HIPPOCAMPUS, V7, P602, DOI 10.1002/(SICI)1098-1063(1997)7:6<602::AID-HIPO3>3.0.CO;2-G; Foster TC, 2002, PROG BRAIN RES, V138, P283, DOI 10.1016/S0079-6123(02)38083-X; Foster TC, 2003, NEUROBIOL AGING, V24, P839, DOI 10.1016/S0197-4580(03)00014-9; Foster TC, 2001, J NEUROSCI, V21, P4066, DOI 10.1523/JNEUROSCI.21-11-04066.2001; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; Foy MR, 2008, BEHAV NEUROSCI, V122, P301, DOI 10.1037/0735-7044.122.2.301; Furman JL, 2010, NEUROSCI LETT, V469, P365, DOI 10.1016/j.neulet.2009.12.029; Furukawa K, 1998, J NEUROCHEM, V70, P1876; Gant JC, 2011, J NEUROSCI, V31, P1693, DOI 10.1523/JNEUROSCI.4805-10.2011; Gavilan MP, 2007, J NEUROCHEM, V103, P984, DOI 10.1111/j.1471-4159.2007.04787.x; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Giordano A, 2006, AM J PHYSIOL-HEART C, V290, pH2459, DOI 10.1152/ajpheart.00750.2005; Golan H, 2004, CEREB CORTEX, V14, P97, DOI 10.1093/cercor/bhg108; Gray R, 1990, PREPARATIONS VERTEBR, P3; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Herman JP, 1998, NEUROBIOL AGING, V19, P581, DOI 10.1016/S0197-4580(98)00099-2; Hsu KS, 2002, HIPPOCAMPUS, V12, P787, DOI 10.1002/hipo.10032; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Jouvenceau A, 2006, J PHYSIOL-PARIS, V99, P154, DOI 10.1016/j.jphysparis.2005.12.009; Kantrow SP, 2000, FEBS LETT, V483, P119, DOI 10.1016/S0014-5793(00)02083-4; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Khachaturian Z S, 1989, Aging (Milano), V1, P17; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Kumar A, 2005, BRAIN RES, V1031, P125, DOI 10.1016/j.brainres.2004.10.023; Kumar A, 2004, J NEUROPHYSIOL, V91, P2437, DOI 10.1152/jn.01148.2003; Kumar A, 2007, J NEUROPHYSIOL, V98, P2729, DOI 10.1152/jn.00514.2007; LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926; Macdonald NJ, 2003, AGING CELL, V2, P245, DOI 10.1046/j.1474-9728.2003.00059.x; Macdonald NJ, 2000, J ANAT, V197, P543, DOI 10.1046/j.1469-7580.2000.19740543.x; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Mathis DM, 2011, JOVE-J VIS EXP, DOI 10.3791/2330; McAlpine FE, 2008, J INFLAMM RES, V1, P29; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; MCMONAGLESTRUCKO K, 1993, PHARMACOL BIOCHEM BE, V44, P827, DOI 10.1016/0091-3057(93)90013-J; MOYER JR, 1994, HIPPOCAMPUS, V4, P11, DOI 10.1002/hipo.450040104; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Norris CM, 2010, NEUROBIOL AGING, V31, P328, DOI 10.1016/j.neurobiolaging.2008.03.026; Norris CM, 1998, J NEUROSCI, V18, P3171; Norris CM, 2002, NEUROSCIENCE, V110, P213, DOI 10.1016/S0306-4522(01)00574-7; Norris CM, 1999, NEUROBIOL LEARN MEM, V71, P194, DOI 10.1006/nlme.1998.3864; Norris CM, 1996, J NEUROSCI, V16, P5382; OHLSSON H, 1986, CELL, V45, P35, DOI 10.1016/0092-8674(86)90535-0; Paredes D, 2010, AGING DIS, V1, P191; Park KM, 2008, J BIOL CHEM, V283, P33069, DOI 10.1074/jbc.M802209200; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Sakmann B, 1983, SINGLE CHANNEL RECOR, P37; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Steed PM, 2003, SCIENCE, V301, P1895, DOI 10.1126/science.1081297; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Sukhareva M, 2002, J NEUROPHYSIOL, V88, P1077, DOI 10.1152/jn.2002.88.3.1077; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Terao A, 2002, J NEUROIMMUNOL, V132, P99, DOI 10.1016/S0165-5728(02)00317-X; Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2001, J NEUROSCI, V21, P9744, DOI 10.1523/JNEUROSCI.21-24-09744.2001; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Thibault O, 2012, BBA-MOL BASIS DIS, V1822, P546, DOI 10.1016/j.bbadis.2012.01.004; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; Veng LM, 2003, MOL BRAIN RES, V110, P193, DOI 10.1016/S0169-328X(02)00643-5; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Vouimba RM, 2000, BRAIN RES BULL, V53, P783, DOI 10.1016/S0361-9230(00)00377-4; Wang JQ, 2005, MOL NEUROBIOL, V32, P237, DOI 10.1385/MN:32:3:237; Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872; Zhang JM, 2002, J NEUROPHYSIOL, V88, P1387, DOI 10.1152/jn.2002.88.3.1387	95	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38170	10.1371/journal.pone.0038170	http://dx.doi.org/10.1371/journal.pone.0038170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666474	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600067
J							PLoS ONE	Expression of Concern: Immune Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine	PLOS ONE			English	Editorial Material																			0	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e39314	10.1371/journal.pone.0039314	http://dx.doi.org/10.1371/journal.pone.0039314			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22685513	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300173
J	Ma, JC; Ibekwe, AM; Leddy, M; Yang, CH; Crowley, DE				Ma, Jincai; Ibekwe, A. Mark; Leddy, Menu; Yang, Ching-Hong; Crowley, David E.			Assimilable Organic Carbon (AOC) in Soil Water Extracts Using Vibrio harveyi BB721 and Its Implication for Microbial Biomass	PLOS ONE			English	Article							BIOCIDAL TREATMENTS; BACTERIAL-GROWTH; MATTER; METABOLISM; INDICATORS; NITROGEN	Assimilable organic carbon (AOC) is commonly used to measure the growth potential of microorganisms in water, but has not yet been investigated for measuring microbial growth potential in soils. In this study, a simple, rapid, and non-growth based assay to determine AOC in soil was developed using a naturally occurring luminous strain Vibrio harveyi BB721 to determine the fraction of low molecular weight organic carbon in soil water extract. Calibration of the assay was achieved by measuring the luminescence intensity of starved V. harveyi BB721 cells in the late exponential phase with a concentration range from 0 to 800 mu g l(-1) glucose (equivalent to 0-16.0 mg glucose C kg(-1) soil) with the detection limit of 10 mu g l(-1) equivalent to 0.20 mg glucose C kg(-1) soil. Results showed that bioluminescence was proportional to the concentration of glucose added to soil. The luminescence intensity of the cells was highly pH dependent and the optimal pH was about 7.0. The average AOC concentration in 32 soils tested was 2.9 +/- 2.2 mg glucose C kg(-1). Our data showed that AOC levels in soil water extracts were significantly correlated (P<0.05) with microbial biomass determined as microbial biomass carbon, indicating that the AOC concentrations determined by the method developed might be a good indicator of soil microbial biomass. Our findings provide a new approach that may be used to determine AOC in environmental samples using a non-growth bioluminescence based assay. Understanding the levels of AOC in soil water extract provides new insights into our ability to estimate the most available carbon pool to bacteria in soil that may be easily assimilated into cells for many metabolic processes and suggest possible the links between AOC, microbial regrowth potential, and microbial biomass in soils.	[Ma, Jincai; Ibekwe, A. Mark] US Dept Agr Agr Res Serv, US Salin Lab, Riverside, CA USA; [Ma, Jincai; Crowley, David E.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Leddy, Menu] Orange Cty Water Dist, Fountain Valley, CA USA; [Yang, Ching-Hong] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA	University of California System; University of California Riverside; University of Wisconsin System; University of Wisconsin Milwaukee	Ma, JC (corresponding author), US Dept Agr Agr Res Serv, US Salin Lab, Riverside, CA USA.	Mark.Ibekwe@ars.usda.gov	MA, JINCAI/D-1290-2013; MA, JINCAI/AAR-3734-2021; Crowley, David/C-1216-2014	MA, JINCAI/0000-0002-0792-0251; MA, JINCAI/0000-0002-0792-0251; Crowley, David/0000-0002-1805-8599; Ibekwe, Abasiofiok/0000-0003-3352-759X	National Institute of Food and Agriculture [2008-35201-18709]; United States Department of Agriculture-Agricultural Research Service; National Natural Science Foundation of China [40971255]	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Institute of Food and Agriculture Agreement no. 2008-35201-18709 and the 214 Manure and Byproduct Utilization Project of the United States Department of Agriculture-Agricultural Research Service. Travel by Dr. Haizhen Wang to our Lab was funded by the National Natural Science Foundation of China (Nos. 40971255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden L, 2001, APPL ENVIRON MICROB, V67, P1830, DOI 10.1128/AEM.67.4.1830-1838.2001; Balaria A, 2009, SOIL SCI SOC AM J, V73, P812, DOI 10.2136/sssaj2008.0075; BASSLER BL, 1994, MOL MICROBIOL, V12, P403, DOI 10.1111/j.1365-2958.1994.tb01029.x; BELAS R, 1982, SCIENCE, V218, P791, DOI 10.1126/science.10636771; ELLIOTT LF, 1994, SOIL RESILIENCE AND SUSTAINABLE LAND USE, P353; Escobar IC, 1999, J AM WATER WORKS ASS, V91, P76; Girvan MS, 2004, APPL ENVIRON MICROB, V70, P2692, DOI 10.1128/AEM.70.5.2692-2701.2004; Grayston SJ, 2004, APPL SOIL ECOL, V25, P63, DOI 10.1016/S0929-1393(03)00098-2; Greenberg A. E., 1993, STANDARD METHODS EXA; Haddix PL, 2004, APPL ENVIRON MICROB, V70, P850, DOI 10.1128/AEM.70.2.850-854.2004; Hammes FA, 2005, ENVIRON SCI TECHNOL, V39, P3289, DOI 10.1021/es048277c; Hem LJ, 2001, WATER RES, V35, P1106, DOI 10.1016/S0043-1354(00)00354-7; Ilstedt U, 2005, SOIL BIOL BIOCHEM, V37, P1407, DOI 10.1016/j.soilbio.2005.01.002; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P167, DOI 10.1016/0038-0717(76)90001-8; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P209, DOI 10.1016/0038-0717(76)90005-5; JORET JC, 1991, WATER SCI TECHNOL, V24, P95, DOI 10.2166/wst.1991.0036; KAPLAN LA, 1993, APPL ENVIRON MICROB, V59, P1532, DOI 10.1128/AEM.59.5.1532-1539.1993; KILLHAM K, 1990, SOIL USE MANAGE, V6, P86, DOI 10.1111/j.1475-2743.1990.tb00811.x; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Klein G, 1998, MOL GEN GENET, V259, P179, DOI 10.1007/s004380050803; Klute A, 2001, AM SOC AGRONOMY AG 1, V9; Landgraf D, 2006, J PLANT NUTR SOIL SC, V169, P76, DOI 10.1002/jpln.200521711; LECHEVALLIER MW, 1993, APPL ENVIRON MICROB, V59, P1526, DOI 10.1128/AEM.59.5.1526-1531.1993; LeChevallier MW, 1996, APPL ENVIRON MICROB, V62, P2201, DOI 10.1128/AEM.62.7.2201-2211.1996; LECHEVALLIER MW, 1987, APPL ENVIRON MICROB, V53, P2714, DOI 10.1128/AEM.53.12.2714-2724.1987; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; QUALLS RG, 1992, SOIL SCI SOC AM J, V56, P578, DOI 10.2136/sssaj1992.03615995005600020038x; SERVAIS P, 1987, WATER RES, V21, P445, DOI 10.1016/0043-1354(87)90192-8; Smith J. L., 1990, Soil biochemistry. Volume 6., P357; van Bruggen AHC, 2000, APPL SOIL ECOL, V15, P13, DOI 10.1016/S0929-1393(00)00068-8; Van Der Kooij, 1990, DRINKING WATER MICRO; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VANDERKOOIJ D, 1982, J AM WATER WORKS ASS, V74, P540; VANDERKOOIJ D, 1992, J AM WATER WORKS ASS, V84, P57, DOI 10.1002/j.1551-8833.1992.tb07305.x; Vital M, 2010, APPL ENVIRON MICROB, V76, P6477, DOI 10.1128/AEM.00794-10; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Weinrich LA, 2011, APPL ENVIRON MICROB, V77, P1148, DOI 10.1128/AEM.01829-10; Weinrich LA, 2009, APPL ENVIRON MICROB, V75, P7385, DOI 10.1128/AEM.01728-09; Yeomans CV, 1999, FEMS MICROBIOL LETT, V176, P79, DOI 10.1111/j.1574-6968.1999.tb13645.x	39	9	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e28519	10.1371/journal.pone.0028519	http://dx.doi.org/10.1371/journal.pone.0028519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22679477	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800001
J	Keicho, N; Matsushita, I; Tanaka, T; Shimbo, T; Nguyen, TLH; Sakurada, S; Kobayashi, N; Hijikata, M; Thuong, PH; Lien, LT				Keicho, Naoto; Matsushita, Ikumi; Tanaka, Takahiro; Shimbo, Takuro; Nguyen Thi Le Hang; Sakurada, Shinsaku; Kobayashi, Nobuyuki; Hijikata, Minako; Pham Huu Thuong; Luu Thi Lien			Circulating Levels of Adiponectin, Leptin, Fetuin-A and Retinol-Binding Protein in Patients with Tuberculosis: Markers of Metabolism and Inflammation	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; PLASMA LEPTIN; DIABETES-MELLITUS; EXPRESSION; OBESITY; RETINOL-BINDING-PROTEIN-4; MALNUTRITION; GLYCOPROTEIN; ASSOCIATION	Background: Wasting is known as a prominent feature of tuberculosis (TB). To monitor the disease state, markers of metabolism and inflammation are potentially useful. We thus analyzed two major adipokines, adiponectin and leptin, and two other metabolic markers, fetuin-A and retinol-binding protein 4 (RBP4). Methods: The plasma levels of these markers were measured using enzyme-linked immunosorbent assays in 84 apparently healthy individuals (= no-symptom group) and 46 patients with active pulmonary TB around the time of treatment, including at the midpoint evaluation (= active-disease group) and compared them with body mass index (BMI), C-reactive protein (CRP), chest radiographs and TB-antigen specific response by interferon-c release assay (IGRA). Results: In the no-symptom group, adiponectin and leptin showed negative and positive correlation with BMI respectively. In the active-disease group, at the time of diagnosis, leptin, fetuin-A and RBP4 levels were lower than in the no-symptom group [adjusted means 2.01 versus 4.50 ng/ml, P<0.0001; 185.58 versus 252.27 mu g/ml, P<0.0001; 23.88 versus 43.79 mu g/ml, P<0.0001, respectively]. High adiponectin and low leptin levels were associated with large infiltrates on chest radiographs even after adjustment for BMI and other covariates (P = 0.0033 and P = 0.0020). During treatment, adiponectin levels increased further and then decreased. Leptin levels remained low. Initial low levels of fetuin-A and RBP4 almost returned to the normal reference range in concert with reduced CRP. Conclusions: Our data and recent literature suggest that low fat store and underlying inflammation may regulate these metabolic markers in TB in a different way. Decreased leptin, increased adiponectin, or this ratio may be a promising marker for severity of the disease independent of BMI. We should further investigate pathological roles of the balance between these adipokines.	[Keicho, Naoto; Matsushita, Ikumi; Tanaka, Takahiro; Sakurada, Shinsaku; Hijikata, Minako] Natl Ctr Global Hlth & Med, Res Inst, Dept Resp Dis, Tokyo, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Dept Clin Res & Informat, Tokyo, Japan; [Nguyen Thi Le Hang] Natl Ctr Global Hlth & Med, Bach Mai Hosp Med Collaborat Ctr, Hanoi, Vietnam; [Pham Huu Thuong; Luu Thi Lien] Hanoi Lung Hosp, Hanoi, Vietnam; [Kobayashi, Nobuyuki] Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Keicho, N (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Resp Dis, Tokyo, Japan.	nkeicho-tky@umin.ac.jp	Tanaka, Takahiro/GRF-0016-2022; Keicho, Naoto/GQZ-0301-2022	Keicho, Naoto/0000-0001-8232-9448	Program of Japan Initiative for Global Research Network on Infectious Diseases, MEXT, Japan	Program of Japan Initiative for Global Research Network on Infectious Diseases, MEXT, Japan	This work was supported by a grant from the Program of Japan Initiative for Global Research Network on Infectious Diseases, MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnalich F, 1999, J INFECT DIS, V180, P908, DOI 10.1086/314963; Bornstein SR, 1998, J INFECT DIS, V178, P887, DOI 10.1086/515349; Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Buyukoglan H, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/64859; Cakir B, 1999, HORM RES, V52, P279, DOI 10.1159/000023495; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Dai GX, 1998, INFECT IMMUN, V66, P3562, DOI 10.1128/IAI.66.8.3562-3568.1998; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Fuhrman P, 2004, J AM DIET ASSOC, V104, P1258, DOI 10.1016/j.jada.2004.05.213; Gangneux C, 2003, NUCLEIC ACIDS RES, V31, P5957, DOI 10.1093/nar/gkg788; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P2838, DOI 10.1210/jc.2002-021721; Gualillo O, 2000, LIFE SCI, V67, P2433, DOI 10.1016/S0024-3205(00)00827-4; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; INGENBLEEK Y, 1975, CLIN CHIM ACTA, V63, P61, DOI 10.1016/0009-8981(75)90379-4; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Kim JH, 2010, CLIN NUTR, V29, P512, DOI 10.1016/j.clnu.2010.01.008; Klempel MC, 2011, NUTR REV, V69, P145, DOI 10.1111/j.1753-4887.2011.00373.x; Klimcakova E, 2010, OBES REV, V11, P446, DOI 10.1111/j.1467-789X.2009.00704.x; Koch A, 2010, CRIT CARE, V14, DOI 10.1186/cc9285; Kuo SM, 2011, INT J OBESITY, V35, P1487, DOI 10.1038/ijo.2011.20; Langouche L, 2009, CRIT CARE, V13, DOI 10.1186/cc7956; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Malli F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-152; Marshall WJ, 2008, J CLIN PATHOL, V61, P1083, DOI 10.1136/jcp.2007.051813; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Moriconi N, 2006, J CLIN ENDOCR METAB, V91, P1586, DOI 10.1210/jc.2005-2135; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Pitombo C, 2006, J ENDOCRINOL, V191, P699, DOI 10.1677/joe.1.07069; Prentice AM, 2008, J CLIN INVEST, V118, P1322, DOI 10.1172/JCI34034; Robinson K, 2011, CRIT CARE, V15, DOI 10.1186/cc10021; Sakurada S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-31; Santucci N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026363; Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; Schwenk A, 2003, AM J CLIN NUTR, V77, P392, DOI 10.1093/ajcn/77.2.392; Sood A, 2010, J APPL PHYSIOL, V108, P744, DOI 10.1152/japplphysiol.00838.2009; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Tanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-71; TVERDAL A, 1986, EUR J RESPIR DIS, V69, P355; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; van Lettow M, 2005, J CLIN ENDOCR METAB, V90, P4771, DOI 10.1210/jc.2004-2539; van Lettow M, 2003, NUTR REV, V61, P81, DOI 10.1301/nr.2003.marr.81-90; Vitkova M, 2007, J CLIN ENDOCR METAB, V92, P2330, DOI 10.1210/jc.2006-2668; Walkey AJ, 2010, CRIT CARE MED, V38, P2329, DOI 10.1097/CCM.0b013e3181fa0561; Wallace AM, 2000, CYTOKINE, V12, P1042, DOI 10.1006/cyto.2000.0674; Wieland CW, 2005, INT IMMUNOL, V17, P1399, DOI 10.1093/intimm/dxh317; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Yuksel I, 2003, ENDOCR RES, V29, P257, DOI 10.1081/ERC-120025033	54	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38703	10.1371/journal.pone.0038703	http://dx.doi.org/10.1371/journal.pone.0038703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685600	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700063
J	Lee, Y; Mick, J; Furdui, C; Beamer, LJ				Lee, Yingying; Mick, Jacob; Furdui, Cristina; Beamer, Lesa J.			A Coevolutionary Residue Network at the Site of a Functionally Important Conformational Change in a Phosphohexomutase Enzyme Family	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MUTUAL INFORMATION; LIPOOLIGOSACCHARIDE BIOSYNTHESIS; LIPOPOLYSACCHARIDE BIOSYNTHESIS; CATALYTIC-REACTION; PHOSPHOGLUCOMUTASE; PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE; NEISSERIA; DYNAMICS; PMM/PGM	Coevolution analyses identify residues that co-vary with each other during evolution, revealing sequence relationships unobservable from traditional multiple sequence alignments. Here we describe a coevolutionary analysis of phosphomannomutase/phosphoglucomutase (PMM/PGM), a widespread and diverse enzyme family involved in carbohydrate biosynthesis. Mutual information and graph theory were utilized to identify a network of highly connected residues with high significance. An examination of the most tightly connected regions of the coevolutionary network reveals that most of the involved residues are localized near an interdomain interface of this enzyme, known to be the site of a functionally important conformational change. The roles of four interface residues found in this network were examined via site-directed mutagenesis and kinetic characterization. For three of these residues, mutation to alanine reduces enzyme specificity to similar to 10% or less of wild-type, while the other has similar to 45% activity of wild-type enzyme. An additional mutant of an interface residue that is not densely connected in the coevolutionary network was also characterized, and shows no change in activity relative to wild-type enzyme. The results of these studies are interpreted in the context of structural and functional data on PMM/PGM. Together, they demonstrate that a network of coevolving residues links the highly conserved active site with the interdomain conformational change necessary for the multi-step catalytic reaction. This work adds to our understanding of the functional roles of coevolving residue networks, and has implications for the definition of catalytically important residues.	[Lee, Yingying; Beamer, Lesa J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Mick, Jacob; Beamer, Lesa J.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Furdui, Cristina] Wake Forest Univ Hlth Sci Winston Salem, Dept Internal Med, Winston Salem, NC USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Wake Forest University	Lee, Y (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	beamerl@missouri.edu		Furdui, Cristina M./0000-0003-3771-7999	 [MCB-0918389]		This work was supported by MCB-0918389 http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017459; Alexander RP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281pe44; Boehr DD, 2008, BIOCHEMISTRY-US, V47, P9227, DOI 10.1021/bi801102e; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Buck MJ, 2005, MOL BIOL EVOL, V22, P1627, DOI 10.1093/molbev/msi157; Chakrabarti S, 2009, PROTEINS, V75, P231, DOI 10.1002/prot.22239; Chen WY, 2011, IEEE T PATTERN ANAL, V33, P568, DOI 10.1109/TPAMI.2010.88; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; Chiang SL, 1999, INFECT IMMUN, V67, P976, DOI 10.1128/IAI.67.2.976-980.1999; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickson RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011082; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fatakia SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027813; Fatakia SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004681; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Gloor GB, 2010, MOL BIOL EVOL, V27, P1181, DOI 10.1093/molbev/msq004; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Jeon J, 2011, MOL BIOL EVOL, V28, P2675, DOI 10.1093/molbev/msr094; Kim SH, 2003, ARCH MICROBIOL, V180, P240, DOI 10.1007/s00203-003-0582-z; Klinman JP, 2009, CHEM PHYS LETT, V471, P179, DOI 10.1016/j.cplett.2009.01.038; Kose F, 2001, BIOINFORMATICS, V17, P1198, DOI 10.1093/bioinformatics/17.12.1198; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; McCarthy TR, 2005, MOL MICROBIOL, V58, P774, DOI 10.1111/j.1365-2958.2005.04862.x; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; McKay GA, 2003, INFECT IMMUN, V71, P3068, DOI 10.1128/IAI.71.6.3068-3075.2003; Min W, 2008, J PHYS CHEM B, V112, P454, DOI 10.1021/jp076533c; Monteiro MA, 2003, CARBOHYD RES, V338, P2905, DOI 10.1016/j.carres.2003.08.014; Naught LE, 2005, BIOCHEMISTRY-US, V44, P6831, DOI 10.1021/bi0501380; Naught LE, 2003, BIOCHEMISTRY-US, V42, P9946, DOI 10.1021/bi034673g; Naught LE, 2001, ARCH BIOCHEM BIOPHYS, V396, P111, DOI 10.1006/abbi.2001.2618; Olvera C, 1999, FEMS MICROBIOL LETT, V179, P85, DOI 10.1111/j.1574-6968.1999.tb08712.x; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; RAY WJ, 1990, BIOCHEMISTRY-US, V29, P2770, DOI 10.1021/bi00463a021; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; Regni C, 2002, STRUCTURE, V10, P269, DOI 10.1016/S0969-2126(02)00705-0; Regni CA, 2000, ACTA CRYSTALLOGR D, V56, P761, DOI 10.1107/S0907444900004431; Regni C, 2006, ACTA CRYSTALLOGR F, V62, P722, DOI 10.1107/S1744309106025887; Regni C, 2006, J BIOL CHEM, V281, P15564, DOI 10.1074/jbc.M600590200; Saen-Oon S, 2008, BIOPHYS J, V94, P4078, DOI 10.1529/biophysj.107.121913; SANDLIN RC, 1994, J BACTERIOL, V176, P2930, DOI 10.1128/JB.176.10.2930-2937.1994; Schramm AM, 2008, BIOCHEMISTRY-US, V47, P9154, DOI 10.1021/bi8005219; Schramm AM, 2010, PROTEIN SCI, V19, P1235, DOI 10.1002/pro.402; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; Travers SAA, 2007, MOL BIOL EVOL, V24, P1032, DOI 10.1093/molbev/msm022; Tungtur S, 2011, PROTEINS, V79, P1589, DOI 10.1002/prot.22985; Venancio TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r33; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; West NP, 2000, INFECT IMMUN, V68, P4673, DOI 10.1128/IAI.68.8.4673-4680.2000; Xu YB, 2010, PROTEINS, V78, P548, DOI 10.1002/prot.22576; ZHOU DG, 1994, J BIOL CHEM, V269, P11162	63	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38114	10.1371/journal.pone.0038114	http://dx.doi.org/10.1371/journal.pone.0038114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685552	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700015
J	Panicker, SP; Ganguly, T; Consolo, M; Price, V; Mirmirani, P; Honda, K; Karnik, P				Panicker, Sreejith P.; Ganguly, Taneeta; Consolo, Mary; Price, Vera; Mirmirani, Paradi; Honda, Kord; Karnik, Pratima			Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTOR-3; LIVER-X-RECEPTORS; LIPID-METABOLISM; RHEUMATOID-ARTHRITIS; INTERFERON SIGNATURE; LICHEN-PLANOPILARIS; SCARRING ALOPECIA; NUCLEAR RECEPTORS; GENE-EXPRESSION	Primary cicatricial alopecia (PCA) is a group of inflammatory hair disorders that cause scarring and permanent hair loss. Previous studies have implicated PPAR gamma, a transcription factor that integrates lipogenic and inflammatory signals, in the pathogenesis of PCA. However, it is unknown what triggers the inflammatory response in these disorders, whether the inflammation is a primary or secondary event in disease pathogenesis, and whether the inflammatory reaction reflects an autoimmune process. In this paper, we show that the cholesterol biosynthetic pathway is impaired in the skin and hair follicles of PCA patients. Treatment of hair follicle cells with BM15766, a cholesterol biosynthesis inhibitor, or 7-dehydrocholesterol (7-DHC), a sterol precursor, stimulates the expression of pro-inflammatory chemokine genes. Painting of mouse skin with 7-DHC or BM15766 inhibits hair growth, causes follicular plugging and induces the infiltration of inflammatory cells into the interfollicular dermis. Our results demonstrate that cholesterologenic changes within hair follicle cells trigger an innate immune response that is associated with the induction of toll-like receptor (TLR) and interferon (IFN) gene expression, and the recruitment of macrophages that surround the hair follicles and initiate their destruction. These findings reveal a previously unsuspected role for cholesterol precursors in PCA pathogenesis and identify a novel link between sterols and inflammation that may prove transformative in the diagnosis and treatment of these disorders.	[Panicker, Sreejith P.; Ganguly, Taneeta; Consolo, Mary; Price, Vera; Mirmirani, Paradi; Honda, Kord; Karnik, Pratima] Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Dept Dermatol, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Panicker, SP (corresponding author), Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Dept Dermatol, Cleveland, OH 44106 USA.	psk11@case.edu		Consolo, Mary/0000-0002-9095-5913	National Institutes of Health (NIH) [R01 AR056245]; National Institute of Arthritis and Musculoskeletal and Skin (NIAMS) [P30 AR039750]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056245, P30AR039750] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the following grants: National Institutes of Health (NIH) R01 AR056245 to Dr. Karnik and P30 AR039750 from National Institute of Arthritis and Musculoskeletal and Skin (NIAMS) http://www.niams.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, Tanpakushitsu Kakusan Koso, V46, P562; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Baechler EC, 2007, MOL MED, V13, P59, DOI 10.2119/2006-00085.Baechler; Baker AD, 2010, BIOCHEM BIOPH RES CO, V393, P682, DOI 10.1016/j.bbrc.2010.02.056; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Cotsarelis G, 2001, TRENDS MOL MED, V7, P293, DOI 10.1016/S1471-4914(01)02027-5; Crow Mary K, 2010, Arthritis Res Ther, V12 Suppl 1, pS5, DOI 10.1186/ar2886; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; Evers BM, 2010, J INVEST DERMATOL, V130, P1237, DOI 10.1038/jid.2009.442; Fontaine C, 2007, CIRC RES, V101, P40, DOI 10.1161/CIRCRESAHA.106.135814; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Harii N, 2005, MOL ENDOCRINOL, V19, P1231, DOI 10.1210/me.2004-0100; Harries MJ, 2010, AM J PATHOL, V177, P2152, DOI 10.2353/ajpath.2010.100454; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Jiang YJ, 2010, J LIPID RES, V51, P3185, DOI 10.1194/jlr.M006445; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Lee WS, 2011, J DERMATOL SCI, V64, P153, DOI 10.1016/j.jdermsci.2011.08.004; Mavragani CP, 2010, J AUTOIMMUN, V35, P225, DOI 10.1016/j.jaut.2010.06.012; Miller Lloyd S, 2008, Adv Dermatol, V24, P71; Mirmirani P, 2005, J AM ACAD DERMATOL, V52, P637, DOI 10.1016/j.jaad.2004.07.069; Mirmirani P, 2009, ARCH DERMATOL, V145, P1363, DOI 10.1001/archdermatol.2009.283; Mobini N, 2005, J CUTAN PATHOL, V32, P675, DOI 10.1111/j.0303-6987.2005.00399.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Otberg Nina, 2008, Skinmed, V7, P19, DOI 10.1111/j.1540-9740.2007.07163.x; Pasolli HA, 2011, MICROSC MICROANAL, V17, P513, DOI 10.1017/S1431927611000419; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Price VH, 2006, SEMIN CUTAN MED SURG, V25, P56, DOI 10.1016/j.sder.2006.01.008; Prummel MF, 2003, THYROID, V13, P547, DOI 10.1089/105072503322238809; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; Stenn KS, 1999, ARCH DERMATOL, V135, P973, DOI 10.1001/archderm.135.8.973; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Stenn KS, 2010, J INVEST DERMATOL, V130, P1205, DOI 10.1038/jid.2010.52; Thurlings RM, 2010, ARTHRITIS RHEUM-US, V62, P3607, DOI 10.1002/art.27702; Tiede S, 2007, EUR J CELL BIOL, V86, P355, DOI 10.1016/j.ejcb.2007.03.006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uematsu Satoshi, 2008, V183, P1; Valledor AF, 2005, IMMUNOBIOLOGY, V210, P127, DOI 10.1016/j.imbio.2005.05.007; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014	47	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38449	10.1371/journal.pone.0038449	http://dx.doi.org/10.1371/journal.pone.0038449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685570	gold, Green Published			2022-12-27	WOS:000305351700033
J	Tollis, M; Ausubel, G; Ghimire, D; Boissinot, S				Tollis, Marc; Ausubel, Gavriel; Ghimire, Dhruba; Boissinot, Stephane			Multi-Locus Phylogeographic and Population Genetic Analysis of Anolis carolinensis: Historical Demography of a Genomic Model Species	PLOS ONE			English	Article							ADAPTIVE RADIATION; BAYESIAN-INFERENCE; STATISTICAL-METHOD; LIZARD; SPECIATION; SOFTWARE; FRAGMENTATION; DIVERGENCE; EXPANSION; CLUSTERS	The green anole (Anolis carolinensis) has been widely used as an animal model in physiology and neurobiology but has recently emerged as an important genomic model. The recent sequencing of its genome has shed new light on the evolution of vertebrate genomes and on the process that govern species diversification. Surprisingly, the patterns of genetic diversity within natural populations of this widespread and abundant North American lizard remain relatively unknown. In the present study, we use 10 novel nuclear DNA sequence loci (N = 62 to 152) and one mitochondrial locus (N = 226) to delimit green anole populations and infer their historical demography. We uncovered four evolutionarily distinct and geographically restricted lineages of green anoles using phylogenetics, Bayesian clustering, and genetic distance methods. Molecular dating indicates that these lineages last shared a common ancestor similar to 2 million years ago. Summary statistics and analysis of the frequency distributions of DNA polymorphisms strongly suggest range-wide expansions in population size. Using Bayesian Skyline Plots, we inferred the timing of population size expansions, which differ across lineages, and found evidence for a relatively recent and rapid westward expansion of green anoles across the Gulf Coastal Plain during the mid-Pleistocene. One surprising result is that the distribution of genetic diversity is not consistent with a latitudinal shift caused by climatic oscillations as is observed for many co-distributed taxa. This suggests that the most recent Pleistocene glacial cycles had a limited impact on the geographic distribution of the green anole at the northern limits of its range.	[Tollis, Marc; Ausubel, Gavriel; Ghimire, Dhruba; Boissinot, Stephane] CUNY, Queens Coll, Dept Biol, Flushing, NY USA; [Tollis, Marc; Boissinot, Stephane] CUNY, Grad Ctr, Biol Program Ecol Evolutionary Biol & Behav, New York, NY 10021 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System	Tollis, M (corresponding author), CUNY, Queens Coll, Dept Biol, Flushing, NY USA.	stephane.boissinot@qc.cuny.edu	Tollis, Marc/AAX-2332-2020	Tollis, Marc/0000-0002-1917-2473; Boissinot, Stephane/0000-0002-8760-1284	PSC-CUNY [61542-00-39]; NIH [R15GM096267-01]; CUNY; American Museum of Natural History; City University of New York High Performance Computing Center under NSF [CNS-0855217, CNS-0958379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM096267] Funding Source: NIH RePORTER	PSC-CUNY; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CUNY; American Museum of Natural History; City University of New York High Performance Computing Center under NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by PSC-CUNY grant 61542-00-39 and NIH grant R15GM096267-01 awarded to Stephane Boissinot. Funding for fieldwork was provided by a Doctoral Student Research Grant from CUNY and a Theodore Roosevelt Memorial Grant from the American Museum of Natural History awarded to Marc Tollis. Analyses were conducted in part with a grant of computer time by the City University of New York High Performance Computing Center under NSF grants CNS-0855217 and CNS-0958379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avise JC, 2000, PHYLOGEOGRAPHY HIST, Vviii, P447; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Church SA, 2003, EVOLUTION, V57, P372; Conant R, 1998, FIELD GUIDE REPTILES, Vxviii; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DRUMMOND AJ, 2010, GENEIOUS V5 5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2011, CONSERVATION GENETIC; Eckalbar WL, 2012, DEV BIOL, V363, P308, DOI 10.1016/j.ydbio.2011.11.021; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Fu YX, 1997, GENETICS, V147, P915; Fujita MK, 2011, GENOME BIOL EVOL, V3, P974, DOI 10.1093/gbe/evr072; Glor RE, 2005, MOL ECOL, V14, P2419, DOI 10.1111/j.1365-294X.2005.02550.x; Glor RE, 2004, P ROY SOC B-BIOL SCI, V271, P2257, DOI 10.1098/rspb.2004.2819; Gratz R, 1972, THESIS U NOTRE DAME; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Holman J.A., 1995, PLEISTOCENE AMPHIBIA; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Janes DE, 2010, ANNU REV GENOM HUM G, V11, P239, DOI 10.1146/annurev-genom-082509-141646; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li CH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-90; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Losos JB, 2009, LIZARDS EVOLUTIONARY, Vxx; Lovern MB, 2004, ILAR J, V45, P54, DOI 10.1093/ilar.45.1.54; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Orozco-terWengel P, 2011, MOL ECOL, V20, P1108, DOI 10.1111/j.1365-294X.2010.04990.x; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2001, TRACER V1 4 MOL EVOL; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider CJ, 2008, INTEGR COMP BIOL, V48, P520, DOI 10.1093/icb/icn082; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smit A, 1996, REPEATMASKER OPEN 30; Sokal RR, 1995, BIOMETRY PRINCIPLES, pXIX; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; VANCE T, 1991, Bulletin of the Maryland Herpetological Society, V27, P43; WADE JK, 1983, COPEIA, P523; Walker D, 1998, ANNU REV ECOL SYST, V29, P23, DOI 10.1146/annurev.ecolsys.29.1.23; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Wood DA, 2011, MOL ECOL, V20, P3856, DOI 10.1111/j.1365-294X.2011.05211.x; Zamudio KR, 2003, EVOLUTION, V57, P1631	61	37	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38474	10.1371/journal.pone.0038474	http://dx.doi.org/10.1371/journal.pone.0038474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685573	Green Published, gold			2022-12-27	WOS:000305351700036
J	Matsuyoshi, D; Ikeda, T; Sawamoto, N; Kakigi, R; Fukuyama, H; Osaka, N				Matsuyoshi, Daisuke; Ikeda, Takashi; Sawamoto, Nobukatsu; Kakigi, Ryusuke; Fukuyama, Hidenao; Osaka, Naoyuki			Differential Roles for Parietal and Occipital Cortices in Visual Working Memory	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREDICTS INDIVIDUAL-DIFFERENCES; NEURAL MECHANISMS; PREFRONTAL CORTEX; INTRAPARIETAL SULCUS; OBJECT IDENTITY; ATTENTION; CAPACITY; INFORMATION; BRAIN	Visual working memory (VWM) is known as a highly capacity-limited cognitive system that can hold 3-4 items. Recent studies have demonstrated that activity in the intraparietal sulcus (IPS) and occipital cortices correlates with the number of representations held in VWM. However, differences among those regions are poorly understood, particularly when task-irrelevant items are to be ignored. The present fMRI-based study investigated whether memory load-sensitive regions such as the IPS and occipital cortices respond differently to task-relevant information. Using a change detection task in which participants are required to remember pre-specified targets, here we show that while the IPS exhibited comparable responses to both targets and distractors, the dorsal occipital cortex manifested significantly weaker responses to an array containing distractors than to an array containing only targets, despite that the number of objects presented was the same for the two arrays. These results suggest that parietal and occipital cortices engage differently in distractor processing and that the dorsal occipital, rather than parietal, activity appears to reflect output of stimulus filtering and selection based on behavioral relevance.	[Matsuyoshi, Daisuke; Ikeda, Takashi; Osaka, Naoyuki] Kyoto Univ, Dept Psychol, Grad Sch Letters, Sakyo Ku, Kyoto, Japan; [Matsuyoshi, Daisuke; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan; [Matsuyoshi, Daisuke; Ikeda, Takashi] Osaka Univ, Dept Psychol, Grad Sch Human Sci, Suita, Osaka, Japan; [Sawamoto, Nobukatsu; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Sakyo Ku, Kyoto, Japan; [Kakigi, Ryusuke] Grad Univ Adv Studies, Dept Physiol Sci, Hayama, Kanagawa, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Osaka University; Kyoto University; Graduate University for Advanced Studies - Japan	Matsuyoshi, D (corresponding author), Kyoto Univ, Dept Psychol, Grad Sch Letters, Sakyo Ku, Kyoto, Japan.	matsuyoshi@hus.osaka-u.ac.jp	Fukuyama, Hidenao/AAI-7118-2020; Sawamoto, Nobukatsu/W-2220-2019	Sawamoto, Nobukatsu/0000-0001-8695-0223	Osaka University Global Center of Excellence Program (Center of Human-friendly Robotics Based on Cognitive Neuroscience), Ministry of Education, Culture, Sports and Technology of Japan; Kyoto University Global Center of Excellence Program (Revitalizing Education for Dynamic Hearts and Minds), Ministry of Education, Culture, Sports and Technology of Japan; Hoso Bunka Foundation; Japan Society for the Promotion of Science [23700315, 22220003]; Grants-in-Aid for Scientific Research [23700315] Funding Source: KAKEN	Osaka University Global Center of Excellence Program (Center of Human-friendly Robotics Based on Cognitive Neuroscience), Ministry of Education, Culture, Sports and Technology of Japan; Kyoto University Global Center of Excellence Program (Revitalizing Education for Dynamic Hearts and Minds), Ministry of Education, Culture, Sports and Technology of Japan; Hoso Bunka Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by grants from the Osaka University Global Center of Excellence Program (Center of Human-friendly Robotics Based on Cognitive Neuroscience), Ministry of Education, Culture, Sports and Technology of Japan to DM http://www.gcoe-cnr.osaka-u.ac.jp/; the Kyoto University Global Center of Excellence Program (Revitalizing Education for Dynamic Hearts and Minds), Ministry of Education, Culture, Sports and Technology of Japan to DM and NO. http://www.educ.kyoto-u.ac.jp/gcoe/; Hoso Bunka Foundation Assistance Grants to DM. http://www.hbf.or.jp/; and Grant-in-aid for Scientific Research #23700315 to DM and #22220003 to NO from the Japan Society for the Promotion of Science http://www.jsps.go.jp/. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Bettencourt KC, 2011, J VISION, V11, DOI 10.1167/11.10.22; Caplovitz GP, 2007, CEREB CORTEX, V17, P1179, DOI 10.1093/cercor/bhl029; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2011, NEUROPSYCHOLOGIA, V49, P1401, DOI 10.1016/j.neuropsychologia.2011.01.035; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Cusack R, 2010, J COGNITIVE NEUROSCI, V22, P32, DOI 10.1162/jocn.2009.21194; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Fougnie D, 2006, PSYCHOL SCI, V17, P526, DOI 10.1111/j.1467-9280.2006.01739.x; Friedman-Hill SR, 2003, P NATL ACAD SCI USA, V100, P4263, DOI 10.1073/pnas.0730772100; Gao ZF, 2011, BRAIN RES, V1406, P30, DOI 10.1016/j.brainres.2011.06.049; Gloor P, 1975, Adv Neurol, V8, P59; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Harrison A, 2010, CEREB CORTEX, V20, P2478, DOI 10.1093/cercor/bhp314; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Lauritzen TZ, 2009, J VISION, V9, DOI 10.1167/9.13.18; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Majerus S, 2007, NEUROIMAGE, V35, P353, DOI 10.1016/j.neuroimage.2006.12.008; Matsuyoshi D, 2010, NEUROPSYCHOLOGIA, V48, P3094, DOI 10.1016/j.neuropsychologia.2010.06.021; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Miller EK, 1996, J NEUROSCI, V16, P5154; Mitchell DJ, 2008, CEREB CORTEX, V18, P1788, DOI 10.1093/cercor/bhm205; Olson IR, 2008, MEM COGNITION, V36, P1360, DOI 10.3758/MC.36.7.1360; Ploner CJ, 2001, EUR J NEUROSCI, V13, P357, DOI 10.1046/j.1460-9568.2001.01397.x; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Robitaille N, 2010, NEUROIMAGE, V53, P1334, DOI 10.1016/j.neuroimage.2010.07.027; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Schira MM, 2004, J NEUROPHYSIOL, V91, P1716, DOI 10.1152/jn.00380.2003; Scholte HS, 2006, BRAIN RES, V1076, P106, DOI 10.1016/j.brainres.2005.10.051; Talairach J., 1988, COPLANAR STEREOTAXIC; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; Vandenberghe R, 2005, BRAIN, V128, P2843, DOI 10.1093/brain/awh522; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Xu YD, 2007, P NATL ACAD SCI USA, V104, P18766, DOI 10.1073/pnas.0705618104; Xu YD, 2010, J NEUROSCI, V30, P14020, DOI 10.1523/JNEUROSCI.3011-10.2010; Xu YD, 2009, J COGNITIVE NEUROSCI, V21, P511, DOI 10.1162/jocn.2008.21024; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	54	6	6	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38623	10.1371/journal.pone.0038623	http://dx.doi.org/10.1371/journal.pone.0038623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679514	Green Published, gold			2022-12-27	WOS:000305343900062
J	Tello, JA; Newton, CL; Bouligand, J; Guiochon-Mantel, A; Millar, RP; Young, J				Tello, Javier A.; Newton, Claire L.; Bouligand, Jerome; Guiochon-Mantel, Anne; Millar, Robert P.; Young, Jacques			Congenital Hypogonadotropic Hypogonadism Due to GNRH Receptor Mutations in Three Brothers Reveal Sites Affecting Conformation and Coupling	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; GENE; ACTIVATION; BINDING; RESISTANCE; AGONIST; DEFICIENCY; RHODOPSIN; PROTEINS; ETIOLOGY	Congenital hypogonadotropic hypogonadism (CHH) is characterized by low gonadotropins and failure to progress normally through puberty. Mutations in the gene encoding the GnRH receptor (GNRHR1) result in CHH when present as compound heterozygous or homozygous inactivating mutations. This study identifies and characterizes the properties of two novel GNRHR1 mutations in a family in which three brothers display normosmic CHH while their sister was unaffected. Molecular analysis in the proband and the affected brothers revealed two novel non-synonymous missense GNRHR1 mutations, present in a compound heterozygous state, whereas their unaffected parents possessed only one inactivating mutation, demonstrating the autosomal recessive transmission in this kindred and excluding X-linked inheritance equivocally suggested by the initial pedigree analysis. The first mutation at c.845 C>G introduces an Arg substitution for the conserved Pro 282 in transmembrane domain (TMD) 6. The Pro282Arg mutant is unable to bind radiolabeled GnRH analogue. As this conserved residue is important in receptor conformation, it is likely that the mutation perturbs the binding pocket and affects trafficking to the cell surface. The second mutation at c.968 A>G introduces a Cys substitution for Tyr 323 in the functionally crucial N/DPxxY motif in TMD 7. The Tyr323Cys mutant has an increased GnRH binding affinity but reduced receptor expression at the plasma membrane and impaired G protein-coupling. Inositol phosphate accumulation assays demonstrated absent and impaired G alpha(q/11) signal transduction by Pro282Arg and Tyr323Cys mutants, respectively. Pretreatment with the membrane permeant GnRHR antagonist NBI-42902, which rescues cell surface expression of many GNRHR1 mutants, significantly increased the levels of radioligand binding and intracellular signaling of the Tyr323Cys mutant but not Pro282Arg. Immunocytochemistry confirmed that both mutants are present on the cell membrane albeit at low levels. Together these molecular deficiencies of the two novel GNRHR1 mutations lead to the CHH phenotype when present as a compound heterozygote.	[Tello, Javier A.; Newton, Claire L.; Millar, Robert P.] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Newton, Claire L.; Millar, Robert P.] Univ Cape Town, MRC, Receptor Biol Unit, ZA-7925 Cape Town, South Africa; [Bouligand, Jerome; Guiochon-Mantel, Anne; Young, Jacques] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Bouligand, Jerome; Guiochon-Mantel, Anne; Young, Jacques] INSERM, U693, IFR93, F-94275 Le Kremlin Bicetre, France; [Bouligand, Jerome; Guiochon-Mantel, Anne] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Millar, Robert P.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Young, Jacques] Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	University of Edinburgh; University of Cape Town; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Pretoria	Tello, JA (corresponding author), Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	robertpetermillar@gmail.com; jacques.young@bct.aphp.fr	Newton, Claire L/B-7114-2011; Newton, Claire/R-1783-2019; Guiochon-Mantel, Anne S/S-8408-2018; Tello, Javier Ananda A/B-3203-2012; Young, Jacques/T-2976-2018; Young, Jacques/N-5251-2019; BOULIGAND, Jérôme/S-5716-2018; Newton, Claire/AAC-4663-2019	Newton, Claire L/0000-0001-6050-556X; Newton, Claire/0000-0001-6050-556X; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Tello, Javier Ananda A/0000-0001-6637-2155; Young, Jacques/0000-0001-9286-5631; Young, Jacques/0000-0001-9286-5631; Millar, Robert P/0000-0003-3606-2708	Medical Research Council, UK; Universite Paris-Sud (Bonus Qualite Recherche); Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de la Recherche Genopath (ANR KALGENOPATH); Fondation pour la Recherche Medicale (FRM); Programme Hospitalier de Recherche Clinique (PHRC)	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Universite Paris-Sud (Bonus Qualite Recherche); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche Genopath (ANR KALGENOPATH)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Programme Hospitalier de Recherche Clinique (PHRC)	The work was supported by the Medical Research Council, UK and by institutional grants from Universite Paris-Sud (Bonus Qualite Recherche), Institut National de la Sante et de la Recherche Medicale (INSERM), Agence Nationale de la Recherche Genopath (ANR KALGENOPATH), Fondation pour la Recherche Medicale (FRM), Programme Hospitalier de Recherche Clinique (PHRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelli A, 2006, EUR J ENDOCRINOL, V155, P201, DOI 10.1530/eje.1.02198; Arora KK, 1996, MOL ENDOCRINOL, V10, P979, DOI 10.1210/me.10.8.979; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Ballesteros JA, 1995, METHODS NEUROSCIENCE, DOI [10.1016/S1043-9471(05, DOI 10.1016/S1043-9471(05]; Bedecarrats GY, 2003, MOL CELL ENDOCRINOL, V205, P51, DOI 10.1016/S0303-7207(03)00201-6; Beranova M, 2001, J CLIN ENDOCR METAB, V86, P1580, DOI 10.1210/jc.86.4.1580; Bhattacharya S, 2008, J MOL BIOL, V382, P539, DOI 10.1016/j.jmb.2008.06.084; Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; Bouvattier C, 2012, NAT REV ENDOCRINOL, V8, P172, DOI 10.1038/nrendo.2011.164; Brioude F, 2010, EUR J ENDOCRINOL, V162, P835, DOI 10.1530/EJE-10-0083; Caron P, 1999, J CLIN ENDOCR METAB, V84, P990, DOI 10.1210/jc.84.3.990; Chengalvala M, 1999, J BIOCHEM BIOPH METH, V38, P163, DOI 10.1016/S0165-022X(98)00046-3; Chevrier L, 2011, MOL CELL ENDOCRINOL, V346, P21, DOI 10.1016/j.mce.2011.04.018; Costa EMF, 2001, J CLIN ENDOCR METAB, V86, P2680, DOI 10.1210/jc.86.6.2680; De Roux N, 1999, J CLIN ENDOCR METAB, V84, P567, DOI 10.1210/jc.84.2.567; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Francou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025614; Herbison AE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1415; Hovelmann S, 2002, BIOCHEMISTRY-US, V41, P1129, DOI 10.1021/bi0113162; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Janovick JA, 2010, P NATL ACAD SCI USA, V107, P4454, DOI 10.1073/pnas.0914261107; Karges B, 2003, J CLIN ENDOCR METAB, V88, P1873, DOI 10.1210/jc.2002-020005; Kottler ML, 2000, J CLIN ENDOCR METAB, V85, P3002, DOI 10.1210/jc.85.9.3002; Kottler ML, 1999, ARCH MED RES, V30, P481, DOI 10.1016/S0188-4409(99)00072-7; Layman LC, 1998, NAT GENET, V18, P14, DOI 10.1038/ng0198-14; Layman LC, 2001, FERTIL STERIL, V75, P1148, DOI 10.1016/S0015-0282(01)01782-4; Leanos-Miranda A, 2002, J CLIN ENDOCR METAB, V87, P4825, DOI 10.1210/jc.2002-020961; Lu ZL, 2007, J BIOL CHEM, V282, P17921, DOI 10.1074/jbc.M610413200; Lu ZL, 2005, J BIOL CHEM, V280, P29796, DOI 10.1074/jbc.M413520200; Maya-Nunez G, 2002, J CLIN ENDOCR METAB, V87, P2144, DOI 10.1210/jc.87.5.2144; Meysing AU, 2004, J CLIN ENDOCR METAB, V89, P3189, DOI 10.1210/jc.2003-031808; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Morgan K, 2006, ENDOCRINOLOGY, V147, P5041, DOI 10.1210/en.2006-0222; Oliveira L, 1999, PROTEIN ENG, V12, P1087, DOI 10.1093/protein/12.12.1087; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pralong FP, 1999, J CLIN ENDOCR METAB, V84, P3811, DOI 10.1210/jc.84.10.3811; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Salenave S, 2008, J CLIN ENDOCR METAB, V93, P758, DOI 10.1210/jc.2007-1168; Sarfati J, 2010, J CLIN ENDOCR METAB, V95, P659, DOI 10.1210/jc.2009-0843; Silveira LFG, 2002, J CLIN ENDOCR METAB, V87, P2973, DOI 10.1210/jc.87.6.2973; Soderlund D, 2001, CLIN ENDOCRINOL, V54, P493, DOI 10.1046/j.1365-2265.2001.01211.x; Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107; Tabarin A, 2000, J CLIN INVEST, V105, P321, DOI 10.1172/JCI7212; Topaloglu AK, 2006, NEUROENDOCRINOLOGY, V84, P301, DOI 10.1159/000098147; Trabado S, 2011, FERTIL STERIL, V95, P2324, DOI 10.1016/j.fertnstert.2011.03.091; Vagenakis GA, 2005, FERTIL STERIL, V84, P1762, DOI 10.1016/j.fertnstert.2005.06.031; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600	48	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38456	10.1371/journal.pone.0038456	http://dx.doi.org/10.1371/journal.pone.0038456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679506	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900044
J	James, MA; Wen, WD; Wang, YA; Byers, LA; Heymach, JV; Coombes, KR; Girard, L; Minna, J; You, M				James, Michael A.; Wen, Weidong; Wang, Yian; Byers, Lauren A.; Heymach, John V.; Coombes, Kevin R.; Girard, Luc; Minna, John; You, Ming			Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus	PLOS ONE			English	Article							CELL-DEATH; SUSCEPTIBILITY; BCL-X(L); EXPRESSION; APOPTOSIS; VARIANTS; INHIBITOR; CARCINOMA; ASSOCIATE; FAMILY	Cleft Lip and Palate Transmembrane Protein 1-Like (CLPTM1L), resides in a region of chromosome 5 for which copy number gain has been found to be the most frequent genetic event in the early stages of non-small cell lung cancer (NSCLC). This locus has been found by multiple genome wide association studies to be associated with lung cancer in both smokers and non-smokers. CLPTM1L has been identified as an overexpressed protein in human ovarian tumor cell lines that are resistant to cisplatin, which is the only insight thus far into the function of CLPTM1L. Here we find CLPTM1L expression to be increased in lung adenocarcinomas compared to matched normal lung tissues and in lung tumor cell lines by mechanisms not exclusive to copy number gain. Upon loss of CLPTM1L accumulation in lung tumor cells, cisplatin and camptothecin induced apoptosis were increased in direct proportion to the level of CLPTM1L knockdown. Bcl-xL accumulation was significantly decreased upon loss of CLPTM1L. Expression of exogenous Bcl-xL abolished sensitization to apoptotic killing with CLPTM1L knockdown. These results demonstrate that CLPTM1L, an overexpressed protein in lung tumor cells, protects from genotoxic stress induced apoptosis through regulation of Bcl-xL. Thus, this study implicates anti-apoptotic CLPTM1L function as a potential mechanism of susceptibility to lung tumorigenesis and resistance to chemotherapy.	[James, Michael A.; You, Ming] Med Coll Wisconsin, Dept Pharmacol & Toxicol, MCW Canc Ctr, Milwaukee, WI 53226 USA; [Wen, Weidong; Wang, Yian] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Byers, Lauren A.; Heymach, John V.; Coombes, Kevin R.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Girard, Luc; Minna, John] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Simmons Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	Medical College of Wisconsin; Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	James, MA (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, MCW Canc Ctr, Milwaukee, WI 53226 USA.	myou@mcw.edu	Heymach, John/AAG-2361-2019; James, Michael/L-7772-2019	Heymach, John/0000-0001-9068-8942; James, Michael/0000-0002-8112-1108; Coombes, Kevin/0000-0002-7630-2123	NCI Cancer Center [P30 CA91842]; Human Protein Atlas project; NCI [U19CA148127]; Knut and Alice Wallenberg Foundation; NATIONAL CANCER INSTITUTE [P50CA070907, P30CA091842, U19CA148127] Funding Source: NIH RePORTER	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Human Protein Atlas project; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by an NCI Cancer Center Support Grant #P30 CA91842, the Human Protein Atlas project, and NCI U19CA148127 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Julie DiMitry for assistance with flow cytometry experiments as well as Peter Vedell and Pengyuan Liu for advice on statistical methods. We would like to thank Haris Vikis and Jay Tichelaar for their discussion and comments on the manuscript. We thank the Tissue Procurement Core at Washington University and the Siteman Cancer Center for providing patient RNA and DNA samples, and the Human Protein Atlas project, funded by the Knut and Alice Wallenberg Foundation, for compiling protein expression profiles and annotated IHC images.	Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; Folgueira MAAK, 2005, CLIN CANCER RES, V11, P7434; Hajji N, 2008, ONCOGENE, V27, P3134, DOI 10.1038/sj.onc.1210976; Ikuta K, 2005, ONCOL REP, V13, P1229; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Jourdain A, 2009, INT J BIOCHEM CELL B, V41, P1884, DOI 10.1016/j.biocel.2009.05.001; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Karczmarek-Borowska B, 2006, LUNG CANCER, V51, P61, DOI 10.1016/j.lungcan.2005.08.010; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; Lei XY, 2007, ACTA BIOCH BIOPH SIN, V39, P344, DOI 10.1111/j.1745-7270.2007.00286.x; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; MIRABELLO L, 2010, HUM MUTAT; Morais C, 2010, APOPTOSIS, V15, P412, DOI 10.1007/s10495-009-0414-y; Pande M, 2011, CARCINOGENESIS, V32, P1493, DOI 10.1093/carcin/bgr136; Pooley KA, 2010, CANC EPIDEMIOL BIOMA; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; SCHOTT AF, 1995, ONCOGENE, V11, P1389; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Taylor JK, 1999, ONCOGENE, V18, P4495, DOI 10.1038/sj.onc.1202836; Turnbull C, 2010, NAT GENET; Varin E, 2010, CARCINOGENESIS, V31, P984, DOI 10.1093/carcin/bgq026; Vazquez-Mena O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032667; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yoshiura K, 1998, GENOMICS, V54, P231, DOI 10.1006/geno.1998.5577; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	30	77	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36116	10.1371/journal.pone.0036116	http://dx.doi.org/10.1371/journal.pone.0036116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675468	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700004
J	Singh, M; Singh, P; Gaudray, G; Musumeci, L; Thielen, C; Vaira, D; Vandergeeten, C; Delacroix, L; Van Gulck, E; Vanham, G; de Leval, L; Rahmouni, S; Moutschen, M				Singh, Maneesh; Singh, Pratibha; Gaudray, Gilles; Musumeci, Lucia; Thielen, Caroline; Vaira, Dolores; Vandergeeten, Claire; Delacroix, Laurence; Van Gulck, Ellen; Vanham, Guido; de Leval, Laurence; Rahmouni, Souad; Moutschen, Michel			An Improved Protocol for Efficient Engraftment in NOD/LTSZ-SCIDIL-2R gamma(NULL) Mice Allows HIV Replication and Development of Anti-HIV Immune Responses	PLOS ONE			English	Article							SCID IL2R-GAMMA(NULL) MICE; HUMANIZED MICE; T-CELLS; INFECTION; EXPRESSION; MOUSE; TRANSMISSION; LYMPHOCYTES; DEPLETION	Cord blood hematopoietic progenitor cells (CB-HPCs) transplanted immunodeficient NOD/LtsZ-scidIL2R gamma(null) (NSG) and NOD/SCID/IL2R gamma(null) (NOG) mice need efficient human cell engraftment for long-term HIV-1 replication studies. Total body irradiation (TBI) is a classical myeloablation regimen used to improve engraftment levels of human cells in these humanized mice. Some recent reports suggest the use of busulfan as a myeloablation regimen to transplant HPCs in neonatal and adult NSG mice. In the present study, we further ameliorated the busulfan myeloablation regimen with fresh CB-CD34+cell transplantation in 3-4 week old NSG mice. In this CB-CD34+transplanted NSG mice engraftment efficiency of human CD45+cell is over 90% in peripheral blood. Optimal engraftment promoted early and increased CD3+T cell levels, with better lymphoid tissue development and prolonged human cell chimerism over 300 days. These humanized NSG mice have shown long-lasting viremia after HIV-1JRCSF and HIV-1Bal inoculation through intravenous and rectal routes. We also saw a gradual decline of the CD4+T cell count, widespread immune activation, up-regulation of inflammation marker and microbial translocation after HIV-1 infection. Humanized NSG mice reconstituted according to our new protocol produced, moderate cellular and humoral immune responses to HIV-1 postinfection. We believe that NSG mice reconstituted according to our easy to use protocol will provide a better in vivo model for HIV-1 replication and anti-HIV-1 therapy trials.	[Singh, Maneesh; Singh, Pratibha; Gaudray, Gilles; Musumeci, Lucia; Vandergeeten, Claire; Delacroix, Laurence; Rahmouni, Souad; Moutschen, Michel] Univ Liege, Immunol & Infect Dis Unit GIGA I3, Liege, Belgium; [Thielen, Caroline; de Leval, Laurence] Univ Liege, Expt Pathol Unit GIGA Canc, Liege, Belgium; [Vaira, Dolores] Univ Liege, Liege AIDS Reference Ctr, Liege, Belgium; [Van Gulck, Ellen; Vanham, Guido] Univ Antwerp, Inst Trop Med, Virol Unit, Antwerp, Belgium	University of Liege; University of Liege; University of Liege; Institute of Tropical Medicine (ITM); University of Antwerp	Singh, M (corresponding author), Univ Liege, Immunol & Infect Dis Unit GIGA I3, Liege, Belgium.	michel.moutschen@ulg.ac.be	de Leval, Laurence/M-4889-2017; Singh, Pratibha/AAI-6066-2020; Singh, Pratibha/AAD-5680-2020	de Leval, Laurence/0000-0003-3994-516X; Singh, Pratibha/0000-0002-6919-8479; Moutschen, Michel/0000-0002-6405-1785; Delacroix, Laurence/0000-0003-3440-5359	Interuniversity Attraction Poles; Belgian National Fund for Scientific Research (FRS-FNRS); University of Liege	Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Belgian National Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege)	This work was supported by grants from The Interuniversity Attraction Poles, The Belgian National Fund for Scientific Research (FRS-FNRS) and The University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKINA RK, 1994, BLOOD, V84, P1393; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Choi B, 2011, J CLIN IMMUNOL, V31, P253, DOI 10.1007/s10875-010-9478-2; Choi B, 2011, CLIN IMMUNOL, V139, P321, DOI 10.1016/j.clim.2011.02.019; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; De Boer F, 1998, BONE MARROW TRANSPL, V22, P1103, DOI 10.1038/sj.bmt.1701495; Douek Daniel, 2007, Top HIV Med, V15, P114; FRANSEN K, 1994, MOL CELL PROBE, V8, P317, DOI 10.1006/mcpr.1994.1043; FRASER CC, 1995, BLOOD, V86, P1680, DOI 10.1182/blood.V86.5.1680.bloodjournal8651680; Hayakawa J, 2009, STEM CELLS, V27, P175, DOI 10.1634/stemcells.2008-0583; Hofer U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000867; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kim M, 2011, J CLIN IMMUNOL, V31, P699, DOI 10.1007/s10875-011-9538-2; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Long BR, 2012, J VIROL; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; Marodon G, 2009, EUR J IMMUNOL, V39, P2136, DOI 10.1002/eji.200939480; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; MOSS GB, 1995, J INFECT DIS, V172, P1469, DOI 10.1093/infdis/172.6.1469; Mota J, 2009, J VIROL, V83, P8638, DOI 10.1128/JVI.00581-09; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pflumio F, 1996, BLOOD, V88, P3731, DOI 10.1182/blood.V88.10.3731.bloodjournal88103731; PIWOWAR EM, 1995, CLIN DIAGN LAB IMMUN, V2, P236, DOI 10.1128/CDLI.2.2.236-237.1995; Schmidt MR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003192; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Sparrow RL, 2006, BONE MARROW TRANSPL, V38, P61, DOI 10.1038/sj.bmt.1705405; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050	35	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38491	10.1371/journal.pone.0038491	http://dx.doi.org/10.1371/journal.pone.0038491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675567	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700079
J	Hewitt, KM; Gerba, CP; Maxwell, SL; Kelley, ST				Hewitt, Krissi M.; Gerba, Charles P.; Maxwell, Sheri L.; Kelley, Scott T.			Office Space Bacterial Abundance and Diversity in Three Metropolitan Areas	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; MICROBIAL DIVERSITY; INDOOR ENVIRONMENT; DUST; AIR; BIOSPHERE; EVOLUTION; PATHOGENS; SEQUENCES; COMMUNITY	People in developed countries spend approximately 90% of their lives indoors, yet we know little about the source and diversity of microbes in built environments. In this study, we combined culture-based cell counting and multiplexed pyrosequencing of environmental ribosomal RNA (rRNA) gene sequences to investigate office space bacterial diversity in three metropolitan areas. Five surfaces common to all offices were sampled using sterile double-tipped swabs, one tip for culturing and one for DNA extraction, in 30 different offices per city (90 offices, 450 total samples). 16S rRNA gene sequences were PCR amplified using bar-coded "universal" bacterial primers from 54 of the surfaces (18 per city) and pooled for pyrosequencing. A three-factorial Analysis of Variance (ANOVA) found significant differences in viable bacterial abundance between offices inhabited by men or women, among the various surface types, and among cities. Multiplex pyrosequencing identified more than 500 bacterial genera from 20 different bacterial divisions. The most abundant of these genera tended to be common inhabitants of human skin, nasal, oral or intestinal cavities. Other commonly occurring genera appeared to have environmental origins (e. g., soils). There were no significant differences in the bacterial diversity between offices inhabited by men or women or among surfaces, but the bacterial community diversity of the Tucson samples was clearly distinguishable from that of New York and San Francisco, which were indistinguishable. Overall, our comprehensive molecular analysis of office building microbial diversity shows the potential of these methods for studying patterns and origins of indoor bacterial contamination. "[H]umans move through a sea of microbial life that is seldom perceived except in the context of potential disease and decay." - Feazel et al. (2009).	[Hewitt, Krissi M.; Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Gerba, Charles P.; Maxwell, Sheri L.] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ USA	California State University System; San Diego State University; University of Arizona	Hewitt, KM (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	skelley@sciences.sdsu.edu			San Diego State University; Clorox Corporation; Alfred P. Sloan Foundation	San Diego State University; Clorox Corporation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This research was funded by grants from San Diego State University, the Clorox Corporation and the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MOL ECOL, V4, P543, DOI 10.1111/j.1365-294X.1995.tb00255.x; Andersson AM, 1999, J APPL MICROBIOL, V86, P622, DOI 10.1046/j.1365-2672.1999.00706.x; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Benson CA, 2011, FEMS MICROBIOL ECOL, V76, P74, DOI 10.1111/j.1574-6941.2011.01047.x; BIRDSELL DC, 1967, J BACTERIOL, V93, P427, DOI 10.1128/JB.93.1.427-437.1967; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Caporaso J.G., 2010, NAT METHODS; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CUSTOVIC A, 1994, CLIN EXP ALLERGY, V24, P1164, DOI 10.1111/j.1365-2222.1994.tb03323.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; GOLDBERG I, 1976, BIOTECHNOL BIOENG, V18, P1657, DOI 10.1002/bit.260181202; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kampfer P, 1999, INT J SYST BACTERIOL, V49, P681, DOI 10.1099/00207713-49-2-681; Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004; Lee L, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-27; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu LJS, 2000, J AIR WASTE MANAGE, V50, P1957, DOI 10.1080/10473289.2000.10464225; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Macher JM, 2001, INDOOR AIR, V11, P134, DOI 10.1034/j.1600-0668.2001.110208.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; McManus CJ, 2005, J APPL MICROBIOL, V99, P502, DOI 10.1111/j.1365-2672.2005.02651.x; Osman S, 2008, ISME J, V2, P482, DOI 10.1038/ismej.2008.11; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PACE NR, 1985, ASM NEWS, V51, P4; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Tsai FC, 2005, INDOOR AIR, V15, P71, DOI 10.1111/j.1600-0668.2005.00346.x; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; VEHKALAHTI MM, 1988, J DENT RES, V67, P911, DOI 10.1177/00220345880670060401; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	44	96	98	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37849	10.1371/journal.pone.0037849	http://dx.doi.org/10.1371/journal.pone.0037849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666400	gold, Green Published			2022-12-27	WOS:000305353400053
J	Roche, DB; Buenavista, MT; McGuffin, LJ				Roche, Daniel B.; Buenavista, Maria T.; McGuffin, Liam J.			FunFOLDQA: A Quality Assessment Tool for Protein-Ligand Binding Site Residue Predictions	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; LOCAL MODEL QUALITY; EVOLUTIONARY CONSERVATION; SEQUENCE; CASP8; ALIGNMENT; ANNOTATION; WEB; IDENTIFICATION; FIRESTAR	The estimation of prediction quality is important because without quality measures, it is difficult to determine the usefulness of a prediction. Currently, methods for ligand binding site residue predictions are assessed in the function prediction category of the biennial Critical Assessment of Techniques for Protein Structure Prediction (CASP) experiment, utilizing the Matthews Correlation Coefficient (MCC) and Binding-site Distance Test (BDT) metrics. However, the assessment of ligand binding site predictions using such metrics requires the availability of solved structures with bound ligands. Thus, we have developed a ligand binding site quality assessment tool, FunFOLDQA, which utilizes protein feature analysis to predict ligand binding site quality prior to the experimental solution of the protein structures and their ligand interactions. The FunFOLDQA feature scores were combined using: simple linear combinations, multiple linear regression and a neural network. The neural network produced significantly better results for correlations to both the MCC and BDT scores, according to Kendall's tau, Spearman's rho and Pearson's iota correlation coefficients, when tested on both the CASP8 and CASP9 datasets. The neural network also produced the largest Area Under the Curve score (AUC) when Receiver Operator Characteristic (ROC) analysis was undertaken for the CASP8 dataset. Furthermore, the FunFOLDQA algorithm incorporating the neural network, is shown to add value to FunFOLD, when both methods are employed in combination. This results in a statistically significant improvement over all of the best server methods, the FunFOLD method (6.43%), and one of the top manual groups (FN293) tested on the CASP8 dataset. The FunFOLDQA method was also found to be competitive with the top server methods when tested on the CASP9 dataset. To the best of our knowledge, FunFOLDQA is the first attempt to develop a method that can be used to assess ligand binding site prediction quality, in the absence of experimental data.	[Roche, Daniel B.; Buenavista, Maria T.; McGuffin, Liam J.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Buenavista, Maria T.] Med Res Council Harwell, Biocomp Sect, Harwell Oxford, Oxon, England; [Buenavista, Maria T.] Diamond Light Source, Beamline B23, Didcot, Oxon, England	University of Reading; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Diamond Light Source	Roche, DB (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	l.j.mcguffin@reading.ac.uk	McGuffin, Liam/A-5598-2008	McGuffin, Liam/0000-0003-4501-4767; Roche, Daniel/0000-0002-9204-1840	RCUK Academic Fellowship; Diamond Light Source Ltd; MRC [MC_U142684171] Funding Source: UKRI; Medical Research Council [MC_U142684171] Funding Source: researchfish	RCUK Academic Fellowship(UK Research & Innovation (UKRI)); Diamond Light Source Ltd; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by RCUK Academic Fellowship (to LJM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; Funding was received from a commercial source, Diamond Light Source Ltd (to MTB), who is also the employer of MTB. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Andersson CD, 2010, PROTEINS, V78, P1408, DOI 10.1002/prot.22655; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, PROTEINS, V77, P173, DOI 10.1002/prot.22532; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Cheng JL, 2009, PROTEINS, V77, P181, DOI 10.1002/prot.22487; Chou WY, 2010, BIOINFORMATICS, V26, P1022, DOI 10.1093/bioinformatics/btq084; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Gentleman R, 2000, J COMPUT GRAPH STAT, V9, P491, DOI 10.2307/1390942; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Kalman M, 2010, BIOINFORMATICS, V26, P1299, DOI 10.1093/bioinformatics/btq114; Larsson P, 2009, PROTEINS, V77, P167, DOI 10.1002/prot.22476; Lopez G, 2007, NUCLEIC ACIDS RES, V35, pW573, DOI 10.1093/nar/gkm297; Lopez G, 2011, NUCLEIC ACIDS RES, V39, pW235, DOI 10.1093/nar/gkr437; Lopez G, 2009, PROTEINS, V77, P138, DOI 10.1002/prot.22557; McGuffin LJ, 2011, PROTEINS, V79, P137, DOI 10.1002/prot.23120; McGuffin LJ, 2010, BIOINFORMATICS, V26, P182, DOI 10.1093/bioinformatics/btp629; Miguel RN, 2004, BIOINFORMATICS, V20, P2380, DOI 10.1093/bioinformatics/bth255; Oh M, 2009, PROTEINS, V77, P152, DOI 10.1002/prot.22572; Pantazes RJ, 2011, CURR OPIN STRUC BIOL, V21, P467, DOI 10.1016/j.sbi.2011.04.005; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Roche DB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-160; Roche DB, 2010, BIOINFORMATICS, V26, P2920, DOI 10.1093/bioinformatics/btq543; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanders MPA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-332; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Sankararaman S, 2009, NUCLEIC ACIDS RES, V37, pW390, DOI 10.1093/nar/gkp339; Schmidt T, 2011, PROTEINS, V79, P126, DOI 10.1002/prot.23174; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Soro S, 2005, PROTEINS, V61, P201, DOI 10.1002/prot.20738; Spitzer R, 2011, PROTEINS, V79, P2746, DOI 10.1002/prot.23103; Talavera D, 2009, BIOINFORMATICS, V25, P1192, DOI 10.1093/bioinformatics/btp116; Wang K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000181; Wang Z, 2011, BIOINFORMATICS, V27, P1715, DOI 10.1093/bioinformatics/btr268; Wang Z, 2009, PROTEINS, V75, P638, DOI 10.1002/prot.22275; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wass MN, 2009, PROTEINS, V77, P147, DOI 10.1002/prot.22513; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	41	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38219	10.1371/journal.pone.0038219	http://dx.doi.org/10.1371/journal.pone.0038219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666491	Green Published, gold, Green Accepted			2022-12-27	WOS:000305353400104
J	Chechko, N; Kellermann, T; Zvyagintsev, M; Augustin, M; Schneider, F; Habel, U				Chechko, Natalia; Kellermann, Thilo; Zvyagintsev, Michael; Augustin, Marc; Schneider, Frank; Habel, Ute			Brain Circuitries Involved in Semantic Interference by Demands of Emotional and Non-Emotional Distractors	PLOS ONE			English	Article							COUNTING STROOP; FRONTAL-CORTEX; TASK; ACTIVATION; AMYGDALA; SYSTEMS; FMRI	Background: Previous studies have indicated that the processes leading to the resolution of emotional and non-emotional interference conflicts are unrelated, involving separate networks. It is also known that conflict resolution itself suggests a considerable overlap of the networks. Our study is an attempt to examine how these findings may be related. Methodology/Principal Findings: We used functional magnetic resonance imaging (fMRI) to study neural responses of 24 healthy subjects to emotional and non-emotional conflict paradigms involving the presentation of congruent and incongruent word-face pairs based on semantic incompatibility between targets and distractors. In the emotional task, the behavioral interference conflict was greater (compared to the non-emotional task) and was paralleled by involvement of the extrastriate visual and posterodorsal medial frontal cortices. In both tasks, we also observed a common network including the dorsal anterior cingulate, the supplemental motor area, the anterior insula and the inferior prefrontal cortex, indicating that these brain structures are markers of experienced conflict. However, the emotional task involved conflict-triggered networks to a considerably higher degree. Conclusions/Significance: Our findings indicate that responses to emotional and non-emotional distractors involve the same systems, which are capable of flexible adjustments based on conflict demands. The function of systems related to conflict resolution is likely to be adjusted on the basis of an evaluation process that primarily involves the extrastriate visual cortex, with target playing a significant role.	[Chechko, Natalia; Kellermann, Thilo; Zvyagintsev, Michael; Augustin, Marc; Schneider, Frank; Habel, Ute] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Kellermann, Thilo; Zvyagintsev, Michael; Schneider, Frank; Habel, Ute] Forschungszentrum Julich GmbH, JARA Translat Brain Med, Julich, Germany	RWTH Aachen University; Helmholtz Association; Research Center Julich	Chechko, N (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	nchechko@ukaachen.de	Kellermann, Thilo/B-1712-2012	Kellermann, Thilo/0000-0003-4081-5581; Schneider, Frank/0000-0003-1557-7956; Habel, Ute/0000-0003-0703-7722; Zvyagintsev, Mikhail/0000-0001-9521-042X				Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Murphy K, 2005, NEUROIMAGE, V27, P771, DOI 10.1016/j.neuroimage.2005.05.007; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Schweizer TA, 2007, J COGNITIVE NEUROSCI, V19, P1974, DOI 10.1162/jocn.2007.19.12.1974; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; Whalen PJ, 2006, NAT PROTOC, V1, P293, DOI 10.1038/nprot.2006.45; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wittchen H.-U., 1997, SKID STRUKTURIERTES	26	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38155	10.1371/journal.pone.0038155	http://dx.doi.org/10.1371/journal.pone.0038155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666470	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349600066
J	Firacative, C; Trilles, L; Meyer, W				Firacative, Carolina; Trilles, Luciana; Meyer, Wieland			MALDI-TOF MS Enables the Rapid Identification of the Major Molecular Types within the Cryptococcus neoformans/C. gattii Species Complex	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ANTIFUNGAL SUSCEPTIBILITY; VAR. NEOFORMANS; POLYMORPHIC DNA; STRAIN; SEROTYPE; AIDS; DIVERSITY; GRUBII	Background: The Cryptococcus neoformans/C. gattii species complex comprises two sibling species that are divided into eight major molecular types, C. neoformans VNI to VNIV and C. gattii VGI to VGIV. These genotypes differ in host range, epidemiology, virulence, antifungal susceptibility and geographic distribution. The currently used phenotypic and molecular identification methods for the species/molecular types are time consuming and expensive. As Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) offers an effective alternative for the rapid identification of microorganisms, the objective of this study was to examine its potential for the identification of C. neoformans and C. gattii strains at the intra-and inter-species level. Methodology: Protein extracts obtained via the formic acid extraction method of 164 C. neoformans/C. gattii isolates, including four inter-species hybrids, were studied. Results: The obtained mass spectra correctly identified 100% of all studied isolates, grouped each isolate according to the currently recognized species, C. neoformans and C. gattii, and detected potential hybrids. In addition, all isolates were clearly separated according to their major molecular type, generating greater spectral differences among the C. neoformans molecular types than the C. gattii molecular types, most likely reflecting a closer phylogenetic relationship between the latter. The number of colonies used and the incubation length did not affect the results. No spectra were obtained from intact yeast cells. An extended validated spectral library containing spectra of all eight major molecular types was established. Conclusions: MALDI-TOF MS is a rapid identification tool for the correct recognition of the two currently recognized human pathogenic Cryptococcus species and offers a simple method for the separation of the eight major molecular types and the detection of hybrid strains within this species complex in the clinical laboratory. The obtained mass spectra provide further evidence that the major molecular types warrant variety or even species status.	[Firacative, Carolina; Trilles, Luciana; Meyer, Wieland] Univ Sydney, Westmead Hosp, Sydney Med School Westmead, Mol Mycol Res Lab,Ctr Infect Dis & Microbiol,West, Sydney, NSW 2006, Australia; [Firacative, Carolina] Inst Nacl Salud, Microbiol Grp, Bogota, Colombia; [Trilles, Luciana] Fundacao Oswaldo Cruz, Lab Micol, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil	University of Sydney; Instituto Nacional de Salud (Colombia); Fundacao Oswaldo Cruz	Firacative, C (corresponding author), Univ Sydney, Westmead Hosp, Sydney Med School Westmead, Mol Mycol Res Lab,Ctr Infect Dis & Microbiol,West, Sydney, NSW 2006, Australia.	w.meyer@usyd.edu.au	Meyer, Wieland/G-1204-2015; Firacative, Carolina/ABB-9942-2021	Meyer, Wieland/0000-0001-9933-8340; Firacative, Carolina/0000-0001-7547-5172	PhD scholarship "Becas Francisco Jose de Caldas" from COLCIEN-CIAS Colombia	PhD scholarship "Becas Francisco Jose de Caldas" from COLCIEN-CIAS Colombia	The authors express their thanks to Elizabeth Castaneda (Emeritus Professor, Instituto Nacional de Salud, Bogota, Colombia) for her useful comments on the manuscript, to Mr. Leith Fremlin (Bruker Daltonic, Australia) for the technical support and to Mojgan Aminnejad for providing the proteins extracts for the inter-species hybrid strains. The authors wish also to thank the following researchers from around the world for generously contributing strains for this study: A. Arechavala, I. Arthur, K. Bartlett, T. Boekhout, B. Calvo, S. Chen, A. Chindamporn, G. Davel, V. Davis, M. Diaz, F. Dromer, D. Ellis, P. Escandon, M. Fyfe, M. Ghannoum, J. Graybill, D. Howard, R. Igreja, E. Jacobsen, M. A. John, M. Krockenberger, S. Kidd, R. Lopez-Martinez, R. Malik, M. S. Matthews, T. Mitchell, M. Montagna, P. Ngamsklrungroj, A. Padhye, D. Parr, C. Perez, T. Pfeiffer, P. Rajendran, M. F. A. Razak, B. Samayoa, B. Speed, A. Sturm, S. Sukroongreung, J. Sykes, K. Tintelnot, J. M. Torres, M. Vainstein, N. Vasilyeva, A. Velegraki, and K. Weeks. Carolina Firacative was supported by a PhD scholarship "Becas Francisco Jose de Caldas" from COLCIEN-CIAS Colombia.	Aminnejad M, 2012, MYCOPATHOLOGIA, V173, P337, DOI 10.1007/s11046-011-9491-x; Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, EMERG INFECT DIS, V14, P1105, DOI 10.3201/eid1407.080122; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Bovers M, 2006, FEMS YEAST RES, V6, P599, DOI 10.1111/j.1567-1364.2006.00082.x; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2011, MICROBES INFECT, V13, P895, DOI 10.1016/j.micinf.2011.05.009; Cassagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028425; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chen SCA, 1996, J INFECT DIS, V173, P754, DOI 10.1093/infdis/173.3.754; Chong HS, 2010, J CLIN MICROBIOL, V48, P4115, DOI 10.1128/JCM.01271-10; Cogliati M, 2012, MYCOPATHOLOGIA, V173, P347, DOI 10.1007/s11046-011-9467-x; Sidrim JJC, 2010, CAN J MICROBIOL, V56, P445, DOI [10.1139/W10-030, 10.1139/w10-030]; Coulibaly O, 2011, MED MYCOL, V49, P621, DOI 10.3109/13693786.2011.555424; Diaz MR, 2005, FEMS YEAST RES, V5, P1129, DOI 10.1016/j.femsyr.2005.05.005; ESPINELINGROFF A, 1992, J CLIN MICROBIOL, V30, P3138, DOI 10.1128/JCM.30.12.3138-3145.1992; Franzot SP, 1999, J CLIN MICROBIOL, V37, P838, DOI 10.1128/JCM.37.3.838-840.1999; Hanafy A, 2008, MED MYCOL, V46, P685, DOI 10.1080/13693780802027062; Hettick JM, 2006, PROTEOMICS, V6, P6416, DOI 10.1002/pmic.200600335; Hettick JM, 2011, ACS SYM SER, V1065, P35; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kluger EK, 2006, MED MYCOL, V44, P561, DOI 10.1080/13693780600582847; Kwon-Chung KJ, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P3; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lemmer K, 2004, MED MYCOL, V42, P135, DOI 10.1080/13693780310001624565; Litvintseva AP, 2007, PLOS PATHOG, V3, P1109, DOI 10.1371/journal.ppat.0030114; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; McTaggart L, 2011, J CLIN MICROBIOL, V49, P2522, DOI 10.1128/JCM.00502-11; McTaggart LR, 2011, J CLIN MICROBIOL, V49, P3050, DOI 10.1128/JCM.00651-11; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; MEYER W, 1995, ELECTROPHORESIS, V16, P1648, DOI 10.1002/elps.11501601273; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2003, PROBLEMS MED MYCOL N, VN3, P8; Meyer W, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P327; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Neville SA, 2011, J CLIN MICROBIOL, V49, P2980, DOI 10.1128/JCM.00431-11; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pinto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025712; Qian J, 2008, ANAL BIOANAL CHEM, V392, P439, DOI 10.1007/s00216-008-2288-1; Santos C, 2010, J APPL MICROBIOL, V108, P375, DOI 10.1111/j.1365-2672.2009.04448.x; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P3482, DOI 10.1128/JCM.00687-09; Trilles L, 2004, J CLIN MICROBIOL, V42, P4815, DOI 10.1128/JCM.42.10.4815-4817.2004; Trilles L, 2012, MED MYCOL, V50, P328, DOI 10.3109/13693786.2011.602126; Tsuchihashi Z., 2002, Pharmacogenomics Journal, V2, P103, DOI 10.1038/sj.tpj.6500094; Velegraki A, 2001, MED MYCOL, V39, P419, DOI 10.1080/mmy.39.5.419.422; Viviani MA, 2001, MED MYCOL, V39, P383, DOI 10.1080/mmy.39.5.383.386	51	95	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37566	10.1371/journal.pone.0037566	http://dx.doi.org/10.1371/journal.pone.0037566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666368	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349600019
J	Sanchez-Martinez, S; Aloia, AL; Harvin, D; Mirro, J; Gorelick, RJ; Jern, P; Coffin, JM; Rein, A				Sanchez-Martinez, Silvia; Aloia, Amanda L.; Harvin, Demetria; Mirro, Jane; Gorelick, Robert J.; Jern, Patric; Coffin, John M.; Rein, Alan			Studies on the Restriction of Murine Leukemia Viruses by Mouse APOBEC3	PLOS ONE			English	Article							REPLICATION; GAG; INFECTION; GENE; PATHOGENESIS; REPLACEMENT; VIRIONS; ENCODES; PROTEIN	APOBEC3 proteins function to restrict the replication of retroviruses. One mechanism of this restriction is deamination of cytidines to uridines in (-) strand DNA, resulting in hypermutation of guanosines to adenosines in viral (+) strands. However, Moloney murine leukemia virus (MoMLV) is partially resistant to restriction by mouse APOBEC3 (mA3) and virtually completely resistant to mA3-induced hypermutation. In contrast, the sequences of MLV genomes that are in mouse DNA suggest that they were susceptible to mA3-induced deamination when they infected the mouse germline. We tested the possibility that sensitivity to mA3 restriction and to deamination resides in the viral gag gene. We generated a chimeric MLV in which the gag gene was from an endogenous MLV in the mouse germline, while the remainder of the viral genome was from MoMLV. This chimera was fully infectious but its response to mA3 was indistinguishable from that of MoMLV. Thus, the Gag protein does not seem to control the sensitivity of MLVs to mA3. We also found that MLVs inactivated by mA3 do not synthesize viral DNA upon infection; thus mA3 restriction of MLV occurs before or at reverse transcription. In contrast, HIV-1 restricted by mA3 and MLVs restricted by human APOBEC3G do synthesize DNA; these DNAs exhibit APOBEC3-induced hypermutation.	[Sanchez-Martinez, Silvia; Aloia, Amanda L.; Harvin, Demetria; Mirro, Jane; Rein, Alan] NCI, HIV Drug Resistance Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Gorelick, Robert J.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Jern, Patric] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Coffin, John M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Uppsala University; Tufts University	Sanchez-Martinez, S (corresponding author), NCI, HIV Drug Resistance Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.	reina@mail.nih.gov	Jern, Patric/AAR-2133-2021	Jern, Patric/0000-0003-3393-5825	NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Swedish Wenner-Gren foundations; Swedish research council FORMAS; American Cancer Society; F.M. Kirby Foundation; NATIONAL CANCER INSTITUTE [ZIABC010773] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Wenner-Gren foundations; Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas); American Cancer Society(American Cancer Society); F.M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. P.J. was supported by the Swedish Wenner-Gren foundations and the Swedish research council FORMAS. J.M.C. was supported by a Research Professorship from the American Cancer Society, with support from the F.M. Kirby Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Browne EP, 2008, J VIROL, V82, P1305, DOI 10.1128/JVI.01371-07; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; EDWARDS SA, 1979, J VIROL, V30, P551, DOI 10.1128/JVI.30.2.551-563.1979; Elion EA, 2007, CURR PROTOC MOL BIOL, P17; Fu W, 2003, J VIROL, V77, P754, DOI 10.1128/JVI.77.1.754-761.2003; Gherghe C, 2010, P NATL ACAD SCI USA, V107, P19248, DOI 10.1073/pnas.1006897107; Gorelick RJ, 1996, J VIROL, V70, P2593, DOI 10.1128/JVI.70.4.2593-2597.1996; GORELICK RJ, 1990, J VIROL, V64, P3207, DOI 10.1128/JVI.64.7.3207-3211.1990; Hakata Y, 2006, J BIOL CHEM, V281, P36624, DOI 10.1074/jbc.M604980200; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Kolokithas A, 2010, J VIROL, V84, P10933, DOI 10.1128/JVI.01023-10; Langlois MA, 2009, J VIROL, V83, P11550, DOI 10.1128/JVI.01430-09; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Low A, 2009, VIROLOGY, V385, P455, DOI 10.1016/j.virol.2008.11.051; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Okeoma CM, 2010, CELL HOST MICROBE, V8, P534, DOI 10.1016/j.chom.2010.11.003; Okeoma CM, 2009, J VIROL, V83, P3029, DOI 10.1128/JVI.02536-08; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PRATS AC, 1989, J MOL BIOL, V205, P363, DOI 10.1016/0022-2836(89)90347-1; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Rulli SJ, 2006, VIROLOGY, V347, P364, DOI 10.1016/j.virol.2005.12.012; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith DS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002284; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Takeda E, 2008, J VIROL, V82, P10998, DOI 10.1128/JVI.01311-08; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	34	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38190	10.1371/journal.pone.0038190	http://dx.doi.org/10.1371/journal.pone.0038190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666481	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349600070
J	Wijnands, KAP; Vink, H; Briede, JJ; van Faassen, EE; Lamers, WH; Buurman, WA; Poeze, M				Wijnands, Karolina A. P.; Vink, Hans; Briede, Jacob J.; van Faassen, Ernst E.; Lamers, Wouter H.; Buurman, Wim A.; Poeze, Martijn			Citrulline a More Suitable Substrate than Arginine to Restore NO Production and the Microcirculation during Endotoxemia	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; CONGENITAL HEART-SURGERY; SEPSIS; METABOLISM; SUPPLEMENTATION; SYNTHASE; DEFICIENCY; MICE; AVAILABILITY; EXPRESSION	Background: Impaired microcirculation during endotoxemia correlates with a disturbed arginine-nitric oxide (NO) metabolism and is associated with deteriorating organ function. Improving the organ perfusion in endotoxemia, as often seen in patients with severe infection or systemic inflammatory response syndrome (SIRS) is, therefore, an important therapeutic target. We hypothesized that supplementation of the arginine precursor citrulline rather than arginine would specifically increase eNOS-induced intracellular NO production and thereby improve the microcirculation during endotoxemia. Methodology/Principal Findings: To study the effects of L-Citrulline and L-Arginine supplementation on jejunal microcirculation, intracellular arginine availability and NO production in a non-lethal prolonged endotoxemia model in mice. C57/Bl6 mice received an 18 hrs intravenous infusion of endotoxin (LPS, 0.4 mu g.g bodyweight(-1).h(-1)), combined with either L-Citrulline (6.25 mg.h(-1)), L-Arginine (6.25 mg.h(-1)), or L-Alanine (isonitrogenous control; 12.5 mg.h(-1)) during the last 6 hrs. The control group received an 18 hrs sterile saline infusion combined with L-Alanine or L-Citrulline during the last 6 hrs. The microcirculation was evaluated at the end of the infusion period using sidestream dark-field imaging of jejunal villi. Plasma and jejunal tissue amino-acid concentrations were measured by HPLC, NO tissue concentrations by electron-spin resonance spectroscopy and NOS protein concentrations using Western blot. Conclusion/Significance: L-Citrulline supplementation during endotoxemia positively influenced the intestinal microvascular perfusion compared to L-Arginine-supplemented and control endotoxemic mice. L-Citrulline supplementation increased plasma and tissue concentrations of arginine and citrulline, and restored intracellular NO production in the intestine. L-Arginine supplementation did not increase the intracellular arginine availability. Jejunal tissues in the L-Citrulline-supplemented group showed, compared to the endotoxemic and L-Arginine-supplemented endotoxemic group, an increase in degree of phosphorylation of eNOS (Ser 1177) and a decrease in iNOS protein level. In conclusion, L-Citrulline supplementation during endotoxemia and not L-Arginine reduced intestinal microcirculatory dysfunction and increased intracellular NO production, likely via increased intracellular citrulline and arginine availability.	[Wijnands, Karolina A. P.; Buurman, Wim A.; Poeze, Martijn] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Wijnands, Karolina A. P.; Lamers, Wouter H.; Buurman, Wim A.; Poeze, Martijn] NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Vink, Hans] Maastricht Univ, Med Ctr, Dept Physiol, Maastricht, Netherlands; [Vink, Hans] CARIM Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Briede, Jacob J.] Maastricht Univ, Med Ctr, Dept Toxicogen, Maastricht, Netherlands; [Briede, Jacob J.] GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [van Faassen, Ernst E.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Lamers, Wouter H.] Maastricht Univ, Med Ctr, Dept Anat & Embryol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University	Wijnands, KAP (corresponding author), Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands.	n.wijnands@maastrichtuniversity.nl	Lamers, Wouter H./D-2965-2012	Briede, Jacco/0000-0003-1405-5232	ZonMw Innovational Research Incentives [VENI 916.76.191]; European Society of Intensive Care Medicine: Eli Lilly Sepsis Elite Award; ESICM; European society of Intensive Care medicine for our peer reviewed research proposal; Eli Lilly	ZonMw Innovational Research Incentives; European Society of Intensive Care Medicine: Eli Lilly Sepsis Elite Award; ESICM; European society of Intensive Care medicine for our peer reviewed research proposal; Eli Lilly(Eli Lilly)	This study was supported by grants from ZonMw Innovational Research Incentives (VENI 916.76.191) and the European Society of Intensive Care Medicine: Eli Lilly Sepsis Elite Award 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors recieved a grant from ESICM, the European society of Intensive Care medicine for our peer reviewed research proposal. Eli Lilly provided the price money to ESICM for this Sepsis Elite award in 2008 without any further conditions. This does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.	Barr FE, 2007, J THORAC CARDIOV SUR, V134, P319, DOI 10.1016/j.jtcvs.2007.02.043; Bode-Boger SM, 1998, BRIT J CLIN PHARMACO, V46, P489, DOI 10.1046/j.1365-2125.1998.00803.x; Boerma EC, 2005, CRIT CARE, V9, pR601, DOI 10.1186/cc3809; Boger RH, 2001, ANNU REV PHARMACOL, V41, P79, DOI 10.1146/annurev.pharmtox.41.1.79; Braulio VB, 2004, AM J PHYSIOL-ENDOC M, V287, pE912, DOI 10.1152/ajpendo.00540.2003; Bruins MJ, 2003, ANN SURG, V237, P44, DOI 10.1097/00000658-200301000-00007; Bruins MJ, 2002, CRIT CARE MED, V30, P508, DOI 10.1097/00003246-200203000-00003; Chen K, 1997, LIFE SCI, V61, P1323, DOI 10.1016/S0024-3205(97)00677-2; Crouser ED, 1999, AM J RESP CRIT CARE, V160, P1347, DOI 10.1164/ajrccm.160.4.9810116; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; Derikx JPM, 2007, SHOCK, V28, P544, DOI 10.1097/shk.0b013e3180644e32; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Elwafi F, 2012, EUR J CLIN INVEST, V42, P282, DOI 10.1111/j.1365-2362.2011.02581.x; Flam BR, 2007, NITRIC OXIDE-BIOL CH, V17, P115, DOI 10.1016/j.niox.2007.07.001; Fukatsu K, 2004, JPEN-PARENTER ENTER, V28, P224, DOI 10.1177/0148607104028004224; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Groner W, 1999, NAT MED, V5, P1209, DOI 10.1038/13529; Hallemeesch MM, 2000, J SURG RES, V92, P193, DOI 10.1006/jsre.2000.5867; Hallemeesch MM, 2002, CLIN NUTR, V21, P273, DOI 10.1054/clnu.2002.0571; HARTMAN WJ, 1994, J NUTR, V124, P1950, DOI 10.1093/jn/124.10.1950; Hollenberg SM, 2000, CIRC RES, V86, P774, DOI 10.1161/01.RES.86.7.774; Ince C, 1999, CRIT CARE MED, V27, P1369, DOI 10.1097/00003246-199907000-00031; Ince C, 2002, AM J RESP CRIT CARE, V166, P1, DOI 10.1164/rccm.2204033; Jeyabalan G, 2008, NITRIC OXIDE-BIOL CH, V19, P29, DOI 10.1016/j.niox.2008.04.002; Orozco-Gutierrez JJ, 2010, CARDIOL J, V17, P612; Kaul DK, 2008, AM J PHYSIOL-HEART C, V295, pH39, DOI 10.1152/ajpheart.00162.2008; Koeners MP, 2007, HYPERTENSION, V50, P1077, DOI 10.1161/HYPERTENSIONAHA.107.095794; Krejci V, 2003, CRIT CARE MED, V31, P203, DOI 10.1097/00003246-200301000-00031; Kubes P, 2000, AM J MED, V109, P150, DOI 10.1016/S0002-9343(00)00480-0; Lehr HA, 2000, J PATHOL, V190, P373, DOI 10.1002/(SICI)1096-9896(200002)190:3&lt;373::AID-PATH593&gt;3.0.CO;2-3; Luiking YC, 2005, AM J PHYSIOL-RENAL, V288, pF816, DOI 10.1152/ajprenal.00308.2004; Luiking YC, 2004, J NUTR, V134, p2768S, DOI 10.1093/jn/134.10.2768S; Luiking YC, 2004, CRIT CARE MED, V32, P2135, DOI 10.1097/01.CCM.0000142939.81045.A0; Luiking YC, 2010, CURR OPIN CLIN NUTR, V13, P97, DOI 10.1097/MCO.0b013e328332f99d; Luiking YC, 2009, AM J CLIN NUTR, V89, P142, DOI 10.3945/ajcn.2007.25765; Luiking YC, 2008, AM J PHYSIOL-ENDOC M, V295, pE1315, DOI 10.1152/ajpendo.00055.2008; Massberg S, 1998, RES EXP MED, V198, P23, DOI 10.1007/s004330050086; Matheson PJ, 2000, J SURG RES, V93, P182, DOI 10.1006/jsre.2000.5862; McCuskey RS, 1999, HEPATO-GASTROENTEROL, V46, P1464; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Olfert E D, 2000, ILAR J, V41, P99; Orea-Tejeda A, 2010, CARDIOL J, V17, P464; Osowska S, 2006, AM J PHYSIOL-ENDOC M, V291, pE582, DOI 10.1152/ajpendo.00398.2005; Pittner A, 2003, INTENS CARE MED, V29, P312, DOI 10.1007/s00134-002-1577-y; Poeze M, 2011, AM J CLIN NUTR, V93, P1237, DOI 10.3945/ajcn.110.007237; Poeze M, 2010, AM J CLIN NUTR, V91, P992, DOI 10.3945/ajcn.2009.27812; Schmidt H, 1996, J SURG RES, V61, P521, DOI 10.1006/jsre.1996.0157; Shen LJ, 2005, BIOCHEM PHARMACOL, V69, P97, DOI 10.1016/j.bcp.2004.09.003; Smith HAB, 2006, J THORAC CARDIOV SUR, V132, P58, DOI 10.1016/j.jtcvs.2006.02.012; Spronk PE, 2002, LANCET, V360, P1395, DOI 10.1016/S0140-6736(02)11393-6; Stechmiller J K, 1997, Am J Crit Care, V6, P204; Tain YL, 2010, NITRIC OXIDE-BIOL CH, V23, P34, DOI 10.1016/j.niox.2010.03.005; van Faassen EE, 2008, NITRIC OXIDE-BIOL CH, V18, P279, DOI 10.1016/j.niox.2008.02.003; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; Ventura G, 2010, AMINO ACIDS, V39, P1417, DOI 10.1007/s00726-010-0601-8; Verdant CL, 2009, CRIT CARE MED, V37, P2875, DOI 10.1097/CCM.0b013e3181b029c1; Vissers YLJ, 2004, NUTR RES REV, V17, P193, DOI 10.1079/NRR200490; Waugh WH, 2001, J NATL MED ASSOC, V93, P363	58	87	94	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37439	10.1371/journal.pone.0037439	http://dx.doi.org/10.1371/journal.pone.0037439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666356	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600015
J	Gilardi, JD; Toft, CA				Gilardi, James D.; Toft, Catherine A.			Parrots Eat Nutritious Foods despite Toxins	PLOS ONE			English	Article							YELLOW-CHEVRONED PARAKEET; DISPERSAL SEED PREDATION; LILAC-CROWNED PARROT; ARTEMIA-SALINA; DRY FOREST; SOIL CHARACTERISTICS; TOXICITY ASSESSMENT; SCARLET MACAW; BRINE SHRIMP; RAIN-FOREST	Background: Generalist herbivores are challenged not only by the low nitrogen and high indigestibility of their plant foods, but also by physical and chemical defenses of plants. This study investigated the foods of wild parrots in the Peruvian Amazon and asked whether these foods contain dietary components that are limiting for generalist herbivores (protein, lipids, minerals) and in what quantity; whether parrots chose foods based on nutrient content; and whether parrots avoid plants that are chemically defended. Methodology/Principal Findings: We made 224 field observations of free-ranging parrots of 17 species in 8 genera foraging on 102 species of trees in an undisturbed tropical rainforest, in two dry seasons (July-August 1992-1993) and one wet season (January-February 1994). We performed laboratory analyses of parts of plants eaten and not eaten by parrots and brine shrimp assays of toxicity as a proxy for vertebrates. Parrots ate seeds, fruits, flowers, leaves, bark, and insect larvae, but up to 70% of their diet comprised seeds of many species of tropical trees, in various stages of ripeness. Plant parts eaten by parrots were rich in protein, lipid, and essential minerals, as well as potentially toxic chemicals. Seeds were higher than other plant materials in protein and lipid and lower in fiber. Large macaws of three species ate foods higher in protein and lipids and lower in fiber compared to plant parts available but not eaten. Macaws ate foods that were lower in phenolic compounds than foods they avoided. Nevertheless, foods eaten by macaws contained measurable levels of toxicity. Macaws did not appear to make dietary selections based on mineral content. Conclusions/Significance: Parrots represent a remarkable example of a generalist herbivore that consumes seeds destructively despite plant chemical defenses. With the ability to eat toxic foods, rainforest-dwelling parrots exploited a diversity of nutritious foods, even in the dry season when food was scarce for other frugivores and granivores.	[Gilardi, James D.; Toft, Catherine A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Gilardi, JD (corresponding author), World Parrot Trust, Lake Alfred, FL USA.	gilardi@worldparrottrust.org			Wildlife Conservation Society	Wildlife Conservation Society	Funding was provided primarily by intramural graduate fellowships for salary support for JDG and intramural small grants for research supplies (UC Davis Graduate Division, Center for Population Biology) and one small extramural award for research supplies from the Wildlife Conservation Society, a scholarly society that mentors graduate students. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo V, 1992, AFA WATCHBIRD, V19, P31; Allen SE, 1989, CHEM ANAL ECOLOGICAL; Banko PC, 2002, J CHEM ECOL, V28, P1393, DOI 10.1023/A:1016248502927; Berg KS, 2007, J FIELD ORNITHOL, V78, P1, DOI 10.1111/j.1557-9263.2006.00080.x; Blohm H, 1962, POISONOUS PLANTS VEN; Bonadie WA, 2000, BIOL CONSERV, V95, P1, DOI 10.1016/S0006-3207(00)00018-5; Bosque C, 2003, COMP BIOCHEM PHYS A, V135, P321, DOI 10.1016/S1095-6433(03)00080-1; Boyes RS, 2010, AFR J ECOL, V48, P769, DOI 10.1111/j.1365-2028.2009.01177.x; Brightsmith DJ, 2004, BIOTROPICA, V36, P534, DOI 10.1646/1602; Brightsmith DJ, 2008, BIOTROPICA, V40, P766, DOI 10.1111/j.1744-7429.2008.00429.x; Brightsmith DJ, 2010, J AVIAN MED SURG, V24, P9, DOI 10.1647/1082-6742-24.1.9; Cano A, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P271; COATESESTRADA R, 1993, J TROP ECOL, V9, P121, DOI 10.1017/S0266467400007070; da Silva PA, 2007, REV BRAS ORNITOL, V15, P127; Favilla M, 2006, FOOD CHEM TOXICOL, V44, P1922, DOI 10.1016/j.fct.2006.06.024; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; FOSTER R., 1994, RAP WORKING PAPERS, V6; Francisco MR, 2008, ACTA OECOL, V33, P240, DOI 10.1016/j.actao.2007.11.002; Francisco MR, 2002, BIOTROPICA, V34, P613, DOI 10.1111/j.1744-7429.2002.tb00582.x; FREELAND WJ, 1989, BIOCHEM SYST ECOL, V17, P493, DOI 10.1016/0305-1978(89)90029-X; GALETTI M, 1992, BIOTROPICA, V24, P222, DOI 10.2307/2388679; Galetti Mauro, 1997, Ararajuba, V5, P115; Herrera LG, 2006, BIOTROPICA, V38, P735, DOI 10.1111/j.1744-7429.2006.00201.x; Gilardi JD, 1998, CONDOR, V100, P641, DOI 10.2307/1369745; Gilardi JD, 1999, J CHEM ECOL, V25, P897, DOI 10.1023/A:1020857120217; Gilardi JD, 1996, THESIS UC DAVIS DAVI; Goering H. K, 1970, FORAGE FIBER ANALYSE, V379; Green AK, 2004, COMP BIOCHEM PHYS A, V139, P325, DOI 10.1016/j.cbpb.2004.09.017; Hartl M, 2000, FOOD CHEM TOXICOL, V38, P1097, DOI 10.1016/S0278-6915(00)00112-5; Haugaasen T, 2008, ORNITOL NEOTROP, V19, P321; Herrerias-Diego Y, 2008, BIOL CONSERV, V141, P241, DOI 10.1016/j.biocon.2007.09.017; Homberger D.G., 1980, Bonner Zoologische Monographien, P1; Horgen FD, 2001, PHYTOMEDICINE, V8, P71, DOI 10.1078/0944-7113-00019; Houston D, 2007, BIOL CONSERV, V138, P248, DOI 10.1016/j.biocon.2007.04.023; Villasenor-Sanchez EI, 2010, J TROP ECOL, V26, P227, DOI 10.1017/S0266467409990447; JAKUBAS WJ, 1995, CAN J ZOOL, V73, P1106, DOI 10.1139/z95-132; JANZEN DH, 1990, BIOTROPICA, V22, P272, DOI 10.2307/2388538; JANZEN DH, 1981, AUK, V98, P841; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Krishnaraju AV, 2005, INT J APPL SCI ENG, V3, P125, DOI [10.6703/IJASE.2005.3(2).125, DOI 10.6703/IJASE.2005.3(2).125]; Mangione AM, 2004, J CHEM ECOL, V30, P1409, DOI 10.1023/B:JOEC.0000037748.19927.a1; Masello JF, 2006, EMU, V106, P69, DOI 10.1071/MU04047; Matuzak GD, 2008, WILSON J ORNITHOL, V120, P353, DOI 10.1676/07-038.1; MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236; Milton K., 1980, FORAGING STRATEGIES; Moegenburg SM, 2003, ECOLOGY, V84, P2600, DOI 10.1890/02-0063; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Norconk MA, 2004, INT J PRIMATOL, V25, P1, DOI 10.1023/B:IJOP.0000014642.68751.ed; Norconk MA, 1997, PRIMATES, V38, P177, DOI 10.1007/BF02382007; Norconk MA, 1998, AM J PRIMATOL, V45, P103, DOI 10.1002/(SICI)1098-2345(1998)45:1<103::AID-AJP8>3.0.CO;2-#; Paranhos SJ, 2007, REV BRAS ORNITOL, V15, P95; Powell LL, 2009, BIOTROPICA, V41, P279, DOI 10.1111/j.1744-7429.2009.00514.x; Pryor GS, 2001, AUK, V118, P1080, DOI 10.1642/0004-8038(2001)118[1080:PROASF]2.0.CO;2; Ragusa-Netto J, 2008, STUD NEOTROP FAUNA E, V43, P99, DOI 10.1080/01650520701510859; Ragusa-Netto J, 2007, STUD NEOTROP FAUNA E, V42, P93, DOI 10.1080/01650520600979643; Renton K, 2006, BIOTROPICA, V38, P280, DOI 10.1111/j.1744-7429.2006.00123.x; Renton K, 2001, CONDOR, V103, P62, DOI 10.1650/0010-5422(2001)103[0062:LCPDAF]2.0.CO;2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robbins C.S., 1981, Studies in Avian Biology, P275; Rodriguez-Ferraro A, 2007, WILSON J ORNITHOL, V119, P602, DOI 10.1676/06-028.1; RUSSELL R M, 1977, Bulletin of the Entomological Society of America, V23, P209; Schaefer HM, 2003, ANIM BEHAV, V65, P531, DOI 10.1006/anbe.2003.2089; SEIBERT R. J., 1948, ANN MISSOURI BOT GARD, V35, P117, DOI 10.2307/2394388; Selman RG, 2002, OSTRICH, V73, P127, DOI 10.1080/00306525.2002.11446741; Shepherd JD, 2008, REV CHIL HIST NAT, V81, P395; Silva da, 2005, REV BRAS ORNITOL, V13, P183; SILVIUS KM, 1995, BIOTROPICA, V27, P96, DOI 10.2307/2388907; SOLIS PN, 1993, PLANTA MED, V59, P250, DOI 10.1055/s-2006-959661; Stattersfield A J, 2000, THREATENED BIRDS WOR, P205; SWEENEY RA, 1989, J ASSOC OFF ANA CHEM, V72, P770; Symes CT, 2007, EMU, V107, P115, DOI 10.1071/MU06041; Symes CT, 2003, TROP ZOOL, V16, P47, DOI 10.1080/03946975.2003.10531183; Taylor S, 2006, OSTRICH, V77, P179, DOI 10.2989/00306520609485531; TERBORGH J, 1992, BIOTROPICA, V24, P283, DOI 10.2307/2388523; Trivedi MR, 2004, BIOTROPICA, V36, P118, DOI 10.1111/j.1744-7429.2004.tb00302.x; Tsahar E, 2006, AUK, V123, P1004, DOI 10.1642/0004-8038(2006)123[1004:DNAFBH]2.0.CO;2; Undersander D., 1993, FORAGE ANALYSES PROC, DOI DOI 10.1093/JAOAC/81.3.620; Vaughan C, 2006, REV BIOL TROP, V54, P919; Vilialba JJ, 2007, ANIMAL, V1, P1360, DOI 10.1017/S1751731107000134; Waterman P., 1994, ANAL PLANT PHENOLIC; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wolf P, 2007, J ANIM PHYSIOL AN N, V91, P282, DOI 10.1111/j.1439-0396.2007.00706.x; Wright TF, 2008, ANIM BEHAV, V76, P1017, DOI 10.1016/j.anbehav.2008.03.025	84	34	35	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38293	10.1371/journal.pone.0038293	http://dx.doi.org/10.1371/journal.pone.0038293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679496	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900026
J	Chen, H; Lu, Y; Jiang, JG				Chen, Hui; Lu, Yan; Jiang, Jian-Guo			Comparative Analysis on the Key Enzymes of the Glycerol Cycle Metabolic Pathway in Dunaliella salina under Osmotic Stresses	PLOS ONE			English	Article							PURIFICATION; DEHYDROGENASE; FERMENTATION; REDUCTASE; CLONING	The glycerol metabolic pathway is a special cycle way; glycerol-3-phosphate dehydrogenase (G3pdh), glycerol-3-phosphate phosphatase (G3pp), dihydroxyacetone reductase (Dhar), and dihydroxyacetone kinase (Dhak) are the key enzymes around the pathway. Glycerol is an important osmolyte for Dunaliella salina to resist osmotic stress. In this study, comparative activities of the four enzymes in D. salina and their activity changes under various salt stresses were investigated, from which glycerol metabolic flow direction in the glycerol metabolic pathway was estimated. Results showed that the salinity changes had different effects on the enzymes activities. NaCl could stimulate the activities of all the four enzymes in various degrees when D. salina was grown under continuous salt stress. When treated by hyperosmotic or hypoosmotic shock, only the activity of G3pdh in D. salina was significantly stimulated. It was speculated that, under osmotic stresses, the emergency response of the cycle pathway in D. salina was driven by G3pdh via its response to the osmotic stress. Subsequently, with the changes of salinity, other three enzymes started to respond to osmotic stress. Dhar played a role of balancing the cycle metabolic pathway by its forward and backward reactions. Through synergy, the four enzymes worked together for the effective flow of the cycle metabolic pathways to maintain the glycerol requirements of cells in order to adapt to osmotic stress environments.	[Chen, Hui; Jiang, Jian-Guo] S China Univ Technol, Coll Food Bioengn, Guangzhou, Guangdong, Peoples R China; [Chen, Hui] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Lu, Yan] S China Univ Technol, Sch Biol Sci & Engn, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; South China University of Technology	Chen, H (corresponding author), S China Univ Technol, Coll Food Bioengn, Guangzhou, Guangdong, Peoples R China.	jgjiang@scut.edu.cn			National Natural Foundation of China [30870025]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Foundation of China (Grant 30870025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkayal F, 2010, PLANT SCI, V179, P437, DOI 10.1016/j.plantsci.2010.07.001; BENAMOTZ A, 1974, PLANT PHYSIOL, V53, P628, DOI 10.1104/pp.53.4.628; Chen H, 2011, SCI TOTAL ENVIRON, V409, P1291, DOI 10.1016/j.scitotenv.2010.12.038; Chen H, 2009, J CELL PHYSIOL, V219, P251, DOI 10.1002/jcp.21715; Chen H, 2009, J AGR FOOD CHEM, V57, P6178, DOI 10.1021/jf900447r; Cui LQ, 2010, J APPL PHYCOL, V22, P563, DOI 10.1007/s10811-009-9494-x; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GANCEDO C, 1968, EUR J BIOCHEM, V5, P165, DOI 10.1111/j.1432-1033.1968.tb00353.x; Ghoshal D, 2002, PROTEIN EXPRES PURIF, V24, P404, DOI 10.1006/prep.2001.1588; Goyal A, 2007, PLANT PHYSIOL BIOCH, V45, P705, DOI 10.1016/j.plaphy.2007.05.009; He QH, 2007, J PLANT PHYSIOL, V164, P214, DOI 10.1016/j.jplph.2006.04.004; He YX, 2009, PLANT MOL BIOL, V71, P193, DOI 10.1007/s11103-009-9517-7; JOHNSON EA, 1984, J BACTERIOL, V160, P55, DOI 10.1128/JB.160.1.55-60.1984; KIRSCH T, 1992, PLANT PHYSIOL, V100, P352, DOI 10.1104/pp.100.1.352; Lamers PP, 2008, TRENDS BIOTECHNOL, V26, P631, DOI 10.1016/j.tibtech.2008.07.002; Lao YM, 2011, BIOINFORMATICS, V27, P2201, DOI 10.1093/bioinformatics/btr371; Liu HJ, 2006, BIOCHEM ENG J, V28, P92, DOI 10.1016/j.bej.2005.08.038; Mishra R, 2008, BIOTECHNOL ADV, V26, P293, DOI 10.1016/j.biotechadv.2008.02.001; Oliveira RP, 1996, FEMS MICROBIOL LETT, V142, P147; Pick U, 2004, SALINITY ENV PLANTS, P97; Raja R, 2007, APPL MICROBIOL BIOT, V74, P517, DOI 10.1007/s00253-006-0777-8; Ribeiro BD, 2011, FOOD BIOPROCESS TECH, V4, P693, DOI 10.1007/s11947-011-0545-3; Wang W, 2003, BIOTECHNOL BIOENG, V83, P525, DOI 10.1002/bit.10701; Wang ZX, 2001, BIOTECHNOL ADV, V19, P201, DOI 10.1016/S0734-9750(01)00060-X; Wei YD, 2001, PLANT PHYSIOL BIOCH, V39, P841, DOI 10.1016/S0981-9428(01)01308-0; Yamada-Onodera K, 1999, J BIOSCI BIOENG, V88, P148, DOI 10.1016/S1389-1723(99)80193-5; Zhu YH, 2008, EUR FOOD RES TECHNOL, V227, P953, DOI 10.1007/s00217-007-0789-3	27	38	39	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37578	10.1371/journal.pone.0037578	http://dx.doi.org/10.1371/journal.pone.0037578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675484	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700017
J	Estruch, SB; Buzon, V; Carbo, LR; Schorova, L; Luders, J; Estebanez-Perpina, E				Estruch, Sara B.; Buzon, Victor; Carbo, Laia R.; Schorova, Lenka; Lueders, Jens; Estebanez-Perpina, Eva			The Oncoprotein BCL11A Binds to Orphan Nuclear Receptor TLX and Potentiates its Transrepressive Function	PLOS ONE			English	Article							NEURAL STEM-CELLS; ANDROGEN-RECEPTOR; TAILLESS; TRANSCRIPTION; EXPRESSION; NEUROGENESIS; COREPRESSOR; PROTEINS; RECRUITS; HOMOLOG	Nuclear orphan receptor TLX (NR2E1) functions primarily as a transcriptional repressor and its pivotal role in brain development, glioblastoma, mental retardation and retinopathologies make it an attractive drug target. TLX is expressed in the neural stem cells (NSCs) of the subventricular zone and the hippocampus subgranular zone, regions with persistent neurogenesis in the adult brain, and functions as an essential regulator of NSCs maintenance and self-renewal. Little is known about the TLX social network of interactors and only few TLX coregulators are described. To identify and characterize novel TLX-binders and possible coregulators, we performed yeast-two-hybrid (Y2H) screens of a human adult brain cDNA library using different TLX constructs as baits. Our screens identified multiple clones of Atrophin-1 (ATN1), a previously described TLX interactor. In addition, we identified an interaction with the oncoprotein and zinc finger transcription factor BCL11A (CTIP1/Evi9), a key player in the hematopoietic system and in major blood-related malignancies. This interaction was validated by expression and coimmunoprecipitation in human cells. BCL11A potentiated the transrepressive function of TLX in an in vitro reporter gene assay. Our work suggests that BCL11A is a novel TLX coregulator that might be involved in TLX-dependent gene regulation in the brain.	[Estruch, Sara B.; Buzon, Victor; Carbo, Laia R.; Schorova, Lenka; Estebanez-Perpina, Eva] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Estruch, Sara B.; Buzon, Victor; Carbo, Laia R.; Schorova, Lenka; Estebanez-Perpina, Eva] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Lueders, Jens] Inst Res Biomed, Cell & Dev Biol Programme, Barcelona, Spain	University of Barcelona; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Estruch, SB (corresponding author), Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain.	evaestebanez@ub.edu	Lüders, Jens/H-2812-2015; Estebanez-Perpina, Eva/L-4021-2014	Lüders, Jens/0000-0002-9018-7977; Estebanez-Perpina, Eva/0000-0003-2687-5801	RyC fellowship; Ministerio de Ciencia e Innovacion (Gobierno de Espana) [SAF-2008-03562, SAF-2011- 29681]; Marie-Curie International Reintegration Grant [224812]; Marato de TV3 Grant-Malalties Rares; Asociacion Espanola Contra el Cancer	RyC fellowship; Ministerio de Ciencia e Innovacion (Gobierno de Espana)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie-Curie International Reintegration Grant(European Commission); Marato de TV3 Grant-Malalties Rares; Asociacion Espanola Contra el Cancer	EEP is supported by a RyC-2007 fellowship, SAF-2008-03562 and SAF-2011- 29681 projects from the Ministerio de Ciencia e Innovacion (Gobierno de Espana), a Marie-Curie International Reintegration Grant (IRG-code 224812) and the Marato de TV3 Grant-Malalties Rares (2010). SBE is recipient of a PPL Grant from the Asociacion Espanola Contra el Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Gui HX, 2011, DEV NEUROSCI-BASEL, V33, P1, DOI 10.1159/000321585; Gunnersen JM, 2002, MOL CELL NEUROSCI, V19, P560, DOI 10.1006/mcne.2001.1098; Ingraham HA, 2005, CURR OPIN STRUC BIOL, V15, P708, DOI 10.1016/j.sbi.2005.10.009; Jackson A, 1998, GENOMICS, V50, P34, DOI 10.1006/geno.1998.5270; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Kuo TY, 2007, J NEUROSCI RES, V85, P1628, DOI 10.1002/jnr.21300; Kuo TY, 2010, J NEUROSCI RES, V88, P2364, DOI 10.1002/jnr.22407; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Li WW, 2008, MOL ENDOCRINOL, V22, P56, DOI 10.1210/me.2007-0290; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; MONAGHAN AP, 1995, DEVELOPMENT, V121, P839; Qu QH, 2009, J CELL PHYSIOL, V221, P5, DOI 10.1002/jcp.21862; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Roy K, 2002, PHYSIOL BEHAV, V77, P595, DOI 10.1016/S0031-9384(02)00902-2; Sankaran VG, 2010, ANN NY ACAD SCI, V1202, P64, DOI 10.1111/j.1749-6632.2010.05574.x; Shen Y, 2009, CELL MOL LIFE SCI, V66, P437, DOI 10.1007/s00018-008-8403-9; Shen YG, 2007, J BIOL CHEM, V282, P5037, DOI 10.1074/jbc.M610274200; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Suzuki Y, 2011, INT J CLIN EXP PATHO, V4, P378; Teixido-Travesa N, 2010, MOL BIOL CELL, V21, P3963, DOI 10.1091/mbc.E10-05-0408; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Wang L, 2008, NUCL RECEPT SIGNAL, P6; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; Young KA, 2002, BEHAV BRAIN RES, V132, P145, DOI 10.1016/S0166-4328(01)00413-2; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Yu RT, 2000, P NATL ACAD SCI USA, V97, P2621, DOI 10.1073/pnas.050566897; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606; Zhang S, 2002, CELL, V108, P45, DOI 10.1016/S0092-8674(01)00630-4	41	22	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37963	10.1371/journal.pone.0037963	http://dx.doi.org/10.1371/journal.pone.0037963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675500	Green Published, gold			2022-12-27	WOS:000305341700029
J	Nagelkerken, I; Grol, MGG; Mumby, PJ				Nagelkerken, Ivan; Grol, Monique G. G.; Mumby, Peter J.			Effects of Marine Reserves versus Nursery Habitat Availability on Structure of Reef Fish Communities	PLOS ONE			English	Article							CORAL-REEFS; SEAGRASS BEDS; PROTECTED AREAS; CLIMATE-CHANGE; MANGROVES; CONNECTIVITY; RESILIENCE; FISHERIES; PATTERNS; PREDATOR	No-take marine fishery reserves sustain commercial stocks by acting as buffers against overexploitation and enhancing fishery catches in adjacent areas through spillover. Likewise, nursery habitats such as mangroves enhance populations of some species in adjacent habitats. However, there is lack of understanding of the magnitude of stock enhancement and the effects on community structure when both protection from fishing and access to nurseries concurrently act as drivers of fish population dynamics. In this study we test the separate as well as interactive effects of marine reserves and nursery habitat proximity on structure and abundance of coral reef fish communities. Reserves had no effect on fish community composition, while proximity to nursery habitat only had a significant effect on community structure of species that use mangroves or seagrass beds as nurseries. In terms of reef fish biomass, proximity to nursery habitat by far outweighed (biomass 249% higher than that in areas with no nursery access) the effects of protection from fishing in reserves (biomass 21% lower than non-reserve areas) for small nursery fish (<= 25 cm total length). For large-bodied individuals of nursery species (>25 cm total length), an additive effect was present for these two factors, although fish benefited more from fishing protection (203% higher biomass) than from proximity to nurseries (139% higher). The magnitude of elevated biomass for small fish on coral reefs due to proximity to nurseries was such that nursery habitats seem able to overrule the usually positive effects on fish biomass by reef reserves. As a result, conservation of nursery habitats gains importance and more consideration should be given to the ecological processes that occur along nursery-reef boundaries that connect neighboring ecosystems.	[Nagelkerken, Ivan; Grol, Monique G. G.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands; [Nagelkerken, Ivan] Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA, Australia; [Mumby, Peter J.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, Brisbane, Qld, Australia	Radboud University Nijmegen; University of Adelaide; University of Queensland	Nagelkerken, I (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands.	ivan.nagelkerken@adelaide.edu.au	Nagelkerken, Ivan/E-1093-2011; Mumby, Peter/F-9914-2010	Nagelkerken, Ivan/0000-0003-4499-3940; Mumby, Peter/0000-0002-6297-9053	Dutch Organization for Scientific Research (NWO); ARC; EU; Department of Environment at Grand Cayman; Natural Environment Research Council [NE/G017344/1] Funding Source: researchfish; NERC [NE/G017344/1] Funding Source: UKRI	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ARC(Australian Research Council); EU(European Commission); Department of Environment at Grand Cayman; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by a Vidi grant from the Dutch Organization for Scientific Research (NWO) to I. Nagelkerken. P.J. Mumby was funded by an ARC Laureate Fellowship and EU FORCE Project. Additional financial support for the field work was provided by the Department of Environment at Grand Cayman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2006, FISH B-NOAA, V104, P360; Aburto-Oropeza O, 2009, MAR BIOL, V156, P2461, DOI 10.1007/s00227-009-1271-5; Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; [Anonymous], 1988, NMFSSEFC215 NOAA; Ault JS, 2006, B MAR SCI, V78, P633; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clifton KE, 1998, REV BIOL TROP, V46, P109; Depczynski M, 2007, OECOLOGIA, V153, P111, DOI 10.1007/s00442-007-0714-2; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Dorenbosch M, 2006, BIOL CONSERV, V129, P277, DOI 10.1016/j.biocon.2005.10.032; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Grol MGG, 2011, OECOLOGIA, V165, P79, DOI 10.1007/s00442-010-1833-8; Harborne AR, 2008, J APPL ECOL, V45, P1010, DOI 10.1111/j.1365-2664.2008.01490.x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jones DL, 2010, MAR ECOL PROG SER, V401, P245, DOI 10.3354/meps08404; Karnauskas M, 2011, MAR ECOL PROG SER, V432, P235, DOI 10.3354/meps09151; Kellner JB, 2007, ECOL APPL, V17, P1039, DOI 10.1890/05-1845; Kendall MS, 2004, AQUAT CONSERV, V14, P113, DOI 10.1002/aqc.601; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Lamb RW, 2010, MAR ECOL PROG SER, V408, P169, DOI 10.3354/meps08509; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; Micheli F, 2004, B MAR SCI, V74, P653; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby P. J., 2004, NATURE, V423, P280; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Munro JL., 1983, CARIBBEAN CORAL REEF, V2, P1; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2000, MAR ECOL PROG SER, V202, P175, DOI 10.3354/meps202175; Nagelkerken I, 2007, B MAR SCI, V80, P595; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; Nakamura Y, 2008, MAR ECOL PROG SER, V355, P257, DOI 10.3354/meps07234; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Spalding M., 2003, WORLD ATLAS SEAGRASS, P5; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stallings CD, 2009, MAR ECOL PROG SER, V383, P251, DOI 10.3354/meps08004; Stone R, 2007, SCIENCE, V316, P678, DOI 10.1126/science.316.5825.678; Verweij MC, 2008, LIMNOL OCEANOGR, V53, P1540, DOI 10.4319/lo.2008.53.4.1540; Verweij MC, 2007, HYDROBIOLOGIA, V592, P257, DOI 10.1007/s10750-007-0772-9; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Wood L MPA news, MPA NEWS, V6	51	71	71	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36906	10.1371/journal.pone.0036906	http://dx.doi.org/10.1371/journal.pone.0036906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675474	Green Published, gold			2022-12-27	WOS:000305341700008
J	Abdelmagid, SM; Barr, AE; Rico, M; Amin, M; Litvin, J; Popoff, SN; Safadi, FF; Barbe, MF				Abdelmagid, Samir M.; Barr, Ann E.; Rico, Mario; Amin, Mamta; Litvin, Judith; Popoff, Steven N.; Safadi, Fayez F.; Barbe, Mary F.			Performance of Repetitive Tasks Induces Decreased Grip Strength and Increased Fibrogenic Proteins in Skeletal Muscle: Role of Force and Inflammation	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; CARPAL-TUNNEL-SYNDROME; FACTOR GENE-EXPRESSION; FLEXOR TENDON CELLS; TNF-ALPHA; RAT MODEL; IN-VIVO; STRAIN INJURY; LENGTHENING CONTRACTIONS	Background: This study elucidates exposure-response relationships between performance of repetitive tasks, grip strength declines, and fibrogenic-related protein changes in muscles, and their link to inflammation. Specifically, we examined forearm flexor digitorum muscles for changes in connective tissue growth factor (CTGF; a matrix protein associated with fibrosis), collagen type I (Col1; a matrix component), and transforming growth factor beta 1 (TGFB1; an upstream modulator of CTGF and collagen), in rats performing one of two repetitive tasks, with or without anti-inflammatory drugs. Methodology/Results: To examine the roles of force versus repetition, rats performed either a high repetition negligible force food retrieval task (HRNF), or a high repetition high force handle-pulling task (HRHF), for up to 9 weeks, with results compared to trained only (TR-NF or TR-HF) and normal control rats. Grip strength declined with both tasks, with the greatest declines in 9-week HRHF rats. Quantitative PCR (qPCR) analyses of HRNF muscles showed increased expression of Col1 in weeks 3-9, and CTGF in weeks 6 and 9. Immunohistochemistry confirmed PCR results, and also showed greater increases of CTGF and collagen matrix in 9-week HRHF rats than 9-week HRNF rats. ELISA, and immunohistochemistry revealed greater increases of TGFB1 in TR-HF and 6-week HRHF, compared to 6-week HRNF rats. To examine the role of inflammation, results from 6-week HRHF rats were compared to rats receiving ibuprofen or anti-TNF-alpha treatment in HRHF weeks 4-6. Both treatments attenuated HRHF-induced increases in CTGF and fibrosis by 6 weeks of task performance. Ibuprofen attenuated TGFB1 increases and grip strength declines, matching our prior results with anti-TNF alpha. Conclusions/Significance: Performance of highly repetitive tasks was associated with force-dependent declines in grip strength and increased fibrogenic-related proteins in flexor digitorum muscles. These changes were attenuated, at least short-term, by anti-inflammatory treatments.	[Abdelmagid, Samir M.] Childrens Hosp Philadelphia, Dept Surg, Plast & Reconstruct Div, Philadelphia, PA 19104 USA; [Barr, Ann E.] Univ Pacific, Coll Hlth Profess, Hillsboro, OR USA; [Rico, Mario] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Amin, Mamta; Litvin, Judith; Popoff, Steven N.; Barbe, Mary F.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA; [Litvin, Judith; Popoff, Steven N.; Safadi, Fayez F.; Barbe, Mary F.] Temple Univ, Sch Med, Musculoskeletal Res Grp, Philadelphia, PA 19122 USA; [Safadi, Fayez F.] NE Ohio Med Univ NEOMED, Dept Anat & Neurobiol, Rootstown, OH USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of the Pacific; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Northeast Ohio Medical University (NEOMED)	Abdelmagid, SM (corresponding author), Childrens Hosp Philadelphia, Dept Surg, Plast & Reconstruct Div, Philadelphia, PA 19104 USA.	mary.barbe@temple.edu	Safadi, Fayez/AAU-8699-2021	Barbe, Mary/0000-0002-5235-9803; Rico, Mario/0000-0002-1356-0416	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) [AR056019, AR051212]; National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) [OH-8599]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U01OH008599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051212, R01AR056019] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by Grant Numbers AR056019 to MFB and AR051212 AEB from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH), and by Grant Number OH-8599 to MFB from the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SM, 2010, J CELL BIOCHEM, V111, P295, DOI 10.1002/jcb.22702; Al-Shatti T, 2005, J NEUROIMMUNOL, V167, P13, DOI 10.1016/j.jneuroim.2005.06.013; Bahcecioglu IH, 2008, INFLAMMATION, V31, P215, DOI 10.1007/s10753-008-9067-1; Baker BA, 2007, MED SCI SPORT EXER, V39, P1275, DOI 10.1249/mss.0b013e3180686dc7; Banes AJ, 1999, OSTEOARTHR CARTILAGE, V7, P141, DOI 10.1053/joca.1998.0169; Barbe MF, 2008, J ORTHOP RES, V26, P1320, DOI 10.1002/jor.20674; Barbe MF, 2003, J ORTHOPAED RES, V21, P167, DOI 10.1016/S0736-0266(02)00086-4; Barr AE, 2003, J BONE MINER RES, V18, P2023, DOI 10.1359/jbmr.2003.18.11.2023; Beddy D, 2006, BRIT J SURG, V93, P1290, DOI 10.1002/bjs.5431; Bosetti M, 2012, J TISSUE ENG REGEN M, V6, P205, DOI [10.1002/term.416, 10.1002/term.1526]; Bureau of Labor Statistics, 2010, BUR LAB STAT PUBL; Byl NN, 2007, ILAR J, V48, P411, DOI 10.1093/ilar.48.4.411; Clark BD, 2004, J ORTHOP SPORT PHYS, V34, P244, DOI 10.2519/jospt.2004.34.5.244; Clark BD, 2003, J NEUROTRAUM, V20, P681, DOI 10.1089/089771503322144590; Clarke MSF, 1996, FASEB J, V10, P502, DOI 10.1096/fasebj.10.4.8647349; Coq JO, 2009, EXP NEUROL, V220, P234, DOI 10.1016/j.expneurol.2009.08.008; Cutlip RG, 2006, APPL PHYSIOL NUTR ME, V31, P573, DOI 10.1139/H06-033; Czarkowska-Paczek B, 2009, J PHYSIOL PHARMACOL, V60, P157; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Driban JB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/691412; Elliott MB, 2010, NEUROSCIENCE, V170, P929, DOI 10.1016/j.neuroscience.2010.07.041; Elliott MB, 2008, BRAIN RES, V1218, P103, DOI 10.1016/j.brainres.2008.04.029; Elliott MB, 2009, NEUROSCI LETT, V454, P34, DOI 10.1016/j.neulet.2009.01.037; Fedorczyk JM, 2010, J ORTHOP RES, V28, P298, DOI 10.1002/jor.20984; FEIT H, 1989, MUSCLE NERVE, V12, P486, DOI 10.1002/mus.880120609; FibroGen, 2012, ANTICTGF MON ANT; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Garrett Q, 2004, INVEST OPHTH VIS SCI, V45, P1109, DOI 10.1167/iovs.03-0660; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Harwood FL, 1999, WOUND REPAIR REGEN, V7, P381, DOI 10.1046/j.1524-475X.1999.00381.x; HARWOOD R, 1976, BIOCHEM J, V156, P81, DOI 10.1042/bj1560081; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Iwasaki T, 2005, AM J PHYSIOL-ENDOC M, V288, pE1222, DOI 10.1152/ajpendo.00370.2004; Khan SB, 2005, KIDNEY INT, V67, P1812, DOI 10.1111/j.1523-1755.2005.00279.x; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Krentz JR, 2008, APPL PHYSIOL NUTR ME, V33, P470, DOI 10.1139/H08-019; Lapointe BM, 2002, AM J PHYSIOL-REG I, V282, pR323, DOI 10.1152/ajpregu.00339.2001; LARSSON B, 1992, ACTA ORTHOP SCAND, V63, P203, DOI 10.3109/17453679209154824; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Machida M, 2010, J PHYSIOL PHARMACOL, V61, P559; Martinez-Salgado C, 2006, EXP CELL RES, V312, P2093, DOI 10.1016/j.yexcr.2006.03.008; Nakama LH, 2006, J ORTHOP RES, V24, P393, DOI 10.1002/jor.20053; NIOSH, 2011, NAT MAN AG JUN 2010; Paradis V, 2002, LAB INVEST, V82, P767, DOI 10.1097/01.LAB.0000017365.18894.D3; Rani S, 2010, J CELL PHYSIOL, V225, P152, DOI 10.1002/jcp.22208; Rani S, 2009, J HISTOCHEM CYTOCHEM, V57, P1061, DOI 10.1369/jhc.2009.954081; Rani S, 2009, BONE, V44, P502, DOI 10.1016/j.bone.2008.11.012; Rice TL, 2008, BRIT J SPORT MED, V42, P758, DOI 10.1136/bjsm.2007.038067; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; Schafers M, 2003, PAIN, V104, P579, DOI 10.1016/S0304-3959(03)00115-5; Shen W, 2008, J CELL PHYSIOL, V214, P405, DOI 10.1002/jcp.21212; Sjogaard G, 2010, EUR J APPL PHYSIOL, V108, P657, DOI 10.1007/s00421-009-1268-2; Smith CA, 2007, J APPL PHYSIOL, V102, P755, DOI 10.1152/japplphysiol.01503.2005; Soltow QA, 2006, MED SCI SPORT EXER, V38, P840, DOI 10.1249/01.mss.0000218142.98704.66; Sommerich CM, 2007, J ORTHOP RES, V25, P713, DOI 10.1002/jor.20363; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Sonnylal S, 2010, ARTHRITIS RHEUM-US, V62, P1523, DOI 10.1002/art.27382; Stauber WT, 1996, MUSCLE NERVE, V19, P423, DOI 10.1002/mus.880190402; STAUBER WT, 1990, J APPL PHYSIOL, V69, P868, DOI 10.1152/jappl.1990.69.3.868; Stauber WT, 2000, MUSCLE NERVE, V23, P1819, DOI 10.1002/1097-4598(200012)23:12<1819::AID-MUS4>3.0.CO;2-2; Topp KS, 1999, MOVEMENT DISORD, V14, P295, DOI 10.1002/1531-8257(199903)14:2<295::AID-MDS1015>3.0.CO;2-J; Trappe TA, 2011, AM J PHYSIOL-REG I, V300, pR655, DOI 10.1152/ajpregu.00611.2010; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Willems MET, 2010, J PHYSIOL SCI, V60, P143, DOI 10.1007/s12576-009-0078-y; Williams RO, 2000, J IMMUNOL, V165, P7240, DOI 10.4049/jimmunol.165.12.7240; Yu F, 2009, CELL SIGNAL, V21, P867, DOI 10.1016/j.cellsig.2009.01.030; Ziltener J. -L., 2010, Annals of Physical and Rehabilitation Medicine, V53, P278, DOI 10.1016/j.rehab.2010.03.001	71	46	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38359	10.1371/journal.pone.0038359	http://dx.doi.org/10.1371/journal.pone.0038359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675458	gold, Green Published			2022-12-27	WOS:000305338500139
J	Hao, J; Meng, LQ; Xu, PC; Chen, M; Zhao, MH				Hao, Jian; Meng, Li-Qiang; Xu, Peng-Cheng; Chen, Min; Zhao, Ming-Hui			p38MAPK, ERK and PI3K Signaling Pathways Are Involved in C5a-Primed Neutrophils for ANCA-Mediated Activation	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; PROTEIN-KINASE; ANTIMYELOPEROXIDASE ANTIBODIES; MOLECULAR-STRUCTURE; REGULATED KINASE; GLOMERULONEPHRITIS; MYELOPEROXIDASE; AUTOANTIBODIES; INHIBITION; VASCULITIS	Background: The complement system is one of the important contributing factors in the development of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). C5a and the neutrophil C5a receptor play a central role in antineutrophil cytoplasmic antibody (ANCA)-mediated neutrophil recruitment and activation. The current study further investigated the signaling pathways of C5a-mediated priming of human neutrophils for ANCA-induced neutrophil activation. Methodology/Principal Findings: The effects of the p38 mitogen-activated protein kinase (p38MAPK) inhibitor (SB202190), extracellular signal-regulated kinase (ERK) inhibitor (PD98059), c-Jun N-terminal kinase (JNK) inhibitor (6o) and phosphoinositol 3-kinase (PI3K) inhibitor (LY294002) were tested on respiratory burst and degranulation of C5a-primed neutrophils activated with ANCA, as well as on C5a-induced increase in expression of membrane-bound PR3 (mPR3) on neutrophils. For C5a-primed neutrophils for MPO-ANCA-induced respiratory burst, the mean fluorescence intensity (MFI) value was 254.8 +/- 67.1, which decreased to 203.6 +/- 60.3, 204.4 +/- 36.7, 202.4 +/- 49.9 and 188 +/- 47.9 upon pre-incubation with SB202190, PD98059, LY294002 and the mixture of above-mentioned three inhibitors (compared with that without inhibitors, P<0.01, P<0.05, P<0.01 and P<0.05), respectively. For PR3-ANCA-positive IgG, the MFI value increased in C5a-primed neutrophils, which decreased upon pre-incubation with above-mentioned inhibitors. The lactoferrin concentration increased in C5a-primed neutrophils induced by MPO or PR3-ANCA-positive IgG supernatant and decreased upon preincubation with above-mentioned three inhibitors. mPR3 expression increased from 923.3 +/- 182.4 in untreated cells to 1278.3 +/- 299.3 after C5a treatment and decreased to 1069.9 +/- 188.9, 1100 +/- 238.2, 1092.3 +/- 231.8 and 1053.9 +/- 200.3 by SB202190, PD98059, LY294002 and the mixture of above-mentioned three inhibitors (compared with that without inhibitors, P<0.01, P<0.05, P<0.01 and P<0.01), respectively. Conclusions/Significance: Activation of p38MAPK, ERK and PI3K are important steps in the translocation of ANCA antigens and C5a-induced activation of neutrophils by ANCA.	[Hao, Jian; Meng, Li-Qiang; Xu, Peng-Cheng; Chen, Min; Zhao, Ming-Hui] Peking Univ, Minist Hlth China, Key Lab Renal Dis, Renal Div,Dept Med,Inst Nephrol,Hosp 1, Beijing 100871, Peoples R China; [Hao, Jian] Inner Mongolia Med Coll, Affiliated Hosp, Dept Med, Div Renal, Hohhot, Inner Mongolia, Peoples R China	Peking University; Inner Mongolia Medical University	Hao, J (corresponding author), Peking Univ, Minist Hlth China, Key Lab Renal Dis, Renal Div,Dept Med,Inst Nephrol,Hosp 1, Beijing 100871, Peoples R China.	leimeng@public3.bta.net.cn	Xu, Pengcheng/J-1429-2012	Xu, Pengcheng/0000-0001-8651-208X	Chinese 973 project [2012CB517702]; National Natural Science Fund [30972733, 81021004]	Chinese 973 project(National Basic Research Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This study is supported by a grant of Chinese 973 project (No. 2012CB517702) and two grants from the National Natural Science Fund (No. 30972733 and No. 81021004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9; CHARLES LA, 1991, J LEUKOCYTE BIOL, V50, P539, DOI 10.1002/jlb.50.6.539; Choi M, 2003, KIDNEY INT, V63, P96, DOI 10.1046/j.1523-1755.2003.00718.x; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Franssen CFM, 1999, J AM SOC NEPHROL, V10, P1506; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hess C, 2000, BLOOD, V96, P2822; Hewins P, 2006, KIDNEY INT, V69, P605, DOI 10.1038/sj.ki.5000167; Huugen D, 2007, KIDNEY INT, V71, P646, DOI 10.1038/sj.ki.5002103; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kauskot A, 2007, J BIOL CHEM, V282, P31990, DOI 10.1074/jbc.M701596200; KEOGAN MT, 1992, CLIN EXP IMMUNOL, V90, P228; Kettritz R, 2001, J AM SOC NEPHROL, V12, P37, DOI 10.1681/ASN.V12137; Kettritz R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019411.36000.06; LONNERDAL B, 1995, ANNU REV NUTR, V15, P93, DOI 10.1146/annurev.nu.15.070195.000521; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; MULDER AHL, 1994, CLIN EXP IMMUNOL, V98, P270; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; PORGES AJ, 1994, J IMMUNOL, V153, P1271; REUMAUX D, 1995, BLOOD, V86, P3189; Rodriguez-Franco Dora Alicia, 2005, Rev Latinoam Microbiol, V47, P102; Runden E, 1998, J NEUROSCI, V18, P7296; Schaeffer V, 2007, SHOCK, V27, P623, DOI 10.1097/SHK.0b013e31802fa0bd; Schreiber A, 2010, KIDNEY INT, V77, P118, DOI 10.1038/ki.2009.420; Schreiber A, 2009, J AM SOC NEPHROL, V20, P289, DOI 10.1681/ASN.2008050497; Talor MV, 2007, CLIN EXP IMMUNOL, V150, P42, DOI 10.1111/j.1365-2249.2007.03453.x; van der Veen BS, 2011, ANN RHEUM DIS, V70, P356, DOI 10.1136/ard.2010.129106; Veeranna, 1998, J NEUROSCI, V18, P4008; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; Wrann CD, 2007, J IMMUNOL, V178, P5940, DOI 10.4049/jimmunol.178.9.5940; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Xiao H, 2005, AM J PATHOL, V167, P39, DOI 10.1016/S0002-9440(10)62951-3; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; Xing GQ, 2009, J CLIN IMMUNOL, V29, P282, DOI 10.1007/s10875-008-9268-2; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946	37	60	67	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38317	10.1371/journal.pone.0038317	http://dx.doi.org/10.1371/journal.pone.0038317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675451	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500129
J	Dafforn, KA; Glasby, TM; Johnston, EL				Dafforn, Katherine A.; Glasby, Tim M.; Johnston, Emma L.			Comparing the Invasibility of Experimental "Reefs" with Field Observations of Natural Reefs and Artificial Structures	PLOS ONE			English	Article							SUBTIDAL EPIBIOTIC ASSEMBLAGES; FRAGILE SSP TOMENTOSOIDES; NORTH ADRIATIC SEA; BIOLOGICAL INVASIONS; BIOTIC RESISTANCE; PLANT INVASIONS; COMMUNITY INVASIBILITY; MARINE-INVERTEBRATES; ALGAL ASSEMBLAGES; SPECIES-DIVERSITY	Natural systems are increasingly being modified by the addition of artificial habitats which may facilitate invasion. Where invaders are able to disperse from artificial habitats, their impact may spread to surrounding natural communities and therefore it is important to investigate potential factors that reduce or enhance invasibility. We surveyed the distribution of non-indigenous and native invertebrates and algae between artificial habitats and natural reefs in a marine subtidal system. We also deployed sandstone plates as experimental 'reefs' and manipulated the orientation, starting assemblage and degree of shading. Invertebrates (non-indigenous and native) appeared to be responding to similar environmental factors (e. g. orientation) and occupied most space on artificial structures and to a lesser extent reef walls. Non-indigenous invertebrates are less successful than native invertebrates on horizontal reefs despite functional similarities. Manipulative experiments revealed that even when non-indigenous invertebrates invade vertical "reefs", they are unlikely to gain a foothold and never exceed covers of native invertebrates (regardless of space availability). Community ecology suggests that invertebrates will dominate reef walls and algae horizontal reefs due to functional differences, however our surveys revealed that native algae dominate both vertical and horizontal reefs in shallow estuarine systems. Few non-indigenous algae were sampled in the study, however where invasive algal species are present in a system, they may present a threat to reef communities. Our findings suggest that non-indigenous species are less successful at occupying space on reef compared to artificial structures, and manipulations of biotic and abiotic conditions (primarily orientation and to a lesser extent biotic resistance) on experimental "reefs" explained a large portion of this variation, however they could not fully explain the magnitude of differences.	[Dafforn, Katherine A.; Johnston, Emma L.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Glasby, Tim M.] Port Stephens Fisheries Inst, New S Wales Dept Primary Ind, Nelson Bay, NSW, Australia	University of New South Wales Sydney; NSW Department of Primary Industries	Dafforn, KA (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	k.dafforn@unsw.edu.au	Glasby, Tim M/Q-3670-2016; Glasby, Tim/AGR-1689-2022; Johnston, Emma/AAC-2878-2022; Johnston, Emma L/B-7210-2009; Dafforn, Katherine A/J-9647-2013	Glasby, Tim M/0000-0001-5011-7731; Glasby, Tim/0000-0001-5011-7731; Johnston, Emma/0000-0002-2117-366X; Johnston, Emma L/0000-0002-2117-366X; Dafforn, Katherine A/0000-0001-8848-377X	New South Wales Department of Primary Industries (NSW DPI); Australian Research Council (ARC) Grant	New South Wales Department of Primary Industries (NSW DPI); Australian Research Council (ARC) Grant(Australian Research Council)	This research was funded by New South Wales Department of Primary Industries (NSW DPI) and an Australian Research Council (ARC) Grant awarded to ELJ and TMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; ANDERSON MJ, 1994, J EXP MAR BIOL ECOL, V184, P217, DOI 10.1016/0022-0981(94)90006-X; Arenas F, 2006, J MAR BIOL ASSOC UK, V86, P1329, DOI 10.1017/S0025315406014354; Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; Baynes TW, 1999, B MAR SCI, V64, P419; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Brown GP, 2006, BIOL CONSERV, V133, P88, DOI 10.1016/j.biocon.2006.05.020; Bulleri F, 2006, HYDROBIOLOGIA, V555, P263, DOI 10.1007/s10750-005-1122-4; Bulleri F, 2005, J APPL ECOL, V42, P1063, DOI 10.1111/j.1365-2664.2005.01096.x; BULLOCK JM, 1995, OIKOS, V72, P273, DOI 10.2307/3546229; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Campbell RW, 1995, BIRDS N AM ACAD NATU; Canning-Clode J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018026; Carlton JT, 1996, ECOLOGY, V77, P1653, DOI 10.2307/2265767; Case C.M., 2000, Biological Invasions, V2, P103, DOI 10.1023/A:1010084305933; CHAPMAN JW, 1991, J CRUSTACEAN BIOL, V11, P386, DOI 10.2307/1548465; Clarke Kevin M., 2008, Urban Ecosystems, V11, P317, DOI 10.1007/s11252-008-0065-8; Clynick BG, 2007, MAR ECOL PROG SER, V332, P201, DOI 10.3354/meps332201; Dafforn KA, 2009, BIOFOULING, V25, P277, DOI 10.1080/08927010802710618; Dafforn KA, 2009, DIVERS DISTRIB, V15, P807, DOI 10.1111/j.1472-4642.2009.00587.x; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; Elton C. S., 1958, ECOLOGY INVASIONS AN; Epelbaum A, 2009, MAR BIOL, V156, P1311, DOI 10.1007/s00227-009-1172-7; Floerl O, 2003, AUSTRAL ECOL, V28, P116, DOI 10.1046/j.1442-9993.2003.01254.x; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Glasby TM, 1999, AMBIO, V28, P595; Glasby TM, 2000, J EXP MAR BIOL ECOL, V248, P177, DOI 10.1016/S0022-0981(00)00169-6; Glasby TM, 2001, MAR ECOL PROG SER, V214, P127, DOI 10.3354/meps214127; Glasby TM, 1999, ESTUAR COAST SHELF S, V48, P281, DOI 10.1006/ecss.1998.0417; Glasby TM, 1999, J EXP MAR BIOL ECOL, V234, P275, DOI 10.1016/S0022-0981(98)00156-7; Glasby TM, 1999, MAR ECOL PROG SER, V190, P113, DOI 10.3354/meps190113; Gollasch S, 2002, BIOFOULING, V18, P105, DOI 10.1080/08927010290011361; Halfwerk W, 2011, P NATL ACAD SCI USA, V108, P14549, DOI 10.1073/pnas.1109091108; Irving AD, 2002, MAR ECOL PROG SER, V245, P83, DOI 10.3354/meps245083; KEOUGH MJ, 1984, ECOLOGY, V65, P423, DOI 10.2307/1941405; Knott NA, 2004, J MAR BIOL ASSOC UK, V84, P1117, DOI 10.1017/S0025315404010550h; Kowarik I., 2008, URBAN ECOLOGY INT PE, P321, DOI DOI 10.1007/978-0-387-73412-5_20; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Lohrer AM, 2008, ECOLOGY, V89, P1299, DOI 10.1890/07-0421.1; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; Miller RJ, 2008, ECOLOGY, V89, P452, DOI 10.1890/06-1099.1; Mineur F, 2007, MAR BIOL, V151, P1299, DOI 10.1007/s00227-006-0567-y; MOOK D, 1983, ESTUARIES, V6, P372, DOI 10.2307/1351396; OSMAN RW, 1992, MAR ECOL PROG SER, V83, P35, DOI 10.3354/meps083035; OSMAN RW, 1977, ECOL MONOGR, V47, P37, DOI 10.2307/1942223; Ostroumov SA, 2005, HYDROBIOLOGIA, V542, P275, DOI 10.1007/s10750-004-1875-1; Parker JD, 2005, ECOL LETT, V8, P959, DOI 10.1111/j.1461-0248.2005.00799.x; Parris KM, 2005, BIOL CONSERV, V124, P267, DOI 10.1016/j.biocon.2005.01.035; Peh KSH, 2002, J WILDLIFE MANAGE, V66, P1128, DOI 10.2307/3802944; Perkol-Finkel S, 2007, J EXP MAR BIOL ECOL, V340, P25, DOI 10.1016/j.jembe.2006.08.008; Petren K, 1996, ECOLOGY, V77, P118, DOI 10.2307/2265661; Pettengill JB, 2007, BIOFOULING, V23, P161, DOI 10.1080/08927010701218952; Pintor LM, 2011, BIOL INVASIONS, V13, P1357, DOI 10.1007/s10530-010-9894-5; Piola RF, 2008, DIVERS DISTRIB, V14, P329, DOI 10.1111/j.1472-4642.2007.00430.x; Piola RF, 2009, BIOFOULING, V25, P633, DOI 10.1080/08927010903063065; Pranty B., 2001, NORTH AMER BIRDS, V55, P389; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; SCHMIDT GH, 1984, MAR ECOL PROG SER, V15, P251, DOI 10.3354/meps015251; Sebens KP, 1986, ECOLOGY ROCKY COASTS, P346; Simpson DA., 1984, WATSONIA J BOT SOC I, V15, P1; Sorace A, 2002, ORNIS FENNICA, V79, P60; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Stapanian MA, 1998, PLANT ECOL, V139, P49, DOI 10.1023/A:1009730702302; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; TYSER RW, 1992, CONSERV BIOL, V6, P253, DOI 10.1046/j.1523-1739.1992.620253.x; Valentine JP, 2003, J EXP MAR BIOL ECOL, V295, P63, DOI 10.1016/S0022-0981(03)00272-7; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williams SL, 2007, ANNU REV ECOL EVOL S, V38, P327, DOI 10.1146/annurev.ecolsys.38.091206.095543; Yap Charlotte A. M., 2004, Ornithological Science, V3, P57, DOI 10.2326/osj.3.57; YOUNG CM, 1984, MAR BIOL, V81, P61, DOI 10.1007/BF00397626	81	87	87	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38124	10.1371/journal.pone.0038124	http://dx.doi.org/10.1371/journal.pone.0038124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666459	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400084
J	Schellenberger, MT; Grova, N; Farinelle, S; Willieme, S; Revets, D; Muller, CP				Schellenberger, Mario T.; Grova, Nathalie; Farinelle, Sophie; Willieme, Stephanie; Revets, Dominique; Muller, Claude P.			Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; IMMUNE-COMPLEXES; LUNG-CANCER; DNA-DAMAGE; IN-VITRO; RESPONSES; MEASLES; CARRIER; CARCINOGENICITY; BENZO(A)PYRENE	The prototype polycyclic aromatic hydrocarbon benzo[a] pyrene (B[a] P) is an environmental pollutant and food contaminant of epidemiological importance. To protect against adverse effects of this ubiquitous carcinogen, we developed an immunoprophylactic strategy based on a B[a] P-protein conjugate vaccine to induce B[a] P specific antibodies (Grova et al., Vaccine. 2009; 27: 4142-51). Here, we investigated in mice the efficacy of B[a] P-peptide conjugates based on promiscuous T cell epitopes (TCE) into further improve this approach. We showed that B[a] P-peptide conjugates induced very different levels of hapten-specific antibodies with variable functional efficacy, depending on the carrier. In some cases peptide carriers induced a more efficient antibody response against B[a] P than tetanus toxoid as a protein carrier, with the capacity to sequester more B[a] P in the blood. Reducing the carrier size to a single TCE can dramatically shift the antibody bias from the carrier to the B[a] P. Conjugates based on the TCE FIGITEL induced the best anti-hapten response and no antibodies against the carrier peptide. Some peptide conjugates increased the selectivity of the antibodies for the activated metabolite 7,8-diol-B[a] P and B[a] P by one or two orders of magnitude. The antibody efficacy was also demonstrated in their ability to sequester B[a] P in the blood and modulate its faecal excretion (15-56%). We further showed that pre-existing immunity to the carrier from which the TCE was derived did not reduce the immunogenicity of the peptide conjugate. In conclusion, we showed that a vaccination against B[a] P using promiscuous TCEs of tetanus toxin as carriers is feasible even in case of a preexisting immunity to the toxoid and that some TCE epitopes dramatically redirect the antibody response to the hapten. Further studies to demonstrate a long-term protection of an immunoprophylactic immunisation against B[a] P are warranted.	[Schellenberger, Mario T.; Grova, Nathalie; Farinelle, Sophie; Willieme, Stephanie; Revets, Dominique; Muller, Claude P.] Ctr Rech Publ Sante, Inst Immunol, Natl Publ Hlth Lab, Luxembourg, Luxembourg	Luxembourg Institute of Health	Schellenberger, MT (corresponding author), Ctr Rech Publ Sante, Inst Immunol, Natl Publ Hlth Lab, Luxembourg, Luxembourg.	claude.muller@.crp-sante.lu		Grova, Nathalie/0000-0002-7042-164X	Fond National de la Recherche Luxembourg [FNR: 01/04/11]; BFR fellowship from Ministry of Health of Luxembourg [BFR06-081]; AFR fellowship [TR-PHD BFR06-081]; Fond National de la Recherche	Fond National de la Recherche Luxembourg(Luxembourg National Research Fund); BFR fellowship from Ministry of Health of Luxembourg; AFR fellowship; Fond National de la Recherche	The authors acknowledge the support of the Fond National de la Recherche Luxembourg (www.fnr.lu, Tobavac project, FNR: 01/04/11). MT Schellenberger was funded by a BFR fellowship (BFR06-081) from the Ministry of Health of Luxembourg and a AFR fellowship (TR-PHD BFR06-081) funded by the Fond National de la Recherche. The authors acknowledge the CRP-Sante (www.crp-sante.lu) and the Ministry of Health of Luxembourg for their continued support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARINGTON T, 1994, INFECT IMMUN, V62, P9, DOI 10.1128/IAI.62.1.9-14.1994; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Bouche FB, 2005, VACCINE, V23, P2074, DOI 10.1016/j.vaccine.2005.01.011; Boysen G, 2003, MUTAT RES-REV MUTAT, V543, P17, DOI 10.1016/S1383-5742(02)00068-6; Carlson EA, 2004, MAR ENVIRON RES, V58, P731, DOI 10.1016/j.marenvres.2004.03.023; CARRERA MRA, 1995, NATURE, V378, P727, DOI 10.1038/378727a0; Davila DR, 1996, TOXICOL APPL PHARM, V139, P333, DOI 10.1006/taap.1996.0173; De Buck SS, 2005, VACCINE, V23, P2403, DOI 10.1016/j.vaccine.2005.01.020; De Buck SS, 2005, J PHARMACOL EXP THER, V313, P640, DOI 10.1124/jpet.104.081034; De Buck SS, 2005, CARCINOGENESIS, V26, P835, DOI 10.1093/carcin/bgi010; De Buck SS, 2009, INT J CANCER; DEMOTZ S, 1989, J IMMUNOL, V142, P394; Deng SX, 2002, J IMMUNOL METHODS, V269, P299, DOI 10.1016/S0022-1759(02)00237-5; Food SCo, 2002, POL AR HYDR OCC FOOD; GRANOFF DM, 1994, JAMA-J AM MED ASSOC, V272, P1116, DOI 10.1001/jama.272.14.1116; Grova N, 2002, INT DAIRY J, V12, P1025, DOI 10.1016/S0958-6946(02)00126-7; Grova N, 2008, CHEMOSPHERE, V73, pS295, DOI 10.1016/j.chemosphere.2007.12.037; Grova N, 2007, NEUROTOXICOLOGY, V28, P630, DOI 10.1016/j.neuro.2007.01.010; Grova N, 2009, VACCINE, V27, P4142, DOI 10.1016/j.vaccine.2009.04.052; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Haney M, 2010, BIOL PSYCHIAT, V67, P59, DOI 10.1016/j.biopsych.2009.08.031; Hatsukami DK, 2005, CLIN PHARMACOL THER, V78, P456, DOI 10.1016/j.clpt.2005.08.007; Hecht S S, 2001, IARC Sci Publ, V154, P245; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Hecht SS, 1996, ADV EXP MED BIOL, V401, P1; Hecht SS, 1996, PREV MED, V25, P7, DOI 10.1006/pmed.1996.0004; HERZENBERG LA, 1980, NATURE, V285, P664, DOI 10.1038/285664a0; HO PC, 1990, EUR J IMMUNOL, V20, P477, DOI 10.1002/eji.1830200304; Hojrup P, 2003, PROTEOLYTIC PEPTIDE, P227; James EA, 2007, INT IMMUNOL, V19, P1291, DOI 10.1093/intimm/dxm099; Johansson AG, 1996, HEPATOLOGY, V24, P169, DOI 10.1053/jhep.1996.v24.pm0008707258; Keyler DE, 2008, INT IMMUNOPHARMACOL, V8, P1589, DOI 10.1016/j.intimp.2008.07.001; Kurikka S, 1996, VACCINE, V14, P1239, DOI 10.1016/S0264-410X(96)00025-4; LIKHACHEV AJ, 1992, PROG CLIN BIOL RES, V374, P435; LISE LD, 1987, INFECT IMMUN, V55, P2658, DOI 10.1128/IAI.55.11.2658-2661.1987; MCLEMORE TL, 1978, CANCER RES, V38, P3805; Muller CP, PEPTIDE VACCINES; Niu QA, 2010, OCCUP ENVIRON MED, V67, P444, DOI 10.1136/oem.2009.047969; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; PERERA F, 1981, ENVIRON HEALTH PERSP, V42, P163, DOI 10.2307/3429207; Polonelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026777; Prodhomme EJF, 2010, J PROTEOME RES, V9, P5598, DOI 10.1021/pr100407w; PROUGH RA, 1977, LIFE SCI, V21, P1629, DOI 10.1016/0024-3205(77)90241-7; Putz MM, 2004, VACCINE, V22, P4173, DOI 10.1016/j.vaccine.2004.06.013; ROSS JA, 1995, CANCER RES, V55, P1039; Schellenberger MT, 2011, HUM VACCINES, V7, P166, DOI 10.4161/hv.7.0.14579; Schellenberger MT, 2009, TOXICOL APPL PHARM; Silbart LK, 1997, VET HUM TOXICOL, V39, P37; Sipinen V, 2010, MUTAGENESIS, V25, P417, DOI 10.1093/mutage/geq024; SKOGH T, 1985, IMMUNOLOGY, V55, P585; SKOGH T, 1988, J CLIN LAB IMMUNOL, V27, P13; THYSSEN J, 1981, J NATL CANCER I, V66, P575; WOLTERBEEK APM, 1995, CANCER LETT, V89, P107, DOI 10.1016/0304-3835(95)90165-5; Younglai EV, 2007, CURR PHARM DESIGN, V13, P3005, DOI 10.2174/138161207782110499	55	3	3	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38329	10.1371/journal.pone.0038329	http://dx.doi.org/10.1371/journal.pone.0038329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666501	gold, Green Submitted, Green Published			2022-12-27	WOS:000305353400112
J	Wessa, P; Holliday, IE				Wessa, Patrick; Holliday, Ian E.			Does Reviewing Lead to Better Learning and Decision Making? Answers from a Randomized Stock Market Experiment	PLOS ONE			English	Article								Background: The literature is not univocal about the effects of Peer Review (PR) within the context of constructivist learning. Due to the predominant focus on using PR as an assessment tool, rather than a constructivist learning activity, and because most studies implicitly assume that the benefits of PR are limited to the reviewee, little is known about the effects upon students who are required to review their peers. Much of the theoretical debate in the literature is focused on explaining how and why constructivist learning is beneficial. At the same time these discussions are marked by an underlying presupposition of a causal relationship between reviewing and deep learning. Objectives: The purpose of the study is to investigate whether the writing of PR feedback causes students to benefit in terms of: perceived utility about statistics, actual use of statistics, better understanding of statistical concepts and associated methods, changed attitudes towards market risks, and outcomes of decisions that were made. Methods: We conducted a randomized experiment, assigning students randomly to receive PR or non-PR treatments and used two cohorts with a different time span. The paper discusses the experimental design and all the software components that we used to support the learning process: Reproducible Computing technology which allows students to reproduce or re-use statistical results from peers, Collaborative PR, and an AI-enhanced Stock Market Engine. Results: The results establish that the writing of PR feedback messages causes students to experience benefits in terms of Behavior, Non-Rote Learning, and Attitudes, provided the sequence of PR activities are maintained for a period that is sufficiently long.	[Wessa, Patrick] Katholieke Univ Leuven, Leuven Inst Res Informat Syst, Louvain, Belgium; [Holliday, Ian E.] Aston Univ, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England	KU Leuven; Aston University	Wessa, P (corresponding author), Katholieke Univ Leuven, Leuven Inst Res Informat Syst, Louvain, Belgium.	patrick@wessa.net			K.U. Leuven Association [OOF 2007/13]	K.U. Leuven Association	This research was funded by the OOF 2007/13 project of the K.U. Leuven Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten M, 2010, ED RES REV IN PRESS; Dabbagh N., 2005, INT J TECHNOLOGY TEA, V1, P25; Directorate General for Environment, 2004, GREEN WEEK DAILY, P1; Hsu MK, 2009, COMPUT HUM BEHAV, V25, P412, DOI 10.1016/j.chb.2008.10.003; Lootens T, 1999, STOCKHUNTER 1 1 SOFT; Lundstrom K, 2009, J SECOND LANG WRIT, V18, P30, DOI 10.1016/j.jslw.2008.06.002; McClave JT, 2007, STAT INLEIDING HOGER; Mondejar-Jimenez J, 2010, TEACH TEACH EDUC, V26, P688, DOI 10.1016/j.tate.2009.10.004; Poelmans S., 2009, INT C P ED NEW LEARN, P5882; R Core Team, 2018, R LANG ENV STAT COMP; Randolph J J, 2005, PRACTICAL ASSESSMENT, V10; Rosnow RL, 1996, PSYCHOL METHODS, V1, P331, DOI 10.1037/1082-989X.1.4.331; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; SMITH VL, 1988, ECONOMETRICA, V56, P1119, DOI 10.2307/1911361; Strijbos JW, 2010, LEARN INSTR, V20, P265, DOI 10.1016/j.learninstruc.2009.08.002; Strijbos JW, 2009, LEARN INSTR, V20, P291; Taylor P., 2000, TEACHING; Tillema H., 2011, STUD EDUC EVAL, V37, P25, DOI [10.1016/j.stueduc.2011.03.004, DOI 10.1016/J.STUEDUC.2011.03.004]; van Gennip NAE, 2009, EDUC RES REV-NETH, V4, P41, DOI 10.1016/j.edurev.2008.11.002; van Zundert M, 2010, LEARN INSTR, V20, P270, DOI 10.1016/j.learninstruc.2009.08.004; Wessa Patrick, 2009, 2009 WRI World Congress on Computer Science and Information Engineering (CSIE 2009), P50, DOI 10.1109/CSIE.2009.710; Wessa P, 2008, P INT C ED RES INN I; Wessa P, 2008, ADV METHODOLOGY STAT, V5, P19; Wessa P, 2010, ICERI 2010 P; WESSA P, 2010, FREE STAT SOFTWARE; Wessa P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025363; Wessa P, 2010, PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON E-LEARNING, P408; Wessa P, 2009, ELECTRON J E-LEARN, V7, P173; Wessa P, 2009, AIP CONF PROC, V1127, P86, DOI 10.1063/1.3146201; Wessa P, 2009, COMPUTATION STAT, V24, P183, DOI 10.1007/s00180-008-0107-y; Yang YF, 2010, LEARN INSTR, V20, P72, DOI 10.1016/j.learninstruc.2009.01.003	31	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37719	10.1371/journal.pone.0037719	http://dx.doi.org/10.1371/journal.pone.0037719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666385	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305353400044
J	Yamaguchi, S; Yamane, T; Takahashi-Niki, K; Kato, I; Niki, T; Goldberg, MS; Shen, J; Ishimoto, K; Doi, T; Iguchi-Ariga, SMM; Ariga, H				Yamaguchi, Shiori; Yamane, Takuya; Takahashi-Niki, Kazuko; Kato, Izumi; Niki, Takeshi; Goldberg, Matthew S.; Shen, Jie; Ishimoto, Kenji; Doi, Takefumi; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Transcriptional Activation of Low-Density Lipoprotein Receptor Gene by DJ-1 and Effect of DJ-1 on Cholesterol Homeostasis	PLOS ONE			English	Article							STEROL REGULATORY ELEMENT; DISEASE PROTEIN DJ-1; HELIX-LOOP-HELIX; PARKINSONS-DISEASE; CELL-DEATH; MITOCHONDRIAL LOCALIZATION; SERUM-LIPOPROTEINS; ANDROGEN RECEPTOR; OXIDATIVE STRESS; ANTIOXIDATIVE STRESS	DJ-1 is a novel oncogene and also causative gene for familial Parkinson's disease park7. DJ-1 has multiple functions that include transcriptional regulation, anti-oxidative reaction and chaperone and mitochondrial regulation. For transcriptional regulation, DJ-1 acts as a coactivator that binds to various transcription factors, resulting in stimulation or repression of the expression of their target genes. In this study, we found the low-density lipoprotein receptor (LDLR) gene is a transcriptional target gene for DJ-1. Reduced expression of LDLR mRNA and protein was observed in DJ-1-knockdown cells and DJ-1-knockout mice and this occurred at the transcription level. Reporter gene assays using various deletion and point mutations of the LDLR promoter showed that DJ-1 stimulated promoter activity by binding to the sterol regulatory element (SRE) with sterol regulatory element binding protein (SREBP) and that stimulating activity of DJ-1 toward LDLR promoter activity was enhanced by oxidation of DJ-1. Chromatin immunoprecipitation, gel-mobility shift and co-immunoprecipitation assays showed that DJ-1 made a complex with SREBP on the SRE. Furthermore, it was found that serum LDL cholesterol level was increased in DJ-1-knockout male, but not female, mice and that the increased serum LDL cholesterol level in DJ-1-knockout male mice was cancelled by administration with estrogen, suggesting that estrogen compensates the increased level of serum LDL cholesterol in DJ-1-knockout female mice. This is the first report that DJ-1 participates in metabolism of fatty acid synthesis through transcriptional regulation of the LDLR gene.	[Yamaguchi, Shiori; Yamane, Takuya; Takahashi-Niki, Kazuko; Kato, Izumi; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Niki, Takeshi; Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Goldberg, Matthew S.; Shen, Jie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA; [Ishimoto, Kenji; Doi, Takefumi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Hokkaido University; Hokkaido University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Osaka University	Yamaguchi, S (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan.	hiro@pharm.hokudai.ac.jp	Ariga, Hiroyoshi/B-5895-2013; Shen, Jie/GXH-9449-2022; Goldberg, Matthew/T-7827-2019; Ariga, Sanae/H-9647-2013	Ariga, Hiroyoshi/0000-0001-7384-2143; Goldberg, Matthew/0000-0002-5172-9841	Ministry of Education, Science, Culture and Sports; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan; Grants-in-Aid for Scientific Research [22300119, 23790970, 24650191, 21390014] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture and Sports and by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey M, 1999, MATURITAS, V33, P259, DOI 10.1016/S0378-5122(99)00054-7; Anthony MS, 1998, AM J CLIN NUTR, V68, p1390S, DOI 10.1093/ajcn/68.6.1390S; ARIGA H, 1983, J VIROL, V48, P481, DOI 10.1128/JVI.48.2.481-491.1983; ARIGA H, 1989, EMBO J, V8, P4273, DOI 10.1002/j.1460-2075.1989.tb08613.x; Bennett MK, 1999, J BIOL CHEM, V274, P13025, DOI 10.1074/jbc.274.19.13025; Berthold HK, 1998, JAMA-J AM MED ASSOC, V279, P1900, DOI 10.1001/jama.279.23.1900; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bruning JC, 2003, J STEROID BIOCHEM, V86, P113, DOI 10.1016/S0960-0760(03)00263-2; CAMUS MC, 1983, J LIPID RES, V24, P1210; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hayashi T, 2009, BIOCHEM BIOPH RES CO, V390, P667, DOI 10.1016/j.bbrc.2009.10.025; Hirata F, 1996, ATHEROSCLEROSIS, V122, P135, DOI 10.1016/0021-9150(95)05769-2; Hst KH, 1981, J IMMUNOL, V126, P1909; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Huang XM, 2008, MOVEMENT DISORD, V23, P1013, DOI 10.1002/mds.22013; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Ishimoto K, 2006, FEBS LETT, V580, P4929, DOI 10.1016/j.febslet.2006.08.010; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Khor HT, 2000, INT J FOOD SCI NUTR, V51, pS3, DOI 10.1080/096374800750049521; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim YC, 2009, INT J ONCOL, V35, P1331, DOI 10.3892/ijo_00000451; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Koide-Yoshida S, 2007, INT J MOL MED, V19, P885; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; MILLS GL, 1971, COMP BIOCHEM PHYSIOL, V40, P489, DOI 10.1016/0305-0491(71)90234-3; Mo JS, 2010, J CELL BIOCHEM, V110, P229, DOI 10.1002/jcb.22530; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Niki T, 2003, MOL CANCER RES, V1, P247; Nishinaga H, 2005, NEUROSCI LETT, V390, P54, DOI 10.1016/j.neulet.2005.07.053; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Ooe H, 2005, TOXICOL SCI, V88, P114, DOI 10.1093/toxsci/kfi278; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Rishi V, 2004, J BIOL CHEM, V279, P11863, DOI 10.1074/jbc.M308000200; Rustembegovic Avdo, 2006, Med Arh, V60, P211; SATO R, 1994, J BIOL CHEM, V269, P17267; Sekito A, 2006, FREE RADICAL RES, V40, P155, DOI 10.1080/10715760500456847; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Shinbo YM, 2005, INT J ONCOL, V26, P641; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Valk-de Roo GW, 1999, ARTERIOSCLER THROMB, V19, P2993; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; WALSH BW, 1991, NEW ENGL J MED, V325, P1196, DOI 10.1056/NEJM199110243251702; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	66	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38144	10.1371/journal.pone.0038144	http://dx.doi.org/10.1371/journal.pone.0038144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666465	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400090
J	Hutson, JR; Stade, B; Lehotay, DC; Collier, CP; Kapur, BM				Hutson, Janine R.; Stade, Brenda; Lehotay, Denis C.; Collier, Christine P.; Kapur, Bhushan M.			Folic Acid Transport to the Human Fetus Is Decreased in Pregnancies with Chronic Alcohol Exposure	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; BLOOD-CELL FOLATE; VITAMIN-B-12 CONCENTRATIONS; S-ADENOSYLMETHIONINE; ETHANOL EXPOSURE; OXIDATIVE STRESS; MATERNAL PLASMA; BIRTH-WEIGHT; FORMIC-ACID; B-VITAMINS	Background: During pregnancy, the demand for folic acid increases since the fetus requires this nutrient for its rapid growth and cell proliferation. The placenta concentrates folic acid into the fetal circulation; as a result the fetal levels are 2 to 4 times higher than the maternal level. Animal and in vitro studies have suggested that alcohol may impair transport of folic acid across the placenta by decreasing expression of transport proteins. We aim to determine if folate transfer to the fetus is altered in human pregnancies with chronic alcohol consumption. Methodology/Principal Findings: Serum folate was measured in maternal blood and umbilical cord blood at the time of delivery in pregnancies with chronic and heavy alcohol exposure (n = 23) and in non-drinking controls (n = 24). In the alcohol-exposed pairs, the fetal: maternal serum folate ratio was <= 1.0 in over half (n = 14), whereas all but one of the controls were >1.0. Mean folate in cord samples was lower in the alcohol-exposed group than in the controls (33.15 +/- 19.89 vs 45.91 +/- 20.73, p = 0.04). Conclusions/Significance: Our results demonstrate that chronic and heavy alcohol use in pregnancy impairs folate transport to the fetus. Altered folate concentrations within the placenta and in the fetus may in part contribute to the deficits observed in the fetal alcohol spectrum disorders.	[Hutson, Janine R.; Kapur, Bhushan M.] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Hutson, Janine R.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Stade, Brenda] St Michaels Hosp, Keenan Res Ctr, Dept Paediat, Toronto, ON M5B 1W8, Canada; [Lehotay, Denis C.] Univ Saskatchewan, Coll Med, Regina, SK, Canada; [Collier, Christine P.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Collier, Christine P.] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada; [Kapur, Bhushan M.] Sunnybrook Hlth Sci Ctr, Dept Clin Pathol, Toronto, ON, Canada; [Kapur, Bhushan M.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Saskatchewan; McMaster University; Queens University - Canada; Queens University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Hutson, JR (corresponding author), Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada.	b.kapur@utoronto.ca			Canadian Institute of Health Research, CIHR NET [ELA-80227]; CIHR Vanier Canada Graduate Scholarship	Canadian Institute of Health Research, CIHR NET(Canadian Institutes of Health Research (CIHR)); CIHR Vanier Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	The study was funded by a grant from the Canadian Institute of Health Research, CIHR NET grant # ELA-80227. JRH is supported by a CIHR Vanier Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony AC, 2007, AM J CLIN NUTR, V85, p598S, DOI 10.1093/ajcn/85.2.598S; AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892; Bisseling TM, 2004, PLACENTA, V25, P588, DOI 10.1016/j.placenta.2003.11.010; Cano MJ, 2001, FREE RADICAL RES, V34, P1, DOI 10.1080/10715760100300011; Chudley AE, 2005, CAN MED ASSOC J, V172, pS1, DOI 10.1503/cmaj.1040302; ECONOMIDES DL, 1992, BRIT J OBSTET GYNAEC, V99, P23, DOI 10.1111/j.1471-0528.1992.tb14386.x; FISHER SE, 1985, J PEDIATR GASTR NUTR, V4, P645, DOI 10.1097/00005176-198508000-00026; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Garcia-Rodriguez S, 2003, FREE RADICAL BIO MED, V35, P428, DOI 10.1016/S0891-5849(03)00321-6; GIUGLIANI ERJ, 1985, J PERINAT MED, V13, P55, DOI 10.1515/jpme.1985.13.2.55; Goh YI, 2008, J OBSTET GYNAECOL, V28, P3, DOI 10.1080/01443610701814195; Guerra-Shinohara EM, 2004, AM J CLIN NUTR, V80, P1312, DOI 10.1093/ajcn/80.5.1312; Gundogan F, 2010, ALCOHOL CLIN EXP RES, V34, P415, DOI 10.1111/j.1530-0277.2009.01106.x; Gutierrez CM, 2007, PATHOLOGY, V39, P495, DOI 10.1080/00313020701449290; Halsted CH, 2002, J NUTR, V132, p2367S, DOI 10.1093/jn/132.8.2367S; HENDERSON GI, 1995, J LAB CLIN MED, V126, P184; Jones KL., 2006, SMITHS RECOGNIZABLE, V6th ed., P268; Kapur BM, 2009, ALCOHOL CLIN EXP RES, V33, p134A; Kapur BM, 2007, ALCOHOL CLIN EXP RES, V31, P2114, DOI 10.1111/j.1530-0277.2007.00541.x; Keating E, 2008, J NUTR BIOCHEM, V19, P91, DOI 10.1016/j.jnutbio.2007.01.007; Keating E, 2009, REPROD TOXICOL, V28, P511, DOI 10.1016/j.reprotox.2009.07.001; Kim JM, 2009, J NUTR BIOCHEM, V20, P172, DOI 10.1016/j.jnutbio.2008.01.010; LARROQUE B, 1992, EUR J OBSTET GYN R B, V43, P19, DOI 10.1016/0028-2243(92)90238-T; LIN GWJ, 1988, NUTR RES, V8, P1151, DOI 10.1016/S0271-5317(88)80116-7; LIN GWJ, 1991, ALCOHOL, V8, P169, DOI 10.1016/0741-8329(91)90726-D; Molloy AM, 2005, AM J CLIN NUTR, V82, P836, DOI 10.1093/ajcn/82.4.836; NAVARRO J, 1984, J PEDIATR GASTR NUTR, V3, P744, DOI 10.1097/00005176-198411000-00019; Obeid R, 2005, AM J CLIN NUTR, V82, P133, DOI 10.1093/ajcn/82.1.133; PRASAD PD, 1995, BIOCHEM BIOPH RES CO, V206, P681, DOI 10.1006/bbrc.1995.1096; Relton CL, 2005, BRIT J NUTR, V93, P593, DOI 10.1079/BJN20041395; Schlotz W, 2010, J CHILD PSYCHOL PSYC, V51, P594, DOI 10.1111/j.1469-7610.2009.02182.x; Sokoro AAH, 2008, METABOLISM, V57, P920, DOI 10.1016/j.metabol.2008.02.006; Solanky N, 2010, PLACENTA, V31, P134, DOI 10.1016/j.placenta.2009.11.017; Stark KD, 2005, AM J CLIN NUTR, V81, P669; Stark KD, 2007, AM J CLIN NUTR, V85, P796, DOI 10.1093/ajcn/85.3.796; Thorand B, 1996, Z GEBURTSH NEONATOL, V200, P176; Veena SR, 2010, J NUTR, V140, P1014, DOI 10.3945/jn.109.118075; Wallace JMW, 2008, AM J CLIN NUTR, V87, P391, DOI 10.1093/ajcn/87.2.391; Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439; Wentzel P, 2008, ALCOHOL CLIN EXP RES, V32, p48A; Xu YJ, 2008, BRIT J NUTR, V99, P455, DOI 10.1017/S0007114507812074; Yanaguita MY, 2008, CHILD NERV SYST, V24, P99, DOI 10.1007/s00381-007-0427-1; Yasuda S, 2008, BIOSCI BIOTECH BIOCH, V72, P329, DOI 10.1271/bbb.70347	43	47	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38057	10.1371/journal.pone.0038057	http://dx.doi.org/10.1371/journal.pone.0038057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666445	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600060
J	Koltsova, SV; Trushina, Y; Haloui, M; Akimova, OA; Tremblay, J; Hamet, P; Orlov, SN				Koltsova, Svetlana V.; Trushina, Yulia; Haloui, Mounsif; Akimova, Olga A.; Tremblay, Johanne; Hamet, Pavel; Orlov, Sergei N.			Ubiquitous [Na+](i)/[K+](i)-Sensitive Transcriptome in Mammalian Cells: Evidence for Ca-i(2+)-Independent Excitation-Transcription Coupling	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; GENE-EXPRESSION; SITE UPSTREAM; SODIUM-PUMP; CALCIUM; PROTEIN; NA+; ACTIVATION; NEURONS; INTERLEUKIN-6	Stimulus-dependent elevation of intracellular Ca2+([Ca2+](i)) affects the expression of numerous genes - a phenomenon known as excitation-transcription coupling. Recently, we found that increases in [Na+](i) trigger c-Fos expression via a novel Ca-i(2+)-independent pathway. In the present study, we identified ubiquitous and tissue-specific [Na+](i)/[K+](i)-sensitive transcriptomes by comparative analysis of differentially expressed genes in vascular smooth muscle cells from rat aorta (RVSMC), the human adenocarcinoma cell line HeLa, and human umbilical vein endothelial cells (HUVEC). To augment [Na+](i) and reduce [K+](i), cells were treated for 3 hrs with the Na+, K+-ATPase inhibitor ouabain or placed for the same time in the K+-free medium. Employing Affymetrix-based technology, we detected changes in expression levels of 684, 737 and 1839 transcripts in HeLa, HUVEC and RVSMC, respectively, that were highly correlated between two treatments (p<0.0001; R-2>0.62). Among these Na-i(+)/K-i(+)-sensitive genes, 80 transcripts were common for all three types of cells. To establish if changes in gene expression are dependent on increases in [Ca2+](i), we performed identical experiments in Ca2+-free media supplemented with extracellular and intracellular Ca2+ chelators. Surprisingly, this procedure elevated rather than decreased the number of ubiquitous and cell-type specific Na-i(+)/ K-i(+)-sensitive genes. Among the ubiquitous Na-i(+)/ K-i(+)-sensitive genes whose expression was regulated independently of the presence of Ca2+ chelators by more than 3-fold, we discovered several transcription factors (Fos, Jun, Hes1, Nfkbia), interleukin-6, protein phosphatase 1 regulatory subunit, dual specificity phosphatase (Dusp8), prostaglandin-endoperoxide synthase 2, cyclin L1, whereas expression of metallopeptidase Adamts1, adrenomedulin, Dups1, Dusp10 and Dusp16 was detected exclusively in Ca2+-depleted cells. Overall, our findings indicate that Ca-i(2+)-independent mechanisms of excitation-transcription coupling are involved in transcriptomic alterations triggered by elevation of the [Na+](i)/[K+](i) ratio. There results likely have profound implications for normal and pathological regulation of mammalian cells, including sustained excitation of neuronal cells, intensive exercise and ischemia-triggered disorders.	[Koltsova, Svetlana V.; Haloui, Mounsif; Tremblay, Johanne; Hamet, Pavel; Orlov, Sergei N.] Univ Montre CRCHUM Technopole Angus, Ctr hosp, Ctr Rech, Montreal, PQ, Canada; [Koltsova, Svetlana V.; Akimova, Olga A.] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Moscow, Russia; [Trushina, Yulia; Akimova, Olga A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Tremblay, Johanne; Hamet, Pavel; Orlov, Sergei N.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Lomonosov Moscow State University; Universite de Montreal	Koltsova, SV (corresponding author), Univ Montre CRCHUM Technopole Angus, Ctr hosp, Ctr Rech, Montreal, PQ, Canada.	sergei.n.orlov@umontreal.ca	ORLOV, SERGEI/I-4071-2013; Cossette, Suzanne/I-8008-2016; Akimova, Olga/I-2669-2014; Tremblay, Johanne/E-2154-2013		Canadian Institutes of Health Research [MOP-62696, 81392]; Kidney Foundation of Canada; Russian Foundation for Fundamental Research [09-04-00646A]; Russian Federation [MK-4641-2011.4]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation)	Canadian Institutes of Health Research - http://www.cihr-irsc.gc.ca (MOP-62696 and 81392); Kidney Foundation of Canada - http://www.kidney.ca; Russian Foundation for Fundamental Research - http://www.rfbr.ru/ (09-04-00646A); the grant of the President of the Russian Federation for young investigators http://grants.extech.ru (MK-4641-2011.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI M, 1990, J CLIN INVEST, V85, P121, DOI 10.1172/JCI114401; Akimova OA, 2005, J BIOL CHEM, V280, P832, DOI 10.1074/jbc.M411011200; Akita T, 2011, J PHYSIOL-LONDON, V589, P3909, DOI 10.1113/jphysiol.2011.208173; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bolli R, 2002, CARDIOVASC RES, V55, P506, DOI 10.1016/S0008-6363(02)00414-5; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Cross AK, 2006, BRAIN RES, V1088, P19, DOI 10.1016/j.brainres.2006.02.136; Davis A, 2003, CELL SIGNAL, V15, P597, DOI 10.1016/S0898-6568(02)00148-1; Doyle S, 2010, J BIOL CHEM, V285, P14366, DOI 10.1074/jbc.M109.080069; Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x; Haloui M, 2007, FEBS J, V274, P3557, DOI 10.1111/j.1742-4658.2007.05885.x; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Lamy CM, 2012, ACS NANO, V6, P1176, DOI 10.1021/nn203822t; Li HF, 2010, J AM SOC NEPHROL, V21, P1003, DOI 10.1681/ASN.2009070690; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Ma H, 2011, NEUROSCI RES, V70, P2, DOI 10.1016/j.neures.2011.02.004; Matt T, 2004, BIOCHEM J, V381, P685, DOI 10.1042/BJ20040564; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; McKenna MJ, 2008, J APPL PHYSIOL, V104, P288, DOI 10.1152/japplphysiol.01037.2007; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; Murphy KT, 2008, EXP PHYSIOL, V93, P1249, DOI 10.1113/expphysiol.2008.042457; Okamura Y, 2011, PHYSIOLOGY, V26, P6, DOI 10.1152/physiol.00035.2010; Orlov SN, 2006, J MEMBRANE BIOL, V210, P161, DOI 10.1007/s00232-006-0857-9; Orlov SN, 2005, CELL CALCIUM, V38, P53, DOI 10.1016/j.ceca.2005.03.006; Orlov SN, 1999, J BIOL CHEM, V274, P16545, DOI 10.1074/jbc.274.23.16545; Orlov SN, 2003, CELL CALCIUM, V34, P511, DOI 10.1016/S0143-4160(03)00125-8; Orlov SN, 1999, CELL DEATH DIFFER, V6, P661, DOI 10.1038/sj.cdd.4400539; Pchejetski D, 2003, BIOCHEM BIOPH RES CO, V301, P735, DOI 10.1016/S0006-291X(02)03002-4; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Santana LF, 2008, CIRC RES, V103, P681, DOI 10.1161/CIRCRESAHA.108.185090; Scheiner-Bobis G, 2002, EUR J BIOCHEM, V269, P2424, DOI 10.1046/j.1432-1033.2002.02909.x; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Suzuki S, 1999, J CEREBR BLOOD F MET, V19, P1256, DOI 10.1097/00004647-199911000-00010; Tang Y, 2006, NEUROBIOL DIS, V21, P18, DOI 10.1016/j.nbd.2005.06.002; Taurin S, 2003, MOL BIOL+, V37, P315, DOI 10.1023/A:1024266722564; Taurin S, 2002, CIRC RES, V91, P915, DOI 10.1161/01.RES.0000043020.45534.3E; Taurin S, 2002, J PHYSIOL-LONDON, V543, P835, DOI 10.1113/jphysiol.2002.023259; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Xiao L, 2008, CIRC RES, V103, P733, DOI 10.1161/CIRCRESAHA.108.171157; Yuen PST, 2006, PHYSIOL GENOMICS, V25, P375, DOI 10.1152/physiolgenomics.00223.2005	57	55	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38032	10.1371/journal.pone.0038032	http://dx.doi.org/10.1371/journal.pone.0038032			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666440	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600056
J	Gelfand, JM; Goodin, DS; Boscardin, WJ; Nolan, R; Cuneo, A; Green, AJ				Gelfand, Jeffrey M.; Goodin, Douglas S.; Boscardin, W. John; Nolan, Rachel; Cuneo, Ami; Green, Ari J.			Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; MAGNETIC-RESONANCE-SPECTROSCOPY; BRAIN ATROPHY; WHITE-MATTER; DISABILITY; LESIONS; THICKNESS; PATHOLOGY; MS	Background: To determine whether retinal axonal loss is detectable in patients with a clinically isolated syndrome (CIS), a first clinical demyelinating attack suggestive of multiple sclerosis (MS), and examine patterns of retinal axonal loss across MS disease subtypes. Methodology/Principal Findings: Spectral-domain Optical Coherence Tomography was performed in 541 patients with MS, including 45 with high-risk CIS, 403 with relapsing-remitting (RR)MS, 60 with secondary-progressive (SP)MS and 33 with primary-progressive (PP) MS, and 53 unaffected controls. Differences in retinal nerve fiber layer (RNFL) thickness and macular volume were analyzed using multiple linear regression and associations with age and disease duration were examined in a cross-sectional analysis. In eyes without a clinical history of optic neuritis (designated as "eyes without optic neuritis''), the total and temporal peripapillary RNFL was thinner in CIS patients compared to controls (temporal RNFL by -5.4 mu m [95% CI -0.9 to -9.9 mm, p = 0.02] adjusting for age and sex). The total (p = 0.01) and temporal (p = 0.03) RNFL was also thinner in CIS patients with clinical disease for less than 1 year compared to controls. In eyes without optic neuritis, total and temporal RNFL thickness was nearly identical between primary and secondary progressive MS, but total macular volume was slightly lower in the primary progressive group (p<0.05). Conclusions/Significance: Retinal axonal loss is increasingly prominent in more advanced stages of disease - progressive MS>RRMS>CIS - with proportionally greater thinning in eyes previously affected by clinically evident optic neuritis. Retinal axonal loss begins early in the course of MS. In the absence of clinically evident optic neuritis, RNFL thinning is nearly identical between progressive MS subtypes.	[Gelfand, Jeffrey M.; Goodin, Douglas S.; Nolan, Rachel; Cuneo, Ami; Green, Ari J.] Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA 94143 USA; [Boscardin, W. John] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Boscardin, W. John] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gelfand, JM (corresponding author), Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA 94143 USA.	AGreen@ucsf.edu			NIH [KL2 RR 024130, T32 MH 090847]; American Academy of Neurology; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH090847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Neurology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Investigators were supported by: NIH KL2 RR 024130 (AJG), T32 MH 090847 and American Academy of Neurology Clinical Research Training Fellowship (JMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audoin B, 2010, J NEUROL NEUROSUR PS, V81, P690, DOI 10.1136/jnnp.2009.188748; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Blumenthal EZ, 2009, EYE, V23, P171, DOI 10.1038/sj.eye.6702942; Brex PA, 2000, NEUROLOGY, V54, P1689, DOI 10.1212/WNL.54.8.1689; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Chen JT, 2004, NEUROIMAGE, V23, P1168, DOI 10.1016/j.neuroimage.2004.07.046; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Costello F, 2010, CAN J OPHTHALMOL, V45, P520, DOI 10.3129/i10-063; Costello F, 2009, J NEUROL SCI, V281, P74, DOI 10.1016/j.jns.2009.02.354; DAVIE CA, 1994, BRAIN, V117, P49, DOI 10.1093/brain/117.1.49; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; FRISEN L, 1974, ARCH OPHTHALMOL-CHIC, V92, P91, DOI 10.1001/archopht.1974.01010010097001; Frohman E, 2006, LANCET NEUROL, V5, P853, DOI 10.1016/S1474-4422(06)70573-7; Ganter P, 1999, NEUROPATH APPL NEURO, V25, P459; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Gourraud PA, 2011, ANN NEUROL, V69, P65, DOI 10.1002/ana.22323; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Henderson APD, 2010, BRAIN, V133, P2592, DOI 10.1093/brain/awq146; Kallenbach K, 2011, MULT SCLER, V17, P89, DOI 10.1177/1352458510382017; KERRISON JB, 1994, RETINA-J RET VIT DIS, V14, P445, DOI 10.1097/00006982-199414050-00010; Kiernan DF, 2010, AM J OPHTHALMOL, V149, P18, DOI 10.1016/j.ajo.2009.08.037; Kitsos G, 2011, EUR J NEUROL, V18, P719, DOI 10.1111/j.1468-1331.2010.03256.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Outteryck O, 2009, ARCH NEUROL-CHICAGO, V66, P1373, DOI 10.1001/archneurol.2009.265; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Rizzo JF, 2005, WALSH HOYTS CLIN NEU, P3; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Rovaris M, 2001, BRAIN, V124, P2540, DOI 10.1093/brain/124.12.2540; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Serbecic N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013877; Siepman TAM, 2010, J NEUROL, V257, P1654, DOI 10.1007/s00415-010-5589-1; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Wattjes MP, 2007, AM J NEURORADIOL, V28, P1517, DOI 10.3174/ajnr.A0594	44	85	85	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36847	10.1371/journal.pone.0036847	http://dx.doi.org/10.1371/journal.pone.0036847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22666330	gold, Green Published			2022-12-27	WOS:000305335800019
J	Emami, K; Askari, V; Ullrich, M; Mohinudeen, K; Anil, AC; Khandeparker, L; Burgess, JG; Mesbahi, E				Emami, Kaveh; Askari, Vahid; Ullrich, Matthias; Mohinudeen, Khwajah; Anil, Arga Chandrashekar; Khandeparker, Lidita; Burgess, J. Grant; Mesbahi, Ehsan			Characterization of Bacteria in Ballast Water Using MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							ASSISTED LASER DESORPTION/IONISATION; DESORPTION IONIZATION-TIME; MICROORGANISM IDENTIFICATION; RAPID IDENTIFICATION; ESCHERICHIA-COLI; FRESH-WATERS; SHIPS; CLASSIFICATION; PROTEOMICS; SEDIMENTS	To evaluate a rapid and cost-effective method for monitoring bacteria in ballast water, several marine bacterial isolates were characterized by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Since International Maritime Organization (IMO) regulations are concerned with the unintended transportation of pathogenic bacteria through ballast water, emphasis was placed on detecting species of Vibrio, enterococci and coliforms. Seawater samples collected from the North Sea were incubated in steel ballast tanks and the presence of potentially harmful species of Pseudomonas was also investigated. At the genus-level, the identification of thirty six isolates using MALDI-TOF MS produced similar results to those obtained by 16S rRNA gene sequencing. No pathogenic species were detected either by 16S rRNA gene analysis or by MALDI-TOF MS except for the opportunistically pathogenic bacterium Pseudomonas aeruginosa. In addition, in house software that calculated the correlation coefficient values (CCV) of the mass spectral raw data and their variation was developed and used to allow the rapid and efficient identification of marine bacteria in ballast water for the first time.	[Emami, Kaveh] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Askari, Vahid] Univ Teesside, Sch Sci & Engn, Middlesbrough, Tees Valley, England; [Ullrich, Matthias] Jacobs Univ Bremen, Mol Life Sci Res Ctr, D-28359 Bremen, Germany; [Mohinudeen, Khwajah] Newcastle Univ, NEPAF Proteome Anal Facil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Anil, Arga Chandrashekar; Khandeparker, Lidita] Natl Inst Oceanog, Panaji, India; [Burgess, J. Grant; Mesbahi, Ehsan] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; University of Teesside; Jacobs University; Newcastle University - UK; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Newcastle University - UK	Emami, K (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	kaveh.emami@ncl.ac.uk		Emami, Kaveh/0000-0003-0182-0070; Ismail Abdul Hameed, Khwajah Mohinudeen/0000-0002-1944-378X	European Union; NERC; UKIERI (UK India Education and Research Initiative); British Council; UK Department for Education and Skills (DfES), Office of Science and Innovation; FCO, Scotland, Northern Ireland, Wales; GSK; BP; Shell; BAE	European Union(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UKIERI (UK India Education and Research Initiative); British Council(The British Council in India); UK Department for Education and Skills (DfES), Office of Science and Innovation; FCO, Scotland, Northern Ireland, Wales; GSK(GlaxoSmithKline); BP; Shell(Royal Dutch Shell); BAE	This document is an output from the North Sea Ballast Water Opportunity project, co-financed by the European Union through the North Sea Region Programme 2007-2013 "Investing in the future by working together for a sustainable and competitive region". The authors also acknowledge support and funding from NERC and the UKIERI (UK India Education and Research Initiative) project funded by the British Council, the UK Department for Education and Skills (DfES), Office of Science and Innovation, the FCO, Scotland, Northern Ireland, Wales, GSK, BP, Shell and BAE for the benefit of the India Higher Education Sector and the UK Higher Education Sector. The views expressed are not necessarily those of the funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by GSK, BP, Shell and BAE for the benefit of the India Higher Education Sector and the UK Higher Education Sector. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ANDREWS WH, 1972, APPL MICROBIOL, V23, P521, DOI 10.1128/AEM.23.3.521-523.1972; ANHALT JP, 1975, ANAL CHEM, V47, P219, DOI 10.1021/ac60352a007; Anil AC, 2002, CURR SCI INDIA, V83, P214; Bohme K, 2010, ANAL METHODS-UK, V2, P1941, DOI 10.1039/c0ay00457j; Bohme K, 2010, J PROTEOME RES, V9, P3169, DOI 10.1021/pr100047q; BUCK JD, 1963, J BACTERIOL, V86, P1125, DOI 10.1128/JB.86.5.1125-1126.1963; CHESTER B, 1980, J CLIN MICROBIOL, V11, P537, DOI 10.1128/JCM.11.5.537-539.1980; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Demirev PA, 2004, J HOPKINS APL TECH D, V25, P27; Demirev PA, 2008, ANNU REV ANAL CHEM, V1, P71, DOI 10.1146/annurev.anchem.1.031207.112838; Dieckmann R, 2005, APPL MICROBIOL BIOT, V67, P539, DOI 10.1007/s00253-004-1812-2; Dieckmann R, 2010, J APPL MICROBIOL, V109, P199, DOI 10.1111/j.1365-2672.2009.04647.x; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Drake LA, 2007, MAR POLLUT BULL, V55, P333, DOI 10.1016/j.marpolbul.2006.11.007; Dworzanski JP, 2005, EXPERT REV PROTEOMIC, V2, P863, DOI 10.1586/14789450.2.6.863; Dworzanski JP, 2010, ANAL CHEM, V82, P145, DOI 10.1021/ac9015648; Dworzanski JP, 2004, ANAL CHEM, V76, P2355, DOI 10.1021/ac0349781; Eddabra R, 2012, MICROBIOL RES, V167, P226, DOI 10.1016/j.micres.2011.09.002; Everley RA, 2008, J AM SOC MASS SPECTR, V19, P1621, DOI 10.1016/j.jasms.2008.07.003; Fagerquist CK, 2009, APPL ENVIRON MICROB, V75, P4341, DOI 10.1128/AEM.00079-09; Fernandez-No IC, 2010, ELECTROPHORESIS, V31, P1116, DOI 10.1002/elps.200900591; Ferranti P, 2011, RAPID COMMUN MASS SP, V25, P1173, DOI 10.1002/rcm.4973; Ferranti P, 2009, RAPID COMMUN MASS SP, V23, P1328, DOI 10.1002/rcm.4006; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Gallo P, 2009, RAPID COMMUN MASS SP, V23, P3279, DOI 10.1002/rcm.4243; GAUTHIER YP, 1995, BIOL TRACE ELEM RES, V47, P37, DOI 10.1007/BF02790099; Gollasch S, 2007, HARMFUL ALGAE, V6, P585, DOI 10.1016/j.hal.2006.12.009; Hazen TH, 2009, APPL ENVIRON MICROB, V75, P6745, DOI 10.1128/AEM.01171-09; Holland RD, 1999, ANAL CHEM, V71, P3226, DOI 10.1021/ac990175v; KING EO, 1954, J LAB CLIN MED, V44, P301; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lasch P, 2009, APPL ENVIRON MICROB, V75, P7229, DOI 10.1128/AEM.00857-09; Mazzeo MF, 2006, APPL ENVIRON MICROB, V72, P1180, DOI 10.1128/AEM.72.2.1180-1189.2006; Mimura H, 2005, MAR POLLUT BULL, V50, P751, DOI 10.1016/j.marpolbul.2005.02.006; Oberbeckmann S, 2011, FEMS MICROBIOL ECOL, V75, P145, DOI 10.1111/j.1574-6941.2010.00998.x; Palmblad M, 2007, J AM SOC MASS SPECTR, V18, P693, DOI 10.1016/j.jasms.2006.11.013; Pennanec X, 2010, RAPID COMMUN MASS SP, V24, P384, DOI 10.1002/rcm.4404; Plotnikova JM, 2000, PLANT PHYSIOL, V124, P1766, DOI 10.1104/pp.124.4.1766; Ruelle V, 2004, RAPID COMMUN MASS SP, V18, P2013, DOI 10.1002/rcm.1584; Ruiz GM, 2000, NATURE, V408, P49, DOI 10.1038/35040695; RYAN WJ, 1976, J CLIN PATHOL, V29, P1014, DOI 10.1136/jcp.29.11.1014; SLANETZ LW, 1957, J BACTERIOL, V74, P591, DOI 10.1128/JB.74.5.591-595.1957; Takahashi CK, 2008, J VENOM ANIM TOXINS, V14, P393, DOI 10.1590/S1678-91992008000300002; Tamelander J., 2010, GLOBALLAST MONOGRAPH; Taylor CE, 2006, PROTEOMICS, P39, DOI 10.1002/pmic.200600549; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Valentine N, 2005, APPL ENVIRON MICROB, V71, P58, DOI 10.1128/AEM.71.1.58-64.2005	48	65	74	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38515	10.1371/journal.pone.0038515	http://dx.doi.org/10.1371/journal.pone.0038515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685576	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700039
J	Lustig, A; Ketter-Katz, H; Katzir, G				Lustig, Avichai; Ketter-Katz, Hadas; Katzir, Gadi			Visually Guided Avoidance in the Chameleon (Chamaeleo chameleon): Response Patterns and Lateralization	PLOS ONE			English	Article							ASYMMETRICAL HATCHING BEHAVIORS; BRAIN LATERALIZATION; SMOOTH-PURSUIT; TELEOST FISH; LEFT-HANDERS; GUARD BEES; EYE USE; AGGRESSION; ADVANTAGES; LIZARDS	The common chameleon, Chamaeleo chameleon, is an arboreal lizard with highly independent, large-amplitude eye movements. In response to a moving threat, a chameleon on a perch responds with distinct avoidance movements that are expressed in its continuous positioning on the side of the perch distal to the threat. We analyzed body-exposure patterns during threat avoidance for evidence of lateralization, that is, asymmetry at the functional/behavioral levels. Chameleons were exposed to a threat approaching horizontally from the left or right, as they held onto a vertical pole that was either wider or narrower than the width of their head, providing, respectively, monocular or binocular viewing of the threat. We found two equal-sized sub-groups, each displaying lateralization of motor responses to a given direction of stimulus approach. Such an anti-symmetrical distribution of lateralization in a population may be indicative of situations in which organisms are regularly exposed to crucial stimuli from all spatial directions. This is because a bimodal distribution of responses to threat in a natural population will reduce the spatial advantage of predators.	[Lustig, Avichai; Ketter-Katz, Hadas] Univ Haifa, Dept Neurobiol & Ethol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Environm & Evolutionary Biol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Marine Biol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Biol, IL-31999 Haifa, Israel	University of Haifa; University of Haifa; University of Haifa; University of Haifa	Lustig, A (corresponding author), Univ Haifa, Dept Neurobiol & Ethol, IL-31999 Haifa, Israel.	Lustigavi@gmail.com			Israel Academy of Sciences and Humanities - Israel Science Foundation [20978009]	Israel Academy of Sciences and Humanities - Israel Science Foundation	The research was funded by the Israel Academy of Sciences and Humanities - Israel Science Foundation (#20978009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisazza A, 1998, BEHAV BRAIN RES, V91, P157, DOI 10.1016/S0166-4328(97)00114-9; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Bisazza A, 2003, BEHAV BRAIN RES, V141, P131, DOI 10.1016/S0166-4328(02)00344-3; Bisazza A, 1997, Laterality, V2, P49, DOI 10.1080/713754252; Bisazza A, 1997, PHYSIOL BEHAV, V62, P1405, DOI 10.1016/S0031-9384(97)00230-8; Boeddeker N, 2003, P ROY SOC B-BIOL SCI, V270, P393, DOI 10.1098/rspb.2002.2240; Bonati B, 2008, BEHAV PROCESS, V79, P171, DOI 10.1016/j.beproc.2008.07.007; Bonati B, 2010, BEHAV BRAIN RES, V207, P1, DOI 10.1016/j.bbr.2009.09.002; Byrne RA, 2002, ANIM BEHAV, V64, P461, DOI 10.1006/anbe.2002.3089; Cantalupo C, 1995, NEUROPSYCHOLOGIA, V33, P1637, DOI 10.1016/0028-3932(95)00043-7; Casey MB, 2005, DEV PSYCHOBIOL, V47, P123, DOI 10.1002/dev.20078; Casey MB, 2000, DEV PSYCHOBIOL, V37, P13, DOI 10.1002/1098-2302(200007)37:1<13::AID-DEV3>3.0.CO;2-M; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Cuadrado M, 2001, BIOL J LINN SOC, V72, P547, DOI 10.1111/j.1095-8312.2001.tb01337.x; Dadda M, 2010, BIOL LETTERS, V6, P414, DOI 10.1098/rsbl.2009.0904; Dimond Stuart, 1972, DOUBLE BRAIN; Hassenstein B, 1999, J EXP BIOL, V202, P1701; HEATWOLE H, 1968, COPEIA, P109, DOI 10.2307/1441557; Hews DK, 2004, ANIM BEHAV, V68, P1201, DOI 10.1016/j.anbehav.2003.11.024; Hews DK, 2001, BRAIN BEHAV EVOLUT, V58, P356, DOI 10.1159/000057576; Hoffmann ER, 1997, INT J IND ERGONOM, V19, P49, DOI 10.1016/0169-8141(95)00092-5; Izawa EI, 2005, BEHAV PROCESS, V69, P357, DOI 10.1016/j.beproc.2005.02.001; JUNGER W, 1991, J COMP PHYSIOL A, V169, P633; KELBER A, 1990, J COMP PHYSIOL A, V167, P569; Keter-Katz H, 2012, ANIM COGN IN PRESS; KILSHAW D, 1983, BRIT J PSYCHOL, V74, P253, DOI 10.1111/j.2044-8295.1983.tb01861.x; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; Malashichev YB, 2004, BIOESSAYS, V26, P512, DOI 10.1002/bies.20036; Malashichev YB, 2006, J COMP PSYCHOL, V120, P401, DOI 10.1037/0735-7036.120.4.401; Miklosi A, 1999, BEHAV BRAIN RES, V105, P199, DOI 10.1016/S0166-4328(99)00071-6; Pearson L, 1976, VERTEBRATE BRAIN, P513; Robins A, 2005, NEUROREPORT, V16, P849, DOI 10.1097/00001756-200505310-00014; Robins A, 1998, ANIM BEHAV, V56, P875, DOI 10.1006/anbe.1998.0877; Robins A, 2006, ANIM BEHAV, V72, P843, DOI 10.1016/j.anbehav.2006.01.022; ROBINSON DA, 1965, J PHYSIOL-LONDON, V180, P569, DOI 10.1113/jphysiol.1965.sp007718; Rogers L. J., 2002, COMP VERTEBRATE LATE, P94; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Tommasi L, 1999, Laterality, V4, P89, DOI 10.1080/713754325; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303; Vallortigara G, 1998, NEUROREPORT, V9, P3341, DOI 10.1097/00001756-199810050-00035; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Yoshioka JG, 1930, PEDAGOG SEMIN J GEN, V38, P471; Zeil J, 2006, J COMP PHYSIOL A, V192, P1, DOI 10.1007/s00359-005-0048-7; ZEIL J, 1989, J COMP PHYSIOL A, V165, P711, DOI 10.1007/BF00611002; ZEIL J, 1986, BEHAV ECOL SOCIOBIOL, V19, P213	48	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37875	10.1371/journal.pone.0037875	http://dx.doi.org/10.1371/journal.pone.0037875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685546	Green Published, gold, Green Submitted			2022-12-27	WOS:000305351700009
J	Meyer, S; Fuchs, TJ; Bosserhoff, AK; Hofstadter, F; Pauer, A; Roth, V; Buhmann, JM; Moll, I; Anagnostou, N; Brandner, JM; Ikenberg, K; Moch, H; Landthaler, M; Vogt, T; Wild, PJ				Meyer, Stefanie; Fuchs, Thomas J.; Bosserhoff, Anja K.; Hofstaedter, Ferdinand; Pauer, Armin; Roth, Volker; Buhmann, Joachim M.; Moll, Ingrid; Anagnostou, Nikos; Brandner, Johanna M.; Ikenberg, Kristian; Moch, Holger; Landthaler, Michael; Vogt, Thomas; Wild, Peter J.			A Seven-Marker Signature and Clinical Outcome in Malignant Melanoma: A Large-Scale Tissue-Microarray Study with Two Independent Patient Cohorts	PLOS ONE			English	Article							BETA-CATENIN; PROGNOSTIC-FACTOR; EXPRESSION; SURVIVAL; GENE; THERAPY; MARKER; BIOMARKERS; EVENT; CELLS	Background: Current staging methods such as tumor thickness, ulceration and invasion of the sentinel node are known to be prognostic parameters in patients with malignant melanoma (MM). However, predictive molecular marker profiles for risk stratification and therapy optimization are not yet available for routine clinical assessment. Methods and Findings: Using tissue microarrays, we retrospectively analyzed samples from 364 patients with primary MM. We investigated a panel of 70 immunohistochemical (IHC) antibodies for cell cycle, apoptosis, DNA mismatch repair, differentiation, proliferation, cell adhesion, signaling and metabolism. A marker selection procedure based on univariate Cox regression and multiple testing correction was employed to correlate the IHC expression data with the clinical follow-up (overall and recurrence-free survival). The model was thoroughly evaluated with two different cross validation experiments, a permutation test and a multivariate Cox regression analysis. In addition, the predictive power of the identified marker signature was validated on a second independent external test cohort (n = 225). A signature of seven biomarkers (Bax, Bcl-X, PTEN, COX-2, loss of beta-Catenin, loss of MTAP, and presence of CD20 positive B-lymphocytes) was found to be an independent negative predictor for overall and recurrence-free survival in patients with MM. The seven-marker signature could also predict a high risk of disease recurrence in patients with localized primary MM stage pT1-2 (tumor thickness <= 2.00 mm). In particular, three of these markers (MTAP, COX-2, Bcl-X) were shown to offer direct therapeutic implications. Conclusions: The seven-marker signature might serve as a prognostic tool enabling physicians to selectively triage, at the time of diagnosis, the subset of high recurrence risk stage I-II patients for adjuvant therapy. Selective treatment of those patients that are more likely to develop distant metastatic disease could potentially lower the burden of untreatable metastatic melanoma and revolutionize the therapeutic management of MM.	[Meyer, Stefanie; Landthaler, Michael] Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany; [Fuchs, Thomas J.; Buhmann, Joachim M.] Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland; [Bosserhoff, Anja K.; Hofstaedter, Ferdinand] Univ Hosp Regensburg, Inst Pathol, Regensburg, Germany; [Pauer, Armin] Cent Tumor Registry Regensburg, Regensburg, Germany; [Roth, Volker] Univ Basel, Dept Comp Sci, Basel, Switzerland; [Fuchs, Thomas J.; Buhmann, Joachim M.] ETH, Inst Cell Biol, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Moll, Ingrid; Anagnostou, Nikos; Brandner, Johanna M.] Univ Hosp Hamburg Eppendorf, Dept Dermatol, Hamburg, Germany; [Ikenberg, Kristian; Moch, Holger; Wild, Peter J.] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Vogt, Thomas] Saarland Univ Hosp, Dept Dermatol, Homburg, Germany	University of Regensburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Regensburg; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital; Universitatsklinikum des Saarlandes	Meyer, S (corresponding author), Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany.	peter.wild@usz.ch	Bosserhoff, Anja/GNH-4801-2022; Roth, Volker/Q-4025-2017; Buhmann, Joachim/AAU-4760-2020	Roth, Volker/0000-0003-0991-0273; Wild, Peter Johannes/0000-0002-1017-3744; Bosserhoff, Anja/0000-0001-8147-394X	German Cancer Aid (Deutsche Krebshilfe e.V.) [108134]	German Cancer Aid (Deutsche Krebshilfe e.V.)(Deutsche Krebshilfe)	This work was funded by the German Cancer Aid (Deutsche Krebshilfe e.V.), grant 108134. The funding source had no involvement in the study design, the collection, analysis, and interpretation of data, the writing of the report, or the decision to submit the paper for publication.	Alonso SR, 2004, AM J PATHOL, V164, P193, DOI 10.1016/S0002-9440(10)63110-0; Ascierto PA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-62; Avivi I, 2003, BRIT J CANCER, V89, P1389, DOI 10.1038/sj.bjc.6601187; Azmi AS, 2009, J CELL PHYSIOL, V218, P13, DOI 10.1002/jcp.21567; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; COX DR, 1972, J R STAT SOC B, V34, P187; Denkert C, 2002, AM J PATHOL, V160, P893, DOI 10.1016/S0002-9440(10)64912-7; Fukushima H, 2001, J EXP CLIN CANC RES, V20, P553; Guldberg P, 1997, CANCER RES, V57, P3660; Heere-Ress E, 2002, INT J CANCER, V99, P29, DOI 10.1002/ijc.10248; Hoek KS, 2007, PIGM CELL RES, V20, P466, DOI 10.1111/j.1600-0749.2007.00412.x; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Ishwaran H, 2010, STAT PROBABIL LETT, V80, P1056, DOI 10.1016/j.spl.2010.02.020; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kashani-Sabet M, 2009, P NATL ACAD SCI USA, V106, P6268, DOI 10.1073/pnas.0901185106; Koesters R, 1999, CANCER RES, V59, P3880; Kuphal S, 2011, INT J ONCOL, V39, P235, DOI 10.3892/ijo.2011.1028; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Meyer S, 2010, PPAR RES, V2010, DOI 10.1155/2010/848645; Meyer S, 2010, EXP DERMATOL, V19, pE251, DOI 10.1111/j.1600-0625.2010.01072.x; Mikhail M, 2005, CLIN CANCER RES, V11, P5153, DOI 10.1158/1078-0432.CCR-05-0397; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Nocito A, 2001, J PATHOL, V194, P349, DOI 10.1002/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D; Reichle A, 2007, MELANOMA RES, V17, P360, DOI 10.1097/CMR.0b013e3282f1d2c8; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rothberg BEG, 2010, J INVEST DERMATOL, V130, P1971, DOI 10.1038/jid.2010.149; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Sarpa HG, 2006, AM J SURG PATHOL, V30, P1396, DOI 10.1097/01.pas.0000213262.61855.7d; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Timar J, 2010, CLIN EXP METASTAS, V27, P371, DOI 10.1007/s10585-010-9307-2; Weinlich G, 2006, BRIT J CANCER, V94, P835, DOI 10.1038/sj.bjc.6603028; Wild PJ, 2006, ARCH DERMATOL, V142, P471, DOI 10.1001/archderm.142.4.471; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465	40	62	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38222	10.1371/journal.pone.0038222	http://dx.doi.org/10.1371/journal.pone.0038222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685558	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305351700021
J	Sumracki, NM; Hutchinson, MR; Gentgall, M; Briggs, N; Williams, DB; Rolan, P				Sumracki, Nicole M.; Hutchinson, Mark R.; Gentgall, Melanie; Briggs, Nancy; Williams, Desmond B.; Rolan, Paul			The Effects of Pregabalin and the Glial Attenuator Minocycline on the Response to Intradermal Capsaicin in Patients with Unilateral Sciatica	PLOS ONE			English	Article							NEUROPATHIC PAIN; PHARMACOLOGICAL MANAGEMENT; CLINICAL-TRIALS; FIBER FUNCTION; OPEN-LABEL; ALLODYNIA; HYPERALGESIA; SAFETY; ACTIVATION; GUIDELINES	Background: Patients with unilateral sciatica have heightened responses to intradermal capsaicin compared to pain-free volunteers. No studies have investigated whether this pain model can screen for novel anti-neuropathic agents in patients with pre-existing neuropathic pain syndromes. Aim: This study compared the effects of pregabalin (300 mg) and the tetracycline antibiotic and glial attenuator minocycline (400 mg) on capsaicin-induced spontaneous pain, flare, allodynia and hyperalgesia in patients with unilateral sciatica on both their affected and unaffected leg. Methods/Results: Eighteen patients with unilateral sciatica completed this randomised, double-blind, placebo-controlled, three-way cross-over study. Participants received a 10 mg dose of capsaicin into the middle section of their calf on both their affected and unaffected leg, separated by an interval of 75 min. Capsaicin-induced spontaneous pain, flare, allodynia and hyperalgesia were recorded pre-injection and at 5, 20, 40, 60 and 90 min post-injection. Minocycline tended to reduce pre-capsaicin injection values of hyperalgesia in the affected leg by 28% (95% CI 0% to 56%). The area under the effect time curves for capsaicin-induced spontaneous pain, flare, allodynia and hyperalgesia were not affected by either treatment compared to placebo. Significant limb differences were observed for flare (AUC) (-38% in affected leg, 95% CI for difference -19% to -52%). Both hand dominance and sex were significant covariates of response to capsaicin. Conclusions: It cannot be concluded that minocycline is unsuitable for further evaluation as an anti-neuropathic pain drug as pregabalin, our positive control, failed to reduce capsaicin-induced neuropathic pain. However, the anti-hyperalgesic effect of minocycline observed pre-capsaicin injection is promising pilot information to support ongoing research into glial-mediated treatments for neuropathic pain. The differences in flare response between limbs may represent a useful biomarker to further investigate neuropathic pain. Inclusion of a positive control is imperative for the assessment of novel therapies for neuropathic pain.	[Sumracki, Nicole M.; Rolan, Paul] Univ Adelaide, Sch Med Sci, Discipline Pharmacol, Adelaide, SA, Australia; [Hutchinson, Mark R.] Univ Adelaide, Sch Med Sci, Discipline Physiol, Adelaide, SA, Australia; [Gentgall, Melanie] Univ Adelaide, Royal Adelaide Hosp, Pain & Anaesthesia Res Clin, Adelaide, SA, Australia; [Briggs, Nancy] Univ Adelaide, Royal Adelaide Hosp, Dept Publ Hlth, Adelaide, SA, Australia; [Williams, Desmond B.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Williams, Desmond B.] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia	University of Adelaide; University of Adelaide; Royal Adelaide Hospital; University of Adelaide; Royal Adelaide Hospital; University of Adelaide; University of South Australia; University of South Australia	Sumracki, NM (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Pharmacol, Adelaide, SA, Australia.	nicole.sumracki@adelaide.edu.au	Hutchinson, Mark R/G-4147-2014; Williams, Desmond B/B-5896-2013; Hutchinson, Mark/N-1815-2019	Hutchinson, Mark R/0000-0003-2154-5950; Williams, Desmond B/0000-0002-5954-2694; Hutchinson, Mark/0000-0003-2154-5950; Briggs, Nancy/0000-0002-1134-0807				ARONSON AL, 1980, J AM VET MED ASSOC, V176, P1061; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Aykanat V, 2012, BRIT J CLIN PHARMACO, V73, P37, DOI 10.1111/j.1365-2125.2011.04059.x; Barkhof F, 2010, NEUROLOGY, V74, P1033, DOI 10.1212/WNL.0b013e3181d7d651; Baron R, 2010, PAIN, V150, P420, DOI 10.1016/j.pain.2010.04.013; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Foster DC, 2005, PAIN, V117, P128, DOI 10.1016/j.pain.2005.05.025; Gelesko S, 2011, J ORAL MAXIL SURG, V69, pE324, DOI 10.1016/j.joms.2011.03.059; Gordon PH, 2008, AMYOTROPH LATERAL SC, V9, P212, DOI 10.1080/17482960802195632; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Grace PM, 2011, BRAIN BEHAV IMMUN, V25, P1322, DOI 10.1016/j.bbi.2011.04.003; Gustafsson H, 2009, BRIT J CLIN PHARMACO, V68, P511, DOI 10.1111/j.1365-2125.2009.03489.x; Ho EL, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-17; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Khiat A, 2010, MAGN RESON IMAGING, V28, P1456, DOI 10.1016/j.mri.2010.06.032; Krishnan STM, 2004, DIABETES CARE, V27, P2930, DOI 10.2337/diacare.27.12.2930; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Landry RP, 2012, EXP NEUROL, V234, P340, DOI 10.1016/j.expneurol.2011.11.006; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; LEVASSEUR SA, 1990, PAIN, V41, P19, DOI 10.1016/0304-3959(90)91104-Q; Liu MW, 1998, J PAIN SYMPTOM MANAG, V16, P10, DOI 10.1016/S0885-3924(98)00026-8; Mika J, 2007, EUR J PHARMACOL, V560, P142, DOI 10.1016/j.ejphar.2007.01.013; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; MORRIS GC, 1995, PAIN, V63, P93, DOI 10.1016/0304-3959(95)00019-O; Moulin DE, 2007, PAIN RES MANAG, V12, P13; Nicotra L, 2012, EXP NEUROL, V234, P316, DOI 10.1016/j.expneurol.2011.09.038; Paribello C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-91; Petersen KL, 2000, PAIN, V88, P125, DOI 10.1016/S0304-3959(00)00311-0; Rolan P, 2008, BRIT J CLIN PHARMACO, V66, P792, DOI 10.1111/j.1365-2125.2008.03270.x; Shenker NG, 2008, RHEUMATOLOGY, V47, P1417, DOI 10.1093/rheumatology/ken251; Smith K, 2005, CLIN THER, V27, P1329, DOI 10.1016/j.clinthera.2005.09.005; Tan AM, 2009, J REHABIL RES DEV, V46, P123, DOI 10.1682/JRRD.2008.03.0048; Wang H, 2008, J PAIN, V9, P1088, DOI 10.1016/j.jpain.2008.05.013; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230; Younger J, 2009, PAIN MED, V10, P663, DOI 10.1111/j.1526-4637.2009.00613.x	36	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38525	10.1371/journal.pone.0038525	http://dx.doi.org/10.1371/journal.pone.0038525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685578	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000305351700041
J	Sukhwinder-Singh; Hernandez, MV; Crossa, J; Singh, PK; Bains, NS; Singh, K; Sharma, I				Sukhwinder-Singh; Hernandez, Mateo V.; Crossa, Jose; Singh, Pawan K.; Bains, Navtej S.; Singh, Kuldeep; Sharma, Indu			Multi-Trait and Multi-Environment QTL Analyses for Resistance to Wheat Diseases	PLOS ONE			English	Article							PYRENOPHORA-TRITICI-REPENTIS; FUSARIUM HEAD BLIGHT; CHROMOSOMAL LOCATION; QUANTITATIVE TRAITS; CONFERS RESISTANCE; DURABLE RESISTANCE; HIGH-RESOLUTION; STRIPE RUST; AESTIVUM L.; MIXED-MODEL	Background: Stripe rust, leaf rust, tan spot, and Karnal bunt are economically significant diseases impacting wheat production. The objectives of this study were to identify quantitative trait loci for resistance to these diseases in a recombinant inbred line (RIL) from a cross HD29/WH542, and to evaluate the evidence for the presence loci on chromosome region conferring multiple disease resistance. Methodology/Principal Findings: The RIL population was evaluated for four diseases and genotyped with DNA markers. Multi-trait (MT) analysis revealed thirteen QTLs on nine chromosomes, significantly associated with resistance. Phenotypic variation explained by all significant QTLs for KB, TS, Yr, Lr diseases were 57%, 55%, 38% and 22%, respectively. Marginal trait analysis identified the most significant QTLs for resistance to KB on chromosomes 1BS, 2DS, 3BS, 4BL, 5BL, and 5DL. Chromosomes 3AS and 4BL showed significant association with TS resistance. Significant QTLs for Yr resistance were identified on chromosomes 2AS, 4BL and 5BL, while Lr was significant on 6DS. MT analysis revealed that all the QTLs except 3BL significantly reduce KB and was contributed from parent HD29 while all resistant QTLs for TS except on chromosomes 2DS. 1, 2DS. 2 and 3BL came from WH542. Five resistant QTLs for Yr and six for Lr were contributed from parents WH542 and HD29 respectively. Chromosome region on 4BL showed significant association to KB, TS, and Yr in the population. The multi environment analysis for KB identified three putative QTLs of which two new QTLs, mapped on chromosomes 3BS and 5DL explained 10 and 20% of the phenotypic variation, respectively. Conclusions/Significance: This study revealed that MT analysis is an effective tool for detection of multi-trait QTLs for disease resistance. This approach is a more effective and practical than individual QTL mapping analyses. MT analysis identified RILs that combine resistance to multiple diseases from parents WH542 and/or HD29.	[Sukhwinder-Singh; Hernandez, Mateo V.; Crossa, Jose; Singh, Pawan K.] Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico; [Hernandez, Mateo V.] Univ Autonoma Chapingo, Chapingo, Mexico; [Bains, Navtej S.; Singh, Kuldeep; Sharma, Indu] Punjab Agr Univ, Dept Plant Breeding Genet & Biotechnol, Ludhiana 141004, Punjab, India	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Punjab Agricultural University	Sukhwinder-Singh (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico.	suk.singh@cgiar.org	Vargas Hernandez, Mateo/AIE-0949-2022; Crossa, Jose/AAE-7898-2019	Vargas Hernandez, Mateo/0000-0002-0735-3242; Crossa, Jose/0000-0001-9429-5855; Singh, Kuldeep/0000-0001-5239-6586; Singh, Pawan/0000-0003-4610-3120	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This research was funded by Department of Biotechnology, Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GENSTAT REL 13; BASTEN CJ, 2004, QTL CARTOGRAPHER VER; Bonin CM, 2009, CROP SCI, V49, P1304, DOI 10.2135/cropsci2008.08.0459; Boshoff W. H. P., 1999, Plant Disease, V83, P591, DOI 10.1094/PDIS.1999.83.6.591C; Bozkurt TO, 2010, MOL PLANT PATHOL, V11, P625, DOI [10.1111/J.1364-3703.2010.00633.X, 10.1111/j.1364-3703.2010.00633.x]; BRENNAN JP, 1990, 9002 CIMMYT; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; CHURCHILL GA, 1994, GENETICS, V138, P963; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Effertz RJ, 2002, PHYTOPATHOLOGY, V92, P527, DOI 10.1094/PHYTO.2002.92.5.527; ELIAS E, 1989, CROP SCI, V29, P299, DOI 10.2135/cropsci1989.0011183X002900020013x; Faris JD, 1999, THEOR APPL GENET, V98, P219, DOI 10.1007/s001220051061; Faris JD, 2005, THEOR APPL GENET, V111, P386, DOI 10.1007/s00122-005-2033-5; Faris JD, 1996, PHYTOPATHOLOGY, V86, P459, DOI 10.1094/Phyto-86-459; Faris JD, 1997, THEOR APPL GENET, V94, P98, DOI 10.1007/s001220050387; Genstat 5 Committee, 2005, GENST WIND REL 12 0; Haen KM, 2004, CROP SCI, V44, P951, DOI 10.2135/cropsci2004.0951; JANSEN RC, 1994, GENETICS, V136, P1447; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; Kota R, 2006, THEOR APPL GENET, V112, P492, DOI 10.1007/s00122-005-0151-8; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin F, 2009, THEOR APPL GENET, V118, P631, DOI 10.1007/s00122-008-0894-0; Luo PG, 2009, PROG NAT SCI-MATER, V19, P9, DOI 10.1016/j.pnsc.2008.02.017; Mago R, 2004, GENOME, V47, P112, DOI 10.1139/G03-096; Malosetti M, 2004, EUPHYTICA, V137, P139, DOI 10.1023/B:EUPH.0000040511.46388.ef; Malosetti M., 2015, P 8 WORLD C GEN APPL; Malosetti M, 2008, EUPHYTICA, V161, P241, DOI 10.1007/s10681-007-9594-0; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; Miedaner T, 2012, MOL BREEDING, V29, P731, DOI 10.1007/s11032-011-9586-6; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Paillard S, 2004, THEOR APPL GENET, V109, P323, DOI 10.1007/s00122-004-1628-6; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Piepho HP, 2000, GENETICS, V156, P2043; Risser P, 2011, PHYTOPATHOLOGY, V101, P1209, DOI 10.1094/PHYTO-08-10-0203; Rush CM, 2005, PLANT DIS, V89, P212, DOI 10.1094/PD-89-0212; Seah S, 2000, MOL PLANT MICROBE IN, V13, P334, DOI 10.1094/MPMI.2000.13.3.334; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; SINGH RP, 1984, CAN J GENET CYTOL, V26, P723, DOI 10.1139/g84-115; Singh S, 2008, PLANT DIS, V92, P91, DOI 10.1094/PDIS-92-1-0091; Singh S, 2007, THEOR APPL GENET, V116, P147, DOI 10.1007/s00122-007-0654-6; Spielmeyer W, 2005, THEOR APPL GENET, V111, P731, DOI 10.1007/s00122-005-2058-9; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; William HM, 2007, EUPHYTICA, V157, P307, DOI 10.1007/s10681-007-9405-7; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Zwonitzer JC, 2010, PHYTOPATHOLOGY, V100, P72, DOI 10.1094/PHYTO-100-1-0072	53	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38008	10.1371/journal.pone.0038008	http://dx.doi.org/10.1371/journal.pone.0038008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679489	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900016
J	Cui, Y; Lee, MY; Huo, NX; Bragg, J; Yan, LJ; Yuan, C; Li, C; Holditch, SJ; Xie, JZ; Luo, MC; Li, DW; Yu, JL; Martin, J; Schackwitz, W; Gu, YQ; Vogel, JP; Jackson, AO; Liu, ZY; Garvin, DF				Cui, Yu; Lee, Mi Yeon; Huo, Naxin; Bragg, Jennifer; Yan, Lijie; Yuan, Cheng; Li, Cui; Holditch, Sara J.; Xie, Jingzhong; Luo, Ming-Cheng; Li, Dawei; Yu, Jialin; Martin, Joel; Schackwitz, Wendy; Gu, Yong Qiang; Vogel, John P.; Jackson, Andrew O.; Liu, Zhiyong; Garvin, David F.			Fine Mapping of the Bsr1 Barley Stripe Mosaic Virus Resistance Gene in the Model Grass Brachypodium distachyon	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; LINKAGE MAP; GENOME; RICE; PATHOGENICITY; SYSTEM; DETERMINANTS; MOVEMENT; ALPHA	The ND18 strain of Barley stripe mosaic virus (BSMV) infects several lines of Brachypodium distachyon, a recently developed model system for genomics research in cereals. Among the inbred lines tested, Bd3-1 is highly resistant at 20 to 25 degrees C, whereas Bd21 is susceptible and infection results in an intense mosaic phenotype accompanied by high levels of replicating virus. We generated an F-6:7 recombinant inbred line (RIL) population from a cross between Bd3-1 and Bd21 and used the RILs, and an F-2 population of a second Bd21 X Bd3-1 cross to evaluate the inheritance of resistance. The results indicate that resistance segregates as expected for a single dominant gene, which we have designated Barley stripe mosaic virus resistance 1 (Bsr1). We constructed a genetic linkage map of the RIL population using SNP markers to map this gene to within 705 Kb of the distal end of the top of chromosome 3. Additional CAPS and Indel markers were used to fine map Bsr1 to a 23 Kb interval containing five putative genes. Our study demonstrates the power of using RILs to rapidly map the genetic determinants of BSMV resistance in Brachypodium. Moreover, the RILs and their associated genetic map, when combined with the complete genomic sequence of Brachypodium, provide new resources for genetic analyses of many other traits.	[Cui, Yu; Yan, Lijie; Yuan, Cheng; Li, Cui; Xie, Jingzhong; Li, Dawei; Yu, Jialin; Liu, Zhiyong] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Cui, Yu; Lee, Mi Yeon; Holditch, Sara J.; Jackson, Andrew O.] Univ Calif Berkeley, Dept Plant & Microbiol, Berkeley, CA 94720 USA; [Huo, Naxin; Bragg, Jennifer; Gu, Yong Qiang; Vogel, John P.] USDA ARS Western Reg Res Ctr, Albany, CA USA; [Luo, Ming-Cheng] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Martin, Joel; Schackwitz, Wendy] US DOE Joint Genome Inst, Walnut Creek, CA USA; [Garvin, David F.] Univ Minnesota, USDA ARS Plant Sci Res Unit, St Paul, MN 55108 USA; [Garvin, David F.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA	China Agricultural University; University of California System; University of California Berkeley; University of California System; University of California Davis; United States Department of Energy (DOE); United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Cui, Y (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	andyoj@berkeley.edu; zhiyongliu@cau.edu.cn	Schackwitz, Wendy/GXH-9536-2022; Luo, Ming-Cheng/C-5600-2011; Li, Dawei/I-8751-2016; Xie, Jingzhong/AAF-5899-2020	Luo, Ming-Cheng/0000-0002-9744-5887; Li, Dawei/0000-0003-4133-1263; Schackwitz, Wendy/0000-0002-3013-9180; Martin, Joel/0000-0001-9511-6441; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233; Yuan, Cheng/0000-0003-2582-4041; Vogel, John/0000-0003-1786-2689	China Scholarship Council; National Natural Science Foundation of China [30971780, 31030056]; 863 project [2011AA100104]; MOA [2009ZX08009-048B]; Program of Introducing Talents of Discipline to Universities [111-2-03]; United States Department of Agriculture [3640-21000-021-00D]; Office of Science (BER), U.S. Department of Energy [DE-AI02-07ER64452, DE-SC0001526]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231];  [2012SKLAB01-7];  [CSREES-2008-35319-19225]	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 project(National High Technology Research and Development Program of China); MOA; Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); United States Department of Agriculture(United States Department of Agriculture (USDA)); Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); ; 	This work was supported by a China Scholarship Council Award to YC, by the National Natural Science Foundation of China (30971780, 31030056), 2012SKLAB01-7, 863 project 2011AA100104, MOA projects 2009ZX08009-048B, and the Program of Introducing Talents of Discipline to Universities (111-2-03) to ZL, by the United States Department of Agriculture (CRIS project no. 3640-21000-021-00D), and Competitive Grant CSREES-2008-35319-19225 to AOJ, and by the Office of Science (BER), U.S. Department of Energy (Interagency Agreement nos. DE-AI02-07ER64452 and DE-SC0001526). Work conducted by the U.S. Department of Energy Joint Genome Institute was supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Bragg JN, 2008, ENCY VIROLOGY, P459; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Carroll T. W., 1980, Plant Disease (formerly Plant Disease Reporter), V64, P136; Carroll TW, 1986, PLANT VIRUSES RODSHA, P373; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Edwards MC, 1996, PHYTOPATHOLOGY, V86, P184, DOI 10.1094/Phyto-86-184; Edwards MC, 2006, NATURAL RESISTANCE MECHANISMS OF PLANTS TO VIRUSES, P465, DOI 10.1007/1-4020-3780-5_22; ESLICH R. F., 1953, PLANT DIS REPORTER, V37, P290; Faris JD, 2008, FUNCT INTEGR GENOMIC, V8, P149, DOI 10.1007/s10142-008-0073-z; Febrer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013461; Filiz E, 2009, GENOME, V52, P876, DOI [10.1139/G09-062, 10.1139/g09-062]; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2007, J SCI FOOD AGR, V87, P1177, DOI 10.1002/jsfa.2868; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Huo NX, 2008, FUNCT INTEGR GENOMIC, V8, P135, DOI 10.1007/s10142-007-0062-7; Huo NX, 2011, THEOR APPL GENET, V123, P455, DOI 10.1007/s00122-011-1598-4; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; Jackson A. O., 1991, Seminars in Virology, V2, P107; Jackson AO, 2009, ANNU REV PHYTOPATHOL, V47, P385, DOI 10.1146/annurev-phyto-080508-081733; JACKSON AO, 1991, CAN J PLANT PATHOL, V13, P163, DOI 10.1080/07060669109500952; JACKSON AO, 1989, ANNU REV PHYTOPATHOL, V27, P95; Jackson AO, 1981, HDB PLANT VIRUS INFE, P565; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Lawrence DM, 1998, METH MOL B, V81, P99; Maule AJ, 2007, MOL PLANT PATHOL, V8, P223, DOI 10.1111/J.1364-3703.2007.00386.X; McKinney HH, 1965, BIOL CHARACTERISTICS; Moffett P, 2009, ADV VIRUS RES, V75, P1, DOI 10.1016/S0065-3527(09)07501-0; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Ozdemir BS, 2008, INT J PLANT GENOMICS; Peraldi A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-100; PETTY ITD, 1994, VIROLOGY, V198, P218, DOI 10.1006/viro.1994.1024; Routledge APM, 2004, MOL PLANT PATHOL, V5, P253, DOI 10.1111/j.1364-3703.2004.00224.x; SISLER W. W., 1956, Plant Disease Reporter, V40, P1106; Timian R. G., 1987, Barley Genetics Newsletter, V17, P79; TIMIAN R. G., 1955, PLANT DIS REPORTER, V39, P550; TIMIAN RG, 1975, PLANT DIS REP, V59, P984; TIMIAN RG, 1974, PHYTOPATHOLOGY, V64, P342, DOI 10.1094/Phyto-64-342; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; VAZQUEZ G, 1974, CROP SCI, V14, P429, DOI 10.2135/cropsci1974.0011183X001400030027x; Verchot-Lubicz J, 2010, MOL PLANT MICROBE IN, V23, P1231, DOI 10.1094/MPMI-04-10-0086; Vogel J, 2006, PLANT CELL TISSUE OR, V84; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel J, 2009, PLANT GENET GENOMICS, V7, P427, DOI 10.1007/978-0-387-77489-3_16; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Weiland JJ, 1996, MOL PLANT MICROBE IN, V9, P62, DOI 10.1094/MPMI-9-0062; WEILAND JJ, 1994, VIROLOGY, V201, P116, DOI 10.1006/viro.1994.1271; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468; ZHENG Y, 1990, J GEN VIROL, V71, P1865, DOI 10.1099/0022-1317-71-8-1865; [No title captured]	56	39	42	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38333	10.1371/journal.pone.0038333	http://dx.doi.org/10.1371/journal.pone.0038333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675544	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700059
J	Liu, B; Tikunova, SB; Kline, KP; Siddiqui, JK; Davis, JP				Liu, Bin; Tikunova, Svetlana B.; Kline, Kristopher P.; Siddiqui, Jalal K.; Davis, Jonathan P.			Disease-Related Cardiac Troponins Alter Thin Filament Ca2+ Association and Dissociation Rates	PLOS ONE			English	Article							CALCIUM-SENSITIZING MUTATIONS; DILATED CARDIOMYOPATHY; MOUSE MODEL; COOPERATIVE ACTIVATION; ALPHA-TROPOMYOSIN; HEART-FAILURE; EXCHANGE; KINETICS; BINDING; CONTRACTION	The contractile response of the heart can be altered by disease-related protein modifications to numerous contractile proteins. By utilizing an IAANS labeled fluorescent troponin C, TnC(IAANS)(T53C), we examined the effects of ten disease-related troponin modifications on the Ca2+ binding properties of the troponin complex and the reconstituted thin filament. The selected modifications are associated with a broad range of cardiac diseases: three subtypes of familial cardiomyopathies (dilated, hypertrophic and restrictive) and ischemia-reperfusion injury. Consistent with previous studies, the majority of the protein modifications had no effect on the Ca2+ binding properties of the isolated troponin complex. However, when incorporated into the thin filament, dilated cardiomyopathy mutations desensitized (up to 3.3-fold), while hypertrophic and restrictive cardiomyopathy mutations, and ischemia-induced truncation of troponin I, sensitized the thin filament to Ca2+ (up to 6.3-fold). Kinetically, the dilated cardiomyopathy mutations increased the rate of Ca2+ dissociation from the thin filament (up to 2.5-fold), while the hypertrophic and restrictive cardiomyopathy mutations, and the ischemia-induced truncation of troponin I decreased the rate (up to 2-fold). The protein modifications also increased (up to 5.4-fold) or decreased (up to 2.5-fold) the apparent rate of Ca2+ association to the thin filament. Thus, the disease-related protein modifications alter Ca2+ binding by influencing both the association and dissociation rates of thin filament Ca2+ exchange. These alterations in Ca2+ exchange kinetics influenced the response of the thin filament to artificial Ca2+ transients generated in a stopped-flow apparatus. Troponin C may act as a hub, sensing physiological and pathological stimuli to modulate the Ca2+-binding properties of the thin filament and influence the contractile performance of the heart.	[Liu, Bin; Kline, Kristopher P.; Siddiqui, Jalal K.; Davis, Jonathan P.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Tikunova, Svetlana B.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX USA	University System of Ohio; Ohio State University; University of Houston System; University of Houston	Liu, B (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	davis.812@osu.edu			American Heart Association; National Institues of Health [HL091986, HL087462]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091986] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the American Heart Association (to BL and JPD), National Institues of Health grants HL091986 (to JPD) and HL087462 (to SBT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Davis JP, 2008, CARDIOVASC RES, V77, P619, DOI 10.1093/cvr/cvm098; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Davis JP, 1999, BIOCHEMISTRY-US, V38, P4235, DOI 10.1021/bi982495z; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Iorga B, 2008, CARDIOVASC RES, V77, P676, DOI 10.1093/cvr/cvm113; Janssen PML, 2010, AM J PHYSIOL-HEART C, V299, pH1741, DOI 10.1152/ajpheart.00759.2010; Juan F, 2008, INT J CARDIOL, V128, P83, DOI 10.1016/j.ijcard.2008.03.006; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; KASTURI R, 1993, J BIOL CHEM, V268, P7958; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kreutziger KL, 2011, J MOL CELL CARDIOL, V50, P165, DOI 10.1016/j.yjmcc.2010.10.025; Kruger M, 2005, J PHYSIOL-LONDON, V564, P347, DOI 10.1113/jphysiol.2004.079095; Kushwaha SS, 1997, NEW ENGL J MED, V336, P267, DOI 10.1056/NEJM199701233360407; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Murphy AM, 2000, MOL MED TODAY, V6, P330, DOI 10.1016/S1357-4310(00)01732-9; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; ROBERTSON S, 1984, METHOD PHARMACOL, V5, P63, DOI DOI 10.1007/978-1-4684-4778-1_6; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Tachampa K, 2008, J BIOL CHEM, V283, P15114, DOI 10.1074/jbc.M801636200; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; van der Velden J, 2011, PFLUG ARCH EUR J PHY, V462, P155, DOI 10.1007/s00424-011-0960-3; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031	40	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38259	10.1371/journal.pone.0038259	http://dx.doi.org/10.1371/journal.pone.0038259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675533	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341700052
J	Yan, P; Shen, WT; Gao, XZ; Li, XY; Zhou, P; Duan, J				Yan, Pu; Shen, Wentao; Gao, XinZheng; Li, Xiaoying; Zhou, Peng; Duan, Jun			High-Throughput Construction of Intron-Containing Hairpin RNA Vectors for RNAi in Plants	PLOS ONE			English	Article							TRANSIENT EXPRESSION SYSTEM; ONE-STEP; ONE-POT; DNA; CLONING; EFFICIENT; SEQUENCE; INTERFERENCE; PROTEINS; DESIGN	With the wide use of double-stranded RNA interference (RNAi) for the analysis of gene function in plants, a high-throughput system for making hairpin RNA (hpRNA) constructs is in great demand. Here, we describe a novel restriction-ligation approach that provides a simple but efficient construction of intron-containing hpRNA (ihpRNA) vectors. The system takes advantage of the type IIs restriction enzyme BsaI and our new plant RNAi vector pRNAi-GG based on the Golden Gate (GG) cloning. This method requires only a single PCR product of the gene of interest flanked with BsaI recognition sequence, which can then be cloned into pRNAi-GG at both sense and antisense orientations simultaneously to form ihpRNA construct. The process, completed in one tube with one restriction-ligation step, produced a recombinant ihpRNA with high efficiency and zero background. We demonstrate the utility of the ihpRNA constructs generated with pRNAi-GG vector for the effective silencing of various individual endogenous and exogenous marker genes as well as two genes simultaneously. This method provides a novel and high-throughput platform for large-scale analysis of plant functional genomics.	[Yan, Pu; Duan, Jun] Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Yan, Pu; Shen, Wentao; Li, Xiaoying; Zhou, Peng] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China; [Gao, XinZheng] Hainan Med Coll, Dept Basic Med Sci, Haikou, Peoples R China; [Yan, Pu] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Tropical Agricultural Sciences; Hainan Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yan, P (corresponding author), Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	zhp6301@126.com; duanj@scib.ac.cn			National Natural Science Foundation of China [30960218]; National Nonprofit Institute Research Grant of CATAS-ITBB [ITBB110212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nonprofit Institute Research Grant of CATAS-ITBB	This work is supported by the National Natural Science Foundation of China (Grant no. 30960218) and the National Nonprofit Institute Research Grant of CATAS-ITBB (ITBB110212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake WJ, 2010, NUCLEIC ACIDS RES, V38, P2594, DOI 10.1093/nar/gkq123; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen PY, 2003, MOL BREEDING, V11, P287, DOI 10.1023/A:1023475710642; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Eamens AL, 2011, METHODS MOL BIOL, V701, P179, DOI 10.1007/978-1-61737-957-4_10; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gunsalus KC, 2005, CURR OPIN CELL BIOL, V17, P3, DOI 10.1016/j.ceb.2004.12.008; Helliwell C, 2003, METHODS, V30, P289, DOI 10.1016/S1046-2023(03)00036-7; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; Himmelbach A, 2007, PLANT PHYSIOL, V145, P1192, DOI 10.1104/pp.107.111575; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kusaba M, 2004, CURR OPIN BIOTECH, V15, P139, DOI 10.1016/j.copbio.2004.02.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; Santos-Rosa M, 2008, PLANT CELL REP, V27, P1053, DOI 10.1007/s00299-008-0531-z; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Xiao YH, 2006, BIOTECHNIQUES, V41, P548, DOI 10.2144/000112295; Xu GY, 2010, NEW PHYTOL, V187, P240, DOI 10.1111/j.1469-8137.2010.03253.x; Yan P, 2009, BIOCHEM BIOPH RES CO, V383, P464, DOI 10.1016/j.bbrc.2009.04.036; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	30	42	53	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38186	10.1371/journal.pone.0038186	http://dx.doi.org/10.1371/journal.pone.0038186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675447	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500104
J	Choi, KH; Licht, S				Choi, Kee-Hyun; Licht, Stuart			ATP-Sensitive Potassium Channels Exhibit Variance in the Number of Open Channels below the Limit Predicted for Identical and Independent Gating	PLOS ONE			English	Article							ION CHANNELS; MEDIATED PHOSPHORYLATION; SUPERPOSITION PROPERTIES; ACETYLCHOLINE-RECEPTORS; NEGATIVE COOPERATIVITY; QUANTAL VARIABILITY; CELLS; MEMBRANE; CONDUCTANCE; PROTEINS	In small cells containing small numbers of ion channels, noise due to stochastic channel opening and closing can introduce a substantial level of variability into the cell's membrane potential. Negatively cooperative interactions that couple a channel's gating conformational change to the conformation of its neighbor(s) provide a potential mechanism for mitigating this variability, but such interactions have not previously been directly observed. Here we show that heterologously expressed ATP-sensitive potassium channels generate noise (i.e., variance in the number of open channels) below the level possible for identical and independent channels. Kinetic analysis with single-molecule resolution supports the interpretation that interchannel negative cooperativity (specifically, the presence of an open channel making a closed channel less likely to open) contributes to the decrease in noise. Functional coupling between channels may be important in modulating stochastic fluctuations in cellular signaling pathways.	[Choi, Kee-Hyun; Licht, Stuart] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Choi, KH (corresponding author), Korea Inst Sci & Technol, Seoul, South Korea.	stuart.licht@sanofi.com			Massachusetts Institute of Technology Department of Chemistry; Beckman Foundation through the Beckman Young Investigators program	Massachusetts Institute of Technology Department of Chemistry; Beckman Foundation through the Beckman Young Investigators program	This work was funded by the Massachusetts Institute of Technology Department of Chemistry (web.mit.edu/chemistry/www/index.html) and the Beckman Foundation (www.beckman-foundation.com) through the Beckman Young Investigators program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT FM, 1988, J PHYSIOL-LONDON, V400, P501, DOI 10.1113/jphysiol.1988.sp017134; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; BROWN GC, 1990, FEBS LETT, V260, P1, DOI 10.1016/0014-5793(90)80051-J; Colquhoun David, 1995, P397; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; Diba K, 2004, J NEUROSCI, V24, P9723, DOI 10.1523/JNEUROSCI.1721-04.2004; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; Franks KM, 2003, J NEUROSCI, V23, P3186; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEHL S, 1993, EUR BIOPHYS J BIOPHY, V22, P1, DOI 10.1007/BF00205806; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; IWASA K, 1986, BIOPHYS J, V50, P531, DOI 10.1016/S0006-3495(86)83491-9; KELESHIAN AM, 1994, BIOPHYS J, V67, P634, DOI 10.1016/S0006-3495(94)80523-5; Keleshian AM, 2000, BIOPHYS J, V78, P1, DOI 10.1016/S0006-3495(00)76568-4; Kenyon JL, 2000, J NEUROSCI METH, V96, P105, DOI 10.1016/S0165-0270(99)00189-2; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; LIU Y, 1993, BIOPHYS J, V64, P26, DOI 10.1016/S0006-3495(93)81337-7; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; McCormick DA, 2007, NATURE, V445, pE1, DOI 10.1038/nature05523; Min W, 2005, ACCOUNTS CHEM RES, V38, P923, DOI 10.1021/ar040133f; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Naundorf B, 2007, NATURE, V445, pE2, DOI 10.1038/nature05534; NEDELMAN J, 1986, AM STAT, V40, P286, DOI 10.2307/2684605; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; NEUMCKE B, 1983, BIOCHIM BIOPHYS ACTA, V727, P177, DOI 10.1016/0005-2736(83)90382-6; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Ribalet B, 2000, J GEN PHYSIOL, V116, P391, DOI 10.1085/jgp.116.3.391; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; Ursell T, 2007, PLOS COMPUT BIOL, V3, P803, DOI 10.1371/journal.pcbi.0030081; YEO GF, 1989, PROC R SOC SER B-BIO, V238, P155, DOI 10.1098/rspb.1989.0073; YERAMIAN E, 1986, BIOPHYS J, V50, P253, DOI 10.1016/S0006-3495(86)83459-2	39	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37399	10.1371/journal.pone.0037399	http://dx.doi.org/10.1371/journal.pone.0037399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666353	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400026
J	Costa, T; Boccignone, G; Ferraro, M				Costa, Tommaso; Boccignone, Giuseppe; Ferraro, Mario			Gaussian Mixture Model of Heart Rate Variability	PLOS ONE			English	Article							SERIES	Heart rate variability (HRV) is an important measure of sympathetic and parasympathetic functions of the autonomic nervous system and a key indicator of cardiovascular condition. This paper proposes a novel method to investigate HRV, namely by modelling it as a linear combination of Gaussians. Results show that three Gaussians are enough to describe the stationary statistics of heart variability and to provide a straightforward interpretation of the HRV power spectrum. Comparisons have been made also with synthetic data generated from different physiologically based models showing the plausibility of the Gaussian mixture parameters.	[Costa, Tommaso] Univ Turin, Dipartimento Psicol, Turin, Italy; [Boccignone, Giuseppe] Univ Milan, Dipartimento Sci Informaz, Milan, Italy; [Ferraro, Mario] Univ Turin, Dipartimento Fis, Turin, Italy	University of Turin; University of Milan; University of Turin	Costa, T (corresponding author), Univ Turin, Dipartimento Psicol, Turin, Italy.	tommaso.costa@unito.it	Boccignone, Giuseppe/G-7542-2012; Boccignone, Giuseppe/AAH-4459-2020	Boccignone, Giuseppe/0000-0002-5572-0924; Boccignone, Giuseppe/0000-0002-5572-0924; BRISCHETTO COSTA, Tommaso/0000-0002-0822-862X				Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Amaral LAN, 1999, COMPUT PHYS COMMUN, V121, P126, DOI 10.1016/S0010-4655(99)00295-7; ANTONIAK CE, 1974, ANN STAT, V2, P1152, DOI 10.1214/aos/1176342871; Aubert AE, 1999, ACTA CARDIOL, V54, P107; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; BERGER RD, 1989, AM J PHYSIOL, V256, pH142, DOI 10.1152/ajpheart.1989.256.1.H142; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BERNTSON GG, 1994, PSYCHOPHYSIOLOGY, V31, P599, DOI 10.1111/j.1469-8986.1994.tb02352.x; Brennan M, 2002, AM J PHYSIOL-HEART C, V283, pH1873, DOI 10.1152/ajpheart.00405.2000; Camm AJ, 1996, EUR HEART J, V17, P354; Chatfield C, 2004, ANAL TIME SERIES INT, V59; Corduneanu A., 2001, ARTIF INTELL, P27, DOI DOI 10.1016/J.CSDA.2006.07.020; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Garg G., 2011, INT J BIOELECTROMAGN, V13, P255; Glasbey CA, 2001, J ROY STAT SOC C-APP, V50, P143, DOI 10.1111/1467-9876.00225; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Hausdorff JM, 1996, PHYS REV E, V54, P2154, DOI 10.1103/PhysRevE.54.2154; Ivanov PC, 1998, EUROPHYS LETT, V43, P363, DOI 10.1209/epl/i1998-00366-3; Kantz H., 2004, NONLINEAR TIME SERIE, V7; MANNEVILLE P, 1980, J PHYS-PARIS, V41, P1235, DOI 10.1051/jphys:0198000410110123500; Martis R, 2009, PATTERN RECOGN; McSharry PE, 2003, IEEE T BIO-MED ENG, V50, P289, DOI 10.1109/TBME.2003.808805; Muller P, 2004, STAT SCI, V19, P95, DOI 10.1214/088342304000000017; Parati G, 2006, J APPL PHYSIOL, V101, P676, DOI 10.1152/japplphysiol.00446.2006; Smith KW, 2007, NONLINEAR PROC GEOPH, V14, P73, DOI 10.5194/npg-14-73-2007; Stein PK, 1999, ANNU REV MED, V50, P249, DOI 10.1146/annurev.med.50.1.249; Thong T, 2004, P ANN INT IEEE EMBS, V26, P271; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Verbeek JJ, 2003, NEURAL COMPUT, V15, P469, DOI 10.1162/089976603762553004; Vlassis N, 1999, IEEE T SYST MAN CY A, V29, P393, DOI 10.1109/3468.769758; Vlassis N, 2002, NEURAL PROCESS LETT, V15, P77, DOI 10.1023/A:1013844811137; Yule GU, 1927, PHILOS T R SOC LOND, V226, P267, DOI 10.1098/rsta.1927.0007	32	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37731	10.1371/journal.pone.0037731	http://dx.doi.org/10.1371/journal.pone.0037731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666386	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400045
J	Hemelrijk, CK; Puga-Gonzalez, I				Hemelrijk, Charlotte K.; Puga-Gonzalez, Ivan			An Individual-Oriented Model on the Emergence of Support in Fights, Its Reciprocation and Exchange	PLOS ONE			English	Article							LONG-TAILED MACAQUES; POST-CONFLICT BEHAVIOR; SOCIAL-INTERACTION PATTERNS; CAPPED CAPUCHIN MONKEYS; ADULT FEMALE BABOONS; MALE BONNET MACAQUES; JAPANESE MACAQUES; MACACA-MULATTA; RHESUS-MONKEYS; COALITION-FORMATION	Complex social behaviour of primates has usually been attributed to the operation of complex cognition. Recently, models have shown that constraints imposed by the socio-spatial structuring of individuals in a group may result in an unexpectedly high number of patterns of complex social behaviour, resembling the dominance styles of egalitarian and despotic species of macaques and the differences between them. This includes affiliative patterns, such as reciprocation of grooming, grooming up the hierarchy, and reconciliation. In the present study, we show that the distribution of support in fights, which is the social behaviour that is potentially most sophisticated in terms of cognitive processes, may emerge in the same way. The model represents the spatial grouping of individuals and their social behaviour, such as their avoidance of risks during attacks, the self-reinforcing effects of winning and losing their fights, their tendency to join in fights of others that are close by (social facilitation), their tendency to groom when they are anxious, the reduction of their anxiety by grooming, and the increase of anxiety when involved in aggression. Further, we represent the difference in intensity of aggression apparent in egalitarian and despotic macaques. The model reproduces many aspects of support in fights, such as its different types, namely, conservative, bridging and revolutionary, patterns of choice of coalition partners attributed to triadic awareness, those of reciprocation of support and 'spiteful acts' and of exchange between support and grooming. This work is important because it suggests that behaviour that seems to result from sophisticated cognition may be a side-effect of spatial structure and dominance interactions and it shows that partial correlations fail to completely omit these effects of spatial structure. Further, the model is falsifiable, since it results in many patterns that can easily be tested in real primates by means of existing data.	[Hemelrijk, Charlotte K.; Puga-Gonzalez, Ivan] Univ Groningen, Ctr Ecol & Evolutionary Studies, Behav Ecol & Self Org, Groningen, Netherlands	University of Groningen	Hemelrijk, CK (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Behav Ecol & Self Org, Groningen, Netherlands.	C.K.Hemelrijk@rug.nl	Hemelrijk, Charlotte K./E-4828-2013	Hemelrijk, Charlotte K./0000-0001-6160-077X; Puga-Gonzalez, Ivan/0000-0003-2510-6760	Centre for Ecological and Evolutionary Studies (CEES) Institute, University of Groningen	Centre for Ecological and Evolutionary Studies (CEES) Institute, University of Groningen	Financial support for IPG was given by the Centre for Ecological and Evolutionary Studies (CEES) Institute, University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHUMADA JA, 1992, INT J PRIMATOL, V13, P33, DOI 10.1007/BF02547726; Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; AURELI F, 1992, BEHAV ECOL SOCIOBIOL, V31, P329; AURELI F, 1989, AM J PRIMATOL, V19, P39, DOI 10.1002/ajp.1350190105; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Balasubramaniam KN, 2012, ANIM BEHAV IN PRESS; Barchas P.R., 1984, SOCIAL HIERARCHIES E, P81; Berghanel A, 2010, ANIM BEHAV, V80, P675, DOI 10.1016/j.anbehav.2010.07.002; Berman CM, 2007, BEHAVIOUR, V144, P631, DOI 10.1163/156853907781347790; Bissonnette A, 2009, ANIM BEHAV, V78, P329, DOI 10.1016/j.anbehav.2009.05.010; Butovskaya M. L., 2004, MACAQUE SOC MODEL ST, P182; Buttelmann D, 2007, DEVELOPMENTAL SCI, V10, pF31, DOI 10.1111/j.1467-7687.2007.00630.x; CALDECOTT JO, 1986, ANIM BEHAV, V34, P208, DOI 10.1016/0003-3472(86)90025-4; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Castles DL, 1998, ETHOLOGY, V104, P148; Chapais Bernard, 1992, P29; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; Cheney Dorothy L., 2007, BABOON METAPHYSICS; Cooper MA, 2005, AM J PRIMATOL, V65, P269, DOI 10.1002/ajp.20114; Cooper MA, 2008, INT J PRIMATOL, V29, P225, DOI 10.1007/s10764-008-9236-y; Cooper MA, 2007, ETHOLOGY, V113, P26, DOI 10.1111/j.1439-0310.2006.01287.x; Das M, 1998, INT J PRIMATOL, V19, P53, DOI 10.1023/A:1020354826422; de Vries H, 2009, BEHAVIOUR, V146, P843, DOI 10.1163/156853909X412241; De Waal FBM, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P85; de Waal FBM, 2010, TRENDS COGN SCI, V14, P201, DOI 10.1016/j.tics.2010.03.003; De Waal Frans B. M., 1992, P1; DEWAAL FBM, 1988, ETHOL SOCIOBIOL, V9, P101, DOI 10.1016/0162-3095(88)90016-7; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; Dufour V, 2009, BIOL LETTERS, V5, P172, DOI 10.1098/rsbl.2008.0644; DUNBAR RIM, 1980, BEHAV ECOL SOCIOBIOL, V7, P253, DOI 10.1007/BF00300665; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; EATON GG, 1984, INT J PRIMATOL, V5, P145, DOI 10.1007/BF02735738; FABRENYS C, 1982, PHARMACOL BIOCHEM BE, V16, P653, DOI 10.1016/0091-3057(82)90432-4; Farmer JD, 2005, P NATL ACAD SCI USA, V102, P2254, DOI 10.1073/pnas.0409157102; Frank RE, 2009, BEHAVIOUR, V146, P1123, DOI 10.1163/156853909X406455; Gomes CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005116; GORE MA, 1994, ANIM BEHAV, V48, P385, DOI 10.1006/anbe.1994.1252; Graves FC, 2002, BEHAV NEUROSCI, V116, P489, DOI 10.1037//0735-7044.116.3.489; Harcourt AH., 1992, COALITIONS ALLIANCES; Hemelrijk C. K., 1996, P 4 INT C SIM AD BEH, P545; Hemelrijk Charlotte K., 2004, Interaction Studies, V5, P131, DOI 10.1075/is.5.1.07hem; Hemelrijk Charlotte K., 2011, P223; Hemelrijk CK, 2011, TRENDS COGN SCI, V15, P185, DOI 10.1016/j.tics.2011.02.007; Hemelrijk Charlotte K., 2005, P81, DOI 10.1017/CBO9780511542275.007; Hemelrijk CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002678; Hemelrijk Charlotte K., 1996, P185, DOI 10.1017/CBO9780511752414.016; HEMELRIJK CK, 1994, ANIM BEHAV, V48, P479, DOI 10.1006/anbe.1994.1264; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2003, BEHAVIOUR, V140, P1247, DOI 10.1163/156853903771980585; Hemelrijk CK, 2002, ETHOLOGY, V108, P655, DOI 10.1046/j.1439-0310.2002.00812.x; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; HEMELRIJK CK, 1990, J THEOR BIOL, V143, P405, DOI 10.1016/S0022-5193(05)80036-0; HEMELRIJK CK, 1991, ANIM BEHAV, V41, P923, DOI 10.1016/S0003-3472(05)80630-X; HEMELRIJK CK, 1997, COM ADAP SY, P511; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; HUNTE W, 1987, BEHAV ECOL SOCIOBIOL, V20, P257, DOI 10.1007/BF00292178; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; IMANISHI K, 1960, CURR ANTHROPOL, V1, P393, DOI 10.1086/200134; Itani J, 1954, MONKEYS MT TAKASAKI; JANSON CH, 1990, ANIM BEHAV, V40, P910, DOI 10.1016/S0003-3472(05)80993-5; Jensen K, 2007, P NATL ACAD SCI USA, V104, P13046, DOI 10.1073/pnas.0705555104; Kapsalis E, 1996, BEHAVIOUR, V133, P1235, DOI 10.1163/156853996X00387; Kaufmann J.H., 1967, pUnpaginated; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; KUMMER H, 1974, RULES DYAD GROUP FOR, P129; LOPEZLUJAN AX, 1989, FOLIA PRIMATOL, V52, P102, DOI 10.1159/000156388; Mardia K., 1972, STAT DIRECTIONAL DAT, V37, DOI 10.2307/2984782; MARTEL FL, 1995, DEV PSYCHOBIOL, V28, P71, DOI 10.1002/dev.420280202; MELLER RE, 1980, PHARMACOL BIOCHEM BE, V13, P663, DOI 10.1016/0091-3057(80)90010-6; MENARD M, 2004, MACAQUE SOC, P237; MENDOZA SP, 1983, J HUM EVOL, V12, P185, DOI 10.1016/S0047-2484(83)80023-2; OBRIEN TG, 1993, ANIM BEHAV, V46, P499, DOI 10.1006/anbe.1993.1218; Parr LA, 1997, ANIM BEHAV, V54, P361, DOI 10.1006/anbe.1996.0419; Paxton R, 2010, J COMP PSYCHOL, V124, P395, DOI 10.1037/a0019751; Perry S, 2004, ANIM BEHAV, V67, P165, DOI 10.1016/j.anbehav.2003.04.005; POPP JL, 1979, GREAT APES, P317; PRUDHOMME J, 1993, PRIMATES, V34, P271, DOI 10.1007/BF02382621; Prudhomme J, 1996, INT J PRIMATOL, V17, P429, DOI 10.1007/BF02736630; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; Range F, 2005, ANIM BEHAV, V69, P445, DOI 10.1016/j.anbehav.2004.02.025; RASMUSSEN DR, 1994, PRIMATES, V35, P393, DOI 10.1007/BF02381949; ROBINSON JG, 1981, ANIM BEHAV, V29, P1036, DOI 10.1016/S0003-3472(81)80057-7; Schelling T., 1978, MICROMOTIVES MACROBE; SCHINO G, 1992, BRAIN RES, V576, P125, DOI 10.1016/0006-8993(92)90617-I; Schino G, 2007, J COMP PSYCHOL, V121, P181, DOI 10.1037/0735-7036.121.2.181; Schino G, 2006, ANIM BEHAV, V71, P1069, DOI 10.1016/j.anbehav.2005.07.019; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEYFARTH RM, 1980, ANIM BEHAV, V28, P798, DOI 10.1016/S0003-3472(80)80140-0; SEYFARTH RM, 1976, ANIM BEHAV, V24, P917, DOI 10.1016/S0003-3472(76)80022-X; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; SILK JB, 1992, CURR ANTHROPOL, V33, P318, DOI 10.1086/204073; SILK JB, 1982, BEHAVIOUR, V79, P162, DOI 10.1163/156853982X00238; Silk JB, 2004, ANIM BEHAV, V67, P573, DOI 10.1016/j.anbehav.2003.07.001; Silk JB, 2002, ANNU REV ANTHROPOL, V31, P21, DOI 10.1146/annurev.anthro.31.032902.101743; Silk JB, 1999, ANIM BEHAV, V58, P45, DOI 10.1006/anbe.1999.1129; Smith JE, 2010, BEHAV ECOL, V21, P284, DOI 10.1093/beheco/arp181; Sornette D, 2007, P NATL ACAD SCI USA, V104, P6562, DOI 10.1073/pnas.0611677104; Stevens JR, 2005, ANNU REV ECOL EVOL S, V36, P499, DOI 10.1146/annurev.ecolsys.36.113004.083814; Stevens JR, 2004, BEHAV BRAIN SCI, V27, P569, DOI 10.1017/S0140525X04320121; Stevens JR, 2004, ANIM BEHAV, V67, P603, DOI 10.1016/j.anbehav.2003.04.012; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; THIERRY B, 1990, J THEOR BIOL, V145, P511, DOI 10.1016/S0022-5193(05)80485-0; Thierry B, 2004, WURZBURG, P267; Thierry B, 2008, ANIM BEHAV, V75, P847, DOI 10.1016/j.anbehav.2007.07.006; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Turner JS, 2002, EXTENDED ORGANISM PH; Van der Post DJ, 2008, ANIM BEHAV, V75, P133, DOI 10.1016/j.anbehav.2007.04.021; van der Post DJ, 2009, BEHAV ECOL SOCIOBIOL, V63, P1643, DOI 10.1007/s00265-009-0771-0; van der Vaart E, 2012, PLOS ONE IN PRESS; van Schaik CP, 2004, BEHAV ECOL SOCIOBIOL, V57, P101, DOI 10.1007/s00265-004-0818-1; Vasey PL, 1996, ANIM BEHAV, V52, P539, DOI 10.1006/anbe.1996.0196; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X; Ventura R, 2006, AM J PRIMATOL, V68, P1138, DOI 10.1002/ajp.20314; WADA K, 1986, INT J PRIMATOL, V7, P1, DOI 10.1007/BF02692306; Wantia J, 2007, SELF ORG DOMINANCE R; Watts DP, 2002, RECIPROCITY INTERCHA, P343; Widdig A, 2000, AM J PRIMATOL, V50, P37, DOI 10.1002/(SICI)1098-2345(200001)50:1<37::AID-AJP4>3.3.CO;2-V; Widdig A, 2006, BEHAV ECOL SOCIOBIOL, V61, P205, DOI 10.1007/s00265-006-0251-8; Wittig RM, 2003, INT J PRIMATOL, V24, P847, DOI 10.1023/A:1024632923180; Wittig RM, 2007, BEHAV ECOL SOCIOBIOL, V61, P899, DOI 10.1007/s00265-006-0319-5; Yamada M., 1966, Primates, V7, P315, DOI 10.1007/BF01730645	128	23	23	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37271	10.1371/journal.pone.0037271	http://dx.doi.org/10.1371/journal.pone.0037271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666348	gold, Green Published			2022-12-27	WOS:000305353400024
J	Rodriguez-Frias, F; Tabernero, D; Quer, J; Esteban, JI; Ortega, I; Domingo, E; Cubero, M; Camos, S; Ferrer-Costa, C; Sanchez, A; Jardi, R; Schaper, M; Homs, M; Garcia-Cehic, D; Guardia, J; Esteban, R; Buti, M				Rodriguez-Frias, Francisco; Tabernero, David; Quer, Josep; Esteban, Juan I.; Ortega, Israel; Domingo, Esteban; Cubero, Maria; Camos, Silvia; Ferrer-Costa, Carles; Sanchez, Alex; Jardi, Rosendo; Schaper, Melanie; Homs, Maria; Garcia-Cehic, Damir; Guardia, Jaume; Esteban, Rafael; Buti, Maria			Ultra-Deep Pyrosequencing Detects Conserved Genomic Sites and Quantifies Linkage of Drug-Resistant Amino Acid Changes in the Hepatitis B Virus Genome	PLOS ONE			English	Article							LAMIVUDINE THERAPY; VIRAL POLYMERASE; NATURAL-HISTORY; SURFACE PROTEIN; ENTECAVIR; MUTATIONS; REPLICATION; CONSEQUENCE; MUTANT; GENE	Background: Selection of amino acid substitutions associated with resistance to nucleos(t)ide-analog (NA) therapy in the hepatitis B virus (HBV) reverse transcriptase (RT) and their combination in a single viral genome complicates treatment of chronic HBV infection and may affect the overlapping surface coding region. In this study, the variability of an overlapping polymerase-surface region, critical for NA resistance, is investigated before treatment and under antiviral therapy, with assessment of NA-resistant amino acid changes simultaneously occurring in the same genome (linkage analysis) and their influence on the surface coding region. Methodology/Principal Findings: Serum samples obtained from chronic HBV-infected patients at pre-treatment and during sequential NA treatment with lamivudine, adefovir, and entecavir were analyzed by ultra-deep pyrosequencing (UDPS) using the GS-FLX platform (454 Life Sciences-Roche). The pre-treatment HBV quasispecies was not enriched with NA-resistant substitutions. The frequencies of this type of substitutions at pre-treatment did not predict the frequencies observed during lamivudine treatment. On linkage analysis of the RT region studied, NA-resistant HBV variants (except for rtA181T) were present in combinations of amino acid substitutions that increased in complexity after viral breakthrough to entecavir, at which time the combined variant rtL180M-S202G-M204V-V207I predominated. In the overlapping surface region, NA-resistant substitutions caused selection of stop codons in a significant percentage of sequences both at pretreatment and during sequential treatment; the rtA181T substitution, related to sW172stop, predominated during treatment with lamivudine and adefovir. A highly conserved RT residue (rtL155), even more conserved than the essential residues in the RT catalytic motif YMDD, was identified in all samples. Conclusions: UDPS methodology enabled quantification of HBV quasispecies variants, even those harboring complex combinations of amino acid changes. The high percentage of potentially defective genomes, especially in the surface region, suggests effective trans-complementation of these variants.	[Rodriguez-Frias, Francisco; Tabernero, David; Camos, Silvia; Jardi, Rosendo; Schaper, Melanie; Homs, Maria] Univ Autonoma Barcelona, HUVH, VHIR, Dept Biochem, E-08193 Barcelona, Spain; [Rodriguez-Frias, Francisco; Tabernero, David; Quer, Josep; Esteban, Juan I.; Domingo, Esteban; Cubero, Maria; Jardi, Rosendo; Schaper, Melanie; Homs, Maria; Garcia-Cehic, Damir; Guardia, Jaume; Esteban, Rafael; Buti, Maria] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Quer, Josep; Esteban, Juan I.; Cubero, Maria; Garcia-Cehic, Damir; Guardia, Jaume; Esteban, Rafael; Buti, Maria] Univ Autonoma Barcelona, VHIR, HUVH, Liver Unit, E-08193 Barcelona, Spain; [Ortega, Israel; Sanchez, Alex] Univ Autonoma Barcelona, VHIR, HUVH, UEB, E-08193 Barcelona, Spain; [Domingo, Esteban] Univ Autonoma Madrid, CSIC, CBMSO, Madrid, Spain; [Ferrer-Costa, Carles] IRB, Mol Modelling & Bioinformat Unit, Barcelona, Spain; [Sanchez, Alex] Univ Barcelona, Fac Biol, Dept Estadist, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Rodriguez-Frias, F (corresponding author), Univ Autonoma Barcelona, HUVH, VHIR, Dept Biochem, E-08193 Barcelona, Spain.	frarodri@vhebron.net	Tabernero, David/AAB-3848-2019; Rodriguez-Frias, Francisco/AAC-3507-2020; Sánchez-Pla, Alex/H-8310-2015; Quer, Josep/A-6741-2012; Domingo, Esteban/K-3937-2014	Tabernero, David/0000-0002-1146-4084; Sánchez-Pla, Alex/0000-0002-8673-7737; Quer, Josep/0000-0003-0014-084X; Homs, Maria/0000-0002-8370-8375; Garcia-Cehic, Damir/0000-0002-0009-038X; Domingo, Esteban/0000-0002-0573-1676; Buti Ferret, Maria/0000-0002-0732-3078; rodriguez-frias, francisco/0000-0002-9128-7013; esteban, rafael/0000-0001-5280-392X	CDTI (Centro para el Desarrollo Tecnologico Industrial) [IDI-20110115]; Spanish Ministry of Economy and Competitiveness [SAF2009-10403, PS09/0899, PI10/01505, PI11/01973]	CDTI (Centro para el Desarrollo Tecnologico Industrial); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the CDTI (Centro para el Desarrollo Tecnologico Industrial, http://www.cdti.es/) (IDI-20110115) and the grants SAF2009-10403, PS09/0899, PI10/01505 and PI11/01973 from the Spanish Ministry of Economy and Competitiveness (http://www.micinn.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Jaoude G, 2007, J VIROL, V81, P13057, DOI 10.1128/JVI.01495-07; Amini-Bavil-Olyaee S, 2009, AIDS, V23, P268, DOI 10.1097/QAD.0b013e3283224316; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Das K, 2001, J VIROL, V75, P4771, DOI 10.1128/JVI.75.10.4771-4779.2001; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Homs M, 2011, NUCLEIC ACIDS RES, V39, P8457, DOI 10.1093/nar/gkr451; Honorati MC, 1997, GASTROENTEROLOGY, V112, P2017, DOI 10.1053/gast.1997.v112.pm9178695; Huang LM, 2011, CURR OPIN IMMUNOL, V23, P237, DOI 10.1016/j.coi.2010.12.013; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jardi R, 2007, J VIRAL HEPATITIS, V14, P835, DOI 10.1111/j.1365-2893.2007.00877.x; Jardi R, 2008, J HEPATOL, V49, P695, DOI 10.1016/j.jhep.2008.03.030; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lanford RE, 1997, J VIROL, V71, P2996, DOI 10.1128/JVI.71.4.2996-3004.1997; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Levine S, 2002, ANTIMICROB AGENTS CH, V46, P2525, DOI 10.1128/AAC.46.8.2525-2532.2002; Locarnini S, 2008, HEPATOL INT, V2, P147, DOI 10.1007/s12072-008-9048-3; Lok ASF, 2002, J CLIN MICROBIOL, V40, P3729, DOI 10.1128/JCM.40.10.3729-3734.2002; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; RADZIWILL G, 1990, J VIROL, V64, P613, DOI 10.1128/JVI.64.2.613-620.1990; Reijnders JGP, 2010, J HEPATOL, V52, P493, DOI 10.1016/j.jhep.2010.01.012; Rhee SY, 2010, ANTIVIR RES, V88, P269, DOI 10.1016/j.antiviral.2010.09.012; Rodriguez-Frias F, 2008, ANTIVIR THER, V13, P991; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Sheldon J, 2006, J VIRAL HEPATITIS, V13, P427, DOI 10.1111/j.1365-2893.2005.00713.x; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Tenney DJ, 2004, ANTIMICROB AGENTS CH, V48, P3498, DOI 10.1128/AAC.48.9.3498-3507.2004; Torresi J, 2002, VIROLOGY, V299, P88, DOI 10.1006/viro.2002.1448; Torresi J, 2002, VIROLOGY, V293, P305, DOI 10.1006/viro.2001.1246; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Urban M, 1998, J GEN VIROL, V79, P1121, DOI 10.1099/0022-1317-79-5-1121; van Hemert FJ, 2008, VIROLOGY, V370, P362, DOI 10.1016/j.virol.2007.08.036; Villet S, 2008, J HEPATOL, V48, P747, DOI 10.1016/j.jhep.2008.01.027; Villet S, 2007, J HEPATOL, V46, P531, DOI 10.1016/j.jhep.2006.11.016; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Warner N, 2008, HEPATOLOGY, V48, P88, DOI 10.1002/hep.22295; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2006, ANTIVIR THER, V11, P909; Xiong XF, 2000, HEPATOLOGY, V31, P219, DOI 10.1002/hep.510310132; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	50	46	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37874	10.1371/journal.pone.0037874	http://dx.doi.org/10.1371/journal.pone.0037874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666402	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400054
J	Abian-Vicen, J; Del Coso, J; Gonzalez-Millan, C; Salinero, JJ; Abian, P				Abian-Vicen, Javier; Del Coso, Juan; Gonzalez-Millan, Cristina; Salinero, Juan Jose; Abian, Pablo			Analysis of Dehydration and Strength in Elite Badminton Players	PLOS ONE			English	Article							EXERCISE INTENSITY; HANDGRIP STRENGTH; VERTICAL JUMP; FLUID; POWER; HYDRATION; TENNIS; PERFORMANCE; FATIGUE; SPORTS	Background: The negative effects of dehydration on aerobic activities are well established. However, it is unknown how dehydration affects intermittent sports performance. The purpose of this study was to identify the level of dehydration in elite badminton players and its relation to muscle strength and power production. Methodology: Seventy matches from the National Spanish badminton championship were analyzed (46 men's singles and 24 women's singles). Before and after each match, jump height and power production were determined during a countermovement jump on a force platform. Participants' body weight and a urine sample were also obtained before and after each match. The amount of liquid that the players drank during the match was also calculated by weighing their individual drinking bottles. Results and Discussion: Sweat rate during the game was 1.14 +/- 0.46 l/h in men and 1.02 +/- 0.64 l/h in women. The players rehydrated at a rate of 1.10 +/- 0.55 l/h and 1.01 +/- 0.44 l/h in the male and female groups respectively. Thus, the dehydration attained during the game was only 0.37 +/- 0.50% in men and 0.32 +/- 0.83% in women. No differences were found in any of the parameters analyzed during the vertical jump (men: from 31.82 +/- 5.29 to 32.90 +/- 4.49 W/kg; p>0.05, women: from 26.36 +/- 4.73 to 27.25 +/- 4.44 W/kg; p>0.05). Post-exercise urine samples revealed proteinuria (60.9% of cases in men and 66.7% in women), leukocyturia (men = 43.5% and women = 50.0%) and erythrocyturia (men = 50.0% and women = 21.7%). Conclusions: Despite a moderate sweat rate, badminton players adequately hydrated during a game and thus the dehydration attained was low. The badminton match did not cause muscle fatigue but it significantly increased the prevalence of proteinuria, leukocyturia and erythrocyturia.	[Abian-Vicen, Javier; Del Coso, Juan; Gonzalez-Millan, Cristina; Salinero, Juan Jose; Abian, Pablo] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain	Camilo Jose Cela University	Abian-Vicen, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jabian@ucjc.edu	Del Coso, Juan/AAC-7117-2020; Salinero, Juan J./GLT-1243-2022; ABIAN, PABLO/AAZ-8278-2021; Abián-Vicén, Javier/I-8509-2012; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012	Del Coso, Juan/0000-0002-5785-984X; Salinero, Juan J./0000-0003-4153-5100; ABIAN, PABLO/0000-0002-6976-0740; Abián-Vicén, Javier/0000-0001-9635-3289; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Gonzalez-Millan, Cristina/0000-0002-3371-9420				Abian J, 2008, J SPORT MED PHYS FIT, V48, P305; Alkurdi ZD, 2010, J APPL BIOMECH, V26, P123, DOI 10.1123/jab.26.2.123; Apostolidis N, 2004, J SPORT MED PHYS FIT, V44, P157; Armstrong LE, 2010, INT J SPORT NUTR EXE, V20, P145, DOI 10.1123/ijsnem.20.2.145; Baker LB, 2007, MED SCI SPORT EXER, V39, P1114, DOI 10.1249/mss.0b013e3180574b02; BOILEAU M, 1980, UROLOGY, V15, P471, DOI 10.1016/0090-4295(80)90007-2; Broad EM, 1996, INT J SPORT NUTR, V6, P307, DOI 10.1123/ijsn.6.3.307; Buono MJ, 2010, J PHYSIOL SCI, V60, P103, DOI 10.1007/s12576-009-0073-3; Cabello Manrique D, 2003, BRIT J SPORT MED, V37, P62; Carr AJ, 2011, INT J SPORT NUTR EXE, V21, P357, DOI 10.1123/ijsnem.21.5.357; Casa DJ, 2000, J ATHL TRAINING, V35, P212; Chen HL, 2008, J EXERC SCI FIT, V6, P34; Del Coso J, 2008, APPL PHYSIOL NUTR ME, V33, P290, DOI 10.1139/H07-188; Dougherty KA, 2006, MED SCI SPORT EXER, V38, P1650, DOI 10.1249/01.mss.0000227640.60736.8e; Ducher G, 2005, CAN J APPL PHYSIOL, V30, P3, DOI 10.1139/h05-101; Espana-Romero V, 2010, J STRENGTH COND RES, V24, P272, DOI 10.1519/JSC.0b013e3181b296a5; Finn JP, 2004, J HUM NUTR DIET, V61, P221; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; GUR H, 1994, BRIT J SPORT MED, V28, P61, DOI 10.1136/bjsm.28.1.61; Gutierrez A, 2003, INT J SPORTS MED, V24, P518; Hamouti N, 2010, EUR J SPORT SCI, V10, P329, DOI 10.1080/17461391003632022; Hamouti N, 2010, EUR J APPL PHYSIOL, V109, P213, DOI 10.1007/s00421-009-1333-x; Hayes LD, 2010, EUR J APPL PHYSIOL, V108, P701, DOI 10.1007/s00421-009-1288-y; HOFFMAN JR, 1995, INT J SPORTS MED, V16, P214, DOI 10.1055/s-2007-972994; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Kane SF, 2009, CURR SPORT MED REP, V8, P77, DOI 10.1249/JSR.0b013e31819e0b8d; KANNUS P, 1995, ANN INTERN MED, V123, P27, DOI 10.7326/0003-4819-123-1-199507010-00003; KRAMER AM, 1992, PERCEPT MOTOR SKILL, V75, P363, DOI 10.2466/PMS.75.5.363-366; Lara AJ, 2006, J SPORT MED PHYS FIT, V46, P419; Lees A, 2003, J SPORT SCI, V21, P707, DOI 10.1080/0264041031000140275; Mahoney CA, 1995, SCI RACKET SPORTS; Maughan RJ, 2010, SCAND J MED SCI SPOR, V20, P59, DOI 10.1111/j.1600-0838.2010.01191.x; Maughan RJ, 2005, J SPORT SCI, V23, P73, DOI 10.1080/02640410410001730115; McInnis MD, 1998, EUR J APPL PHYSIOL O, V79, P99; NOAKES TD, 1988, EUR J APPL PHYSIOL O, V57, P210, DOI 10.1007/BF00640665; Passe D, 2007, INT J SPORT NUTR EXE, V17, P284, DOI 10.1123/ijsnem.17.3.284; Penders J, 2002, CLIN CHEM, V48, P2236; Poortmans J R, 1977, Exerc Sport Sci Rev, V5, P255; POORTMANS JR, 1984, SPORTS MED, V1, P125, DOI 10.2165/00007256-198401020-00003; Popowski LA, 2001, MED SCI SPORT EXER, V33, P747; Riggs MP, 2009, J HUM SPORT EXERC, V4, P221, DOI 10.4100/jhse.2009.43.04; Enriquez OR, 2010, NUTR HOSP, V25, P768, DOI 10.3305/nh.2010.25.5.4542; Sawka M.N., 2006, ACSMS ADV EXERCISE P, V26, P535; Segura-Orti E, 2011, PHYS THER, V91, P1244, DOI 10.2522/ptj.20100141; Sharp NC, 1998, SCI RACKET SPORTS, P52; Shi XC, 1998, SPORTS MED, V25, P157, DOI 10.2165/00007256-199825030-00003; Silva RP, 2010, J SPORT SCI MED, V9, P464; Tippet ML, 2011, J ATHL TRAINING, V46, P55, DOI 10.4085/1062-6050-46.1.55; VIITASALO JT, 1987, INT J SPORTS MED, V8, P281, DOI 10.1055/s-2008-1025670; WALSH RM, 1994, INT J SPORTS MED, V15, P392, DOI 10.1055/s-2007-1021076; Watson G, 2005, MED SCI SPORT EXER, V37, P1168, DOI 10.1249/01.mss.0000170100.93279.be; Wilson DW, 1925, J BIOL CHEM, V65, P755; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zemkova E, 2009, KINESIOLOGY, V41, P195	54	33	33	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37821	10.1371/journal.pone.0037821	http://dx.doi.org/10.1371/journal.pone.0037821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666396	Green Accepted, Green Published, gold			2022-12-27	WOS:000305349600032
J	Prows, DR; Gibbons, WJ; Burzynski, BB				Prows, Daniel R.; Gibbons, William J., Jr.; Burzynski, Benjamin B.			Synchronizing Allelic Effects of Opposing Quantitative Trait Loci Confirmed a Major Epistatic Interaction Affecting Acute Lung Injury Survival in Mice	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; QTL; SUSCEPTIBILITY; INTERCROSS; DISSECTION; OUTCOMES; GROWTH; DAMAGE; CELLS	Increased oxygen (O-2) levels help manage severely injured patients, but too much for too long can cause acute lung injury (ALI), acute respiratory distress syndrome (ARDS) and even death. In fact, continuous hyperoxia has become a prototype in rodents to mimic salient clinical and pathological characteristics of ALI/ARDS. To identify genes affecting hyperoxia-induced ALI (HALI), we previously established a mouse model of differential susceptibility. Genetic analysis of backcross and F-2 populations derived from sensitive (C57BL/6J; B) and resistant (129X1/SvJ; X1) inbred strains identified five quantitative trait loci (QTLs; Shali1-5) linked to HALI survival time. Interestingly, analysis of these recombinant populations supported opposite within-strain effects on survival for the two major-effect QTLs. Whereas Shali1 alleles imparted the expected survival time effects (i.e., X1 alleles increased HALI resistance and B alleles increased sensitivity), the allelic effects of Shali2 were reversed (i.e., X1 alleles increased HALI sensitivity and B alleles increased resistance). For in vivo validation of these inverse allelic effects, we constructed reciprocal congenic lines to synchronize the sensitivity or resistance alleles of Shali1 and Shali2 within the same strain. Specifically, B-derived Shali1 or Shali2 QTL regions were transferred to X1 mice and X1-derived QTL segments were transferred to B mice. Our previous QTL results predicted that substituting Shali1 B alleles onto the resistant X1 background would add sensitivity. Surprisingly, not only were these mice more sensitive than the resistant X1 strain, they were more sensitive than the sensitive B strain. In stark contrast, substituting the Shali2 interval from the sensitive B strain onto the X1 background markedly increased the survival time. Reciprocal congenic lines confirmed the opposing allelic effects of Shali1 and Shali2 on HALI survival time and provide unique models to identify their respective quantitative trait genes and to critically assess the apparent bidirectional epistatic interactions between these major-effect loci.	[Prows, Daniel R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Prows, Daniel R.; Gibbons, William J., Jr.; Burzynski, Benjamin B.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA	University of Cincinnati; Cincinnati Children's Hospital Medical Center	Prows, DR (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.	daniel.prows@cchmc.org			National Institutes of Health, Heart, Lung and Blood Institute [HL75562]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL075562, R01HL075562] Funding Source: NIH RePORTER	National Institutes of Health, Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was financially supported by the National Institutes of Health, Heart, Lung and Blood Institute, grant HL75562 (DRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MN, 2011, EXP LUNG RES, V37, P10, DOI 10.3109/01902148.2010.497893; Ariyarajah A, 2004, J HYPERTENS, V22, P1495, DOI 10.1097/01.hjh.0000133720.94075.6f; Bolivar VJ, 2001, GENOME RES, V11, P1549, DOI 10.1101/gr.194001; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Butterfield RJ, 2003, GENETICS, V163, P1041; CHEVERUD JM, 1995, GENETICS, V139, P1455; Craig TR, 2011, AM J RESP CRIT CARE, V183, P620, DOI 10.1164/rccm.201003-0423OC; Curley MAQ, 2005, JAMA-J AM MED ASSOC, V294, P229, DOI 10.1001/jama.294.2.229; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Donahoe Michael, 2011, Pulm Circ, V1, P192, DOI 10.4103/2045-8932.83454; Eastwood G, 2012, INTENS CARE MED, V38, P91, DOI 10.1007/s00134-011-2419-6; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Farber CR, 2007, MAMM GENOME, V18, P635, DOI 10.1007/s00335-007-9046-0; Fawcett GL, 2010, OBESITY, V18, P1383, DOI 10.1038/oby.2009.411; Ferraro TN, 2010, PHYSIOL GENOMICS, V42A, P1, DOI 10.1152/physiolgenomics.00096.2010; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; Hernandez-Valladares M, 2004, MAMM GENOME, V15, P390, DOI 10.1007/s00335-004-3042-4; Ishikawa A, 2007, MAMM GENOME, V18, P229, DOI 10.1007/s00335-007-9009-5; KISTLER GS, 1967, J CELL BIOL, V32, P605, DOI 10.1083/jcb.32.3.605; Knaapi J, 2011, EXP LUNG RES, V37, P408, DOI 10.3109/01902148.2011.581738; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Legare ME, 2000, GENOME RES, V10, P42; Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; Mollah MBR, 2011, MAMM GENOME, V22, P282, DOI 10.1007/s00335-011-9323-9; Norgard EA, 2008, J BONE MINER RES, V23, P887, DOI 10.1359/JBMR.080210; Palijan A, 2003, PHYSIOL GENOMICS, V15, P1, DOI 10.1152/physiolgenomics.00084.2003; Prows DR, 2007, PHYSIOL GENOMICS, V30, P271, DOI 10.1152/physiolgenomics.00038.2007; Prows DR, 2007, PHYSIOL GENOMICS, V30, P262, DOI 10.1152/physiolgenomics.00232.2006; Prows DR, 2009, PHYSIOL GENOMICS, V38, P158, DOI 10.1152/physiolgenomics.90392.2008; Reddy NM, 2011, AM J RESP CELL MOL, V45, P1161, DOI 10.1165/rcmb.2011-0144OC; Roper RJ, 2003, J IMMUNOL, V170, P5886, DOI 10.4049/jimmunol.170.12.5886; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2003, CRIT CARE MED, V31, pS276, DOI 10.1097/01.CCM.0000057904.62683.2B; Spragg RG, 2011, AM J RESP CRIT CARE, V183, P1055, DOI 10.1164/rccm.201009-1424OC; van der Windt GJW, 2011, AM J RESP CELL MOL, V44, P377, DOI 10.1165/rcmb.2010-0158OC; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WISPE JR, 1992, J BIOL CHEM, V267, P23937; Yen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026870	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38177	10.1371/journal.pone.0038177	http://dx.doi.org/10.1371/journal.pone.0038177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666475	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600068
J	Seminoff, JA; Benson, SR; Arthur, KE; Eguchi, T; Dutton, PH; Tapilatu, RF; Popp, BN				Seminoff, Jeffrey A.; Benson, Scott R.; Arthur, Karen E.; Eguchi, Tomoharu; Dutton, Peter H.; Tapilatu, Ricardo F.; Popp, Brian N.			Stable Isotope Tracking of Endangered Sea Turtles: Validation with Satellite Telemetry and delta N-15 Analysis of Amino Acids	PLOS ONE			English	Article							DERMOCHELYS-CORIACEA; LEATHERBACK TURTLES; TROPHIC POSITION; FORAGING AREAS; CARBON; DICHOTOMY; BUTTERFLIES; CALIFORNIA; PREDATORS; MOVEMENTS	Effective conservation strategies for highly migratory species must incorporate information about long-distance movements and locations of high-use foraging areas. However, the inherent challenges of directly monitoring these factors call for creative research approaches and innovative application of existing tools. Highly migratory marine species, such as marine turtles, regularly travel hundreds or thousands of kilometers between breeding and feeding areas, but identification of migratory routes and habitat use patterns remains elusive. Here we use satellite telemetry in combination with compound-specific isotope analysis of amino acids to confirm that insights from bulk tissue stable isotope analysis can reveal divergent migratory strategies and within-population segregation of foraging groups of critically endangered leatherback sea turtles (Dermochelys coriacea) across the Pacific Ocean. Among the 78 turtles studied, we found a distinct dichotomy in delta N-15 values of bulk skin, with distinct "low delta N-15" and "high delta N-15" groups. delta N-15 analysis of amino acids confirmed that this disparity resulted from isotopic differences at the base of the food chain and not from differences in trophic position between the two groups. Satellite tracking of 13 individuals indicated that their bulk skin delta N-15 value was linked to the particular foraging region of each turtle. These findings confirm that prevailing marine isoscapes of foraging areas can be reflected in the isotopic compositions of marine turtle body tissues sampled at nesting beaches. We use a Bayesian mixture model to show that between 82 and 100% of the 78 skin-sampled turtles could be assigned with confidence to either the eastern Pacific or western Pacific, with 33 to 66% of all turtles foraging in the eastern Pacific. Our forensic approach validates the use of stable isotopes to depict leatherback turtle movements over broad spatial ranges and is timely for establishing wise conservation efforts in light of this species' imminent risk of extinction in the Pacific.	[Seminoff, Jeffrey A.; Benson, Scott R.; Eguchi, Tomoharu; Dutton, Peter H.] NOAA, Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA USA; [Arthur, Karen E.; Popp, Brian N.] Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Tapilatu, Ricardo F.] State Univ Papua, Marine Lab, Manokwari, Papua Barat Pro, Indonesia; [Tapilatu, Ricardo F.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; University of Papua; University of Alabama System; University of Alabama Birmingham	Seminoff, JA (corresponding author), NOAA, Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA USA.	jeffrey.seminoff@noaa.gov	Tapilatu, Ricardo F./ABA-6112-2020	Tapilatu, Ricardo F./0000-0001-5216-104X; Popp, Brian/0000-0001-7021-5478	U.S. National Marine Fisheries Service; University of Hawai'i; Directorate For Geosciences [1041329] Funding Source: National Science Foundation; Division Of Ocean Sciences [1040810] Funding Source: National Science Foundation	U.S. National Marine Fisheries Service; University of Hawai'i; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this research was provided by the U.S. National Marine Fisheries Service and the University of Hawai'i. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, FED REGISTER, V75, P316; Balazs G.H., 1991, BRIT HERPETOLOGICAL, V37, P33; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bolten Alan B., 1999, P110; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Castro CG, 2001, GLOBAL BIOGEOCHEM CY, V15, P819, DOI 10.1029/2000GB001324; Caut S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001845; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Congdon P., 2001, BAYESIAN STAT MODELI; Crowder L, 2000, NATURE, V405, P881, DOI 10.1038/35016247; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Deutsch C. A., 2011, GLOBAL BIOGEOCHEM CY, V15, P483; Dodge KL, 2011, MAR BIOL, V158, P2813, DOI 10.1007/s00227-011-1780-x; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Eckert Scott A., 1997, Marine Turtle Newsletter, V78, P2; Evershed RP, 2007, ECOL METHOD CONCEPT, P480, DOI 10.1002/9780470691854.ch14; Faure G., 1986, PRINCIPLES ISOTOPE G, V2nd; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Fossette S, 2012, BIOL LETTERS, V8, P351, DOI 10.1098/rsbl.2011.0965; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; Garrison Tom, 2009, ESSENTIALS OCEANOGRA, V5th; Gelman A., 2004, BAYESIAN DATA ANAL; Gemperline PJ, 2002, CHEMOMETR INTELL LAB, V60, P135, DOI 10.1016/S0169-7439(01)00191-5; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Graham BS, MOVEMENT UNDERSTANDI, P299; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; Hatase H, 2002, MAR ECOL PROG SER, V233, P273, DOI 10.3354/meps233273; Hitipeuw C, 2007, CHELONIAN CONSERV BI, V6, P28, DOI 10.2744/1071-8443(2007)6[28:PSAIMO]2.0.CO;2; Hobson KA, 2008, TERR ECOL SER, V2, P1; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; James Michael C., 2001, Chelonian Conservation and Biology, V4, P202; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MacKenzie KM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00021; Macko SA, 1997, ANAL CHEM, V69, P926, DOI 10.1021/ac960956l; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; Miller NG, 2011, BIOL LETTERS, V7, P43, DOI 10.1098/rsbl.2010.0525; Minami H, 1997, MAR ECOL PROG SER, V158, P249, DOI 10.3354/meps158249; MINAMI H, 1995, CONDOR, V97, P565, DOI 10.2307/1369042; Montoya JP, 2007, ECOL METHOD CONCEPT, P176, DOI 10.1002/9780470691854.ch7; Musick J.A., 1997, BIOL SEA TURTLES; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Pajuelo M, 2010, MAR ECOL PROG SER, V417, P277, DOI 10.3354/meps08804; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; Popp BN, 2007, TERR ECOL SER, V1, P173; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rau GH, 2003, DEEP-SEA RES PT II, V50, P2431, DOI 10.1016/S0967-0645(03)00128-0; Reich KJ, 2008, OECOLOGIA, V155, P651, DOI 10.1007/s00442-007-0949-y; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Seminoff JA, 2007, COPEIA, P534, DOI 10.1643/0045-8511(2007)2007[534:SCANID]2.0.CO;2; Seminoff JA, 2009, J EXP MAR BIOL ECOL, V381, P33, DOI 10.1016/j.jembe.2009.08.018; Sherwood OA, 2011, P NATL ACAD SCI USA, V108, P1011, DOI 10.1073/pnas.1004904108; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Somes CJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003767; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Tagliabue A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003037; Voss M, 2001, DEEP-SEA RES PT I, V48, P1905, DOI 10.1016/S0967-0637(00)00110-2; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Wallace BP, 2006, MAR BIOL, V149, P953, DOI 10.1007/s00227-006-0247-y; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871	71	106	109	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37403	10.1371/journal.pone.0037403	http://dx.doi.org/10.1371/journal.pone.0037403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666354	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349600014
J	Jung, CH; Wong, CE; Singh, MB; Bhalla, PL				Jung, Chol-Hee; Wong, Chui E.; Singh, Mohan B.; Bhalla, Prem L.			Comparative Genomic Analysis of Soybean Flowering Genes	PLOS ONE			English	Article							MADS-BOX GENE; ARABIDOPSIS-THALIANA; FINGER PROTEIN; GLYCINE-MAX; LOCUS-T; SHOOT; TIME; VERNALIZATION; ACTS; SEQUENCE	Flowering is an important agronomic trait that determines crop yield. Soybean is a major oilseed legume crop used for human and animal feed. Legumes have unique vegetative and floral complexities. Our understanding of the molecular basis of flower initiation and development in legumes is limited. Here, we address this by using a computational approach to examine flowering regulatory genes in the soybean genome in comparison to the most studied model plant, Arabidopsis. For this comparison, a genome-wide analysis of orthologue groups was performed, followed by an in silico gene expression analysis of the identified soybean flowering genes. Phylogenetic analyses of the gene families highlighted the evolutionary relationships among these candidates. Our study identified key flowering genes in soybean and indicates that the vernalisation and the ambient-temperature pathways seem to be the most variant in soybean. A comparison of the orthologue groups containing flowering genes indicated that, on average, each Arabidopsis flowering gene has 2-3 orthologous copies in soybean. Our analysis highlighted that the CDF3, VRN1, SVP, AP3 and PIF3 genes are paralogue-rich genes in soybean. Furthermore, the genome mapping of the soybean flowering genes showed that these genes are scattered randomly across the genome. A paralogue comparison indicated that the soybean genes comprising the largest orthologue group are clustered in a 1.4 Mb region on chromosome 16 of soybean. Furthermore, a comparison with the undomesticated soybean (Glycine soja) revealed that there are hundreds of SNPs that are associated with putative soybean flowering genes and that there are structural variants that may affect the genes of the light-signalling and ambient-temperature pathways in soybean. Our study provides a framework for the soybean flowering pathway and insights into the relationship and evolution of flowering genes between a short-day soybean and the long-day plant, Arabidopsis.	[Jung, Chol-Hee; Wong, Chui E.; Singh, Mohan B.; Bhalla, Prem L.] Univ Melbourne, Plant Mol Biol & Biotechnol Lab, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia	University of Melbourne	Jung, CH (corresponding author), Univ Melbourne, Plant Mol Biol & Biotechnol Lab, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia.	premlb@unimelb.edu.au	Jung, Cholhee/S-8670-2019	Bhalla, Prem/0000-0002-2910-0393; Singh, Mohan/0000-0001-9427-8975	Australian Research Council [CE0348212]	Australian Research Council(Australian Research Council)	Funding for this research was provided by the Australian Research Council (http://www.arc.gov.au) in form of the ARC Centre of Excellence grant (CE0348212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Alexandre CM, 2008, J EXP BOT, V59, P1127, DOI 10.1093/jxb/ern070; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; BARTON MK, 1993, DEVELOPMENT, V119, P823; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen MJ, 2006, PLANT J, V46, P823, DOI 10.1111/j.1365-313X.2006.02740.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; Ferl RJ, 2002, GENOME BIOL, V3; Fornara Fabio, 2010, Cell, V141, DOI 10.1016/j.cell.2010.04.024; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Gu Q, 1998, DEVELOPMENT, V125, P1509; Han P, 2008, PLANT J, V55, P253, DOI 10.1111/j.1365-313X.2008.03499.x; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Hecht V, 2011, PLANT CELL, V23, P147, DOI 10.1105/tpc.110.081042; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laux T, 1996, DEVELOPMENT, V122, P87; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Liscum E, 2003, PLANT PHYSIOL, V133, P1429, DOI 10.1104/pp.103.030601; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; MANDEL MA, 1995, PLANT CELL, V7, P1763, DOI 10.1105/tpc.7.11.1763; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Nakaminami K, 2009, J EXP BOT, V60, P1047, DOI 10.1093/jxb/ern351; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Robles P, 2005, INT J DEV BIOL, V49, P633, DOI 10.1387/ijdb.052020pr; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Summerfield RJ, 1985, GLYCINE MAX, P139; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Tucker SC, 2003, PLANT PHYSIOL, V131, P911, DOI 10.1104/pp.102.017459; Veley KM, 2008, PLANT PHYSIOL, V147, P682, DOI 10.1104/pp.108.118927; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Washburn CF, 2000, AM J BOT, V87, P1425, DOI 10.2307/2656869; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Yu H, 2002, P NATL ACAD SCI USA, V99, P16336, DOI 10.1073/pnas.212624599; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang QZ, 2008, P NATL ACAD SCI USA, V105, P21028, DOI 10.1073/pnas.0810585105	56	74	76	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38250	10.1371/journal.pone.0038250	http://dx.doi.org/10.1371/journal.pone.0038250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679494	Green Published, gold			2022-12-27	WOS:000305343900024
J	Macdonald, SHF; Woodward, E; Coleman, MM; Dorris, ER; Nadarajan, P; Chew, WM; McLaughlin, AM; Keane, J				Macdonald, Stephen H. -F.; Woodward, Elliott; Coleman, Michelle M.; Dorris, Emma R.; Nadarajan, Parthiban; Chew, Wui-Mei; McLaughlin, Anne-Marie; Keane, Joseph			Networked T Cell Death following Macrophage Infection by Mycobacterium tuberculosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANTIGEN PRESENTATION; EXPRESSION ANALYSIS; APOPTOSIS; SECRETION; MODULATION; MECHANISMS; RESPONSES; EVASION; PROTEIN	Background: Depletion of T cells following infection by Mycobacterium tuberculosis (Mtb) impairs disease resolution, and interferes with clinical test performance that relies on cell-mediated immunity. A number of mechanisms contribute to this T cell suppression, such as activation-induced death and trafficking of T cells out of the peripheral circulation and into the diseased lungs. The extent to which Mtb infection of human macrophages affects T cell viability however, is not well characterised. Methodology/Principal Findings: We found that lymphopenia (<1.5x10(9) cells/l) was prevalent among culture-positive tuberculosis patients, and lymphocyte counts significantly improved post-therapy. We previously reported that Mtb-infected human macrophages resulted in death of infected and uninfected bystander macrophages. In the current study, we sought to examine the influence of infected human alveolar macrophages on T cells. We infected primary human alveolar macrophages (the primary host cell for Mtb) or PMA-differentiated THP-1 cells with Mtb H37Ra, then prepared cell-free supernatants. The supernatants of Mtb-infected macrophages caused dose-dependent, caspase-dependent, T cell apoptosis. This toxic effect of infected macrophage secreted factors did not require TNF-alpha or Fas. The supernatant cytotoxic signal(s) were heat-labile and greater than 50 kDa in molecular size. Although ESAT-6 was toxic to T cells, other Mtb-secreted factors tested did not influence T cell viability; nor did macrophage-free Mtb bacilli or broth from Mtb cultures. Furthermore, supernatants from Mycobacterium bovis Bacille de Calmette et Guerin (BCG)-infected macrophages also elicited T cell death suggesting that ESAT-6 itself, although cytotoxic, was not the principal mediator of T cell death in our system. Conclusions: Mtb-Infected macrophages secrete heat-labile factors that are toxic to T cells, and may contribute to the immunosuppression seen in tuberculosis as well as interfere with microbial eradication in the granuloma.	[Macdonald, Stephen H. -F.; Woodward, Elliott; Coleman, Michelle M.; Dorris, Emma R.; Nadarajan, Parthiban; Chew, Wui-Mei; McLaughlin, Anne-Marie; Keane, Joseph] St James Hosp, Trinity Inst Mol Med, Dept Clin Med, Dublin, Ireland	Trinity College Dublin	Macdonald, SHF (corresponding author), St James Hosp, Trinity Inst Mol Med, Dept Clin Med, Dublin, Ireland.	macdonaldez@gmail.com	Keane, Joseph/AAX-6658-2021; Dorris, Emma/AAJ-6563-2020	Keane, Joseph/0000-0001-5313-385X; Dorris, Emma/0000-0003-2014-934X; Nadarajan, Parthiban/0000-0002-1685-1876; Coleman, Michelle/0000-0002-6752-3266; Macdonald, Stephen/0000-0001-6306-8035	Science Foundation Ireland (SFI); Health Research Board (HRB); SFI as part of the Immunology Research Centre, (SFI) Strategic Research Cluster [07/SRC/B1144, E02209420]; HRB's PhD Scholars' Program	Science Foundation Ireland (SFI)(Science Foundation Ireland); Health Research Board (HRB); SFI as part of the Immunology Research Centre, (SFI) Strategic Research Cluster(Science Foundation Ireland); HRB's PhD Scholars' Program	This work was funded by the Science Foundation Ireland (SFI; www.sfi.ie) and the Health Research Board (HRB; www.hrb.ie). JK, SHFM and MMC were supported by SFI as part of the Immunology Research Centre, (SFI) Strategic Research Cluster grant (07/SRC/B1144 Cluster Grant E02209420). ERD was funded by the HRB's PhD Scholars' Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Blanchette J, 2003, IMMUNOLOGY, V108, P513, DOI 10.1046/j.1365-2567.2003.01620.x; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; Davoudi S, 2008, BRAZ J INFECT DIS, V12, P483, DOI 10.1590/S1413-86702008000600008; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gilbertson B, 1999, J IMMUNOL, V163, P2073; Green JA, 2010, J IMMUNOL, V184, P6492, DOI 10.4049/jimmunol.0903811; Gupta RK, 2010, MICROBIOL-SGM, V156, P2714, DOI 10.1099/mic.0.037622-0; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Hirsch CS, 2005, J CLIN IMMUNOL, V25, P353, DOI 10.1007/s10875-005-4841-4; Jendro MC, 2004, MED MICROBIOL IMMUN, V193, P45, DOI 10.1007/s00430-003-0182-1; Jones BE, 1997, CLIN INFECT DIS, V24, P988, DOI 10.1093/clinids/24.5.988; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kelly DM, 2008, INFECT IMMUN, V76, P351, DOI 10.1128/IAI.00614-07; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Mahon RN, 2009, INFECT IMMUN, V77, P4574, DOI 10.1128/IAI.00222-09; Mariani F, 2000, GENE, V253, P281, DOI 10.1016/S0378-1119(00)00249-3; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Mustafa T, 2006, IMMUNOLOGY, V117, P454, DOI 10.1111/j.1365-2567.2005.02318.x; Mustafa T, 2008, VIRCHOWS ARCH, V452, P449, DOI 10.1007/s00428-008-0575-z; O'Leary S, 2010, AM J RESP CELL MOL B; O'Sullivan MP, 2007, INFECT IMMUN, V75, P1984, DOI 10.1128/IAI.01107-06; Pilheu JA, 1997, INT J TUBERC LUNG D, V1, P422; Placido R, 2006, CELL IMMUNOL, V244, P10, DOI 10.1016/j.cellimm.2007.02.001; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Ryan RCM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-237; Samten B, 2009, TUBERCULOSIS, V89, pS74, DOI 10.1016/S1472-9792(09)70017-4; Sanchez A, 2009, SCAND J IMMUNOL, V69, P20, DOI 10.1111/j.1365-3083.2008.02193.x; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schmolke M, 2010, CELL MICROBIOL, V12, P873, DOI 10.1111/j.1462-5822.2010.01475.x; Sharma S, 2009, IMMUNOL CELL BIOL, V87, P226, DOI 10.1038/icb.2008.97; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Welsh KJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/307631; Wojtas B, 2011, MICROB PATHOGENESIS, V51, P9, DOI 10.1016/j.micpath.2011.03.004; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Zhong J, 2003, IMMUNOL CELL BIOL, V81, P480, DOI 10.1046/j.1440-1711.2003.01193.x	45	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38488	10.1371/journal.pone.0038488	http://dx.doi.org/10.1371/journal.pone.0038488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675566	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700078
J	Lis, R; Touboul, C; Raynaud, CM; Malek, JA; Suhre, K; Mirshahi, M; Rafii, A				Lis, Raphael; Touboul, Cyril; Raynaud, Christophe M.; Malek, Joel A.; Suhre, Karsten; Mirshahi, Massoud; Rafii, Arash			Mesenchymal Cell Interaction with Ovarian Cancer Cells Triggers Pro-Metastatic Properties	PLOS ONE			English	Article							STEM-CELLS; AIRWAY EPITHELIUM; TUMOR PROGRESSION; GENE-EXPRESSION; STROMAL CELLS; FIBROBLASTS; RECRUITMENT; CARCINOMA; SMOKERS; NICHE	Tumor microenvironement is an important actor of ovarian cancer progression but the relations between mesenchymal cells and ovarian cancer cells remain unclear. The objective of this study was to determine the ovarian cancer cells' biological modifications induced by mesenchymal cells. To address this issue, we used two different ovarian cancer cell lines (NIH: OVCAR3 and SKOV3) and co-cultured them with mesenchymal cells. Upon co-culture the different cell populations were sorted to study their transcriptome and biological properties. Transcriptomic analysis revealed three biologicalfunction gene clusters were enriched upon contact with mesenchymal cells. These were related to the increase of metastatic abilities (adhesion, migration and invasion), proliferation and chemoresistance in vitro. Therefore, contact with the mesenchymal cell niche could increase metastatic initiation and expansion through modification of cancer cells. Taken together these findings suggest that pathways involved in hetero-cellular interaction may be targeted to disrupt the acquired pro-metastatic profile.	[Lis, Raphael; Touboul, Cyril; Raynaud, Christophe M.; Rafii, Arash] Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar; [Lis, Raphael; Touboul, Cyril; Mirshahi, Massoud] Univ Paris 06, INSERM, UMRS 872, Ctr Rech Cordeliers,Equipe 18, Paris, France; [Suhre, Karsten] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Lis, Raphael; Rafii, Arash] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Cornell University; Cornell University	Lis, R (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar.	jat2021@qatar-med.cornell.edu	Raynaud, Christophe/AAQ-9426-2020; Suhre, Karsten/AAF-1778-2020; Rafii, Arash/E-4106-2013	Raynaud, Christophe/0000-0003-1551-8075; Suhre, Karsten/0000-0001-9638-3912; 	Qatar National Research Fund under National Priorities Research Program [NPRP 09-1174-3-291, NPRP 4-640-1-096.]	Qatar National Research Fund under National Priorities Research Program(Qatar National Research Fund (QNRF))	This publication was made possible by a grant from the Qatar National Research Fund under its National Priorities Research Program award number NPRP 09-1174-3-291 and NPRP 4-640-1-096. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Qatar National Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NATURE, V474, P609; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carolan BJ, 2008, J IMMUNOL, V181, P5760, DOI 10.4049/jimmunol.181.8.5760; Ceelen WP, 2009, LANCET ONCOL, V10, P72, DOI 10.1016/S1470-2045(08)70335-8; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kenny HA, 2011, CANCER DISCOV, V1, P100, DOI 10.1158/2159-8290.CD-11-0117; Kenny HA, 2009, CELL CYCLE, V8, P683, DOI 10.4161/cc.8.5.7703; Lis R, 2011, INT J CANCER, V128, P715, DOI 10.1002/ijc.25619; Martinet L, 2010, INT J CANCER, V126, P2143, DOI 10.1002/ijc.24881; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Pasquet M, 2010, INT J CANCER, V126, P2090, DOI 10.1002/ijc.24886; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Zhang SM, 2009, CLIN EXP METASTAS, V26, P993, DOI 10.1007/s10585-009-9289-0	24	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38340	10.1371/journal.pone.0038340	http://dx.doi.org/10.1371/journal.pone.0038340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666502	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400113
J	Nande, R; Di Benedetto, A; Aimola, P; De Carlo, F; Carper, M; Claudio, CD; Denvir, J; Valluri, J; Duncan, GC; Claudio, PP				Nande, Rounak; Di Benedetto, Altomare; Aimola, Pierpaolo; De Carlo, Flavia; Carper, Miranda; Claudio, Charlene D.; Denvir, Jim; Valluri, Jagan; Duncan, Gary C.; Claudio, Pier Paolo			Targeting a Newly Established Spontaneous Feline Fibrosarcoma Cell Line by Gene Transfer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; APOPTOSIS INDUCING CYTOKINE; CANCER TERMINATOR VIRUS; INJECTION-SITE SARCOMAS; PHASE-I; GROWTH; CATS; P53; MDA-7/IL-24; MUTATIONS	Fibrosarcoma is a deadly disease in cats and is significantly more often located at classical vaccine injections sites. More rare forms of spontaneous non-vaccination site (NSV) fibrosarcomas have been described and have been found associated to genetic alterations. Purpose of this study was to compare the efficacy of adenoviral gene transfer in NVS fibrosarcoma. We isolated and characterized a NVS fibrosarcoma cell line (Cocca-6A) from a spontaneous fibrosarcoma that occurred in a domestic calico cat. The feline cells were karyotyped and their chromosome number was counted using a Giemsa staining. Adenoviral gene transfer was verified by western blot analysis. Flow cytometry assay and Annexin-V were used to study cell-cycle changes and cell death of transduced cells. Cocca-6A fibrosarcoma cells were morphologically and cytogenetically characterized. Giemsa block staining of metaphase spreads of the Cocca-6A cells showed deletion of one of the E1 chromosomes, where feline p53 maps. Semi-quantitative PCR demonstrated reduction of p53 genomic DNA in the Cocca-6A cells. Adenoviral gene transfer determined a remarkable effect on the viability and growth of the Cocca-6A cells following single transduction with adenoviruses carrying Mda-7/IL-24 or IFN-gamma or various combination of RB/p105, Ras-DN, IFN-gamma, and Mda-7 gene transfer. Therapy for feline fibrosarcomas is often insufficient for long lasting tumor eradication. More gene transfer studies should be conducted in order to understand if these viral vectors could be applicable regardless the origin (spontaneous vs. vaccine induced) of feline fibrosarcomas.	[Nande, Rounak; Di Benedetto, Altomare; Aimola, Pierpaolo; De Carlo, Flavia; Carper, Miranda; Claudio, Charlene D.; Denvir, Jim; Claudio, Pier Paolo] Marshall Univ, Joan C Edwards Sch Med, Dept Biochem & Microbiol, Huntington, WV 25755 USA; [Nande, Rounak; Di Benedetto, Altomare; Aimola, Pierpaolo; De Carlo, Flavia; Carper, Miranda; Claudio, Charlene D.; Denvir, Jim; Claudio, Pier Paolo] Edwards Comprehens Canc Ctr, McKown Translat Res Inst, Huntington, WV USA; [Di Benedetto, Altomare; Aimola, Pierpaolo] Univ Aquila, Fac Sci, Dept Basic & Appl Biol, I-67100 Laquila, Italy; [Valluri, Jagan] Marshall Univ, Dept Biol Sci, Huntington, WV USA; [Duncan, Gary C.] Martin Vet Clin, Ashland, KY USA; [Claudio, Pier Paolo] Marshall Univ, Joan C Edwards Sch Med, Dept Surg, Huntington, WV USA	Marshall University; University of L'Aquila; Marshall University; Marshall University	Nande, R (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Biochem & Microbiol, Huntington, WV 25755 USA.	claudiop@marshall.edu	Claudio, Pier Paolo/AAW-7282-2021	Claudio, Pier Paolo/0000-0001-7790-1622	National Cancer Institute [CA131395, CA140024]; National Institutes of Health - Center of Biological Research Excellence [5P20RR020180, WV-INBRE 5P20RR016477]; Marshall University Biochemistry Department; Marshall University Microbiology & Surgery Department; NATIONAL CANCER INSTITUTE [R03CA140024, R21CA131395] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477, P20RR020180] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health - Center of Biological Research Excellence; Marshall University Biochemistry Department; Marshall University Microbiology & Surgery Department; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The present studies were supported in part by the awards number CA131395 and CA140024 from the National Cancer Institute (to PPC), and in part by National Institutes of Health - Center of Biological Research Excellence 5P20RR020180, WV-INBRE 5P20RR016477 (West Virginia-IDeA Networks of Biomedical Research Excellence.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the Marshall University Biochemistry and Microbiology & Surgery Departments for their support.	Arber N, 1999, APOPTOSIS, V4, P383, DOI 10.1023/A:1009651406017; Barber LG, 2000, J AM ANIM HOSP ASSOC, V36, P416, DOI 10.5326/15473317-36-5-416; Bergman PJ, 1998, J AM VET MED ASSOC, V213, P1424; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Claudio PP, 2000, CANCER RES, V60, P372; Doddy FD, 1996, J COMP PATHOL, V114, P165, DOI 10.1016/S0021-9975(96)80005-3; ESPLIN DG, 1993, J AM VET MED ASSOC, V202, P1245; Fisher PB, 2003, CANCER BIOL THER, V2, pS23; Gemmill LT, 1998, J AM VET MED ASSOC, V213, P955; Gemmill LT, 1997, J AM VET MED ASSOC, V210, P889; Genovese C, 2006, ONCOGENE, V25, P5201, DOI 10.1038/sj.onc.1209652; Greco A, 2010, MOL THER, V18, P295, DOI 10.1038/mt.2009.252; GRUFFYDDJONES TJ, 1994, VET REC, V134, P310, DOI 10.1136/vr.134.12.310-a; Hampel V, 2007, J VET INTERN MED, V21, P1340, DOI 10.1892/06-201.1; HARASEN GLG, 1984, CAN VET J, V25, P207; Huang EY, 2001, ONCOGENE, V20, P7051, DOI 10.1038/sj.onc.1204897; Jahnke A, 2007, J VET MED A, V54, P599, DOI 10.1111/j.1439-0442.2007.01002.x; Jourdier TM, 2003, GENE THER, V10, P2126, DOI 10.1038/sj.gt.3302124; Kelly SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010035; Lebedeva IV, 2007, INT J ONCOL, V31, P985; Martin M, 2003, CAN VET J, V44, P660; Mayr B, 1998, VET RES COMMUN, V22, P21, DOI 10.1023/A:1005931127067; MAYR B, 1995, BRIT VET J, V151, P707, DOI 10.1016/S0007-1935(95)80151-0; Mayr B, 2000, RES VET SCI, V68, P63, DOI 10.1053/rvsc.1999.0339; Nambiar PR, 2001, VET PATHOL, V38, P236, DOI 10.1354/vp.38-2-236; OKUDA M, 1993, J VET MED SCI, V55, P801, DOI 10.1292/jvms.55.801; Poirier VJ, 2002, J VET INTERN MED, V16, P726, DOI 10.1111/j.1939-1676.2002.tb02415.x; QuintinColonna F, 1996, GENE THER, V3, P1104; Santos S, 2006, J HERED, V97, P114, DOI 10.1093/jhered/esj016; Sarkar D, 2008, CANCER GENE THER, V15, P293, DOI 10.1038/cgt.2008.14; Sarkar D, 2002, BIOTECHNIQUES, P30; Sarkar D, 2007, CANCER RES, V67, P5434, DOI 10.1158/0008-5472.CAN-07-0195; Sarkar D, 2006, CELL CYCLE, V5, P1531, DOI 10.4161/cc.5.14.3095; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Sironi Giuseppe, 1999, Vet Ophthalmol, V2, P227, DOI 10.1046/j.1463-5224.1999.00086.x; Spugnini EP, 2008, IN VIVO, V22, P751; Su ZZ, 1998, P NATL ACAD SCI USA, V95, P14400, DOI 10.1073/pnas.95.24.14400; Vattemi E, 2007, DRUG NEWS PERSPECT, V20, P511, DOI 10.1358/dnp.2007.20.8.1157613; von Erichsen J, 2011, VET PATHOLOGY	39	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37743	10.1371/journal.pone.0037743	http://dx.doi.org/10.1371/journal.pone.0037743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666387	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400046
J	Oreza, LAN; Alvarez, AF; Arias-Olguin, II; Larios, AT; Georgellis, D				Nunez Oreza, Luis Alberto; Alvarez, Adrian F.; Arias-Olguin, Imilla I.; Torres Larios, Alfredo; Georgellis, Dimitris			The ArcB Leucine Zipper Domain Is Required for Proper ArcB Signaling	PLOS ONE			English	Article							ESCHERICHIA-COLI; SENSOR KINASE; 2-COMPONENT SYSTEM; IN-VITRO; TRANSDUCTION SYSTEM; PHOSPHATE REGULON; REGULATOR PROTEIN; ACETYL PHOSPHATE; ACETATE KINASE; REDOX SIGNAL	The Arc two-component system modulates the expression of numerous genes in response to respiratory growth conditions. This system comprises ArcA as the response regulator and ArcB as the sensor kinase. ArcB is a tripartite histidine kinase whose activity is regulated by the oxidation of two cytosol-located redox-active cysteine residues that participate in intermolecular disulfide bond formation. Here, we report that the ArcB protein segment covering residues 70-121, fulfills the molecular characteristics of a leucine zipper containing coiled coil structure. Also, mutational analyses of this segment reveal three different phenotypical effects to be distributed along the coiled coil structure of ArcB, demonstrating that this motif is essential for proper ArcB signaling.	[Nunez Oreza, Luis Alberto; Alvarez, Adrian F.; Georgellis, Dimitris] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico; [Arias-Olguin, Imilla I.] Univ Nacl Autonoma Mexico, Fac Med, Dept Fis, Mexico City 04510, DF, Mexico; [Torres Larios, Alfredo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biolo Estruct, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Oreza, LAN (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico.	dimitris@ifc.unam.mx	Georgellis, Dimitris/U-2517-2017; Alvarez, Adrian F./L-4656-2019; Alvarez, Adrian F./L-7575-2013	Georgellis, Dimitris/0000-0002-6114-795X; Alvarez, Adrian F./0000-0003-4381-5691; Alvarez, Adrian F./0000-0003-4381-5691; Torres-Larios, Alfredo/0000-0002-0702-350X; Nunez Oreza, Luis Alberto/0000-0002-4583-8080	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [80684]; DGAPA-PAPIIT, UNAM [IN219709]; International Centre for Genetic Engineering and Biothecnology (ICGEB) [CRPMEX008-02]; DGAPA-UNAM	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT, UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); International Centre for Genetic Engineering and Biothecnology (ICGEB); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by Grants 80684 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT), IN219709 from DGAPA-PAPIIT, UNAM, and CRPMEX008-02 from the International Centre for Genetic Engineering and Biothecnology (ICGEB). A. F. Alvarez is indebted to DGAPA-UNAM for the award of a postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AF, 2010, METHOD ENZYMOL, V471, P205, DOI 10.1016/S0076-6879(10)71012-0; Alvarez AF, 2010, J BACTERIOL, V192, P391, DOI 10.1128/JB.00881-09; Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; BUCKLAND R, 1989, NATURE, V338, P547, DOI 10.1038/338547a0; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Croasdale R, 2011, J BIOL CHEM, V286, P27537, DOI 10.1074/jbc.M110.196972; DAILEY FE, 1993, J BACTERIOL, V175, P3236, DOI 10.1128/JB.175.10.3236-3239.1993; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; FENG JL, 1992, J BACTERIOL, V174, P6061, DOI 10.1128/JB.174.19.6061-6070.1992; Fry AM, 1999, J BIOL CHEM, V274, P16304, DOI 10.1074/jbc.274.23.16304; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Georgellis D, 2001, J BACTERIOL, V183, P7206, DOI 10.1128/JB.183.24.7206-7212.2001; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Gregoret LM, 1998, FOLD DES, V3, P119, DOI 10.1016/S1359-0278(98)00017-0; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; IUCHI S, 1990, MOL MICROBIOL, V4, P715, DOI 10.1111/j.1365-2958.1990.tb00642.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jung WS, 2008, FEMS MICROBIOL LETT, V284, P109, DOI 10.1111/j.1574-6968.2008.01187.x; Kwon O, 2003, J BIOL CHEM, V278, P13192, DOI 10.1074/jbc.M210647200; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Kwon O, 2000, J BACTERIOL, V182, P2960, DOI 10.1128/JB.182.10.2960-2966.2000; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lau PCK, 1997, P NATL ACAD SCI USA, V94, P1453, DOI 10.1073/pnas.94.4.1453; LEE TY, 1990, J BACTERIOL, V172, P2245, DOI 10.1128/jb.172.5.2245-2249.1990; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matsushika A, 2000, J BIOCHEM, V127, P855, DOI 10.1093/oxfordjournals.jbchem.a022679; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Miller JH., 1972, EXPT MOL GENETICS; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V199, P897, DOI 10.1006/bbrc.1994.1313; Pena-Sandoval GR, 2010, J BACTERIOL, V192, P1735, DOI 10.1128/JB.01401-09; Pena-Sandoval GR, 2005, J BACTERIOL, V187, P3267, DOI 10.1128/JB.187.9.3267-3272.2005; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Swain KE, 2009, BIOCHEMISTRY-US, V48, P9266, DOI 10.1021/bi901020d; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; WANNER BL, 1992, J BACTERIOL, V174, P2124, DOI 10.1128/JB.174.7.2124-2130.1992; Yaku H, 1997, FEBS LETT, V417, P409, DOI 10.1016/S0014-5793(97)01329-X; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	50	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38187	10.1371/journal.pone.0038187	http://dx.doi.org/10.1371/journal.pone.0038187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666479	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400097
J	Power, EF; Kelly, DL; Stout, JC				Power, Eileen F.; Kelly, Daniel L.; Stout, Jane C.			Organic Farming and Landscape Structure: Effects on Insect-Pollinated Plant Diversity in Intensively Managed Grasslands	PLOS ONE			English	Article							SPECIES COMPOSITION; FIELD BOUNDARIES; BIODIVERSITY; BUMBLEBEES; DIPTERA; COMMUNITIES; SYRPHIDAE; HEDGEROWS; ABUNDANCE; BRITAIN	Parallel declines in insect-pollinated plants and their pollinators have been reported as a result of agricultural intensification. Intensive arable plant communities have previously been shown to contain higher proportions of self-pollinated plants compared to natural or semi-natural plant communities. Though intensive grasslands are widespread, it is not known whether they show similar patterns to arable systems nor whether local and/or landscape factors are influential. We investigated plant community composition in 10 pairs of organic and conventional dairy farms across Ireland in relation to the local and landscape context. Relationships between plant groups and local factors (farming system, position in field and soil parameters) and landscape factors (e. g. landscape complexity) were investigated. The percentage cover of unimproved grassland was used as an inverse predictor of landscape complexity, as it was negatively correlated with habitat-type diversity. Intensive grasslands (organic and conventional) contained more insect-pollinated forbs than non-insect pollinated forbs. Organic field centres contained more insect-pollinated forbs than conventional field centres. Insect-pollinated forb richness in field edges (but not field centres) increased with increasing landscape complexity (% unimproved grassland) within 1, 3, 4 and 5 km radii around sites, whereas non-insect pollinated forb richness was unrelated to landscape complexity. Pollination systems within intensive grassland communities may be different from those in arable systems. Our results indicate that organic management increases plant richness in field centres, but that landscape complexity exerts strong influences in both organic and conventional field edges. Insect-pollinated forb richness, unlike that for non-insect pollinated forbs, showed positive relationships to landscape complexity reflecting what has been documented for bees and other pollinators. The insect-pollinated forbs, their pollinators and landscape context are clearly linked. This needs to be taken into account when managing and conserving insect-pollinated plant and pollinator communities.	[Power, Eileen F.; Kelly, Daniel L.; Stout, Jane C.] Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin, Ireland; [Kelly, Daniel L.; Stout, Jane C.] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Power, EF (corresponding author), Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin, Ireland.	eileen.power@newcastle.ac.uk	Stout, Jane C/B-1631-2010; Stout, Jane/AAS-8867-2020	Stout, Jane C/0000-0002-2027-0863; Stout, Jane/0000-0002-2027-0863; Power, Eileen/0000-0002-5941-4676	Irish Department of Agriculture, Fisheries and Food Research Stimulus Fund (RSF) under the National Development Plan	Irish Department of Agriculture, Fisheries and Food Research Stimulus Fund (RSF) under the National Development Plan	This project is part of a collaborative project led by Michael O'Donovan, Teagasc, and was funded by the Irish Department of Agriculture, Fisheries and Food (http://www.agriculture.gov.ie) Research Stimulus Fund (RSF), funded under the National Development Plan (2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2008, MAJOR MICRONUTIENT A; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bossard M, 2000, CORINE LAND COVER TE; Buchmann SL, 1996, FORGOTTEN POLLINATOR; Burel F, 1996, CRIT REV PLANT SCI, V15, P169, DOI 10.1080/713608130; Ceulemans T, 2011, J APPL ECOL, V48, P1155, DOI 10.1111/j.1365-2664.2011.02023.x; CONN DLT, 1976, J APPL ECOL, V13, P429, DOI 10.2307/2401792; Cope T, 2009, GRASSES BRIT ISLES B, V13; Cranmer L, 2012, OIKOS, V121, P562, DOI 10.1111/j.1600-0706.2011.19704.x; Dauber J, 2005, GLOBAL ECOL BIOGEOGR, V14, P213, DOI 10.1111/j.1466-822x.2005.00150.x; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Deckers B, 2004, ACTA OECOL, V26, P23, DOI 10.1016/j.actao.2004.03.002; Department of Agriculture, 2009, FACT SHEET IR AGR; Dziock F, 2006, INT REV HYDROBIOL, V91, P341, DOI 10.1002/iroh.200510889; Ekroos J, 2008, AGR ECOSYST ENVIRON, V124, P155, DOI 10.1016/j.agee.2007.09.003; European Environment Agency, 2007, CLC2006 TECHN GUID; Fitzpatrick U, 2007, BIOL CONSERV, V136, P185, DOI 10.1016/j.biocon.2006.11.012; Gabbett M, 2007, SEMINATURAL GRASSLAN; Gabriel D, 2007, AGR ECOSYST ENVIRON, V118, P43, DOI 10.1016/j.agee.2006.04.005; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; Gorley C.K., 2006, GETTING STARTED PRIM; Haenke S, 2009, J APPL ECOL, V46, P1106, DOI 10.1111/j.1365-2664.2009.01685.x; Irish Organic Farmers and Growers Association, 2006, IOFGA STAND ORG FOOD; IVIMEYCO.RB, 1966, P ROY IRISH ACAD B, V64, P211; Jacobs JH, 2009, ANN BOT-LONDON, V104, P1397, DOI 10.1093/aob/mcp236; James L. F., 1992, POISONOUS PLANTS; Kleijn D, 2000, J APPL ECOL, V37, P256, DOI 10.1046/j.1365-2664.2000.00486.x; Klotz S, 2002, SCHRIFTENREIHE VEGET, V38; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Le Coeur D, 2002, AGR ECOSYST ENVIRON, V89, P23, DOI 10.1016/S0167-8809(01)00316-4; McMahon BJ, 2010, AGR ECOSYST ENVIRON, V139, P232, DOI 10.1016/j.agee.2010.08.008; Michener C.D., 2007, BEES WORLD, Vsecond; Morandin LA, 2005, ECOL APPL, V15, P871, DOI 10.1890/03-5271; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Ouin A, 2002, AGR ECOSYST ENVIRON, V93, P45, DOI 10.1016/S0167-8809(02)00004-X; Parton K, 2002, NEW ZEAL VET J, V50, P22, DOI 10.1080/00480169.2002.36262; Petersen S, 2006, AGR ECOSYST ENVIRON, V113, P302, DOI 10.1016/j.agee.2005.09.016; PINHEIRO J., 2009, NLME LINEAR NONLINEA; PLANTUREUX S, 2005, AGRONOMY RES, V3, P152; Power EF, 2011, J APPL ECOL, V48, P561, DOI 10.1111/j.1365-2664.2010.01949.x; Pugnaire F.I., 2007, FUNCTIONAL PLANT ECO; R Development Core Team, 2007, R LANG ENV STAT COMP; REGAL PJ, 1982, ANNU REV ECOL SYST, V13, P497, DOI 10.1146/annurev.es.13.110182.002433; Romero A, 2008, AGR ECOSYST ENVIRON, V124, P97, DOI 10.1016/j.agee.2007.08.002; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Rundlof M, 2010, ECOGRAPHY, V33, P514, DOI 10.1111/j.1600-0587.2009.05938.x; Santorum Veronica, 2005, Tearmann, V4, P79; Schippers P, 2002, AGR ECOSYST ENVIRON, V93, P351, DOI 10.1016/S0167-8809(01)00339-5; Speight M.C., 2008, DATABASE IRISH SYRPH; Stace C.A., 2010, STACE, V3rd Edn; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Sullivan CA, 2010, BIOL CONSERV, V143, P1529, DOI 10.1016/j.biocon.2010.03.035; Van Geert A, 2010, J ECOL, V98, P178, DOI 10.1111/j.1365-2745.2009.01600.x; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6; Wratten SD, 2003, OECOLOGIA, V134, P605, DOI 10.1007/s00442-002-1128-9; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	61	35	36	0	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38073	10.1371/journal.pone.0038073	http://dx.doi.org/10.1371/journal.pone.0038073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666450	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400077
J	Tsai, WC; Hsu, CC; Pang, JHS; Lin, MS; Chen, YH; Liang, FC				Tsai, Wen-Chung; Hsu, Chih-Chin; Pang, Jong-Hwei S.; Lin, Miao-Sui; Chen, Ying-Hsun; Liang, Fang-Chen			Low-Level Laser Irradiation Stimulates Tenocyte Migration with Up-Regulation of Dynamin II Expression	PLOS ONE			English	Article							LIGHT-EMITTING DIODE; NEAR-INFRARED LIGHT; CELL-MIGRATION; IN-VITRO; ACHILLES-TENDON; NITRIC-OXIDE; IR RADIATION; THERAPY; TENDINOPATHY; NM	Low-level laser therapy (LLLT) is commonly used to treat sports-related tendinopathy or tendon injury. Tendon healing requires tenocyte migration to the repair site, followed by proliferation and synthesis of the extracellular matrix. This study was designed to determine the effect of laser on tenocyte migration. Furthermore, the correlation between this effect and expression of dynamin 2, a positive regulator of cell motility, was also investigated. Tenocytes intrinsic to rat Achilles tendon were treated with low-level laser (660 nm with energy density at 1.0, 1.5, and 2.0 J/cm(2)). Tenocyte migration was evaluated by an in vitro wound healing model and by transwell filter migration assay. The messenger RNA (mRNA) and protein expressions of dynamin 2 were determined by reverse transcription/real-time polymerase chain reaction (real-time PCR) and Western blot analysis respectively. Immunofluorescence staining was used to evaluate the dynamin 2 expression in tenocytes. Tenocytes with or without laser irradiation was treated with dynasore, a dynamin competitor and then underwent transwell filter migration assay. In vitro wound model revealed that more tenocytes with laser irradiation migrated across the wound border to the cell-free zone. Transwell filter migration assay confirmed that tenocyte migration was enhanced dose-dependently by laser. Real-time PCR and Western-blot analysis demonstrated that mRNA and protein expressions of dynamin 2 were up-regulated by laser irradiation dose-dependently. Confocal microscopy showed that laser enhanced the expression of dynamin 2 in cytoplasm of tenocytes. The stimulation effect of laser on tenocytes migration was suppressed by dynasore. In conclusion, low-level laser irradiation stimulates tenocyte migration in a process that is mediated by up-regulation of dynamin 2, which can be suppressed by dynasore.	[Tsai, Wen-Chung; Hsu, Chih-Chin; Lin, Miao-Sui; Chen, Ying-Hsun; Liang, Fang-Chen] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Tao Yuan, Taoyuan County, Taiwan; [Tsai, Wen-Chung; Hsu, Chih-Chin; Lin, Miao-Sui] Chang Gung Univ, Coll Med, Guishan, Taoyuan County, Taiwan; [Pang, Jong-Hwei S.] Chang Gung Univ, Grad Inst Clin Med Sci, Guishan, Taoyuan County, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Tsai, WC (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Tao Yuan, Taoyuan County, Taiwan.	jonghwei@mail.cgu.edu.tw		PANG, JONG-HWEI/0000-0003-3432-0208	National Science Council, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The study received financial support for National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anders JJ, 2008, IEEE J SEL TOP QUANT, V14, P118, DOI 10.1109/JSTQE.2008.916181; Baxter GD, 2010, DELISAS PHYS MED REH, P1706; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Bjordal JM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-75; Bjordal JM., 2001, PHYS THER REV, V6, P91, DOI [10.1179/ptr.2001.6.2.91, DOI 10.1179/PTR.2001.6.2.91]; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Casalechi HL, 2009, LASER MED SCI, V24, P659, DOI 10.1007/s10103-008-0607-6; Chao PHG, 2007, CONNECT TISSUE RES, V48, P188, DOI 10.1080/03008200701424451; Chen CH, 2009, J ORTHOP RES, V27, P646, DOI 10.1002/jor.20800; Crespi R, 2006, J PERIODONTOL, V77, P1217, DOI 10.1902/jop.2006.050416; Dominik M, 2005, CELL MOTIL CYTOSKEL, V61, P172, DOI 10.1002/cm.20075; Eppinga RD, 2011, ONCOGENE; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Fillipin LI, 2005, LASER SURG MED, V37, P293, DOI 10.1002/lsm.20225; Goldman JA, 1981, BIOMEDICAL LASER TEC, P293; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Kipshidze N, 2000, PHOTOCHEM PHOTOBIOL, V72, P579, DOI 10.1562/0031-8655(2000)072<0579:POVIAE>2.0.CO;2; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Kujawa J, 2004, J CLIN LASER MED SUR, V22, P111, DOI 10.1089/104454704774076163; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; LEADBETTER WB, 1992, CLIN SPORT MED, V11, P533; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Lubart R, 2006, PHOTOMED LASER SURG, V24, P179, DOI 10.1089/pho.2006.24.179; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; OBRIEN M, 1992, CLIN SPORT MED, V11, P505; Oliveira FS, 2009, LASER SURG MED, V41, P271, DOI 10.1002/lsm.20760; Rochkind S, 2009, LASER SURG MED, V41, P277, DOI 10.1002/lsm.20757; Samoilova KA, 2008, PHOTOMED LASER SURG, V26, P443, DOI 10.1089/pho.2007.2205; Saunders L., 2003, PHYSIOTHERAPY, V89, P365; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Stergioulas A, 2008, AM J SPORT MED, V36, P881, DOI 10.1177/0363546507312165; Tafur J, 2008, PHOTOMED LASER SURG, V26, P323, DOI 10.1089/pho.2007.2184; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tsai WC, 2008, CONNECT TISSUE RES, V49, P367, DOI 10.1080/03008200802325359; Tumilty S, 2010, PHOTOMED LASER SURG, V28, P3, DOI 10.1089/pho.2008.2470; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Xie ZG, 2004, CELL CYCLE, V3, P108; Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105; Zhang JT, 2008, J CELL PHYSIOL, V217, P518, DOI 10.1002/jcp.21529; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707	46	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38235	10.1371/journal.pone.0038235	http://dx.doi.org/10.1371/journal.pone.0038235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666495	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400108
J	Noulas, A; Scellato, S; Lambiotte, R; Pontil, M; Mascolo, C				Noulas, Anastasios; Scellato, Salvatore; Lambiotte, Renaud; Pontil, Massimiliano; Mascolo, Cecilia			A Tale of Many Cities: Universal Patterns in Human Urban Mobility	PLOS ONE			English	Article							INTERVENING OPPORTUNITIES; SPATIAL-DISTRIBUTION; MIGRATION; DISTANCE; MODEL	The advent of geographic online social networks such as Foursquare, where users voluntarily signal their current location, opens the door to powerful studies on human movement. In particular the fine granularity of the location data, with GPS accuracy down to 10 meters, and the worldwide scale of Foursquare adoption are unprecedented. In this paper we study urban mobility patterns of people in several metropolitan cities around the globe by analyzing a large set of Foursquare users. Surprisingly, while there are variations in human movement in different cities, our analysis shows that those are predominantly due to different distributions of places across different urban environments. Moreover, a universal law for human mobility is identified, which isolates as a key component the rank-distance, factoring in the number of places between origin and destination, rather than pure physical distance, as considered in some previous works. Building on our findings, we also show how a rank-based movement model accurately captures real human movements in different cities.	[Noulas, Anastasios; Scellato, Salvatore; Mascolo, Cecilia] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Lambiotte, Renaud] Univ Namur, Dept Math, Namur, Belgium; [Pontil, Massimiliano] UCL, Dept Comp Sci, London, England	University of Cambridge; University of Namur; University of London; University College London	Noulas, A (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	anastasios.noulas@cl.cam.ac.uk	Lambiotte, Renaud/HDO-4530-2022	Lambiotte, Renaud/0000-0002-0583-4595; Mascolo, Cecilia/0000-0001-9614-4380	National Science Foundation [NSF PHY05-51164]; Engineering and Physical Sciences Research Council (EPSRC); EPSRC [EP/G069557/1, EP/G065802/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G069557/1, EP/G065802/1] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported in part by the National Science Foundation under Grant No. NSF PHY05-51164 and the Engineering and Physical Sciences Research Council (EPSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; CARROTHERS GAP, 1956, J AM I PLANNERS, V22, P94, DOI 10.1080/01944365608979229; Cheung C, 2005, J E ASIA SOC TRANSP, V6, P3773; Cho E, 2011, P KDD 11; Clauset A, 2009, ARXIVPHYSICS07061062; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; EASA SM, 1993, J TRANSP ENG-ASCE, V119, P793, DOI 10.1061/(ASCE)0733-947X(1993)119:6(793); Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; FREYMEYER RH, 1985, SOCIOL PERSPECT, V28, P419, DOI 10.2307/1389227; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; HAYNES KE, 1973, ECON GEOGR, V49, P68, DOI 10.2307/142746; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Isaacman S, 2010, 11 WORKSH MOB COMP S; Jung WS, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48005; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Levy M, 2010, PHYSICA A, V389, P4913, DOI 10.1016/j.physa.2010.07.008; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; MILLER E, 1972, J REGIONAL SCI, V12, P475, DOI 10.1111/j.1467-9787.1972.tb00369.x; Nicholson KG, 1998, TXB INFLUENZA, P219; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Quercia D, 2010, P IEEE ICDM 10; Ravenstein EG, 1885, LAWS MIGRATION, V48, P167; Scellato S, 2011, P ICWSM 11; Scellato S, 2011, P WWW 11; Simini F, 2012, NATURE; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; WADYCKI WJ, 1975, DEMOGRAPHY, V12, P121, DOI 10.2307/2060737; WILSON AG, 1967, TRANSPORT RES, V1, P253, DOI 10.1016/0041-1647(67)90035-4; Zheng VW, 2010, P WWW 10; Zheng Y, 2009, P WWW 09	35	382	392	7	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37027	10.1371/journal.pone.0037027	http://dx.doi.org/10.1371/journal.pone.0037027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22666339	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600008
J	Izzi, B; Francois, I; Labarque, V; Thys, C; Wittevrongel, C; Devriendt, K; Legius, E; Van den Bruel, A; D'Hooghe, M; Lambrechts, D; de Zegher, F; Van Geet, C; Freson, K				Izzi, Benedetta; Francois, Inge; Labarque, Veerle; Thys, Chantal; Wittevrongel, Christine; Devriendt, Koen; Legius, Eric; Van den Bruel, Annick; D'Hooghe, Marc; Lambrechts, Diether; de Zegher, Francis; Van Geet, Chris; Freson, Kathleen			Methylation Defect in Imprinted Genes Detected in Patients with an Albright's Hereditary Osteodystrophy Like Phenotype and Platelet Gs Hypofunction	PLOS ONE			English	Article							PSEUDOHYPOPARATHYROIDISM TYPE-IB; STIMULATORY G-PROTEIN; XL-ALPHA-S; AUTOSOMAL-DOMINANT; EPIGENETIC DEFECTS; GNAS1 GENE; HORMONE RESISTANCE; MOLECULAR ANALYSIS; ADENYLATE-CYCLASE; CONTROL ELEMENT	Background: Pseudohypoparathyroidism (PHP) indicates a group of heterogeneous disorders whose common feature is represented by impaired signaling of hormones that activate Gsalpha, encoded by the imprinted GNAS gene. PHP-Ib patients have isolated Parathormone (PTH) resistance and GNAS epigenetic defects while PHP-Ia cases present with hormone resistance and characteristic features jointly termed as Albright's Hereditary Osteodystrophy (AHO) due to maternally inherited GNAS mutations or similar epigenetic defects as found for PHP-Ib. Pseudopseudohypoparathyroidism (PPHP) patients with an AHO phenotype and no hormone resistance and progressive osseous heteroplasia (POH) cases have inactivating paternally inherited GNAS mutations. Methodology/Principal Findings: We here describe 17 subjects with an AHO-like phenotype that could be compatible with having PPHP but none of them carried Gsalpha mutations. Functional platelet studies however showed an obvious Gs hypofunction in the 13 patients that were available for testing. Methylation for the three differentially methylated GNAS regions was quantified via the Sequenom EpiTYPER. Patients showed significant hypermethylation of the XL amplicon compared to controls (36 +/- 3 vs. 29 +/- 3%; p<0.001); a pattern that is reversed to XL hypomethylation found in PHPIb. Interestingly, XL hypermethylation was associated with reduced XLalphaS protein levels in the patients' platelets. Methylation for NESP and ExonA/B was significantly different for some but not all patients, though most patients have site-specific CpG methylation abnormalities in these amplicons. Since some AHO features are present in other imprinting disorders, the methylation of IGF2, H19, SNURF and GRB10 was quantified. Surprisingly, significant IGF2 hypermethylation (20 +/- 10 vs. 14 +/- 7%; p<0.05) and SNURF hypomethylation (23 +/- 6 vs. 32 +/- 6%; p<0.001) was found in patients vs. controls, while H19 and GRB10 methylation was normal. Conclusion/Significance: In conclusion, this is the first report of methylation defects including GNAS in patients with an AHO-like phenotype without endocrinological abnormalities. Additional studies are still needed to correlate the methylation defect with the clinical phenotype.	[Izzi, Benedetta; Thys, Chantal; Wittevrongel, Christine; Van Geet, Chris; Freson, Kathleen] Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Francois, Inge; Labarque, Veerle; de Zegher, Francis; Van Geet, Chris] Univ Leuven, Dept Pediat, Louvain, Belgium; [Devriendt, Koen; Legius, Eric] Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Van den Bruel, Annick; D'Hooghe, Marc] Gen Hosp Sint Jan Brugge, Brugge, Belgium; [Lambrechts, Diether] Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [Lambrechts, Diether] VIB, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB)	Izzi, B (corresponding author), Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium.	kathleen.freson@med.kuleuven.be	Verdrengh, Evelien/H-4571-2012; Lambrechts, Diether/AAJ-3167-2020; Izzi, Benedetta/B-4563-2016	Lambrechts, Diether/0000-0002-3429-302X; Izzi, Benedetta/0000-0002-3649-7931; freson, kathleen/0000-0002-4381-2442	Excellentie financiering KULeuven [EF/05/013]; Fund for Scientific Research - Flanders (FWO-Vlaanderen, Belgium) [G.0490.10N, G.0743.09]; Research Council of the University of Leuven (Onderzoeksraad KULeuven, Belgium) [GOA/2009/13]	Excellentie financiering KULeuven(KU Leuven); Fund for Scientific Research - Flanders (FWO-Vlaanderen, Belgium)(FWO); Research Council of the University of Leuven (Onderzoeksraad KULeuven, Belgium)(KU Leuven)	This work was supported by the 'Excellentie financiering KULeuven' (EF/05/013), by research grants G.0490.10N and G.0743.09 from the Fund for Scientific Research - Flanders (FWO-Vlaanderen, Belgium), GOA/2009/13 from the Research Council of the University of Leuven (Onderzoeksraad KULeuven, Belgium). C. V. G. is holder of a clinical-fundamental research mandate of the Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium and of the Bayer and Norbert Heimburger (CSL Behring) Chairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbite NS, 2008, AM J MED GENET A, V146A, P1788, DOI 10.1002/ajmg.a.32346; Ahrens W, 2001, J CLIN ENDOCR METAB, V86, P4630, DOI 10.1210/jc.86.10.4630; Ahrens W, 2006, J PEDIATR ENDOCR MET, V19, P647; Aldred MA, 2002, AM J MED GENET, V113, P167, DOI 10.1002/ajmg.10751; Ammerpohl O, 2009, BBA-GEN SUBJECTS, V1790, P847, DOI 10.1016/j.bbagen.2009.02.001; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; Baple EL, 2011, EUR J HUM GENET, V19, P360, DOI 10.1038/ejhg.2010.218; Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bastepe M, 2001, HUM MOL GENET, V10, P1231, DOI 10.1093/hmg/10.12.1231; Bliek J, 2009, EUR J HUM GENET, V17, P611, DOI 10.1038/ejhg.2008.233; Bruce S, 2009, J CLIN ENDOCR METAB, V94, P579, DOI 10.1210/jc.2008-1805; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Cavaco BM, 2010, ENDOCRINE, V37, P408, DOI 10.1007/s12020-010-9321-9; Chillambhi S, 2010, J CLIN ENDOCR METAB, V95, P3993, DOI 10.1210/jc.2009-2205; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; DAVIES SJ, 1993, J MED GENET, V30, P101, DOI 10.1136/jmg.30.2.101; de Beur SJ, 2003, AM J HUM GENET, V73, P314, DOI 10.1086/377136; de Nanclares GP, 2007, J CLIN ENDOCR METAB, V92, P2370, DOI 10.1210/jc.2006-2287; de Sanctis L, 2003, PEDIATR RES, V53, P749, DOI 10.1203/01.PDR.0000059752.07086.A2; Eggermann Thomas, 2010, Pediatr Endocrinol Rev, V8, P86; Fernandez-Rebollo E, 2011, J BONE MINER RES, V26, P1854, DOI 10.1002/jbmr.408; Freson K, 2004, J CLIN INVEST, V113, P905, DOI 10.1172/JCI200419252; Freson K, 2003, HUM MOL GENET, V12, P1121, DOI 10.1093/hmg/ddg130; Freson K, 2002, HUM MOL GENET, V11, P2741, DOI 10.1093/hmg/11.22.2741; Freson K, 2001, THROMB HAEMOSTASIS, V86, P733, DOI 10.1055/s-0037-1616126; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Freson K, 2008, J CLIN ENDOCR METAB, V93, P4851, DOI 10.1210/jc.2008-0883; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Genevieve D, 2005, EUR J HUM GENET, V13, P1033, DOI 10.1038/sj.ejhg.5201448; Germain-Lee EL, 2003, J CLIN ENDOCR METAB, V88, P4059, DOI 10.1210/jc.2003-030028; Izzi B, 2012, J HUM GENET, V57, P277, DOI 10.1038/jhg.2012.1; Izzi B, 2010, CLIN CHIM ACTA, V411, P2033, DOI 10.1016/j.cca.2010.08.034; Krechowec SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029753; Lania A, 2001, EUR J ENDOCRINOL, V145, P543, DOI 10.1530/eje.0.1450543; Levine MA, 2002, PRINCIPLES BONE BIOL, P1137, DOI [10.1016/b978-012098652-1/50166-9, DOI 10.1016/B978-012098652-1/50166-9]; Linglart A, 2005, AM J HUM GENET, V76, P804, DOI 10.1086/429932; Linglart A, 2007, CLIN ENDOCRINOL, V67, P822, DOI 10.1111/j.1365-2265.2007.02969.x; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Liu J, 2005, HUM MOL GENET, V14, P95, DOI 10.1093/hmg/ddi009; Liu Z, 2011, J BIOL CHEM, V286, P38558, DOI 10.1074/jbc.M111.240150; Liu Z, 2011, ENDOCRINOLOGY, V152, P1222, DOI 10.1210/en.2010-1034; Long DN, 2007, J CLIN ENDOCR METAB, V92, P1073, DOI 10.1210/jc.2006-1497; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Mantovani G, 2003, J CLIN ENDOCR METAB, V88, P4070, DOI 10.1210/jc.2002-022028; Mantovani G, 2000, J CLIN ENDOCR METAB, V85, P4243, DOI 10.1210/jc.85.11.4243; Mantovani G, 2010, J CLIN ENDOCR METAB, V95, P651, DOI 10.1210/jc.2009-0176; Mariot V, 2008, J CLIN ENDOCR METAB, V93, P661, DOI 10.1210/jc.2007-0927; Mariot V, 2011, BONE, V48, P312, DOI 10.1016/j.bone.2010.09.032; Maupetit-Mehouas S, 2011, J MED GENET, V48, P55, DOI 10.1136/jmg.2010.081356; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Poole RL, 2010, AM J MED GENET A, V152A, P1990, DOI 10.1002/ajmg.a.33530; Richard N, 2012, J CLIN ENDOCR METAB, V97, pE863, DOI 10.1210/jc.2011-2804; Shirohzu H, 2002, AM J MED GENET, V112, P31, DOI 10.1002/ajmg.10658; Shore EM, 2002, NEW ENGL J MED, V346, P99, DOI 10.1056/NEJMoa011262; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Turner CLS, 2010, EUR J HUM GENET, V18, P648, DOI 10.1038/ejhg.2009.246; Unluturk U, 2008, AM J MED SCI, V336, P84, DOI 10.1097/MAJ.0b013e31815b218f; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; WILSON LC, 1994, J MED GENET, V31, P779, DOI 10.1136/jmg.31.10.779; WILSON LC, 1994, J MED GENET, V31, P835, DOI 10.1136/jmg.31.11.835; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zazo C, 2011, J BONE MINER RES, V26, P1864, DOI 10.1002/jbmr.369	68	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38579	10.1371/journal.pone.0038579	http://dx.doi.org/10.1371/journal.pone.0038579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679513	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900060
J	Indig, FE; Rybanska, I; Karmakar, P; Devulapalli, C; Fu, HQ; Carrier, F; Bohr, VA				Indig, Fred E.; Rybanska, Ivana; Karmakar, Parimal; Devulapalli, Chakravarty; Fu, Haiqing; Carrier, France; Bohr, Vilhelm A.			Nucleolin Inhibits G4 Oligonucleotide Unwinding by Werner Helicase	PLOS ONE			English	Article							REPLICATION PROTEIN-A; DNA TOPOISOMERASE-I; PROTEOMIC ANALYSIS; COMPLEX-FORMATION; BINDING-PROTEIN; SYNDROME GENE; WRN HELICASE; CELL-LINES; CAMPTOTHECIN; LOCALIZATION	Background: The Werner protein (WRNp), a member of the RecQ helicase family, is strongly associated with the nucleolus, as is nucleolin (NCL), an important nucleolar constituent protein. Both WRNp and NCL respond to the effects of DNA damaging agents. Therefore, we have investigated if these nuclear proteins interact and if this interaction has a possible functional significance in DNA damage repair. Methodology/Principal Findings: Here we report that WRNp interacts with the RNA-binding protein, NCL, based on immunoprecipitation, immunofluorescent co-localization in live and fixed cells, and direct binding of purified WRNp to nucleolin. We also map the binding region to the C-terminal domains of both proteins. Furthermore, treatment of U2OS cells with 15 mu M of the Topoisomerase I inhibitor, camptothecin, causes the dissociation of the nucleolin-Werner complex in the nucleolus, followed by partial re-association in the nucleoplasm. Other DNA damaging agents, such as hydroxyurea, Mitomycin C, and aphidicolin do not have these effects. Nucleolin or its C-terminal fragment affected the helicase, but not the exonuclease activity of WRNp, by inhibiting WRN unwinding of G4 tetraplex DNA structures, as seen in activity assays and electrophoretic mobility shift assays (EMSA). Conclusions/Significance: These data suggest that nucleolin may regulate G4 DNA unwinding by WRNp, possibly in response to certain DNA damaging agents. We postulate that the NCL-WRNp complex may contain an inactive form of WRNp, which is released from the nucleolus upon DNA damage. Then, when required, WRNp is released from inhibition and can participate in the DNA repair processes.	[Indig, Fred E.] NIA, Clin Invest Lab, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Rybanska, Ivana; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Karmakar, Parimal] Jadavpur Univ, Dept Life Sci & Biotechnol, Kolkata, India; [Devulapalli, Chakravarty; Carrier, France] Univ Maryland, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Fu, Haiqing] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Jadavpur University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Indig, FE (corresponding author), NIA, Clin Invest Lab, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA.	indigf@mail.nih.gov	Bohr, Vilhelm/AAP-5931-2020	Carrier, France/0000-0002-5517-5284	National Institutes of Health (NIH), National Institute on Aging; NIH/National Cancer Institute (NCI) [RO1 1CA116491-01]; NIH/National Insitute of General Medical Sciences (NIGMS) [RO1 GM57827]; National Kidney Foundation; NATIONAL CANCER INSTITUTE [R01CA116491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000721, ZICAG000615] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/National Insitute of General Medical Sciences (NIGMS); National Kidney Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging; by grants NIH/National Cancer Institute (NCI) RO1 1CA116491-01 and NIH/National Insitute of General Medical Sciences (NIGMS) RO1 GM57827 to FC; and a National Kidney Foundation post-doctoral fellowship to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bjergbaek L, 2002, SWISS MED WKLY, V132, P433; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Danks MK, 1996, CANCER RES, V56, P1664; De AY, 2006, BIOCHEM BIOPH RES CO, V344, P206, DOI 10.1016/j.bbrc.2006.03.113; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Gerbi SA, 2003, CURR OPIN CELL BIOL, V15, P318, DOI 10.1016/S0955-0674(03)00049-8; Ginisty H, 1999, J CELL SCI, V112, P761; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Harrigan JA, 2003, J BIOL CHEM, V278, P22686, DOI 10.1074/jbc.M213103200; Hernandez-Verdun D, 2002, J CELL SCI, V115, P2265; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Indig FE, 1997, BIOCHEM J, V327, P291, DOI 10.1042/bj3270291; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; Laine JP, 2003, CANCER RES, V63, P7136; Lam YW, 2005, J CELL SCI, V118, P1335, DOI 10.1242/jcs.01736; Leung AKL, 2003, BIOCHEM J, V376, P553, DOI 10.1042/BJ20031169; Linke SP, 2003, CANCER RES, V63, P2596; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; MI ZH, 1994, BIOCHEMISTRY-US, V33, P10325, DOI 10.1021/bi00200a013; Nalabothula Narasimharao, 2010, Mol Cell Pharmacol, V2, P203; OCHS R, 1983, EXP CELL RES, V146, P139, DOI 10.1016/0014-4827(83)90332-4; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Otterlei M, 2006, J CELL SCI, V119, P5137, DOI 10.1242/jcs.03291; Partridge JJ, 2003, MOL BIOL CELL, V14, P4221, DOI 10.1091/mbc.E03-02-0111; Pederson T, 2000, J CELL BIOL, V148, P1091, DOI 10.1083/jcb.148.6.1091; Pichierri P, 2000, MUTAT RES-FUND MOL M, V456, P45, DOI 10.1016/S0027-5107(00)00109-3; Pollice A, 2000, BIOCHEM BIOPH RES CO, V268, P909, DOI 10.1006/bbrc.2000.2237; Pommier Y, 1998, BIOCHEMISTRY-US, V37, P3818, DOI 10.1021/bi972067d; Poot M, 1999, HUM GENET, V104, P10, DOI 10.1007/s004390050903; POOT M, 1992, MUTAT RES, V270, P185, DOI 10.1016/0027-5107(92)90129-P; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Sakamoto S, 2001, GENES CELLS, V6, P421, DOI 10.1046/j.1365-2443.2001.00433.x; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; SCHULTE RJ, 1994, J IMMUNOL, V153, P5465; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; SEN D, 1992, METHOD ENZYMOL, V211, P191; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Shen JC, 2001, MECH AGEING DEV, V122, P921, DOI 10.1016/S0047-6374(01)00248-2; Shiratori M, 2002, ONCOGENE, V21, P2447, DOI 10.1038/sj.onc.1205334; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Suzuki N, 1999, NUCLEIC ACIDS RES, V27, P2361, DOI 10.1093/nar/27.11.2361; Suzuki N, 1997, NUCLEIC ACIDS RES, V25, P2973, DOI 10.1093/nar/25.15.2973; Suzuki T, 2001, ONCOGENE, V20, P2551, DOI 10.1038/sj.onc.1204344; Vaitiekunaite R, 2007, MECH AGEING DEV, V128, P650, DOI 10.1016/j.mad.2007.09.004; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; von Kobbe C, 2002, J CELL SCI, V115, P3901, DOI 10.1242/jcs.00076; Wang YZ, 2001, J BIOL CHEM, V276, P20579, DOI 10.1074/jbc.M100874200; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yang Chonglin, 2009, Mol Cell Pharmacol, V1, P130; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhang SS, 2004, EXP CELL RES, V293, P248, DOI 10.1016/j.yexcr.2003.10.018	67	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e35229	10.1371/journal.pone.0035229	http://dx.doi.org/10.1371/journal.pone.0035229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675465	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700002
J	Manning, CF; Bundros, AM; Trimmer, JS				Manning, Colleen F.; Bundros, Angeliki M.; Trimmer, James S.			Benefits and Pitfalls of Secondary Antibodies: Why Choosing the Right Secondary Is of Primary Importance	PLOS ONE			English	Article							K+ CHANNELS; POTASSIUM CHANNELS; MAMMALIAN BRAIN; SURFACE EXPRESSION; ALPHA-SUBUNITS; LOCALIZATION; CELLS; PHOSPHORYLATION; NEURONS; PSD-95	Simultaneous labeling of multiple targets in a single sample, or multiplexing, is a powerful approach to directly compare the amount, localization and/or molecular properties of different targets in the same sample. Here we highlight the robust reliability of the simultaneous use of multiple mouse monoclonal antibodies (mAbs) of different immunoglobulin G (IgG) subclasses in a wide variety of multiplexing applications employing anti-mouse IgG subclass-specific secondary antibodies (2 degrees Abs). We also describe the unexpected finding that IgG subclass-specific 2 degrees Abs are superior to general anti-mouse IgG 2 degrees Abs in every tested application in which mouse mAbs were used. This was due to a detection bias of general anti-mouse IgG-specific 2 degrees Abs against mAbs of the most common mouse IgG subclass, IgG1, and to a lesser extent IgG2b mAbs. Thus, when using any of numerous mouse mAbs available through commercial and non-profit sources, for cleaner and more robust results each mAb should be detected with its respective IgG subclass-specific 2 degrees Ab and not a general anti-mouse IgG-specific 2 degrees Ab.	[Manning, Colleen F.; Bundros, Angeliki M.; Trimmer, James S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Trimmer, James S.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Manning, CF (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu			National Institutes of Health [NS34383, NS42225, NS50606]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225, U24NS050606, R37NS034383, R01NS034383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NS34383, NS42225, and NS50606) to J.S.T. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Brouns I, 2002, J HISTOCHEM CYTOCHEM, V50, P575, DOI 10.1177/002215540205000415; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Couchman JR, 2009, J HISTOCHEM CYTOCHEM, V57, P7, DOI 10.1369/jhc.2008.952820; Daneshtalab N, 2010, J PHARMACOL TOXICOL, V61, P127, DOI 10.1016/j.vascn.2009.12.002; Frisch J, 2011, METHODS MOL BIOL, V717, P233, DOI 10.1007/978-1-61779-024-9_13; Fritschy JM, 2008, EUR J NEUROSCI, V28, P2365, DOI 10.1111/j.1460-9568.2008.06552.x; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Kaufmann WA, 2009, J COMP NEUROL, V515, P215, DOI 10.1002/cne.22066; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; NATSUUMESAKAI S, 1977, IMMUNOLOGY, V32, P861; Park Kang-Sik, 2007, Channels (Austin), V1, P59; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Rasband MN, 2001, J COMP NEUROL, V429, P166, DOI 10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y; Rasband MN, 2002, J CELL BIOL, V159, P663, DOI 10.1083/jcb.200206024; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; SHI GY, 1994, J BIOL CHEM, V269, P23204; Strassle BW, 2005, J COMP NEUROL, V484, P144, DOI 10.1002/cne.20443; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Zhu W, 2009, THERAPEUTIC MONOCLON, P151	29	34	34	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38313	10.1371/journal.pone.0038313	http://dx.doi.org/10.1371/journal.pone.0038313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675541	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339900023
J	Meyer, P; Landgraf, K; Hogel, B; Eiermann, W; Ataseven, B				Meyer, Peter; Landgraf, Katharina; Hoegel, Bernhard; Eiermann, Wolfgang; Ataseven, Beyhan			BRCA2 Mutations and Triple-Negative Breast Cancer	PLOS ONE			English	Article							PREVALENCE; CARRIERS	Recently, BRCA1 germline mutations were found in a high proportion (14-34%) of patients with triple-negative breast cancer (TNBC). BRCA2 was either not analyzed or showed much lower mutation frequencies. Therefore, we screened a group of TNBC patients (n = 30) of white European descent for mutations in BRCA2 as well as in BRCA1. Cases were unselected for age of disease-onset (median age at breast cancer diagnosis was 58 years, ranging from 37 to 74 years), family history of cancer and BRCA1 and BRCA2 mutation status. Half of the patients (15/30) showed a family history of breast and/or ovarian cancer. A high frequency of deleterious germline mutations was observed in BRCA2 (5/30; 16.7%), and only one case showed a BRCA1 mutation (3.3%). Although the study group was small, these results point to BRCA2 mutations being important in TNBC.	[Meyer, Peter; Landgraf, Katharina] Univ Hosp, Inst Med Genet, Rostock, Germany; [Hoegel, Bernhard] Red Cross Hosp, Inst Pathol, Munich, Germany; [Eiermann, Wolfgang; Ataseven, Beyhan] Frauenklin Roten Kreuz, Munich, Germany	University of Rostock	Meyer, P (corresponding author), Univ Hosp, Inst Med Genet, Rostock, Germany.	pm@uni.de			Human Genetics Foundation Munich (Germany)	Human Genetics Foundation Munich (Germany)	This study was supported by the Human Genetics Foundation Munich (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2005, J MED GENET, V42, P602, DOI 10.1136/jmg.2004.024133; Bauerfeind I, 2011, MAMMAKARZINOME DIAGN, VXII; Borg A, 2010, HUM MUTAT, V31, pE1200, DOI 10.1002/humu.21202; Comen E, 2011, BREAST CANCER RES TR, V129, P185, DOI 10.1007/s10549-011-1433-2; Evans DG, 2011, J MED GENET, V48, P520, DOI 10.1136/jmedgenet-2011-100006; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gadzicki D, 2011, J COMMUN GENET, V2, P53, DOI 10.1007/s12687-011-0042-4; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Krupa R., 2009, Experimental Oncology, V31, P250; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Meyer P, 2003, HUM MUTAT, V22; Rajasekaran R, 2007, GENOMICS, V90, P447, DOI 10.1016/j.ygeno.2007.07.004; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Young SR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-86	15	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38361	10.1371/journal.pone.0038361	http://dx.doi.org/10.1371/journal.pone.0038361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666503	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400114
J	Taylor, DL; Bina, XWR; Bina, JE				Taylor, Dawn L.; Bina, Xiaowen R.; Bina, James E.			Vibrio cholerae vexH Encodes a Multiple Drug Efflux Pump That Contributes to the Production of Cholera Toxin and the Toxin Co-Regulated Pilus	PLOS ONE			English	Article							MANNOSE-SENSITIVE HEMAGGLUTININ; VIRULENCE FACTOR EXPRESSION; MULTIDRUG EFFLUX; CRYSTAL-STRUCTURE; BILE RESISTANCE; FATTY-ACIDS; MEMBRANE; SYSTEM; GENES; TOLC	The resistance-nodulation-division (RND) efflux systems are ubiquitous transporters that function in antimicrobial resistance. Recent studies showed that RND systems were required for virulence factor production in Vibrio cholerae. The V. cholerae genome encodes six RND efflux systems. Three of the RND systems (VexB, VexD, and VexK) were previously shown to be redundant for in vitro resistance to bile acids and detergents. A mutant lacking the VexB, VexD, and VexK RND pumps produced wild-type levels of cholera toxin (CT) and the toxin co-regulated pilus (TCP) and was moderately attenuated for intestinal colonization. In contrast, a RND negative mutant produced significantly reduced amounts of CT and TCP and displayed a severe colonization defect. This suggested that one or more of the three uncharacterized RND efflux systems (i.e. VexF, VexH, and VexM) were required for pathogenesis. In this study, a genetic approach was used to generate a panel of V. cholerae RND efflux pump mutants in order to determine the function of VexH in antimicrobial resistance, virulence factor production, and intestinal colonization. VexH contributed to in vitro antimicrobial resistance and exhibited a broad substrate specificity that was redundant with the VexB, VexD, and VexK RND efflux pumps. These four efflux pumps were responsible for in vitro antimicrobial resistance and were required for virulence factor production and intestinal colonization. Mutation of the VexF and/or VexM efflux pumps did not affect in vitro antimicrobial resistance, but did negatively affect CT and TCP production. Collectively, our results demonstrate that the V. cholerae RND efflux pumps have redundant functions in antimicrobial resistance and virulence factor production. This suggests that the RND efflux systems contribute to V. cholerae pathogenesis by providing the bacterium with protection against antimicrobial compounds that are present in the host and by contributing to the regulated expression of virulence factors.	[Taylor, Dawn L.; Bina, Xiaowen R.; Bina, James E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Taylor, DL (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	JBina@pitt.edu	Bina, Xiaowen/AAE-9100-2022		National Institute of Allergy and Infectious Diseases [R01AI091845, R21AI092007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091845, R21AI092007] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by award numbers R01AI091845 and R21AI092007 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; BETLEY MJ, 1986, ANNU REV MICROBIOL, V40, P577, DOI 10.1146/annurev.mi.40.100186.003045; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; Bina JE, 2006, ARCH MICROBIOL, V186, P171, DOI 10.1007/s00203-006-0133-5; Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001; Bina XR, 2008, INFECT IMMUN, V76, P3595, DOI 10.1128/IAI.01620-07; Bina XR, 2008, FEMS MICROBIOL LETT, V279, P226, DOI 10.1111/j.1574-6968.2007.01033.x; Bina XWR, 2010, J BACTERIOL, V192, P3829, DOI 10.1128/JB.00191-10; BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Cerda-Maira FA, 2008, J BACTERIOL, V190, P7441, DOI 10.1128/JB.00584-08; Chakrabarti Sr, 1996, J BACTERIOL, V178, P524, DOI 10.1128/jb.178.2.524-530.1996; Chatterjee A, 2004, J BACTERIOL, V186, P6809, DOI 10.1128/JB.186.20.6809-6814.2004; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; Chiang SL, 1998, MOL MICROBIOL, V27, P797, DOI 10.1046/j.1365-2958.1998.00726.x; Davies BW, 2011, P NATL ACAD SCI USA, V108, P12467, DOI 10.1073/pnas.1107894108; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Giles DK, 2011, MOL MICROBIOL, V79, P716, DOI 10.1111/j.1365-2958.2010.07476.x; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; HIGGINS DE, 1992, J BACTERIOL, V174, P6974, DOI 10.1128/JB.174.21.6974-6980.1992; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; IREDELL JR, 1994, FEMS MICROBIOL LETT, V121, P47, DOI 10.1016/0378-1097(94)90144-9; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; KAUFMAN MR, 1993, GENE, V126, P43, DOI 10.1016/0378-1119(93)90588-T; Klose KE, 2000, TRENDS MICROBIOL, V8, P189, DOI 10.1016/S0966-842X(00)01721-2; Klose KE, 1998, J BACTERIOL, V180, P303, DOI 10.1128/JB.180.2.303-316.1998; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Krukonis ES, 2000, MOL MICROBIOL, V38, P67, DOI 10.1046/j.1365-2958.2000.02111.x; Lamarche MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024310; LaRocque RC, 2005, INFECT IMMUN, V73, P4488, DOI 10.1128/IAI.73.8.4488-4493.2005; Lombardo MJ, 2007, P NATL ACAD SCI USA, V104, P18229, DOI 10.1073/pnas.0705636104; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mey AR, 2012, INFECT IMMUN, V80, P518, DOI 10.1128/IAI.05851-11; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Ogierman MA, 1996, GENE, V170, P9, DOI 10.1016/0378-1119(95)00744-X; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rahman MM, 2007, MICROBIOL IMMUNOL, V51, P1061, DOI 10.1111/j.1348-0421.2007.tb04001.x; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Schuhmacher DA, 1999, J BACTERIOL, V181, P1508, DOI 10.1128/JB.181.5.1508-1514.1999; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Van Bambeke F, 2003, J ANTIMICROB CHEMOTH, V51, P1055, DOI 10.1093/jac/dkg224; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; Yu RR, 1999, J BACTERIOL, V181, P2584, DOI 10.1128/JB.181.8.2584-2592.1999; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	63	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38208	10.1371/journal.pone.0038208	http://dx.doi.org/10.1371/journal.pone.0038208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666485	Green Published, gold, Green Accepted			2022-12-27	WOS:000305353400101
J	Tikoo, A; Roh, V; Montgomery, KG; Ivetac, I; Waring, P; Pelzer, R; Hare, L; Shackleton, M; Humbert, P; Phillips, WA				Tikoo, Anjali; Roh, Vincent; Montgomery, Karen G.; Ivetac, Ivan; Waring, Paul; Pelzer, Rebecca; Hare, Lauren; Shackleton, Mark; Humbert, Patrick; Phillips, Wayne A.			Physiological Levels of Pik3ca(H1047R) Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ER alpha-Positive Tumors	PLOS ONE			English	Article							PIK3CA MUTATIONS; BREAST-CANCER; EPITHELIAL-CELLS; STEM-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; BRANCHING MORPHOGENESIS; PROGENITOR CELLS; GENE; ACTIVATION; PATHWAY	PIK3CA, the gene coding for the p110 alpha subunit of phosphoinositide 3-kinase, is frequently mutated in a variety of human tumors including breast cancers. To better understand the role of mutant PIK3CA in the initiation and/or progression of breast cancer, we have generated mice with a conditional knock-in of the common activating mutation, Pik3ca(H1047R), into one allele of the endogenous gene in the mammary gland. These mice developed a ductal anaplasia and hyperplasia by 6 weeks of age characterized by multi-layering of the epithelial lining of the mammary ducts and expansion of the luminal progenitor (Lin(-); CD29(lo); CD24(+); CD6(+)) cell population. The Pik3ca(H1047R) expressing mice eventually develop mammary tumors with 100% penetrance but with a long latency (> 12 months). This is significantly longer than has been reported for transgenic models where expression of the mutant Pik3ca is driven by an exogenous promoter. Histological analysis of the tumors formed revealed predominantly ER alpha-positive fibroadenomas, carcinosarcomas and sarcomas. In vitro induction of Pik3ca(H1047R) in immortalized mammary epithelial cells also resulted in tumor formation when injected into the mammary fat pad of immunodeficient recipient mice. This novel model, which reproduces the scenario of a heterozygous somatic mutation occurring in the endogenous PIK3CA gene, will thus be a valuable tool for investigating the role of Pik3ca(H1047R) mutation in mammary tumorigenesis both in vivo and in vitro.	[Tikoo, Anjali; Roh, Vincent; Montgomery, Karen G.; Ivetac, Ivan; Pelzer, Rebecca; Hare, Lauren; Phillips, Wayne A.] Peter MacCallum Canc Ctr, Surg Oncol Res Lab, Melbourne, Vic, Australia; [Shackleton, Mark; Humbert, Patrick; Phillips, Wayne A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Tikoo, Anjali; Phillips, Wayne A.] Univ Melbourne, St Vincents Hosp, Dept Surg, Parkville, Vic 3052, Australia; [Waring, Paul; Shackleton, Mark; Humbert, Patrick] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Humbert, Patrick] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Humbert, Patrick] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, Melbourne, Vic, Australia; [Hare, Lauren; Phillips, Wayne A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Shackleton, Mark] Peter MacCallum Canc Ctr, Melanoma Res Lab, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Peter Maccallum Cancer Center; Monash University; Peter Maccallum Cancer Center	Tikoo, A (corresponding author), Peter MacCallum Canc Ctr, Surg Oncol Res Lab, Melbourne, Vic, Australia.	wayne.phillips@petermac.org	Phillips, Wayne A/H-8070-2013; Humbert, Patrick O/L-4264-2016; Ivetac, Ivan/AAE-9859-2020	Phillips, Wayne A/0000-0002-7961-638X; Humbert, Patrick O/0000-0002-1366-6691; Ivetac, Ivan/0000-0003-1263-8346	National Health and Medical Research Council (NHMRC) of Australia [628620]; Association of International Cancer Research [10-0052]; NHMRC; Swiss National Science Foundation; Cure Cancer Australia Foundation; Cancer Australia; Australian Postgraduate Research Award; Pfizer Australia; VESKI	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Association of International Cancer Research; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cure Cancer Australia Foundation; Cancer Australia; Australian Postgraduate Research Award; Pfizer Australia(PfizerPfizer Australia); VESKI	This work was funded by grants from the National Health and Medical Research Council (NHMRC) of Australia (project grant No. 628620) and the Association of International Cancer Research (grant No 10-0052) to WAP. POH was supported by an NHMRC Career Development Award. VR was supported by the Swiss National Science Foundation. II was supported, in part, by the Cure Cancer Australia Foundation and Cancer Australia and LH is the recipient of an Australian Postgraduate Research Award. MS was supported by fellowships from Pfizer Australia and VESKI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Bozhanov SS, 2010, J CANCER RES CLIN, V136, P1657, DOI 10.1007/s00432-010-0824-9; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Dunlap J, 2010, BREAST CANCER RES TR, V120, P409, DOI 10.1007/s10549-009-0406-1; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hutchinson J, 2001, MOL CELL BIOL, V21, P2203, DOI 10.1128/MCB.21.6.2203-2212.2001; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Karantza-Wadsworth V, 2008, METHOD ENZYMOL, V446, P61, DOI 10.1016/S0076-6879(08)01604-2; Kim D, 2007, DEV BIOL, V307, P290, DOI 10.1016/j.ydbio.2007.04.051; Kinross KM, 2012, J CLIN INVEST; Lai YL, 2008, ANN SURG ONCOL, V15, P1064, DOI 10.1245/s10434-007-9751-7; Li H, 2010, EXP MOL PATHOL, V88, P150, DOI 10.1016/j.yexmp.2009.09.016; Li SY, 2006, BREAST CANCER RES TR, V96, P91, DOI 10.1007/s10549-005-9048-0; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Meyer DS, 2011, CANCER RES, V71, P4344, DOI 10.1158/0008-5472.CAN-10-3827; Miron A, 2010, CANCER RES, V70, P5674, DOI 10.1158/0008-5472.CAN-08-2660; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Renner O, 2008, CANCER RES, V68, P9643, DOI 10.1158/0008-5472.CAN-08-1539; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Samuels Y, 2011, CURR TOP MICROBIOL, V347, P21, DOI 10.1007/82_2010_68; Sebastian J, 1998, CELL GROWTH DIFFER, V9, P777; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tang MJ, 2002, DEV BIOL, V243, P128, DOI 10.1006/dbio.2001.0557; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wang LP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-248; Whyte DB, 2006, BIOCHEM BIOPH RES CO, V340, P469, DOI 10.1016/j.bbrc.2005.12.025; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang HJ, 2008, BREAST CANCER RES TR, V112, P217, DOI 10.1007/s10549-007-9847-6; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	50	42	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36924	10.1371/journal.pone.0036924	http://dx.doi.org/10.1371/journal.pone.0036924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666336	Green Published, gold			2022-12-27	WOS:000305353400018
J	Zhang, HL; Hassan, MY; Zheng, XY; Azimullah, S; Quezada, HC; Amir, N; Elwasila, M; Mix, E; Adem, A; Zhu, J				Zhang, Hong-Liang; Hassan, Mohammed Y.; Zheng, Xiang-Yu; Azimullah, Sheikh; Quezada, Hernan Concha; Amir, Naheed; Elwasila, Mohamed; Mix, Eilhard; Adem, Abdu; Zhu, Jie			Attenuated EAN in TNF-alpha Deficient Mice Is Associated with an Altered Balance of M1/M2 Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE NEURITIS; PERIPHERAL NERVOUS-SYSTEM; GUILLAIN-BARRE-SYNDROME; FACTOR (TNF)-ALPHA; FACTOR RECEPTORS; CELL RESPONSES; LEWIS RATS; T-CELLS; DEMYELINATION	The role of tumor necrosis factor (TNF)-alpha and its receptors in neuroautoimmune and neuroinflammatory diseases has been controversial. On the basis of our previous studies, we hereby aimed to further clarify TNF-alpha's mechanism of action and to explore the potential role of TNF-alpha receptor (TNFR) 1 as a therapeutic target in experimental autoimmune neuritis (EAN). EAN was induced by immunization with P0 peptide 180-199 in TNF-alpha knockout (KO) mice and anti-TNFR1 antibodies were used to treat EAN. Particularly, the effects of TNF-alpha deficiency and TNFR1 blockade on macrophage functions were investigated. The onset of EAN in TNF-alpha KO mice was markedly later than that in wild type (WT) mice. From day 14 post immunization, the clinical signs of TNF-alpha KO mice were significantly milder than those of their WT counterparts. Further, we showed that the clinical severity of WT mice treated with anti-TNFR1 antibodies was less severe than that of the control WT mice receiving PBS. Nevertheless, no difference with regard to the clinical signs of EAN or inflammatory infiltration in cauda equina was seen between TNF-alpha KO and WT mice with EAN after blockade of TNFR1. Although TNF-alpha deficiency did not alter the proliferation of lymphocytes in response to either antigenic or mitogenic stimuli, it down-regulated the production of interleukin (IL)-12 and nitric oxide (NO), and enhanced the production of IL-10 in macrophages. Increased ratio of regulatory T cells (Tregs) and reduced production of interferon (IFN)-gamma in cauda equina infiltrating cells, and elevated levels of IgG2b antibodies against P0 peptide 180-199 in sera were found in TNF-alpha KO mice with EAN. In conclusion, TNF-alpha deficiency attenuates EAN via altering the M1/M2 balance of macrophages.	[Zhang, Hong-Liang; Zheng, Xiang-Yu; Zhu, Jie] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Hassan, Mohammed Y.; Azimullah, Sheikh; Amir, Naheed; Elwasila, Mohamed; Adem, Abdu] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pharmacol, Al Ain, U Arab Emirates; [Quezada, Hernan Concha] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden; [Mix, Eilhard] Univ Rostock, Dept Neurol, Rostock, Germany; [Zhu, Jie] Jilin Univ, First Hosp, Dept Neurol, Changchun 130023, Peoples R China	Karolinska Institutet; United Arab Emirates University; Karolinska Institutet; Karolinska University Hospital; University of Rostock; Jilin University	Zhang, HL (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	Jie.Zhu@ki.se	Zhang, Hongliang/AAN-3077-2020; Adem, Abdu/AAN-8271-2021; amir, naheed/AAP-5152-2020	Zhang, Hongliang/0000-0001-9205-5559; Adem, Abdu/0000-0002-9289-5301; 	Swedish Medical Association; Swedish National Board of Health and Welfare; China Scholarship Council; Faculty of Medicine & Health Science, United Arab Emirates University; Karolinska Institute	Swedish Medical Association; Swedish National Board of Health and Welfare; China Scholarship Council(China Scholarship Council); Faculty of Medicine & Health Science, United Arab Emirates University; Karolinska Institute(Karolinska Institutet)	This study was supported by Swedish Medical Association, Swedish National Board of Health and Welfare, and China Scholarship Council, as well as grants from Faculty of Medicine & Health Science, United Arab Emirates University and from Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2003, NEUROBIOL DIS, V12, P73, DOI 10.1016/S0969-9961(02)00007-4; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chan WC, 2000, FMOC SOLID PHASE PEP; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; Creange A, 1996, J NEUROIMMUNOL, V68, P95, DOI 10.1016/0165-5728(96)00075-6; Deng H, 2008, EUR J NEUROL, V15, P1100, DOI 10.1111/j.1468-1331.2008.02261.x; Duan RS, 2004, NEUROBIOL DIS, V16, P630, DOI 10.1016/j.nbd.2004.04.007; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kiefer R, 1998, BRAIN, V121, P469, DOI 10.1093/brain/121.3.469; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2006, CURR OPIN NEUROL, V19, P437, DOI 10.1097/01.wco.0000245365.51823.72; Korn T, 2001, BRAIN, V124, P1791, DOI 10.1093/brain/124.9.1791; Lu MO, 2007, J NEUROIMMUNOL, V186, P19, DOI 10.1016/j.jneuroim.2007.02.004; Mao XJ, 2010, NEUROSCI LETT, V470, P19, DOI 10.1016/j.neulet.2009.12.045; Mao XJ, 2010, NEURAL REGEN RES, V5, P70, DOI 10.3969/j.issn.1673-5374.2010.01.012; Masli S, 2009, IMMUNOLOGY, V127, P62, DOI 10.1111/j.1365-2567.2008.02933.x; Notley CA, 2008, J EXP MED, V205, P2491, DOI 10.1084/jem.20072707; Oka N, 1998, ACTA NEUROPATHOL, V95, P57, DOI 10.1007/s004010050765; Prasad KN, 2010, HUM IMMUNOL, V71, P905, DOI 10.1016/j.humimm.2010.06.013; Radhakrishnan VV, 2004, ACTA NEUROL SCAND, V109, P71, DOI 10.1034/j.1600-0404.2003.00179.x; REDFORD EJ, 1995, BRAIN, V118, P869, DOI 10.1093/brain/118.4.869; SAID G, 1992, RES IMMUNOL, V143, P589, DOI 10.1016/0923-2494(92)80040-R; SHARIEF MK, 1993, ANN NEUROL, V33, P591, DOI 10.1002/ana.410330606; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STOLL G, 1993, J NEUROIMMUNOL, V45, P175, DOI 10.1016/0165-5728(93)90178-2; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; Zhang HL, 2012, J NEUROIMMUNOL, V246, P18, DOI 10.1016/j.jneuroim.2012.02.011; Zhang HL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357412; Zhang HL, 2011, EXP NEUROL, V230, P197, DOI 10.1016/j.expneurol.2011.04.016; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Zhu J, 1999, CLIN EXP IMMUNOL, V115, P56; Zhu J, 1997, CLIN IMMUNOL IMMUNOP, V84, P85, DOI 10.1006/clin.1997.4356; Zou LP, 2000, NEUROPHARMACOLOGY, V39, P324, DOI 10.1016/S0028-3908(99)00144-6	36	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38157	10.1371/journal.pone.0038157	http://dx.doi.org/10.1371/journal.pone.0038157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666471	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400092
J	Bevacqua, D; Capoccioni, F; Melia, P; Vincenzi, S; Pujolar, JM; De Leo, GA; Ciccotti, E				Bevacqua, Daniele; Capoccioni, Fabrizio; Melia, Paco; Vincenzi, Simone; Pujolar, Jose M.; De Leo, Giulio A.; Ciccotti, Eleonora			Fishery-Induced Selection for Slow Somatic Growth in European Eel	PLOS ONE			English	Article							ANGUILLA-ANGUILLA; SEX-DIFFERENTIATION; MORTALITY; MATURATION; JUVENILE; BRACKISH; LAGOONS; TRAITS; LESINA	Both theoretical and experimental studies have shown that fishing mortality can induce adaptive responses in body growth rates of fishes in the opposite direction of natural selection. We compared body growth rates in European eel (Anguilla anguilla) from three Mediterranean stocks subject to different fishing pressure. Results are consistent with the hypotheses that i) fast-growing individuals are more likely to survive until sexual maturity than slow-growing ones under natural conditions (no fishing) and ii) fishing can select for slow-growing individuals by removing fast-growing ones. Although the possibility of human-induced evolution seems remote for a panmictic species like such as the European eel, further research is desirable to assess the implications of the intensive exploitation on this critically endangered fish.	[Bevacqua, Daniele; De Leo, Giulio A.] Univ Parma, Dipartimento Sci Ambientali, I-43100 Parma, Italy; [Bevacqua, Daniele] INRA, PSH UR1115, Avignon, France; [Capoccioni, Fabrizio; Ciccotti, Eleonora] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Melia, Paco] Politecn Milan, Dipartimento Elettron & Informaz, I-20133 Milan, Italy; [Vincenzi, Simone] Univ Calif Santa Cruz, Ctr Stock Assessment Res, Santa Cruz, CA 95064 USA; [Pujolar, Jose M.] Univ Padua, Dipartimento Biol, Padua, Italy; [De Leo, Giulio A.] Stanford Univ, Hopkins Marine Stn, Stanford, CA 94305 USA	University of Parma; INRAE; University of Rome Tor Vergata; Polytechnic University of Milan; University of California System; University of California Santa Cruz; University of Padua; Stanford University	Bevacqua, D (corresponding author), Univ Parma, Dipartimento Sci Ambientali, I-43100 Parma, Italy.	fabrizio.capoccioni@uniroma2.it	Capoccioni, Fabrizio/AFE-2116-2022; De Leo, Giulio/AAC-5098-2019; Melià, Paco/E-8844-2012; Bevacqua, Daniele/ABA-7173-2021; Bevacqua, Daniele/D-9421-2012; Vincenzi, Simone/D-9547-2012	Capoccioni, Fabrizio/0000-0002-4752-6881; De Leo, Giulio/0000-0002-4186-3369; Melià, Paco/0000-0002-7763-9836; Bevacqua, Daniele/0000-0002-3341-1696; Vincenzi, Simone/0000-0002-8436-8608; CICCOTTI, ELEONORA/0000-0001-6687-7102; pujolar, marti/0000-0002-5037-8840	Italian Ministry of Research (PRIN project 153) [2006054928]	Italian Ministry of Research (PRIN project 153)	This work was supported by the Italian Ministry of Research (PRIN project 153 #2006054928). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Bevacqua D, 2006, J FISH BIOL, V69, P200, DOI 10.1111/j.1095-8649.2006.01265.x; Bevacqua D, 2011, HYDROBIOLOGIA, V671, P259, DOI 10.1007/s10750-011-0725-1; Bevacqua D, 2011, OECOLOGIA, V165, P333, DOI 10.1007/s00442-010-1727-9; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Cairns DK, 2009, J FISH BIOL, V74, P2094, DOI 10.1111/j.1095-8649.2009.02290.x; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Ciccotti E, 2011, 48 ICES EIFAC WORK G; Colombo G, 1996, J FISH BIOL, V48, P493, DOI 10.1111/j.1095-8649.1996.tb01443.x; Dekker W, 2003, CAN J FISH AQUAT SCI, V60, P787, DOI 10.1139/F03-066; Enberg K, 2012, MAR ECOL-EVOL PERSP, V33, P1, DOI 10.1111/j.1439-0485.2011.00460.x; GRAVINA MF, 1989, MAR ECOL-P S Z N I, V10, P141, DOI 10.1111/j.1439-0485.1989.tb00071.x; ICES, 2011, 48 ICES EIFAC WORK G; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lorenzen K, 1996, J FISH BIOL, V49, P627, DOI 10.1111/j.1095-8649.1996.tb00060.x; Marzano CN, 2003, OCEANOL ACTA, V26, P57, DOI 10.1016/S0399-1784(02)01229-X; Melia P, 2006, J FISH BIOL, V69, P1228, DOI 10.1111/j.1095-8649.2006.01170.x; Melia P, 2006, J FISH BIOL, V68, P876, DOI 10.1111/j.0022-1112.2006.00975.x; PANKHURST NW, 1982, J FISH BIOL, V21, P127, DOI 10.1111/j.1095-8649.1982.tb03994.x; PETTINE M, 1982, MAR POLLUT BULL, V13, P327, DOI 10.1016/0025-326X(82)90398-8; Poole WR, 1998, BIOL ENVIRON, V98B, P141; Regione Lazio-Centro Funzionale Regionale, 2011, UFF IDR MAR AR D2 2S; Roselli L, 2009, ESTUAR COAST SHELF S, V84, P539, DOI 10.1016/j.ecss.2009.07.023; ROSSI R, 1980, J FISH BIOL, V16, P413, DOI 10.1111/j.1095-8649.1980.tb03719.x; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Signorini A, 2008, AQUAT CONSERV, V18, pS27, DOI 10.1002/aqc.953; Sogard SM, 1997, B MAR SCI, V60, P1129; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rspb.2006.0275; Tesch F-W., 2003, EEL; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x	30	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37622	10.1371/journal.pone.0037622	http://dx.doi.org/10.1371/journal.pone.0037622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22666373	Green Published, gold			2022-12-27	WOS:000305345300062
J	Santana-Farre, R; Mirecki-Garrido, M; Bocos, C; Henriquez-Hernandez, LA; Kahlon, N; Herrera, E; Norstedt, G; Parini, P; Flores-Morales, A; Fernandez-Perez, L				Santana-Farre, Ruyman; Mirecki-Garrido, Mercedes; Bocos, Carlos; Henriquez-Hernandez, Luis A.; Kahlon, Nusrat; Herrera, Emilio; Norstedt, Gunnar; Parini, Paolo; Flores-Morales, Amilcar; Fernandez-Perez, Leandro			Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood	PLOS ONE			English	Article							CATCH-UP GROWTH; MALIC ENZYME GENE; DENSITY-LIPOPROTEIN RECEPTOR; THYROID-HORMONE; INSULIN-RESISTANCE; BINDING PROTEIN; TRANSCRIPTIONAL REGULATION; SIGNAL-TRANSDUCTION; RESPONSE ELEMENT; MICROARRAY DATA	Thyroid hormones are required for normal growth and development in mammals. Congenital-neonatal hypothyroidism (CH) has a profound impact on physiology, but its specific influence in liver is less understood. Here, we studied how CH influences the liver gene expression program in adulthood. Pregnant rats were given the antithyroid drug methimazole (MMI) from GD12 until PND30 to induce CH in male offspring. Growth defects due to CH were evident as reductions in body weight and tail length from the second week of life. Once the MMI treatment was discontinued, the feed efficiency increased in CH, and this was accompanied by significant catch-up growth. On PND80, significant reductions in body mass, tail length, and circulating IGF-I levels remained in CH rats. Conversely, the mRNA levels of known GH target genes were significantly upregulated. The serum levels of thyroid hormones, cholesterol, and triglycerides showed no significant differences. In contrast, CH rats showed significant changes in the expression of hepatic genes involved in lipid metabolism, including an increased transcription of PPAR alpha and a reduced expression of genes involved in fatty acid and cholesterol uptake, cellular sterol efflux, triglyceride assembly, bile acid synthesis, and lipogenesis. These changes were associated with a decrease of intrahepatic lipids. Finally, CH rats responded to the onset of hypothyroidism in adulthood with a reduction of serum fatty acids and hepatic cholesteryl esters and to T3 replacement with an enhanced activation of malic enzyme. In summary, we provide in vivo evidence that neonatal hypothyroidism influences the hepatic transcriptional program and tissue sensitivity to hormone treatment in adulthood. This highlights the critical role that a euthyroid state during development plays on normal liver physiology in adulthood.	[Santana-Farre, Ruyman; Mirecki-Garrido, Mercedes; Henriquez-Hernandez, Luis A.; Fernandez-Perez, Leandro] Univ Las Palmas, GC Canc Res Inst Canary Isl ICIC, Dept Clin Sci, Mol & Translat Endocrinol Grp, Las Palmas Gran Canaria, Spain; [Bocos, Carlos; Herrera, Emilio] Univ San Pablo CEU, Fac Pharm & Med, Dept Biol, Madrid, Spain; [Kahlon, Nusrat; Norstedt, Gunnar; Flores-Morales, Amilcar] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Parini, Paolo] Karolinska Inst, Div Clin Chem, Dept Lab Med, Ctr Nutr & Toxicol, Stockholm, Sweden; [Parini, Paolo] Karolinska Inst, Ctr Nutr & Toxicol, Mol Nutr Unit, Stockholm, Sweden; [Flores-Morales, Amilcar] Univ Copenhagen, Novo Nordisk Ctr Prot Res, Copenhagen, Denmark	Universidad de Las Palmas de Gran Canaria; San Pablo CEU University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Copenhagen	Santana-Farre, R (corresponding author), Univ Las Palmas, GC Canc Res Inst Canary Isl ICIC, Dept Clin Sci, Mol & Translat Endocrinol Grp, Las Palmas Gran Canaria, Spain.	lfernandez@dcc.ulpgc.es	Mirecki-Garrido, Mercedes/H-6075-2015; Fernandez-Perez, Leandro/H-1493-2015; Henriquez-Hernandez, Luis Alberto/H-8981-2019; Bocos, Carlos/B-8460-2015; Herrera-Castillon, Emilio/D-9143-2012	Mirecki-Garrido, Mercedes/0000-0003-0488-6307; Fernandez-Perez, Leandro/0000-0001-7802-465X; Henriquez-Hernandez, Luis Alberto/0000-0003-3237-0316; Bocos, Carlos/0000-0003-0364-5958; Herrera-Castillon, Emilio/0000-0002-8152-787X; Norstedt, Gunnar/0000-0002-7759-3241	Spanish Ministry of Science and Innovation; European Regional Development Fund-European Social Fund [SAF2003-02117, SAF2006-07824]; Canary Islands Government (ACIISI) [PI2007/033]; Novo Nordisk Foundation; MCYT [SAF2003-02117]; ACIISI-FSE [SE-10/13]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund-European Social Fund; Canary Islands Government (ACIISI); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); MCYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ACIISI-FSE	This work was supported by grants-in-aid to LF-P from the Spanish Ministry of Science and Innovation with the funding of European Regional Development Fund-European Social Fund (SAF2003-02117 and SAF2006-07824) and Canary Islands Government (ACIISI; PI2007/033). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: AF-M is supported by the Novo Nordisk Foundation. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.; The excellent technical assistance of M. Morante and C. J. Mateos-Diaz is greatly appreciated. R.S-F was recipient of pre-doctoral fellowships from the MCYT (SAF2003-02117) and ACIISI-FSE (SE-10/13) and M.M-G and L.H-H were recipients from University of Las Palmas de GC and MEC (AP2001-3499), respectively.	Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Angelin B, 2010, CURR OPIN LIPIDOL, V21, P499, DOI 10.1097/MOL.0b013e3283402e9c; Boersma B, 1997, ENDOCR REV, V18, P646, DOI 10.1210/er.18.5.646; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; CALVO R, 1990, J CLIN INVEST, V86, P889, DOI 10.1172/JCI114790; CASTELEIN H, 1994, J BIOL CHEM, V269, P26754; Chen LL, 2011, METABOLISM, V60, P569, DOI 10.1016/j.metabol.2010.05.014; Chen Y, 2007, AM J PHYSIOL-ENDOC M, V292, pE1856, DOI 10.1152/ajpendo.00581.2006; COOKE PS, 1991, ENDOCRINOLOGY, V129, P244, DOI 10.1210/endo-129-1-244; COOPER DS, 1984, ENDOCRINOLOGY, V114, P786, DOI 10.1210/endo-114-3-786; DAVENPORT JW, 1976, DEV PSYCHOBIOL, V9, P67, DOI 10.1002/dev.420090110; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; de GROOT C. A., 1963, ACTA ENDOCRINOL, V42, P423; DEESCOBAR GM, 1988, ENDOCRINOLOGY, V122, P1521, DOI 10.1210/endo-122-4-1521; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Fang XX, 1998, ARCH BIOCHEM BIOPHYS, V349, P138, DOI 10.1006/abbi.1997.0406; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Flores-Morales A, 2006, MOL ENDOCRINOL, V20, P241, DOI 10.1210/me.2005-0170; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fraser A, 2008, AM J EPIDEMIOL, V168, P179, DOI 10.1093/aje/kwn106; GonzalezManchon C, 1997, DNA CELL BIOL, V16, P533, DOI 10.1089/dna.1997.16.533; Gullberg H, 2000, MOL ENDOCRINOL, V14, P1739, DOI 10.1210/me.14.11.1739; Hashimoto K, 2006, ENDOCRINOLOGY, V147, P4292, DOI 10.1210/en.2006-0116; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Henriquez-Hernandez LA, 2007, J PHARMACOL EXP THER, V320, P695, DOI 10.1124/jpet.106.113209; Ho KKY, 2006, FRONT HORM RES, V35, P115, DOI 10.1159/000094314; Holness MJ, 2006, CURR OPIN CLIN NUTR, V9, P482, DOI 10.1097/01.mco.0000232912.69236.e0; Hoogerbrugge N, 1996, METABOLISM, V45, P680, DOI 10.1016/S0026-0495(96)90131-6; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YF, 2010, HORM RES PAEDIAT, V74, P106, DOI 10.1159/000313374; Hunt MC, 2000, J BIOL CHEM, V275, P28947, DOI 10.1074/jbc.M002782200; Kirby JD, 1997, ENDOCRINOLOGY, V138, P2713, DOI 10.1210/en.138.7.2713; Klieverik LP, 2009, P NATL ACAD SCI USA, V106, P5966, DOI 10.1073/pnas.0805355106; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Larsen PR, 2009, NAT CLIN PRACT ENDOC, V5, P1, DOI 10.1038/ncpendmet1025; Lazar MA, 2007, CELL METAB, V5, P159, DOI 10.1016/j.cmet.2007.02.001; Lee EK, 2010, ENDOCRINOLOGY, V151, P1403, DOI 10.1210/en.2009-1123; LEE MMC, 1969, AM J ANAT, V124, P239, DOI 10.1002/aja.1001240207; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Lopez D, 2007, BBA-MOL CELL BIOL L, V1771, P1216, DOI 10.1016/j.bbalip.2007.05.001; Lui JC, 2011, ENDOCR REV, V32, P422, DOI 10.1210/er.2011-0001; Marino R, 2008, ENDOCRINOLOGY, V149, P1820, DOI 10.1210/en.2007-0993; MEYER JH, 1963, J NUTR, V80, P343, DOI 10.1093/jn/80.4.343; Moreno B, 1997, ENDOCRINOLOGY, V138, P1194, DOI 10.1210/en.138.3.1194; Morrison JL, 2010, PEDIATR NEPHROL, V25, P669, DOI 10.1007/s00467-009-1407-3; Mullis PE, 1999, MOL CELL ENDOCRINOL, V147, P17, DOI 10.1016/S0303-7207(98)00232-9; NANTOSALONEN K, 1991, ENDOCRINOLOGY, V129, P2563; NANTOSALONEN K, 1993, ENDOCRINOLOGY, V132, P781, DOI 10.1210/en.132.2.781; NESS GC, 1995, ARCH BIOCHEM BIOPHYS, V323, P404, DOI 10.1006/abbi.1995.0061; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; PEAKE GT, 1973, ENDOCRINOLOGY, V92, P487, DOI 10.1210/endo-92-2-487; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; RASMUSSEN MH, 1994, METABOLISM, V43, P315, DOI 10.1016/0026-0495(94)90099-X; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; RODD C, 1992, ENDOCRINOLOGY, V131, P2559, DOI 10.1210/en.131.6.2559; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz JI, 1997, J LIPID RES, V38, P1482; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; SAMUELS MH, 1989, ENDOCRINOLOGY, V124, P2277, DOI 10.1210/endo-124-5-2277; Schaefer F, 2001, J CLIN INVEST, V108, P467, DOI 10.1172/JCI200111895; Shahkhalili Y, 2010, AM J PHYSIOL-REG I, V298, pR141, DOI 10.1152/ajpregu.00128.2009; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; VLAHCEVIC ZR, 1991, HEPATOLOGY, V13, P590, DOI 10.1002/hep.1840130331; Vujovic M, 2009, ENDOCRINOLOGY, V150, P2940, DOI 10.1210/en.2008-1085; Wang YT, 2002, BIOCHEM J, V361, P391, DOI 10.1042/bj3610391; Wang YT, 2001, J BIOL CHEM, V276, P23838, DOI 10.1074/jbc.M102166200; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Xiong SB, 1998, P NATL ACAD SCI USA, V95, P12260, DOI 10.1073/pnas.95.21.12260; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yin LY, 2005, MOL CELL ENDOCRINOL, V245, P43, DOI 10.1016/j.mce.2005.10.002	82	17	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37386	10.1371/journal.pone.0037386	http://dx.doi.org/10.1371/journal.pone.0037386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22666351	Green Published, gold			2022-12-27	WOS:000305341300108
J	Flori, L; Gonzatti, MI; Thevenon, S; Chantal, I; Pinto, J; Berthier, D; Aso, PM; Gautier, M				Flori, Laurence; Gonzatti, Mary Isabel; Thevenon, Sophie; Chantal, Isabelle; Pinto, Joar; Berthier, David; Aso, Pedro M.; Gautier, Mathieu			A Quasi-Exclusive European Ancestry in the Senepol Tropical Cattle Breed Highlights the Importance of the slick Locus in Tropical Adaptation	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; BOS-TAURUS; HEAT TOLERANCE; ARTIFICIAL SELECTION; POLLED LOCUS; R-PACKAGE; GENOME; SIGNATURES; DIVERSITY; ADMIXTURE	Background: The Senepol cattle breed (SEN) was created in the early XXth century from a presumed cross between a European (EUT) breed (Red Poll) and a West African taurine (AFT) breed (N'Dama). Well adapted to tropical conditions, it is also believed trypanotolerant according to its putative AFT ancestry. However, such origins needed to be verified to define relevant husbandry practices and the genetic background underlying such adaptation needed to be characterized. Methodology/Principal Findings: We genotyped 153 SEN individuals on 47,365 SNPs and combined the resulting data with those available on 18 other populations representative of EUT, AFT and Zebu (ZEB) cattle. We found on average 89% EUT, 10.4% ZEB and 0.6% AFT ancestries in the SEN genome. We further looked for footprints of recent selection using standard tests based on the extent of haplotype homozygosity. We underlined i) three footprints on chromosome (BTA) 01, two of which are within or close to the polled locus underlying the absence of horns and ii) one footprint on BTA20 within the slick hair coat locus, involved in thermotolerance. Annotation of these regions allowed us to propose three candidate genes to explain the observed signals (TIAM1, GRIK1 and RAI14). Conclusions/Significance: Our results do not support the accepted concept about the AFT origin of SEN breed. Initial AFT ancestry (if any) might have been counter-selected in early generations due to breeding objectives oriented in particular toward meat production and hornless phenotype. Therefore, SEN animals are likely susceptible to African trypanosomes which questions the importation of SEN within the West African tsetse belt, as promoted by some breeding societies. Besides, our results revealed that SEN breed is predominantly a EUT breed well adapted to tropical conditions and confirmed the importance in thermotolerance of the slick locus.	[Flori, Laurence] INRA, UMR GABI 1313, F-78350 Jouy En Josas, France; [Flori, Laurence; Thevenon, Sophie; Chantal, Isabelle; Berthier, David] CIRAD, UMR INTERTRYP, Montpellier, France; [Gonzatti, Mary Isabel; Pinto, Joar; Aso, Pedro M.] Univ Simon Bolivar, Dept Biol Celular, Caracas, Venezuela; [Gautier, Mathieu] INRA, UMR CBGP, Montferrier Sur Lez, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CIRAD; Simon Bolivar University; INRAE; Institut de Recherche pour le Developpement (IRD)	Flori, L (corresponding author), INRA, UMR GABI 1313, F-78350 Jouy En Josas, France.	laurence.flori@jouy.inra.fr	gautier, mathieu/AAU-8789-2020; Flori, Laurence/H-3683-2013; gautier, mathieu/F-7429-2010	gautier, mathieu/0000-0001-7257-5880; gautier, mathieu/0000-0001-7257-5880; David, BERTHIER/0000-0002-3283-6588; Thevenon, Sophie/0000-0001-6059-5884; Isabelle, CHANTAL/0000-0002-3429-484X; Gonzatti, Mary Isabel/0000-0003-4266-2988	INRA (Institut National de la Recherche Agronomique)-Animal Genetics Department; ECOS (Evaluation-orientation de la COoperation Scientifique) [PI-2008002104]; FONACIT (FOnds NAtional pour les Sciences, les Technologies et l'Innovation) [G98-3462, 2007-1425]; Agence Nationale de la Recherche [EMILE 09-BLAN-0145-01]	INRA (Institut National de la Recherche Agronomique)-Animal Genetics Department; ECOS (Evaluation-orientation de la COoperation Scientifique); FONACIT (FOnds NAtional pour les Sciences, les Technologies et l'Innovation); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by an INRA (Institut National de la Recherche Agronomique)-Animal Genetics Department Grant (TROPSENEPOL project), an ECOS (Evaluation-orientation de la COoperation Scientifique) Nord No. PI-2008002104 grant and by FONACIT (FOnds NAtional pour les Sciences, les Technologies et l'Innovation) projects G98-3462 and 2007-1425. MG acknowledges partial funding by the Agence Nationale de la Recherche programme BLANC EMILE 09-BLAN-0145-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; BENNETT JW, 1964, P AUST SOC ANIM PROD, V5, P160; Bergfeld WF, 1998, J AM ACAD DERMATOL, V39, pS86, DOI 10.1016/S0190-9622(98)70452-9; Berman A, 2004, J DAIRY SCI, V87, P1400, DOI 10.3168/jds.S0022-0302(04)73289-0; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Chessel D., 2004, R NEWS, V4, P5; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; d'Ieteren GDM, 1998, REV SCI TECH OIE, V17, P154, DOI 10.20506/rst.17.1.1088; Dayo GK, 2009, MOL ECOL, V18, P1801, DOI 10.1111/j.1365-294X.2009.04141.x; De Alba J, 1987, ANIMAL GENETIC RESOU, P17; Dikmen S, 2008, J DAIRY SCI, V91, P3395, DOI 10.3168/jds.2008-1072; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Felius M., 2011, Diversity, V3, P660, DOI 10.3390/d3040660; Fleming CB, 1999, INT SEN RES S ST CRO; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Foitzik K, 2005, J INVEST DERMATOL, V124, P1119, DOI 10.1111/j.0022-202X.2005.23686.x; Freeman AR, 2006, ANIM GENET, V37, P1, DOI 10.1111/j.1365-2052.2005.01363.x; Freeman AR, 2004, MOL ECOL, V13, P3477, DOI 10.1111/j.1365-294X.2004.02311.x; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gautier M, 2011, MOL ECOL, V20, P3128, DOI 10.1111/j.1365-294X.2011.05163.x; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Godfrey RW, 1999, INT SEN RES S ST CRO; Goto H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-224; Hammond AC, 1998, J ANIM SCI, V76, P1568; Hammond AC, 1996, J ANIM SCI, V74, P295; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hanotte O, 2000, MOL ECOL, V9, P387, DOI 10.1046/j.1365-294x.2000.00858.x; Hansen PJ, 2004, ANIM REPROD SCI, V82-3, P349, DOI 10.1016/j.anireprosci.2004.04.011; Hayes BJ, 2009, ANIM GENET, V40, P176, DOI 10.1111/j.1365-2052.2008.01815.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kutty RK, 2001, J BIOL CHEM, V276, P2831, DOI 10.1074/jbc.M007421200; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Mariasegaram M, 2007, ANIM GENET, V38, P54, DOI 10.1111/j.1365-2052.2007.01560.x; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; MURRAY M, 1984, J INFECT DIS, V149, P311, DOI 10.1093/infdis/149.3.311; Neto LRP, 2011, VET PARASITOL, V180, P165, DOI 10.1016/j.vetpar.2011.05.048; Olson TA, 2003, J ANIM SCI, V81, P80; Padda DS, 1999, P INT SEN RES S KING; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Payne W.J.A., 1997, TROPICAL CATTLE ORIG; Petit J P, 1973, Rev Elev Med Vet Pays Trop, V26, P97; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Queval R, 1971, Rev Elev Med Vet Pays Trop, V24, P667; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Seidlitz EP, 2010, CAN J PHYSIOL PHARM, V88, P929, DOI [10.1139/Y10-070, 10.1139/y10-070]; Shepherd TR, 2010, J MOL BIOL, V398, P730, DOI 10.1016/j.jmb.2010.03.047; Souvenir Zafindrajaona P., 1999, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V52, P155; Stella A, 2010, GENETICS, V185, P1451, DOI 10.1534/genetics.110.116111; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Teasdale M. D., 2012, BOVINE GENOMICS, P1; Toll-Riera M, 2011, MOL BIOL EVOL, V28, P383, DOI 10.1093/molbev/msq206; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wunderlich KR, 2006, ANIM GENET, V37, P592, DOI 10.1111/j.1365-2052.2006.01538.x	64	38	39	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36133	10.1371/journal.pone.0036133	http://dx.doi.org/10.1371/journal.pone.0036133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22675421	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100018
J	Lefebvre, JF; Vello, E; Ge, B; Montgomery, SB; Dermitzakis, ET; Pastinen, T; Labuda, D				Lefebvre, Jean Francois; Vello, Emilio; Ge, Bing; Montgomery, Stephen B.; Dermitzakis, Emmanouil T.; Pastinen, Tomi; Labuda, Damian			Genotype-Based Test in Mapping Cis-Regulatory Variants from Allele-Specific Expression Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION; COMMON; LOCUS; MODEL; RISK	Identifying and understanding the impact of gene regulatory variation is of considerable importance in evolutionary and medical genetics; such variants are thought to be responsible for human-specific adaptation [1] and to have an important role in genetic disease. Regulatory variation in cis is readily detected in individuals showing uneven expression of a transcript from its two allelic copies, an observation referred to as allelic imbalance (AI). Identifying individuals exhibiting AI allows mapping of regulatory DNA regions and the potential to identify the underlying causal genetic variant(s). However, existing mapping methods require knowledge of the haplotypes, which make them sensitive to phasing errors. In this study, we introduce a genotype-based mapping test that does not require haplotype-phase inference to locate regulatory regions. The test relies on partitioning genotypes of individuals exhibiting AI and those not expressing AI in a 2x3 contingency table. The performance of this test to detect linkage disequilibrium (LD) between a potential regulatory site and a SNP located in this region was examined by analyzing the simulated and the empirical AI datasets. In simulation experiments, the genotype-based test outperforms the haplotype-based tests with the increasing distance separating the regulatory region from its regulated transcript. The genotype-based test performed equally well with the experimental AI datasets, either from genome-wide cDNA hybridization arrays or from RNA sequencing. By avoiding the need of haplotype inference, the genotype-based test will suit AI analyses in population samples of unknown haplotype structure and will additionally facilitate the identification of cis-regulatory variants that are located far away from the regulated transcript.	[Lefebvre, Jean Francois; Vello, Emilio; Labuda, Damian] Univ Montreal, Ctr Rech, CHU Sainte Justine, Montreal, PQ H3C 3J7, Canada; [Ge, Bing; Pastinen, Tomi] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Montgomery, Stephen B.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Montgomery, Stephen B.; Dermitzakis, Emmanouil T.] Wellcome Trust Sanger Inst, Cambridge, England; [Pastinen, Tomi] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada; [Pastinen, Tomi] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada; [Labuda, Damian] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; University of Geneva; Wellcome Trust Sanger Institute; McGill University; McGill University; Universite de Montreal	Lefebvre, JF (corresponding author), Univ Montreal, Ctr Rech, CHU Sainte Justine, Montreal, PQ H3C 3J7, Canada.	damian.labuda@umontreal.ca	Dermitzakis, Emmanouil/B-7687-2013	Montgomery, Stephen/0000-0002-5200-3903	GenomeQuebec/GenomeCanada; Canada Research Chairs; Canadian Institutes of Health Research; Reseau de Medecine Genetique Appliquee of the Fonds de Recherche en Sante du Quebec	GenomeQuebec/GenomeCanada(Genome Canada); Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Reseau de Medecine Genetique Appliquee of the Fonds de Recherche en Sante du Quebec	Financial support from GenomeQuebec/GenomeCanada, from Canada Research Chairs (TP), the Canadian Institutes of Health Research and the Reseau de Medecine Genetique Appliquee of the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Delaneau O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-540; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Forton JT, 2007, GENOME RES, V17, P82, DOI 10.1101/gr.5663007; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freilinger T, 2009, STROKE, V40, P970, DOI 10.1161/STROKEAHA.107.510800; Gao L, 2009, EUR J CANCER, V45, P428, DOI 10.1016/j.ejca.2008.09.019; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hellenthal G, 2007, BIOINFORMATICS, V23, P520, DOI 10.1093/bioinformatics/btl622; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lefebvre JF, 2008, GENETICS, V178, P2069, DOI 10.1534/genetics.107.082255; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; LEWONTIN RC, 1988, GENETICS, V120, P849; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morcos L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r25; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wagner JR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000849; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38667	10.1371/journal.pone.0038667	http://dx.doi.org/10.1371/journal.pone.0038667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685595	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700058
J	Zhu, JQ; Liu, SM; Ma, Y; Zhang, JQ; Qi, HS; Wei, ZJ; Yao, Q; Zhang, WQ; Li, S				Zhu, Jin-Qi; Liu, Shumin; Ma, Yao; Zhang, Jia-Qi; Qi, Hai-Sheng; Wei, Zhao-Jun; Yao, Qiong; Zhang, Wen-Qing; Li, Sheng			Improvement of Pest Resistance in Transgenic Tobacco Plants Expressing dsRNA of an Insect-Associated Gene EcR	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; JUVENILE-HORMONE; COTTON BOLLWORM; MULTIPLE CROPS; INTERFERENCE; 20-HYDROXYECDYSONE; SUPPRESSION; INGESTION; POTENT	The adoption of pest-resistant transgenic plants to reduce yield loss and pesticide utilization has been successful in the past three decades. Recently, transgenic plant expressing double-stranded RNA (dsRNA) targeting pest genes emerges as a promising strategy for improving pest resistance in crops. The steroid hormone, 20-hydroxyecdysone (20E), predominately controls insect molting via its nuclear receptor complex, EcR-USP. Here we report that pest resistance is improved in transgenic tobacco plants expressing dsRNA of EcR from the cotton bollworm, Helicoverpa armigera, a serious lepidopteran pest for a variety of crops. When H. armigera larvae were fed with the whole transgenic tobacco plants expressing EcR dsRNA, resistance to H. armigera was significantly improved in transgenic plants. Meanwhile, when H. armigera larvae were fed with leaves of transgenic tobacco plants expressing EcR dsRNA, its EcR mRNA level was dramatically decreased causing molting defects and larval lethality. In addition, the transgenic tobacco plants expressing H. armigera EcR dsRNA were also resistant to another lepidopteran pest, the beet armyworm, Spodoptera exigua, due to the high similarity in the nucleotide sequences of their EcR genes. This study provides additional evidence that transgenic plant expressing dsRNA targeting insect-associated genes is able to improve pest resistance.	[Zhu, Jin-Qi; Liu, Shumin; Ma, Yao; Zhang, Jia-Qi; Qi, Hai-Sheng; Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China; [Zhang, Jia-Qi; Qi, Hai-Sheng; Wei, Zhao-Jun] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Yao, Qiong; Zhang, Wen-Qing] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Yao, Qiong; Zhang, Wen-Qing] Sun Yat Sen Univ, Sch Life Sci, Inst Entomol, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Hefei University of Technology; Sun Yat Sen University; Sun Yat Sen University	Zhu, JQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China.	shengli@sippe.ac.cn	zhang, wenqing/GYA-0786-2022; Wei, Zhaojun/H-5341-2017	Wei, Zhaojun/0000-0003-1729-209X	Shanghai Natural Science Foundation [11ZR1443300]; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2010KIP308]; Chinese Academy of Sciences [SKLBC08K01]; State Key Laboratory of Biocontrol, Sun Yat-sen University [KSCX2-EW-J-12]; Outstanding Youth Investigator award [31125025]; SA-SIBS	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Biocontrol, Sun Yat-sen University; Outstanding Youth Investigator award; SA-SIBS	This work was supported by Shanghai Natural Science Foundation (11ZR1443300) and Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2010KIP308) to JZ, Chinese Academy of Sciences (SKLBC08K01) to SL, and the State Key Laboratory of Biocontrol, Sun Yat-sen University (KSCX2-EW-J-12) to SL and WZ. SL received the Outstanding Youth Investigator award (31125025) and the SA-SIBS award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista L, 2009, CIRC RES, V104, P1364, DOI 10.1161/CIRCRESAHA.108.190645; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Gordon KHJ, 2006, ADV VIRUS RES, V68, P459, DOI 10.1016/S0065-3527(06)68013-5; Graham LD, 2010, MOL BIOCHEM PARASIT, V171, P104, DOI 10.1016/j.molbiopara.2010.03.003; Hall BL, 1998, DEVELOPMENT, V125, P4709; He HJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-1; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kos M, 2009, TRENDS BIOTECHNOL, V27, P621, DOI 10.1016/j.tibtech.2009.08.002; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Parihar M, 2010, GEN COMP ENDOCR, V167, P11, DOI 10.1016/j.ygcen.2010.02.005; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Poethig RS, 2006, COLD SPRING HARB SYM, V71, P165, DOI 10.1101/sqb.2006.71.030; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Sharma HC, 2004, CRIT REV PLANT SCI, V23, P47, DOI 10.1080/07352680490273400; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Tenllado F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-3; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Tzertzinis G, 2010, PLOS NEGLECT TROP D, V4, pe65; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu JJ, 2010, J INSECT PHYSIOL, V56, P1471, DOI 10.1016/j.jinsphys.2010.04.004; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	45	115	128	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38572	10.1371/journal.pone.0038572	http://dx.doi.org/10.1371/journal.pone.0038572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685585	Green Submitted, gold, Green Published			2022-12-27	WOS:000305351700048
J	Klinth, JE; Castelain, M; Uhlin, BE; Axner, O				Klinth, Jeanna E.; Castelain, Mickael; Uhlin, Bernt Eric; Axner, Ove			The Influence of pH on the Specific Adhesion of P Piliated Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; SURFACE-PLASMON RESONANCE; OPTICAL TWEEZERS; PHYSICAL-PROPERTIES; PILUS BIOGENESIS; CRANBERRY JUICE; HUMAN-CELLS; ANTIBACTERIAL ACTIVITY; GALABIOSE DERIVATIVES; BINDING INTERACTIONS	Adhesion to host tissues is an initiating step in a majority of bacterial infections. In the case of Gram-negative bacteria this adhesion is often mediated by a specific interaction between an adhesin, positioned at the distal end of bacterial pili, and its receptor on the surface of the host tissue. Furthermore, the rod of the pilus, and particularly its biomechanical properties, is believed to be crucial for the ability of bacteria to withstand external forces caused by, for example, (in the case of urinary tract infections) urinary rinsing flows by redistributing the force to several pili. In this work, the adhesion properties of P-piliated E. coli and their dependence of pH have been investigated in a broad pH range by both the surface plasmon resonance technique and force measuring optical tweezers. We demonstrate that P piliated bacteria have an adhesion ability throughout the entire physiologically relevant pH range (pH 4.5 - 8). We also show that pH has a higher impact on the binding rate than on the binding stability or the biomechanical properties of pili; the binding rate was found to have a maximum around pH 5 while the binding stability was found to have a broader distribution over pH and be significant over the entire physiologically relevant pH range. Force measurements on a single organelle level show that the biomechanical properties of P pili are not significantly affected by pH.	[Klinth, Jeanna E.; Castelain, Mickael; Axner, Ove] Umea Univ, Dept Phys, Umea, Sweden; [Klinth, Jeanna E.; Uhlin, Bernt Eric] Umea Univ, Dept Mol Biol, Umea, Sweden; [Klinth, Jeanna E.; Uhlin, Bernt Eric; Axner, Ove] Umea Univ, UCMR, Umea, Sweden; [Klinth, Jeanna E.; Uhlin, Bernt Eric] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Klinth, JE (corresponding author), Umea Univ, Dept Phys, Umea, Sweden.	jeanna.klinth@physics.umu.se	Klinth, Jeanna/E-3662-2013; Castelain, Mickaël/A-9647-2011; Uhlin, Bernt Eric/AAO-6292-2021	Klinth, Jeanna/0000-0002-5977-847X; Castelain, Mickaël/0000-0002-0256-7663; Uhlin, Bernt Eric/0000-0002-2991-8072; Axner, Ove/0000-0002-8580-9700	Swedish Research Council [349-2007-8673, 621-2008-3280, 621-2009-5720, VR-MH 2010-3031]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Grants from Swedish Research Council numbers: 349-2007-8673, 621-2008-3280; 621-2009-5720 and VR-MH 2010-3031 (URL: http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg V, 2007, ORG BIOMOL CHEM, V5, P1827, DOI 10.1039/b702397a; Andersson M, 2008, CHEMPHYSCHEM, V9, P221, DOI 10.1002/cphc.200700389; Andersson M, 2007, BIOPHYS J, V93, P3008, DOI 10.1529/biophysj.107.110643; Andersson M, 2006, BIOPHYS J, V91, P2717, DOI 10.1529/biophysj.106.087429; Andersson M, 2006, PROC SPIE, V6088, DOI 10.1117/12.642266; ASSCHER AW, 1966, LANCET, V2, P1037; Axner O, 2010, SPRINGER SER CHEM PH, V96, P337, DOI 10.1007/978-3-642-02597-6_18; BAGA M, 1987, CELL, V49, P241, DOI 10.1016/0092-8674(87)90565-4; Balsalobre C, 2003, J BACTERIOL, V185, P620, DOI 10.1128/JB.185.2.620-629.2003; Bjarnsholt Thomas, 2008, Curr Infect Dis Rep, V10, P22, DOI 10.1007/s11908-008-0006-y; Bjornham O, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3148027; Bjornham O, 2008, EUR BIOPHYS J BIOPHY, V37, P381, DOI 10.1007/s00249-007-0223-6; Bjornham O, 2009, EUR BIOPHYS J BIOPHY, V38, P245, DOI 10.1007/s00249-008-0376-y; Blatherwick NR, 1923, J BIOL CHEM, V57, P815; BODEL PT, 1959, J LAB CLIN MED, V54, P881; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Chorell E, 2010, J MED CHEM, V53, P5690, DOI 10.1021/jm100470t; Davenport K, 2007, UROL RES, V35, P207, DOI 10.1007/s00240-007-0100-x; Dessi A, 2011, REV BRAS FARMACOGN, V21, P807, DOI 10.1590/S0102-695X2011005000126; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Emtenas H, 2002, J COMB CHEM, V4, P630, DOI 10.1021/cc020032d; Fallman E, 2004, BIOSENS BIOELECTRON, V19, P1429, DOI 10.1016/j.bios.2003.12.029; Fallman E, 2005, EMBO REP, V6, P52, DOI 10.1038/sj.embor.7400310; GONG MF, 1992, J MOL BIOL, V228, P735, DOI 10.1016/0022-2836(92)90860-M; HOSCHUTZKY H, 1989, INFECT IMMUN, V57, P76; Jass J, 2004, BIOPHYS J, V87, P4271, DOI 10.1529/biophysj.104.044867; Jimenez-Lozano J, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041901; KAYE D, 1968, J CLIN INVEST, V47, P2374, DOI 10.1172/JCI105921; Kim SH, 2011, J INFECT CHEMOTHER, V17, P322, DOI 10.1007/s10156-010-0170-5; Klinth JE, 2012, EUR BIOPHYS J BIOPHY, V41, P285, DOI 10.1007/s00249-011-0784-2; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; Larsson A, 2003, BIOORGAN MED CHEM, V11, P2255, DOI 10.1016/S0968-0896(03)00114-7; LINDBERG F, 1987, NATURE, V328, P84, DOI 10.1038/328084a0; LINDBERG FP, 1984, EMBO J, V3, P1167, DOI 10.1002/j.1460-2075.1984.tb01946.x; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; MARQUARDT H, 1973, UROLOGE A, V12, P173; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; MOU TW, 1962, J UROLOGY, V87, P978, DOI 10.1016/S0022-5347(17)65077-8; Nilsson U, 1996, BIOORGAN MED CHEM, V4, P1809, DOI 10.1016/S0968-0896(96)00163-0; NORGREN M, 1984, EMBO J, V3, P1159, DOI 10.1002/j.1460-2075.1984.tb01945.x; O'Grady F, 1966, Br J Urol, V38, P149, DOI 10.1111/j.1464-410X.1966.tb09693.x; Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1; Ohlsson J, 2002, CHEMBIOCHEM, V3, P772, DOI 10.1002/1439-7633(20020802)3:8<772::AID-CBIC772>3.0.CO;2-8; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Pourshafie MR, 2004, J MICROBIOL METH, V58, P313, DOI 10.1016/j.mimet.2004.04.009; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Rossi R, 2010, J CLIN GASTROENTEROL, V44, pS61, DOI 10.1097/MCG.0b013e3181d2dc8e; SAEKI H, 1986, UROL INT, V41, P174, DOI 10.1159/000281192; Salminen A, 2007, J ANTIMICROB CHEMOTH, V60, P495, DOI 10.1093/jac/dkm251; Salo J, 2012, CLIN INFECT DIS, V54, P340, DOI 10.1093/cid/cir801; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; SOKURENKO EV, 1992, INFECT IMMUN, V60, P4709, DOI 10.1128/IAI.60.11.4709-4719.1992; SOMMERKA.H, 1971, UROLOGE, V10, P145; Stapleton AE, 2012, MAYO CLIN PROC, V87, P143, DOI 10.1016/j.mayocp.2011.10.006; UHLIN BE, 1985, P NATL ACAD SCI USA, V82, P1800, DOI 10.1073/pnas.82.6.1800; Ulett GC, 2007, MICROBIOL-SGM, V153, P2321, DOI 10.1099/mic.0.2006/004648-0; Vahidi B, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003316; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Vogel A, 2004, CR MECANIQUE, V332, P737, DOI 10.1016/j.crme.2004.03.017; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; WATERS WE, 1967, BRIT J PREV SOC MED, V21, P129; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x	62	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38548	10.1371/journal.pone.0038548	http://dx.doi.org/10.1371/journal.pone.0038548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679512	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900057
J	Dey, N; Das, F; Ghosh-Choudhury, N; Mandal, CC; Parekh, DJ; Block, K; Kasinath, BS; Abboud, HE; Choudhury, GG				Dey, Nirmalya; Das, Falguni; Ghosh-Choudhury, Nandini; Mandal, Chandi Charan; Parekh, Dipen J.; Block, Karen; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh			microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; HIPPEL-LINDAU GENE; NF-KAPPA-B; KIDNEY CANCER; HIGH GLUCOSE; MAMMALIAN TARGET; BINDING PARTNER; DOWN-REGULATION; PTEN LOSS; EXPRESSION	Metastatic renal cancer manifests multiple signatures of gene expression. Deviation in expression of mature miRNAs has been linked to human cancers. Importance of miR-21 in renal cell carcinomas is proposed from profiling studies using tumor tissue samples. However, the role of miR-21 function in causing renal cancer cell proliferation and invasion has not yet been shown. Using cultured renal carcinoma cells, we demonstrate enhanced expression of mature miR-21 along with pre-and pri-miR-21 by increased transcription compared to normal proximal tubular epithelial cells. Overexpression of miR-21 Sponge to quench endogenous miR-21 levels inhibited proliferation, migration and invasion of renal cancer cells. In the absence of mutation in the PTEN tumor suppressor gene, PTEN protein levels are frequently downregulated in renal cancer. We show that miR-21 targets PTEN mRNA 3'untranslated region to decrease PTEN protein expression and augments Akt phosphorylation in renal cancer cells. Downregulation of PTEN as well as overexpression of constitutively active Akt kinase prevented miR-21 Sponge-induced inhibition of renal cancer cell proliferation and migration. Moreover, we show that miR-21 Sponge inhibited the inactivating phosphorylation of the tumor suppressor protein tuberin and attenuated TORC1 activation. Finally, we demonstrate that expression of constitutively active TORC1 attenuated miR-21 Sponge-mediated suppression of proliferation and migration of renal cancer cells. Our results uncover a layer of post-transcriptional regulation of PTEN by transcriptional activation of miR-21 to force the canonical oncogenic Akt/TORC1 signaling conduit to drive renal cancer cell proliferation and invasion.	[Dey, Nirmalya; Das, Falguni; Block, Karen; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Block, Karen; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Adm Res, San Antonio, TX USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Ghosh-Choudhury, Nandini; Mandal, Chandi Charan] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Parekh, Dipen J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Dey, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	United States National Institutes of Health (NIH) [RO1 DK50190]; VA Research Service Merit Review; Juvenile Diabetes Research Foundation [1-2008-185]; VA Senior Research Career Scientist Award; VA Merit Review, NIH [RO1 AR 52425]; Cancer Therapy and Research Center, San Antonio, Texas; VA Research Service Career Scientist Award; Merit Review Awards;  [NIH RO1 CA 131272];  [NIH RO1 DK 077295];  [NIH RO1 DK078971];  [NIH RC2A 036613]; NATIONAL CANCER INSTITUTE [R01CA131272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077295, R01DK050190, R01DK078971] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Research Service Merit Review(US Department of Veterans Affairs); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); VA Senior Research Career Scientist Award; VA Merit Review, NIH; Cancer Therapy and Research Center, San Antonio, Texas; VA Research Service Career Scientist Award; Merit Review Awards; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A United States National Institutes of Health (NIH) RO1 DK50190 grant to GGC supported this work. Part of this work was also supported by VA Research Service Merit Review grant to GGC. GGC is also supported by Juvenile Diabetes Research Foundation 1-2008-185 grants and is recipient of VA Senior Research Career Scientist Award. NGC is supported by VA Merit Review, NIH RO1 AR 52425 grants and Ronald P. Williams Orthopedic Oncology Developmental Research Award from Cancer Therapy and Research Center, San Antonio, Texas. KB, BSK and HEA are supported by grants, NIH RO1 CA 131272 (KB), NIH RO1 DK 077295 (BSK), NIH RO1 DK078971 (HEA), NIH RC2A 036613 (BSK) and VA Research Service Career Scientist Award (KB) and Merit Review Awards (KB, BSK and HEA).	Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett KL, 2011, GENE CHROMOSOME CANC, V50, P654, DOI 10.1002/gcc.20887; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Cairns P, 1998, ONCOGENE, V16, P3215, DOI 10.1038/sj.onc.1201855; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Castaneda CA, 2010, CANCER METAST REV, V29, P751, DOI 10.1007/s10555-010-9261-0; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dahinden C, 2010, CLIN CANCER RES, V16, P88, DOI 10.1158/1078-0432.CCR-09-0260; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fahmy MA, 2010, CANCER, V117, P290; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146pe39; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lee JS, 2003, J SURG ONCOL, V84, P166, DOI 10.1002/jso.10302; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luan FL, 2003, KIDNEY INT, V63, P917, DOI 10.1046/j.1523-1755.2003.00805.x; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mahimainathan L, 2004, J BIOL CHEM, V279, P15258, DOI 10.1074/jbc.M314328200; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Milowsky MI, 2003, UROL CLIN N AM, V30, P601, DOI 10.1016/S0094-0143(03)00031-4; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Neal CS, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-64; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Novick AC, 2007, UROL ONCOL-SEMIN ORI, V25, P188, DOI 10.1016/j.urolonc.2007.03.006; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Oya M, 2001, ONCOGENE, V20, P3888, DOI 10.1038/sj.onc.1204525; Oya M, 2003, CARCINOGENESIS, V24, P377, DOI 10.1093/carcin/24.3.377; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Pasquinelli AE, 2010, SCIENCE, V328, P1494, DOI 10.1126/science.1191531; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Poon JS, 2010, CELL CYCLE, V9, P4450, DOI 10.4161/cc.9.22.13936; Powers MP, 2011, DIAGN MOL PATHOL, V20, P63, DOI 10.1097/PDM.0b013e3181efe2a9; Rouviere O, 2006, NAT CLIN PRACT ONCOL, V3, P200, DOI 10.1038/ncponc0479; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Smits KM, 2008, CLIN CANCER RES, V14, P782, DOI 10.1158/1078-0432.CCR-07-1753; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Traynor K, 2009, AM J HEALTH-SYST PH, V66, P788, DOI 10.2146/news090037; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; Venkatesan B, 2008, FASEB J, V22, P3469, DOI 10.1096/fj.08-109488; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Weber K, 2007, CANCER METAST REV, V26, P691, DOI 10.1007/s10555-007-9090-y; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yi Z, 2011, J CANCER RES CLIN, V136, P855; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhou HY, 2010, CRIT REV EUKAR GENE, V20, P1; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	118	56	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37366	10.1371/journal.pone.0037366	http://dx.doi.org/10.1371/journal.pone.0037366			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22685542	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700013
J	Moser, MJ; DiFrancesco, RA; Gowda, K; Klingele, AJ; Sugar, DR; Stocki, S; Mead, DA; Schoenfeld, TW				Moser, Michael J.; DiFrancesco, Robert A.; Gowda, Krishne; Klingele, Audrey J.; Sugar, Darby R.; Stocki, Stacy; Mead, David A.; Schoenfeld, Thomas W.			Thermostable DNA Polymerase from a Viral Metagenome Is a Potent RT-PCR Enzyme	PLOS ONE			English	Article							VIRUS REVERSE-TRANSCRIPTASE; STRUCTURAL DETERMINANTS; AMPLIFICATION; EXPRESSION; FIDELITY; REPLICATION; PROTEIN; ASSAY; GENE; BACTERIOPHAGE-MS2	Viral metagenomic libraries are a promising but previously untapped source of new reagent enzymes. Deep sequencing and functional screening of viral metagenomic DNA from a near-boiling thermal pool identified clones expressing thermostable DNA polymerase (Pol) activity. Among these, 3173 Pol demonstrated both high thermostability and innate reverse transcriptase (RT) activity. We describe the biochemistry of 3173 Pol and report its use in single-enzyme reverse transcription PCR (RT-PCR). Wild-type 3173 Pol contains a proofreading 3'-5' exonuclease domain that confers high fidelity in PCR. An easier-to-use exonuclease-deficient derivative was incorporated into a PyroScript RT-PCR master mix and compared to one-enzyme (Tth) and two-enzyme (MMLV RT/Taq) RT-PCR systems for quantitative detection of MS2 RNA, influenza A RNA, and mRNA targets. Specificity and sensitivity of 3173 Pol-based RT-PCR were higher than Tth Pol and comparable to three common two-enzyme systems. The performance and simplified set-up make this enzyme a potential alternative for research and molecular diagnostics.	[Moser, Michael J.; DiFrancesco, Robert A.; Gowda, Krishne; Klingele, Audrey J.; Sugar, Darby R.; Stocki, Stacy; Mead, David A.; Schoenfeld, Thomas W.] Lucigen Corp, Middleton, WI USA		Moser, MJ (corresponding author), Lucigen Corp, Middleton, WI USA.	tschoenfeld@lucigen.com		MEAD, David/0000-0003-1982-9356	National Science Foundation [0109756, 0215988, 0839404]; National Institutes of Health [1 R43 HG002714-01, 2 R44 HG002714-02A1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG002714, R43HG002714] Funding Source: NIH RePORTER; Directorate For Engineering [1058238] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation (grant numbers 0109756, 0215988, and 0839404) and the National Institutes of Health (grant numbers 1 R43 HG002714-01 and 2 R44 HG002714-02A1) to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ando T, 1997, J CLIN MICROBIOL, V35, P570, DOI 10.1128/JCM.35.3.570-577.1997; Andraos N, 2004, J BIOL CHEM, V279, P50609, DOI 10.1074/jbc.M408428200; Bambara RA, 1995, METHOD ENZYMOL, V262, P270; Bebenek A, 2001, J BIOL CHEM, V276, P10387, DOI 10.1074/jbc.M007707200; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Bolufer P, 2001, HAEMATOLOGICA, V86, P570; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brincat JL, 2002, J VIROL, V76, P88, DOI 10.1128/JVI.76.1.88-95.2002; Canceill D, 1999, J BIOL CHEM, V274, P27481, DOI 10.1074/jbc.274.39.27481; Chandler DP, 1998, APPL ENVIRON MICROB, V64, P669; CHUMAKOV KM, 1994, PCR METH APPL, V4, P62; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Coyle DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016174; CREIGHTON S, 1992, J BIOL CHEM, V267, P2633; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Desombere I, 2005, J CLIN MICROBIOL, V43, P2590, DOI 10.1128/JCM.43.6.2590-2597.2005; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; FEHLMANN C, 1993, CLIN CHEM, V39, P368; FIERS W, 1975, NATURE, V256, P273, DOI 10.1038/256273a0; Gerard GF, 1997, MOL BIOTECHNOL, V8, P61, DOI 10.1007/BF02762340; GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817; Halvas EK, 2000, J VIROL, V74, P312, DOI 10.1128/JVI.74.1.312-319.2000; Hogrefe HH, 2001, METHOD ENZYMOL, V334, P91; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Konnick EQ, 2005, J CLIN MICROBIOL, V43, P2133, DOI 10.1128/JCM.43.5.2133-2140.2005; Konnick EQ, 2005, J CLIN MICROBIOL, V43, P596, DOI 10.1128/JCM.43.2.596-603.2005; KOTEWICZ ML, 1988, NUCLEIC ACIDS RES, V16, P265, DOI 10.1093/nar/16.1.265; Kurihara Y, 2002, BIOL PHARM BULL, V25, P1272, DOI 10.1248/bpb.25.1272; Lawyer F C, 1993, PCR Methods Appl, V2, P275; Levesque-Sergerie JP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-93; Li H, 2007, J CLIN ENDOCR METAB, V92, P4046, DOI 10.1210/jc.2006-2358; Lima SMB, 2006, FEBS J, V273, P1463, DOI 10.1111/j.1742-4658.2006.05167.x; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; Liu DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-77; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lotti LV, 2007, J CELL PHYSIOL, V212, P633, DOI 10.1002/jcp.21056; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Lyamichev V, 1999, P NATL ACAD SCI USA, V96, P6143, DOI 10.1073/pnas.96.11.6143; Mbisa JL, 2005, J VIROL, V79, P419, DOI 10.1128/JVI.79.1.419-427.2005; MEAD DA, 1991, BIOTECHNIQUES, V11, P76; MYERS TW, 1991, BIOCHEMISTRY-US, V30, P7661, DOI 10.1021/bi00245a001; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; O'Connell KP, 2006, APPL ENVIRON MICROB, V72, P478, DOI 10.1128/AEM.72.1.478-483.2006; Perler FB, 1996, ADV PROTEIN CHEM, V48, P377; RICCHETTI M, 1990, EMBO J, V9, P1583, DOI 10.1002/j.1460-2075.1990.tb08278.x; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; Sambrook J., 2001, MOL CLONING LAB MANU; Sauter KBM, 2006, ANGEW CHEM INT EDIT, V45, P7633, DOI 10.1002/anie.200602772; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Schoenfeld T, 2010, TRENDS MICROBIOL, V18, P20, DOI 10.1016/j.tim.2009.10.001; Schonbrunner NJ, 2006, BIOCHEMISTRY-US, V45, P12786, DOI 10.1021/bi0609117; SELLMANN E, 1992, J BACTERIOL, V174, P4350, DOI 10.1128/JB.174.13.4350-4355.1992; SELLNER LN, 1992, NUCLEIC ACIDS RES, V20, P1487, DOI 10.1093/nar/20.7.1487; SKERRA A, 1992, NUCLEIC ACIDS RES, V20, P3551, DOI 10.1093/nar/20.14.3551; Suslov O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni176; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Svarovskaia ES, 2000, J VIROL, V74, P7171, DOI 10.1128/JVI.74.15.7171-7178.2000; TABOR S, 1987, J BIOL CHEM, V262, P16212; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514	62	32	39	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38371	10.1371/journal.pone.0038371	http://dx.doi.org/10.1371/journal.pone.0038371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675552	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341700066
J	Schaette, R; Turtle, C; Munro, KJ				Schaette, Roland; Turtle, Charlotte; Munro, Kevin J.			Reversible Induction of Phantom Auditory Sensations through Simulated Unilateral Hearing Loss	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; COMPUTATIONAL MODEL; HOMEOSTATIC PLASTICITY; NEURONAL HYPERACTIVITY; TINNITUS PITCH; DEPRIVATION; MECHANISMS; LISTENERS; AMPLITUDE	Tinnitus, a phantom auditory sensation, is associated with hearing loss in most cases, but it is unclear if hearing loss causes tinnitus. Phantom auditory sensations can be induced in normal hearing listeners when they experience severe auditory deprivation such as confinement in an anechoic chamber, which can be regarded as somewhat analogous to a profound bilateral hearing loss. As this condition is relatively uncommon among tinnitus patients, induction of phantom sounds by a lesser degree of auditory deprivation could advance our understanding of the mechanisms of tinnitus. In this study, we therefore investigated the reporting of phantom sounds after continuous use of an earplug. 18 healthy volunteers with normal hearing wore a silicone earplug continuously in one ear for 7 days. The attenuation provided by the earplugs simulated a mild high-frequency hearing loss, mean attenuation increased from,10 dB at 0.25 kHz to >30 dB at 3 and 4 kHz. 14 out of 18 participants reported phantom sounds during earplug use. 11 participants presented with stable phantom sounds on day 7 and underwent tinnitus spectrum characterization with the earplug still in place. The spectra showed that the phantom sounds were perceived predominantly as high-pitched, corresponding to the frequency range most affected by the earplug. In all cases, the auditory phantom disappeared when the earplug was removed, indicating a causal relation between auditory deprivation and phantom sounds. This relation matches the predictions of our computational model of tinnitus development, which proposes a possible mechanism by which a stabilization of neuronal activity through homeostatic plasticity in the central auditory system could lead to the development of a neuronal correlate of tinnitus when auditory nerve activity is reduced due to the earplug.	[Schaette, Roland] UCL, Ear Inst, London, England; [Turtle, Charlotte; Munro, Kevin J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of London; University College London; University of Manchester	Schaette, R (corresponding author), UCL, Ear Inst, London, England.	r.schaette@ucl.ac.uk	munro, kevin j/A-2899-2015	munro, kevin j/0000-0001-6543-9098	British Tinnitus Association	British Tinnitus Association	This study was supported by the British Tinnitus Association (www.tinnitus.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Chrostowski M, 2011, J COMPUT NEUROSCI, V30, P279, DOI 10.1007/s10827-010-0256-1; Del Bo L, 2008, OTOLARYNG HEAD NECK, V139, P391, DOI 10.1016/j.otohns.2008.06.019; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; HELLER MF, 1953, ANN OTO RHINOL LARYN, V62, P73, DOI 10.1177/000348945306200107; Kaltenbach JA, 2004, NEUROSCI LETT, V355, P121, DOI 10.1016/j.neulet.2003.10.038; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Lecluyse W, 2009, J ACOUST SOC AM, V126, P2570, DOI 10.1121/1.3238248; Moore BCJ, 2004, EAR HEARING, V25, P98, DOI 10.1097/01.AUD.0000120359.49711.D7; Munro KJ, 2009, J ACOUST SOC AM, V126, P568, DOI 10.1121/1.3161829; Nicolas-Puel Cecile, 2002, Int Tinnitus J, V8, P37; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Parra LC, 2007, J ACOUST SOC AM, V121, P1632, DOI 10.1121/1.2431346; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Schaette R, 2008, HEARING RES, V240, P57, DOI 10.1016/j.heares.2008.02.006; Schaette R, 2006, EUR J NEUROSCI, V23, P3124, DOI 10.1111/j.1460-9568.2006.04774.x; Schaette R, 2010, HEARING RES, V269, P95, DOI 10.1016/j.heares.2010.06.022; Schaette R, 2009, J NEUROPHYSIOL, V101, P3042, DOI 10.1152/jn.91256.2008; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Whiting B, 2009, NEUROSCIENCE, V163, P1264, DOI 10.1016/j.neuroscience.2009.07.049; YOUNG ED, 2002, INTEGRATIVE FUNCTION, P121	26	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e35238	10.1371/journal.pone.0035238	http://dx.doi.org/10.1371/journal.pone.0035238			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675466	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700003
J	Domenech, E; Gomez-Lopez, G; Gzlez-Pena, D; Lopez, M; Herreros, B; Menezes, J; Gomez-Lozano, N; Carro, A; Grana, O; Pisano, DG; Dominguez, O; Garcia-Marco, JA; Piris, MA; Sanchez-Beato, M				Domenech, Elena; Gomez-Lopez, Gonzalo; Gzlez-Pena, Daniel; Lopez, Mar; Herreros, Beatriz; Menezes, Juliane; Gomez-Lozano, Natalia; Carro, Angel; Grana, Osvaldo; Pisano, David G.; Dominguez, Orlando; Garcia-Marco, Jose A.; Piris, Miguel A.; Sanchez-Beato, Margarita			New Mutations in Chronic Lymphocytic Leukemia Identified by Target Enrichment and Deep Sequencing	PLOS ONE			English	Article							NF-KAPPA-B; CELL LYMPHOMA; TYROSINE KINASE; RECEPTOR; CANCER; ARID1A; GENES; ACTIVATION; EXPRESSION; COMPLEXES	Chronic lymphocytic leukemia (CLL) is a heterogeneous disease without a well-defined genetic alteration responsible for the onset of the disease. Several lines of evidence coincide in identifying stimulatory and growth signals delivered by B-cell receptor (BCR), and co-receptors together with NFkB pathway, as being the driving force in B-cell survival in CLL. However, the molecular mechanism responsible for this activation has not been identified. Based on the hypothesis that BCR activation may depend on somatic mutations of the BCR and related pathways we have performed a complete mutational screening of 301 selected genes associated with BCR signaling and related pathways using massive parallel sequencing technology in 10 CLL cases. Four mutated genes in coding regions (KRAS, SMARCA2, NFKBIE and PRKD3) have been confirmed by capillary sequencing. In conclusion, this study identifies new genes mutated in CLL, all of them in cases with progressive disease, and demonstrates that next-generation sequencing technologies applied to selected genes or pathways of interest are powerful tools for identifying novel mutational changes.	[Domenech, Elena; Lopez, Mar; Herreros, Beatriz; Menezes, Juliane; Piris, Miguel A.; Sanchez-Beato, Margarita] Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid, Spain; [Gomez-Lopez, Gonzalo; Gzlez-Pena, Daniel; Carro, Angel; Grana, Osvaldo; Pisano, David G.] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid, Spain; [Gzlez-Pena, Daniel] Univ Vigo, Pontevedra, Spain; [Gomez-Lozano, Natalia; Garcia-Marco, Jose A.; Sanchez-Beato, Margarita] Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain; [Dominguez, Orlando] Spanish Natl Canc Res Ctr CNIO, Biotechnol Programme, Madrid, Spain; [Piris, Miguel A.] Fdn Marques Valdecilla, IFIMAV, Santander, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Universidade de Vigo; Hospital Puerta de Hierro-Majadahonda; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario Marques de Valdecilla (HUMV)	Domenech, E (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid, Spain.	msbeato@idiphim.org	Sanchez-Beato, Margarita/G-8753-2012; Piris, Miguel A/B-7067-2008; Gomez-Lopez, Gonzalo/D-9123-2016; Piris, Miguel A/AAP-1445-2020; Garcia Marco, Jose/H-2554-2015; Pisano, David/N-5817-2014; Dominguez, Orlando/M-7515-2018; Gomez-Lozano, Natalia/K-6488-2014; Glez-Pena, Daniel/D-5922-2014	Sanchez-Beato, Margarita/0000-0002-0058-7599; Piris, Miguel A/0000-0001-5839-3634; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Piris, Miguel A/0000-0001-5839-3634; Garcia Marco, Jose/0000-0002-8993-5982; Pisano, David/0000-0002-4895-4124; Gomez-Lozano, Natalia/0000-0003-3959-9519; Menezes, Juliane/0000-0003-3727-2096; Glez-Pena, Daniel/0000-0002-6129-7245; Grana-Castro, Osvaldo/0000-0003-1615-4242	Ministerio de Educacion y Ciencia, Spain [SAF2008-03871]; Fondo de Investigaciones Sanitarias (FIS), Spain [PI10/00621, RTICC RD06/0020/0107, CP11/00018]; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Spain; FIS, Spain; "Angeles Alvarino" fellowship; Xunta de Galicia, Spain; Ministerio de Educacion y Ciencia, Spain; la Fundacion La Caixa, Spain; Contracts Miguel Servet from FIS	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Fondo de Investigaciones Sanitarias (FIS), Spain(Instituto de Salud Carlos III); Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Spain; FIS, Spain(Instituto de Salud Carlos III); "Angeles Alvarino" fellowship; Xunta de Galicia, Spain(Xunta de Galicia); Ministerio de Educacion y Ciencia, Spain(Spanish Government); la Fundacion La Caixa, Spain; Contracts Miguel Servet from FIS	This work was supported by grants from the Ministerio de Educacion y Ciencia, Spain (SAF2008-03871), Fondo de Investigaciones Sanitarias (FIS), Spain (PI10/00621, RTICC RD06/0020/0107, CP11/00018), and Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Spain. ED is supported by a fellowship from FIS, Spain; DG-P by a "Angeles Alvarino" fellowship and a visiting scholar grant from Xunta de Galicia, Spain; BH by a contract from Ministerio de Educacion y Ciencia, Spain; JM by a fellowship from la Fundacion La Caixa, Spain; and NGL and MS-B are supported by Contracts Miguel Servet from FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, LEUKEMIA LYMPHOMA, V50, P1699, DOI 10.1080/10428190903189035; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Dal-Bo M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-76; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Emmerich F, 2003, J PATHOL, V201, P413, DOI 10.1002/path.1454; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Gougopoulou DM, 1996, STEM CELLS, V14, P725, DOI 10.1002/stem.140725; Haxhinasto SA, 2003, J IMMUNOL, V171, P4655, DOI 10.4049/jimmunol.171.9.4655; Herreros B, 2010, LEUKEMIA, V24, P872, DOI 10.1038/leu.2009.285; Hirano M, 2004, INT IMMUNOL, V16, P747, DOI 10.1093/intimm/dxh076; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Juszczynski P, 2009, BLOOD, V114, P5315, DOI 10.1182/blood-2009-02-204362; Ke JY, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-132; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Nedergaard T, 1997, INT J CANCER, V71, P364, DOI 10.1002/(SICI)1097-0215(19970502)71:3<364::AID-IJC10>3.0.CO;2-G; Pracht C, 2007, CELL SIGNAL, V19, P715, DOI 10.1016/j.cellsig.2006.07.023; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rodriguez A, 2007, LEUKEMIA, V21, P1984, DOI 10.1038/sj.leu.2404831; Rodriguez A, 2004, CLIN CANCER RES, V10, P6796, DOI 10.1158/1078-0432.CCR-04-0753; Rodriguez-Nieto S, 2010, HUMAN MUTATION; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Stevenson FK, 2004, BLOOD, V103, P4389, DOI 10.1182/blood-2003-12-4312; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; Thorselius M, 2006, BLOOD, V107, P2889, DOI 10.1182/blood-2005-06-2227; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433	35	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38158	10.1371/journal.pone.0038158	http://dx.doi.org/10.1371/journal.pone.0038158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675518	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339900015
J	Turpin, W; Humblot, C; Noordine, ML; Thomas, M; Guyot, JP				Turpin, Williams; Humblot, Christele; Noordine, Marie-Louise; Thomas, Muriel; Guyot, Jean-Pierre			Lactobacillaceae and Cell Adhesion: Genomic and Functional Screening	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; INTESTINAL EPITHELIAL-CELLS; ESCHERICHIA-COLI; GENE-EXPRESSION; IN-VITRO; STRESS TOLERANCE; MUC2 MUCIN; PROTEINS; PLANTARUM; SURFACE	The analysis of collections of lactic acid bacteria (LAB) from traditional fermented plant foods in tropical countries may enable the detection of LAB with interesting properties. Binding capacity is often the main criterion used to investigate the probiotic characteristics of bacteria. In this study, we focused on a collection of 163 Lactobacillaceace comprising 156 bacteria isolated from traditional amylaceous fermented foods and seven strains taken from a collection and used as controls. The collection had a series of analyses to assess binding potential for the selection of new probiotic candidates. The presence/absence of 14 genes involved in binding to the gastrointestinal tract was assessed. This enabled the detection of all the housekeeping genes (ef-Tu, eno, gap, groEl and srtA) in the entire collection, of some of the other genes (apf, cnb, fpbA, mapA, mub) in 86% to 100% of LAB, and of the other genes (cbsA, gtf, msa, slpA) in 0% to 8% of LAB. Most of the bacteria isolated from traditional fermented foods exhibited a genetic profile favorable for their binding to the gastrointestinal tract. We selected 30 strains with different genetic profiles to test their binding ability to non-mucus (HT29) and mucus secreting (HT29-MTX) cell lines as well as their ability to degrade mucus. Assays on both lines revealed high variability in binding properties among the LAB, depending on the cell model used. Finally, we investigated if their binding ability was linked to tighter cross-talk between bacteria and eukaryotic cells by measuring the expression of bacterial genes and of the eukaryotic MUC2 gene. Results showed that wild LAB from tropical amylaceous fermented food had a much higher binding capacity than the two LAB currently known to be probiotics. However their adhesion was not linked to any particular genetic equipment.	[Turpin, Williams; Humblot, Christele; Guyot, Jean-Pierre] IRD, UMR Nutripass, IRD Montpellier2 Montpellier1, Montpellier, France; [Noordine, Marie-Louise; Thomas, Muriel] INRA, Commensal & Probiot Host Interact Team, UMR1319, Jouy En Josas, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Turpin, W (corresponding author), IRD, UMR Nutripass, IRD Montpellier2 Montpellier1, Montpellier, France.	Christele.Humblot@ird.fr	Humblot, Christèle/A-7932-2008; Williams, Turpin/H-3255-2019; thomas, muriel/HDO-3887-2022	Humblot, Christèle/0000-0002-9797-1625; Williams, Turpin/0000-0001-9364-5868; 	French Ministry of Education and Research	French Ministry of Education and Research	Williams Turpin acknowledges a PhD grant from the French Ministry of Education and Research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati V, 1998, J APPL MICROBIOL, V85, P512, DOI 10.1046/j.1365-2672.1998.853527.x; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Buck BL, 2005, APPL ENVIRON MICROB, V71, P8344, DOI 10.1128/AEM.71.12.8344-8351.2005; Caballero-Franco C, 2007, AM J PHYSIOL-GASTR L, V292, pG315, DOI 10.1152/ajpgi.00265.2006; Castaldo C, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-14; Chagnaud P, 2001, J MICROBIOL METH, V44, P139, DOI 10.1016/S0167-7012(00)00244-X; Champomier-Verges MC, 2001, RES MICROBIOL, V152, P839, DOI 10.1016/S0923-2508(01)01267-0; Christie J, 2002, MICROBIOL-SGM, V148, P1615, DOI 10.1099/00221287-148-6-1615; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11; Fakhry S, 2009, RES MICROBIOL, V160, P817, DOI 10.1016/j.resmic.2009.09.009; de Palencia PF, 2009, APPL ENVIRON MICROB, V75, P4887, DOI 10.1128/AEM.00394-09; Giegerich R, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P68; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Giraud E, 1991, APPL MICROBIOL BIOTE, P36; Goh YJ, 2010, APPL ENVIRON MICROB, V76, P5005, DOI 10.1128/AEM.00030-10; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Hinton JCD, 2004, CURR OPIN MICROBIOL, V7, P277, DOI 10.1016/j.mib.2004.04.009; Hufner E, 2008, SYST APPL MICROBIOL, V31, P323, DOI 10.1016/j.syapm.2008.06.005; Hurmalainen V, 2007, MICROBIOL-SGM, V153, P1112, DOI 10.1099/mic.0.2006/000901-0; Izquierdo E, 2009, ELECTROPHORESIS, V30, P949, DOI 10.1002/elps.200800399; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; KERNEIS S, 1994, GUT, V35, P1449, DOI 10.1136/gut.35.10.1449; Kim Y, 2008, J MICROBIOL BIOTECHN, V18, P1278; Kim Y, 2009, INT J FOOD MICROBIOL, V131, P224, DOI 10.1016/j.ijfoodmicro.2009.03.002; Kinoshita H, 2008, J APPL MICROBIOL, V104, P1667, DOI 10.1111/j.1365-2672.2007.03679.x; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kravtsov EG, 2008, B EXP BIOL MED+, V145, P232, DOI 10.1007/s10517-008-0058-x; Laparra JM, 2009, LETT APPL MICROBIOL, V49, P695, DOI 10.1111/j.1472-765X.2009.02729.x; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; LESUFFLEUR T, 1995, J BIOL CHEM, V270, P13665, DOI 10.1074/jbc.270.23.13665; LESUFFLEUR T, 1993, J CELL SCI, V106, P771; Ljungh A, 2009, LACTOBACILLUS MOL BI; Luquet FM, 2005, BACTERIES LACTIQUES; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Michail S, 2002, J PEDIATR GASTR NUTR, V35, P350, DOI 10.1097/00005176-200209000-00021; Miyoshi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1622, DOI 10.1271/bbb.50688; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Morlon-Guyot J, 1998, INT J SYST BACTERIOL, V48, P1101, DOI 10.1099/00207713-48-4-1101; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; O'Flaherty SJ, 2010, MICROBIOL-SGM, V156, P3360, DOI 10.1099/mic.0.043158-0; Pfeiler EA, 2009, APPL ENVIRON MICROB, V75, P6013, DOI 10.1128/AEM.00495-09; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Ramiah K, 2007, INT J FOOD MICROBIOL, V116, P405, DOI 10.1016/j.ijfoodmicro.2007.02.011; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; Rozen S, 2000, Methods Mol Biol, V132, P365; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez B, 2011, APPL ENVIRON MICROB, V77, P1123, DOI 10.1128/AEM.02080-10; Sanchez B, 2010, J MICROBIOL BIOTECHN, V20, P978, DOI 10.4014/jmb.0911.11007; Smeianov VV, 2007, APPL ENVIRON MICROB, V73, P2661, DOI 10.1128/AEM.00005-07; Subramani DB, 2010, BENEF MICROBES, V1, P343, DOI 10.3920/BM2010.0039; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028789; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOBA T, 1995, APPL ENVIRON MICROB, V61, P2467, DOI 10.1128/AEM.61.7.2467-2471.1995; Turpin W, 2011, APPL ENVIRON MICROB, V77, P8722, DOI 10.1128/AEM.05988-11; Turpin W, 2010, INT J FOOD MICROBIOL, V143, P87, DOI 10.1016/j.ijfoodmicro.2010.07.032; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Pijkeren JP, 2006, APPL ENVIRON MICROB, V72, P4143, DOI 10.1128/AEM.03023-05; VANKLINKEN BJW, 1995, AM J PHYSIOL-GASTR L, V269, pG613, DOI 10.1152/ajpgi.1995.269.5.G613; Velez MP, 2010, FEMS IMMUNOL MED MIC, V59, P386, DOI 10.1111/j.1574-695X.2010.00680.x; Vieira MAM, 2010, INFECT IMMUN, V78, P927, DOI 10.1128/IAI.01115-09; von Ossowski I, 2011, APPL ENVIRON MICROB, V77, P4465, DOI 10.1128/AEM.02497-10; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Watanabe M, 2010, J APPL MICROBIOL, V109, P927, DOI 10.1111/j.1365-2672.2010.04719.x; Yasuda E, 2011, APPL ENVIRON MICROB, V77, P4539, DOI 10.1128/AEM.00240-11; Zago M, 2011, FOOD MICROBIOL, V28, P1033, DOI 10.1016/j.fm.2011.02.009; Zhou JS, 2001, INT J FOOD MICROBIOL, V63, P81, DOI 10.1016/S0168-1605(00)00398-6	76	71	72	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38034	10.1371/journal.pone.0038034	http://dx.doi.org/10.1371/journal.pone.0038034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675431	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500078
J	Nguyen, TA; Sarkar, P; Veetil, JV; Koushik, SV; Vogel, SS				Nguyen, Tuan A.; Sarkar, Pabak; Veetil, Jithesh V.; Koushik, Srinagesh V.; Vogel, Steven S.			Fluorescence Polarization and Fluctuation Analysis Monitors Subunit Proximity, Stoichiometry, and Protein Complex Hydrodynamics	PLOS ONE			English	Article							ENERGY-TRANSFER-FRET; KINASE-II; CORRELATION SPECTROSCOPY; LIVING CELLS; CAM KINASE; CALMODULIN; IDENTIFICATION; MICROSCOPY; EFFICIENCY; VARIANT	Forster resonance energy transfer (FRET) microscopy is frequently used to study protein interactions and conformational changes in living cells. The utility of FRET is limited by false positive and negative signals. To overcome these limitations we have developed Fluorescence Polarization and Fluctuation Analysis (FPFA), a hybrid single-molecule based method combining time-resolved fluorescence anisotropy (homo-FRET) and fluorescence correlation spectroscopy. Using FPFA, homo-FRET (a 1-10 nm proximity gauge), brightness (a measure of the number of fluorescent subunits in a complex), and correlation time (an attribute sensitive to the mass and shape of a protein complex) can be simultaneously measured. These measurements together rigorously constrain the interpretation of FRET signals. Venus based control-constructs were used to validate FPFA. The utility of FPFA was demonstrated by measuring in living cells the number of subunits in the alpha-isoform of Venus-tagged calcium-calmodulin dependent protein kinase-II (CaMKII alpha) holoenzyme. Brightness analysis revealed that the holoenzyme has, on average, 11.9+/-1.2 subunit, but values ranged from 10-14 in individual cells. Homo-FRET analysis simultaneously detected that catalytic domains were arranged as dimers in the dodecameric holoenzyme, and this paired organization was confirmed by quantitative hetero-FRET analysis. In freshly prepared cell homogenates FPFA detected only 10.2+/-1.3 subunits in the holoenzyme with values ranging from 9-12. Despite the reduction in subunit number, catalytic domains were still arranged as pairs in homogenates. Thus, FPFA suggests that while the absolute number of subunits in an auto-inhibited holoenzyme might vary from cell to cell, the organization of catalytic domains into pairs is preserved.	[Nguyen, Tuan A.; Sarkar, Pabak; Veetil, Jithesh V.; Koushik, Srinagesh V.; Vogel, Steven S.] NIAAA, Sect Cellular Biophoton, Lab Mol Physiol, Natl Inst Hlth, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Nguyen, TA (corresponding author), NIAAA, Sect Cellular Biophoton, Lab Mol Physiol, Natl Inst Hlth, Rockville, MD 20852 USA.	stevevog@mail.nih.gov	Veetil, Jithesh/G-5185-2012	Vogel, Steven/0000-0002-3005-2667	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000452] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the intramural program of the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AN, 2009, BIOPHYS J, V97, P2613, DOI 10.1016/j.bpj.2009.07.059; Becker W, 2005, ADV TIME CORRELATED; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Bevington PR, 1969, DATA REDUCTION ERROR; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Chen Y, 2010, METHOD ENZYMOL, V472, P345, DOI 10.1016/S0076-6879(10)72026-7; Clegg RM, 2009, LAB TECH BIOCHEM MOL, V33, P1, DOI 10.1016/S0075-7535(08)00001-6; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; ELSON EL, 1975, ANNU REV BIOPHYS BIO, V4, P311, DOI 10.1146/annurev.bb.04.060175.001523; Enderlein J, 2004, CURR PHARM BIOTECHNO, V5, P155, DOI 10.2174/1389201043377020; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; Kim SA, 2005, BIOPHYS J, V88, P4319, DOI 10.1529/biophysj.104.055319; Kolb SJ, 1998, J BIOL CHEM, V273, P31555, DOI 10.1074/jbc.273.47.31555; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kremers GJ, 2009, LAB TECH BIOCHEM MOL, V33, P171, DOI 10.1016/S0075-7535(08)00005-3; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Muller JD, 2003, METHOD ENZYMOL, V361, P69; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sahoo H, 2011, CHEMPHYSCHEM, V12, P532, DOI 10.1002/cphc.201000776; Sanabria H, 2008, BIOPHYS J, V95, P6002, DOI 10.1529/biophysj.108.138974; Sarkar P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3156842; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; Thompson NL, 1991, TOPICS FLUORESCENCE, P337; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; Vogel SS, 2010, FLIM MICROSCOPY BIOL, P245; Vogel Steven S, 2006, Sci STKE, V2006, pre2; Wang P, 2000, FEBS LETT, V475, P107, DOI 10.1016/S0014-5793(00)01634-3; Weidtkamp-Peters S, 2009, PHOTOCH PHOTOBIO SCI, V8, P470, DOI 10.1039/b903245m; Williams DJ, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00181; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	54	33	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38209	10.1371/journal.pone.0038209	http://dx.doi.org/10.1371/journal.pone.0038209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666486	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400102
J	Page, AL; Alberti, KP; Mondonge, V; Rauzier, J; Quilici, ML; Guerin, PJ				Page, Anne-Laure; Alberti, Kathryn P.; Mondonge, Vital; Rauzier, Jean; Quilici, Marie-Laure; Guerin, Philippe J.			Evaluation of a Rapid Test for the Diagnosis of Cholera in the Absence of a Gold Standard	PLOS ONE			English	Article							O1; SPECIFICITY; SENSITIVITY	Background: Early detection and confirmation of cholera outbreaks are crucial for rapid implementation of control measures. Because cholera frequently affects regions with limited laboratory resources, rapid diagnostic tests (RDT) designed for field conditions are important to enhance rapid response. Stool culture remains the "gold standard'' for cholera diagnosis; however, its lack of sensitivity may lead to underestimation of test specificity. We evaluated the Crystal VC (R) immunochromatographic test (Span Diagnostics, India) for cholera diagnosis using a modified reference standard that combines culture-dependent and independent assays, or a Bayesian latent class model (LCM) analysis. Methodology/Principal Findings: The study was conducted during a cholera epidemic in 2008, in Lubumbashi, Democratic Republic of Congo. Stools collected from 296 patients were used to perform the RDT on site and sent to Institut Pasteur, Paris, for bacterial culture. In comparison with culture as the gold standard, the RDT showed good sensitivity (92.2%; 95% CI: 86.8%-95.9%) but poor specificity when used by a trained laboratory technician (70.6%; 95% CI: 60.7%-79.2%) or by clinicians with no specific test training (60.4%, 95% CI: 50.2%-70.0%). The specificity of the test performed by the laboratory technician increased to 88.6% (95% CI: 78.7-94.9) when PCR was combined with culture results as the reference standard, and to 85.0% (95% CI: 70.4-99.2), when the Bayesian LCM analysis was used for performance evaluation. In both cases, the sensitivity remained high. Conclusion: Using an improved reference standard or appropriate statistical methods for diagnostic test evaluations in the absence of a gold standard, we report better performance of the Crystal VC (R) RDT than previously published. Our results confirm that this test can be used for early outbreak detection or epidemiological surveillance, key components of efficient global cholera control. Our analysis also highlights the importance of improving evaluations of RDT when no reliable gold standard is available.	[Page, Anne-Laure; Alberti, Kathryn P.; Guerin, Philippe J.] Epictr, Paris, France; [Mondonge, Vital] Minist Hlth, Kinshasa, DEM REP CONGO; [Rauzier, Jean; Quilici, Marie-Laure] Ctr Natl Reference Vibr & Cholera, Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Guerin, Philippe J.] Univ Oxford, CCVTM, Ctr Trop Med, Nuffield Dept Clin Med, Oxford, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford	Page, AL (corresponding author), Epictr, Paris, France.	anne-laure.page@epicentre.msf.org	Guerin, Philippe/AAH-8873-2021; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Guerin, Philippe/0000-0002-6008-2963	Medecins Sans Frontieres	Medecins Sans Frontieres	This research was funded by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2010, J CLIN MICROBIOL, V48, P3918, DOI 10.1128/JCM.00616-10; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P325; Bhuiyan NA, 2003, J CLIN MICROBIOL, V41, P3939, DOI 10.1128/JCM.41.8.3939-3941.2003; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P1133, DOI 10.1128/JCM.15.6.1133-1140.1982; Cavallaro EC, 2009, TROP MED INT HLTH; Dendukuri N, 2010, STAT MED, V29, P2688, DOI 10.1002/sim.4037; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Fournier J. M., 1992, LAB METHODS DIAGNOSI, P59; Garrett ES, 2002, STAT MED, V21, P1289, DOI 10.1002/sim.1105; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Hoshino K, 1998, FEMS IMMUNOL MED MIC, V20, P201, DOI 10.1111/j.1574-695X.1998.tb01128.x; Kalluri P, 2006, TROP MED INT HEALTH, V11, P49, DOI 10.1111/j.1365-3156.2005.01539.x; Limmathurotsakul D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012485; Mukherjee P, 2010, JPN J INFECT DIS, V63, P234; Nato F, 2003, CLIN DIAGN LAB IMMUN, V10, P476, DOI 10.1128/CDLI.10.3.476-478.2003; Page AL, 2011, J CLIN MICROBIOL, V49, P3021, DOI 10.1128/JCM.00514-11; Spiegelhalter DJ, 1996, BUGS BAYESIAN INFERE; Wang XY, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-17; World Health Organization, 2005, TREATM DIARRH MAN PH	20	38	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37360	10.1371/journal.pone.0037360	http://dx.doi.org/10.1371/journal.pone.0037360			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666350	gold, Green Published			2022-12-27	WOS:000305353400025
J	Agundez, JA; Garcia-Martin, E; Maestro, ML; Cuenca, F; Martinez, C; Ortega, L; Carballo, M; Vidaurreta, M; Agreda, M; Diaz-Zelaya, G; Suarez, A; Diaz-Rubio, M; Ladero, JM				Agundez, Jose A.; Garcia-Martin, Elena; Maestro, Maria L.; Cuenca, Francisca; Martinez, Carmen; Ortega, Luis; Carballo, Miguel; Vidaurreta, Marta; Agreda, Marta; Diaz-Zelaya, Gabriela; Suarez, Avelina; Diaz-Rubio, Manuel; Ladero, Jose M.			Relation of IL28B Gene Polymorphism with Biochemical and Histological Features in Hepatitis C Virus-Induced Liver Disease	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GENOME-WIDE-ASSOCIATION; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; GENOTYPE; FIBROSIS; THERAPY; CLEARANCE; INFLAMMATION; PROGRESSION	Background/Aims: Polymorphism at the IL28B gene may modify the course of hepatitis C virus (HCV) chronic infection. Our aim was to study the influence of IL28B rs12979860 gene polymorphism on the biochemistry and pathology of HCV-induced disease in the clinical course from mild chronic hepatitis C to hepatocellular carcinoma. Methods: We have determined the rs12979860 single nucleotide polymorphism (SNP) upstream IL28B gene in two groups of patients with HCV-induced chronic liver disease: 1) 268 patients (159 men) with biopsy-proven chronic hepatitis C, to analyse its relation with biochemical, virological and histological features; and 2) 134 patients (97 men) with HCV-related hepatocellular carcinoma. The distribution of the analysed SNP in hepatocellular carcinoma patients was compared with that found in untreated chronic hepatitis C patients. All patients were white and most were Spaniards. Results: In multivariate analysis ALT values were higher (P = 0.001) and GGT values were lower (P, 0.001) in chronic hepatitis C patients homozygotes for the major rs12979860C allele as compared with carriers of the mutated rs12979860T allele. Steatosis was more frequent (Odds ratio = 1.764, 95% C.I. 1.053-2.955) and severe (P = 0.026) in carriers of the rs12979860T allele. No relation was found between the analysed SNP and METAVIR scores for necroinflammation and fibrosis, and there were no differences in the distribution of the analysed SNP between hepatocellular carcinoma and untreated chronic hepatitis C patients. Conclusion: The IL28B rs12979860 polymorphism correlates with the biochemical activity and the presence and severity of liver steatosis in chronic hepatitis C.	[Agundez, Jose A.; Martinez, Carmen] Univ Extremadura, Dept Pharmacol, Caceres, Spain; [Garcia-Martin, Elena] Univ Extremadura, Dept Biochem & Mol Biol, Caceres, Spain; [Maestro, Maria L.; Vidaurreta, Marta] Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos IdISCC, Serv Clin Biochem, Genom Unit, Madrid, Spain; [Cuenca, Francisca; Agreda, Marta] Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos IdISCC, Serv Gastroenterol, Liver Unit, Madrid, Spain; [Ortega, Luis; Diaz-Zelaya, Gabriela] Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos IdISCC, Serv Pathol, Madrid, Spain; [Carballo, Miguel] Hosp Terrassa, Mol Genet Lab, Terrassa, Barcelona, Spain; [Suarez, Avelina] Hosp Clin San Carlos IdISCC, Serv Clin Microbiol, Madrid, Spain; [Diaz-Rubio, Manuel] Univ Complutense, Inst Invest Sanitaria Hosp Clin San Carlos IdISCC, Hosp Clin San Carlos, Dept Med,Sch Med,Liver Unit,Serv Gastreoenterol, E-28040 Madrid, Spain	Universidad de Extremadura; Universidad de Extremadura; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos	Agundez, JA (corresponding author), Univ Extremadura, Dept Pharmacol, Caceres, Spain.	jladero.hcsc@salud.madrid.org	García-Martin, Elena/H-9828-2016; Agúndez, José A. G./A-5503-2008	García-Martin, Elena/0000-0002-8094-046X; Agúndez, José A. G./0000-0001-6895-9160; Vidaurreta, Marta/0000-0002-7790-6252; Ortega, Luis/0000-0002-7987-8531	FIS [PS09/00943, PS09/00469]; RETICS [RD07/0064]; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain; Junta de Extremadura, Spain [GR10068]; FEDER funds; European Union	FIS(Instituto de Salud Carlos III); RETICS; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Junta de Extremadura, Spain; FEDER funds(European Commission); European Union(European Commission)	Financial support: FIS PS09/00943, PS09/00469, and RETICS RD07/0064 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain GR10068 from Junta de Extremadura, Spain. Financed in part with FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Ahlenstiel G, 2010, J GASTROENTEROL, V45, P903, DOI 10.1007/s00535-010-0287-4; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Asahina Y, 2011, J HEPATOL, V54, pS37, DOI 10.1016/S0168-8278(11)60084-6; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Cuenca F, 2010, REV ESP ENFERM DIG, V102, P234, DOI 10.4321/s1130-01082010000400003; Di Marco V, 2011, HAEMATOLOGICA; Eurich D, 2012, TRANSPLANTATION, V93, P644, DOI 10.1097/TP.0b013e318244f774; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Falleti E, 2011, J CLIN IMMUNOL, V31, P891, DOI 10.1007/s10875-011-9547-1; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hayes CN, 2011, GUT, V60, P261, DOI 10.1136/gut.2010.223495; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Joshita S, 2012, HUM IMMUNOL, V73, P298, DOI 10.1016/j.humimm.2011.12.021; Kanzler S, 2001, J VIRAL HEPATITIS, V8, P430, DOI 10.1046/j.1365-2893.2001.00314.x; Kurosaki M, 2011, J HEPATOL, V54, P439, DOI 10.1016/j.jhep.2010.07.037; Ladero JM, 2012, J GASTROEN HEPATOL, V27, P279, DOI 10.1111/j.1440-1746.2011.06834.x; Lencioni R, 2011, J HEPATOL, V54, P184, DOI 10.1016/j.jhep.2010.07.050; Li JH, 2010, HEPATOLOGY, V51, P1904, DOI 10.1002/hep.23592; Martinez C, 2007, J INFECT DIS, V195, P1320, DOI 10.1086/513569; Maruoka D, 2012, J GASTROEN HEPATOL, V27, P291, DOI 10.1111/j.1440-1746.2011.06871.x; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Minton EJ, 1998, J INFECT DIS, V178, P39, DOI 10.1086/514258; Miura M, 2011, HEPATOL INT; Ohnishi M, 2012, J GASTROENTEROL; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Ren S, 2012, CANC IMMUNOL IMMUNOT; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Thompson AJ, 2010, HEPATOLOGY, V52, p1220A; Thompson AJ, 2010, HEPATOLOGY, V52, p437A; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Trapero-Marugan M, 2011, WORLD J GASTROENTERO, V17, P493, DOI 10.3748/wjg.v17.i4.493; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wang H, 2005, WORLD J GASTROENTERO, V11, P1929, DOI 10.3748/wjg.v11.i13.1929; Williams MJ, 2011, J VIRAL HEPATITIS, V18, P17, DOI 10.1111/j.1365-2893.2009.01262.x; Witthoft T, 2007, J VIRAL HEPATITIS, V14, P788, DOI 10.1111/j.1365-2893.2007.00871.x	51	48	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37998	10.1371/journal.pone.0037998	http://dx.doi.org/10.1371/journal.pone.0037998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666430	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600049
J	Bertucci, F; Lagarde, A; Ferrari, A; Finetti, P; Charafe-Jauffret, E; Van Laere, S; Adelaide, J; Viens, P; Thomas, G; Birnbaum, D; Olschwang, S				Bertucci, Francois; Lagarde, Arnaud; Ferrari, Anthony; Finetti, Pascal; Charafe-Jauffret, Emmanuelle; Van Laere, Steven; Adelaide, Jose; Viens, Patrice; Thomas, Gilles; Birnbaum, Daniel; Olschwang, Sylviane			8q24 Cancer Risk Allele Associated with Major Metastatic Risk in Inflammatory Breast Cancer	PLOS ONE			English	Article							LONG-RANGE INTERACTION; COLORECTAL-CANCER; PROSTATE-CANCER; MYC; EXPRESSION; RS6983267; VARIANT; LOCI	Background: Association studies have identified low penetrance alleles that participate to the risk of cancer development. The 8q24 chromosomal region contains several such loci involved in various cancers that have been recently studied for their propensity to influence the clinical outcome of prostate cancer. We investigated here two 8q24 breast and colon cancer risk alleles in the close vicinity of the MYC gene for their role in the occurrence of distant metastases. Methodology/Principal findings: A retrospective series of 449 patients affected with breast or colon adenocarcinoma was genotyped for the rs13281615 and/or rs6983267 SNPs. Statistical analyses were done using the survival package v2.30 in the R software v2.9.1. The two SNPs did not influence the development of distant metastases of colon cancer; rs6983267 showed a mild effect on breast cancer. However, this effect was greatly emphasized when considering inflammatory breast cancer (IBC) solely. Replicated on a larger and independent series of IBC the contribution of the genotype to the metastatic risk of IBC was found an independent predictor of outcome (p = 2e-4; OR 8.3, CI95: 2.6-33). Conclusions/Significance: Our study shows first that the monitoring of this specific germline variation may add a substantial tool for IBC prognostication, an aggressive disease that evolves towards distant metastases much more frequently than non-IBC and for which no reliable prognostic factor is available in medical practice. Second, it more generally suggests that risk alleles, while associated with low susceptibility, could correlate with a high risk of metastasis.	[Bertucci, Francois; Lagarde, Arnaud; Ferrari, Anthony; Finetti, Pascal; Charafe-Jauffret, Emmanuelle; Adelaide, Jose; Viens, Patrice; Birnbaum, Daniel; Olschwang, Sylviane] Inst J Paoli I Calmettes, Dept Mol Oncol, Ctr Rech Cancerol Marseille, F-13009 Marseille, France; [Bertucci, Francois; Finetti, Pascal; Charafe-Jauffret, Emmanuelle; Adelaide, Jose; Birnbaum, Daniel; Olschwang, Sylviane] INSERM, UMR 1068, Marseille, France; [Bertucci, Francois; Charafe-Jauffret, Emmanuelle; Viens, Patrice] Aix Marseille Univ, Marseille, France; [Ferrari, Anthony; Thomas, Gilles] Ctr Leon Berard, Fdn Synergie Lyon Canc, F-69373 Lyon, France; [Van Laere, Steven] Univ Hosp, Translat Canc Res Grp, Antwerp, Belgium	UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Centre Leon Berard	Bertucci, F (corresponding author), Inst J Paoli I Calmettes, Dept Mol Oncol, Ctr Rech Cancerol Marseille, F-13009 Marseille, France.	sylviane.olschwang@inserm.fr	Lagarde, Arnaud/Z-1811-2019; Viens, Patrice/Q-8499-2018; ADELAIDE, José JA/O-4390-2017; lagarde, arnaud/M-3364-2016; lagarde, arnaud/AAC-8382-2020; Olschwang, Sylviane/G-2716-2013; Van Laere, Steven/GQA-8872-2022; Finetti, Pascal/O-8669-2017; Charafe-Jauffret, emmanuelle/P-6009-2017	Viens, Patrice/0000-0003-1511-1048; ADELAIDE, José JA/0000-0003-4364-9857; lagarde, arnaud/0000-0003-1619-3452; lagarde, arnaud/0000-0003-1619-3452; Olschwang, Sylviane/0000-0001-7078-3029; Van Laere, Steven/0000-0002-2640-0040; Finetti, Pascal/0000-0002-2674-3123; Bertucci, Francois/0000-0002-0157-0959; Charafe-Jauffret, emmanuelle/0000-0002-0286-1299	French National Cancer Institute INCa	French National Cancer Institute INCa(Institut National du Cancer (INCA) France)	Funding provided by French National Cancer Institute INCa: this funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Ahn J, 2011, CLIN CANCER RES, V17, P1075, DOI 10.1158/1078-0432.CCR-10-0881; Bekhouche I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016950; Bertucci F, 2010, CANCER-AM CANCER SOC, V116, P2783, DOI 10.1002/cncr.25165; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Glinskii AB, 2011, CELL CYCLE, V10, P3571, DOI 10.4161/cc.10.20.17842; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Robinson DR, 2008, CURR DRUG TARGETS, V9, P571; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schlange T, 2007, BREAST CANC RES GENE, V41, P885; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09	17	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37943	10.1371/journal.pone.0037943	http://dx.doi.org/10.1371/journal.pone.0037943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666420	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349600047
J	Hustedt, JW; Christie, C; Hustedt, MM; Esposito, D; Vazquez, M				Hustedt, Joshua W.; Christie, Celia; Hustedt, Madison M.; Esposito, Daina; Vazquez, Marietta			Seroepidemiology of Human Bocavirus Infection in Jamaica	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS; YOUNG-CHILDREN; IDENTIFICATION; CORONAVIRUS; PARVOVIRUS; PNEUMONIA; ETIOLOGY	Background: Human bocavirus (HBoV) is a newly identified human parvovirus. HBoV is associated with upper and lower respiratory tract infections and gastroenteritis in children. Little is known about the seroepidemiology of HBoV in populations in the Caribbean. Methods: In a cross-sectional study conducted at the University Hospital of the West Indies in Kingston, Jamaica, 287 blood samples were collected from pediatric patients and tested for the presence of HBoV-specific antibody using a virus-like-particle based enzyme-linked immunosorbent assay (ELISA). Results: HBoV-specific antibodies were found to be present in 220/287 (76.7%) of samples collected from the pediatric population. Seroprevalence of HBoV was highest in those >= 2 years old. The seroepidemiological profile suggests that most children are exposed to HBoV during the first two years of life in Jamaica. Conclusion: HBoV infection is common in children in Jamaica. HBoV seroprevalence rates in the Caribbean are similar to those previously reported in other areas of the world.	[Hustedt, Joshua W.; Hustedt, Madison M.; Esposito, Daina; Vazquez, Marietta] Yale Univ, Sch Med, Dept Pediat, Div Infect Dis, New Haven, CT 06510 USA; [Christie, Celia] Univ W Indies, Dept Pediat, Kingston 7, Jamaica	Yale University; University West Indies Mona Jamaica	Hustedt, JW (corresponding author), Yale Univ, Sch Med, Dept Pediat, Div Infect Dis, New Haven, CT 06510 USA.	joshua.hustedt@yale.edu		Hustedt, Joshua/0000-0002-9110-7115; Christie, Celia DC/0000-0002-8981-3934	Yale University; Infectious Disease Society of America	Yale University; Infectious Disease Society of America	JWH received a Wilbur Downs International Student Travel Fellowship from Yale University and a Medical Scholars award from the Infectious Disease Society of America to complete this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2006, EMERG INFECT DIS, V12, P848, DOI 10.3201/eid1205.051424; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Foulongne V, 2006, EMERG INFECT DIS, V12, P1251, DOI 10.3201/eid1708.060213.; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Henrickson Kelly J, 1998, Semin Pediatr Infect Dis, V9, P217, DOI 10.1016/S1045-1870(98)80035-6; Hustedt Joshua W., 2010, Yale Journal of Biology and Medicine, V83, P193; Kahn JS, 2008, J INFECT DIS, V198, P41, DOI 10.1086/588674; Kahn JS, 2007, CURR OPIN PHARMACOL, V7, P478, DOI 10.1016/j.coph.2007.07.004; Kaplan NM, 2006, EMERG INFECT DIS, V12, P1418, DOI 10.3201/eid1209.060417; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Leung J, 2005, J CLIN MICROBIOL, V43, P1213, DOI 10.1128/JCM.43.3.1213-1219.2005; Lin F, 2008, J VIROL METHODS, V149, P110, DOI 10.1016/j.jviromet.2007.12.016; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Maggi F, 2007, J CLIN VIROL, V38, P321, DOI 10.1016/j.jcv.2007.01.008; Mathers C, 2008, GLOBAL DURDEN DIS 20; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Smuts H, 2006, EMERG INFECT DIS, V12, P1457, DOI 10.3201/eid1209.051616; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; van Woensel JBM, 2003, BMJ-BRIT MED J, V327, P36, DOI 10.1136/bmj.327.7405.36; VEJTORP M, 1981, ACTA PATH MICRO IM B, V89, P369; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005	33	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38206	10.1371/journal.pone.0038206	http://dx.doi.org/10.1371/journal.pone.0038206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666484	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349600071
J	Wilson, CE; Palermo, R; Brock, J				Wilson, C. Ellie; Palermo, Romina; Brock, Jon			Visual Scan Paths and Recognition of Facial Identity in Autism Spectrum Disorder and Typical Development	PLOS ONE			English	Article							FACE RECOGNITION; EYE-MOVEMENTS; WILLIAMS-SYNDROME; GAZE DIRECTION; CHILDREN; INDIVIDUALS; PERCEPTION; DISCRIMINATION; PROSOPAGNOSIA; FIXATION	Background: Previous research suggests that many individuals with autism spectrum disorder (ASD) have impaired facial identity recognition, and also exhibit abnormal visual scanning of faces. Here, two hypotheses accounting for an association between these observations were tested: i) better facial identity recognition is associated with increased gaze time on the Eye region; ii) better facial identity recognition is associated with increased eye-movements around the face. Methodology and Principal Findings: Eye-movements of 11 children with ASD and 11 age-matched typically developing (TD) controls were recorded whilst they viewed a series of faces, and then completed a two alternative forced-choice recognition memory test for the faces. Scores on the memory task were standardized according to age. In both groups, there was no evidence of an association between the proportion of time spent looking at the Eye region of faces and age-standardized recognition performance, thus the first hypothesis was rejected. However, the `Dynamic Scanning Index' which was incremented each time the participant saccaded into and out of one of the core-feature interest areas - was strongly associated with age-standardized face recognition scores in both groups, even after controlling for various other potential predictors of performance. Conclusions and Significance: In support of the second hypothesis, results suggested that increased saccading between core-features was associated with more accurate face recognition ability, both in typical development and ASD. Causal directions of this relationship remain undetermined.	[Wilson, C. Ellie; Brock, Jon] Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia; [Wilson, C. Ellie] Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, London WC2R 2LS, England; [Palermo, Romina] Univ Western Australia, Sch Psychol, Nedlands, WA 6009, Australia; [Palermo, Romina; Brock, Jon] Australian Res Council, Ctr Excellence Cognit & Disorders, Sydney, NSW, Australia	Macquarie University; University of London; King's College London; University of Western Australia	Wilson, CE (corresponding author), Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia.	ellie.wilson@kcl.ac.uk	Palermo, Romina/G-2533-2014	Palermo, Romina/0000-0002-8678-4592; Brock, Jon/0000-0002-9655-3667	Macquarie University Research Excellence Scholarship; ARC Australian Research Fellowship [DP098466]	Macquarie University Research Excellence Scholarship; ARC Australian Research Fellowship(Australian Research Council)	Ellie Wilson was supported by a Macquarie University Research Excellence Scholarship. Jon Brock was supported by an ARC Australian Research Fellowship (DP098466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barton JJS, 2004, BRAIN, V127, P1706, DOI 10.1093/brain/awh194; Bishop D. V. M, 1989, TEST RECEPTION GRAMM, V2; BOUCHER J, 1992, J CHILD PSYCHOL PSYC, V33, P843, DOI 10.1111/j.1469-7610.1992.tb01960.x; Bowles DC, 2009, COGN NEUROPSYCHOL, V26, P423, DOI 10.1080/02643290903343149; Brock J, 2007, CLIN LINGUIST PHONET, V21, P673, DOI 10.1080/02699200701541433; Chawarska K, 2009, J AUTISM DEV DISORD, V39, P1663, DOI 10.1007/s10803-009-0803-7; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; de Gelder B., 1991, EUROPEAN J COGNITIVE, V3, P69, DOI [10.1080/09541449108406220, DOI 10.1080/09541449108406220]; Deruelle C, 2004, J AUTISM DEV DISORD, V34, P199, DOI 10.1023/B:JADD.0000022610.09668.4c; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Faja S, 2008, DEV NEUROPSYCHOL, V33, P1, DOI 10.1080/87565640701729573; Fletcher-Watson S, 2009, NEUROPSYCHOLOGIA, V47, P248, DOI 10.1016/j.neuropsychologia.2008.07.016; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Hauck M, 1998, CHILD NEUROPSYCHOL, V4, P187, DOI 10.1076/chin.4.3.187.3174; Hedley D, 2011, AUTISM RES, V4, P449, DOI 10.1002/aur.214; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; Hills PJ, 2011, Q J EXP PSYCHOL, V64, P17, DOI 10.1080/17470218.2010.537926; Hood BM, 2003, DEVELOPMENTAL SCI, V6, P67, DOI 10.1111/1467-7687.00256; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Jeffrey L, 2004, AUST J PSYCHOL, V56, P119; Jemel B, 2006, J AUTISM DEV DISORD, V36, P91, DOI 10.1007/s10803-005-0050-5; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Joseph RM, 2003, J CHILD PSYCHOL PSYC, V44, P529, DOI 10.1111/1469-7610.00142; Joseph RM, 2008, J INT NEUROPSYCH SOC, V14, P947, DOI 10.1017/S1355617708081344; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 1999, J AUTISM DEV DISORD, V29, P499, DOI 10.1023/A:1022299920240; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; Lahaie A, 2006, NEUROPSYCHOLOGY, V20, P30, DOI 10.1037/0894-4105.20.1.30; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 2001, AUTISM DIAGNOSTIC OB; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; MAURER D, 1976, CHILD DEV, V47, P523, DOI 10.2307/1128813; McKone E, 2010, P NATL ACAD SCI USA, V107, P4795, DOI 10.1073/pnas.1000567107; McKone E, 2009, VISION RES, V49, P268, DOI 10.1016/j.visres.2008.10.020; MERTENS I, 1993, NEUROPSYCHOLOGIA, V31, P989, DOI 10.1016/0028-3932(93)90154-R; NOTON D, 1971, VISION RES, V11, P929, DOI 10.1016/0042-6989(71)90213-6; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Riby D, 2009, J INTELL DISABIL RES, V53, P169, DOI 10.1111/j.1365-2788.2008.01142.x; Rotshtein P, 2007, J COGNITIVE NEUROSCI, V19, P1435, DOI 10.1162/jocn.2007.19.9.1435; Rutherford MD, 2007, VISION RES, V47, P2099, DOI 10.1016/j.visres.2007.01.029; Rutter M., 2003, SCQ SOCIAL COMMUNICA; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Schmalzl L, 2008, COGN NEUROPSYCHOL, V25, P704, DOI 10.1080/02643290802299350; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Schwarzer G, 2007, PSYCHOL RES-PSYCH FO, V71, P583, DOI 10.1007/s00426-006-0068-0; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; Sekiguchi T, 2011, ACTA PSYCHOL, V137, P1, DOI 10.1016/j.actpsy.2011.01.014; Serra M, 2003, J AUTISM DEV DISORD, V33, P303, DOI 10.1023/A:1024458618172; Smith AD, 2006, DEVELOPMENTAL SCI, V9, P465, DOI 10.1111/j.1467-7687.2006.00513.x; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; Stephan BCM, 2009, BRAIN COGNITION, V69, P262, DOI 10.1016/j.bandc.2008.07.015; Sterling L, 2008, J AUTISM DEV DISORD, V38, P1011, DOI 10.1007/s10803-007-0477-y; TANTAM D, 1989, J CHILD PSYCHOL PSYC, V30, P623, DOI 10.1111/j.1469-7610.1989.tb00274.x; Van Belle G, 2010, NEUROPSYCHOLOGIA, V48, P2620, DOI 10.1016/j.neuropsychologia.2010.04.034; van der Geest JN, 2002, J CHILD PSYCHOL PSYC, V43, P669, DOI 10.1111/1469-7610.00055; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Weschler D., 1999, WESCHLER ABBREVIATED; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; Wilson CE, 2010, J INTELL DISABIL RES, V54, P1104, DOI 10.1111/j.1365-2788.2010.01340.x; Wilson CE, 2011, Q J EXP PSYCHOL, V64, P1939, DOI 10.1080/17470218.2011.603052; Wilson CE, 2010, COGN NEUROPSYCHOL, V27, P30, DOI 10.1080/02643294.2010.490207; Yarbus A.L., 1967, EYE MOVEMENT VISION	69	24	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37681	10.1371/journal.pone.0037681	http://dx.doi.org/10.1371/journal.pone.0037681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22666378	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349600027
J	Hacker, K; Choi, YS; Trebino, L; Hicks, L; Friedman, E; Blanchfield, B; Gazelle, GS				Hacker, Karen; Choi, Yoon Susan; Trebino, Lisa; Hicks, LeRoi; Friedman, Elisa; Blanchfield, Bonnie; Gazelle, G. Scott			Exploring the Impact of Language Services on Utilization and Clinical Outcomes for Diabetics	PLOS ONE			English	Article							LIMITED ENGLISH PROFICIENCY; HEALTH-CARE QUALITY; MEDICAL INTERPRETATION; INTERPRETER SERVICES; CONCORDANCE; SPEAKING; SATISFACTION; DISPARITIES; MANAGEMENT; BARRIERS	Background: Significant health disparities exist between limited English proficient and English-proficient patients. Little is known about the impact of language services on chronic disease outcomes such as for diabetes. Methods/Principal Findings: To determine whether the amount and type of language services received during primary care visits had an impact on diabetes-related outcomes (hospitalization, emergency room utilization, glycemic control) in limited English proficient patients, a retrospective cohort design was utilized. Hospital and medical record data was examined for 1425 limited English proficient patients in the Cambridge Health Alliance diabetes registry. We categorized patients receiving usual care into 7 groups based on the amount and combination of language services (language concordant providers, formal interpretation and nothing) received at primary care visits during a 9 month period. Bivariate analyses and multiple logistic regression were used to determine relationships between language service categories and outcomes in the subsequent 6 months. Thirty-one percent of patients (445) had no documentation of interpreter use or seeing a language concordant provider in any visits. Patients who received 100% of their primary care visits with language concordant providers were least likely to have diabetes-related emergency department visits compared to other groups (p<0001) in the following 6 months. Patients with higher numbers of co-morbidities were more likely to receive formal interpretation. Conclusions/Significance: Language concordant providers may help reduce health care utilization for limited English proficient patients with diabetes. However, given the lack of such providers in sufficient numbers to meet patients' communication needs, strategies are needed to both increase their numbers and ensure that the highest risk patients receive the most appropriate language services. In addition, systems serving diverse populations must clarify why some limited English proficient patients do not receive language services at some or all of their visits and whether this has an impact on quality of care.	[Hacker, Karen; Choi, Yoon Susan; Trebino, Lisa; Friedman, Elisa] Cambridge Hlth Alliance, Inst Community Hlth, Cambridge, MA USA; [Hacker, Karen; Gazelle, G. Scott] Harvard Univ, Sch Med, Boston, MA USA; [Hicks, LeRoi] Univ Massachusetts, Sch Med, Umass Mem Hlth Care, Worcester, MA USA; [Blanchfield, Bonnie; Gazelle, G. Scott] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA	Harvard University; Cambridge Health Alliance; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital	Hacker, K (corresponding author), Cambridge Hlth Alliance, Inst Community Hlth, Cambridge, MA USA.	Khacker@challiance.org			Robert Wood Johnson Foundation [55881]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This work was funded in part by a grant from the Robert Wood Johnson Foundation Grant #55881 Cost Effectiveness of Language Services. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality (AHRQ), 2005, REC START SET AMB CA; Association IMI, 2007, MED INT STAND PRACT; Baker DW, 1998, MED CARE, V36, P1461, DOI 10.1097/00005650-199810000-00004; Bernstein Judith, 2002, J Immigr Health, V4, P171, DOI 10.1023/A:1020125425820; Carrasquillo O, 1999, J GEN INTERN MED, V14, P82, DOI 10.1046/j.1525-1497.1999.00293.x; CHA, 2009, PAT DEM REP; Crossman KL, 2010, PEDIATRICS, V125, pE631, DOI 10.1542/peds.2009-0769; Dang J, 2010, J CANCER EDUC, V25, P253, DOI 10.1007/s13187-010-0074-1; DuBard CA, 2008, AM J PUBLIC HEALTH, V98, P2021, DOI 10.2105/AJPH.2007.119008; Eamranond PP, 2009, J IMMIGR MINOR HEALT, V11, P494, DOI 10.1007/s10903-008-9222-7; Egede LE, 2004, DIABETES CARE, V27, P1748, DOI 10.2337/diacare.27.7.1748; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ferguson WJ, 2008, HEALTH AFFAIR, V27, P1695, DOI 10.1377/hlthaff.27.6.1695; Fernandez A, 2011, J GEN INTERN MED, V26, P170, DOI 10.1007/s11606-010-1507-6; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Flores G, 2003, PEDIATRICS, V111, P6, DOI 10.1542/peds.111.1.6; Flores G, 2003, ERRORS MED INTERPRET; Gany F, 2007, J GEN INTERN MED, V22, P319, DOI 10.1007/s11606-007-0361-7; Gentile NT, 2008, ETHNIC DIS, V18, P330; Gonzalez HM, 2010, J AM BOARD FAM MED, V23, P745, DOI 10.3122/jabfm.2010.06.090264; Green AR, 2005, J GEN INTERN MED, V20, P1050, DOI 10.1111/j.1525-1497.2005.0223.x; Hampers LC, 1999, PEDIATRICS, V103, P1253, DOI 10.1542/peds.103.6.1253; Holman H, 2004, PUBLIC HEALTH REP, V119, P239, DOI 10.1016/j.phr.2004.04.002; Jacobs E, 2006, MILBANK Q, V84, P111, DOI 10.1111/j.1468-0009.2006.00440.x; Jacobs EA, 2005, AM J PUBLIC HEALTH, V95, P1410, DOI 10.2105/AJPH.2004.041418; Jacobs EA, 2001, J GEN INTERN MED, V16, P468, DOI 10.1046/j.1525-1497.2001.016007468.x; John-Baptiste A, 2004, J GEN INTERN MED, V19, P221, DOI 10.1111/j.1525-1497.2004.21205.x; Karliner LS, 2008, J GEN INTERN MED, V23, P1555, DOI 10.1007/s11606-008-0693-y; Karliner LS, 2007, HEALTH SERV RES, V42, P727, DOI 10.1111/j.1475-6773.2006.00629.x; Lasater LM, 2001, ARCH INTERN MED, V161, P77, DOI 10.1001/archinte.161.1.77; Lerman I, 2004, BIOMED PHARMACOTHER, V58, P566, DOI 10.1016/j.biopha.2004.09.003; Lopez-Quintero C, 2010, J AM DIET ASSOC, V110, pS62, DOI 10.1016/j.jada.2010.03.009; MANSON A, 1988, MED CARE, V26, P1119, DOI 10.1097/00005650-198812000-00003; Moreno G, 2010, J GEN INTERN MED, V25, P1282, DOI 10.1007/s11606-010-1467-x; Nam S, 2011, DIABETES RES CLIN PR; Ngo-Metzger Q, 2007, J GEN INTERN MED, V22, P324, DOI 10.1007/s11606-007-0340-z; Parchman ML, 2009, PATIENT EDUC COUNS, V77, P55, DOI 10.1016/j.pec.2009.03.006; Perez-Stable EJ, 1997, MED CARE, V35, P1212, DOI 10.1097/00005650-199712000-00005; Pippins JR, 2007, MED CARE, V45, P1020, DOI 10.1097/MLR.0b013e31814847be; Robinson S, 2009, POPUL HEALTH MANAG, V12, P139, DOI 10.1089/pop.2008.0026; Rogers AJ, 2004, AM J EMERG MED, V22, P534, DOI 10.1016/j.ajem.2004.08.012; Schenker Y, 2010, PATIENT EDUC COUNS, V81, P222, DOI 10.1016/j.pec.2010.02.005; Sequist TD, 2008, J GEN INTERN MED, V23, P678, DOI 10.1007/s11606-008-0510-7; Tocher TM, 1998, WESTERN J MED, V168, P504; Tomlin AM, 2006, DIABETES RES CLIN PR, V73, P260, DOI 10.1016/j.diabres.2006.01.008; Traylor AH, 2010, J GEN INTERN MED, V25, P1172, DOI 10.1007/s11606-010-1424-8; Vargas RB, 2004, J HEALTH CARE POOR U, V15, P562, DOI 10.1353/hpu.2004.0074; Wilson E, 2005, J GEN INTERN MED, V20, P800, DOI 10.1111/j.1525-1497.2005.0174.x; Zhang Q, 2009, ETHNIC HEALTH, V14, P439, DOI 10.1080/13557850802699155	49	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38507	10.1371/journal.pone.0038507	http://dx.doi.org/10.1371/journal.pone.0038507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675571	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700083
J	Lahey, T; Ghosh, M; Fahey, JV; Shen, Z; Mukura, LR; Song, Y; Cu-Uvin, S; Mayer, KH; Wright, PF; Kappes, JC; Ochsenbauer, C; Wira, CR				Lahey, Timothy; Ghosh, Mimi; Fahey, John V.; Shen, Zheng; Mukura, Lucy R.; Song, Yan; Cu-Uvin, Susan; Mayer, Kenneth H.; Wright, Peter F.; Kappes, John C.; Ochsenbauer, Christina; Wira, Charles R.			Selective Impact of HIV Disease Progression on the Innate Immune System in the Human Female Reproductive Tract	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LEUKOCYTE PROTEASE INHIBITOR; UTERINE EPITHELIAL-CELLS; HETEROSEXUAL TRANSMISSION; ACTIVATION MARKERS; T-CELLS; IDENTIFICATION; ELAFIN; SUSCEPTIBILITY; PROTECTION	Background: We have previously demonstrated intrinsic anti-HIV activity in cervicovaginal lavage (CVL) from HIV-infected women with high CD4 counts and not on antiretroviral therapy. However, the impact of HIV disease progression on CVL innate immune responses has not been delineated. Methods: CVL from 57 HIV-infected women not on antiretroviral therapy were collected by washing the cervicovaginal area with 10 mu l of sterile normal saline. We characterized subject HIV disease progression by CD4 count strata: >500 cells/mu l, 200-500 cells/mu l, or <200 cells/mu l of blood. To assess CVL anti-HIV activity, we incubated TZM-bl cells with HIV plus or minus CVL. Antimicrobials, cytokines, chemokines and anti-gp160 HIV IgG antibodies were measured by ELISA and Luminex. Results: CVL exhibited broad anti-HIV activity against multiple laboratory-adapted and transmitted/founder (T/F) viruses, with anti-HIV activity ranging from 0 to 100% showing wide variation between viral strains. Although there was broad CVL inhibition of most both laboratory-adapted and T/F virus strains, there was practically no inhibition of T/F strain RHPA.c, which was isolated from a woman newly infected via heterosexual intercourse. HIV disease progression, measured by declining CD4 T cell counts, resulted in a selective reduction in intrinsic anti-HIV activity in CVL that paralleled CVL decreases in human beta-defensin 2 and increases in Elafin and secretory leukocyte protease inhibitor. HIV disease progress predicted decreased CVL anti-HIV activity against both laboratory-adapted and T/F strains of HIV. Anti-HIV activity exhibited close associations with CVL levels of fourteen cytokines and chemokines. Conclusions: Amid a multifaceted immune defense against HIV-1 and other sexually transmitted pathogens, HIV disease progression is associated with selective disturbances in both CVL anti-HIV activity and specific innate immune defenses in the human female reproductive tract (FRT). Overall, these studies indicate that innate immune protection in the FRT is compromised as women progress to AIDS.	[Lahey, Timothy] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Ghosh, Mimi; Fahey, John V.; Shen, Zheng; Mukura, Lucy R.; Song, Yan; Wira, Charles R.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA; [Cu-Uvin, Susan; Mayer, Kenneth H.] Brown Univ, Dept Obstet & Gynecol & Med, Alpert Sch Med, Providence, RI 02912 USA; [Wright, Peter F.] Geisel Sch Med Dartmouth, Dept Pediat, Lebanon, NH USA; [Kappes, John C.; Ochsenbauer, Christina] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	Dartmouth College; Dartmouth College; Brown University; Dartmouth College; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Lahey, T (corresponding author), Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA.	Timothy.Lahey@Dartmouth.edu			National Institutes of Health (NIH) Grants Allergy and Infectious Diseases [AI51877, AI13541, AI40350, AI066884]; NIH Center for HIV/AIDS Vaccine Immunology [U01-AI067854]; Lifespan/Tufts/Brown Centers for AIDS Research (CFAR) [P30AI42853]; Centers for Disease Control [106795]; Virology and Nucleotide Sequencing Cores of the University of Alabama at Birmingham CFAR, NIH [P30-AI27767]; National Center for Research Resources, Centers for Biomedical Research Excellence [5P20RR016437-08]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040350, K24AI066884, R01AI102838, R01AI013541, U01AI067854, P30AI027767, R37AI013541, P30AI042853, R55AI013541, R21AI040350] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Grants Allergy and Infectious Diseases; NIH Center for HIV/AIDS Vaccine Immunology; Lifespan/Tufts/Brown Centers for AIDS Research (CFAR); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Virology and Nucleotide Sequencing Cores of the University of Alabama at Birmingham CFAR, NIH; National Center for Research Resources, Centers for Biomedical Research Excellence; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Grants Allergy and Infectious Diseases AI51877 and AI13541 (CRW), AI40350 and AI066884, (SCU), NIH Center for HIV/AIDS Vaccine Immunology U01-AI067854 (JCK and CO); Lifespan/Tufts/Brown Centers for AIDS Research (CFAR) P30AI42853, Centers for Disease Control 106795 (SCU and KHM) and the Virology and Nucleotide Sequencing Cores of the University of Alabama at Birmingham CFAR (P30-AI27767) NIH, National Center for Research Resources, Centers for Biomedical Research Excellence 5P20RR016437-08 (TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Blaak H, 1998, J VIROL, V72, P218, DOI 10.1128/JVI.72.1.218-224.1998; Cohen MS, N ENGL J MED, V365, P493; COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fahey JV, 2002, J INFECT DIS, V185, P1606, DOI 10.1086/340512; FUCHS D, 1990, IMMUNOL LETT, V26, P75, DOI 10.1016/0165-2478(90)90178-S; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Guyot N, 2005, BIOL CHEM, V386, P391, DOI 10.1515/BC.2005.047; Hasan L, 2006, J IMMUNOL, V176, P6512, DOI 10.4049/jimmunol.176.11.6512; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Ishikawa C, 2010, J INNATE IMMUN, V2, P66, DOI 10.1159/000242114; Joint United Nations Program on HIV/AIDS (UNAIDS) and World Health Organization (WHO), 2007, AIDS EP UPD; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; King AE, 2003, BIOCHEM BIOPH RES CO, V310, P594, DOI 10.1016/j.bbrc.2003.08.151; King AE, 2003, J CLIN ENDOCR METAB, V88, P4426, DOI 10.1210/jc.2003-030239; King Anne E, 2003, Reprod Biol Endocrinol, V1, P116, DOI 10.1186/1477-7827-1-116; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Montefiori DC, 2010, PROTOCOL NEUTRALIZIN; Ochsenbauer C, 2011, J VIROL; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; PITCHENIK AE, 1983, ANN INTERN MED, V98, P277, DOI 10.7326/0003-4819-98-3-277; Pitt J, 1998, J ACQ IMMUN DEF SYND, V19, P462, DOI 10.1097/00042560-199812150-00004; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Seth N, 2005, J IMMUNOL, V175, P6948, DOI 10.4049/jimmunol.175.10.6948; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Tuomala RE, 2003, J INFECT DIS, V187, P375, DOI 10.1086/367706; Uvin SC, 1997, OBSTET GYNECOL, V90, P739, DOI 10.1016/S0029-7844(97)00411-0; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2011, AM J REPROD IMMUNOL, V65, P196, DOI 10.1111/j.1600-0897.2011.00970.x; Wright PF, 2002, AIDS RES HUM RETROV, V18, P1291, DOI 10.1089/088922202320886334; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yeaman GR, 1998, AIDS RES HUM RETROV, V14, pS57	47	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38100	10.1371/journal.pone.0038100	http://dx.doi.org/10.1371/journal.pone.0038100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675510	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341700037
J	Parnell, SC; Puri, S; Wallace, DP; Calvet, JP				Parnell, Stephen C.; Puri, Sanjeev; Wallace, Darren P.; Calvet, James P.			Protein Phosphatase-1 alpha Interacts with and Dephosphorylates Polycystin-1	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; KIDNEY-DISEASE; STRUCTURAL BASIS; PKD1 GENE; IN-VITRO; 3' REGION; PHOSPHORYLATION; MUTATIONS; KINASE; DOMAIN	Polycystin signaling is likely to be regulated by phosphorylation. While a number of potential protein kinases and their target phosphorylation sites on polycystin-1 have been identified, the corresponding phosphatases have not been extensively studied. We have now determined that polycystin-1 is a regulatory subunit for protein phosphatase-1 alpha (PP1 alpha). Sequence analysis has revealed the presence of a highly conserved PP1-interaction motif in the cytosolic, C-terminal tail of polycystin-1; and we have shown that transfected PP1 alpha specifically co-immunoprecipitates with a polycystin-1 C-tail construct. To determine whether PP1 alpha dephosphorylates polycystin-1, a PKA-phosphorylated GST-polycystin-1 fusion protein was shown to be dephosphorylated by PP1 alpha but not by PP2B (calcineurin). Mutations within the PP1-binding motif of polycystin-1, including an autosomal dominant polycystic kidney disease (ADPKD)-associated mutation, significantly reduced PP1 alpha-mediated dephosphorylation of polycystin-1. The results suggest that polycystin-1 forms a holoenzyme complex with PP1 alpha via a conserved PP1-binding motif within the polycystin-1 C-tail, and that PKA-phosphorylated polycystin-1 serves as a substrate for the holoenzyme.	[Parnell, Stephen C.; Calvet, James P.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA; [Parnell, Stephen C.; Wallace, Darren P.; Calvet, James P.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA; [Puri, Sanjeev] Panjab Univ, Univ Inst Engn & Technol, Dept Biotechnol, Chandigarh 160014, India; [Wallace, Darren P.] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Panjab University; University of Kansas; University of Kansas Medical Center	Parnell, SC (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA.	sparnell@kumc.edu; jcalvet@kumc.edu		Puri, Sanjeev/0000-0002-3967-987X; Puri, Sanjeev/0000-0002-4314-9871; Wallace, Darren/0000-0003-4616-7669	PKD Foundation [131a2f]; National Institutes of Health [P50 DK057301]; Pilot & Feasibility award [P50]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301] Funding Source: NIH RePORTER	PKD Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot & Feasibility award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by PKD Foundation (www.pkdcure.org) fellowship award 131a2f to Stephen Parnell, and by National Institutes of Health (www.nih.gov) Grant P50 DK057301 to James Calvet and a P50 Pilot & Feasibility award (SCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AR, 1999, HUM GENET, V105, P648, DOI 10.1007/s004390051157; Ayllon V, 2002, EUR J IMMUNOL, V32, P1847, DOI 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7; Badenas C, 1999, KIDNEY INT, V55, P1225, DOI 10.1046/j.1523-1755.1999.00368.x; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Beullens M, 2002, J BIOL CHEM, V277, P19855, DOI 10.1074/jbc.M200847200; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Boucher CA, 2011, BBA-MOL BASIS DIS, V1812, P1225, DOI 10.1016/j.bbadis.2010.11.006; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Garcia A, 2004, CR BIOL, V327, P93, DOI 10.1016/j.crvi.2004.01.001; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Heroes E., 2012, FEBS J; Hu JH, 2006, MOL BIOL CELL, V17, P2200, DOI 10.1091/mbc.E05-10-0935; Huang HB, 1999, J BIOL CHEM, V274, P7870, DOI 10.1074/jbc.274.12.7870; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Li HP, 1999, BIOCHEM BIOPH RES CO, V259, P356, DOI 10.1006/bbrc.1999.0780; Liu J, 2000, J BIOL CHEM, V275, P26074, DOI 10.1074/jbc.M003843200; Mi J, 2007, CANCER RES, V67, P1082, DOI 10.1158/0008-5472.CAN-06-3071; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Parnell SC, 1999, BIOCHEM BIOPH RES CO, V259, P539, DOI 10.1006/bbrc.1999.0810; Perrichot RA, 1999, HUM GENET, V105, P231, DOI 10.1007/s004390051094; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Reed B, 2008, AM J KIDNEY DIS, V52, P1042, DOI 10.1053/j.ajkd.2008.05.015; Schillace RV, 2001, J BIOL CHEM, V276, P12128, DOI 10.1074/jbc.M010398200; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Sutters M, 2001, KIDNEY INT, V60, P484, DOI 10.1046/j.1523-1755.2001.060002484.x; Tan YC, 2009, HUM MUTAT, V30, P264, DOI 10.1002/humu.20842; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Trinkle-Mulcahy L, 1999, J CELL SCI, V112, P157; Tsiokas L, 2009, AM J PHYSIOL-RENAL, V297, pF1, DOI 10.1152/ajprenal.90277.2008; Van Bodegom D, 2006, J BIOL CHEM, V281, P31234, DOI 10.1074/jbc.M606510200; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200	50	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36798	10.1371/journal.pone.0036798	http://dx.doi.org/10.1371/journal.pone.0036798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675472	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341700006
J	Wenzel, EM; Morton, A; Ebert, K; Welzel, O; Kornhuber, J; Cousin, MA; Groemer, TW				Wenzel, Eva M.; Morton, Andrew; Ebert, Katrin; Welzel, Oliver; Kornhuber, Johannes; Cousin, Michael A.; Groemer, Teja W.			Key Physiological Parameters Dictate Triggering of Activity-Dependent Bulk Endocytosis in Hippocampal Synapses	PLOS ONE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; NERVE-TERMINALS; CHROMAFFIN CELLS; CLATHRIN; RELEASE; DYNAMIN; RETRIEVAL; MEMBRANE; POOLS; PHOSPHORYLATION	To maintain neurotransmission in central neurons, several mechanisms are employed to retrieve synaptically exocytosed membrane. The two major modes of synaptic vesicle (SV) retrieval are clathrin-mediated endocytosis and activity-dependent bulk endocytosis (ADBE). ADBE is the dominant SV retrieval mode during intense stimulation, however the precise physiological conditions that trigger this mode are not resolved. To determine these parameters we manipulated rat hippocampal neurons using a wide spectrum of stimuli by varying both the pattern and duration of stimulation. Using live-cell fluorescence imaging and electron microscopy approaches, we established that stimulation frequency, rather than the stimulation load, was critical in the triggering of ADBE. Thus two hundred action potentials, when delivered at high frequency, were sufficient to induce near maximal bulk formation. Furthermore we observed a strong correlation between SV pool size and ability to perform ADBE. We also identified that inhibitory nerve terminals were more likely to utilize ADBE and had a larger SV recycling pool. Thus ADBE in hippocampal synaptic terminals is tightly coupled to stimulation frequency and is more likely to occur in terminals with large SV pools. These results implicate ADBE as a key modulator of both hippocampal neurotransmission and plasticity.	[Wenzel, Eva M.; Ebert, Katrin; Welzel, Oliver; Kornhuber, Johannes; Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Morton, Andrew; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Wenzel, Eva M.] Univ Oslo, Ctr Canc Biomed, Fac Med, Oslo, Norway	University of Erlangen Nuremberg; University of Edinburgh; University of Oslo	Wenzel, EM (corresponding author), Oslo Univ Hosp, Dept Biochem, Inst Canc Res, Norwegian Radium Hosp, Montebello, Norway.	eva.wenzel@rr-research.no	Kornhuber, Johannes/B-9613-2014	Kornhuber, Johannes/0000-0002-8096-3987; Morton, Andrew/0000-0002-8180-542X; Cousin, Michael/0000-0002-1762-160X; Groemer, Teja/0000-0003-3854-716X; Wenzel, Eva Maria/0000-0002-5561-3344	Interdisciplinary Center of Clinical Research (IZKF) in Erlangen [J5, E10]; Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN; Biotechnology and Biology Sciences Research Council; Wellcome Trust [084277]	Interdisciplinary Center of Clinical Research (IZKF) in Erlangen; Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN; Biotechnology and Biology Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	TWG is supported by the Interdisciplinary Center of Clinical Research (IZKF) in Erlangen (Project J5 and E10). EMW was supported by a stipend from the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN. AM is supported by a Biotechnology and Biology Sciences Research Council studentship and work was supported by a Wellcome Trust award to MAC (084277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Cheung G, 2010, J NEUROSCI, V30, P8151, DOI 10.1523/JNEUROSCI.0293-10.2010; Clayton EL, 2008, NEUROCHEM INT, V53, P51, DOI 10.1016/j.neuint.2008.06.002; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Clayton EL, 2009, J NEUROSCI METH, V185, P76, DOI 10.1016/j.jneumeth.2009.09.016; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Dorostkar MM, 2010, J NEUROSCI METH, V188, P141, DOI 10.1016/j.jneumeth.2010.01.033; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Henkel AW, 2001, J CELL SCI, V114, P4613; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Hua YF, 2011, NAT NEUROSCI, V14, P833, DOI 10.1038/nn.2838; Kim SH, 2006, GENES CELLS, V11, P1197, DOI 10.1111/j.1365-2443.2006.01008.x; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; LENCER WI, 1990, AM J PHYSIOL, V258, pC309, DOI 10.1152/ajpcell.1990.258.2.C309; Martens H, 2008, J NEUROSCI, V28, P13125, DOI 10.1523/JNEUROSCI.3887-08.2008; Meunier FA, 2010, J CELL SCI, V123, P1131, DOI 10.1242/jcs.049296; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Paillart C, 2003, J NEUROSCI, V23, P4092; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Stroebel A, 2010, MICROSC RES TECHNIQ, V73, P1115, DOI 10.1002/jemt.20858; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Teng HB, 2007, J PHYSIOL-LONDON, V582, P243, DOI 10.1113/jphysiol.2007.130989; Welzel O, 2011, BIOPHYS J, V100, P593, DOI 10.1016/j.bpj.2010.12.3706; Welzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013514; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005	43	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38188	10.1371/journal.pone.0038188	http://dx.doi.org/10.1371/journal.pone.0038188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675521	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700044
J	Corver, WE; Ruano, D; Weijers, K; den Hartog, WCE; van Nieuwenhuizen, MP; de Miranda, N; van Eijk, R; Middeldorp, A; Jordanova, ES; Oosting, J; Kapiteijn, E; Hovens, G; Smit, J; van Wezel, T; Morreau, H				Corver, Willem E.; Ruano, Dina; Weijers, Karin; den Hartog, Wietske C. E.; van Nieuwenhuizen, Merlijn P.; de Miranda, Noel; van Eijk, Ronald; Middeldorp, Anneke; Jordanova, Ekaterina S.; Oosting, Jan; Kapiteijn, Ellen; Hovens, Guido; Smit, Jan; van Wezel, Tom; Morreau, Hans			Genome Haploidisation with Chromosome 7 Retention in Oncocytic Follicular Thyroid Carcinoma	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; RENAL-CELL CARCINOMAS; COMPLEX-I; PLOIDY ANALYSIS; FLOW-CYTOMETRY; COPY NUMBER; TUMORS; CANCER; BRAF; HYBRIDIZATION	Background: Recurrent non-medullary thyroid carcinoma (NMTC) is a rare disease. We initially characterized 27 recurrent NMTC: 13 papillary thyroid cancers (PTC), 10 oncocytic follicular carcinomas (FTC-OV), and 4 non-oncocytic follicular carcinomas (FTC). A validation cohort composed of benign and malignant (both recurrent and non-recurrent) thyroid tumours was subsequently analysed (n = 20). Methods: Data from genome-wide SNP arrays and flow cytometry were combined to determine the chromosomal dosage (allelic state) in these tumours, including mutation analysis of components of PIK3CA/AKT and MAPK pathways. Results: All FTC-OVs showed a very distinct pattern of genomic alterations. Ten out of 10 FTC-OV cases showed near-haploidisation with or without subsequent genome endoreduplication. Near-haploidisation was seen in 5/10 as extensive chromosome-wide monosomy (allelic state [A]) with near-haploid DNA indices and retention of especially chromosome 7 (seen as a heterozygous allelic state [AB]). In the remaining 5/10 chromosomal allelic states AA with near diploid DNA indices were seen with allelic state AABB of chromosome 7, suggesting endoreduplication after preceding haploidisation. The latter was supported by the presence of both near-haploid and endoreduplicated tumour fractions in some of the cases. Results were confirmed using FISH analysis. Relatively to FTC-OV limited numbers of genomic alterations were identified in other types of recurrent NMTC studied, except for chromosome 22q which showed alterations in 6 of 13 PTCs. Only two HRAS, but no mutations of EGFR or BRAF were found in FTC-OV. The validation cohort showed two additional tumours with the distinct pattern of genomic alterations (both with oncocytic features and recurrent). Conclusions: We demonstrate that recurrent FTC-OV is frequently characterised by genome-wide DNA haploidisation, heterozygous retention of chromosome 7, and endoreduplication of a near-haploid genome. Whether normal gene dosage on especially chromosome 7 (containing EGFR, BRAF, cMET) is crucial for FTC-OV tumour survival is an important topic for future research. Microarrays: Data are made available at GEO (GSE31828).	[Corver, Willem E.; Ruano, Dina; Weijers, Karin; den Hartog, Wietske C. E.; van Nieuwenhuizen, Merlijn P.; de Miranda, Noel; van Eijk, Ronald; Middeldorp, Anneke; Jordanova, Ekaterina S.; Oosting, Jan; van Wezel, Tom; Morreau, Hans] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Kapiteijn, Ellen] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Hovens, Guido; Smit, Jan] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Corver, WE (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	w.e.corver@lumc.nl; j.morreau@lumc.nl	van Wezel, Tom/Z-3092-2019; de Miranda, NFCC/I-2520-2015; Smit, J.W.A./H-8091-2014; Kapiteijn, Ellen/AAK-6065-2020; van Wezel, Tom/AAL-5626-2021; van Wezel, Tom/A-9599-2008; Corver, Willem/T-6576-2018; de Miranda, Noel/F-4518-2010	van Wezel, Tom/0000-0001-5773-7730; de Miranda, NFCC/0000-0001-6122-1024; Smit, J.W.A./0000-0003-1052-9314; Kapiteijn, Ellen/0000-0002-4814-6426; van Wezel, Tom/0000-0001-5773-7730; de Miranda, Noel/0000-0001-6122-1024; Corver, Willem/0000-0001-8313-3658; Jordanova, Ekaterina S./0000-0002-8121-1322; van Eijk, Ronald/0000-0001-7955-6295; Jordanova, Ekaterina/0000-0003-3890-7102				Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; Bovee JVMG, 2000, AM J PATHOL, V157, P1587, DOI 10.1016/S0002-9440(10)64796-7; Corver WE, 2005, J PATHOL, V206, P233, DOI 10.1002/path.1765; Corver WE, 2008, CANCER RES, V68, P10333, DOI 10.1158/0008-5472.CAN-08-2665; Dettori T, 2003, GENE CHROMOSOME CANC, V38, P22, DOI 10.1002/gcc.10238; ELNAGGAR AK, 1988, ARCH OTOLARYNGOL, V114, P520; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; Frisk T, 1999, GENE CHROMOSOME CANC, V25, P349, DOI 10.1002/(SICI)1098-2264(199908)25:4<349::AID-GCC6>3.3.CO;2-4; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gasparre G, 2010, MOL CELL ENDOCRINOL, V321, P67, DOI 10.1016/j.mce.2010.02.022; GregoriRomero MA, 1996, CANCER GENET CYTOGEN, V92, P28, DOI 10.1016/S0165-4608(96)00026-X; Gupta-Abramson V, 2008, J CLIN ONCOL, V26, P4714, DOI 10.1200/JCO.2008.16.3279; HEDLEY DW, 1983, J HISTOCHEM CYTOCHEM, V31, P1333, DOI 10.1177/31.11.6619538; Hoftijzer H, 2009, EUR J ENDOCRINOL, V161, P923, DOI 10.1530/EJE-09-0702; Hogan Thomas, 2009, J Oncol Pharm Pract, V15, P111, DOI 10.1177/1078155208101212; Kapiteijn E, 2012, ANN ONCOL, V23, P10, DOI 10.1093/annonc/mdr117; Kim HJ, 2009, AM J SURG PATHOL, V33, P1276, DOI 10.1097/PAS.0b013e3181a2aa36; Lee MH, 2011, J CLIN ENDOCR METAB, V96, pE19, DOI 10.1210/jc.2010-1071; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Masago K, 2009, INT J CANCER, V124, P2744, DOI 10.1002/ijc.24250; Mayr JA, 2008, CLIN CANCER RES, V14, P2270, DOI 10.1158/1078-0432.CCR-07-4131; MCLEOD MK, 1988, ARCH SURG-CHICAGO, V123, P849; Nagy A, 2002, GENE CHROMOSOME CANC, V35, P256, DOI 10.1002/gcc.10118; Nikiforov YE, 2011, ARCH PATHOL LAB MED, V135, P569, DOI 10.1043/2010-0664-RAIR.1; Nikiforova MN, 2008, EXPERT REV MOL DIAGN, V8, P83, DOI 10.1586/14737159.8.1.83; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P2318, DOI 10.1210/jc.2002-021907; Oosting J, 2007, GENOME RES, V17, P368, DOI 10.1101/gr.5686107; Ribeiro FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-371; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Rivera M, 2010, MODERN PATHOL, V23, P1191, DOI 10.1038/modpathol.2010.112; RIZZONI M, 1974, CHROMOSOMA, V45, P151, DOI 10.1007/BF00362308; Savagner F, 2001, J CLIN ENDOCR METAB, V86, P4920, DOI 10.1210/jc.86.10.4920; Savagner F, 2001, THYROID, V11, P327, DOI 10.1089/10507250152039055; SCHULTZ DS, 1992, AM J CLIN PATHOL, V98, P291, DOI 10.1093/ajcp/98.3.291; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; SPEICHER MR, 1994, AM J PATHOL, V145, P356; Stankov K, 2004, INT J CANCER, V111, P463, DOI 10.1002/ijc.20259; Stankov K, 2006, THYROID, V16, P325, DOI 10.1089/thy.2006.16.325; Tallini G, 1999, LAB INVEST, V79, P547; Tan MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-196; Tung WS, 1997, GENE CHROMOSOME CANC, V19, P43, DOI 10.1002/(SICI)1098-2264(199705)19:1<43::AID-GCC7>3.0.CO;2-0; Unger K, 2008, ONCOGENE, V27, P4592, DOI 10.1038/onc.2008.99; Wada N, 2002, J CLIN ENDOCR METAB, V87, P4595, DOI 10.1210/jc.2002-020339; Xu XL, 2003, CANCER RES, V63, P4561; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; ZEDENIUS J, 1995, HUM GENET, V96, P27, DOI 10.1007/BF00214182; Zielke A, 1998, THYROID, V8, P475, DOI 10.1089/thy.1998.8.475; Zimmermann Franz A, 2011, Front Biosci (Elite Ed), V3, P315	49	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38287	10.1371/journal.pone.0038287	http://dx.doi.org/10.1371/journal.pone.0038287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675538	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339900021
J	Low, C; Jegerschold, C; Kovermann, M; Moberg, P; Nordlund, P				Low, Christian; Jegerschold, Caroline; Kovermann, Michael; Moberg, Per; Nordlund, Par			Optimisation of Over-Expression in E. coli and Biophysical Characterisation of Human Membrane Protein Synaptogyrin 1	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; BACTERIOPHAGE-T7 RNA-POLYMERASE; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; SCAMP1 FUNCTION; SYNAPTOPHYSIN; GENE; OVEREXPRESSION; SCHIZOPHRENIA; ENDOCYTOSIS	Progress in functional and structural studies of integral membrane proteins (IMPs) is lacking behind their soluble counterparts due to the great challenge in producing stable and homogeneous IMPs. Low natural abundance, toxicity when over-expressed and potential lipid requirements of IMPs are only a few reasons for the limited progress. Here, we describe an optimised workflow for the recombinant over-expression of the human tetraspan vesicle protein (TVP) synaptogyrin in Escherichia coli and its biophysical characterisation. TVPs are ubiquitous and abundant components of vesicles. They are believed to be involved in various aspects of the synaptic vesicle cycle, including vesicle biogenesis, exocytosis and endocytotic recycling. Even though TVPs are found in most cell types, high-resolution structural information for this class of membrane proteins is still missing. The optimisation of the N-terminal sequence of the gene together with the usage of the recently developed Lemo21(DE3) strain which allows the balancing of the translation with the membrane insertion rate led to a 50-fold increased expression rate compared to the classical BL21(DE3) strain. The protein was soluble and stable in a variety of mild detergents and multiple biophysical methods confirmed the folded state of the protein. Crosslinking experiments suggest an oligomeric architecture of at least four subunits. The protein stability is significantly improved in the presence of cholesteryl hemisuccinate as judged by differential light scattering. The approach described here can easily be adapted to other eukaryotic IMPs.	[Low, Christian; Moberg, Per; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Jegerschold, Caroline] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Kovermann, Michael] Univ Halle Wittenberg, Inst Phys, Saale, Germany; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Karolinska Institutet; Karolinska Institutet; Martin Luther University Halle Wittenberg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Low, C (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	christian.low@ki.se; par.nordlund@ki.se		Jegerschold, Caroline/0000-0003-2419-6354; Loew, Christian/0000-0003-0764-7483	EMBO (European Molecular Biology Organization) postdoctoral fellowship; Swedish Research council; Swedish Cancer Society; integrated EU project EDICT (European drug initiative on channels and transporters); Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant	EMBO (European Molecular Biology Organization) postdoctoral fellowship; Swedish Research council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); integrated EU project EDICT (European drug initiative on channels and transporters); Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant(National Research Foundation, Singapore)	CL was supported by an EMBO (European Molecular Biology Organization) postdoctoral fellowship. This research was supported by grants from the Swedish Research council, Swedish Cancer Society and the integrated EU project EDICT (European drug initiative on channels and transporters), as well as Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abraham C, 2006, P NATL ACAD SCI USA, V103, P8227, DOI 10.1073/pnas.0509400103; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Belizaire R, 2004, J COMP NEUROL, V470, P266, DOI 10.1002/cne.20008; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Casagrande F, 2009, J MOL BIOL, V394, P708, DOI 10.1016/j.jmb.2009.09.048; Chen R, 2011, BIOTECHNOL ADV; Cheng MC, 2007, J PSYCHIATR RES, V41, P1027, DOI 10.1016/j.jpsychires.2006.08.010; Chua JJE, 2010, J CELL SCI, V123, P819, DOI 10.1242/jcs.052696; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Felkl M, 2008, NEUROSCIENCE, V156, P344, DOI 10.1016/j.neuroscience.2008.07.033; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Fernandez-Chacon R, 1999, J BIOL CHEM, V274, P32551, DOI 10.1074/jbc.274.46.32551; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Hitchcock IS, 2004, NEUROSCI LETT, V362, P196, DOI 10.1016/j.neulet.2004.02.071; Horikawa HPM, 2002, MOL CELL NEUROSCI, V21, P454, DOI 10.1006/mcne.2002.1191; Hubner K, 2002, INT REV CYTOL, V214, P103; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Iatropoulos P, 2009, PSYCHIAT GENET, V19, P237, DOI 10.1097/YPG.0b013e32832cebf7; IOST I, 1992, J BACTERIOL, V174, P619, DOI 10.1128/jb.174.2.619-622.1992; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kedra D, 1998, HUM GENET, V103, P131, DOI 10.1007/s004390050795; Klepsch MM, 2011, J MOL BIOL, V407, P532, DOI 10.1016/j.jmb.2011.02.007; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nguyen TA, 2010, J MOL MICROB BIOTECH, V18, P85, DOI 10.1159/000283512; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Schlegel S, 2010, MICROB BIOTECHNOL, V3, P403, DOI 10.1111/j.1751-7915.2009.00148.x; Senisterra GA, 2010, J BIOMOL SCREEN, V15, P314, DOI 10.1177/1087057109357117; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Stenius K, 1995, J CELL BIOL, V131, P1801, DOI 10.1083/jcb.131.6.1801; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Verma R, 2005, J HUM GENET, V50, P635, DOI 10.1007/s10038-005-0307-z; Verma R, 2004, BIOL PSYCHIAT, V55, P196, DOI 10.1016/j.biopsych.2003.10.012; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Welch M, 2011, METHOD ENZYMOL, V498, P43, DOI 10.1016/B978-0-12-385120-8.00003-6; Woestenenk Esmeralda A., 2004, Journal of Structural and Functional Genomics, V5, P217, DOI 10.1023/B:jsfg.0000031965.37625.0e; Zhao HJ, 2001, MOL BIOL CELL, V12, P2275, DOI 10.1091/mbc.12.8.2275	53	20	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38244	10.1371/journal.pone.0038244	http://dx.doi.org/10.1371/journal.pone.0038244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675529	gold, Green Published			2022-12-27	WOS:000305339900019
J	McElroy, SJ; Hobbs, S; Kallen, M; Tejera, N; Rosen, MJ; Grishin, A; Matta, P; Schneider, C; Upperman, J; Ford, H; Polk, DB; Weitkamp, JH				McElroy, Steven J.; Hobbs, Stuart; Kallen, Michael; Tejera, Noemi; Rosen, Michael J.; Grishin, Anatoly; Matta, Poojitha; Schneider, Claus; Upperman, Jeffrey; Ford, Henri; Polk, D. Brent; Weitkamp, Joern-Hendrik			Transactivation of EGFR by LPS Induces COX-2 Expression in Enterocytes	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EXPERIMENTAL NECROTIZING ENTEROCOLITIS; INTESTINAL EPITHELIUM; PRETERM INFANTS; COLONIC INJURY; TLR4; RAT; PATHOGENESIS; RECEPTOR; CYCLOOXYGENASE-2	Necrotizing enterocolitis (NEC) is the leading cause of gastrointestinal morbidity and mortality in preterm infants. NEC is characterized by an exaggerated inflammatory response to bacterial flora leading to bowel necrosis. Bacterial lipopolysaccharide (LPS) mediates inflammation through TLR4 activation and is a key molecule in the pathogenesis of NEC. However, LPS also induces cyclooxygenase-2 (COX-2), which promotes intestinal barrier restitution through stimulation of intestinal cell survival, proliferation, and migration. Epidermal growth factor receptor (EGFR) activation prevents experimental NEC and may play a critical role in LPS-stimulated COX-2 production. We hypothesized that EGFR is required for LPS induction of COX-2 expression. Our data show that inhibiting EGFR kinase activity blocks LPS-induced COX-2 expression in small intestinal epithelial cells. LPS induction of COX-2 requires Src-family kinase signaling while LPS transactivation of EGFR requires matrix metalloprotease (MMP) activity. EGFR tyrosine kinase inhibitors block LPS stimulation of mitogen-activated protein kinase ERK, suggesting an important role of the MAPK/ERK pathway in EGFR-mediated COX-2 expression. LPS stimulates proliferation of IEC-6 cells, but this stimulation is inhibited with either the EGFR kinase inhibitor AG1478, or the selective COX-2 inhibitor Celecoxib. Taken together, these data show that EGFR plays an important role in LPS-induction of COX-2 expression in enterocytes, which may be one mechanism for EGF in inhibition of NEC.	[McElroy, Steven J.; Rosen, Michael J.; Matta, Poojitha; Weitkamp, Joern-Hendrik] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Hobbs, Stuart] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Tejera, Noemi; Schneider, Claus] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Tejera, Noemi; Schneider, Claus] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA; [Grishin, Anatoly; Upperman, Jeffrey; Ford, Henri] Childrens Hosp Los Angeles, Saban Res Inst, Div Pediat Surg, Los Angeles, CA 90027 USA; [Polk, D. Brent] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Polk, D. Brent] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Children's Hospital Los Angeles; University of Southern California; University of Southern California	McElroy, SJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	hendrik.weitkamp@vanderbilt.edu	Tejera, Noemi/O-1558-2016; McElroy, Steven/AGR-6835-2022; McElroy, Steven/AAC-7204-2019; Weitkamp, Joern-Hendrik/AAZ-8272-2020	McElroy, Steven/0000-0002-4321-723X; McElroy, Steven/0000-0002-4321-723X; Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Tejera, Noemi/0000-0001-8100-6022; Rosen, Michael/0000-0002-5149-718X	National Institutes of Health (NIH) [K08DK083677, R21AI083612, R01GM076592, R01AI014032, R01DK54993, R01DK56008, K08HD061607]; Vanderbilt Physician Scientist Development Award; Vanderbilt Digestive Diseases Research Center [NIH P30DK058404]; Center's Pilot and Feasibility Program, Flow Cytometry and Cellular and Animal Modeling Shared Resources and the National Institutes of Health funded Vanderbilt Summer Research and Training Program [1T35 ES016534-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD061607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083612, R01AI014032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK083677, R01DK056008, P30DK058404, R01DK054993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T35ES016534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Physician Scientist Development Award; Vanderbilt Digestive Diseases Research Center; Center's Pilot and Feasibility Program, Flow Cytometry and Cellular and Animal Modeling Shared Resources and the National Institutes of Health funded Vanderbilt Summer Research and Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health (NIH) Grants: K08DK083677 (to SJM); R21AI083612 (to AG); R01GM076592 (to CS); R01AI014032 (to HRF); R01DK54993 and R01DK56008 (to DBP); and K08HD061607 (to JHW). It was also supported in part by a Vanderbilt Physician Scientist Development Award (to JHW), and the Vanderbilt Digestive Diseases Research Center (NIH P30DK058404) including the Center's Pilot and Feasibility Program, Flow Cytometry and Cellular and Animal Modeling Shared Resources and the National Institutes of Health funded Vanderbilt Summer Research and Training Program 1T35 ES016534-01 (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Cetin S, 2004, J BIOL CHEM, V279, P24592, DOI 10.1074/jbc.M313620200; Chailler Pierre, 1999, Frontiers in Bioscience, V4, pD87, DOI 10.2741/Chailler; Chung DH, 2001, ANN SURG, V233, P835, DOI 10.1097/00000658-200106000-00014; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Crow JD, 2000, J PEDIATR SURG, V35, P177; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Fagbemi AO, 2001, EARLY HUM DEV, V65, P1, DOI 10.1016/S0378-3782(01)00164-5; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Grishin A, 2004, SURGERY, V136, P329, DOI 10.1016/j.surg.2004.05.008; Grishin AV, 2006, J IMMUNOL, V176, P580, DOI 10.4049/jimmunol.176.1.580; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; Halpern MD, 2003, J PEDIATR GASTR NUTR, V36, P126, DOI 10.1097/00005176-200301000-00024; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Lugo B, 2007, J PEDIATR SURG, V42, P1165, DOI 10.1016/j.jpedsurg.2007.02.006; Maynard AA, 2010, AM J PHYSIOL-GASTR L, V299, pG614, DOI 10.1152/ajpgi.00076.2010; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Nair RR, 2008, SEMIN PERINATOL, V32, P107, DOI 10.1053/j.semperi.2008.01.007; Petrosyan M, 2009, PEDIATR SURG INT, V25, P309, DOI 10.1007/s00383-009-2344-8; Reuter BK, 1996, J CLIN INVEST, V98, P2076, DOI 10.1172/JCI119013; Shin CE, 2000, J PEDIATR SURG, V35, P173, DOI 10.1016/S0022-3468(00)90005-8; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Warner BB, 2007, J PEDIATR-US, V150, P358, DOI 10.1016/j.jpeds.2006.11.059; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105	34	46	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38373	10.1371/journal.pone.0038373	http://dx.doi.org/10.1371/journal.pone.0038373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675459	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000305338500140
J	Sahu, SN; Lewis, J; Patel, I; Bozdag, S; Lee, JH; LeClerc, JE; Cinar, HN				Sahu, Surasri N.; Lewis, Jada; Patel, Isha; Bozdag, Serdar; Lee, Jeong H.; LeClerc, Joseph E.; Cinar, Hediye Nese			Genomic Analysis of Immune Response against Vibrio cholerae Hemolysin in Caenorhabditis elegans	PLOS ONE			English	Article							EL-TOR HEMOLYSIN; INNATE IMMUNITY; VIRULENCE FACTORS; CELL VACUOLATION; RECEPTOR; GENES; EXPRESSION; SURVIVAL; PATHWAY; TOXIN	Vibrio cholerae cytolysin (VCC) is among the accessory V. cholerae virulence factors that may contribute to disease pathogenesis in humans. VCC, encoded by hlyA gene, belongs to the most common class of bacterial toxins, known as pore-forming toxins (PFTs). V. cholerae infects and kills Caenorhabditis elegans via cholerae toxin independent manner. VCC is required for the lethality, growth retardation and intestinal cell vacuolation during the infection. However, little is known about the host gene expression responses against VCC. To address this question we performed a microarray study in C. elegans exposed to V. cholerae strains with intact and deleted hlyA genes. Many of the VCC regulated genes identified, including C-type lectins, Prion-like (glutamine [Q]/asparagine [N]-rich)-domain containing genes, genes regulated by insulin/IGF-1-mediated signaling (IIS) pathway, were previously reported as mediators of innate immune response against other bacteria in C. elegans. Protective function of the subset of the genes up-regulated by VCC was confirmed using RNAi. By means of a machine learning algorithm called FastMEDUSA, we identified several putative VCC induced immune regulatory transcriptional factors and transcription factor binding motifs. Our results suggest that VCC is a major virulence factor, which induces a wide variety of immune response-related genes during V. cholerae infection in C. elegans.	[Sahu, Surasri N.; Lee, Jeong H.; Cinar, Hediye Nese] US FDA, Div Virulence Assessment, Laurel, MD USA; [Lewis, Jada; Patel, Isha; LeClerc, Joseph E.] US FDA, Div Mol Biol, Laurel, MD USA; [Bozdag, Serdar] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA; [Sahu, Surasri N.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Lee, Jeong H.] Kyungpook Natl Univ, Taegu, South Korea	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Kyungpook National University	Sahu, SN (corresponding author), US FDA, Div Virulence Assessment, Laurel, MD USA.	hediye.cinar@fda.hhs.gov						Abdillahi SM, 2012, J INNATE IMMUN, V4, P371, DOI 10.1159/000335239; ALM RA, 1991, VACCINE, V9, P588, DOI 10.1016/0264-410X(91)90247-4; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Antebi Adam, 2006, WormBook, P1; Barrasa MI, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-21; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bozdag S, 2010, BIOINFORMATICS, V26, P1792, DOI 10.1093/bioinformatics/btq275; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Cinar HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011558; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Engelmann I, 2010, ADV EXP MED BIOL, V708, P105; FEELEY JC, 1963, B WORLD HEALTH ORGAN, V28, P347; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Glavis-Bloom J, 2012, ADV EXP MED BIOL, V710, P11, DOI 10.1007/978-1-4419-5638-5_2; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Huffman DL, 2004, INT J MED MICROBIOL, V293, P599, DOI 10.1078/1438-4221-00303; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Ikigai H, 1996, INFECT IMMUN, V64, P2968, DOI 10.1128/IAI.64.8.2968-2973.1996; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kundaje A, 2007, ANN NY ACAD SCI, V1115, P178, DOI 10.1196/annals.1407.020; Kundaje A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000224; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Maglich JM, 2001, GENOME BIOL, V2; Marroquin LD, 2000, GENETICS, V155, P1693; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; MICHALSKI J, 1993, INFECT IMMUN, V61, P4462, DOI 10.1128/IAI.61.10.4462-4468.1993; Mitra R, 2000, INFECT IMMUN, V68, P1928, DOI 10.1128/IAI.68.4.1928-1933.2000; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Olson R, 2003, PROTEIN SCI, V12, P379, DOI 10.1110/ps.0231703; PARSOT C, 1990, P NATL ACAD SCI USA, V87, P9898, DOI 10.1073/pnas.87.24.9898; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Reddy KC, 2011, P NATL ACAD SCI USA, V108, P12887, DOI 10.1073/pnas.1108265108; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Saka HA, 2007, AUTOPHAGY, V3, P363, DOI 10.4161/auto.4159; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; Sluder AE, 1999, GENOME RES, V9, P103; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Van Gilst M, 2002, CRIT REV EUKAR GENE, V12, P65; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x	66	35	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38200	10.1371/journal.pone.0038200	http://dx.doi.org/10.1371/journal.pone.0038200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675448	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500108
J	Kaneoke, Y; Donishi, T; Iwatani, J; Ukai, S; Shinosaki, K; Terada, M				Kaneoke, Yoshiki; Donishi, Tomohiro; Iwatani, Jun; Ukai, Satoshi; Shinosaki, Kazuhiro; Terada, Masaki			Variance and Autocorrelation of the Spontaneous Slow Brain Activity	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; NETWORK; VARIABILITY; PRECUNEUS; ANATOMY; CORTEX; SIGNAL; BOLD	Slow (<0.1 Hz) oscillatory activity in the human brain, as measured by functional magnetic imaging, has been used to identify neural networks and their dysfunction in specific brain diseases. Its intrinsic properties may also be useful to investigate brain functions. We investigated the two functional maps: variance and first order autocorrelation coefficient (r(1)). These two maps had distinct spatial distributions and the values were significantly different among the subdivisions of the precuneus and posterior cingulate cortex that were identified in functional connectivity (FC) studies. The results reinforce the functional segregation of these subdivisions and indicate that the intrinsic properties of the slow brain activity have physiological relevance. Further, we propose a sample size (degree of freedom) correction when assessing the statistical significance of FC strength with r(1) values, which enables a better understanding of the network changes related to various brain diseases.	[Kaneoke, Yoshiki; Donishi, Tomohiro] Wakayama Med Univ, Grad Sch, Dept Syst Neurophysiol, Wakayama, Japan; [Iwatani, Jun; Ukai, Satoshi; Shinosaki, Kazuhiro] Wakayama Med Univ, Grad Sch, Dept Neuropsychiat, Wakayama, Japan; [Terada, Masaki] Wakayama Minami Radiol Clin, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University	Kaneoke, Y (corresponding author), Wakayama Med Univ, Grad Sch, Dept Syst Neurophysiol, Wakayama, Japan.	kaneoke@wakayama-med.ac.jp		Ukai, Satoshi/0000-0002-9776-8379	Grants-in-Aid for Scientific Research [24591303] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		[Anonymous], 1964, HDB APPL HYROLOGY 3, P868; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Bartzokis G, 2007, ALZHEIMERS DEMENT, V3, P122, DOI 10.1016/j.jalz.2007.01.019; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; Garrett DD, 2010, J NEUROSCI, V30, P4914, DOI 10.1523/JNEUROSCI.5166-09.2010; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Hughett P., 2007, CODE SNIPPETS, V23, P1; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; Vos BP, 1999, J NEUROSCI, V19; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	36	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38131	10.1371/journal.pone.0038131	http://dx.doi.org/10.1371/journal.pone.0038131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666461	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400086
J	Rey-Cuille, MA; Seck, A; Njouom, R; Chartier, L; Sow, HD; MamadouBa; Ka, AS; Njankouo, M; Rousset, D; Giles-Vernick, T; Unal, G; Sire, JM; Garin, B; Simon, F; Vray, M				Rey-Cuille, Marie-Anne; Seck, Abdoulaye; Njouom, Richard; Chartier, Loic; Sow, Housseyn Dembel; MamadouBa; Ka, Amadou Sidy; Njankouo, Mohamadou; Rousset, Dominique; Giles-Vernick, Tamara; Unal, Guillemette; Sire, Jean-Marie; Garin, Benoit; Simon, Francois; Vray, Muriel			Low Immune Response to Hepatitis B Vaccine among Children in Dakar, Senegal	PLOS ONE			English	Article							EXPANDED PROGRAM; EPIDEMIOLOGY; IMMUNOGENICITY; INFECTION; VIRUS	HBV vaccine was introduced into the Expanded Programme on Immunization (EPI) in Senegal and Cameroon in 2005. We conducted a cross-sectional study in both countries to assess the HBV immune protection among children. All consecutive children under 4 years old, hospitalized for any reason between May 2009 and May 2010, with an immunisation card and a complete HBV vaccination, were tested for anti-HBs and anti-HBc. A total of 242 anti-HBc-negative children (128 in Cameroon and 114 in Senegal) were considered in the analysis. The prevalence of children with anti-HBs >= 10 IU/L was higher in Cameroon with 92% (95% CI: 87%-97%) compared to Senegal with 58% (95% CI: 49%-67%), (p<0.001). The response to vaccination in Senegal was lower in 2006-2007 (43%) than in 2008-2009 (65%), (p = 0.028). Our results, although not based on a representative sample of Senegalese or Cameroonian child populations, reveal a significant problem in vaccine response in Senegal. This response problem extends well beyond hepatitis B: the same children who have not developed an immune response to the HBV vaccine are also at risk for diphtheria, tetanus, pertussis (DTwP) and Haemophilus influenzae type b (Hib). Field biological monitoring should be carried out regularly in resource-poor countries to check quality of the vaccine administered.	[Rey-Cuille, Marie-Anne; Chartier, Loic; Giles-Vernick, Tamara; Unal, Guillemette; Vray, Muriel] Inst Pasteur, Unite Rech & Expertise Epidemiol Malad Emergentes, Paris, France; [Rey-Cuille, Marie-Anne] CNRS, Inst Biol Sci, Paris, France; [Seck, Abdoulaye; Sire, Jean-Marie; Garin, Benoit] Inst Pasteur, Med Biol Lab, Dakar, Senegal; [Njouom, Richard; Njankouo, Mohamadou; Rousset, Dominique] Ctr Pasteur Cameroun, Serv Virol, Yaounde, Cameroon; [Sow, Housseyn Dembel; MamadouBa] Hop Enfants Albert Royer, Dakar, Senegal; [Ka, Amadou Sidy] Hop Principal, Serv Pediat, Dakar, Senegal; [Sire, Jean-Marie; Simon, Francois] Hop St Louis, Dept Virol, Paris, France; [Vray, Muriel] INSERM, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Centre Pasteur du Cameroun; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rey-Cuille, MA (corresponding author), Inst Pasteur, Unite Rech & Expertise Epidemiol Malad Emergentes, Paris, France.	muriel.vray@pasteur.fr	Rey-Cuille, Marie-Anne/J-7486-2012; Rousset, Dominique/S-5400-2019; Vray, Muriel/M-7947-2018	Rousset, Dominique/0000-0002-1473-3147; 	"Actions concertees du Reseau International des Instituts Pasteur", France	"Actions concertees du Reseau International des Instituts Pasteur", France	The study was funded by the "Actions concertees du Reseau International des Instituts Pasteur", France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2000, VACCINE, V18, pS20, DOI 10.1016/S0264-410X(99)00456-9; Aspinall S, 1998, S AFR MED J, V88, P36; CHIARAMONTE M, 1991, J MED VIROL, V33, P95, DOI 10.1002/jmv.1890330206; Coursaget P, 1984, IARC Sci Publ, P319; DAO H, 1992, J TROP PEDIATRICS, V38, P179, DOI 10.1093/tropej/38.4.179; ElGamal Y, 1996, J TROP PEDIATRICS, V42, P144, DOI 10.1093/tropej/42.3.144; Foupouapouognigni Y, 2011, J CLIN MICROBIOL, V49, P737, DOI 10.1128/JCM.01475-10; GARRIGUE G, 1985, B SOC PATHOL EXOT, V78, P883; Gatchalian S, 2005, HUM VACCINES, V1, P198, DOI 10.4161/hv.1.5.2163; Kanra G, SAFETY IMMUNOGENICIT; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Lakshmi G, 2000, VACCINE, V18, P2009, DOI 10.1016/S0264-410X(99)00529-0; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Moore SE, 2003, ACTA PAEDIATR, V92, P170, DOI 10.1111/j.1651-2227.2003.tb00522.x; Plotkin SA, 2013, VACCINES; Roingeard Philippe, 1993, Viral Immunology, V6, P65, DOI 10.1089/vim.1993.6.65; Sall Diallo A, 2004, Dakar Med, V49, P136; Tsebe KV, 2001, VACCINE, V19, P3919, DOI 10.1016/S0264-410X(01)00120-7; Vray M, 2006, J MED VIROL, V78, P329, DOI 10.1002/jmv.20544; Wamukonya N., 2005, EC POLITICAL WKLY, V40, P5302; WHO, 2010, IMM STAND VACC QUAL; WHO, 2010, IMM SURV ASS MON; WHO, 1991, WHOEPIGEN9291	23	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38153	10.1371/journal.pone.0038153	http://dx.doi.org/10.1371/journal.pone.0038153			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666468	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400091
J	Santos, JR; Molto, J; Llibre, JM; Negredo, E; Bravo, I; Ornelas, A; Clotet, B; Paredes, R				Santos, Jose R.; Molto, Jose; Llibre, Josep M.; Negredo, Eugenia; Bravo, Isabel; Ornelas, Arelly; Clotet, Bonaventura; Paredes, Roger			Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile	PLOS ONE			English	Article							MONET TRIAL; NUCLEOSIDE ANALOGS; HIV RNA; EFFICACY	Background: Simplification of antiretroviral treatment (ART) with darunavir/ritonavir (DRV/r) monotherapy has achieved sustained suppression of plasma viral load (pVL) in clinical trials; however, its effectiveness and safety profile has not been evaluated in routine clinical practice. Methodology/Principal Findings: We performed a retrospective cohort analysis of HIV-1-infected patients who initiated DRV/r monotherapy once daily with a pVL <50 copies/mL under ART and at least 1 subsequent follow-up visit in our clinic. The primary study endpoints were the percentage of patients with virological failure (VF, defined as 2 consecutive pVL>50 copies/mL) at week 48, and time to VF. Other causes of treatment discontinuation and changes in lipid profile were evaluated up to week 48. Ninety-two patients were followed for a median (IQR) of 73 (57-92) weeks. The median baseline and nadir CD4+ T-cell counts were 604 (433-837) and 238 (150-376) cells/mm3, respectively. Patients had previously received a median of 5 (3-9) ART lines and maintained a pVL<50 copies/mL for a median of 76 (32-176) weeks before initiating DRV/r monotherapy. Nine (9.8%) patients developed VF at week 48; time to VF was 47.1 (IQR: 36.1-47.8) weeks among patients with VF. Other reasons for changing ART were gastrointestinal disturbances (n = 3), rash (n = 1), and impaired CD4 recovery (n = 2). Median low-density lipoprotein cholesterol levels increased from 116.1 mg/dL at baseline to 137.3 mg/dL at 48 weeks (p = 0.001). Conclusions/Significance: Treatment simplification with DRV/r monotherapy seems safe and effective in routine clinical practice. Further research is needed to elucidate the effect of DRV/r monotherapy on cholesterol levels.	[Santos, Jose R.; Molto, Jose; Llibre, Josep M.; Negredo, Eugenia; Bravo, Isabel; Ornelas, Arelly; Clotet, Bonaventura; Paredes, Roger] Hosp Badalona Germans Trias & Pujol, Lluita SIDA Fdn, Barcelona, Spain; [Santos, Jose R.; Molto, Jose; Llibre, Josep M.; Negredo, Eugenia] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Ornelas, Arelly] Univ Barcelona, Dept Econometr Stat & Spanish Econ, Barcelona, Spain; [Clotet, Bonaventura; Paredes, Roger] IrsiCaixa Fdn, Barcelona, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; University of Barcelona; Institut de Recerca de la Sida - IrsiCaixa	Santos, JR (corresponding author), Hosp Badalona Germans Trias & Pujol, Lluita SIDA Fdn, Barcelona, Spain.	jrsantos@flsida.org		Negredo, Eugenia/0000-0001-5298-1734; Molto, Jose/0000-0003-4564-1963	Spanish AIDS Network "Red Tematica Cooperativa de Investigacion en SIDA" [RIS,RD06/0006]; NEAT (European AIDS Treatment Network); Lluita contra la SIDA Foundation; Abbott; Boehringer Ingelheim; Gilead Sciences; Glaxo Smith-Kline; Janssen-Cilag; Bristol-Myers Squibb; ViiV Healthcare; Pfizer; Merck Sharp Dohme; Roche; Panacos; Tibotec; Roche Diagnostics; Siemens	Spanish AIDS Network "Red Tematica Cooperativa de Investigacion en SIDA"; NEAT (European AIDS Treatment Network); Lluita contra la SIDA Foundation; Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Gilead Sciences(Gilead Sciences); Glaxo Smith-Kline(GlaxoSmithKline); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb); ViiV Healthcare; Pfizer(Pfizer); Merck Sharp Dohme(Merck & Company); Roche(Roche Holding); Panacos; Tibotec; Roche Diagnostics; Siemens(Siemens AG)	This study was funded in part by grants from the Spanish AIDS Network "Red Tematica Cooperativa de Investigacion en SIDA" (RIS,RD06/0006), NEAT (European AIDS Treatment Network) and Lluita contra la SIDA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jose R Santos has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Bristol-Myers Squibb, ViiV Healthcare, and Pfizer. Jose Molto has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Bristol-Myers Squibb, ViiV Healthcare, and Pfizer. Josep M Llibre has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer-Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Merck Sharp & Dohme, Pfizer, and Roche. Eugenia Negredo has received research honoraria for speaking and serving on advisory boards from Abbott, Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Roche, Janssen-Cilag, and Merck Sharp & Dohme. Bonaventura Clotet has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer-Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Merck Sharp & Dohme, Panacos, Pfizer, Roche, and Tibotec. Arelly Ornelas and Isabel Bravo declare no competing interests. Roger Paredes has received consulting fees from Pfizer, Merck Sharp and Dohme, Roche Diagnostics. The IrsiCaixa AIDS Research Institute and the Lluita contra la SIDA Foundation have received grant support from Pfizer, ViiV Healthcare, Siemens, Merck Sharp and Dohme, and Boehringer Ingelheim for studies in which Dr. Paredes serves as principal investigator. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 3 REP NAT CHOL ED PR; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Bedimo R, 2006, HIV MED, V7, P530, DOI 10.1111/j.1468-1293.2006.00416.x; Bedimo R, 2010, HIV MED, V11, P462, DOI 10.1111/j.1468-1293.2009.00815.x; Boffito M, 2008, HIV CLIN TRIALS, V9, P418, DOI 10.1310/hct0906-418; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Campo R, 2011, 51 INT C ANT AG CHEM; Chen JY, 2010, J GASTROEN HEPATOL, V25, P1763, DOI 10.1111/j.1440-1746.2010.06300.x; Clumeck N, 2011, J ANTIMICROB CHEMOTH, V66, P1878, DOI 10.1093/jac/dkr199; EUROPEAN AIDS CLINICAL SOCIETY GUIDELINES (EACS), 2011, GUID CLIN MAN TREATM; Gazzard B, 2011, APPL HEALTH ECON HEA, V9, P217, DOI 10.2165/11592220-000000000-00000; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Kolta S, 2011, CURR HIV RES, V9, P31, DOI 10.2174/157016211794582687; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tungsiripat M, 2010, AIDS, V24, P1781, DOI 10.1097/QAD.0b013e32833ad8b4; Valantin MA, 2010, J ANTIMICROB CHEMOTH, V65, P556, DOI 10.1093/jac/dkp462; Valantin MA, 2010, 17 C RETR OPP INF FE	19	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37442	10.1371/journal.pone.0037442	http://dx.doi.org/10.1371/journal.pone.0037442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666357	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600016
J	Sergeant, MJ; Constantinidou, C; Cogan, T; Penn, CW; Pallen, MJ				Sergeant, Martin J.; Constantinidou, Chrystala; Cogan, Tristan; Penn, Charles W.; Pallen, Mark J.			High-Throughput Sequencing of 16S rRNA Gene Amplicons: Effects of Extraction Procedure, Primer Length and Annealing Temperature	PLOS ONE			English	Article							PCR; BACTERIAL; MICROBIOTA; DIVERSITY; MISMATCH	The analysis of 16S-rDNA sequences to assess the bacterial community composition of a sample is a widely used technique that has increased with the advent of high throughput sequencing. Although considerable effort has been devoted to identifying the most informative region of the 16S gene and the optimal informatics procedures to process the data, little attention has been paid to the PCR step, in particular annealing temperature and primer length. To address this, amplicons derived from 16S-rDNA were generated from chicken caecal content DNA using different annealing temperatures, primers and different DNA extraction procedures. The amplicons were pyrosequenced to determine the optimal protocols for capture of maximum bacterial diversity from a chicken caecal sample. Even at very low annealing temperatures there was little effect on the community structure, although the abundance of some OTUs such as Bifidobacterium increased. Using shorter primers did not reveal any novel OTUs but did change the community profile obtained. Mechanical disruption of the sample by bead beating had a significant effect on the results obtained, as did repeated freezing and thawing. In conclusion, existing primers and standard annealing temperatures captured as much diversity as lower annealing temperatures and shorter primers.	[Sergeant, Martin J.; Constantinidou, Chrystala; Penn, Charles W.; Pallen, Mark J.] Univ Birmingham, Sch Biosci, Ctr Syst Biol, Birmingham, W Midlands, England; [Cogan, Tristan] Univ Bristol, Sch Vet Sci, Bristol, Avon, England	University of Birmingham; University of Bristol	Sergeant, MJ (corresponding author), Univ Birmingham, Sch Biosci, Ctr Syst Biol, Birmingham, W Midlands, England.	m.pallen@bham.ac.uk		Sergeant, Martin/0000-0001-7264-2668; Pallen, Mark/0000-0003-1807-3657	Biotechnology and Biological Sciences Research Council [BB/H019340/1]; BBSRC [BB/H019340/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant Number: BB/H019340/1 (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apajalahti J, 2005, J APPL POULTRY RES, V14, P444, DOI 10.1093/japr/14.2.444; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Hajati H., 2010, INT J POULT SCI, V9, P298, DOI [10.3923/ijps.2010.298.304, DOI 10.3923/IJPS.2010.298.304]; Isenbarger TA, 2008, APPL ENVIRON MICROB, V74, P840, DOI 10.1128/AEM.01933-07; Kabir SML, 2009, INT J MOL SCI, V10, P3531, DOI 10.3390/ijms10083531; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Scupham AJ, 2007, J APPL MICROBIOL, V102, P401, DOI 10.1111/j.1365-2672.2006.03094.x; Scupham AJ, 2010, APPL ENVIRON MICROB, V76, P8026, DOI 10.1128/AEM.00678-10; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Torok VA, 2011, APPL ENVIRON MICROB, V77, P3380, DOI 10.1128/AEM.02300-10; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255	22	55	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38094	10.1371/journal.pone.0038094	http://dx.doi.org/10.1371/journal.pone.0038094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666455	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600062
J	Xue, Y; Wang, ML; Zhong, DY; Tong, N; Chu, HY; Sheng, XJ; Zhang, ZD				Xue, Yao; Wang, Meilin; Zhong, Dongyan; Tong, Na; Chu, Haiyan; Sheng, Xiaojing; Zhang, Zhengdong			ADH1C Ile350Val Polymorphism and Cancer Risk: Evidence from 35 Case-Control Studies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ALCOHOL-DEHYDROGENASE 3; UPPER AERODIGESTIVE TRACT; S-TRANSFERASE M1; GENETIC POLYMORPHISMS; BREAST-CANCER; ALCOHOL-DEHYDROGENASE-3 GENOTYPE; NECK-CANCER; ESOPHAGEAL CANCER; ALDEHYDE DEHYDROGENASES	Background: Alcohol dehydrogenase 1C (ADH1C) is the key enzyme catalyze oxidation of alcohol to acetaldehyde, which plays vital roles in the etiology of various cancer. To date, studies investigated the association between a functional polymorphism in ADH1C, Ile350Val (rs698), and risk of cancer have shown inclusive results. Methods: A meta-analysis based on 35 case-control studies was performed to address this issue. Odds ratios (OR) with 95% confidence intervals (CIs) were used to assess the association. The statistical heterogeneity across studies was examined with chi 2-based Q-test. Results: Overall, no significant associations between ADH1C Ile350Val polymorphism and cancer risk were observed in any genetic models (P > 0.05). In the stratified analyses, there was a significantly increased cancer risk among African (Val/Val vs. Ile/Ile OR = 2.19, 95% CI = 1.29-3.73, P-heterogeneity = 0.989; Ile/Val + Val/Val vs. Ile/Ile: OR = 1.79, 95% CI = 1.18-2.71, P-heterogeneity = 0.761; Val/Val vs. Ile/Val + Ile/Ile: OR = 1.92, 95% CI = 1.16-3.17, P-heterogeneity = 0.981) and Asian ( Ile/ Val vs. Ile/ Ile: OR = 1.58, 95% CI = 1.32-1.90, P-heterogeneity = 0.375; Val/Val vs. Ile/Ile: OR = 3.84, 95% CI = 1.74-8.49, P-heterogeneity = 0.160; Ile/Val + Val/Val vs. Ile/Ile: OR = 1.65, 95% CI = 1.38-1.96, P-heterogeneity = 0.330; Val/Val vs. Ile/Val + Ile/Ile: OR = 3.54, 95% CI = 1.62-7.75, P-heterogeneity = 0.154) studies. Conclusions: The results indicate that ADH1C Ile350Val polymorphism may contribute to cancer risk among Africans and Asians. Additional comprehensive system analyses are required to validate this association combined with other related polymorphisms.	[Xue, Yao; Zhong, Dongyan; Chu, Haiyan; Zhang, Zhengdong] Nanjing Med Univ, State Key Lab Reprod Med, Inst Toxicol, Nanjing, Jiangsu, Peoples R China; [Xue, Yao; Wang, Meilin; Zhong, Dongyan; Chu, Haiyan; Sheng, Xiaojing; Zhang, Zhengdong] Nanjing Med Univ, Dept Mol & Genet Toxicol, Key Lab Modern Toxicol, Minist Educ,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Tong, Na; Sheng, Xiaojing; Zhang, Zhengdong] Nanjing Med Univ, Dept Occupat Med & Environm Hlth, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Xue, Y (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Inst Toxicol, Nanjing, Jiangsu, Peoples R China.	drzdzhang@gmail.com	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [30972444, 81102089]; Key Program of Natural Science Foundation of Jiangsu Province [BK2010080]; National Natural Science Foundation of Jiangsu Province [BK2011773, BK2011775]; Key Program for Basic Research of Jiangsu Provincial Department of Education [11KJB330002]; Qin Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Program for Basic Research of Jiangsu Provincial Department of Education; Qin Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was partly supported by National Natural Science Foundation of China (30972444 and 81102089), the Key Program of Natural Science Foundation of Jiangsu Province (BK2010080), National Natural Science Foundation of Jiangsu Province (BK2011773 and BK2011775), the Key Program for Basic Research of Jiangsu Provincial Department of Education (11KJB330002), the Qin Lan Project of Jiangsu Provincial Department of Education, and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Bouchardy C, 2000, INT J CANCER, V87, P734, DOI 10.1002/1097-0215(20000901)87:5<734::AID-IJC17>3.0.CO;2-E; Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003; Brocic M, 2011, OTOLARYNG HEAD NECK, V145, P586, DOI 10.1177/0194599811408778; Chang JS, 2012, MUTAGENESIS, V27, P275, DOI 10.1093/mutage/ger073; Chao YC, 2000, AM J GASTROENTEROL, V95, P2958, DOI 10.1111/j.1572-0241.2000.02328.x; Chen WJ, 1996, BRIT J PSYCHIAT, V168, P762, DOI 10.1192/bjp.168.6.762; Chen YC, 2009, CHEM-BIOL INTERACT, V178, P2, DOI 10.1016/j.cbi.2008.10.029; Chen YJ, 2006, INT J CANCER, V119, P2827, DOI 10.1002/ijc.22199; Chou CF, 2002, J BIOL CHEM, V277, P25209, DOI 10.1074/jbc.M201947200; Coutelle C, 2004, INT J ONCOL, V25, P1127; Coutelle C, 1997, HUM GENET, V99, P319, DOI 10.1007/s004390050365; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; Deng HW, 2001, GENETICS, V157, P885; Druesne-Pecollo N, 2009, LANCET ONCOL, V10, P173, DOI 10.1016/S1470-2045(09)70019-1; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Eriksson CJP, 2001, ALCOHOL CLIN EXP RES, V25, p157S, DOI 10.1097/00000374-200105051-00027; Freudenheim JL, 2003, J NUTR, V133, P3619, DOI 10.1093/jn/133.11.3619; Freudenheim JL, 1999, CANCER CAUSE CONTROL, V10, P369, DOI 10.1023/A:1008950717205; Harty LC, 1997, JNCI-J NATL CANCER I, V89, P1698, DOI 10.1093/jnci/89.22.1698; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Holmes R S, 1994, Alcohol Alcohol Suppl, V2, P127; Homann N, 2006, INT J CANCER, V118, P1998, DOI 10.1002/ijc.21583; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; Hoog JO, 2001, J BIOMED SCI, V8, P71, DOI 10.1159/000054015; *IARC, 1988, IARC MON EV CARC RIS, V44, P153; Iwasaki M, 2011, CANCER SCI, V102, P1607, DOI 10.1111/j.1349-7006.2011.01996.x; Jelski W, 2008, CLIN CHIM ACTA, V395, P1, DOI 10.1016/j.cca.2008.05.001; Jelski W, 2006, J CLIN LAB ANAL, V20, P105, DOI 10.1002/jcla.20109; Kortunay S, 2010, METHOD FIND EXP CLIN, V32, P187, DOI 10.1358/mf.2010.32.3.1440739; Li DP, 2008, CLIN CHEM LAB MED, V46, P323, DOI 10.1515/CCLM.2008.073; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Mohelnikova-Duchonova B, 2010, PANCREAS, V39, P144, DOI 10.1097/MPA.0b013e3181bab6c2; Nishimoto IN, 2004, ARCH OTOLARYNGOL, V130, P78, DOI 10.1001/archotol.130.1.78; Garcia SMN, 2010, ALCOHOL ALCOHOLISM, V45, P6, DOI 10.1093/alcalc/agp078; Olshan AF, 2001, CARCINOGENESIS, V22, P57, DOI 10.1093/carcin/22.1.57; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Peters ES, 2005, CANCER EPIDEM BIOMAR, V14, P476, DOI 10.1158/1055-9965.EPI-04-0431; Risch A, 2003, PHARMACOGENETICS, V13, P225, DOI 10.1097/00008571-200304000-00007; Schwartz SM, 2001, CANCER EPIDEM BIOMAR, V10, P1137; Seitz HK, 2007, TRANSL RES, V149, P293, DOI 10.1016/j.trsl.2006.12.002; Seitz HK, 2007, ALCOHOL RES HEALTH, V30, P38; Seitz HK, 2001, ALCOHOL CLIN EXP RES, V25, p137S, DOI 10.1097/00000374-200105051-00024; SEITZ HK, 2009, GENES NUTR; Solomon PR, 2008, ORAL DIS, V14, P633, DOI 10.1111/j.1601-0825.2007.01437.x; Soucek P, 2010, NEOPLASMA, V57, P415, DOI 10.4149/neo_2010_05_415; Staab CA, 2008, CELL MOL LIFE SCI, V65, P3950, DOI 10.1007/s00018-008-8592-2; Sturgis EM, 2001, CANCER EPIDEM BIOMAR, V10, P273; Terry MB, 2007, CANCER CAUSE CONTROL, V18, P1039, DOI 10.1007/s10552-007-9046-0; Terry MB, 2006, CARCINOGENESIS, V27, P840, DOI 10.1093/carcin/bgi285; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Tiemersma EW, 2003, CANCER EPIDEM BIOMAR, V12, P419; van der Logt EMJ, 2006, MUTAT RES-FUND MOL M, V593, P39, DOI 10.1016/j.mrfmmm.2005.06.018; van Dijk BAC, 2001, EUR UROL, V40, P509, DOI 10.1159/000049827; Visvanathan K, 2007, ALCOHOL CLIN EXP RES, V31, P467, DOI 10.1111/j.1530-0277.2006.00334.x; Wang DH, 2005, CANCER EPIDEM BIOMAR, V14, P626, DOI 10.1158/1055-9965.EPI-04-0343; Yang Chun-Xia, 2005, Asian Pac J Cancer Prev, V6, P256; Yin G, 2007, CANCER SCI, V98, P1248, DOI 10.1111/j.1349-7006.2007.00519.x; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851; Yokoyama A, 2010, ALCOHOL CLIN EXP RES, V34, P1246, DOI 10.1111/j.1530-0277.2010.01202.x; Zavras AI, 2002, INT J CANCER, V97, P526, DOI 10.1002/ijc.1642; Zhang FF, 2007, INT J CANCER, V121, P2060, DOI 10.1002/ijc.22973	62	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37227	10.1371/journal.pone.0037227	http://dx.doi.org/10.1371/journal.pone.0037227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22675424	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500079
J	Jakobi, AJ; Huizinga, EG				Jakobi, Arjen J.; Huizinga, Eric G.			A Rapid Cloning Method Employing Orthogonal End Protection	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; VON-WILLEBRAND-FACTOR; PROTEIN; CONSTRUCTION; DOMAIN; FIBRONECTIN; FRAGMENTS; STRATEGY; SYSTEM; PCR	We describe a novel in vitro cloning strategy that combines standard tools in molecular biology with a basic protecting group concept to create a versatile framework for the rapid and seamless assembly of modular DNA building blocks into functional open reading frames. Analogous to chemical synthesis strategies, our assembly design yields idempotent composite synthons amenable to iterative and recursive split-and-pool reaction cycles. As an example, we illustrate the simplicity, versatility and efficiency of the approach by constructing an open reading frame composed of tandem arrays of a human fibronectin type III (FNIII) domain and the von Willebrand Factor A2 domain (VWFA2), as well as chimeric (FNIII)(n)-VWFA2-(FNIII)(n) constructs. Although we primarily designed this strategy to accelerate assembly of repetitive constructs for single-molecule force spectroscopy, we anticipate that this approach is equally applicable to the reconstitution and modification of complex modular sequences including structural and functional analysis of multi-domain proteins, synthetic biology or the modular construction of episomal vectors.	[Jakobi, Arjen J.; Huizinga, Eric G.] Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Utrecht University	Jakobi, AJ (corresponding author), Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	e.g.huizinga@uu.nl		Jakobi, Arjen/0000-0002-7761-2027	Council of Chemical Sciences of the Netherlands Organization for Scientific Research (NWO) [700.55.012]	Council of Chemical Sciences of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by ECHO (Excellent CHemisch Onderzoek (Excellent Chemical Research)) grant 700.55.012 from the Council of Chemical Sciences of the Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/) to EGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit RM, 2006, PROTEIN EXPRES PURIF, V45, P66, DOI 10.1016/j.pep.2005.09.022; Bieniossek C, 2009, NAT METHODS, V6, P447, DOI [10.1038/NMETH.1326, 10.1038/nmeth.1326]; Blake WJ, 2010, NUCLEIC ACIDS RES, V38, P2594, DOI 10.1093/nar/gkq123; Bornschlogl T, 2011, METHODS MOL BIOL, V783, P233, DOI 10.1007/978-1-61779-282-3_13; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fernandes S, 2009, ANAL BIOCHEM, V385, P171, DOI 10.1016/j.ab.2008.10.008; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Mcintyre GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003827; NOVOKHATNY V, 1992, J MOL BIOL, V227, P1182, DOI 10.1016/0022-2836(92)90530-W; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Suzuki Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni103; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhou HX, 2004, BIOCHEMISTRY-US, V43, P2141, DOI 10.1021/bi036269n; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	25	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37617	10.1371/journal.pone.0037617	http://dx.doi.org/10.1371/journal.pone.0037617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685543	gold, Green Published			2022-12-27	WOS:000305351700007
J	Maire, V; Martre, P; Kattge, J; Gastal, F; Esser, G; Fontaine, S; Soussana, JF				Maire, Vincent; Martre, Pierre; Kattge, Jens; Gastal, Francois; Esser, Gerd; Fontaine, Sebastien; Soussana, Jean-Francois			The Coordination of Leaf Photosynthesis Links C and N Fluxes in C-3 Plant Species	PLOS ONE			English	Article							MESOPHYLL DIFFUSION CONDUCTANCE; NITROGEN DISTRIBUTION; CARBON GAIN; STOMATAL CONDUCTANCE; GAS-EXCHANGE; CANOPY PHOTOSYNTHESIS; TEMPERATURE RESPONSE; BIOCHEMICAL-MODEL; USE EFFICIENCY; CELL-WALLS	Photosynthetic capacity is one of the most sensitive parameters in vegetation models and its relationship to leaf nitrogen content links the carbon and nitrogen cycles. Process understanding for reliably predicting photosynthetic capacity is still missing. To advance this understanding we have tested across C-3 plant species the coordination hypothesis, which assumes nitrogen allocation to photosynthetic processes such that photosynthesis tends to be co-limited by ribulose-1,5-bisphosphate (RuBP) carboxylation and regeneration. The coordination hypothesis yields an analytical solution to predict photosynthetic capacity and calculate area-based leaf nitrogen content (N-a). The resulting model linking leaf photosynthesis, stomata conductance and nitrogen investment provides testable hypotheses about the physiological regulation of these processes. Based on a dataset of 293 observations for 31 species grown under a range of environmental conditions, we confirm the coordination hypothesis: under mean environmental conditions experienced by leaves during the preceding month, RuBP carboxylation equals RuBP regeneration. We identify three key parameters for photosynthetic coordination: specific leaf area and two photosynthetic traits (k(3), which modulates N investment and is the ratio of RuBP carboxylation/oxygenation capacity (V-Cmax) to leaf photosynthetic N content (N-pa); and J(fac), which modulates photosynthesis for a given k(3) and is the ratio of RuBP regeneration capacity (J(max)) to V-Cmax). With species-specific parameter values of SLA, k(3) and J(fac), our leaf photosynthesis coordination model accounts for 93% of the total variance in N-a across species and environmental conditions. A calibration by plant functional type of k(3) and J(fac) still leads to accurate model prediction of N-a, while SLA calibration is essentially required at species level. Observed variations in k(3) and J(fac) are partly explained by environmental and phylogenetic constraints, while SLA variation is partly explained by phylogeny. These results open a new avenue for predicting photosynthetic capacity and leaf nitrogen content in vegetation models.	[Maire, Vincent; Fontaine, Sebastien; Soussana, Jean-Francois] INRA, UREP, UR874, Clermont Ferrand, France; [Martre, Pierre] INRA, UMR1095, GDEC, Clermont Ferrand, France; [Martre, Pierre] Blaise Pascal Univ, UMR1095, GDEC, Aubiere, France; [Kattge, Jens] Max Planck Inst Biogeochem, Jena, Germany; [Gastal, Francois] INRA, UR4 P3F, Lusignan, France; [Esser, Gerd] Univ Giessen, Inst Plant Ecol, Giessen, Germany	INRAE; INRAE; Universite Clermont Auvergne (UCA); Max Planck Society; INRAE; Justus Liebig University Giessen	Maire, V (corresponding author), INRA, UREP, UR874, Clermont Ferrand, France.	vmaire24@gmail.com; jfsoussana@clermont.inra.fr	Soussana, Jean-Francois/M-2814-2017; Martre, Pierre/G-5399-2013; Martre, Pierre/AAB-5118-2019; Soussana, Jean-Francois/P-2094-2016; Kattge, Jens/J-8283-2016; Soussana, Jean-Francois/E-2543-2012; Martre, Pierre/M-5282-2013	Martre, Pierre/0000-0002-7419-6558; Martre, Pierre/0000-0002-7419-6558; Soussana, Jean-Francois/0000-0002-1932-6583; Kattge, Jens/0000-0002-1022-8469; Martre, Pierre/0000-0002-7419-6558; Gastal, Francois/0000-0001-9191-5916; Maire, Vincent/0000-0002-3245-2568	French research ministry (MENRT); French ANR DISCOVER project [ANR-05-BDIV-010-01]	French research ministry (MENRT)(Ministry of Research, France); French ANR DISCOVER project(French National Research Agency (ANR))	This study contributes to the French ANR DISCOVER project (ANR-05-BDIV-010-01). VM was funded by a PhD grant of the French research ministry (MENRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; BALDOCCHI D, 1994, TREE PHYSIOL, V14, P1069, DOI 10.1093/treephys/14.7-8-9.1069; Bernacchi CJ, 2003, PLANT CELL ENVIRON, V26, P1419, DOI 10.1046/j.0016-8025.2003.01050.x; Bertheloot J, 2008, PLANT PHYSIOL, V148, P1707, DOI 10.1104/pp.108.124156; CHEN JL, 1993, OECOLOGIA, V93, P63, DOI 10.1007/BF00321192; Damour G, 2010, PLANT CELL ENVIRON, V33, P1419, DOI 10.1111/j.1365-3040.2010.02181.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dreccer M. F., 1998, Journal of Crop Production, V1, P47; Dreccer MF, 2000, ANN BOT-LONDON, V86, P821, DOI 10.1006/anbo.2000.1244; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; Evans J.R., 1989, PHOTOSYNTHESIS, P183; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Falge E, 1996, TREES-STRUCT FUNCT, V10, P277; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Farquhar GD, 2002, SILVA FENN, V36, P625, DOI 10.14214/sf.530; FIELD C, 1983, OECOLOGIA, V56, P341, DOI 10.1007/BF00379710; Field C. H., 1986, EC FORM FUNCTION, P25; Flexas J, 2009, J EXP BOT, V60, P2215, DOI 10.1093/jxb/erp150; Harrison MT, 2009, PLANT CELL ENVIRON, V32, P259, DOI 10.1111/j.1365-3040.2008.01918.x; Haxeltine A, 1996, FUNCT ECOL, V10, P551, DOI 10.2307/2390165; HIKOSAKA K, 1994, OECOLOGIA, V97, P451, DOI 10.1007/BF00325881; Hikosaka K, 1996, PLANTA, V198, P144, DOI 10.1007/BF00197597; HIROSE T, 1989, ECOLOGY, V70, P1610, DOI 10.2307/1938094; HIROSE T, 1988, OECOLOGIA, V77, P145, DOI 10.1007/BF00379180; HIROSE T, 1987, OECOLOGIA, V72, P520, DOI 10.1007/BF00378977; Irving LJ, 2006, NEW PHYTOL, V169, P493, DOI 10.1111/j.1469-8137.2005.01584.x; Johnson IR, 2010, ANN BOT-LONDON, V106, P735, DOI 10.1093/aob/mcq183; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kattge J, 2007, PLANT CELL ENVIRON, V30, P1176, DOI 10.1111/j.1365-3040.2007.01690.x; Kattge J, 2009, GLOBAL CHANGE BIOL, V15, P976, DOI 10.1111/j.1365-2486.2008.01744.x; Kull O, 2002, OECOLOGIA, V133, P267, DOI 10.1007/s00442-002-1042-1; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lemaire G., 1997, DIAGNOSIS NITROGEN S, P3, DOI [DOI 10.1007/978-3-642-60684-7, 10.1007/978-3-642-60684-7, DOI 10.1007/978-3-642-60684-7_1]; Lotscher M, 2003, ANN BOT-LONDON, V92, P679, DOI 10.1093/aob/mcg188; MAIRE V, 2009, THESIS B PASCAL U CL; Maire V, 2012, ECOL MODEL IN PRESS, P231; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1167, DOI 10.1046/j.1365-3040.2002.00891.x; Medlyn BE, 1996, AUST J PLANT PHYSIOL, V23, P593, DOI 10.1071/PP9960593; Misson L, 2006, TREE PHYSIOL, V26, P729, DOI 10.1093/treephys/26.6.729; MOONEY HA, 1978, OECOLOGIA, V36, P103, DOI 10.1007/BF00344575; Niinemets U, 1997, PLANT CELL ENVIRON, V20, P845, DOI 10.1046/j.1365-3040.1997.d01-133.x; Niinemets U, 2009, J EXP BOT, V60, P2249, DOI 10.1093/jxb/erp036; Niinemets U, 2009, J EXP BOT, V60, P2271, DOI 10.1093/jxb/erp063; Onoda Y, 2004, FUNCT ECOL, V18, P419, DOI 10.1111/j.0269-8463.2004.00847.x; Onoda Y, 2005, J EXP BOT, V56, P755, DOI 10.1093/jxb/eri052; Pons TL, 2009, J EXP BOT, V60, P2217, DOI 10.1093/jxb/erp081; Press W.H., 1992, NUMERICAL RECIPES, Vsecond; Reynolds JF, 1996, PLANT SOIL, V185, P65, DOI 10.1007/BF02257565; Rousseaux MC, 1999, CROP SCI, V39, P1093, DOI 10.2135/cropsci1999.0011183X003900040023x; Schieving F, 1999, NEW PHYTOL, V143, P201, DOI 10.1046/j.1469-8137.1999.00431.x; SCHIEVING F, 1992, PLANT SOIL, V142, P9, DOI 10.1007/BF00010170; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Soussana JF, 2012, ECOL MODEL, V231, P134, DOI 10.1016/j.ecolmodel.2012.02.002; Suzuki Y, 2001, PLANT CELL ENVIRON, V24, P1353, DOI 10.1046/j.0016-8025.2001.00789.x; Terashima I, 2005, ANN BOT-LONDON, V95, P507, DOI 10.1093/aob/mci049; THOMPSON WA, 1992, AUST J PLANT PHYSIOL, V19, P19; VONCAEMMERER S, 1984, PLANTA, V160, P320, DOI 10.1007/BF00393413; WERGER MJA, 1991, VEGETATIO, V97, P11; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; Wilson KB, 2000, TREE PHYSIOL, V20, P565; Wohlfahrt G, 1999, PLANT CELL ENVIRON, V22, P1281, DOI 10.1046/j.1365-3040.1999.00479.x; Wohlfahrt G, 1998, ECOL MODEL, V113, P179, DOI 10.1016/S0304-3800(98)00143-4; WONG SC, 1979, NATURE, V282, P424, DOI 10.1038/282424a0; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; WULLSCHLEGER SD, 1993, J EXP BOT, V44, P907, DOI 10.1093/jxb/44.5.907; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395	67	86	88	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38345	10.1371/journal.pone.0038345	http://dx.doi.org/10.1371/journal.pone.0038345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685562	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700025
J	Moss, WN; Dela-Moss, LI; Kierzek, E; Kierzek, R; Priore, SF; Turner, DH				Moss, Walter N.; Dela-Moss, Lumbini I.; Kierzek, Elzbieta; Kierzek, Ryszard; Priore, Salvatore F.; Turner, Douglas H.			The 3 ' Splice Site of Influenza A Segment 7 mRNA Can Exist in Two Conformations: A Pseudoknot and a Hairpin	PLOS ONE			English	Article							PHYLOGENETIC-COMPARATIVE-ANALYSIS; SELECTIVE 2'-HYDROXYL ACYLATION; NEAREST-NEIGHBOR MODEL; METAL-ION BINDING; SECONDARY STRUCTURE; INTERNAL LOOP; BASE-PAIRS; THERMODYNAMIC PROPERTIES; COUNTERION CONDENSATION; TETRAHYMENA RIBOZYME	The 3' splice site of influenza A segment 7 is used to produce mRNA for the M2 ion-channel protein, which is critical to the formation of viable influenza virions. Native gel analysis, enzymatic/chemical structure probing, and oligonucleotide binding studies of a 63 nt fragment, containing the 3' splice site, key residues of an SF2/ASF splicing factor binding site, and a polypyrimidine tract, provide evidence for an equilibrium between pseudoknot and hairpin structures. This equilibrium is sensitive to multivalent cations, and can be forced towards the pseudoknot by addition of 5 mM cobalt hexammine. In the two conformations, the splice site and other functional elements exist in very different structural environments. In particular, the splice site is sequestered in the middle of a double helix in the pseudoknot conformation, while in the hairpin it resides in a two-by-two nucleotide internal loop. The results suggest that segment 7 mRNA splicing can be controlled by a conformational switch that exposes or hides the splice site.	[Moss, Walter N.; Dela-Moss, Lumbini I.; Priore, Salvatore F.; Turner, Douglas H.] Univ Rochester, Ctr RNA Biol, Dept Chem, Rochester, NY 14627 USA; [Kierzek, Elzbieta; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Noskowskiego, Poland	University of Rochester; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Moss, WN (corresponding author), Univ Rochester, Ctr RNA Biol, Dept Chem, Rochester, NY 14627 USA.	turner@chem.rochester.edu	Moss, Walter/H-8096-2019	Moss, Walter/0000-0001-6419-5570; Kierzek, Ryszard/0000-0002-7644-0016; Kierzek, Elzbieta/0000-0002-5563-003X	National Institutes of Health (NIH) [R01 GM22939]; FOGARTY INTERNATIONAL CENTER [R03TW008739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) R01 GM22939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Almakarem AS, 2012, NUCLEIC ACIDS RES, V40, P1407, DOI 10.1093/nar/gkr810; Aggarwal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010372; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barik S, 2010, VIRUSES-BASEL, V2, P1448, DOI 10.3390/v2071448; BROWN RS, 1985, BIOCHEMISTRY-US, V24, P4785, DOI 10.1021/bi00339a012; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; Cao S, 2006, NUCLEIC ACIDS RES, V34, P2634, DOI 10.1093/nar/gkl346; Cao S, 2010, RNA, V16, P538, DOI 10.1261/rna.1800210; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Chen C, 2010, MOL CELL BIOL, V30, P4108, DOI 10.1128/MCB.00531-10; Chen JL, 2012, BIOCHEMISTRY-US, V51, P3508, DOI 10.1021/bi3002709; Childs JL, 2002, P NATL ACAD SCI USA, V99, P11091, DOI 10.1073/pnas.172391199; Ciesiolka J, 1998, J MOL BIOL, V275, P211, DOI 10.1006/jmbi.1997.1462; Cornish PV, 2006, BIOCHEMISTRY-US, V45, P11162, DOI 10.1021/bi060430n; Dallas A, 1997, STRUCTURE, V5, P1639, DOI 10.1016/S0969-2126(97)00311-0; DESHLER JO, 1991, GENE DEV, V5, P1252, DOI 10.1101/gad.5.7.1252; Disney MD, 2008, J AM CHEM SOC, V130, P11185, DOI 10.1021/ja803234t; Disney MD, 2004, BIOPOLYMERS, V73, P151, DOI 10.1002/bip.10520; Disney MD, 2001, BIOCHEMISTRY-US, V40, P6507, DOI 10.1021/bi002008r; DOMENJOUD L, 1991, MOL CELL BIOL, V11, P4581, DOI 10.1128/MCB.11.9.4581; Du QS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009388; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Fouchier RAM, 2012, NATURE, V481, P443, DOI 10.1038/481443a; Frank DN, 2000, RNA, V6, P1895, DOI 10.1017/S1355838200001461; Frugier M, 1997, P NATL ACAD SCI USA, V94, P11291, DOI 10.1073/pnas.94.21.11291; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Girish V, 2004, Indian J Cancer, V41, P47; Gonzalez RL, 1999, J MOL BIOL, V289, P1267, DOI 10.1006/jmbi.1999.2841; Gultyaev AP, 2007, BIOINFORMATICS, V23, P272, DOI 10.1093/bioinformatics/btl559; Gultyaev AP, 2010, RNA BIOL, V7, P125, DOI 10.4161/rna.7.2.11287; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Heilman-Miller SL, 2001, J MOL BIOL, V306, P1157, DOI 10.1006/jmbi.2001.4437; Heilman-Miller SL, 2001, J MOL BIOL, V309, P57, DOI 10.1006/jmbi.2001.4660; Hermann T, 1999, CHEM BIOL, V6, pR335, DOI 10.1016/S1074-5521(00)80003-4; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Holland JA, 1999, RNA, V5, P257, DOI 10.1017/S1355838299981360; Honig A, 2002, MOL CELL BIOL, V22, P5698, DOI 10.1128/MCB.22.16.5698-5707.2002; Hung LW, 2000, P NATL ACAD SCI USA, V97, P5107, DOI 10.1073/pnas.090588197; Jacquenet S, 2001, NUCLEIC ACIDS RES, V29, P464, DOI 10.1093/nar/29.2.464; Jaeger L, 1996, BIOCHIMIE, V78, P466, DOI 10.1016/0300-9084(96)84753-5; Jang SB, 1998, BIOCHEMISTRY-US, V37, P11726, DOI 10.1021/bi980758j; Jenkins JL, 2008, J BIOL CHEM, V283, P33641, DOI 10.1074/jbc.M806297200; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kierzek E, 2008, NUCLEIC ACIDS RES, V36, P1770, DOI 10.1093/nar/gkm1085; Kierzek E, 2009, BIOCHEMISTRY-US, V48, P11344, DOI 10.1021/bi901264v; Kierzek E, 2009, J MOL BIOL, V390, P428, DOI 10.1016/j.jmb.2009.04.048; Kirsebom L.A., 2005, HDB RNA BIOCH, P214; Krug RM, 2003, ANTIVIR RES, V57, P147, DOI 10.1016/S0166-3542(02)00207-3; Labuda LP, 2009, ACS CHEM BIOL, V4, P299, DOI 10.1021/cb800313m; LAMB RA, 1981, P NATL ACAD SCI-BIOL, V78, P4170, DOI 10.1073/pnas.78.7.4170; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerman YV, 2011, RNA, V17, P1664, DOI 10.1261/rna.2641911; Liang RT, 2010, BIOCHEMISTRY-US, V49, P8155, DOI 10.1021/bi100286n; Loeb DD, 2002, J VIROL, V76, P10195, DOI 10.1128/JVI.76.20.10195-10202.2002; Madjid M, 2003, J ROY SOC MED, V96, P345, DOI 10.1258/jrsm.96.7.345; Massin P, 2010, VET MICROBIOL, V142, P232, DOI 10.1016/j.vetmic.2009.10.012; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mei HY, 1998, BIOCHEMISTRY-US, V37, P14204, DOI 10.1021/bi981308u; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Muro AF, 1999, MOL CELL BIOL, V19, P2657; Nagaswamy U, 2000, NUCLEIC ACIDS RES, V28, P375, DOI 10.1093/nar/28.1.375; Nixon PL, 1999, BIOPOLYMERS, V50, P443, DOI 10.1002/(SICI)1097-0282(19991005)50:4<443::AID-BIP9>3.3.CO;2-3; PACE NR, 1989, GENE, V82, P65, DOI 10.1016/0378-1119(89)90031-0; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Pasternak A, 2008, BIOCHEMISTRY-US, V47, P1249, DOI 10.1021/bi701758z; Pasternak A, 2007, NUCLEIC ACIDS RES, V35, P4055, DOI 10.1093/nar/gkm421; Priore SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035989; Robb NC, 2012, J GEN VIROL, V93, P113, DOI 10.1099/vir.0.035485-0; Rudisser S, 2000, J MOL BIOL, V295, P1211, DOI 10.1006/jmbi.1999.3421; SHIH SR, 1995, P NATL ACAD SCI USA, V92, P6324, DOI 10.1073/pnas.92.14.6324; Shih SR, 1996, EMBO J, V15, P5415, DOI 10.1002/j.1460-2075.1996.tb00925.x; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Stiver G, 2003, CAN MED ASSOC J, V168, P49; STREICHER B, 1993, NUCLEIC ACIDS RES, V21, P311; Sucheck SJ, 2000, CURR OPIN CHEM BIOL, V4, P678, DOI 10.1016/S1367-5931(00)00142-3; Tan X, 2012, P NATL ACAD SCI USA, V109, P869, DOI 10.1073/pnas.1119873109; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Theimer CA, 1998, J MOL BIOL, V279, P545, DOI 10.1006/jmbi.1998.1812; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Ulyanov NB, 2007, NUCLEIC ACIDS RES, V35, P6150, DOI 10.1093/nar/gkm660; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; WATAKABE A, 1989, NUCLEIC ACIDS RES, V17, P8159, DOI 10.1093/nar/17.20.8159; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilson WD, 2000, CURR MED CHEM, V7, P73, DOI 10.2174/0929867003375434; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Woodson SA, 2001, CURR PROTOC NUCL ACI, DOI [10.1002/0471142700.nc1106s06, DOI 10.1002/047114270.NC1104S02]; World Health Organization, 2009, INFL SEAS FACT SHEET; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Ziehler W A, 2001, Curr Protoc Nucleic Acid Chem, VChapter 6, DOI 10.1002/0471142700.nc0601s00	98	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38323	10.1371/journal.pone.0038323	http://dx.doi.org/10.1371/journal.pone.0038323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685560	gold, Green Published, Green Submitted			2022-12-27	WOS:000305351700023
J	Silvente, S; Sobolev, AP; Lara, M				Silvente, Sonia; Sobolev, Anatoly P.; Lara, Miguel			Metabolite Adjustments in Drought Tolerant and Sensitive Soybean Genotypes in Response to Water Stress	PLOS ONE			English	Article							SYMBIOTIC N-2 FIXATION; PROLINE ACCUMULATION; MOLECULAR ANALYSIS; NITROGEN-FIXATION; GRAIN LEGUMES; CULTIVARS; NODULES; NMR; L.; CARBON	Soybean (Glycine max L.) is an important source of protein for human and animal nutrition, as well as a major source of vegetable oil. The soybean crop requires adequate water all through its growth period to attain its yield potential, and the lack of soil moisture at critical stages of growth profoundly impacts the productivity. In this study, utilizing H-1 NMR-based metabolite analysis combined with the physiological studies we assessed the effects of short-term water stress on overall growth, nitrogen fixation, ureide and proline dynamics, as well as metabolic changes in drought tolerant (NA5009RG) and sensitive (DM50048) genotypes of soybean in order to elucidate metabolite adjustments in relation to the physiological responses in the nitrogen-fixing plants towards water limitation. The results of our analysis demonstrated critical differences in physiological responses between these two genotypes, and identified the metabolic pathways that are affected by short-term water limitation in soybean plants. Metabolic changes in response to drought conditions highlighted pools of metabolites that play a role in the adjustment of metabolism and physiology of the soybean varieties to meet drought effects.	[Silvente, Sonia; Lara, Miguel] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico; [Sobolev, Anatoly P.] CNR, Ist Metodol Chimiche, Lab Risonanza Magnet Annalaura Segre, Rome, Italy	Universidad Nacional Autonoma de Mexico; Consiglio Nazionale delle Ricerche (CNR); Istituto di Metodologie Chimiche (IMC-CNR)	Silvente, S (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico.	silvente@ccg.unam.mx	Sobolev, Anatoly/AAX-1170-2020	Sobolev, Anatoly/0000-0001-8709-7666	Direccion General de Asuntos del Personal Academico/UNAM, Mexico [PAPIIT: IN212110]	Direccion General de Asuntos del Personal Academico/UNAM, Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by Direccion General de Asuntos del Personal Academico/UNAM, Mexico (grant no. PAPIIT: IN212110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamillo JM, 2010, PLANT CELL ENVIRON, V33, P1828, DOI 10.1111/j.1365-3040.2010.02187.x; Alia, 2001, AMINO ACIDS, V21, P195; Angra S., 2010, International Journal of Agricultural Research, V5, P328, DOI 10.3923/ijar.2010.328.345; Arrese-Igor C, 1999, SYMBIOSIS, V27, P189; Ashraf M, 2005, FLORA, V200, P535, DOI 10.1016/j.flora.2005.06.005; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bligny R, 2001, CURR OPIN PLANT BIOL, V4, P191, DOI 10.1016/S1369-5266(00)00160-6; Charlton AJ, 2008, METABOLOMICS, V4, P312, DOI 10.1007/s11306-008-0128-0; Colquhoun IJ, 2007, J PESTIC SCI, V32, P200, DOI 10.1584/jpestics.R07-03; CONROY MJ, 1988, J WILDLIFE MANAGE, V52, P694, DOI 10.2307/3800933; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; FORD CW, 1984, PHYTOCHEMISTRY, V23, P1007, DOI 10.1016/S0031-9422(00)82601-1; FUKUTOKU Y, 1981, PLANT CELL PHYSIOL, V22, P1397, DOI 10.1093/oxfordjournals.pcp.a076292; Galvez L, 2005, J EXP BOT, V56, P2551, DOI 10.1093/jxb/eri249; Gonzalez EM, 1998, J EXP BOT, V49, P1705, DOI 10.1093/jexbot/49.327.1705; Goodacre R, 2000, ANAL CHEM, V72, P119, DOI 10.1021/ac990661i; HARDY RWF, 1968, PLANT PHYSIOL, V43, P1185, DOI 10.1104/pp.43.8.1185; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hien DT, 2003, PLANT SCI, V165, P1059, DOI 10.1016/S0168-9452(03)00301-7; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; KELLER F, 1993, J EXP BOT, V44, P1351, DOI 10.1093/jxb/44.8.1351; King CA, 2005, PLANT PHYSIOL, V137, P1389, DOI 10.1104/pp.104.056317; Lazcano-Ferrat I, 1999, CROP SCI, V39, P467, DOI 10.2135/cropsci1999.0011183X0039000200028x; Marino D, 2007, PLANT PHYSIOL, V143, P1968, DOI 10.1104/pp.106.097139; Masoumi H, 2011, AUST J CROP SCI, V5, P544; McManus MT, 2000, ENVIRON EXP BOT, V43, P11, DOI 10.1016/S0098-8472(99)00041-6; Mohsenzadeh S, 2006, ENVIRON EXP BOT, V56, P314, DOI 10.1016/j.envexpbot.2005.03.008; Neo HH, 1997, PLANT PHYSIOL, V113, P259, DOI 10.1104/pp.113.1.259; PANDEY RK, 1984, AGRON J, V76, P557, DOI 10.2134/agronj1984.00021962007600040011x; Pimentel D., 2008, BIOFUELS SOLAR WIND, P373; Pinheiro C, 2004, J PLANT PHYSIOL, V161, P1203, DOI 10.1016/j.jplph.2004.01.016; Premachandra GS, 1995, J EXP BOT, V46, P1833, DOI 10.1093/jxb/46.12.1833; Rampino P, 2006, PLANT CELL ENVIRON, V29, P2143, DOI 10.1111/j.1365-3040.2006.01588.x; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Ronde J. A. de, 2000, African Crop Science Journal, V8, P85; Samarah N, 2004, J PLANT NUTR, V27, P815, DOI 10.1081/PLN-120030673; Sanchez FJ, 1998, FIELD CROP RES, V59, P225, DOI 10.1016/S0378-4290(98)00125-7; Sassi S, 2010, AFR J BIOTECHNOL, V9, P6061; Serraj R, 1999, J EXP BOT, V50, P143, DOI 10.1093/jexbot/50.331.143; Serraj R, 2001, AGRONOMIE, V21, P621, DOI 10.1051/agro:2001153; Sobolev AP, 2003, MAGN RESON CHEM, V41, P237, DOI 10.1002/mrc.1176; SPRENT JI, 1972, NEW PHYTOL, V71, P603, DOI 10.1111/j.1469-8137.1972.tb01270.x; SUMMERFIELD RJ, 1977, EXP AGR, V13, P81, DOI 10.1017/S0014479700007638; SUNDARESAN S, 1995, PHYSIOL PLANTARUM, V94, P635, DOI 10.1111/j.1399-3054.1995.tb00978.x; VOGELS GD, 1970, ANAL BIOCHEM, V33, P143, DOI 10.1016/0003-2697(70)90448-3	47	174	177	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38554	10.1371/journal.pone.0038554	http://dx.doi.org/10.1371/journal.pone.0038554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685583	gold, Green Published, Green Submitted			2022-12-27	WOS:000305351700046
J	Guo, QS; Xia, B; Zhang, F; Richardson, MM; Li, MH; Zhang, JS; Chen, F; Zhang, XA				Guo, Qiusha; Xia, Bing; Zhang, Feng; Richardson, Mekel M.; Li, Minghao; Zhang, Julian S.; Chen, Feng; Zhang, Xin A.			Tetraspanin CO-029 Inhibits Colorectal Cancer Cell Movement by Deregulating Cell-Matrix and Cell-Cell Adhesions	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; STEM-CELLS; E-CADHERIN; INTRAHEPATIC METASTASIS; TUMOR INVASION; GROWTH-FACTOR; ASSOCIATION; EXPRESSION; MOTILITY; MIGRATION	Alterations in tetraspanin CO-029 expression are associated with the progression and metastasis of cancers in the digestive system. However, how CO-029 promotes cancer metastasis is still poorly understood. To determine the mechanism, we silenced CO-029 expression in HT29 colon cancer cells and found that the CO-029 knockdown significantly reduced cell migratory ability. The diminished cell migration was accompanied by the upregulation of both integrin-dependent cell-matrix adhesion on laminin and calcium-dependent cell-cell adhesion. The cell surface levels of laminin-binding integrin alpha 3 beta 1 and fibronectin-integrin alpha 5 beta 1 were increased while the level of CD44 was decreased upon CO-029 silencing. These changes contribute to the altered cell-matrix adhesion. The deregulated cell-cell adhesion results, at least partially, from increased activity of cadherins and reduced level of MelCAM. In conclusion, CO-029 functions as a regulator of both cell-matrix and cell-cell adhesion. During colon cancer progression, CO-029 promotes cancer cell movement by deregulating cell adhesions.	[Guo, Qiusha; Zhang, Feng; Richardson, Mekel M.; Li, Minghao; Zhang, Julian S.; Zhang, Xin A.] Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr, Memphis, TN 38163 USA; [Guo, Qiusha; Zhang, Feng; Richardson, Mekel M.; Li, Minghao; Zhang, Julian S.; Zhang, Xin A.] Univ Tennessee, Ctr Hlth Sci, Ctr Canc, Memphis, TN 38163 USA; [Guo, Qiusha; Zhang, Feng; Richardson, Mekel M.; Li, Minghao; Zhang, Julian S.; Zhang, Xin A.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Guo, Qiusha; Zhang, Feng; Richardson, Mekel M.; Li, Minghao; Zhang, Julian S.; Zhang, Xin A.] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Guo, Qiusha; Xia, Bing] Wuhan Univ, Sch Med, Zhongnan Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Guo, Qiusha; Chen, Feng] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Wuhan University; Washington University (WUSTL)	Guo, QS (corresponding author), Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr, Memphis, TN 38163 USA.	bingxiawh@gmail.com; xin-zhang-1@ouhsc.edu	Zhang, Feng/B-6691-2012	Zhang, Feng/0000-0002-6103-1498	National Institutes of Health [CA096991]; NATIONAL CANCER INSTITUTE [R01CA096991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health CA096991. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; BERDITCHEVSKI F, 1995, J BIOL CHEM, V270, P17784, DOI 10.1074/jbc.270.30.17784; Boucheix C, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002381; BOUCHEIX C, 1983, FEBS LETT, V161, P289, DOI 10.1016/0014-5793(83)81027-8; Claas C, 1998, J CELL BIOL, V141, P267, DOI 10.1083/jcb.141.1.267; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; de Both NJ, 1999, BRIT J CANCER, V81, P934, DOI 10.1038/sj.bjc.6690790; DELWEL GO, 1993, J BIOL CHEM, V268, P25865; FIDLER IJ, 1987, BREAST CANCER RES TR, V9, P17, DOI 10.1007/BF01806690; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gesierich S, 2005, CLIN CANCER RES, V11, P2840, DOI 10.1158/1078-0432.CCR-04-1935; Gesierich S, 2006, CANCER RES, V66, P7083, DOI 10.1158/0008-5472.CAN-06-0391; Glinsky GV, 1996, CANCER LETT, V101, P43, DOI 10.1016/0304-3835(96)04112-2; Greco C, 2010, CANCER RES, V70, P7674, DOI 10.1158/0008-5472.CAN-09-4482; He B, 2005, J BIOL CHEM, V280, P3346, DOI 10.1074/jbc.M406680200; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Herlevsen M, 2003, J CELL SCI, V116, P4373, DOI 10.1242/jcs.00760; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Huerta S, 2003, INT J ONCOL, V22, P663; Inoue G, 2001, INT J MOL MED, V7, P67; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones PH, 1996, CELL ADHES COMMUN, V4, P297, DOI 10.3109/15419069609010773; Kanetaka K, 2003, J GASTROEN HEPATOL, V18, P1309, DOI 10.1046/j.1440-1746.2003.03182.x; Kanetaka K, 2001, J HEPATOL, V35, P637, DOI 10.1016/S0168-8278(01)00183-0; Koyama Y, 1998, BIOCHEM BIOPH RES CO, V246, P841, DOI 10.1006/bbrc.1998.8725; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Lazo PA, 2007, CANCER SCI, V98, P1666, DOI 10.1111/j.1349-7006.2007.00584.x; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Marhaba R, 2004, J MOL HISTOL, V35, P211; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Martin M, 2006, EUR J CELL BIOL, V85, P769, DOI 10.1016/j.ejcb.2006.02.013; Mazzocca A, 2008, GASTROENTEROLOGY, V135, P244, DOI 10.1053/j.gastro.2008.03.024; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Nakazawa Y, 2008, BLOOD; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Ovalle S, 2007, INT J CANCER, V121, P2140, DOI 10.1002/ijc.22902; PAGET S, 1989, CANCER METAST REV, V8, P98; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Richardson MM, 2011, CLIN EXP METASTAS, V28, P261, DOI 10.1007/s10585-010-9365-5; Sales KM, 2007, STEM CELL REV, V3, P249, DOI 10.1007/s12015-007-9002-0; SELA BA, 1989, HYBRIDOMA, V8, P481, DOI 10.1089/hyb.1989.8.481; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sho M, 1998, INT J CANCER, V79, P509, DOI 10.1002/(SICI)1097-0215(19981023)79:5<509::AID-IJC11>3.0.CO;2-X; Stutzmann J, 2000, MICROSC RES TECHNIQ, V51, P179, DOI 10.1002/1097-0029(20001015)51:2<179::AID-JEMT9>3.0.CO;2-4; SZALA S, 1990, P NATL ACAD SCI USA, V87, P6833, DOI 10.1073/pnas.87.17.6833; Szollosi J, 1996, J IMMUNOL, V157, P2939; TAICHMAN DB, 1991, CELL REGUL, V2, P347, DOI 10.1091/mbc.2.5.347; Tanaka F, 2002, J BIOCHEM, V131, P39, DOI 10.1093/oxfordjournals.jbchem.a003075; Testa JE, 1999, CANCER RES, V59, P3812; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Weinberg, 2007, BIOL CANC, P587; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yang XH, 2006, J BIOL CHEM, V281, P12976, DOI 10.1074/jbc.M510617200; Yu Q, 2000, GENE DEV, V14, P163; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351; Zhang XA, 2003, J BIOL CHEM, V278, P27319, DOI 10.1074/jbc.M303039200; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543; Zou GM, 2007, J CELL PHYSIOL, V213, P440, DOI 10.1002/jcp.21140	66	17	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38464	10.1371/journal.pone.0038464	http://dx.doi.org/10.1371/journal.pone.0038464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679508	Green Published, gold			2022-12-27	WOS:000305343900046
J	Zhang, Q; Tan, DM; Luo, WP; Lu, JJ; Tan, Y				Zhang, Qian; Tan, Dongmei; Luo, Wenping; Lu, Junjie; Tan, Yi			Expression of CD82 in Human Trophoblast and Its Role in Trophoblast Invasion	PLOS ONE			English	Article							METASTASIS SUPPRESSOR GENE; MATERNAL-FETAL INTERFACE; EPITHELIAL-MESENCHYMAL TRANSITION; EMBRYO IMPLANTATION; TUMOR INVASION; CELLS; KAI1; CANCER; DIFFERENTIATION; INVASIVENESS	Background: Well-controlled trophoblast invasion at maternal-fetal interface is a critical event for the normal development of placenta. CD82 is a member of transmembrane 4 superfamily, which showed important role in inhibiting tumor cell invasion and migration. We surmised that CD82 are participates in trophoblast differentiation during placenta development. Methodology/Principal Findings: CD82 was found to be strongly expressed in human first trimester placental villous and extravillous trophoblast cells as well as in trophoblast cell lines. To investigate whether CD82 plays a role in trophoblast invasion and migration, we further utilized human villous explants culture model on matrigel and invasion/migration assay of trophoblast cell line HTR8/SVneo. CD82 siRNA significantly promoted outgrowth of villous explants in vitro (P<0.01), as well as invasion and migration of HTR8/SVneo cells (P<0.05), whereas the trophoblast proliferation was not affected. The enhanced effect of CD82 siRNA on invasion and migration of trophoblast cells was found associated with increased gelatinolytic activities of matrix metalloproteinase MMP9 while over-expression of CD82 markedly decreased trphoblast cell invasion and migration as well as MMP9 activities. Conclusions/Significance: These findings suggest that CD82 is an important negative regulator at maternal-fetal interface during early pregnancy, inhibiting human trophoblast invasion and migration.	[Zhang, Qian; Tan, Dongmei; Luo, Wenping; Lu, Junjie; Tan, Yi] Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China	Chongqing Medical University	Zhang, Q (corresponding author), Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China.	tanyee66@hotmail.com			Chongqing National Natural Science Foundation [CSTC2009BB5409]; Research Fund for the Doctoral Program of Department of Education of China [20095503110006]	Chongqing National Natural Science Foundation; Research Fund for the Doctoral Program of Department of Education of China	This study was supported by Chongqing National Natural Science Foundation (CSTC2009BB5409), and the Research Fund for the Doctoral Program of Department of Education of China (20095503110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryee DNT, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000019120.48685.02; BASS KE, 1994, DEV BIOL, V164, P550, DOI 10.1006/dbio.1994.1223; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Bischof P, 1995, Early Pregnancy, V1, P263; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Dong JT, 1996, CANCER RES, V56, P4387; Drake PM, 2004, DEV DYNAM, V229, P877, DOI 10.1002/dvdy.10477; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891; Friess H, 1998, INT J CANCER, V79, P349, DOI 10.1002/(SICI)1097-0215(19980821)79:4<349::AID-IJC7>3.0.CO;2-V; Fu JJ, 2010, J BIOL CHEM, V285, P10870, DOI 10.1074/jbc.M109.004200; Gellersen B, 2007, AM J PATHOL, V170, P126, DOI 10.2353/ajpath.2007.060175; Guo XZ, 1998, HEPATOLOGY, V28, P1481, DOI 10.1002/hep.510280606; Hannan NJ, 2007, CURR OPIN OBSTET GYN, V19, P266, DOI 10.1097/GCO.0b013e328133885f; Jee BK, 2006, BIOCHEM BIOPH RES CO, V342, P655, DOI 10.1016/j.bbrc.2006.01.153; Kilani RT, 2007, REPRODUCTION, V133, P257, DOI 10.1530/REP-06-0080; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Lee JH, 2003, CANCER RES, V63, P7247; Li MQ, 2011, J MOL ENDOCRINOL, V47, P195, DOI 10.1530/JME-10-0165; Li MQ, 2011, INT J CLIN EXP PATHO, V4, P276; Li MQ, 2010, BIOL REPROD, V82, P968, DOI 10.1095/biolreprod.109.080739; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mannion BA, 1996, J IMMUNOL, V157, P2039; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4; Ren L, 2011, HUM REPROD; Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Vicovac L, 1996, ACTA ANAT, V156, P202; Wu X, 2004, BIOL REPROD, V70, P1877, DOI 10.1095/biolreprod.103.024729; Yang XH, 1997, CANCER LETT, V119, P149, DOI 10.1016/S0304-3835(97)00273-5; Zhou Z, 2009, PLACENTA, V30, P929, DOI 10.1016/j.placenta.2009.09.003	37	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38487	10.1371/journal.pone.0038487	http://dx.doi.org/10.1371/journal.pone.0038487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679510	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343900048
J	Favaro, LCD; Sebastianes, FLD; Araujo, WL				de Lima Favaro, Leia Cecilia; de Souza Sebastianes, Fernanda Luiza; Araujo, Welington Luiz			Epicoccum nigrum P16, a Sugarcane Endophyte, Produces Antifungal Compounds and Induces Root Growth	PLOS ONE			English	Article							POSTHARVEST BROWN-ROT; FUNGAL ENDOPHYTES; BIOLOGICAL-CONTROL; RHIZOCTONIA-SOLANI; NITROGEN-FIXATION; MONILINIA-LAXA; PURPURASCENS; DIVERSITY; BIOCONTROL; PATHOGENS	Background: Sugarcane is one of the most important crops in Brazil, mainly because of its use in biofuel production. Recent studies have sought to determine the role of sugarcane endophytic microbial diversity in microorganism-plant interactions, and their biotechnological potential. Epicoccum nigrum is an important sugarcane endophytic fungus that has been associated with the biological control of phytopathogens, and the production of secondary metabolites. In spite of several studies carried out to define the better conditions to use E. nigrum in different crops, little is known about the establishment of an endophytic interaction, and its potential effects on plant physiology. Methodology/Principal Findings: We report an approach based on inoculation followed by re-isolation, molecular monitoring, microscopic analysis, plant growth responses to fungal colonization, and antimicrobial activity tests to study the basic aspects of the E. nigrum endophytic interaction with sugarcane, and the effects of colonization on plant physiology. The results indicate that E. nigrum was capable of increasing the root system biomass and producing compounds that inhibit the in vitro growth of sugarcane pathogens Fusarium verticillioides, Colletotrichum falcatum, Ceratocystis paradoxa, and Xanthomomas albilineans. In addition, E. nigrum preferentially colonizes the sugarcane surface and, occasionally, the endophytic environment. Conclusions/Significance: Our work demonstrates that E. nigrum has great potential for sugarcane crop application because it is capable of increasing the root system biomass and controlling pathogens. The study of the basic aspects of the interaction of E. nigrum with sugarcane demonstrated the facultative endophytism of E. nigrum and its preference for the phylloplane environment, which should be considered in future studies of biocontrol using this species. In addition, this work contributes to the knowledge of the interaction of this ubiquitous endophyte with the host plant, and also to a better use of microbial endophytes in agriculture.	[de Lima Favaro, Leia Cecilia] Brazilian Agr Res Corp, Embrapa Agroenergia, Brasilia, DF, Brazil; [de Souza Sebastianes, Fernanda Luiza] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Sao Paulo, Brazil; [Araujo, Welington Luiz] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade de Sao Paulo	Favaro, LCD (corresponding author), Brazilian Agr Res Corp, Embrapa Agroenergia, Brasilia, DF, Brazil.	leia.favaro@embrapa.br	DE LIMA FAVARO, LEIA CECILIA/F-7350-2012; Araújo, Welington/G-4905-2012	DE LIMA FAVARO, LEIA CECILIA/0000-0003-3260-0310; Araújo, Welington/0000-0002-2120-8172	FAPESP (State of Sao Paulo Research Foundation) [02/14143-3, 10/08286-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	FAPESP (State of Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by FAPESP (State of Sao Paulo Research Foundation) (Grants 02/14143-3 and 10/08286-2). The authors also thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for a doctoral fellowship to LCLF (Graduate Program in Plant Genetics and Breeding, "Luiz de Queiroz" College of Agriculture, University of Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akello J, 2007, J INVERTEBR PATHOL, V96, P34, DOI 10.1016/j.jip.2007.02.004; Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; [Anonymous], 1994, BIOTECHNOLOGY ENDOPH; Araujo FDS, 2012, ZIANG NAT PROD C LAN; Arnold AE, 2007, J TROP ECOL, V23, P369, DOI 10.1017/S0266467407004038; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Azevedo JL, 2007, FUNGI MULTIFACETED M, P189; Backman PA, 2008, BIOL CONTROL, V46, P1, DOI 10.1016/j.biocontrol.2008.03.009; Baldani JI, 2002, FUNCT PLANT BIOL, V29, P417, DOI 10.1071/PP01083; BAMFORD PHILIP C., 1961, TRANS BRIT MYCOL SOC, V44, P354; BAUTE MA, 1978, J ANTIBIOT, V31, P1099, DOI 10.7164/antibiotics.31.1099; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Boddey RM, 2003, PLANT SOIL, V252, P139, DOI 10.1023/A:1024152126541; BROWN AE, 1987, SOIL BIOL BIOCHEM, V19, P657, DOI 10.1016/0038-0717(87)90044-7; Camatti-Sartori V, 2005, J BASIC MICROB, V45, P397, DOI 10.1002/jobm.200410547; Campanile G, 2007, EUR J PLANT PATHOL, V117, P237, DOI 10.1007/s10658-006-9089-1; CHAND T, 1984, T BRIT MYCOL SOC, V83, P107, DOI 10.1016/S0007-1536(84)80250-8; de Almeida CV, 2005, PESQUI AGROPECU BRAS, V40, P467, DOI 10.1590/S0100-204X2005000500007; de Azeredo L A, 1998, Int Microbiol, V1, P205; De Cal A, 2009, J APPL MICROBIOL, V106, P592, DOI 10.1111/j.1365-2672.2008.04030.x; Favaro LCD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014828; Dini-Andreote F, 2010, PLANT SOIL, V336, P337, DOI 10.1007/s11104-010-0486-z; Elmer PAG, 2001, P 13 BIENN C AUSTR P, P339; Favaro LCL, 2007, RES 5 C BRAS MIC, P199; FISHER PJ, 1992, NEW PHYTOL, V120, P137, DOI 10.1111/j.1469-8137.1992.tb01066.x; Fowler S. R., 1999, Proceedings of the Fifty Second New Zealand Plant Protection Conference, Auckland Airport Centra, Auckland, New Zealand, 10-12 August, 1999, P141; Frohlich J, 2000, MYCOL RES, V104, P1202, DOI 10.1017/S095375620000263X; GRATTAPAGLIA D, 1990, TECNICAS APLICACOES, P99; Hashem M., 2004, Archives of Phytopathology and Plant Protection, V37, P283, DOI 10.1080/03235400310001612955; ICHIKAWA T, 1971, FOLIA MICROBIOL, V16, P218, DOI 10.1007/BF02884210; IKAWA M, 1978, J ANTIBIOT, V31, P159, DOI 10.7164/antibiotics.31.159; Wangun HVK, 2007, ORG BIOMOL CHEM, V5, P1702, DOI 10.1039/b702378b; Kortekamp A, 1997, VITIS, V36, P215; Kuldau G, 2008, BIOL CONTROL, V46, P57, DOI 10.1016/j.biocontrol.2008.01.023; Lahlali R, 2010, FEMS MICROBIOL LETT, V311, P152, DOI 10.1111/j.1574-6968.2010.02084.x; Larena I, 2005, BIOL CONTROL, V32, P305, DOI 10.1016/j.biocontrol.2004.10.010; Larena I, 2009, POSTHARVEST BIOL TEC, V54, P63, DOI 10.1016/j.postharvbio.2009.05.007; Larran S, 2007, WORLD J MICROB BIOT, V23, P565, DOI 10.1007/s11274-006-9266-6; Luvizotto DM, 2010, WORLD J MICROB BIOT, V26, P1829, DOI 10.1007/s11274-010-0364-0; MADRIGAL C, 1991, MYCOL RES, V95, P1375, DOI 10.1016/S0953-7562(09)80388-2; MADRIGAL C, 1995, CAN J BOT, V73, P425, DOI 10.1139/b95-043; Mari M, 2007, J SCI FOOD AGR, V87, P1271, DOI 10.1002/jsfa.2839; Martini M, 2009, PLANT DIS, V93, P993, DOI 10.1094/PDIS-93-10-0993; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; Mielnichuk N, 2007, FOREST PATHOL, V37, P236, DOI 10.1111/j.1439-0329.2007.00496.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Musetti R, 2011, J APPL MICROBIOL, V110, P746, DOI 10.1111/j.1365-2672.2011.04937.x; Nasim G, 2008, PAK J BOT, V40, P2587; Newcombe George, 2009, Commun Integr Biol, V2, P29; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pallu APS, 2009, 3 INT C ENV IND APPL, P130; Pieckenstain FL, 2001, MYCOL RES, V105, P77, DOI 10.1017/S0953756200003129; Pinto LSRC, 2000, NEW PHYTOL, V147, P609, DOI 10.1046/j.1469-8137.2000.00722.x; Quecine MC, 2008, RES 54 C BRAS GEN, P133; Rojas JD, 2012, MICROB ECOL, V63, P565, DOI 10.1007/s00248-011-9938-0; Romao AS, 2007, MICOLOGIA AVANCOS CO, P150; Romao AS, 2010, THESIS U SAO PAULO L; ROYSE DJ, 1978, PHYTOPATHOLOGY, V68, P603, DOI 10.1094/Phyto-68-603; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Singh LP, 2011, PLANT SIGNAL BEHAV, V6, P175, DOI 10.4161/psb.6.2.14146; SPELHAUG SR, 1989, J FOOD PROTECT, V52, P856, DOI 10.4315/0362-028X-52.12.856; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Stuart RM, 2010, ARCH MICROBIOL, V192, P307, DOI 10.1007/s00203-010-0557-9; Suryanarayanan T., 2011, FOR SCI, V80, P67, DOI DOI 10.1007/978-94-007-1599-8_4; Suryanarayanan T. S., 2009, Fungal Biology Reviews, V23, P9, DOI 10.1016/j.fbr.2009.07.001; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; WEBBER JF, 1986, T BRIT MYCOL SOC, V86, P93, DOI 10.1016/S0007-1536(86)80120-6; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Zhang YG, 2007, J NAT PROD, V70, P1522, DOI 10.1021/np070239u; ZHOU T, 1991, PHYTOPATHOLOGY, V81, P774, DOI 10.1094/Phyto-81-774; ZHOU T, 1991, CAN J BOT, V69, P2503, DOI 10.1139/b91-311	75	80	108	3	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36826	10.1371/journal.pone.0036826	http://dx.doi.org/10.1371/journal.pone.0036826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675473	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700007
J	Kurouski, D; Washington, J; Ozbil, M; Prabhakar, R; Shekhtman, A; Lednev, IK				Kurouski, Dmitry; Washington, Jacqueline; Ozbil, Mehmet; Prabhakar, Rajeev; Shekhtman, Alexander; Lednev, Igor K.			Disulfide Bridges Remain Intact while Native Insulin Converts into Amyloid Fibrils	PLOS ONE			English	Article							SECONDARY STRUCTURE; MOLECULAR-DYNAMICS; PROTEIN; BETA(2)-MICROGLOBULIN; FIBRILLATION; BONDS; NMR; SPECTROSCOPY; MECHANISM; EVOLUTION	Amyloid fibrils are beta-sheet-rich protein aggregates commonly found in the organs and tissues of patients with various amyloid-associated diseases. Understanding the structural organization of amyloid fibrils can be beneficial for the search of drugs to successfully treat diseases associated with protein misfolding. The structure of insulin fibrils was characterized by deep ultraviolet resonance Raman (DUVRR) and Nuclear Magnetic Resonance (NMR) spectroscopy combined with hydrogen-deuterium exchange. The compositions of the fibril core and unordered parts were determined at single amino acid residue resolution. All three disulfide bonds of native insulin remained intact during the aggregation process, withstanding scrambling. Three out of four tyrosine residues were packed into the fibril core, and another aromatic amino acid, phenylalanine, was located in the unordered parts of insulin fibrils. In addition, using all-atom MD simulations, the disulfide bonds were confirmed to remain intact in the insulin dimer, which mimics the fibrillar form of insulin.	[Kurouski, Dmitry; Washington, Jacqueline; Shekhtman, Alexander; Lednev, Igor K.] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Ozbil, Mehmet; Prabhakar, Rajeev] Univ Miami, Dept Chem, Coral Gables, FL 33124 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Miami	Kurouski, D (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	ilednev@albany.edu	Özbil, Mehmet/ABH-2905-2020; Lednev, Igor K/J-8387-2017; Ozbil, Mehmet/AAI-1882-2019	Özbil, Mehmet/0000-0002-1465-7674; Lednev, Igor K/0000-0002-6504-531X; Cobbert, Jacqueline/0000-0001-7782-0953; Prabhakar, Rajeev/0000-0003-1137-1272; Shekhtman, Alexander/0000-0003-2649-2675; Kurouski, Dmitry/0000-0002-6040-4213	National Institutes of Health [R01 GM085006-01A2]; National Institute on Aging of the National Institutes of Health [R01AG033719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by R01 GM085006-01A2 from National Institutes of Health (AS) and award R01AG033719 from the National Institute on Aging of the National Institutes of Health (IKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chang SG, 2003, MOL CELLS, V16, P323; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Jaimohan SM, 2009, ACTA CRYSTALLOGR F, V65, P1027, DOI 10.1107/S1744309109034071; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Katou H, 2002, PROTEIN SCI, V11, P2218, DOI 10.1110/ps.0213202; Kim T, 2006, J AM CHEM SOC, V128, P5330, DOI 10.1021/ja0607382; KLINE AD, 1990, BIOCHEMISTRY-US, V29, P2906, DOI 10.1021/bi00464a003; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Kurouski Dmitry, 2011, Int J Biomed Nanosci Nanotechnol, V2, P167, DOI 10.1504/IJBNN.2011.041000; Kurouski D, 2010, CHEM COMMUN, V46, P7154, DOI 10.1039/c0cc02423f; Lednev I. K., 2007, PROTEIN STRUCTURES M, P1; Lednev IK, 2005, ANAL BIOANAL CHEM, V381, P431, DOI 10.1007/s00216-004-2991-5; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Masse JE, 2006, J MAGN RESON, V181, P45, DOI 10.1016/j.jmr.2006.03.012; Mikhonin AV, 2006, J PHYS CHEM B, V110, P1928, DOI 10.1021/jp054593h; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mossuto ME, 2011, ANGEW CHEM INT EDIT, V50, P7048, DOI 10.1002/anie.201100986; Nayak A, 2009, PROTEINS, V74, P556, DOI 10.1002/prot.22169; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schoneich C, 2002, ARCH BIOCHEM BIOPHYS, V397, P370, DOI 10.1006/abbi.2001.2621; Shashilov VA, 2010, CHEM REV, V110, P5692, DOI 10.1021/cr900152h; Shashilov VA, 2010, METHODS, V52, P23, DOI 10.1016/j.ymeth.2010.05.004; Tu A.T., 1982, RAMAN SPECTROSCOPY B; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xu M, 2007, J AM CHEM SOC, V129, P11002, DOI 10.1021/ja073798w; Xu M, 2007, PROTEIN SCI, V16, P815, DOI 10.1110/ps.062639307; Yip CC, 2003, J BIOL CHEM, V278, P27329, DOI 10.1074/jbc.R300021200; Zako T, 2009, BIOPHYS J, V96, P3331, DOI 10.1016/j.bpj.2008.12.3957; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	51	64	65	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e36989	10.1371/journal.pone.0036989	http://dx.doi.org/10.1371/journal.pone.0036989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675475	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339900004
J	Garcia-Fraile, P; Carro, L; Robledo, M; Ramirez-Bahena, MH; Flores-Felix, JD; Fernandez, MT; Mateos, PF; Rivas, R; Igual, JM; Martinez-Molina, E; Peix, A; Velazquez, E				Garcia-Fraile, Paula; Carro, Lorena; Robledo, Marta; Ramirez-Bahena, Martha-Helena; Flores-Felix, Jose-David; Teresa Fernandez, Maria; Mateos, Pedro F.; Rivas, Raul; Mariano Igual, Jose; Martinez-Molina, Eustoquio; Peix, Alvaro; Velazquez, Encarna			Rhizobium Promotes Non-Legumes Growth and Quality in Several Production Steps: Towards a Biofertilization of Edible Raw Vegetables Healthy for Humans	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA; ESCHERICHIA-COLI; IMPROVING GROWTH; ACC-DEAMINASE; PLANT; LEGUMINOSARUM; RHIZOSPHERE; INDUCTION; LETTUCE; STRAIN	The biofertilization of crops with plant-growth-promoting microorganisms is currently considered as a healthy alternative to chemical fertilization. However, only microorganisms safe for humans can be used as biofertilizers, particularly in vegetables that are raw consumed, in order to avoid sanitary problems derived from the presence of pathogenic bacteria in the final products. In the present work we showed that Rhizobium strains colonize the roots of tomato and pepper plants promoting their growth in different production stages increasing yield and quality of seedlings and fruits. Our results confirmed those obtained in cereals and alimentary oil producing plants extending the number of non-legumes susceptible to be biofertilized with rhizobia to those whose fruits are raw consumed. This is a relevant conclusion since safety of rhizobia for human health has been demonstrated after several decades of legume inoculation ensuring that they are optimal bacteria for biofertilization.	[Garcia-Fraile, Paula; Carro, Lorena; Robledo, Marta; Flores-Felix, Jose-David; Teresa Fernandez, Maria; Mateos, Pedro F.; Rivas, Raul; Martinez-Molina, Eustoquio; Velazquez, Encarna] Univ Salamanca, Dept Genet & Microbiol, E-37008 Salamanca, Spain; [Robledo, Marta; Mateos, Pedro F.; Martinez-Molina, Eustoquio] Ctr Hispanoluso Invest Agr, Salamanca, Spain; [Ramirez-Bahena, Martha-Helena; Mariano Igual, Jose; Peix, Alvaro] CSIC, Inst Recursos Nat & Agrobiol, Salamanca, Spain; [Ramirez-Bahena, Martha-Helena; Mateos, Pedro F.; Rivas, Raul; Mariano Igual, Jose; Martinez-Molina, Eustoquio; Peix, Alvaro; Velazquez, Encarna] Univ Salamanca, Unidad Asociada, Grupo Interacc Planta Microorganismo, Consejo Super Invest Cient, E-37008 Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca	Garcia-Fraile, P (corresponding author), John Innes Ctr, Norwich Res Pk Colney, Norwich, Norfolk, England.	evp@usal.es	Robledo, Marta/F-4879-2016; Igual, José M/B-6993-2015; Robledo, Marta/P-9938-2019; Ramírez-Bahena, Martha Helena/ABB-3717-2021; Mateos, Pedro/L-6001-2014; Flores-Félix, Jose David/B-2082-2017; Rivas, Raúl/B-1869-2017; Carro, Lorena/G-3126-2016; Ramirez-Bahena, Martha Helena/B-8564-2017; Peix, Alvaro/A-7196-2010; Velázquez, Encarna/B-3669-2017; Fraile, Paula Garcia/N-8193-2014	Robledo, Marta/0000-0002-4049-7635; Igual, José M/0000-0002-5080-0378; Robledo, Marta/0000-0002-4049-7635; Mateos, Pedro/0000-0003-1628-598X; Flores-Félix, Jose David/0000-0003-2200-4400; Rivas, Raúl/0000-0003-2202-1470; Carro, Lorena/0000-0001-8833-642X; Ramirez-Bahena, Martha Helena/0000-0002-0744-8313; Peix, Alvaro/0000-0001-5084-1586; Velázquez, Encarna/0000-0002-5946-7241; Fraile, Paula Garcia/0000-0002-9576-2184; Martinez-Molina, Eustoquio/0000-0002-0983-9780	Ministerio de Ciencia e Innovacion (Ministry of Science and Innovation, Spanish Central Government) [AGL2010-17380, AGL2011-29227]; Regional Development Funds; Junta de Castilla y Leon (Castilla and Leon Council, Spanish Regional Government) [SA183A11-2]; JAE-DOC from Consejo Superior de Investigaciones Cientificas (Spanish National Research Council); Spanish International Cooperation Agency (Spanish Central Government)	Ministerio de Ciencia e Innovacion (Ministry of Science and Innovation, Spanish Central Government)(Ministry of Science and Innovation, Spain (MICINN)); Regional Development Funds; Junta de Castilla y Leon (Castilla and Leon Council, Spanish Regional Government); JAE-DOC from Consejo Superior de Investigaciones Cientificas (Spanish National Research Council); Spanish International Cooperation Agency (Spanish Central Government)	This work was supported by Ministerio de Ciencia e Innovacion (Ministry of Science and Innovation, Spanish Central Government, Grant AGL2010-17380, that includes co-financial support of Regional Development Funds, and Grant AGL2011-29227) and Junta de Castilla y Leon (Castilla and Leon Council, Spanish Regional Government, Grant SA183A11-2). Martha Helena Ramirez-Bahena is recipient of a postdoctoral researcher contract JAE-DOC from Consejo Superior de Investigaciones Cientificas (Spanish National Research Council). Maria Teresa Fernandez was supported by a fellowship of Spanish International Cooperation Agency (Spanish Central Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami Y, 2000, APPL ENVIRON MICROB, V66, P3393, DOI 10.1128/AEM.66.8.3393-3398.2000; ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Antoun H, 1998, PLANT SOIL, V204, P57, DOI 10.1023/A:1004326910584; Bashan Y, 1998, BIOTECHNOL ADV, V16, P729, DOI 10.1016/S0734-9750(98)00003-2; Berg G, 2005, ENVIRON MICROBIOL, V84, P11; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bhattacharjee RB, 2008, APPL MICROBIOL BIOT, V80, P199, DOI 10.1007/s00253-008-1567-2; Cerqueira GM, 2011, IUBMB LIFE, V63, P1055, DOI 10.1002/iub.533; Chabot R, 1996, APPL ENVIRON MICROB, V62, P2767, DOI 10.1128/AEM.62.8.2767-2772.1996; Chabot R, 1996, PLANT SOIL, V184, P311, DOI 10.1007/BF00010460; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Coutinho TA, 2009, MOL PLANT PATHOL, V10, P325, DOI [10.1111/j.1364-3703.2009.00542.x, 10.1111/J.1364-3703.2009.00542.X]; DAZZO FB, 1984, APPL ENVIRON MICROB, V48, P1140, DOI 10.1128/AEM.48.6.1140-1150.1984; Dinu LD, 2011, APPL ENVIRON MICROB, V77, P8295, DOI 10.1128/AEM.05020-11; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Eberl L, 2004, INT J MED MICROBIOL, V294, P123, DOI 10.1016/j.ijmm.2004.06.022; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Garcia-Fraile P, 2009, 1 IB C BEN MICR PLAN; Gaunt MW, 2001, INT J SYST EVOL MICR, V51, P2037, DOI 10.1099/00207713-51-6-2037; Gulati A, 2010, ARCH MICROBIOL, V192, P975, DOI 10.1007/s00203-010-0615-3; Gutierrez-Zamora ML, 2001, J BIOTECHNOL, V91, P117, DOI 10.1016/S0168-1656(01)00332-7; Ingram DT, 2007, J FOOD PROTECT, V70, P828, DOI 10.4315/0362-028X-70.4.828; Kang SH, 2007, J MICROBIOL BIOTECHN, V17, P96; Khalid A, 2004, J APPL MICROBIOL, V96, P473, DOI 10.1046/j.1365-2672.2003.02161.x; Kim J, 2009, J FOOD PROTECT, V72, P1576, DOI 10.4315/0362-028X-72.7.1576; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kone SB, 2010, BIOL CONTROL, V52, P167, DOI 10.1016/j.biocontrol.2009.10.018; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; Liu Y, 2011, CURR MICROBIOL, V62, P1113, DOI 10.1007/s00284-010-9835-7; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Martin A, 2011, INT J FOOD MICROBIOL, V146, P99, DOI 10.1016/j.ijfoodmicro.2011.01.041; Mishra RPN, 2006, CURR MICROBIOL, V52, P383, DOI 10.1007/s00284-005-0296-3; Noel TC, 1996, CAN J MICROBIOL, V42, P279, DOI 10.1139/m96-040; OGARA F, 1976, BIOCHIM BIOPHYS ACTA, V451, P342, DOI 10.1016/0304-4165(76)90129-X; OHARA GW, 1989, APPL ENVIRON MICROB, V55, P1870, DOI 10.1128/AEM.55.8.1870-1876.1989; Peix A, 2001, SOIL BIOL BIOCHEM, V33, P103, DOI 10.1016/S0038-0717(00)00120-6; Peix A, 2009, SYST APPL MICROBIOL, V32, P334, DOI 10.1016/j.syapm.2009.03.004; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Ramirez-Bahena MH, 2009, CAN J MICROBIOL, V55, P1207, DOI [10.1139/W09-074, 10.1139/w09-074]; Robledo M, 2011, MOL PLANT MICROBE IN, V24, P798, DOI 10.1094/MPMI-10-10-0249; Rokhbakhsh-Zamin F, 2011, J MICROBIOL BIOTECHN, V21, P556, DOI 10.4014/jmb.1012.12006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sang MK, 2010, PHYTOPATHOLOGY, V100, P774, DOI 10.1094/PHYTO-100-8-0774; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vial L, 2011, ENVIRON MICROBIOL, V13, P1, DOI 10.1111/j.1462-2920.2010.02343.x; Volksch B, 2009, INFECT GENET EVOL, V9, P1381, DOI 10.1016/j.meegid.2009.09.016; Yanni YG, 2001, AUST J PLANT PHYSIOL, V28, P845, DOI 10.1071/PP01069; Zahir ZA, 2009, ARCH MICROBIOL, V191, P415, DOI 10.1007/s00203-009-0466-y	53	92	108	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38122	10.1371/journal.pone.0038122	http://dx.doi.org/10.1371/journal.pone.0038122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675441	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338500090
J	Manoli, DS; Subramanyam, D; Carey, C; Sudin, E; Van Westerhuyzen, JA; Bales, KL; Blelloch, R; Shah, NM				Manoli, Devanand S.; Subramanyam, Deepa; Carey, Catriona; Sudin, Erik; Van Westerhuyzen, Julie A.; Bales, Karen L.; Blelloch, Robert; Shah, Nirao M.			Generation of Induced Pluripotent Stem Cells from the Prairie Vole	PLOS ONE			English	Article							MICROTUS-OCHROGASTER; HUMAN FIBROBLASTS; VASOPRESSIN; MOUSE; INDUCTION; OXYTOCIN; NEUROBIOLOGY; MONOGAMY; PATTERNS; BEHAVIOR	The vast majority of animals mate more or less promiscuously. A few mammals, including humans, utilize more restrained mating strategies that entail a longer term affiliation with a single mating partner. Such pair bonding mating strategies have been resistant to genetic analysis because of a lack of suitable model organisms. Prairie voles are small mouse-like rodents that form enduring pair bonds in the wild as well as in the laboratory, and consequently they have been used widely to study social bonding behavior. The lack of targeted genetic approaches in this species however has restricted the study of the molecular and neural circuit basis of pair bonds. As a first step in rendering the prairie vole amenable to reverse genetics, we have generated induced pluripotent stem cell (IPSC) lines from prairie vole fibroblasts using retroviral transduction of reprogramming factors. These IPSC lines display the cellular and molecular hallmarks of IPSC cells from other organisms, including mice and humans. Moreover, the prairie vole IPSC lines have pluripotent differentiation potential since they can give rise to all three germ layers in tissue culture and in vivo. These IPSC lines can now be used to develop conditions that facilitate homologous recombination and eventually the generation of prairie voles bearing targeted genetic modifications to study the molecular and neural basis of pair bond formation.	[Manoli, Devanand S.; Carey, Catriona; Sudin, Erik; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Manoli, Devanand S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Subramanyam, Deepa; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Blelloch, Robert; Shah, Nirao M.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Van Westerhuyzen, Julie A.; Bales, Karen L.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Manoli, DS (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	nms@ucsf.edu		Manoli, Devanand/0000-0002-7238-2330; Subramanyam, Deepa/0000-0002-1650-5690	University of California, San Francisco Program for Breakthrough Biomedical Research; National Institute of Health Director's Pioneer Award [DP1OD006425]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006425] Funding Source: NIH RePORTER	University of California, San Francisco Program for Breakthrough Biomedical Research(University of California System); National Institute of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funds to Nirao Shah from the University of California, San Francisco Program for Breakthrough Biomedical Research and an National Institute of Health Director's Pioneer Award (DP1OD006425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Berry K, 2008, BEHAV RES THER, V46, P1275, DOI 10.1016/j.brat.2008.08.009; Bora E, 2009, CURR OPIN PSYCHIATR, V22, P320, DOI 10.1097/YCO.0b013e328329e970; Bosch OJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1406, DOI 10.1038/npp.2008.154; Byrne RW, 2010, NEURON, V65, P815, DOI 10.1016/j.neuron.2010.03.010; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; CARTER CS, 1993, SCI AM, V268, P100, DOI 10.1038/scientificamerican0693-100; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Donaldson ZR, 2009, BIOL REPROD, V81, P1189, DOI 10.1095/biolreprod.109.077529; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; HARTKE GT, 1974, J HERED, V65, P301, DOI 10.1093/oxfordjournals.jhered.a108533; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; INSEL TR, 1994, J NEUROSCI, V14, P5381; Insel TR, 1997, AM J PSYCHIAT, V154, P726; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Li XY, 2007, CELL TISSUE RES, V327, P607, DOI 10.1007/s00441-006-0354-6; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; McGraw LA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-70; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2010, EXP CELL RES, V316, P2565, DOI 10.1016/j.yexcr.2010.04.023; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Phelps SM, 2003, J COMP NEUROL, V466, P564, DOI 10.1002/cne.10902; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Rebuzzini P, 2008, CYTOTECHNOLOGY, V58, P17, DOI 10.1007/s10616-008-9164-x; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suwinska A, 2010, INT J DEV BIOL, V54, P113, DOI 10.1387/ijdb.082704as; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2011, PHILOS T R SOC B, V366, P2222, DOI 10.1098/rstb.2011.0003; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilson E.O., 1975, P1; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; You Y, 1997, NAT GENET, V15, P285, DOI 10.1038/ng0397-285; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zhou HY, 2010, CURR OPIN HEMATOL, V17, P276, DOI 10.1097/MOH.0b013e328339f2ee	56	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38119	10.1371/journal.pone.0038119	http://dx.doi.org/10.1371/journal.pone.0038119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675440	gold, Green Published			2022-12-27	WOS:000305338500089
J	Desantis, A; Weiss, C; Schutz-Bosbach, S; Waszak, F				Desantis, Andrea; Weiss, Carmen; Schuetz-Bosbach, Simone; Waszak, Florian			Believing and Perceiving: Authorship Belief Modulates Sensory Attenuation	PLOS ONE			English	Article							SELF; PERCEPTION; AGENCY; CONSEQUENCES; SCHIZOPHRENIA; SUPPRESSION; EXPERIENCE; CAUSATION; INFERENCE; AWARENESS	Sensory attenuation refers to the observation that self-generated stimuli are attenuated, both in terms of their phenomenology and their cortical response compared to the same stimuli when generated externally. Accordingly, it has been assumed that sensory attenuation might help individuals to determine whether a sensory event was caused by themselves or not. In the present study, we investigated whether this dependency is reciprocal, namely whether sensory attenuation is modulated by prior beliefs of authorship. Participants had to judge the loudness of auditory effects that they believed were either self-generated or triggered by another person. However, in reality, the sounds were always triggered by the participants' actions. Participants perceived the tones' loudness attenuated when they believed that the sounds were self-generated compared to when they believed that they were generated by another person. Sensory attenuation is considered to contribute to the emergence of people's belief of authorship. Our results suggest that sensory attenuation is also a consequence of prior belief about the causal link between an action and a sensory change in the environment.	[Desantis, Andrea; Waszak, Florian] Univ Paris 05, Paris, France; [Desantis, Andrea; Waszak, Florian] CNRS, UMR 8158, Lab Psychol Percept, Paris, France; [Weiss, Carmen; Schuetz-Bosbach, Simone] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Desantis, Andrea] Ecole Hautes Etud Sci Sociales, Paris, France; [Desantis, Andrea] CNRS, Inst Jean Nicod, UMR 8129, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Desantis, A (corresponding author), Univ Paris 05, Paris, France.	aerdna.desantis@gmail.com		Schutz-Bosbach, Simone/0000-0002-0937-9454	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC Grant [263067]	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC Grant(European Research Council (ERC))	The research leading to these results received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement n<SUP>o</SUP>263067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2005, CONSCIOUS COGN, V14, P439, DOI 10.1016/j.concog.2004.11.001; Aliu SO, 2009, J COGNITIVE NEUROSCI, V21, P791, DOI 10.1162/jocn.2009.21055; Anton-Erxleben K, 2010, J VISION, V10, DOI 10.1167/10.11.6; Baess P, 2009, EUR J NEUROSCI, V29, P1514, DOI 10.1111/j.1460-9568.2009.06683.x; Bass P, 2008, INT J PSYCHOPHYSIOL, V70, P137, DOI 10.1016/j.ijpsycho.2008.06.005; Bays PM, 2005, CURR BIOL, V15, P1125, DOI 10.1016/j.cub.2005.05.023; Bays PM, 2006, PLOS BIOL, V4, P281, DOI 10.1371/journal.pbio.0040028; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buehner MJ, 2009, PSYCHOL SCI, V20, P1221, DOI 10.1111/j.1467-9280.2009.02435.x; Cardoso-Leite P, 2010, PSYCHOL SCI, V21, P1740, DOI 10.1177/0956797610389187; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Desantis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029557; Desantis A, 2011, CONSCIOUS COGN, V20, P1211, DOI 10.1016/j.concog.2011.02.012; Dogge M, 2012, CONSCIOUS COGN, V21, P501, DOI 10.1016/j.concog.2011.10.014; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Ford JM, 2004, J PSYCHIATR RES, V38, P37, DOI 10.1016/S0022-3956(03)00095-5; Gentsch A, 2011, J COGNITIVE NEUROSCI, V23, P3817, DOI 10.1162/jocn_a_00012; Green DM, 1966, SIGNAL DETECTION THE; HAERING C, ACTA PSYCHOL, V152, P109, DOI DOI INTENTIONALBINDINGISINDEPENDENTOFTHEVALIDITYOFTHEACTIONEFFECTSIDENTITY   BY:HAERING,CAROLA;KIESEL,ANDREA   ACTAPSYCHOLOGICAVOLUME:?152PAGES:?109-119PUBLISHED:?OCT2014; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hughes G, 2012, PSYCHOL B IN PRESS; Hughes G, 2011, NEUROIMAGE, V56, P1632, DOI 10.1016/j.neuroimage.2011.02.057; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; Moore JW, 2012, CONSCIOUS COGN, V21, P59, DOI 10.1016/j.concog.2011.08.010; Moore J, 2008, CONSCIOUS COGN, V17, P136, DOI 10.1016/j.concog.2006.12.004; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Sato A, 2008, CONSCIOUS COGN, V17, P1219, DOI 10.1016/j.concog.2008.01.003; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Wegner DM, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1201; Wegner DM, 1999, AM PSYCHOL, V54, P480, DOI 10.1037/0003-066X.54.7.480; Weiss C, 2011, COGNITION, V121, P207, DOI 10.1016/j.cognition.2011.06.011; Weiss C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022723; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; YOUNG ME, 1995, PSYCHON B REV, V2, P83, DOI 10.3758/BF03214413	45	69	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37959	10.1371/journal.pone.0037959	http://dx.doi.org/10.1371/journal.pone.0037959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22666424	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349600048
J	Tostar, U; Finta, C; Rahman, MFU; Shimokawa, T; Zaphiropoulos, PG				Tostar, Ulrica; Finta, Csaba; Rahman, Mohammed Ferdous-Ur; Shimokawa, Takashi; Zaphiropoulos, Peter G.			Novel Mechanism of Action on Hedgehog Signaling by a Suppressor of Fused Carboxy Terminal Variant	PLOS ONE			English	Article							NEGATIVE REGULATOR; GLI PROTEINS; 1ST EXON; SUFU; PATHWAY; GENE; DEGRADATION; PATCHED1	The Suppressor of Fused (SUFU) protein plays an essential role in the Hedgehog (HH) signaling pathway, by regulation of the GLI transcription factors. Two major isoforms of human SUFU are known, a full-length (SUFU-FL) and a carboxy-terminal truncated (SUFU-Delta C) variant. Even though SUFU-Delta C is expressed at an equivalent level as SUFU-FL in certain tissues, the function of SUFU-Delta C and its impact on HH signal transduction is still unclear. In two cell lines from rhabdomyosarcoma, a tumor type associated with deregulated HH signaling, SUFU-Delta C mRNA was expressed at comparable levels as SUFU-FL mRNA, but at the protein level only low amounts of SUFU-Delta C were detectable. Heterologous expression provided support to the notion that the SUFU-Delta C protein is less stable compared to SUFU-FL. Despite this, biochemical analysis revealed that SUFU-Delta C could repress GLI2 and GLI1 Delta N, but not GLI1FL, transcriptional activity to the same extent as SUFU-FL. Moreover, under conditions of activated HH signaling SUFU-Delta C was more effective than SUFU-FL in inhibiting GLI1 Delta N. Importantly, co-expression with GLI1FL indicated that SUFU-Delta C but not SUFU-FL reduced the protein levels of GLI1FL. Additionally, confocal microscopy revealed a co-localization of GLI1FL with SUFU-Delta C but not SUFU-FL in aggregate structures. Moreover, specific siRNA mediated knock-down of SUFU-Delta C resulted in up-regulation of the protein levels of GLI1FL and the HH signaling target genes PTCH1 and HHIP. Our results are therefore suggesting the presence of novel regulatory controls in the HH signaling pathway, which are elicited by the distinct mechanism of action of the two alternative spliced SUFU proteins.	[Tostar, Ulrica; Finta, Csaba; Rahman, Mohammed Ferdous-Ur; Shimokawa, Takashi; Zaphiropoulos, Peter G.] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	Karolinska Institutet	Tostar, U (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	peter.zaphiropoulos@ki.se	Shimokawa, Takashi/AAA-5870-2020; RAHMAN, MOHAMMED FERDOUS UR/AAO-5991-2020	Shimokawa, Takashi/0000-0001-6549-9277; RAHMAN, MOHAMMED FERDOUS UR/0000-0002-0239-7414; Zaphiropoulos, Peter/0000-0003-4298-3861	Swedish Research Council [K2008-67X-20778-01-3]; Swedish Cancer Fund [09 0788]; Swedish Childhood Cancer Foundation [PROJ10/011]; Magnus Bergvall foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Fund; Swedish Childhood Cancer Foundation(European Commission); Magnus Bergvall foundation	The work was supported by the following sources of funding: Swedish Research Council, Grant number K2008-67X-20778-01-3, www.vr.se; Swedish Cancer Fund, Grant number 09 0788, www.cancerfonden.se; Swedish Childhood Cancer Foundation, Grant number PROJ10/011, www.barncancerfonden.se; and Magnus Bergvall foundation, www.magnbergvallsstiftelse.nu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Cheng SY, 2008, ADV CANCER RES, V101, P29, DOI 10.1016/S0065-230X(08)00402-8; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Ekblad CMS, 2002, J MOL BIOL, V320, P431, DOI 10.1016/S0022-2836(02)00478-3; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gorlin RJ, 2004, GENET MED, V6, P530, DOI 10.1097/01.GIM.0000144188.15902.C4; Grimm T, 2001, FEBS LETT, V505, P13, DOI 10.1016/S0014-5793(01)02682-5; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Shimokawa T, 2007, ONCOGENE, V26, P4889, DOI 10.1038/sj.onc.1210301; Shimokawa T, 2004, FEBS LETT, V578, P157, DOI 10.1016/j.febslet.2004.11.006; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Stone DM, 1999, J CELL SCI, V112, P4437; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Tostar Ulrica, 2010, Genes Cancer, V1, P941, DOI 10.1177/1947601910385449; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403	24	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37761	10.1371/journal.pone.0037761	http://dx.doi.org/10.1371/journal.pone.0037761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666390	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600029
J	Beets, IAM; Mace, M; Meesen, RLJ; Cuypers, K; Levin, O; Swinnen, SP				Beets, Iseult A. M.; Mace, Marc; Meesen, Raf L. J.; Cuypers, Koen; Levin, Oron; Swinnen, Stephan P.			Active versus Passive Training of a Complex Bimanual Task: Is Prescriptive Proprioceptive Information Sufficient for Inducing Motor Learning?	PLOS ONE			English	Article							INTERLIMB COORDINATION; SKILL ACQUISITION; RHYTHMIC MOVEMENT; VOLUNTARY DRIVE; PERCEPTION; FREQUENCY; MODEL; BRAIN; ACTIVATION; KNOWLEDGE	Perceptual processes play an important role in motor learning. While it is evident that visual information greatly contributes to learning new movements, much less is known about provision of prescriptive proprioceptive information. Here, we investigated whether passive (proprioceptively-based) movement training was comparable to active training for learning a new bimanual task. Three groups practiced a bimanual coordination pattern with a 1: 2 frequency ratio and a 90 degrees phase offset between both wrists with Lissajous feedback over the course of four days: 1) passive training; 2) active training; 3) no training (control). Retention findings revealed that passive as compared to active training resulted in equally successful acquisition of the frequency ratio but active training was more effective for acquisition of the new relative phasing between the limbs in the presence of augmented visual feedback. However, when this feedback was removed, performance of the new relative phase deteriorated in both groups whereas the frequency ratio was better preserved. The superiority of active over passive training in the presence of augmented feedback is hypothesized to result from active involvement in processes of error detection/correction and planning.	[Beets, Iseult A. M.; Mace, Marc; Meesen, Raf L. J.; Cuypers, Koen; Levin, Oron; Swinnen, Stephan P.] Katholieke Univ Leuven, Dept Biomed Kinesiol, Motor Control Lab, B-3001 Heverlee, Belgium; [Mace, Marc] Univ Toulouse 3, Inst Rech Informat Toulouse, F-31062 Toulouse, France; [Meesen, Raf L. J.; Cuypers, Koen] Univ Coll Limburg, Dept Hlth Care, REVAL Rehabil & Hlth Care Res Ctr, Hasselt, Belgium; [Meesen, Raf L. J.; Cuypers, Koen] Hasselt Univ, Sch Life Sci, Biomed Res Inst, Diepenbeek, Belgium	KU Leuven; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite Toulouse 1 Capitole; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); Hasselt University	Beets, IAM (corresponding author), Katholieke Univ Leuven, Dept Biomed Kinesiol, Motor Control Lab, B-3001 Heverlee, Belgium.	iseult.beets@faber.kuleuven.be	Levin, Oron/GQP-4656-2022; Meesen, Raf L/F-2582-2019; Cuypers, Koen/N-9918-2018; Levin, Oron/J-9405-2015	Meesen, Raf L/0000-0002-7938-3758; Levin, Oron/0000-0002-9072-5122	Katholieke Universiteit Leuven, Belgium [OT/07/073, OT/11/071]; Flanders Fund for Scientific Research [G.0593.08, G0483.10]; Belgian federal government [P6/29]	Katholieke Universiteit Leuven, Belgium(KU Leuven); Flanders Fund for Scientific Research(FWO); Belgian federal government	This work was supported by grants from the Research Fund of the Katholieke Universiteit Leuven, Belgium [OT/07/073, OT/11/071], the Flanders Fund for Scientific Research [G.0593.08, G0483.10] and Grant P6/29 from the Interuniversity Attraction Poles program of the Belgian federal government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P415, DOI 10.1016/j.neuropsychologia.2008.09.012; Beek PJ, 2002, BRAIN COGNITION, V48, P149, DOI 10.1006/brcg.2001.1310; Beets IAM, 2010, J NEUROPHYSIOL, V104, P1612, DOI 10.1152/jn.00974.2009; Bingham GP, 2004, ECOL PSYCHOL, V16, P45, DOI 10.1207/s15326969eco1601_6; Bingham GP, 1999, PERCEPT PSYCHOPHYS, V61, P246, DOI 10.3758/BF03206886; CARROLL WR, 1982, J MOTOR BEHAV, V14, P153; Crespo LM, 2008, J MOTOR BEHAV, V40, P545, DOI 10.3200/JMBR.40.6.545-557; Debaere F, 2004, NEUROPSYCHOLOGIA, V42, P855, DOI 10.1016/j.neuropsychologia.2003.12.010; Denis M., 1985, CANADIAN J APPL SCI, V4, P4; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fitts PM., 1967, HUM PERFORM; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; GANDEVIA SC, 1992, TRENDS NEUROSCI, V15, P62, DOI 10.1016/0166-2236(92)90028-7; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hecht H, 2001, PSYCHOL RES-PSYCH FO, V65, P3, DOI 10.1007/s004260000043; Hesse S, 2003, ARCH PHYS MED REHAB, V84, P915, DOI 10.1016/S0003-9993(02)04954-7; Hodges NJ, 2000, HUM MOVEMENT SCI, V19, P843, DOI 10.1016/S0167-9457(01)00025-2; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Kaelin-Lang A, 2005, J NEUROPHYSIOL, V93, P1099, DOI 10.1152/jn.00143.2004; KAWATO M, 1992, BIOL CYBERN, V68, P95, DOI 10.1007/BF00201431; Kovacs AJ, 2011, ACTA PSYCHOL, V136, P311, DOI 10.1016/j.actpsy.2010.12.004; Kovacs AJ, 2010, EXP BRAIN RES, V201, P249, DOI 10.1007/s00221-009-2031-y; Kovacs AJ, 2009, EXP BRAIN RES, V193, P129, DOI 10.1007/s00221-008-1676-2; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Luttgen J, HUM MOV SCI IN PRESS; Magill R.A., 2007, MOTOR LEARNING CONTR; MATTHEWS PBC, 1988, CAN J PHYSIOL PHARM, V66, P430, DOI 10.1139/y88-073; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Miall RC, 1996, J MOTOR BEHAV, V28, P125, DOI 10.1080/00222895.1996.9941739; NEWELL KM, 1991, ANNU REV PSYCHOL, V42, P213, DOI 10.1146/annurev.ps.42.020191.001241; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PEPER CE, 1995, BIOL CYBERN, V73, P301, DOI 10.1007/BF00199466; Ronsse R, 2011, CEREB CORTEX; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; SUMMERS JJ, 1993, J EXP PSYCHOL HUMAN, V19, P416, DOI 10.1037/0096-1523.19.2.416; Swinnen SP, 1997, MOVEMENT DISORD, V12, P958, DOI 10.1002/mds.870120619; Swinnen SP, 1997, J EXP PSYCHOL HUMAN, V23, P1087; Swinnen SP, 1997, HUM MOVEMENT SCI, V16, P749, DOI 10.1016/S0167-9457(97)00020-1; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Swinnen SP., 1996, ADV MOTOR LEARNING C, P37; Weiller C, 1996, NEUROIMAGE, V4, P105, DOI 10.1006/nimg.1996.0034; WEILLER C, 1995, CEREBROVASC DIS, V5, P282, DOI 10.1159/000107864; Wilson AD, 2005, EXP BRAIN RES, V164, P517, DOI 10.1007/s00221-005-2272-3; Wilson AD, 2010, J EXP PSYCHOL HUMAN, V36, P1508, DOI 10.1037/a0020412; WINSTEIN CJ, 1990, J EXP PSYCHOL LEARN, V16, P677, DOI 10.1037/0278-7393.16.4.677; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	58	46	46	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37687	10.1371/journal.pone.0037687	http://dx.doi.org/10.1371/journal.pone.0037687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22666379	Green Published, gold			2022-12-27	WOS:000305335800071
J	Dichosa, AEK; Fitzsimons, MS; Lo, CC; Weston, LL; Preteska, LG; Snook, JP; Zhang, XJ; Gu, W; McMurry, K; Green, LD; Chain, PS; Detter, JC; Han, CS				Dichosa, Armand E. K.; Fitzsimons, Michael S.; Lo, Chien-Chi; Weston, Lea L.; Preteska, Lara G.; Snook, Jeremy P.; Zhang, Xiaojing; Gu, Wei; McMurry, Kim; Green, Lance D.; Chain, Patrick S.; Detter, J. Chris; Han, Cliff S.			Artificial Polyploidy Improves Bacterial Single Cell Genome Recovery	PLOS ONE			English	Article							DIVISION PROTEIN FTSZ; TARGETING FTSZ; SMALL-MOLECULE; AMPLIFICATION; CYTOKINESIS; METABOLISM; POLYMERASE; DISCOVERY	Background: Single cell genomics (SCG) is a combination of methods whose goal is to decipher the complete genomic sequence from a single cell and has been applied mostly to organisms with smaller genomes, such as bacteria and archaea. Prior single cell studies showed that a significant portion of a genome could be obtained. However, breakages of genomic DNA and amplification bias have made it very challenging to acquire a complete genome with single cells. We investigated an artificial method to induce polyploidy in Bacillus subtilis ATCC 6633 by blocking cell division and have shown that we can significantly improve the performance of genomic sequencing from a single cell. Methodology/Principal Findings: We inhibited the bacterial cytoskeleton protein FtsZ in B. subtilis with an FtsZ-inhibiting compound, PC190723, resulting in larger undivided single cells with multiple copies of its genome. qPCR assays of these larger, sorted cells showed higher DNA content, have less amplification bias, and greater genomic recovery than untreated cells. Significance: The method presented here shows the potential to obtain a nearly complete genome sequence from a single bacterial cell. With millions of uncultured bacterial species in nature, this method holds tremendous promise to provide insight into the genomic novelty of yet-to-be discovered species, and given the temporary effects of artificial polyploidy coupled with the ability to sort and distinguish differences in cell size and genomic DNA content, may allow recovery of specific organisms in addition to their genomes.	[Dichosa, Armand E. K.; Fitzsimons, Michael S.; Lo, Chien-Chi; Weston, Lea L.; Preteska, Lara G.; Snook, Jeremy P.; Zhang, Xiaojing; Gu, Wei; McMurry, Kim; Green, Lance D.; Chain, Patrick S.; Detter, J. Chris; Han, Cliff S.] Los Alamos Natl Lab, Dept Energy DOE Joint Genome Inst, Los Alamos, NM 87545 USA; [Lo, Chien-Chi; Zhang, Xiaojing; Gu, Wei; McMurry, Kim; Green, Lance D.; Chain, Patrick S.; Detter, J. Chris; Han, Cliff S.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Dichosa, AEK (corresponding author), Los Alamos Natl Lab, Dept Energy DOE Joint Genome Inst, Los Alamos, NM 87545 USA.	han_cliff@lanl.gov	t, lf/AAJ-4924-2020; Chain, Patrick/O-4140-2019; chain, patrick/B-9777-2013	Chain, Patrick/0000-0003-3949-3634; Dichosa, Armand/0000-0003-0640-6629; Han, Cliff/0000-0003-1972-0692; Lo, Chien-Chi/0000-0003-3470-1078	Los Alamos National Laboratory: Laboratory Directed Research and Development Fund [20100034DR]; Department of Defense: Defense Threat Reduction Agency [R-3708-09]	Los Alamos National Laboratory: Laboratory Directed Research and Development Fund(United States Department of Energy (DOE)Los Alamos National Laboratory); Department of Defense: Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Los Alamos National Laboratory: Laboratory Directed Research and Development Fund, Grant# 20100034DR, and by the Department of Defense: Defense Threat Reduction Agency, Contract# R-3708-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMARAL L, 1986, DRUG EXP CLIN RES, V12, P653; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Domadia P, 2007, BIOCHEM PHARMACOL, V74, P831, DOI 10.1016/j.bcp.2007.06.029; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Erickson HP, 2000, J CELL BIOL, V148, P1103, DOI 10.1083/jcb.148.6.1103; Fox J., 2014, R COMPANION APPL REG; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Huang Q, 2006, J MED CHEM, V49, P463, DOI 10.1021/jm050920y; Ito H, 2006, MICROBIOL IMMUNOL, V50, P759, DOI 10.1111/j.1348-0421.2006.tb03851.x; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lappchen T, 2005, BIOCHEMISTRY-US, V44, P7879, DOI 10.1021/bi047297o; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Ohashi Y, 1999, J BACTERIOL, V181, P1348, DOI 10.1128/JB.181.4.1348-1351.1999; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rozen S, 2000, Methods Mol Biol, V132, P365; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Sokal RR, 1995, BIOMETRY PRINCIPLES, P521; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Urgaonkar S, 2005, ORG LETT, V7, P5609, DOI 10.1021/ol052269z; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	42	20	20	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37387	10.1371/journal.pone.0037387	http://dx.doi.org/10.1371/journal.pone.0037387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22666352	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345300037
J	Gupta, PK; Prabhakar, S; Sharma, NK; Anand, A				Gupta, Pawan K.; Prabhakar, Sudesh; Sharma, Neel K.; Anand, Akshay			Possible Association between Expression of Chemokine Receptor-2 (CCR2) and Amyotrophic Lateral Sclerosis (ALS) Patients of North India	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ENDOTHELIAL GROWTH-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; SPINAL CORD BARRIER; CEREBROSPINAL-FLUID; BLOOD-BRAIN; MOUSE MODEL; FACTOR-A; MCP-1; MICE	Background and Objectives: We earlier reported elevated chemokine ligand-2 (CCL2) in Indian amyotrophic lateral sclerosis (ALS) patients. We now analysed chemokine receptor-2 (CCR2), the receptor of CCL2, in these ALS patients. Methods: Indian sporadic ALS patients (n = 50) were included on the basis of El Escorial criteria. Percentage (%) of CCR2 expressing peripheral blood mononuclear cells (PBMCs) was evaluated using Flow Cytometry. Real Time Polymerase Chain Reaction (PCR) was used to quantitate CCR2 mRNA expression in PBMCs. Normal controls (n = 40) were also included for comparison. Results: Flow Cytometry revealed significantly reduced CCR2 expressing PBMCs in the ALS patients. We also found a significant decline in number of CCR2 expressing PBMCs in limb onset ALS when compared to bulbar onset ALS. PBMCs from ALS patients showed substantial down-regulation of CCR2 mRNA. CCR2 mRNA expression was found to be decreased among limb ALS patients as compared to bulbar onset ALS. Further, the count of CCR2+ PBMCs and CCR2 mRNA transcript in PBMCs was significantly lower in severe and moderate ALS as compared to ALS patients with mild impairments. Conclusions: Downregulation of PBMCs CCR2 may indicate its etio-pathological relevance in ALS pathogenesis. Reduced PBMCs CCR2 may result in decreased infiltration of leukocytes at the site of degeneration as a compensatory response to ALS. CCR2 levels measurements in hematopoietic stem cells and estimation of comparative PBMCs count among ALS, disease controls and normal controls can unveil its direct neuroprotective role. However, the conclusions are restricted by the absence of neurological/non-neurological disease controls in the study.	[Gupta, Pawan K.; Prabhakar, Sudesh; Sharma, Neel K.; Anand, Akshay] PGIMER, Dept Neurol, Neurosci Res Lab, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Gupta, PK (corresponding author), PGIMER, Dept Neurol, Neurosci Res Lab, Chandigarh, India.	akshay1anand@rediffmail.com			ICMR (Indian Council of Medical Research) [5/4-5/10/Neuro/2005- NCD - I]	ICMR (Indian Council of Medical Research)(Indian Council of Medical Research (ICMR))	Funding agency: ICMR (Indian Council of Medical Research) Grant No. 5/4-5/10/Neuro/2005- NCD - I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock AA, 2003, J NEUROSCI, V23, P7922; Baron P, 2005, MUSCLE NERVE, V32, P541, DOI 10.1002/mus.20376; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Bosco MC, 2006, J IMMUNOL, V177, P1941, DOI 10.4049/jimmunol.177.3.1941; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Gupta PK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-114; Gupta PK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-47; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Ilzecka J, 2004, CLIN NEUROL NEUROSUR, V106, P289, DOI 10.1016/j.clineuro.2003.12.007; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Kuhle J, 2009, EUR J NEUROL, V16, P771, DOI 10.1111/j.1468-1331.2009.02560.x; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Kyrkanides S, 2008, J NEUROIMMUNOL, V203, P50, DOI 10.1016/j.jneuroim.2008.06.024; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Mantovani S, 2009, J NEUROIMMUNOL, V210, P73, DOI 10.1016/j.jneuroim.2009.02.012; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Nagata T, 2007, NEUROL RES, V29, P772, DOI 10.1179/016164107X229795; Nalini A, 2008, J NEUROL SCI, V272, P60, DOI 10.1016/j.jns.2008.04.034; Nicaise C, 2009, BRAIN RES, V1301, P152, DOI 10.1016/j.brainres.2009.09.018; Pellicano M, 2010, J ALZHEIMERS DIS, V21, P181, DOI 10.3233/JAD-2010-091714; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Tateishi T, 2010, J NEUROIMMUNOL, V222, P76, DOI 10.1016/j.jneuroim.2010.03.004; Verstraete E, 2010, AMYOTROPH LATERAL SC, V11, P555, DOI 10.3109/17482968.2010.513053; Wilms H, 2003, J NEUROIMMUNOL, V144, P139, DOI 10.1016/j.jneuroim.2003.08.042; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Zhang RZ, 2006, J NEUROIMMUNOL, V179, P87, DOI 10.1016/j.jneuroim.2006.06.008; Zhang RZ, 2005, J NEUROIMMUNOL, V159, P215, DOI 10.1016/j.jneuroim.2004.10.009	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38382	10.1371/journal.pone.0038382	http://dx.doi.org/10.1371/journal.pone.0038382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685564	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700027
J	Abd-Alla, AMM; Adun, H; Parker, AG; Vreysen, MJB; Bergoin, M				Abd-Alla, Adly M. M.; Adun, Henry; Parker, Andrew G.; Vreysen, Marc J. B.; Bergoin, Max			The Antiviral Drug Valacyclovir Successfully Suppresses Salivary Gland Hypertrophy Virus (SGHV) in Laboratory Colonies of Glossina pallidipes	PLOS ONE			English	Article							DNA VIRUS; TSETSE-FLIES; DIPTERA; HYPERPLASIA; BREVIPALPIS; LESIONS; KENYA	Many species of tsetse flies are infected with a virus that causes salivary gland hypertrophy (SGH) symptoms associated with a reduced fecundity and fertility. A high prevalence of SGH has been correlated with the collapse of two laboratory colonies of Glossina pallidipes and colony maintenance problems in a mass rearing facility in Ethiopia. Mass-production of G. pallidipes is crucial for programs of tsetse control including the sterile insect technique (SIT), and therefore requires a management strategy for this virus. Based on the homology of DNA polymerase between salivary gland hypertrophy virus and herpes viruses at the amino acid level, two antiviral drugs, valacyclovir and acyclovir, classically used against herpes viruses were selected and tested for their toxicity on tsetse flies and their impact on virus replication. While long term per os administration of acyclovir resulted in a significant reduction of productivity of the colonies, no negative effect was observed in colonies fed with valacyclovir-treated blood. Furthermore, treatment of a tsetse colony with valacyclovir for 83 weeks resulted in a significant reduction of viral loads and consequently suppression of SGH symptoms. The combination of initial selection of SGHV-negative flies by non-destructive PCR, a clean feeding system, and valacyclovir treatment resulted in a colony that was free of SGH syndromes in 33 weeks. This is the first report of the use of a drug to control a viral infection in an insect and of the demonstration that valacyclovir can be used to suppress SGH in colonies of G. pallidipes.	[Abd-Alla, Adly M. M.; Adun, Henry; Parker, Andrew G.; Vreysen, Marc J. B.] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Bergoin, Max] Univ Montpellier, Lab Pathol Comparee, F-34059 Montpellier, France	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Universite de Montpellier	Abd-Alla, AMM (corresponding author), Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	a.m.m.abd-alla@iaea.org		Parker, Andrew Gordon/0000-0001-8187-1278; ABD-ALLA, Adly/0000-0001-7540-4462				Abd-Alla A, 2007, J VIROL METHODS, V139, P143, DOI 10.1016/j.jviromet.2006.09.018; Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Abd-Alla AMM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001220; Abd-Alla AMM, 2010, VIRUS RES, V150, P103, DOI 10.1016/j.virusres.2010.03.001; Abd-Alla AMM, 2009, VIRUS RES, V139, P48, DOI 10.1016/j.virusres.2008.10.006; [Anonymous], 2010, R LANG ENV STAT COMP; Baier T, 2007, COMPUTATION STAT, V22, P91, DOI 10.1007/s00180-007-0023-6; Bras A P, 2001, Can J Clin Pharmacol, V8, P207; De Clercq E, 2003, CLIN MICROBIOL REV, V16, P569, DOI 10.1128/CMR.16.4.569-596.2003; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P941, DOI 10.1038/nrd2485; ELLIS DS, 1987, ENTOMOL EXP APPL, V45, P167, DOI 10.1007/BF00305643; Enserink M, 2007, SCIENCE, V317, P310, DOI 10.1126/science.317.5836.310; Feldmann U, 1994, TECHNIQUES INSECT RE, P13; Feldmann U, 1994, TECHNIQUES INSECT RE, P449; Geerts S., 1998, DRUG MANAGEMENT PARA; JAENSON TGT, 1978, T ROY SOC TROP MED H, V72, P234, DOI 10.1016/0035-9203(78)90200-6; Jordan A, 1986, TRYPANOSOMIASIS CONT; JURA WGZO, 1989, CURR MICROBIOL, V18, P1, DOI 10.1007/BF01568821; JURA WGZO, 1988, J INVERTEBR PATHOL, V52, P1, DOI 10.1016/0022-2011(88)90095-X; Leak SGA., 1998, TSETSE BIOL ECOLOGY, DOI [10.1079/9780851993003.0000, DOI 10.1079/9780851993003.0000]; Lietze VU, 2011, ANNU REV ENTOMOL, V56, P63, DOI 10.1146/annurev-ento-120709-144841; MINTERGOEDBLOED E, 1989, T ROY SOC TROP MED H, V83, P640, DOI 10.1016/0035-9203(89)90380-5; ODINDO MO, 1982, INSECT SCI APPL, V3, P65, DOI 10.1017/S1742758400001922; OTIENO LH, 1980, J INVERTEBR PATHOL, V36, P113, DOI 10.1016/0022-2011(80)90142-1; Sasanya JJ, 2010, J CHROMATOGR B, V878, P2384, DOI 10.1016/j.jchromb.2010.07.008; SHAW MK, 1993, J INVERTEBR PATHOL, V61, P162, DOI 10.1006/jipa.1993.1029; Sokal R. R, 1981, BIOMETRY; STEELMAN CD, 1976, ANNU REV ENTOMOL, V21, P155, DOI 10.1146/annurev.en.21.010176.001103; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123	29	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38417	10.1371/journal.pone.0038417	http://dx.doi.org/10.1371/journal.pone.0038417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679503	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343900039
J	Keary, N; Bischof, HJ				Keary, Nina; Bischof, Hans-Joachim			Activation Changes in Zebra Finch (Taeniopygia guttata) Brain Areas Evoked by Alterations of the Earth Magnetic Field	PLOS ONE			English	Article							COMPASS ORIENTATION; HIPPOCAMPAL-FORMATION; GEOMAGNETIC-FIELD; HOMING PIGEONS; VISUAL WULST; CLUSTER-N; BEAK; BEHAVIOR; MAGNETORECEPTION; RESPONSES	Many animals are able to perceive the earth magnetic field and to use it for orientation and navigation within the environment. The mechanisms underlying the perception and processing of magnetic field information within the brain have been thoroughly studied, especially in birds, but are still obscure. Three hypotheses are currently discussed, dealing with ferromagnetic particles in the beak of birds, with the same sort of particles within the lagena organs, or describing magnetically influenced radical-pair processes within retinal photopigments. Each hypothesis is related to a well-known sensory organ and claims parallel processing of magnetic field information with somatosensory, vestibular and visual input, respectively. Changes in activation within nuclei of the respective sensory systems have been shown previously. Most of these previous experiments employed intensity enhanced magnetic stimuli or lesions. We here exposed unrestrained zebra finches to either a stationary or a rotating magnetic field of the local intensity and inclination. C-Fos was used as an activity marker to examine whether the two treatments led to differences in fourteen brain areas including nuclei of the somatosensory, vestibular and visual system. An ANOVA revealed an overall effect of treatment, indicating that the magnetic field change was perceived by the birds. While the differences were too small to be significant in most areas, a significant enhancement of activation by the rotating stimulus was found in a hippocampal subdivision. Part of the hyperpallium showed a strong, nearly significant, increase. Our results are compatible with previous studies demonstrating an involvement of at least three different sensory systems in earth magnetic field perception and suggest that these systems, probably less elaborated, may also be found in nonmigrating birds.	[Keary, Nina; Bischof, Hans-Joachim] Univ Bielefeld, Lehrstuhl Verhaltensforsch, D-33615 Bielefeld, Germany	University of Bielefeld	Keary, N (corresponding author), Univ Bielefeld, Lehrstuhl Verhaltensforsch, Morgenbreede 45, D-33615 Bielefeld, Germany.	nina.keary@uni-bielefeld.de			Deutsche Forschungsgemeinschaft [Bi 245/18-2]; University of Bielefeld	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Bielefeld	Funding was provided by a grant of the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) to H-JB and Wolfgang Wiltschko, grant number Bi 245/18-2 and a scholarship of the University of Bielefeld to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atoji Y, 2004, J COMP NEUROL, V475, P426, DOI 10.1002/cne.20186; BEASON RC, 1987, NEUROSCI LETT, V80, P229, DOI 10.1016/0304-3940(87)90659-8; Bingman VP, 2003, BRAIN BEHAV EVOLUT, V62, P117, DOI 10.1159/000072442; BINGMAN VP, 1990, BEHAV BRAIN RES, V40, P227, DOI 10.1016/0166-4328(90)90079-T; Bischof Hans-Joachim, 2011, Communicative & Integrative Biology, V4, P713; BISCHOF HJ, 1981, BRAIN RES BULL, V7, P435, DOI 10.1016/0361-9230(81)90042-3; BREDENKOTTER M, 1990, VISUAL NEUROSCI, V5, P155, DOI 10.1017/S0952523800000201; BURDA H, 1990, EXPERIENTIA, V46, P528, DOI 10.1007/BF01954256; CLAYTON NS, 1995, J NEUROSCI, V15, P2796; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Falkenberg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009231; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Hanzlik M, 2000, BIOMETALS, V13, P325, DOI 10.1023/A:1009214526685; Harada Y, 2002, ACTA OTO-LARYNGOL, V122, P132, DOI 10.1080/00016480252814126; Harada Y, 2001, ACTA OTO-LARYNGOL, V121, P590, DOI 10.1080/000164801316878872; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Kahn MC, 2003, J COMP NEUROL, V459, P127, DOI 10.1002/cne.10601; Keary N, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-25; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; LOHMANN KJ, 1991, J EXP BIOL, V155, P37; Mayer U, 2012, J EXP BIOL IN PRESS; Mayer U, 2010, NEUROBIOL LEARN MEM, V93, P322, DOI 10.1016/j.nlm.2009.11.006; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Niessner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020091; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; PRESTI D, 1980, NATURE, V285, P99, DOI 10.1038/285099a0; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Schulten K., 1986, P PHYS, P99, DOI 10.1007/978-3-642-71526-6_16; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; SEMM P, 1986, J COMP PHYSIOL A, V159, P619, DOI 10.1007/BF00612035; Shcherbakov VP, 1999, EUR BIOPHYS J BIOPHY, V28, P380, DOI 10.1007/s002490050222; SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; SINSCH U, 1987, J COMP PHYSIOL A, V161, P715, DOI 10.1007/BF00605013; Sinsch U., 1990, Progress in Zoology, V38, P75; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; Vargas JP, 2006, BRAIN RES BULL, V70, P158, DOI 10.1016/j.brainresbull.2006.03.018; Voss J, 2007, NEUROREPORT, V18, P1053, DOI 10.1097/WNR.0b013e32818b2a21; Watanabe S, 2004, BEHAV BRAIN RES, V155, P147, DOI 10.1016/j.bbr.2004.04.007; Watanabe S, 2006, REV NEUROSCI, V17, P1; Watanabe S, 2011, BEHAV BRAIN RES, V222, P51, DOI 10.1016/j.bbr.2011.03.035; Williams MN, 2001, BRAIN RES, V889, P243, DOI 10.1016/S0006-8993(00)03114-0; Wiltscbko W., 1968, Zeitschrift fuer Tierpsychologie, V25, P537; Wiltschko R, 1998, NATURWISSENSCHAFTEN, V85, P164, DOI 10.1007/s001140050476; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko R, 2010, CURR BIOL, V20, P1534, DOI 10.1016/j.cub.2010.06.073; Wiltschko W, 1996, J EXP BIOL, V199, P29; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; WILTSCHKO W, 1981, NATURE, V291, P433, DOI 10.1038/291433a0; Wiltschko W., 1966, Zoologischer Anzeiger Suppl, V29, P362; Wiltschko W, 2007, J EXP BIOL, V210, P2300, DOI 10.1242/jeb.004853; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wu LQ, 2011, CURR BIOL, V21, P418, DOI 10.1016/j.cub.2011.01.058; Zapka M, 2010, EUR J NEUROSCI, V32, P619, DOI 10.1111/j.1460-9568.2010.07311.x; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	63	18	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38697	10.1371/journal.pone.0038697	http://dx.doi.org/10.1371/journal.pone.0038697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679515	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900063
J	Dabrowski, PW; Nitsche, A				Dabrowski, Piotr Wojtek; Nitsche, Andreas			mPSQed: A Software for the Design of Multiplex Pyrosequencing Assays	PLOS ONE			English	Article								Molecular-based diagnostic assays are the gold standard for infectious diseases today, since they allow a rapid and sensitive identification and typing of various pathogens. While PCR can be designed to be specific for a certain pathogen, a subsequent sequence analysis is frequently required for confirmation or typing. The design of appropriate PCR-based assays is a complex task, especially when conserved discriminating polymorphisms are rare or if the number of types which need to be differentiated is high. One extremely useful but underused method for this purpose is the multiplex pyrosequencing technique. Unfortunately there is no software available to aid researchers in designing multiplex pyrosequencing assays. Here, we present mPSQed (Multiplex PyroSeQuencing EDitor), a program targeted at closing this gap. We also present the design of an exemplarily theoretical assay for the differentiation of human adenovirus types A-F using two pyrosequencing primers on two distinct PCR products, designed quickly and easily using our software.	[Dabrowski, Piotr Wojtek] Robert Koch Inst, Cent Adm IT 4, Berlin, Germany; [Dabrowski, Piotr Wojtek; Nitsche, Andreas] Robert Koch Inst, Ctr Biol Secur 1, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Dabrowski, PW (corresponding author), Robert Koch Inst, Cent Adm IT 4, Berlin, Germany.	DabrowskiW@rki.de	Dabrowski, Piotr Wojtek/L-1423-2015	Dabrowski, Piotr Wojtek/0000-0003-4893-805X; Nitsche, Andreas/0000-0001-8185-3176	Robert Koch Institute	Robert Koch Institute	Both authors are directly employed by the Robert Koch Institute, and as such no third party funding was used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bio C, 2011, CLC WORKB; DNASTAR, 2011, LAS; DRUMMOND AJ, 2010, GENEIOUS V5 5; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; Hillbrecht D, 2003, HELPSETMAKER TOOL PR; Katoh M, NUCL ACIDS RES; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Patel Pritesh, 2007, V373, P75; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rozen S, 2000, Methods Mol Biol, V132, P365; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	13	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38140	10.1371/journal.pone.0038140	http://dx.doi.org/10.1371/journal.pone.0038140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675516	Green Published, gold			2022-12-27	WOS:000305341700041
J	Jerng, HH; Pfaffinger, PJ				Jerng, Henry H.; Pfaffinger, Paul J.			Incorporation of DPP6a and DPP6K Variants in Ternary Kv4 Channel Complex Reconstitutes Properties of A-type K Current in Rat Cerebellar Granule Cells	PLOS ONE			English	Article							DIFFERENTIAL DISTRIBUTION; INACTIVATION PROPERTIES; VOLTAGE-CLAMP; PROTEIN DPPX; T-TYPE; EXPRESSION; SUBUNITS; MODULATION; KCHIPS; TRAFFICKING	Dipeptidyl peptidase-like protein 6 (DPP6) proteins co-assemble with Kv4 channel alpha-subunits and Kv channel-interacting proteins (KChIPs) to form channel protein complexes underlying neuronal somatodendritic A-type potassium current (I-SA). DPP6 proteins are expressed as N-terminal variants (DPP6a, DPP6K, DPP6S, DPP6L) that result from alternative mRNA initiation and exhibit overlapping expression patterns. Here, we study the role DPP6 variants play in shaping the functional properties of I-SA found in cerebellar granule (CG) cells using quantitative RT-PCR and voltage-clamp recordings of whole-cell currents from reconstituted channel complexes and native I-SA channels. Differential expression of DPP6 variants was detected in rat CG cells, with DPP6K (41 +/- 3%)>DPP6a (33 +/- 3%)>>DPP6S (18 +/- 2%)>DPP6L (8 +/- 3%). To better understand how DPP6 variants shape native neuronal I-SA, we focused on studying interactions between the two dominant variants, DPP6K and DPP6a. Although previous studies did not identify unique functional effects of DPP6K, we find that the unique N-terminus of DPP6K modulates the effects of KChIP proteins, slowing recovery and producing a negative shift in the steady-state inactivation curve. By contrast, DPP6a uses its distinct N-terminus to directly confer rapid N-type inactivation independently of KChIP3a. When DPP6a and DPP6K are co-expressed in ratios similar to those found in CG cells, their distinct effects compete in modulating channel function. The more rapid inactivation from DPP6a dominates during strong depolarization; however, DPP6K produces a negative shift in the steady-state inactivation curve and introduces a slow phase of recovery from inactivation. A direct comparison to the native CG cell I-SA shows that these mixed effects are present in the native channels. Our results support the hypothesis that the precise expression and co-assembly of different auxiliary subunit variants are important factors in shaping the I-SA functional properties in specific neuronal populations.	[Jerng, Henry H.; Pfaffinger, Paul J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Jerng, HH (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hjerng@cns.bcm.edu			National Institutes of Health [R01 NS37444, R01 GM090029]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 NS37444 and R01 GM090029 (located at http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; Anderson D, 2010, CHANNELS, V4, P163, DOI 10.4161/chan.4.3.11955; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; BARDONI R, 1993, J NEUROPHYSIOL, V69, P2222, DOI 10.1152/jn.1993.69.6.2222; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Clark BD, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.008.2008; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; Dougherty K, 2009, CHANNELS, V3, P122, DOI 10.4161/chan.3.2.8333; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HOCKBERGER PE, 1987, J NEUROSCI, V7, P1370; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hu CL, 2006, NEUROPHARMACOLOGY, V51, P737, DOI 10.1016/j.neuropharm.2006.05.013; Jerng H. H., 2008, Society for Neuroscience Abstract Viewer and Itinerary Planner, V38; Jerng HH, 2007, MOL CELL NEUROSCI, V35, P604, DOI 10.1016/j.mcn.2007.03.008; Jerng HH, 2009, CHANNELS, V3, P448, DOI 10.4161/chan.3.6.10216; Jerng HH, 2008, J BIOL CHEM, V283, P36046, DOI 10.1074/jbc.M806852200; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; LACERDA AE, 1994, BIOPHYS J, V66, P1833, DOI 10.1016/S0006-3495(94)80977-4; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; Maffie J, 2009, NEUROSCI LETT, V449, P189, DOI 10.1016/j.neulet.2008.10.098; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nadin BM, 2010, J NEUROSCI, V30, P8551, DOI 10.1523/JNEUROSCI.5489-09.2010; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; ROBELLO M, 1989, BIOSCIENCE REP, V9, P451, DOI 10.1007/BF01117047; ROSSI P, 1994, PFLUG ARCH EUR J PHY, V429, P107, DOI 10.1007/BF02584036; Savalli N, 2007, J GEN PHYSIOL, V130, P117, DOI 10.1085/jgp.200709803; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Soh H, 2008, J BIOL CHEM, V283, P15072, DOI 10.1074/jbc.M706964200; STEFANI A, 1992, NEUROSCI LETT, V144, P4, DOI 10.1016/0304-3940(92)90703-A; Strassle BW, 2005, J COMP NEUROL, V484, P144, DOI 10.1002/cne.20443; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Takimoto K, 2006, BIOCHEM BIOPH RES CO, V348, P1094, DOI 10.1016/j.bbrc.2006.07.157; Talley EM, 1999, J NEUROSCI, V19, P1895; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang X, 2005, J NEUROSCI RES, V81, P530, DOI 10.1002/jnr.20576; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Xia XM, 2003, J GEN PHYSIOL, V121, P125, DOI 10.1085/jgp.20028667; Xiong H, 2004, MOL BRAIN RES, V128, P103, DOI 10.1016/j.molbrainres.2004.06.024; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; ZEGARRAMORAN O, 1994, EXP BRAIN RES, V98, P298	57	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38205	10.1371/journal.pone.0038205	http://dx.doi.org/10.1371/journal.pone.0038205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675523	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700046
J	Killaspy, H; White, S; Wright, C; Taylor, TL; Turton, P; Kallert, T; Schuster, M; Cervilla, JA; Brangier, P; Raboch, J; Kalisova, L; Onchev, G; Alexiev, S; Mezzina, R; Ridente, P; Wiersma, D; Visser, E; Kiejna, A; Piotrowski, P; Ploumpidis, D; Gonidakis, F; Caldas-de-Almeida, JM; Cardoso, G; King, M				Killaspy, Helen; White, Sarah; Wright, Christine; Taylor, Tatiana L.; Turton, Penny; Kallert, Thomas; Schuster, Mirjam; Cervilla, Jorge A.; Brangier, Paulette; Raboch, Jiri; Kalisova, Lucie; Onchev, Georgi; Alexiev, Spiridon; Mezzina, Roberto; Ridente, Pina; Wiersma, Durk; Visser, Ellen; Kiejna, Andrzej; Piotrowski, Patryk; Ploumpidis, Dimitris; Gonidakis, Fragiskos; Caldas-de-Almeida, Jose Miguel; Cardoso, Graca; King, Michael			Quality of Longer Term Mental Health Facilities in Europe: Validation of the Quality Indicator for Rehabilitative Care against Service Users' Views	PLOS ONE			English	Article							INSTITUTIONAL CARE; COMMUNITY; CONSEQUENCES; PEOPLE; SCALE	Background: The Quality Indicator for Rehabilitative Care (QuIRC) is a staff rated, international toolkit that assesses care in longer term hospital and community based mental health facilities. The QuIRC was developed from review of the international literature, an international Delphi exercise with over 400 service users, practitioners, carers and advocates from ten European countries at different stages of deinstitutionalisation, and review of the care standards in these countries. It can be completed in under an hour by the facility manager and has robust content validity, acceptability and inter-rater reliability. In this study, we investigated the internal validity of the QuIRC. Our aim was to identify the QuIRC domains of care that independently predicted better service user experiences of care. Method: At least 20 units providing longer term care for adults with severe mental illness were recruited in each of ten European countries. Service users completed standardised measures of their experiences of care, quality of life, autonomy and the unit's therapeutic milieu. Unit managers completed the QuIRC. Multilevel modelling allowed analysis of associations between service user ratings as dependent variables with unit QuIRC domain ratings as independent variables. Results: 1750/2495 (70%) users and the managers of 213 units from across ten European countries participated. QuIRC ratings were positively associated with service users' autonomy and experiences of care. Associations between QuIRC ratings and service users' ratings of their quality of life and the unit's therapeutic milieu were explained by service user characteristics (age, diagnosis and functioning). A hypothetical 10% increase in QuIRC rating resulted in a clinically meaningful improvement in autonomy. Conclusions: Ratings of the quality of longer term mental health facilities made by service managers were positively associated with service users' autonomy and experiences of care. Interventions that improve quality of care in these settings may promote service users' autonomy.	[Killaspy, Helen; Taylor, Tatiana L.; King, Michael] UCL, Mental Hlth Sci Unit, London, England; [White, Sarah; Wright, Christine; Turton, Penny] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [Kallert, Thomas] Pk Hosp Leipzig, Dept Psychiat Psychosomat Med & Psychotherapy, Leipzig, Germany; [Schuster, Mirjam] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Univ Hosp, Dresden, Germany; [Cervilla, Jorge A.] Univ Granada, San Cecilio Univ Hosp, Mental Hlth Unit, Granada, Spain; [Brangier, Paulette] Univ Granada, Biomed Res Ctr, Mental Hlth Network, Granada, Spain; [Raboch, Jiri; Kalisova, Lucie] Charles Univ Prague, Dept Psychiat, Prague, Czech Republic; [Onchev, Georgi; Alexiev, Spiridon] Med Univ Sofia, Dept Psychiat, Sofia, Bulgaria; [Mezzina, Roberto; Ridente, Pina] Trieste Healthcare Agcy, Dept Mental Hlth, Trieste, Italy; [Wiersma, Durk; Visser, Ellen] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Kiejna, Andrzej; Piotrowski, Patryk] Wroclaw Med Univ, Dept Psychiat, Wroclaw, Poland; [Ploumpidis, Dimitris; Gonidakis, Fragiskos] Univ Mental Hlth Res Inst, Athens, Greece; [Caldas-de-Almeida, Jose Miguel; Cardoso, Graca] Univ Nova Lisboa, Fac Med Sci, Lisbon, Portugal	University of London; University College London; St Georges University London; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Hospital Universitario San Cecilio; University of Granada; University of Granada; Charles University Prague; Medical University Sofia; University of Groningen; Wroclaw Medical University; Universidade Nova de Lisboa	Killaspy, H (corresponding author), UCL, Mental Hlth Sci Unit, London, England.	h.killaspy@ucl.ac.uk	Cervilla, Jorge A/O-2106-2016; raboch, jiri/N-7445-2017; King, Michael B/D-7477-2011; Salisbury, Tatiana/CAF-8877-2022; Piotrowski, Patryk/ABD-4063-2021; Kališová, Lucie/N-1373-2017; gonidakis, fragiskos/AAC-5296-2020	Cervilla, Jorge A/0000-0001-6891-1992; raboch, jiri/0000-0001-6667-1497; King, Michael B/0000-0003-4715-7171; Piotrowski, Patryk/0000-0001-7208-0562; Kališová, Lucie/0000-0003-0695-2048; Onchev, Georgi/0000-0002-5139-5917; Cardoso, Graca/0000-0003-1756-0197; Taylor Salisbury, Tatiana/0000-0002-8249-3886; Killaspy, Helen/0000-0003-2481-4802; Urban, Mirjam/0000-0003-1714-4847; White, Sarah/0000-0003-2468-6193; caldas de almeida, jose miguel/0000-0003-1902-6772	European Commission [SP5A-CT-2007-044088]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by a three-year grant from the European Commission's 6th Framework (SP5A-CT-2007-044088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cullen D, 1997, IRISH J PSYCHOL MED, V14, P92; Dunlap WP, 2004, BEHAV RES METH INS C, V36, P695, DOI 10.3758/BF03206551; European Commission, 2005, GREEN PAP IMPR MENT; Green MF, 1996, AM J PSYCHIAT, V153, P321; Hatton C, 2004, J INTELL DISABIL RES, V48, P103, DOI 10.1111/j.1365-2788.2004.00499.x; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; Killaspy H, 2010, BMC PSYCHIATRY, V11, P35; Killaspy H, 2008, J MENT HEALTH, V17, P207, DOI 10.1080/09638230701506275; Killaspy H, 2010, PSYCHIATR BULL, V34, P265, DOI 10.1192/pb.bp.109.028530; Killaspy H, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-36; Knapp M, 2011, HEALTH SOC CARE COMM, V19, P113, DOI 10.1111/j.1365-2524.2010.00969.x; Liegeois A, 2005, J MED ETHICS, V31, P452, DOI 10.1136/jme.2003.006999; Meltzer HY, 1997, CURR MED RES OPIN, V14, P1, DOI 10.1185/03007999709113338; Mueser K.T., 1998, HDB SOCIAL FUNCTIONI; Muijen M, 2008, PSYCHIAT SERV, V59, P479, DOI 10.1176/ps.2008.59.5.479; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Rehabilitation Social Faculty, 2009, FRRS04 ROYAL COLL PS; Rossberg JI, 2003, ACTA PSYCHIAT SCAND, V108, P374, DOI 10.1034/j.1600-0447.2003.00191.x; Taylor TL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-55; Trauer T, 2001, SOC PSYCH PSYCH EPID, V36, P416, DOI 10.1007/s001270170032; Trieman N, 2002, BRIT J PSYCHIAT, V181, P428, DOI 10.1192/bjp.181.5.428; Turton P, 2010, PSYCHIAT SERV, V61, P293, DOI 10.1176/ps.2010.61.3.293; Webb Y, 2000, Int J Health Care Qual Assur Inc Leadersh Health Serv, V13, P273, DOI 10.1108/09526860010373253; World Health Organization (WHO), 2005, MENT HLTH ATL	25	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38070	10.1371/journal.pone.0038070	http://dx.doi.org/10.1371/journal.pone.0038070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675508	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000305341700036
J	Salinero-Fort, MA; Jimenez-Garcia, R; del Otero-Sanz, L; de Burgos-Lunar, C; Chico-Moraleja, RM; Martin-Madrazo, C; Gomez-Campelo, P				Salinero-Fort, Miguel A.; Jimenez-Garcia, Rodrigo; del Otero-Sanz, Laura; de Burgos-Lunar, Carmen; Chico-Moraleja, Rosa M.; Martin-Madrazo, Carmen; Gomez-Campelo, Paloma		Hlth & Immigration Grp	Self-Reported Health Status in Primary Health Care: The Influence of Immigration and Other Associated Factors	PLOS ONE			English	Article							SOCIAL SUPPORT; LATINO IMMIGRANTS; MENTAL-HEALTH; RATED HEALTH; LIFE-STYLES; POPULATION; SPAIN; ACCULTURATION; RESOURCES; MODEL	Objective: The aims of this study are to compare self-reported health status between Spanish-born and Latin American-born Spanish residents, adjusted by length of residence in the host country; and additionally, to analyse sociodemographic and psychosocial variables associated with a better health status. Design: This is a cross-sectional population based study of Latin American-born (n = 691) and Spanish-born (n = 903) in 15 urban primary health care centres in Madrid (Spain), carried out between 2007 and 2009. The participants provided information, through an interview, about self-reported health status, socioeconomic characteristics, psychosocial factors and migration conditions. Descriptive and multiple logistic regression analyses were conducted. Results: The Spanish-born participants reported a better health status than the Latin America-born participants (79.8% versus 69.3%, p<0.001). Different patterns of self-reported health status were observed depending on the length of residence in the host country. The proportion of immigrants with a better health status is greater in those who have been in Spain for less than five years compared to those who have stayed longer. Better health status is significantly associated with being men, under 34 years old, being Spanish-born, having a monthly incomes of over 1000 euros, and having considerable social support and low stress. Conclusions: Better self-reported health status is associated with being Spanish-born, men, under 34 years old, having an uppermiddle-socioeconomic status, adequate social support, and low stress. Additionally, length of residence in the host country is seen as a related factor in the self-reported health status of immigrants.	[Salinero-Fort, Miguel A.; Gomez-Campelo, Paloma] Hosp Carlos III, Fdn Invest Biomed, Serv Madrileno Salud, Madrid, Spain; [Jimenez-Garcia, Rodrigo] Univ Rey Juan Carlos, Dept Prevent Med, Madrid, Spain; [del Otero-Sanz, Laura] Hosp Univ Insular Materno Infantil, Serv Med Prevent, Las Palmas Gran Canaria, Spain; [de Burgos-Lunar, Carmen] Hosp Carlos III, Serv Madrileno Salud, Unidad Epidemiol Clin, Madrid, Spain; [Chico-Moraleja, Rosa M.] Hosp Cent Def Gomez Ulla, Serv Madrileno Salud, Unidad Med Interna, Madrid, Spain; [Martin-Madrazo, Carmen] Ctr Salud Monovar, Serv Madrileno Salud, Madrid, Spain	Hospital Carlos III; Universidad Rey Juan Carlos; Hospital Carlos III	Salinero-Fort, MA (corresponding author), Hosp Carlos III, Fdn Invest Biomed, Serv Madrileno Salud, Madrid, Spain.	miguel.salinero@salud.madrid.org	de Santa Pau, Enrique Carrillo/AAV-7544-2021; SALINERO-FORT, MIGUEL A./GOP-2536-2022; Jimenez-Garcia, Rodrigo/D-4953-2019	de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Gomez Campelo, Paloma/0000-0003-2299-1741; DEL OTERO SANZ, LAURA/0000-0001-6976-5253	Instituto de la Salud Carlos III [PI06/1407]	Instituto de la Salud Carlos III(Instituto de Salud Carlos III)	Funding for the study was supplied by the "Instituto de la Salud Carlos III'' (PI06/1407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2010, SOC SCI MED, V71, P1161, DOI 10.1016/j.socscimed.2010.05.034; Perreten NA, 2010, GAC SANIT, V24, P136, DOI 10.1016/j.gaceta.2009.10.007; Arango J., 2004, INFORM SITUACION DEM, P161; Berk ML, 2000, HEALTH AFFAIR, V19, P51, DOI 10.1377/hlthaff.19.4.51; Borrell C, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2006.055269; Cabassa LJ, 2006, ADM POLICY MENT HLTH, V33, P316, DOI 10.1007/s10488-006-0040-8; Carrasco-Garrido P, 2007, EUR J PUBLIC HEALTH, V17, P503, DOI 10.1093/eurpub/ckl279; Carrasco-Garrido P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-201; Cavazos-Rehg PA, 2007, J NATL MED ASSOC, V99, P1126; De la Revilla L, 2005, MED FAM, V1, P10; de la Revilla L, 2007, ATEN PRIM, V39, P305, DOI 10.1157/13106286; Dunn JR, 2000, SOC SCI MED, V51, P1573, DOI 10.1016/S0277-9536(00)00053-8; Esteban y Pena M M, 2001, Aten Primaria, V27, P25; Fox P G, 2001, Int J Psychiatr Nurs Res, V7, P778; Franzini Luisa, 2001, Ethnicity and Disease, V11, P496; Fuertes MC, 2010, AN SIST SANIT NAVAR, V33, P179, DOI 10.4321/s1137-66272010000300006; Gonzalez De Rivera Y., 1983, PSIQUIS, V4, P7; Hernandez-Plaza S, 2004, J COMMUNITY APPL SOC, V14, P284, DOI 10.1002/casp.782; Hernandez-Quevedo C, 2009, SOC SCI MED, V69, P370, DOI 10.1016/j.socscimed.2009.05.005; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Johnson KL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-53; LillieBlanton M, 1996, SOC SCI MED, V43, P83, DOI 10.1016/0277-9536(95)00337-1; Mitchell DA, 2006, AM J PUBLIC HEALTH, V96, P2093, DOI 10.2105/AJPH.2005.082818; Newbold KB, 2005, SOC SCI MED, V60, P1359, DOI 10.1016/j.socscimed.2004.06.048; NIS (National Institute of Statistics), 2011, STAT MUN; Phinney JS, 2001, J SOC ISSUES, V57, P493, DOI 10.1111/0022-4537.00225; Pumariega AJ, 2005, COMMUNITY MENT HLT J, V41, P581, DOI 10.1007/s10597-005-6363-1; Reijneveld SA, 1998, J EPIDEMIOL COMMUN H, V52, P298, DOI 10.1136/jech.52.5.298; Salgado de Snyder N., 1991, PSYCHOL ASSESSMENT, V3, P438, DOI [10.1037/1040-3590.3.3.438, DOI 10.1037/1040-3590.3.3.438]; Salinero-Fort MA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-46; Saraiva T, 2009, ETHN HLTH, V14, P93; Sherbourne C D, 1992, Qual Life Res, V1, P235, DOI 10.1007/BF00435632; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Wiking E, 2004, J EPIDEMIOL COMMUN H, V58, P574, DOI 10.1136/jech.2003.011387	35	22	22	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38462	10.1371/journal.pone.0038462	http://dx.doi.org/10.1371/journal.pone.0038462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675564	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700076
J	Seeger, MA; Mittal, A; Velamakanni, S; Hohl, M; Schauer, S; Salaa, I; Grutter, MG; van Veen, HW				Seeger, Markus A.; Mittal, Anshumali; Velamakanni, Saroj; Hohl, Michael; Schauer, Stefan; Salaa, Ihsene; Gruetter, Markus G.; van Veen, Hendrik W.			Tuning the Drug Efflux Activity of an ABC Transporter in vivo by in vitro Selected DARPin Binders	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; LACTOCOCCUS-LACTIS; ATP-BINDING; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; RIBOSOME DISPLAY; REPEAT PROTEINS; FUNCTIONAL-ROLE; PHAGE DISPLAY; ANTIBODY	ABC transporters use the energy from binding and hydrolysis of ATP to import or extrude substrates across the membrane. Using ribosome display, we raised designed ankyrin repeat proteins (DARPins) against detergent solubilized LmrCD, a heterodimeric multidrug ABC exporter from Lactococcus lactis. Several target-specific DARPin binders were identified that bind to at least three distinct, partially overlapping epitopes on LmrD in detergent solution as well as in native membranes. Remarkably, functional screening of the LmrCD-specific DARPin pools in L. lactis revealed three homologous DARPins which, when generated in LmrCD-expressing cells, strongly activated LmrCD-mediated drug transport. As LmrCD expression in the cell membrane was unaltered upon the co-expression of activator DARPins, the activation is suggested to occur at the level of LmrCD activity. Consistent with this, purified activator DARPins were found to stimulate the ATPase activity of LmrCD in vitro when reconstituted in proteoliposomes. This study suggests that membrane transporters are tunable in vivo by in vitro selected binding proteins. Our approach could be of biopharmaceutical importance and might facilitate studies on molecular mechanisms of ABC transporters.	[Seeger, Markus A.; Velamakanni, Saroj; Salaa, Ihsene; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Seeger, Markus A.; Mittal, Anshumali; Hohl, Michael; Gruetter, Markus G.] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Schauer, Stefan] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Cambridge; University of Zurich; University of Zurich	Seeger, MA (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	m.seeger@bioc.uzh.ch; hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008; Mittal, Anshumali/G-9685-2012	van Veen, Hendrik W./0000-0002-9658-8077; Seeger, Markus/0000-0003-1761-8571; Mittal, Anshumali/0000-0002-0478-2682	Swiss National Science Foundation Prospective Researcher; European Molecular Biology Organization; Novartis Foundation; Swiss National Science Foundation; Ambizione Fellowship; Research Credit (Forschungskredit) of the University of Zurich; British Society for Antimicrobial Chemotherapy; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I002383/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I002383/1] Funding Source: researchfish	Swiss National Science Foundation Prospective Researcher; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Novartis Foundation(Novartis); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ambizione Fellowship; Research Credit (Forschungskredit) of the University of Zurich; British Society for Antimicrobial Chemotherapy; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by the Swiss National Science Foundation Prospective Researcher (to MAS), European Molecular Biology Organization Long Term fellowship (to MAS), Novartis Foundation (to MAS), Swiss National Science Foundation, Ambizione Fellowship (to MAS), Research Credit (Forschungskredit) of the University of Zurich (to MAS), British Society for Antimicrobial Chemotherapy (to HWvV), and Biotechnology and Biological Sciences Research Council (to HWvV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustiandari H, 2008, J BACTERIOL, V190, P759, DOI 10.1128/JB.01151-07; Balakrishnan L, 2004, J BIOL CHEM, V279, P11273, DOI 10.1074/jbc.M308494200; BALL WJ, 1986, BIOCHEMISTRY-US, V25, P7155, DOI 10.1021/bi00370a058; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Boersma YL, 2011, J BIOL CHEM, V286, P41273, DOI 10.1074/jbc.M111.293266; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Davidson AL, 1996, J BIOL CHEM, V271, P4858; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEBIEC H, 1993, J BIOL CHEM, V268, P13356; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAMADA H, 1986, P NATL ACAD SCI USA, V83, P7785, DOI 10.1073/pnas.83.20.7785; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hotzel I, 2011, PROTEIN ENG DES SEL, V24, P679, DOI 10.1093/protein/gzr039; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Huber T, 2007, J STRUCT BIOL; Hunte C, 2002, CURR OPIN STRUC BIOL, V12, P503, DOI 10.1016/S0959-440X(02)00354-8; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kim J, 2011, METHODS; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kondratov RV, 2001, P NATL ACAD SCI USA, V98, P14078, DOI 10.1073/pnas.241314798; LEENHOUTS KJ, 1991, J BACTERIOL, V173, P4794, DOI 10.1128/jb.173.15.4794-4798.1991; LEPPERT G, 1990, GENETICS, V125, P13; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Lubelski J, 2004, J BIOL CHEM, V279, P34449, DOI 10.1074/jbc.M404072200; Lubelski J, 2006, MOL MICROBIOL, V61, P771, DOI 10.1111/j.1365-2958.2006.05267.x; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Merz T, 2008, J MOL BIOL, V376, P232, DOI 10.1016/j.jmb.2007.11.047; Milovnik P, 2009, PROTEIN ENG DES SEL, V22, P357, DOI 10.1093/protein/gzp011; Monroe N, 2011, J STRUCT BIOL, V174, P269, DOI 10.1016/j.jsb.2011.01.014; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Padan E, 1998, FEBS LETT, V441, P53, DOI 10.1016/S0014-5793(98)01524-5; Pajic M, 2009, CANCER RES, V69, P6396, DOI 10.1158/0008-5472.CAN-09-0041; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rothlisberger D, 2004, FEBS LETT, V564, P340, DOI 10.1016/S0014-5793(04)00359-X; Rubinstein JL, 2003, ANAL BIOCHEM, V314, P294, DOI 10.1016/S0003-2697(02)00649-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuck P, 2010, METHODS MOL BIOL, V627, P15, DOI 10.1007/978-1-60761-670-2_2; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Sennhauser G, 2008, STRUCTURE, V16, P1443, DOI 10.1016/j.str.2008.08.010; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Stefan N, 2011, J MOL BIOL, V413, P826, DOI 10.1016/j.jmb.2011.09.016; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Velamakanni S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006137; Venter H, 2005, BIOCHEM SOC T, V33, P1008, DOI 10.1042/BST20051008; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	76	14	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37845	10.1371/journal.pone.0037845	http://dx.doi.org/10.1371/journal.pone.0037845			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675494	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700024
J	Sato, A; Koda, H; Lemasson, A; Nagumo, S; Masataka, N				Sato, Anna; Koda, Hiroki; Lemasson, Alban; Nagumo, Sumiharu; Masataka, Nobuo			Visual Recognition of Age Class and Preference for Infantile Features: Implications for Species-Specific vs Universal Cognitive Traits in Primates	PLOS ONE			English	Article							ANTHROPOID PRIMATES; FACE RECOGNITION; BABY SCHEMA; FACIAL FEATURES; HOMO-SAPIENS; HEAD SHAPE; EVOLUTION; MACAQUES; CUTENESS; MONKEYS	Despite not knowing the exact age of individuals, humans can estimate their rough age using age-related physical features. Nonhuman primates show some age-related physical features; however, the cognitive traits underlying their recognition of age class have not been revealed. Here, we tested the ability of two species of Old World monkey, Japanese macaques (JM) and Campbell's monkeys (CM), to spontaneously discriminate age classes using visual paired comparison (VPC) tasks based on the two distinct categories of infant and adult images. First, VPCs were conducted in JM subjects using conspecific JM stimuli. When analyzing the side of the first look, JM subjects significantly looked more often at novel images. Based on analyses of total looking durations, JM subjects looked at a novel infant image longer than they looked at a familiar adult image, suggesting the ability to spontaneously discriminate between the two age classes and a preference for infant over adult images. Next, VPCs were tested in CM subjects using heterospecific JM stimuli. CM subjects showed no difference in the side of their first look, but looked at infant JM images longer than they looked at adult images; the fact that CMs were totally naive to JMs suggested that the attractiveness of infant images transcends species differences. This is the first report of visual age class recognition and a preference for infant over adult images in nonhuman primates. Our results suggest not only species-specific processing for age class recognition but also the evolutionary origins of the instinctive human perception of baby cuteness schema, proposed by the ethologist Konrad Lorenz.	[Sato, Anna; Koda, Hiroki; Nagumo, Sumiharu; Masataka, Nobuo] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Lemasson, Alban] Univ Rennes 1, Stn Biol, EthoS Ethol Anim & Humaine CNRS UMR6552, Paimpont, France; [Lemasson, Alban] Inst Univ France, Paris, France	Kyoto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Institut Universitaire de France	Sato, A (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	koda.hiroki.7a@kyoto-u.ac.jp			JSPS [22330200]; Primate Research Institute, Kyoto University; Program for International Collaboration of Science-Centre National de Recherche Scientifique; JSPS Research Fellowship for Young Scientists; Grants-in-Aid for Scientific Research [23653316] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Primate Research Institute, Kyoto University; Program for International Collaboration of Science-Centre National de Recherche Scientifique; JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported in part by a JSPS Grant-in-Aid for Scientific Research (B, #22330200) to HK, under the Young Researcher Overseas Visits Program for the Vitalizing Brain Circulation from the Primate Research Institute, Kyoto University; by a grant from the Program for International Collaboration of Science-Centre National de Recherche Scientifique to AL; and by a JSPS Research Fellowship for Young Scientists to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; ALBERT EM, 1964, AM ANTHROPOL, V66, P35, DOI 10.1525/aa.1964.66.suppl_3.02a00020; ALLEY TR, 1983, MERRILL PALMER QUART, V29, P411; ALLEY TR, 1983, CHILD DEV, V54, P241, DOI 10.2307/1129882; ALLEY TR, 1981, DEV PSYCHOL, V17, P650, DOI 10.1037/0012-1649.17.5.650; Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; Archer J, 2011, ETHOLOGY, V117, P217, DOI 10.1111/j.1439-0310.2010.01863.x; Bascom WR, 1942, AM ANTHROPOL, V44, P37, DOI 10.1525/aa.1942.44.1.02a00050; Brosch T, 2007, BABY CAUGHT MY EYE A; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; DEWAAL F, 1982, CHIMPANZEE POLITICS; Dufour V, 2006, BEHAV PROCESS, V73, P107, DOI 10.1016/j.beproc.2006.04.006; Dufour V, 2010, J ETHOL, V28, P231, DOI 10.1007/s10164-009-0174-8; Dunbar R. I., 1998, BRAIN, V9, P10; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; FAGAN JF, 1973, J EXP CHILD PSYCHOL, V16, P424, DOI 10.1016/0022-0965(73)90005-2; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; FULLARD W, 1976, CHILD DEV, V47, P1191, DOI 10.2307/1128462; Gittleman J.L., 1985, EVOLUTION ESSAYS HON, P187; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Gothard KM, 2009, ANIM COGN, V12, P155, DOI 10.1007/s10071-008-0179-7; Gothard KM, 2004, ANIM COGN, V7, P25, DOI 10.1007/s10071-003-0179-6; GOULD SJ, 1979, NAT HIST, V88, P30; HINDE RA, 1985, ANIM BEHAV, V33, P1371, DOI 10.1016/S0003-3472(85)80205-0; Hodsoll J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012509; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Koba R, 2008, BEHAV PROCESS, V79, P70, DOI 10.1016/j.beproc.2008.04.005; Lemasson A, 2008, BEHAV ECOL SOCIOBIOL, V62, P1027, DOI 10.1007/s00265-007-0530-z; Lemasson A, 2010, BIOL LETTERS, V6, P325, DOI 10.1098/rsbl.2009.0875; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Luo LZ, 2011, J EXP CHILD PSYCHOL, V110, P115, DOI 10.1016/j.jecp.2011.04.002; Mareschal D, 2002, COGNITIVE SCI, V26, P377, DOI 10.1207/s15516709cog2603_8; Masataka N., 2003, ONSET LANGUAGE; Mitani JC, 1997, BEHAV ECOL SOCIOBIOL, V40, P213, DOI 10.1007/s002650050335; Murai C, 2005, DEVELOPMENTAL SCI, V8, P240, DOI 10.1111/j.1467-7687.2005.00413.x; Murai C, 2004, PRIMATES, V45, P1, DOI 10.1007/s10329-003-0053-9; Noe Ronald, 2001, P93, DOI 10.1017/CBO9780511752421.008; PACKER C, 1992, ANIM BEHAV, V43, P265, DOI 10.1016/S0003-3472(05)80222-2; Palombit RA, 1997, ANIM BEHAV, V54, P599, DOI 10.1006/anbe.1996.0457; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; Quinn PC, 2008, DEVELOPMENTAL SCI, V11, P76, DOI 10.1111/j.1467-7687.2007.00647.x; Quinn PC, 2002, PERCEPTION, V31, P1109, DOI 10.1068/p3331; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Ross C, 2000, FOLIA PRIMATOL, V71, P93, DOI 10.1159/000021733; Sanefuji W, 2007, J ETHOL, V25, P249, DOI 10.1007/s10164-006-0018-8; Silk JB, 1999, ANIM BEHAV, V57, P1021, DOI 10.1006/anbe.1998.1065; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; STERNGLANZ SH, 1977, ANIM BEHAV, V25, P108, DOI 10.1016/0003-3472(77)90072-0; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318	54	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38387	10.1371/journal.pone.0038387	http://dx.doi.org/10.1371/journal.pone.0038387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22685529	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500142
J	Burton, AC; Sam, MK; Balangtaa, C; Brashares, JS				Burton, A. Cole; Sam, Moses K.; Balangtaa, Cletus; Brashares, Justin S.			Hierarchical Multi-Species Modeling of Carnivore Responses to Hunting, Habitat and Prey in a West African Protected Area	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; COMMUNITY STRUCTURE; SPATIAL AUTOCORRELATION; SPECIES DISTRIBUTION; PANTHERA-PARDUS; SPOTTED HYENAS; NATIONAL-PARK; CONSERVATION; EXTINCTION; BIODIVERSITY	Protected areas (PAs) are a cornerstone of global efforts to shield wildlife from anthropogenic impacts, yet their effectiveness at protecting wide-ranging species prone to human conflict - notably mammalian carnivores - is increasingly in question. An understanding of carnivore responses to human-induced and natural changes in and around PAs is critical not only to the conservation of threatened carnivore populations, but also to the effective protection of ecosystems in which they play key functional roles. However, an important challenge to assessing carnivore communities is the often infrequent and imperfect nature of survey detections. We applied a novel hierarchical multi-species occupancy model that accounted for detectability and spatial autocorrelation to data from 224 camera trap stations (sampled between October 2006 and January 2009) in order to test hypotheses about extrinsic influences on carnivore community dynamics in a West African protected area (Mole National Park, Ghana). We developed spatially explicit indices of illegal hunting activity, law enforcement patrol effort, prey biomass, and habitat productivity across the park, and used a Bayesian model selection framework to identify predictors of site occurrence for individual species and the entire carnivore community. Contrary to our expectation, hunting pressure and edge proximity did not have consistent, negative effects on occurrence across the nine carnivore species detected. Occurrence patterns for most species were positively associated with small prey biomass, and several species had either positive or negative associations with riverine forest (but not with other habitat descriptors). Influences of sampling design on carnivore detectability were also identified and addressed within our modeling framework (e. g., road and observer effects), and the multi-species approach facilitated inference on even the rarest carnivore species in the park. Our study provides insight for the conservation of these regionally significant carnivore populations, and our approach is broadly applicable to the robust assessment of communities of rare and elusive species subject to environmental change.	[Burton, A. Cole; Brashares, Justin S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Burton, A. Cole] Univ Alberta, Alberta Biodivers Monitoring Inst, Edmonton, AB, Canada; [Sam, Moses K.; Balangtaa, Cletus] Forestry Commiss Ghana, Wildlife Div, Accra, Ghana	University of California System; University of California Berkeley; University of Alberta	Burton, AC (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	acburton@ualberta.ca	Burton, Cole/J-3184-2012; Burton, Cole/AAF-9234-2019	Burton, Cole/0000-0002-8799-3847; Burton, Cole/0000-0002-8799-3847	Panthera/Wildlife Conservation Society Kaplan Awards Program; Safari Club International; Hellman Family Fund; College of Natural Resources of the University of California, Berkeley; U.S. National Science Foundation; Natural Sciences and Engineering Research Council of Canada	Panthera/Wildlife Conservation Society Kaplan Awards Program; Safari Club International; Hellman Family Fund; College of Natural Resources of the University of California, Berkeley; U.S. National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was received from the Panthera/Wildlife Conservation Society Kaplan Awards Program, Safari Club International, Hellman Family Fund, and College of Natural Resources of the University of California, Berkeley. ACB was supported by fellowships from the U.S. National Science Foundation and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; [Anonymous], 2010, R LANG ENV STAT COMP; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Bauer H, 2003, CR BIOL, V326, pS112, DOI 10.1016/S1631-0691(03)00047-7; Boydston EE, 2003, ANIM CONSERV, V6, P207, DOI 10.1017/S1367943003003263; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton AC, 2011, BIOL CONSERV, V144, P2344, DOI 10.1016/j.biocon.2011.06.014; Burton AC, 2010, THESIS U CALIFORNIA; Caro T, 2007, AFR J ECOL, V45, P233, DOI 10.1111/j.1365-2028.2007.00814.x; Caro TM, 2003, BIOL CONSERV, V110, P67, DOI 10.1016/S0006-3207(02)00177-5; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Carroll C, 2004, CONSERV BIOL, V18, P1110, DOI 10.1111/j.1523-1739.2004.00083.x; Carroll C, 2010, CONSERV BIOL, V24, P1538, DOI 10.1111/j.1523-1739.2010.01528.x; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Cleaveland S, 2007, CONSERV BIOL, V21, P612, DOI 10.1111/j.1523-1739.2007.00701.x; Cohen WB, 2004, BIOSCIENCE, V54, P535, DOI 10.1641/0006-3568(2004)054[0535:LRIEAO]2.0.CO;2; Colyn Marc, 2004, Small Carnivore Conservation, V31, P15; Congdon P, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0470092394; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fensholt R, 2005, INT J REMOTE SENS, V26, P2561, DOI 10.1080/01431160500033724; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gelman A., 2004, BAYESIAN DATA ANAL; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Henschel P, 2003, LEOPARDS AFRICAN RAI; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jachmann H, 2008, BIOL CONSERV, V141, P1906, DOI 10.1016/j.biocon.2008.05.009; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 1998, ECOLOGY, V79, P2852; Keane A, 2011, J APPL ECOL, V48, P1164, DOI 10.1111/j.1365-2664.2011.02034.x; Kery M., 2010, INTRO WINBUGS ECOLOG; Kery M, 2009, ENVIRON ECOL STAT SE, V3, P639, DOI 10.1007/978-0-387-78151-8_28; Klop E, 2008, J TROP ECOL, V24, P39, DOI 10.1017/S0266467407004609; Kolowski JM, 2009, J ZOOL, V277, P23, DOI 10.1111/j.1469-7998.2008.00505.x; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Larrucea ES, 2007, J WILDLIFE MANAGE, V71, P1682, DOI 10.2193/2006-407; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lindsey P, 2011, ORYX, V45, P587, DOI 10.1017/S003060531000150X; Linkie M, 2003, ORYX, V37, P41, DOI 10.1017/S0030605303000103; Linnell JDC, 2005, CONSERV BIOL SER, V9, P162; Long RA, 2008, NONINVASIVE SURVEY M; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Marker LL, 2005, S AFR J WILDL RES, V35, P105; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; Millar RB, 2009, BIOMETRICS, V65, P962, DOI 10.1111/j.1541-0420.2008.01162.x; Mordecai RS, 2011, J APPL ECOL, V48, P56, DOI 10.1111/j.1365-2664.2010.01921.x; Moruzzi TL, 2002, WILDLIFE SOC B, V30, P380; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; NEWMARK WD, 1987, NATURE, V325, P430, DOI 10.1038/325430a0; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Nicholson E, 2006, CONSERV BIOL, V20, P871, DOI 10.1111/j.1523-1739.2006.00369.x; O'Brien TG, 2010, ANIM CONSERV, V13, P335, DOI 10.1111/j.1469-1795.2010.00357.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Pangle WM, 2010, J MAMMAL, V91, P154, DOI [10.1644/08-MAMM-A-359R.1, 10.1644/08-MAMM-A-359R.1.]; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2010, ANIM CONSERV, V13, P131, DOI 10.1111/j.1469-1795.2009.00309.x; Pettorelli N, 2009, AM NAT, V173, P698, DOI 10.1086/597379; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ray J.C., 2005, 24 WILDL CONS SOC; Reed SE, 2008, CONSERV LETT, V1, P146, DOI 10.1111/j.1755-263X.2008.00019.x; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2008, BIOMETRICS, V64, P364, DOI 10.1111/j.1541-0420.2007.00891.x; Royle J. Andrew, 2008, P293; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Sberze M, 2010, ANIM CONSERV, V13, P3, DOI 10.1111/j.1469-1795.2009.00312.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Shivik JA, 2006, BIOSCIENCE, V56, P253, DOI 10.1641/0006-3568(2006)056[0253:TFTEWN]2.0.CO;2; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thompson WL, 2004, SAMPLING RARE ELUSIV; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wildlife Division of Ghana, 2005, 54 WDSP GOV GHAN WIL, P141; Wintle BA, 2006, ECOL APPL, V16, P1945, DOI 10.1890/1051-0761(2006)016[1945:MSRWSA]2.0.CO;2; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woodroffe R, 2007, BIODIVERS CONSERV, V16, P1245, DOI 10.1007/s10531-006-9124-8; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x; Zuur Alain F., 2009, P1	112	102	104	2	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38007	10.1371/journal.pone.0038007	http://dx.doi.org/10.1371/journal.pone.0038007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666433	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400068
J	Calzolari, M; Gaibani, P; Bellini, R; Defilippo, F; Pierro, A; Albieri, A; Maioli, G; Luppi, A; Rossini, G; Balzani, A; Tamba, M; Galletti, G; Gelati, A; Carrieri, M; Poglayen, G; Cavrini, F; Natalini, S; Dottori, M; Sambri, V; Angelini, P; Bonilauri, P				Calzolari, Mattia; Gaibani, Paolo; Bellini, Romeo; Defilippo, Francesco; Pierro, Anna; Albieri, Alessandro; Maioli, Giulia; Luppi, Andrea; Rossini, Giada; Balzani, Agnese; Tamba, Marco; Galletti, Giorgio; Gelati, Antonio; Carrieri, Marco; Poglayen, Giovanni; Cavrini, Francesca; Natalini, Silvano; Dottori, Michele; Sambri, Vittorio; Angelini, Paola; Bonilauri, Paolo			Mosquito, Bird and Human Surveillance of West Nile and Usutu Viruses in Emilia-Romagna Region (Italy) in 2010	PLOS ONE			English	Article							SEROLOGICAL EVIDENCE; PCR ASSAY; EMERGENCE; INFECTION; TRANSMISSION; TEMPERATURE; FLAVIVIRUS; AUSTRIA; AMPLIFICATION; ESTABLISHMENT	Background: In 2008, after the first West Nile virus (WNV) detection in the Emilia-Romagna region, a surveillance system, including mosquito-and bird-based surveillance, was established to evaluate the virus presence. Surveillance was improved in following years by extending the monitoring to larger areas and increasing the numbers of mosquitoes and birds tested. Methodology/Principal Findings: A network of mosquito traps, evenly distributed and regularly activated, was set up within the surveyed area. A total of 438,558 mosquitoes, grouped in 3,111 pools and 1,276 birds (1,130 actively sampled and 146 from passive surveillance), were tested by biomolecular analysis. The survey detected WNV in 3 Culex pipiens pools while Usutu virus (USUV) was found in 89 Cx. pipiens pools and in 2 Aedes albopictus pools. Two birds were WNV-positive and 12 were USUV-positive. Furthermore, 30 human cases of acute meningoencephalitis, possibly caused by WNV or USUV, were evaluated for both viruses and 1,053 blood bags were tested for WNV, without any positive result. Conclusions/Significance: Despite not finding symptomatic human WNV infections during 2010, the persistence of the virus, probably due to overwintering, was confirmed through viral circulation in mosquitoes and birds, as well as for USUV. In 2010, circulation of the two viruses was lower and more delayed than in 2009, but this decrease was not explained by the relative abundance of Cx. pipiens mosquito, which was greater in 2010. The USUV detection in mosquito species confirms the role of Cx. pipiens as the main vector and the possible involvement of Ae. albopictus in the virus cycle. The effects of meteorological conditions on the presence of USUV-positive mosquito pools were considered finding an association with drought conditions and a wide temperature range. The output produced by the surveillance system demonstrated its usefulness and reliability in terms of planning public health policies.	[Calzolari, Mattia; Defilippo, Francesco; Maioli, Giulia; Luppi, Andrea; Balzani, Agnese; Tamba, Marco; Galletti, Giorgio; Dottori, Michele; Bonilauri, Paolo] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Gaibani, Paolo; Pierro, Anna; Rossini, Giada; Cavrini, Francesca; Sambri, Vittorio] S Orsola Malpighi Univ Hosp, Reg Reference Ctr Microbiol Emergencies CRREM, Bologna, Italy; [Bellini, Romeo; Albieri, Alessandro; Carrieri, Marco] Ctr Agr Ambiente G Nicoli CAA, Crevalcore, Italy; [Gelati, Antonio] Serv Vet Azienda USL Modena, Mirandola, Italy; [Poglayen, Giovanni] Alma Mater Studiorum Univ Bologna, Bologna, Italy; [Natalini, Silvano; Angelini, Paola] Reg Emilia Romagna, DG Sanita & Polit Sociali, Bologna, Italy	IZS Lombardia e Emilia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Calzolari, M (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy.	mattia.calzolari@izsler.it	Tamba, Marco/J-5495-2016; balzani, agnese/X-6719-2019; gaibani, paolo/K-7690-2016; Maioli, Giulia/AAB-7559-2019; Sambri, Vittorio/H-5372-2019; dottori, michele/AAB-3815-2019; Pierro, Anna/AAC-7407-2022; Rossini, Giada/K-8815-2016; Calzolari, Mattia/AAB-9487-2019	Tamba, Marco/0000-0002-5878-4595; balzani, agnese/0000-0002-4535-0026; gaibani, paolo/0000-0003-3791-8635; Maioli, Giulia/0000-0002-7076-9005; Sambri, Vittorio/0000-0002-5012-7355; Pierro, Anna/0000-0001-9873-0367; Rossini, Giada/0000-0002-8917-6680; Calzolari, Mattia/0000-0001-7489-2556; Galletti, Giorgio/0000-0003-4522-8976; Dottori, Michele/0000-0002-9975-0367; Bonilauri, Paolo/0000-0002-2625-7993; defilippo, francesco/0000-0002-1898-0997; Carrieri, Marco/0000-0001-6444-0636	Regione Emilia-Romagna [COMM07001]; Italian Ministry of Health on West Nile virus overwintering mechanisms in Emilia-Romagna region [PRC2009004]	Regione Emilia-Romagna(Regione Emilia Romagna); Italian Ministry of Health on West Nile virus overwintering mechanisms in Emilia-Romagna region	The Regione Emilia-Romagna (www.regione.emilia-romagna.it/) had partially funded this work to IZSLER (www.izsler.it) and CAA (www.caa.it) by the Regional project on insect borne diseases (COMM07001). Also funds obtained by the IZSLER project, financed by the Italian Ministry of Health (http://www.salute.gov.it/), on West Nile virus overwintering mechanisms in Emilia-Romagna region (PRC2009004) were utilized. No other external funding was utilized for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini P, 2010, EUROSURVEILLANCE, V15, P11; [Anonymous], 2010, CAA B ZANZ AUT; Antolini G, 2006, ATT CONV AIAM TOR IT; Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005; Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bellini R., 2002, 68 ANN M AM MOSQ CON; Biggerstaff B.J., 2006, POOLEDINFRATE VERSIO; Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0; Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Calistri P, 2010, ZOONOSES PUBLIC HLTH, V57, P211, DOI 10.1111/j.1863-2378.2009.01303.x; Calzolari M, 2012, J GEN VIROL IN PRESS; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; Calzolari M, 2010, VECTOR-BORNE ZOONOT, V10, P875, DOI 10.1089/vbz.2009.0176; Cavrini F, 2009, EUROSURVEILLANCE, V14, P17; Cavrini F, 2011, J CLIN VIROL, V50, P221, DOI 10.1016/j.jcv.2010.11.008; Chisenhall DM, 2008, J AM MOSQUITO CONTR, V24, P311, DOI 10.2987/5671.1; Chvala S, 2007, VET MICROBIOL, V122, P237, DOI 10.1016/j.vetmic.2007.01.029; Deichmeister JM, 2011, J VECTOR ECOL, V36, P75, DOI 10.1111/j.1948-7134.2011.00143.x; Deubel V, 2001, ENCY ARTHROPOD TRANS, P563; Erdelyi K, 2007, VECTOR-BORNE ZOONOT, V7, P181, DOI 10.1089/vbz.2006.0586; Gaibani P, 2011, VECTOR BORN IN PRESS; Gaibani P, 2010, J CLIN MICROBIOL, V48, P3338, DOI 10.1128/JCM.02501-09; Glavits R, 2005, AVIAN PATHOL, V34, P408, DOI 10.1080/03079450500268039; Gould EA, 2003, EPIDEMIOL INFECT, V131, P583, DOI 10.1017/S0950268803008707; Gratz NG, 2006, VECTOR-AND RODENT-BORNE DISEASES OF EUROPE AND NORTH AMERICA: THEIR DISTRIBUTION AND PUBLIC HEALTH BURDEN, P1, DOI 10.2277/ 0521854474; Hubalek Z, 2008, VECTOR-BORNE ZOONOT, V8, P659, DOI 10.1089/vbz.2007.0283; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Hubalek Z, 2000, VIRAL IMMUNOL, V13, P415, DOI 10.1089/vim.2000.13.415; Hubalek Z, 2008, VIRAL IMMUNOL, V21, P247, DOI 10.1089/vim.2007.0111; Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lelli R, 2008, ZOONOSES PUBLIC HLTH, V55, P361, DOI 10.1111/j.1863-2378.2008.01146.x; Liu H, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-66; Macini P., 2008, Eurosurveillance, V13, P18990; Manarolla G, 2010, VET MICROBIOL, V141, P159, DOI 10.1016/j.vetmic.2009.07.036; Mannelli A, 2012, EN234 EFSA; Meister T, 2008, VET MICROBIOL, V127, P237, DOI 10.1016/j.vetmic.2007.08.023; Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Pecorari M, 2009, EUROSURVEILLANCE, V14, P15; Pierro A, 2011, VECTOR-BORNE ZOONOT, V11, P1605, DOI 10.1089/vbz.2011.0616; Reiter P, 2010, EUROSURVEILLANCE, V15, P4; Rizzoli A, 2007, VECTOR-BORNE ZOONOT, V7, P411, DOI 10.1089/vbz.2006.0626; Rossini G, 2011, EMERG INFECT DIS, V17, P903, DOI 10.3201/eid1705.101569; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Savage HM, 2004, J AM MOSQUITO CONTR, V20, P208; Savini G, 2011, VET MICROBIOL, V151, P264, DOI 10.1016/j.vetmic.2011.03.036; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Schaffner E., 2001, MOSQUITOES EUROPE; Severini Francesco, 2009, Fragmenta Entomologica, V41, P213; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Smartt CT, 2010, ENVIRON ENTOMOL, V39, P190, DOI 10.1603/EN09172; Sotelo E, 2011, J GEN VIROL, V92, P2512, DOI 10.1099/vir.0.033829-0; Steinmetz HW, 2011, VET MICROBIOL, V148, P207, DOI 10.1016/j.vetmic.2010.09.018; Stojanovich CJ, 1997, MOSQUITOES ITALIAN B; Sutherland GL, 2007, J AM MOSQUITO CONTR, V23, P389, DOI 10.2987/5630.1; Tamba M, 2011, VECTOR-BORNE ZOONOT, V11, P551, DOI 10.1089/vbz.2010.0055; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YL, 2006, J CLIN VIROL, V36, P177, DOI 10.1016/j.jcv.2006.02.008; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Weissenbock H, 2007, ECOL CONT VECTOR-BOR, V1, P153	68	78	79	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38058	10.1371/journal.pone.0038058	http://dx.doi.org/10.1371/journal.pone.0038058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666446	Green Published, gold			2022-12-27	WOS:000305353400073
J	Close, RA; Rayfield, EJ				Close, Roger A.; Rayfield, Emily J.			Functional Morphometric Analysis of the Furcula in Mesozoic Birds	PLOS ONE			English	Article							ENANTIORNITHINE BIRD; AVIAN FLIGHT; EVOLUTIONARY RADIATION; PHYLOGENETIC SIGNAL; WINGBEAT FREQUENCY; SOUTHERN FRANCE; CRETACEOUS BIRD; PRIMITIVE BIRD; FLYING BIRDS; CHINA	The furcula displays enormous morphological and structural diversity. Acting as an important origin for flight muscles involved in the downstroke, the form of this element has been shown to vary with flight mode. This study seeks to clarify the strength of this form-function relationship through the use of eigenshape morphometric analysis coupled with recently developed phylogenetic comparative methods (PCMs), including phylogenetic Flexible Discriminant Analysis (pFDA). Additionally, the morphospace derived from the furculae of extant birds is used to shed light on possible flight adaptations of Mesozoic fossil taxa. While broad conclusions of earlier work are supported (U-shaped furculae are associated with soaring, strong anteroposterior curvature with wing-propelled diving), correlations between form and function do not appear to be so clear-cut, likely due to the significantly larger dataset and wider spectrum of flight modes sampled here. Interclavicular angle is an even more powerful discriminator of flight mode than curvature, and is positively correlated with body size. With the exception of the close relatives of modern birds, the ornithuromorphs, Mesozoic taxa tend to occupy unique regions of morphospace, and thus may have either evolved unfamiliar flight styles or have arrived at similar styles through divergent musculoskeletal configurations.	[Close, Roger A.] Monash Univ, Sch Geosci, Clayton, Vic, Australia; [Rayfield, Emily J.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England	Monash University; University of Bristol	Close, RA (corresponding author), Monash Univ, Sch Geosci, Clayton, Vic, Australia.	roger.close@monash.edu	Close, Roger/V-3052-2019; Rayfield, Emily/F-5038-2010	Close, Roger/0000-0003-3302-9902; Rayfield, Emily/0000-0002-2618-750X	Faculty of Science Dean's Postgraduate (PhD) Scholarship from Monash University	Faculty of Science Dean's Postgraduate (PhD) Scholarship from Monash University	This study was funded via Faculty of Science Dean's Postgraduate (PhD) Scholarship from Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; BAILEY JP, 1991, CAN J ZOOL, V69, P2751, DOI 10.1139/z91-387; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Baumel JJ, 1993, NOMINA ANATOMICA AVI, P45; Bell A, 2011, J SYST PALAEONTOL, V9, P119, DOI 10.1080/14772019.2010.525536; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bruderer B, 2010, IBIS, V152, P272, DOI 10.1111/j.1474-919X.2010.01014.x; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Buffetaut E, 1998, J GEOL SOC LONDON, V155, P1, DOI 10.1144/gsjgs.155.1.0001; Buffetaut E, 2000, CR ACAD SCI II A, V331, P557, DOI 10.1016/S1251-8050(00)01451-8; Burnham David A., 2000, University of Kansas Paleontological Contributions New Series, V13, P1; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe LM, 2002, MESOZOIC BIRDS HEADS, P1; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Dyke GJ, 2009, LETHAIA, V42, P248, DOI 10.1111/j.1502-3931.2008.00135.x; Dyke GJ, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P275; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gardiner E., 2011, LIVING DINOSAURS, P146; Gatesy SM, 1997, J VERTEBR PALEONTOL, V17, P308, DOI 10.1080/02724634.1997.10010977; GOSLOW GE, 1990, BIOSCIENCE, V40, P108, DOI 10.2307/1311343; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Habib M, 2010, BIOL J LINN SOC, V99, P687, DOI 10.1111/j.1095-8312.2010.01372.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harmon L, 2009, GEIGER ANAL EVOLUTIO; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hinic-Frlog S, 2010, J EVOLUTION BIOL, V23, P372, DOI 10.1111/j.1420-9101.2009.01909.x; Hinic-Frlog S, 2008, THESIS U CALIFORNIA; Hornik K., 2011, R FAQ; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hui CA, 2002, J MORPHOL, V251, P284, DOI 10.1002/jmor.1089; Hui CA, 1999, ENVIRON TOXICOL CHEM, V18, P970, DOI [10.1897/1551-5028(1999)018&lt;0970:EOHACO&gt;2.3.CO;2, 10.1002/etc.5620180523]; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Lentink D, 2007, NATURE, V446, P1082, DOI 10.1038/nature05733; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Livezey BC, 2010, ZOOL J LINN SOC-LOND, V160, P567, DOI 10.1111/j.1096-3642.2010.00635.x; MacLeod N, 1999, PALEOBIOLOGY, V25, P107; Maddison WP, 2011, MESQUITE MODULAR SYS; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Middleton KM, 2000, ZOOL J LINN SOC-LOND, V128, P149; Motani R, 2011, EVOLUTION, V65, P2245, DOI 10.1111/j.1558-5646.2011.01271.x; Naish D, 2012, BIOL LETTERS, V8, P97, DOI 10.1098/rsbl.2011.0683; Nesbitt SJ, 2009, J MORPHOL, V270, P856, DOI 10.1002/jmor.10724; Nudds RL, 2007, J ZOOL, V272, P218, DOI 10.1111/j.1469-7998.2006.00261.x; Nudds RL, 2004, P ROY SOC B-BIOL SCI, V271, pS324, DOI 10.1098/rsbl.2004.0167; O'Connor JMK, 2011, ACTA PALAEONTOL POL, V56, P463, DOI 10.4202/app.2010.0047; O'Connor JK, 2010, J VERTEBR PALEONTOL, V30, P311, DOI 10.1080/02724631003617498; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; OLSON SL, 1979, NATURE, V278, P247, DOI 10.1038/278247a0; Ostrom J.H., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P1; Ostrom JH, 1999, SM C PALEOB, P301; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Pennycuick CJ, 2001, J EXP BIOL, V204, P3283; PENNYCUICK CJ, 1990, J EXP BIOL, V150, P171; RAYNER JMV, 1985, J THEOR BIOL, V117, P47, DOI 10.1016/S0022-5193(85)80164-8; Rayner JMV, 2003, EXPTL BIOL REV, P297; Rayner JMV, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P363; Revell L. J., 2011, PHYTOOLS PHYLOGENETI; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Sanz JL, 1996, NATURE, V382, P442, DOI 10.1038/382442a0; SANZ JL, 1988, NATURE, V331, P433, DOI 10.1038/331433a0; SANZ JL, 1992, PALAEONTOLOGY, V35, P829; Schmaljohann H, 2009, J EXP BIOL, V212, P3633, DOI 10.1242/jeb.031435; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Simons ELR, 2011, J MORPHOL, V272, P958, DOI 10.1002/jmor.10963; Simons ELR, 2010, ZOOLOGY, V113, P39, DOI 10.1016/j.zool.2009.05.002; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Tobalske BW, 2009, EXP FLUIDS, V46, P963, DOI 10.1007/s00348-009-0614-9; Tobalske BW, 1999, J EXP BIOL, V202, P1725; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; VISCOR G, 1987, COMP BIOCHEM PHYS A, V87, P231, DOI 10.1016/0300-9629(87)90118-6; Wang XM, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/419343; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2001, CHINESE SCI BULL, V46, P945, DOI 10.1007/BF02900473; Zhang FC, 2004, CAN J EARTH SCI, V41, P1097, DOI 10.1139/E04-055; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; ZHOU Z, 1995, COUR FORSCHUNGSINST, V181, P9; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2008, J ANAT, V212, P565, DOI 10.1111/j.1469-7580.2008.00880.x; Zhou Z, 2010, P ROY SOC B-BIOL SCI, V277, P219, DOI 10.1098/rspb.2009.0885	95	30	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36664	10.1371/journal.pone.0036664	http://dx.doi.org/10.1371/journal.pone.0036664			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666324	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400010
J	Kaul, D; Habbel, P; Derkow, K; Kruger, C; Franzoni, E; Wulczyn, FG; Bereswill, S; Nitsch, R; Schott, E; Veh, R; Naumann, T; Lehnardt, S				Kaul, David; Habbel, Piet; Derkow, Katja; Krueger, Christina; Franzoni, Eleonora; Wulczyn, F. Gregory; Bereswill, Stefan; Nitsch, Robert; Schott, Eckart; Veh, Ruediger; Naumann, Thomas; Lehnardt, Seija			Expression of Toll-Like Receptors in the Developing Brain	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEGATIVE REGULATOR; NEUROFILAMENT SUBUNITS; MONOCLONAL-ANTIBODIES; SIGNALING PATHWAY; IMMUNE CELLS; ACTIVATION; DROSOPHILA; NEURONS; DISEASE	Toll-like receptors (TLR) are key players of the innate and adaptive immune response in vertebrates. The original protein Toll in Drosophila melanogaster regulates both host defense and morphogenesis during development. Making use of real-time PCR, in situ hybridization, and immunohistochemistry we systematically examined the expression of TLR1-9 and the intracellular adaptor molecules MyD88 and TRIF during development of the mouse brain. Expression of TLR7 and TLR9 in the brain was strongly regulated during different embryonic, postnatal, and adult stages. In contrast, expression of TLR1-6, TLR8, MyD88, and TRIF mRNA displayed no significant changes in the different phases of brain development. Neurons of various brain regions including the neocortex and the hippocampus were identified as the main cell type expressing both TLR7 and TLR9 in the developing brain. Taken together, our data reveal specific expression patterns of distinct TLRs in the developing mouse brain and lay the foundation for further investigation of the pathophysiological significance of these receptors for developmental processes in the central nervous system of vertebrates.	[Kaul, David; Habbel, Piet; Derkow, Katja; Krueger, Christina; Lehnardt, Seija] Charite, Dept Neurol, D-13353 Berlin, Germany; [Franzoni, Eleonora; Wulczyn, F. Gregory; Veh, Ruediger; Naumann, Thomas; Lehnardt, Seija] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Nitsch, Robert] Johannes Gutenberg Univ Mainz, Inst Microscop Anat & Neurobiol, Mainz, Germany; [Schott, Eckart] Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; [Lehnardt, Seija] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kaul, D (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	seija.lehnardt@charite.de	Lehnardt, Seija/AAA-4113-2022; Nitsch, Robert/AAI-9129-2021	Veh, Rudiger/0000-0002-6253-9808	Deutsche Forschungsgemeinschaft [SFB-TRR43/A1]; NeuroCure [Exc 257]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp) SFB-TRR43/A1 and NeuroCure Exc 257 (to SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornig M, 1999, P NATL ACAD SCI USA, V96, P12102, DOI 10.1073/pnas.96.21.12102; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Larsen Peter H, 2007, Sci STKE, V2007, ppe47, DOI 10.1126/stke.4022007pe47; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107; Owens T, 2009, CURR TOP MICROBIOL, V336, P105, DOI 10.1007/978-3-642-00549-7_6; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Rose D, 1997, DEVELOPMENT, V124, P1561; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TROJANOWSKI JQ, 1985, J HISTOCHEM CYTOCHEM, V33, P557, DOI 10.1177/33.6.3889140; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; Visser L, 2006, AM J PATHOL, V169, P1671, DOI 10.2353/ajpath.2006.060143; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	31	83	87	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37767	10.1371/journal.pone.0037767	http://dx.doi.org/10.1371/journal.pone.0037767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666391	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400048
J	Young, JC; Dill, BD; Pan, CL; Hettich, RL; Banfield, JF; Shah, M; Fremaux, C; Horvath, P; Barrangou, R; VerBerkmoes, NC				Young, Jacque C.; Dill, Brian D.; Pan, Chongle; Hettich, Robert L.; Banfield, Jillian F.; Shah, Manesh; Fremaux, Christophe; Horvath, Philippe; Barrangou, Rodolphe; VerBerkmoes, Nathan C.			Phage-Induced Expression of CRISPR-Associated Proteins Is Revealed by Shotgun Proteomics in Streptococcus thermophilus	PLOS ONE			English	Article							IMMUNE-SYSTEM; COMMUNITY PROTEOMICS; ACQUIRED-RESISTANCE; RNA; IDENTIFICATION; BACTERIA; TRANSCRIPTION; SEQUENCE; RECOGNITION; EVOLUTION	The CRISPR/Cas system, comprised of clustered regularly interspaced short palindromic repeats along with their associated (Cas) proteins, protects bacteria and archaea from viral predation and invading nucleic acids. While the mechanism of action for this acquired immunity is currently under investigation, the response of Cas protein expression to phage infection has yet to be elucidated. In this study, we employed shotgun proteomics to measure the global proteome expression in a model system for studying the CRISPR/Cas response in S. thermophilus DGCC7710 infected with phage 2972. Host and viral proteins were simultaneously measured following inoculation at two different multiplicities of infection and across various time points using two-dimensional liquid chromatography tandem mass spectrometry. Thirty-seven out of forty predicted viral proteins were detected, including all proteins of the structural virome and viral effector proteins. In total, 1,013 of 2,079 predicted S. thermophilus proteins were detected, facilitating the monitoring of host protein synthesis changes in response to virus infection. Importantly, Cas proteins from all four CRISPR loci in the S. thermophilus DGCC7710 genome were detected, including loci previously thought to be inactive. Many Cas proteins were found to be constitutively expressed, but several demonstrated increased abundance following infection, including the signature Cas9 proteins from the CRISPR1 and CRISPR3 loci, which are key players in the interference phase of the CRISPR/Cas response. Altogether, these results provide novel insights into the proteomic response of S. thermophilus, specifically CRISPR-associated proteins, upon phage 2972 infection.	[Young, Jacque C.] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN 37920 USA; [Young, Jacque C.; Dill, Brian D.; Pan, Chongle; Hettich, Robert L.; Shah, Manesh; VerBerkmoes, Nathan C.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Fremaux, Christophe; Horvath, Philippe] DuPont Nutr & Hlth, Dange St Romain, France; [Barrangou, Rodolphe] DuPont Nutr & Hlth, Madison, WI USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California Berkeley; DuPont	Young, JC (corresponding author), Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN 37920 USA.	verberkmoesn@ornl.gov	HORVATH, Philippe/K-5266-2015; Pan, Chongle/C-6960-2008; Hettich, Robert L/N-1458-2016; Barrangou, Rodolphe/I-2878-2014	HORVATH, Philippe/0000-0003-2015-8123; Pan, Chongle/0000-0003-2860-0334; Hettich, Robert L/0000-0001-7708-786X; Barrangou, Rodolphe/0000-0002-0648-3504; Dill, Brian/0000-0002-4532-3044; Banfield, Jill/0000-0001-8203-8771	US Department of Energy's Office of Science, Biological and Environmental Research Program [DE-FG02-07ER64505]; Danisco	US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); Danisco	This work was funded by the US Department of Energy's Office of Science, Biological and Environmental Research Program; grant number DE-FG02-07ER64505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; The authors have read the journal's policy and have the following conflicts: authors Rodolphe Barrangou, Christophe Fremaux, and Philippe Horvath are supported and employed by Danisco and are co-inventors on patents and patent applications relating to various uses of CRISPR technologies (patent number 7,919,277: Detection and Typing of Bacterial Strains, and patent applications 20110300538: Bifidobacteria CRISPR Sequences, 20110002889: Cultures with Improved Phage Resistance, 20100104690: Tagged Microorganisms and Methods of Tagging, 20100093617: Use, 20080124725: Tagged Microorganisms and Methods of Tagging). They do not, however, have financial interests such as stock, equity nor consultancies. Further, their affiliation and inventorships do not impact their scientific objectivity. There are no other patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Agari Y, 2010, J MOL BIOL, V395, P270, DOI 10.1016/j.jmb.2009.10.057; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Azcarate-Peril MA, 2005, APPL ENVIRON MICROB, V71, P5794, DOI 10.1128/AEM.71.10.5794-5804.2005; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANN REV GENETICS, V45; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Duplessis M, 2005, VIROLOGY, V340, P192, DOI 10.1016/j.virol.2005.05.033; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gagnaire V, 2009, J DAIRY SCI, V92, P811, DOI 10.3168/jds.2008-1476; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Juranek S, 2012, RNA; Levesque C, 2005, APPL ENVIRON MICROB, V71, P4057, DOI 10.1128/AEM.71.7.4057-4068.2005; Li M, 2010, J PROTEOME RES; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Sambrook J., 2001, MOL CLONING LAB MANU; Sapranauskas R, 2011, NUCL ACIDS RES; Semenova E, 2011, P NATL ACAD SCI US; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thompson DK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-311; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Washburn MP, 2002, ANAL CHEM, V74, P1650, DOI 10.1021/ac015704l; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yosef I, 2012, NUCL ACIDS RES	52	52	53	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38077	10.1371/journal.pone.0038077	http://dx.doi.org/10.1371/journal.pone.0038077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666452	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400078
J	Bhowmik, D; Das, S; Hossain, M; Haq, L; Kumar, GS				Bhowmik, Debipreeta; Das, Suman; Hossain, Maidul; Haq, Lucy; Kumar, Gopinatha Suresh			Biophysical Characterization of the Strong Stabilization of the RNA Triplex poly(U).poly(A)(*)poly(U) by 9-O-(omega-amino) Alkyl Ether Berberine Analogs	PLOS ONE			English	Article							SEQUENCE-SPECIFIC RECOGNITION; PHENYLALANINE TRANSFER-RNA; PLANT ALKALOID BERBERINE; SELF-STRUCTURE INDUCTION; DOUBLE-HELICAL DNA; SMALL MOLECULES; TAR RNA; ISOQUINOLINE ALKALOIDS; STRANDED POLY(A); BINDING ASPECTS	Background: Binding of two 9-O-(omega-amino) alkyl ether berberine analogs BC1 and BC2 to the RNA triplex poly(U).poly(A)(*)poly(U) was studied by various biophysical techniques. Methodology/Principal Findings: Berberine analogs bind to the RNA triplex non-cooperatively. The affinity of binding was remarkably high by about 5 and 15 times, respectively, for BC1 and BC2 compared to berberine. The site size for the binding was around 4.3 for all. Based on ferrocyanide quenching, fluorescence polarization, quantum yield values and viscosity results a strong intercalative binding of BC1 and BC2 to the RNA triplex has been demonstrated. BC1 and BC2 stabilized the Hoogsteen base paired third strand by about 18.1 and 20.5 degrees C compared to a 17.5 degrees C stabilization by berberine. The binding was entropy driven compared to the enthalpy driven binding of berbeine, most likely due to additional contacts within the grooves of the triplex and disruption of the water structure by the alkyl side chain. Conclusions/Significance: Remarkably higher binding affinity and stabilization effect of the RNA triplex by the amino alkyl berberine analogs was achieved compared to berberine. The length of the alkyl side chain influence in the triplex stabilization phenomena.	[Bhowmik, Debipreeta; Hossain, Maidul; Kumar, Gopinatha Suresh] CSIR Indian Inst Chem Biol, Biophys Chem Lab, Div Chem, Kolkata, India; [Das, Suman; Haq, Lucy] Jadavpur Univ, Dept Chem, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Jadavpur University	Bhowmik, D (corresponding author), CSIR Indian Inst Chem Biol, Biophys Chem Lab, Div Chem, Kolkata, India.	gskumar@csiriicb.in	Kumar, Gopinatha Suresh/W-1461-2019; Hossain, Maidul/AAW-7669-2021; Kumar, Dr Suresh/HHZ-2615-2022; Bhowmik, Debipreeta/AAX-6860-2021	Kumar, Dr Suresh/0000-0002-2539-6553; Bhowmik, Debipreeta/0000-0003-4726-5922; Hossain, Maidul/0000-0003-1408-2273	Network Project NWP 0036 of Council of Scientific and Industrial Research (CSIR), Government of India; University Grants Commission, Government of India fellowship; CSIR Research Associateship	Network Project NWP 0036 of Council of Scientific and Industrial Research (CSIR), Government of India; University Grants Commission, Government of India fellowship; CSIR Research Associateship	This work was supported by the grants from Network Project NWP 0036 of Council of Scientific and Industrial Research (CSIR), Government of India, University Grants Commission, Government of India fellowship (to DB) and CSIR Research Associateship (to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOULELA F, 1995, J MOL BIOL, V253, P313, DOI 10.1006/jmbi.1995.0555; Arya DP, 2011, ACCOUNTS CHEM RES, V44, P134, DOI 10.1021/ar100113q; Auyeung KKW, 2009, INT J MOL MED, V24, P571, DOI 10.3892/ijmm_00000267; Basu A, 2012, BIOORGAN MED CHEM, V20, P2498, DOI 10.1016/j.bmc.2012.03.006; Bhadra K, 2007, BBA-GEN SUBJECTS, V1770, P1071, DOI 10.1016/j.bbagen.2007.03.001; Bhadra K, 2011, MED RES REV, V31, P821, DOI 10.1002/med.20202; Bhowmik D, 2012, J PHYS CHEM B, V116, P2314, DOI 10.1021/jp210072a; Buske FA, 2011, RNA BIOL, V8, P427, DOI 10.4161/rna.8.3.14999; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; CHASTAIN M, 1992, BIOCHEMISTRY-US, V31, P12733, DOI 10.1021/bi00166a004; Choi MS, 2008, ANTICANCER RES, V28, P3777; Das S, 2003, J BIOMOL STRUCT DYN, V20, P703, DOI 10.1080/07391102.2003.10506887; Dinman JD, 2002, P NATL ACAD SCI USA, V99, P5331, DOI 10.1073/pnas.082102199; DOAN TL, 1987, NUCLEIC ACIDS RES, V15, P7749; ESCUDE C, 1993, NUCLEIC ACIDS RES, V21, P5547, DOI 10.1093/nar/21.24.5547; FELSENFELD G, 1957, J AM CHEM SOC, V79, P2023, DOI 10.1021/ja01565a074; Ferraroni M, 2011, CHEM COMMUN, V47, P4917, DOI 10.1039/c1cc10971e; Fox KR, 2004, 3 HELIX SPECIFIC LIG, P360; Giri P, 2008, ARCH BIOCHEM BIOPHYS, V474, P183, DOI 10.1016/j.abb.2008.03.013; Giri P, 2008, MOL BIOSYST, V4, P341, DOI 10.1039/b716356h; Giri P, 2010, MINI-REV MED CHEM, V10, P568, DOI 10.2174/138955710791384009; GREEN R, 1994, J MOL BIOL, V235, P140, DOI 10.1016/S0022-2836(05)80022-1; Halimani M, 2009, LANGMUIR, V25, P2339, DOI 10.1021/la802761b; HAN HY, 1993, P NATL ACAD SCI USA, V90, P3806, DOI 10.1073/pnas.90.9.3806; Ho YT, 2009, ANTICANCER RES, V29, P4063; Holland JA, 1996, NUCLEIC ACIDS RES, V24, P2841, DOI 10.1093/nar/24.14.2841; Hsu WH, 2007, ARCH TOXICOL, V81, P719, DOI 10.1007/s00204-006-0169-y; HUANG CY, 1982, METHOD ENZYMOL, V87, P509; Huang L, 2010, BIOORGAN MED CHEM, V18, P4475, DOI 10.1016/j.bmc.2010.04.063; Islam M, 2007, BIOPHYS CHEM, V125, P508, DOI 10.1016/j.bpc.2006.11.001; Islam MM, 2011, MEDCHEMCOMM, V2, P631, DOI 10.1039/c0md00209g; Islam MM, 2011, DNA CELL BIOL, V30, P123, DOI 10.1089/dna.2010.1109; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Islam MM, 2009, MOL BIOSYST, V5, P244, DOI 10.1039/b816480k; Jain A, 2010, BIOCHEMISTRY-US, V49, P6992, DOI 10.1021/bi100795m; James MA, 2011, MOL CARCINOGEN, V50, P1, DOI 10.1002/mc.20690; Job P, 1928, ANN CHIM FRANCE, V9, P113; Kanak M, 2010, APPL IMMUNOHISTO M M, V18, P532, DOI 10.1097/PAI.0b013e3181e1ef6a; Keppler MD, 1999, EUR J BIOCHEM, V263, P817, DOI 10.1046/j.1432-1327.1999.00566.x; Kim DW, 2007, J KOREAN NEUROSURG S, V42, P392, DOI 10.3340/jkns.2007.42.5.392; KIM SH, 1973, SCIENCE, V179, P285, DOI 10.1126/science.179.4070.285; KINNIBURGH AJ, 1994, GENE, V149, P93, DOI 10.1016/0378-1119(94)90416-2; KLINCK R, 1994, FEBS LETT, V355, P297, DOI 10.1016/0014-5793(94)01228-8; Krishnan P, 2000, ANTI-CANCER DRUG DES, V15, P255; KUMAR CV, 1992, J CHEM SOC CHEM COMM, P470, DOI 10.1039/c39920000470; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE; LERMAN LS, 1961, J MOL BIOL, V3, P18, DOI 10.1016/S0022-2836(61)80004-1; LIQUIER J, 1995, NUCLEIC ACIDS RES, V23, P1722, DOI 10.1093/nar/23.10.1722; Long YH, 2006, BIOORGAN MED CHEM, V14, P4670, DOI 10.1016/j.bmc.2006.03.004; Ma Y, 2008, BIOORGAN MED CHEM, V16, P7582, DOI 10.1016/j.bmc.2008.07.029; Ma Y, 2009, BIOORG MED CHEM LETT, V19, P3414, DOI 10.1016/j.bmcl.2009.05.030; MAHER LJ, 1989, SCIENCE, V245, P725, DOI 10.1126/science.2549631; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MICHEL F, 1990, NATURE, V347, P578, DOI 10.1038/347578a0; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; Pang JY, 2005, BIOORGAN MED CHEM, V13, P5835, DOI 10.1016/j.bmc.2005.05.048; Patil JB, 2010, EUR J PHARMACOL, V645, P70, DOI 10.1016/j.ejphar.2010.07.037; PUGLISI JD, 1993, P NATL ACAD SCI USA, V90, P3680, DOI 10.1073/pnas.90.8.3680; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Ray A, 1999, BIOCHEMISTRY-US, V38, P6239, DOI 10.1021/bi982128n; REINHARDT CG, 1982, BIOCHEM BIOPH RES CO, V104, P1376, DOI 10.1016/0006-291X(82)91402-4; ROBERTS RW, 1992, SCIENCE, V258, P1463, DOI 10.1126/science.1279808; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; SARI MA, 1990, BIOCHEMISTRY-US, V29, P4205, DOI 10.1021/bi00469a025; SCARIA PV, 1991, J BIOL CHEM, V266, P5417; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Shan WJ, 2011, EUR J MED CHEM, V46, P5885, DOI 10.1016/j.ejmech.2011.09.051; Sharma N.K., 2011, AM J BIOCH BIOTECHNO, V7, P130, DOI [10.3844/ajbbsp.2011.132.137, DOI 10.3844/AJBBSP.2011.132.137]; Shi AD, 2011, BIOORGAN MED CHEM, V19, P2298, DOI 10.1016/j.bmc.2011.02.025; Sinha R, 2006, BIOORGAN MED CHEM, V14, P800, DOI 10.1016/j.bmc.2005.09.007; Sinha R, 2007, BBA-GEN SUBJECTS, V1770, P1636, DOI 10.1016/j.bbagen.2007.08.018; Sinha R, 2009, J PHYS CHEM B, V113, P13410, DOI 10.1021/jp9069515; Song YJ, 2011, NUCLEIC ACIDS RES, V39, P6835, DOI 10.1093/nar/gkr322; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; Yu FS, 2007, IN VIVO, V21, P407; Zhang WJ, 2007, BIOORGAN MED CHEM, V15, P5493, DOI 10.1016/j.bmc.2007.05.050; Zheng RP, 2010, J CELL SCI, V123, P3734, DOI 10.1242/jcs.070466	80	54	59	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37939	10.1371/journal.pone.0037939	http://dx.doi.org/10.1371/journal.pone.0037939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666416	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600044
J	Ribeiro, GS; Tartof, SY; Oliveira, DWS; Guedes, ACS; Reis, MG; Riley, LW; Ko, AI				Ribeiro, Guilherme S.; Tartof, Sara Y.; Oliveira, Dalton W. S.; Guedes, Aldalice C. S.; Reis, Mitermayer G.; Riley, Lee W.; Ko, Albert I.			Surgery for Valvular Heart Disease: A Population-Based Study in a Brazilian Urban Center	PLOS ONE			English	Article							VALVE-REPLACEMENT; MITRAL-VALVE; EPIDEMIOLOGY; PREDICTION; MORTALITY	Background: In middle income countries, the burden of rheumatic heart disease (RHD) remains high, but the prevalence of other heart valve diseases may rise as the population life expectancy increases. Here, we compared population-based data on surgical procedures to assess the relative importance of causes of heart valve disease in Salvador, Brazil. Methodology/Principal Findings: Medical charts of patients who underwent surgery for valvular heart disease from January 2002-December 2005 were reviewed. Incidence of surgery for valvular heart disease was calculated. Logistic regression was used to identify factors associated with in-hospital death following surgery. The most common etiologies for valvular dysfunction in 491 valvular heart surgery patients were RHD (60.3%), degenerative valve disease (15.3%), and endocarditis (4.5%). Mean annual incidence for surgeries due to any valvular heart diseases, RHD, and degenerative valvular disease were 5.02, 3.03, and 0.77 per 100,000 population, respectively. Incidence of surgery due to RHD was highest in young adults; procedures were predominantly paid by the public health sector. In contrast, the incidence of surgery due to degenerative valvular disease was highest among those older than 60 years of age; procedures were mostly paid by the private sector. The overall in-hospital case-fatality ratio was 11.9%. Independent factors associated with death included increase in age (odds ratio: 1.04 per year of age; 95% confidence interval: 1.02-1.06), endocarditis (6.35; 1.92-21.04), multiple valve operative procedures (4.35; 2.12-8.95), and prior heart valve surgery (2.49; 1.05-5.87). Conclusions/Significance: RHD remains the main cause for valvular heart surgery in Salvador, which primarily affects young adults without private health insurance. In contrast, surgery due to degenerative valvular disease primarily impacts the elderly with private health insurance. Strategies to reduce the burden of valvular heart disease will need to address the disparate factors that contribute to RHD as well as degenerative valve disease.	[Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Ribeiro, Guilherme S.; Oliveira, Dalton W. S.; Guedes, Aldalice C. S.; Reis, Mitermayer G.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil; [Tartof, Sara Y.; Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis Div, New Haven, CT USA	Universidade Federal da Bahia; Fundacao Oswaldo Cruz; University of California System; University of California Berkeley; Yale University	Ribeiro, GS (corresponding author), Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.	gsribeiro@ufba.br	Ribeiro, Guilherme/B-6624-2008; Reis, Mitermayer/AAO-9742-2020; Ko, Albert/P-2343-2015	Ribeiro, Guilherme/0000-0002-6798-2059; Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert/0000-0001-9023-2339; Tartof, Sara/0000-0003-2336-8476	Brazilian National Council for Scientific and Technological Development, Training and Research in Global Infectious Disease, Fogarty International Center, National Institutes of Health [TW006563]; Centers for Disease Control and Prevention Grants for Public Health Research Dissertation [R36]; FOGARTY INTERNATIONAL CENTER [D43TW006563, R01TW009504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052473] Funding Source: NIH RePORTER	Brazilian National Council for Scientific and Technological Development, Training and Research in Global Infectious Disease, Fogarty International Center, National Institutes of Health; Centers for Disease Control and Prevention Grants for Public Health Research Dissertation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Brazilian National Council for Scientific and Technological Development, Training and Research in Global Infectious Disease, Fogarty International Center, National Institutes of Health (TW006563), and Centers for Disease Control and Prevention Grants for Public Health Research Dissertation (R36). The funding sources had no involvement in study design, data collection, analysis, interpretation, report writing, or publication. The authors had full access to all data and accept full responsibility for the content of this report.	Boudoulas H, 1994, J Heart Valve Dis, V3, P516; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Datasus Departamento de Informatica do SUS Secretaria Executiva Ministerio da Saude, 2012, POP RES AN 2 FAIX ET, P2002; Edwards FH, 2001, J AM COLL CARDIOL, V37, P885, DOI 10.1016/S0735-1097(00)01202-X; Enriquez-Sarano M, 2009, LANCET, V373, P1382, DOI 10.1016/S0140-6736(09)60692-9; Enriquez-Sarano R, 1999, J AM COLL CARDIOL, V34, P1129, DOI 10.1016/S0735-1097(99)00314-9; Instituto Brasileiro de Geografia e Estatistica, 2008, PROJ POP BRAS SEX ID; Iung B, 2011, NAT REV CARDIOL, V8, P162, DOI 10.1038/nrcardio.2010.202; Jamieson WRE, 1999, ANN THORAC SURG, V67, P943, DOI 10.1016/S0003-4975(99)00175-7; Kleinert S, 2011, LANCET, V377, P1721, DOI 10.1016/S0140-6736(11)60433-9; Lisboa LAF, 2010, ARQ BRAS CARDIOL, V94, P174, DOI 10.1590/S0066-782X2010000200006; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Monin JL, 2005, J AM COLL CARDIOL, V46, P302, DOI 10.1016/j.jacc.2005.03.064; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Nowicki ER, 2004, ANN THORAC SURG, V77, P1966, DOI 10.1016/j.athoracsur.2003.12.035; OLSON LJ, 1987, MAYO CLIN PROC, V62, P22, DOI 10.1016/S0025-6196(12)61522-5; Ray S, 2010, CLIN MED, V10, P168; Rose AG, 1996, CURR OPIN CARDIOL, V11, P98, DOI 10.1097/00001573-199603000-00002; Soler-Soler J, 2000, HEART, V83, P721, DOI 10.1136/heart.83.6.721; WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease, 2004, RHEUM FEV RHEUM HEAR	20	27	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37855	10.1371/journal.pone.0037855	http://dx.doi.org/10.1371/journal.pone.0037855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666401	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600034
J	Ma, Y; Wang, SQ; Xu, WR; Wang, RL; Chou, KC				Ma, Ying; Wang, Shu-Qing; Xu, Wei-Ren; Wang, Run-Ling; Chou, Kuo-Chen			Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping Approach	PLOS ONE			English	Article							FREQUENCY VIBRATIONS PHONONS; PROTEASE CLEAVAGE SITES; LIGAND-BINDING DOMAIN; BIOLOGICAL FUNCTIONS; PPAR-GAMMA; ALLOSTERIC TRANSITION; MOLECULAR-DYNAMICS; COLLECTIVE MOTION; 3D STRUCTURE; FATTY-ACIDS	Owing to their unique functions in regulating glucose, lipid and cholesterol metabolism, PPARs (peroxisome proliferator-activated receptors) have drawn special attention for developing drugs to treat type-2 diabetes. By combining the lipid benefit of PPAR-alpha agonists (such as fibrates) with the glycemic advantages of the PPAR-gamma agonists (such as thiazolidinediones), the dual PPAR agonists approach can both improve the metabolic effects and minimize the side effects caused by either agent alone, and hence has become a promising strategy for designing effective drugs against type-2 diabetes. In this study, by means of the powerful "core hopping" and "glide docking" techniques, a novel class of PPAR dual agonists was discovered based on the compound GW409544, a well-known dual agonist for both PPAR-alpha and PPAR-gamma modified from the farglitazar structure. It was observed by molecular dynamics simulations that these novel agonists not only possessed the same function as GW409544 did in activating PPAR-alpha and PPAR-gamma, but also had more favorable conformation for binding to the two receptors. It was further validated by the outcomes of their ADME (absorption, distribution, metabolism, and excretion) predictions that the new agonists hold high potential to become drug candidates. Or at the very least, the findings reported here may stimulate new strategy or provide useful insights for discovering more effective dual agonists for treating type-2 diabetes. Since the "core hopping" technique allows for rapidly screening novel cores to help overcome unwanted properties by generating new lead compounds with improved core properties, it has not escaped our notice that the current strategy along with the corresponding computational procedures can also be utilized to find novel and more effective drugs for treating other illnesses.	[Ma, Ying; Wang, Shu-Qing; Wang, Run-Ling] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin, Peoples R China; [Xu, Wei-Ren] TIPR, Tianjin, Peoples R China; [Wang, Shu-Qing; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Tianjin Medical University	Ma, Y (corresponding author), Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin, Peoples R China.	sqwang@gordonlifescience.org; wangrunling@tijmu.edu.cn	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [20972112, 21102103]; Doctoral Program of Higher Education of China [20091202110010]; China Postdoctoral Science Foundation [2011M500532]; Tianjin Municipal Natural Science Foundation [09JCZDJC21600]; Tianjin medical university [2011KY43]; Tianjin Institute of Pharmaceutical Research (TIPR)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin); Tianjin medical university; Tianjin Institute of Pharmaceutical Research (TIPR)	This study was supported by grants (20972112 and 21102103) from the National Natural Science Foundation of China; a grant (20091202110010) from the Doctoral Program of Higher Education of China; a grant (2011M500532) from the China Postdoctoral Science Foundation; a grant (09JCZDJC21600) from the Key Program of Tianjin Municipal Natural Science Foundation; a grant (2011KY43) from the Tianjin medical university, as well as Tianjin Institute of Pharmaceutical Research (TIPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, LIGPRE2 3; [Anonymous], 2009, QIKPROP3 2; [Anonymous], 2009, PRIME2 1 GLIDE5 5; [Anonymous], 2009, COMBIGLIDE2 5; Balakumar P, 2007, PHARMACOL RES, V56, P91, DOI 10.1016/j.phrs.2007.03.002; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BLASCHKE F, 2006, ENDOCRIN METAB CLIN, V35, pR9; Blaschke F, 2006, ENDOCRIN METAB CLIN, V35, P561, DOI 10.1016/j.ecl.2006.06.001; Bowers K.J., 2006, P ACM IEEE C SUP SC0, DOI 10.1109/SC.2006.54; Cai L, 2011, MED CHEM, V7, P121, DOI 10.2174/157340611794859343; Carpino PA, 2010, EXPERT OPIN THER PAT, V20, P1627, DOI 10.1517/13543776.2010.533171; CHOU KC, 1984, BIOPHYS CHEM, V20, P61, DOI 10.1016/0301-4622(84)80005-8; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; CHOU KC, 1987, BIOPOLYMERS, V26, P285, DOI 10.1002/bip.360260209; Chou KC, 2004, J PROTEOME RES, V3, P1284, DOI 10.1021/pr049849v; CHOU KC, 1989, TRENDS BIOCHEM SCI, V14, P212, DOI 10.1016/0968-0004(89)90026-1; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V319, P433, DOI 10.1016/j.bbrc.2004.05.016; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; Chou KC, 1999, BIOCHEM BIOPH RES CO, V259, P420, DOI 10.1006/bbrc.1999.0792; CHOU KC, 1988, BIOPOLYMERS, V27, P1795, DOI 10.1002/bip.360271109; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; CHOU KC, 1984, BIOPHYS J, V45, P881, DOI 10.1016/S0006-3495(84)84234-4; CHOU KC, 1994, BIOPOLYMERS, V34, P143, DOI 10.1002/bip.360340114; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Concu R, 2009, J PROTEOME RES, V8, P4372, DOI 10.1021/pr9003163; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Dea-Ayuela MA, 2008, BIOORGAN MED CHEM, V16, P7770, DOI 10.1016/j.bmc.2008.07.023; Du QS, 2009, J COMPUT CHEM, V30, P295, DOI 10.1002/jcc.21056; Ebdrup S, 2003, J MED CHEM, V46, P1306, DOI 10.1021/jm021027r; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; Gangloff M, 2001, J BIOL CHEM, V276, P15059, DOI 10.1074/jbc.M009870200; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou XB, 2011, PROTEIN PEPTIDE LETT, V18, P440, DOI 10.2174/092986611794927992; Housaindokht MR, 2008, J THEOR BIOL, V254, P294, DOI 10.1016/j.jtbi.2008.04.036; Husslein T, 1998, FARADAY DISCUSS, V111, P201; HUSSLEIN T, 1998, FARADAY DISCUSS, P225; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Javangula KC, 2006, ANN THORAC SURG, V81, P1913, DOI 10.1016/j.athoracsur.2005.03.045; Ji CG, 2008, J AM CHEM SOC, V130, P17129, DOI 10.1021/ja807374x; Jorgensen WL, 2002, ADV DRUG DELIVER REV, V54, P355, DOI 10.1016/S0169-409X(02)00008-X; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kochendoerfer GG, 1999, BIOCHEMISTRY-US, V38, P11905, DOI 10.1021/bi990720m; Lewis SN, 2010, PPAR RES, V2010, DOI 10.1155/2010/861238; Li XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028111; Liao QH, 2011, MED CHEM, V7, P24, DOI 10.2174/157340611794072698; Liu G, 2003, J MED CHEM, V46, P4232, DOI 10.1021/jm034122o; Liu XY, 2011, PROTEIN PEPT LETT; Markt P, 2007, J COMPUT AID MOL DES, V21, P575, DOI 10.1007/s10822-007-9140-0; Michalik L, 2007, J BIOL CHEM, V282, P9666, DOI 10.1074/jbc.M610523200; Mochizuki K, 2001, BBA-MOL CELL BIOL L, V1531, P68, DOI 10.1016/S0167-4889(01)00071-4; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Prado-Prado FJ, 2008, BIOORGAN MED CHEM, V16, P5871, DOI 10.1016/j.bmc.2008.04.068; Prado-Prado FJ, 2009, BIOORGAN MED CHEM, V17, P569, DOI 10.1016/j.bmc.2008.11.075; PRADOPRADO FJ, 2009, BIOORG MED IN PRESS; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schrodinger, 2009, COR HOPP; Shearer BG, 2007, BBA-MOL CELL BIOL L, V1771, P1082, DOI 10.1016/j.bbalip.2007.05.005; Shen HB, 2008, ANAL BIOCHEM, V375, P388, DOI 10.1016/j.ab.2008.01.012; Singh KD, 2011, J MOL MODEL; Sirois S, 2004, J CHEM INF COMP SCI, V44, P1111, DOI 10.1021/ci034270n; Song ZY, 2000, BIOPHYS J, V79, P767, DOI 10.1016/S0006-3495(00)76334-X; Wang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018414; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yue LD, 2005, BIOCHIMIE, V87, P539, DOI 10.1016/j.biochi.2005.02.002; Zhang JW, 2002, PROTEINS, V48, P447, DOI 10.1002/prot.10173	80	107	108	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38546	10.1371/journal.pone.0038546	http://dx.doi.org/10.1371/journal.pone.0038546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685582	Green Published, gold			2022-12-27	WOS:000305351700045
J	Otero, JE; Chen, T; Zhang, KH; Abu-Amer, Y				Otero, Jesse E.; Chen, Tim; Zhang, Kaihua; Abu-Amer, Yousef			Constitutively Active Canonical NF-kappa B Pathway Induces Severe Bone Loss in Mice	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION; ACTIVATION	Physiologic osteoclastogenesis entails activation of multiple signal transduction pathways distal to the cell membrane receptor RANK. However, atypical osteoclastogenesis driven by pro-inflammatory stimuli has been described. We have reported recently a novel mechanism whereby endogenous mutational activation of the classical NF-kappa B pathway is sufficient to induce RANKL/RANK-independent osteoclastogenesis. Here we investigate the physiologic relevance of this phenomenon in vivo. Using a knock-in approach, the active form of IKK2, namely IKK2SSEE, was introduced into the myeloid lineage with the aid of CD11b-cre mice. Phenotypic assessment revealed that expression of IKK2SSEE in the myeloid compartment induced significant bone loss in vivo. This observation was supported by a dramatic increase in the number and size of osteoclasts in trabecular regions, elevated levels of circulating TRACP-5b, and reduced bone volume. Mechanistically, we observed that IKK2SSEE induced high expression of not only p65 but also p52 and RelB; the latter two molecules are considered exclusive members of the alternative NF-kB pathway. Intriguingly, RelB and P52 were both required to mediate the osteoclastogenic effect of IKK2SSEE and co-expression of these two proteins was sufficient to recapitulate osteoclastogenesis in the absence of RANKL or IKK2SSEE. Furthermore, we found that NF-kB2/p100 is a potent inhibitor of IKK2SSEE-induced osteoclastogenesis. Deletion of p52 enabled more robust osteoclast formation by the active kinase. In summary, molecular activation of IKK2 may play a role in conditions of pathologic bone destruction, which may be refractory to therapeutic interventions targeting the proximal RANKL/RANK signal.	[Otero, Jesse E.] Univ Iowa Hosp & Clin, Dept Orthoped Surg, Iowa City, IA 52242 USA; [Chen, Tim; Zhang, Kaihua; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Orthoped Surg & Cell Biol & Physiol, St Louis, MO USA	University of Iowa; Washington University (WUSTL)	Otero, JE (corresponding author), Univ Iowa Hosp & Clin, Dept Orthoped Surg, Iowa City, IA 52242 USA.	abuamery@wustl.edu			National Institutes of Health [R01-AR049192, R01-AR054326, P30-AR057235]; Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049192, P30AR057235, R01AR054326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the National Institutes of Health (grants R01-AR049192, R01-AR054326, and P30-AR057235) and a grant from the Shriners Hospital for Children. www.nih.gov/.www.shrinershq.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y, 2008, AUTOIMMUNITY, V41, P204, DOI 10.1080/08916930701694543; Abu-Amer Yousef, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P347, DOI 10.2174/1568008054863808; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Boyce BF, 1999, BONE, V25, P137, DOI 10.1016/S8756-3282(99)00105-2; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Darwech I, 2009, J CELL BIOCHEM, V108, P1337, DOI 10.1002/jcb.22364; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Hunter DJ, 2000, ARTHRITIS RES, V2, P441, DOI 10.1186/ar125; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kim HB, 2010, BIOSYSTEMS, V99, P140, DOI 10.1016/j.biosystems.2009.10.009; Kim JY, 2011, J CELL SCI, V124, P647, DOI 10.1242/jcs.075770; Madge LA, 2010, J BIOL CHEM, V285, P38069, DOI 10.1074/jbc.M110.147207; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Otero JE, 2010, J BONE MINER RES, V25, P1282, DOI 10.1002/jbmr.4; Otero JE, 2008, J BIOL CHEM, V283, P24546, DOI 10.1074/jbc.M800434200; Ruocco MG, 2007, ADV EXP MED BIOL, V602, P125; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716	24	25	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38694	10.1371/journal.pone.0038694	http://dx.doi.org/10.1371/journal.pone.0038694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685599	Green Submitted, gold, Green Published			2022-12-27	WOS:000305351700062
J	Cai, H; Jiang, J; Yang, Q; Chen, QM; Deng, YQ				Cai, Hua; Jiang, Jun; Yang, Qi; Chen, Qingmei; Deng, Yiqun			Functional Characterization of a First Avian Cytochrome P450 of the CYP2D Subfamily (CYP2D49)	PLOS ONE			English	Article							TESTOSTERONE 16-ALPHA-HYDROXYLASE C-P-45016-ALPHA; CHICKEN XENOBIOTIC RECEPTOR; DOG LIVER-MICROSOMES; DRUG OXIDATION; TRANSCRIPTIONAL ACTIVATION; DEBRISOQUINE 4-HYDROXYLASE; CATALYTIC SPECIFICITY; CIRCULAR-DICHROISM; MOLECULAR-CLONING; ACTIVE-SITE	The CYP2D family members are instrumental in the metabolism of 20-25% of commonly prescribed drugs. Although many CYP2D isoforms have been well characterized in other animal models, research concerning the chicken CYP2Ds is limited. In this study, a cDNA encoding a novel CYP2D enzyme (CYP2D49) was cloned from the chicken liver for the first time. The CYP2D49 cDNA contained an open reading frame of 502 amino acids that shared 52%-57% identities with other CYP2Ds. The gene structure and neighboring genes of CYP2D49 are conserved and similar to those of human CYP2D6. Additionally, similar to human CYP2D6, CYP2D49 is un-inducible in the liver and expressed predominantly in the liver, kidney and small intestine, with detectable levels in several other tissues. Metabolic assays of the CYP2D49 protein heterologously expressed in E. coli and Hela cells indicated that CYP2D49 metabolized the human CYP2D6 substrate, bufuralol, but not debrisoquine. Moreover, quinidine, a potent inhibitor of human CYP2D6, only inhibited the bufuralol 1'-hydroxylation activity of CYP2D49 to a negligible degree. All these results indicated that CYP2D49 had functional characteristics similar to those of human CYP2D6 but measurably differed in the debrisoquine 4'-hydroxylation and quinidine inhibitory profile. Further structure-function investigations that employed site-directed mutagenesis and circular dichroism spectroscopy identified the importance of Val-126, Glu-222, Asp-306, Phe-486 and Phe-488 in keeping the enzymatic activity of CYP2D49 toward bufuralol as well as the importance of Asp-306, Phe-486 and Phe-488 in maintaining the conformation of CYP2D49 protein. The current study is only the first step in characterizing the metabolic mechanism of CYP2D49; further studies are still required.	[Cai, Hua; Jiang, Jun; Yang, Qi; Chen, Qingmei; Deng, Yiqun] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Deng, YQ (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	yqdeng@scau.edu.cn	Deng, Yiqun/K-7709-2013	Deng, Yiqun/0000-0002-6838-3779	National Basic Research Program of China (973 program) [2009CB118802]; National Natural Science Foundation of China [31172087]; Guangdong Province Universities and Colleges Special Funds for Talents; China Postdoctoral Science Foundation [201104362]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Special Funds for Talents; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Basic Research Program of China (973 program, 2009CB118802), the National Natural Science Foundation of China grant (31172087), Guangdong Province Universities and Colleges Special Funds for Talents (2010), and the Special Financial Grant from the China Postdoctoral Science Foundation (201104362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABBAGH SG, 1981, J PHARM PHARMACOL, V33, P161, DOI 10.1111/j.2042-7158.1981.tb13740.x; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Baader M, 2002, J BIOL CHEM, V277, P15647, DOI 10.1074/jbc.M109882200; Bogaards JJP, 2000, XENOBIOTICA, V30, P1131, DOI 10.1080/00498250010021684; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Daly AK, 1996, PHARMACOGENETICS, V6, P319, DOI 10.1097/00008571-199608000-00005; de Graaf C, 2007, CURR DRUG METAB, V8, P59, DOI 10.2174/138920007779315062; ELLIS SW, 1995, J BIOL CHEM, V270, P29055, DOI 10.1074/jbc.270.49.29055; Flanagan JU, 2004, BIOCHEM J, V380, P353, DOI 10.1042/BJ20040062; Gilday D, 1996, J BIOL CHEM, V271, P33054, DOI 10.1074/jbc.271.51.33054; GONZALEZ FJ, 1987, DNA-J MOLEC CELL BIO, V6, P149, DOI 10.1089/dna.1987.6.149; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; GUT J, 1986, J BIOL CHEM, V261, P1734; Hadidi S, 2001, IMMUNOL LETT, V77, P97, DOI 10.1016/S0165-2478(01)00208-5; Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362; Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571; Hayhurst GP, 2001, BIOCHEM J, V355, P373, DOI 10.1042/0264-6021:3550373; Hichiya H, 2004, BIOCHEM PHARMACOL, V68, P165, DOI 10.1016/j.bcp.2004.03.018; Hichiya H, 2002, BIOCHEM PHARMACOL, V64, P1101, DOI 10.1016/S0006-2952(02)01287-X; Hiroi T, 2002, DRUG METAB DISPOS, V30, P970, DOI 10.1124/dmd.30.9.970; JIANG QS, 1995, BIOCHEM BIOPH RES CO, V209, P1149, DOI 10.1006/bbrc.1995.1617; Keizers PHJ, 2004, BIOCHEM PHARMACOL, V68, P2263, DOI 10.1016/j.bcp.2004.08.013; Khalil WF, 2001, J VET PHARMACOL THER, V24, P343, DOI 10.1046/j.1365-2885.2001.00349.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Masuda K, 2005, CHIRALITY, V17, P37, DOI 10.1002/chir.20092; MATSUNAGA E, 1990, J MOL EVOL, V30, P155, DOI 10.1007/BF02099942; Michael PP, 2005, CYTOCHROME P450 PROT, P19; MURA C, 1991, NUCLEIC ACIDS RES, V19, P1162, DOI 10.1093/nar/19.5.1162; Narimatsu S, 2009, BIOCHEM PHARMACOL, V77, P920, DOI 10.1016/j.bcp.2008.11.006; Nelson David R, 2006, Methods Mol Biol, V320, P1; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Niwa T, 2011, CURR DRUG METAB, V12, P412, DOI 10.2174/138920011795495286; Okey AB, 1992, PHARMACOGENETICS DRU, P594; Ourlin JC, 2000, ARCH BIOCHEM BIOPHYS, V373, P375, DOI 10.1006/abbi.1999.1566; Paine MJI, 2003, J BIOL CHEM, V278, P4021, DOI 10.1074/jbc.M209519200; Perrins, 2003, ENCY BRITANNICA FIRE; Roussel F, 1998, ARCH BIOCHEM BIOPHYS, V357, P27, DOI 10.1006/abbi.1998.0801; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; SAKAMOTO K, 1995, ARCH BIOCHEM BIOPHYS, V319, P372, DOI 10.1006/abbi.1995.1307; Sakuyama K, 2008, DRUG METAB DISPOS, V36, P2460, DOI 10.1124/dmd.108.023242; SUZUKI T, 1992, DRUG METAB DISPOS, V20, P367; Tasaki T, 1998, J BIOCHEM, V123, P747; TSUNEOKA Y, 1992, EUR J BIOCHEM, V208, P739, DOI 10.1111/j.1432-1033.1992.tb17242.x; Wan J, 1997, ARCH BIOCHEM BIOPHYS, V348, P383, DOI 10.1006/abbi.1997.0402; WONG G, 1989, J BIOL CHEM, V264, P2920; WONG G, 1987, BIOCHEMISTRY-US, V26, P8683, DOI 10.1021/bi00400a029; WOOLHOUSE NM, 1979, CLIN PHARMACOL THER, V26, P586; Yamamoto Y, 1998, J BIOCHEM-TOKYO, V124, P503, DOI 10.1093/oxfordjournals.jbchem.a022141; Yu AM, 2004, DRUG METAB REV, V36, P243, DOI 10.1081/DMR-120034000; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P761, DOI 10.2165/11318070-000000000-00000; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P689, DOI 10.2165/11318030-000000000-00000; Zuber R, 2002, J CELL MOL MED, V6, P189, DOI 10.1111/j.1582-4934.2002.tb00186.x	53	8	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38395	10.1371/journal.pone.0038395	http://dx.doi.org/10.1371/journal.pone.0038395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675558	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700070
J	Ryu, YU; Buchanan, JJ				Ryu, Young U.; Buchanan, John J.			Accuracy, Stability, and Corrective Behavior in a Visuomotor Tracking Task: A Preliminary Study	PLOS ONE			English	Article							NONEQUILIBRIUM PHASE-TRANSITIONS; RHYTHMIC MOVEMENT COORDINATION; VISUAL-PERCEPTION; RELATIVE PHASE; DYNAMICS; SYNCHRONIZATION; FEEDBACK; MODEL	Visuomotor tracking tasks have been used to elucidate the underlying mechanisms that allow for the coordination of a movement to an environmental event. The main purpose of the present study was to examine the relationship between accuracy and stability of tracking performance and the amount of corrective movements that emerge for various coordination patterns in a unimanual visuomotor tracking task. Participants (N = 6) produced rhythmic elbow flexion-extension motions and were required to track an external sinusoidal signal at five different relative phases, 0 degrees, 45 degrees, 90 degrees, 135 degrees, and 180 degrees. Differential accuracy and stability were found among the five tracking patterns with the 0 degrees relative phase pattern being the most accurate and stable pattern. Corrective movements were correlated with changes in accuracy only for the 0 degrees relative phase pattern, with more corrections emerging for less accurate performance. The amount of corrective movements decreased as the stability of tracking performance increased for the 0 degrees, 45 degrees, and 135 degrees patterns. For the 90 degrees and 180 degrees tracking patterns, the amount of corrective movements was not correlated with pattern accuracy or pattern stability. The results demonstrate that corrective behaviors are an important motor process in maintaining the stability of stable perceptionaction coordination patterns, while offering little benefit for unstable perception-action patterns.	[Ryu, Young U.] Catholic Univ Daegu, Dept Phys Therapy, Gyongsan, South Korea; [Buchanan, John J.] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA	Catholic University of Daegu; Texas A&M University System; Texas A&M University College Station	Ryu, YU (corresponding author), Catholic Univ Daegu, Dept Phys Therapy, Gyongsan, South Korea.	ryuyounguk@gmail.com		Ryu, Young Uk/0000-0003-1601-4477	National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0006539]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0006539) awarded to YUR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham GP, 1999, PERCEPT PSYCHOPHYS, V61, P246, DOI 10.3758/BF03206886; Buekers MJ, 2000, NEUROSCI LETT, V290, P181, DOI 10.1016/S0304-3940(00)01350-1; BURGESSLIMERICK R, 1991, J MOTOR BEHAV, V23, P301, DOI 10.1080/00222895.1991.9942041; Ceux T, 2003, NEUROSCI LETT, V349, P103, DOI 10.1016/S0304-3940(03)00799-7; Craik KJW, 1947, B J PSYCHOL-GEN SECT, V38, P56, DOI 10.1111/j.2044-8295.1947.tb01141.x; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Mardia KV, 1972, FUNDAMENTALS EXPT DE; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; NOBLE M, 1955, J EXP PSYCHOL, V49, P249, DOI 10.1037/h0047910; Peper CLE, 1998, BIOL CYBERN, V79, P291, DOI 10.1007/s004220050479; Russell DM, 2001, J MOTOR BEHAV, V33, P329, DOI 10.1080/00222890109601918; Ryu YU, 2009, EXP BRAIN RES, V196, P279, DOI 10.1007/s00221-009-1847-9; SCHONER G, 1986, BIOL CYBERN, V53, P247, DOI 10.1007/BF00336995; SCHONER G, 1992, J MOTOR BEHAV, V24, P29, DOI 10.1080/00222895.1992.9941599; Snapp-Childs W, 2011, EXP BRAIN RES, V215, P89, DOI 10.1007/s00221-011-2874-x; Tallet J, 2008, J MOTOR BEHAV, V40, P103, DOI 10.3200/JMBR.40.2.103-116; Wickens CD, 1995, HUM FACTORS, V37, P474; Wilson AD, 2005, EXP BRAIN RES, V164, P517, DOI 10.1007/s00221-005-2272-3; Wilson AD, 2010, J EXP PSYCHOL HUMAN, V36, P1508, DOI 10.1037/a0020412; Wilson AD, 2010, EXP BRAIN RES, V205, P513, DOI 10.1007/s00221-010-2388-y; WIMMERS RH, 1992, HUM MOVEMENT SCI, V11, P217, DOI 10.1016/0167-9457(92)90062-G; Zaal FTJM, 2000, J EXP PSYCHOL HUMAN, V26, P1209, DOI 10.1037//0096-1523.26.3.1209; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403; Zanone PG, 1997, J EXP PSYCHOL HUMAN, V23, P1454, DOI 10.1037/0096-1523.23.5.1454	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38537	10.1371/journal.pone.0038537	http://dx.doi.org/10.1371/journal.pone.0038537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UU	22675574	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341700086
J	Adams, AC; Coskun, T; Rovira, ARI; Schneider, MA; Raches, DW; Micanovic, R; Bina, HA; Dunbar, JD; Kharitonenkov, A				Adams, Andrew C.; Coskun, Tamer; Rovira, Armando R. Irizarry; Schneider, Michael A.; Raches, David W.; Micanovic, Radmila; Bina, Holly A.; Dunbar, James D.; Kharitonenkov, Alexei			Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; KLOTHO GENE FAMILY; FACTOR RECEPTOR 4; BETA-KLOTHO; INSULIN-RESISTANCE; METABOLIC-ACTIVITY; PPAR-ALPHA; FIBROBLAST-GROWTH-FACTOR-21; OBESITY; MICE	Fibroblast growth factors 19 (FGF19) and 21 (FGF21) have emerged as key regulators of energy metabolism. Several studies have been conducted to understand the mechanism of FGF19 and FGF21 action, however, the data presented has often been inconsistent and at times contradictory. Here in a single study we compare the mechanisms mediating FGF19/FGF21 actions, and how similarities/differences in actions at the cellular level between these two factors translate to common/divergent physiological outputs. Firstly, we show that in cell culture FGF19/FGF21 are very similar, however, key differences are still observed differentiating the two. In vitro we found that both FGF's activate FGFRs in the context of beta Klotho (KLB) expression. Furthermore, both factors alter ERK phosphorylation and glucose uptake with comparable potency. Combination treatment of cells with both factors did not have additive effects and treatment with a competitive inhibitor, the FGF21 delta N17 mutant, also blocked FGF19' s effects, suggestive of a shared receptor activation mechanism. The key differences between FGF21/FGF19 were noted at the receptor interaction level, specifically the unique ability of FGF19 to bind/signal directly via FGFR4. To determine if differential effects on energy homeostasis and hepatic mitogenicity exist we treated DIO and ob/ob mice with FGF19/FGF21. We find comparable efficacy of the two proteins to correct body weight and serum glucose in both DIO and ob/ob mice. Nevertheless, FGF21 and FGF19 had distinctly different effects on proliferation in the liver. Interestingly, in vivo blockade of FGF21 signaling in mice using Delta N17 caused profound changes in glycemia indicative of the critical role KLB and FGF21 play in the regulation of glucose homeostasis. Overall, our data demonstrate that while subtle differences exist in vitro the metabolic effects in vivo of FGF19/FGF21 are indistinguishable, supporting a shared mechanism of action for these two hormones in the regulation of energy balance.	[Adams, Andrew C.; Coskun, Tamer; Rovira, Armando R. Irizarry; Schneider, Michael A.; Raches, David W.; Micanovic, Radmila; Bina, Holly A.; Dunbar, James D.; Kharitonenkov, Alexei] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly	Adams, AC (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA.	Kharitonenkov_Alexei@lilly.com	Coskun, Tamer/AAR-8422-2021	Adams, Andrew/0000-0002-7465-1856				Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, AM J PHYSL ENDOCRINO; Chen Gregory J, 2006, Recent Pat Cardiovasc Drug Discov, V1, P211, DOI 10.2174/157489006777442478; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Crissman JW, 2004, TOXICOL PATHOL, V32, P126, DOI 10.1080/01926230490268756; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Goetz R, 2012, MOL CELL BIOL; Hale C, 2012, ENDOCRINOLOGY, V153, P69, DOI 10.1210/en.2010-1262; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2008, CURR OPIN NEPHROL HY, V17, P368, DOI 10.1097/MNH.0b013e3282ffd994; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; Long YC, 2011, BBA-MOL BASIS DIS, V1812, P791, DOI 10.1016/j.bbadis.2011.04.002; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Motoda N, 2011, INT J ONCOL, V38, P133, DOI 10.3892/ijo_00000832; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Roidl A, 2009, CLIN CANCER RES, V15, P2058, DOI 10.1158/1078-0432.CCR-08-0890; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Wu XL, 2007, J BIOL CHEM, V282, P29069, DOI 10.1074/jbc.C700130200; Wu XL, 2012, J MOL BIOL, V418, P82, DOI 10.1016/j.jmb.2012.02.027; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu XL, 2010, J BIOL CHEM, V285, P5165, DOI 10.1074/jbc.M109.068783; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Yeoh JSG, 2007, MECH AGEING DEV, V128, P17, DOI 10.1016/j.mad.2006.11.005	42	85	88	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38438	10.1371/journal.pone.0038438	http://dx.doi.org/10.1371/journal.pone.0038438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675463	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500147
J	Duffield, GE; Mikkelsen, JD; Ebling, FJP				Duffield, Giles E.; Mikkelsen, Jens D.; Ebling, Francis J. P.			Conserved Expression of the Glutamate NMDA Receptor 1 Subunit Splice Variants during the Development of the Siberian Hamster Suprachiasmatic Nucleus	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MESSENGER-RNA; CIRCADIAN SYSTEM; GENE-EXPRESSION; PHOTIC REGULATION; NURSING MOTHERS; NERVOUS-SYSTEM; PHASE-SHIFTS; CLOCK GENES; RAT-BRAIN	Glutamate neurotransmission and the N-methyl-D-aspartate receptor (NMDAR) are central to photic signaling to the master circadian pacemaker located in the hypothalamic suprachiasmatic nucleus (SCN). NMDARs also play important roles in brain development including visual input circuits. The functional NMDAR is comprised of multiple subunits, but each requiring the NR1 subunit for normal activity. The NR1 can be alternatively spliced to produce isoforms that confer different functional properties on the NMDAR. The SCN undergoes extensive developmental changes during postnatal life, including synaptogenesis and acquisition of photic signaling. These changes are especially important in the highly photoperiodic Siberian hamster, in which development of sensitivity to photic cues within the SCN could impact early physiological programming. In this study we examined the expression of NR1 isoforms in the hamster at different developmental ages. Gene expression in the forebrain was quantified by in situ hybridization using oligonucleotide probes specific to alternatively spliced regions of the NR1 heteronuclear mRNA, including examination of anterior hypothalamus, piriform cortex, caudate-putamen, thalamus and hippocampus. Gene expression analysis within the SCN revealed the absence of the N1 cassette, the presence of the C2 cassette alone and the combined absence of C1 and C2 cassettes, indicating that the dominant splice variants are NR1-2a and NR1-4a. Whilst we observe changes at different developmental ages in levels of NR1 isoform probe hybridization in various forebrain structures, we find no significant changes within the SCN. This suggests that a switch in NR1 isoform does not underlie or is not produced by developmental changes within the hamster SCN. Consistency of the NR1 isoforms would ensure that the response of the SCN cells to photic signals remains stable throughout life, an important aspect of the function of the SCN as a responder to environmental changes in quality/quantity of light over the circadian day and annual cycle.	[Duffield, Giles E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Mikkelsen, Jens D.] Univ Copenhagen Hosp, Neurobiol Res Unit, Rigshosp, DK-2100 Copenhagen, Denmark; [Ebling, Francis J. P.] Univ Nottingham, Sch Med, Sch Biomed Sci, Nottingham, England	University of Notre Dame; Rigshospitalet; University of Copenhagen; University of Nottingham	Duffield, GE (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	duffield.2@nd.edu	Ebling, Francis/A-1900-2013; Ebling, Francis/Q-6193-2019	Ebling, Francis/0000-0002-7316-9582; Ebling, Francis/0000-0002-7316-9582	Medical Research Council; Lundbeck Foundation; NovoNordisk Foundation; University of Notre Dame; American Heart Association [10SDG4030011]; National Institute of General Medical Sciences [R01-GM087508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087508] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); University of Notre Dame; American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards from the Medical Research Council (Postgraduate studentship to GED), the Lundbeck Foundation (to JDM), the NovoNordisk Foundation (to JDM), the University of Notre Dame (to GED), the American Heart Association (10SDG4030011 to GED) and the National Institute of General Medical Sciences (R01-GM087508 to GED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendova Z, 2009, NEUROSCIENCE, V159, P599, DOI 10.1016/j.neuroscience.2009.01.016; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Campusano JM, 2005, NEUROCHEM RES, V30, P567, DOI 10.1007/s11064-005-2691-3; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; Colonnese MT, 2006, J COMP NEUROL, V494, P738, DOI 10.1002/cne.20841; Colwell CS, 2004, AM J PHYSIOL-REG I, V287, pR1194, DOI 10.1152/ajpregu.00268.2004; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cramer KS, 1996, PROG BRAIN RES, V108, P235, DOI 10.1016/S0079-6123(08)62543-1; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Duffield GE, 1998, J NEUROENDOCRINOL, V10, P871; DUFFIELD GE, 1995, EUR J NEUROSCI, V7, P1089, DOI 10.1111/j.1460-9568.1995.tb01096.x; Duffield GE, 1998, J BIOL RHYTHM, V13, P315, DOI 10.1177/074873098129000156; Duffield GE, 1999, J COMP NEUROL, V408, P73; DURAND GM, 1993, P NATL ACAD SCI USA, V90, P6731, DOI 10.1073/pnas.90.14.6731; EBLING FJP, 1994, GEN COMP ENDOCR, V95, P475, DOI 10.1006/gcen.1994.1147; Ebling FJP, 1996, PROG NEUROBIOL, V50, P109, DOI 10.1016/S0301-0082(96)00032-9; EBLING FJP, 1995, J NEUROENDOCRINOL, V7, P555, DOI 10.1111/j.1365-2826.1995.tb00792.x; Ebling FJP, 2010, MOL CELL ENDOCRINOL, V324, P95, DOI 10.1016/j.mce.2010.03.018; El-Hennamy R, 2008, J BIOL RHYTHM, V23, P435, DOI 10.1177/0748730408322635; GANNON RL, 1994, MOL BRAIN RES, V23, P338, DOI 10.1016/0169-328X(94)90244-5; Ghosh PK, 1997, DEV BRAIN RES, V102, P1, DOI 10.1016/S0165-3806(97)00066-7; Golombek DA, 2004, NEUROCHEM INT, V45, P929, DOI 10.1016/j.neuint.2004.03.023; Grosse J, 1999, BRAIN RES BULL, V48, P185, DOI 10.1016/S0361-9230(98)00162-2; HARTGRAVES MD, 1994, BRAIN RES, V640, P113, DOI 10.1016/0006-8993(94)91863-5; Hastings MH, 1998, CHRONOBIOL INT, V15, P425, DOI 10.3109/07420529808998700; HOFER M, 1994, PROG BRAIN RES, V102, P277; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; HORTON TH, 1990, BIOL REPROD, V42, P441, DOI 10.1095/biolreprod42.3.441; ISHIDA N, 1994, NEUROSCI LETT, V166, P211, DOI 10.1016/0304-3940(94)90488-X; IVELL R, 1984, P NATL ACAD SCI-BIOL, V81, P2006, DOI 10.1073/pnas.81.7.2006; JENSEN AM, 1993, J NEUROSCI, V13, P1664; KAUFMAN CM, 1994, BRAIN RES, V633, P162, DOI 10.1016/0006-8993(94)91535-0; Kennaway DJ, 2002, TRENDS ENDOCRIN MET, V13, P398, DOI 10.1016/S1043-2760(02)00692-6; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kovacikova Z, 2006, J BIOL RHYTHM, V21, P140, DOI 10.1177/0748730405285876; KUS L, 1995, MOL BRAIN RES, V28, P55, DOI 10.1016/0169-328X(94)00179-I; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LEE TM, 1989, BIOL REPROD, V40, P495, DOI 10.1095/biolreprod40.3.495; Llansola M, 2004, J NEUROCHEM, V91, P591, DOI 10.1111/j.1471-4159.2004.02730.x; Manta G, 2011, NEUROCHEM RES, V36, P1417, DOI 10.1007/s11064-011-0467-5; Mateju K, 2009, EUR J NEUROSCI, V29, P490, DOI 10.1111/j.1460-9568.2009.06609.x; McNulty S, 1998, EUR J NEUROSCI, V10, P1063, DOI 10.1046/j.1460-9568.1998.00114.x; MIKKELSEN JD, 1993, BRAIN RES, V632, P329, DOI 10.1016/0006-8993(93)91171-N; MIKKELSEN JD, 1995, NEUROCHEM INT, V27, P263, DOI 10.1016/0197-0186(95)00039-B; Miskevich F, 2006, J NEUROSCI METH, V152, P65, DOI 10.1016/j.jneumeth.2005.08.010; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOORE RY, 1989, RES PERINATAL MED, V9, P1; MORIN LP, 1994, BRAIN RES REV, V19, P102, DOI 10.1016/0165-0173(94)90005-1; Moriya T, 2000, MOL PHARMACOL, V58, P1554, DOI 10.1124/mol.58.6.1554; Muller C, 1998, DEV BRAIN RES, V110, P203, DOI 10.1016/S0165-3806(98)00108-4; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; NISHIZAWA M, 1985, FEBS LETT, V183, P55, DOI 10.1016/0014-5793(85)80953-4; Ohta H, 2003, EUR J NEUROSCI, V17, P1628, DOI 10.1046/j.1460-9568.2003.02584.x; Ohta H, 2002, EUR J NEUROSCI, V15, P1953, DOI 10.1046/j.1460-9568.2002.02016.x; Okabe S, 1999, J NEUROSCI, V19, P7781; PETRALIA RS, 1994, J NEUROSCI, V14, P667; RAUSCHECKER JP, 1991, PHYSIOL REV, V71, P587, DOI 10.1152/physrev.1991.71.2.587; SATO K, 1995, NEUROSCIENCE, V64, P459, DOI 10.1016/0306-4522(94)00335-3; Schurov IL, 1999, J NEUROENDOCRINOL, V11, P43; Smolen AJ, 1990, IN SITU HYBRIDIZATIO, P175; SPEH JC, 1993, DEV BRAIN RES, V76, P171, DOI 10.1016/0165-3806(93)90205-O; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; Sumova A, 2006, FEBS LETT, V580, P2836, DOI 10.1016/j.febslet.2006.03.023; THOMAS KL, 1994, NEUROREPORT, V6, P119, DOI 10.1097/00001756-199412300-00031; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; VANDENPOL AN, 1994, J COMP NEUROL, V343, P428, DOI 10.1002/cne.903430307; VANDENPOL AN, 1994, J NEUROSCI, V14, P3816; Varcoe TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018504; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WATANABE M, 1993, J COMP NEUROL, V338, P377, DOI 10.1002/cne.903380305; WEAVER DR, 1995, MOL BRAIN RES, V33, P136, DOI 10.1016/0169-328X(95)00117-B; Weaver DR, 1989, RES PERINATAL MED, P209; Weiss SW, 1998, J NEUROSCI, V18, P1725; Young III WS, 1986, IN SITU HYBRIDIZATIO, P243; Zhao JP, 2006, J NEUROSCI, V26, P12647, DOI 10.1523/JNEUROSCI.3678-06.2006; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	81	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37496	10.1371/journal.pone.0037496	http://dx.doi.org/10.1371/journal.pone.0037496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675426	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500039
J	Sharp, JA; Echague, CG; Hair, PS; Ward, MD; Nyalwidhe, JO; Geoghegan, JA; Foster, TJ; Cunnion, KM				Sharp, Julia A.; Echague, Charlene G.; Hair, Pamela S.; Ward, Michael D.; Nyalwidhe, Julius O.; Geoghegan, Joan A.; Foster, Timothy J.; Cunnion, Kenji M.			Staphylococcus aureus Surface Protein SdrE Binds Complement Regulator Factor H as an Immune Evasion Tactic	PLOS ONE			English	Article							FACTOR-I; CLUMPING FACTOR; BORRELIA-BURGDORFERI; ACQUISITION; ACTIVATION; CLEAVAGE; PATHOGENS; FAMILY; C3B; FHL-1/RECONECTIN	Similar to other highly successful invasive bacterial pathogens, Staphylococcus aureus recruits the complement regulatory protein factor H (fH) to its surface to inhibit the alternative pathway of complement. Here, we report the identification of the surface-associated protein SdrE as a fH-binding protein using purified fH overlay of S. aureus fractionated cell wall proteins and fH cross-linking to S. aureus followed by mass spectrometry. Studies using recombinant SdrE revealed that rSdrE bound significant fH whether from serum or as a purified form, in both a time- and dose-dependent manner. Furthermore, rSdrE-bound fH exhibited cofactor functionality for factor I (fI)-mediated cleavage of C3b to iC3b which correlated positively with increasing amounts of fH. Expression of SdrE on the surface of the surrogate bacterium Lactococcus lactis enhanced recruitment of fH which resulted in increased iC3b generation. Moreover, surface expression of SdrE led to a reduction in C3-fragment deposition, less C5a generation, and reduced killing by polymorphonuclear cells. Thus, we report the first identification of a S. aureus protein associated with the staphylococcal surface that binds factor H as an immune evasion mechanism.	[Sharp, Julia A.; Echague, Charlene G.; Hair, Pamela S.; Nyalwidhe, Julius O.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Ward, Michael D.; Nyalwidhe, Julius O.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Geoghegan, Joan A.; Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland; [Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA USA; [Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA USA	Eastern Virginia Medical School; Eastern Virginia Medical School; Trinity College Dublin	Sharp, JA (corresponding author), Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA.	sharpja@evms.edu		Geoghegan, Joan/0000-0002-3788-0668	National Institutes of Health [R21AI082398]; Science Foundation Ireland Programme Investigator grant [08/IN.1/B1845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland Programme Investigator grant(Science Foundation Ireland); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health: R21AI082398 (www.nih.gov) to KM Cunnion and by Science Foundation Ireland Programme Investigator grant 08/IN.1/B1845 to TJ Foster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bestebroer J, 2010, CELL MICROBIOL, V12, P1506, DOI 10.1111/j.1462-5822.2010.01486.x; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; CHEUNG AL, 1988, INFECT IMMUN, V56, P1061, DOI 10.1128/IAI.56.5.1061-1065.1988; Cunnion KM, 2005, J LAB CLIN MED, V146, P279, DOI 10.1016/j.lab.2005.07.001; Cunnion KM, 2004, INFECT IMMUN, V72, P2858, DOI 10.1128/IAI.72.5.2858-2863.2004; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Liszewski MK, 2008, VACCINE, V26, pI22, DOI 10.1016/j.vaccine.2008.11.001; Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Pandiripally V, 2002, INFECT IMMUN, V70, P6206, DOI 10.1128/IAI.70.11.6206-6214.2002; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Sharp JA, 2011, MOL IMMUNOL, V48, P683, DOI 10.1016/j.molimm.2010.11.014; Sitkiewicz I, 2010, ANTON LEEUW INT J G, V99, P409; Smith EJ, 2011, INFECT IMMUN; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971; Zipfel PF, 1999, IMMUNOL TODAY, V20, P135, DOI 10.1016/S0167-5699(98)01432-7	43	74	76	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38407	10.1371/journal.pone.0038407	http://dx.doi.org/10.1371/journal.pone.0038407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675461	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338500145
J	Goodwin, R; Takahashi, M; Sun, SJ; Gaines, SO				Goodwin, Robin; Takahashi, Masahito; Sun, Shaojing; Gaines, Stanley O., Jr.			Modelling Psychological Responses to the Great East Japan Earthquake and Nuclear Incident	PLOS ONE			English	Article							NIIGATA-CHUETSU EARTHQUAKE; MENTAL-HEALTH-CARE; RISK PERCEPTIONS; COMMUNITY; DISTRESS; DISASTER; VALUES; ATTRIBUTIONS; INFORMATION; EXPOSURE	The Great East Japan (Tohoku/Kanto) earthquake of March 2011 was followed by a major tsunami and nuclear incident. Several previous studies have suggested a number of psychological responses to such disasters. However, few previous studies have modelled individual differences in the risk perceptions of major events, or the implications of these perceptions for relevant behaviours. We conducted a survey specifically examining responses to the Great Japan earthquake and nuclear incident, with data collected 11-13 weeks following these events. 844 young respondents completed a questionnaire in three regions of Japan; Miyagi (close to the earthquake and leaking nuclear plants), Tokyo/Chiba (approximately 220 km from the nuclear plants), and Western Japan (Yamaguchi and Nagasaki, some 1000 km from the plants). Results indicated significant regional differences in risk perception, with greater concern over earthquake risks in Tokyo than in Miyagi or Western Japan. Structural equation analyses showed that shared normative concerns about earthquake and nuclear risks, conservation values, lack of trust in governmental advice about the nuclear hazard, and poor personal control over the nuclear incident were positively correlated with perceived earthquake and nuclear risks. These risk perceptions further predicted specific outcomes (e. g. modifying homes, avoiding going outside, contemplating leaving Japan). The strength and significance of these pathways varied by region. Mental health and practical implications of these findings are discussed in the light of the continuing uncertainties in Japan following the March 2011 events.	[Goodwin, Robin; Gaines, Stanley O., Jr.] Brunel Univ, Sch Social Sci, Dept Psychol, Uxbridge UB8 3PH, Middx, England; [Takahashi, Masahito] Yamaguchi Univ, Fac Humanities, Yamaguchi, Japan; [Sun, Shaojing] Fudan Univ, Sch Journalism, Shanghai 200433, Peoples R China	Brunel University; Yamaguchi University; Fudan University	Goodwin, R (corresponding author), Brunel Univ, Sch Social Sci, Dept Psychol, Uxbridge UB8 3PH, Middx, England.	robin.goodwin@brunel.ac.uk						[Anonymous], 2011, REUTERS; [Anonymous], 2011, NEW SCI; [Anonymous], 2011, WASHINGTON POST 0324; Bardi A, 2011, J CROSS CULT PSYCHOL, V42, P271, DOI 10.1177/0022022110396916; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Chang EC, 2001, J PERS SOC PSYCHOL, V81, P476, DOI 10.1037/0022-3514.81.3.476; Cowan J, 2002, ASIAN J SOC PSYCHOL, V5, P169, DOI 10.1111/1467-839X.00102; Dumont M, 2003, PERS SOC PSYCHOL B, V29, P1509, DOI 10.1177/0146167203256923; Frink DD, 2004, J APPL SOC PSYCHOL, V34, P85, DOI 10.1111/j.1559-1816.2004.tb02538.x; Furukawa K, 2011, J NEUROL, DOI [10.1007/s00415-0110-6329-x, DOI 10.1007/S00415-0110-6329-X]; Gierlach E, 2010, RISK ANAL, V30, P1539, DOI 10.1111/j.1539-6924.2010.01451.x; Goodwin R, 2011, INT J BEHAV MED, V18, P88, DOI 10.1007/s12529-010-9083-z; Goto Toyomi, 2003, Trauma Violence Abuse, V4, P195, DOI 10.1177/1524838003004003001; Hatfield E., 1994, REV PERSONALITY SOCI; Hine DW, 1997, RISK ANAL, V17, P293, DOI 10.1111/j.1539-6924.1997.tb00867.x; Hobfoll SE, 2001, APPL PSYCHOL-INT REV, V50, P337, DOI 10.1111/1464-0597.00062; Jonas E, 2003, PERS SOC PSYCHOL B, V29, P1181, DOI 10.1177/0146167203254599; Kaniasty K., 2004, BIOTERRORISM PSYCHOL, P200, DOI DOI 10.1056/NEJM200506163522421; Kasperson J.X., 2003, SOC CONTOURS RISK, p217.; Kim J, 2008, J APPL SOC PSYCHOL, V38, P2821, DOI 10.1111/j.1559-1816.2008.00415.x; Kim Y, 2011, GUIDELINE LOCAL MENT; Kim Y, 2011, PSYCHIAT CLIN NEUROS, V65, P539, DOI 10.1111/j.1440-1819.2011.02270.x; Kim Y, 2011, LANCET, V378, P317, DOI 10.1016/S0140-6736(11)61169-0; Kline RB, 2005, PRINCIPLES PRACTICE; Kuwabara H, 2008, PSYCHIAT CLIN NEUROS, V62, P503, DOI 10.1111/j.1440-1819.2008.01842.x; Kwon Y S, 2001, Environ Health Prev Med, V6, P97, DOI 10.1007/BF02897953; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Lindeman M, 2005, J PERS ASSESS, V85, P170, DOI 10.1207/s15327752jpa8502_09; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; McClure J, 1999, APPL PSYCHOL-INT REV, V48, P239, DOI 10.1080/026999499377637; McClure J, 2007, ASIAN J SOC PSYCHOL, V10, P233, DOI 10.1111/j.1467-839X.2007.00232.x; McClure J, 2007, J APPL SOC PSYCHOL, V37, P1956, DOI 10.1111/j.1559-1816.2007.00245.x; Meguro K, 2011, NEUROLOGY, V77, pE12, DOI 10.1212/WNL.0b013e31822511a5; Miyadai S, 2011, ESCAPE SOC BASED NUC; National Police Agency of Japan, 2012, DAM SIT POL COUNT AS; Nishio A, 2009, PSYCHIAT CLIN NEUROS, V63, P247, DOI 10.1111/j.1440-1819.2009.01942.x; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; Oyama Mari, 2012, Environmental Health and Preventive Medicine, V17, P118, DOI 10.1007/s12199-011-0225-y; Piotrkowski CS, 2002, AM J ORTHOPSYCHIAT, V72, P476, DOI 10.1037//0002-9432.72.4.476; Rencher AC, 2002, METHODS MULTIVARIATE; Satomi S, 2011, SURG TODAY, V41, P1171, DOI 10.1007/s00595-011-4587-y; Schwartz SH, 2000, J PERS, V68, P309, DOI 10.1111/1467-6494.00099; Seo M, 2011, COMMUN RES, DOI 10.11.1177/0093650210388407; Silove D, 2010, J TRAUMA STRESS, V23, P151, DOI 10.1002/jts.20499; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Sullivan H. S., 1953, INTERPERSONAL THEORY; Suzuki Y, 2011, LANCET, V378, P317, DOI 10.1016/S0140-6736(11)61168-9; Suzuki Y, 2011, J EPIDEMIOL, V21, P144, DOI 10.2188/jea.JE20100093; Takahashi M, 2012, MEDIA EFFECTS RISK B; Toyabe S, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-230; Triandis H. C., 1995, INDIVIDUALISM COLLEC, DOI 10.4324/9780429499845; US Geological Survey, 2011, GREAT TOH EARTHQ NE; Valeo T, 2011, NEUROL TODAY, V21, P10; VAUGHAN E, 1993, HEALTH PSYCHOL, V12, P74, DOI 10.1037/0278-6133.12.1.74; Wilson JP, 1989, TRAUMA TRANSFORMATIO; Yamamoto T, 2011, LANCET, V378, P318, DOI 10.1016/S0140-6736(11)61170-7	57	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37690	10.1371/journal.pone.0037690	http://dx.doi.org/10.1371/journal.pone.0037690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666380	Green Published, gold			2022-12-27	WOS:000305353400039
J	Honda, T; Hirashima, M; Nozaki, D				Honda, Takuya; Hirashima, Masaya; Nozaki, Daichi			Adaptation to Visual Feedback Delay Influences Visuomotor Learning	PLOS ONE			English	Article							CEREBELLAR CONTRIBUTIONS; SENSORIMOTOR CONTROL; RHYTHMIC MOVEMENTS; SENSORY PREDICTION; REACHING MOVEMENTS; PRISM ADAPTATION; MOTOR ADAPTATION; ERROR-CORRECTION; VOLUNTARY ACTION; SMITH PREDICTOR	Computational theory of motor control suggests that the brain continuously monitors motor commands, to predict their sensory consequences before actual sensory feedback becomes available. Such prediction error is a driving force of motor learning, and therefore appropriate associations between motor commands and delayed sensory feedback signals are crucial. Indeed, artificially introduced delays in visual feedback have been reported to degrade motor learning. However, considering our perceptual ability to causally bind our own actions with sensory feedback, demonstrated by the decrease in the perceived time delay following repeated exposure to an artificial delay, we hypothesized that such perceptual binding might alleviate deficits of motor learning associated with delayed visual feedback. Here, we evaluated this hypothesis by investigating the ability of human participants to adapt their reaching movements in response to a novel visuomotor environment with 3 visual feedback conditions-no-delay, sudden-delay, and adapted-delay. To introduce novelty into the trials, the cursor position, which originally indicated the hand position in baseline trials, was rotated around the starting position. In contrast to the no-delay condition, a 200-ms delay was artificially introduced between the cursor and hand positions during the presence of visual rotation (sudden-delay condition), or before the application of visual rotation (adapted-delay condition). We compared the learning rate (representing how the movement error modifies the movement direction in the subsequent trial) between the 3 conditions. In comparison with the no-delay condition, the learning rate was significantly degraded for the sudden-delay condition. However, this degradation was significantly alleviated by prior exposure to the delay (adapted-delay condition). Our data indicate the importance of appropriate temporal associations between motor commands and sensory feedback in visuomotor learning. Moreover, they suggest that the brain is able to account for such temporal associations in a flexible manner.	[Honda, Takuya; Hirashima, Masaya; Nozaki, Daichi] Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan; [Honda, Takuya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science	Honda, T (corresponding author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan.	nozaki@p.u-tokyo.ac.jp		Nozaki, Daichi/0000-0002-1338-8337	Japan Society for the Promotion of Science [22-9430]; Funding Program for Next Generation World-Leading Researchers [LS034];  [20670008]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This research was supported by Grants-in-Aid for Research Fellow of the Japan Society for the Promotion of Science (#22-9430) to TH and by Grants-in-Aid for Young Scientists (#20670008) and the Funding Program for Next Generation World-Leading Researchers (#LS034) to DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard C, 1999, EXP BRAIN RES, V125, P410, DOI 10.1007/s002210050697; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; COOKE JD, 1984, J MOTOR BEHAV, V16, P348; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Fine MS, 2006, J NEUROPHYSIOL, V96, P710, DOI 10.1152/jn.00215.2006; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Haggard P, 2003, CONSCIOUS COGN, V12, P695, DOI 10.1016/S1053-8100(03)00052-7; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; HELD R, 1963, SCIENCE, V142, P455, DOI 10.1126/science.142.3591.455; Heron J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007681; Hinder MR, 2008, BRAIN RES, V1197, P123, DOI 10.1016/j.brainres.2007.12.067; Hinder MR, 2010, EXP BRAIN RES, V201, P191, DOI 10.1007/s00221-009-2025-9; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; Huang VS, 2009, J NEUROPHYSIOL, V102, P931, DOI 10.1152/jn.00237.2009; Ikegami T, 2012, J NEUROSCI, V32, P653, DOI 10.1523/JNEUROSCI.4230-11.2012; Ikegami T, 2010, J NEUROSCI, V30, P4515, DOI 10.1523/JNEUROSCI.3066-09.2010; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Kasuga S, 2011, J NEUROPHYSIOL, V106, P1218, DOI 10.1152/jn.00278.2011; Kawato M, 2002, HDB BRAIN THEORY NEU; KITAZAWA S, 1995, J NEUROSCI, V15, P7644; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Ljung L., SYSTEM IDENTIFICATIO; Malfait N, 2004, J NEUROSCI, V24, P8084, DOI 10.1523/JNEUROSCI.1742-04.2004; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Miall RC, 2006, EXP BRAIN RES, V172, P77, DOI 10.1007/s00221-005-0306-5; Miall RC, 2007, PLOS BIOL, V5, P2733, DOI 10.1371/journal.pbio.0050316; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; Saijo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009399; Saunders JA, 2005, EXP BRAIN RES, V162, P458, DOI 10.1007/s00221-004-2064-1; Shabbott BA, 2010, EXP BRAIN RES, V203, P75, DOI 10.1007/s00221-010-2209-3; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Synofzik M, 2006, J NEUROPHYSIOL, V96, P1592, DOI 10.1152/jn.00104.2006; Tanaka H, 2011, EXP BRAIN RES, V208, P257, DOI 10.1007/s00221-010-2476-z; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wei YJ, 2005, IEEE INT CONF ROBOT, P4406; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009	51	47	47	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37900	10.1371/journal.pone.0037900	http://dx.doi.org/10.1371/journal.pone.0037900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666408	Green Submitted, gold, Green Published			2022-12-27	WOS:000305353400056
J	Padgham, M				Padgham, Mark			Human Movement Is Both Diffusive and Directed	PLOS ONE			English	Article							TRAVEL BEHAVIOR; MOBILITY; MODEL; LAWS	Understanding the influence of the built environment on human movement requires quantifying spatial structure in a general sense. Because of the difficulty of this task, studies of movement dynamics often ignore spatial heterogeneity and treat movement through journey lengths or distances alone. This study analyses public bicycle data from central London to reveal that, although journey distances, directions, and frequencies of occurrence are spatially variable, their relative spatial patterns remain largely constant, suggesting the influence of a fixed spatial template. A method is presented to describe this underlying space in terms of the relative orientation of movements toward, away from, and around locations of geographical or cultural significance. This produces two fields: one of convergence and one of divergence, which are able to accurately reconstruct the observed spatial variations in movement. These two fields also reveal categorical distinctions between shorter journeys merely serving diffusion away from significant locations, and longer journeys intentionally serving transport between spatially distinct centres of collective importance. Collective patterns of human movement are thus revealed to arise from a combination of both diffusive and directed movement, with aggregate statistics such as mean travel distances primarily determined by relative numbers of these two kinds of journeys.	Univ New England, Dept Geog & Planning, Armidale, NSW 2351, Australia	University of New England	Padgham, M (corresponding author), Univ New England, Dept Geog & Planning, Armidale, NSW 2351, Australia.	mark.padgham@email.com						[Anonymous], 2011, GUARDIAN NEWSPAPER; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Belik V., 2009, P INT C COMP SCI ENG, P932, DOI DOI 10.1109/CSE.2009.432; Benhamou S, 1997, BEHAV PROCESS, V40, P149, DOI 10.1016/S0376-6357(97)00775-4; Benhamou S, 2006, ECOLOGY, V87, P518, DOI 10.1890/05-0495; Borgnat P, 2011, ADV COMPLEX SYST, V14, P415, DOI 10.1142/S0219525911002950; Boyer D, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434015; Boyer D, 2011, J ROYAL SOC INTERFAC; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockmann D, 2008, IEEE PERVAS COMPUT, V7, P28, DOI 10.1109/MPRV.2008.77; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; De Montis A, 2007, ENVIRON PLANN B, V34, P905, DOI 10.1068/b32128; Ewing R, 2001, TRANSPORT RES REC, P87, DOI 10.3141/1780-10; Froehlich J, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1420; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Green N, 2007, URBAN STUD, V44, P2077, DOI 10.1080/00420980701518941; Handy S, 2005, TRANSPORT RES D-TR E, V10, P427, DOI 10.1016/j.trd.2005.05.002; HANKIN BD, 1958, OPER RES QUART, V9, P81, DOI 10.2307/3006732; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; HENDERSON LF, 1971, NATURE, V229, P381, DOI 10.1038/229381a0; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Kolbl R, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/348; Kurant M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138701; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Miller HJ, 2010, J REGIONAL SCI, V50, P181, DOI 10.1111/j.1467-9787.2009.00641.x; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; Mueller T, 2011, THEOR ECOL-NETH, V4, P341, DOI 10.1007/s12080-010-0081-1; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Sauer Carl O., 1925, GEOGRAPHY, V2, P19; Sevtsuk A, 2010, J URBAN TECHNOL, V17, P41, DOI 10.1080/10630731003597322; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Sun JB, 2011, PHYSICA A, V390, P929, DOI 10.1016/j.physa.2010.10.033; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Transport for London (TfL), PASS DAT YEAR 2010; Vuilleumier S, 2006, ECOL MODEL, V190, P159, DOI 10.1016/j.ecolmodel.2005.04.017	43	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37754	10.1371/journal.pone.0037754	http://dx.doi.org/10.1371/journal.pone.0037754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666388	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400047
J	Sandhu, G; Battaglia, F; Ely, BK; Athanasakis, D; Montoya, R; Valencia, T; Gilman, RH; Evans, CA; Friedland, JS; Fernandez-Reyes, D; Agranoff, DD				Sandhu, Gurjinder; Battaglia, Francesca; Ely, Barry K.; Athanasakis, Dimitrios; Montoya, Rosario; Valencia, Teresa; Gilman, Robert H.; Evans, Carlton A.; Friedland, Jon S.; Fernandez-Reyes, Delmiro; Agranoff, Daniel D.			Discriminating Active from Latent Tuberculosis in Patients Presenting to Community Clinics	PLOS ONE			English	Article							SELDI-TOF-MS; POTENTIAL BIOMARKERS; DIAGNOSTIC-TEST; SKIN-TEST; GAMMA; TB; STRATEGIES; INFARCTION; PROTEOMICS; DISCOVERY	Background: Because of the high global prevalence of latent TB infection (LTBI), a key challenge in endemic settings is distinguishing patients with active TB from patients with overlapping clinical symptoms without active TB but with coexisting LTBI. Current methods are insufficiently accurate. Plasma proteomic fingerprinting can resolve this difficulty by providing a molecular snapshot defining disease state that can be used to develop point-of-care diagnostics. Methods: Plasma and clinical data were obtained prospectively from patients attending community TB clinics in Peru and from household contacts. Plasma was subjected to high-throughput proteomic profiling by mass spectrometry. Statistical pattern recognition methods were used to define mass spectral patterns that distinguished patients with active TB from symptomatic controls with or without LTBI. Results: 156 patients with active TB and 110 symptomatic controls (patients with respiratory symptoms without active TB) were investigated. Active TB patients were distinguishable from undifferentiated symptomatic controls with accuracy of 87% (sensitivity 84%, specificity 90%), from symptomatic controls with LTBI (accuracy of 87%, sensitivity 89%, specificity 82%) and from symptomatic controls without LTBI (accuracy 90%, sensitivity 90%, specificity 92%). Conclusions: We show that active TB can be distinguished accurately from LTBI in symptomatic clinic attenders using a plasma proteomic fingerprint. Translation of biomarkers derived from this study into a robust and affordable point-of-care format will have significant implications for recognition and control of active TB in high prevalence settings.	[Sandhu, Gurjinder; Evans, Carlton A.; Friedland, Jon S.; Agranoff, Daniel D.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [Sandhu, Gurjinder; Evans, Carlton A.; Friedland, Jon S.; Agranoff, Daniel D.] Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Ctr Clin Trop Med, London, England; [Battaglia, Francesca; Ely, Barry K.; Athanasakis, Dimitrios; Fernandez-Reyes, Delmiro] Natl Inst Med Res, Div Parasitol, Med Res Council, London NW7 1AA, England; [Gilman, Robert H.; Evans, Carlton A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Montoya, Rosario; Gilman, Robert H.] Univ Peruana Cayetano Heredia, Assoc Benef PRISMA, San Miguel Lab Invest Enfermedades Infecciosas, Lima, Peru; [Valencia, Teresa; Gilman, Robert H.; Evans, Carlton A.] Univ Peruana Cayetano Heredia, Fac Sci & Philosophy, Lima, Peru	Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Sandhu, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England.	dfernan@nimr.mrc.ac.uk; d.agranoff@imperial.ac.uk	Evans, Carlton/AAI-1653-2020	Evans, Carlton/0000-0002-6873-5447; Friedland, Jonathan S/0000-0001-7789-9649; Montoya Villanueva, Maria del Rosario/0000-0001-8692-9475; Fernandez-Reyes, Delmiro/0000-0001-5070-9198	Wellcome Trust; DFID Civil Society Challenge Fund; Innovation For Health And Development (IFHAD); Foundation for Innovative New Diagnostics (FIND); UK Medical Research Council; National Institute of Health Biomedical Research Centre at Imperial College; Medical Research Council [MC_U117585869, MR/K007467/1] Funding Source: researchfish; MRC [MC_U117585869, MR/K007467/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); DFID Civil Society Challenge Fund; Innovation For Health And Development (IFHAD); Foundation for Innovative New Diagnostics (FIND); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Biomedical Research Centre at Imperial College; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research and members of the project team were supported by the Wellcome Trust, the DFID Civil Society Challenge Fund, the Innovation For Health And Development (IFHAD), the Foundation for Innovative New Diagnostics (FIND) and UK Medical Research Council. G. S. was a Wellcome Trust Clinical Tropical Research Training Fellow (0783404/Z4/05/Z). J.S.F. and C. E. were in part supported by the Wellcome Trust. J.S.F. and D. A. are grateful for support from the National Institute of Health Biomedical Research Centre at Imperial College. D.F.-R. is supported by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration USDaF, 2009, FDA CLEARS TEST OV C; Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Bamford ARJ, 2010, ARCH DIS CHILD, V95, P180, DOI 10.1136/adc.2009.169805; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Engwegen JYMN, 2006, TRENDS PHARMACOL SCI, V27, P251, DOI 10.1016/j.tips.2006.03.003; Fung ET, 2010, CLIN CHEM, V56, P327, DOI 10.1373/clinchem.2009.140855; Fung ET, 2000, CURR OPIN MOL THER, V2, P643; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hodgetts A, 2007, FUTURE MICROBIOL, V2, P35, DOI 10.2217/17460913.2.1.35; Hong M, 2009, THROMB RES, V123, P556, DOI 10.1016/j.thromres.2008.05.019; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pang RTK, 2006, CLIN CHEM, V52, P421, DOI 10.1373/clinchem.2005.061689; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; Pinet F, 2008, PROTEOMICS, V8, P1798, DOI 10.1002/pmic.200700781; Sanghavi DM, 1998, AM J EPIDEMIOL, V148, P384, DOI 10.1093/oxfordjournals.aje.a009657; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; World Health Organization, 2008, GLOB TUB CONTR SURV; Wu C, 2009, J GASTROEN HEPATOL, V24, P55, DOI 10.1111/j.1440-1746.2008.05580.x; Wu FX, 2009, CANCER LETT, V279, P163, DOI 10.1016/j.canlet.2009.01.034; Yi R, 2004, PROTEOMICS, V4, P3477, DOI 10.1002/pmic.200400897; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; Zhang XP, 2008, AM J CLIN PATHOL, V130, P299, DOI 10.1309/CA242R5VY14HUGE8	31	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38080	10.1371/journal.pone.0038080	http://dx.doi.org/10.1371/journal.pone.0038080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666453	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305353400079
J	Fujimura, Y; Sumida, M; Sugihara, K; Tsukamoto, S; Yamada, K; Tachibana, H				Fujimura, Yoshinori; Sumida, Mami; Sugihara, Kaori; Tsukamoto, Shuntaro; Yamada, Koji; Tachibana, Hirofumi			Green Tea Polyphenol EGCG Sensing Motif on the 67-kDa Laminin Receptor	PLOS ONE			English	Article							EPSILON-RI EXPRESSION; (-)-EPIGALLOCATECHIN GALLATE; BINDING PROTEIN; PRION PROTEIN; CELLS; CANCER; PRECURSOR; VIRUS; EPIGALLOCATECHIN-3-O-GALLATE; PATHWAY	Background: We previously identified the 67-kDa laminin receptor (67LR) as the cell-surface receptor conferring the major green tea polyphenol (-)-epigallocatechin-3-O-gallate (EGCG) responsiveness to cancer cells. However, the underlying mechanism for interaction between EGCG and 67LR remains unclear. In this study, we investigated the possible role of EGCG-67LR interaction responsible for its bioactivities. Methodology/Principal Findings: We synthesized various peptides deduced from the extracellular domain corresponding to the 102-295 region of human 67LR encoding a 295-amino acid. The neutralizing activity of these peptides toward EGCG cell-surface binding and inhibition of cancer cell growth were assayed. Both activities were inhibited by a peptide containing the 10-amino acid residues, IPCNNKGAHS, corresponding to residues 161-170. Furthermore, mass spectrometric analysis revealed the formation of a EGCG-LR161-170 peptide complex. A study of the amino acid deletion/replacement of the peptide LR161-170 indicated that the 10-amino acid length and two basic amino acids, K-166 and H-169, have a critical role in neutralizing EGCG's activities. Moreover, neutralizing activity against the anti-proliferation action of EGCG was observed in a recombinant protein of the extracellular domain of 67LR, and this effect was abrogated by a deletion of residues 161-170. These findings support that the 10 amino-acid sequence, IPCNNKGAHS, might be the functional domain responsible for the anti-cancer activity of EGCG. Conclusions/Significance: Overall, our results highlight the nature of the EGCG-67LR interaction and provide novel structural insights into the understanding of 67LR-mediated functions of EGCG, and could aid in the development of potential anti-cancer compounds for chemopreventive or therapeutic uses that can mimic EGCG-67LR interactions.	[Fujimura, Yoshinori; Tachibana, Hirofumi] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan; [Sumida, Mami; Sugihara, Kaori; Tsukamoto, Shuntaro; Yamada, Koji; Tachibana, Hirofumi] Fac Agr, Dept Biosci & Biotechnol, Fukuoka, Japan; [Tachibana, Hirofumi] Kyushu Univ, Bioarchitecture Ctr, Fukuoka 812, Japan	Kyushu University; Kyushu University	Fujimura, Y (corresponding author), Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan.	tatibana@agr.kyushu-u.ac.jp	Fujimura, Yoshinori/AAG-4403-2019	Fujimura, Yoshinori/0000-0003-0798-0649	Scientific Research (S) [22228002]	Scientific Research (S)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (S) (Grant 22228002) (to HT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Byun EH, 2011, FEBS LETT, V585, P814, DOI 10.1016/j.febslet.2011.02.010; Cao D, 2009, RAPID COMMUN MASS SP, V23, P1147, DOI 10.1002/rcm.3985; CASTRONOVO V, 1991, J BIOL CHEM, V266, P20440; Chen XL, 2004, ANAL CHEM, V76, P211, DOI 10.1021/ac035027q; Dorchies OM, 2009, BIOFACTORS, V35, P279, DOI 10.1002/biof.34; Fujimura Y, 2005, BIOCHEM BIOPH RES CO, V336, P674, DOI 10.1016/j.bbrc.2005.08.146; Fujimura Y, 2004, FEBS LETT, V556, P204, DOI 10.1016/S0014-5793(03)01432-7; Fujimura Y, 2008, ARCH BIOCHEM BIOPHYS, V476, P133, DOI 10.1016/j.abb.2008.03.002; Fujimura Y, 2006, BIOCHEM BIOPH RES CO, V348, P524, DOI 10.1016/j.bbrc.2006.07.086; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Jamieson KV, 2008, J BIOL CHEM, V283, P3002, DOI 10.1074/jbc.C700206200; Kim KJ, 2005, J BIOL CHEM, V280, P1360, DOI 10.1074/jbc.M410176200; Ku HC, 2009, AM J PHYSIOL-CELL PH, V297, pC121, DOI 10.1152/ajpcell.00272.2008; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; Lee JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011051; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Osanai K, 2007, BIOORGAN MED CHEM, V15, P5076, DOI 10.1016/j.bmc.2007.05.041; Park OJ, 2004, TOXICOL LETT, V150, P43, DOI 10.1016/j.toxlet.2003.06.001; Rambold AS, 2008, J NEUROCHEM, V107, P218, DOI 10.1111/j.1471-4159.2008.05611.x; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Shammas MA, 2006, BLOOD, V108, P2804, DOI 10.1182/blood-2006-05-022814; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tachibana H, 2009, FORUM NUTR, V61, P156, DOI 10.1159/000212748; Tanaka M, 2000, CANCER LETT, V153, P161, DOI 10.1016/S0304-3835(00)00365-7; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Umeda D, 2008, BIOCHEM BIOPH RES CO, V371, P172, DOI 10.1016/j.bbrc.2008.04.041; Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200; Vana K, 2006, J MOL BIOL, V358, P57, DOI 10.1016/j.jmb.2006.02.011; Wan SB, 2005, BIOORGAN MED CHEM, V13, P2177, DOI 10.1016/j.bmc.2004.12.056; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang CS, 2006, MOL NUTR FOOD RES, V50, P170, DOI 10.1002/mnfr.200500105; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	45	61	64	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37942	10.1371/journal.pone.0037942	http://dx.doi.org/10.1371/journal.pone.0037942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666419	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600046
J	Hu, YH; Lan, GY; Sha, LQ; Cao, M; Tang, Y; Li, YD; Xu, DP				Hu, Yue-Hua; Lan, Guo-Yu; Sha, Li-Qing; Cao, Min; Tang, Yong; Li, Yi-De; Xu, Da-Ping			Strong Neutral Spatial Effects Shape Tree Species Distributions across Life Stages at Multiple Scales	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; HABITAT ASSOCIATIONS; DISPERSAL LIMITATION; NEOTROPICAL FOREST; SUBTROPICAL FOREST; PATTERNS; CHINA; AUTOCORRELATION; XISHUANGBANNA; RECRUITMENT	Traditionally, ecologists use lattice (regional summary) count data to simulate tree species distributions to explore species coexistence. However, no previous study has explicitly compared the difference between using lattice count and basal area data and analyzed species distributions at both individual species and community levels while simultaneously considering the combined scenarios of life stage and scale. In this study, we hypothesized that basal area data are more closely related to environmental variables than are count data because of strong environmental filtering effects. We also address the contribution of niche and the neutral (i.e., solely dependent on distance) factors to species distributions. Specifically, we separately modeled count data and basal area data while considering life stage and scale effects at the two levels with simultaneous autoregressive models and variation partitioning. A principal coordinates of neighbor matrix (PCNM) was used to model neutral spatial effects at the community level. The explained variations of species distribution data did not differ significantly between the two types of data at either the individual species level or the community level, indicating that the two types of data can be used nearly identically to model species distributions. Neutral spatial effects represented by spatial autoregressive parameters and the PCNM eigenfunctions drove species distributions on multiple scales, different life stages and individual species and community levels in this plot. We concluded that strong neutral spatial effects are the principal mechanisms underlying the species distributions and thus shape biodiversity spatial patterns.	[Hu, Yue-Hua; Sha, Li-Qing; Cao, Min; Tang, Yong] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Hu, Yue-Hua; Li, Yi-De; Xu, Da-Ping] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China; [Lan, Guo-Yu] Minist Agr, Danzhou Key Field Stn Observat & Res Trop Agr Res, Danzhou, Hainan, Peoples R China; [Lan, Guo-Yu] Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou, Hainan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Hu, YH (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	caom@xtbg.ac.cn		Hu, Yue-Hua/0000-0003-3027-1410	National Science Foundation of China [31061160188]; Queensland-Chinese Academy of Science Joint Biotechnology Projects [GJHZ1130]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Queensland-Chinese Academy of Science Joint Biotechnology Projects	This study was supported by a grant from the National Science Foundation of China (31061160188) and a grant from the Queensland-Chinese Academy of Science Joint Biotechnology Projects (GJHZ1130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Cao M, 2006, BIOTROPICA, V38, P306, DOI 10.1111/j.1744-7429.2006.00146.x; Cao M., 2008, XISHUANGBANNA TROPIC; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Debarre F, 2011, ECOL LETT, V14, P260, DOI 10.1111/j.1461-0248.2010.01580.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dungan JL, 2002, ECOGRAPHY, V25, P626, DOI 10.1034/j.1600-0587.2002.250510.x; Etienne RS, 2004, AM NAT, V163, P69, DOI 10.1086/380582; Ficetola GF, 2009, ECOGRAPHY, V32, P1075, DOI 10.1111/j.1600-0587.2009.05571.x; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; He FL, 2002, LANDSCAPE ECOL, V17, P559, DOI 10.1023/A:1021514104193; Hu YH, 2011, OIKOS IN PRESS; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell Stephen P., 2001, V32, pi; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kanagaraj R, 2011, J ECOL, V99, P1441, DOI 10.1111/j.1365-2745.2011.01878.x; Kuhn I, 2007, DIVERS DISTRIB, V13, P66, DOI 10.1111/j.1472-4642.2006.00293.x; Lai JS, 2009, J VEG SCI, V20, P415, DOI 10.1111/j.1654-1103.2009.01065.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Liu G., 1996, SOIL PHYS CHEM ANAL; Morlon H, 2009, ECOL LETT, V12, P488, DOI 10.1111/j.1461-0248.2009.01318.x; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Paoli GD, 2008, OECOLOGIA, V155, P287, DOI 10.1007/s00442-007-0906-9; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Wall MM, 2004, J STAT PLAN INFER, V121, P311, DOI 10.1016/S0378-3758(03)00111-3; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Zhu H, 2006, BIOTROPICA, V38, P310, DOI 10.1111/j.1744-7429.2006.00147.x	41	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38247	10.1371/journal.pone.0038247	http://dx.doi.org/10.1371/journal.pone.0038247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666497	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600075
J	Korkalainen, M; Huumonen, K; Naarala, J; Viluksela, M; Juutilainen, J				Korkalainen, Merja; Huumonen, Katriina; Naarala, Jonne; Viluksela, Matti; Juutilainen, Jukka			Dioxin Induces Genomic Instability in Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; IONIZING-RADIATION; IN-VITRO; DNA-DAMAGE; CELLS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; MECHANISMS; ASSAY; ANIMALS; AGENTS	Ionizing radiation and certain other exposures have been shown to induce genomic instability (GI), i.e., delayed genetic damage observed many cell generations later in the progeny of the exposed cells. The aim of this study was to investigate induction of GI by a nongenotoxic carcinogen, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Mouse embryonic fibroblasts (C3H10T1/2) were exposed to 1, 10 or 100 nM TCDD for 2 days. Micronuclei (MN) and expression of selected cancer-related genes were assayed both immediately and at a delayed point in time (8 days). For comparison, similar experiments were done with cadmium, a known genotoxic agent. TCDD treatment induced an elevated frequency of MN at 8 days, but not directly after the exposure. TCDD-induced alterations in gene expression were also mostly delayed, with more changes observed at 8 days than at 2 days. Exposure to cadmium produced an opposite pattern of responses, with pronounced effects immediately after exposure but no increase in MN and few gene expression changes at 8 days. Although all responses to TCDD alone were delayed, menadione-induced DNA damage (measured by the Comet assay), was found to be increased directly after a 2-day TCDD exposure, indicating that the stability of the genome was compromised already at this time point. The results suggested a flat dose-response relationship consistent with dose-response data reported for radiation-induced GI. These findings indicate that TCDD, although not directly genotoxic, induces GI, which is associated with impaired DNA damage response.	[Korkalainen, Merja; Viluksela, Matti] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland; [Huumonen, Katriina; Naarala, Jonne; Juutilainen, Jukka] Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland	Finland National Institute for Health & Welfare; University of Eastern Finland	Korkalainen, M (corresponding author), Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland.	merja.korkalainen@thl.fi		Korkalainen, Merja/0000-0002-1221-0617	Academy of Finland [123439]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland [grant number 123439] (www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Aypar U, 2011, INT J RADIAT BIOL, V87, P179, DOI 10.3109/09553002.2010.522686; Baverstock K, 2011, MUTAT RES-GEN TOX EN, V718, P1, DOI 10.1016/j.mrgentox.2010.11.003; Birnbaum LS, 2000, FOOD ADDIT CONTAM A, V17, P275, DOI 10.1080/026520300283351; Brennan RJ, 2001, RADIAT RES, V155, P768, DOI 10.1667/0033-7587(2001)155[0768:PGIITY]2.0.CO;2; Bryce SM, 2007, MUTAT RES-GEN TOX EN, V630, P78, DOI 10.1016/j.mrgentox.2007.03.002; Coen N, 2001, J PATHOL, V195, P293; Dubrova YE, 2003, ONCOGENE, V22, P7087, DOI 10.1038/sj.onc.1206993; Falt S, 2003, CARCINOGENESIS, V24, P1837, DOI 10.1093/carcin/bgg134; Hernandez LG, 2009, MUTAT RES-REV MUTAT, V682, P94, DOI 10.1016/j.mrrev.2009.07.002; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huang L, 2007, CANCER RES, V67, P1099, DOI 10.1158/0008-5472.CAN-06-3697; Ilnytskyy Y, 2011, MUTAT RES-FUND MOL M, V714, P113, DOI 10.1016/j.mrfmmm.2011.06.014; International Agency for Research on Cancer (IARC), 1997, IARC MON EV CARC RIS, V69; Katic J, 2010, FOOD CHEM TOXICOL, V48, P2612, DOI 10.1016/j.fct.2010.06.030; Linden J, 2010, FRONT NEUROENDOCRIN, V31, P452, DOI 10.1016/j.yfrne.2010.07.002; Luukkonen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018021; Markkanen A, 2008, INT J RADIAT BIOL, V84, P742, DOI 10.1080/09553000802360836; Morgan WF, 1996, RADIAT RES, V146, P247, DOI 10.2307/3579454; Morgan WF, 2009, HEALTH PHYS, V97, P426, DOI 10.1097/HP.0b013e3181ab98c7; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; Parfett CL, 2006, MUTAT RES-GEN TOX EN, V604, P42, DOI 10.1016/j.mrgentox.2005.12.008; Phillipson RP, 2002, FREE RADICAL BIO MED, V32, P474, DOI 10.1016/S0891-5849(01)00829-2; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; Puga A, 2000, BIOCHEM PHARMACOL, V60, P1129, DOI 10.1016/S0006-2952(00)00403-2; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Valic E, 2004, INT ARCH OCC ENV HEA, V77, P301, DOI 10.1007/s00420-004-0508-3; Viluksela M, 2000, CANCER RES, V60, P6911; White SS, 2009, J ENVIRON SCI HEAL C, V27, P197, DOI 10.1080/10590500903310047	30	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37895	10.1371/journal.pone.0037895	http://dx.doi.org/10.1371/journal.pone.0037895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666406	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349600037
J	Rousseau, L; Etienne, O; Roque, T; Desmaze, C; Haton, C; Mouthon, MA; Bernardino-Sgherri, J; Essers, J; Kanaar, R; Boussin, FD				Rousseau, Laure; Etienne, Olivier; Roque, Telma; Desmaze, Chantal; Haton, Celine; Mouthon, Marc-Andre; Bernardino-Sgherri, Jacqueline; Essers, Jeroen; Kanaar, Roland; Boussin, Francois D.			In vivo Importance of Homologous Recombination DNA Repair for Mouse Neural Stem and Progenitor Cells	PLOS ONE			English	Article							STRAND BREAK REPAIR; INTERKINETIC NUCLEAR MIGRATION; NERVOUS-SYSTEM; MAMMALIAN-CELLS; NEURONAL DEVELOPMENT; VENTRICULAR ZONE; PATHWAY CHOICE; DAMAGE REPAIR; S-PHASE; RAD54	We characterized the in vivo importance of the homologous recombination factor RAD54 for the developing mouse brain cortex in normal conditions or after ionizing radiation exposure. Contrary to numerous homologous recombination genes, Rad54 disruption did not impact the cortical development without exogenous stress, but it dramatically enhanced the radiation sensitivity of neural stem and progenitor cells. This resulted in the death of all cells irradiated during S or G2, whereas the viability of cells irradiated in G1 or G0 was not affected by Rad54 disruption. Apoptosis occurred after long arrests at intra-S and G2/M checkpoints. This concerned every type of neural stem and progenitor cells, showing that the importance of Rad54 for radiation response was linked to the cell cycle phase at the time of irradiation and not to the differentiation state. In the developing brain, RAD54-dependent homologous recombination appeared absolutely required for the repair of damages induced by ionizing radiation during S and G2 phases, but not for the repair of endogenous damages in normal conditions. Altogether our data support the existence of RAD54-dependent and -independent homologous recombination pathways.	[Rousseau, Laure; Etienne, Olivier; Roque, Telma; Desmaze, Chantal; Haton, Celine; Mouthon, Marc-Andre; Boussin, Francois D.] CEA, Lab Radiopathol, SCSR, iRCM,DSV, Fontenay Aux Roses, France; [Rousseau, Laure; Etienne, Olivier; Roque, Telma; Desmaze, Chantal; Haton, Celine; Mouthon, Marc-Andre; Bernardino-Sgherri, Jacqueline; Boussin, Francois D.] INSERM, U967, Fontenay Aux Roses, France; [Rousseau, Laure; Etienne, Olivier; Roque, Telma; Desmaze, Chantal; Haton, Celine; Mouthon, Marc-Andre; Bernardino-Sgherri, Jacqueline; Boussin, Francois D.] Univ Paris Diderot, UMR 967, Fontenay Aux Roses, France; [Rousseau, Laure; Etienne, Olivier; Roque, Telma; Desmaze, Chantal; Haton, Celine; Mouthon, Marc-Andre; Bernardino-Sgherri, Jacqueline; Boussin, Francois D.] Univ Paris Sud, UMR 967, Fontenay Aux Roses, France; [Bernardino-Sgherri, Jacqueline] CEA, Lab Gametogenese Apoptose & Genotoxicite, SCSR, iRCM,DSV, Fontenay Aux Roses, France; [Essers, Jeroen; Kanaar, Roland] Erasmus MC, Dept Cell Biol & Genet, Canc Genom Ctr, Rotterdam, Netherlands; [Essers, Jeroen; Kanaar, Roland] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands; [Essers, Jeroen] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Rousseau, L (corresponding author), CEA, Lab Radiopathol, SCSR, iRCM,DSV, Fontenay Aux Roses, France.	boussin@cea.fr		Bernardino-Sgherri, Jacqueline/0000-0003-3980-4041; Desmaze, Chantal/0000-0003-0777-8854; Mouthon, Marc-Andre/0000-0003-2633-9179; Boussin, francois/0000-0003-3778-4403	l'Agence Nationale de la Recherche - Sante-Environnement et Sante-Travail(ANR-SEST, Neurorad); Electricite de France; Association pour la Recherche sur le Cancer [ARC3900]; European Community [HEALTH-F2-2010-259893]; Netherlands Organization for Scientific Research:De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Netherlands Genomics Initiative/NWO	l'Agence Nationale de la Recherche - Sante-Environnement et Sante-Travail(ANR-SEST, Neurorad)(French National Research Agency (ANR)); Electricite de France; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); European Community(European Commission); Netherlands Organization for Scientific Research:De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative/NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from l'Agence Nationale de la Recherche - Sante-Environnement et Sante-Travail(ANR-SEST, Neurorad), Electricite de France and Association pour la Recherche sur le Cancer (ARC3900). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007 2013) under grant agreement [HEALTH-F2-2010-259893] and from grants from the Netherlands Organization for Scientific Research:De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) and Netherlands Genomics Initiative/NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; D'Sa-Eipper C, 2001, DEVELOPMENT, V128, P137; Daboussi F, 2008, J CELL SCI, V121, P162, DOI 10.1242/jcs.010330; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Eppink B, 2011, DNA REPAIR, V10, P1095, DOI 10.1016/j.dnarep.2011.08.006; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; Gatz SA, 2011, J NEUROSCI, V31, P10088, DOI 10.1523/JNEUROSCI.1324-11.2011; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; HEYER WD, 1994, EXPERIENTIA, V50, P189, DOI 10.1007/BF01924001; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Latasa MJ, 2009, INT J DEV BIOL, V53, P895, DOI 10.1387/ijdb.082721ml; Lee Y, 2007, NEUROSCIENCE, V145, P1365, DOI 10.1016/j.neuroscience.2006.07.026; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Nowak E, 2006, RADIAT RES, V165, P155, DOI 10.1667/RR3496.1; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Roque T, 2012, STEM CELLS, V30, P537, DOI 10.1002/stem.1010; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; SAUER ME, 1959, P SOC EXP BIOL MED, V101, P557; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; SHIBATA K, 1993, J BIOL CHEM, V268, P18431; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; Sii-Felice K, 2008, CELL CYCLE, V7, P1911, DOI 10.4161/cc.7.13.6235; Sii-Felice K, 2008, EMBO J, V27, P770, DOI 10.1038/emboj.2008.14; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Stephan AK, 2011, MOL CELL BIOL, V31, P1369, DOI 10.1128/MCB.00786-10; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tanori M, 2011, ONCOGENE; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006	54	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37194	10.1371/journal.pone.0037194	http://dx.doi.org/10.1371/journal.pone.0037194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666344	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600012
J	Traister, A; Aafaqi, S; Masse, S; Dai, XJ; Li, M; Hinek, A; Nanthakumar, K; Hannigan, G; Coles, JG				Traister, Alexandra; Aafaqi, Shabana; Masse, Stephane; Dai, Xiaojing; Li, Mark; Hinek, Aleksander; Nanthakumar, Kumaraswamy; Hannigan, Gregory; Coles, John G.			ILK Induces Cardiomyogenesis in the Human Heart	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; CARDIOVASCULAR PROGENITORS; SELF-RENEWAL; CANCER-CELLS; EXPRESSION; DIFFERENTIATION; CARDIOMYOCYTES; MOUSE; CONTRACTILITY; PATHWAYS	Background: Integrin-linked kinase (ILK) is a widely conserved serine/threonine kinase that regulates diverse signal transduction pathways implicated in cardiac hypertrophy and contractility. In this study we explored whether experimental overexpression of ILK would up-regulate morphogenesis in the human fetal heart. Methodology/Principal Findings: Primary cultures of human fetal myocardial cells (19-22 weeks gestation) yielded scattered aggregates of cardioblasts positive for the early cardiac lineage marker nkx2.5 and containing nascent sarcomeres. Cardiac cells in colonies uniformly expressed the gap junction protein connexin 43 (Cx43) and displayed a spectrum of differentiation with only a subset of cells exhibiting the late cardiomyogenic marker troponin T (cTnT) and evidence of electrical excitability. Adenovirus-mediated overexpression of ILK potently increased the number of new aggregates of primitive cardioblasts (p<0.001). The number of cardioblast colonies was significantly decreased (p<0.05) when ILK expression was knocked down with ILK targeted siRNA. Interestingly, overexpression of the activation resistant ILK mutant (ILKR211A) resulted in much greater increase in the number of new cell aggregates as compared to overexpression of wild-type ILK (ILKWT). The cardiomyogenic effects of ILKR211A and ILKWT were accompanied by concurrent activation of beta-catenin (p<0.001) and increase expression of progenitor cell marker islet-1, which was also observed in lysates of transgenic mice with cardiac-specific over-expression of ILKR211A and ILKWT. Finally, endogenous ILK expression was shown to increase in concert with those of cardiomyogenic markers during directed cardiomyogenic differentiation in human embryonic stem cells (hESCs). Conclusions/Significance: In the human fetal heart ILK activation is instructive to the specification of mesodermal precursor cells towards a cardiomyogenic lineage. Induction of cardiomyogenesis by ILK overexpression bypasses the requirement of proximal PI3K activation for transduction of growth factor-and beta 1-integrin-mediated differentiation signals. Altogether, our data indicate that ILK represents a novel regulatory checkpoint during human cardiomyogenesis.	[Traister, Alexandra; Aafaqi, Shabana; Dai, Xiaojing; Li, Mark; Hinek, Aleksander; Coles, John G.] Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada; [Masse, Stephane; Nanthakumar, Kumaraswamy] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Hannigan, Gregory] Monash Univ, Monash Inst Med Res, Cell Adhes Signaling Lab, Melbourne, Vic 3004, Australia	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Monash University	Traister, A (corresponding author), Hosp Sick Children, Div Cardiovasc Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.coles@sickkids.ca	Hinek, Aleksander/V-8790-2019; , Nanthakumar/AAA-9943-2020		Canadian Institute of Health Research [MOP-86625]; Australian National Health and Medical Research Council; Victorian Operational Infrastructure Program; GL2 grant: Cardiovascular Biomarker Discovery and Validation	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Operational Infrastructure Program; GL2 grant: Cardiovascular Biomarker Discovery and Validation	This work was supported by Canadian Institute of Health Research grant #MOP-86625. Grant support to Gregory Hannigan by Australian National Health and Medical Research Council, funds from the Victorian Operational Infrastructure Program, and the GL2 grant: Cardiovascular Biomarker Discovery and Validation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud ER, 2007, INT J ONCOL, V30, P113; Anton R, 2007, BIOESSAYS, V29, P422, DOI 10.1002/bies.20562; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; CARY RB, 1994, J CELL BIOL, V126, P445, DOI 10.1083/jcb.126.2.445; de Boer TP, 2010, J MOL CELL CARDIOL, V48, P254, DOI 10.1016/j.yjmcc.2009.05.004; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Durbin AD, 2009, J CLIN INVEST, V119, P1558, DOI 10.1172/JCI37958; Durbin AD, 2010, CELL CYCLE, V9, P1951, DOI 10.4161/cc.9.10.11554; Easley CAB-YA, 2009, 7 ANN M INT SOC STEM; Engel FB, 1999, CIRC RES, V85, P294, DOI 10.1161/01.RES.85.3.294; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Fudim MBJ, 2009, P ISSCR C; Genead R, 2010, STEM CELL RES, V4, P69, DOI 10.1016/j.scr.2009.10.001; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kattman SJ, 2011, J CARDIOVASC TRANSL, V4, P66, DOI 10.1007/s12265-010-9235-1; Kirby M. L., 2007, CARDIAC DEV; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lee SP, 2006, CIRCULATION, V114, P150, DOI 10.1161/CIRCULATIONAHA.105.595918; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Oloumi A, 2004, BBA-MOL CELL RES, V1691, P1, DOI 10.1016/j.bbamcr.2003.12.002; Pan WJ, 2006, J CELL SCI, V119, P4850, DOI 10.1242/jcs.03257; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Xie J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024115; Yamabi H, 2006, J THORAC CARDIOV SUR, V132, P1272, DOI 10.1016/j.jtcvs.2006.08.028; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229	45	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37802	10.1371/journal.pone.0037802	http://dx.doi.org/10.1371/journal.pone.0037802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666394	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600030
J	Han, ZQ; Yanagimoto, T; Zhang, YP; Gao, TX				Han, Zhiqiang; Yanagimoto, Takashi; Zhang, Yaping; Gao, Tianxiang			Phylogeography Study of Ammodytes personatus in Northwestern Pacific: Pleistocene Isolation, Temperature and Current Conducted Secondary Contact	PLOS ONE			English	Article							MARINE FISH; GENETIC-DIVERGENCE; LIMITED DISPERSAL; POPULATIONS; JAPANESE; HISTORY; SEA; DNA; JAPONICUS; SANDEEL	To assess the role of historical process and contemporary factors in shaping population structures in Northwestern Pacific, mitochondrial control region sequences were analyzed to characterize the phylogeography and population structure of the Japanese sand lance Ammodytes personatus. A total of 429 individuals sampled from 17 populations through the species' range are sequenced. Two distinct lineages are detected, which might have been divergent in the Sea of Japan and Pacific costal waters of Japanese Island, during the low sea level. Significant genetic structure is revealed between the Kuroshio and Oyashio Currents. However, significant genetic structure is also detected in the Sea of Japan, contracting expected homogenization hypothesis in Tsushima Current. The haplotype frequency of lineages in both sides of Japanese Island and significant genetic structure between north and south groups revealed that the distribution of lineage B and north group were highly limited by the annual sea temperature. The lack of lineage B in Qingdao population with low sea temperature reflects the sea temperature barrier. Lack of genetic structure in the south group and north group populations indicated that ocean currents within groups facilitated the dispersal of A. personatus.	[Han, Zhiqiang] Zhejiang Ocean Univ, Fishery Coll, Zhoushan, Zhejiang, Peoples R China; [Yanagimoto, Takashi] Natl Res Inst Far Seas Fisheries, Yokohama, Kanagawa, Japan; [Zhang, Yaping; Gao, Tianxiang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Han, Zhiqiang; Gao, Tianxiang] Ocean Univ China, Fishery Coll, Qingdao, Shandong, Peoples R China	Zhejiang Ocean University; Japan Fisheries Research & Education Agency (FRA); Chinese Academy of Sciences; Kunming Institute of Zoology; Ocean University of China	Han, ZQ (corresponding author), Zhejiang Ocean Univ, Fishery Coll, Zhoushan, Zhejiang, Peoples R China.	gaozhang@ouc.edu.cn			open funds of State Key Laboratory of Genetic Resources and Evolution [GREKF09-07]; Special Fund for Agro-scientific Research in the Public Interest [201003068]; Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang [20100104]; Department of Education of Zhejiang Province [Y200803409]	open funds of State Key Laboratory of Genetic Resources and Evolution; Special Fund for Agro-scientific Research in the Public Interest; Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang; Department of Education of Zhejiang Province	The study was supported by the open funds of State Key Laboratory of Genetic Resources and Evolution (GREKF09-07), Special Fund for Agro-scientific Research in the Public Interest (201003068), the Open Foundation from Ocean Fishery Science and Technology in the Most Important Subjects of Zhejiang (20100104), and Grant from the Department of Education of Zhejiang Province (Y200803409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDELT HJ, 1995, GENETICS, V141, P743; Fauvelot C, 2002, MAR BIOL, V141, P773, DOI 10.1007/s00227-002-0869-7; Fu YX, 1997, GENETICS, V147, P915; Gao TX, 1998, FISHERIES SCI, V64, P198, DOI 10.2331/fishsci.64.198; Hamada T., 1985, FISHERY BIOL SAND LA; HASHIMOTO H, 1991, Journal of the Faculty of Applied Biological Science Hiroshima University, V30, P135; HASHIMOTO H, 1981, Tohoku Journal of Agricultural Research, V31, P173; HASHIMOTO H, 1984, B JPN SOC SCI FISH, V50, P1357; Hemmer-Hansen J, 2007, MOL ECOL, V16, P3104, DOI 10.1111/j.1365-294X.2007.03367.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Imron, 2007, MOL ECOL, V16, P289, DOI 10.1111/j.1365-294X.2006.03141.x; Inoue A., 1949, B JAPAN SOC SCI FISH, V15, P458; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kitagawa D., 1986, NIPPON SUISAN GAKKI, V50, P205; Kitamura A, 2006, PALAEOGEOGR PALAEOCL, V236, P355, DOI 10.1016/j.palaeo.2005.11.015; LEE WJ, 1995, J MOL EVOL, V41, P54; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu JX, 2006, MOL PHYLOGENET EVOL, V40, P712, DOI 10.1016/j.ympev.2006.04.019; Liu JX, 2006, MOL PHYLOGENET EVOL, V39, P799, DOI 10.1016/j.ympev.2006.01.009; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Nei M., 1987, MOL EVOLUTIONARY GEN; NEILL WH, 1994, NETH J SEA RES, V32, P135, DOI 10.1016/0077-7579(94)90037-X; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; Oba T, 2006, GLOBAL PLANET CHANGE, V53, P5, DOI 10.1016/j.gloplacha.2006.05.002; OKAMOTO H, 1988, NIPPON SUISAN GAKK, V54, P1297; OKAMOTO H, 1989, CAN J FISH AQUAT SCI, V46, P1945, DOI 10.1139/f89-244; Palumbi Stephen R., 1995, P369; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Planes S, 2001, EVOLUTION, V55, P2263; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robards MD, 1999, SAND LANCE REV BIOL; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Sassa C, 2004, FISH OCEANOGR, V13, P267, DOI 10.1111/j.1365-2419.2004.00289.x; Schmidt PS, 1999, EVOLUTION, V53, P135, DOI 10.1111/j.1558-5646.1999.tb05339.x; Schneider S., 2000, ARLEQUIN VERSION 20; Schulte PM, 2001, COMP BIOCHEM PHYS B, V128, P597, DOI 10.1016/S1096-4959(00)00357-2; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tomiyama M, 2004, FISH OCEANOGR, V13, P81, DOI 10.1046/j.1365-2419.2003.00272.x; Yokogawa K, 1997, FISHERIES SCI, V63, P332, DOI 10.2331/fishsci.63.332	44	56	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37425	10.1371/journal.pone.0037425	http://dx.doi.org/10.1371/journal.pone.0037425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22685527	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300043
J	Genin, P; Lin, RT; Hiscott, J; Civas, A				Genin, Pierre; Lin, Rongtuan; Hiscott, John; Civas, Ahmet			Recruitment of Histone Deacetylase 3 to the Interferon-A Gene Promoters Attenuates Interferon Expression	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS; I INTERFERON; NEGATIVE REGULATION; REGULATORY FACTORS; VIRUS-INFECTION; BETA GENE; INFLAMMATORY RESPONSE; DNA-BINDING	Background: Induction of Type I Interferon (IFN) genes constitutes an essential step leading to innate immune responses during virus infection. Sendai virus (SeV) infection of B lymphoid Namalwa cells transiently induces the transcriptional expression of multiple IFN-A genes. Although transcriptional activation of IFN-A genes has been extensively studied, the mechanism responsible for the attenuation of their expression remains to be determined. Principal Findings: In this study, we demonstrate that virus infection of Namalwa cells induces transient recruitment of HDAC3 (histone deacetylase 3) to IFN-A promoters. Analysis of chromatin-protein association by Chip-QPCR demonstrated that recruitment of interferon regulatory factor (IRF)3 and IRF7, as well as TBP correlated with enhanced histone H3K9 and H3K14 acetylation, whereas recruitment of HDAC3 correlated with inhibition of histone H3K9/K14 acetylation, removal of IRF7 and TATA-binding protein (TBP) from IFN-A promoters and inhibition of virus-induced IFN-A gene transcription. Additionally, HDAC3 overexpression reduced, and HDAC3 depletion by siRNA enhanced IFN-A gene expression. Furthermore, activation of IRF7 enhanced histone H3K9/K14 acetylation and IFN-A gene expression, whereas activation of both IRF7 and IRF3 led to recruitment of HDAC3 to the IFN-A gene promoters, resulting in impaired histone H3K9 acetylation and attenuation of IFN-A gene transcription. Conclusion: Altogether these data indicate that reversal of histone H3K9/K14 acetylation by HDAC3 is required for attenuation of IFN-A gene transcription during viral infection.	[Genin, Pierre; Civas, Ahmet] Paris Descartes Univ, Ctr Natl Rech Sci FRE3235, Paris, France; [Lin, Rongtuan; Hiscott, John] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Hiscott, John] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA	UDICE-French Research Universities; Universite Paris Cite; Lady Davis Institute; McGill University; Vaccine & Gene Therapy Institute of Florida	Genin, P (corresponding author), Paris Descartes Univ, Ctr Natl Rech Sci FRE3235, Paris, France.	ahmet.civas@parisdescartes.fr	Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503; Genin, Pierre/0000-0002-7502-3851	Centre National de la Recherche Scientifique; Canadian Institutes of Health Research (CIHR); Canadian Cancer Society; Canadian Foundation for AIDS Research (CANFAR); Universite Paris Descartes; NATIONAL CANCER INSTITUTE [R21CA192185] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Foundation for AIDS Research (CANFAR); Universite Paris Descartes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Centre National de la Recherche Scientifique and Universite Paris Descartes. This work was also supported by grants to JH from the Canadian Institutes of Health Research (CIHR), the Canadian Cancer Society, and the Canadian Foundation for AIDS Research (CANFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Au WC, 2001, J BIOL CHEM, V276, P41629, DOI 10.1074/jbc.M105121200; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chen JB, 2004, J INTERF CYTOK RES, V24, P687, DOI 10.1089/jir.2004.24.687; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Civas A, 2006, J BIOL CHEM, V281, P4856, DOI 10.1074/jbc.M506812200; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Ford E, 2010, BBA-GENE REGUL MECH, V1799, P328, DOI 10.1016/j.bbagrm.2010.01.010; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Genin P, 2009, CYTOKINE GROWTH F R, V20, P283, DOI 10.1016/j.cytogfr.2009.07.005; Genin P, 2009, MOL CELL BIOL, V29, P3435, DOI 10.1128/MCB.01805-08; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Higgs R, 2008, BIOCHEM SOC T, V36, P453, DOI 10.1042/BST0360453; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Koutroubas G, 2008, MOL CELL BIOL, V28, P926, DOI 10.1128/MCB.01344-07; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Liang QM, 2011, J IMMUNOL, V186, P1001, DOI 10.4049/jimmunol.1002240; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Makkonen KM, 2009, J MOL BIOL, V393, P261, DOI 10.1016/j.jmb.2009.08.024; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; PALOMBELLA VJ, 1992, MOL CELL BIOL, V12, P3325, DOI 10.1128/MCB.12.8.3325; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Seto Edward, 2006, P61; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Topalidou I, 2003, MOL CELL BIOL, V23, P7809, DOI 10.1128/MCB.23.21.7809-7817.2003; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Van den Wyngaert I, 2000, FEBS LETT, V478, P77, DOI 10.1016/S0014-5793(00)01813-5; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; WHITTEMORE LA, 1990, P NATL ACAD SCI USA, V87, P7799, DOI 10.1073/pnas.87.20.7799; Woelk CH, 2007, GENE, V397, P38, DOI 10.1016/j.gene.2007.03.018; Yang HM, 2003, J BIOL CHEM, V278, P15495, DOI 10.1074/jbc.M212940200; Ye JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020681; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027	77	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38336	10.1371/journal.pone.0038336	http://dx.doi.org/10.1371/journal.pone.0038336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685561	gold, Green Published, Green Submitted			2022-12-27	WOS:000305351700024
J	Mayer, FL; Wilson, D; Jacobsen, ID; Miramon, P; Slesiona, S; Bohovych, IM; Brown, AJP; Hube, B				Mayer, Francois L.; Wilson, Duncan; Jacobsen, Ilse D.; Miramon, Pedro; Slesiona, Silvia; Bohovych, Iryna M.; Brown, Alistair J. P.; Hube, Bernhard			Small but Crucial: The Novel Small Heat Shock Protein Hsp21 Mediates Stress Adaptation and Virulence in Candida albicans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ALPHA-CRYSTALLIN; CELL-WALL; TRANSCRIPTIONAL RESPONSE; DECREASES INFECTIVITY; MOLECULAR CHAPERONES; IN-VIVO; OROPHARYNGEAL CANDIDIASIS; TREHALOSE ACCUMULATION; FUNGAL MORPHOGENESIS	Small heat shock proteins (sHsps) have multiple cellular functions. However, the biological function of sHsps in pathogenic microorganisms is largely unknown. In the present study we identified and characterized the novel sHsp Hsp21 of the human fungal pathogen Candida albicans. Using a reverse genetics approach we demonstrate the importance of Hsp21 for resistance of C. albicans to specific stresses, including thermal and oxidative stress. Furthermore, a hsp21 Delta/Delta mutant was defective in invasive growth and formed significantly shorter filaments compared to the wild type under various filament-inducing conditions. Although adhesion to and invasion into human-derived endothelial and oral epithelial cells was unaltered, the hsp21 Delta/Delta mutant exhibited a strongly reduced capacity to damage both cell lines. Furthermore, Hsp21 was required for resisting killing by human neutrophils. Measurements of intracellular levels of stress protective molecules demonstrated that Hsp21 is involved in both glycerol and glycogen regulation and plays a major role in trehalose homeostasis in response to elevated temperatures. Mutants defective in trehalose and, to a lesser extent, glycerol synthesis phenocopied HSP21 deletion in terms of increased susceptibility to environmental stress, strongly impaired capacity to damage epithelial cells and increased sensitivity to the killing activities of human primary neutrophils. Via systematic analysis of the three main C. albicans stress-responsive kinases (Mkc1, Cek1, Hog1) under a range of stressors, we demonstrate Hsp21-dependent phosphorylation of Cek1 in response to elevated temperatures. Finally, the hsp21 Delta/Delta mutant displayed strongly attenuated virulence in two in vivo infection models. Taken together, Hsp21 mediates adaptation to specific stresses via fine-tuning homeostasis of compatible solutes and activation of the Cek1 pathway, and is crucial for multiple stages of C. albicans pathogenicity. Hsp21 therefore represents the first reported example of a small heat shock protein functioning as a virulence factor in a eukaryotic pathogen.	[Mayer, Francois L.; Wilson, Duncan; Jacobsen, Ilse D.; Miramon, Pedro; Slesiona, Silvia; Hube, Bernhard] Hans Knoell Inst, Dept Microbial Pathogen Mech, Jena, Germany; [Slesiona, Silvia] Hans Knoell Inst, Dept Microbial Biochem & Physiol, Jena, Germany; [Bohovych, Iryna M.; Brown, Alistair J. P.] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Foresterhill, Aberdeen, Scotland; [Hube, Bernhard] Univ Klinikum Jena, Ctr Sepsis Control & Care, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); University of Aberdeen; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Mayer, FL (corresponding author), Hans Knoell Inst, Dept Microbial Pathogen Mech, Jena, Germany.	Bernhard.Hube@hki-jena.de	Jacobsen, Ilse/B-3155-2011; Brown, Alistair J.P./B-6627-2014	Jacobsen, Ilse/0000-0002-6033-9984; Mayer, Francois/0000-0002-6800-9429; Miramon, Pedro/0000-0002-6867-7697; Hube, Bernhard/0000-0002-6028-0425; Wilson, Duncan/0000-0001-6617-0123; Brown, Alistair JP/0000-0003-1406-4251	International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC); ERA-NET PathoGenoMics Program (Candicol) [BMBF 0315 901 B]; European Commission through the FINSysB Marie Curie Initial Training Network [PITN-GA-2008-214004]; German Science Foundation (DFG) [BR2216/4-1]; Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute); Federal Ministry of Education and Health (BMBF) [0314108]; Center for Sepsis Control and Care (CSCC) [BMBF 01EO1002]; Deutsche Forschungsgemeinschaft (DFG) [Hu 528/15, Hu 528/16, Hu 528/17]; UK Biotechnology and Biological Sciences Research Council [BB/F00513X/1]; European Reseach Council [STRIFE: ERC-2009-AdG-249793]; BBSRC [BB/D009308/1, BB/F00513X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D009308/1, BB/F00513X/1] Funding Source: researchfish	International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC); ERA-NET PathoGenoMics Program (Candicol); European Commission through the FINSysB Marie Curie Initial Training Network; German Science Foundation (DFG)(German Research Foundation (DFG)); Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute); Federal Ministry of Education and Health (BMBF)(Federal Ministry of Education & Research (BMBF)); Center for Sepsis Control and Care (CSCC); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Reseach Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	FLM and BH were supported by the International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC). DW and BH were supported by the ERA-NET PathoGenoMics Program (Candicol; BMBF 0315 901 B). PM, IMB, AJPB and BH were funded by the European Commission through the FINSysB Marie Curie Initial Training Network (PITN-GA-2008-214004). IDJ and SS were financially supported by a grant from the German Science Foundation (DFG, grant BR2216/4-1) and the Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute). IDJ was also supported by the Federal Ministry of Education and Health (BMBF 0314108). BH was also supported by the Center for Sepsis Control and Care (CSCC; BMBF 01EO1002) and the Deutsche Forschungsgemeinschaft (DFG Hu 528/15, 16 and 17). AJPB was also supported by the UK Biotechnology and Biological Sciences Research Council (BB/F00513X/1) and the European Reseach Council (STRIFE: ERC-2009-AdG-249793).	Alvarez-Peral FJ, 2002, MICROBIOL-SGM, V148, P2599, DOI 10.1099/00221287-148-8-2599; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Arguelles JC, 1997, FEMS MICROBIOL LETT, V146, P65, DOI 10.1016/S0378-1097(96)00455-7; Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Brown AJP, 2005, FUNGAL GENOMICS MYCO, P185; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Buchner J, 1996, FASEB J, V10, P10, DOI 10.1096/fasebj.10.1.8566529; Burnie JR, 2006, FEMS MICROBIOL REV, V30, P53, DOI 10.1111/j.1574-6976.2005.00001.x; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Calderone RA., 2002, CANDIDA CANDIDIASIS; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; CHAPUT M, 1983, BIOCHIMIE, V65, P501, DOI 10.1016/S0300-9084(83)80132-1; CHESTER VE, 1968, J GEN MICROBIOL, V51, P47, DOI 10.1099/00221287-51-1-49; Chiang LY, 2007, CELL MICROBIOL, V9, P233, DOI 10.1111/j.1462-5822.2006.00784.x; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; CRAIG EA, 1989, BIOESSAYS, V11, P48, DOI 10.1002/bies.950110203; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diamant S, 2003, MOL MICROBIOL, V49, P401, DOI 10.1046/j.1365-2958.2003.03553.x; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Dubaquie Y, 1997, P NATL ACAD SCI USA, V94, P9011, DOI 10.1073/pnas.94.17.9011; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Elson SL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000664; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; Enjalbert B, 2009, MOL MICROBIOL, V72, P216, DOI 10.1111/j.1365-2958.2009.06640.x; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Eyles SJ, 2010, P NATL ACAD SCI USA, V107, P2727, DOI 10.1073/pnas.0915160107; Fan JJ, 2005, FEMS MICROBIOL LETT, V245, P107, DOI 10.1016/j.femsle.2005.02.031; Ferrer J, 2000, INT J GYNECOL OBSTET, V71, pS21, DOI 10.1016/S0020-7292(00)00350-7; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; Filler Scott G., 2002, P341; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Gow NAR, 2009, CURR BIOL, V19, pR333, DOI 10.1016/j.cub.2009.03.027; HARTL A, 1995, ARZNEIMITTEL-FORSCH, V45-2, P926; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hube B, 2001, MICROBIOL-SGM, V147, P1997, DOI 10.1099/00221287-147-8-1997; Hubel A, 1997, MOL CELL BIOL, V17, P5987; Jacobsen ID, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019741; Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; KAUFMANN SHE, 1991, SPRINGER SEMIN IMMUN, V13, P25, DOI 10.1007/BF01225276; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lindquist S, 1992, CURR OPIN GENET DEV, V2, P748, DOI 10.1016/S0959-437X(05)80135-2; Lis M, 2010, FEMS YEAST RES, V10, P579, DOI 10.1111/j.1567-1364.2010.00638.x; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Martinez-Esparza M, 2011, GLYCOBIOLOGY, V21, P796, DOI 10.1093/glycob/cwr007; Martinez-Esparza M, 2009, INT J MED MICROBIOL, V299, P453, DOI 10.1016/j.ijmm.2008.12.001; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; MOLLER F, 1974, ANAL BIOCHEM, V59, P248, DOI 10.1016/0003-2697(74)90030-X; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Nicholls S, 2010, FUNGAL GENET BIOL; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; Nobile CJ, 2008, CELL MICROBIOL, V10, P2180, DOI 10.1111/j.1462-5822.2008.01198.x; ODDS FC, 1987, CRC CR REV MICROBIOL, V15, P1; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; PETKO L, 1986, CELL, V45, P885, DOI 10.1016/0092-8674(86)90563-5; Phan QT, 2000, INFECT IMMUN, V68, P3485, DOI 10.1128/IAI.68.6.3485-3490.2000; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Piper PW, 1997, CELL STRESS CHAPERON, V2, P12, DOI 10.1379/1466-1268(1997)002<0012:HTIPMH>2.3.CO;2; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Ramirez MA, 2007, EUKARYOT CELL, V6, P280, DOI 10.1128/EC.00372-06; Ramsdale M, 2008, MOL BIOL CELL, V19, P4393, DOI 10.1091/mbc.E07-09-0946; Ratnakar P, 1996, MICROB PATHOGENESIS, V21, P471, DOI 10.1006/mpat.1996.0077; Ribatti D, 2001, ANAT RECORD, V264, P317, DOI 10.1002/ar.10021; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Ruhnke M, 2002, CANDIDA CANDIDIASIS, P307; RUIS H, 1995, BIOESSAYS, V17, P959, DOI 10.1002/bies.950171109; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Sales K, 2000, BBA-BIOMEMBRANES, V1463, P267, DOI 10.1016/S0005-2736(99)00215-1; Sanchez AA, 2004, INFECT IMMUN, V72, P598, DOI 10.1128/IAI.72.1.598-601.2004; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Sheth CC, 2008, FUNGAL GENET BIOL, V45, P1075, DOI 10.1016/j.fgb.2008.04.004; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Stewart GR, 2005, MOL MICROBIOL, V55, P1127, DOI 10.1111/j.1365-2958.2004.04450.x; Sun JN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001181; SUSEK RE, 1990, MOL CELL BIOL, V10, P6362, DOI 10.1128/MCB.10.12.6362; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; Tsai YL, 2010, J BIOL CHEM, V285, P19757, DOI 10.1074/jbc.M110.110296; Tsai YL, 2009, MICROBIOL-SGM, V155, P3270, DOI 10.1099/mic.0.030676-0; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Van Dijck P, 2002, INFECT IMMUN, V70, P1772, DOI 10.1128/IAI.70.4.1772-1782.2002; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yamaguchi H, 1996, J MED MICROBIOL, V45, P270, DOI 10.1099/00222615-45-4-270; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zaragoza O, 1998, J BACTERIOL, V180, P3809, DOI 10.1128/JB.180.15.3809-3815.1998; Zaragoza O, 2002, MICROBIOL-SGM, V148, P1281, DOI 10.1099/00221287-148-5-1281; Zhu Y, 2009, MOL MICROBIOL, V74, P862, DOI 10.1111/j.1365-2958.2009.06898.x	125	61	66	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38584	10.1371/journal.pone.0038584	http://dx.doi.org/10.1371/journal.pone.0038584			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685587	Green Published, gold			2022-12-27	WOS:000305351700050
J	Graves, HK; Woodfield, SE; Yang, CC; Halder, G; Bergmann, A				Graves, Hillary K.; Woodfield, Sarah E.; Yang, Chih-Chao; Halder, Georg; Bergmann, Andreas			Notch Signaling Activates Yorkie Non-Cell Autonomously in Drosophila	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; IMAGINAL DISC GROWTH; PROLIFERATION ARREST; APOPTOSIS; PROMOTES; JAK/STAT; PATHWAY; FAMILY; CANCER; VPS25	In Drosophila imaginal epithelia, cells mutant for the endocytic neoplastic tumor suppressor gene vps25 stimulate nearby untransformed cells to express Drosophila Inhibitor-of-Apoptosis-Protein-1 (DIAP-1), conferring resistance to apoptosis non-cell autonomously. Here, we show that the non-cell autonomous induction of DIAP-1 is mediated by Yorkie, the conserved downstream effector of Hippo signaling. The non-cell autonomous induction of Yorkie is due to Notch signaling from vps25 mutant cells. Moreover, activated Notch in normal cells is sufficient to induce non-cell autonomous Yorkie activity in wing imaginal discs. Our data identify a novel mechanism by which Notch promotes cell survival non-cell autonomously and by which neoplastic tumor cells generate a supportive microenvironment for tumor growth.	[Graves, Hillary K.; Woodfield, Sarah E.; Yang, Chih-Chao; Halder, Georg; Bergmann, Andreas] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Woodfield, Sarah E.; Halder, Georg; Bergmann, Andreas] Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA; [Yang, Chih-Chao; Halder, Georg; Bergmann, Andreas] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Graves, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	Andreas.Bergmann@umassmed.edu	Halder, Georg/F-2966-2015; Woodfield, Sarah/AAG-9602-2022; Graves, Hillary/K-6690-2012; Woodfield, Sarah/AEW-0563-2022	Halder, Georg/0000-0001-7580-3236; 	National Institutes of Health [GM068016, GM67997]; Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067997, R01GM068016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM068016 to AB and GM67997 to GH) and the Cancer Prevention and Research Institute of Texas (CPRIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; FIALKOW PJ, 1976, BIOCHIM BIOPHYS ACTA, V458, P283, DOI 10.1016/0304-419X(76)90003-2; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Go MJ, 1998, DEVELOPMENT, V125, P2031; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Herz HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004165; Herz HM, 2009, BIOCHEM SOC T, V37, P204, DOI 10.1042/BST0370204; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Gutierrez-Avino FJ, 2009, EMBO REP, V10, P1051, DOI 10.1038/embor.2009.140; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Lee SB, 2005, J CELL SCI, V118, P1851, DOI 10.1242/jcs.02312; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; NOWELL P, 1976, CANCER, V38, P1873, DOI 10.1002/1097-0142(197611)38:5<1873::AID-CNCR2820380502>3.0.CO;2-I; OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Reynolds-Kenneally J, 2005, DEV BIOL, V285, P38, DOI 10.1016/j.ydbio.2005.05.038; RING JM, 1993, DEVELOPMENT, P251; Robinson BS, 2011, CELL CYCLE, V10, P4110, DOI 10.4161/cc.10.23.18243; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Tanaka N, 2008, CANCER SCI, V99, P1293, DOI 10.1111/j.1349-7006.2008.00825.x; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006	46	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e37615	10.1371/journal.pone.0037615	http://dx.doi.org/10.1371/journal.pone.0037615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679484	Green Published, gold			2022-12-27	WOS:000305343900009
J	Harrison, RD; Ronsted, N; Xu, L; Rasplus, JY; Cruaud, A				Harrison, Rhett D.; Ronsted, Nina; Xu, Lei; Rasplus, Jean-Yves; Cruaud, Astrid			Evolution of Fruit Traits in Ficus Subgenus Sycomorus (Moraceae): To What Extent Do Frugivores Determine Seed Dispersal Mode?	PLOS ONE			English	Article							FIG-POLLINATOR MUTUALISM; COMMUNITY; COEVOLUTION; PHYLOGENY; DIVERSITY; ECOLOGY; DIOECY; WASPS	Fig trees are a ubiquitous component of tropical rain forests and exhibit an enormous diversity of ecologies. Focusing on Ficus subgenus Sycomorus, a phenotypically diverse and ecologically important Old World lineage, we examined the evolution of fruit traits using a molecular phylogeny constructed using 5 kilobases of DNA sequence data from 63 species (50% of global diversity). In particular, we ask whether patterns of trait correlations are consistent with dispersal agents as the primary selective force shaping morphological diversity or if other ecological factors may provide a better explanation? Fig colour, size and placement (axial, cauliflorous, or geocarpic) were all highly evolutionarily liable, and the same fruit traits have evolved in different biogeographic regions with substantially different dispersal agents. After controlling for phylogenetic autocorrelation, we found that fig colour and size were significantly associated with fig placement and plant-life history traits (maximum plant height and leaf area, respectively). However, contrary to prevailing assumptions, fig placement correlated poorly with known dispersal agents and appears more likely determined by other factors, such as flowering phenology, nutrient economy, and habitat preference. Thus, plant life-history, both directly and through its influence on fig placement, appears to have played a prominent role in determining fruit traits in these figs.	[Harrison, Rhett D.; Xu, Lei] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Ronsted, Nina] Nat Hist Museum Denmark, Bot Garden, Copenhagen, Denmark; [Rasplus, Jean-Yves; Cruaud, Astrid] CBGP INRA IRD CIRAD Montpellier SupAgro, INRA UMR Ctr Biol & Gest Populat, Montferrier Sur Lez, France	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Harrison, RD (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China.	rharrison@xtbg.org.cn	Rønsted, Nina/A-5065-2013; Rasplus, Jean-Yves/O-2873-2017	Rønsted, Nina/0000-0002-2002-5809; Rasplus, Jean-Yves/0000-0001-8614-6665; Harrison, Rhett/0000-0001-9055-3546	330 National Science Foundation China (NSFC) [30972294, 30571507, 30670358]; ANR	330 National Science Foundation China (NSFC); ANR(French National Research Agency (ANR))	This project was supported by 330 National Science Foundation China grants (NSFC Grant No. 30972294) to RDH and Yang Darong (NSFC Grant No. 30571507, 30670358) to LX, and ANR projects "NiceFigs" and "BioFigs" to AC and JYR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker NP, 2005, ANN MO BOT GARD, V92, P445; Berg C.C., 1992, AFRICAN FIG TREES FI; Berg CC, 2005, FLORA MALESIANA 1, V17; BRONSTEIN JL, 1989, EXPERIENTIA, V45, P601, DOI 10.1007/BF01975676; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Corlett RT, 2011, ACTA OECOL, V37, P674, DOI 10.1016/j.actao.2011.01.005; Corlett RT, 1998, BIOL REV, V73, P413, DOI 10.1017/S0006323198005234; Corner E. J. H., 1978, Philosophical Transactions of the Royal Society of London, B, V281, P373, DOI 10.1098/rstb.1978.0003; Corner EJH, 1988, WAYSIDE TREES MALAYA, P861; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; Emshwiller E, 1999, MOL PHYLOGENET EVOL, V12, P310, DOI 10.1006/mpev.1999.0613; Hao GY, 2011, ECOLOGY, V92, P2117, DOI 10.1890/11-0269.1; Harrison R.D., 2005, POLLINATION ECOLOGY, V111-127, P246, DOI DOI 10.1093/molbev/mst010; Harrison RD, 2005, BIOSCIENCE, V55, P1053, DOI 10.1641/0006-3568(2005)055[1053:FATDOT]2.0.CO;2; Harrison RD, 2003, OIKOS, V100, P628, DOI 10.1034/j.1600-0706.2003.11829.x; HERRE EA, 1989, EXPERIENTIA, V45, P637, DOI 10.1007/BF01975680; Herre EA, 1996, J BIOGEOGR, V23, P593, DOI 10.1111/j.1365-2699.1996.tb00020.x; Ichie T, 2005, J TROP ECOL, V21, P237, DOI 10.1017/S0266467404002214; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Jousselin E, 2003, EVOLUTION, V57, P1255, DOI 10.1111/j.0014-3820.2003.tb00334.x; Kameyama T, 1999, RES POPUL ECOL, V41, P243, DOI 10.1007/s101440050028; Kerdelhue C, 1996, OIKOS, V75, P3, DOI 10.2307/3546315; Korine C, 2000, OECOLOGIA, V123, P560, DOI 10.1007/PL00008861; Lomascolo SB, 2010, P NATL ACAD SCI USA, V107, P14668, DOI 10.1073/pnas.1008773107; NYLANDER J.A.A., 2004, MRAIC PL PROGRAM DIS; Patel A, 1996, J ECOL, V84, P667, DOI 10.2307/2261330; PATINO S, 1994, OECOLOGIA, V100, P13, DOI 10.1007/BF00317125; Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ronsted N, 2008, SYMBIOSIS, V45, P45; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Silvieus SI, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P225; Stamatakis A, 2006, INT PAR DISTR PROC S; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Whitney KD, 2009, P ROY SOC B-BIOL SCI, V276, P2941, DOI 10.1098/rspb.2009.0483	38	19	21	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38432	10.1371/journal.pone.0038432	http://dx.doi.org/10.1371/journal.pone.0038432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679505	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343900042
J	Peng, C; Chen, YY; Shan, Y; Zhang, HJ; Guo, ZR; Li, DG; Li, SG				Peng, Cong; Chen, Yaoyu; Shan, Yi; Zhang, Haojian; Guo, Zhiru; Li, Dongguang; Li, Shaoguang			LSK Derived LSK- Cells Have a High Apoptotic Rate Related to Survival Regulation of Hematopoietic and Leukemic Stem Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; COMMON LYMPHOID PROGENITORS; CHRONIC MYELOCYTIC-LEUKEMIA; BINDING-PROTEIN ICSBP; BONE-MARROW; CLONAL ORIGIN; MICE; GENE; PTEN; DIFFERENTIATION	A balanced pool of hematopoietic stem cells (HSCs) in bone marrow is tightly regulated, and this regulation is disturbed in hematopoietic malignancies such as chronic myeloid leukemia (CML). The underlying mechanisms are largely unknown. Here we show that the Lin(-)Sca-1(+) c-Kit(-) (LSK-) cell population derived from HSC-containing Lin(-)Sca-1(+) c-Kit(+) (LSK) cells has significantly higher numbers of apoptotic cells. Depletion of LSK cells by radiation or the cytotoxic chemical 5-fluorouracil results in an expansion of the LSK- population. In contrast, the LSK- population is reduced in CML mice, and depletion of leukemia stem cells (LSCs; BCR-ABL-expressing HSCs) by deleting Alox5 or by inhibiting heat shock protein 90 causes an increase in this LSK- population. The transition of LSK to LSK- cells is controlled by the Icsbp gene and its downstream gene Lyn, and regulation of this cellular transition is critical for the survival of normal LSK cells and LSCs. These results indicate a potential function of the LSK- cells in the regulation of LSK cells and LSCs.	[Peng, Cong; Chen, Yaoyu; Shan, Yi; Zhang, Haojian; Guo, Zhiru; Li, Shaoguang] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA USA; [Li, Dongguang] Edith Cowan Univ, Sch Comp & Secur Sci, Mt Lawley, WA, Australia	University of Massachusetts System; University of Massachusetts Worcester; Edith Cowan University	Peng, C (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA.	shaoguang.li@umassmed.edu	Zhang, Haojian/H-7897-2013; Shan, Yi/E-3862-2016		Leukemia and Lymphoma Society; National Institutes of Health [R01-CA122142, R01-CA114199]; NATIONAL CANCER INSTITUTE [R01CA122142, R01CA114199] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Leukemia and Lymphoma Society and the National Institutes of Health (R01-CA122142, R01-CA114199) to S.L. S.L. is a Scholar of the Leukemia and Lymphoma Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Chen Y, 2009, LEUKEMIA, V23, P1446, DOI 10.1038/leu.2009.52; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; FIALKOW PJ, 1967, P NATL ACAD SCI USA, V58, P1468, DOI 10.1073/pnas.58.4.1468; FIALKOW PJ, 1977, AM J MED, V63, P125, DOI 10.1016/0002-9343(77)90124-3; FINER MH, 1994, BLOOD, V83, P43; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Harder KW, 2004, BLOOD, V104, P3901, DOI 10.1182/blood-2003-12-4396; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Kabarowski JHS, 2000, STEM CELLS, V18, P399, DOI 10.1002/stem.180399; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kumar R, 2008, J IMMUNOL, V181, P7507, DOI 10.4049/jimmunol.181.11.7507; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Liang Y, 2007, NAT GENET, V39, P178, DOI 10.1038/ng1938; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; OKADA S, 1992, BLOOD, V80, P3044; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Randall TD, 1998, STEM CELLS, V16, P38, DOI 10.1002/stem.160038; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Takahashi N, 1998, BLOOD, V92, P4758, DOI 10.1182/blood.V92.12.4758; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; VISSER JWM, 1984, J EXP MED, V159, P1576, DOI 10.1084/jem.159.6.1576; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	34	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38614	10.1371/journal.pone.0038614	http://dx.doi.org/10.1371/journal.pone.0038614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675576	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700088
J	Qian, F; Reiter, K; Zhang, YL; Shimp, RL; Nguyen, V; Aebig, JA; Rausch, KM; Zhu, DM; Lambert, L; Mullen, GED; Martin, LB; Long, CA; Miller, LH; Narum, DL				Qian, Feng; Reiter, Karine; Zhang, Yanling; Shimp, Richard L., Jr.; Vu Nguyen; Aebig, Joan A.; Rausch, Kelly M.; Zhu, Daming; Lambert, Lynn; Mullen, Gregory E. D.; Martin, Laura B.; Long, Carole A.; Miller, Louis H.; Narum, David L.			Immunogenicity of Self-Associated Aggregates and Chemically Cross-Linked Conjugates of the 42 kDa Plasmodium falciparum Merozoite Surface Protein-1	PLOS ONE			English	Article							AERUGINOSA EXOPROTEIN-A; BLOOD-STAGE VACCINE; MALARIA VACCINE; TERMINAL FRAGMENT; CPG OLIGODEOXYNUCLEOTIDE; ANTIBODY-RESPONSES; AOTUS-NANCYMAI; FUSION PROTEIN; CLINICAL-TRIAL; EFFICACY	Self-associated protein aggregates or cross-linked protein conjugates are, in general, more immunogenic than oligomeric or monomeric forms. In particular, the immunogenicity in mice of a recombinant malaria transmission blocking vaccine candidate, the ookinete specific Plasmodium falciparum 25 kDa protein (Pfs25), was increased more than 1000-fold when evaluated as a chemical cross-linked protein-protein conjugate as compared to a formulated monomer. Whether alternative approaches using protein complexes improve the immunogenicity of other recombinant malaria vaccine candidates is worth assessing. In this work, the immunogenicity of the recombinant 42 kDa processed form of the P. falciparum merozoite surface protein 1 (MSP1(42)) was evaluated as a self-associated, non-covalent aggregate and as a chemical cross-linked protein-protein conjugate to ExoProtein A, which is a recombinant detoxified form of Pseudomonas aeruginosa exotoxin A. MSP1(42) conjugates were prepared and characterized biochemically and biophysically to determine their molar mass in solution and stoichiometry, when relevant. The immunogenicity of the MSP1(42) self-associated aggregates, cross-linked chemical conjugates and monomers were compared in BALB/c mice after adsorption to aluminum hydroxide adjuvant, and in one instance in association with the TLR9 agonist CPG7909 with an aluminum hydroxide formulation. Antibody titers were assessed by ELISA. Unlike observations made for Pfs25, no significant enhancement in MSP1(42) specific antibody titers was observed for any conjugate as compared to the formulated monomer or dimer, except for the addition of the TLR9 agonist CPG7909. Clearly, enhancing the immunogenicity of a recombinant protein vaccine candidate by the formation of protein complexes must be established on an empirical basis.	[Qian, Feng; Reiter, Karine; Zhang, Yanling; Shimp, Richard L., Jr.; Vu Nguyen; Aebig, Joan A.; Rausch, Kelly M.; Zhu, Daming; Lambert, Lynn; Mullen, Gregory E. D.; Martin, Laura B.; Long, Carole A.; Miller, Louis H.; Narum, David L.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Qian, Feng] Second Mil Med Univ, Changzheng Hosp, Dept Rheumatol & Immunol, Shanghai, Peoples R China; [Long, Carole A.; Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Mullen, Gregory E. D.] Kings Coll London, Sch Med, Div Imaging Sci, London WC2R 2LS, England; [Martin, Laura B.] Novartis Vaccines Inst Global Hlth Srl NVGH, Siena, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Naval Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; King's College London; Novartis	Qian, F (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA.	dnarum@niaid.nih.gov	Martin, Laura/N-1789-2013	Martin, Laura/0000-0002-4431-4381; Narum, David/0000-0003-3041-5402	National Institutes of Health; MRC [G0600698] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, ZIAAI001020] Funding Source: NIH RePORTER; Medical Research Council [G0600698] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Aebig JA, 2007, J IMMUNOL METHODS, V323, P139, DOI 10.1016/j.jim.2007.04.003; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Bargieri DY, 2010, VACCINE, V28, P2818, DOI 10.1016/j.vaccine.2010.02.004; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Brady CP, 2001, PROTEIN EXPRES PURIF, V23, P468, DOI 10.1006/prep.2001.1526; Broker M, 2009, VACCINE, V27, P5574, DOI 10.1016/j.vaccine.2009.07.036; Coban C, 2004, INFECT IMMUN, V72, P584, DOI 10.1128/IAI.72.1.584-588.2004; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Egan A, 1997, INFECT IMMUN, V65, P3024, DOI 10.1128/IAI.65.8.3024-3031.1997; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Faber BW, 2007, INFECT IMMUN, V75, P5947, DOI 10.1128/IAI.01804-06; Hirunpetcharat C, 2003, VACCINE, V21, P2923, DOI 10.1016/S0264-410X(03)00132-4; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; Holder AA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P409; Huaman MC, 2008, J IMMUNOL, V180, P1451, DOI 10.4049/jimmunol.180.3.1451; Jeamwattanalert P, 2007, CLIN VACCINE IMMUNOL, V14, P342, DOI 10.1128/CVI.00397-06; Kubler-Kielb J, 2007, P NATL ACAD SCI USA, V104, P293, DOI 10.1073/pnas.0609885104; Kumar S, 2004, INFECT IMMUN, V72, P949, DOI 10.1128/IAI.72.2.949-957.2004; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Mullen GED, 2006, VACCINE, V24, P2497, DOI 10.1016/j.vaccine.2005.12.034; Near KA, 2002, INFECT IMMUN, V70, P692, DOI 10.1128/IAI.70.2.692-701.2002; Ogun SA, 2008, INFECT IMMUN, V76, P3817, DOI 10.1128/IAI.01369-07; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Pichyangkul S, 2009, VACCINE, V28, P452, DOI 10.1016/j.vaccine.2009.10.022; Poolman J, 2011, CLIN VACCINE IMMUNOL, V18, P327, DOI 10.1128/CVI.00402-10; Qian F, 2008, VACCINE, V26, P2521, DOI 10.1016/j.vaccine.2008.03.005; Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073; Qian F, 2009, MICROBES INFECT, V11, P408, DOI 10.1016/j.micinf.2008.12.009; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Rosa DS, 2004, IMMUNOL LETT, V92, P259, DOI 10.1016/j.imlet.2004.01.006; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; Saul A, 2008, PARASITOLOGY, V135, P1497, DOI 10.1017/S0031182008000280; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Shimp RL, 2006, PROTEIN EXPRES PURIF, V50, P58, DOI 10.1016/j.pep.2006.06.018; SHULER KR, 1992, J IMMUNOL METHODS, V156, P137, DOI 10.1016/0022-1759(92)90020-T; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stanisic DI, 2003, INFECT IMMUN, V71, P5700, DOI 10.1128/IAI.71.10.5700-5713.2003; Stowers AW, 2002, P NATL ACAD SCI USA, V99, P339, DOI 10.1073/pnas.012590199; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Torano G, 2006, CLIN VACCINE IMMUNOL, V13, P1052, DOI 10.1128/CVI.00144-06; Thiem VD, 2011, CLIN VACCINE IMMUNOL, V18, P730, DOI 10.1128/CVI.00532-10; Weiss R, 2010, VACCINE, V28, P4515, DOI 10.1016/j.vaccine.2010.04.054; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Xue XY, 2010, VACCINE, V28, P3152, DOI 10.1016/j.vaccine.2010.02.054	48	17	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e36996	10.1371/journal.pone.0036996	http://dx.doi.org/10.1371/journal.pone.0036996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675476	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700009
J	Swingley, WD; Meyer-Dombard, DR; Shock, EL; Alsop, EB; Falenski, HD; Havig, JR; Raymond, J				Swingley, Wesley D.; Meyer-Dombard, D'Arcy R.; Shock, Everett L.; Alsop, Eric B.; Falenski, Heinz D.; Havig, Jeff R.; Raymond, Jason			Coordinating Environmental Genomics and Geochemistry Reveals Metabolic Transitions in a Hot Spring Ecosystem	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; MICROBIAL COMMUNITY; PHYLOGENETIC CLASSIFICATION; RIBOSOMAL-RNA; SEQUENCE; THERMOPHILUS; DIVERSITY; ENERGY; ARCHAEAL; PROGRAM	We have constructed a conceptual model of biogeochemical cycles and metabolic and microbial community shifts within a hot spring ecosystem via coordinated analysis of the "Bison Pool" (BP) Environmental Genome and a complementary contextual geochemical dataset of similar to 75 geochemical parameters. 2,321 16S rRNA clones and 470 megabases of environmental sequence data were produced from biofilms at five sites along the outflow of BP, an alkaline hot spring in Sentinel Meadow (Lower Geyser Basin) of Yellowstone National Park. This channel acts as a >22 m gradient of decreasing temperature, increasing dissolved oxygen, and changing availability of biologically important chemical species, such as those containing nitrogen and sulfur. Microbial life at BP transitions from a 92 degrees C chemotrophic streamer biofilm community in the BP source pool to a 56 degrees C phototrophic mat community. We improved automated annotation of the BP environmental genomes using BLAST-based Markov clustering. We have also assigned environmental genome sequences to individual microbial community members by complementing traditional homology-based assignment with nucleotide word-usage algorithms, allowing more than 70% of all reads to be assigned to source organisms. This assignment yields high genome coverage in dominant community members, facilitating reconstruction of nearly complete metabolic profiles and in-depth analysis of the relation between geochemical and metabolic changes along the outflow. We show that changes in environmental conditions and energy availability are associated with dramatic shifts in microbial communities and metabolic function. We have also identified an organism constituting a novel phylum in a metabolic "transition" community, located physically between the chemotroph- and phototroph-dominated sites. The complementary analysis of biogeochemical and environmental genomic data from BP has allowed us to build ecosystem-based conceptual models for this hot spring, reconstructing whole metabolic networks in order to illuminate community roles in shaping and responding to geochemical variability.	[Swingley, Wesley D.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Meyer-Dombard, D'Arcy R.] Univ Illinois, Dept Earth & Environm Sci, Chicago, IL USA; [Shock, Everett L.; Alsop, Eric B.; Falenski, Heinz D.; Havig, Jeff R.; Raymond, Jason] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Shock, Everett L.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	University of California System; University of California Merced; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Swingley, WD (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	jason.raymond@asu.edu		Shock, Everett/0000-0002-4283-0163; Havig, Jeff/0000-0002-1326-3382	NASA Exobiology and Evolutionary Biology Program [NNX08AP61G]; NASA Astrobiology Institute at ASU [08-NAI5-0018]	NASA Exobiology and Evolutionary Biology Program(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute at ASU	WDS and JR acknowledge support from the NASA Exobiology and Evolutionary Biology Program (NNX08AP61G). EBA and JR acknowledge support from the NASA Astrobiology Institute at ASU (08-NAI5-0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arai H, 2010, J BACTERIOL, V192, P2651, DOI 10.1128/JB.00158-10; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; BOONE DR, 2001, BERGEYS MANUAL SYSTE, V1; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cox A, 2011, CHEM GEOL, V280, P344, DOI 10.1016/j.chemgeo.2010.11.022; D'Imperio S, 2008, APPL ENVIRON MICROB, V74, P5802, DOI 10.1128/AEM.00852-08; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dick JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022782; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Hall JR, 2008, APPL ENVIRON MICROB, V74, P4910, DOI 10.1128/AEM.00233-08; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Havig JR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001415; Hedlund BP, 2011, GEOBIOLOGY, V9, P471, DOI 10.1111/j.1472-4669.2011.00295.x; Hugenholtz P, 2004, INT J SYST EVOL MICR, V54, P2049, DOI 10.1099/ijs.0.03028-0; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kislyuk A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-316; Klatt CG, 2011, ISME J, V5, P1262, DOI 10.1038/ismej.2011.73; Krause L, 2008, NUCLEIC ACIDS RES; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McHardy AC, 2007, CURR OPIN MICROBIOL, V10, P499, DOI 10.1016/j.mib.2007.08.004; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Meyer-Dombard DR, 2012, EXTREMOPHILES, V16, P317, DOI 10.1007/s00792-012-0432-5; Meyer-Dombard DR, 2011, ENVIRON MICROBIOL, V13, P2216, DOI 10.1111/j.1462-2920.2011.02476.x; Nakashima H, 1998, DNA Res, V5, P251, DOI 10.1093/dnares/5.5.251; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Ren Y, 2010, J BACTERIOL, V192, P2463, DOI 10.1128/JB.00067-10; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shock EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4005, DOI 10.1016/j.gca.2009.08.036; Sikorski J, 2010, STAND GENOMIC SCI, V3, P37, DOI 10.4056/sigs.1042812; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tang KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-334; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Van Dongen S. M., 2000, GRAPH CLUSTERING FLO; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Windman T, 2007, ASTROBIOLOGY, V7, P873, DOI 10.1089/ast.2007.0127; Wirth R, 2010, STAND GENOMIC SCI, V2, P194, DOI 10.4056/sigs.761490; Wu DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004207; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08	59	57	58	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38108	10.1371/journal.pone.0038108	http://dx.doi.org/10.1371/journal.pone.0038108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675512	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341700038
J	Talbert, A; Thuo, N; Karisa, J; Chesaro, C; Ohuma, E; Ignas, J; Berkley, JA; Toromo, C; Atkinson, S; Maitland, K				Talbert, Alison; Thuo, Nahashon; Karisa, Japhet; Chesaro, Charles; Ohuma, Eric; Ignas, James; Berkley, James A.; Toromo, Christopher; Atkinson, Sarah; Maitland, Kathryn			Diarrhoea Complicating Severe Acute Malnutrition in Kenyan Children: A Prospective Descriptive Study of Risk Factors and Outcome	PLOS ONE			English	Article							MALNOURISHED CHILDREN; INTESTINAL PERMEABILITY; CRITICAL-APPRAISAL; MANAGEMENT; BACTEREMIA; MORTALITY; KILIFI; REHYDRATION; EFFICACY; SAFETY	Background: Severe acute malnutrition (SAM) accounts for two million deaths worldwide annually. In those hospitalised with SAM, concomitant infections and diarrhoea are frequent complications resulting in adverse outcome. We examined the clinical and laboratory features on admission and outcome of children with SAM and diarrhoea at a Kenyan district hospital. Methods: A 4-year prospective descriptive study involving 1,206 children aged 6 months to 12 years, hospitalized with SAM and managed in accordance with WHO guidelines. Data on clinical features, haematological, biochemical and microbiological findings for children with diarrhoea (>= 3 watery stools/day) were systematically collected and analyzed to identify risk factors associated with poor outcome. Results: At admission 592 children (49%) had diarrhoea of which 122 (21%) died compared to 72/614 (12%) deaths in those without diarrhoea at admission (X-2 = 17.6 p<0.001). A further 187 (16%) children developed diarrhoea after 48 hours of admission and 33 died (18%). Any diarrhoea during admission resulted in a significantly higher mortality 161/852 (19%) than those uncomplicated by diarrhoea 33/351 (9%) (X-2 = 16.6 p<0.001). Features associated with a fatal outcome in children presenting with diarrhoea included bacteraemia, hyponatraemia, low mid-upper arm circumference <10 cm, hypoxia, hypokalaemia and oedema. Bacteraemia had the highest risk of death (adjusted OR 6.1; 95% C.I 2.3, 16.3 p<0.001); and complicated 24 (20%) of fatalities. Positive HIV antibody status was more frequent in cases with diarrhoea at admission (23%) than those without (15%, X-2 = 12.0 p = 0.001) but did not increase the risk of death in diarrhoea cases. Conclusion: Children with SAM complicated by diarrhoea had a higher risk of death than those who did not have diarrhoea during their hospital stay. Further operational and clinical research is needed to reduce mortality in children with SAM in the given setting.	[Talbert, Alison; Thuo, Nahashon; Karisa, Japhet; Chesaro, Charles; Ohuma, Eric; Ignas, James; Berkley, James A.; Toromo, Christopher; Atkinson, Sarah; Maitland, Kathryn] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Berkley, James A.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Atkinson, Sarah] Univ Oxford, Dept Paediat, Oxford, England; [Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wellcome Trust Ctr Clin Trop Med, London, England	Kenya Medical Research Institute; University of Oxford; University of Oxford; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Talbert, A (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.	kathryn.maitland@gmail.com		Maitland, Kathryn/0000-0002-0007-0645; Berkley, James/0000-0002-1236-849X; CHESARO, CHARLES/0000-0003-1510-1296; Thuo, Nahashon/0000-0003-3719-6695	Wellcome Trust [077092/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funded by the Wellcome Trust grant number 077092/Z/05/Z, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Akech SO, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-71; Alam NH, 2003, J PEDIATR-US, V143, P614, DOI 10.1067/S0022-3476(03)00500-6; Alam NH, 2009, J PEDIATR GASTR NUTR, V48, P318, DOI 10.1097/MPG.0b013e318180af27; Amadi B, 2002, J PEDIATR GASTR NUTR, V34, pS54, DOI 10.1097/00005176-200205001-00013; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Brewster DR, 2006, J PAEDIATR CHILD H, V42, P583, DOI 10.1111/j.1440-1754.2006.00933.x; Brewster DR, 2006, J PAEDIATR CHILD H, V42, P568, DOI 10.1111/j.1440-1754.2006.00931.x; Brewster DR, 1997, ARCH DIS CHILD, V76, P236, DOI 10.1136/adc.76.3.236; Collins S, 2007, ARCH DIS CHILD, V92, P453, DOI 10.1136/adc.2006.098327; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; Heikens GT, 2007, PLOS MED, V4, P222, DOI 10.1371/journal.pmed.0040045; Irena AH, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-110; Kukuruzovic RH, 2002, J PEDIATR GASTR NUTR, V35, P206, DOI 10.1097/00005176-200208000-00020; Kukuruzovic RH, 2002, J PAEDIATR CHILD H, V38, P571, DOI 10.1046/j.1440-1754.2002.00044.x; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Muchohi SN, 2011, J CHROMATOGR B, V879, P146, DOI 10.1016/j.jchromb.2010.11.032; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Nyeko Richard, 2010, BMC Pediatr, V10, P31, DOI 10.1186/1471-2431-10-31; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Rohner P, 1997, J CLIN MICROBIOL, V35, P1427, DOI 10.1128/JCM.35.6.1427-1432.1997; St-Arnaud-McKenzie D, 2004, PLOS MED, V59, P1304; Thuo N, 2011, J ANTIMICROB CHEMOTH; Waterlow J, 1999, LANCET, V354, P1142, DOI 10.1016/S0140-6736(99)00329-3; World Health Organization, 1999, MAN SEV MALN MAN PHY	29	93	95	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38321	10.1371/journal.pone.0038321	http://dx.doi.org/10.1371/journal.pone.0038321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675542	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700058
J	Boughter, JD; Mulligan, MK; St John, SJ; Tokita, K; Lu, L; Heck, DH; Williams, RW				Boughter, John D., Jr.; Mulligan, Megan K.; St John, Steven J.; Tokita, Kenichi; Lu, Lu; Heck, Detlef H.; Williams, Robert W.			Genetic Control of a Central Pattern Generator: Rhythmic Oromotor Movement in Mice Is Controlled by a Major Locus near Atp1a2	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; NEURONAL-ACTIVITY; MOUSE STRAINS; ION CHANNELS; KCNJ9 GIRK3; LICKING; MOTOR; C57BL/6J; RAT; BXD	Fluid licking in mice is a rhythmic behavior that is controlled by a central pattern generator (CPG) located in a complex of brainstem nuclei. C57BL/6J (B6) and DBA/2J (D2) strains differ significantly in water-restricted licking, with a highly heritable difference in rates (h(2)>= 0.62) and a corresponding 20% difference in interlick interval (mean +/- SEM = 116.3 +/- 1 vs 95.4 +/- 1.1 ms). We systematically quantified motor output in these strains, their F-1 hybrids, and a set of 64 BXD progeny strains. The mean primary interlick interval (MPI) varied continuously among progeny strains. We detected a significant quantitative trait locus (QTL) for a CPG controlling lick rate on Chr 1 (Lick1), and a suggestive locus on Chr 10 (Lick10). Linkage was verified by testing of B6. D2-1D congenic stock in which a segment of Chr 1 of the D2 strain was introgressed onto the B6 parent. The Lick1 interval on distal Chr 1 contains several strong candidate genes. One of these is a sodium/potassium pump subunit (Atp1a2) with widespread expression in astrocytes, as well as in a restricted population of neurons. Both this subunit and the entire Na+/K+-ATPase molecule have been implicated in rhythmogenesis for respiration and locomotion. Sequence variants in or near Apt1a2 strongly modulate expression of the cognate mRNA in multiple brain regions. This gene region has recently been sequenced exhaustively and we have cataloged over 300 non-coding and synonymous mutations segregating among BXD strains, one or more of which is likely to contribute to differences in central pattern generator tempo.	[Boughter, John D., Jr.; Mulligan, Megan K.; Tokita, Kenichi; Lu, Lu; Heck, Detlef H.; Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [St John, Steven J.] Rollins Coll, Dept Psychol, Winter Pk, FL 32789 USA	University of Tennessee System; University of Tennessee Health Science Center; Rollins College	Boughter, JD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	jboughter@uthsc.edu	Heck, Detlef/GPS-4854-2022; Williams, Robert W./H-8789-2016	Mulligan, Megan/0000-0003-4909-635X; Williams, Robert W./0000-0001-8924-4447; Heck, Detlef/0000-0003-2438-4064	National Institute of Neurological Disorders and Stroke [NS052366, NS060887A]; National Institute on Alcohol Abuse and Alcoholism [U01AA017590, U01AA13499]; UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052366, R01NS060887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, U01AA013499, U01AA017590] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by grants from the National Institute of Neurological Disorders and Stroke to JDB (NS052366) and DHH (NS060887A), and from the National Institute on Alcohol Abuse and Alcoholism to RWW (U01AA017590 and U01AA13499). GeneNetwork is supported in part by the UT Center for Integrative and Translational Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado C, 2008, J NEUROCHEM, V105, P497, DOI 10.1111/j.1471-4159.2007.05153.x; Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; Ballerini L, 1997, J NEUROPHYSIOL, V77, P17, DOI 10.1152/jn.1997.77.1.17; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; Boughter JD, 2007, GENES BRAIN BEHAV, V6, P619, DOI 10.1111/j.1601-183X.2006.00293.x; Boughter JD, 2005, CHEM SENSES, V30, pA106; Brocard F, 2010, NEUROSCIENTIST, V16, P139, DOI 10.1177/1073858409346339; Brozek G, 1996, P NATL ACAD SCI USA, V93, P3325, DOI 10.1073/pnas.93.8.3325; Bryant JL, 2010, EUR J NEUROSCI, V32, P41, DOI 10.1111/j.1460-9568.2010.07244.x; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Castro-Alamancos MA, 2007, J NEUROPHYSIOL, V97, P1883, DOI 10.1152/jn.01358.2006; Chen ZX, 2003, AM J PHYSIOL-REG I, V285, pR68, DOI 10.1152/ajpregu.00054.2003; Chen ZX, 2001, AM J PHYSIOL-REG I, V280, pR1085, DOI 10.1152/ajpregu.2001.280.4.R1085; Ciobanu DC, 2010, GENETICS, V184, P119, DOI 10.1534/genetics.109.107474; Darbon P, 2003, J NEUROPHYSIOL, V90, P3119, DOI 10.1152/jn.00579.2003; Davis RC, 2005, GENOMICS, V86, P259, DOI 10.1016/j.ygeno.2005.05.010; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Del Negro CA, 2009, J PHYSIOL-LONDON, V587, P1217, DOI 10.1113/jphysiol.2008.164079; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Ferraro TN, 2007, PHYSIOL GENOMICS, V31, P458, DOI 10.1152/physiolgenomics.00123.2007; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Glendinning JI, 2005, CHEM SENSES, V30, P601, DOI 10.1093/chemse/bji054; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2000, BRAIN RES, V886, P224, DOI 10.1016/S0006-8993(00)03088-2; Grosse G, 2003, MOL CELL NEUROSCI, V24, P709, DOI 10.1016/S1044-7431(03)00234-3; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; Hayar A, 2006, J NEUROSCI METH, V153, P203, DOI 10.1016/j.jneumeth.2005.10.023; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; HOROWITZ GP, 1977, PHYSIOL BEHAV, V19, P493, DOI 10.1016/0031-9384(77)90224-4; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; JUCH PJW, 1985, ARCH ORAL BIOL, V30, P415, DOI 10.1016/0003-9969(85)90069-X; Kelly MA, 2003, MAMM GENOME, V14, P692, DOI 10.1007/s00335-003-2273-0; Kiehn O, 2004, NEURON, V41, P317, DOI 10.1016/S0896-6273(04)00042-X; Korostynski M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-146; Kozell LB, 2009, J NEUROSCI, V29, P11662, DOI 10.1523/JNEUROSCI.1413-09.2009; Lang IM, 2009, DYSPHAGIA, V24, P333, DOI 10.1007/s00455-009-9211-6; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Li ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012181; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Lionikas A, 2005, PHYSIOL GENOMICS, V21, P184, DOI 10.1152/physiolgenomics.00209.2004; Ljungberg K, 2004, BIOINFORMATICS, V20, P1887, DOI 10.1093/bioinformatics/bth175; Loguercio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013920; Lohoff FW, 2005, NEUROSCI LETT, V382, P33, DOI 10.1016/j.neulet.2005.02.057; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moseley AE, 2003, J BIOL CHEM, V278, P5317, DOI 10.1074/jbc.M211315200; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Nair HK, 2011, PAIN, V152, P599, DOI 10.1016/j.pain.2010.11.029; NAKAMURA Y, 1995, NEUROSCI RES, V23, P1, DOI 10.1016/0168-0102(95)00925-J; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Onimaru H, 2007, J PHYSIOL-LONDON, V584, P271, DOI 10.1113/jphysiol.2007.136572; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Peng L, 1997, J NEUROSCI, V17, P3488; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; Pruss H, 2008, NEUROSCI LETT, V445, P89, DOI 10.1016/j.neulet.2008.08.041; Reiner DJ, 2008, CHEM SENSES, V33, P693, DOI 10.1093/chemse/bjn025; Rosen GD, 2009, GENES BRAIN BEHAV, V8, P296, DOI 10.1111/j.1601-183X.2009.00473.x; Saba L, 2006, MAMM GENOME, V17, P669, DOI 10.1007/s00335-005-0190-0; Selverston AI, 2010, PHILOS T R SOC B, V365, P2329, DOI 10.1098/rstb.2009.0270; Shires CB, 2011, OTOLARYNG HEAD NECK, V144, P915, DOI 10.1177/0194599811399722; Smith BK, 2001, AM J PHYSIOL-REG I, V281, pR596, DOI 10.1152/ajpregu.2001.281.2.R596; Smith SB, 2008, PHARMACOGENET GENOM, V18, P231, DOI 10.1097/FPC.0b013e3282f55ab2; STELLAR E, 1952, J COMP PHYSIOL PSYCH, V45, P96, DOI 10.1037/h0062150; Tang XF, 2009, GLIA, V57, P1706, DOI 10.1002/glia.20882; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Tordoff MG, 2007, CHEM SENSES, V32, P655, DOI 10.1093/chemse/bjm034; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Travers JB, 2002, NEUROSCIENCE, V115, P1139, DOI 10.1016/S0306-4522(02)00489-X; Venugopal S, 2010, NEUROSCIENCE, V168, P31, DOI 10.1016/j.neuroscience.2010.03.036; Wang GH, 1999, PSYCHOPHARMACOLOGY, V147, P38, DOI 10.1007/s002130051140; Weijnen JAWM, 1998, NEUROSCI BIOBEHAV R, V22, P751, DOI 10.1016/S0149-7634(98)00003-7; Zhang H, 2008, PHYSIOL BEHAV, V93, P461, DOI 10.1016/j.physbeh.2007.10.004; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	78	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38169	10.1371/journal.pone.0038169	http://dx.doi.org/10.1371/journal.pone.0038169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675444	gold, Green Published			2022-12-27	WOS:000305338500099
J	Shiozaki, A; Bai, XH; Shen-Tu, G; Moodley, S; Takeshita, H; Fung, SY; Wang, YC; Keshavjee, S; Liu, MY				Shiozaki, Atsushi; Bai, Xiao-hui; Shen-Tu, Grace; Moodley, Serisha; Takeshita, Hiroki; Fung, Shan-Yu; Wang, Yingchun; Keshavjee, Shaf; Liu, Mingyao			Claudin 1 Mediates TNF alpha-Induced Gene Expression and Cell Migration in Human Lung Carcinoma Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; FACTOR-KAPPA-B; ADAPTER PROTEIN; TIGHT JUNCTIONS; RECEPTOR; XB130; OVEREXPRESSION; LAMELLIPODIA; METASTASIS	Epithelial-mesenchymal transition (EMT) is an important mechanism in carcinogenesis. To determine the mechanisms that are involved in the regulation of EMT, it is crucial to develop new biomarkers and therapeutic targets towards cancers. In this study, when TGF beta 1 and TNF alpha were used to induce EMT in human lung carcinoma A549 cells, we found an increase in an epithelial cell tight junction marker, Claudin 1. We further identified that it was the TNF alpha and not the TGF beta 1 that induced the fibroblast-like morphology changes. TNF alpha also caused the increase in Claudin-1 gene expression and protein levels in Triton X-100 soluble cytoplasm fraction. Down-regulation of Claudin-1, using small interfering RNA (siRNA), inhibited 75% of TNF alpha-induced gene expression changes. Claudin-1 siRNA effectively blocked TNF alpha-induced molecular functional networks related to inflammation and cell movement. Claudin-1 siRNA was able to significantly reduce TNF-enhanced cell migration and fibroblast-like morphology. Furthermore, over expression of Claudin 1 with a Claudin 1-pcDNA3.1/V5-His vector enhanced cell migration. In conclusion, these observations indicate that Claudin 1 acts as a critical signal mediator in TNF alpha-induced gene expression and cell migration in human lung cancer cells. Further analyses of these cellular processes may be helpful in developing novel therapeutic strategies.	[Shiozaki, Atsushi; Bai, Xiao-hui; Shen-Tu, Grace; Moodley, Serisha; Takeshita, Hiroki; Fung, Shan-Yu; Wang, Yingchun; Keshavjee, Shaf; Liu, Mingyao] Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Univ Hlth Network, Toronto, ON, Canada; [Keshavjee, Shaf; Liu, Mingyao] Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Shiozaki, A (corresponding author), Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Univ Hlth Network, Toronto, ON, Canada.	mingyao.liu@utoronto.ca	Fung, Shan-Yu/E-3477-2014	Fung, Shan-Yu/0000-0002-4547-8740; Liu, Mingyao/0000-0002-9188-8417; Keshavjee, Shaf/0000-0003-4547-8094	Canadian Institutes of Health Research [MOP-13270, MOP-42546]; Uehara Memorial Foundation; International Society of Heart and Lung Transplantation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Uehara Memorial Foundation(Uehara Memorial Foundation); International Society of Heart and Lung Transplantation	This research is funded by Canadian Institutes of Health Research (grants MOP-13270, MOP-42546). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Helan Xiao for technical assistance. We also thank Dr. Patricia Pintor dos Reis and Dr. Suzanne Kamel-Reid for giving Claudin 1-pcDNA3.1/V5-His plasmid. Dr. Atsushi Shiozaki was a recipient of Research Fellowship Awards from Uehara Memorial Foundation and International Society of Heart and Lung Transplantation.	Arnott CH, 2004, ONCOGENE, V23, P1902, DOI 10.1038/sj.onc.1207317; Baker OJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1191, DOI 10.1152/ajpcell.00144.2008; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Chuang MJ, 2008, CANCER SCI, V99, P905, DOI 10.1111/j.1349-7006.2008.00756.x; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dong R, 2007, BRAZ J MED BIOL RES, V40, P1071, DOI 10.1590/S0100-879X2007000800007; dos Reis PP, 2008, CANCER-AM CANCER SOC, V113, P3169, DOI 10.1002/cncr.23934; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; dos Santos CC, 2008, CRIT CARE MED, V36, P855, DOI 10.1097/CCM.0B013E3181659333; Fujita H, 2011, J ALLERGY CLIN IMMUN, V127, P1612, DOI 10.1016/j.jaci.2011.03.039; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; Harrison ML, 2007, J CLIN ONCOL, V25, P4542, DOI 10.1200/JCO.2007.11.2136; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Kim KB, 2011, J BIOL CHEM, V286, P23093, DOI 10.1074/jbc.M111.233304; Kitakata H, 2002, CANCER RES, V62, P6682; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; Kominsky Scott L., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000056; Kondo J, 2008, INT J MOL MED, V22, P645, DOI 10.3892/ijmm_00000067; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Liu XD, 2008, CELL MOTIL CYTOSKEL, V65, P935, DOI 10.1002/cm.20315; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Lodyga M, 2010, J CELL SCI, V123, P4156, DOI 10.1242/jcs.071050; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; MALIK STA, 1990, EUR J CANCER, V26, P1031, DOI 10.1016/0277-5379(90)90044-T; MALIK STA, 1989, INT J CANCER, V44, P918, DOI 10.1002/ijc.2910440529; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Mura M, 2006, CRIT CARE, V10, DOI 10.1186/cc5042; Nishiyama R, 2001, J BIOL CHEM, V276, P35571, DOI 10.1074/jbc.M106013200; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Poritz LS, 2004, J SURG RES, V116, P14, DOI 10.1016/S0022-4804(03)00311-1; Shiozaki A, 2011, AM J PATHOL, V178, P391, DOI 10.1016/j.ajpath.2010.11.024; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Tang PS, 2006, J CELL PHYSIOL, V209, P457, DOI 10.1002/jcp.20751; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wu ST, 2011, EXP BIOL MED, V236, P1022, DOI 10.1258/ebm.2011.011058; Xiao HL, 2010, MOL CELL BIOL, V30, P5545, DOI 10.1128/MCB.00382-10; Xiao H, 2009, J CELL PHYSIOL, V218, P366, DOI 10.1002/jcp.21609; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yamauchi Y, 2010, EXP LUNG RES, V36, P12, DOI 10.3109/01902140903042589; Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048; Yoon CH, 2010, J BIOL CHEM, V285, P226, DOI 10.1074/jbc.M109.054189	56	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38049	10.1371/journal.pone.0038049	http://dx.doi.org/10.1371/journal.pone.0038049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675434	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500081
J	Illeghems, K; De Vuyst, L; Papalexandratou, Z; Weckx, S				Illeghems, Koen; De Vuyst, Luc; Papalexandratou, Zoi; Weckx, Stefan			Phylogenetic Analysis of a Spontaneous Cocoa Bean Fermentation Metagenome Reveals New Insights into Its Bacterial and Fungal Community Diversity	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; RIBOSOMAL-RNA; STARTER CULTURE; TAXONOMIC CLASSIFICATION; HEAP FERMENTATION; SPECIES-DIVERSITY; GHANAIAN; POPULATIONS; SEQUENCES; CHOCOLATE	This is the first report on the phylogenetic analysis of the community diversity of a single spontaneous cocoa bean box fermentation sample through a metagenomic approach involving 454 pyrosequencing. Several sequence-based and composition-based taxonomic profiling tools were used and evaluated to avoid software-dependent results and their outcome was validated by comparison with previously obtained culture-dependent and culture-independent data. Overall, this approach revealed a wider bacterial (mainly gamma-Proteobacteria) and fungal diversity than previously found. Further, the use of a combination of different classification methods, in a software-independent way, helped to understand the actual composition of the microbial ecosystem under study. In addition, bacteriophage-related sequences were found. The bacterial diversity depended partially on the methods used, as composition-based methods predicted a wider diversity than sequence-based methods, and as classification methods based solely on phylogenetic marker genes predicted a more restricted diversity compared with methods that took all reads into account. The metagenomic sequencing analysis identified Hanseniaspora uvarum, Hanseniaspora opuntiae, Saccharomyces cerevisiae, Lactobacillus fermentum, and Acetobacter pasteurianus as the prevailing species. Also, the presence of occasional members of the cocoa bean fermentation process was revealed (such as Erwinia tasmaniensis, Lactobacillus brevis, Lactobacillus casei, Lactobacillus rhamnosus, Lactococcus lactis, Leuconostoc mesenteroides, and Oenococcus oeni). Furthermore, the sequence reads associated with viral communities were of a restricted diversity, dominated by Myoviridae and Siphoviridae, and reflecting Lactobacillus as the dominant host. To conclude, an accurate overview of all members of a cocoa bean fermentation process sample was revealed, indicating the superiority of metagenomic sequencing over previously used techniques.	[Illeghems, Koen; De Vuyst, Luc; Papalexandratou, Zoi; Weckx, Stefan] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Res Grp Ind Microbiol & Food Biotechnol IMDO, Brussels, Belgium	Vrije Universiteit Brussel	Illeghems, K (corresponding author), Vrije Univ Brussel, Fac Sci & Bioengn Sci, Res Grp Ind Microbiol & Food Biotechnol IMDO, Brussels, Belgium.	Stefan.Weckx@vub.ac.be	Weckx, Stefan/AAF-8996-2019; Weckx, Stefan/J-4254-2014; Weckx, Stefan/ABB-5390-2021	Weckx, Stefan/0000-0002-1380-8610; De Vuyst, Luc/0000-0002-7534-7186	Research Council of the Vrije Universiteit Brussel; Research Foundation Flanders (FWO) [1.5.108.09N]; Titanium FLX-award of the Flanders Institute for Biotechnology (VIB); Roche Diagnostics Belgium; Agency for Innovation by Science and Technology (IWT)	Research Council of the Vrije Universiteit Brussel; Research Foundation Flanders (FWO)(FWO); Titanium FLX-award of the Flanders Institute for Biotechnology (VIB); Roche Diagnostics Belgium; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was financed by the Research Council of the Vrije Universiteit Brussel, the Research Foundation Flanders (FWO; project number 1.5.108.09N) and a Titanium FLX-award of the Flanders Institute for Biotechnology (VIB) and Roche Diagnostics Belgium. KI is the receiver of a post-graduate Grant of the Agency for Innovation by Science and Technology (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Afoakwa E.O., 2010, CHOCOLATE SCI TECHNO; Afoakwa EO, 2008, CRIT REV FOOD SCI, V48, P840, DOI 10.1080/10408390701719272; Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; Ardhana MM, 2003, INT J FOOD MICROBIOL, V86, P87, DOI 10.1016/S0168-1605(03)00081-3; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Becket ST, 2009, IND CHOCOLATE MANUFA; Bernardeau M, 2006, FEMS MICROBIOL REV, V30, P487, DOI 10.1111/j.1574-6976.2006.00020.x; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Camu N, 2008, APPL ENVIRON MICROB, V74, P86, DOI 10.1128/AEM.01512-07; Camu N, 2007, APPL ENVIRON MICROB, V73, P1809, DOI 10.1128/AEM.02189-06; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; Carr J. G., 1979, 7 INT COC RES C DOUA, V4, P573; Daniel HM, 2009, FEMS YEAST RES, V9, P774, DOI 10.1111/j.1567-1364.2009.00520.x; Daniel HM, 2003, INT J FOOD MICROBIOL, V86, P61, DOI 10.1016/S0168-1605(03)00248-4; De Vuyst L., 2010, BIOTECHNOLOGY LACTIC, P301, DOI DOI 10.1002/9780813820866.CH17; De Vuyst L., 2010, P 16 INT COC RES C N, P1325; Devriese LA, 2002, J APPL MICROBIOL, V92, P821, DOI 10.1046/j.1365-2672.2002.01586.x; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Dobson A, 2011, FEMS MICROBIOL LETT, V320, P56, DOI 10.1111/j.1574-6968.2011.02290.x; Emond Eric, 2007, P93; Finn R. D., 2008, NUCLEIC ACIDS RES, V38, pD211; Galvez SL, 2007, INT J FOOD MICROBIOL, V114, P124, DOI 10.1016/j.ijfoodmicro.2006.10.041; Garcia-Armisen T, 2010, APPL MICROBIOL BIOT, V87, P2281, DOI 10.1007/s00253-010-2698-9; Garneau JE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S20; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Giraffa G, 2001, INT J FOOD MICROBIOL, V67, P19, DOI 10.1016/S0168-1605(01)00445-7; Hansen CE, 1998, J SCI FOOD AGR, V77, P273, DOI [10.1002/(SICI)1097-0010(199806)77:2&lt;273::AID-JSFA40&gt;3.0.CO;2-M, 10.1002/(SICI)1097-0010(199806)77:2<273::AID-JSFA40>3.3.CO;2-D]; Hauben L, 1998, SYST APPL MICROBIOL, V21, P384, DOI 10.1016/S0723-2020(98)80048-9; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hunt J, 2004, MICROB ECOL, V47, P385, DOI 10.1007/s00248-003-2018-3; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Jespersen L, 2005, FEMS YEAST RES, V5, P441, DOI 10.1016/j.femsyr.2004.11.002; Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10; Kelley DR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-544; Kobayashi M, 1998, J FERMENT BIOENG, V85, P642, DOI 10.1016/S0922-338X(98)80021-4; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kostinek M, 2008, CURR MICROBIOL, V56, P306, DOI 10.1007/s00284-008-9097-9; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lefeber T, 2012, FOOD MICROBIOL, V30, P379, DOI 10.1016/j.fm.2011.12.021; Lefeber T, 2011, APPL ENVIRON MICROB, V77, P6694, DOI 10.1128/AEM.00594-11; Lefeber T, 2011, FOOD MICROBIOL, V28, P457, DOI 10.1016/j.fm.2010.10.010; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lima LJR, 2011, CRIT REV FOOD SCI, V51, P731, DOI 10.1080/10408391003799913; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Mohammed MH, 2011, BIOINFORMATICS, V27, P22, DOI 10.1093/bioinformatics/btq608; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Nalbantoglu OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41; Neufeld JD, 2005, APPL ENVIRON MICROB, V71, P5710, DOI 10.1128/AEM.71.10.5710-5718.2005; Nielsen DS, 2007, INT J FOOD MICROBIOL, V114, P168, DOI 10.1016/j.ijfoodmicro.2006.09.010; Nielsen DS, 2007, INT J SYST EVOL MICR, V57, P1468, DOI 10.1099/ijs.0.64811-0; Nielsen DS, 2005, YEAST, V22, P271, DOI 10.1002/yea.1207; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; Papalexandratou Z, 2011, APPL ENVIRON MICROB, V77, P7698, DOI 10.1128/AEM.05523-11; Papalexandratou Z, 2011, FEMS YEAST RES, V11, P564, DOI 10.1111/j.1567-1364.2011.00747.x; Papalexandratou Z, 2011, FOOD MICROBIOL, V28, P1326, DOI 10.1016/j.fm.2011.06.003; Papalexandratou Z, 2011, FOOD MICROBIOL, V28, P964, DOI 10.1016/j.fm.2011.01.010; Park EJ, 2011, APPL ENVIRON MICROB, V77, P1284, DOI 10.1128/AEM.01859-10; PASSOS FML, 1984, J FOOD SCI, V49, P205, DOI 10.1111/j.1365-2621.1984.tb13708.x; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Sakamoto N, 2011, INT J FOOD MICROBIOL, V144, P352, DOI 10.1016/j.ijfoodmicro.2010.10.017; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Schwan RF, 1998, APPL ENVIRON MICROB, V64, P1477; Schwan RF, 2004, CRIT REV FOOD SCI, V44, P205, DOI 10.1080/10408690490464104; Shapiro OH, 2010, ISME J, V4, P327, DOI 10.1038/ismej.2009.118; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Thompson SS, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P837; Villion M, 2009, FRONT BIOSCI-LANDMRK, V14, P1661, DOI 10.2741/3332; WOOD G. A. R., 2001, COCOA	77	81	87	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38040	10.1371/journal.pone.0038040	http://dx.doi.org/10.1371/journal.pone.0038040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666442	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349600058
J	Cartelli, D; Goldwurm, S; Casagrande, F; Pezzoli, G; Cappelletti, G				Cartelli, Daniele; Goldwurm, Stefano; Casagrande, Francesca; Pezzoli, Gianni; Cappelletti, Graziella			Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson's Disease Patient Fibroblasts	PLOS ONE			English	Article							CELL-DEATH; DOPAMINERGIC-NEURONS; CLINICAL-DIAGNOSIS; FEATURES IMPROVE; G2019S MUTATION; ALPHA-SYNUCLEIN; TUBULIN; PROTEIN; LRRK2; NEURODEGENERATION	Data from both toxin-based and gene-based models suggest that dysfunction of the microtubule system contributes to the pathogenesis of Parkinson's disease, even if, at present, no evidence of alterations of microtubules in vivo or in patients is available. Here we analyze cytoskeleton organization in primary fibroblasts deriving from patients with idiopathic or genetic Parkinson's disease, focusing on mutations in parkin and leucine-rich repeat kinase 2. Our analyses reveal that genetic and likely idiopathic pathology affects cytoskeletal organization and stability, without any activation of autophagy or apoptosis. All parkinsonian fibroblasts have a reduced microtubule mass, represented by a higher fraction of unpolymerized tubulin in respect to control cells, and display significant changes in microtubule stability-related signaling pathways. Furthermore, we show that the reduction of microtubule mass is so closely related to the alteration of cell morphology and behavior that both pharmacological treatment with microtubule-targeted drugs, and genetic approaches, by transfecting the wild type parkin or leucine-rich repeat kinase 2, restore the proper microtubule stability and are able to rescue cell architecture. Taken together, our results suggest that microtubule destabilization is a point of convergence of genetic and idiopathic forms of parkinsonism and highlight, for the first time, that microtubule dysfunction occurs in patients and not only in experimental models of Parkinson's disease. Therefore, these data contribute to the knowledge on molecular and cellular events underlying Parkinson's disease and, revealing that correction of microtubule defects restores control phenotype, may offer a new therapeutic target for the management of the disease.	[Cartelli, Daniele; Casagrande, Francesca; Cappelletti, Graziella] Univ Milan, Dept Biol, Milan, Italy; [Goldwurm, Stefano; Pezzoli, Gianni] Ist Clin Perfezionamento, Parkinson Inst, Milan, Italy	University of Milan	Cartelli, D (corresponding author), Univ Milan, Dept Biol, Milan, Italy.	graziella.cappelletti@unimi.it	Cappelletti, Graziella/AAS-7780-2021; Cartelli, Daniele/K-5110-2018; Goldwurm, Stefano/Q-8978-2016; CASAGRANDE, FRANCESCA/AAC-1296-2019; Cartelli, Daniele/AAI-3424-2021	Cartelli, Daniele/0000-0002-7069-420X; Goldwurm, Stefano/0000-0002-1651-567X; CASAGRANDE, FRANCESCA/0000-0002-2093-1393; Cartelli, Daniele/0000-0002-7069-420X; Pezzoli, Gianni/0000-0003-4665-6710; Cappelletti, Graziella/0000-0003-0903-5392	Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy; "Dote ricerca", FSE, Regione Lombardia, Italy; Telethon Genetic Biobank Network [GTB07001]	Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy; "Dote ricerca", FSE, Regione Lombardia, Italy; Telethon Genetic Biobank Network(Fondazione Telethon)	This work was supported by Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy (to G.C.) and "Dote ricerca", FSE, Regione Lombardia, Italy (to D.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Jennifer S. Hartwig for reading and editing the manuscript, Dr Jenny Sassone (IRCCS Istituto Auxologico Italiano, Milano, Italy) and Dr Elisa Greggio (Department of Biology, University of Padova, Padova, Italy) for providing constructs. The samples were obtained from the "Cell Line and DNA Biobank from Patients affected by Genetic Diseases" (G. Gaslini Institute) and "Parkinson Institute Biobank" (Milan, http://www.parkinson.it/dnabank.html) of the Telethon Genetic Biobank Network (http://www.biobanknetwork.org) (project n. GTB07001).	Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Auburger G, 2012, MOL NEUROBIOL; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Cappelletti G, 2005, FEBS LETT, V579, P4781, DOI 10.1016/j.febslet.2005.07.058; Cappelletti G, 2003, EXP CELL RES, V288, P9, DOI 10.1016/S0014-4827(03)00209-X; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Goldwurm S, 2006, PARKINSONISM RELAT D, V12, P410, DOI 10.1016/j.parkreldis.2006.04.001; Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hughes AJ, 2001, NEUROLOGY, V57, pS34; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Liang YJ, 2008, J NEUROCHEM, V106, P1815, DOI 10.1111/j.1471-4159.2008.05526.x; MACEJAK DG, 1991, VIRUS RES, V19, P31, DOI 10.1016/0168-1702(91)90092-A; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; MARSHALL LE, 1978, BIOCHIM BIOPHYS ACTA, V543, P590, DOI 10.1016/0304-4165(78)90315-X; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mitra G, 2007, PROTEINS, V67, P112, DOI 10.1002/prot.21286; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Reed MJ, 2001, MECH AGEING DEV, V122, P1203, DOI 10.1016/S0047-6374(01)00260-3; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Ren Y, 2003, J NEUROSCI, V23, P3316; Ren Y, 2009, J BIOL CHEM, V284, P4009, DOI 10.1074/jbc.M806245200; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Schulze C, 2010, BIOPHYS J, V99, P2434, DOI 10.1016/j.bpj.2010.08.026; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sironi F, 2008, PARKINSONISM RELAT D, V14, P326, DOI 10.1016/j.parkreldis.2007.10.003; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Wu GH, 2011, BRAIN RES, V1394, P105, DOI 10.1016/j.brainres.2011.04.013; Xiao DH, 2003, CANCER RES, V63, P6825; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Yang F, 2005, J BIOL CHEM, V280, P17154, DOI 10.1074/jbc.M500843200	52	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37467	10.1371/journal.pone.0037467	http://dx.doi.org/10.1371/journal.pone.0037467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22666358	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300044
J	Maidment, SCR; Linton, DH; Upchurch, P; Barrett, PM				Maidment, Susannah C. R.; Linton, Deborah H.; Upchurch, Paul; Barrett, Paul M.			Limb-Bone Scaling Indicates Diverse Stance and Gait in Quadrupedal Ornithischian Dinosaurs	PLOS ONE			English	Article							LONG BONES; MAMMALS; LOCOMOTION; ALLOMETRY; EVOLUTION; POSTURE; MASS; HADROSAURIDAE; ORNITHOPODA; PERSPECTIVE	Background: The most primitive ornithischian dinosaurs were small bipeds, but quadrupedality evolved three times independently in the clade. The transition to quadrupedality from bipedal ancestors is rare in the history of terrestrial vertebrate evolution, and extant analogues do not exist. Constraints imposed on quadrupedal ornithischians by their ancestral bipedal bauplan remain unexplored, and consequently, debate continues about their stance and gait. For example, it has been proposed that some ornithischians could run, while others consider that none were cursorial. Methodology/Principal Findings: Drawing on biomechanical concepts of limb bone scaling and locomotor theory developed for extant taxa, we use the largest dataset of ornithischian postcranial measurements so far compiled to examine stance and gait in quadrupedal ornithischians. Differences in femoral midshaft eccentricity in hadrosaurs and ceratopsids may indicate that hadrosaurs placed their feet on the midline during locomotion, while ceratopsids placed their feet more laterally, under the hips. More robust humeri in the largest ceratopsids relative to smaller taxa may be due to positive allometry in skull size with body mass in ceratopsids, while slender humeri in the largest stegosaurs may be the result of differences in dermal armor distribution within the clade. Hadrosaurs are found to display the most cursorial morphologies of the quadrupedal ornithischian cades, indicating higher locomotor performance than in ceratopsids and thyreophorans. Conclusions/Significance: Limb bone scaling indicates that a previously unrealised diversity of stances and gaits were employed by quadrupedal ornithischians despite apparent convergence in limb morphology. Grouping quadrupedal ornithischians together as a single functional group hides this disparity. Differences in limb proportions and scaling are likely due to the possession of display structures such as horns, frills and dermal armor that may have affected the center of mass of the animal, and differences in locomotor behaviour such as migration, predator escape or home range size.	[Maidment, Susannah C. R.; Linton, Deborah H.; Barrett, Paul M.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Linton, Deborah H.; Upchurch, Paul] UCL, Dept Earth Sci, London, England	Natural History Museum London; University of London; University College London	Maidment, SCR (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	s.maidment@nhm.ac.uk	Barrett, Paul M/A-2648-2010; Maidment, Susannah C. R./A-5100-2010; Upchurch, Paul/C-1654-2008	Barrett, Paul M/0000-0003-0412-3000; Maidment, Susannah C. R./0000-0002-7741-2500; 	Natural Environment Research Council [NE/G001898/1]; NERC [NE/G001898/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DHL was funded by a Natural Environment Research Council studentship during the course of this work. SCRM is funded by Natural Environment Research Council grant number NE/G001898/1 awarded to PMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1989, DYNAMICS DINOSAURS O; Alexander R. M. N., 1985, FUNCTIONAL VERTEBRAT, P26; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; ALEXANDER RM, 1979, J ZOOL, V189, P305; Apesteguia S, 2005, LIFE O PAST, P321; BAKKER R T, 1968, Discovery (New Haven), V3, P11; BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Bates KT, 2012, J ANAT, V220, P212, DOI 10.1111/j.1469-7580.2011.01469.x; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Bonnan MF, 2003, J VERTEBR PALEONTOL, V23, P595, DOI 10.1671/A1108; Brett-Surman Michael K., 2007, P135; Brown CM, 2011, ZOOL J LINN SOC-LOND, V163, P1157, DOI 10.1111/j.1096-3642.2011.00735.x; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2010, ZOOL J LINN SOC-LOND, V160, P648, DOI 10.1111/j.1096-3642.2009.00631.x; Carpenter K, 2008, ANN CARNEGIE MUS, V76, P227, DOI 10.2992/0097-4463(2008)76[227:ANSOCO]2.0.CO;2; Carrano MT, 1999, J MORPHOL, V240, P237, DOI 10.1002/(SICI)1097-4687(199906)240:3<237::AID-JMOR3>3.3.CO;2-E; Carrano MT, 1998, PALEOBIOLOGY, V24, P450, DOI 10.1017/S0094837300020108; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Christiansen P, 1999, J ZOOL, V247, P333, DOI 10.1017/S0952836999003052; Christiansen P, 2002, ZOOL J LINN SOC-LOND, V136, P685, DOI 10.1046/j.1096-3642.2002.00041.x; Christiansen P, 2002, J MORPHOL, V251, P195, DOI 10.1002/jmor.1083; Colbert E.H., 1981, Museum of Northern Arizona Bulletin, P1; COLBERT EDWIN H., 1962, AMER MUS NOVITATES, V2076, P1; COOMBS WP, 1978, Q REV BIOL, V53, P393, DOI 10.1086/410790; Coombs WP., 1971, THESIS COLUMBIA U; Cuthbertson RS, 2010, ZOOL J LINN SOC-LOND, V159, P373, DOI 10.1111/j.1096-3642.2009.00612.x; Day JJ, 2002, NATURE, V415, P494, DOI 10.1038/415494a; Dilkes DW, 2001, CAN J EARTH SCI, V38, P1205, DOI 10.1139/e01-016; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Eaton TH, 1944, J MORPHOL, V75, P167, DOI 10.1002/jmor.1050750108; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; FARLOW JO, 1981, NATURE, V294, P746; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Galton P.M., 1985, Journal of Vertebrate Paleontology, V5, P211; Galton P.M., 1982, Geologica et Palaeontologica, V15, P139; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P343; GARLAND T, 1993, J ZOOL, V229, P133, DOI 10.1111/j.1469-7998.1993.tb02626.x; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gatton P. M., 1970, J. Paleont., V44, P464; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HARWELL MR, 1988, PSYCHOL BULL, V104, P268, DOI 10.1037/0033-2909.104.2.268; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hildebrand M., 1985, P38; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Janis Christine M., 1993, Journal of Mammalian Evolution, V1, P103, DOI 10.1007/BF01041590; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Lanyon L.E., 1985, P1; Lockley Martin G., 2001, P428; Lockley MG, 1995, J VERTEBR PALEONTOL, V15, P592, DOI 10.1080/02724634.1995.10011251; Maidment SCR, 2010, SWISS J GEOSCI, V103, P199, DOI 10.1007/s00015-010-0023-3; Marsh O.C., 1881, AM J SCI, V21, P167, DOI DOI 10.2475/AJS.S3-21.122.167; MARYANSKA T, 1984, Palaeontologia Polonica, P119; Mcdonald AT, 2010, ZOOTAXA, P1; McDonald AT, 2010, ROYAL TYRRELL MUSEUM, P156; NORMAN D B, 1980, Institut Royal des Sciences Naturelles de Belgique Memoires, P1; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P325; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Olejnik SF., 1984, J ED STAT, V9, P129, DOI [DOI 10.3102/10769986009002129, 10.3102/10769986009002129]; OSTROM JH, 1964, AM J SCI, V262, P975, DOI 10.2475/ajs.262.8.975; Paul Gregory S., 1997, P129; Prieto-Marquez Albert, 2007, P91; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; PROTHERO DR, 1982, PALEOBIOLOGY, V8, P16, DOI 10.1017/S0094837300004322; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sellers WI, 2009, PALAEONTOL ELECTRON, V12; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Senter P, 2007, J ZOOL, V273, P305, DOI 10.1111/j.1469-7998.2007.00329.x; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P168; Sereno PC, 2007, ACTA PALAEONTOL POL, V52, P275; Sereno Paul C., 2010, P21; STERNBERG CHARLES M., 1927, CANADIAN FIELD NAT, V41, P67; Tereshchenko V. S., 1996, PALEONTOL J, V30, P232; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Thompson S, 2007, PALAEONTOL ELECTRON, V10; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch P, 2007, SPEC PAP PALAEONTOL, P57; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Xu X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013835; Yates AM, 2007, SPEC PAP PALAEONTOL, P9	90	29	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36904	10.1371/journal.pone.0036904	http://dx.doi.org/10.1371/journal.pone.0036904			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22666333	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300014
J	Kelsch, W; Stolfi, A; Lois, C				Kelsch, Wolfgang; Stolfi, Alberto; Lois, Carlos			Genetic Labeling of Neuronal Subsets through Enhancer Trapping in Mice	PLOS ONE			English	Article							TRANSGENIC MICE; THY-1 GENE; LENTIVIRAL VECTORS; HUMAN GENOME; EXPRESSION; DROSOPHILA; BRAIN; CELLS; INTERNEURONS; INTEGRATION	The ability to label, visualize, and manipulate subsets of neurons is critical for elucidating the structure and function of individual cell types in the brain. Enhancer trapping has proved extremely useful for the genetic manipulation of selective cell types in Drosophila. We have developed an enhancer trap strategy in mammals by generating transgenic mice with lentiviral vectors carrying single-copy enhancer-detector probes encoding either the marker gene lacZ or Cre recombinase. This transgenic strategy allowed us to genetically identify a wide variety of neuronal subpopulations in distinct brain regions. Enhancer detection by lentiviral transgenesis could thus provide a complementary method for generating transgenic mouse libraries for the genetic labeling and manipulation of neuronal subsets.	[Kelsch, Wolfgang] Heidelberg Univ, Med Fac Mannheim, Bernstein Ctr Computat Neurosci, CIMH, Heidelberg, Germany; [Stolfi, Alberto] New York Univ, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; [Lois, Carlos] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; New York University; University of Massachusetts System; University of Massachusetts Worcester	Kelsch, W (corresponding author), Heidelberg Univ, Med Fac Mannheim, Bernstein Ctr Computat Neurosci, CIMH, Heidelberg, Germany.	Carlos.Lois@umassmed.edu	Stolfi, Alberto/AAS-8031-2021	Kelsch, Wolfgang/0000-0002-3470-8125	David and Lucille Packard Foundation	David and Lucille Packard Foundation(The David & Lucile Packard Foundation)	This work was funded by an award from the David and Lucille Packard Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1989, PLANT CELL, V1, P623, DOI 10.1105/tpc.1.6.623; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GORDON JW, 1987, CELL, V50, P445, DOI 10.1016/0092-8674(87)90498-3; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCKNIGHT GS, 1983, CELL, V34, P335; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PERRIMON N, 1991, DEV GENET, V12, P238, DOI 10.1002/dvg.1020120309; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; SPANOPOULOU E, 1988, MOL CELL BIOL, V8, P3847, DOI 10.1128/MCB.8.9.3847; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	30	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38593	10.1371/journal.pone.0038593	http://dx.doi.org/10.1371/journal.pone.0038593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685588	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305351700051
J	Rippe, RCA; Meulman, JJ; Eilers, PHC				Rippe, Ralph C. A.; Meulman, Jacqueline J.; Eilers, Paul H. C.			Visualization of Genomic Changes by Segmented Smoothing Using an L-0 Penalty	PLOS ONE			English	Article								Copy number variations (CNV) and allelic imbalance in tumor tissue can show strong segmentation. Their graphical presentation can be enhanced by appropriate smoothing. Existing signal and scatterplot smoothers do not respect segmentation well. We present novel algorithms that use a penalty on the L-0 norm of differences of neighboring values. Visualization is our main goal, but we compare classification performance to that of VEGA.	[Rippe, Ralph C. A.] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Meulman, Jacqueline J.] Leiden Univ, Inst Math, NL-2300 RA Leiden, Netherlands; [Eilers, Paul H. C.] Erasmus MC, Dept Biostat, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Rippe, RCA (corresponding author), Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	R.C.A.Rippe@lumc.nl						Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Budinska E, 2009, BIOINFORMATICS, V25, P703, DOI 10.1093/bioinformatics/btp022; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Eilers P, 2005, BIOINFORMATICS; Eilers PHC, 2004, BIOINFORMATICS, V20, P623, DOI 10.1093/bioinformatics/btg454; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Fraley C, 2004, J STAT SOFTWARE, P18; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Liu Z, 2010, PLOS ONE, P5; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; Morganella S, 2010, BIOINFORMATICS, V21, P1146; Muggeo VMR, 2011, BIOINFORMATICS, V27, P161, DOI 10.1093/bioinformatics/btq647; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SCHLOSSMACHER EJ, 1973, J AM STAT ASSOC, V68, P857, DOI 10.2307/2284512; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tsuang DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014456; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511	21	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38230	10.1371/journal.pone.0038230	http://dx.doi.org/10.1371/journal.pone.0038230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679492	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900022
J	Morgado, A; Almeida, F; Teixeira, A; Silva, AL; Romao, L				Morgado, Ana; Almeida, Fatima; Teixeira, Alexandre; Silva, Ana Luisa; Romao, Luisa			Unspliced Precursors of NMD-Sensitive beta-Globin Transcripts Exhibit Decreased Steady-State Levels in Erythroid Cells	PLOS ONE			English	Article							MESSENGER-RNA DECAY; PREMATURE TERMINATION CODON; NONSENSE-MEDIATED DECAY; EXON JUNCTION COMPLEX; OPEN READING FRAME; QUALITY-CONTROL; MAMMALIAN-CELLS; GENE-EXPRESSION; NUCLEAR; MUTATIONS	Nonsense-mediated mRNA decay (NMD) is a quality control mechanism that detects and rapidly degrades mRNAs carrying premature translation-termination codons (PTCs). Mammalian NMD depends on both splicing and translation, and requires recognition of the premature stop codon by the cytoplasmic ribosomes. Surprisingly, some published data have suggested that nonsense codons may also affect the nuclear metabolism of the nonsense-mutated transcripts. To determine if nonsense codons could influence nuclear events, we have directly assessed the steady-state levels of the unspliced transcripts of wild-type and PTC-containing human beta-globin genes stably transfected in mouse erythroleukemia (MEL) cells, after erythroid differentiation induction, or in HeLa cells. Our analyses by ribonuclease protection assays and reverse transcription-coupled quantitative PCR show that beta-globin pre-mRNAs carrying NMD-competent PTCs, but not those containing a NMD-resistant PTC, exhibit a significant decrease in their steady-state levels relatively to the wild-type or to a missense-mutated beta-globin pre-mRNA. On the contrary, in HeLa cells, human beta-globin pre-mRNAs carrying NMD-competent PTCs accumulate at normal levels. Functional analyses of these pre-mRNAs in MEL cells demonstrate that their low steady-state levels do not reflect significantly lower pre-mRNA stabilities when compared to the normal control. Furthermore, our results also provide evidence that the relative splicing efficiencies of intron 1 and 2 are unaffected. This set of data highlights potential nuclear pathways that might be promoter-and/or cell line-specific, which recognize the NMD-sensitive transcripts as abnormal. These specialized nuclear pathway(s) may be superimposed on the general NMD mechanism.	[Morgado, Ana; Almeida, Fatima; Teixeira, Alexandre; Silva, Ana Luisa; Romao, Luisa] Inst Nacl Saude Dr Ricardo Jorge, Dept Genet, Lisbon, Portugal; [Teixeira, Alexandre] Univ Nova Lisboa, Fac Ciencias Med, Ctr Invest Genet Mol Humana, P-1200 Lisbon, Portugal; [Morgado, Ana; Silva, Ana Luisa; Romao, Luisa] Univ Lisbon, Fac Ciencias, BioFIG Ctr Biodivers Funct & Integrat Genom, Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade Nova de Lisboa; Universidade de Lisboa	Morgado, A (corresponding author), Inst Nacl Saude Dr Ricardo Jorge, Dept Genet, Lisbon, Portugal.	luisa.romao@insa.min-saude.pt	Romão, Luísa/A-2289-2016; Teixeira, Alexandre/N-9654-2013	Romão, Luísa/0000-0002-5061-5287; Teixeira, Alexandre/0000-0001-8899-9514; Morgado, Ana/0000-0002-8909-3615; Silva, Ana Luisa/0000-0002-4839-8279	Programa de Financiamento Plurianual do Centro de Investigacao em Genetica Molecular Humana (CIGMH); Fundacao para a Ciencia e a Tecnologia [SFRH/BD/31920/2006, PRAXIS XXI/BPD/18880/98, SFRH/BD/8351/2002]	Programa de Financiamento Plurianual do Centro de Investigacao em Genetica Molecular Humana (CIGMH); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially supported by Fundacao para a Ciencia e a Tecnologia [Programa de Financiamento Plurianual do Centro de Investigacao em Genetica Molecular Humana (CIGMH) and Center for Biodiversity, Functional and Integrative Genomics (BioFIG)]. AM, FA and ALS were supported by fellowships from Fundacao para a Ciencia e a Tecnologia (SFRH/BD/31920/2006, PRAXIS XXI/BPD/18880/98 and SFRH/BD/8351/2002, respectively). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; Bhalla AD, 2009, J BIOL CHEM, V284, P4062, DOI 10.1074/jbc.M805193200; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855; Custodio N, 2001, J CELL MOL MED, V5, P267, DOI 10.1111/j.1582-4934.2001.tb00160.x; de Turris V, 2011, RNA, V17, P2094, DOI 10.1261/rna.02918111; DEISSEROTH A, 1978, CELL, V15, P55, DOI 10.1016/0092-8674(78)90082-X; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Eberle AB, 2009, RNA, V15, P1021, DOI 10.1261/rna.1516409; ENSSLE J, 1993, P NATL ACAD SCI USA, V90, P10091, DOI 10.1073/pnas.90.21.10091; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gersappe A, 1999, J BIOL CHEM, V274, P22452, DOI 10.1074/jbc.274.32.22452; HALL GW, 1994, BLOOD, V83, P2031; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Huang LL, 2011, MOL CELL, V43, P950, DOI 10.1016/j.molcel.2011.06.031; HUMPHRIES RK, 1984, BLOOD, V64, P23; Iborra FJ, 2004, J CELL SCI, V117, P899, DOI 10.1242/jcs.00933; Imam JS, 2010, NUCLEIC ACIDS RES, V38, P1559, DOI 10.1093/nar/gkp1115; Inacio A, 2004, J BIOL CHEM, V279, P32170, DOI 10.1074/jbc.M405024200; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kessler O, 1996, MOL CELL BIOL, V16, P4426; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kong J, 2007, NAT STRUCT MOL BIOL, V14, P670, DOI 10.1038/nsmb1256; KUGLER W, 1995, NUCLEIC ACIDS RES, V23, P413, DOI 10.1093/nar/23.3.413; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lemieux C, 2011, MOL CELL, V44, P108, DOI 10.1016/j.molcel.2011.06.035; Li SL, 1997, J EXP MED, V185, P985, DOI 10.1084/jem.185.6.985; Liebhaber SA, 1996, MOL CELL BIOL, V16, P2637; LIM SK, 1992, EMBO J, V11, P3271, DOI 10.1002/j.1460-2075.1992.tb05405.x; LIM SK, 1989, EMBO J, V8, P2613, DOI 10.1002/j.1460-2075.1989.tb08401.x; LIM SK, 1992, MOL CELL BIOL, V12, P1149, DOI 10.1128/MCB.12.3.1149; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Lytle JR, 2004, RNA, V10, P657, DOI 10.1261/rna.5241404; MAQUAT LE, 1985, NUCLEIC ACIDS RES, V13, P2855, DOI 10.1093/nar/13.8.2855; MAQUAT LE, 1981, CELL, V27, P543, DOI 10.1016/0092-8674(81)90396-2; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Muhlemann O, 2010, RNA BIOL, V7, P28; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; Nicholson P, 2010, BIOCHEM SOC T, V38, P1615, DOI 10.1042/BST0381615; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Romao L, 2000, BLOOD, V96, P2895; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Silva AL, 2006, RNA, V12, P2160, DOI 10.1261/rna.201406; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Stalder L, 2007, J BIOL CHEM, V282, P16079, DOI 10.1074/jbc.M610595200; Stevens A, 2002, P NATL ACAD SCI USA, V99, P12741, DOI 10.1073/pnas.192442399; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang J, 2002, SCIENCE, V297, P108, DOI 10.1126/science.1069757; Wilkinson MF, 2002, NAT CELL BIOL, V4, pE144, DOI 10.1038/ncb0602-e144; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	69	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38505	10.1371/journal.pone.0038505	http://dx.doi.org/10.1371/journal.pone.0038505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675570	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341700082
J	Crinelli, R; Carloni, E; Giacomini, E; Penna, A; Dominici, S; Battocchi, C; Ciminiello, P; Dell'Aversano, C; Fattorusso, E; Forino, M; Tartaglione, L; Magnani, M				Crinelli, Rita; Carloni, Elisa; Giacomini, Elisa; Penna, Antonella; Dominici, Sabrina; Battocchi, Cecilia; Ciminiello, Patrizia; Dell'Aversano, Carmela; Fattorusso, Ernesto; Forino, Martino; Tartaglione, Luciana; Magnani, Mauro			Palytoxin and an Ostreopsis Toxin Extract Increase the Levels of mRNAs Encoding Inflammation-Related Proteins in Human Macrophages via p38 MAPK and NF-kappa B	PLOS ONE			English	Article							PUTATIVE PALYTOXIN; TUMOR PROMOTER; GENE-EXPRESSION; KINASE; ACTIVATION; INHIBITION; STRESS; OVATA; SEA; CYCLOOXYGENASE-2	Background: Palytoxin and, likely, its analogues produced by the dinoflagellate genus Ostreopsis, represent a class of nonproteinaceous compounds displaying high toxicity in animals. Owing to the wide distribution and the poisonous effects of these toxins in humans, their chemistry and mechanism of action have generated a growing scientific interest. Depending on the exposure route, palytoxin and its Ostreopsis analogues may cause several adverse effects on human health, including acute inflammatory reactions which seem more typical of cutaneous and inhalation contact. These observations have led us to hypothesize that these toxins may activate pro-inflammatory signalling cascades. Methodology and Principal Findings: Here we demonstrate that palytoxin and a semi-purified Ostreopsis cf. ovata toxin extract obtained from a cultured strain isolated in the NW Adriatic Sea and containing a putative palytoxin and all the ovatoxins so far known - including the recently identified ovatoxin-f - significantly increase the levels of mRNAs encoding inflammation-related proteins in immune cells, i.e. monocyte-derived human macrophages, as assessed by Real-Time PCR analysis. Western immunoblot and electrophoretic mobility shift assays revealed that nuclear transcription factor -kappa B (NF-kappa B) is activated in cells exposed to toxins in coincidence with reduced levels of the inhibitory protein I kappa B-alpha. Moreover, Mitogen-Activated Protein Kinases (MAPK) were phosphorylated in response to palytoxin, as also reported by others, and to the Ostreopsis toxin extract, as shown here for the first time. By using specific chemical inhibitors, the involvement of NF-kappa B and p38 MAPK in the toxin-induced transcription and accumulation of Cycloxigenase-2, Tumor Necrosis Factor-alpha, and Interleukin-8 transcripts has been demonstrated. Conclusions and Significance: The identification of specific molecular targets of palytoxin and its Ostreopsis analogues, besides contributing to expand the still limited knowledge of the intracellular signalling cascades affected by these toxins, may have important implications in setting up focused pharmacological interventions, replacing currently used symptomatic treatments.	[Crinelli, Rita; Carloni, Elisa; Giacomini, Elisa; Dominici, Sabrina; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Sect Biochem & Mol Biol, Urbino, PU, Italy; [Penna, Antonella; Battocchi, Cecilia] Univ Urbino Carlo Bo, Sect Environm Biol, Urbino, PU, Italy; [Ciminiello, Patrizia; Dell'Aversano, Carmela; Fattorusso, Ernesto; Forino, Martino; Tartaglione, Luciana] Univ Naples 2, Dept Chem Nat Prod, Naples, Italy	University of Urbino; University of Urbino; Universita della Campania Vanvitelli	Crinelli, R (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Sect Biochem & Mol Biol, Urbino, PU, Italy.	rita.crinelli@uniurb.it	Tartaglione, Luciana/ABG-1088-2020; Giacomini, Elisa/K-3208-2016; Dell'Aversano, Carmela/H-1803-2013; Tartaglione, Luciana/F-4651-2010; Magnani, Mauro/A-1919-2008	Giacomini, Elisa/0000-0003-3289-3221; Dell'Aversano, Carmela/0000-0001-8337-3029; Carloni, Elisa/0000-0003-1178-9353; Magnani, Mauro/0000-0001-6456-6626; Crinelli, Rita/0000-0002-1235-8910; Forino, Martino/0000-0001-8036-3546; Tartaglione, Luciana/0000-0003-0742-6955	ARPAC-Regione Campania D.D. [133 31/12/2008]; ISPRA Project "Ostreopsis ovata e Ostreopsis spp.: nuovi rischi di tossicita' microalgale nei mari italiani";  [2008BP25KN_001];  [2009JS5YX9_004]	ARPAC-Regione Campania D.D.; ISPRA Project "Ostreopsis ovata e Ostreopsis spp.: nuovi rischi di tossicita' microalgale nei mari italiani"; ; 	This work was supported by PRIN 2008 prot. 2008BP25KN_001 granted to M. Magnani, PRIN 2009 prot. 2009JS5YX9_004 granted to P. Ciminiello, ARPAC-Regione Campania D.D. 133 31/12/2008 granted to E. Fattorusso, ISPRA Project 2008-2009 "Ostreopsis ovata e Ostreopsis spp.: nuovi rischi di tossicita' microalgale nei mari italiani" granted to A. Penna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accoroni S, 2011, MAR POLLUT BULL, V62, P2512, DOI 10.1016/j.marpolbul.2011.08.003; ALCALA AC, 1988, TOXICON, V26, P105, DOI 10.1016/0041-0101(88)90142-0; Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Battocchi C, 2010, MAR POLLUT BULL, V60, P1074, DOI 10.1016/j.marpolbul.2010.01.017; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bianchi M, 2009, GENE, V448, P88, DOI 10.1016/j.gene.2009.08.013; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Louzao MC, 2007, FEBS J, V274, P1991, DOI 10.1111/j.1742-4658.2007.05743.x; Louzao MC, 2008, FEBS J, V275, P6067, DOI 10.1111/j.1742-4658.2008.06712.x; Charlson AT, 2009, TOXICOL APPL PHARM, V241, P143, DOI 10.1016/j.taap.2009.08.021; Ciminiello P, 2008, J AM SOC MASS SPECTR, V19, P111, DOI 10.1016/j.jasms.2007.11.001; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Ciminiello P, 2012, CHEM RES TOXICOL, V25, P1243, DOI 10.1021/tx300085e; Ciminiello P, 2011, TOXICON, V57, P362, DOI 10.1016/j.toxicon.2010.09.005; Ciminiello P, 2010, RAPID COMMUN MASS SP, V24, P2735, DOI 10.1002/rcm.4696; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; Crinelli R, 2004, NUCLEIC ACIDS RES, V32, P1874, DOI 10.1093/nar/gkh503; Crinelli R, 2010, ACS NANO, V4, P2791, DOI 10.1021/nn100057c; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Durando P., 2007, EUROSURVEILLANCE, V12, P1, DOI DOI 10.2807/ESW.12.23.03212-EN; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; FUJIKI H, 1986, CARCINOGENESIS, V7, P707, DOI 10.1093/carcin/7.5.707; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gallitelli M, 2005, JAMA-J AM MED ASSOC, V293, P2599, DOI 10.1001/jama.293.21.2599-c; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guo YS, 2002, J BIOL CHEM, V277, P48755, DOI 10.1074/jbc.M209016200; HABERMANN E, 1989, TOXICON, V27, P1171, DOI 10.1016/0041-0101(89)90026-3; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Honsell G, 2011, ENVIRON SCI TECHNOL, V45, P7051, DOI 10.1021/es201373e; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Iordanov MS, 1998, J BIOL CHEM, V273, P3528, DOI 10.1074/jbc.273.6.3528; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LEVINE L, 1985, CARCINOGENESIS, V6, P1631, DOI 10.1093/carcin/6.11.1631; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li SN, 1999, TOXICOL APPL PHARM, V160, P109, DOI 10.1006/taap.1999.8754; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mangialajo L, 2011, TOXICON, V57, P408, DOI 10.1016/j.toxicon.2010.11.019; MONROE JJ, 1995, AM J PHYSIOL-CELL PH, V269, pC582, DOI 10.1152/ajpcell.1995.269.3.C582; MOORE RE, 1971, SCIENCE, V172, P495, DOI 10.1126/science.172.3982.495; MOORE RE, 1981, J AM CHEM SOC, V103, P2491, DOI 10.1021/ja00399a093; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; OHUCHI K, 1985, BIOCHIM BIOPHYS ACTA, V834, P42, DOI 10.1016/0005-2760(85)90174-2; Onuma Y, 1999, TOXICON, V37, P55, DOI 10.1016/S0041-0101(98)00133-0; Pelin M, 2011, TOXICOLOGY, V282, P30, DOI 10.1016/j.tox.2011.01.010; Penna A, 2010, J BIOGEOGR, V37, P830, DOI 10.1111/j.1365-2699.2009.02265.x; Pezzolesi L, 2012, WATER RES, V46, P82, DOI 10.1016/j.watres.2011.10.029; Prandi S, 2011, CHEM RES TOXICOL, V24, P1283, DOI 10.1021/tx2001866; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3; Rossini GP, 2011, TOXICON, V57, P429, DOI 10.1016/j.toxicon.2010.09.011; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sagara T, 2013, J APPL TOXICOL, V33, P120, DOI 10.1002/jat.1728; Sala GL, 2009, CHEM RES TOXICOL, V22, P2009, DOI 10.1021/tx900297g; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Thevenod F, 1999, FASEB J, V13, P1751, DOI 10.1096/fasebj.13.13.1751; THRONDSEN J, 1995, IOC MANUALS GUIDES, V33, P63; Tichadou L, 2010, CLIN TOXICOL, V48, P839, DOI 10.3109/15563650.2010.513687; Totti C, 2010, HARMFUL ALGAE, V9, P233, DOI 10.1016/j.hal.2009.10.006; Tubaro A, 2011, TOXICON, V57, P478, DOI 10.1016/j.toxicon.2011.01.005; UEMURA D, 1981, TETRAHEDRON LETT, V22, P2781, DOI 10.1016/S0040-4039(01)90551-9; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wattenberg EV, 2007, AM J PHYSIOL-CELL PH, V292, pC24, DOI 10.1152/ajpcell.00254.2006; Wattenberg EV, 2011, TOXICON, V57, P440, DOI 10.1016/j.toxicon.2010.11.003; Westra J, 2004, ARTHRITIS RES THER, V6, pR384, DOI 10.1186/ar1204; WILES JS, 1974, TOXICON, V12, P427, DOI 10.1016/0041-0101(74)90011-7; Xiao C, 2008, BRAIN RES, V1215, P76, DOI 10.1016/j.brainres.2008.03.065	73	27	28	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38139	10.1371/journal.pone.0038139	http://dx.doi.org/10.1371/journal.pone.0038139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675515	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900014
J	Weiss, EM; Schulter, G; Freudenthaler, HH; Hofer, E; Pichler, N; Papousek, I				Weiss, Elisabeth M.; Schulter, Guenter; Freudenthaler, H. Harald; Hofer, Ellen; Pichler, Natascha; Papousek, Ilona			Potential Markers of Aggressive Behavior: The Fear of Other Persons' Laughter and Its Overlaps with Mental Disorders	PLOS ONE			English	Article							EMOTION REGULATION; CRIMINAL BEHAVIOR; GELOTOPHOBIA; VIOLENCE; QUESTIONNAIRE; RECOGNITION; DIMENSIONS; VERSION	Background: Anecdotal evidence suggested that some outbreaks of aggression and violence may be related to a fear of being laughed at and ridiculed. The present study examined the potential association of the fear of other persons' laughter (gelotophobia) with emotion-related deficits predisposing for aggression, anger and aggression proneness, and its overlaps with relevant mental disorders. Methodology/Principal Findings: Gelotophobic individuals were compared to a non-phobic control group with respect to emotion regulation skills and strategies, alexithymia, anger proneness, and aggressive behavior. Social phobia was diagnosed using the Structural Clinical Interview (SCID-I) for DSM IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition). Additionally, the SCID-II modules for Cluster A Personality Disorders, which includes schizoid, paranoid, and schizotypal personality disorder were administered to all participants. The findings show that gelotophobia is associated with deficits in the typical handling of an individual's own affective states, greater anger proneness and more aggressive behavior according to self-report as compared to non-phobic individuals. 80% of the subjects in the gelotophobia group had an additional diagnosis of social phobia and/or Cluster A personality disorder. The additional diagnoses did not predict additional variance of anger or aggressive behavior as compared to gelotophobia alone. Conclusions/Significance: Features related to aggression and violence that are inherent in mental disorders such as social phobia and Cluster A personality disorders may be particularly evident in the symptom of fear of other persons' laughter.	[Weiss, Elisabeth M.; Schulter, Guenter; Freudenthaler, H. Harald; Hofer, Ellen; Pichler, Natascha; Papousek, Ilona] Karl Franzens Univ Graz, Dept Psychol, Biol Psychol Unit, Graz, Austria	University of Graz	Weiss, EM (corresponding author), Karl Franzens Univ Graz, Dept Psychol, Biol Psychol Unit, Graz, Austria.	ilona.papousek@uni-graz.at	Papousek, Ilona/H-3043-2019	Papousek, Ilona/0000-0002-6620-0318; Weiss, Elisabeth/0000-0003-1296-3448				Abler B, 2009, DIAGNOSTICA, V55, P144, DOI 10.1026/0012-1924.55.3.144; [Anonymous], 1992, STATE TRAIT ARGERAUS; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Berkowitz L., 1962, AGGRESSION SOCIAL PS; Carretero-Dios H., 2010, PSYCHOL TEST ASSESS, V52, P108, DOI DOI 10.5167/UZH-33204; Carretero-Dios H, 2010, INT J CLIN HLTH PSYC, V10, P345; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; DODGE KA, 1993, ANNU REV PSYCHOL, V44, P559, DOI 10.1146/annurev.ps.44.020193.003015; Dodge KA, 1991, DEV TREATMENT CHILDH, P201; Edwards K., 2010, PSYCHOL TEST ASSESSM, P52; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Forabosco G, 2009, HUMOR, V22, P233, DOI 10.1515/HUMR.2009.011; Freudenthaler HH, 2005, PERS INDIV DIFFER, V39, P569, DOI 10.1016/j.paid.2005.02.004; Grabe HJ, 2004, AM J PSYCHIAT, V161, P1299, DOI 10.1176/appi.ajp.161.7.1299; Gradinger P, 2009, Z PSYCHOL, V217, P205, DOI 10.1027/0044-3409.217.4.205; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; Harper FWK, 2005, J INTERPERS VIOLENCE, V20, P1648, DOI 10.1177/0886260505278717; Holden C., 2009, SCIENCE, V324, P699, DOI [10.1126/science.324_699d, DOI 10.1126/SCIENCE.324_699D]; Jakupcak Matthew, 2003, Violence Vict, V18, P533, DOI 10.1891/088667003780928116; Johnson JG, 2000, AM J PSYCHIAT, V157, P1406, DOI 10.1176/appi.ajp.157.9.1406; Kupfer J, 2001, TAS 26 TORONTO ALEXI; Little TD, 2003, INT J BEHAV DEV, V27, P122, DOI 10.1080/01650250244000128; Marshall AD, 2010, J FAM PSYCHOL, V24, P21, DOI 10.1037/a0017952; McNiel DE, 2003, J CONSULT CLIN PSYCH, V71, P399, DOI 10.1037/0022-006X.71.2.399; Nestor PG, 2002, AM J PSYCHIAT, V159, P1973, DOI 10.1176/appi.ajp.159.12.1973; Papousek I, 2009, PERS INDIV DIFFER, V47, P58, DOI 10.1016/j.paid.2009.01.047; Platt T., 2009, PSYCHOL SCI Q, P51, DOI DOI 10.5167/UZH-19396; Raine A, 2011, SCHIZOPHRENIA BULL, V37, P937, DOI 10.1093/schbul/sbr082; Ruch W., 2010, PSYCHOL TEST ASSESSM, V52, P77, DOI [10.5167/uzh-33203, DOI 10.5167/UZH-33203]; Ruch W, 2008, SWISS J PSYCHOL, V67, P19, DOI 10.1024/1421-0185.67.1.19; Ruch W, 2008, HUMOR, V21, P47, DOI 10.1515/HUMOR.2008.002; Ruch W, 2009, HUMOR, V22, P1, DOI 10.1515/HUMR.2009.001; Samson AC, 2010, EUR REV APPL PSYCHOL, V60, P247, DOI 10.1016/j.erap.2010.07.002; Sarid O, 2011, ISR J PSYCHIATR REL, V48, P12; Shorey RC, 2011, VIOLENCE VICTIMS, V26, P271, DOI 10.1891/0886-6708.26.3.271; Taylor G.J., 1997, DISORDERS AFFECT REG; Titze M, 2009, HUMOR, V22, P27, DOI 10.1515/HUMR.2009.002; van der Meer L, 2009, PSYCHIAT RES, V170, P108, DOI 10.1016/j.psychres.2009.07.010; Weiss EM, 2006, AGGRESSIVE BEHAV, V32, P187, DOI 10.1002/ab.20120	40	36	37	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38088	10.1371/journal.pone.0038088	http://dx.doi.org/10.1371/journal.pone.0038088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22675438	Green Published, gold			2022-12-27	WOS:000305338500087
J	Daners, MS; Knobloch, V; Soellinger, M; Boesiger, P; Seifert, B; Guzzella, L; Kurtcuoglu, V				Daners, Marianne Schmid; Knobloch, Verena; Soellinger, Michaela; Boesiger, Peter; Seifert, Burkhardt; Guzzella, Lino; Kurtcuoglu, Vartan			Age-Specific Characteristics and Coupling of Cerebral Arterial Inflow and Cerebrospinal Fluid Dynamics	PLOS ONE			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; PHASE-CONTRAST MRI; RATE WAVE-FORMS; BRAIN STRUCTURE; RISK-FACTORS; FLOW; BLOOD; AQUEDUCT; ATROPHY; GENDER	The objective of this work is to quantify age-related differences in the characteristics and coupling of cerebral arterial inflow and cerebrospinal fluid (CSF) dynamics. To this end, 3T phase-contrast magnetic resonance imaging blood and CSF flow data of eleven young (24+/-3 years) and eleven elderly subjects (70+/-5 years) with a comparable sex-ratio were acquired. Flow waveforms and their frequency composition, transfer functions from blood to CSF flows and cross-correlations were analyzed. The magnitudes of the frequency components of CSF flow in the aqueduct differ significantly between the two age groups, as do the frequency components of the cervical spinal CSF and the arterial flows. The males' aqueductal CSF stroke volumes and average flow rates are significantly higher than those of the females. Transfer functions and cross-correlations between arterial blood and CSF flow reveal significant age-dependence of phase-shift between these, as do the waveforms of arterial blood, as well as cervical-spinal and aqueductal CSF flows. These findings accentuate the need for age- and sex-matched control groups for the evaluation of cerebral pathologies such as hydrocephalus.	[Daners, Marianne Schmid; Guzzella, Lino] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Inst Dynam Syst & Control, Zurich, Switzerland; [Knobloch, Verena; Soellinger, Michaela; Boesiger, Peter] Univ & ETH Zurich, Inst Biomed Engn, Zurich, Switzerland; [Soellinger, Michaela] Med Univ Graz, Dept Neurol, Neuroimaging Res Unit, Graz, Austria; [Seifert, Burkhardt] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland; [Kurtcuoglu, Vartan] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Lab Thermodynam Emerging Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Medical University of Graz; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Daners, MS (corresponding author), Swiss Fed Inst Technol, Dept Mech & Proc Engn, Inst Dynam Syst & Control, Zurich, Switzerland.	vartan.kurtcuoglu@ethz.ch	Kurtcuoglu, Vartan/A-8940-2008; Schmid Daners, Marianne/E-1800-2013	Kurtcuoglu, Vartan/0000-0003-2665-0995; Schmid Daners, Marianne/0000-0002-6411-8871; Seifert, Burkhardt/0000-0002-5829-2478	Swiss National Science Foundation (SNSF) through SmartShunt - The Hydrocephalus Project [K-32K1-120531]	Swiss National Science Foundation (SNSF) through SmartShunt - The Hydrocephalus Project	This work was funded by the Swiss National Science Foundation (SNSF) through SmartShunt - The Hydrocephalus Project, Grant No. K-32K1-120531. The SNSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperin N, 1996, MAGNET RESON MED, V35, P741, DOI 10.1002/mrm.1910350516; Baledent O, 2004, INVEST RADIOL, V39, P45, DOI 10.1097/01.rli.0000100892.87214.49; BARKHOF E, 1994, ACTA RADIOL, V35, P123, DOI 10.1177/028418519403500204; Bateman GA, 2005, NEURORADIOLOGY, V47, P741, DOI 10.1007/s00234-005-1418-0; Bombardini T, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-15; Bradley WG, 1996, RADIOLOGY, V198, P523, DOI 10.1148/radiology.198.2.8596861; Chen YF, 2009, NEUROIMAGE, V44, P647, DOI 10.1016/j.neuroimage.2008.09.057; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; de Marco G, 2004, J COMPUT ASSIST TOMO, V28, P247, DOI 10.1097/00004728-200403000-00015; Doepp F, 2004, NEURORADIOLOGY, V46, P565, DOI 10.1007/s00234-004-1213-3; DOLAN RJ, 1985, PSYCHOL MED, V15, P873, DOI 10.1017/S0033291700005110; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; Ford MD, 2005, PHYSIOL MEAS, V26, P477, DOI 10.1088/0967-3334/26/4/013; FRITSCH FN, 1980, SIAM J NUMER ANAL, V17, P238, DOI 10.1137/0717021; GIDEON P, 1994, ACTA NEUROL SCAND, V89, P362; GIDEON P, 1994, NEURORADIOLOGY, V36, P210, DOI 10.1007/BF00588133; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; Grichisch Y, 2012, HUM BRAIN MAPP, V33, P280, DOI 10.1002/hbm.21216; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Han ME, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-110; Hirata K, 2006, STROKE, V37, P2552, DOI 10.1161/01.STR.0000242289.20381.f4; Hoi Y, 2010, PHYSIOL MEAS, V31, P291, DOI 10.1088/0967-3334/31/3/002; Ljung L., 1999, SYSTEM IDENTIFICATIO; Lotz J, 2002, RADIOGRAPHICS, V22, P651, DOI 10.1148/radiographics.22.3.g02ma11651; Luetmer PH, 2002, NEUROSURGERY, V50, P534, DOI 10.1097/00006123-200203000-00020; Miyati T, 2003, EUR RADIOL, V13, P1019, DOI 10.1007/s00330-002-1697-3; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Orfanidis SJ, 1996, INTRO SIGNAL PROCESS, V1st; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P9, DOI 10.1016/j.spen.2009.01.002; Ropele S, 2010, AM J NEURORADIOL, V31, P1297, DOI 10.3174/ajnr.A2042; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Schibli M, 2009, BIOMED TECH, V54, P161, DOI 10.1515/BMT.2009.021; Stoquart-ElSankari S, 2007, J CEREBR BLOOD F MET, V27, P1563, DOI 10.1038/sj.jcbfm.9600462; Stoquart-ElSankari S, 2009, J CEREBR BLOOD F MET, V29, P1208, DOI [10.1038/sj.jcbfm.jcbfm200929, 10.1038/jcbfm.2009.29]; Tain RW, 2009, IEEE T BIO-MED ENG, V56, P544, DOI 10.1109/TBME.2008.2006010; THOMSEN C, 1990, RADIOLOGY, V177, P659, DOI 10.1148/radiology.177.3.2243965; Uftring SJ, 2000, MAGN RESON IMAGING, V18, P991, DOI 10.1016/S0730-725X(00)00195-8; Xu J, 2000, AM J NEURORADIOL, V21, P112	42	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37502	10.1371/journal.pone.0037502	http://dx.doi.org/10.1371/journal.pone.0037502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666360	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400029
J	Fan, ZX; Liu, SY; Liu, Y; Liao, LH; Zhang, XY; Yue, BS				Fan, Zhenxin; Liu, Shaoying; Liu, Yang; Liao, Lihuan; Zhang, Xiuyue; Yue, Bisong			Phylogeography of the South China Field Mouse (Apodemus draco) on the Southeastern Tibetan Plateau Reveals High Genetic Diversity and Glacial Refugia	PLOS ONE			English	Article							VOLE MICROTUS-OECONOMUS; POPULATION-GROWTH; MITOCHONDRIAL PHYLOGEOGRAPHY; PLEISTOCENE GLACIATIONS; MOLECULAR PHYLOGENY; SOFTWARE PACKAGE; NEUTRALITY TESTS; SNOW FINCH; QUATERNARY; EVOLUTION	The southeastern margin of the Tibetan Plateau (SEMTP) is a particularly interesting region due to its topographic complexity and unique geologic history, but phylogeographic studies that focus on this region are rare. In this study, we investigated the phylogeography of the South China field mouse, Apodemus draco, in order to assess the role of geologic and climatic events on the Tibetan Plateau in shaping its genetic structure. We sequenced mitochondrial cytochrome b (cyt b) sequences in 103 individuals from 47 sampling sites. In addition, 23 cyt b sequences were collected from GenBank for analyses. Phylogenetic, demographic and landscape genetic methods were conducted. Seventy-six cyt b haplotypes were found and the genetic diversity was extremely high (pi = 0.0368; h = 0.989). Five major evolutionary clades, based on geographic locations, were identified. Demographic analyses implied subclade 1A and subclade 1B experienced population expansions at about 0.052-0.013 Mya and 0.014-0.004 Mya, respectively. The divergence time analysis showed that the split between clade 1 and clade 2 occurred 0.26 Mya, which fell into the extensive glacial period (EGP, 0.5-0.17 Mya). The divergence times of other main clades (2.20-0.55 Mya) were congruent with the periods of the Qingzang Movement (3.6-1.7 Mya) and the Kun-Huang Movement (1.2-0.6 Mya), which were known as the most intense uplift events in the Tibetan Plateau. Our study supported the hypothesis that the SEMTP was a large late Pleistocene refugium, and further inferred that the Gongga Mountain Region and Hongya County were glacial refugia for A. draco in clade 1. We hypothesize that the evolutionary history of A. draco in the SEMTP primarily occurred in two stages. First, an initial divergence would have been shaped by uplift events of the Tibetan Plateau. Then, major glaciations in the Pleistocene added complexity to its demographic history and genetic structure.	[Fan, Zhenxin; Zhang, Xiuyue] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Peoples R China; [Liu, Shaoying; Liu, Yang] Sichuan Acad Forestry, Chengdu, Peoples R China; [Liao, Lihuan; Yue, Bisong] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Fan, ZX (corresponding author), Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Peoples R China.	bsyue@scu.edu.cn		Yue, Bisong/0000-0001-6731-538X	National Key Technology RD Program [2012BAC01B06]	National Key Technology RD Program(National Key Technology R&D Program)	This research was funded by the National Key Technology R&D Program (2012BAC01B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise JC, 1998, MOL ECOL, V7, P371, DOI 10.1046/j.1365-294x.1998.00391.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brouat C, 2009, J BIOGEOGR, V36, P2237, DOI 10.1111/j.1365-2699.2009.02184.x; Brunhoff C, 2003, MOL ECOL, V12, P957, DOI 10.1046/j.1365-294X.2003.01796.x; Chen WC, 2010, ZOOL SCI, V27, P487, DOI 10.2108/zsj.27.487; Ci HX, 2009, J ZOOL, V279, P396, DOI 10.1111/j.1469-7998.2009.00635.x; Drummond AJ, 2008, BEAST WEBSITE BEAST; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Egea R, 2008, NUCLEIC ACIDS RES, V36, pW157, DOI 10.1093/nar/gkn337; Ehlers J, 2007, QUATERN INT, V164-65, P6, DOI 10.1016/j.quaint.2006.10.008; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan ZX, 2011, GENETICA, V139, P339, DOI 10.1007/s10709-011-9553-5; Fan ZX, 2009, MOL PHYLOGENET EVOL, V51, P447, DOI 10.1016/j.ympev.2009.03.005; Fedorov VB, 2008, MOL ECOL, V17, P598, DOI 10.1111/j.1365-294X.2007.03595.x; Fu YX, 1997, GENETICS, V147, P915; Galbreath KE, 2004, MOL ECOL, V13, P135, DOI 10.1046/j.1365-294X.2004.02026.x; Hafner JC, 2008, J BIOGEOGR, V35, P2102, DOI 10.1111/j.1365-2699.2008.01942.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hu J.C., 1984, SICHUAN FAUNA EC, V2; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jaarola M, 2002, MOL ECOL, V11, P2613, DOI 10.1046/j.1365-294X.2002.01639.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jin YT, 2008, MOL ECOL, V17, P1971, DOI 10.1111/j.1365-294X.2008.03721.x; Krystufek B, 2009, HEREDITY, V103, P129, DOI 10.1038/hdy.2009.41; Kuhle M., 1988, GeoJournal, V17, P581; Lehmkuhl F, 2005, BOREAS, V34, P87, DOI 10.1080/03009480510012908; Li JJ, 1981, PROCESS UPLIFT QINGH; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu GQ, 2006, J W CHINA FORESTRY S, V35, P147; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031453; Liu XM, 2004, MOL PHYLOGENET EVOL, V33, P1, DOI 10.1016/j.ympev.2004.05.011; Luo ZX, 2000, FAUNA SINICA MAMMALI; MANTEL N, 1967, CANCER RES, V27, P209; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nylander J.A.A, 2004, MRMODELTEST V2; Oshida T, 2005, MOL ECOL, V14, P1191, DOI 10.1111/j.1365-294X.2005.02475.x; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Qu YH, 2009, MOL PHYLOGENET EVOL, V51, P312, DOI 10.1016/j.ympev.2009.01.013; Qu YH, 2005, MOL ECOL, V14, P1767, DOI 10.1111/j.1365-294X.2005.02528.x; Rambaut A., 2008, MOL EVOLUTION PHYLOG; Rambaut A., 2007, FIGTREE V1; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakka H, 2010, BIOL J LINN SOC, V100, P797, DOI 10.1111/j.1095-8312.2010.01477.x; Sambrook J., 2001, MOL CLONING LAB MANU; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Shi Y, 1990, J GLACIOLOGY GEOCRYO, V12, P1; Shi YF, 1998, UPLIFT ENV CHANGES Q; SLATKIN M, 1991, GENETICS, V129, P555; Song MK, 1987, EXPLORATION NATURE, V6, P145; [苏珍 Su Zhen], 2002, [地球科学进展, Advance in Earth Sciences], V17, P639; Suzuki H, 2003, BIOL J LINN SOC, V80, P469, DOI 10.1046/j.1095-8312.2003.00253.x; Suzuki H, 2008, BIOCHEM GENET, V46, P329, DOI 10.1007/s10528-008-9149-7; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang LZ, 2010, J BIOGEOGR, V37, P657, DOI 10.1111/j.1365-2699.2009.02232.x; Wang YZ, 1999, SICHUAN MAMMAL PRIMI; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; XIA W, 1984, Acta Theriologica Sinica, V4, P93; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang SJ, 2006, MOL PHYLOGENET EVOL, V41, P257, DOI 10.1016/j.ympev.2006.06.003; Yang XP, 2004, QUATERN INT, V118, P69, DOI 10.1016/S1040-6182(03)00131-9; Zeng Zongyong, 1994, Sichuan Daxue Xuebao (Ziran Kexueban), V31, P540; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang FF, 2006, MOL PHYLOGENET EVOL, V41, P313, DOI 10.1016/j.ympev.2006.05.024; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zheng HB, 2000, GEOLOGY, V28, P715, DOI 10.1130/0091-7613(2000)028<0715:PUOTNT>2.3.CO;2	74	30	34	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38184	10.1371/journal.pone.0038184	http://dx.doi.org/10.1371/journal.pone.0038184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666478	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400096
J	Joly, M; Scheumann, M; Zimmermann, E				Joly, Marine; Scheumann, Marina; Zimmermann, Elke			Posture Does Not Matter! Paw Usage and Grasping Paw Preference in a Small-Bodied Rooting Quadrupedal Mammal	PLOS ONE			English	Article							HAND PREFERENCES; MANUAL LATERALITY; EVOLUTION; FORELIMB; METAANALYSIS; TROGLODYTES; ORANGUTANS; LOCOMOTION; MORPHOLOGY; HANDEDNESS	Background: Recent results in birds, marsupials, rodents and nonhuman primates suggest that phylogeny and ecological factors such as body size, diet and postural habit of a species influence limb usage and the direction and strength of limb laterality. To examine to which extent these findings can be generalised to small-bodied rooting quadrupedal mammals, we studied trees shrews (Tupaia belangeri). Methodology/Principal Findings: We established a behavioural test battery for examining paw usage comparable to small-bodied primates and tested 36 Tupaia belangeri. We studied paw usage in a natural foraging situation (simple food grasping task) and measured the influence of varying postural demands (triped, biped, cling, sit) on paw preferences by applying a forced-food grasping task similar to other small-bodied primates. Our findings suggest that rooting tree shrews prefer mouth over paw usage to catch food in a natural foraging situation. Moreover, we demonstrated that despite differences in postural demand, tree shrews show a strong and consistent individual paw preference for grasping across different tasks, but no paw preference at a population level. Conclusions/Significance: Tree shrews showed less paw usage than small-bodied quadrupedal and arboreal primates, but the same paw preference. Our results confirm that individual paw preferences remain constant irrespective of postural demand in some small-bodied quadrupedal non primate and primate mammals which do not require fine motoric control for manipulating food items. Our findings suggest that the lack of paw/hand preference for grasping food at a population level is a universal pattern among those species and that the influence of postural demand on manual lateralisation in quadrupeds may have evolved in large-bodied species specialised in fine manipulations of food items.	[Joly, Marine; Scheumann, Marina; Zimmermann, Elke] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Zimmermann, Elke] Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Joly, M (corresponding author), Univ Vet Med Hannover, Inst Zool, Hannover, Germany.	marine.joly@tiho-hannover.de	Joly, Marine/P-5990-2014	Joly, Marine/0000-0002-0784-5167; Scheumann, Marina/0000-0002-4091-9500	DAAD (Deutscher Akademischer Austauschdienst) [D/0811448]	DAAD (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by DAAD (Deutscher Akademischer Austauschdienst) (grant number: D/0811448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blois-Heulin C, 2007, J COMP PSYCHOL, V121, P205, DOI 10.1037/0735-7036.121.2.205; Blois-Heulin C, 2006, AM J PRIMATOL, V68, P429, DOI 10.1002/ajp.20239; Blois-Heulin C, 2004, FOLIA PRIMATOL, V75, P237; Braccini S, 2010, J HUM EVOL, V58, P234, DOI 10.1016/j.jhevol.2009.11.008; Brown C, 2011, BEHAV ECOL, V22, P1201, DOI 10.1093/beheco/arr114; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; Chapelain A, 2006, BEHAV BRAIN RES, V173, P237, DOI 10.1016/j.bbr.2006.06.028; Clarke CM, 2009, BIOL LETTERS, V5, P632, DOI 10.1098/rsbl.2009.0311; DEVLEESCHOUWER K, 1995, J COMP PSYCHOL, V109, P203, DOI 10.1037/0735-7036.109.2.203; DODSON DL, 1992, AM J PRIMATOL, V26, P191, DOI 10.1002/ajp.1350260305; Emmons L.H., 2000, TUPAI FIELD STUDY BO; FORSYTHE C, 1988, J COMP PSYCHOL, V102, P248, DOI 10.1037/0735-7036.102.3.248; Giljov A, 2012, ANIM BEHAV, V83, P525, DOI 10.1016/j.anbehav.2011.11.031; Guven M, 2003, INT J NEUROSCI, V113, P1675, DOI 10.1080/00207450390249258; Hanbury DB, 2010, AM J PRIMATOL, V72, P206, DOI 10.1002/ajp.20769; HOPKINS WD, 1993, J COMP PSYCHOL, V107, P162, DOI 10.1037/0735-7036.107.2.162; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Hopkins WD, 2011, J HUM EVOL, V60, P605, DOI 10.1016/j.jhevol.2010.12.008; Ivanco TL, 1996, BEHAV BRAIN RES, V79, P163, DOI 10.1016/0166-4328(96)00011-3; Iwaniuk AN, 1998, AUST J ZOOL, V46, P235, DOI 10.1071/ZO98004; Iwaniuk AN, 2000, CAN J ZOOL, V78, P1110, DOI 10.1139/cjz-78-7-1110; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Joly M, 2008, AM J PRIMATOL, V70, P892, DOI 10.1002/ajp.20560; Joly M, 2011, BIOL LETTERS, V7, P638, DOI 10.1098/rsbl.2011.0258; Joly-Radko M, 2010, DEV PRIMATOL-PROG PR, P141, DOI 10.1007/978-1-4419-6661-2_7; Konerding WS, 2012, J COMP PSYCHOL, V126, P15, DOI 10.1037/a0024638; LARSON CF, 1989, BRAIN BEHAV EVOLUT, V33, P261, DOI 10.1159/000115934; Laska M, 1996, PRIMATES, V37, P457, DOI 10.1007/BF02381379; Leliveld LMC, 2008, AM J PHYS ANTHROPOL, V137, P156, DOI 10.1002/ajpa.20852; Lonsdorf EV, 2005, P NATL ACAD SCI USA, V102, P12634, DOI 10.1073/pnas.0505806102; Magat M, 2009, P ROY SOC B-BIOL SCI, V276, P4155, DOI 10.1098/rspb.2009.1397; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; Milliken GW, 2005, J COMP PSYCHOL, V119, P430, DOI 10.1037/0735-7036.119.4.430; OLSON DA, 1990, AM J PRIMATOL, V20, P83, DOI 10.1002/ajp.1350200203; Papademetriou E, 2005, J COMP PSYCHOL, V119, P33, DOI 10.1037/0735-7036.119.1.33; Radespiel U, 2006, INT J PRIMATOL, V27, P311, DOI 10.1007/s10764-005-9005-0; Rogers LJ, 2009, PHILOS T R SOC B, V364, P943, DOI 10.1098/rstb.2008.0225; ROGERS LJ, 1993, ANIM BEHAV, V45, P409, DOI 10.1006/anbe.1993.1049; RONEY LS, 1993, J COMP PSYCHOL, V107, P380, DOI 10.1037/0735-7036.107.4.380; SANFORD C, 1984, BRAIN BEHAV EVOLUT, V25, P217, DOI 10.1159/000118867; Sargis EJ, 2002, J MORPHOL, V253, P10, DOI 10.1002/jmor.1110; Sargis EJ, 2001, J ZOOL, V253, P485, DOI 10.1017/S0952836901000449; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Schehka S, 2009, BEHAV BRAIN RES, V203, P223, DOI 10.1016/j.bbr.2009.05.007; Scheumann M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-52; Schmitt V, 2008, LATERALITY, V13, P143, DOI 10.1080/13576500701757532; Schweitzer C, 2007, ETHOLOGY, V113, P983, DOI 10.1111/j.1439-0310.2007.01405.x; Singer SS, 1999, BEHAVIOUR, V136, P119, DOI 10.1163/156853999500703; Sovrano VA, 2007, LATERALITY, V12, P458, DOI 10.1080/13576500701479822; Ward Jeannette P., 1993, P43; Ward JP, 1995, CREATURES OF THE DARK, P293; Wells DL, 2009, ANIM BEHAV, V78, P537, DOI 10.1016/j.anbehav.2009.06.010; Wells K, 2011, J TROP ECOL, V27, P347, DOI 10.1017/S0266467411000162; Westergaard G C, 1997, Laterality, V2, P65, DOI 10.1080/135765097397657; Westergaard GC, 1998, J COMP PSYCHOL, V112, P55, DOI 10.1037//0735-7036.112.1.55; Zucca P, 2010, BEHAV PROCESS, V84, P693, DOI 10.1016/j.beproc.2010.04.006	56	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38228	10.1371/journal.pone.0038228	http://dx.doi.org/10.1371/journal.pone.0038228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666494	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400107
J	Maruzzo, D; Aldred, N; Clare, AS; Hoeg, JT				Maruzzo, Diego; Aldred, Nick; Clare, Anthony S.; Hoeg, Jens T.			Metamorphosis in the Cirripede Crustacean Balanus amphitrite	PLOS ONE			English	Article							AMPHIBALANUS AMPHITRITE; BARNACLE NOMENCLATURE; LARVAL METAMORPHOSIS; SETTLEMENT BEHAVIOR; METHYL FARNESOATE; CYPRIS; ULTRASTRUCTURE; RHIZOCEPHALA; THORACICA	Stalked and acorn barnacles (Cirripedia Thoracica) have a complex life cycle that includes a free-swimming nauplius larva, a cypris larva and a permanently attached sessile juvenile and adult barnacle. The barnacle cyprid is among the most highly specialized of marine invertebrate larvae and its settlement biology has been intensively studied. By contrast, surprisingly few papers have dealt with the critical series of metamorphic events from cementation of the cyprid to the substratum until the appearance of a suspension feeding juvenile. This metamorphosis is both ontogenetically complex and critical to the survival of the barnacle. Here we use video microscopy to present a timeline and description of morphological events from settled cyprid to juvenile barnacle in the model species Balanus amphitrite, representing an important step towards both a broader understanding of the settlement ecology of this species and a platform for studying the factors that control its metamorphosis. Metamorphosis in B. amphitrite involves a complex sequence of events: cementation, epidermis separation from the cypris cuticle, degeneration of cypris musculature, rotation of the thorax inside the mantle cavity, building of the juvenile musculature, contraction of antennular muscles, raising of the body, shedding of the cypris cuticle, shell plate and basis formation and, possibly, a further moult to become a suspension feeding barnacle. We compare these events with developmental information from other barnacle species and discuss them in the framework of barnacle settlement ecology.	[Maruzzo, Diego] Univ Padua, Dept Biol, Padua, Italy; [Aldred, Nick; Clare, Anthony S.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hoeg, Jens T.] Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark	University of Padua; Newcastle University - UK; University of Copenhagen	Maruzzo, D (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	maruzzo@bio.unipd.it	Aldred, Nick/H-7896-2012; Hoeg, Jens Thorvald/D-5784-2015	Aldred, Nick/0000-0003-2285-5133; Hoeg, Jens Thorvald/0000-0002-3596-1691; Clare, Anthony S./0000-0002-7692-9583	European Union Synthesys-2 program [DK-TAF-1091]; Carlsberg Foundation [2007_01_0095]; Danish Council for Independent Research [09-063868-FNU]; Office of Naval Research [N00014-08-1-1240]; Synthesys [DK-TAF-355]	European Union Synthesys-2 program; Carlsberg Foundation(Carlsberg Foundation); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Office of Naval Research(Office of Naval Research); Synthesys	DM was financed the European Union Synthesys-2 program (DK-TAF-1091). JTH was financed by the Carlsberg Foundation (2007_01_0095) and by The Danish Council for Independent Research (09-063868-FNU). NA was supported by Office of Naval Research Grant N00014-08-1-1240 to ASC and Synthesys (DK-TAF-355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred N, 2008, BIOFOULING, V24, P351, DOI 10.1080/08927010802256117; Anderson D.T., 1994, BARNACLES STRUCTURE; BERNARD FJ, 1962, J MORPHOL, V110, P19, DOI 10.1002/jmor.1051100103; Blomsterberg M, 2004, J MORPHOL, V260, P141, DOI 10.1002/jmor.10131; Bourget E, 1975, J MAR BIOL ASSOC UK, V554, P39; Brickner I, 2010, J EXP MAR BIOL ECOL, V392, P115, DOI 10.1016/j.jembe.2010.04.015; Carlton J, 2009, BIOFOULING, V25, P77, DOI 10.1080/08927010802535247; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Clare AS, 2009, WOODHEAD PUBL MATER, P46, DOI 10.1533/9781845696313.1.46; Clare AS, 2008, BIOFOULING, V24, P55, DOI 10.1080/08927010701830194; CLARE AS, 1994, J CRUSTACEAN BIOL, V14, P27, DOI 10.2307/1549052; Clare AS, 1987, NEW FRONTIERS BARNAC, P49; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; COSTLOW JOHN D., 1956, J MORPH, V99, P359, DOI 10.1002/jmor.1050990206; Crisp D.J., 1988, P409; CRISP DJ, 1985, B MAR SCI, V37, P478; CRISP DJ, 1953, J ANIM ECOL, V22, P331, DOI 10.2307/1821; DANIEL A., 1958, JOUR MADRAS UNIV, V28B, P23; De Gregoris TB, 2011, BIOFOULING, V27, P367, DOI 10.1080/08927014.2011.577211; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; DOOCHIN HERMAN D., 1951, BULL MARINE SCI GULF AND CARIBBEAN, V1, P15; GLENNER H, 1993, MAR BIOL, V117, P431; Glenner H, 2001, J MORPHOL, V249, P43, DOI 10.1002/jmor.1040.abs; Glenner H, 1998, J CRUSTACEAN BIOL, V18, P463, DOI 10.2307/1549411; Hoeg JT, 2006, INVERTEBR REPROD DEV, V49, P125, DOI 10.1080/07924259.2006.9652204; HOEG JT, 1985, ACTA ZOOL-STOCKHOLM, V66, P1, DOI 10.1111/j.1463-6395.1985.tb00645.x; HOEG JT, 1987, ZOOMORPHOLOGY, V107, P299, DOI 10.1007/BF00312176; Hoeg JT, 2012, INTEGR COMP IN PRESS; Hoeg JT, 1995, NEW FRONTIERS BARNAC, P195; Hoeg JT., 2005, MARINE PARASITES, P154; Kuhl H., 1950, ZOOL ANZ, V145, P461; Lagersson NC, 2002, MAR BIOL, V141, P513, DOI 10.1007/s00227-002-0854-1; LEFURGEY A, 1995, FASEB J, V9, pA639; Maruzzo D, 2011, BIOFOULING, V27, P225, DOI 10.1080/08927014.2011.555534; Pearse V., 1987, LIVING INVERTEBRATES; Petrone L, 2011, BIOFOULING, V27, P1043, DOI 10.1080/08927014.2011.625474; PFEIFFER CJ, 1989, ACTA ZOOL-STOCKHOLM, V70, P243, DOI 10.1111/j.1463-6395.1989.tb00937.x; RITCHIE L E, 1981, Journal of Crustacean Biology, V1, P334, DOI 10.2307/1547966; Smith PA, 2000, INSECT BIOCHEM MOLEC, V30, P885, DOI 10.1016/S0965-1748(00)00062-X; TAKENAKA M, 1993, DEV GROWTH DIFFER, V35, P245; Thiyagarajan V, 2008, PROTEOMICS, V8, P3164, DOI 10.1002/pmic.200700904; WALKER G, 1992, MICROSCOPIC ANATOMY, V9, P249; Walker G, 1995, NEW FRONTIERS BARNAC, V10, P69; WALLEY LJ, 1969, PHILOS T ROY SOC B, V256, P237, DOI 10.1098/rstb.1969.0042; Yamamoto H, 1997, J EXP ZOOL, V278, P349, DOI 10.1002/(SICI)1097-010X(19970815)278:6<349::AID-JEZ2>3.0.CO;2-O; Yamamoto H, 1997, ZOOL SCI, V14, P887, DOI 10.2108/zsj.14.887	46	45	47	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37408	10.1371/journal.pone.0037408	http://dx.doi.org/10.1371/journal.pone.0037408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666355	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400027
J	Tsigkari, KK; Acevedo, SF; Skoulakis, EMC				Tsigkari, K. Kirki; Acevedo, Summer F.; Skoulakis, Efthimios M. C.			14-3-3 epsilon Is Required for Germ Cell Migration in Drosophila	PLOS ONE			English	Article							14-3-3 PROTEINS; 14-3-3-PROTEINS; EXPRESSION; LEONARDO; BINDING; FAMILY; RAF	Although 14-3-3 proteins participate in multiple biological processes, isoform-specific specialized functions, as well as functional redundancy are emerging with tissue and developmental stage-specificity. Accordingly, the two 14-3-3 epsilon proteins in Drosophila exhibit functional specificity and redundancy. Homozygotes for loss of function alleles of D14-3-3 epsilon contain significantly fewer germ line cells (pole cells) in their gonads, a phenotype not shared by mutants in the other 14-3-3 gene leo. We show that although D14-3-3 epsilon is enriched within pole cells it is required in mesodermal somatic gonad precursor cells which guide pole cells in their migration through the mesoderm and coalesce with them to form the embryonic gonad. Loss of D14-3-3 epsilon results in defective pole cell migration, reduced pole cell number. We present evidence that D14-3-3 epsilon loss results in reduction or loss of the transcription factor Zfh-1, one of the main regulatory molecules of the pole cell migration, from the somatic gonad precursor cells.	[Tsigkari, K. Kirki; Acevedo, Summer F.; Skoulakis, Efthimios M. C.] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece	Alexander Fleming Biomedical Sciences Research Center	Tsigkari, KK (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Vari, Greece.	skoulakis@fleming.gr		Acevedo, Summer/0000-0002-3206-6819	National Science Foundation [IBN-0080687]; PENED grant from the Greek Secretariat for Research and Technology (GSRT) [01EDelta207]	National Science Foundation(National Science Foundation (NSF)); PENED grant from the Greek Secretariat for Research and Technology (GSRT)	Initial phases of this work were supported by National Science Foundation IBN-0080687 and by a PENED grant (01E Delta 207) from the Greek Secretariat for Research and Technology (GSRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo SF, 2007, GENETICS, V177, P239, DOI 10.1534/genetics.107.072280; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Boyle M, 1997, DEVELOPMENT, V124, P971; BOYLE M, 1995, DEVELOPMENT, V121, P1815; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Broihier HT, 1998, DEVELOPMENT, V125, P655; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; CALLAINI G, 1995, DEV BIOL, V170, P365, DOI 10.1006/dbio.1995.1222; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132; Dalal SN, 2004, CELL CYCLE, V3, P672; Ferl RJ, 2002, GENOME BIOL, V3; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; JAGLARZ MK, 1995, DEVELOPMENT, V121, P3495; Kockel L, 1997, GENE DEV, V11, P1140, DOI 10.1101/gad.11.9.1140; Li W, 1997, DEVELOPMENT, V124, P4163; Mershin A, 2004, LEARN MEMORY, V11, P277, DOI 10.1101/lm.70804; Messaritou G, 2009, FEBS LETT, V583, P2934, DOI 10.1016/j.febslet.2009.08.003; Mils V, 2000, ONCOGENE, V19, P1257, DOI 10.1038/sj.onc.1203419; Moore LA, 1998, DEVELOPMENT, V125, P667; Moore MAS, 2001, BIOESSAYS, V23, P674, DOI 10.1002/bies.1095; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Philip N, 2001, J NEUROSCI, V21, P8417, DOI 10.1523/JNEUROSCI.21-21-08417.2001; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; REUTER R, 1994, DEVELOPMENT, V120, P1123; Rudolph T, 1999, DROSOPHILA INF SERV, V82, P99; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Sokal R. R., 1981, BIOMETRY; Stallock J, 2003, DEVELOPMENT, V130, P6589, DOI 10.1242/dev.00898; Su TT, 2001, J CELL SCI, V114, P3445; Tsichritzis T, 2007, DEVELOPMENT, V177, P89; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Wang WF, 1996, J MOL EVOL, V43, P384; WARRIOR R, 1994, DEV BIOL, V166, P180, DOI 10.1006/dbio.1994.1306; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Wylie C, 2000, CURR OPIN GENET DEV, V10, P410, DOI 10.1016/S0959-437X(00)00105-2; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36702	10.1371/journal.pone.0036702	http://dx.doi.org/10.1371/journal.pone.0036702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666326	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400012
J	Carnini, A; Scott, LOM; Ahrendt, E; Proft, J; Winkfein, RJ; Kim, SW; Colicos, MA; Braun, JEA				Carnini, Anna; Scott, Lucas O. M.; Ahrendt, Eva; Proft, Juliane; Winkfein, Robert J.; Kim, Sung-Woo; Colicos, Michael A.; Braun, Janice E. A.			Cell Line Specific Modulation of Extracellular A beta(42) by Hsp40	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; AMYLOID-BETA OLIGOMERS; ALPHA-B-CRYSTALLIN; PRION PROTEIN; ALZHEIMERS-DISEASE; MOLECULAR CHAPERONES; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; CORTICAL-NEURONS; STRESS-RESPONSE	Heat shock proteins (Hsps) are a set of molecular chaperones involved in cellular repair. They provide protective mechanisms that allow cells to survive potentially lethal insults, In response to a conditioning stress their expression is increased. Here we examined the connection between Hsps and A beta(42), the amyloid peptide involved in the pathological sequence of Alzheimer's disease (AD). Extracellular A beta(42) associates with neuronal cells and is a major constituent of senile plaques, one of the hallmarks of AD. Although Hsps are generally thought to prevent accumulation of misfolded proteins, there is a lack of mechanistic evidence that heat shock chaperones directly modulate A beta(42) toxicity. In this study we show that neither extracellular A beta(42) nor A beta(42)/PrPC trigger the heat shock response in neurons. To address the influence of the neuroprotective heat shock response on cellular A beta(42), Western analysis of A beta(42) was performed following external A beta(42) application. Five hours after a conditioning heat shock, A beta(42) association with CAD cells was increased compared to control neurons. However, at forty-eight hours following heat shock A beta(42) levels were reduced compared to that found for control cells. Moreover, transient transfection of the stress induced Hsp40, decreased CAD levels of A beta(42). In contrast to CAD cells, hippocampal neurons transfected with Hsp40 retained A beta(42) indicating that Hsp40 modulation of A beta(42) proteostasis is cell specific. Mutation of the conserved HPD motif within Hsp40 significantly reduced the Hsp40-mediated A beta(42) increase in hippocampal cultures indicating the importance of this motif in regulating cellular A beta(42). Our data reveal a biochemical link between Hsp40 expression and A beta(42) proteostasis that is cell specific. Therefore, increasing Hsp40 therapeutically with the intention of interfering with the pathogenic cascade leading to neurodegeneration in AD should be pursued with caution.	[Carnini, Anna; Scott, Lucas O. M.; Ahrendt, Eva; Proft, Juliane; Winkfein, Robert J.; Colicos, Michael A.; Braun, Janice E. A.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Kim, Sung-Woo] Univ Calgary, So Alberta Canc Res Inst, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; University of Calgary	Carnini, A (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada.	braunj@ucalgary.ca	Proft, Juliane/H-6549-2014	Proft, Juliane/0000-0003-0980-8930	Canadian Institute of Health Research [74713, 7944]; Alberta Prion Research Institute	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Prion Research Institute	This work was supported by funding from the Canadian Institute of Health Research MOP#74713 (Dr. Braun) and MOP#7944 (Dr. Colicos) and the Alberta Prion Research Institute. Dr. Braun is a Senior Scholar of the Alberta Heritage Foundation for Medical Research. Dr. Colicos is a Scholar of the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bateman DA, 2011, INT J ALZHEIMERS DIS, V2011; Bateman DA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-29; Bateman DA, 2009, BIOPHYS J, V96, P4260, DOI 10.1016/j.bpj.2009.01.056; Batulan Z, 2003, J NEUROSCI, V23, P5789; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Carnini A, 2007, CURR ALZHEIMER RES, V4, P233; Chen S, 2005, J NEUROSCI RES, V81, P522, DOI 10.1002/jnr.20575; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Eiden M, 2006, J VET MED B, V53, P251, DOI 10.1111/j.1439-0450.2006.00966.x; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Florio T, 1998, J NEUROSCI RES, V54, P341, DOI 10.1002/(SICI)1097-4547(19981101)54:3<341::AID-JNR5>3.0.CO;2-G; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; Gibbs SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004595; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gutierrez RC, 2009, NEUROSCIENCE, V162, P208, DOI 10.1016/j.neuroscience.2009.04.062; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; King M, 2009, J NEUROSCI RES, V87, P3161, DOI 10.1002/jnr.22145; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Magrane J, 2005, J NEUROSCI, V25, P10960, DOI 10.1523/JNEUROSCI.1723-05.2005; Magrane Jordi, 2008, V3, P25, DOI 10.1007/978-1-4020-8231-3_2; Mohamed A, 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/127984; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Ojha J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016550; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; PEREZ N, 1991, MOL BRAIN RES, V11, P249, DOI 10.1016/0169-328X(91)90033-T; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Schwarze-Eicker KA, 2005, NEUROBIOL AGING, V26, P1177, DOI 10.1016/j.neurobiolaging.2004.10.004; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Suzuki T, 1999, BRAIN RES, V816, P99, DOI 10.1016/S0006-8993(98)01083-X; Takeuchi H, 2002, BRAIN RES, V949, P11, DOI 10.1016/S0006-8993(02)02568-4; Tampellini D, 2011, J NEUROSCI, V31, P15384, DOI 10.1523/JNEUROSCI.2986-11.2011; Tyszkiewicz JP, 2005, J NEUROPHYSIOL, V93, P3102, DOI 10.1152/jn.00939.2004; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Watson ED, 2007, DEVELOPMENT, V134, P1809, DOI 10.1242/dev.02843; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Westhoff B, 2005, CURR BIOL, V15, P1058, DOI 10.1016/j.cub.2005.04.058; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z	63	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37755	10.1371/journal.pone.0037755	http://dx.doi.org/10.1371/journal.pone.0037755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666389	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600028
J	Gibson, CM; Kao, RH; Blevins, KK; Travers, PD				Gibson, Cara M.; Kao, Rebecca H.; Blevins, Kali K.; Travers, Patrick D.			Integrative Taxonomy for Continental-Scale Terrestrial Insect Observations	PLOS ONE			English	Article							GROUND BEETLES COLEOPTERA; SPECIES IDENTIFICATION; MITOCHONDRIAL-DNA; CARABIDAE; POPULATION; ECOLOGY; SYSTEMATICS; BARCODES; MTDNA; LIFE	Although 21st century ecology uses unprecedented technology at the largest spatio-temporal scales in history, the data remain reliant on sound taxonomic practices that derive from 18th century science. The importance of accurate species identifications has been assessed repeatedly and in instances where inappropriate assignments have been made there have been costly consequences. The National Ecological Observatory Network (NEON) will use a standardized system based upon an integrative taxonomic foundation to conduct observations of the focal terrestrial insect taxa, ground beetles and mosquitoes, at the continental scale for a 30 year monitoring program. The use of molecular data for continental-scale, multi-decadal research conducted by a geographically widely distributed set of researchers has not been evaluated until this point. The current paper addresses the development of a reference library for verifying species identifications at NEON and the key ways in which this resource will enhance a variety of user communities.	[Gibson, Cara M.; Kao, Rebecca H.; Blevins, Kali K.; Travers, Patrick D.] Natl Ecol Observ Network, Boulder, CO USA		Gibson, CM (corresponding author), Natl Ecol Observ Network, Boulder, CO USA.	cara.m.gibson@gmail.com	Gibson, Cara/B-4138-2017		National Science Foundation (NSF) [DBI-0752017]; Direct For Biological Sciences [0752017] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by National Science Foundation (NSF) grant DBI-0752017 to NEON, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBSnews, 2007, BIOSCIENCE, V57, P198; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Butovsky RO, 2011, ZOOKEYS, P215, DOI 10.3897/zookeys.100.1529; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frank JH, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.14.188; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018123; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Koivula MJ, 2011, ZOOKEYS, P287, DOI 10.3897/zookeys.100.1533; Kotze DJ, 2011, ZOOKEYS, P55, DOI 10.3897/zookeys.100.1523; Lees DC, 2011, FRONT ECOL ENVIRON, V9, P322, DOI 10.1890/100098; Lis JA, 2011, ZOOTAXA, P47, DOI 10.11646/zootaxa.2932.1.5; Locke J.M., 2008, P 11 INT COR REEF S, P1348; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Maddison DR, 2008, ANN CARNEGIE MUS, V77, P147, DOI 10.2992/0097-4463-77.1.147; Pearson DL, 2011, BIOSCIENCE, V61, P58, DOI 10.1525/bio.2011.61.1.11; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rodriguez-Fernandez JI, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2933.1.3; Ronquist F, 2010, ANNU REV ENTOMOL, V55, P189, DOI 10.1146/annurev.ento.54.110807.090529; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wallace SK, 2004, THESIS U MONTANA BOZ; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Woodcock RM, 2009, ENTOMOL NEWS, V120, P341, DOI 10.3157/021.120.0401	35	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37528	10.1371/journal.pone.0037528	http://dx.doi.org/10.1371/journal.pone.0037528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666362	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349600018
J	Johnston, V; Fielding, K; Charalambous, S; Mampho, M; Churchyard, G; Phillips, A; Grant, AD				Johnston, Victoria; Fielding, Katherine; Charalambous, Salome; Mampho, Mildred; Churchyard, Gavin; Phillips, Andrew; Grant, Alison D.			Second-Line Antiretroviral Therapy in a Workplace and Community-Based Treatment Programme in South Africa: Determinants of Virological Outcome	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; DRUG-RESISTANCE MUTATIONS; HIV-INFECTED PATIENTS; HIGH EARLY MORTALITY; SUB-SAHARAN AFRICA; RISK-FACTORS; FOLLOW-UP; TREATMENT FAILURE; ADULT PATIENTS; ADHERENCE	Background: As antiretroviral treatment (ART) programmes in resource-limited settings mature, more patients are experiencing virological failure. Without resistance testing, deciding who should switch to second-line ART can be difficult. The consequences for second-line outcomes are unclear. In a workplace- and community-based multi-site programme, with 6-monthly virological monitoring, we describe outcomes and predictors of viral suppression on second-line, protease inhibitor-based ART. Methods: We used prospectively collected clinic data from patients commencing first-line ART between 1/1/03 and 31/12/08 to construct a study cohort of patients switched to second-line ART in the presence of a viral load (VL) >= 400 copies/ml. Predictors of VL <400 copies/ml within 15 months of switch were assessed using modified Poisson regression to estimate risk ratios. Results: 205 workplace patients (91.7% male; median age 43 yrs) and 212 community patients (38.7% male; median age 36 yrs) switched regimens. At switch compared to community patients, workplace patients had a longer duration of viraemia, higher VL, lower CD4 count, and higher reported non-adherence on first-line ART. Non-adherence was the reported reason for switching in a higher proportion of workplace patients. Following switch, 48.3% (workplace) and 72.0% (community) achieved VL, 400, with non-adherence (17.9% vs. 1.4%) and virological rebound (35.6% vs. 13.2% with available measures) reported more commonly in the workplace programme. In adjusted analysis of the workplace programme, lower switch VL and younger age were associated with VL <400. In the community programme, shorter duration of viraemia, higher CD4 count and transfers into programme on ART were associated with VL <400. Conclusion: High levels of viral suppression on second-line ART can be, but are not always, achieved in multi-site treatment programmes with both individual-and programme-level factors influencing outcomes. Strategies to support both healthcare workers and patients during this switch period need to be evaluated; sub-optimal adherence, particularly in the workplace programme must be addressed.	[Johnston, Victoria; Churchyard, Gavin; Grant, Alison D.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Fielding, Katherine] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Charalambous, Salome; Mampho, Mildred; Churchyard, Gavin] Aurum Inst, Dept Res, Johannesburg, South Africa; [Churchyard, Gavin] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa; [Phillips, Andrew] UCL, Dept Infect & Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Kwazulu Natal; University of London; University College London	Johnston, V (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.	victoria.johnston@lshtm.ac.uk	Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; Charalambous, Salome/0000-0001-7143-1009; Churchyard, Gavin/0000-0002-4269-3699	Wellcome Trust Clinical PhD Programme [087261/Z/08/Z]; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) [5U2GPS000811]; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U2GPS000811] Funding Source: NIH RePORTER	Wellcome Trust Clinical PhD Programme(Wellcome Trust); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this study was provided through a Wellcome Trust Clinical PhD Programme (VJ; Grant number 087261/Z/08/Z). The community programme was funded by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR; Grant number 5U2GPS000811) and the workplace programme by the employers. The content of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of these funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Barth RE, 2008, AIDS, V22, P2210, DOI 10.1097/QAD.0b013e328313bf87; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bartlett J, 2011, 18 C RETR OPP INF BO; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2011, 18 C RETR OPP INF BO; Bunupuradah T, 2011, 18 C RETR OPP INF BO; Bussmann H, 2009, JAIDS-J ACQ IMM DEF, V51, P37, DOI 10.1097/QAI.0b013e31819ff102; Cambiano V, 2010, HIV MED, V11, P216, DOI 10.1111/j.1468-1293.2009.00771.x; Charalambous S, 2007, AIDS CARE, V19, P34, DOI 10.1080/09500340600677872; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Cozzi-Lepri A, 2009, J INFECT DIS, V200, P687, DOI 10.1086/604731; Dahab M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-430; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Fielding KL, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-93; Fox MP, 2010, JAIDS-J ACQ IMM DEF, V53, P500, DOI 10.1097/QAI.0b013e3181bcdac1; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Johnston V, 2012, 19 C RETR OPP INF SE; Kaleebu P, 2006, AIDS, V20, P1391, DOI 10.1097/01.aids.0000233572.59522.45; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Kantor R, 2004, AIDS, V18, P1503, DOI 10.1097/01.aids.0000131358.29586.6b; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Keiser O, 2010, TROP MED INT HEALTH, V15, P251, DOI 10.1111/j.1365-3156.2009.02445.x; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Kimmel AD, 2012, AIDS CARE, V24, P778, DOI 10.1080/09540121.2011.630366; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Laurent C, 2008, AIDS RES HUM RETROV, V24, P393, DOI 10.1089/aid.2007.0219; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Levison JH, 2011, ANTIVIR THER, V16, P853, DOI 10.3851/IMP1819; Lodwick R, 2010, ARCH INTERN MED, V170, P410, DOI 10.1001/archinternmed.2009.472; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Manosuthi W, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-8; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Murphy R, 2011, 18 C RETR OPP INF BO; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nicastri E, 2005, J MED VIROL, V76, P153, DOI 10.1002/jmv.20352; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Orrell C, 2009, ANTIVIR THER, V14, P523; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Prosperi MCF, 2011, J ANTIMICROB CHEMOTH, V66, P1886, DOI 10.1093/jac/dkr171; Pujades-Rodriguez M, 2010, 18 INT AIDS C VIENN; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; Rosen S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-24; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Russell EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-433; Seyler C, 2007, AIDS, V21, P1157, DOI 10.1097/QAD.0b013e3281c615da; Sigaloff KCE, 2012, AIDS RES HUM RETROV, V28, P171, DOI 10.1089/aid.2011.0136; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; van Zyl GU, 2011, J MED VIROL, V83, P1764, DOI 10.1002/jmv.22189; van Zyl GU, 2011, JAIDS-J ACQ IMM DEF, V56, P333, DOI 10.1097/QAI.0b013e31820dc0cc; Wallis CL, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/769627; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wouters E, 2009, SOC SCI MED, V69, P1177, DOI 10.1016/j.socscimed.2009.07.034; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0; Zhou J, 2010, HIV MED, V11, P31, DOI 10.1111/j.1468-1293.2009.00738.x; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	72	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e36997	10.1371/journal.pone.0036997	http://dx.doi.org/10.1371/journal.pone.0036997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22666338	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305349600007
J	Medan, D; Luanpitpong, S; Azad, N; Wang, LY; Jiang, BH; Davis, ME; Barnett, JB; Guo, L; Rojanasakul, Y				Medan, Djordje; Luanpitpong, Sudjit; Azad, Neelam; Wang, Liying; Jiang, Bing-Hua; Davis, Mary E.; Barnett, John B.; Guo, Lan; Rojanasakul, Yon			Multifunctional Role of Bcl-2 in Malignant Transformation and Tumorigenesis of Cr(VI)-Transformed Lung Cells	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; CANCER; P53; EXPRESSION; ABNORMALITIES; INDUCTION; CHROMIUM	B-cell lymphoma-2 (Bcl-2) is an antiapoptotic protein known to be important in the regulation of apoptosis in various cell types. However, its role in malignant transformation and tumorigenesis of human lung cells is not well understood. We previously reported that chronic exposure of human lung epithelial cells to the carcinogenic hexavalent chromium Cr(VI) caused malignant transformation and Bcl-2 upregulation; however, the role of Bcl-2 in the transformation is unclear. Using a gene silencing approach, we showed that Bcl-2 plays an important role in the malignant properties of Cr(VI)-transformed cells. Downregulation of Bcl-2 inhibited the invasive and proliferative properties of the cells as well as their colony forming and angiogenic activities, which are upregulated in the transformed cells as compared to control cells. Furthermore, animal studies showed the inhibitory effect of Bcl-2 knockdown on the tumorigenesis of Cr(VI)-transformed cells. The role of Bcl-2 in malignant transformation and tumorigenesis was confirmed by gene silencing experiments using human lung carcinoma NCI-H460 cells. These cells exhibited aggressive malignant phenotypes similar to those of Cr(VI)-transformed cells. Knockdown of Bcl-2 in the H460 cells inhibited malignant and tumorigenic properties of the cells, indicating the general role of Bcl-2 in human lung tumorigenesis. Ingenuity Pathways Analysis (IPA) revealed potential effectors of Bcl-2 in tumorigenesis regulation. Additionally, using IPA together with ectopic expression of p53, we show p53 as an upstream regulator of Bcl-2 in Cr(VI)-transformed cells. Together, our results indicate the novel and multifunctional role of Bcl-2 in malignant transformation and tumorigenesis of human lung epithelial cells chronically exposed to Cr(VI).	[Medan, Djordje; Luanpitpong, Sudjit; Rojanasakul, Yon] W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA; [Azad, Neelam] Hampton Univ, Dept Pharmaceut Sci, Hampton, VA 23668 USA; [Wang, Liying] NIOSH, Pathol & Physiol Res Branch, Morgantown, WV USA; [Jiang, Bing-Hua] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Davis, Mary E.] W Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA; [Barnett, John B.] W Virginia Univ, Dept Immunol Microbiol & Cell Biol, Morgantown, WV 26506 USA; [Guo, Lan] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	West Virginia University; Hampton University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Jefferson University; West Virginia University; West Virginia University; West Virginia University	Medan, D (corresponding author), W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA.	yrojan@hsc.wvu.edu	Barnett, John/AAW-6642-2020; Luanpitpong, Sudjit/ABF-1962-2021	Luanpitpong, Sudjit/0000-0002-1639-4935; Jiang, Bing-Hua/0000-0003-4526-2031; Rojanasakul, Yon/0000-0002-8839-6462	National Institutes of Health [HL095579, HL076340-04S1, P20-RR016477]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076340, R01HL095579] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institutes of Health [grant numbers HL095579, HL076340-04S1, and P20-RR016477]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; [Anonymous], 1990, IARC MON EV CARC RIS, V49; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Azad N, 2010, AM J RESP CELL MOL, V42, P578, DOI 10.1165/rcmb.2009-0094OC; BAETJER A M, 1959, AMA Arch Ind Health, V20, P124; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; CARNEY DN, 1980, CANCER RES, V40, P1820; Ciardiello F, 2002, ANN ONCOL, V13, P501, DOI 10.1093/annonc/mdf191; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Cohen AJ, 1995, ENVIRON HEALTH PERSP, V103, P219, DOI 10.2307/3432314; Costa AN, 2010, MOL CARCINOGEN, V49, P582, DOI 10.1002/mc.20624; De Flora S, 2000, CARCINOGENESIS, V21, P533, DOI 10.1093/carcin/21.4.533; Fahy BN, 2005, CANCER CHEMOTH PHARM, V56, P46, DOI 10.1007/s00280-004-0944-5; GERWIN BI, 1992, P NATL ACAD SCI USA, V89, P2759, DOI 10.1073/pnas.89.7.2759; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HALDAR S, 1994, CANCER RES, V54, P2095; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; HUEPER W C, 1959, Am Ind Hyg Assoc J, V20, P274, DOI 10.1080/00028895909343716; Hussain SP, 2003, CANCER RES, V113, P238; JIANG SX, 1995, J PATHOL, V177, P135, DOI 10.1002/path.1711770206; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Khatlani TS, 2007, ONCOGENE, V26, P2658, DOI 10.1038/sj.onc.1210050; LANGARD S, 1990, AM J IND MED, V17, P189, DOI 10.1002/ajim.4700170205; Laudanski J, 2001, EUR RESPIR J, V17, P660, DOI 10.1183/09031936.01.17406600; LEHMAN TA, 1991, ENVIRON HEALTH PERSP, V93, P133, DOI 10.2307/3431181; Liao WT, 2007, TOXICOL APPL PHARM, V225, P162, DOI 10.1016/j.taap.2007.07.017; Luanpitpong S, 2010, J BIOL CHEM, V285, P38832, DOI 10.1074/jbc.M110.124958; MACHLE W, 1948, PUBLIC HEALTH REP, V63, P1114, DOI 10.2307/4586677; MACKENZIE R D, 1958, AMA Arch Ind Health, V18, P232; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MIYASHITA T, 1994, CANCER RES, V54, P3131; Ohmura Y, 2000, CLIN CANCER RES, V6, P2980; Oxford SME, 2004, CURR MED CHEM, V11, P1031, DOI 10.2174/0929867043455486; Rodrigues CFD, 2009, MUTAT RES-FUND MOL M, V670, P42, DOI 10.1016/j.mrfmmm.2009.07.004; Sargent LM, 2009, ENVIRON MOL MUTAGEN, V50, P708, DOI 10.1002/em.20529; SIMONATO L, 1991, BRIT J IND MED, V48, P145; Sutton R., 2010, CHROMIUM 6 US TAP WA; USEPA, 2000, CHROM COMP FACTSH; Van Vleet TR, 2006, TOXICOL SCI, V89, P399, DOI 10.1093/toxsci/kfj039; Wang LY, 2011, NANO LETT, V11, P2796, DOI 10.1021/nl2011214; Woodruff TJ, 1998, ENVIRON HEALTH PERSP, V106, P245, DOI 10.2307/3434011	42	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37045	10.1371/journal.pone.0037045	http://dx.doi.org/10.1371/journal.pone.0037045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666341	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600009
J	Hadrys, H; Simon, S; Kaune, B; Schmitt, O; Schoner, A; Jakob, W; Schierwater, B				Hadrys, Heike; Simon, Sabrina; Kaune, Barbara; Schmitt, Oliver; Schoener, Anja; Jakob, Wolfgang; Schierwater, Bernd			Isolation of Hox Cluster Genes from Insects Reveals an Accelerated Sequence Evolution Rate	PLOS ONE			English	Article							LARVAL DEVELOPMENT; HOMEOBOX GENES; BODY PLANS; ULTRABITHORAX; BEETLE; ANTENNAPEDIA; ORGANIZATION; EXPRESSION; PHYLOGENY; PARAHOX	Among gene families it is the Hox genes and among metazoan animals it is the insects (Hexapoda) that have attracted particular attention for studying the evolution of development. Surprisingly though, no Hox genes have been isolated from 26 out of 35 insect orders yet, and the existing sequences derive mainly from only two orders (61% from Hymenoptera and 22% from Diptera). We have designed insect specific primers and isolated 37 new partial homeobox sequences of Hox cluster genes (lab, pb, Hox3, ftz, Antp, Scr, abd-a, Abd-B, Dfd, and Ubx) from six insect orders, which are crucial to insect phylogenetics. These new gene sequences provide a first step towards comparative Hox gene studies in insects. Furthermore, comparative distance analyses of homeobox sequences reveal a correlation between gene divergence rate and species radiation success with insects showing the highest rate of homeobox sequence evolution.	[Hadrys, Heike; Simon, Sabrina; Kaune, Barbara; Schmitt, Oliver; Schoener, Anja; Jakob, Wolfgang; Schierwater, Bernd] Stiftung Tieraerztliche Hsch Hannover, Div Ecol & Evolut, ITZ, Hannover, Germany; [Schierwater, Bernd] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Hadrys, Heike; Schierwater, Bernd] Amer Museum Nat Hist, New York, NY 10024 USA	University of Veterinary Medicine Hannover, Foundation; Yale University; American Museum of Natural History (AMNH)	Hadrys, H (corresponding author), Stiftung Tieraerztliche Hsch Hannover, Div Ecol & Evolut, ITZ, Hannover, Germany.	heike.hadrys@ecolevol.de		Simon, Sabrina/0000-0001-8560-0985	German Research Foundation (DFG) [SP1174, DFG HA 1947/5]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a German Research Foundation (DFG) special priority program "Deep Metazoan Phylogeny" SP1174 grant given to H. H. (DFG HA 1947/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Angelini DR, 2005, ANNU REV GENET, V39, P95, DOI 10.1146/annurev.genet.39.073003.112310; Angelini DR, 2005, DEV BIOL, V287, P440, DOI 10.1016/j.ydbio.2005.08.010; BEEMAN RW, 1993, BIOESSAYS, V15, P439, DOI 10.1002/bies.950150702; Brown SJ, 2002, GENETICS, V160, P1067; Casillas S, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-106; Chesebro J, 2009, DEV BIOL, V329, P142, DOI 10.1016/j.ydbio.2009.01.032; Cook CE, 2001, CURR BIOL, V11, P759, DOI 10.1016/S0960-9822(01)00222-6; Damen WGM, 2010, ADV EXP MED BIOL, V689, P125; Deutsch J, 2005, BIOESSAYS, V27, P673, DOI 10.1002/bies.20260; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Ferrier DEK, 2010, ADV EXP MED BIOL, V689, P91; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; Hadrys H, 1992, MOL ECOL, V1, P55, DOI 10.1111/j.1365-294X.1992.tb00155.x; HADRYS H, 1993, MOL ECOL, V2, P79, DOI 10.1111/j.1365-294X.1993.tb00002.x; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Ikuta T, 2010, DEVELOPMENT, V137, P1505, DOI 10.1242/dev.046938; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; Jakob W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000694; Jockusch EL, 2004, J HERED, V95, P382, DOI 10.1093/jhered/esh064; Kamm K, 2006, J EXP ZOOL PART B, V306B, P589, DOI 10.1002/jez.b.21123; Kamm K, 2006, CURR BIOL, V16, P920, DOI 10.1016/j.cub.2006.03.036; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Marden JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P751, DOI 10.1086/318109; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Michaut L, 2011, DEV GROWTH DIFFER, V53, P982, DOI 10.1111/j.1440-169X.2011.01307.x; Mulley JF, 2006, P NATL ACAD SCI USA, V103, P10369, DOI 10.1073/pnas.0600341103; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; Ober KA, 2006, DEV BIOL, V294, P391, DOI 10.1016/j.ydbio.2006.02.053; Ogishima S, 2007, GENE, V387, P21, DOI 10.1016/j.gene.2006.08.011; Pavlopoulos A, 2011, P NATL ACAD SCI USA, V108, P2855, DOI 10.1073/pnas.1015077108; Peel AD, 2006, P ROY SOC B-BIOL SCI, V273, P1733, DOI 10.1098/rspb.2006.3497; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; Pernice M, 2006, MOL PHYLOGENET EVOL, V40, P872, DOI 10.1016/j.ympev.2006.04.004; Prohaska SJ, 2006, J EXP ZOOL PART B, V306B, P481, DOI 10.1002/jez.b.21099; Rogers BT, 1997, DEVELOPMENT, V124, P149; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Saenko SV, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-9; Samadi L, 2010, DEV GENES EVOL, V220, P161, DOI 10.1007/s00427-010-0338-0; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Sandhall A, 1974, INSEKTEN WEICHTIERE; Schierwater B, 2002, MOL PHYLOGENET EVOL, V24, P374, DOI 10.1016/S1055-7903(02)00238-5; Schierwater B, 2010, ADV EXP MED BIOL, V689, P81; Schierwater B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002457; SCOTT MP, 1993, NUCLEIC ACIDS RES, V21, P1687, DOI 10.1093/nar/21.8.1687; Sicheritz-Ponten T, 2001, NUCLEIC ACIDS RES, V29, P545, DOI 10.1093/nar/29.2.545; Simon S, 2009, MOL BIOL EVOL, V26, P2719, DOI 10.1093/molbev/msp191; Slattery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014686; Swalla BJ, 2006, HEREDITY, V97, P235, DOI 10.1038/sj.hdy.6800872; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; von Reumont BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-119; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Yasukochi Y, 2004, DEV GENES EVOL, V214, P606, DOI 10.1007/s00427-004-0441-1; Yeates DK, 2012, AUSTR J ENTOMOLOGY; ZUCKERKANDL EMILE, 1965, P97	59	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e34682	10.1371/journal.pone.0034682	http://dx.doi.org/10.1371/journal.pone.0034682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685537	gold, Green Published, Green Submitted			2022-12-27	WOS:000305351700001
J	Lamb, MR; El-Sadr, WM; Geng, E; Nash, D				Lamb, Matthew R.; El-Sadr, Wafaa M.; Geng, Elvin; Nash, Denis			Association of Adherence Support and Outreach Services with Total Attrition, Loss to Follow-Up, and Death among ART Patients in Sub-Saharan Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAMS; RESOURCE-LIMITED SETTINGS; HIV-INFECTED PATIENTS; RANDOMIZED-TRIAL; INCOME COUNTRIES; SOUTH-AFRICA; OUTCOMES; MORTALITY; KENYA; INTERVENTION	Background: Loss to follow-up (LTF) after antiretroviral therapy (ART) initiation is common in HIV clinics. We examined the effect of availability of adherence support and active patient outreach services on patient attrition following ART initiation. Methods and Findings: This ecologic study examined clinic attrition rates (total attrition, LTF, and death) among 232,389 patients initiating ART at 349 clinics during 2004-2008 in 10 sub-Saharan African countries, and cohort attrition (proportion retained at 6 and 12 months after ART initiation) among a subset of patients with follow-up information (n = 83,389). Log-linear regression compared mean rates of attrition, LTF, and death between clinics with and without adherence support and outreach services. Cumulative attrition, LTF, and death rates were 14.2, 9.2, and 4.9 per 100 person-years on ART, respectively. In multivariate analyses, clinic availability of >2 adherence support services was marginally associated with lower attrition rates (RRadj = 0.59, 95%CI: 0.35-1.0). Clinics with availability of counseling services (RRadj = 0.62, 95%CI: 0.42-0.92), educational materials (RRadj = 0.73, 95%CI: 0.63-0.85), reminder tools (RRadj = 0.79, 95%CI: 0.64-0.97), and food rations (RRadj = 0.72, 95%CI: 0.58-0.90) had significantly lower attrition, with similar results observed for LTF. Outreach services were not significantly associated with attrition. In cohort analyses, attrition was significantly lower at clinics offering >2 adherence support services (RRadj,6m = 0.84, 95%CI: 0.73-0.96), dedicated pharmacy services (RRadj,6m = 0.78, 95%CI: 0.69-0.90), and active patient outreach (RRadj,6m = 0.85, 95%CI: 0.73-0.99). Availability of food rations was marginally associated with increased retention at 6 (RRadj,6m = 0.82, 95%CI: 0.64-1.05) but not 12 months (RRadj,12m = 0.98, 95%CI: 0.78-1.21). Conclusions: Availability of adherence support services, active patient outreach and food rations at HIV care clinics may improve retention following ART initiation.	[Lamb, Matthew R.; El-Sadr, Wafaa M.] Columbia Univ, Int Ctr AIDS Care & Treatment Programs ICAP, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Lamb, Matthew R.; El-Sadr, Wafaa M.; Nash, Denis] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [El-Sadr, Wafaa M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Geng, Elvin] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Nash, Denis] CUNY, Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; City University of New York (CUNY) System; Hunter College (CUNY)	Lamb, MR (corresponding author), Columbia Univ, Int Ctr AIDS Care & Treatment Programs ICAP, Mailman Sch Publ Hlth, New York, NY 10027 USA.	mrl2013@columbia.edu	Nash, Denis/AFI-7485-2022	Nash, Denis/0000-0002-3280-5386	US Centers for Disease Control and Prevention; US Agency for International Development (USAID); Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI084544] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Agency for International Development (USAID)(United States Agency for International Development (USAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge the financial support by the President's Emergency Plan for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention, the US Agency for International Development (USAID) and by the Doris Duke Charitable Foundation. Indicators used to construct the non-retention, loss to follow-up, and reported death rate outcomes were derived from CDC-designed Track 1.0 HIV care and treatment reporting indicators. The funders had no further role in study design, data collection and analysis or preparation of the manuscript.	An MW, 2009, BIOMETRICS, V65, P301, DOI 10.1111/j.1541-0420.2008.01043.x; Anema A, 2012, PUBLIC HEALTH NUTR, V15, P938, DOI 10.1017/S136898001100125X; Attaran A, 2007, PLOS MED, V4, P390, DOI 10.1371/journal.pmed.0040083; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof M, 2008, PLOS MED IN PRESS; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Byron E, 2008, FOOD NUTR BULL, V29, P87, DOI 10.1177/156482650802900202; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Chesney MA, 2000, SOC SCI MED, V50, P1599, DOI 10.1016/S0277-9536(99)00468-2; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; de Pee S, 2010, FOOD NUTR BULL, V31, pS313, DOI 10.1177/15648265100314S403; Demeester R, 2005, JAIDS-J ACQ IMM DEF, V40, P113, DOI 10.1097/01.qai.0000176590.68430.59; Deribe K, 2008, TROP MED INT HEALTH, V13, P328, DOI 10.1111/j.1365-3156.2008.02006.x; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Fairley CK, 2003, INT J STD AIDS, V14, P805, DOI 10.1258/095646203322556129; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Geng EH, 2012, AM J EPIDEMIOLOGY; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Goujard C, 2003, JAIDS-J ACQ IMM DEF, V34, P191, DOI 10.1097/00126334-200310010-00009; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Kip E, 2009, J NURS SCHOLARSHIP, V41, P149, DOI 10.1111/j.1547-5069.2009.01266.x; Kuria EN, 2010, PUBLIC HEALTH NUTR, V13, P475, DOI 10.1017/S1368980009990826; Lahuerta M, 2011, JAIDS-J ACQ IMM DEF, V58, pE75, DOI 10.1097/QAI.0b013e31822ac0a9; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Milam J, 2005, JAIDS-J ACQ IMM DEF, V40, P356, DOI 10.1097/01.qai.0000159710.98960.81; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Murray LK, 2009, AIDS CARE, V21, P78, DOI 10.1080/09540120802032643; Nash D, 2007, C RETR OPP INF CROI; Pradier C, 2003, HIV CLIN TRIALS, V4, P121; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Thomson KA, 2011, T ROY SOC TROP MED H, V105, P320, DOI 10.1016/j.trstmh.2011.02.011; Torpey KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002204; Traore AANV, 2004, 15 INT AIDS C BANGK; Weber R, 2004, ANTIVIR THER, V9, P85; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	47	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38443	10.1371/journal.pone.0038443	http://dx.doi.org/10.1371/journal.pone.0038443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685569	Green Published, gold			2022-12-27	WOS:000305351700032
J	Tutarel, O; Golla, P; Beutel, G; Bauersachs, J; David, S; Schmidt, BMW; Lichtinghagen, R; Kielstein, JT				Tutarel, Oktay; Golla, Paulina; Beutel, Gernot; Bauersachs, Johann; David, Sascha; Schmidt, Bernhard M. W.; Lichtinghagen, Ralf; Kielstein, Jan T.			Therapeutic Plasma Exchange Decreases Levels of Routinely Used Cardiac and Inflammatory Biomarkers	PLOS ONE			English	Article							HEART-TRANSPLANTATION; REJECTION; APHERESIS; PARAMETERS; FAILURE	Background: Therapeutic plasma exchange (TPE) plays a key role in the management of various diseases, from thrombotic thrombocytopenic purpura and Goodpasture's syndrome to cardiac allograft rejection. In many of these disease states cardiac and inflammatory involvement is common and biomarkers are routinely used for diagnosis or assessment of therapeutic success. The effect of TPE on biomarkers used in the clinical routine has not been investigated. Methods: TPE was initiated for established clinical conditions in 21 patients. Troponin T, NT-proBNP, C-reactive protein, procalcitonin and routine chemistry were drawn before and after TPE, as well as before and after the 2nd TPE. The total amount of these markers in the waste bag was also analyzed. Results: In 21 patients 42 TPEs were performed. The procedure reduced plasma levels of the examined biomarkers: 23% for NT-proBNP (pre vs. post: 4637 +/- 10234 ng/l to 3565 +/- 8295 ng/l, p < 0.001), 64% for CRP (21.9 +/- 47.0 mg/l vs. 7.8 +/- 15.8 mg/l, p < 0.001) and 31% for procalcitonin (0.39 +/- 1.1 mu g/l vs. 0.27 +/- 0.72 mu g/l, p = 0.004). TPE also tended to reduce plasma levels of troponin T by about 14% (60.7 +/- 175.5 ng/l vs. 52.2 +/- 141.3 ng/l), however this difference was not statistical significant (p = 0.95). There was a significant correlation between the difference of pre TPE levels to post TPE levels of all examined biomarkers and the total amount of the removed biomarker in the collected removed plasma. Conclusions: TPE significantly reduces plasma levels of inflammatory and cardiac biomarkers. Therefore, post TPE levels of cardiac and inflammatory biomarkers should be viewed with caution.	[Tutarel, Oktay; Bauersachs, Johann] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany; [Golla, Paulina; David, Sascha; Schmidt, Bernhard M. W.; Kielstein, Jan T.] Hannover Med Sch, Dept Hypertens & Nephrol, D-3000 Hannover, Germany; [Beutel, Gernot] Hannover Med Sch, Dept Hematol Hemostaseol Oncol & Stem Cell Transp, D-3000 Hannover, Germany; [Lichtinghagen, Ralf] Hannover Med Sch, Dept Clin Chem, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Tutarel, O (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany.	kielstein@yahoo.com	Kielstein, Jan T./I-2956-2019; David, Sascha/AAL-6909-2021	Kielstein, Jan T./0000-0001-8110-9064; Tutarel, Oktay/0000-0002-5201-5509	Deutsche Forschungsgemeinsschaft; Caridian BCT	Deutsche Forschungsgemeinsschaft(German Research Foundation (DFG)); Caridian BCT	Publication costs are covered by the program "Open Access Publication" of the Deutsche Forschungsgemeinsschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JTK has received research funding from Caridian BCT for an investigator-initiated study with unrestricted research support, i.e. no influence on the current study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. There are no other competing interests.	Abel JJ, 1914, J PHARMACOL EXP THER, V5, P625; Bektas M, 2008, J CLIN GASTROENTEROL, V42, P517, DOI 10.1097/MCG.0b013e31815878ff; Dengler TJ, 1998, J AM COLL CARDIOL, V32, P405, DOI 10.1016/S0735-1097(98)00257-5; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Grauhan O, 2001, J HEART LUNG TRANSPL, V20, P316, DOI 10.1016/S1053-2498(00)00211-4; Hamm CW, 2011, EUR HEART J; Hershcovici T, 2004, J CLIN APHERESIS, V19, P90, DOI 10.1002/jca.20006; Kielstein JT, 2011, NEPHROL DIAL TRANSPL, V26, P2723, DOI 10.1093/ndt/gfr462; Kittleson MM, 2009, J HEART LUNG TRANSPL, V28, P704, DOI 10.1016/j.healun.2009.04.019; Morath C, 2007, NEPHROL DIAL TRANSPL, V22, P2701, DOI 10.1093/ndt/gfm353; Okafor C, 2010, J CLIN APHERESIS, V25, P240, DOI 10.1002/jca.20247; Patschan D, 2006, NEPHROL DIAL TRANSPL, V21, P1549, DOI 10.1093/ndt/gfl127; Szczepiorkowski ZM, 2010, J CLIN APHERESIS, V25, P83, DOI 10.1002/jca.20240; Ward DM, 2011, J CLIN APHERESIS, V26, P230, DOI 10.1002/jca.20302	14	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38573	10.1371/journal.pone.0038573	http://dx.doi.org/10.1371/journal.pone.0038573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22685586	Green Published, Green Submitted, gold			2022-12-27	WOS:000305351700049
J	Ionescu, D; Siebert, C; Polerecky, L; Munwes, YY; Lott, C; Hausler, S; Bizic-Ionescu, M; Quast, C; Peplies, J; Glockner, FO; Ramette, A; Rodiger, T; Dittmar, T; Oren, A; Geyer, S; Stark, HJ; Sauter, M; Licha, T; Laronne, JB; de Beer, D				Ionescu, Danny; Siebert, Christian; Polerecky, Lubos; Munwes, Yaniv Y.; Lott, Christian; Haeusler, Stefan; Bizic-Ionescu, Mina; Quast, Christian; Peplies, Joerg; Gloeckner, Frank Oliver; Ramette, Alban; Roediger, Tino; Dittmar, Thorsten; Oren, Aharon; Geyer, Stefan; Staerk, Hans-Joachim; Sauter, Martin; Licha, Tobias; Laronne, Jonathan B.; de Beer, Dirk			Microbial and Chemical Characterization of Underwater Fresh Water Springs in the Dead Sea	PLOS ONE			English	Article							HALOPHILIC ARCHAEA; GROUNDWATER-FLOW; HYDROGEN-SULFIDE; RARE-EARTHS; BACTERIA; IRON; DIVERSITY; OXIDATION; SYSTEM; IDENTIFICATION	Due to its extreme salinity and high Mg concentration the Dead Sea is characterized by a very low density of cells most of which are Archaea. We discovered several underwater fresh to brackish water springs in the Dead Sea harboring dense microbial communities. We provide the first characterization of these communities, discuss their possible origin, hydrochemical environment, energetic resources and the putative biogeochemical pathways they are mediating. Pyrosequencing of the 16S rRNA gene and community fingerprinting methods showed that the spring community originates from the Dead Sea sediments and not from the aquifer. Furthermore, it suggested that there is a dense Archaeal community in the shoreline pore water of the lake. Sequences of bacterial sulfate reducers, nitrifiers iron oxidizers and iron reducers were identified as well. Analysis of white and green biofilms suggested that sulfide oxidation through chemolitotrophy and phototrophy is highly significant. Hyperspectral analysis showed a tight association between abundant green sulfur bacteria and cyanobacteria in the green biofilms. Together, our findings show that the Dead Sea floor harbors diverse microbial communities, part of which is not known from other hypersaline environments. Analysis of the water's chemistry shows evidence of microbial activity along the path and suggests that the springs supply nitrogen, phosphorus and organic matter to the microbial communities in the Dead Sea. The underwater springs are a newly recognized water source for the Dead Sea. Their input of microorganisms and nutrients needs to be considered in the assessment of possible impact of dilution events of the lake surface waters, such as those that will occur in the future due to the intended establishment of the Red Sea-Dead Sea water conduit.	[Ionescu, Danny; Polerecky, Lubos; Lott, Christian; Haeusler, Stefan; Bizic-Ionescu, Mina; Quast, Christian; Gloeckner, Frank Oliver; Ramette, Alban; Dittmar, Thorsten; de Beer, Dirk] Max Planck Inst Marine Microbiol, Bremen, Germany; [Siebert, Christian; Roediger, Tino; Geyer, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Catchment Hydrol, Halle, Germany; [Munwes, Yaniv Y.; Laronne, Jonathan B.] Ben Gurion Univ Negev, Dept Geog & Environm Dev, IL-84105 Beer Sheva, Israel; [Lott, Christian] Elba Field Stn, HYDRA Inst Marine Sci, Campo Nellelba, LI, Italy; [Bizic-Ionescu, Mina] Leibniz Inst Freshwater Ecol & Inland Fisheries B, Dept Stratified Lakes, Stechlin, Germany; [Peplies, Joerg] Ribocon GmbH, Bremen, Germany; [Gloeckner, Frank Oliver] Jacobs Univ Bremen GmbH, Bremen, Germany; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-2900 Oldenburg, Germany; [Oren, Aharon] Hebrew Univ Jerusalem, Inst Life Sci, Dept Plant & Environm Sci, IL-91904 Jerusalem, Israel; [Staerk, Hans-Joachim] UFZ Helmholtz Ctr Environm Res, Dept Analyt Chem, Leipzig, Germany; [Sauter, Martin; Licha, Tobias] Univ Gottingen, Geosci Ctr, Gottingen, Germany	Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Ben Gurion University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Jacobs University; Carl von Ossietzky Universitat Oldenburg; Hebrew University of Jerusalem; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Gottingen	Ionescu, D (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	dionescu@mpi-bremen.de	Geyer, Stefan/D-4785-2015; Siebert, Christian/D-3380-2013; Bizic, Mina/AAC-4802-2022; Dittmar, Thorsten/L-7796-2013; Ionescu, Danny/P-3261-2017; de Beer, Dirk/L-4840-2013; Bizic, Mina/AEB-9802-2022; Ramette, Alban/E-9197-2016; Polerecky, Lubos/E-1134-2014	Geyer, Stefan/0000-0003-1746-9019; Siebert, Christian/0000-0001-7266-8112; Bizic, Mina/0000-0002-6870-4018; Dittmar, Thorsten/0000-0002-3462-0107; Ionescu, Danny/0000-0002-4658-8597; de Beer, Dirk/0000-0001-5274-1781; Bizic, Mina/0000-0002-6870-4018; Ramette, Alban/0000-0002-3437-4639; Polerecky, Lubos/0000-0003-4425-585X; Licha, Tobias/0000-0003-3122-6048; Quast, Christian/0000-0001-6409-2352	German Federal Ministry of Education and Science through the project SUMAR [02WM0848]	German Federal Ministry of Education and Science through the project SUMAR	Funding for this study was obtained from the German Federal Ministry of Education and Science through the project SUMAR (grant code: 02WM0848). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akawwi Emad, 2008, American Journal of Environmental Sciences, V4, P693, DOI 10.3844/ajessp.2008.693.700; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; ANATI DA, 1987, EARTH PLANET SC LETT, V84, P109, DOI 10.1016/0012-821X(87)90181-6; Barkan E, 2001, GEOCHIM COSMOCHIM AC, V65, P355, DOI 10.1016/S0016-7037(00)00540-8; Bau M, 1999, GEOCHIM COSMOCHIM AC, V63, P67, DOI 10.1016/S0016-7037(99)00014-9; Ben-Itzhak LL, 2005, J HYDROL, V312, P51, DOI 10.1016/j.jhydrol.2005.02.009; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141; Bosecker K, 1997, FEMS MICROBIOL REV, V20, P591, DOI 10.1016/S0168-6445(97)00036-3; Caccavo F, 1996, ARCH MICROBIOL, V165, P370, DOI 10.1007/s002030050340; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Closson D, 2009, EARTH SURF PROC LAND, V34, P1408, DOI 10.1002/esp.1829; COHEN Y, 1986, APPL ENVIRON MICROB, V51, P398, DOI 10.1128/AEM.51.2.398-407.1986; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dulski P, 2001, GEOSTANDARD NEWSLETT, V25, P87, DOI 10.1111/j.1751-908X.2001.tb00790.x; DULSKI P, 1994, FRESEN J ANAL CHEM, V350, P194, DOI 10.1007/BF00322470; ELAZARIVOLCANI B, 1940, NATURE, V145, P975; Elshahed MS, 2004, APPL ENVIRON MICROB, V70, P2230, DOI 10.1128/AEM.70.4.2230-2239.2004; Engel AS, 2004, GEOLOGY, V32, P369, DOI 10.1130/G20288.1; Engel AS, 2003, APPL ENVIRON MICROB, V69, P5503, DOI 10.1128/AEM.69.9.5503-5511.2003; Frigaard NU, 2004, ARCH MICROBIOL, V182, P265, DOI 10.1007/s00203-004-0718-9; Gavrieli I, 2001, EARTH PLANET SC LETT, V186, P199, DOI 10.1016/S0012-821X(01)00247-3; Goldscheider N, 2006, HYDROGEOL J, V14, P926, DOI 10.1007/s10040-005-0009-9; GOOD IJ, 1956, BIOMETRIKA, V43, P45; Gracas DA, 2011, MICROB ECOL, V62, P853, DOI 10.1007/s00248-011-9906-8; Greene AC, 1997, INT J SYST BACTERIOL, V47, P505, DOI 10.1099/00207713-47-2-505; Gross H., 1977, GEOLOGICAL SURVEY IS, V70, P1; Gvirtzman H, 2000, J GEOCHEM EXPLOR, V69, P207, DOI 10.1016/S0375-6742(00)00057-1; Hammer O, 2009, PALAEONTOL ELECT, P4; Hannigan RE, 2001, CHEM GEOL, V175, P495, DOI 10.1016/S0009-2541(00)00355-7; Hansell DA., 2002, BIOGEOCHEMISTRY MARI, V1; Haveman SA, 2010, MOL BIOL, P37; Huber H, 2002, BERGEYS MANUAL SYSTE, P465; Ionescu D, 2009, FEMS MICROBIOL ECOL, V69, P425, DOI 10.1111/j.1574-6941.2009.00721.x; Johannesson KH, 1999, GEOCHIM COSMOCHIM AC, V63, P2697, DOI 10.1016/S0016-7037(99)00184-2; Katz A, 2009, EARTH PLANET SC LETT, V286, P219, DOI 10.1016/j.epsl.2009.06.031; Katz A, 2009, AQUAT GEOCHEM, V15, P159, DOI 10.1007/s10498-008-9045-0; Keough BP, 2003, MICROBIAL ECOL, V46, P238, DOI 10.1007/s00248-003-1003-1; La Cono V, 2011, ENVIRON MICROBIOL, V13, P2250, DOI 10.1111/j.1462-2920.2011.02478.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lazar Michael, 2002, Israel Journal of Earth Sciences, V51, P211, DOI 10.1560/5MPK-UJDN-L6CV-024K; LOVLEY DR, 1995, APPL ENVIRON MICROB, V61, P2132, DOI 10.1128/AEM.61.6.2132-2138.1995; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Macalady JL, 2007, ENVIRON MICROBIOL, V9, P1402, DOI 10.1111/j.1462-2920.2007.01256.x; Moller P, 2007, CHEM GEOL, V239, P27, DOI 10.1016/j.chemgeo.2006.12.004; Moller P, 2003, APPL GEOCHEM, V18, P1613, DOI 10.1016/S0883-2927(03)00044-1; NISHRI A, 1984, EARTH PLANET SC LETT, V71, P405, DOI 10.1016/0012-821X(84)90106-7; NISSENBA.A, 1972, GEOCHIM COSMOCHIM AC, V37, P709; O'Connell SP, 2003, FEMS MICROBIOL ECOL, V44, P165, DOI 10.1016/S0168-6496(02)00465-8; Oren A, 1995, HYDROBIOLOGIA, V315, P149, DOI 10.1007/BF00033627; Oren A, 2004, J MARINE SYST, V46, P121, DOI 10.1016/j.jmarsys.2003.11.017; Oren A., 2002, HALOPHILIC MICROORGA; Oren A, 2005, ARCH HYDROBIOL S, V117, P339, DOI DOI 10.1127/1864-1318/2005/0117-0339; Oren Aharon, 2010, Lakes & Reservoirs Research and Management, V15, P215, DOI 10.1111/j.1440-1770.2010.00435.x; Overmann J, 2006, PROKARYOTES, V7, P359, DOI DOI 10.1007/0-387-30747-8_13; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; PEDERSEN K, 1990, MICROBIAL ECOL, V20, P37, DOI 10.1007/BF02543865; Polerecky L, 2009, APPL ENVIRON MICROB, V75, P758, DOI 10.1128/AEM.00819-08; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Ravenschlag K, 2000, APPL ENVIRON MICROB, V66, P3592, DOI 10.1128/AEM.66.8.3592-3602.2000; Reznik IJ, 2009, GEOCHIM COSMOCHIM AC, V73, P6218, DOI 10.1016/j.gca.2009.07.018; Rhodes ME, 2010, ENVIRON MICROBIOL, V12, P2613, DOI 10.1111/j.1462-2920.2010.02232.x; Salman V, 2011, SYST APPL MICROBIOL, V34, P243, DOI 10.1016/j.syapm.2011.02.001; SAND W, 1995, APPL MICROBIOL BIOT, V43, P961, DOI 10.1007/BF00166909; Schink B, 2006, PROKARYOTES, V3, P5, DOI DOI 10.1007/0-387-30747-8_1; Semenza M, 2002, LAT AM APPL RES, V32, P303; Shalev E., 2008, ASSESSMENT GEOTHERMA; Shatkay M., 1993, INT J SALT LAKE RES, V2, P93, DOI 10.1007/BF02905903.; Shen YN, 2004, EARTH-SCI REV, V64, P243, DOI 10.1016/S0012-8252(03)00054-0; Siebert C, 2006, THESIS FREIEI U BERL; Siebert C, 2009, WATER JORDAN VALLEY, P219; SIEGEL AF, 1982, BIOMETRICS, V38, P235; Stein M, 2004, RADIOCARBON, V46, P649, DOI 10.1017/S0033822200035700; STEINHORN I, 1979, SCIENCE, V206, P55, DOI 10.1126/science.206.4414.55; Stiller M, 1999, GEOCHIM COSMOCHIM AC, V63, P3467, DOI 10.1016/S0016-7037(99)00272-0; Straub KL, 1996, APPL ENVIRON MICROB, V62, P1458, DOI 10.1128/AEM.62.4.1458-1460.1996; Swarieh A., 2000, P WORLD GEOTH C KYUS, P469; Teira E, 2004, APPL ENVIRON MICROB, V70, P4411, DOI 10.1128/AEM.70.7.4411-4414.2004; Tujula NA, 2006, J MICROBIOL METH, V65, P604, DOI 10.1016/j.mimet.2005.09.006; USDOWSKI E, 1973, CONTRIB MINERAL PETR, V38, P177, DOI 10.1007/BF00374765; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; Volcani BE, 1944, NATURE, V154, P335; Volcani BE, 1943, NATURE, V152, P301; Waddell EJ, 2010, ENVIRON TECHNOL, V31, P979, DOI 10.1080/09593331003789511; Wilransky B, 1936, NATURE, V138, P467; Yechieli Y, 1997, CHEM GEOL, V138, P93, DOI 10.1016/S0009-2541(97)00002-8	91	104	105	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38319	10.1371/journal.pone.0038319	http://dx.doi.org/10.1371/journal.pone.0038319			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679498	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343900029
J	Mohammadi, S; Keller, SS; Glauche, V; Kugel, H; Jansen, A; Hutton, C; Floel, A; Deppe, M				Mohammadi, Siawoosh; Keller, Simon S.; Glauche, Volkmar; Kugel, Harald; Jansen, Andreas; Hutton, Chloe; Floeel, Agnes; Deppe, Michael			The Influence of Spatial Registration on Detection of Cerebral Asymmetries Using Voxel-Based Statistics of Fractional Anisotropy Images and TBSS	PLOS ONE			English	Article							ECHO-PLANAR IMAGES; DIFFUSION TENSOR; WHITE-MATTER; HUMAN BRAIN; LANGUAGE LATERALIZATION; FIBER IMPAIRMENT; HEALTHY-SUBJECTS; WATER DIFFUSION; TRACTOGRAPHY; PATHWAYS	The sensitivity of diffusion tensor imaging (DTI) for detecting microstructural white matter alterations has motivated the application of voxel-based statistics (VBS) to fractional anisotropy (FA) images (FA-VBS). However, detected group differences may depend on the spatial registration method used. The objective of this study was to investigate the influence of spatial registration on detecting cerebral asymmetries in FA-VBS analyses with reference to data obtained using Tract-Based Spatial Statistics (TBSS). In the first part of this study we performed FA-VBS analyses using three single-contrast and one multi-contrast registration: (i) whole-brain registration based on T2 contrast, (ii) whole-brain registration based on FA contrast, (iii) individual-hemisphere registration based on FA contrast, and (iv) a combination of (i) and (iii). We then compared the FA-VBS results with those obtained from TBSS. We found that the FA-VBS results depended strongly on the employed registration approach, with the best correspondence between FA-VBS and TBSS results when approach (iv), the "multi-contrast individual-hemisphere" method was employed. In the second part of the study, we investigated the spatial distribution of residual misregistration for each registration approach and the effect on FA-VBS results. For the FA-VBS analyses using the three single-contrast registration methods, we identified FA asymmetries that were (a) located in regions prone to misregistrations, (b) not detected by TBSS, and (c) specific to the applied registration approach. These asymmetries were considered candidates for apparent FA asymmetries due to systematic misregistrations associated with the FA-VBS approach. Finally, we demonstrated that the "multi-contrast individual-hemisphere" approach showed the least residual spatial misregistrations and thus might be most appropriate for cerebral FA-VBS analyses.	[Mohammadi, Siawoosh; Keller, Simon S.; Deppe, Michael] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Mohammadi, Siawoosh; Hutton, Chloe] UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Keller, Simon S.] Kings Coll London, Dept Clin Neurosci, Inst Psychiat, London WC2R 2LS, England; [Glauche, Volkmar] Univ Clin Freiburg, Neurozentrum, Dept Neurol, Freiburg, Germany; [Kugel, Harald] Univ Munster, Dept Clin Radiol, Munster, Germany; [Jansen, Andreas] Univ Marburg, Dept Psychiat & Psychotherapy, Sect BrainImaging, Marburg, Germany; [Floeel, Agnes] Charite, Dept Neurol, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Floeel, Agnes] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany	University of Munster; University of London; University College London; University of London; King's College London; University of Freiburg; University of Munster; Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mohammadi, S (corresponding author), Univ Munster, Dept Neurol, D-4400 Munster, Germany.	siawoosh.mohammadi@ucl.ac.uk	Deppe, Michael/C-5780-2017; Mohammadi, Siawoosh/H-9539-2012; Mohammadi, Siawoosh/AAG-8251-2022; Mohammadi, Siawoosh/AFL-8250-2022; Floel, Agnes/A-9426-2017; Jansen, Andreas/AAL-5264-2020; Kugel, Harald/A-4963-2013	Deppe, Michael/0000-0002-8372-9678; Mohammadi, Siawoosh/0000-0003-1311-9636; Mohammadi, Siawoosh/0000-0003-1311-9636; Mohammadi, Siawoosh/0000-0003-1311-9636; Jansen, Andreas/0000-0002-3140-8207; Kugel, Harald/0000-0002-4349-1984; Keller, Simon/0000-0001-5247-9795	Deutsche Forschungsgemeinschaft (DFG) [SFB/TR 3]; Wellcome Trust [091593/Z/10/Z]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the transregional Collaborative Research Centre SFB/TR 3 (Project A8) of the Deutsche Forschungsgemeinschaft (DFG), and by the Wellcome Trust 091593/Z/10/Z. Open access was supported by the Wellcome Trust 091593/Z/10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 2001, NEUROREPORT, V12, P2251, DOI 10.1097/00001756-200107200-00041; Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; BEAR D, 1986, ARCH NEUROL-CHICAGO, V43, P598, DOI 10.1001/archneur.1986.00520060060019; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Caan MWA, 2006, MED IMAGE ANAL, V10, P841, DOI 10.1016/j.media.2006.07.006; Camara E, 2007, NEUROIMAGE, V34, P1588, DOI 10.1016/j.neuroimage.2006.09.045; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Deppe M, 2008, NEUROLOGY, V71, P1981, DOI 10.1212/01.wnl.0000336969.98241.17; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Friston KJ, 2006, STAT PARAMETRIC MAPP; Gallichan D, 2010, HUM BRAIN MAPP, V31, P193, DOI 10.1002/hbm.20856; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glauche V, 2010, P INT SOC MAG RESON, V18; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Johansen-Berg H, 2006, CURR OPIN NEUROL, V19, P379, DOI 10.1097/01.wco.0000236618.82086.01; Jones DK, 2006, HUM BRAIN MAPP, V27, P230, DOI 10.1002/hbm.20179; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Keller SS, 2011, EPILEPSIA, V52, P1715, DOI 10.1111/j.1528-1167.2011.03117.x; Keller SS, 2011, J COGNITIVE NEUROSCI, V23, P2013, DOI 10.1162/jocn.2010.21563; Kleffner I, 2008, NEUROLOGY, V70, P1867, DOI 10.1212/01.wnl.0000280580.95671.01; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Knecht S, 2002, NAT NEUROSCI, V5, P695, DOI 10.1038/nn868; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; LEMAY M, 1976, ANN NY ACAD SCI, V280, P349, DOI 10.1111/j.1749-6632.1976.tb25499.x; Li LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012886; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; Meinzer M, 2010, NEUROIMAGE, V53, P283, DOI 10.1016/j.neuroimage.2010.06.004; Mohammadi S, 2010, P 18 ANN M ISMRM STO; Mohammadi S, 2009, NEUROIMAGE, V47, pS128; Mohammadi S, 2009, NEUROIMAGE S1, V47, pS122; Mohammadi S, 2012, MAGN RESON MED, V68, P882, DOI 10.1002/mrm.23308; Mohammadi S, 2012, NEUROIMAGE, V60, P562, DOI 10.1016/j.neuroimage.2011.12.009; Mohammadi S, 2010, MAGN RESON MED, V64, P1047, DOI 10.1002/mrm.22501; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Sullivan M, 2005, NEUROLOGY, V65, P1584, DOI 10.1212/01.wnl.0000184480.07394.fb; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Park HJ, 2003, NEUROIMAGE, V20, P1995, DOI 10.1016/j.neuroimage.2003.08.008; Park HJ, 2004, NEUROIMAGE, V23, P213, DOI 10.1016/j.neuroimage.2004.04.036; Peelle J., 2009, NEUROIMAGE, V47, pS122; Pereira JMS, 2010, NEUROIMAGE, V49, P2205, DOI 10.1016/j.neuroimage.2009.10.068; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Rademacher J, 2001, BRAIN, V124, P2232, DOI 10.1093/brain/124.11.2232; Rodrigo S, 2007, AM J NEURORADIOL, V28, P1526, DOI 10.3174/ajnr.A0584; Sachs L., 1997, ANGEW STAT ANWENDUNG; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Skare S, 2000, MAGN RESON IMAGING, V18, P659, DOI 10.1016/S0730-725X(00)00153-3; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; WHITE LE, 1994, NATURE, V368, P197, DOI 10.1038/368197a0; Zollei L, 2010, NEUROIMAGE, V51, P206, DOI 10.1016/j.neuroimage.2010.01.101	75	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e36851	10.1371/journal.pone.0036851	http://dx.doi.org/10.1371/journal.pone.0036851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22679481	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900003
J	Cankorur-Cetinkaya, A; Dereli, E; Eraslan, S; Karabekmez, E; Dikicioglu, D; Kirdar, B				Cankorur-Cetinkaya, Ayca; Dereli, Elif; Eraslan, Serpil; Karabekmez, Erkan; Dikicioglu, Duygu; Kirdar, Betul			A Novel Strategy for Selection and Validation of Reference Genes in Dynamic Multidimensional Experimental Design in Yeast	PLOS ONE			English	Article							REAL-TIME PCR; QUANTITATIVE RT-PCR; POLYMERASE-CHAIN-REACTION; RELIABLE REFERENCE GENES; SACCHAROMYCES-CEREVISIAE; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; COLON-CANCER; NORMALIZATION; IDENTIFICATION	Background: Understanding the dynamic mechanism behind the transcriptional organization of genes in response to varying environmental conditions requires time-dependent data. The dynamic transcriptional response obtained by real-time RT-qPCR experiments could only be correctly interpreted if suitable reference genes are used in the analysis. The lack of available studies on the identification of candidate reference genes in dynamic gene expression studies necessitates the identification and the verification of a suitable gene set for the analysis of transient gene expression response. Principal Findings: In this study, a candidate reference gene set for RT-qPCR analysis of dynamic transcriptional changes in Saccharomyces cerevisiae was determined using 31 different publicly available time series transcriptome datasets. Ten of the twelve candidates (TPI1, FBA1, CCW12, CDC19, ADH1, PGK1, GCN4, PDC1, RPS26A and ARF1) we identified were not previously reported as potential reference genes. Our method also identified the commonly used reference genes ACT1 and TDH3. The most stable reference genes from this pool were determined as TPI1, FBA1, CDC19 and ACT1 in response to a perturbation in the amount of available glucose and as FBA1, TDH3, CCW12 and ACT1 in response to a perturbation in the amount of available ammonium. The use of these newly proposed gene sets outperformed the use of common reference genes in the determination of dynamic transcriptional response of the target genes, HAP4 and MEP2, in response to relaxation from glucose and ammonium limitations, respectively. Conclusions: A candidate reference gene set to be used in dynamic real-time RT-qPCR expression profiling in yeast was proposed for the first time in the present study. Suitable pools of stable reference genes to be used under different experimental conditions could be selected from this candidate set in order to successfully determine the expression profiles for the genes of interest.	[Cankorur-Cetinkaya, Ayca; Dereli, Elif; Eraslan, Serpil; Karabekmez, Erkan; Dikicioglu, Duygu; Kirdar, Betul] Bogazici Univ, Dept Chem Engn, Istanbul, Turkey	Bogazici University	Cankorur-Cetinkaya, A (corresponding author), Bogazici Univ, Dept Chem Engn, Istanbul, Turkey.	kirdar@boun.edu.tr	Dikicioglu, Duygu/W-4354-2019; Kirdar, Betul/ABI-7250-2020	Dikicioglu, Duygu/0000-0002-3018-4790; DERELI EKE, Elif/0000-0002-7576-9864; Karabekmez, Muhammed Erkan/0000-0002-0517-5227; Cankorur Cetinkaya, Ayca/0000-0002-4431-7259; Eraslan, Serpil/0000-0002-7674-7384	Bogazici University [07M106, 5562]; TUBITAK [106M444]; Turkish State Planning Organization [DPT 09K120520]	Bogazici University(Bogazici University); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish State Planning Organization	The research was financially supported by Bogazici University Research Fund through Projects No 07M106 and 5562, TUBITAK through Project No 106M444, and Turkish State Planning Organization through Project No DPT 09K120520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baganz F, 1997, YEAST, V13, P1563, DOI 10.1002/(SICI)1097-0061(199712)13:16<1563::AID-YEA240>3.3.CO;2-Y; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brachmann CB, 1998, YEAST, V14, P115; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Canelas AB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1150; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Hashimoto JG, 2004, BIOTECHNIQUES, V36, P54, DOI 10.2144/04361BM06; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; Ling DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029788; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Liu ZL, 2007, J MICROBIOL METH, V68, P486, DOI 10.1016/j.mimet.2006.10.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marini AM, 1997, MOL CELL BIOL, V17, P8; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Passmore M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-72; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Raghevendran V, 2006, J BIOL CHEM, V281, P12308, DOI 10.1074/jbc.M512972200; Rozen S, 2000, Methods Mol Biol, V132, P365; *SGD PROJ, SACCH GEN DAT; Sirakov M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-70; Sorby LA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-144; Stahlberg A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-170; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Vandesompele J., 2009, REFERENCE GENE VALID; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaudano E, 2009, INT J FOOD MICROBIOL, V129, P30, DOI 10.1016/j.ijfoodmicro.2008.10.027; Vaudano E, 2011, BIOTECHNOL LETT, V33, P1593, DOI 10.1007/s10529-011-0603-y; Vincent S, 1993, NUCLEIC ACIDS RES, V21, P6; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008	40	40	43	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38351	10.1371/journal.pone.0038351	http://dx.doi.org/10.1371/journal.pone.0038351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675547	Green Published, gold			2022-12-27	WOS:000305341700062
J	Sann, SB; Crane, MM; Lu, H; Jin, YS				Sann, Sharon B.; Crane, Matthew M.; Lu, Hang; Jin, Yishi			Rabx-5 Regulates RAB-5 Early Endosomal Compartments and Synaptic Vesicles in C. elegans	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; EXCHANGE FACTOR RABEX-5; CAENORHABDITIS-ELEGANS; HIPPOCAMPAL-NEURONS; NEUROTRANSMITTER RELEASE; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; STRUCTURAL BASIS; FINGER DOMAIN; PATHWAY	Early endosomal membrane compartments are required for the formation and recycling of synaptic vesicles, but how these compartments are regulated is incompletely understood. We performed a forward genetic screen in C. elegans for mutations that affect RAB-5 labeled early endosomal compartments in GABAergic motoneurons. Here we report the isolation and characterization of one mutation, rabx-5. The rabx-5 mutation leads to decreased intensity of YFP::RAB-5 in the cell soma but increased intensity in the synaptic and intersynaptic regions of the axon. This effect is due to the bias of the cycling state of RAB-5, and results from a change in the organization of the early endosomal compartment as well as the membrane binding state of RAB-5. Synaptic vesicle accumulation is altered in rabx-5 mutants, and synaptic transmission from cholinergic neurons is decreased. Early endosomal membrane compartments show disorganization with ageing and rabx-5 mutant animals age faster. These results suggest that rabx-5 regulation of RAB-5 compartments is important for maintaining proper synaptic function throughout the lifetime.	[Sann, Sharon B.; Jin, Yishi] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Crane, Matthew M.; Lu, Hang] Georgia Inst Technol, Interdisciplinary Program Bioengn, Atlanta, GA 30332 USA; [Jin, Yishi] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University System of Georgia; Georgia Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California San Diego	Sann, SB (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	ssann@ucsd.edu; yijin@ucsd.edu		Lu, Hang/0000-0002-6881-660X; Jin, Yishi/0000-0002-9371-9860	National Institute of Health (NIH) [R01 NS035546]; NIH [R01 GM088333, R01 AG035317, R21 EB012803]; National Science Foundation (NSF) [CBET-0954578]; Alfred P. Sloan Foundation; NIH NINDS [F32NS067891]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB012803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS067891, R01NS035546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035317] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the following funding sources: National Institute of Health (NIH) R01 NS035546 to YJ; NIH R01 GM088333, NIH R01 AG035317, NIH R21 EB012803, National Science Foundation (NSF) CBET-0954578, and Alfred P. Sloan Foundation to HL; and NIH NINDS F32NS067891 to SS. YJ is an Investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://grants.nih.gov/grants/funding/r01.htm http://grants.nih.gov/training/nrsa.htm http://www.nsf.gov/div/index.jsp?div = cbet http://www.sloan.org/program/1 http://www.hhmi.org/research/investigators/.	Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; BRENNER S, 1974, GENETICS, V77, P71; Brown HM, 2009, DEV NEUROBIOL, V69, P174, DOI 10.1002/dneu.20690; Burre J, 2006, PROTEOMICS, V6, P6250, DOI 10.1002/pmic.200600357; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; De-Miguel FF, 2005, CELL MOL NEUROBIOL, V25, P297, DOI 10.1007/s10571-005-3061-z; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dresbach T, 2006, J BIOL CHEM, V281, P6038, DOI 10.1074/jbc.M508784200; Fuenzalida LC, 2011, ENDOCRINOLOGY, V152, P4310, DOI 10.1210/en.2011-1416; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Ginsberg SD, 2010, J ALZHEIMERS DIS, V22, P631, DOI 10.3233/JAD-2010-101080; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; Klassen MP, 2010, NEURON, V66, P710, DOI 10.1016/j.neuron.2010.04.033; Laifenfeld D, 2007, J NEUROSCI, V27, P7141, DOI 10.1523/JNEUROSCI.4599-06.2007; Lee JA, 2008, AUTOPHAGY, V4, P230, DOI 10.4161/auto.5384; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; MATTEOLI M, 1991, J CELL BIOL, V115, P625, DOI 10.1083/jcb.115.3.625; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Pal A, 2008, METHOD ENZYMOL, V438, P239, DOI 10.1016/S0076-6879(07)38017-8; Pavlos NJ, J NEUROSCI, V30, P13441; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Prekeris R, 1999, J NEUROSCI, V19, P10324; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Royle SJ, TRAFFIC; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Shimizu H, 2003, J CELL SCI, V116, P3583, DOI 10.1242/jcs.00676; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Star EN, 2005, J PHYSIOL-LONDON, V569, P103, DOI 10.1113/jphysiol.2005.092528; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang M, 2008, FRONT BIOSCI-LANDMRK, V13, P6086, DOI 10.2741/3140; Zou L, 2010, INT J MOL MED, V25, P401, DOI 10.3892/ijmm_00000358	58	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37930	10.1371/journal.pone.0037930	http://dx.doi.org/10.1371/journal.pone.0037930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675499	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700028
J	Matthews, PR; Eastwood, SL; Harrison, PJ				Matthews, Paul R.; Eastwood, Sharon L.; Harrison, Paul J.			Reduced Myelin Basic Protein and Actin-Related Gene Expression in Visual Cortex in Schizophrenia	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RECEPTOR MESSENGER-RNAS; BINDING-SITE DENSITIES; BIPOLAR DISORDER; DENDRITIC SPINES; HUMAN BRAIN; NEUROPATHOLOGY-CONSORTIUM; MITOCHONDRIAL DYSFUNCTION; HIPPOCAMPAL-FORMATION; PREFRONTAL CORTEX	Most brain gene expression studies of schizophrenia have been conducted in the frontal cortex or hippocampus. The extent to which alterations occur in other cortical regions is not well established. We investigated primary visual cortex (Brodmann area 17) from the Stanley Neuropathology Consortium collection of tissue from 60 subjects with schizophrenia, bipolar disorder, major depression, or controls. We first carried out a preliminary array screen of pooled RNA, and then used RT-PCR to quantify five mRNAs which the array identified as differentially expressed in schizophrenia (myelin basic protein [MBP], myelin-oligodendrocyte glycoprotein [MOG], beta-actin [ACTB], thymosin beta-10 [TB10], and superior cervical ganglion-10 [SCG10]). Reduced mRNA levels were confirmed by RT-PCR for MBP, ACTB and TB10. The MBP reduction was limited to transcripts containing exon 2. ACTB and TB10 mRNAs were also decreased in bipolar disorder. None of the transcripts were altered in subjects with major depression. Reduced MBP mRNA in schizophrenia replicates findings in other brain regions and is consistent with oligodendrocyte involvement in the disorder. The decreases in expression of ACTB, and the actin-binding protein gene TB10, suggest changes in cytoskeletal organisation. The findings confirm that the primary visual cortex shows molecular alterations in schizophrenia and extend the evidence for a widespread, rather than focal, cortical pathophysiology.	[Matthews, Paul R.; Eastwood, Sharon L.; Harrison, Paul J.] Univ Oxford, Dept Psychiat, Oxford, England	University of Oxford	Matthews, PR (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	paul.harrison@psych.ox.ac.uk		Harrison, Paul/0000-0002-6719-1126	Wellcome Trust; Stanley Medical Research Institute Center award	Wellcome Trust(Wellcome TrustEuropean Commission); Stanley Medical Research Institute Center award	Supported by a Wellcome Trust studentship to PRM, with additional funding from a Stanley Medical Research Institute Center award to PJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Bamm VV, 2011, BIOPHYS J, V101, P1248, DOI 10.1016/j.bpj.2011.07.035; Boggs JM, 2011, BBA-BIOMEMBRANES, V1808, P761, DOI 10.1016/j.bbamem.2010.12.016; BORDER BG, 1993, J NEUROCHEM, V61, P2104, DOI 10.1111/j.1471-4159.1993.tb07448.x; Burnet PWJ, 1996, NEUROPSYCHOPHARMACOL, V15, P442, DOI 10.1016/S0893-133X(96)00053-X; BURNET PWJ, 1994, NEUROSCI LETT, V178, P85, DOI 10.1016/0304-3940(94)90296-8; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Campagnoni CW, 2001, DEV NEUROSCI-BASEL, V23, P452, DOI 10.1159/000048732; Carpintero P, 1999, MOL BRAIN RES, V70, P141, DOI 10.1016/S0169-328X(99)00115-1; Chen L, 1999, BRAIN RES PROTOC, V4, P132, DOI 10.1016/S1385-299X(99)00009-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Dean B, 2007, AUST NZ J PSYCHIAT, V41, P308, DOI 10.1080/00048670701213245; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Dorph-Petersen KA, 2007, J COMP NEUROL, V501, P290, DOI 10.1002/cne.21243; Dorph-Petersen KA, 2011, BIOL PSYCHIAT, V69, P113, DOI 10.1016/j.biopsych.2010.04.030; Dunaevsky A, 2004, NEURON, V44, P216, DOI 10.1016/j.neuron.2004.10.003; Eastwood SL, 2007, J PSYCHOPHARMACOL, V21, P635, DOI 10.1177/0269881106068825; Eastwood SL, 1998, NEUROSCIENCE, V86, P437, DOI 10.1016/S0306-4522(98)00040-2; Eastwood SL, 2000, BRIT J PSYCHIAT, V176, P236, DOI 10.1192/bjp.176.3.236; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; HALL AK, 1991, MOL BRAIN RES, V9, P9, DOI 10.1016/0169-328X(91)90124-G; Halpain S, 1998, J NEUROSCI, V18, P9835; Harrison P.J., 2011, SCHIZOPHRENIA, P372; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Harrison PJ, 2002, BRAIN, V125, P1428, DOI 10.1093/brain/awf149; Harrison PJ, 2001, HIPPOCAMPUS, V11, P508, DOI 10.1002/hipo.1067.abs; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Horvath S, 2011, BIOL PSYCHIAT, V69, P157, DOI 10.1016/j.biopsych.2010.07.017; KAMHOLZ J, 1988, J NEUROSCI RES, V21, P62, DOI 10.1002/jnr.490210110; Karoutzou G, 2008, MOL PSYCHIATR, V13, P245, DOI 10.1038/sj.mp.4002096; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kim S, 2010, MOL PSYCHIATR, V15, P326, DOI 10.1038/mp.2008.99; Knable MB, 2001, BRAIN RES BULL, V55, P651, DOI 10.1016/S0361-9230(01)00521-4; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Konradi C, 2012, NEUROBIOL DIS, V45, P37, DOI 10.1016/j.nbd.2011.01.025; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Lauriat TL, 2006, NEUROSCIENCE, V137, P843, DOI 10.1016/j.neuroscience.2005.10.003; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; Martins-de-Souza D, 2010, J PSYCHIATR RES, V44, P149, DOI 10.1016/j.jpsychires.2009.07.007; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Micheva KD, 1998, EUR J NEUROSCI, V10, P3785, DOI 10.1046/j.1460-9568.1998.00391.x; MILLS JW, 1994, FASEB J, V8, P1161, DOI 10.1096/fasebj.8.14.7958622; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Sequeira PA, 2012, NEUROBIOL DIS, V45, P23, DOI 10.1016/j.nbd.2011.03.001; Shao L, 2008, BIOL PSYCHIAT, V64, P89, DOI 10.1016/j.biopsych.2007.11.010; Silberberg G, 2009, ANAL BIOCHEM, V391, P91, DOI 10.1016/j.ab.2009.05.026; Sribenja S, 2009, CANCER INVEST, V27, P1016, DOI 10.3109/07357900902849640; Sun HQ, 2007, ANN NY ACAD SCI, V1112, P45, DOI 10.1196/annals.1415.021; Tamminga CA, 2010, AM J PSYCHIAT, V167, P1178, DOI 10.1176/appi.ajp.2010.09081187; TANAKA J, 1994, J NEUROSCI, V14, P1038, DOI 10.1523/JNEUROSCI.14-03-01038.1994; TANAKA J, 1993, DEV BRAIN RES, V76, P268, DOI 10.1016/0165-3806(93)90217-X; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weinberger R, 1996, J NEUROSCI, V16, P238; Zhang WD, 2002, J NEUROSCI RES, V69, P427, DOI 10.1002/jnr.10313; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	74	39	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38211	10.1371/journal.pone.0038211	http://dx.doi.org/10.1371/journal.pone.0038211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675524	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900017
J	Cohen, HS; Cox, C; Springer, G; Hoffman, HJ; Young, MA; Margolick, JB; Plankey, MW				Cohen, Helen S.; Cox, Christopher; Springer, Gayle; Hoffman, Howard J.; Young, Mary A.; Margolick, Joseph B.; Plankey, Michael W.			Prevalence of Abnormalities in Vestibular Function and Balance among HIV-Seropositive and HIV-Seronegative Women and Men	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; PAROXYSMAL POSITIONAL VERTIGO; ACTIVE ANTIRETROVIRAL THERAPY; MULTICENTER AIDS COHORT; SENSORY INTERACTION; VESTIBULOOCULAR REFLEX; POSTURAL CONTROL; INTERAGENCY HIV; CLINICAL-TEST; VIRUS	Background: Most HIV-seropositive subjects in western countries receive highly active antiretroviral therapy (HAART). Although many aspects of their health have been studied, little is known about their vestibular and balance function. The goals of this study were to determine the prevalences of vestibular and balance impairments among HIV-seropositive and comparable seronegative men and women and to determine if those groups differed. Methods: Standard screening tests of vestibular and balance function, including head thrusts, Dix-Hallpike maneuvers, and Romberg balance tests on compliant foam were performed during semiannual study visits of participants who were enrolled in the Baltimore and Washington, D. C. sites of the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Results: No significant differences by HIV status were found on most tests, but HIV-seropositive subjects who were using HAART had a lower frequency of abnormal Dix-Hallpike nystagmus than HIV-seronegative subjects. A significant number of nonclassical Dix-Hallpike responses were found. Age was associated with Romberg scores on foam with eyes closed. Sex was not associated with any of the test scores. Conclusion: These findings suggest that HAART-treated HIV infection has no harmful association with vestibular function in community-dwelling, ambulatory men and women. The association with age was expected, but the lack of association with sex was unexpected. The presence of nonclassical Dix-Hallpike responses might be consistent with central nervous system lesions.	[Cohen, Helen S.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Cox, Christopher; Springer, Gayle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Hoffman, Howard J.] Natl Inst Deafness & Other Commun Disorders, Epidemiol & Stat Program, NIH, Bethesda, MD USA; [Young, Mary A.; Plankey, Michael W.] Georgetown Univ, Med Ctr, Dept Med, Div Infect Dis, Washington, DC 20007 USA; [Margolick, Joseph B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cohen, HS (corresponding author), Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA.	mwp23@georgetown.edu		Cohen, Helen/0000-0002-1605-640X; Hoffman, Howard/0000-0003-4105-0808	National Institute on Deafness and Other Communication Disorders (NIDCD) [U01 AI-035042-18, U01 AI-034994-17]; Baltimore-Washington, D.C.; National Cancer Institute [UO1-AI-35042, UL1RR025005]; Metropolitan Washington, D.C.; National Institute on Drug Abuse; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035042, U01AI034994] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Baltimore-Washington, D.C.; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Metropolitan Washington, D.C.; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute on Deafness and Other Communication Disorders (NIDCD) via interagency agreement with NIAID for Cooperative Agreements U01 AI-035042-18 (MACS) and U01 AI-034994-17 (WIHS). Support of the Baltimore-Washington, D.C. MAC site was provided by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute (UO1-AI-35042, UL1RR025005)(GCRC). Support of the Metropolitan Washington, D.C. WIHS site was provided by the National Institute of Allergy and Infectious Diseases (UO1-AI34994) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study was co-funded by the National Cancer Institute, the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aw ST, 1999, J VESTIBUL RES-EQUIL, V9, P173; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bronstein AM, 2010, RESTOR NEUROL NEUROS, V28, P83, DOI 10.3233/RNN-2010-0530; Bronstein AM, 2007, DIZZINESS PRACTICAL; Castello E, 1998, ANN OTO RHINOL LARYN, V107, P1054, DOI 10.1177/000348949810701210; Celebisoy N, 2008, EUR NEUROL, V59, P315, DOI 10.1159/000121422; CHANDRASEKHAR SS, 1992, AM J OTOL, V13, P207; COATS AC, 1986, EAR HEARING, V7, P143, DOI 10.1097/00003446-198606000-00005; Coats AC, 1975, PHYSL MEASURES AUDIO, P37; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; Cohen H, 1996, AGE AGEING, V25, P39, DOI 10.1093/ageing/25.1.39; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; COLLINS JJ, 1995, EXP BRAIN RES, V104, P480, DOI 10.1007/BF00231982; Dellepiane M, 2005, Acta Otorhinolaryngol Ital, V25, P353; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; FREGLY A R, 1970, Acta Oto-Laryngologica, V69, P216, DOI 10.3109/00016487009123356; FREGLY AR, 1972, AEROSPACE MED, V43, P395; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; HALMAGYI GM, 1990, EXP BRAIN RES, V81, P479, DOI 10.1007/BF02423496; HAUSLER R, 1991, ACTA OTO-LARYNGOL, P515; Heinze B, 2011, J LARYNGOL OTOL, V125, P881, DOI 10.1017/S0022215111001423; HORAK FB, 1987, PHYS THER, V67, P1881, DOI 10.1093/ptj/67.12.1881; Hultin LE, 2007, CYTOM PART B-CLIN CY, V72B, P249, DOI 10.1002/cyto.b.20176; Jackson LE, 2007, OTOL NEUROTOL, V28, P218, DOI 10.1097/01.mao.0000247825.90774.6b; Johnston JL, 1996, NEUROLOGY, V46, P451, DOI 10.1212/WNL.46.2.451; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; KOHAN D, 1988, ANN OTO RHINOL LARYN, V97, P636, DOI 10.1177/000348948809700611; Kohan D, 1991, LARYNGOSCOPE, V100, P1326; MICHAELS L, 1994, AM J OTOL, V15, P515; NASHNER LM, 1982, J NEUROSCI, V2, P536; National Institutes of Health, 2011, GUID US ANT AG HIV 1, P1; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Paige G D, 1992, J Vestib Res, V2, P133; Palacios GC, 2008, INT J PEDIATR OTORHI, V72, P1671, DOI 10.1016/j.ijporl.2008.08.002; PAPPAS DG, 1995, AM J OTOL, V16, P140; Peterka R J, 1990, J Vestib Res, V1, P73; Peterka R J, 1990, J Vestib Res, V1, P49; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Teggi R, 2008, J LARYNGOL OTOL, V122, P1289, DOI 10.1017/S0022215107001624; Teggi R, 2006, Acta Otorhinolaryngol Ital, V26, P140; Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Whitney SL, 2004, ARCH PHYS MED REHAB, V85, P439, DOI 10.1016/j.apmr.2003.05.005	47	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38419	10.1371/journal.pone.0038419	http://dx.doi.org/10.1371/journal.pone.0038419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675462	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338500146
J	Garrido-Laguna, I; Hong, DS; Janku, F; Nguyen, LM; Falchook, GS; Fu, SQ; Wheler, JJ; Luthra, R; Naing, A; Wang, XM; Kurzrock, R				Garrido-Laguna, Ignacio; Hong, David S.; Janku, Filip; Nguyen, Ly M.; Falchook, Gerald S.; Fu, Siqing; Wheler, Jenifer J.; Luthra, Rajyalakshmi; Naing, Aung; Wang, Xuemei; Kurzrock, Razelle			KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors	PLOS ONE			English	Article							CETUXIMAB PLUS IRINOTECAN; MUTATION STATUS; CHEMOTHERAPY; METASTASES; PREDICTION; RESISTANCE; TUMORS	Purpose: To evaluate clinicopathologic and molecular features of patients with metastatic colorectal cancer (mCRC) and their outcomes in early-phase trials using pathway-targeting agents. Patients and Methods: We analyzed characteristics of 238 patients with mCRC referred to the phase 1 trials unit at MD Anderson Cancer Center. KRAS, PIK3CA and BRAF status were tested using PCR-based DNA sequencing. Results: Fifty-one percent of patients harbored KRAS mutations; 15% had PIK3CA mutations. In the multivariate regression model for clinical characteristics KRAS mutations were associated with an increased incidence of lung and bone metastases and decreased incidence of adrenal metastases; PIK3CA mutations were marginally correlated with mucinous tumors (p = 0.05). In the univariate analysis, KRAS and PIK3CA mutations were strongly associated. Advanced Duke's stage (p < 0.0001) and KRAS mutations (p = 0.01) were the only significant independent predictors of poor survival (Cox proportional hazards model). Patients with PIK3CA mutations had a trend toward shorter progression-free survival when treated with anti-EGFR therapies (p = 0.07). Eighteen of 78 assessable patients (23%) treated with PI3K/Akt/mTOR axis inhibitors achieved stable disease [SD] >= 6 months or complete response/partial response (CR/PR), only one of whom were in the subgroup (N = 15) with PIK3CA mutations, perhaps because 10 of these 15 patients (67%) had coexisting KRAS mutations. No SD >= 6 months/CR/PR was observed in the 10 patients treated with mitogen-activating protein kinase (MAPK) pathway targeting drugs. Conclusions: KRAS and PIK3CA mutations frequently coexist in patients with colorectal cancer, and are associated with clinical characteristics and outcome. Overcoming resistance may require targeting both pathways.	[Garrido-Laguna, Ignacio; Hong, David S.; Janku, Filip; Nguyen, Ly M.; Falchook, Gerald S.; Fu, Siqing; Wheler, Jenifer J.; Naing, Aung; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Phase Clin Trials Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Luthra, Rajyalakshmi] Univ Texas MD Anderson Canc Ctr, Dept Mol Diagnost Lab, Houston, TX 77030 USA; [Wang, Xuemei] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Garrido-Laguna, I (corresponding author), Univ Texas MD Anderson Canc Ctr, Phase Clin Trials Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA.	Ignacio.garrido-laguna@hci.utah.edu	Janku, Filip/ABB-9136-2020; Kurzrock, Razelle/AAU-9782-2020; Wang, Xuemei/GXF-3702-2022; Garrido-Laguna, Ignacio/ABD-1875-2020	Garrido-Laguna, Ignacio/0000-0003-2273-9028; Naing, Aung/0000-0002-4803-8513; Fu, Siqing/0000-0002-1933-0419	National Center for Research Resources, NIH Roadmap for Medical Research [RR024148]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources, NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Grant Number RR024148 from the National Center for Research Resources, a component of the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Cejas P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008199; COX DR, 1972, J R STAT SOC B, V34, P187; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; MANTEL N, 1966, CANC CHEMOTHER REP, V60, P163; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Price TJ, 2011, J CLIN ONCOL, V29, P2675, DOI 10.1200/JCO.2010.34.5520; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Tie J, 2011, CLIN CANCER RES, V17, P1122, DOI 10.1158/1078-0432.CCR-10-1720; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Zuo Z, 2009, MODERN PATHOL, V22, P1023, DOI 10.1038/modpathol.2009.59	19	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38033	10.1371/journal.pone.0038033	http://dx.doi.org/10.1371/journal.pone.0038033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675430	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338500077
J	Hoogeboom, TJ; Oosting, E; Vriezekolk, JE; Veenhof, C; Siemonsma, PC; de Bie, RA; van den Ende, CHM; van Meeteren, NLU				Hoogeboom, Thomas J.; Oosting, Ellen; Vriezekolk, Johanna E.; Veenhof, Cindy; Siemonsma, Petra C.; de Bie, Rob A.; van den Ende, Cornelia H. M.; van Meeteren, Nico L. U.			Therapeutic Validity and Effectiveness of Preoperative Exercise on Functional Recovery after Joint Replacement: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							QUALITY-OF-LIFE; TOTAL KNEE ARTHROPLASTY; TOTAL HIP-REPLACEMENT; PATIENT CHARACTERISTICS; RANDOMIZED-TRIALS; CONSORT STATEMENT; EFFECT SIZE; SURGERY; OSTEOARTHRITIS; PHYSIOTHERAPY	Background: Our aim was to develop a rating scale to assess the therapeutic validity of therapeutic exercise programmes. By use of this rating scale we investigated the therapeutic validity of therapeutic exercise in patients awaiting primary total joint replacement (TJR). Finally, we studied the association between therapeutic validity of preoperative therapeutic exercise and its effectiveness in terms of postoperative functional recovery. Methods: (Quasi) randomised clinical trials on preoperative therapeutic exercise in adults awaiting TJR on postoperative recovery of functioning within three months after surgery were identified through database and reference screening. Two reviewers extracted data and assessed the risk of bias and therapeutic validity. Therapeutic validity of the interventions was assessed with a nine-itemed, expert-based rating scale (scores range from 0 to 9; score >= 6 reflecting therapeutic validity), developed in a four-round Delphi study. Effects were pooled using a random-effects model and meta-regression was used to study the influence of therapeutic validity. Results: Of the 7,492 articles retrieved, 12 studies (737 patients) were included. None of the included studies demonstrated therapeutic validity and two demonstrated low risk of bias. Therapeutic exercise was not associated with 1) observed functional recovery during the hospital stay (Standardised Mean Difference [SMD]: -1.19; 95%-confidence interval [CI], -2.46 to 0.08); 2) observed recovery within three months of surgery (SMD: -0.15; 95%-CI, -0.42 to 0.12); and 3) self-reported recovery within three months of surgery (SMD -0.07; 95%-CI, -0.35 to 0.21) compared with control participants. Meta-regression showed no statistically significant relationship between therapeutic validity and pooled-effects. Conclusion: Preoperative therapeutic exercise for TJR did not demonstrate beneficial effects on postoperative functional recovery. However, poor therapeutic validity of the therapeutic exercise programmes may have hampered potentially beneficial effects, since none of the studies met the predetermined quality criteria. Future review studies on therapeutic exercise should address therapeutic validity.	[Hoogeboom, Thomas J.; Vriezekolk, Johanna E.; van den Ende, Cornelia H. M.] Sint Maartensklin, Dept Rheumatol, Nijmegen, Netherlands; [Hoogeboom, Thomas J.; de Bie, Rob A.] Maastricht Univ, Sch Publ Hlth & Primary Care Caphri, Dept Epidemiol, Maastricht, Netherlands; [Oosting, Ellen] Gelderse Vallei Hosp, Dept Physiotherapy, Ede, Netherlands; [Veenhof, Cindy] NIVEL, Dept Allied Hlth Care, Utrecht, Netherlands; [Siemonsma, Petra C.] TNO, Expertise Ctr Life Style, Leiden, Netherlands; [van Meeteren, Nico L. U.] TNO, Innovat Area Healthy Life, Leiden, Netherlands; [van Meeteren, Nico L. U.] Ctr Care Technol Res, Maastricht, Netherlands	Sint Maartens Clinic; Maastricht University; Gelderse Vallei Hospital; Netherlands Institute for Health Services Research; Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Maastricht University	Hoogeboom, TJ (corresponding author), Sint Maartensklin, Dept Rheumatol, Nijmegen, Netherlands.	thomashoogeboom@gmail.com	van den Ende, Cornelia/G-9559-2011; van den Ende, Cornelia/ABG-7626-2020; Hoogeboom, Thomas J/G-8767-2015; Vriezekolk, Johanna/J-8684-2016	van den Ende, Cornelia/0000-0002-4352-2824; Hoogeboom, Thomas J/0000-0003-2103-419X; Veenhof, Cindy/0000-0003-0970-2896	Ministry of Health, The Netherlands	Ministry of Health, The Netherlands	This study was funded by the Ministry of Health, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman IN, 2004, AUST J PHYSIOTHER, V50, P25, DOI 10.1016/S0004-9514(14)60245-2; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Anderson JG, 1996, J ARTHROPLASTY, V11, P831, DOI 10.1016/S0883-5403(96)80183-5; Barbay K, 2009, ORTHOP NURS, V28, P127, DOI 10.1097/NOR.0b013e3181a46a09; Beaupre LA, 2004, J RHEUMATOL, V31, P1166; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Coudeyre E., 2007, Annales de Readaptation et de Medecine Physique, V50, P189, DOI 10.1016/j.annrmp.2007.02.002; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Daanen HA, 2012, INT J SPORTS PH 0215; Dauty M, 2007, Ann Readapt Med Phys, V50, P462, DOI 10.1016/j.annrmp.2007.04.012; Ditmyer Marcia M, 2002, Orthop Nurs, V21, P43; DLima DD, 1996, CLIN ORTHOP RELAT R, P174; Escobar A, 2007, RHEUMATOLOGY, V46, P112, DOI 10.1093/rheumatology/kel184; Evgeniadis G, 2008, J BACK MUSCULOSKELET, V21, P161, DOI 10.3233/BMR-2008-21303; Ewald FC, 1999, J ARTHROPLASTY, V14, P473, DOI 10.1016/S0883-5403(99)90104-3; Ferrara PE, 2008, CLIN REHABIL, V22, P977, DOI 10.1177/0269215508094714; Fitz Gerald JD, 2004, ARTHRIT RHEUM-ARTHR, V51, P100, DOI 10.1002/art.20090; Gilbey HJ, 2003, CLIN ORTHOP RELAT R, P193, DOI 10.1097/01.blo.0000053168.71678.2b; Glasziou P, 2005, BMJ-BRIT MED J, V330, P644, DOI 10.1136/bmj.330.7492.644; Gocen Z, 2004, CLIN REHABIL, V18, P353, DOI 10.1191/0269215504cr758oa; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hawker GA, 2006, CURR OPIN RHEUMATOL, V18, P526; Herbert RD, 2005, BMJ-BRIT MED J, V331, P507, DOI 10.1136/bmj.331.7515.507; Hoeksma HL, 2005, RHEUMATOLOGY, V44, P461, DOI 10.1093/rheumatology/keh482; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hoogeboom TJ, 2009, OSTEOARTHR CARTILAGE, V17, P1420, DOI 10.1016/j.joca.2009.05.008; Hoogeboom TJ, 2010, CLIN REHABIL, V24, P901, DOI 10.1177/0269215510371427; Hulzebos EHJ, 2006, JAMA-J AM MED ASSOC, V296, P1851, DOI 10.1001/jama.296.15.1851; JACK S, 2011, CLIN ANAESTHESIOL, V25, P461; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kennedy LG, 2003, KNEE, V10, P161, DOI 10.1016/S0968-0160(02)00138-2; Kettunen JA, 2004, SCAND J MED SCI SPOR, V14, P138, DOI 10.1111/j.1600-0838.2004.00396.x; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008; Liu CK, 2011, CLIN GERIATR MED, V27, P101, DOI 10.1016/j.cger.2010.08.001; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mahomed NN, 2002, J RHEUMATOL, V29, P1273; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Pasquina P, 2003, BMJ-BRIT MED J, V327, P1379, DOI 10.1136/bmj.327.7428.1379; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Rodgers JA, 1998, J ARTHROPLASTY, V13, P414, DOI 10.1016/S0883-5403(98)90007-9; Rooks DS, 2006, ARTHRIT RHEUM-ARTHR, V55, P700, DOI 10.1002/art.22223; Santaguida PL, 2008, CAN J SURG, V51, P428; Schmidt H, 2010, MED LAW, V29, P565; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Topp R, 2009, PM&R, V1, P729, DOI 10.1016/j.pmrj.2009.06.003; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Valkenet K, 2011, CLIN REHABIL, V25, P99, DOI 10.1177/0269215510380830; van Rijn RM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5688; van Tulder MW, 2009, SPINE, V34, P1685, DOI 10.1097/BRS.0b013e3181ab6a78; Veenhof C, 2007, INT J BEHAV MED, V14, P86, DOI 10.1007/BF03004173; Wallis JA, 2011, OSTEOARTHR CARTILAGE, V19, P1381, DOI 10.1016/j.joca.2011.09.001; WEIDENHIELM L, 1993, SCAND J REHABIL MED, V25, P25; Williamson L, 2007, RHEUMATOLOGY, V46, P1445, DOI 10.1093/rheumatology/kem119; Wright AA, 2011, PHYS THER, V91, P510, DOI 10.2522/ptj.20100171; Wylde V, 2007, KNEE, V14, P417, DOI 10.1016/j.knee.2007.06.001; Yates SL, 2005, PAIN, V117, P314, DOI 10.1016/j.pain.2005.06.018; Zeni JA, 2010, J BONE JOINT SURG AM, V92A, P1130, DOI 10.2106/JBJS.I.00299	65	118	119	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38031	10.1371/journal.pone.0038031	http://dx.doi.org/10.1371/journal.pone.0038031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675429	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338500076
J	Leclerque, A; Kleespies, RG				Leclerque, Andreas; Kleespies, Regina G.			A Rickettsiella Bacterium from the Hard Tick, Ixodes woodi: Molecular Taxonomy Combining Multilocus Sequence Typing (MLST) with Significance Testing	PLOS ONE			English	Article							ELECTRON-MICROSCOPIC CHARACTERIZATION; LARGE PHYLOGENIES; POSITION; GENUS; TOPOLOGIES; GENERATION; ALGORITHM; GENETICS; ORDER; RATES	Hard ticks (Acari: Ixodidae) are known to harbour intracellular bacteria from several phylogenetic groups that can develop both mutualistic and pathogenic relationships to the host. This is of particular importance for public health as tick derived bacteria can potentially be transmitted to mammals, including humans, where e. g. Rickettsia or Coxiella act as severe pathogens. Exact molecular taxonomic identification of tick associated prokaryotes is a necessary prerequisite of the investigation of their relationship to both the tick and possible vertebrate hosts. Previously, an intracellular bacterium had been isolated from a monosexual, parthenogenetically reproducing laboratory colony of females of the hard tick, Ixodes woodi Bishopp, and had preliminarily been characterized as a "Rickettsiella-related bacterium". In the present molecular taxonomic study that is based on phylogenetic reconstruction from both 16 S ribosomal RNA and protein-encoding marker sequences complemented with likelihood-based significance testing, the bacterium from I. woodi has been identified as a strain of the taxonomic species Rickettsiella grylli. It is the first time that a multilocus sequence typing (MLST) approach based on a four genes comprising MLST scheme has been implemented in order to classify a Rickettsiella-like bacterium to this species. The study demonstrated that MLST holds potential for a better resolution of phylogenetic relationships within the genus Rickettsiella, but requires sequence determination from further Rickettsiella-like bacteria in order to complete the current still fragmentary picture of Rickettsiella systematics.	[Leclerque, Andreas; Kleespies, Regina G.] Fed Res Ctr Cultivated Plants, JKI, Inst Biol Control, Darmstadt, Germany	Julius Kuhn-Institut	Leclerque, A (corresponding author), Fed Res Ctr Cultivated Plants, JKI, Inst Biol Control, Darmstadt, Germany.	leclerque@hotmail.com		LECLERQUE, ANDREAS/0000-0003-0688-4137				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fournier P-E, 2005, BERGEYS MANUAL SYSTE, V2, P241; Fournier PE, 2006, INT J SYST EVOL MICR, V56, P1025, DOI 10.1099/ijs.0.63903-0; FRUTOS R, 1994, J INVERTEBR PATHOL, V63, P294, DOI 10.1006/jipa.1994.1054; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Gomez-Valero L, 2009, INFECT GENET EVOL, V9, P727, DOI 10.1016/j.meegid.2009.05.004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kleespies RG, 2011, J INVERTEBR PATHOL, V107, P206, DOI 10.1016/j.jip.2011.05.017; Kurtti TJ, 2002, J MED ENTOMOL, V39, P534, DOI 10.1603/0022-2585-39.3.534; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leclerque A, 2008, FEMS MICROBIOL LETT, V283, P117, DOI 10.1111/j.1574-6968.2008.01158.x; Leclerque A, 2008, J INVERTEBR PATHOL, V98, P329, DOI 10.1016/j.jip.2008.02.005; Leclerque A, 2008, FEMS MICROBIOL LETT, V279, P167, DOI 10.1111/j.1574-6968.2007.01025.x; Leclerque A, 2008, INT J SYST EVOL MICR, V58, P749, DOI 10.1099/ijs.0.65359-0; Leclerque A, 2011, FEMS MICROBIOL LETT, V324, P125, DOI 10.1111/j.1574-6968.2011.02396.x; Leclerque A, 2011, CURR MICROBIOL, V63, P158, DOI 10.1007/s00284-011-9958-5; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Mediannikov O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011478; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; NEI M, 1986, MOL BIOL EVOL, V3, P418; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Roux V, 1997, INT J SYST BACTERIOL, V47, P1255, DOI 10.1099/00207713-47-4-1255; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sekeyova Z, 1999, FEMS MICROBIOL LETT, V180, P61, DOI 10.1016/S0378-1097(99)00462-0; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanada Y, 1993, INSECT PATHOL, P153; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Vilcins IME, 2009, EXP APPL ACAROL, V49, P229, DOI 10.1007/s10493-009-9260-4; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Weiss E, 1984, BERGEYS MANUAL SYSTE, VI, P713; Werren JH, 1997, INFLUENTIAL PASSENGERS, P1; Wille H, 1952, Z ALLG PATHOL BAKTER, V15, P470; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	49	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38062	10.1371/journal.pone.0038062	http://dx.doi.org/10.1371/journal.pone.0038062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675436	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338500084
J	Butler, MW; McGraw, KJ				Butler, Michael W.; McGraw, Kevin J.			Differential Effects of Early- and Late-Life Access to Carotenoids on Adult Immune Function and Ornamentation in Mallard Ducks (Anas platyrhynchos)	PLOS ONE			English	Article							MULTIPLE MALE ORNAMENTS; DIETARY CAROTENOIDS; MATING PREFERENCES; NEONATAL NUTRITION; THRIFTY PHENOTYPE; LOCAL RECRUITMENT; SEXUAL ORNAMENTS; NITRIC-OXIDE; COLORATION; IMMUNOCOMPETENCE	Environmental conditions early in life can affect an organism's phenotype at adulthood, which may be tuned to perform optimally in conditions that mimic those experienced during development (Environmental Matching hypothesis), or may be generally superior when conditions during development were of higher quality (Silver Spoon hypothesis). Here, we tested these hypotheses by examining how diet during development interacted with diet during adulthood to affect adult sexually selected ornamentation and immune function in male mallard ducks (Anas platyrhynchos). Mallards have yellow, carotenoid-pigmented beaks that are used in mate choice, and the degree of beak coloration has been linked to adult immune function. Using a 2x2 factorial experimental design, we reared mallards on diets containing either low or high levels of carotenoids (nutrients that cannot be synthesized de novo) throughout the period of growth, and then provided adults with one of these two diets while simultaneously quantifying beak coloration and response to a variety of immune challenges. We found that both developmental and adult carotenoid supplementation increased circulating carotenoid levels during dietary treatment, but that birds that received low-carotenoid diets during development maintained relatively higher circulating carotenoid levels during an adult immune challenge. Individuals that received low levels of carotenoids during development had larger phytohemagglutinin (PHA)-induced cutaneous immune responses at adulthood; however, dietary treatment during development and adulthood did not affect antibody response to a novel antigen, nitric oxide production, natural antibody levels, hemolytic capacity of the plasma, or beak coloration. However, beak coloration prior to immune challenges positively predicted PHA response, and strong PHA responses were correlated with losses in carotenoid-pigmented coloration. In sum, we did not find consistent support for either the Environmental Matching or Silver Spoon hypotheses. We then describe a new hypothesis that should be tested in future studies examining developmental plasticity.	[Butler, Michael W.; McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Butler, MW (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	Mike.Butler@asu.edu		Butler, Michael/0000-0002-8390-2960	Sigma-Xi; Frank M. Chapman Research Grant; Graduate and Professional Student Association; Animal Behavior Society; National Science Foundation [0746364]; Arizona State University Graduate College; Faculty Emeriti Association	Sigma-Xi; Frank M. Chapman Research Grant; Graduate and Professional Student Association; Animal Behavior Society; National Science Foundation(National Science Foundation (NSF)); Arizona State University Graduate College; Faculty Emeriti Association	The ASU Chapter of Sigma-Xi Grants-in-Aid of Research, the Frank M. Chapman Research Grant, the Graduate and Professional Student Association JumpStart Research Grant, the Sigma-Xi Grants-in-Aid of Research, and the Animal Behavior Society Student Research Grant provided financial support to MWB, and the National Science Foundation (#0746364) provided support to KJM. MWB was partially supported by the Arizona State University Graduate College Dissertation Fellowship and the Faculty Emeriti Association Fellowship during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera E, 2007, NATURWISSENSCHAFTEN, V94, P895, DOI 10.1007/s00114-007-0268-5; ALLEN PC, 1987, COMP BIOCHEM PHYS B, V87, P313, DOI 10.1016/0305-0491(87)90145-3; Auer SK, 2010, AM NAT, V176, P818, DOI 10.1086/657061; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bauerfeind SS, 2009, ENTOMOL EXP APPL, V130, P229, DOI 10.1111/j.1570-7458.2008.00814.x; Biard C, 2009, J EXP BIOL, V212, P1336, DOI 10.1242/jeb.028449; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; Bischoff LL, 2009, BEHAV ECOL, V20, P265, DOI 10.1093/beheco/arp012; Bland ST, 2010, BRAIN BEHAV IMMUN, V24, P329, DOI 10.1016/j.bbi.2009.09.012; Blount JD, 2003, P ROY SOC B-BIOL SCI, V270, P1691, DOI 10.1098/rspb.2003.2411; Blount JD, 2006, IBIS, V148, P509, DOI 10.1111/j.1474-919X.2006.00554.x; Bourgeon S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P793, DOI 10.1086/504609; Butler MW, 2012, FUNCT ECOL, V26, P406, DOI 10.1111/j.1365-2435.2011.01942.x; Butler MW, 2012, P ROY SOC B-BIOL SCI, V279, P326, DOI 10.1098/rspb.2011.0842; Butler MW, 2011, J COMP PHYSIOL B, V181, P551, DOI 10.1007/s00360-010-0529-z; Butler MW, 2011, BEHAV ECOL SOCIOBIOL, V65, P401, DOI 10.1007/s00265-010-1074-1; Butler MW, 2010, ARCH BIOCHEM BIOPHYS, V504, P154, DOI 10.1016/j.abb.2010.07.003; Butler MW, 2009, AVIAN BIOL RES, V2, P203, DOI 10.3184/175815509X12570082777157; Butler MW, 2009, AUK, V126, P536, DOI 10.1525/auk.2009.08179; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Connor WE, 2007, INVEST OPHTH VIS SCI, V48, P4226, DOI 10.1167/iovs.06-1275; Cote J, 2010, J EXP BIOL, V213, P2116, DOI 10.1242/jeb.040220; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Drilling N., 2002, MALLARD ANAS PLATYRH; Fenoglio S, 2002, ETHOL ECOL EVOL, V14, P149; Giraudeau M, 2011, P ROY SOC B-BIOL SCI, V278, P781, DOI 10.1098/rspb.2010.1115; Graham AL, 2011, FUNCT ECOL, V25, P5, DOI 10.1111/j.1365-2435.2010.01777.x; Gray DA, 2008, AM J PHYSIOL-REG I, V294, pR1666, DOI 10.1152/ajpregu.00865.2007; Grether GF, 2008, FUNCT ECOL, V22, P294, DOI 10.1111/j.1365-2435.2007.01365.x; Hill G. E., 2006, BIRD COLORATION, VI; Hill GE, 2009, J EXP BIOL, V212, P1225, DOI 10.1242/jeb.026963; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Huggins KA, 2010, NATURWISSENSCHAFTEN, V97, P637, DOI 10.1007/s00114-010-0679-6; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; Koutsos EA, 2003, COMP BIOCHEM PHYS A, V135, P635, DOI 10.1016/S1095-6433(03)00158-2; Koutsos EA, 2003, J NUTR, V133, P1132, DOI 10.1093/jn/133.4.1132; Krause ET, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005015; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lin SM, 2010, PHYSIOL BIOCHEM ZOOL, V83, P333, DOI 10.1086/649965; Lopez-Rull I, 2011, FUNCT ECOL, V25, P500, DOI 10.1111/j.1365-2435.2010.01783.x; Macedo RC, 2010, EUR J NUTR, V49, P447, DOI 10.1007/s00394-010-0103-1; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martinez-Padilla J, 2010, J EVOLUTION BIOL, V23, P902, DOI 10.1111/j.1420-9101.2010.01956.x; Martucci RB, 2004, J CELL BIOCHEM, V92, P414, DOI 10.1002/jcb.20073; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; McGraw KJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P1991, DOI 10.1007/s00265-008-0622-4; McGraw KJ, 2011, J COMP PHYSIOL A, V197, P683, DOI 10.1007/s00359-011-0631-z; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Monaghan P, 2012, P ROY SOC B-BIOL SCI, V279, P709, DOI 10.1098/rspb.2011.1291; Montgomerie R., 2008, CLR COLOUR ANAL PROG; Moreno J, 2005, J AVIAN BIOL, V36, P251, DOI 10.1111/j.0908-8857.2005.03413.x; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Mugabo M, 2010, J EVOLUTION BIOL, V23, P1886, DOI 10.1111/j.1420-9101.2010.02052.x; Ohlsson T, 2003, ETHOL ECOL EVOL, V15, P31; Okai Y, 1996, INT J IMMUNOPHARMACO, V18, P753, DOI 10.1016/S0192-0561(97)85558-0; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Omland KE, 1996, BEHAV ECOL SOCIOBIOL, V39, P361, DOI 10.1007/s002650050301; Omland KE, 1996, BEHAV ECOL SOCIOBIOL, V39, P353, DOI 10.1007/s002650050300; Palozza P, 2010, CURR MED CHEM, V17, P2547, DOI 10.2174/092986710791556041; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; Peters A, 2004, AM NAT, V164, P51, DOI 10.1086/421302; Ruiz M, 2010, HORM BEHAV, V57, P134, DOI 10.1016/j.yhbeh.2009.09.019; Saastamoinen M, 2010, AM NAT, V176, P686, DOI 10.1086/657038; Salvante KG, 2006, AUK, V123, P575, DOI 10.1642/0004-8038(2006)123[575:TFSIIF]2.0.CO;2; Sanchez MM, 2006, HORM BEHAV, V50, P623, DOI 10.1016/j.yhbeh.2006.06.012; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; SCHRANK CS, 1990, J WILDLIFE DIS, V26, P307, DOI 10.7589/0090-3558-26.3.307; Searcy WA, 2004, J AVIAN BIOL, V35, P269, DOI 10.1111/j.0908-8857.2004.03247.x; Sild E, 2009, BEHAV ECOL SOCIOBIOL, V63, P959, DOI 10.1007/s00265-009-0710-0; Smith HG, 2007, J EVOLUTION BIOL, V20, P310, DOI 10.1111/j.1420-9101.2006.01203.x; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Spencer KA, 2010, BEHAV ECOL, V21, P999, DOI 10.1093/beheco/arq090; Strasser R, 2004, BEHAV ECOL SOCIOBIOL, V56, P491, DOI 10.1007/s00265-004-0810-9; SULLIVAN KA, 1989, J ANIM ECOL, V58, P275, DOI 10.2307/5000; Vinkler M, 2012, ANIM BEHAV, V83, P17, DOI 10.1016/j.anbehav.2011.10.001; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; Woodall AA, 1997, BBA-GEN SUBJECTS, V1336, P575, DOI 10.1016/S0304-4165(97)00007-X; Zheng CL, 2003, INFLAMMATION, V27, P247, DOI 10.1023/A:1025092615584	79	10	10	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38043	10.1371/journal.pone.0038043	http://dx.doi.org/10.1371/journal.pone.0038043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666443	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400072
J	Chesters, D; Wang, Y; Yu, F; Bai, M; Zhang, TX; Hu, HY; Zhu, CD; Li, CD; Zhang, YZ				Chesters, Douglas; Wang, Ying; Yu, Fang; Bai, Ming; Zhang, Tong-Xin; Hu, Hao-Yuan; Zhu, Chao-Dong; Li, Cheng-De; Zhang, Yan-Zhou			The Integrative Taxonomic Approach Reveals Host Specific Species in an Encyrtid Parasitoid Species Complex	PLOS ONE			English	Article							DNA BARCODES; BIOLOGICAL IDENTIFICATIONS; DIVERGENCE TIMES; NATURAL-HISTORY; FLIES DIPTERA; HONEY-BEES; HYMENOPTERA; BRACONIDAE; POPULATIONS; DIVERSITY	Integrated taxonomy uses evidence from a number of different character types to delimit species and other natural groupings. While this approach has been advocated recently, and should be of particular utility in the case of diminutive insect parasitoids, there are relatively few examples of its application in these taxa. Here, we use an integrated framework to delimit independent lineages in Encyrtus sasakii (Hymenoptera: Chalcidoidea: Encyrtidae), a parasitoid morphospecies previously considered a host generalist. Sequence variation at the DNA barcode (cytochrome c oxidase I, COI) and nuclear 28S rDNA loci were compared to morphometric recordings and mating compatibility tests, among samples of this species complex collected from its four scale insect hosts, covering a broad geographic range of northern and central China. Our results reveal that Encyrtus sasakii comprises three lineages that, while sharing a similar morphology, are highly divergent at the molecular level. At the barcode locus, the median K2P molecular distance between individuals from three primary populations was found to be 11.3%, well outside the divergence usually observed between Chalcidoidea conspecifics (0.5%). Corroborative evidence that the genetic lineages represent independent species was found from mating tests, where compatibility was observed only within populations, and morphometric analysis, which found that despite apparent morphological homogeneity, populations clustered according to forewing shape. The independent lineages defined by the integrated analysis correspond to the three scale insect hosts, suggesting the presence of host specific cryptic species. The finding of hidden host specificity in this species complex demonstrates the critical role that DNA barcoding will increasingly play in revealing hidden biodiversity in taxa that present difficulties for traditional taxonomic approaches.	[Chesters, Douglas; Wang, Ying; Yu, Fang; Bai, Ming; Zhu, Chao-Dong; Zhang, Yan-Zhou] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Wang, Ying; Li, Cheng-De] NE Forestry Univ, Sch Forestry, Div Forest Protect, Harbin, Peoples R China; [Zhang, Tong-Xin] Ningbo Technol Extens Ctr Forestry & Specialty Fo, Ningbo, Peoples R China; [Hu, Hao-Yuan] Anhui Normal Univ, Coll Life Sci, Wuhu, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Northeast Forestry University - China; Ningbo University of Technology; Anhui Normal University	Chesters, D (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	zhangyz@ioz.ac.cn	ZHU, Chao-Dong/E-5961-2011; Chesters, Douglas/AAF-7926-2019	ZHU, Chao-Dong/0000-0002-9347-3178; 	National Natural Science Foundation of China (NSFC) [30870321, 31071950]; Public Welfare Project from the Ministry of Agriculture, China [201103022, 201103024]; Program of Ministry of Science and Technology of the People's Republic of China [2011FY120200]; Programs of Chinese Academy of Sciences [KSCX2-YW-NF-02, KSCX2-EW-G-4]; Ningbo Science and Technology Bureau [2009C10004]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Public Welfare Project from the Ministry of Agriculture, China; Program of Ministry of Science and Technology of the People's Republic of China; Programs of Chinese Academy of Sciences; Ningbo Science and Technology Bureau	This research was supported by the National Natural Science Foundation of China (NSFC grant no. 30870321, 31071950), Public Welfare Project from the Ministry of Agriculture, China (Grant No. 201103022, 201103024); the Program of Ministry of Science and Technology of the People's Republic of China (2011FY120200), the Programs of Chinese Academy of Sciences (KSCX2-YW-NF-02, KSCX2-EW-G-4), and partially by Ningbo Science and Technology Bureau (2009C10004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021600; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Billah MK, 2008, B ENTOMOL RES, V98, P63, DOI 10.1017/S000748530700541X; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell B., 2000, P59; Campbell B. C., 1993, Insect Molecular Biology, V2, P225, DOI 10.1111/j.1365-2583.1994.tb00142.x; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Daane KM, 2000, BIOCONTROL, V45, P269, DOI 10.1023/A:1009960223681; May-Itza WD, 2010, CONSERV GENET, V11, P2079, DOI 10.1007/s10592-010-0087-7; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; DONOGHUE MJ, 1985, BRYOLOGIST, V88, P172, DOI 10.2307/3243026; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Emery VJ, 2009, MOL ECOL RESOUR, V9, P217, DOI 10.1111/j.1755-0998.2009.02647.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francoy TM, 2008, APIDOLOGIE, V39, P488, DOI 10.1051/apido:2008028; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Guerrieri E, 2001, J NAT HIST, V35, P41, DOI 10.1080/002229301447880; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassell M.P., 2000, SPATIAL TEMPORAL DYN; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heraty JM, 2007, MOL PHYLOGENET EVOL, V45, P480, DOI 10.1016/j.ympev.2007.06.021; Herre EA, 2006, P NATL ACAD SCI USA, V103, P3949, DOI 10.1073/pnas.0600550103; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; Huang J., 2004, CHINESE FAUNA PARASI; Jones OR, 2009, INSECT CONSERV DIVER, V2, P204, DOI 10.1111/j.1752-4598.2009.00057.x; Kandemir I, 2009, J APICULT RES, V48, P238, DOI 10.3896/IBRA.1.48.4.03; Leo SST, 2010, J MED ENTOMOL, V47, P565, DOI 10.1603/ME10006; Liao DX, 1987, EC INSECT FAUNA CHIN, V34, P1; Locke SA, 2010, MOL ECOL, V19, P2813, DOI 10.1111/j.1365-294X.2010.04713.x; Lou JX, 2011, CHALCIDOIDEA CHRYSID; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; Lu XP, 2006, FOREST SCI TECHNOLOG, V31, P34; Lysyk TJ, 2008, J MED ENTOMOL, V45, P1064, DOI 10.1603/0022-2585(2008)45[1064:RCOPAM]2.0.CO;2; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; McBride CS, 2009, MOL ECOL, V18, P3639, DOI 10.1111/j.1365-294X.2009.04309.x; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Mendes Marcelo Fidelis Marques, 2007, Bioscience Journal, V23, P147; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; NOYES JS, 1982, J NAT HIST, V16, P315, DOI 10.1080/00222938200770261; Nylander J, 2005, MRAIC 1 4 COMPUTER S; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pfenninger M, 2007, MOL ECOL, V16, P1957, DOI 10.1111/j.1365-294X.2006.03136.x; Phillips CB, 2008, MOL PHYLOGENET EVOL, V49, P467, DOI 10.1016/j.ympev.2008.08.005; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Poulin R, 2008, TRENDS PARASITOL, V24, P24, DOI 10.1016/j.pt.2007.10.002; Prinsloo G.L., 1991, South Africa Department of Agricultural Development Entomology Memoir, P1; Quicke D. L. J., 1997, PARASITIC WASPS; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, MOL ECOLOGY NOTES, V7, P355; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rohlf F. J., 2006, TPS DIG DIGITIZE LAN; Rohlf FJ, 2006, TPS RELW RELATIVE WA; Rokas A, 2002, MOL PHYLOGENET EVOL, V22, P206, DOI 10.1006/mpev.2001.1032; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Santos AMC, 2010, INSECT CONSERV DIVER, V3, P72, DOI 10.1111/j.1752-4598.2010.00079.x; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SEQUEIRA R, 1992, ECOLOGY, V73, P183, DOI 10.2307/1938730; Sha ZL, 2006, BIOL CONTROL, V38, P380, DOI 10.1016/j.biocontrol.2006.04.008; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; SPSS, 2007, SPSS VERS 16 0 WIND; Sugonjaev ES, 1981, ENTOMOL REV, V60, P124; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Van valen L, 1976, EVOL THEORY, V1, P179; Villemant C, 2007, SYST ENTOMOL, V32, P625, DOI 10.1111/j.1365-3113.2007.00389.x; Westenberger SJ, 2004, PARASITOLOGY, V129, P537, DOI 10.1017/S003118200400592X; Whiteman NK, 2006, J PARASITOL, V92, P1218, DOI 10.1645/GE-918R.1; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; Xie Ying-ping, 2007, Entomotaxonomia, V29, P145; Xie YP, 1998, SCALE INSECTS FOREST, P46; Yassin A, 2008, MOL ECOL RESOUR, V8, P491, DOI 10.1111/j.1471-8286.2007.02020.x; Zhang YZ, 2011, BIOL CONTROL, V58, P182, DOI 10.1016/j.biocontrol.2011.05.006	90	32	38	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37655	10.1371/journal.pone.0037655	http://dx.doi.org/10.1371/journal.pone.0037655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666375	Green Published, gold			2022-12-27	WOS:000305353400037
J	Dohn, A; Garza-Villarreal, EA; Heaton, P; Vuust, P				Dohn, Anders; Garza-Villarreal, Eduardo A.; Heaton, Pamela; Vuust, Peter			Do Musicians with Perfect Pitch Have More Autism Traits than Musicians without Perfect Pitch? An Empirical Study	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; SPECTRUM QUOTIENT AQ; ABSOLUTE PITCH; ASPERGER-SYNDROME; SYSTEMATIZING QUOTIENT; WILLIAMS-SYNDROME; MUSICAL ABILITY; PERCEPTION; CHILDREN; SAVANT	Perfect pitch, also known as absolute pitch (AP), refers to the rare ability to identify or produce a musical tone correctly without the benefit of an external reference. AP is often considered to reflect musical giftedness, but it has also been associated with certain disabilities due to increased prevalence of AP in individuals with sensory and developmental disorders. Here, we determine whether individual autistic traits are present in people with AP. We quantified subclinical levels of autism traits using the Autism-Spectrum Quotient (AQ) in three matched groups of subjects: 16 musicians with AP (APs), 18 musicians without AP (non-APs), and 16 non-musicians. In addition, we measured AP ability by a pitch identification test with sine wave tones and piano tones. We found a significantly higher degree of autism traits in APs than in non-APs and non-musicians, and autism scores were significantly correlated with pitch identification scores (r = .46, p = .003). However, our results showed that APs did not differ from non-APs on diagnostically crucial social and communicative domain scores and their total AQ scores were well below clinical thresholds for autism. Group differences emerged on the imagination and attention switching subscales of the AQ. Thus, whilst these findings do link AP with autism, they also show that AP ability is most strongly associated with personality traits that vary widely within the normal population.	[Dohn, Anders; Garza-Villarreal, Eduardo A.; Vuust, Peter] Univ Aarhus, CFIN, Aarhus, Denmark; [Dohn, Anders; Garza-Villarreal, Eduardo A.; Vuust, Peter] Royal Acad Mus, Aarhus, Denmark; [Garza-Villarreal, Eduardo A.] Univ Autonoma Nuevo Leon, Univ Hosp, Dept Neurol, Nuevo Leon, Mexico; [Garza-Villarreal, Eduardo A.] Univ Autonoma Nuevo Leon, Ctr Res & Dev Hlth Sci CIDICS, Neurosci Unit, Nuevo Leon, Mexico; [Heaton, Pamela] Goldsmiths Univ London, Dept Psychol, London, England	Aarhus University; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University of London; Goldsmiths University London	Dohn, A (corresponding author), Univ Aarhus, CFIN, Aarhus, Denmark.	dohn@pet.auh.dk	Garza-Villarreal, Eduardo/A-7879-2008	Garza-Villarreal, Eduardo/0000-0003-1381-8648	Royal Academy of Music, Aarhus; Danish Ministry of Culture; Danish National Research Foundation's Center of Functionally Integrative Neuroscience (CFIN)	Royal Academy of Music, Aarhus; Danish Ministry of Culture; Danish National Research Foundation's Center of Functionally Integrative Neuroscience (CFIN)	This study was financially supported by The Royal Academy of Music, Aarhus, the Danish Ministry of Culture, and the Danish National Research Foundation's Center of Functionally Integrative Neuroscience (CFIN). The authors declare that the funders had no influence in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 2000, DIAGN STAT MAN MENT; Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; BACHEM A, 1955, J ACOUST SOC AM, V27, P1180, DOI 10.1121/1.1908155; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1998, AUTISM, V2, P296, DOI [10.1177/1362361398023008, DOI 10.1177/1362361398023008]; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Brown WA, 2003, J AUTISM DEV DISORD, V33, P163, DOI 10.1023/A:1022987309913; Brown WA, 2002, MUSIC PERCEPT, V19, P595, DOI 10.1525/mp.2002.19.4.595; Chin C. S., 2003, PSYCHOL MUSIC, V31, P155, DOI [10.1177/0305735603031002292, DOI 10.1177/0305735603031002292]; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Gomot M, 2008, BRAIN, V131, P2479, DOI 10.1093/brain/awn172; Gregersen PK, 1999, AM J HUM GENET, V65, P911, DOI 10.1086/302541; Grinter EJ, 2009, J AUTISM DEV DISORD, V39, P670, DOI 10.1007/s10803-008-0658-3; Hamilton R, 2000, SOC NEUR ABSTR, V26; Hamilton RH, 2004, NEUROREPORT, V15, P803, DOI 10.1097/00001756-200404090-00012; Heaton P, 1998, MUSIC PERCEPT, V15, P291; Heaton P, 1999, NEUROCASE, V5, P503, DOI 10.1080/13554799908402745; Heaton P, 2003, J CHILD PSYCHOL PSYC, V44, P543, DOI 10.1111/1469-7610.00143; Heaton P, 2008, NEUROPSYCHOLOGIA, V46, P2095, DOI 10.1016/j.neuropsychologia.2008.02.006; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Howlin P, 2003, J AUTISM DEV DISORD, V33, P3, DOI 10.1023/A:1022270118899; Lenhoff HM, 2001, MUSIC PERCEPT, V18, P491, DOI 10.1525/mp.2001.18.4.491; Levitin DJ, 2004, ANN PSYCHOL, V104, P103; Martens MA, 2010, NEUROPSYCHOLOGIA, V48, P2602, DOI 10.1016/j.neuropsychologia.2010.05.007; Miyazaki K., 2004, ACOUSTICAL SCI TECHN, V25, P426, DOI [DOI 10.1250/AST.25.426, 10.1250/ast.25.426]; Miyazaki K, 2006, MUSIC PERCEPT, V24, P63, DOI 10.1525/mp.2006.24.1.63; Monson Ingrid, 1996, SAYING SOMETHING JAZ; Mottron L, 1999, NEUROCASE, V5, P485, DOI 10.1093/neucas/5.6.485; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2009, PHILOS T R SOC B, V364, P1385, DOI 10.1098/rstb.2008.0333; PROFITA J, 1988, AM J MED GENET, V29, P763, DOI 10.1002/ajmg.1320290405; RIMLAND B, 1988, EXCEPTIONAL BRAIN NE, P474; SERGEANT D, 1969, J RES MUSIC EDUC, V17, P135, DOI 10.2307/3344200; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; Vuust P, 2008, COGNITIVE SEMIOTICS, P135; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004; Ward W.D., 1999, PSYCHOL MUSIC PP, P265, DOI DOI 10.1016/B978-012213564-4/50009-3; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Wikioo, 2021, THINKING JAZZ INFINI; Woodbury-Smith MR, 2005, J AUTISM DEV DISORD, V35, P331, DOI 10.1007/s10803-005-3300-7	44	29	30	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37961	10.1371/journal.pone.0037961	http://dx.doi.org/10.1371/journal.pone.0037961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959YF	22666425	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400063
J	Labar, AS; Millman, JS; Ruebush, E; Opintan, JA; Bishar, RA; Aboderin, O; Newman, MJ; Lamikanra, A; Okeke, IN				Labar, Amy S.; Millman, Jennifer S.; Ruebush, Ellen; Opintan, Japheth A.; Bishar, Rima A.; Aboderin, Oladipo; Newman, Mercy J.; Lamikanra, Adebayo; Okeke, Iruka N.			Regional Dissemination of a Trimethoprim-Resistance Gene Cassette via a Successful Transposable Element	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; VIBRIO-CHOLERAE O1; DIHYDROFOLATE-REDUCTASE GENES; ENTERICA SEROVAR TYPHIMURIUM; COMPLETE GENOME SEQUENCE; ADHERENCE FACTOR PLASMID; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; MOLECULAR CHARACTERIZATION; COTRIMOXAZOLE PROPHYLAXIS	Background: Antimicrobial resistance is a growing international problem. We observed a 50% increase in the prevalence of trimethoprim resistance among fecal Escherichia coli from healthy Nigerian students between 1998 and 2005, a trend to increase that continued in 2009. Methods and Findings: A PCR-based screen revealed that 131 (43.1%) of isolates obtained in Nigeria in 2005 and 2009 carried integron-borne dfrA cassettes. In the case of 67 (51.1%) of these isolates, the cassette was a class 1-integron-borne dfrA7 gene, which has been reported at high prevalence from E. coli isolates from other parts of Africa. Complete sequencing of a 27 Kb dfrA7-bearing plasmid from one isolate located the dfrA7 gene within a Tn21-type transposon. The transposon also contained an IS26-derived bla/sul/str element, encoding resistance to beta-lactams, sulphonamides and streptomycin, and mercury resistance genes. Although the plasmid backbone was only found in 12 (5.8%) of trimethoprim-resistant isolates, dfrA7 and other transposon-borne genes were detected in 14 (16.3%) and 32 (26.3%) of trimethoprim resistant isolates collected in Nigeria in 2005 and 2009, respectively. Additionally, 37 (19.3%) of trimethoprim-resistant E. coli isolates collected between 2006 and 2008 from Ghana were positive for the dfrA7 and a transposon marker, but only 4 (2.1%) harbored the plasmid backbone. Conclusions: Our data point to transposition as a principal mechanism for disseminating dfrA7 among E. coli from Nigeria and Ghana. On-going intensive use of the affordable broad-spectrum antibacterials is likely to promote selective success of a highly prevalent transposable element in West Africa.	[Labar, Amy S.; Millman, Jennifer S.; Ruebush, Ellen; Bishar, Rima A.; Okeke, Iruka N.] Haverford Coll, Dept Biol, Haverford, PA 19041 USA; [Opintan, Japheth A.; Newman, Mercy J.] Univ Ghana, Sch Med, Dept Microbiol, Accra, Ghana; [Aboderin, Oladipo] Obafemi Awolowo Univ, Dept Med Microbiol & Parasitol, Ife, Nigeria; [Lamikanra, Adebayo] Obafemi Awolowo Univ, Dept Pharmaceut, Ife, Nigeria	Haverford College; University of Ghana; Obafemi Awolowo University; Obafemi Awolowo University	Labar, AS (corresponding author), Haverford Coll, Dept Biol, Haverford, PA 19041 USA.	iokeke@haverford.edu	Okeke, Iruka N/N-1595-2019; Aboderin, Aaron/V-8025-2019	Okeke, Iruka N/0000-0002-1694-7587; Aboderin, Aaron/0000-0002-4280-2218	Branco Weiss Fellowship from the Society-in-Science, ETHZ, Switzerland INO; undergraduate research studentships from the Howard Hughes Medical Institute through Haverford College	Branco Weiss Fellowship from the Society-in-Science, ETHZ, Switzerland INO; undergraduate research studentships from the Howard Hughes Medical Institute through Haverford College	This work was supported by a Branco Weiss Fellowship from the Society-in-Science, ETHZ, Switzerland INO. AL and RAB were supported by undergraduate research studentships from the Howard Hughes Medical Institute through Haverford College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN PV, 1995, J ANTIMICROB CHEMOTH, V35, P497, DOI 10.1093/jac/35.4.497; Ahmed AM, 2006, J MED MICROBIOL, V55, P643, DOI 10.1099/jmm.0.46378-0; Ajiboye RM, 2009, CLIN INFECT DIS, V49, P365, DOI 10.1086/600301; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Ashley EA, 2011, TROP MED INT HEALTH, V16, P1167, DOI 10.1111/j.1365-3156.2011.02822.x; Bailey JK, 2010, J MED MICROBIOL, V59, P1331, DOI 10.1099/jmm.0.022475-0; Brinkley C, 2006, INFECT IMMUN, V74, P5408, DOI 10.1128/IAI.01840-05; Brolund A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009233; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Ceccarelli D, 2006, J ANTIMICROB CHEMOTH, V58, P1095, DOI 10.1093/jac/dkl352; Ceccarelli D, 2006, ANTIMICROB AGENTS CH, V50, P2493, DOI 10.1128/AAC.01310-05; Chah KF, 2010, J BASIC MICROB, V50, pS18, DOI 10.1002/jobm.200900325; Chen CY, 2007, PLASMID, V57, P29, DOI 10.1016/j.plasmid.2006.05.005; Crespo O, 2005, INT J ANTIMICROB AG, V25, P341, DOI 10.1016/j.ijantimicag.2005.01.016; Dahmen S, 2010, MICROB DRUG RESIST, V16, P43, DOI 10.1089/mdr.2009.0091; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; Djie-Maletz A, 2008, J ANTIMICROB CHEMOTH, V61, P1315, DOI 10.1093/jac/dkn108; Douard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015302; Eckert C, 2006, J ANTIMICROB CHEMOTH, V57, P14, DOI 10.1093/jac/dki398; El-Najjar NG, 2010, LETT APPL MICROBIOL, V51, P456, DOI 10.1111/j.1472-765X.2010.02926.x; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Ford N, 2009, NEW ENGL J MED, V360, P1808, DOI 10.1056/NEJMp0902820; France AM, 2005, CLIN INFECT DIS, V40, P1101, DOI 10.1086/428727; Frank T, 2007, J ANTIMICROB CHEMOTH, V59, P742, DOI 10.1093/jac/dkl538; Gangoue-Pieboji Joseph, 2006, Afr Health Sci, V6, P232; Gassama A, 2004, MICROB DRUG RESIST, V10, P27, DOI 10.1089/107662904323047763; Gill CJ, 2008, B WORLD HEALTH ORGAN, V86, P929, DOI 10.2471/BLT.07.049668; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; HEIKKILA E, 1990, J ANTIMICROB CHEMOTH, V25, P275, DOI 10.1093/jac/25.2.275; HEIKKILA E, 1990, J INFECT DIS, V161, P1242, DOI 10.1093/infdis/161.6.1242; HEIKKILA E, 1991, ANTIMICROB AGENTS CH, V35, P1562, DOI 10.1128/AAC.35.8.1562; HEIKKILA E, 1990, ANTIMICROB AGENTS CH, V34, P2013, DOI 10.1128/AAC.34.10.2013; Holt KE, 2007, J BACTERIOL, V189, P4257, DOI 10.1128/JB.00232-07; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; HUOVINEN P, 1995, ANTIMICROB AGENTS CH, V39, P279, DOI 10.1128/AAC.39.2.279; JANSSON C, 1991, ANTIMICROB AGENTS CH, V35, P1891, DOI 10.1128/AAC.35.9.1891; JANSSON C, 1992, ANTIMICROB AGENTS CH, V36, P2704, DOI 10.1128/AAC.36.12.2704; Johnson JR, 2011, EMERG INFECT DIS, V17, P2001, DOI 10.3201/eid1711.110488; Johnson JR, 2002, LANCET, V359, P2249, DOI 10.1016/S0140-6736(02)09264-4; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Jun L, 2002, PLASMID, V48, P24, DOI 10.1016/S0147-619X(02)00007-0; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; KRAFT CA, 1986, J MED MICROBIOL, V22, P125, DOI 10.1099/00222615-22-2-125; Lamikanra A, 1996, INT J ANTIMICROB AG, V7, P59, DOI 10.1016/0924-8579(96)00011-8; LAMIKANRA A, 1989, FEMS MICROBIOL LETT, V59, P275; Lamikanra A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-312; Lee JC, 2001, J ANTIMICROB CHEMOTH, V47, P599, DOI 10.1093/jac/47.5.599; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Lu ST, 2011, J BACTERIOL, V193, P7005, DOI 10.1128/JB.06284-11; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Morpeth SC, 2008, JAIDS-J ACQ IMM DEF, V47, P585, DOI 10.1097/QAI.0b013e31816856db; Namboodiri SS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-44; NCCLS, 2003, M2A8 NCCLS, P130; Newman Mercy J, 2002, West Afr J Med, V21, P48; Nield BS, 2001, FEMS MICROBIOL LETT, V195, P59, DOI 10.1016/S0378-1097(00)00546-2; Nwaneshiudu AI, 2007, J BACTERIOL, V189, P6074, DOI 10.1128/JB.00349-07; OBRIEN TF, 1995, EMERG INFECT DIS, V1, P66, DOI 10.3201/eid0102.950209; Ojo KK, 2002, J ANTIMICROB CHEMOTH, V49, P573, DOI 10.1093/jac/49.3.573; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; Okeke IN, 2000, EMERG INFECT DIS, V6, P393; Okeke IN, 2002, J CLIN MICROBIOL, V40, P301, DOI 10.1128/JCM.40.1.301-305.2002; Okeke IN, 2001, CLIN INFECT DIS, V33, P364, DOI 10.1086/321877; Opintan JA, 2008, J ANTIMICROB CHEMOTH, V62, P929, DOI 10.1093/jac/dkn334; Pallecchi L, 2007, ANTIMICROB AGENTS CH, V51, P1179, DOI 10.1128/AAC.01101-06; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Ploy MC, 2003, ANTIMICROB AGENTS CH, V47, P1427, DOI 10.1128/AAC.47.4.1427-1429.2003; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2001, MOL CLONING LAB MANU; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skurnik D, 2009, MICROB DRUG RESIST, V15, P173, DOI 10.1089/mdr.2009.0918; Solberg OD, 2006, J CLIN MICROBIOL, V44, P1347, DOI 10.1128/JCM.44.4.1347-1351.2006; STEEN R, 1985, ANTIMICROB AGENTS CH, V27, P933, DOI 10.1128/AAC.27.6.933; SUNDSTROM L, 1993, J BACTERIOL, V175, P1796; TAIT S, 1994, EPIDEMIOL INFECT, V113, P247, DOI 10.1017/S0950268800051670; Tobe T, 1999, INFECT IMMUN, V67, P5455, DOI 10.1128/IAI.67.10.5455-5462.1999; TOWNER KJ, 1994, J ANTIMICROB CHEMOTH, V33, P25, DOI 10.1093/jac/33.1.25; Vasilakopoulou A, 2009, FOODBORNE PATHOG DIS, V6, P1211, DOI 10.1089/fpd.2009.0281; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; Vinue L, 2008, J ANTIMICROB CHEMOTH, V62, P934, DOI 10.1093/jac/dkn331; Wain J, 2003, ANTIMICROB AGENTS CH, V47, P2732, DOI 10.1128/AAC.47.9.2732-2739.2003; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; WOMBLE DD, 1988, MICROBIOL REV, V52, P433, DOI 10.1128/MMBR.52.4.433-451.1988; World Health Organization, 2001, Afr Health Sci, V1, P30; Yang CM, 2009, JPN J INFECT DIS, V62, P177; Yau S, 2010, MICROB DRUG RESIST, V16, P249, DOI 10.1089/mdr.2010.0033	93	35	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38142	10.1371/journal.pone.0038142	http://dx.doi.org/10.1371/journal.pone.0038142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666464	Green Submitted, gold, Green Published			2022-12-27	WOS:000305353400089
J	Lorat, Y; Schanz, S; Schuler, N; Wennemuth, G; Rube, C; Rube, CE				Lorat, Yvonne; Schanz, Stefanie; Schuler, Nadine; Wennemuth, Gunther; Ruebe, Christian; Ruebe, Claudia E.			Beyond Repair Foci: DNA Double-Strand Break Repair in Euchromatic and Heterochromatic Compartments Analyzed by Transmission Electron Microscopy	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; NORMAL-TISSUES; CHROMATIN; KU; PHOSPHORYLATION; GAMMA-H2AX; ORGANIZATION; HETERODIMER; CHROMOSOMES; COMPLEX	Purpose: DNA double-strand breaks (DSBs) generated by ionizing radiation pose a serious threat to the preservation of genetic and epigenetic information. The known importance of local chromatin configuration in DSB repair raises the question of whether breaks in different chromatin environments are recognized and repaired by the same repair machinery and with similar efficiency. An essential step in DSB processing by non-homologous end joining is the high-affinity binding of Ku70-Ku80 and DNA-PKcs to double-stranded DNA ends that holds the ends in physical proximity for subsequent repair. Methods and Materials: Using transmission electron microscopy to localize gold-labeled pKu70 and pDNA-PKcs within nuclear ultrastructure, we monitored the formation and repair of actual DSBs within euchromatin (electron-lucent) and heterochromatin (electron-dense) in cortical neurons of irradiated mouse brain. Results: While DNA lesions in euchromatin (characterized by two pKu70-gold beads, reflecting the Ku70-Ku80 heterodimer) are promptly sensed and rejoined, DNA packaging in heterochromatin appears to retard DSB processing, due to the time needed to unravel higher-order chromatin structures. Complex pKu70-clusters formed in heterochromatin (consisting of 4 or >= 6 gold beads) may represent multiple breaks in close proximity caused by ionizing radiation of highly-compacted DNA. All pKu70-clusters disappeared within 72 hours post-irradiation, indicating efficient DSB rejoining. However, persistent 53BP1 clusters in heterochromatin (comprising >= 10 gold beads), occasionally co-localizing with gamma H2AX, but not pKu70 or pDNA-PKcs, may reflect incomplete or incorrect restoration of chromatin structure rather than persistently unrepaired DNA damage. Discussion: Higher-order organization of chromatin determines the accessibility of DNA lesions to repair complexes, defining how readily DSBs are detected and processed. DNA lesions in heterochromatin appear to be more complex, with multiple breaks in spatial vicinity inducing severe chromatin disruptions. Imperfect restoration of chromatin configurations may leave DSB-induced epigenetic memory of damage with potentially pathological repercussions.	[Lorat, Yvonne; Schanz, Stefanie; Schuler, Nadine; Ruebe, Christian; Ruebe, Claudia E.] Univ Saarland, Dept Radiat Oncol, D-6650 Homburg, Germany; [Wennemuth, Gunther] Univ Saarland, Dept Cell Biol & Anat, D-6650 Homburg, Germany	Saarland University; Saarland University	Lorat, Y (corresponding author), Univ Saarland, Dept Radiat Oncol, D-6650 Homburg, Germany.	claudia.ruebe@uks.eu		Wennemuth, Gunther/0000-0003-3313-2475	Deutsche Forschungsgemeinschaft [Ru821/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft (Ru821/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Bhogal N, 2009, INT J RADIAT BIOL, V85, P732, DOI 10.1080/09553000902785791; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chan DW, 1999, BIOCHEMISTRY-US, V38, P1819, DOI 10.1021/bi982584b; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Daban JR, 2000, BIOCHEMISTRY-US, V39, P3861, DOI 10.1021/bi992628w; Dellaire G, 2009, CELL CYCLE, V8, P3750, DOI 10.4161/cc.8.22.10065; Doherty AJ, 2001, CURR BIOL, V11, pR920, DOI 10.1016/S0960-9822(01)00555-3; Douglas P, 2005, DNA REPAIR, V4, P1006, DOI 10.1016/j.dnarep.2005.05.003; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Orlowski C, 2011, CHROMOSOMA, V120, P129, DOI 10.1007/s00412-010-0305-6; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Rube CE, 2008, INT J RADIAT ONCOL, V72, P1180, DOI 10.1016/j.ijrobp.2008.07.017; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Rube CE, 2011, DNA REPAIR, V10, P427, DOI 10.1016/j.dnarep.2011.01.012; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Rube CE, 2010, INT J RADIAT ONCOL, V78, P359, DOI 10.1016/j.ijrobp.2009.08.052; Rube CE, 2010, INT J RADIAT ONCOL, V76, P1206, DOI 10.1016/j.ijrobp.2009.10.009; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Takahashi A, 2010, J RADIAT RES, V51, P91, DOI [10.1269/jrr.09111, 10.1269/jrr.0911]; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000	29	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38165	10.1371/journal.pone.0038165	http://dx.doi.org/10.1371/journal.pone.0038165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666473	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400094
J	Mir, O; Coriat, R; Blanchet, B; Durand, JP; Boudou-Rouquette, P; Michels, J; Ropert, S; Vidal, M; Pol, S; Chaussade, S; Goldwasser, F				Mir, Olivier; Coriat, Romain; Blanchet, Benoit; Durand, Jean-Philippe; Boudou-Rouquette, Pascaline; Michels, Judith; Ropert, Stanislas; Vidal, Michel; Pol, Stanislas; Chaussade, Stanislas; Goldwasser, Francois			Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							CANCER-PATIENTS; BODY-COMPOSITION; SKELETAL-MUSCLE; PHASE-I; VALIDATION; INHIBITOR	Background: Sorafenib induces frequent dose limiting toxicities (DLT) in patients with advanced hepatocellular carcinoma (HCC). Sarcopenia has been associated with poor performance status and shortened survival in cancer patients. Patients and Methods: The characteristics of Child Pugh A cirrhotic patients with HCC receiving sorafenib in our institution were retrospectively analyzed. Sorafenib plasma concentrations were determined at each visit. Toxicities were recorded during the first month of treatment, and sarcopenia was determined from baseline CT-scans. Results: Forty patients (30 males) were included. Eleven (27.5%) were sarcopenic. Eighteen patients (45%) experienced a DLT during the first month of treatment. Sarcopenic patients experienced significantly more DLTs than non-sarcopenic patients did (82% versus 31%, p = 0.005). Grade 3 diarrhea was significantly more frequent in sarcopenic patients than in non-sarcopenic patients (45.5% versus 6.9%, p = 0.01), but not grade 3 hand foot syndrome reaction (9% versus 17.2%, p = 1). On day 28, median sorafenib AUC (n = 17) was significantly higher in sarcopenic patients (102.4 mg/l. h versus 53.7 mg/l. h, p = 0.013). Conclusions: Among cirrhotic Child Pugh A patients with advanced HCC, sarcopenia predicts sorafenib exposure and the occurrence of DLT within the first month of treatment.	[Mir, Olivier; Coriat, Romain; Blanchet, Benoit; Durand, Jean-Philippe; Boudou-Rouquette, Pascaline; Michels, Judith; Ropert, Stanislas; Goldwasser, Francois] Univ Paris 05, AP HP, Ctr Res Angiogenesis Inhibitors CERIA, Cochin Teaching Hosp,Dept Med Oncol, Paris, France; [Mir, Olivier] Univ Paris 05, AP HP, Cochin Teaching Hosp, Dept Clin Pharmacol, Paris, France; [Coriat, Romain; Chaussade, Stanislas] Univ Paris 05, AP HP, Cochin Teaching Hosp, Dept Gastroenterol, Paris, France; [Blanchet, Benoit; Vidal, Michel] Univ Paris 05, AP HP, Cochin Teaching Hosp, Lab Pharmacol & Toxicol, Paris, France; [Pol, Stanislas] Univ Paris 05, AP HP, Cochin Teaching Hosp, Dept Hepatol, Paris, France; [Pol, Stanislas] Univ Paris 05, AP HP, Cochin Teaching Hosp, INSERM U1016, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mir, O (corresponding author), Univ Paris 05, AP HP, Ctr Res Angiogenesis Inhibitors CERIA, Cochin Teaching Hosp,Dept Med Oncol, Paris, France.	olivier.mir@cch.aphp.fr	/AFP-4402-2022; Vidal, Michel/ABA-3396-2020; /ABG-4006-2020; Mir, Olivier/GNP-7828-2022; Goldwasser, François/P-4861-2017; Michels, Judith/Q-5693-2018; Coriat, Romain/O-7902-2017	/0000-0002-4860-305X; /0000-0002-4860-305X; Mir, Olivier/0000-0002-6761-4002; Michels, Judith/0000-0002-9640-0222; Vidal, Michel/0000-0002-4858-1591				Antoun S, 2010, ANN ONCOL, V21, P1594, DOI 10.1093/annonc/mdp605; Blanchet B, 2009, J PHARMACEUT BIOMED, V49, P1109, DOI 10.1016/j.jpba.2009.02.008; Cosqueric G, 2006, BRIT J NUTR, V96, P895, DOI 10.1017/BJN20061943; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Heymsfield SB, 1997, ANNU REV NUTR, V17, P527, DOI 10.1146/annurev.nutr.17.1.527; Hornecker M, 2011, INVEST NEW DRUGS, DOI [10.1007/s10637-10011-19760-z, DOI 10.1007/S10637-10011-19760-Z]; Izzedine H, 2009, ANN ONCOL, V20, P807, DOI 10.1093/annonc/mdn713; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kacevska M, 2008, EXPERT OPIN DRUG MET, V4, P137, DOI 10.1517/17425255.4.2.137; Kim JE, 2012, ONCOLOGY-BASEL, V82, P119, DOI 10.1159/000336082; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Meza-Junco J, 2011, J CLIN ONCOL, V29; Miller AA, 2009, J CLIN ONCOL, V27, P1800, DOI 10.1200/JCO.2008.20.0931; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2011, CANCER CHEMOTH PHARM, V67, P93, DOI 10.1007/s00280-010-1288-y; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130	23	210	214	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37563	10.1371/journal.pone.0037563	http://dx.doi.org/10.1371/journal.pone.0037563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666367	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400034
J	Piazza, BP; La Peyre, MK				Piazza, Bryan P.; La Peyre, Megan K.			Measuring Changes in Consumer Resource Availability to Riverine Pulsing in Breton Sound, Louisiana, USA	PLOS ONE			English	Article							FRESH-WATER FLOW; TERRESTRIAL INVERTEBRATES; PERIODICAL CICADAS; ESTUARINE HABITATS; GAMBUSIA-AFFINIS; DELTAIC ESTUARY; ENERGY DENSITY; SALMON; NUTRIENTS; DYNAMICS	Resource pulses are thought to structure communities and food webs through the assembly of consumers. Aggregated consumers represent a high quality resource subsidy that becomes available for trophic transfer during and after the pulse. In estuarine systems, riverine flood pulses deliver large quantities of basal resources and make high quality habitat available for exploitation by consumers. These consumers represent a change in resources that may be available for trophic transfer. We quantified this increased consumer resource availability (nekton density, biomass, energy density) provided by riverine flood pulsing in Breton Sound, Louisiana, USA. We used water level differences between an area subject to two experimental riverine flood pulses (inflow) and a reference area not receiving inflow to identify the percentage of nekton standing stock and energy density that may be attributable solely to riverine pulsing and may represent a consumer resource subsidy. Riverine pulsing accounted for more than 60% of resident nekton density (ind m(-2)), biomass (g m(-2)), and energy density (cal m(-2)) on the flooded marsh surface during two experimental pulse events in 2005. Our results document the potential subsidy of resident nekton standing stock from a riverine flood pulse available for export to subtidal habitats. Given predicted large scale changes in river discharge globally, this approach could provide a useful tool for quantifying the effects of changes in riverine discharge on consumer resource availability.	[Piazza, Bryan P.] Louisiana State Univ Agr Ctr, Sch Renewable Nat Resources, Baton Rouge, LA USA; [La Peyre, Megan K.] Louisiana State Univ Agr Ctr, Sch Renewable Nat Resources, Louisiana Fish & Wildlife Cooperat Res Unit, US Geol Survey, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; United States Department of the Interior; United States Geological Survey	Piazza, BP (corresponding author), Nature Conservancy, Baton Rouge, LA 70821 USA.	bpiazza@tnc.org			Louisiana Governor's Applied Coastal Research and Development Program (LACRDP); Coastal Restoration and Enhancement through Science and Technology (CREST) Program; Louisiana Department of Wildlife and Fisheries	Louisiana Governor's Applied Coastal Research and Development Program (LACRDP); Coastal Restoration and Enhancement through Science and Technology (CREST) Program; Louisiana Department of Wildlife and Fisheries	This work was funded by grants from the Louisiana Governor's Applied Coastal Research and Development Program (LACRDP), the Coastal Restoration and Enhancement through Science and Technology (CREST; www.gulfcrest.org) Program and by the Louisiana Department of Wildlife and Fisheries. The use of trade, product, industry or firm names, or products is for informative purposes only and does not constitute an endorsement by the U.S. Government or the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2002, ESTUARIES, V25, P1246, DOI 10.1007/BF02692222; Anderson WB, 2008, ECOLOGY, V89, P660, DOI 10.1890/07-0234.1; Banasek-Richter C, 2009, ECOLOGY, V90, P1470, DOI 10.1890/08-2207.1; Barletta M, 2005, J FISH BIOL, V66, P45, DOI 10.1111/j.0022-1112.2005.00582.x; Brock CS, 2007, LIMNOL OCEANOGR, V52, P1588, DOI 10.4319/lo.2007.52.4.1588; Ciancio Javier, 2006, Ecol. austral, V16, P91; Claeson SM, 2006, CAN J FISH AQUAT SCI, V63, P1230, DOI 10.1139/F06-029; Connolly RM, 2005, OECOLOGIA, V144, P684, DOI 10.1007/s00442-005-0167-4; Connolly RM, 2009, MAR BIOL RES, V5, P164, DOI 10.1080/17451000802266625; de Mutsert K, 2010, THESIS LOUISIANA STA; DURBIN AG, 1979, ECOLOGY, V60, P8, DOI 10.2307/1936461; Eberle LC, 2010, RIVER RES APPL, V26, P682, DOI 10.1002/rra.1270; Gillanders BM, 2002, OCEANOGR MAR BIOL, V40, P233; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Howe ER, 2007, MAR ECOL PROG SER, V351, P65, DOI 10.3354/meps07120; Jonsson B, 2005, ECOL FRESHW FISH, V14, P296, DOI 10.1111/j.1600-0633.2005.00098.x; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Kawaguchi Y, 2001, FRESHWATER BIOL, V46, P303, DOI 10.1046/j.1365-2427.2001.00667.x; Kimmerer WJ, 2002, ESTUARIES, V25, P1275, DOI 10.1007/BF02692224; Kitchell JF, 1999, LIMNOL OCEANOGR, V44, P828, DOI 10.4319/lo.1999.44.3_part_2.0828; Kneib Ronald T., 1997, Oceanography and Marine Biology an Annual Review, V35, P163; Kneib RT, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P267; Lane RR, 2004, ESTUAR COAST SHELF S, V60, P1, DOI 10.1016/j.ecss.2003.11.015; Livingston RJ, 1997, ECOL APPL, V7, P277, DOI 10.1890/1051-0761(1997)007[0277:FITAGE]2.0.CO;2; Loneragan NR, 1999, AUST J ECOL, V24, P431, DOI 10.1046/j.1442-9993.1999.00975.x; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Nowlin WH, 2008, ECOLOGY, V89, P647, DOI 10.1890/07-0303.1; Nowlin WH, 2007, ECOLOGY, V88, P2174, DOI 10.1890/06-0570.1; Odum EP, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P3; ODUM WE, 1995, ESTUARIES, V18, P547, DOI 10.2307/1352375; Palmer MA, 2008, FRONT ECOL ENVIRON, V6, P81, DOI 10.1890/060148; Pangle KL, 2005, J FISH BIOL, V66, P1060, DOI 10.1111/j.0022-1112.2005.00660.x; Pedersen J, 2001, J FISH BIOL, V59, P380, DOI 10.1006/jfbi.2001.1649; Perez M.A., 1994, NMFSAFSC32 NOAA; Piazza BP, 2007, AQUAT BIOL, V1, P109, DOI 10.3354/ab00013; Piazza BP, 2011, ESTUAR COAST SHELF S, V91, P379, DOI 10.1016/j.ecss.2010.11.001; Piazza BP, 2010, MAR ECOL PROG SER, V412, P231, DOI 10.3354/meps08686; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Rozas LP, 2005, ESTUAR COAST SHELF S, V65, P319, DOI 10.1016/j.ecss.2005.05.019; Rozas LP, 1997, ESTUARIES, V20, P199, DOI 10.2307/1352731; Rutherford DA, 2001, T AM FISH SOC, V130, P276, DOI 10.1577/1548-8659(2001)130&lt;0276:PEOTFP&gt;2.0.CO;2; Schlacher TA, 2009, AQUAT ECOL, V43, P383, DOI 10.1007/s10452-008-9196-5; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Sklar FH, 1998, ENVIRON MANAGE, V22, P547, DOI 10.1007/s002679900127; Snedden GA, 2007, ESTUAR COAST, V30, P802, DOI 10.1007/BF02841335; Snedden GA, 2007, ESTUAR COAST SHELF S, V71, P181, DOI 10.1016/j.ecss.2006.06.035; Stevens PW, 2006, MAR ECOL PROG SER, V327, P267, DOI 10.3354/meps327267; STRANGE RJ, 1987, T AM FISH SOC, V116, P60, DOI 10.1577/1548-8659(1987)116<60:NCOCFF>2.0.CO;2; Vinagre C, 2011, ESTUAR COAST, V34, P663, DOI 10.1007/s12237-010-9315-0; VONDRACEK B, 1988, ENVIRON BIOL FISH, V21, P45, DOI 10.1007/BF02984442; Wanless S, 2005, MAR ECOL PROG SER, V294, P1, DOI 10.3354/meps294001; Williams AJ, 2006, HYDROBIOLOGIA, V569, P493, DOI 10.1007/s10750-006-0151-y; Winemiller K. O, 2004, P 2 INT S MAN LARG R, V2, P285, DOI DOI 10.1017/CBO9781107415324.004; Winemiller Kirk O., 2005, P10; WINEMILLER KO, 1993, OECOLOGIA, V95, P266, DOI 10.1007/BF00323499; Wissel B, 2005, OECOLOGIA, V144, P659, DOI 10.1007/s00442-005-0119-z; Yang LH, 2004, SCIENCE, V306, P1565, DOI 10.1126/science.1103114; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Zimmerman RJ, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P293	61	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37536	10.1371/journal.pone.0037536	http://dx.doi.org/10.1371/journal.pone.0037536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666363	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400030
J	Tobi, EW; Slagboom, PE; van Dongen, J; Kremer, D; Stein, AD; Putter, H; Heijmans, BT; Lumey, LH				Tobi, Elmar W.; Slagboom, P. Eline; van Dongen, Jenny; Kremer, Dennis; Stein, Aryeh D.; Putter, Hein; Heijmans, Bastiaan T.; Lumey, L. H.			Prenatal Famine and Genetic Variation Are Independently and Additively Associated with DNA Methylation at Regulatory Loci within IGF2/H19	PLOS ONE			English	Article							FOLIC-ACID USE; INSULIN GENE; TANDEM REPEAT; BIRTH-WEIGHT; COMMON; MASS; EXPRESSION; EXPOSURE; REGION; H19	Both the early environment and genetic variation may affect DNA methylation, which is one of the major molecular marks of the epigenome. The combined effect of these factors on a well-defined locus has not been studied to date. We evaluated the association of periconceptional exposure to the Dutch Famine of 1944-45, as an example of an early environmental exposure, and single nucleotide polymorphisms covering the genetic variation (tagging SNPs) with DNA methylation at the imprinted IGF2/H19 region, a model for an epigenetically regulated genomic region. DNA methylation was measured at five differentially methylated regions (DMRs) that regulate the imprinted status of the IGF2/H19 region. Small but consistent differences in DNA methylation were observed comparing 60 individuals with periconceptional famine exposure with unexposed same-sex siblings at all IGF2 DMRs (P-BH<0.05 after adjustment for multiple testing), but not at the H19 DMR. IGF2 DMR0 methylation was associated with IGF2 SNP rs2239681 (P-BH=0.027) and INS promoter methylation with INS SNPs, including rs689, which tags the INS VNTR, suggesting a mechanism for the reported effect of the VNTR on INS expression (P-BH=3.4x10(-3)). Prenatal famine and genetic variation showed similar associations with IGF2/H19 methylation and their contributions were additive. They were small in absolute terms (<3%), but on average 0.5 standard deviations relative to the variation in the population. Our analyses suggest that environmental and genetic factors could have independent and additive similarly sized effects on DNA methylation at the same regulatory site.	[Tobi, Elmar W.; Slagboom, P. Eline; Heijmans, Bastiaan T.] Leiden Univ, Med Ctr, Netherlands Consortium Healthy Ageing, Leiden, Netherlands; [van Dongen, Jenny] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Stein, Aryeh D.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Lumey, L. H.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Emory University; Rollins School Public Health; Columbia University	Tobi, EW (corresponding author), Leiden Univ, Med Ctr, Netherlands Consortium Healthy Ageing, Leiden, Netherlands.	B.T.Heijmans@lumc.nl	Slagboom, P. Eline/R-4790-2016; Putter, Hein/C-2244-2018; Tobi, Elmar W/C-1834-2014	Slagboom, P. Eline/0000-0002-2875-4723; Putter, Hein/0000-0001-5395-1422; Tobi, Elmar W/0000-0002-1378-3687; van Dongen, Jenny/0000-0003-2063-8741; Stein, Aryeh/0000-0003-1138-6458	European Union [FP6 036894]; European Union's Seventh Framework Program IDEAL [259679]; Netherlands Consortium for Healthy Ageing [05060810]; United States National Institutes of Health [R01-HL067914]	European Union(European Commission); European Union's Seventh Framework Program IDEAL; Netherlands Consortium for Healthy Ageing; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a grant from the European Union-funded Network of Excellence LifeSpan [FP6 036894], the European Union's Seventh Framework Program IDEAL [FP7/2007-2011] under grant agreement no 259679, the Netherlands Consortium for Healthy Ageing [Grant 05060810] in the framework of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research and the United States National Institutes of Health ([R01-HL067914 to LHL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2008, INT J OBESITY, V32, P372, DOI 10.1038/sj.ijo.0803700; Adkins RM, 2007, PEDIATR RES, V62, P451, DOI 10.1203/PDR.0b013e3181425841; Adkins RM, 2010, PEDIATR RES, V68, P429, DOI 10.1203/PDR.0b013e3181f1ca99; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bennett A, 2005, DIABETOLOGIA, V48, P886, DOI 10.1007/s00125-005-1737-z; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Bouchard L, 2010, DIABETES CARE, V33, P2436, DOI 10.2337/dc10-1024; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Burger G., 1948, MALNUTRITION STARVAT; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Coolen MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025590; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cui HM, 2002, CANCER RES, V62, P6442; D'Aleo V, 2011, NUTR METAB CARDIOVAS, V21, pE9, DOI 10.1016/j.numecd.2010.10.005; Davey Smith G, 2009, ADV EXP MED BIOL, V646, P1, DOI 10.1007/978-1-4020-9173-5_1; Dejeux E, 2009, ENDOCR-RELAT CANCER, V16, P939, DOI 10.1677/ERC-08-0331; Du MJ, 2003, HUM MOL GENET, V12, P1927, DOI 10.1093/hmg/ddg194; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ferguson LA, 2009, FEBS LETT, V583, P3181, DOI 10.1016/j.febslet.2009.08.041; Gaunt TR, 2001, HUM MOL GENET, V10, P1491, DOI 10.1093/hmg/10.14.1491; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Heijmans BT, 2012, INT J EPIDEMIOL, V41, P74, DOI 10.1093/ije/dyr225; Heijmans BT, 2009, EPIGENETICS-US, V4, P526, DOI 10.4161/epi.4.8.10265; Heude B, 2007, J CLIN ENDOCR METAB, V92, P2734, DOI 10.1210/jc.2006-1948; Heude B, 2006, J CLIN ENDOCR METAB, V91, P2770, DOI 10.1210/jc.2005-2055; Hoyo C, 2012, CANCER CAUSE CONTROL, V23, P635, DOI 10.1007/s10552-012-9932-y; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Le Stunff C, 2000, NAT GENET, V26, P444, DOI 10.1038/82579; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; Lumey LH, 2012, INT J EPIDEMIOL, V41, P116, DOI 10.1093/ije/dyr137; Maas JAJBM, 2010, HORM RES PAEDIAT, V73, P120, DOI 10.1159/000277631; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore GE, 2001, DIABETES, V50, P199, DOI 10.2337/diabetes.50.1.199; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Nagaya K, 2009, PEDIATR RES, V66, P135, DOI 10.1203/PDR.0b013e3181a9e818; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; O'Dell SD, 1999, EUR J HUM GENET, V7, P821, DOI 10.1038/sj.ejhg.5200381; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Otte K, 1998, NUCLEIC ACIDS RES, V26, P1605, DOI 10.1093/nar/26.7.1605; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Petry CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-22; Petry CJ, 2009, HUM GENET, V126, P375, DOI 10.1007/s00439-009-0681-2; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Stoger R, 2008, BIOESSAYS, V30, P156, DOI 10.1002/bies.20700; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Talens RP, 2012, INT J EPIDEMIOL, V41, P106, DOI 10.1093/ije/dyr153; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382; Tobi EW, 2011, EPIGENETICS-US, V6, P171, DOI 10.4161/epi.6.2.13516; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Trienekens G., 2000, FOOD SCI POLICY REGU, P117; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Waterland RA, 2009, HUM MOL GENET, V18, P3026, DOI 10.1093/hmg/ddp241; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	78	102	104	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37933	10.1371/journal.pone.0037933	http://dx.doi.org/10.1371/journal.pone.0037933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666415	gold, Green Submitted, Green Published			2022-12-27	WOS:000305353400058
J	Bennett, A; Smith, SJ; Yambasu, S; Jambai, A; Alemu, W; Kabano, A; Eisele, TP				Bennett, Adam; Smith, Samuel Juana; Yambasu, Sahr; Jambai, Amara; Alemu, Wondimagegnehu; Kabano, Augustin; Eisele, Thomas P.			Household Possession and Use of Insecticide-Treated Mosquito Nets in Sierra Leone 6 Months after a National Mass-Distribution Campaign	PLOS ONE			English	Article							BED NETS; INTEGRATED CAMPAIGN; PREGNANT-WOMEN; TARGET GROUPS; SCALE-UP; COVERAGE; OWNERSHIP; CHILDREN; TANZANIA; IMPLEMENTATION	Background: In November 2010, Sierra Leone distributed over three million long-lasting insecticide-treated nets (LLINs) with the objective of providing protection from malaria to individuals in all households in the country. Methods: We conducted a nationally representative survey six months after the mass distribution campaign to evaluate its impact on household insecticide-treated net (ITN) ownership and use. We examined factors associated with household ITN possession and use with logistic regression models. Results: The survey included 4,620 households with equal representation in each of the 14 districts. Six months after the campaign, 87.6% of households own at least one ITN, which represents an increase of 137% over the most recent estimate of 37% in 2008. Thirty-six percent of households possess at least one ITN per two household members; rural households were more likely than urban households to have >= 1:2 ITN to household members, but there was no difference by socioeconomic status or household head education. Among individuals in households possessing >= 1 ITN, 76.5% slept under an ITN the night preceding the survey. Individuals in households where the household head had heard malaria messaging, had correct knowledge of malaria transmission, and where at least one ITN was hanging, were more likely to have slept under an ITN. Conclusions: The mass distribution campaign was effective at achieving high coverage levels across the population, notably so among rural households where the malaria burden is higher. These important gains in equitable access to malaria prevention will need to be maintained to produce long-term reductions in the malaria burden.	[Bennett, Adam; Eisele, Thomas P.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA; [Smith, Samuel Juana] Minist Hlth & Sanitat, Natl Malaria Control Programme, Freetown, Sierra Leone; [Yambasu, Sahr] Stat Sierra Leone, Freetown, Sierra Leone; [Jambai, Amara] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Alemu, Wondimagegnehu] World Hlth Org, Freetown, Sierra Leone; [Kabano, Augustin] UNICEF, Freetown, Sierra Leone	Tulane University; Ministry of Health & Sanitation Sierra Leone; Ministry of Health & Sanitation Sierra Leone; World Health Organization	Bennett, A (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA.	abennett@tulane.edu	Eisele, Thom/AAE-8958-2020		UNICEF	UNICEF	This study was funded by UNICEF (http://www.unicef.org/). UNICEF supported study design, data collection and analysis, approved the decision to publish, and assisted in preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; Bernard J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-65; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Eisele TP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001019; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Eng JLV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-133; ESRI, 2009, ARCGIS DESKT 9 3 1; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Goesch JN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-60; Grabowsky M, 2005, TROP MED INT HEALTH, V10, P1151, DOI 10.1111/j.1365-3156.2005.01502.x; Hanson K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2434; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hightower A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-183; . ICF Macro Statistics Sierra Leone, 2009, SIERR LEON DEM HLTH; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kulkarni MA, 2010, AM J TROP MED HYG, V82, P420, DOI 10.4269/ajtmh.2010.09-0597; Larsen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013129; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Macintyre K, 2011, HLTH POLICY PLAN; Ministry of Health and Sanitation Republic of Sierra Leone, 2004, SIT AN MAL 2004; RBM, 2011, GLOB MAL ACT PLAN; Rutstein S. O., 2004, DHS WEALTH INDEX; SAS, 2004, SAS 9 1 3; StataCorp LP, 2007, STAT 10 0; Statistics Sierra Leone, 2004, 2004 SIERR LEON POP; Steketee RW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008409; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Thwing JI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-86; Wolkon A, 2010, AM J TROP MED HYG, V83, P1014, DOI 10.4269/ajtmh.2010.09-0599	30	66	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37927	10.1371/journal.pone.0037927	http://dx.doi.org/10.1371/journal.pone.0037927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666414	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600043
J	Catala-Lopez, F; Alonso-Arroyo, A; Aleixandre-Benavent, R; Ridao, M; Bolanos, M; Garcia-Altes, A; Sanfelix-Gimeno, G; Peiro, S				Catala-Lopez, Ferran; Alonso-Arroyo, Adolfo; Aleixandre-Benavent, Rafael; Ridao, Manuel; Bolanos, Maxima; Garcia-Altes, Anna; Sanfelix-Gimeno, Gabriel; Peiro, Salvador			Coauthorship and Institutional Collaborations on Cost-Effectiveness Analyses: A Systematic Network Analysis	PLOS ONE			English	Article							HEALTH-CARE INTERVENTIONS; ECONOMIC EVALUATIONS; PUBLIC-HEALTH; OF-INTEREST; DRUG; ONCOLOGY; INDUSTRY; AUSTRALIA; PATTERNS; MEDICINE	Background: Cost-Effectiveness Analysis (CEA) has been promoted as an important research methodology for determining the efficiency of healthcare technology and guiding medical decision-making. Our aim was to characterize the collaborative patterns of CEA conducted over the past two decades in Spain. Methods and Findings: A systematic analysis was carried out with the information obtained through an updated comprehensive literature review and from reports of health technology assessment agencies. We identified CEAs with outcomes expressed as a time-based summary measure of population health (e.g. quality-adjusted life-years or disability-adjusted life-years), conducted in Spain and published between 1989 and 2011. Networks of coauthorship and institutional collaboration were produced using PAJEK software. One-hundred and thirty-one papers were analyzed, in which 526 authors and 230 institutions participated. The overall signatures per paper index was 5.4. Six major groups (one with 14 members, three with 7 members and two with 6 members) were identified. The most prolific authors were generally affiliated with the private-for-profit sector (e.g. consulting firms and the pharmaceutical industry). The private-for-profit sector mantains profuse collaborative networks including public hospitals and academia. Collaboration within the public sector (e.g. healthcare administration and primary care) was weak and fragmented. Conclusions: This empirical analysis reflects critical practices among collaborative networks that contributed substantially to the production of CEA, raises challenges for redesigning future policies and provides a framework for similar analyses in other regions.	[Catala-Lopez, Ferran; Ridao, Manuel; Sanfelix-Gimeno, Gabriel; Peiro, Salvador] CSISP, Valencia, Spain; [Catala-Lopez, Ferran; Garcia-Altes, Anna; Peiro, Salvador] Fdn Inst Invest Serv Salud, Valencia, Spain; [Catala-Lopez, Ferran] Spanish Med & Healthcare Prod Agcy AEMPS, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain; [Alonso-Arroyo, Adolfo; Aleixandre-Benavent, Rafael; Bolanos, Maxima] Univ Valencia CSIC, Unidad Informac & Invest Social & Sanitaria UISYS, Valencia, Spain; [Alonso-Arroyo, Adolfo] Univ Valencia, Fac Med & Odontol, Dept Hist Ciencia & Documentac, Valencia, Spain; [Ridao, Manuel] Inst Aragones Ciencias Salud I CS, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia	Catala-Lopez, F (corresponding author), CSISP, Valencia, Spain.	ferran_catala@hotmail.com	Bolaños-Pizarro, Máxima/F-9269-2013; Alonso-Arroyo, Adolfo/K-8182-2013; Peiro, Salvador/H-5778-2017; Catalá-López, Ferrán/N-6018-2018; Aleixandre-Benavent, Rafael/G-1011-2015; Bolaños-Pizarro, Máxima/AAD-2131-2022; Bolaños-Pizarro, Máxima/AAH-3223-2021; Sanfélix-Gimeno, Gabriel/E-9140-2012	Bolaños-Pizarro, Máxima/0000-0003-1680-0080; Alonso-Arroyo, Adolfo/0000-0002-5084-2818; Peiro, Salvador/0000-0002-3902-569X; Catalá-López, Ferrán/0000-0002-3833-9312; Aleixandre-Benavent, Rafael/0000-0002-6678-8844; Bolaños-Pizarro, Máxima/0000-0003-1680-0080; Sanfélix-Gimeno, Gabriel/0000-0001-7098-4576; Ridao Lopez, Manuel/0000-0001-7837-5759				Antonanzas F, 2007, EUR J HEALTH ECON, V8, P297, DOI 10.1007/s10198-007-0050-9; Baker CB, 2003, BRIT J PSYCHIAT, V183, P498, DOI 10.1192/bjp.183.6.498; Bales ME, 2011, AM J PREV MED, V41, P112, DOI 10.1016/j.amepre.2011.03.018; Batagelj V, 2010, PAJEK 1 28 PROGRAM L; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Blanchet K, 2011, HLTH POLICY PLAN; Bosch X, 2011, EMBO REP, V12, P489, DOI 10.1038/embor.2011.87; Catala-Lopez F, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-75; Catala-Lopez F, 2010, REV ESP SALUD PUBLIC, V84, P353, DOI [10.1590/S1135-57272010000400002, 10.1590/s1135-57272010000400002]; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Garattini L, 2010, INT J TECHNOL ASSESS, V26, P330, DOI 10.1017/S0266462310000322; Gold MR, 1996, COST EFFECTIVENESS H; Gonzalez-Alcaide G, 2008, FERTIL STERIL, V90, P941, DOI 10.1016/j.fertnstert.2007.07.1378; Gotzsche PC, 2009, PLOS MED, V6, P122, DOI 10.1371/journal.pmed.1000023; Greenberg D, 2010, MED DECIS MAKING, V30, P320, DOI 10.1177/0272989X09360066; Hartmann M, 2003, BRIT J CANCER, V89, P1405, DOI 10.1038/sj.bjc.6601308; Hartmann Michael, 2003, J Intensive Care Med, V18, P265, DOI 10.1177/0885066603255683; Howes F, 2004, J PUBLIC HEALTH-UK, V26, P101, DOI 10.1093/pubmed/fdh119; Hyder AA, 2011, HEALTH POLICY PLANN, V26, P73, DOI 10.1093/heapol/czq020; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jang S, 2010, BREAST CANCER RES TR, V121, P273, DOI 10.1007/s10549-010-0870-7; Knox KS, 2000, ANN ONCOL, V11, P1591, DOI 10.1023/A:1008309817708; Laupacis A, 2006, PHARMACOECONOMICS, V24, P1157, DOI 10.2165/00019053-200624110-00011; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Mar J, 2005, CEREBROVASC DIS, V20, P193, DOI 10.1159/000087204; Mar J, 2003, EUR RESPIR J, V21, P515, DOI 10.1183/09031936.03.00040903; Mar J, 2001, J HYPERTENS, V19, P149, DOI 10.1097/00004872-200101000-00020; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Moffatt B, 2007, PERSPECT BIOL MED, V50, P18, DOI 10.1353/pbm.2007.0009; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; Peiró S., 2003, Gac Sanit, V17, P342, DOI 10.1157/13051035; Peiro S, 2011, REFUNDACION ATENCION; Peura PK, 2011, MED DECIS MAKIN 0413; Raftery JP, 2008, MED J AUSTRALIA, V188, P26, DOI 10.5694/j.1326-5377.2008.tb01500.x; Reinhardt UE, 1997, SOC SCI MED, V45, P555, DOI 10.1016/S0277-9536(96)00396-6; Rovira J, 2008, PHARMACOECONOMICS, V26, P181, DOI 10.2165/00019053-200826030-00002; Sculpher M J, 2004, Health Technol Assess, V8, piii; Sculpher MJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Spanish Ministry of Health Social Policy and Equality, 2009, QUAL PLAN NAT HLTH S; Valderrama-Zurian JC, 2007, REV ESP CARDIOL, V60, P117, DOI 10.1157/13099458	44	25	27	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38012	10.1371/journal.pone.0038012	http://dx.doi.org/10.1371/journal.pone.0038012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22666435	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600053
J	Lee, S; Jung, KJ; Jung, HS; Chang, S				Lee, Suho; Jung, Kyung Jin; Jung, Hyun Suk; Chang, Sunghoe			Dynamics of Multiple Trafficking Behaviors of Individual Synaptic Vesicles Revealed by Quantum-Dot Based Presynaptic Probe	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FROG NEUROMUSCULAR JUNCTION; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; LATERAL DIFFUSION; LIVING CELLS; RECEPTORS; TRACKING; PLASTICITY; MEMBRANE	Although quantum dots (QDs) have provided invaluable information regarding the diffusive behaviors of postsynaptic receptors, their application in presynaptic terminals has been rather limited. In addition, the diffraction-limited nature of the presynaptic bouton has hampered detailed analyses of the behaviors of synaptic vesicles (SVs) at synapses. Here, we created a quantum-dot based presynaptic probe and characterized the dynamic behaviors of individual SVs. As previously reported, the SVs exhibited multiple exchanges between neighboring boutons. Actin disruption induced a dramatic decrease in the diffusive behaviors of SVs at synapses while microtubule disruption only reduced extrasynaptic mobility. Glycine-induced synaptic potentiation produced significant increases in synaptic and inter-boutonal trafficking of SVs, which were NMDA receptor-and actin-dependent while NMDA-induced synaptic depression decreased the mobility of the SVs at synapses. Together, our results show that sPH-AP-QD revealed previously unobserved trafficking properties of SVs around synapses, and the dynamic modulation of SV mobility could regulate presynaptic efficacy during synaptic activity.	[Lee, Suho; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Dept Physiol & Biomed Sci, Seoul, South Korea; [Lee, Suho; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Med Res Ctr, Seoul, South Korea; [Chang, Sunghoe] Seoul Natl Univ, Coll Med, Biomembrane Plast Res Ctr, Seoul, South Korea; [Chang, Sunghoe] Seoul Natl Univ, Coll Med, Biomax Inst, Seoul, South Korea; [Lee, Suho] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju, South Korea; [Jung, Kyung Jin; Jung, Hyun Suk] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Korea Basic Science Institute (KBSI)	Lee, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Physiol & Biomed Sci, Seoul, South Korea.	sunghoe@snu.ac.kr	Chang, Sunghoe/J-2784-2012	chang, sunghoe/0000-0002-3446-7288	Korea Science and Engineering Foundation [R01-2006-000-10818-0]; National Research Foundation of Korea [SRC. 20100029395]; BRC of the 21st Century Frontier Research Program [M103KV010009-06K2201-00910]; MEST, Republic of Korea	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); National Research Foundation of Korea(National Research Foundation of Korea); BRC of the 21st Century Frontier Research Program; MEST, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Korea Science and Engineering Foundation (R01-2006-000-10818-0), from the National Research Foundation of Korea (SRC. 20100029395), the BRC of the 21st Century Frontier Research Program (M103KV010009-06K2201-00910) to S.C. funded by the MEST, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Bayazitov IT, 2007, J NEUROSCI, V27, P11510, DOI 10.1523/JNEUROSCI.3077-07.2007; Bender VA, 2009, J NEUROSCI, V29, P10974, DOI 10.1523/JNEUROSCI.2123-09.2009; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Empedocles SA, 1996, PHYS REV LETT, V77, P3873, DOI 10.1103/PhysRevLett.77.3873; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Johnstone VPA, 2011, LEARN MEMORY, V18, P625, DOI 10.1101/lm.2245911; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lemke EA, 2005, J NEUROSCI, V25, P11034, DOI 10.1523/JNEUROSCI.2971-05.2005; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; MCGUINNESS TL, 1989, J NEUROSCI, V9, P4138; Park H, 2012, SCIENCE, V335, P1362, DOI 10.1126/science.1216937; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; Ratnayaka A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1534; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Staras K, 2010, NEURON, V66, P37, DOI 10.1016/j.neuron.2010.03.020; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tsuriel S, 2009, J NEUROSCI, V29, P351, DOI 10.1523/JNEUROSCI.4777-08.2009; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Yeung C, 2007, BIOPHYS J, V92, P2271, DOI 10.1529/biophysj.106.081794; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	35	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38045	10.1371/journal.pone.0038045	http://dx.doi.org/10.1371/journal.pone.0038045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666444	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349600059
J	Han, YS; Yambot, AV; Zhang, H; Hung, CL				Han, Yu-San; Yambot, Apolinario V.; Zhang, Heng; Hung, Chia-Ling			Sympatric Spawning but Allopatric Distribution of Anguilla japonica and Anguilla marmorata: Temperature- and Oceanic Current-Dependent Sieving	PLOS ONE			English	Article							TROPICAL EELS ANGUILLA; FRESH-WATER EELS; EARLY-LIFE-HISTORY; GIANT MOTTLED EEL; GLASS-EELS; JAPANESE EEL; WESTERN PACIFIC; SEASONAL OCCURRENCE; INSHORE MIGRATION; EUROPEAN EEL	Anguilla japonica and Anguilla marmorata share overlapping spawning sites, similar drifting routes, and comparable larval durations. However, they exhibit allopatric geographical distributions in East Asia. To clarify this ecological discrepancy, glass eels from estuaries in Taiwan, the Philippines, Indonesia, and China were collected monthly, and the survival rate of A. marmorata under varying water salinities and temperatures was examined. The composition ratio of these 2 eel species showed a significant latitude cline, matching the 24 degrees C sea surface temperature isotherm in winter. Both species had opposing temperature preferences for recruitment. A. marmorata prefer high water temperatures and die at low water temperatures. In contrast, A. japonica can endure low water temperatures, but their recruitment is inhibited by high water temperatures. Thus, A. japonica glass eels, which mainly spawn in summer, are preferably recruited to Taiwan, China, Korea, and Japan by the Kuroshio and its branch waters in winter. Meanwhile, A. marmorata glass eels, which spawn throughout the year, are mostly screened out in East Asia in areas with low-temperature coastal waters in winter. During summer, the strong northward currents from the South China Sea and Changjiang River discharge markedly block the Kuroshio invasion and thus restrict the approach of A. marmorata glass eels to the coasts of China and Korea. The differences in the preferences of the recruitment temperature for glass eels combined with the availability of oceanic currents shape the real geographic distribution of Anguilla japonica and Anguilla marmorata, making them "temperate" and "tropical" eels, respectively.	[Han, Yu-San; Hung, Chia-Ling] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei 10764, Taiwan; [Yambot, Apolinario V.] Cent Luzon State Univ, Coll Fisheries, Freshwater Aquaculture Ctr, Sci City Munoz, Philippines; [Zhang, Heng] Chinese Acad Fishery Sci, E China Sea Fisheries Res Inst, Shanghai, Peoples R China	National Taiwan University; Central Luzon State University; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Han, YS (corresponding author), Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei 10764, Taiwan.	yshan@ntu.edu.tw		HAN, YU-SAN/0000-0002-9236-9045	National Science Council (NSC) of the Executive Yuan, Taiwan [NSC 99-2923-B-002-005-MY3, NSC 99-2313-B-002-021-MY3]; Council of Agriculture of the Executive Yuan, Taiwan [98 AS-10.3.1-F2-5, 99 AS-9.1-F-01-15-2]	National Science Council (NSC) of the Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); Council of Agriculture of the Executive Yuan, Taiwan	This study was funded by the National Science Council (NSC) of the Executive Yuan, Taiwan (NSC 99-2923-B-002-005-MY3 and NSC 99-2313-B-002-021-MY3), and by the Council of Agriculture of the Executive Yuan, Taiwan (98 AS-10.3.1-F2-5 and 99 AS-9.1-F-01-15-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Jun, 2009, Aqua-Bioscience Monographs, V2, P1; Arai T, 2002, FISHERIES SCI, V68, P152, DOI 10.1046/j.1444-2906.2002.00401.x; Arai T, 2001, MAR BIOL, V138, P887; Arai T, 2001, MAR ECOL PROG SER, V216, P253, DOI 10.3354/meps216253; August SM, 2008, ENVIRON BIOL FISH, V81, P195, DOI 10.1007/s10641-007-9191-z; BEUMER J, 1990, INT REV GES HYDROBIO, V75, P721, DOI 10.1002/iroh.19900750606; Beumer JP, 1996, FRESHWATER FISHES SE; Bruton NM, 1987, AM FISH SOC S, V1, P104; Chen CTA, 2008, J OCEANOGR, V64, P737, DOI 10.1007/s10872-008-0062-9; Chen CTA, 2009, J MARINE SYST, V78, P394, DOI 10.1016/j.jmarsys.2008.11.016; Cheng PW, 1996, MAR ECOL PROG SER, V131, P87, DOI 10.3354/meps131087; Chow S, 2009, FISHERIES SCI, V75, P257, DOI 10.1007/s12562-008-0017-5; Dannewitz J, 2005, P ROY SOC B-BIOL SCI, V272, P1129, DOI 10.1098/rspb.2005.3064; Dou S, 2003, J FISH BIOL, V63, P152, DOI 10.1111/j.1095-8649.2003.00211.x; Ege V., 1939, DANA REP, V16, P1, DOI DOI 10.1007/S11160-005-7431-X; Fukuda N, 2009, J FISH BIOL, V74, P1915, DOI 10.1111/j.1095-8649.2009.02287.x; GUAN B.X., 1994, OCEANOLOGY CHINA SEA, V1, P17, DOI DOI 10.1007/978-94-011-0862-1_3; Han YS, 2002, J FISH BIOL, V60, P1608, DOI 10.1006/jfbi.2002.2022; Han YS, 2012, FISH OCEANO IN PRESS; Han YS, 2012, EELS PHYSL IN PRESS; Han YS, 2011, MAR BIOL, V158, P2349, DOI 10.1007/s00227-011-1739-y; Han YS, 2010, MAR ECOL PROG SER, V401, P221, DOI 10.3354/meps08422; Hsueh Y, 1996, J GEOPHYS RES-OCEANS, V101, P3851, DOI 10.1029/95JC03754; Hsueh Y, 2000, J MARINE SYST, V24, P131, DOI 10.1016/S0924-7963(99)00083-4; Ishikawa S, 2004, ICHTHYOL RES, V51, P343, DOI 10.1007/s10228-004-0241-7; Jan S, 2002, J MARINE SYST, V35, P249, DOI 10.1016/S0924-7963(02)00130-6; Jubb R. A., 1964, Monographiae Biologicae, V14, P186; Kim WS, 2002, MAR ECOL PROG SER, V243, P209, DOI 10.3354/meps243209; KIMURA S, 1994, MAR BIOL, V119, P185, DOI 10.1007/BF00349555; Kuroki M, 2006, MAR ECOL PROG SER, V309, P233, DOI 10.3354/meps309233; Kuroki M, 2009, J FISH BIOL, V74, P1853, DOI 10.1111/j.1095-8649.2009.02299.x; Kuroki M, 2008, MAR FRESHWATER RES, V59, P1035, DOI 10.1071/MF08041; Matsui I., 1952, Journal of the Shimonoseki College of Fisheries, VNo.2, P1; Minegishi Y, 2008, MOL ECOL, V17, P3109, DOI 10.1111/j.1365-294X.2008.03822.x; Pous S, 2010, PROG OCEANOGR, V86, P396, DOI 10.1016/j.pocean.2010.06.002; Robinet T, 2008, MAR BIOL, V154, P453, DOI 10.1007/s00227-008-0938-7; Robinet T, 2003, MAR ECOL PROG SER, V259, P263, DOI 10.3354/meps259263; Schmidt J., 1925, Annual Report Smithsonian Institution, V1924, P279; Shiao JC, 2002, MAR FRESHWATER RES, V53, P687, DOI 10.1071/MF01037; Sinclair M, 1988, MARINE POPULATIONS E; SU JL, 1990, OCEANOGR MAR BIOL, V28, P11; Sugeha HY, 2001, MAR ECOL PROG SER, V221, P233, DOI 10.3354/meps221233; TABETA O, 1976, B JPN SOC SCI FISH, V42, P421; Teng HY, 2009, ZOOL STUD, V48, P808; Tesch FW, 2003, EEL, P100; Tsukamoto K, 2001, MAR ECOL PROG SER, V220, P265, DOI 10.3354/meps220265; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; Tsukamoto K, 1998, NATURE, V396, P635, DOI 10.1038/25264; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 2009, MAR BIOL, V156, P835, DOI 10.1007/s00227-008-1123-8; Tzeng WN, 2002, MAR ECOL PROG SER, V245, P213, DOI 10.3354/meps245213; Wang CH, 2000, FISH RES, V46, P191, DOI 10.1016/S0165-7836(00)00146-6; Watanabe S, 2008, COPEIA, P680, DOI 10.1643/CG-07-080; Watanabe S, 2009, FISHERIES SCI, V75, P387, DOI 10.1007/s12562-009-0087-z; Xiong Guo-Qiang, 1992, Acta Zoologica Sinica, V38, P254; Yamamoto T, 2001, FISHERIES SCI, V67, P530, DOI 10.1046/j.1444-2906.2001.00285.x; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x	57	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e37484	10.1371/journal.pone.0037484	http://dx.doi.org/10.1371/journal.pone.0037484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675481	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341700014
J	Kraiselburd, I; Alet, AI; Tondo, ML; Petrocelli, S; Daurelio, LD; Monzon, J; Ruiz, OA; Losi, A; Orellano, EG				Kraiselburd, Ivana; Alet, Analia I.; Laura Tondo, Maria; Petrocelli, Silvana; Daurelio, Lucas D.; Monzon, Jesica; Ruiz, Oscar A.; Losi, Aba; Orellano, Elena G.			A LOV Protein Modulates the Physiological Attributes of Xanthomonas axonopodis pv. citri Relevant for Host Plant Colonization	PLOS ONE			English	Article							BLUE-LIGHT RECEPTOR; PHOTOTROPIN-RELATED PROTEIN; BIOFILM FORMATION; SIGNALING MECHANISM; TWITCHING MOTILITY; BACILLUS-SUBTILIS; DOMAIN; CAMPESTRIS; BACTERIA; BINDING	Recent studies have demonstrated that an appropriate light environment is required for the establishment of efficient vegetal resistance responses in several plant-pathogen interactions. The photoreceptors implicated in such responses are mainly those belonging to the phytochrome family. Data obtained from bacterial genome sequences revealed the presence of photosensory proteins of the BLUF (Blue Light sensing Using FAD), LOV (Light, Oxygen, Voltage) and phytochrome families with no known functions. Xanthomonas axonopodis pv. citri is a Gram-negative bacterium responsible for citrus canker. The in silico analysis of the X. axonopodis pv. citri genome sequence revealed the presence of a gene encoding a putative LOV photoreceptor, in addition to two genes encoding BLUF proteins. This suggests that blue light sensing could play a role in X. axonopodis pv. citri physiology. We obtained the recombinant Xac-LOV protein by expression in Escherichia coli and performed a spectroscopic analysis of the purified protein, which demonstrated that it has a canonical LOV photochemistry. We also constructed a mutant strain of X. axonopodis pv. citri lacking the LOV protein and found that the loss of this protein altered bacterial motility, exopolysaccharide production and biofilm formation. Moreover, we observed that the adhesion of the mutant strain to abiotic and biotic surfaces was significantly diminished compared to the wild-type. Finally, inoculation of orange (Citrus sinensis) leaves with the mutant strain of X. axonopodis pv. citri resulted in marked differences in the development of symptoms in plant tissues relative to the wild-type, suggesting a role for the Xac-LOV protein in the pathogenic process. Altogether, these results suggest the novel involvement of a photosensory system in the regulation of physiological attributes of a phytopathogenic bacterium. A functional blue light receptor in Xanthomonas spp. has been described for the first time, showing an important role in virulence during citrus canker disease.	[Kraiselburd, Ivana; Alet, Analia I.; Laura Tondo, Maria; Petrocelli, Silvana; Daurelio, Lucas D.; Monzon, Jesica; Orellano, Elena G.] Univ Nacl Rosario, Div Mol Biol, Inst Biol Mol & Celular Rosario IBR, CONICET,Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Argentina; [Ruiz, Oscar A.] IIB INTECH, Unidad Biotecnol, Buenos Aires, DF, Argentina; [Losi, Aba] Univ Parma, Dept Phys, I-43100 Parma, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Parma	Kraiselburd, I (corresponding author), Univ Nacl Rosario, Div Mol Biol, Inst Biol Mol & Celular Rosario IBR, CONICET,Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Argentina.	orellano@ibr.gov.ar	Losi, Aba/M-8709-2015; Daurelio, Lucas/AAT-6969-2020; Kraiselburd, Ivana/AAI-8743-2020	Losi, Aba/0000-0003-0497-2723; Kraiselburd, Ivana/0000-0002-9677-6094; Tondo, Maria Laura/0000-0002-0160-1882; Daurelio, Lucas Damian/0000-0002-1156-2266	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-1762]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 112-2009-01-00873]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants PICT 2010-1762, Agencia Nacional de Promocion Cientifica y Tecnologica to EGO; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina (www.agencia.mincyt.gov.ar); and PIP 112-2009-01-00873 to EGO from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina. EGO, LDD, and OAR are staff members and IK, AA, MLT, and SP are Fellows of the CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Bechtold U, 2005, PLANT CELL ENVIRON, V28, P1046, DOI 10.1111/j.1365-3040.2005.01340.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Cao Z, 2008, BIOPHYS J, V94, P897, DOI 10.1529/biophysj.107.108977; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Daurelio Lucas D., 2009, P187; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Griebel T, 2008, PLANT PHYSIOL, V147, P790, DOI 10.1104/pp.108.119503; GUO A, 1993, PHYSIOL MOL PLANT P, V42, P413, DOI 10.1006/pmpp.1993.1031; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hellingwerf KJ, 1996, MOL MICROBIOL, V21, P683, DOI 10.1046/j.1365-2958.1996.411402.x; Hendrischk AK, 2009, PHOTOCHEM PHOTOBIOL, V85, P1254, DOI 10.1111/j.1751-1097.2009.00554.x; Herrou J, 2011, NAT REV MICROBIOL, V9, P713, DOI 10.1038/nrmicro2622; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Idnurm A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000470; Kanazawa T, 2010, BIOCHEMISTRY-US, V49, P10647, DOI 10.1021/bi101448t; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krauss U, 2005, PHYS CHEM CHEM PHYS, V7, P2804, DOI 10.1039/b504554a; Tondo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010803; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; Li JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021804; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; Losi A, 2004, PHOTOCHEM PHOTOBIOL, V80, P150, DOI 10.1562/2004-03-17-RC-116.1; Losi A, 2004, PHOTOCH PHOTOBIO SCI, V3, P566, DOI 10.1039/b400728j; Losi A, 2004, BIOPHYS J, V86, P1051, DOI 10.1016/S0006-3495(04)74180-6; Losi A, 2003, PHOTOCH PHOTOBIO SCI, V2, P759, DOI 10.1039/b301782f; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Losi A, 2011, PHOTOCHEM PHOTOBIOL, V87, P491, DOI 10.1111/j.1751-1097.2011.00913.x; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Malamud F, 2011, MICROBIOL-SGM, V157, P819, DOI 10.1099/mic.0.044255-0; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oberpichler I, 2008, ENVIRON MICROBIOL, V10, P2020, DOI 10.1111/j.1462-2920.2008.01618.x; Ondrusch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016151; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; Purcell EB, 2008, ADV EXP MED BIOL, V631, P122, DOI 10.1007/978-0-387-78885-2_8; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Qian W, 2008, MOL PLANT MICROBE IN, V21, P151, DOI 10.1094/MPMI-21-2-0151; Raffelberg S, 2011, J AM CHEM SOC, V133, P5346, DOI 10.1021/ja1097379; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Romling U, 1998, J BACTERIOL, V180, P722; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Song SH, 2011, BIOCHEMISTRY-US, V50, P2411, DOI 10.1021/bi200198x; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; van der Horst MA, 2007, TRENDS MICROBIOL, V15, P554, DOI 10.1016/j.tim.2007.09.009; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Wengelnik K, 1996, J BACTERIOL, V178, P1061, DOI 10.1128/jb.178.4.1061-1069.1996; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	86	48	52	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2012	7	6							e38226	10.1371/journal.pone.0038226	http://dx.doi.org/10.1371/journal.pone.0038226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UU	22675525	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341700047
J	Domingues, N; Matos, AR; da Silva, JM; Cartaxana, P				Domingues, Nuno; Matos, Ana Rita; da Silva, Jorge Marques; Cartaxana, Paulo			Response of the Diatom Phaeodactylum tricornutum to Photooxidative Stress Resulting from High Light Exposure	PLOS ONE			English	Article							PHOTOSYSTEM-II; DIADINOXANTHIN CYCLE; PLANKTONIC DIATOMS; ENERGY-DISSIPATION; PROTEIN; PHOTOPROTECTION; PHYTOPLANKTON; PHOTOINHIBITION; FLUORESCENCE; PHOTOSYNTHESIS	The response of microalgae to photooxidative stress resulting from high light exposure is a well-studied phenomenon. However, direct analyses of photosystem II (PSII) D1 protein (the main target of photoinhibition) in diatoms are scarce. In this study, the response of the diatom model species Phaeodactylum tricornutum to short-term exposure to high light was examined and the levels of D1 protein determined immunochemically. Low light (LL) acclimated cells (40 mu mol photons m(-2) s(-1)) subjected to high light (HL, 1,250 mmol photons m(-2) s(-1)) showed rapid induction of non-photochemical quenching (NPQ) and ca. 20-fold increase in diatoxanthin (DT) concentration. This resulted from the conversion of diadinoxanthin (DD) to DT through the activation of the DD-cycle. D1 protein levels under LL decreased about 30% after 1 h of the addition of lincomycin (LINC), a chloroplast protein synthesis inhibitor, showing significant D1 degradation and repair under low irradiance. Exposure to HL lead to a 3.2-fold increase in D1 degradation rate, whereas average D1 repair rate was 1.3-x higher under HL than LL, leading to decreased levels of D1 protein under HL. There were significant effects of both HL and LINC on P. tricornutum maximum quantum yield of PSII (F-v/F-m), showing a reduction of active PSII reaction centres. Partial recovery of F-v/F-m in the dark demonstrates the photosynthetic resilience of this diatom to changes in the light regime. P. tricornutum showed high allocation of total protein to D1 and an active D1-repair cycle to limit photoinhibition.	[Domingues, Nuno; Matos, Ana Rita; da Silva, Jorge Marques] Univ Lisbon, Fac Ciencias, Ctr Biodiversidade Genom Integrat & Func, Lisbon, Portugal; [Domingues, Nuno; Cartaxana, Paulo] Univ Lisbon, Fac Ciencias, Ctr Oceanog, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Domingues, N (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biodiversidade Genom Integrat & Func, Lisbon, Portugal.	pcartaxana@fc.ul.pt	Domingues, Nuno/H-2482-2017; da Silva, Jorge M L Marques/A-4905-2012; Cartaxana, Paulo/A-2063-2012	Domingues, Nuno/0000-0002-0692-9270; da Silva, Jorge M L Marques/0000-0002-5583-2715; Cartaxana, Paulo/0000-0001-5088-843X; Matos, Ana Rita/0000-0002-3495-2195	project MigROS [PTDC/MAR/112473/2009]; Portuguese Foundation for Science and Technology (FCT)	project MigROS; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was supported by project MigROS (PTDC/MAR/112473/2009) funded by the Portuguese Foundation for Science and Technology (FCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Bouchard JN, 2005, J PHYCOL, V41, P273, DOI 10.1111/j.1529-8817.2005.04126.x; Cruz S, 2008, AQUAT BOT, V88, P256, DOI 10.1016/j.aquabot.2007.11.001; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Edelman M, 2008, PHOTOSYNTH RES, V98, P609, DOI 10.1007/s11120-008-9342-x; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; Grouneva I, 2009, BBA-BIOENERGETICS, V1787, P929, DOI 10.1016/j.bbabio.2009.02.004; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Jansen MAK, 1999, EUR J BIOCHEM, V260, P527, DOI 10.1046/j.1432-1327.1999.00196.x; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; KRAAY GW, 1992, J PHYCOL, V28, P708, DOI 10.1111/j.0022-3646.1992.00708.x; Kropuenske LR, 2009, LIMNOL OCEANOGR, V54, P1176, DOI 10.4319/lo.2009.54.4.1176; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lavaud J, 2002, PHOTOSYNTH RES, V74, P51, DOI 10.1023/A:1020890625141; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; MATTOO AK, 1984, P NATL ACAD SCI-BIOL, V81, P1380, DOI 10.1073/pnas.81.5.1380; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; OLAIZOLA M, 1994, PHOTOSYNTH RES, V41, P357, DOI 10.1007/BF00019413; Petrou K, 2010, LIMNOL OCEANOGR, V55, P1400, DOI 10.4319/lo.2010.55.3.1400; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Ruivo M, 2011, J PLANKTON RES, V33, P1012, DOI 10.1093/plankt/fbr019; TING CS, 1994, PLANT PHYSIOL, V106, P763, DOI 10.1104/pp.106.2.763; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772	29	52	53	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38162	10.1371/journal.pone.0038162	http://dx.doi.org/10.1371/journal.pone.0038162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	22675519	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339900016
J	Hill, S; Yang, AN; Bero, L				Hill, Suzanne; Yang, Annie; Bero, Lisa			Priority Medicines for Maternal and Child Health: A Global Survey of National Essential Medicines Lists	PLOS ONE			English	Article							COUNTRIES; AVAILABILITY	Background: In April 2011, the World Health Organization (WHO) published a list of "priority medicines" for maternal and child health based on 1) the global burden of disease and 2) evidence of efficacy and safety. The objective of this study was to examine the occurrence of these priority medicines on national essential medicines lists. Methods and Findings: All essential medicines lists published since 1999 were selected from the WHO website collection. The most-up-to date list for each country was then selected, resulting in 89 unique country lists. Each list was evaluated for inclusion of medicines (chemical entity, concentration, and dosage form) on the Priority Medicines List. There was global variation in the listing of the Priority Medicines. The most frequently listed medicine was paracetamol, on 94% (84/89) of lists. Sodium chloride, gentamicin and oral rehydration solution were on 93% (83/89) of lists. The least frequently listed medicine was the children's antimalarial rectal artesunate, on 8% of lists (7/89); artesunate injection was on 16% (14/89) of lists. Pediatric artemisinin combination therapy, as dispersible tablets or flexible oral solid dosage form, appeared on 36% (32/89) of lists. Procaine benzylpenicillin, for treatment of pediatric pneumonia and neonatal sepsis, was on 50% (45/89) of the lists. Zinc, for treatment of diarrhoea in children, was included on only 15% (13/89) of lists. For prevention and treatment of postpartum hemorrhage in women, oxytocin was more prevalent on the lists than misoprostol; they were included on 55 (62%) and 31 (35%) of lists, respectively. Cefixime, for treatment of uncomplicated anogenital gonococcal infection in woman was on 26% (23/89) of lists. Magnesium sulfate injection for treatment of severe pre-eclampsia and eclampsia was on 50% (45/89) of the lists. Conclusions: The findings suggest that countries need to urgently amend their lists to provide all priority medicines as part of the efforts to improve maternal and child health.	[Hill, Suzanne] World Hlth Org, Dept Essential Med & Pharmaceut Policies, Geneva, Switzerland; [Yang, Annie] Stanford Hosp & Clin, Stanford, CA USA; [Bero, Lisa] Univ Calif San Francisco, San Francisco, CA 94143 USA	World Health Organization; Stanford University; University of California System; University of California San Francisco	Hill, S (corresponding author), Australian Pharmaceut Benefits Advisory Comm, Dept Hlth & Aging, Canberra, ACT, Australia.	berol@pharmacy.ucsf.edu		Bero, Lisa/0000-0003-1893-6651	World Health Organization	World Health Organization(World Health Organization)	The study was partially funded by the World Health Organization. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Cham Mamady, 2009, Reprod Health, V6, P5, DOI 10.1186/1742-4755-6-5; Chen W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-211; Gitanjali B, 2011, J PHARMACOL PHARMACO, V2, P95, DOI 10.4103/0976-500X.81900; Hill S, 2011, B WHO; Hogerzeil HV, 2004, BRIT MED J, V329, P1169, DOI 10.1136/bmj.329.7475.1169; Hoppu K, 2011, ARCH DIS CHILD, V96, P764, DOI 10.1136/adc.2009.180000; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Oshikoya KA, 2010, ANN AFR MED, V9, P203, DOI 10.4103/1596-3519.70954; Ridge AL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-340; Robertson J, 2007, CLIN PHARMACOL THER, V82, P498, DOI 10.1038/sj.clpt.6100392; Robertson J, 2009, B WORLD HEALTH ORGAN, V87, P231, DOI 10.2471/BLT.08.053645; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2011, PRIOR MED MOTH CHILD; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2010, RAP ADV US ANT DRUGS; World Health Organization, 2010, DEF CONC ESS MED	17	29	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38055	10.1371/journal.pone.0038055	http://dx.doi.org/10.1371/journal.pone.0038055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22675435	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338500082
J	Weber, CM; Martindale, MQ; Tapscott, SJ; Unguez, GA				Weber, Christopher M.; Martindale, Mark Q.; Tapscott, Stephen J.; Unguez, Graciela A.			Activation of Pax7-Positive Cells in a Non-Contractile Tissue Contributes to Regeneration of Myogenic Tissues in the Electric Fish S. macrurus	PLOS ONE			English	Article							MUSCLE SATELLITE CELLS; SKELETAL-MUSCLE; SPINAL-CORD; STEM-CELLS; LIMB REGENERATION; URODELE LIMB; PAX7; EXPRESSION; DIFFERENTIATION; DEDIFFERENTIATION	The ability to regenerate tissues is shared across many metazoan taxa, yet the type and extent to which multiple cellular mechanisms come into play can differ across species. For example, urodele amphibians can completely regenerate all lost tissues, including skeletal muscles after limb amputation. This remarkable ability of urodeles to restore entire limbs has been largely linked to a dedifferentiation-dependent mechanism of regeneration. However, whether cell dedifferentiation is the fundamental factor that triggers a robust regeneration capacity, and whether the loss or inhibition of this process explains the limited regeneration potential in other vertebrates is not known. Here, we studied the cellular mechanisms underlying the repetitive regeneration of myogenic tissues in the electric fish S. macrurus. Our in vivo microinjection studies of high molecular weight cell lineage tracers into single identified adult myogenic cells (muscle or noncontractile muscle-derived electrocytes) revealed no fragmentation or cellularization proximal to the amputation plane. In contrast, ultrastructural and immunolabeling studies verified the presence of myogenic stem cells that express the satellite cell marker Pax7 in mature muscle fibers and electrocytes of S. macrurus. These data provide the first example of Pax-7 positive muscle stem cells localized within a non-contractile electrogenic tissue. Moreover, upon amputation, Pax-7 positive cells underwent a robust replication and were detected exclusively in regions that give rise to myogenic cells and dorsal spinal cord components revealing a regeneration process in S. macrurus that is dependent on the activation of myogenic stem cells for the renewal of both skeletal muscle and the muscle-derived electric organ. These data are consistent with the emergent concept in vertebrate regeneration that different tissues provide a distinct progenitor cell population to the regeneration blastema, and these progenitor cells subsequently restore the original tissue.	[Weber, Christopher M.; Unguez, Graciela A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Martindale, Mark Q.] Univ Hawaii, Kewalo Marine Lab, Honolulu, HI 96822 USA; [Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA	New Mexico State University; University of Hawaii System; Fred Hutchinson Cancer Center	Weber, CM (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98195 USA.	gunguez@nmsu.edu		Tapscott, Stephen/0000-0002-0319-0968; Weber, Christopher/0000-0002-4285-8131	National Institutes of Health [S06-GM008136, RR16480, U56-CA96286]; NATIONAL CANCER INSTITUTE [U56CA096286, U54CA132383] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM092297, S06GM008136, R25GM061222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by National Institutes of Health grants S06-GM008136 (GAU), RR16480 (GAU), and U56-CA96286 (GAU and SJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; ANDERSON MJ, 1981, CELL TISSUE RES, V219, P1; Archer E, 2008, DIFFERENTIAL POTENTI; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; BAILLETDERBIN C, 1978, BIOL CELLULAIRE, V33, P15; Bennett MVL., 1971, FISH PHYSIOL, P347, DOI DOI 10.1016/S1546-5098(08)60051-5; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonavaud S, 2001, NEUROMUSCULAR DISORD, V11, P747, DOI 10.1016/S0960-8966(01)00222-X; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Brockes JP, 1998, CELLULAR AND MOLECULAR BASIS OF REGENERATION: FROM INVERTEBRATES TO HUMANS, P63; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Brusca R.C., 1990, INVERTEBRATES; Carlson Bruce M., 2005, Anatomical Record Part B:The New Anatomist, V287, P4, DOI 10.1002/ar.b.20079; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen Y, 2006, DEVELOPMENT, V133, P2303, DOI 10.1242/dev.02397; Choi D, 2002, J NEUROSCI METH, V117, P167, DOI 10.1016/S0165-0270(02)00098-5; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cuellar H, 2006, FASEB J, V20, P2540, DOI 10.1096/fj.06-6474fje; Duckmanton A, 2005, CHEM BIOL, V12, P1117, DOI 10.1016/j.chembiol.2005.07.011; DUSTERHOFT S, 1993, DIFFERENTIATION, V53, P25, DOI 10.1111/j.1432-0436.1993.tb00642.x; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; FELDMAN JL, 1993, PROG CLIN BIOL RES, V383, P563; FELDMAN JL, 1991, DEV BIOL, V143, P320, DOI 10.1016/0012-1606(91)90083-F; Gabillard JC, 2010, CELL TISSUE RES, V342, P471, DOI 10.1007/s00441-010-1071-8; Gotensparre SM, 2006, GENE, V373, P8, DOI 10.1016/j.gene.2005.12.026; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Ishido M, 2009, ACTA PHYSIOL, V195, P459, DOI 10.1111/j.1748-1716.2008.01905.x; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; Kim JA, 2004, DEV GENES EVOL, V214, P380, DOI 10.1007/s00427-004-0421-5; Kim JA, 2008, J EXP BIOL, V211, P2172, DOI 10.1242/jeb.016592; Kirschbaum F., 1988, Monographs in Developmental Biology, V21, P112; KIRSCHBAUM F, 1981, J MORPHOL, V168, P121, DOI 10.1002/jmor.1051680202; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kumar A, 2000, DEV BIOL, V218, P125, DOI 10.1006/dbio.1999.9569; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; Meunier FJ, 1979, COMP ANATOMY AXIAL C; Morrison JI, 2010, FASEB J, V24, P750, DOI 10.1096/fj.09-134825; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; PATTERSON JM, 1993, J NEUROBIOL, V24, P660, DOI 10.1002/neu.480240510; Redshaw Z, 2010, CELL BIOCHEM FUNCT, V28, P403, DOI 10.1002/cbf.1670; Rosenblatt JD, 1996, DIFFERENTIATION, V60, P39, DOI 10.1046/j.1432-0436.1996.6010039.x; Schnapp E, 2005, DEV DYNAM, V232, P162, DOI 10.1002/dvdy.20203; Schultz E, 2006, DEV DYNAM, V235, P3230, DOI 10.1002/dvdy.20976; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seo HC, 1998, MECH DEVELOP, V70, P49, DOI 10.1016/S0925-4773(97)00175-5; Shadd V, 2009, CULTURE MYOGENIC CEL; Shimotori T, 2001, DEV GROWTH DIFFER, V43, P371; Sibthorpe D, 2006, COMP BIOCHEM PHYS B, V145, P371, DOI 10.1016/j.cbpb.2006.08.013; Singh NK, 2007, J ANIM SCI, V85, P1126, DOI 10.2527/jas.2006-524; Sirbulescu RF, 2009, J COMP PHYSIOL A, V195, P699, DOI 10.1007/s00359-009-0445-4; Steinbacher P, 2007, DEV DYNAM, V236, P1106, DOI 10.1002/dvdy.21103; Stocum DL, 2004, CURR TOP MICROBIOL, V280, P1; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tsonis PA, 2000, DEV BIOL, V221, P273, DOI 10.1006/dbio.2000.9667; Unguez GA, 1998, J COMP NEUROL, V399, P20; Unguez GA, 2002, J NEUROBIOL, V53, P391, DOI 10.1002/neu.10121; van Bekkum DW, 2004, BLOOD CELL MOL DIS, V32, P11, DOI 10.1016/j.bcmd.2003.09.009; Wada MR, 2002, DEVELOPMENT, V129, P2987; ZAKON HH, 1991, CIBA F SYMP, V160, P294; Zakon HH, 1999, J EXP BIOL, V202, P1427; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Ziman MR, 1997, INT J BIOCHEM CELL B, V29, P1029, DOI 10.1016/S1357-2725(97)00023-X	71	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e36819	10.1371/journal.pone.0036819	http://dx.doi.org/10.1371/journal.pone.0036819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22685526	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338500020
J	Azibani, F; Devaux, Y; Coutance, G; Schlossarek, S; Polidano, E; Fazal, L; Merval, R; Carrier, L; Solal, AC; Chatziantoniou, C; Launay, JM; Samuel, JL; Delcayre, C				Azibani, Feriel; Devaux, Yvan; Coutance, Guillaume; Schlossarek, Saskia; Polidano, Evelyne; Fazal, Loubina; Merval, Regine; Carrier, Lucie; Solal, Alain Cohen; Chatziantoniou, Christos; Launay, Jean-Marie; Samuel, Jane-Lise; Delcayre, Claude			Aldosterone Inhibits the Fetal Program and Increases Hypertrophy in the Heart of Hypertensive Mice	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ENZYME GENE-EXPRESSION; CARDIAC-HYPERTROPHY; TRANSGENIC MICE; CORONARY DYSFUNCTION; SPIRONOLACTONE; FIBROSIS; FAILURE; ACTIVATION; MICRORNAS	Background: Arterial hypertension (AH) induces cardiac hypertrophy and reactivation of "fetal" gene expression. In rodent heart, alpha-Myosin Heavy Chain (MyHC) and its micro-RNA miR-208a regulate the expression of beta-MyHC and of its intronic miR-208b. However, the role of aldosterone in these processes remains unclear. Methodology/Principal Findings: RT-PCR and western-blot were used to investigate the genes modulated by arterial hypertension and cardiac hyperaldosteronism. We developed a model of double-transgenic mice (AS-Ren) with cardiac hyperaldosteronism (AS mice) and systemic hypertension (Ren). AS-Ren mice had increased (x2) angiotensin II in plasma and increased (x2) aldosterone in heart. Ren and AS-Ren mice had a robust and similar hypertension (+70%) versus their controls. Anatomical data and echocardiography showed a worsening of cardiac hypertrophy (+41%) in AS-Ren mice (P<0.05 vs Ren). The increase of ANP (x 2.5; P<0.01) mRNA observed in Ren mice was blunted in AS-Ren mice. This non-induction of antitrophic natriuretic peptides may be involved in the higher trophic cardiac response in AS-Ren mice, as indicated by the markedly reduced cardiac hypertrophy in ANP-infused AS-Ren mice for one month. Besides, the AH-induced increase of ssMyHC and its intronic miRNA-208b was prevented in AS-Ren. The inhibition of miR 208a (-75%, p<0.001) in AS-Ren mice compared to AS was associated with increased Sox 6 mRNA (x 1.34; p<0.05), an inhibitor of ssMyHC transcription. Eplerenone prevented all aldosterone-dependent effects. Conclusions/Significance: Our results indicate that increased aldosterone in heart inhibits the induction of atrial natriuretic peptide expression, via the mineralocorticoid receptor. This worsens cardiac hypertrophy without changing blood pressure. Moreover, this work reveals an original aldosterone-dependent inhibition of miR-208a in hypertension, resulting in the inhibition of beta-myosin heavy chain expression through the induction of its transcriptional repressor Sox6. Thus, aldosterone inhibits the fetal program and increases cardiac hypertrophy in hypertensive mice.	[Azibani, Feriel; Coutance, Guillaume; Polidano, Evelyne; Fazal, Loubina; Merval, Regine; Solal, Alain Cohen; Launay, Jean-Marie; Samuel, Jane-Lise; Delcayre, Claude] INSERM, Unit 942, Paris, France; [Azibani, Feriel; Coutance, Guillaume; Polidano, Evelyne; Fazal, Loubina; Merval, Regine; Solal, Alain Cohen; Launay, Jean-Marie; Samuel, Jane-Lise; Delcayre, Claude] Univ Paris Diderot, Paris, France; [Devaux, Yvan] Ctr Rech Publ Sante, Luxembourg, Luxembourg; [Schlossarek, Saskia; Carrier, Lucie] Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Schlossarek, Saskia; Carrier, Lucie] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Carrier, Lucie] Inst Myol, UPMC, INSERM,UMR7215, UMR S974,CNRS, Paris, France; [Solal, Alain Cohen; Launay, Jean-Marie; Samuel, Jane-Lise] Lariboisiere Hosp, AP HP, Paris, France; [Chatziantoniou, Christos] INSERM, Unit 702, Paris, France; [Chatziantoniou, Christos] Univ Paris 06, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Luxembourg Institute of Health; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Azibani, F (corresponding author), INSERM, Unit 942, Paris, France.	Claude.Delcayre@inserm.fr	Coutance, Guillaume/ABE-9491-2020; Chatziantoniou, Christos/L-2501-2016; DEVAUX, Yvan/AAK-3463-2020	Coutance, Guillaume/0000-0003-4939-2175; Samuel, Jane-Lise/0000-0002-7346-2404; Devaux, Yvan/0000-0002-5321-8543	Universite Pierre et Marie Curie; INSERM; CNRS; ANR; GRRC; Fondation de France; Societe Francaise d'Hypertension	Universite Pierre et Marie Curie; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); GRRC; Fondation de France(Fondation de France); Societe Francaise d'Hypertension	This work was supported by Universite Pierre et Marie Curie (LF), INSERM, CNRS, ANR, GRRC and Fondation de France. FA is the recipient of a PhD grant from the Societe Francaise d'Hypertension. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Ambroisine ML, 2007, CIRCULATION, V116, P2435, DOI 10.1161/CIRCULATIONAHA.107.722009; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; BAUWENS FR, 1991, AM J CARDIOL, V68, P925, DOI 10.1016/0002-9149(91)90410-M; BRILLA CG, 1992, J LAB CLIN MED, V120, P893; Caron KMI, 2002, P NATL ACAD SCI USA, V99, P8248, DOI 10.1073/pnas.112222199; Dartsch T, 2011, INT J CARDI IN PRESS; El Jamali A, 2004, FASEB J, V18, P1096, DOI 10.1096/fj.03-1054fje; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Garnier A, 2004, CIRCULATION, V110, P1819, DOI 10.1161/01.CIR.0000142858.44680.27; Grossmann C, 2010, FASEB J, V24, P2010, DOI 10.1096/fj.09-146985; Harada E, 2001, CIRCULATION, V104, P137, DOI 10.1161/01.CIR.104.2.137; Huby AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006721; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Levy BI, 2001, AM J HYPERTENS, V14, P7, DOI 10.1016/S0895-7061(00)01212-7; Lopez-Andres N, 2011, AM J PHYSIOL-HEART C, V301, pH2372, DOI 10.1152/ajpheart.00283.2011; Matsumura K, 2006, AM J HYPERTENS, V19, P13, DOI 10.1016/j.amjhyper.2005.05.013; Messaoudi S, 2009, FASEB J, V23, P2176, DOI 10.1096/fj.08-125302; Milliez P, 2005, EUR HEART J, V26, P2193, DOI 10.1093/eurheartj/ehi478; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Okoshi MP, 2004, J CARD FAIL, V10, P511, DOI 10.1016/j.cardfail.2004.03.002; Pitt B, 2003, CIRCULATION, V108, P1831, DOI 10.1161/01.CIR.0000091405.00772.6E; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; ROBERT V, 1994, HYPERTENSION, V24, P30, DOI 10.1161/01.HYP.24.1.30; Robert V, 1999, HYPERTENSION, V33, P981, DOI 10.1161/01.HYP.33.4.981; Sepulveda JL, 2002, J BIOL CHEM, V277, P25775, DOI 10.1074/jbc.M203122200; Sugiyama T, 2005, ENDOCRINOLOGY, V146, P3900, DOI 10.1210/en.2004-1674; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Takeda Y, 2002, CIRCULATION, V105, P677, DOI 10.1161/hc0602.104675; Tanabe A, 1997, Hypertens Res, V20, P85, DOI 10.1291/hypres.20.85; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Yoshida C, 2011, J HYPERTENS, V29, P357, DOI 10.1097/HJH.0b013e32834103d4; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700	37	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38197	10.1371/journal.pone.0038197	http://dx.doi.org/10.1371/journal.pone.0038197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666483	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400100
J	Gualda, GAR; Pamukcu, AS; Ghiorso, MS; Anderson, AT; Sutton, SR; Rivers, ML				Gualda, Guilherme A. R.; Pamukcu, Ayla S.; Ghiorso, Mark S.; Anderson, Alfred T., Jr.; Sutton, Stephen R.; Rivers, Mark L.			Timescales of Quartz Crystallization and the Longevity of the Bishop Giant Magma Body	PLOS ONE			English	Article							CRYSTAL SIZE DISTRIBUTIONS; TUFF RHYOLITIC MAGMA; X-RAY TOMOGRAPHY; LONG-VALLEY; U-TH; ZONED PHENOCRYSTS; PHASE-EQUILIBRIA; MELT INCLUSIONS; PUMICE CLASTS; EXSOLVED GAS	Supereruptions violently transfer huge amounts (100 s-1000 s km(3)) of magma to the surface in a matter of days and testify to the existence of giant pools of magma at depth. The longevity of these giant magma bodies is of significant scientific and societal interest. Radiometric data on whole rocks, glasses, feldspar and zircon crystals have been used to suggest that the Bishop Tuff giant magma body, which erupted similar to 760,000 years ago and created the Long Valley caldera (California), was long-lived (>100,000 years) and evolved rather slowly. In this work, we present four lines of evidence to constrain the timescales of crystallization of the Bishop magma body: (1) quartz residence times based on diffusional relaxation of Ti profiles, (2) quartz residence times based on the kinetics of faceting of melt inclusions, (3) quartz and feldspar crystallization times derived using quartz+feldspar crystal size distributions, and (4) timescales of cooling and crystallization based on thermodynamic and heat flow modeling. All of our estimates suggest quartz crystallization on timescales of <10,000 years, more typically within 500-3,000 years before eruption. We conclude that large-volume, crystal-poor magma bodies are ephemeral features that, once established, evolve on millennial timescales. We also suggest that zircon crystals, rather than recording the timescales of crystallization of a large pool of crystal-poor magma, record the extended periods of time necessary for maturation of the crust and establishment of these giant magma bodies.	[Gualda, Guilherme A. R.; Pamukcu, Ayla S.] Vanderbilt Univ, Nashville, TN 37240 USA; [Ghiorso, Mark S.] OFM Res W, Seattle, WA USA; [Anderson, Alfred T., Jr.; Sutton, Stephen R.] Univ Chicago, Chicago, IL 60637 USA; [Sutton, Stephen R.; Rivers, Mark L.] Univ Chicago, Ctr Adv Radiat Sources, Argonne, IL USA	Vanderbilt University; University of Chicago; University of Chicago	Gualda, GAR (corresponding author), Vanderbilt Univ, Nashville, TN 37240 USA.	g.gualda@vanderbilt.edu	; Gualda, Guilherme/A-2467-2009	Ghiorso, Mark/0000-0002-0489-0018; Gualda, Guilherme/0000-0003-0720-2679	NSF [EAR-0408707, EAR-0948528, EAR-0948734, EAR-0622171]; Department of Energy-Geosciences [DE-FG02-94ER14466]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Directorate For Geosciences [0948532] Funding Source: National Science Foundation; Division Of Earth Sciences [0948734] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Department of Energy-Geosciences(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support was provided by NSF to ATA (EAR-0408707), GARG (EAR-0948528) and MSG (EAR-0948734). Portions of this work were performed at GeoSoilEnviroCARS (Sector 13), Advanced Photon Source (APS), Argonne National Laboratory; GeoSoilEnviroCARS is supported by NSF (EAR-0622171) and Department of Energy-Geosciences (DE-FG02-94ER14466); use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences (Contract No. DE-AC02-06CH11357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AT, 2000, J PETROL, V41, P449, DOI 10.1093/petrology/41.3.449; Annen C, 2011, TECTONOPHYSICS, V500, P3, DOI 10.1016/j.tecto.2009.04.010; Bachmann O, 2004, J PETROL, V45, P1565, DOI 10.1093/petrology/egh019; BAILEY RA, 1976, J GEOPHYS RES, V81, P725, DOI 10.1029/JB081i005p00725; BAKER DR, 1991, CONTRIB MINERAL PETR, V106, P462, DOI 10.1007/BF00321988; BEDDOESTEPHENS B, 1983, CONTRIB MINERAL PETR, V83, P278, DOI 10.1007/BF00371196; BERMAN RG, 1988, J PETROL, V29, P445, DOI 10.1093/petrology/29.2.445; Bindeman IN, 2008, J PETROL, V49, P163, DOI 10.1093/petrology/egm075; Bindeman IN, 2002, CONTRIB MINERAL PETR, V144, P185, DOI 10.1007/s00410-002-0371-8; Carslaw HS, 1984, CONDUCTION HEAT SOLI; Chaigneau M., 1980, B VOLCANOL, V43, P233; Chakraborty S, 2008, ANNU REV EARTH PL SC, V36, P153, DOI 10.1146/annurev.earth.36.031207.124125; Charlier BLA, 2005, J PETROL, V46, P3, DOI 10.1093/petrology/egh060; Cherniak DJ, 2007, CHEM GEOL, V236, P65, DOI 10.1016/j.chemgeo.2006.09.001; Claiborne LL, 2010, GEOLOGY, V38, P1011, DOI 10.1130/G31285.1; Crank J, 1979, MATH DIFFUSION, P13; Crowley JL, 2007, GEOLOGY, V35, P1123, DOI 10.1130/G24017A.1; Dowty E., 1980, PHYS MAGMATIC PROCES; Fowler SJ, 2010, J PETROL, V51, P1783, DOI 10.1093/petrology/egq039; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Gualda GAR, 2006, J PETROL, V47, P1245, DOI 10.1093/petrology/egl010; Gualda GAR, 2004, T ROY SOC EDIN-EARTH, V95, P375; Gualda GAR, 2007, THESIS U CHICAGO; Gualda GAR, 2006, J VOLCANOL GEOTH RES, V154, P48, DOI 10.1016/j.jvolgeores.2005.09.019; Gualda GAR, 2012, J PETROL, V53, P875, DOI 10.1093/petrology/egr080; Gualda GAR, 2011, J PETROL, V52, P431, DOI 10.1093/petrology/egq097; HERVIG RL, 1992, EARTH PLANET SC LETT, V111, P97, DOI 10.1016/0012-821X(92)90172-R; Hildreth W, 1979, GEOLOGICAL SOC AM SP; Hildreth W, 2007, J PETROL, V48, P951, DOI 10.1093/petrology/egm007; Holtz F, 2001, CONTRIB MINERAL PETR, V141, P347, DOI 10.1007/s004100100245; Johannes W., 1996, PETROGENESIS EXPT PE, DOI 10.1007/978-3-642-61049-3_2; Lipman PW, 2008, GEOL SOC AM BULL, V120, P771, DOI 10.1130/B26330.1; Lovering TS, 1936, BULL GEOL SOC AM, V47, P87; Lowenstern JB, 2006, PHILOS T R SOC A, V364, P2055, DOI 10.1098/rsta.2006.1813; MAHOOD GA, 1990, EARTH PLANET SC LETT, V99, P395, DOI 10.1016/0012-821X(90)90145-N; Manley CR, 1996, AM MINERAL, V81, P158; MARSH BD, 1988, CONTRIB MINERAL PETR, V99, P277, DOI 10.1007/BF00375362; Marsh BD, 1998, J PETROL, V39, P553, DOI 10.1093/petrology/39.4.553; McCanta MC, 2007, J VOLCANOL GEOTH RES, V160, P263, DOI 10.1016/j.jvolgeores.2006.10.004; MICHAEL PJ, 1983, GEOLOGY, V11, P31, DOI 10.1130/0091-7613(1983)11<31:CDOTBT>2.0.CO;2; MILLER CF, 1984, EARTH PLANET SC LETT, V68, P151, DOI 10.1016/0012-821X(84)90147-X; Miller JS, 2007, J VOLCANOL GEOTH RES, V167, P282, DOI 10.1016/j.jvolgeores.2007.04.019; Morgan DJ, 2006, GEOLOGY, V34, P845, DOI 10.1130/G22604.1; Morgan DJ, 2006, CONTRIB MINERAL PETR, V151, P58, DOI 10.1007/s00410-005-0045-4; Oppenheimer C, 2003, PROG PHYS GEOG, V27, P230, DOI 10.1191/0309133303pp379ra; Pabst S, 2008, B VOLCANOL, V70, P961, DOI 10.1007/s00445-007-0180-z; Pamukcu AS, 2012, J PETROL, V53, P589, DOI 10.1093/petrology/egr072; Pamukcu AS, 2010, GEOSPHERE, V6, P775, DOI 10.1130/GES00565.1; Papale P, 2006, CHEM GEOL, V229, P78, DOI 10.1016/j.chemgeo.2006.01.013; Paul A., 1982, CHEM GLASSES; Peppard BT, 2001, AM MINERAL, V86, P1034; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; Roedder E, 1984, REV MINERAL, V12, P59; Schmitt AK, 2010, EARTH PLANET SC LETT, V295, P91, DOI 10.1016/j.epsl.2010.03.028; Self S, 2006, PHILOS T R SOC A, V364, P2073, DOI 10.1098/rsta.2006.1814; Shewmon PG, 1969, TRANSFORMATIONS META; Simon JI, 2007, GEOCHIM COSMOCHIM AC, V71, P2014, DOI 10.1016/j.gca.2007.01.023; Simon JI, 2005, EARTH PLANET SC LETT, V235, P123, DOI 10.1016/j.epsl.2005.03.013; Storm S, 2011, EARTH PLANET SC LETT, V301, P511, DOI 10.1016/j.epsl.2010.11.034; Sutton SR, 2002, REV MINERAL GEOCHEM, V49, P429, DOI 10.2138/rmg.2002.49.8; Tamic N, 2001, CHEM GEOL, V174, P333, DOI 10.1016/S0009-2541(00)00324-7; Thomas JB, 2010, CONTRIB MINERAL PETR, V160, P743, DOI 10.1007/s00410-010-0505-3; Vazquez JA, 2004, SCIENCE, V305, P991, DOI 10.1126/science.1096994; Walker BA, 2007, J VOLCANOL GEOTH RES, V167, P239, DOI 10.1016/j.jvolgeores.2006.12.008; Wallace PJ, 1999, J GEOPHYS RES-SOL EA, V104, P20097, DOI 10.1029/1999JB900207; WALLACE PJ, 1995, NATURE, V377, P612, DOI 10.1038/377612a0; Wark DA, 2007, GEOLOGY, V35, P235, DOI 10.1130/G23316A.1; Wark DA, 2006, CONTRIB MINERAL PETR, V152, P743, DOI 10.1007/s00410-006-0132-1; Watson EB, 1996, T ROY SOC EDIN-EARTH, V87, P43, DOI 10.1017/S0263593300006465; Whittington AG, 2009, NATURE, V458, P319, DOI 10.1038/nature07818; Wilson CJN, 2009, J PETROL, V50, P875, DOI 10.1093/petrology/egp023; Wilson CJN, 1997, J GEOL, V105, P407, DOI 10.1086/515937; Wortis M, 1988, CHEM PHYS SOLID SURF, VVII; Zandt G, 2003, PURE APPL GEOPHYS, V160, P789, DOI 10.1007/PL00012557	74	90	91	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37492	10.1371/journal.pone.0037492	http://dx.doi.org/10.1371/journal.pone.0037492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666359	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400028
J	Kong, R; Jia, G; Cheng, ZX; Wang, YW; Mu, M; Wang, SJ; Pan, SH; Gao, Y; Jiang, HC; Dong, DL; Sun, B				Kong, Rui; Jia, Guang; Cheng, Zhuo-xin; Wang, Yong-wei; Mu, Ming; Wang, Shuang-jia; Pan, Shang-ha; Gao, Yue; Jiang, Hong-chi; Dong, De-li; Sun, Bei			Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; LIGAND-INDUCED APOPTOSIS; HUMAN PROSTATE-CANCER; IN-VITRO; DOWN-REGULATION; ARTEMISININ; CASPASE-8; THERAPY; GROWTH; VIVO	Background: Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has recently shown antitumor activity in various cancer cells. Apo2 ligand or tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) is regarded as a promising anticancer agent, but chemoresistance affects its efficacy as a treatment strategy. Apoptosis induced by the combination of DHA and Apo2L/TRAIL has not been well documented, and the mechanisms involved remain unclear. Methodology/Principal Findings: Here, we report that DHA enhances the efficacy of Apo2L/TRAIL for the treatment of pancreatic cancer. We found that combined therapy using DHA and Apo2L/TRAIL significantly enhanced apoptosis in BxPC-3 and PANC-1 cells compared with single-agent treatment in vitro. The effect of DHA was mediated through the generation of reactive oxygen species, the induction of death receptor 5 (DR5) and the modulation of apoptosis-related proteins. However, N-acetyl cysteine significantly reduced the enhanced apoptosis observed with the combination of DHA and Apo2L/TRAIL. In addition, knockdown of DR5 by small interfering RNA also significantly reduced the amount of apoptosis induced by DHA and Apo2L/TRAIL. Conclusions/Significance: These results suggest that DHA enhances Apo2L/TRAIL-mediated apoptosis in human pancreatic cancer cells through reactive oxygen species-mediated up-regulation of DR5.	[Kong, Rui; Jia, Guang; Cheng, Zhuo-xin; Wang, Yong-wei; Wang, Shuang-jia; Pan, Shang-ha; Gao, Yue; Jiang, Hong-chi; Sun, Bei] Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China; [Mu, Ming] Univ Wisconsin Madison, Sch Agr & Life Sci, Dept Biol, Madison, WI USA; [Dong, De-li] Harbin Med Univ, Dept Pharmacol, Harbin, Peoples R China	Harbin Medical University; University of Wisconsin System; University of Wisconsin Madison; Harbin Medical University	Kong, R (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China.	sunbei70@tom.com	shuangjia, wang/AFX-8272-2022; Jiang, HongChi/M-5031-2018	Jiang, HongChi/0000-0001-8215-8984	Foundation of the First Affiliated Hospital of Harbin Medical University [2011BS007]; National Science Foundation for Post-doctoral Scientists of China [20110491109]; Research Foundation of Education Bureau of Heilongjiang Province, China [12511246]	Foundation of the First Affiliated Hospital of Harbin Medical University; National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); Research Foundation of Education Bureau of Heilongjiang Province, China	This work was supported in part by grants from the Foundation of the First Affiliated Hospital of Harbin Medical University (2011BS007), the National Science Foundation for Post-doctoral Scientists of China (20110491109), and the Research Foundation of Education Bureau of Heilongjiang Province, China (12511246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beger HG, 2003, WORLD J SURG, V27, P1075, DOI 10.1007/s00268-003-7165-7; Cabello CM, 2011, INVEST NEW DRUGS; Chandra J, 2009, ANTIOXID REDOX SIGN, V11, P1123, DOI [10.1089/ars.2008.2302, 10.1089/ARS.2008.2302]; Chen H, 2009, ANTI-CANCER DRUG, V20, P131, DOI 10.1097/CAD.0b013e3283212ade; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; Fulda S, 2009, J CELL MOL MED, V13, P1221, DOI 10.1111/j.1582-4934.2009.00748.x; He Q, 2010, CANCER BIOL THER, V9, P819, DOI 10.4161/cbt.9.10.11552; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HIEN TT, 1993, LANCET, V341, P603; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kim SJ, 2006, J CANCER RES CLIN, V132, P129, DOI 10.1007/s00432-005-0052-x; Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kong R, 2010, CANCER LETT, V291, P90, DOI 10.1016/j.canlet.2009.10.001; Lu YY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-16; Manda G., 2009, CURR CHEM BIOL, V3, P22, DOI [10.2174/187231309787158271, DOI 10.2174/187231309787158271, DOI 10.2174/22127968109030]; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Mizutani Y, 2001, J UROLOGY, V165, P263, DOI 10.1097/00005392-200101000-00076; Mu DG, 2008, CANCER CHEMOTH PHARM, V61, P639, DOI 10.1007/s00280-007-0517-5; Nam W, 2007, HEAD NECK-J SCI SPEC, V29, P335, DOI 10.1002/hed.20524; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; Posner GH, 2004, ACCOUNTS CHEM RES, V37, P397, DOI 10.1021/ar020227u; Prasad S, 2010, MOL CANCER THER, V9, P856, DOI 10.1158/1535-7163.MCT-09-1113; Raraty MGT, 2002, ACTA ONCOL, V41, P582, DOI 10.1080/028418602321028184; Schuler S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-80; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shiraishi T, 2005, CANCER RES, V65, P6364, DOI 10.1158/0008-5472.CAN-05-0312; SHTERMAN N, 1991, PATHOBIOLOGY, V59, P19, DOI 10.1159/000163611; Singh NP, 2004, ANTICANCER RES, V24, P2277; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Trauzold A, 2003, ONCOGENE, V22, P8939, DOI 10.1038/sj.onc.1207001; van Agtmael MA, 1999, TRENDS PHARMACOL SCI, V20, P199, DOI 10.1016/S0165-6147(99)01302-4; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; White SJ, 2007, FREE RADICAL BIO MED, V43, P1313, DOI 10.1016/j.freeradbiomed.2007.06.015; White-Gilbertson SJ, 2009, J UROLOGY, V182, P1178, DOI 10.1016/j.juro.2009.05.005; WOERDENBAG HJ, 1994, PHARM WORLD SCI, V16, P169, DOI 10.1007/BF01872865; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Yang XZ, 2003, CANCER RES, V63, P1122; Yasuda T, 2008, MOL CANCER RES, V6, P1852, DOI 10.1158/1541-7786.MCR-08-0012; Yasui H, 2005, INT J ONCOL, V26, P537; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161	54	54	58	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e37222	10.1371/journal.pone.0037222	http://dx.doi.org/10.1371/journal.pone.0037222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666346	gold, Green Submitted, Green Published			2022-12-27	WOS:000305353400022
J	Mitro, S; Gordon, AR; Olsson, MJ; Lundstrom, JN				Mitro, Susanna; Gordon, Amy R.; Olsson, Mats J.; Lundstrom, Johan N.			The Smell of Age: Perception and Discrimination of Body Odors of Different Ages	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; PERCEIVED INTENSITY; KIN RECOGNITION; OLFACTORY CUES; MOUSE URINE; IDENTIFICATION; COMMUNICATION; HUMANS; SEX; GENDER	Our natural body odor goes through several stages of age-dependent changes in chemical composition as we grow older. Similar changes have been reported for several animal species and are thought to facilitate age discrimination of an individual based on body odors, alone. We sought to determine whether humans are able to discriminate between body odor of humans of different ages. Body odors were sampled from three distinct age groups: Young (20-30 years old), Middle-age (45-55), and Old-age (75-95) individuals. Perceptual ratings and age discrimination performance were assessed in 41 young participants. There were significant differences in ratings of both intensity and pleasantness, where body odors from the Old-age group were rated as less intense and less unpleasant than body odors originating from Young and Middle-age donors. Participants were able to discriminate between age categories, with body odor from Old-age donors mediating the effect also after removing variance explained by intensity differences. Similarly, participants were able to correctly assign age labels to body odors originating from Old-age donors but not to body odors originating from other age groups. This experiment suggests that, akin to other animals, humans are able to discriminate age based on body odor alone and that this effect is mediated mainly by body odors emitted by individuals of old age.	[Mitro, Susanna; Gordon, Amy R.; Lundstrom, Johan N.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Mitro, Susanna] Swarthmore Coll, Swarthmore, PA 19081 USA; [Gordon, Amy R.; Olsson, Mats J.; Lundstrom, Johan N.] Karolinska Inst, Dept Clin Neurosci, Psychol Sect, Stockholm, Sweden; [Lundstrom, Johan N.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; Swarthmore College; Karolinska Institutet; University of Pennsylvania	Mitro, S (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	jlundstrom@monell.org	Lundström, Johan N./AAK-5002-2020; Lundström, Johan N/E-9482-2014	Lundström, Johan N./0000-0002-3529-8981; Lundström, Johan N/0000-0002-3529-8981; Mitro, Susanna/0000-0003-3202-1941; Olsson, Mats/0000-0001-5592-3759	National Institute on Deafness and other Communication Disorders - NIDCD [R03DC009869]; Swedish Research Council - VR [2008-20712]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC009869] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders - NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Swedish Research Council - VR(Swedish Research Council); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by the National Institute on Deafness and other Communication Disorders - NIDCD (R03DC009869) [http://www.nidcd.nih.gov] and the Swedish Research Council - VR (2008-20712)[http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; BAUM MJ, 1990, BEHAV NEUROSCI, V104, P183, DOI 10.1037/0735-7044.104.1.183; Beauchamp GK, 2003, BIOCHEM SOC T, V31, P147; Bonadonna F, 2007, J CHEM ECOL, V33, P1819, DOI 10.1007/s10886-007-9345-7; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; Djordjevic J, 2008, J NEUROPHYSIOL, V99, P386, DOI 10.1152/jn.00896.2007; DOTY RL, 1978, BEHAV BIOL, V23, P373, DOI 10.1016/S0091-6773(78)91393-7; DOTY RL, 1982, HORM BEHAV, V16, P13, DOI 10.1016/0018-506X(82)90002-2; Eggert F, 1998, GENETICA, V104, P191, DOI 10.1023/A:1026402531196; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; GOODRICH BS, 1972, J MAMMAL, V53, P540, DOI 10.2307/1379043; GOWER DB, 1993, J ENDOCRINOL, V137, P167, DOI 10.1677/joe.0.1370167; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Havlicek J, 2006, CHEM SENSES, V31, P747, DOI 10.1093/chemse/bjl017; Haze S, 2001, J INVEST DERMATOL, V116, P520, DOI 10.1046/j.0022-202x.2001.01287.x; Hepper PG, 2010, CHEM SENSES, V35, P263, DOI 10.1093/chemse/bjq015; HOLD B, 1977, Z TIERPSYCHOL, V43, P225; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Kean EF, 2011, CHEM SENSES, V36, P555, DOI 10.1093/chemse/bjr025; Labows JN, 1999, COSMET SCI TECHNOL S, V20, P59; Lenochova P, 2009, CHEM SENSES, V34, P127, DOI 10.1093/chemse/bjn067; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Lundstrom JN, 2010, VITAM HORM, V83, P1, DOI 10.1016/S0083-6729(10)83001-8; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Lundstrom JN, 2009, HORM BEHAV, V55, P280, DOI 10.1016/j.yhbeh.2008.11.009; Lundstrom JN, 2006, BIOL PSYCHOL, V71, P244, DOI 10.1016/j.biopsycho.2005.07.001; Lundstrom JN, 2005, BIOL PSYCHOL, V70, P197, DOI 10.1016/j.biopsycho.2005.01.008; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; Macdonald EA, 2008, AM J PRIMATOL, V70, P12, DOI 10.1002/ajp.20450; Martins Y, 2005, PSYCHOL SCI, V16, P694, DOI 10.1111/j.1467-9280.2005.01598.x; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; MULLERSCHWARZE D, 1971, ANIM BEHAV, V19, P141, DOI 10.1016/S0003-3472(71)80149-5; NAZZAROPORRO M, 1979, J INVEST DERMATOL, V73, P112, DOI 10.1111/1523-1747.ep12532793; Nieberding CM, 2012, ECOL LETT; OLSEN RL, 1983, BIOCHEM J, V209, P781, DOI 10.1042/bj2090781; Olsson SB, 2006, J CHEM ECOL, V32, P1635, DOI 10.1007/s10886-006-9098-8; Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308; Osada K, 2008, CHEM SENSES, V33, P815, DOI 10.1093/chemse/bjn045; Penn D, 1998, P ROY SOC B-BIOL SCI, V265, P1299, DOI 10.1098/rspb.1998.0433; Pierman S, 2006, HORM BEHAV, V49, P96, DOI 10.1016/j.yhbeh.2005.05.007; POCHI PE, 1979, J INVEST DERMATOL, V73, P108, DOI 10.1111/1523-1747.ep12532792; PORTER RH, 1981, PHYSIOL BEHAV, V27, P493, DOI 10.1016/0031-9384(81)90337-1; ROBINSON AB, 1976, EXP GERONTOL, V11, P11, DOI 10.1016/0531-5565(76)90005-X; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; RUSSELL MJ, 1976, NATURE, V260, P520, DOI 10.1038/260520a0; SCHAAL B, 1991, ADV STUD BEHAV, V20, P135, DOI 10.1016/S0065-3454(08)60321-6; Sergeant MJT, 2007, ARCH SEX BEHAV, V36, P395, DOI 10.1007/s10508-006-9126-3; WALLACE P, 1977, PHYSIOL BEHAV, V19, P577, DOI 10.1016/0031-9384(77)90238-4; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; WYSOCKI CJ, 2000, JPN J SMELL TASTE RE, V7, P19; Yamazaki K, 2000, P NATL ACAD SCI USA, V97, P10500, DOI 10.1073/pnas.180320997; Yamazaki K, 2007, ADV GENET, V59, P129, DOI 10.1016/S0065-2660(07)59005-X	52	85	87	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e38110	10.1371/journal.pone.0038110	http://dx.doi.org/10.1371/journal.pone.0038110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959YF	22666457	Green Submitted, gold, Green Published			2022-12-27	WOS:000305353400082
J	Kadir, R; Bakhrat, A; Tokarsky, R; Abdu, U				Kadir, Rotem; Bakhrat, Anna; Tokarsky, Ronit; Abdu, Uri			Localization of the Drosophila Rad9 Protein to the Nuclear Membrane Is Regulated by the C-Terminal Region and Is Affected in the Meiotic Checkpoint	PLOS ONE			English	Article							RECOMBINATION PARTNER CHOICE; DNA-DAMAGE CHECKPOINTS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; REPAIR; COMPLEX; CLAMP; ACTIVATION; OOGENESIS; MEIOSIS	Rad9, Rad1, and Hus1 (9-1-1) are part of the DNA integrity checkpoint control system. It was shown previously that the C-terminal end of the human Rad9 protein, which contains a nuclear localization sequence (NLS) nearby, is critical for the nuclear transport of Rad1 and Hus1. In this study, we show that in Drosophila, Hus1 is found in the cytoplasm, Rad1 is found throughout the entire cell and that Rad9 (DmRad9) is a nuclear protein. More specifically, DmRad9 exists in two alternatively spliced forms, DmRad9A and DmRad9B, where DmRad9B is localized at the cell nucleus, and DmRad9A is found on the nuclear membrane both in Drosophila tissues and also when expressed in mammalian cells. Whereas both alternatively spliced forms of DmRad9 contain a common NLS near the C terminus, the 32 C-terminal residues of DmRad9A, specific to this alternative splice form, are required for targeting the protein to the nuclear membrane. We further show that activation of a meiotic checkpoint by a DNA repair gene defect but not defects in the anchoring of meiotic chromosomes to the oocyte nuclear envelope upon ectopic expression of non-phosphorylatable Barrier to Autointegration Factor (BAF) dramatically affects DmRad9A localization. Thus, by studying the localization pattern of DmRad9, our study reveals that the DmRad9A C-terminal region targets the protein to the nuclear membrane, where it might play a role in response to the activation of the meiotic checkpoint.	[Kadir, Rotem; Bakhrat, Anna; Tokarsky, Ronit; Abdu, Uri] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University	Kadir, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	abdu@bgu.ac.il						Abdu U, 2003, GENETICS, V165, P197; Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Abdu U, 2007, J CELL SCI, V120, P1042, DOI 10.1242/jcs.03414; Aylon Y, 2003, MOL CELL BIOL, V23, P6585, DOI 10.1128/MCB.23.18.6585-6596.2003; Barbour L, 2006, GENETICS, V174, P1789, DOI 10.1534/genetics.106.056283; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Ghabrial A, 1999, NAT CELL BIOL, V1, P354, DOI 10.1038/14046; Ghabrial A, 1998, GENE DEV, V12, P2711, DOI 10.1101/gad.12.17.2711; Grushcow JM, 1999, GENETICS, V153, P607; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; Hirai I, 2004, ONCOGENE, V23, P5124, DOI 10.1038/sj.onc.1207658; Hirai I, 2002, J BIOL CHEM, V277, P25722, DOI 10.1074/jbc.M203079200; Ivanovska I, 2005, GENE DEV, V19, P2571, DOI 10.1101/gad.1348905; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Komatsu K, 2000, NAT CELL BIOL, V2, P1, DOI 10.1038/71316; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lancaster OM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001179; Lee MW, 2003, ONCOGENE, V22, P6340, DOI 10.1038/sj.onc.1206729; Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCaffrey R, 2006, GENETICS, V174, P1273, DOI 10.1534/genetics.106.058289; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Peretz G, 2009, MECH DEVELOP, V126, P677, DOI 10.1016/j.mod.2009.05.004; Queenan AM, 1999, MECH DEVELOP, V89, P35, DOI 10.1016/S0925-4773(99)00196-3; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Staeva-Vieira E, 2003, EMBO J, V22, P5863, DOI 10.1093/emboj/cdg564; Van Doren M, 1998, CURR BIOL, V8, P243; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Yin YX, 2004, P NATL ACAD SCI USA, V101, P8864, DOI 10.1073/pnas.0403130101; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002	36	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38010	10.1371/journal.pone.0038010	http://dx.doi.org/10.1371/journal.pone.0038010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666434	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600052
J	Kim, YS; Kim, KS; Han, I; Kim, MH; Jung, MH; Park, HK				Kim, Young-Sun; Kim, Kyung Sook; Han, Ihn; Kim, Mi-Hyun; Jung, Min Hyung; Park, Hun-Kuk			Quantitative and Qualitative Analysis of the Antifungal Activity of Allicin Alone and in Combination with Antifungal Drugs	PLOS ONE			English	Article							CANDIDA-ALBICANS; AMPHOTERICIN-B; INHIBITION; CELLS	The antifungal activity of allicin and its synergistic effects with the antifungal agents flucytosine and amphotericin B (AmB) were investigated in Candida albicans (C. albicans). C. albicans was treated with different conditions of compounds alone and in combination (allicin, AmB, flucytosine, allicin + AmB, allicin + flucytosine, allicin + AmB + flucytosine). After a 24-hour treatment, cells were examined by scanning electron microscopy (SEM) and atomic force microscopy (AFM) to measure morphological and biophysical properties associated with cell death. The clearing assay was conducted to confirm the effects of allicin. The viability of C. albicans treated by allicin alone or with one antifungal drug (AmB, flucytosine) in addition was more than 40% after a 24-hr treatment, but the viability of groups treated with combinations of more than two drugs was less than 32%. When the cells were treated with allicin alone or one type of drug, the morphology of the cells did not change noticeably, but when cells were treated with combinations of drugs, there were noticeable morphological changes. In particular, cells treated with allicin + AmB had significant membrane damage (burst or collapsed membranes). Classification of cells according to their cell death phase (CDP) allowed us to determine the relationship between cell viability and treatment conditions in detail. The adhesive force was decreased by the treatment in all groups compare to the control. Cells treated with AmB + allicin had a greater adhesive force than cells treated with AmB alone because of the secretion of molecules due to collapsed membranes. All cells treated with allicin or drugs were softer than the control cells. These results suggest that allicin can reduce MIC of AmB while keeping the same efficacy.	[Kim, Young-Sun; Jung, Min Hyung] Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Kyung Sook; Kim, Mi-Hyun; Park, Hun-Kuk] Kyung Hee Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Kim, Kyung Sook; Kim, Mi-Hyun; Park, Hun-Kuk] Kyung Hee Univ, Healthcare Ind Res Inst, Seoul, South Korea; [Han, Ihn] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Park, Hun-Kuk] Kyung Hee Univ, Program Med Engn, Seoul, South Korea	Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Kim, YS (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Dept Obstet & Gynecol, Seoul, South Korea.	webhospital@naver.com; sigmoidus@khu.ac.kr	Kim, Youngsun/AAY-5946-2021; Han, Ihn/ABH-6275-2020	Kim, Youngsun/0000-0002-1725-0968; Han, Ihn/0000-0002-1372-7319	Kyung Hee University [KHU-20110093]; Seoul Research and Business Development program [CR070054]	Kyung Hee University; Seoul Research and Business Development program(Seoul RBD program)	This study was supported by a grant from Kyung Hee University in 2011 (KHU-20110093) and the Seoul Research and Business Development program (Grant No. CR070054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADETUMBI M, 1986, ANTIMICROB AGENTS CH, V30, P499, DOI 10.1128/AAC.30.3.499; An MM, 2009, INT J ANTIMICROB AG, V33, P258, DOI 10.1016/j.ijantimicag.2008.09.014; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Aplin AE, 1998, PHARMACOL REV, V50, P197; Brito GNB, 2011, BRAZ ORAL RES, V25, P28, DOI 10.1590/S1806-83242011005000001; Baginski M, 2009, CURR DRUG METAB, V10, P459, DOI 10.2174/138920009788898019; Borjihan H, 2009, J ANTIBIOT, V62, P691, DOI 10.1038/ja.2009.103; Cai Y, 2007, J ANTIBIOT, V60, P335, DOI 10.1038/ja.2007.45; Davis SR, 2005, MYCOSES, V48, P95, DOI 10.1111/j.1439-0507.2004.01076.x; GHANNOUM MA, 1990, J APPL BACTERIOL, V68, P163, DOI 10.1111/j.1365-2672.1990.tb02562.x; KENNEDY MJ, 1985, INFECT IMMUN, V49, P654, DOI 10.1128/IAI.49.3.654-663.1985; Khodavandi A, 2010, MYCOPATHOLOGIA, V169, P287, DOI 10.1007/s11046-009-9251-3; Kim KSKim, PLOS ONE, V6; Lee Jeong Ah, 2010, Mycobiology, V38, P328, DOI 10.4489/MYCO.2010.38.4.328; Low CF, 2008, J APPL MICROBIOL, V105, P2169, DOI 10.1111/j.1365-2672.2008.03912.x; Lyon GM, 2010, J CLIN MICROBIOL, V48, P1270, DOI 10.1128/JCM.02363-09; Na G, 2010, FEMS IMMUNOL MED MIC, V58, P193; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Ogita A, 2005, TOXICOLOGY, V215, P205, DOI 10.1016/j.tox.2005.07.006; Okamoto Y, 2004, MYCOPATHOLOGIA, V158, P9, DOI 10.1023/B:MYCO.0000038430.20669.80; Shuford JA, 2005, ANTIMICROB AGENTS CH, V49, P473, DOI 10.1128/AAC.49.1.473.2005; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Volle CB, 2008, LANGMUIR, V24, P8102, DOI 10.1021/la8009354; YAMADA Y, 1977, ANTIMICROB AGENTS CH, V11, P743, DOI 10.1128/AAC.11.4.743; Zakaria Z, 2011, ASIAN PACIFIC J TROP, V1, P20; Zhang JD, 2006, J ETHNOPHARMACOL, V103, P76, DOI 10.1016/j.jep.2005.07.006	26	38	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38242	10.1371/journal.pone.0038242	http://dx.doi.org/10.1371/journal.pone.0038242			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	23144990	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343900023
J	Lee, CL; Lin, YT; Chang, FR; Chen, GY; Backlund, A; Yang, JC; Chen, SL; Wu, YC				Lee, Chia-Lin; Lin, Ying-Ting; Chang, Fang-Rong; Chen, Guan-Yu; Backlund, Anders; Yang, Juan-Chang; Chen, Shu-Li; Wu, Yang-Chang			Synthesis and Biological Evaluation of Phenanthrenes as Cytotoxic Agents with Pharmacophore Modeling and ChemGPS-NP Prediction as Topo II Inhibitors	PLOS ONE			English	Article							DENBINOBIN INDUCES APOPTOSIS; CANCER; CELLS	In a structure-activity relationship (SAR) study, 3-methoxy-1,4-phenanthrenequinones, calanquinone A (6a), denbinobin (6b), 5-OAc-calanquinone A (7a) and 5-OAc-denbinobin (7b), have significantly promising cytotoxicity against various human cancer cell lines (IC50 0.08-1.66 mu g/mL). Moreover, we also established a superior pharmacophore model for cytotoxicity (r = 0.931) containing three hydrogen bond acceptors (HBA1, HBA2 and HBA3) and one hydrophobic feature (HYD) against MCF-7 breast cancer cell line. The pharmacophore model indicates that HBA3 is an essential feature for the oxygen atom of 5-OH in 6a-b and for the carbonyl group of 5-OCOCH3 in 7a-b, important for their cytotoxic properties. The SAR for moderately active 5a-b (5-OCH3), and highly active 6a-b and 7a-b, are also elaborated in a spatial aspect model. Further rational design and synthesis of new cytotoxic phenanthrene analogs can be implemented via this model. Additionally, employing a ChemGPS-NP based model for cytotoxicity mode of action (MOA) provides support for a preliminary classification of compounds 6a-b as topoisomerase II inhibitors.	[Lee, Chia-Lin; Wu, Yang-Chang] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lee, Chia-Lin; Chen, Guan-Yu; Wu, Yang-Chang] China Med Univ Hosp, Nat Med Prod Res Ctr, Taichung, Taiwan; [Lin, Ying-Ting] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Chang, Fang-Rong; Yang, Juan-Chang; Chen, Shu-Li; Wu, Yang-Chang] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Chang, Fang-Rong] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Backlund, Anders] Uppsala Univ, BMC, Dept Med Chem, Div Pharmacognosy, Uppsala, Sweden; [Wu, Yang-Chang] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Uppsala University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, CL (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.	aaronfrc@kmu.edu.tw; yachwu@mail.cmu.edu.tw	Lee, Chia-Lin/P-2038-2015; Wu, Yang-Chang/C-5682-2009; Yang, Juan-Cheng/D-1442-2011	Lee, Chia-Lin/0000-0002-5949-1989; Wu, Yang-Chang/0000-0001-7815-2686; Chang, Fang-Rong/0000-0003-2549-4193; Chen, Guan-Yu/0000-0002-2773-8748	National Science Council, Taiwan [NSC99-2113-M-039-003]; Department of Health, Executive Yuan, Taiwan [DOH99-TD-C-111-002]; NATIONAL CANCER INSTITUTE [R01CA071599, P01CA094045, R01CA135368] Funding Source: NIH RePORTER	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the grants from National Science Council, Taiwan awarded to YW (NSC99-2113-M-039-003) and the Department of Health, Executive Yuan, Taiwan awarded to KMU (DOH99-TD-C-111-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CYC, 2009, J TAIWAN INST CHEM E, V40, P155, DOI 10.1016/j.jtice.2008.07.010; Chen TH, 2008, N-S ARCH PHARMACOL, V378, P447, DOI 10.1007/s00210-008-0324-5; FARINA F, 1986, SYNTHETIC COMMUN, V16, P1015, DOI 10.1080/00397918608056343; Huang YC, 2005, J BIOMED SCI, V12, P113, DOI 10.1007/s11373-004-8171-y; Kovacs A, 2008, PHYTOCHEMISTRY, V69, P1084, DOI 10.1016/j.phytochem.2007.12.005; Kraus GA, 2002, TETRAHEDRON LETT, V43, P9597, DOI 10.1016/S0040-4039(02)02411-5; Kraus GA, 2002, TETRAHEDRON LETT, V43, P5319, DOI 10.1016/S0040-4039(02)01026-2; Kuo CT, 2008, TOXICOL LETT, V177, P48, DOI 10.1016/j.toxlet.2007.12.009; Kuo CT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-43; Larsson J, 2007, J NAT PROD, V70, P789, DOI 10.1021/np070002y; Lee CL, 2008, BIOORG MED CHEM LETT, V18, P4275, DOI 10.1016/j.bmcl.2008.06.099; Lee CL, 2009, J NAT PROD, V72, P210, DOI 10.1021/np800622a; Lindsey RH, 2004, BIOCHEMISTRY-US, V43, P7563, DOI 10.1021/bi049756r; Magwere T, 2009, BRIT J PHARMACOL, V157, P1172, DOI 10.1111/j.1476-5381.2009.00286.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Rosen J, 2009, QSAR COMB SCI, V28, P436, DOI 10.1002/qsar.200810162; Sadiq AA, 2010, INVEST NEW DRUG, V28, P20, DOI 10.1007/s10637-008-9209-1; Sanchez-Duffhues G, 2009, BIOCHEM PHARMACOL, V77, P1401, DOI 10.1016/j.bcp.2009.01.004; Schmalle HW, 2001, ARKIVOC, V1, P88; Yang CR, 2009, BRIT J PHARMACOL, V157, P1175, DOI 10.1111/j.1476-5381.2009.00237.x; Yang KC, 2005, WORLD J GASTROENTERO, V11, P3040, DOI 10.3748/wjg.v11.i20.3040	21	115	116	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37897	10.1371/journal.pone.0037897	http://dx.doi.org/10.1371/journal.pone.0037897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22253887	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349600038
J	Dent, R; Blackmore, A; Peterson, J; Habib, R; Kay, GP; Gervais, A; Taylor, V; Wells, G				Dent, Robert; Blackmore, Angelique; Peterson, Joan; Habib, Rami; Kay, Gary Peter; Gervais, Alan; Taylor, Valerie; Wells, George			Changes in Body Weight and Psychotropic Drugs: A Systematic Synthesis of the Literature	PLOS ONE			English	Review							LONG-TERM TREATMENT; DOUBLE-BLIND; ATYPICAL ANTIPSYCHOTICS; BIPOLAR DISORDER; 2ND-GENERATION ANTIDEPRESSANTS; SCHIZOAFFECTIVE DISORDER; DIABETES-MELLITUS; EXTENDED-RELEASE; HALOPERIDOL DECANOATE; MONITORING PRACTICES	Introduction: Psychotropic medication use is associated with weight gain. While there are studies and reviews comparing weight gain for psychotropics within some classes, clinicians frequently use drugs from different classes to treat psychiatric disorders. Objective: To undertake a systematic review of all classes of psychotropics to provide an all encompassing evidence-based tool that would allow clinicians to determine the risks of weight gain in making both intra-class and interclass choices of psychotropics. Methodology and Results: We developed a novel hierarchical search strategy that made use of systematic reviews that were already available. When such evidence was not available we went on to evaluate randomly controlled trials, followed by cohort and other clinical trials, narrative reviews, and, where necessary, clinical opinion and anecdotal evidence. The data from the publication with the highest level of evidence based on our hierarchical classification was presented. Recommendations from an expert panel supplemented the evidence used to rank these drugs within their respective classes. Approximately 9500 articles were identified in our literature search of which 666 citations were retrieved. We were able to rank most of the psychotropics based on the available evidence and recommendations from subject matter experts. There were few discrepancies between published evidence and the expert panel in ranking these drugs. Conclusion: Potential for weight gain is an important consideration in choice of any psychotropic. This tool will help clinicians select psychotropics on a case-by-case basis in order to minimize the impact of weight gain when making both intra-class and interclass choices.	[Dent, Robert; Blackmore, Angelique; Gervais, Alan] Ottawa Hosp, Weight Management Clin, Toronto, ON, Canada; [Peterson, Joan] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Dent, Robert; Habib, Rami; Kay, Gary Peter] Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; [Taylor, Valerie] Univ Toronto, Toronto, ON, Canada; [Wells, George] Univ Ottawa, Inst Heart, Cardiovasc Res Methods Ctr, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University of Ottawa; University of Ottawa Heart Institute	Dent, R (corresponding author), Ottawa Hosp, Weight Management Clin, Toronto, ON, Canada.	bdent@ottawahospital.on.ca	Wells, George A/M-4549-2017; Taylor, Valerie H/H-6242-2015; Hoekstra, Hopi/I-6690-2012	Wells, George A/0000-0002-2289-9139; Peterson, Brant/0000-0002-0433-3035; Taylor, Valerie/0000-0002-8948-638X; Hoekstra, Hopi/0000-0003-1431-1769; Fisher, Heidi S./0000-0001-5622-4335; Weber, Jesse/0000-0003-4839-6684; Delaney, Emily/0000-0003-3609-5702	NIGMS NIH HHS [F32 GM084719] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmer S, 2005, PSYCHIATR BULL, V29, P302, DOI 10.1192/pb.29.8.302; Allard P, 2004, INT J GERIATR PSYCH, V19, P1123, DOI 10.1002/gps.1190; Allison DB, 2003, PSYCHIAT SERV, V54, P565, DOI 10.1176/appi.ps.54.4.565; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Allison DB, 2001, J CLIN PSYCHIAT, V62, P22; Alvarez-Jimenez M, 2008, CNS DRUGS, V22, P547, DOI 10.2165/00023210-200822070-00002; Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Anderson IM, 2000, J PSYCHOPHARMACOL, V14, P3, DOI 10.1177/026988110001400101; Anderson T, 2004, PRIM PSYCHIAT, V11, P48; Aronne LJ, 2003, J CLIN PSYCHIAT, V64, P22; Ashton AK, 2005, CURR THER RES CLIN E, V66, P96, DOI 10.1016/j.curtheres.2005.04.006; Bagnall A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002083.pub2; Barbui C, 2004, J CLIN PSYCHOPHARM, V24, P126, DOI 10.1097/01.jcp.0000115665.45074.0d; Beasley CM, 2007, J CLIN PSYCHOPHARM, V27, P252, DOI 10.1097/JCP.0b013e3180582426; BECHELLI LPC, 1985, CURR THER RES CLIN E, V37, P662; Benazzi F, 1998, PSYCHOTHER PSYCHOSOM, V67, P271, DOI 10.1159/000012291; Bergman RN, 2005, J CLIN PSYCHIAT, V66, P504, DOI 10.4088/JCP.v66n0414; Bisol LW, 2008, J CLIN PSYCHIAT, V69, P1572, DOI 10.4088/JCP.v69n1007; Bitter I, 2004, PROG NEURO-PSYCHOPH, V28, P173, DOI 10.1016/j.pnpbp.2003.09.033; BJERTNAES A, 1982, ACTA PSYCHIAT SCAND, V66, P199, DOI 10.1111/j.1600-0447.1982.tb00928.x; Boilson M, 2003, PSYCHIAT B, V27, P424; Bowden CL, 2006, AM J PSYCHIAT, V163, P1199, DOI 10.1176/appi.ajp.163.7.1199; Bowden CL, 2010, INT CLIN PSYCHOPHARM, V25, P60, DOI 10.1097/YIC.0b013e328333ac1b; Bramlage P, 2004, INT J OBESITY, V28, P1299, DOI 10.1038/sj.ijo.0802752; Buckley PF, 2005, SCHIZOPHR RES, V79, P281, DOI 10.1016/j.schres.2005.04.010; Canas F, 2010, EXPERT OPIN DRUG SAF, V9, P683, DOI 10.1517/14740338.2010.506712; CANTU TG, 1988, DRUG INTEL CLIN PHAR, V22, P755, DOI 10.1177/106002808802201002; Cash TF, 2000, PERCEPT MOTOR SKILL, V90, P453, DOI 10.2466/PMS.90.2.453-456; Chakrabarti A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001943.pub2; Chwieduk CM, 2010, DRUGS, V70, P1295, DOI 10.2165/11204840-000000000-00000; Citrome L, 2010, INT J CLIN PRACT, V64, P216, DOI 10.1111/j.1742-1241.2009.02240.x; Citrome L, 2009, INT J CLIN PRACT, V63, P1762, DOI 10.1111/j.1742-1241.2009.02228.x; Citrome L, 2007, J CLIN PSYCHIAT, V68, P12; Davidson J, 2004, J CLIN PSYCHOPHARM, V24, P118, DOI 10.1097/01.jcp.0000106222.36344.96; El-Khayat R, 1998, J PSYCHOPHARMACOL, V12, P323, DOI 10.1177/026988119801200401; Feeney Larkin, 2006, Irish Journal of Psychological Medicine, V23, P100, DOI [10.1017/S0790966700009113, 10.1017/S0790966700009721]; FEIGHNER J, 1986, J CLIN PSYCHOPHARM, V6, P27; Fenton M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001944.pub2; Fontaine KR, 2001, PSYCHIAT RES, V101, P277, DOI 10.1016/S0165-1781(01)00234-7; Gao KM, 2006, J CLIN PSYCHIAT, V67, P1327, DOI 10.4088/JCP.v67n0902; GARLAND EJ, 1988, J CLIN PSYCHOPHARM, V8, P323; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Gartlehner G, 2010, J CLIN EPIDEMIOL, V63, P117, DOI 10.1016/j.jclinepi.2008.09.019; Gartlehner G, 2008, DRUG SAFETY, V31, P851, DOI 10.2165/00002018-200831100-00004; Gebhardt S, 2009, J PSYCHIATR RES, V43, P620, DOI 10.1016/j.jpsychires.2008.11.001; Gentile S, 2009, OBES REV, V10, P527, DOI 10.1111/j.1467-789X.2009.00589.x; GITLIN MJ, 1989, J CLIN PSYCHIAT, V50, P127; Goethe JW, 2007, J CLIN PSYCHOPHARM, V27, P451, DOI 10.1097/jcp.0b013e31815152a5; Haddad PM, 2007, CNS DRUGS, V21, P911, DOI 10.2165/00023210-200721110-00004; Hale Katherine S., 2010, JOURNAL OF PHARMACY TECHNOLOGY, V26, P193; Hamer S, 2007, BRIT J PSYCHIAT, V191, pS64, DOI 10.1192/bjp.191.50.s64; Hansen RA, 2005, ANN INTERN MED, V143, P415, DOI 10.7326/0003-4819-143-6-200509200-00006; HARRIS B, 1986, BRIT J PSYCHIAT, V148, P590, DOI 10.1192/bjp.148.5.590; Hedenmalm K, 2002, DRUG SAFETY, V25, P1107, DOI 10.2165/00002018-200225150-00005; Henderson DC, 2007, J CLIN PSYCHIAT, V68, P18; Henderson DC, 2000, AM J PSYCHIAT, V157, P975, DOI 10.1176/appi.ajp.157.6.975; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Jeste DV, 2004, J PSYCHIATR RES, V38, P73, DOI 10.1016/S0022-3956(03)00094-3; Johnsen E, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-31; JOHNSON DAW, 1979, ACTA PSYCHIAT SCAND, V59, P525, DOI 10.1111/j.1600-0447.1979.tb00252.x; Karagianis J, 2008, HUM PSYCHOPHARM CLIN, V23, P275, DOI 10.1002/hup.933; Ketter TA, 2004, J CLIN PSYCHIAT, V65, P668; Kinon BJ, 2001, J CLIN PSYCHIAT, V62, P92, DOI 10.4088/JCP.v62n0204; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006624.pub2; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006654.pub2; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006625.pub2; Komossa K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006627.pub2; Komossa K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006569.pub3; Kumar A, 2009, SCHIZOPHRENIA BULL, V35, P855, DOI 10.1093/schbul/sbp077; Kurzthaler I, 2001, J CLIN PSYCHIAT, V62, P32; Kwon JS, 2009, PSYCHIAT CLIN NEUROS, V63, P73, DOI 10.1111/j.1440-1819.2008.01907.x; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Lencz Todd, 2009, Dialogues Clin Neurosci, V11, P405; Leslie DL, 2004, AM J PSYCHIAT, V161, P1709, DOI 10.1176/appi.ajp.161.9.1709; Leslie WS, 2007, QJM-INT J MED, V100, P395, DOI 10.1093/qjmed/hcm044; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lieberman JA, 2003, NEUROPSYCHOPHARMACOL, V28, P995, DOI 10.1038/sj.npp.1300157; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lindenmayer JP, 2009, J CLIN PSYCHIAT, V70, P990, DOI 10.4088/JCP.08m04221; Lindenmayer JP, 2004, J CLIN PSYCHIAT, V65, P1084; Mackin P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-28; Malone M, 2005, ANN PHARMACOTHER, V39, P2046, DOI 10.1345/aph.1G333; Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; Marino J, 2010, ANN PHARMACOTHER, V44, P863, DOI 10.1345/aph.1M603; Marques L.O., 2004, COCHRANE DB SYST REV; Masand PS, 2003, CLIN THER, V25, P2289, DOI 10.1016/S0149-2918(03)80220-5; McEvoy JP, 2007, AM J PSYCHIAT, V164, P1050, DOI 10.1176/appi.ajp.164.7.1050; McIntyre RS, 2001, CAN J PSYCHIAT, V46, P273, DOI 10.1177/070674370104600308; Melvin CL, 2008, J PSYCHIATR PRACT, V14, P9, DOI 10.1097/01.pra.0000333583.75741.8b; Montgomery SA, 1998, INT CLIN PSYCHOPHARM, V13, P63, DOI 10.1097/00004850-199803000-00002; Morrato EH, 2009, DIABETES CARE, V32, P1037, DOI 10.2337/dc08-1720; Nasrallah HA, 2003, CNS SPECTRUMS, V8, P23, DOI 10.1017/S1092852900008166; Nasrallah HA, 2007, J CLIN PSYCHIAT, V68, P5; Nasrallah Henry A, 2004, J Clin Psychopharmacol, V24, pS7, DOI 10.1097/01.jcp.0000142282.62336.e9; Newcomer JW, 2004, CLIN THER, V26, P1936, DOI 10.1016/j.clinthera.2004.12.003; Nguyen D, 2009, AUSTRALAS PSYCHIATRY, V17, P295, DOI 10.1080/10398560902842519; Okugawa G, 2009, PSYCHIAT CLIN NEUROS, V63, P322, DOI 10.1111/j.1440-1819.2009.01947.x; OSWALD I, 1980, BRIT MED J, V281, P1039, DOI 10.1136/bmj.281.6247.1039-a; Perkins DO, 2002, J CLIN PSYCHIAT, V63, P1121, DOI 10.4088/JCP.v63n1206; Perry R, 2009, CLIN THER, V31, P1374, DOI 10.1016/j.clinthera.2009.07.012; Perucca E, 2005, ACTA NEUROL SCAND, V112, P30, DOI 10.1111/j.1600-0404.2005.00506.x; Reinstein MJ, 2003, CLIN DRUG INVEST, V23, P671, DOI 10.2165/00044011-200323100-00006; Rosenheck RA, 2009, SCHIZOPHR RES, V107, P22, DOI 10.1016/j.schres.2008.09.031; Sachs GS, 1999, J CLIN PSYCHIAT, V60, P16; Schatzberg AF, 2007, J CLIN PSYCHIAT, V68, P26; Seeman MV, 2009, SCHIZOPHRENIA BULL, V35, P937, DOI 10.1093/schbul/sbn023; Sernyak MJ, 2002, AM J PSYCHIAT, V159, P561, DOI 10.1176/appi.ajp.159.4.561; Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shelton RC, 2007, PRIMARY PSYCHIAT, V14, P42; Simpson GM, 2005, AM J PSYCHIAT, V162, P1535, DOI 10.1176/appi.ajp.162.8.1535; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Sivaraman P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007779.pub2; Smith MC, 2004, EPILEPSY BEHAV, V5, P746, DOI 10.1016/j.yebeh.2004.07.007; Smits JAJ, 2010, J PSYCHIATR RES, V44, P1010, DOI 10.1016/j.jpsychires.2010.04.007; Spina E, 2000, PSYCHOPHARMACOLOGY, V148, P83, DOI 10.1007/s002130050028; Stoffers J, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005653.pub2, 10.1002/1465185.CD005653.pub2]; Sun SX, 2007, CURR MED RES OPIN, V23, P2305, DOI 10.1185/030079907X226050; Suppes T, 2007, PSYCHOPHARMACOL BULL, V40, P22; Sussman N, 2003, J CLIN PSYCHOPHARM, V23, pS21, DOI 10.1097/00004714-200306001-00005; Taylor DM, 2000, ACTA PSYCHIAT SCAND, V101, P416, DOI 10.1034/j.1600-0447.2000.101006416.x; Tham M.S.P., 2007, J MENT HEALTH, V16, P771, DOI [DOI 10.1080/09638230701496352, 10.1080/09638230701496352]; Thieda P, 2003, PSYCHIAT SERV, V54, P508, DOI 10.1176/appi.ps.54.4.508; Tran PV, 1999, BRIT J PSYCHIAT, V174, P15, DOI 10.1192/bjp.174.1.15; Velligan DI, 2009, J CLIN PSYCHIAT, V70, P6; Weiden PJ, 2007, J CLIN PSYCHIAT, V68, P34; Weiden PJ, 2004, SCHIZOPHR RES, V66, P51, DOI 10.1016/S0920-9964(02)00498-X; Westenberg HGM, 2004, J CLIN PSYCHOPHARM, V24, P49, DOI 10.1097/01.jcp.0000104906.75206.8b; WISTEDT B, 1984, CURR THER RES CLIN E, V35, P804; Yuanguang CC, 1998, CHINESE J PSYCHIAT, V31, P43; Zipursky RB, 2005, BRIT J PSYCHIAT, V187, P537, DOI 10.1192/bjp.187.6.537	131	1070	1079	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e36889	10.1371/journal.pone.0036889	http://dx.doi.org/10.1371/journal.pone.0036889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719834	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350000002
J	Lee, CT; Zhong, LW; Mace, TA; Repasky, EA				Lee, Chen-Ting; Zhong, Lingwen; Mace, Thomas A.; Repasky, Elizabeth A.			Elevation in Body Temperature to Fever Range Enhances and Prolongs Subsequent Responsiveness of Macrophages to Endotoxin Challenge	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEAT-SHOCK PROTEINS; NF-KAPPA-B; LIPOPOLYSACCHARIDE TOLERANCE; THERMOREGULATORY RESPONSES; SYSTEMIC INFLAMMATION; HOST-DEFENSE; CYTOKINE; HYPERTHERMIA; ACTIVATION	Macrophages are often considered the sentries in innate immunity, sounding early immunological alarms, a function which speeds the response to infection. Compared to the large volume of studies on regulation of macrophage function by pathogens or cytokines, relatively little attention has been devoted to the role of physical parameters such as temperature. Given that temperature is elevated during fever, a long-recognized cardinal feature of inflammation, it is possible that macrophage function is responsive to thermal signals. To explore this idea, we used LPS to model an aseptic endotoxin induced inflammatory response in BALB/c mice and found that raising mouse body temperature by mild external heat treatment significantly enhances subsequent LPS-induced release of TNF-alpha into the peritoneal fluid. It also reprograms macrophages, resulting in sustained subsequent responsiveness to LPS, i.e., this treatment reduces "endotoxin tolerance" in vitro and in vivo. At the molecular level, elevating body temperature of mice results in a increase in LPS-induced downstream signaling including enhanced phosphorylation of IKK and I kappa B, NF kappa B nuclear translocation and binding to the TNF-alpha promoter in macrophages upon secondary stimulation. Mild heat treatment also induces expression of HSP70 and use of HSP70 inhibitors (KNK437 or Pifithrin-mu) largely abrogates the ability of the thermal treatment to enhance TNF-alpha, suggesting that the induction of HSP70 is important for mediation of thermal effects on macrophage function. Collectively, these results support the idea that there has been integration between the evolution of body temperature regulation and macrophage function that could help to explain the known survival benefits of fever in organisms following infection.	[Lee, Chen-Ting; Zhong, Lingwen; Mace, Thomas A.; Repasky, Elizabeth A.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Lee, CT (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	elizabeth.repasky@roswellpark.org	Lee, Chia-Lin/P-2038-2015; Wu, Yang-Chang/C-5682-2009; Yang, Juan-Cheng/D-1442-2011	Lee, Chia-Lin/0000-0002-5949-1989; Wu, Yang-Chang/0000-0001-7815-2686; Chang, Fang-Rong/0000-0003-2549-4193; Chen, Guan-Yu/0000-0002-2773-8748	NIH [P01 CA094045, R01 CA135368, R01 CA071599]; NATIONAL CANCER INSTITUTE [R01CA071599, P01CA094045, R01CA135368] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants NIH P01 CA094045, R01 CA135368 and R01 CA071599. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINS C, 1991, PHYSIOL BEHAV, V50, P461, DOI 10.1016/0031-9384(91)90095-6; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asea Alexzander, 2006, Current Immunology Reviews, V2, P209, DOI 10.2174/157339506778018514; ASTIZ ME, 1995, CRIT CARE MED, V23, P9, DOI 10.1097/00003246-199501000-00006; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BLATTEIS CM, 1980, EXPERIENTIA, V36, P1086, DOI 10.1007/BF01965985; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen TY, 2009, J IMMUNOL, V182, P1449, DOI 10.4049/jimmunol.182.3.1449; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; Dai WJ, 1997, J IMMUNOL, V158, P5297; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; Depraetere V, 2000, NAT CELL BIOL, V2, pE104, DOI 10.1038/35014098; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; ENSOR JE, 1994, AM J PHYSIOL, V266, pC967, DOI 10.1152/ajpcell.1994.266.4.C967; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; FREUDENBERG MA, 1988, INFECT IMMUN, V56, P1352, DOI 10.1128/IAI.56.5.1352-1357.1988; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; GORDON CJ, 1985, PHYSIOL BEHAV, V34, P687, DOI 10.1016/0031-9384(85)90365-8; Gordon CJ, 1993, FEVER TEMPERATURE RE, P45; Guptill V, 2011, ANESTHESIOLOGY, V114, P1190, DOI 10.1097/ALN.0b013e318212515b; HABICHT GS, 1981, MECH AGEING DEV, V16, P97, DOI 10.1016/0047-6374(81)90037-3; Hagiwara S, 2007, INFLAMM RES, V56, P297, DOI 10.1007/s00011-007-6161-z; Hasday JD, 2000, MICROBES INFECT, V2, P1891, DOI 10.1016/S1286-4579(00)01337-X; Hasday JD, 1996, INFLUENCE TEMPERATUR; Horan P K, 1990, Methods Cell Biol, V33, P469; Ivanov AI, 2000, AUTON NEUROSCI-BASIC, V85, P111, DOI 10.1016/S1566-0702(00)00229-0; Jiang QQ, 1999, INFECT IMMUN, V67, P1539; Jiang QQ, 2000, INFECT IMMUN, V68, P1265, DOI 10.1128/IAI.68.3.1265-1270.2000; Jiang QQ, 1999, AM J PHYSIOL-REG I, V276, pR1653; Kluger M J, 1979, Int Rev Physiol, V20, P209; Kluger MJ, 1998, ANN NY ACAD SCI, V856, P224, DOI 10.1111/j.1749-6632.1998.tb08329.x; Kluger MJ., 1979, FEVER ITS BIOL EVOLU; Kluger MJ, 1991, ADAPTIVE VALUE FEVER, P105; Kox M, 2011, CRIT CARE MED, V39, P1866, DOI 10.1097/CCM.0b013e3182190d5d; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lehner MD, 2001, INFECT IMMUN, V69, P463, DOI 10.1128/IAI.69.1.463-471.2001; Lenz AM, 2011, CYTOKINE, V53, P84, DOI 10.1016/j.cyto.2010.08.012; Leon LR, 2002, J APPL PHYSIOL, V92, P2648, DOI 10.1152/japplphysiol.01005.2001; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; MACKOWIAK PA, 1981, REV INFECT DIS, V3, P508; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; MELNICOFF MJ, 1989, CELL IMMUNOL, V118, P178, DOI 10.1016/0008-8749(89)90367-5; MELNICOFF MJ, 1988, J LEUKOCYTE BIOL, V43, P387, DOI 10.1002/jlb.43.5.387; MELNICOFF MJ, 1988, J LEUKOCYTE BIOL, V44, P367, DOI 10.1002/jlb.44.5.367; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; Paul WE, 1989, INFLAMMATION FUNDAME, P721; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Robert R, 2009, CRIT CARE MED, V37, P2860, DOI 10.1097/CCM.0b013e3181b3a0e1; Romanovsky AA, 1998, MED HYPOTHESES, V50, P219, DOI 10.1016/S0306-9877(98)90022-6; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Romanovsky AA, 2006, CELL CYCLE, V5, P2195, DOI 10.4161/cc.5.19.3321; Rudaya AY, 2005, AM J PHYSIOL-REG I, V289, pR1244, DOI 10.1152/ajpregu.00370.2005; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Steiner AA, 2008, J APPL PHYSIOL, V105, P1028, DOI 10.1152/japplphysiol.90619.2008; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Steiner AA, 2006, BLOOD, V107, P4000, DOI 10.1182/blood-2005-11-4743; TITE JP, 1991, J IMMUNOL, V147, P3161; Torigoe T, 2009, INT J HYPERTHER, V25, P610, DOI 10.3109/02656730903315831; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Wheeler DS, 2008, SHOCK, V30, P267, DOI 10.1097/shk.0b013e318162c190; Xaus J, 2001, IMMUNOBIOLOGY, V204, P543, DOI 10.1078/0171-2985-00091; Yokota S, 2000, CANCER RES, V60, P2942	76	115	116	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					393	405	e30077	10.1371/journal.pone.0030077	http://dx.doi.org/10.1371/journal.pone.0030077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253887	Green Published, gold, Green Submitted			2022-12-27	WOS:000301353900040
J	Zhou, BY; Buckley, ST; Patel, V; Liu, YX; Luo, J; Krishnaveni, MS; Ivan, M; DeMaio, L; Kim, KJ; Ehrhardt, C; Crandall, ED; Borok, Z				Zhou, Beiyun; Buckley, Stephen T.; Patel, Vipul; Liu, Yixin; Luo, Jiao; Krishnaveni, Manda Sai; Ivan, Mihaela; DeMaio, Lucas; Kim, Kwang-Jin; Ehrhardt, Carsten; Crandall, Edward D.; Borok, Zea			Troglitazone Attenuates TGF-beta 1-Induced EMT in Alveolar Epithelial Cells via a PPAR gamma-Independent Mechanism	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; IDIOPATHIC PULMONARY-FIBROSIS; GLYCOGEN-SYNTHASE KINASE-3; ACUTE LUNG INJURY; MESENCHYMAL TRANSITION; BETA-CATENIN; CARCINOMA-CELLS; IN-VIVO; EXPRESSION; AGONISTS	Peroxisome proliferator activated receptor gamma (PPAR gamma) agonists are effective antifibrotic agents in a number of tissues. Effects of these agents on epithelial-mesenchymal transition (EMT) of primary alveolar epithelial cells (AEC) and potential mechanisms underlying effects on EMT have not been well delineated. We examined effects of troglitazone, a synthetic PPAR gamma agonist, on transforming growth factor (TGF)-beta 1-induced EMT in primary rat AEC and an alveolar epithelial type II (AT2) cell line (RLE-6TN). TGF-beta 1 (2.5 ng/mL) induced EMT in both cell types, as evidenced by acquisition of spindle-like morphology, increased expression of the mesenchymal marker a-smooth muscle actin (alpha-SMA) and downregulation of the tight junctional protein zonula occludens-1 (ZO-1). Concurrent treatment with troglitazone (or rosiglitazone), ameliorated effects of TGF-beta 1. Furthermore, following stimulation with TGF-beta 1 for 6 days, troglitazone reversed EMT-related morphological changes and restored both epithelial and mesenchymal markers to control levels. Treatment with GW9662 (an irreversible PPAR gamma antagonist), or overexpression of a PPAR gamma dominant negative construct, failed to inhibit these effects of troglitazone in AEC. Troglitazone not only attenuated TGF-beta 1-induced phosphorylation of Akt and glycogen synthase kinase (GSK)-3 beta, but also inhibited nuclear translocation of beta-catenin, phosphorylation of Smad2 and Smad3 and upregulation of the EMT-associated transcription factor SNAI1. These results demonstrate inhibitory actions of troglitazone on TGF-beta 1-induced EMT in AEC via a PPAR gamma-independent mechanism likely through inhibition of beta-catenin-dependent signaling downstream of TGF-beta 1, supporting a role for interactions between TGF-beta and Wnt/beta-catenin signaling pathways in EMT.	[Zhou, Beiyun; Patel, Vipul; Liu, Yixin; Luo, Jiao; Krishnaveni, Manda Sai; Ivan, Mihaela; DeMaio, Lucas; Kim, Kwang-Jin; Crandall, Edward D.; Borok, Zea] Univ So Calif, Dept Med, Will Rogers Inst Pulm Res Ctr, Div Pulm Crit Care & Sleep Med, Los Angeles, CA 90089 USA; [Buckley, Stephen T.; Ehrhardt, Carsten] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin, Ireland; [Borok, Zea] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA	University of Southern California; Trinity College Dublin; University of Southern California	Zhou, BY (corresponding author), Univ So Calif, Dept Med, Will Rogers Inst Pulm Res Ctr, Div Pulm Crit Care & Sleep Med, Los Angeles, CA 90089 USA.	boro@usc.edu	Borok, Zea/J-9015-2013; Ehrhardt, Carsten/B-1259-2010; CRANDALL, EDWARD/AAD-8382-2020	Ehrhardt, Carsten/0000-0003-0730-1829; Tanaka, Yasuhito/0000-0002-2473-6966; sun, jian/0000-0001-5320-227X; Borok, Zea/0000-0001-8673-8177	United States National Institutes of Health [HL038578, HL062569, HL089445, ES017034, ES018782, HL038621]; Whittier Foundation; Hastings Foundation; American Thoracic Society/Coalition for Pulmonary Fibrosis/Pulmonary Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038578, R37HL062569, R01HL038621, R37HL038578, R01HL089445, R01HL062569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017034, RC2ES018782] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whittier Foundation; Hastings Foundation; American Thoracic Society/Coalition for Pulmonary Fibrosis/Pulmonary Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by research grants HL038578 (ZB), HL062569 (ZB), HL089445 (ZB), ES017034 (EDC), ES018782 (EDC) and HL038621 (EDC) from the United States National Institutes of Health, as well as the Whittier Foundation and the Hastings Foundation. B. Zhou is supported by an American Thoracic Society/Coalition for Pulmonary Fibrosis/Pulmonary Fibrosis Foundation Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2009, RESPIRATION, V77, P311, DOI 10.1159/000168676; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Belvisi MG, 2006, EUR J PHARMACOL, V533, P101, DOI 10.1016/j.ejphar.2005.12.048; BOROK Z, 1994, IN VITRO CELL DEV-AN, V30A, P99; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Cao LQ, 2007, ACTA PHARMACOL SIN, V28, P879, DOI 10.1111/j.1745-7254.2007.00571.x; Cheng HC, 2008, MOL VIS, V14, P95; Chojkier M, 2005, HEPATOLOGY, V41, P237, DOI 10.1002/hep.20567; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; DRISCOLL KE, 1995, IN VITRO CELL DEV-AN, V31, P516; Ferguson HE, 2009, AM J RESP CELL MOL, V41, P722, DOI 10.1165/rcmb.2009-0006OC; Frankel SK, 2009, CURR OPIN PULM MED, V15, P463, DOI 10.1097/MCP.0b013e32832ea4b3; Genovese T, 2005, EUR RESPIR J, V25, P225, DOI 10.1183/09031936.05.00049704; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Guarino M, 2009, HUM PATHOL, V40, P1365, DOI 10.1016/j.humpath.2009.02.020; Honda K, 2004, J ALLERGY CLIN IMMUN, V113, P882, DOI 10.1016/j.jaci.2004.02.036; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; KAO WWY, 1977, NATURE, V266, P63, DOI 10.1038/266063a0; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim Robert, 2008, Ther Adv Respir Dis, V2, P319, DOI 10.1177/1753465808096948; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Lakatos HF, 2007, PPAR RES, V2007, DOI 10.1155/2007/71323; Lee YJ, 2010, AM J PHYSIOL-RENAL, V298, pF1263, DOI 10.1152/ajprenal.00475.2009; Liu D, 2006, PHYSIOL RES, V55, P291, DOI 10.33549/physiolres.930822; Lu DS, 2010, EUR J PHARMACOL, V636, P198, DOI 10.1016/j.ejphar.2010.03.010; Milam JE, 2008, AM J PHYSIOL-LUNG C, V294, pL891, DOI 10.1152/ajplung.00333.2007; Mughal RS, 2009, CLIN EXP PHARMACOL P, V36, P478, DOI 10.1111/j.1440-1681.2008.05088.x; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Reka AK, 2010, MOL CANCER THER, V9, P3221, DOI 10.1158/1535-7163.MCT-10-0570; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Simon DM, 2006, FASEB J, V20, P1507, DOI 10.1096/fj.05-5410fje; Tan XH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-21; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	44	120	123	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38827	10.1371/journal.pone.0038827	http://dx.doi.org/10.1371/journal.pone.0038827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745681	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200024
J	Yin, X; Yin, Y; Cao, FL; Chen, YF; Peng, Y; Hou, WG; Sun, SK; Luo, ZJ				Yin, Xin; Yin, Yue; Cao, Fa-Le; Chen, Yu-Fei; Peng, Ye; Hou, Wu-Gang; Sun, Shu-Kai; Luo, Zhuo-Jing			Tanshinone IIA Attenuates the Inflammatory Response and Apoptosis after Traumatic Injury of the Spinal Cord in Adult Rats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; GLIAL APOPTOSIS; FACTOR-ALPHA; CELL-DEATH; EXPRESSION; CYTOKINES; INHIBITION; ASTROCYTES	Background: Spinal cord injury (SCI), including immediate mechanical injury and secondary injury, is associated with the inflammatory response, apoptosis and oxidative stress in response to traumatic injury. Tanshinone IIA (TIIA) is one of the major extracts obtained from Salvia miltiorrhiza BUNGE, which has anti-inflammatory and anti-apoptotic effects on many diseases. However, little is known about the effects of TIIA treatment on SCI. Therefore, the aim of the present study is to evaluate the pharmacological action of TIIA on secondary damage and the underlying mechanisms of experimental SCI in rats. Methodology/Principal Findings: SCI was generated using a weight drop device on the dorsal spinal cord via a two-level T9-T11 laminectomy. SCI in rats resulted in severe trauma, characterized by locomotor disturbance, edema, neutrophil infiltration, the production of astrocytes and inflammatory mediators, apoptosis and oxidative stress. TIIA treatment (20 mg/kg, i.p.) after SCI induced significant effects: (1) improved motor function (Basso, Beattie and Bresnahan scores), (2) reduced the degree of tissue injury (histological score), neutrophil infiltration (myeloperoxidase activity) and the expression of astrocytes, (3) inhibited the activation of SCI-related pathways, such as NF-kappa B and MAPK signaling pathways, (4) decreased the production of pro-inflammatory cytokines (TNF-alpha, IL-1 beta, and IL-6) and iNOS, (5) reduced apoptosis (TUNEL staining, and Bcl-2 and caspase-3 expression) and (6) reversed the redox state imbalance. Conclusions/Significance: The results clearly show that TIIA has a prominent protective effect against SCI through inhibiting the inflammatory response and apoptosis in the spinal cord tissue after SCI.	[Yin, Xin; Chen, Yu-Fei; Peng, Ye; Luo, Zhuo-Jing] Fourth Mil Med Univ, Xijing Hosp, Inst Orhopaed Surg, Xian 710032, Shaanxi, Peoples R China; [Yin, Yue] Fourth Mil Med Univ, Xijing Hosp, Dept Plast Surg, Xian 710032, Shaanxi, Peoples R China; [Cao, Fa-Le] 222th Hosp CPLA, Dept Neurol & Respirat, Jilin, Peoples R China; [Hou, Wu-Gang] Xijing Hosp, Dept Anesthesia, Xian, Shaanxi, Peoples R China; [Sun, Shu-Kai] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yin, X (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orhopaed Surg, Xian 710032, Shaanxi, Peoples R China.	zjluo@fmmu.edu.cn	peng, ye/GXZ-9245-2022	, Chen/0000-0003-3224-5662	Istitute of Orthopaedics, Fourth Military Medical University	Istitute of Orthopaedics, Fourth Military Medical University	This study was supported by a grant from the Istitute of Orthopaedics, Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen F, 1999, CLIN CHEM, V45, P7; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Esposito E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012170; Fang ZY, 2008, J ETHNOPHARMACOL, V115, P217, DOI 10.1016/j.jep.2007.09.025; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Gao M, 2008, TRANSL RES, V151, P79, DOI [10.1016/j.trs1.2007.11.005, 10.1016/j.trsl.2007.11.005]; Genovese T, 2007, SHOCK, V27, P258, DOI 10.1097/01.shk.0000239775.41022.54; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Lam BYH, 2003, PHYTOMEDICINE, V10, P286, DOI 10.1078/094471103322004776; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; Li JH, 2011, RESP PHYSIOL NEUROBI, V176, P39, DOI 10.1016/j.resp.2011.01.005; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu XZ, 1997, J NEUROSCI, V17, P5395; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Taoka Y, 2000, J NEUROTRAUM, V17, P219, DOI 10.1089/neu.2000.17.219; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Uto T, 2005, BIOCHEM PHARMACOL, V70, P1211, DOI 10.1016/j.bcp.2005.07.011; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Yang RF, 2008, J CARDIOVASC PHARM, V51, P396, DOI 10.1097/FJC.0b013e3181671439; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zhao BL, 1996, BIOCHEM MOL BIOL INT, V38, P1171; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	40	146	172	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38381	10.1371/journal.pone.0038381	http://dx.doi.org/10.1371/journal.pone.0038381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	23251642	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900026
